"","gene_id","LCM_1","LCM_11","LCM_12","LCM_17","LCM_18","LCM_24","LCM_25","LCM_3","LCM_32","LCM_33","mean_percent_meth_ALL","Oral_mean_perc_meth","Aboral_mean_perc_meth","n_DML","mean_methdiff","median_methdiff","mean_methdiff_qvalue","min_methdiff_qvalue","max_methdiff_qvalue","LCM_15","LCM_16","LCM_20","LCM_21","LCM_26","LCM_27","LCM_4","LCM_5","LCM_8","LCM_9","vst_mean_gene_expression","Oral_mean_vst_expr","Aboral_mean_vst_expr","DEseq_baseMean","DEseq_log2FoldChange","DEseq_lfcSE","DEseq_pvalue","DEseq_padj","blast_hit","evalue","ProteinNames","BiologicalProcess","GeneOntologyIDs"
"1","Pocillopora_acuta_HIv2___RNAseq.g27406.t1",0,66.6666666666667,NA,79.1666666666667,0,7.54716981132075,0,NA,NA,0,21.9115004492363,51.1268343815514,0,NA,NA,NA,NA,NA,NA,5.69008050215398,9.94728948184982,8.55840824321401,10.3993573806794,4.99332554465423,7.6179290796022,6.54983813759369,7.90902087320942,3.68233641306884,3.68233641306884,6.90299220690944,6.1666343152601,7.63935009855879,313.576723304792,0.734668343145297,1.17082051569926,0.0744372312728574,0.210614263131966,NA,NA,NA,NA,NA
"2","Pocillopora_acuta_HIv2___RNAseq.g27429.t1",4.16666666666667,0,0,0,0,1.98675496688742,6.06060606060606,0,7.89473684210526,0,2.01087645362654,1.97629836179854,2.04545454545455,NA,NA,NA,NA,NA,NA,6.47868055454933,7.18946904881997,6.50448097751675,7.47098189621969,6.58551772595729,7.47620947122109,7.41617057752188,7.21602452626304,3.68233641306884,7.87825228538505,6.78981234765229,6.09340803947105,7.48621665583354,111.226192607965,0.597313327049901,0.964847012783197,0.208214518787808,0.43460553514228,"F1NWE3",0,"Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha)","negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; peptidyl-tyrosine dephosphorylation [GO:0035335]; synaptic membrane adhesion [GO:0099560]","GO:0004725; GO:0005886; GO:0008201; GO:0030424; GO:0030426; GO:0030517; GO:0030672; GO:0035335; GO:0042803; GO:0043204; GO:0043395; GO:0048671; GO:0048681; GO:0061000; GO:0098839; GO:0099560"
"3","Pocillopora_acuta_HIv2___TS.g10192.t2",0,4.8780487804878,0,0,1.42857142857143,1.65745856353591,0,3.125,0,0,1.10890787725951,1.93210146880474,0.285714285714286,NA,NA,NA,NA,NA,NA,10.84032603231,11.8120676012639,10.4348891978606,11.993303278465,10.8208078411662,11.6539452018739,12.4472626203766,10.9774196807166,6.10133000554887,12.6458413304507,10.9727192790032,9.83495455152045,12.110484006486,2974.62546417778,1.07985182850903,1.02233200638427,0.0578469463900724,0.174239531983758,"P23468",0,"Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]","GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0006796; GO:0007157; GO:0007185; GO:0030182; GO:0042734; GO:0046426; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0070062; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099054; GO:0099151; GO:0099545; GO:0099560"
"4","Pocillopora_acuta_HIv2___RNAseq.g27433.t1",NA,NA,NA,0,0,0,75,0,NA,0,12.5,0,25,NA,NA,NA,NA,NA,NA,6.25760738373578,9.68511491093645,7.3083152768306,10.6085909167715,6.98985932682562,10.038426773231,7.21775444370806,8.44649846873451,6.60889967998377,11.6364085295702,8.47974757103275,7.12223602722206,9.83725911484344,732.86833028706,2.38655533467572,1.40931482251937,0.00116467422675389,0.0066689817956327,NA,NA,NA,NA,NA
"5","Pocillopora_acuta_HIv2___TS.g10198.t2",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.00237851673687,6.81522472615292,8.52672070879525,3.68233641306884,9.87010301968713,7.2119491386412,3.68233641306884,8.42620134867823,9.64200093020476,3.68233641306884,6.95415876281029,8.89348090482045,5.01483662080013,278.968072165855,-1.30414638725108,2.3870971289624,2.75747325458169e-06,3.76976305805951e-05,"Q9UMZ3",1.08e-40,"Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48)","regulation of fat cell differentiation [GO:0045598]","GO:0004725; GO:0009925; GO:0016324; GO:0043235; GO:0045598; GO:0120044"
"6","Pocillopora_acuta_HIv2___RNAseq.g27452.t1",0,0,0,0,0,2.1505376344086,0,0,0,0,0.21505376344086,0.43010752688172,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.60911950749454,7.76506976026997,8.01456480640263,3.68233641306884,3.68233641306884,3.68233641306884,3.68233641306884,5.5336018834485,8.59512945492368,5.59291674778835,4.869136176585,6.31669731899171,98.2250723692597,0.308678953592933,1.04275366417571,0.259102558679331,0.501018546834095,"O00339",2.57e-61,"Matrilin-2","axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; response to axon injury [GO:0048678]","GO:0001764; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0048678; GO:0062023; GO:0120216"
"7","Pocillopora_acuta_HIv2___TS.g10216.t2",0,0,0,0,NA,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.5855866595958,9.24285011781547,10.8191296239812,11.6385970295481,10.1384258419856,10.4824033227849,11.6980366147236,10.4289683763683,10.8996849312922,9.59746345937709,10.5531145977472,10.5743590866446,10.5318701088498,1682.59432723946,-0.0152970623016712,0.633887367782958,0.960031256502547,0.985234290765776,"O95714",0,"E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)","DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]","GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630"
"8","Pocillopora_acuta_HIv2___RNAseq.g27474.t1",0,0,NA,0,NA,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,7.73482020810787,9.25296372067976,7.3286115711524,7.84571335344804,5.21442834742072,3.68233641306884,11.6538120032833,3.68233641306884,8.45509888891413,9.25731083832564,7.41074317574695,6.48305908573279,8.33842726576112,523.872812381721,0.203791089180989,0.962277501552079,0.5642664013835,0.775960185359474,"Q5M9N0",5.33e-47,"Coiled-coil domain-containing protein 158","",""
"9","Pocillopora_acuta_HIv2___TS.g10243.t2",100,66.6666666666667,NA,NA,100,100,100,NA,66.6666666666667,NA,88.8888888888889,77.7777777777778,100,NA,NA,NA,NA,NA,NA,11.5731410214812,12.5111856427017,9.98139846819643,12.2152077767326,11.5556925522913,11.6652106719361,8.11333685089601,11.7363341818524,12.6094015878374,10.1521081698873,11.2113016923812,11.4911935623317,10.9314098224307,3172.84959846225,-0.190799164759393,0.806370268806187,0.628272985109588,0.8195825458512,"Q9UHB7",1.67e-53,"AF4/FMR2 family member 4 (ALL1-fused gene from chromosome 5q31 protein) (Protein AF-5q31) (Major CDK9 elongation factor-associated protein)","regulation of gene expression [GO:0010468]; response to endoplasmic reticulum stress [GO:0034976]; spermatid development [GO:0007286]","GO:0000791; GO:0001650; GO:0005654; GO:0007286; GO:0008023; GO:0010468; GO:0032783; GO:0034976"
"10","Pocillopora_acuta_HIv2___RNAseq.g27502.t1",0,0,NA,0,8.10810810810811,0,0,0,NA,NA,1.15830115830116,0,2.7027027027027,NA,NA,NA,NA,NA,NA,12.1291034781586,13.125411529901,12.476152222108,13.2008791848026,12.2430080818367,13.2854915571938,13.4234790186714,11.8750520798963,12.4230094671119,12.8967675708256,12.7078354190506,12.2292650658223,13.1864057722789,7096.53669506982,0.774801104085451,0.537237872116271,0.090270125418881,0.242283743562571,"O15294",0,"UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT)","apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; hemopoiesis [GO:0030097]; mitophagy [GO:0000423]; negative regulation of cell migration [GO:0030336]; negative regulation of non-canonical inflammasome complex assembly [GO:0160076]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of proteolysis [GO:0045862]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; positive regulation of translation [GO:0045727]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of necroptotic process [GO:0060544]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rac protein signal transduction [GO:0035020]; regulation of synapse assembly [GO:0051963]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]","GO:0000122; GO:0000123; GO:0000423; GO:0000432; GO:0005547; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006110; GO:0006111; GO:0006325; GO:0006357; GO:0006493; GO:0006915; GO:0007165; GO:0007584; GO:0008375; GO:0016485; GO:0017122; GO:0030097; GO:0030336; GO:0030512; GO:0031397; GO:0031490; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0035020; GO:0042995; GO:0044545; GO:0045727; GO:0045862; GO:0045893; GO:0045944; GO:0046626; GO:0046889; GO:0051963; GO:0060544; GO:0070822; GO:0071333; GO:0097363; GO:0098696; GO:0098978; GO:0120162; GO:0160076; GO:1902455; GO:1902459; GO:1904263"
"11","Pocillopora_acuta_HIv2___TS.g10279.t1b",26.9230769230769,NA,NA,0,22.2222222222222,17.3913043478261,85.7142857142857,0,37.5,NA,27.107269886773,13.7228260869565,44.953194953195,NA,NA,NA,NA,NA,NA,7.48631699375706,7.47670412910099,8.1263054097228,8.20522855326283,7.68593987239162,7.57223291016523,7.64658910810218,7.70891506725395,6.88347796904334,8.1280249602126,7.69197349730126,7.57819106243375,7.80575593216877,188.714632143647,0.179341064524989,0.561910063725476,0.70162460272758,0.864029036971656,NA,NA,NA,NA,NA
"12","Pocillopora_acuta_HIv2___RNAseq.g27523.t1",NA,0,0,12.962962962963,0,0,5.71428571428571,0,8.57142857142857,18.4210526315789,5.07441443113958,4.30687830687831,6.03383458646617,NA,NA,NA,NA,NA,NA,7.90979005498889,8.71569691288499,10.8238728379697,8.08906047224294,9.33480806628529,3.68233641306884,3.68233641306884,9.40041883113749,3.68233641306884,8.52599624145614,7.3846652656172,8.23024524069004,6.53908529054435,425.897632238146,-0.164307242125209,1.01015535057908,0.164221915677426,0.369829467731919,"Q2LD37",0,"Bridge-like lipid transfer protein family member 1 (Fragile site-associated protein)","endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intermembrane lipid transfer [GO:0120009]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488]","GO:0001558; GO:0005634; GO:0005789; GO:0005886; GO:0006909; GO:0016020; GO:0016197; GO:0030856; GO:0031966; GO:0032456; GO:0048488; GO:0098793; GO:0120009; GO:0140268; GO:1904121"
"13","Pocillopora_acuta_HIv2___TS.g10303.t2",0,0,0,0,0.432900432900433,1.39372822299652,1.46862483311081,0,0,0,0.329525348900776,0.278745644599303,0.380305053202249,NA,NA,NA,NA,NA,NA,8.34627273025484,9.04750534458592,8.79922339432452,5.11193581531555,7.47561178648212,9.78992002403837,3.68233641306884,7.74221169803492,7.54029722811113,9.21004307760133,7.67453575118175,7.98072336744151,7.368348134922,316.828784164416,-0.0833201362438537,0.931470984674866,0.699775851456112,0.862690501413325,NA,NA,NA,NA,NA
"14","Pocillopora_acuta_HIv2___RNAseq.g27560.t1",0,0,0,NA,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.47868055454933,8.6289994693056,7.06354452251705,3.68233641306884,6.20863827020002,8.94575657143888,8.70653617046614,8.97767940000979,6.6827526322222,3.68233641306884,6.90572604168467,7.08225907589968,6.72919300746966,201.352542096693,-0.0905326367410442,0.961572443133593,0.57032250226559,0.781014402677303,"Q9TU53",5.89e-14,"Cubilin","cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031]","GO:0005509; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419; GO:0031526; GO:0043235"
"15","Pocillopora_acuta_HIv2___TS.g10321.t1",0,0,0,NA,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.07920420214897,4.70263489215087,5.56232777220043,5.13665622490825,7.47620947122109,7.14120933074607,7.82610252698821,3.68233641306884,3.68233641306884,5.59713536595704,5.006013294037,6.18825743787708,62.8655883735864,0.476518572171036,1.06978745631407,0.146332841476757,0.342762464634789,"O57460",6.59e-26,"Dorsal-ventral patterning tolloid-like protein 1 (EC 3.4.24.-) (Mini fin protein)","blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; protein processing [GO:0016485]; proteolysis [GO:0006508]","GO:0001568; GO:0001707; GO:0001885; GO:0004222; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0016485; GO:0030513; GO:0035124; GO:0035162; GO:0036342; GO:0048264"
"16","Pocillopora_acuta_HIv2___RNAseq.g27577.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.38069197253326,10.6645994415422,8.90604113392728,8.23832351102165,9.75445034317874,10.05269783434,11.9765729727104,9.42999619410681,10.8382276007134,6.61366512258304,9.58552661266568,9.6618814488919,9.50917177643946,1139.26875282797,0.0468539228592579,0.79562994011336,0.944741767143945,0.979358127252709,"O43182",6.79e-70,"Rho GTPase-activating protein 6 (Rho-type GTPase-activating protein 6) (Rho-type GTPase-activating protein RhoGAPX-1)","actin filament polymerization [GO:0030041]; focal adhesion assembly [GO:0048041]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of phospholipase activity [GO:0010518]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]","GO:0005096; GO:0005737; GO:0005829; GO:0005884; GO:0007266; GO:0010518; GO:0015629; GO:0016004; GO:0017124; GO:0030041; GO:0043274; GO:0048041; GO:0051056; GO:0051497; GO:0051895"
"17","Pocillopora_acuta_HIv2___TS.g10394.t2",0,NA,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.16247966683365,3.68233641306884,5.89089308266057,3.68233641306884,6.64499589542844,10.7414448151808,3.68233641306884,9.7545952768211,3.68233641306884,9.93194902016621,6.58557034093661,6.82706006696252,6.34408061491071,384.995429679067,-0.0912634556903294,1.02137645946364,0.00147044978214129,0.00814264381657414,"Q3UGF1",0,"WD repeat-containing protein 19 (Intraflagellar transport 144 homolog)","cell morphogenesis [GO:0000902]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; intraciliary retrograde transport [GO:0035721]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein localization to ciliary membrane [GO:1903441]; protein localization to cilium [GO:0061512]; protein-containing complex assembly [GO:0065003]; receptor clustering [GO:0043113]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]","GO:0000902; GO:0001701; GO:0001750; GO:0005737; GO:0005856; GO:0005886; GO:0005929; GO:0007224; GO:0008406; GO:0030326; GO:0030991; GO:0031076; GO:0031514; GO:0032391; GO:0035721; GO:0042471; GO:0043113; GO:0048701; GO:0050877; GO:0055123; GO:0060271; GO:0060831; GO:0061055; GO:0061512; GO:0065003; GO:0097730; GO:1903441"
"18","Pocillopora_acuta_HIv2___RNAseq.g27639.t1",0,0,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,5.49100155379421,6.8289815458267,5.06095373478716,6.17770847719114,4.89684440866119,6.13692185768316,5.90680277481292,5.70976195638337,3.68233641306884,6.94153598059022,5.68328487027989,4.96817961333895,6.39839012722083,39.6206237035626,1.05376864551011,1.22302757424631,0.0541539041541821,0.165144859727196,"P46023",8.18e-76,"G-protein coupled receptor GRL101","","GO:0004930; GO:0005886"
"19","Pocillopora_acuta_HIv2___RNAseq.g27669.t1",0,0,NA,0,5.61797752808989,0,1.08695652173913,NA,0,NA,0.957847721404146,0,2.23497801660967,NA,NA,NA,NA,NA,NA,8.13549223134047,3.68233641306884,9.85963282644285,3.68233641306884,10.1216180284097,9.05617629930348,3.68233641306884,9.37022191784003,9.18004434408147,10.2448976914989,7.70150925781234,9.3334018696229,6.06961664600178,513.411508495059,-0.469786238050329,1.12148984947613,1.15093981424401e-05,0.000128948051690359,"Q8IZD9",0,"Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein) (PBP)","neurotrophin TRK receptor signaling pathway [GO:0048011]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase-mediated signal transduction [GO:0007264]","GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0017124; GO:0031267; GO:0048011; GO:0051056"
"20","Pocillopora_acuta_HIv2___RNAseq.g27677.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,6.4545116118486,3.68233641306884,6.87896002582645,6.98333603148276,3.68233641306884,7.61470949026634,5.28924211491062,6.85831417532123,3.68233641306884,5.48084191019314,5.29911302957046,5.66257079081581,54.006368336697,0.083482862245056,1.01623309489049,0.235131108289337,0.470848172545614,NA,NA,NA,NA,NA
"21","Pocillopora_acuta_HIv2___RNAseq.g27691.t1",0,NA,0,NA,0,8.33333333333333,NA,0,0,0,1.19047619047619,2.77777777777778,0,NA,NA,NA,NA,NA,NA,6.4342051856516,7.09062453168391,8.61703144250268,7.34446020722041,7.42381535912268,10.4140421555981,9.95814453656524,9.78177718515053,3.68233641306884,6.42959658710632,7.71760336036703,7.18783311709927,8.2473736036348,405.200724838438,0.50659055250116,0.956937906528228,0.206697939713279,0.432618500075633,"Q6A548",1.03e-121,"Telomerase reverse transcriptase (EC 2.7.7.49) (Telomerase catalytic subunit)","telomere maintenance via telomerase [GO:0007004]","GO:0000333; GO:0000781; GO:0003720; GO:0003721; GO:0005697; GO:0005730; GO:0005737; GO:0007004; GO:0016605; GO:0042162; GO:0046872; GO:0070034"
"22","Pocillopora_acuta_HIv2___TS.g10461.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,6.70002980369271,6.0681601509144,7.42363838165424,9.71406728581871,3.68233641306884,7.622746242824,8.06502170597144,10.3667990032395,3.68233641306884,6.70074718133215,7.57927691180258,5.82221745086173,279.502668752156,-0.068031112917783,0.988383550014116,0.605045811502279,0.803793391691069,"Q6ZR37",9.97e-84,"Pleckstrin homology domain-containing family G member 7 (PH domain-containing family G member 7)","Rho protein signal transduction [GO:0007266]","GO:0005085; GO:0007266"
"23","Pocillopora_acuta_HIv2___RNAseq.g27714.t1",32.258064516129,0.892857142857143,50.188679245283,23.728813559322,20,13.8461538461538,7.92682926829268,0,4.42477876106195,NA,17.0295751487889,8.57852066187899,27.5933932574262,NA,NA,NA,NA,NA,NA,7.11283993360409,3.68233641306884,7.41968306595897,9.99776260389347,5.8732988169146,3.68233641306884,4.51171232812315,7.29694698575117,5.75167028831017,7.23934222464913,6.25679290733424,6.6908878181078,5.82269799656069,158.78481825328,-0.302165553053757,1.03943953272353,0.0153913531034567,0.0597158077490336,"Q96DM1",1.4e-54,"PiggyBac transposable element-derived protein 4","",""
"24","Pocillopora_acuta_HIv2___TS.g10551.t2",0,0,NA,5,NA,0,33.3333333333333,NA,NA,0,6.38888888888889,1.66666666666667,11.1111111111111,NA,NA,NA,NA,NA,NA,11.5103206471121,11.0444346588072,10.2639159326584,12.4548069342435,10.5659790510903,11.712037467972,10.8748870425371,11.4210168985769,11.8586160331704,11.1167900145339,11.2822804680702,11.1239697125216,11.4405912236187,2704.16412766037,0.177007896310684,0.647857135939217,0.713169085876749,0.870561031152106,"Q05876",6.47e-09,"Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn)","cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell shape [GO:0008360]","GO:0001764; GO:0004672; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007169; GO:0008360; GO:0015631; GO:0018108; GO:0030154; GO:0030900; GO:0038026; GO:0043204; GO:0045087; GO:0045121; GO:0046872"
"25","Pocillopora_acuta_HIv2___TS.g10554.t3",NA,NA,0,0,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,11.3705413055161,10.8788639925049,10.7176528340206,11.2785924246533,9.86132543657046,10.1631476018754,8.28987181369227,9.81724064482515,9.09475679691269,9.47619925904458,10.0948192109615,10.172303403569,10.0173350183541,1299.50013821896,-0.0975979777152487,0.579499371816889,0.827497441076153,0.930118254318428,"P15056",0,"Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1)","animal organ morphogenesis [GO:0009887]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; cellular response to calcium ion [GO:0071277]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to xenobiotic stimulus [GO:0071466]; endothelial cell apoptotic process [GO:0072577]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; establishment of protein localization to membrane [GO:0090150]; face development [GO:0060324]; head morphogenesis [GO:0060323]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of axon regeneration [GO:0048680]; positive regulation of axonogenesis [GO:0050772]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of T cell differentiation [GO:0045580]; response to cAMP [GO:0051591]; response to peptide hormone [GO:0043434]; somatic stem cell population maintenance [GO:0035019]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic vesicle exocytosis [GO:0016079]; T cell differentiation in thymus [GO:0033077]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; visual learning [GO:0008542]","GO:0000165; GO:0002318; GO:0004672; GO:0004674; GO:0004708; GO:0004709; GO:0005509; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006468; GO:0007173; GO:0008542; GO:0009887; GO:0010628; GO:0010764; GO:0010828; GO:0016079; GO:0030878; GO:0031434; GO:0033077; GO:0033138; GO:0034446; GO:0035019; GO:0042127; GO:0042802; GO:0043005; GO:0043066; GO:0043149; GO:0043231; GO:0043367; GO:0043369; GO:0043434; GO:0043524; GO:0044297; GO:0044877; GO:0045580; GO:0048538; GO:0048680; GO:0050772; GO:0050852; GO:0051496; GO:0051591; GO:0060291; GO:0060323; GO:0060324; GO:0070371; GO:0070374; GO:0071277; GO:0071466; GO:0072577; GO:0090150; GO:0097110; GO:0098793; GO:0106310; GO:1900026; GO:1990090; GO:2000301; GO:2000352"
"26","Pocillopora_acuta_HIv2___RNAseq.g27794.t1b",0,NA,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.18524234540962,6.54125763453179,3.68233641306884,9.35887971402338,6.66153407096926,5.44887968569328,9.07960943095631,7.88315412751572,5.59984979127766,8.46685343608961,6.99075966495355,6.20242334964822,7.77909598025887,200.197146921575,0.337136891125195,0.969501503163306,0.289130239242188,0.535601918596184,NA,NA,NA,NA,NA
"27","Pocillopora_acuta_HIv2___TS.g10560.t2",0,0,0,0,0,0.45045045045045,0,0,0.75187969924812,NA,0.133592238855397,0.240466029939714,0,NA,NA,NA,NA,NA,NA,7.06563673075528,8.58961299098714,4.4496922765333,9.66664662601031,8.73845249809789,3.68233641306884,10.474949189258,6.31424499730879,3.68233641306884,3.68233641306884,6.63462445481572,6.05007258315282,7.21917632647863,311.594111573446,0.267529289759261,1.03632008953348,0.126186303611857,0.309570276440494,"P08183",0,"ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)","carboxylic acid transmembrane transport [GO:1905039]; ceramide translocation [GO:0099040]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport across blood-brain barrier [GO:1990962]","GO:0000086; GO:0005524; GO:0005737; GO:0005886; GO:0006805; GO:0008559; GO:0009410; GO:0009986; GO:0015562; GO:0016020; GO:0016324; GO:0016887; GO:0022857; GO:0031625; GO:0042626; GO:0042910; GO:0045332; GO:0046865; GO:0046943; GO:0047484; GO:0055085; GO:0070062; GO:0070633; GO:0072089; GO:0090554; GO:0090555; GO:0098591; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:0150104; GO:1901529; GO:1905039; GO:1990961; GO:1990962; GO:2001225"
"28","Pocillopora_acuta_HIv2___RNAseq.445_t",4.76190476190476,0,0,0,8.69565217391304,0,0,0,0,NA,1.49528410397976,0,3.36438923395445,NA,NA,NA,NA,NA,NA,12.1788662466776,12.0728903996305,11.8261374183221,12.5034580258775,11.4592435061792,11.2909117287934,10.8989755556452,11.4759742631978,12.3297127998182,12.5942585112403,11.8630428455382,11.853986846839,11.8720988442374,3953.66839196447,0.0150480570930428,0.51052400596554,0.976935382088816,0.992220049005353,"Q6AYC8",3.64e-45,"SH2 domain-containing protein 4A","","GO:0005737; GO:0005829; GO:0019902"
"29","Pocillopora_acuta_HIv2___RNAseq.g27841.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.4427510910294,9.31461507968184,11.2616212272496,10.3623732645103,10.078342394476,10.8618116401816,6.99953765449245,10.3843514799406,10.104026333542,9.65152885173299,9.94609590168368,10.4542185052475,9.43797329811984,1185.7448641528,-0.59374535630623,0.752822593995801,0.228385786013378,0.462139340920188,"Q9TTK0",5.14e-165,"Cyclin-dependent kinase-like 2 (EC 2.7.11.22) (Serine/threonine-protein kinase KKIAMRE)","","GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0106310"
"30","Pocillopora_acuta_HIv2___TS.g10608.t2",0,0,NA,0,0,7.14285714285714,0,NA,0,NA,1.02040816326531,1.78571428571429,0,NA,NA,NA,NA,NA,NA,9.68470295498949,11.0400627650883,10.5652424428616,7.8880869822455,11.0125506782527,10.9865948970433,10.0485573863072,10.5154637402815,11.5017279056179,11.8594848958609,10.5102474648548,10.6559375444006,10.364557385309,1765.89548798743,-0.132535004560322,0.67661972325433,0.767414547997394,0.899140058504197,"Q8N264",5.9e-112,"Rho GTPase-activating protein 24 (Filamin-A-associated RhoGAP) (FilGAP) (RAC1- and CDC42-specific GTPase-activating protein of 72 kDa) (RC-GAP72) (Rho-type GTPase-activating protein 24) (RhoGAP of 73 kDa) (Sarcoma antigen NY-SAR-88) (p73RhoGAP)","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]","GO:0001525; GO:0005096; GO:0005737; GO:0005856; GO:0005912; GO:0005925; GO:0007165; GO:0030154; GO:0035021; GO:0035313; GO:0042995; GO:1900028"
"31","Pocillopora_acuta_HIv2___TS.g10627.t2",0,0,NA,0,0,5.55555555555556,0,NA,NA,NA,0.925925925925926,1.85185185185185,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,6.58642216671358,9.71635260230834,9.82927628122283,9.2950682274674,3.68233641306884,9.64043449259903,9.45559349405116,3.68233641306884,6.92524929166377,7.83881256953109,6.01168601379645,382.421362259183,-0.169012116421456,1.00977555234176,0.385049375614325,0.633601156869807,"O95352",0,"Ubiquitin-like modifier-activating enzyme ATG7 (ATG12-activating enzyme E1 ATG7) (Autophagy-related protein 7) (APG7-like) (hAGP7) (Ubiquitin-activating enzyme E1-like protein)","autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to hyperoxia [GO:0071455]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; defense response to virus [GO:0051607]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]","GO:0000045; GO:0000407; GO:0000423; GO:0005576; GO:0005737; GO:0005829; GO:0005930; GO:0006497; GO:0006914; GO:0006995; GO:0009267; GO:0015031; GO:0016236; GO:0019778; GO:0019779; GO:0031401; GO:0032446; GO:0034727; GO:0034774; GO:0042752; GO:0042803; GO:0043065; GO:0045732; GO:0048511; GO:0051607; GO:0071455; GO:1904813"
"32","Pocillopora_acuta_HIv2___RNAseq.g27877.t1",NA,0,NA,0,0,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,9.76159408651957,8.81464828177475,8.31025247179496,10.0374101618176,7.81560771910048,10.6997380282279,9.1450032675314,9.04406860791353,8.3019311419541,3.68233641306884,8.56125901797031,8.64669080545653,8.4758272304841,575.681080355066,0.0216962659570664,0.885513466789171,0.971528799341589,0.990847028181973,NA,NA,NA,NA,NA
"33","Pocillopora_acuta_HIv2___TS.g10724.t2c",0,0,NA,NA,0,0,NA,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.85124408540131,9.82554342269253,9.26302944499166,3.68233641306884,9.29232841321621,9.57602568061724,9.59905149700857,10.7516793792009,8.36958085695223,3.68233641306884,8.38931556062183,9.50557243595246,7.2730586852912,646.265444759946,-0.413076381482913,1.0202113660116,0.113634367271481,0.286792442543133,"Q15269",0,"Periodic tryptophan protein 2 homolog","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]","GO:0000028; GO:0000462; GO:0003723; GO:0005654; GO:0032040; GO:0034388; GO:0042274"
"34","Pocillopora_acuta_HIv2___RNAseq.g27961.t1",NA,NA,NA,0,0,33.3333333333333,0,NA,0,0,5.55555555555556,11.1111111111111,0,NA,NA,NA,NA,NA,NA,10.3255022112939,9.2504419648408,11.3915027067791,10.2027609587357,11.3735794134627,8.77253124101927,8.97402963750492,11.1614984836736,9.55568042536067,3.68233641306884,9.46898634557395,10.761552648114,8.17642004303391,1216.44603866266,-1.16967635309628,1.28845238439914,0.03779539643116,0.12481109908226,"Q8WXX0",0,"Dynein axonemal heavy chain 7 (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2)","cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]","GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005829; GO:0005858; GO:0005874; GO:0005929; GO:0008569; GO:0016887; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729"
"35","Pocillopora_acuta_HIv2___TS.g10733.t1",50,NA,NA,0,37.5,0,100,NA,0,NA,31.25,0,62.5,NA,NA,NA,NA,NA,NA,12.7771401725818,11.6969114774119,12.1296030970699,12.0606471315763,12.3266791029194,11.6188121730442,11.8030073990347,12.5367546837804,12.6733860587551,11.7026233334432,12.1325564629617,12.4887126230213,11.7764003029021,4649.82979276197,-0.561499987944343,0.520753475534523,0.2045759038392,0.429460939496399,"A5PJX7",9.85e-132,"Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Solute carrier family 6 member 13)","amino acid transport [GO:0006865]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]","GO:0005332; GO:0005886; GO:0006836; GO:0006865; GO:0016323; GO:0035725; GO:0042995"
"36","Pocillopora_acuta_HIv2___RNAseq.g27972.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.67974561220581,9.63380351053781,8.32708151857713,6.98772252729676,9.40293886179854,9.37487181840115,10.6719598780735,9.53550639640678,8.10422827110476,3.68233641306884,8.34001948074711,8.6099001320186,8.07013882947561,521.035810969485,-0.0991899304945766,0.872309945211071,0.742424338565499,0.886025347094372,"Q2KID6",0,"Pleiotropic regulator 1","mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]","GO:0000398; GO:0000974; GO:0001650; GO:0005634; GO:0005662; GO:0016607; GO:0031965; GO:0034504; GO:0071007; GO:0071013; GO:1900087"
"37","Pocillopora_acuta_HIv2___TS.g10739.t1",0,NA,NA,0,100,85.7142857142857,50,NA,100,NA,55.9523809523809,61.9047619047619,50,NA,NA,NA,NA,NA,NA,10.3637206147777,10.0866585901723,10.4859105124337,10.0926534263973,10.2182725846161,9.62619799283828,7.53175536625655,10.7270338874188,11.28445576237,8.87831473390622,9.92949734711869,10.6158786723233,9.24311602191413,1150.30364610903,-0.912114500050658,0.785565204709055,0.0817185378105716,0.225353085012795,"Q52KB6",2.33e-176,"C2 domain-containing protein 3 (Protein hearty)","brain development [GO:0007420]; centriole elongation [GO:0061511]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; pattern specification process [GO:0007389]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589]","GO:0001701; GO:0001947; GO:0005737; GO:0005814; GO:0007389; GO:0007420; GO:0008589; GO:0016485; GO:0021915; GO:0021997; GO:0030162; GO:0030326; GO:0034451; GO:0036064; GO:0042733; GO:0060271; GO:0061511; GO:0071539; GO:1905515"
"38","Pocillopora_acuta_HIv2___RNAseq.g27978.t1",0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,11.9641471135734,9.27298050082544,11.4440505201475,8.58545166315126,10.6448095403786,9.59727861669281,3.68233641306884,10.7228850554997,10.8294587521669,3.68233641306884,9.04257345885733,11.1210701963532,6.96407672136144,1346.56742915342,-0.966757032491966,1.54866437373907,0.00566641354961095,0.0258464224476735,"P23634",1.01e-131,"Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4)","calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; nitric oxide-cGMP-mediated signaling [GO:0038060]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832]","GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005886; GO:0005901; GO:0006357; GO:0006874; GO:0007283; GO:0010629; GO:0014832; GO:0015085; GO:0016020; GO:0016323; GO:0016525; GO:0016887; GO:0017080; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0032991; GO:0034220; GO:0036126; GO:0036487; GO:0038060; GO:0043231; GO:0043537; GO:0045019; GO:0045121; GO:0046872; GO:0048787; GO:0050998; GO:0051001; GO:0051480; GO:0051599; GO:0070588; GO:0070885; GO:0071872; GO:0071878; GO:0097110; GO:0097228; GO:0097553; GO:0098703; GO:0098736; GO:0098978; GO:0150104; GO:1900082; GO:1901660; GO:1902083; GO:1902305; GO:1902548; GO:1902806; GO:1903078; GO:1903243; GO:1903249; GO:1903779; GO:1905145"
"39","Pocillopora_acuta_HIv2___RNAseq.g27979.t1",0,0,0,0,21.0526315789474,0,0,NA,0,0,2.33918128654971,0,4.21052631578947,NA,NA,NA,NA,NA,NA,11.0447477818257,9.43497870382834,11.1991057244934,8.88593206173109,8.23065898728289,9.36537292338283,3.68233641306884,10.9165098426662,10.5409753442581,9.98905280076338,9.32896705833008,10.3863995361053,8.2715345805549,1079.85760999725,-0.475226406637577,0.992884497428973,0.219450626970144,0.450539714036078,"Q9WVM6",6.94e-15,"Tolloid-like protein 2 (EC 3.4.24.-)","cell differentiation [GO:0030154]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of skeletal muscle tissue growth [GO:0048632]; protein processing [GO:0016485]","GO:0004222; GO:0005509; GO:0005615; GO:0008270; GO:0009953; GO:0016485; GO:0030154; GO:0048632"
"40","Pocillopora_acuta_HIv2___TS.g10811.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.34389667623395,3.68233641306884,10.1757522425494,6.2462771951713,9.1496244106913,8.89910495266423,7.96348259476953,10.5851149371269,8.66702239556097,3.68233641306884,7.83949482309053,9.5842821324325,6.09470751374855,491.89720636027,-1.28190423194249,2.05137534799281,0.00097460648340659,0.00573036917723289,"Q9JLG8",0,"Calpain-15 (EC 3.4.22.-) (Small optic lobes homolog)","proteolysis [GO:0006508]","GO:0004198; GO:0005737; GO:0006508; GO:0046872"
"41","Pocillopora_acuta_HIv2___RNAseq.g28040.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.58425436173005,8.03648948185279,7.37487447386323,9.65445783249139,8.30256178415943,3.68233641306884,9.05614986436118,8.51055382611831,7.8434762799534,11.7202943955884,8.2765448713187,8.12314414516488,8.42994559747252,620.801932415294,0.138710475566739,0.917454188519371,0.682986104119267,0.85324538306621,"A1L112",1.85e-97,"WD repeat-containing protein 55","rRNA processing [GO:0006364]","GO:0005730; GO:0005737; GO:0006364"
"42","Pocillopora_acuta_HIv2___RNAseq.665_t",NA,NA,0,0,0,8.33333333333333,0,0,NA,NA,1.38888888888889,2.77777777777778,0,NA,NA,NA,NA,NA,NA,8.86425333289065,3.68233641306884,10.5431205939019,3.68233641306884,9.70133505877326,6.2434550875973,8.88361579571106,9.44896393042823,7.99414001711824,3.68233641306884,7.27258930556272,9.31036258662246,5.23481602450298,411.692398983122,-1.01246311347492,1.77334033083325,4.4580291760241e-06,5.69116804960393e-05,"Q15319",1.61e-90,"POU domain, class 4, transcription factor 3 (Brain-specific homeobox/POU domain protein 3C) (Brain-3C) (Brn-3C)","axon extension [GO:0048675]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601]","GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007601; GO:0007605; GO:0021562; GO:0031290; GO:0042472; GO:0042491; GO:0045944; GO:0048675; GO:0050885; GO:0051402; GO:1990837"
"43","Pocillopora_acuta_HIv2___RNAseq.g28070.t1",0,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,7.16748500850389,8.17613327516216,8.47934738650483,8.92706331886005,7.71752284896075,3.68233641306884,3.68233641306884,4.37784214571138,3.68233641306884,3.68233641306884,5.95747396359784,6.28490676054994,5.63004116664575,136.509062356006,-0.196295249247053,0.982837781417732,0.499927244876043,0.729800912185482,"Q4V8V2",6.88e-55,"Nucleoside diphosphate-linked moiety X motif 17 (Nudix motif 17) (EC 3.6.1.-)","NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]","GO:0005777; GO:0006734; GO:0006742; GO:0019677; GO:0035529; GO:0046872"
"44","Pocillopora_acuta_HIv2___RNAseq.g28097.t1b",16.2162162162162,52.6315789473684,33.9622641509434,28.0898876404494,37.5,26.7772511848341,33.5329341317365,56.5217391304348,27,NA,34.6924301557759,38.2040913806173,30.302853624724,NA,NA,NA,NA,NA,NA,7.98735600926529,3.68233641306884,6.85453915175415,3.68233641306884,7.66988319675762,3.68233641306884,3.68233641306884,8.85216124356356,6.54686386219783,3.68233641306884,5.63224855288826,7.58216069270769,3.68233641306884,100.538406776974,-11.3173809194611,3.65397707790143,3.85660689815218e-08,9.53537814955097e-07,NA,NA,NA,NA,NA
"45","Pocillopora_acuta_HIv2___RNAseq.g28164.t1",0,NA,0,NA,4.34782608695652,0,NA,0,0,36.5853658536585,5.84759884865929,0,10.2332979851538,NA,NA,NA,NA,NA,NA,6.7792912387703,7.72302631647394,7.26683347298246,9.4463265672231,6.06421730587923,9.73049611281746,3.68233641306884,7.48117056512432,9.83758531805481,3.68233641306884,7.16936197234633,7.48581958016222,6.85290436453044,298.477720951273,-0.000894381632429745,0.97396190916866,0.963416643986411,0.986832858278677,"P50430",1.12e-145,"Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)","anterior head development [GO:0097065]; autophagy [GO:0006914]; colon epithelial cell migration [GO:0061580]; dermatan sulfate catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]","GO:0003943; GO:0004065; GO:0005764; GO:0006914; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065"
"46","Pocillopora_acuta_HIv2___RNAseq.g28180.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.8766977630804,9.62214869763182,10.0066524941317,8.89632549336012,9.54676134737926,10.0538807398142,10.9030883953611,8.78604271057008,9.31870575843587,3.68233641306884,9.16926398128334,9.70697201471946,8.63155594784722,875.017969568651,-0.213221062540765,0.894924420519921,0.527842456064932,0.75004043640768,"Q14980",1.17e-10,"Nuclear mitotic apparatus protein 1 (Nuclear matrix protein-22) (NMP-22) (Nuclear mitotic apparatus protein) (NuMA protein) (SP-H antigen)","anastral spindle assembly [GO:0055048]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; meiotic cell cycle [GO:0051321]; microtubule bundle formation [GO:0001578]; nucleus organization [GO:0006997]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; positive regulation of hair follicle development [GO:0051798]; positive regulation of intracellular transport [GO:0032388]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic spindle elongation [GO:1902846]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to spindle pole body [GO:1902365]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]","GO:0000132; GO:0000922; GO:0001578; GO:0005198; GO:0005634; GO:0005654; GO:0005694; GO:0005813; GO:0005819; GO:0005829; GO:0005876; GO:0005886; GO:0005938; GO:0006997; GO:0008017; GO:0015631; GO:0016328; GO:0016363; GO:0019904; GO:0030425; GO:0030513; GO:0030953; GO:0031116; GO:0031616; GO:0032388; GO:0032991; GO:0035091; GO:0035371; GO:0036449; GO:0043025; GO:0044877; GO:0045618; GO:0051010; GO:0051011; GO:0051301; GO:0051321; GO:0051798; GO:0051984; GO:0055028; GO:0055048; GO:0060236; GO:0061673; GO:0070062; GO:0070840; GO:0072686; GO:0090235; GO:0097427; GO:0097431; GO:0097575; GO:0097718; GO:0099738; GO:1902365; GO:1902846; GO:1904778; GO:1905720; GO:1905820; GO:1905832; GO:1990023"
"47","Pocillopora_acuta_HIv2___TS.g10969.t1",NA,0,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.26147673713321,9.1938169358223,7.99336016744145,3.68233641306884,7.58678057169964,3.68233641306884,10.1266167339502,5.36237875279434,3.68233641306884,3.68233641306884,6.32537755511165,6.5772665284275,6.0734885817958,235.10445305187,-0.0330031202110311,0.995865501931569,0.687588500771817,0.855807810980062,"P95329",8.97e-117,"Malate synthase (EC 2.3.3.9)","glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]","GO:0004474; GO:0005737; GO:0006097; GO:0006099"
"48","Pocillopora_acuta_HIv2___RNAseq.g28187.t1",0,0,0,0,0,0,NA,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.22868826190456,10.0319290553305,10.1063891837559,8.52419391542848,9.04184108484496,9.23791312461303,8.04335505963054,10.183121606688,11.0110380424772,3.68233641306884,8.7090805747742,9.51421563593412,7.90394551361428,706.061945802238,-0.284874829255247,0.951121239838377,0.366340700076169,0.615847499523676,"Q80UM3",0,"N-alpha-acetyltransferase 15, NatA auxiliary subunit (N-terminal acetyltransferase 1) (NMDA receptor-regulated protein 1) (Protein tubedown-1)","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]","GO:0001525; GO:0005634; GO:0005737; GO:0008080; GO:0030154; GO:0031415; GO:0048471"
"49","Pocillopora_acuta_HIv2___RNAseq.g28193.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.94132135187028,10.4151146775755,3.68233641306884,3.68233641306884,8.56967758387937,8.9810247798628,3.68233641306884,6.86711664385428,6.76651737006592,11.9237379769533,7.2511519623268,6.76539387254774,7.73691005210586,643.19710468307,0.165718947775807,0.977378113289616,0.508283333802831,0.736211710406984,"P52046",4.2e-31,"Short-chain-enoyl-CoA hydratase (EC 4.2.1.150) (3-hydroxybutyryl-CoA dehydratase) (Crotonase)","butyrate metabolic process [GO:0019605]; fatty acid beta-oxidation [GO:0006635]","GO:0006635; GO:0016836; GO:0019605"
"50","Pocillopora_acuta_HIv2___RNAseq.g28199.t1",0,4,0,NA,0,0,0,0,0,NA,0.5,1,0,NA,NA,NA,NA,NA,NA,6.89223359574533,6.08712839408766,8.78712071333689,8.52419391542848,6.550353694785,9.65766469777978,3.68233641306884,7.80656939979663,8.11478681900153,3.68233641306884,6.9784724056099,7.63021284453308,6.32673196668672,220.17094651832,-0.283267094135085,0.998738632306815,0.187921069957952,0.406230810920912,"Q29611",7.35e-105,"Battenin (Protein CLN3)","amyloid precursor protein catabolic process [GO:0042987]; autophagosome-lysosome fusion [GO:0061909]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; intracellular water homeostasis [GO:0009992]; L-arginine transmembrane transport [GO:1903826]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; negative regulation of apoptotic process [GO:0043066]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of fibroblast migration [GO:0010762]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496]","GO:0000139; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0005794; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0005901; GO:0006898; GO:0007040; GO:0007042; GO:0007611; GO:0008021; GO:0009992; GO:0010762; GO:0016020; GO:0031901; GO:0032228; GO:0035752; GO:0036359; GO:0042987; GO:0042998; GO:0043005; GO:0043066; GO:0044754; GO:0044857; GO:0045121; GO:0046474; GO:0046836; GO:0047496; GO:0048172; GO:0048549; GO:0051493; GO:0051861; GO:0051966; GO:0055037; GO:0061909; GO:0070613; GO:0090160; GO:0090384; GO:0090385; GO:0106049; GO:0120146; GO:1900079; GO:1901096; GO:1903076; GO:1903826; GO:1905146; GO:1905162; GO:1905244; GO:2001288"
"51","Pocillopora_acuta_HIv2___RNAseq.g28202.t1",0.988700564971751,0.208768267223382,1.42857142857143,0.140056022408964,0.849256900212314,0.550314465408805,0.792079207920792,0.622406639004149,0.413223140495868,0.558659217877095,0.655203585409455,0.386953706908234,0.923453463910676,NA,NA,NA,NA,NA,NA,12.0910596834054,3.68233641306884,12.3995868728907,10.9113648211108,11.9164742521858,3.68233641306884,3.68233641306884,10.9323170159811,12.4235392463943,3.68233641306884,8.54036875442435,11.9525954141715,5.12814209467723,2285.1584368848,-1.3318538696491,3.13168218468487,7.84045237564535e-14,1.59724370649767e-11,"P12391",1.25e-61,"Neuronal acetylcholine receptor subunit beta-3","acetylcholine receptor signaling pathway [GO:0095500]; membrane depolarization [GO:0051899]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; response to nicotine [GO:0035094]; synaptic transmission, cholinergic [GO:0007271]","GO:0004888; GO:0005886; GO:0005892; GO:0007271; GO:0022848; GO:0032991; GO:0035094; GO:0042166; GO:0043005; GO:0045202; GO:0045211; GO:0051899; GO:0095500; GO:0098691; GO:0098793; GO:0099171"
"52","Pocillopora_acuta_HIv2___RNAseq.g28203.t1",NA,0,NA,NA,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,11.0124208021543,3.68233641306884,11.4887903764397,8.58116152422802,11.2100439686684,11.2152291203419,10.0924441520741,11.0774792878513,3.68233641306884,3.68233641306884,8.57245784709642,9.69421416963651,7.45070152455634,1314.30192621738,-0.405732042923222,1.02499261393458,0.290068748401646,0.536678485807815,"Q28CH8",1.86e-96,"Protein YIPF6 (YIP1 family member 6)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]","GO:0000138; GO:0000139; GO:0005797; GO:0005802; GO:0006888"
"53","Pocillopora_acuta_HIv2___RNAseq.g28204.t1",0,0,0,NA,2.63157894736842,0,1.14942528735632,0,0,NA,0.472625529340593,0,0.945251058681186,NA,NA,NA,NA,NA,NA,11.1968772544259,9.94261194979259,11.6369662709033,12.1235143599763,11.287427802839,12.098762952484,10.6515696579801,11.7184735124015,11.0368909426031,11.8671196572736,11.3560214360679,11.3753271566346,11.3367157155013,2842.31361723754,-0.0159467147024565,0.602389658875805,0.966775973839741,0.988159683811605,"Q9U7E0",1.31e-165,"Transcriptional regulator ATRX homolog (EC 3.6.4.12) (ATP-dependent helicase xnp-1) (X-linked nuclear protein 1)","DNA repair [GO:0006281]; embryo development ending in birth or egg hatching [GO:0009792]; gonad development [GO:0008406]; morphogenesis of an epithelium [GO:0002009]; reproductive process [GO:0022414]; vulval development [GO:0040025]","GO:0002009; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006281; GO:0008406; GO:0009792; GO:0016887; GO:0022414; GO:0040025; GO:0140658"
"54","Pocillopora_acuta_HIv2___TS.g11020.t1",NA,0,0,NA,16.6666666666667,0,0,0,NA,NA,2.77777777777778,0,5.55555555555556,NA,NA,NA,NA,NA,NA,3.68233641306884,6.77312724931675,8.27599171875922,3.68233641306884,5.76632859445463,7.10557681894167,10.7100186784113,12.3725072935091,3.68233641306884,11.7195916934275,7.37701512860267,6.75590008657213,7.99813017063321,1078.84491161933,0.104273972191834,0.994641102140323,0.33781163525686,0.588545831408724,"O75339",8.98e-48,"Cartilage intermediate layer protein 1 (CILP-1) (Cartilage intermediate-layer protein) [Cleaved into: Cartilage intermediate layer protein 1 C1; Cartilage intermediate layer protein 1 C2]","negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]","GO:0005615; GO:0010629; GO:0030512; GO:0043569; GO:0060392; GO:0062023; GO:0070062"
"55","Pocillopora_acuta_HIv2___TS.g11023.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.83340400713327,3.68233641306884,7.56343725350454,3.68233641306884,9.61415018064534,3.68233641306884,3.68233641306884,6.29140637299107,3.68233641306884,9.59132912006858,5.9305408999687,6.99694684546861,4.86413495446879,192.639885387546,-0.26635427977503,1.0717448137786,8.7946487235061e-06,0.000102173332639994,"O75691",0,"Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6)","endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]","GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006364; GO:0008285; GO:0030686; GO:0030688; GO:0032040; GO:0042274"
"56","Pocillopora_acuta_HIv2___RNAseq.g28244.t1",0,NA,0,0,1.6304347826087,1.94552529182879,0,0,0,NA,0.446995009304686,0.486381322957198,0.407608695652174,NA,NA,NA,NA,NA,NA,7.45015090580822,7.43267390932227,8.21941748892048,3.68233641306884,8.85452977473803,8.18381287343643,3.68233641306884,9.25566778727233,6.41379501761528,6.11483358357707,6.92895541668278,8.03871219487087,5.81919863849469,196.774562780021,-0.434392319959931,1.03348973381045,0.117264019394962,0.293755937938627,"O88871",6.38e-134,"Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]","GO:0004965; GO:0005737; GO:0005886; GO:0007193; GO:0007214; GO:0030425; GO:0038039; GO:0042734; GO:0043005; GO:0043204; GO:0045211; GO:0046982; GO:0051932; GO:0098978; GO:0098982; GO:0150099; GO:1902710; GO:1902712"
"57","Pocillopora_acuta_HIv2___RNAseq.g28255.t1",NA,0,0,0,0,0,NA,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,11.5307051076418,7.56088992856599,10.6984102912981,9.71243857099063,11.6491579966465,8.63058148338476,8.80132849854016,10.6455423883354,11.1785867090708,6.51149074430832,9.69191317187825,11.1404804985985,8.24334584515797,1346.05577356654,-2.49066334758191,1.0146433461041,0.000329154523598931,0.00228999087510098,"Q6DIR8",0,"Paladin","","GO:0005829"
"58","Pocillopora_acuta_HIv2___RNAseq.953_t",0,4.16666666666667,0,7.84313725490196,0,2.94117647058824,0,0,5.55555555555556,0,2.05065359477124,4.10130718954248,0,NA,NA,NA,NA,NA,NA,11.139857477116,8.71935049078991,10.2178070288942,9.90478652318717,11.5067270914672,7.39595400278476,5.63253479849075,10.6897892034136,10.4902877652294,3.68233641306884,8.93794307944418,10.8088937132241,7.06699244566429,1081.97867628544,-2.2437900583519,2.40405010288745,0.00113780824203377,0.00653065810030811,"Q87PP5",5.95e-102,"Glycine betaine/proline/choline/ectoine transporter VP1456","amino acid transport [GO:0006865]","GO:0005886; GO:0006865; GO:0022857"
"59","Pocillopora_acuta_HIv2___RNAseq.g28344.t1b",100,100,100,80,100,100,95,100,NA,NA,96.875,95,98.75,NA,NA,NA,NA,NA,NA,7.23722033106713,3.68233641306884,8.4823543496129,3.68233641306884,6.32874911315906,7.08704609984966,3.68233641306884,6.79689746336218,3.68233641306884,3.68233641306884,5.43439494223951,6.50551153405402,4.363278350425,71.3963709148558,-0.294207702787388,1.0635997758138,0.00306738096354263,0.015453360590972,"A5HUI5",0,"Aminopeptidase A (AP-A) (APA) (EC 3.4.11.7) (Glutamyl aminopeptidase) (EAP)","proteolysis [GO:0006508]","GO:0004177; GO:0005886; GO:0006508; GO:0008237; GO:0008270"
"60","Pocillopora_acuta_HIv2___RNAseq.g28345.t1b",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,6.81522472615292,10.4896466786688,3.68233641306884,8.74419736863991,10.7755413897059,10.2205799121708,10.7208061562996,9.97694999198017,3.68233641306884,7.87899554628246,8.72278732173146,7.03520377083346,744.345783435306,-0.0556073780149844,0.987172819186671,0.632476366386286,0.822378475675229,"P23508",1.24e-120,"Colorectal mutant cancer protein (Protein MCC)","establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]","GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0016055; GO:0030027; GO:0038023; GO:0045184; GO:0050680; GO:0090090"
"61","Pocillopora_acuta_HIv2___RNAseq.g28351.t1",0,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.09392406096189,7.976594044287,10.875044089289,10.5329462565593,9.71211578395195,9.83603182740995,9.34698085750427,10.4232264516117,11.5422953400213,3.68233641306884,9.30214951246652,10.3293211451672,8.27497787976587,1068.84301635849,-0.415057278066397,0.934969081920896,0.32134959781501,0.571288173893351,"P97742",0,"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-)","aflatoxin metabolic process [GO:0046222]; carnitine metabolic process [GO:0009437]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of fatty acid oxidation [GO:0046320]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641]","GO:0001666; GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0005743; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0007584; GO:0009410; GO:0009437; GO:0010883; GO:0014070; GO:0030855; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045471; GO:0046222; GO:0046320; GO:0050796; GO:0071398; GO:0097421; GO:1904772"
"62","Pocillopora_acuta_HIv2___RNAseq.g28385.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.3300358393823,9.93635154748812,10.3111323810753,10.9699037998223,11.0772673941939,9.86732009269409,11.3313279662978,11.3705280370271,11.49367754364,11.5006582756575,10.9188202877278,11.1165282390637,10.721112336392,2067.50091076673,-0.276839721463229,0.586162531544842,0.552119148257857,0.767932032877992,NA,NA,NA,NA,NA
"63","Pocillopora_acuta_HIv2___TS.g11182.t1",0,NA,8.33333333333333,0,0,0,NA,0,NA,0,1.19047619047619,0,2.08333333333333,NA,NA,NA,NA,NA,NA,9.1078544423473,8.92632565796471,9.10045871331929,10.4519410395541,7.35000901468309,3.68233641306884,9.82051951382199,7.64871506591188,7.123712339569,3.68233641306884,7.6894208613309,8.06614991516611,7.3126918074957,419.422276578445,-0.144279351665073,0.953285247717653,0.429010974662246,0.673381957408,"Q498G2",1.14e-65,"Centrosomal protein of 152 kDa (Cep152)","cell projection organization [GO:0030030]; centriole replication [GO:0007099]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]","GO:0000242; GO:0005737; GO:0005814; GO:0007099; GO:0030030; GO:0098535; GO:0098536"
"64","Pocillopora_acuta_HIv2___TS.g11189.t1",2.4662633783155,2.36344537815126,2.73055126223596,2.7260926006058,2.14574898785425,2.68636668905306,2.63578274760383,2.98126064735945,4.66942148760331,2.33948531323109,2.77444184920135,3.08531736055457,2.46356633784813,NA,NA,NA,NA,NA,NA,11.2776220325158,3.68233641306884,10.7485405630047,3.68233641306884,11.1176253872288,3.68233641306884,3.68233641306884,9.99033678875318,9.47412951432438,11.5330150589132,7.88706149970154,10.5216508571654,5.25247214223771,1096.33207078482,-0.574999420027475,1.26197938819847,2.45973362177033e-11,1.8824120161527e-09,"Q8IS64",1.23e-145,"Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)","proteolysis [GO:0006508]","GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0008270"
"65","Pocillopora_acuta_HIv2___RNAseq.g28406.t1",0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.8044391567073,12.1584000036617,11.7872032074958,7.40425219505693,11.5483298261056,9.55946140688164,10.323600095137,9.81236700742792,7.45952232732554,3.68233641306884,9.45399116388683,10.2823723050124,8.62561002276122,1594.11227847414,-0.530358496400056,1.02730714053992,0.0964425657518041,0.254445294217536,"P28494",0,"Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)","in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]","GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005615; GO:0005794; GO:0005797; GO:0005801; GO:0006013; GO:0006486; GO:0006491; GO:0007005; GO:0007033; GO:0007585; GO:0008270; GO:0015923; GO:0016787; GO:0016799; GO:0030246; GO:0042802; GO:0042803; GO:0048286; GO:0050769; GO:0060042"
"66","Pocillopora_acuta_HIv2___RNAseq.g28452.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.749247440873,3.68233641306884,8.6707275774248,11.3209716611959,9.62870719261771,3.68233641306884,3.68233641306884,4.78747788616564,3.68233641306884,8.60125271221105,6.84877301227635,7.50369930203,6.19384672252269,574.781250671605,-0.0840334846738262,1.01514248476227,0.00145332945913553,0.00806946537310417,"P97814",3.59e-92,"Proline-serine-threonine phosphatase-interacting protein 1 (PEST phosphatase-interacting protein 1)","actin filament polymerization [GO:0030041]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]","GO:0001725; GO:0001931; GO:0003779; GO:0005737; GO:0005826; GO:0005884; GO:0005886; GO:0006897; GO:0006954; GO:0007155; GO:0019903; GO:0030027; GO:0030041; GO:0032154; GO:0045087; GO:0048471; GO:0051015"
"67","Pocillopora_acuta_HIv2___RNAseq.g28466.t1",0,NA,NA,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,8.65240708182078,5.96448686545822,10.7119069751483,3.68233641306884,9.64925125664371,3.68233641306884,3.68233641306884,10.0286592586379,8.49198375939081,7.08949304564378,7.163519748195,9.5068416663283,4.8201978300617,431.131496060928,-1.0856487203892,1.94272677367197,1.14790425564083e-07,2.44525583999838e-06,"O73874",8.06e-14,"Ephrin-B2a","angioblast cell migration involved in selective angioblast sprouting [GO:0035475]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; optic vesicle morphogenesis [GO:0003404]; regulation of chemotaxis [GO:0050920]; rhombomere boundary formation [GO:0021654]; somitogenesis [GO:0001756]; synaptic target recognition [GO:0008039]","GO:0001568; GO:0001756; GO:0002042; GO:0003404; GO:0005886; GO:0007155; GO:0007411; GO:0007412; GO:0008039; GO:0009952; GO:0021654; GO:0035475; GO:0042734; GO:0046875; GO:0048013; GO:0048514; GO:0050920; GO:0098978"
"68","Pocillopora_acuta_HIv2___RNAseq.g28468.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.79990573373047,10.4374498983513,8.17547586494681,3.68233641306884,9.67352390259758,9.86866517376477,11.1625033190399,7.16145990783134,3.68233641306884,10.5390226868381,8.3182679313238,7.49854036443501,9.13799549821258,759.359167226739,0.255414785102088,1.00379271333866,0.292713918354637,0.539787772304071,"O73874",2.64e-12,"Ephrin-B2a","angioblast cell migration involved in selective angioblast sprouting [GO:0035475]; anterior/posterior pattern specification [GO:0009952]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; optic vesicle morphogenesis [GO:0003404]; regulation of chemotaxis [GO:0050920]; rhombomere boundary formation [GO:0021654]; somitogenesis [GO:0001756]; synaptic target recognition [GO:0008039]","GO:0001568; GO:0001756; GO:0002042; GO:0003404; GO:0005886; GO:0007155; GO:0007411; GO:0007412; GO:0008039; GO:0009952; GO:0021654; GO:0035475; GO:0042734; GO:0046875; GO:0048013; GO:0048514; GO:0050920; GO:0098978"
"69","Pocillopora_acuta_HIv2___RNAseq.g28487.t1",2.4390243902439,0,0,0,0,0,0,0,NA,NA,0.304878048780488,0,0.609756097560976,NA,NA,NA,NA,NA,NA,5.52146481986391,5.39185996804635,5.49419692800081,6.33264566750265,5.71763198038475,7.44754517716341,5.40984312721881,6.19602632709643,6.37842387115414,8.11094191681231,6.20005797832436,5.86154878530001,6.53856717134871,68.5489379991737,0.482361413435816,0.76853852499164,0.321679836824723,0.571664474730655,"Q06805",1.36e-17,"Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)","angiogenesis [GO:0001525]; positive regulation of angiogenesis [GO:0045766]","GO:0001525; GO:0004714; GO:0005524; GO:0005886; GO:0043235; GO:0045766"
"70","Pocillopora_acuta_HIv2___TS.g11272.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.38877138209431,8.49044103951188,9.44804486802612,8.53754183487098,8.84029803322418,9.95604234574693,3.68233641306884,8.82142434140143,9.55568042536067,3.68233641306884,7.94029170963742,9.01084381002134,6.86973960925349,421.878090443781,-0.327464936567408,0.999723256011829,0.179289885774473,0.393370294234837,"Q55E58",3.48e-17,"Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)","cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856]","GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310"
"71","Pocillopora_acuta_HIv2___TS.g11273.t1",0,0,0,10.8695652173913,6.52173913043478,1.70940170940171,8,0,6.66666666666667,0,3.37673727238945,3.84912671869194,2.90434782608696,NA,NA,NA,NA,NA,NA,8.75633596690587,8.29362364263554,6.36503790894442,9.65445783249139,8.19751020292709,6.35805096381544,8.93597345203167,8.79595844217485,3.68233641306884,3.68233641306884,7.2721621238064,7.15943578680421,7.38488846080858,274.536350868825,0.0425636435823539,0.839960404677103,0.878294397998837,0.952989331554126,"Q26627",3.15e-08,"Sperm receptor for egg jelly (suREJ)","detection of mechanical stimulus [GO:0050982]","GO:0005262; GO:0005509; GO:0005886; GO:0016020; GO:0030246; GO:0050982"
"72","Pocillopora_acuta_HIv2___RNAseq.g28495.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.2937092774432,12.7666962776578,11.8820683853039,12.7965377332279,12.4579217995021,12.6558182271537,13.9025508261557,12.2461349754396,12.3927564433478,13.906431497599,12.7300625442831,12.2545181762073,13.2056069123588,7560.60632447015,0.741718483427701,0.579833637425071,0.119760267123882,0.29809198135946,"Q9Y490",0,"Talin-1","cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; platelet aggregation [GO:0070527]; regulation of focal adhesion assembly [GO:0051893]","GO:0001726; GO:0001786; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0045296; GO:0051015; GO:0051893; GO:0070062; GO:0070527; GO:0098609"
"73","Pocillopora_acuta_HIv2___TS.g11286.t1",0,0,0,0,0,2.56410256410256,0,NA,0,NA,0.320512820512821,0.641025641025641,0,NA,NA,NA,NA,NA,NA,7.16748500850389,10.6359150647471,4.94123562252982,11.3216140229217,7.71752284896075,12.4398512056848,12.3321020844522,8.13553162203908,3.68233641306884,12.6163220178957,9.09899159108039,6.32882230302048,11.8691608791403,2158.52113630256,4.9130627473798,1.83181419715166,7.18578044666268e-06,8.58968003144868e-05,"B3EWZ3",3.6e-28,"Coadhesin","","GO:0016020"
"74","Pocillopora_acuta_HIv2___TS.g11290.t1",0,NA,NA,0,0,0,0,NA,4.76190476190476,NA,0.793650793650794,1.58730158730159,0,NA,NA,NA,NA,NA,NA,6.37258314463392,3.68233641306884,7.1034540551447,9.12267049138052,6.77213038688595,3.68233641306884,3.68233641306884,3.68233641306884,7.58665737684829,3.68233641306884,5.53691775202376,6.30343227531634,4.77040322873118,95.6807611831978,-0.278598565418938,1.05847895976056,0.00549563419915638,0.0251865820838396,"Q64449",1.08e-24,"C-type mannose receptor 2 (Lectin lambda) (Macrophage mannose receptor 2) (CD antigen CD280)","collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]","GO:0005518; GO:0005886; GO:0006897; GO:0009986; GO:0030246; GO:0030574; GO:0038023"
"75","Pocillopora_acuta_HIv2___RNAseq.g28513.t1",0,0,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.6094356912979,9.73105061460219,9.67767636724741,10.299849035045,8.74228495705164,9.70210528341736,10.2544567098988,10.0151498526079,9.25104178284357,10.2967045804927,9.85797548745045,9.65911773020968,10.0568332446912,962.14661460262,0.30193861780039,0.574570153031978,0.516296494812605,0.741212158905163,NA,NA,NA,NA,NA
"76","Pocillopora_acuta_HIv2___TS.g11318.t1",0,0,0,0,0,0.555555555555556,1.51515151515152,NA,NA,NA,0.295815295815296,0.185185185185185,0.378787878787879,NA,NA,NA,NA,NA,NA,5.99355402052038,5.85749282533549,5.35722166815878,6.63240153016127,6.4000384077095,6.72794348889772,7.44368669316089,5.95306534505293,5.1802014623539,6.11483358357707,6.16604390249279,5.7768161807591,6.55527162422649,56.2338655108748,0.765054202362492,0.732826775989969,0.146075163169584,0.342540187162101,NA,NA,NA,NA,NA
"77","Pocillopora_acuta_HIv2___RNAseq.g28568.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.13391848923153,3.68233641306884,7.75513657317841,3.68233641306884,3.68233641306884,9.5776716899023,7.27001054207962,8.77204498786488,3.68233641306884,3.68233641306884,5.69204643476009,5.8051545752825,5.57893829423769,148.55296430643,-0.125533585801222,1.01244319642201,0.107847073164753,0.276209685224963,NA,NA,NA,NA,NA
"78","Pocillopora_acuta_HIv2___RNAseq.1177_t",0,0,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.92650798752011,3.68233641306884,9.28039460830977,10.9821446768009,8.66564774979486,3.68233641306884,3.68233641306884,8.8502592833714,3.68233641306884,3.68233641306884,6.61166363711412,8.081029208413,5.14229806581525,435.830108672458,-0.259595702583643,1.05381820294213,0.000207718018184442,0.00154152561057966,"Q9ERH3",0,"WD repeat-containing protein 7 (TGF-beta resistance-associated protein TRAG)","hematopoietic progenitor cell differentiation [GO:0002244]","GO:0002244; GO:0005737; GO:0008021"
"79","Pocillopora_acuta_HIv2___RNAseq.g28575.t1a",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,11.4848962009134,3.68233641306884,11.5410279701395,3.68233641306884,12.7059579226714,13.7954501858296,3.68233641306884,3.68233641306884,10.8347426792948,7.87737570241929,3.68233641306884,12.0724149917697,2844.3905409903,17.5525503314959,3.97246411802524,4.35406812870942e-20,3.14886207068265e-16,"G5EBQ8",7.13e-107,"Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2)","cell wall chitin biosynthetic process [GO:0006038]; chitin biosynthetic process [GO:0006031]; positive regulation of nematode larval development [GO:0061063]","GO:0004100; GO:0005886; GO:0006031; GO:0006038; GO:0030428; GO:0061063; GO:0071944"
"80","Pocillopora_acuta_HIv2___RNAseq.g28582.t1",0,1.02040816326531,0,NA,0.819672131147541,0,0,0,0,NA,0.230010036801606,0.255102040816327,0.204918032786885,NA,NA,NA,NA,NA,NA,9.13758278776356,9.2927231201274,9.18772117787148,9.90478652318717,10.4241931042168,10.7890995720966,10.4694124429272,8.90990994623538,8.38709600717497,11.5583879133969,9.80609125949975,9.20930060465244,10.4028819143471,1087.06174204451,0.806129529180893,0.725612615645702,0.119878056855967,0.298333829037286,"Q9Y4I1",0,"Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain 12) (Myosin-12) (Myoxin)","actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; cellular response to insulin stimulus [GO:0032869]; melanosome transport [GO:0032402]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]","GO:0000146; GO:0001726; GO:0003723; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006892; GO:0007015; GO:0015031; GO:0015629; GO:0016020; GO:0016192; GO:0016459; GO:0030048; GO:0030050; GO:0030426; GO:0031267; GO:0032402; GO:0032433; GO:0032593; GO:0032869; GO:0042470; GO:0043005; GO:0051015; GO:0070062; GO:0072659"
"81","Pocillopora_acuta_HIv2___RNAseq.g28585.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.4548276658549,6.71656868271498,8.42712219499703,5.61428486132265,9.23791312461303,9.23914877654576,6.95560773578551,3.68233641306884,6.75413069443622,6.97642765624078,5.33022682119216,8.62262849128939,244.392613219257,2.83398824224019,2.55427539746746,0.000521687335161671,0.00339131937787794,NA,NA,NA,NA,NA
"82","Pocillopora_acuta_HIv2___TS.g11388.t2",0,0,0,NA,2.4390243902439,0,0,NA,0,NA,0.348432055749129,0,0.609756097560976,NA,NA,NA,NA,NA,NA,9.69242518691729,3.68233641306884,9.30435966305754,9.74919979865633,9.54127565247577,5.03801277448085,8.57647316906817,9.02565106552041,6.6827526322222,3.68233641306884,7.49748227685362,8.84929284003864,6.14567171366861,390.669129479117,-0.677329451163051,1.22792535062423,0.00153769794194905,0.00845675400469623,NA,NA,NA,NA,NA
"83","Pocillopora_acuta_HIv2___RNAseq.g28610.t1",5.55555555555556,0,0.617283950617284,0,0.495049504950495,0.462962962962963,0.778210116731518,0,0,NA,0.878784676757535,0.0925925925925926,1.86152478196371,NA,NA,NA,NA,NA,NA,7.87755006797665,9.47872216811105,9.31282296358217,10.3944806121494,10.1463956452654,3.68233641306884,3.68233641306884,7.42579401114328,4.4808124149756,3.68233641306884,7.01635871224101,7.84867502058862,6.18404240389339,408.833965394524,-0.278688349728934,1.02440928724373,0.0503163480774153,0.156041093180046,"Q39433",2.71e-34,"Ras-related protein RAB1BV","","GO:0003924; GO:0005525; GO:0005886"
"84","Pocillopora_acuta_HIv2___TS.g11400.t1",0,NA,NA,NA,0,6.89655172413793,0,0,0,NA,1.14942528735632,2.29885057471264,0,NA,NA,NA,NA,NA,NA,10.7425695051014,10.3052418196045,11.3067918380325,11.5956914588148,9.28183900487062,10.6521110001008,10.9531366641536,9.73309378009657,10.6253760328443,3.68233641306884,9.88781875166879,10.3379340321891,9.43770347114851,1502.16802047659,-0.0289550797667632,0.871377570415499,0.91318558256246,0.967643845446301,"P22045",6.02e-45,"9,11-endoperoxide prostaglandin H2 reductase (EC 1.1.1.-) (Prostaglandin F2-alpha synthase)","prostaglandin biosynthetic process [GO:0001516]","GO:0000166; GO:0001516; GO:0004033; GO:0005737; GO:0036130"
"85","Pocillopora_acuta_HIv2___RNAseq.g28618.t1",3.2258064516129,2.38095238095238,0,0,0,0,0,NA,0,NA,0.70084485407066,0.595238095238095,0.806451612903226,NA,NA,NA,NA,NA,NA,3.68233641306884,8.12189365008233,7.32187822721292,7.83852772052873,8.10518255534107,4.21083509301726,7.9697869252993,8.41851549145483,11.1697717872529,3.68233641306884,7.0521064276327,7.73953689486611,6.36467596039929,366.558781912305,-0.124303866731231,0.980078182117365,0.456356179539812,0.697457288764141,"Q9C8V0",2.33e-23,"Immune-associated nucleotide-binding protein 6 (AtIAN6) (AIG1-like protein)","cellular response to heat [GO:0034605]; endoplasmic reticulum unfolded protein response [GO:0030968]","GO:0005525; GO:0005783; GO:0005886; GO:0030968; GO:0034605"
"86","Pocillopora_acuta_HIv2___TS.g11409.t1",0,0,0,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.64227287388026,8.12189365008233,9.84687113984658,10.7383828921143,8.01287997146903,9.65610756474315,9.58887241525128,8.28960488863631,9.4617986842675,3.68233641306884,8.70410204933596,9.05068551161994,8.35751858705198,633.19940377042,-0.0375922122079161,0.883790631401055,0.88805914380307,0.957002492621637,"P42111",1.59e-36,"Uncharacterized protein YxaL","","GO:0005576"
"87","Pocillopora_acuta_HIv2___RNAseq.g28626.t1",0,NA,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,4.51677976470286,9.74723568233672,8.9738039318025,9.80356223497108,9.58565401710817,8.09909073650838,8.75106295318757,7.74631987145943,8.34738265562321,3.68233641306884,7.92532282607688,7.83398804813923,8.01665760401452,407.189237438067,0.0399909785106983,0.923988503585633,0.91595480127195,0.969168333631514,"Q9T0F4",4.75e-26,"Immune-associated nucleotide-binding protein 13 (AtIAN13) (AIG1-like protein)","","GO:0005525"
"88","Pocillopora_acuta_HIv2___RNAseq.1261_t",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.5952647091742,3.68233641306884,7.67308893932296,3.68233641306884,9.04494652802873,3.68233641306884,3.68233641306884,6.42306225265296,10.632726174021,3.68233641306884,6.1780770668544,8.67381772063997,3.68233641306884,305.429133816307,-12.9853549239705,3.7662653418995,9.4860263725037e-11,5.40180651385408e-09,"Q58116",2.27e-71,"3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34)","coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; sterol biosynthetic process [GO:0016126]","GO:0004420; GO:0008299; GO:0015936; GO:0016126"
"89","Pocillopora_acuta_HIv2___RNAseq.g28678.t1",3.92156862745098,0,0,5,0,0,0,0,NA,NA,1.11519607843137,1.25,0.980392156862745,NA,NA,NA,NA,NA,NA,11.1821469116966,6.63867229711208,10.7516555025728,8.88940487736171,11.468230419893,9.89266454295479,5.82167741730566,10.7265159355119,11.0690768564038,3.68233641306884,9.01223811738812,11.0395251252156,6.98495110956062,1207.91590211953,-2.71256532017639,2.21113672774191,0.000655504616627681,0.00411935206542067,"D3UW23",0,"Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Rhiminopeptidase A)","proteolysis [GO:0006508]","GO:0004177; GO:0005886; GO:0006508; GO:0008237; GO:0008270"
"90","Pocillopora_acuta_HIv2___TS.g11457.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.9348312484292,12.2179921292961,11.0886522099373,9.66664662601031,12.1868644573175,10.6434943166367,10.7859253917685,11.1068290635052,13.0304559227638,9.79987484977496,11.346156621544,12.0695265803906,10.6227866626973,3482.00713149224,-1.03992146343207,0.726307522803726,0.048171766950967,0.151399738391854,"A5HUI5",0,"Aminopeptidase A (AP-A) (APA) (EC 3.4.11.7) (Glutamyl aminopeptidase) (EAP)","proteolysis [GO:0006508]","GO:0004177; GO:0005886; GO:0006508; GO:0008237; GO:0008270"
"91","Pocillopora_acuta_HIv2___RNAseq.1270_t",NA,0,0,0,15.3846153846154,0,0,NA,NA,NA,2.56410256410256,0,5.12820512820513,NA,NA,NA,NA,NA,NA,10.8875000944578,9.97809123953996,9.65122792065155,9.40811457997635,10.9226072904928,9.51376339745893,3.68233641306884,10.2638734009615,3.68233641306884,3.68233641306884,8.16721871627454,9.0815090239265,7.25292840862258,810.940647743653,-0.377820996556908,0.995292411465376,0.396361755686249,0.642550770097065,"Q66IC9",8.03e-69,"Ropporin-1-like protein","spermatid development [GO:0007286]","GO:0001534; GO:0007286; GO:0031514"
"92","Pocillopora_acuta_HIv2___RNAseq.g28694.t2",0,0,NA,0,100,0,33.3333333333333,0,NA,NA,19.047619047619,0,44.4444444444444,NA,NA,NA,NA,NA,NA,11.0142701017267,11.7966008953544,11.0683100069472,10.6429212891518,10.510364250375,11.228383760964,8.1019074575871,10.8197906460635,9.33005757413356,3.68233641306884,9.81949423953721,10.5485585158492,9.09042996322523,1572.60997917977,-0.33487986059573,0.923105542537157,0.354160413029243,0.605147810284108,"Q99755",0,"Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha (PIP5K1-alpha) (PtdIns(4)P-5-kinase 1 alpha) (EC 2.7.1.68) (68 kDa type I phosphatidylinositol 4-phosphate 5-kinase alpha) (Phosphatidylinositol 4-phosphate 5-kinase type I alpha) (PIP5KIalpha)","actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; glycerophospholipid metabolic process [GO:0006650]; keratinocyte differentiation [GO:0030216]; phagocytosis [GO:0006909]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phospholipid biosynthetic process [GO:0008654]; protein localization to plasma membrane [GO:0072659]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; ruffle assembly [GO:0097178]; signal transduction [GO:0007165]","GO:0000285; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005925; GO:0006650; GO:0006661; GO:0006909; GO:0007165; GO:0008654; GO:0010761; GO:0016308; GO:0016477; GO:0016607; GO:0019900; GO:0030027; GO:0030036; GO:0030216; GO:0032587; GO:0046854; GO:0048041; GO:0051896; GO:0052742; GO:0052810; GO:0060326; GO:0072659; GO:0090630; GO:0097178"
"93","Pocillopora_acuta_HIv2___RNAseq.g28706.t2",0,NA,0,11.1111111111111,0,5.26315789473684,0,0,0,NA,2.04678362573099,4.09356725146199,0,NA,NA,NA,NA,NA,NA,9.91994542739152,11.8955022487969,3.68233641306884,12.6668104899218,9.23910097643923,11.8174704685025,12.9288617750336,9.6922913982537,3.68233641306884,3.68233641306884,8.92069920235458,7.24320212564443,10.5981962790647,2394.09027443237,0.79076320095075,1.33999884699233,0.034307980616878,0.115518968724658,"Q32LQ0",0,"Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249)","cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]","GO:0003081; GO:0004177; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008270; GO:0008283; GO:0016477; GO:0042277; GO:0043171; GO:0070006"
"94","Pocillopora_acuta_HIv2___RNAseq.g10158.t1",NA,0,0,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.32215683786057,5.91207600133758,11.7248572855515,10.1631662320485,11.3778933071634,3.68233641306884,3.68233641306884,10.1198396764802,12.5081420550262,7.36045386352634,8.5853258085132,11.0105778324164,6.16007378461002,1479.44456660291,-3.13221368670166,3.97890151945225,9.61737019656354e-05,0.000803614341554564,"Q812E0",2.04e-137,"Cytoplasmic polyadenylation element-binding protein 2 (CPE-BP2) (CPE-binding protein 2) (mCPEB-2)","cellular response to arsenic-containing substance [GO:0071243]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of cytoplasmic translational elongation [GO:1900248]; negative regulation of translational elongation [GO:0045900]; regulation of translation at synapse, modulating synaptic transmission [GO:0099547]","GO:0000900; GO:0003730; GO:0005095; GO:0005634; GO:0005737; GO:0005840; GO:0008135; GO:0008187; GO:0032869; GO:0034599; GO:0035925; GO:0043005; GO:0043022; GO:0043023; GO:0043024; GO:0045202; GO:0045900; GO:0071243; GO:0071456; GO:0098978; GO:0099547; GO:1900248; GO:1990124; GO:2000766"
"95","Pocillopora_acuta_HIv2___RNAseq.g10164.t1",77.0833333333333,41.6666666666667,77.7777777777778,40.2597402597403,32.2033898305085,26.865671641791,28.5714285714286,66.1290322580645,70.1863354037267,65.1282051282051,52.5871580871242,49.0214892459978,56.1528269282507,NA,NA,NA,NA,NA,NA,8.41517652044097,8.76248534121948,9.00756979532748,9.77382290508381,9.55549527732361,10.1609536317461,10.2113216336423,8.55795729648213,5.77998567012395,8.19439564745621,8.8419163718846,8.26323691193963,9.42059583182958,572.248854806189,0.921158843951089,0.708966892756989,0.0794023590038539,0.221329795756707,"Q8BH74",0,"Nuclear pore complex protein Nup107 (107 kDa nucleoporin) (Nucleoporin Nup107)","female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]","GO:0000776; GO:0000973; GO:0005635; GO:0005643; GO:0006406; GO:0006606; GO:0006913; GO:0008585; GO:0017056; GO:0031080; GO:0031965; GO:0034399; GO:0051292; GO:0072006"
"96","Pocillopora_acuta_HIv2___RNAseq.g10169.t1",0,NA,0,28.5714285714286,0,0,0,NA,0,NA,4.08163265306122,9.52380952380952,0,NA,NA,NA,NA,NA,NA,13.2408544933762,13.1901392910446,13.9072620681228,12.7536264908731,13.3482616100999,12.880256116775,11.3398486800985,13.443704971715,13.8627028881295,13.5505549447003,13.1517211554935,13.5605572062887,12.7428851046983,9963.69318498531,-0.583392848704499,0.600769527392728,0.218026095293505,0.448337637059185,"Q5DTN8",2.63e-58,"Janus kinase and microtubule-interacting protein 3 (Neuroendocrine long coiled-coil protein 2)","","GO:0005794; GO:0008017; GO:0019900"
"97","Pocillopora_acuta_HIv2___RNAseq.g10172.t1",0,0,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.2882830075676,9.90463529410206,10.3403939197878,8.01456480640263,7.53005307756441,10.1935178367458,3.68233641306884,6.47440906252077,11.1506993177511,3.68233641306884,8.12612291485799,9.15676767703834,7.09547815267763,728.094359253717,-0.36307785425783,1.0352778015997,0.0770535721030642,0.216745014955022,"Q8BGF7",0,"PAN2-PAN3 deadenylation complex catalytic subunit Pan2 (EC 3.1.13.4) (Inactive ubiquitin carboxyl-terminal hydrolase 52) (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 2) (PAN deadenylation complex subunit 2)","mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]","GO:0000175; GO:0000289; GO:0000932; GO:0000956; GO:0003676; GO:0004535; GO:0005634; GO:0005737; GO:0006397; GO:0010606; GO:0031251; GO:0046872"
"98","Pocillopora_acuta_HIv2___RNAseq.g10173.t1",5.26315789473684,NA,0,0,0,0,NA,NA,0,NA,0.87719298245614,0,1.75438596491228,NA,NA,NA,NA,NA,NA,9.56529713715211,10.3447745836149,10.5366340591047,10.9392579432441,10.0345090319053,10.2575473752059,3.68233641306884,10.0462004661064,7.20548442133826,3.68233641306884,8.62943778438093,9.47762502312135,7.78125054564052,878.153294506483,-0.251155766196012,0.966088578390412,0.294765453467976,0.541808046633729,"Q9BSG0",6.81e-52,"Protease-associated domain-containing protein 1 (Protease-associated domain-containing protein of 21 kDa) (hPAP21)","","GO:0005576"
"99","Pocillopora_acuta_HIv2___RNAseq.g10183.t2",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.88936696569912,5.47000929073246,9.6202001066349,9.31308317152089,9.04339464299622,6.58890355943315,7.21775444370806,8.32018394145828,3.68233641306884,3.68233641306884,7.28275689483208,8.11109641397147,6.45441737569268,331.077727680795,-0.982729745460328,1.16642201509311,0.092638549854232,0.247036132944619,"Q5SNQ7",1.24e-139,"Protein SERAC1 (Serine active site-containing protein 1)","phospholipid biosynthetic process [GO:0008654]","GO:0005739; GO:0005783; GO:0008654; GO:0016020"
"100","Pocillopora_acuta_HIv2___TS.g28380.t1",75,NA,16.6666666666667,11.1111111111111,NA,0,0,NA,62.5,NA,27.5462962962963,24.537037037037,30.5555555555556,NA,NA,NA,NA,NA,NA,5.45976149983951,3.68233641306884,5.46801386253237,8.15411178501296,6.17395423718631,7.89192537626846,3.68233641306884,6.30287333300819,3.68233641306884,3.68233641306884,5.41799857461232,5.41738786912704,5.41860928009759,62.0864403220184,-0.0612996654880494,0.997888253636392,0.78064719519109,0.906275064711769,NA,NA,NA,NA,NA
"101","Pocillopora_acuta_HIv2___RNAseq.g10258.t1",0,11.7647058823529,0,0,0,0,0,NA,0,NA,1.47058823529412,2.94117647058824,0,NA,NA,NA,NA,NA,NA,9.63267198068178,8.72299482239946,11.7850766377646,3.68233641306884,11.8158198332899,9.65922015113216,9.26751085422486,9.5980161342024,11.6719119238911,10.7952689631252,9.66308277137803,10.900699301966,8.4254662407901,1536.07274437983,-0.561347015720823,1.00793209500119,0.191343611923309,0.410988120412642,"Q9P2E3",0,"NFX1-type zinc finger-containing protein 1","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"102","Pocillopora_acuta_HIv2___RNAseq.g10266.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.6305431643296,10.6598581476401,7.07964346771683,9.77382290508381,8.16357875140148,9.19350856641533,3.68233641306884,9.25423057809316,3.68233641306884,5.16462945902469,7.32844878658427,6.96206647492198,7.69483109824655,404.985273827796,0.389861115343751,1.05357467378386,0.129456936749558,0.315548556310349,"A1L1V4",1.97e-161,"Lysyl oxidase homolog 2B (EC 1.4.3.13) (Lysyl oxidase-like protein 2B)","collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]","GO:0000122; GO:0000785; GO:0001666; GO:0001837; GO:0001935; GO:0002040; GO:0004720; GO:0005507; GO:0005509; GO:0005604; GO:0005615; GO:0005634; GO:0005783; GO:0010718; GO:0016020; GO:0018057; GO:0030199; GO:0032332; GO:0043542; GO:0045892; GO:0062023; GO:0070828; GO:1902455"
"103","Pocillopora_acuta_HIv2___RNAseq.g10267.t1",0,NA,0,13.3333333333333,0,0,NA,NA,42.8571428571429,NA,9.36507936507936,18.7301587301587,0,NA,NA,NA,NA,NA,NA,7.80510606841379,7.34982382480446,7.48737098476787,8.55514865369028,6.90261169119261,7.9337598457867,9.03830110607458,9.59574864416972,9.05972216677657,5.84054469821112,7.95681376838877,8.17011191106411,7.74351562571343,294.910897877237,-0.168463955684103,0.745860602257838,0.710516544138376,0.86856924395009,"Q924Y0",4.63e-84,"Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)","carnitine biosynthetic process [GO:0045329]","GO:0005506; GO:0005739; GO:0005829; GO:0008270; GO:0008336; GO:0042802; GO:0045329"
"104","Pocillopora_acuta_HIv2___RNAseq.g10268.t1",0,0,0,0,NA,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.55063052532354,9.22754540130885,9.50676008046635,8.86138506883246,5.26345523824995,7.71720190845086,3.68233641306884,8.44649846873451,6.60889967998377,3.68233641306884,7.1547049197488,7.67524879855162,6.63416104094597,266.54453788582,-0.198712313721562,0.97221341163598,0.333342800173643,0.583992736642476,"Q5R5D8",3.91e-60,"Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)","carnitine biosynthetic process [GO:0045329]","GO:0005506; GO:0005739; GO:0008270; GO:0008336; GO:0045329"
"105","Pocillopora_acuta_HIv2___RNAseq.g10312.t2b",0,NA,NA,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.4090036334935,10.14889338463,9.23480256653339,11.0426173311569,10.4808723000625,10.5350208236373,3.68233641306884,9.12808203182104,9.01820994697393,11.6688041151233,9.63486425465007,9.85419409577687,9.41553441352327,1358.35315162472,-0.0048688341235705,0.893887071370781,0.949891377431702,0.980673010933058,"Q91WL6",8.58e-26,"Sorting nexin-11","intracellular protein transport [GO:0006886]; vesicle organization [GO:0016050]","GO:0005737; GO:0005768; GO:0005886; GO:0006886; GO:0016050; GO:1901981"
"106","Pocillopora_acuta_HIv2___RNAseq.g10324.t1",0,NA,NA,15.3846153846154,10,43.75,85.1851851851852,16.1290322580645,100,NA,38.6355475468379,43.81591191067,31.7283950617284,NA,NA,NA,NA,NA,NA,11.9972488908557,12.0711060055669,10.8520091984731,12.2962004824991,11.9899759839791,11.1111294217281,12.6862761650024,11.6619008182529,11.288533101434,11.1896405516674,11.7144020619459,11.557933598599,11.8708705252928,3596.07460447132,0.220291651001049,0.588832690807285,0.644601313902021,0.829494075113774,"Q20591",1.26e-09,"V-type proton ATPase subunit e (V-ATPase subunit e) (Vacuolar proton pump subunit e)","embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; regulation of syncytium formation by plasma membrane fusion [GO:0060142]; transmembrane transport [GO:0055085]","GO:0009792; GO:0010172; GO:0016324; GO:0033179; GO:0033181; GO:0043296; GO:0046961; GO:0055085; GO:0060142"
"107","Pocillopora_acuta_HIv2___RNAseq.g10332.t1",0,NA,NA,0,0,3.84615384615385,0,0,3.7037037037037,0,0.943732193732194,1.88746438746439,0,NA,NA,NA,NA,NA,NA,11.4686667330789,11.8715077846691,11.499947096591,10.7121666273761,11.4739988587474,11.1297574379119,11.868831109067,11.3860250803628,11.4661710505078,10.0417340541554,11.2918805832467,11.4589617638576,11.1247994026359,2628.36654805314,-0.230017075752669,0.570005165988897,0.608643232483284,0.805730890960847,"Q14185",0,"Dedicator of cytokinesis protein 1 (180 kDa protein downstream of CRK) (DOCK180)","apoptotic process [GO:0006915]; cell migration [GO:0016477]; integrin-mediated signaling pathway [GO:0007229]; myoblast fusion [GO:0007520]; phagocytosis, engulfment [GO:0006911]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of postsynapse assembly [GO:0150052]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]","GO:0005085; GO:0005096; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007165; GO:0007229; GO:0007264; GO:0007520; GO:0010634; GO:0016477; GO:0016607; GO:0017124; GO:0031267; GO:0032045; GO:0098794; GO:0098978; GO:0150052; GO:1900026"
"108","Pocillopora_acuta_HIv2___RNAseq.g10343.t1",0,NA,NA,0,0,5.88235294117647,0,0,NA,NA,0.980392156862745,1.96078431372549,0,NA,NA,NA,NA,NA,NA,3.68233641306884,8.62120790929901,3.68233641306884,7.15999107231523,7.32453244996143,8.4941803305107,8.09615847586979,3.68233641306884,3.68233641306884,9.29555005973397,6.37209659499655,4.41077562044736,8.33341756954574,180.956691067974,9.46293255639878,3.31399728006812,1.50181989303073e-07,3.08118055784346e-06,"Q8R508",1.12e-09,"Protocadherin Fat 3 (FAT tumor suppressor homolog 3)","cell morphogenesis involved in neuron differentiation [GO:0048667]; cell-cell adhesion [GO:0098609]; dendrite development [GO:0016358]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; interneuron migration [GO:1904936]; negative regulation of dendrite development [GO:2000171]; retina layer formation [GO:0010842]","GO:0005509; GO:0005886; GO:0007156; GO:0010842; GO:0016358; GO:0030425; GO:0048667; GO:0098609; GO:1904936; GO:2000171"
"109","Pocillopora_acuta_HIv2___TS.g28510.t1",3.03085299455535,3.54592260421857,3.10077519379845,3.14514973491904,3.18141342184085,2.83661119515885,3.35365853658537,2.55506607929515,2.9019334610695,2.63885933177272,3.02902425532139,2.99693661493222,3.06111189571055,NA,NA,NA,NA,NA,NA,11.1113437230856,11.5365017222324,9.72409444635252,9.04072922744591,11.0696681877765,11.8136352463873,11.2490607754768,11.321984137189,10.1302301064214,11.3288457440446,10.8326093316412,10.671464120165,10.9937545431174,2073.56149776526,0.235608368326449,0.558074794786992,0.610441017772278,0.807196680406437,"Q27245",7.4e-137,"Putative aminopeptidase W07G4.4 (EC 3.4.11.-)","proteolysis [GO:0006508]","GO:0005737; GO:0006508; GO:0008233; GO:0030145; GO:0070006"
"110","Pocillopora_acuta_HIv2___TS.g28519.t2",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.07520399501629,7.04438020601615,9.91403537940295,3.68233641306884,9.70330119506077,10.9816313977427,3.68233641306884,7.23961881407069,8.50807837694937,11.9237379769533,7.97546601673499,8.48804755210001,7.46288448136997,828.675999264355,-0.100463538680809,0.964279103088097,0.529365429303466,0.751089229202613,"Q6GQV7",0,"Erythroid differentiation-related factor 1","positive regulation of DNA-templated transcription [GO:0045893]","GO:0005634; GO:0045893"
"111","Pocillopora_acuta_HIv2___RNAseq.g10378.t1",0,0,0,NA,0,0.649350649350649,0,2.7027027027027,0,NA,0.419006669006669,0.838013338013338,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.82892698801727,3.68233641306884,11.6981824552172,3.68233641306884,11.750478446316,11.0645555604008,3.68233641306884,3.68233641306884,11.1733103769905,7.3927135892286,3.68233641306884,11.1030907653884,1200.09323446445,16.1580082923622,3.7327526613979,6.29738672866728e-18,8.28049105849486e-15,"P22897",1.35e-39,"Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)","cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898]","GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353"
"112","Pocillopora_acuta_HIv2___RNAseq.g10391.t1",NA,0,0,NA,0,5.88235294117647,0,0,NA,NA,0.980392156862745,1.96078431372549,0,NA,NA,NA,NA,NA,NA,10.8228459591682,10.7203117358136,9.12758054862443,10.4935824008778,11.3211007664751,10.4140421555981,11.6459804459506,10.1921538192403,11.12095616988,5.3719891395326,10.1230543141161,10.5169274526776,9.72918117555454,1581.38095306334,-0.108480895912516,0.819191285975805,0.767967420995897,0.899350722798531,"P21804",7.47e-161,"Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (Tyrosine kinase receptor CEK1)","epicardial cell to mesenchymal cell transition [GO:0003347]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of MAP kinase activity [GO:0043406]","GO:0003347; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0008201; GO:0008284; GO:0017134; GO:0018108; GO:0031410; GO:0043235; GO:0043406; GO:0045597; GO:0045893"
"113","Pocillopora_acuta_HIv2___RNAseq.g10400.t1",69.2307692307692,100,100,NA,NA,10,0,0,NA,NA,46.5384615384615,36.6666666666667,56.4102564102564,NA,NA,NA,NA,NA,NA,7.54234269767134,9.56647818007754,5.29770193163976,3.68233641306884,9.18383234974313,8.78684054235706,8.32468560390437,9.54140953139528,7.99984958653483,3.68233641306884,7.3607813249461,7.91302721939687,6.80853543049533,313.088992622955,-0.410755729240725,1.01095794106391,0.142304802225195,0.336738379200575,"O13067",1.92e-126,"Condensin complex subunit 2 (Barren homolog) (Chromosome assembly protein xCAP-H) (Chromosome-associated protein H) (Non-SMC condensin I complex subunit H)","cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]","GO:0000796; GO:0005634; GO:0005829; GO:0007076; GO:0051301"
"114","Pocillopora_acuta_HIv2___RNAseq.g10411.t1",0,1.17647058823529,1.06382978723404,NA,0,0,6.4327485380117,0,0,10.5263157894737,2.13326274477275,0.294117647058824,3.60457882294388,NA,NA,NA,NA,NA,NA,3.68233641306884,6.77312724931675,9.73168757660773,4.11054575398787,8.02553521909383,9.07728000736896,9.88183135960973,10.1800982561138,3.68233641306884,3.68233641306884,6.88271146613052,7.06039877559061,6.70502415667043,371.399738346123,0.045724702171365,0.961948242338097,0.803810684403687,0.917677827204095,NA,NA,NA,NA,NA
"115","Pocillopora_acuta_HIv2___TS.g28575.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.3723982736367,6.97205094875064,9.72789600924421,8.86491749563458,9.23910097643923,9.37297703992093,8.46055785917695,7.63547889605305,10.9019679311665,6.94153598059022,8.8488881410613,9.57536841730794,8.12240786481466,636.864562509553,-0.678282187137007,0.918307568436213,0.136730148513642,0.328095886076094,"P50429",7.61e-99,"Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)","anterior head development [GO:0097065]; autophagy [GO:0006914]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; dermatan sulfate catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]","GO:0003943; GO:0004065; GO:0005764; GO:0006914; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030207; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065"
"116","Pocillopora_acuta_HIv2___TS.g28592.t1",0,0,0,0,0,0,0,0,6.66666666666667,NA,0.740740740740741,1.33333333333333,0,NA,NA,NA,NA,NA,NA,10.2374665340492,3.68233641306884,7.40065151733208,9.87708254069058,8.47378357104876,3.68233641306884,3.68233641306884,7.6791315170708,6.10133000554887,3.68233641306884,6.44987913380156,7.97847262900994,4.92128563859319,279.658368326163,-0.560268153881869,1.25078693995987,3.51327475520528e-08,8.81026640538631e-07,NA,NA,NA,NA,NA
"117","Pocillopora_acuta_HIv2___TS.g28611.t1c",0,NA,0,0,0,5.98290598290598,0,0,0,NA,0.747863247863248,1.4957264957265,0,NA,NA,NA,NA,NA,NA,9.08456176348129,5.96448686545822,6.94541193766045,3.68233641306884,7.07816103693054,3.68233641306884,3.68233641306884,3.68233641306884,10.2521665779218,3.68233641306884,5.77364702467965,7.40852754581258,4.13876650354672,196.055853456284,-0.700382402065787,1.39514553886053,0.000455554775840023,0.00302389754922089,"P70584",0,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (SBCAD) (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-MEBCAD) (2-methylbutyryl-coenzyme A dehydrogenase) (2-methylbutyryl-CoA dehydrogenase)","acyl-CoA metabolic process [GO:0006637]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; isoleucine catabolic process [GO:0006550]","GO:0003853; GO:0003995; GO:0004085; GO:0005739; GO:0005759; GO:0006550; GO:0006631; GO:0006635; GO:0006637; GO:0009055; GO:0016937; GO:0042802; GO:0050660; GO:0102035"
"118","Pocillopora_acuta_HIv2___TS.g28628.t1",NA,NA,0,0,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,13.2013591558649,10.9466105953681,13.3173150618162,11.0999079491544,13.233675129469,11.9026503416321,12.3753727196416,11.9356826445453,13.3018297590713,11.0411893009257,12.2355592657489,12.9979723501533,11.4731461813444,5843.58070078185,-1.15590659724647,0.757470305468879,0.0313109053405711,0.10713537072197,"O75923",0,"Dysferlin (Dystrophy-associated fer-1-like protein) (Fer-1-like protein 1)","macrophage activation involved in immune response [GO:0002281]; monocyte activation involved in immune response [GO:0002280]; negative regulation of phagocytosis [GO:0050765]; regulation of neurotransmitter secretion [GO:0046928]","GO:0002280; GO:0002281; GO:0005509; GO:0005543; GO:0005544; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0030139; GO:0030315; GO:0030659; GO:0030672; GO:0034451; GO:0042383; GO:0046928; GO:0050765; GO:0070062"
"119","Pocillopora_acuta_HIv2___RNAseq.g10471.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.1572797975657,7.41968306595897,3.68233641306884,9.98688256397385,7.35792596442826,3.68233641306884,9.5425872637072,5.93804482828044,6.58881646192222,6.50382291850432,7.31390682699786,5.69373901001077,222.42465505848,-0.180218295246087,1.01205409023297,0.157720345919305,0.360450459071588,"Q5ZI67",0,"NHL repeat-containing protein 2","","GO:0005829"
"120","Pocillopora_acuta_HIv2___RNAseq.g10475.t1",0,0,0,0,2.63157894736842,2.30769230769231,0,0,0,NA,0.54880791722897,0.461538461538462,0.657894736842105,NA,NA,NA,NA,NA,NA,9.177758267203,3.68233641306884,8.73262645402442,3.68233641306884,4.93003625965001,3.68233641306884,3.68233641306884,7.12388258861865,7.58665737684829,3.68233641306884,5.59626430116886,7.51019218926887,3.68233641306884,124.644748807805,-11.4286991319928,3.80269829475197,8.74590770391492e-08,1.91958739043134e-06,"Q9NZM1",0,"Myoferlin (Fer-1-like protein 3)","blood circulation [GO:0008015]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; regulation of neurotransmitter secretion [GO:0046928]","GO:0001778; GO:0005509; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0006936; GO:0008015; GO:0030672; GO:0031410; GO:0031965; GO:0034451; GO:0043231; GO:0046928; GO:0070062"
"121","Pocillopora_acuta_HIv2___RNAseq.g10476.t1",NA,NA,0,0,0,3.94736842105263,0,NA,0,NA,0.657894736842105,1.31578947368421,0,NA,NA,NA,NA,NA,NA,6.70689227093755,7.54444492362095,8.20855739098366,8.5507670998478,8.78564044127335,8.98847123139205,3.68233641306884,7.43091797997457,3.68233641306884,5.75038415558079,6.93307483197484,6.96286889924759,6.90328076470209,194.035569012156,0.0967684162529203,0.922543277634825,0.756678794267505,0.893363976841498,"Q5ZKD5",0,"RRP12-like protein","rRNA processing [GO:0006364]","GO:0003723; GO:0005730; GO:0006364; GO:0031965"
"122","Pocillopora_acuta_HIv2___RNAseq.g10492.t3",0,0,0,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.6591379197004,8.21291850728319,9.8198170145748,11.6947155664929,10.8499367782142,11.2949187650262,8.33935160288026,9.49471105790083,11.405247620349,7.43123314299026,9.9201987975412,10.4457700781478,9.39462751693456,1416.66920689575,-0.476383303723978,0.860895409841942,0.264297933984369,0.507609257356249,"Q9Y251",1.3e-108,"Heparanase (EC 3.2.1.166) (Endo-glucoronidase) (Heparanase-1) (Hpa1) [Cleaved into: Heparanase 8 kDa subunit; Heparanase 50 kDa subunit]","angiogenesis involved in wound healing [GO:0060055]; cell-matrix adhesion [GO:0007160]; establishment of endothelial barrier [GO:0061028]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin metabolic process [GO:0030202]; positive regulation of blood coagulation [GO:0030194]; positive regulation of hair follicle development [GO:0051798]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein transmembrane transport [GO:0071806]; proteoglycan metabolic process [GO:0006029]; regulation of hair follicle development [GO:0051797]; vascular wound healing [GO:0061042]","GO:0004566; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005764; GO:0005765; GO:0006029; GO:0007160; GO:0010575; GO:0030194; GO:0030200; GO:0030202; GO:0030305; GO:0031012; GO:0033690; GO:0035580; GO:0043202; GO:0043231; GO:0045121; GO:0045545; GO:0051797; GO:0051798; GO:0051897; GO:0060055; GO:0061028; GO:0061042; GO:0071806"
"123","Pocillopora_acuta_HIv2___TS.g28669.t2",0,0,0,0,0,0,1.12359550561798,0,NA,NA,0.140449438202247,0,0.280898876404494,NA,NA,NA,NA,NA,NA,8.62035545127034,6.34267098328276,9.4185499034729,10.8503495025272,9.71113904175288,10.3089814008435,3.68233641306884,8.35012626776362,5.22517199274777,3.68233641306884,7.61920173697987,8.2650685314015,6.97333494255823,527.832482087352,-0.446633028687861,1.04161045185264,0.0887433981627484,0.239162383272963,"Q9VY86",2.07e-66,"TM2 domain-containing protein amaretto (TM2D2)","positive regulation of Notch signaling pathway [GO:0045747]","GO:0005886; GO:0045747"
"124","Pocillopora_acuta_HIv2___RNAseq.g10523.t1",0,NA,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.07277270383655,8.46454219346938,6.63116616429788,5.7042294826067,9.9828417779223,9.27491485399286,10.8115326724436,8.20274232164201,3.68233641306884,3.68233641306884,7.5509414996349,7.51437187615352,7.58751112311628,456.746621102865,-0.032545452467463,0.787871493709502,0.958137895784644,0.984472733402787,"Q9P3U4",1.18e-26,"E3 ubiquitin-protein ligase dbl4 (EC 2.3.2.31) (DNA-break-localizing protein 4) (Histone E3 ligase 1) (RING-type E3 ubiquitin transferase dbl4)","meiosis I [GO:0007127]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0007127; GO:0008270; GO:0031624; GO:0035861; GO:0061630"
"125","Pocillopora_acuta_HIv2___RNAseq.g10524.t1",NA,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.29806064110399,10.4778798658706,10.7385273137647,8.62766417813255,10.9865551596419,10.0703403482893,11.0608787961232,10.2559986509068,10.2675941641994,10.1521081698873,10.193560728792,10.3093471859234,10.0777742716606,1273.83374510119,-0.120870201503699,0.655415726138251,0.783492137079552,0.907974542962794,"Q14690",0,"Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11)","rRNA processing [GO:0006364]","GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0032040; GO:0051059"
"126","Pocillopora_acuta_HIv2___RNAseq.g10529.t1",0,NA,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.37346221971597,11.4923824052252,6.051458458319,12.4682125804814,8.50119371632014,11.0490197859987,12.9892995903744,7.54396176493916,3.68233641306884,12.2100150584497,9.43613419928925,6.83048251447262,12.0417858841059,2425.59091314201,4.28260794289436,2.05288901626838,3.78839937676238e-05,0.000358608694931224,NA,NA,NA,NA,NA
"127","Pocillopora_acuta_HIv2___RNAseq.g10539.t1",NA,100,NA,66.6666666666667,50,100,100,NA,NA,100,86.1111111111111,88.8888888888889,83.3333333333333,NA,NA,NA,NA,NA,NA,10.3762383169704,9.42606845816916,11.3202815625424,11.6380814029629,9.77702858185629,10.3898913483828,9.4200027824133,9.17289220777975,9.00976203881632,10.400321389207,10.09305680891,9.93124054159303,10.254873076227,1285.4570871294,0.242591554099396,0.580033655602079,0.612073402846786,0.808569704884091,NA,NA,NA,NA,NA
"128","Pocillopora_acuta_HIv2___RNAseq.g10559.t1",0,0,0,0,NA,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.18524234540962,6.54125763453179,6.71656868271498,6.92073451612509,5.98573247127087,8.1794761914649,8.68756916100612,6.58108861241956,6.76651737006592,3.68233641306884,6.72465233980777,6.64702989637619,6.80227478323935,121.675541685344,0.0798124227269619,0.880531315898657,0.852070180438006,0.941559311367103,"Q90Z00",2.19e-39,"Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)","anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; cartilage development [GO:0051216]; cell migration in hindbrain [GO:0021535]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; mesoderm development [GO:0007498]; negative regulation of endodermal cell fate specification [GO:0042664]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; pectoral fin development [GO:0033339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589]","GO:0001889; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008201; GO:0008284; GO:0008543; GO:0009953; GO:0017134; GO:0018108; GO:0021535; GO:0021628; GO:0031101; GO:0031410; GO:0033339; GO:0036342; GO:0042664; GO:0043235; GO:0043406; GO:0043589; GO:0045471; GO:0045597; GO:0048738; GO:0048916; GO:0051216; GO:0060249; GO:0071699"
"129","Pocillopora_acuta_HIv2___RNAseq.g10560.t1",0,0,NA,0,0,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,7.78205843074092,6.68494107039366,8.32373142797256,3.68233641306884,4.89684440866119,9.1163185259133,10.0559652128951,6.90466504079117,5.66277130452222,6.28126538983346,6.93908972247924,6.71401412253761,7.16416532242087,232.544753341095,0.164145541084822,0.953902225434766,0.561967421425116,0.774224072338466,"Q7T2H2",1.06e-38,"Fibroblast growth factor receptor-like 1","negative regulation of cell population proliferation [GO:0008285]","GO:0005007; GO:0005886; GO:0008201; GO:0008285; GO:0017134"
"130","Pocillopora_acuta_HIv2___TS.g28716.t2",0,0,0,5.3030303030303,3.14465408805031,0.440528634361233,0,0,0,0,0.888821302544185,1.14871178747831,0.628930817610063,NA,NA,NA,NA,NA,NA,11.3570035394115,13.1039302696031,11.3505909254375,12.7659502142755,9.50791582262198,12.6693858382691,13.1434381930662,11.7103765959392,11.792478539738,9.98671807609604,11.7387788014458,11.1436730846296,12.333884518262,4495.09538138323,0.774911321846177,0.842398630276943,0.131880486033435,0.319785305949304,"Q90Z00",8.06e-173,"Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A)","anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; cartilage development [GO:0051216]; cell migration in hindbrain [GO:0021535]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; mesoderm development [GO:0007498]; negative regulation of endodermal cell fate specification [GO:0042664]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; pectoral fin development [GO:0033339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589]","GO:0001889; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008201; GO:0008284; GO:0008543; GO:0009953; GO:0017134; GO:0018108; GO:0021535; GO:0021628; GO:0031101; GO:0031410; GO:0033339; GO:0036342; GO:0042664; GO:0043235; GO:0043406; GO:0043589; GO:0045471; GO:0045597; GO:0048738; GO:0048916; GO:0051216; GO:0060249; GO:0071699"
"131","Pocillopora_acuta_HIv2___RNAseq.g10571.t2",100,NA,NA,0,100,0,8.33333333333333,0,NA,NA,34.7222222222222,0,69.4444444444444,NA,NA,NA,NA,NA,NA,7.71060374849395,8.5816047084155,9.66979264516464,11.9511684158828,10.263608750114,10.2779367267377,3.68233641306884,9.17136999962046,7.13419520346623,3.68233641306884,8.2124953024033,8.78991406937186,7.63507653543474,835.245418261617,-0.163410483034914,0.959395265185186,0.426500533247745,0.67089763054871,"Q155U0",0,"Vacuolar protein sorting-associated protein 51 homolog (Protein fat-free)","endocytic recycling [GO:0032456]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; lipid digestion [GO:0044241]; lipid transport [GO:0006869]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000938; GO:0005829; GO:0006869; GO:0007030; GO:0007041; GO:0015031; GO:0016020; GO:0031267; GO:0032456; GO:0042147; GO:0044241; GO:0048193; GO:0055037; GO:1990745"
"132","Pocillopora_acuta_HIv2___TS.g28749.t2",100,100,NA,NA,100,100,100,100,NA,NA,100,100,100,NA,NA,NA,NA,NA,NA,9.99928375663534,7.7661671588452,10.5531531369643,4.52967082297852,8.26572797413929,8.07593932466908,10.8698525938353,10.2393930134844,11.6159945778485,3.68233641306884,8.55975187724688,10.1347104918144,6.98479326267939,934.186056200257,-0.529688756433366,1.08240251622657,0.0433288378569018,0.139175729682928,"Q6DRN3",4.13e-159,"Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein)","DNA replication initiation [GO:0006270]; muscle organ development [GO:0007517]; regulation of lipid metabolic process [GO:0019216]","GO:0003682; GO:0005634; GO:0005730; GO:0006270; GO:0007517; GO:0019216"
"133","Pocillopora_acuta_HIv2___TS.g28772.t1b",18.3673469387755,0,7.14285714285714,9.61538461538461,5.26315789473684,17.0731707317073,3.48837209302326,100,3.84615384615385,NA,18.3107159180709,26.1069418386492,8.56543351734819,NA,NA,NA,NA,NA,NA,10.0697491819078,10.3763325939149,9.07082176627209,7.49865221587083,7.69786528086486,7.15975907427809,8.1019074575871,8.79990569909095,11.3041529098917,3.68233641306884,8.37614825927472,9.38849896760548,7.36379755094395,649.561972885432,-0.43774300497314,0.946793756276091,0.293323580470509,0.540187454535961,NA,NA,NA,NA,NA
"134","Pocillopora_acuta_HIv2___RNAseq.g10667.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.72892691866849,6.81522472615292,10.0588925642694,10.6834673845515,10.2958855447891,9.07728000736896,3.68233641306884,9.39129524057586,8.57835652673245,10.1183815059524,8.84300468321299,9.61067135900706,8.07533800741892,740.711460808462,-0.349890164864785,0.95598649635242,0.285005001854517,0.531088939297055,"Q8IYW2",0,"Cilia- and flagella-associated protein 46 (Tetratricopeptide repeat protein 40)","axoneme assembly [GO:0035082]; cilium movement involved in cell motility [GO:0060294]","GO:0005930; GO:0035082; GO:0060294"
"135","Pocillopora_acuta_HIv2___RNAseq.g10671.t1",100,NA,NA,100,100,90,100,NA,100,NA,98.3333333333333,96.6666666666667,100,NA,NA,NA,NA,NA,NA,6.79100259980268,3.68233641306884,6.31061316215391,3.68233641306884,6.03856483543094,6.52080719718656,3.68233641306884,3.68233641306884,10.0140122009672,3.68233641306884,5.40866820608855,6.56730584228471,4.25003056989238,126.131239976767,-0.326579272894552,1.07132559999987,0.00521196106367902,0.0240849216693461,"Q6P4W0",2.82e-33,"BRISC complex subunit Abraxas 2 (Abraxas brother protein 1) (BRISC complex subunit Abro1) (Protein FAM175B)","attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; protein K63-linked deubiquitination [GO:0070536]; response to ischemia [GO:0002931]","GO:0000278; GO:0000922; GO:0002931; GO:0005737; GO:0005874; GO:0007059; GO:0008017; GO:0008608; GO:0031593; GO:0051301; GO:0070536; GO:0070552; GO:0090307"
"136","Pocillopora_acuta_HIv2___RNAseq.g10675.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.56356363373408,7.67854539303102,9.82692368906039,3.68233641306884,9.32206712341433,6.73992398508141,11.5021045831201,9.45021961732666,3.68233641306884,6.68566082080521,7.51336816717109,7.76902209532086,7.25771423902132,545.864901122435,0.0672723123517645,0.965455443837378,0.814648468399197,0.92278764562033,"Q9NY93",0,"Probable ATP-dependent RNA helicase DDX56 (EC 3.6.4.13) (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 21) (DEAD box protein 56)","defense response to virus [GO:0051607]; modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of type I interferon production [GO:0032480]; positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364]","GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005829; GO:0006364; GO:0010976; GO:0016020; GO:0016887; GO:0032480; GO:0035613; GO:0044830; GO:0051607; GO:0140311"
"137","Pocillopora_acuta_HIv2___TS.g28868.t3b",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.90673003465521,7.58520805892439,10.1257269137746,10.5734235479739,9.00723206100263,4.42568256259181,11.0386192174367,7.21006425203984,7.62417468898769,9.28037588240969,8.67772372197965,8.77478559009199,8.5806618538673,715.455080828935,-0.00385413761516608,0.893713570099562,0.937557798082582,0.976536811102885,"O75882",4.5e-78,"Attractin (DPPT-L) (Mahogany homolog)","cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; myelination [GO:0042552]; pigmentation [GO:0043473]; regulation of multicellular organism growth [GO:0040014]","GO:0005615; GO:0005794; GO:0005886; GO:0006954; GO:0021549; GO:0030246; GO:0038023; GO:0040014; GO:0042552; GO:0043473; GO:0070062"
"138","Pocillopora_acuta_HIv2___TS.g28912.t1",0,4.76190476190476,0,0,NA,4.34782608695652,1.96078431372549,0,0,NA,1.38381439532335,1.82194616977226,0.65359477124183,NA,NA,NA,NA,NA,NA,9.6597101835665,10.3786429865617,9.18403502245729,9.89100105496667,10.9162656535731,6.97046070240566,8.45608009706679,10.4573400721582,10.8011978682085,3.68233641306884,9.03970700540333,10.2037097599927,7.87570425081393,904.252286574446,-0.485156036779276,1.02893267249414,0.12643744179913,0.310069711458566,"Q9H173",8.39e-85,"Nucleotide exchange factor SIL1 (BiP-associated protein) (BAP)","cotranslational protein targeting to membrane [GO:0006613]; intracellular protein transport [GO:0006886]; protein folding [GO:0006457]","GO:0000774; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0006613; GO:0006886; GO:0042802; GO:0051082"
"139","Pocillopora_acuta_HIv2___RNAseq.g10754.t1",71.4285714285714,NA,NA,100,100,100,100,100,NA,NA,95.2380952380952,100,90.4761904761905,NA,NA,NA,NA,NA,NA,11.1119195564393,11.9159264355676,11.2462444908701,10.7959146107603,10.8477168546953,11.1652129542341,9.66060678084091,11.2145409602133,11.7385727960438,12.3076955085879,11.2004350948253,11.2317989316524,11.1690712579982,2584.02869383556,-0.0305211746361902,0.588349834698412,0.945169546229449,0.979433465873531,"O94844",6.63e-141,"Rho-related BTB domain-containing protein 1","actin filament organization [GO:0007015]; Cdc42 protein signal transduction [GO:0032488]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]","GO:0003924; GO:0005525; GO:0005886; GO:0006897; GO:0007015; GO:0007163; GO:0010008; GO:0019901; GO:0032488"
"140","Pocillopora_acuta_HIv2___RNAseq.g10760.t1",0,NA,NA,NA,0,0,8.33333333333333,0,0,0,1.19047619047619,0,2.08333333333333,NA,NA,NA,NA,NA,NA,7.93088772907051,3.68233641306884,10.29243086444,3.68233641306884,10.3879852282002,10.6707342634831,3.68233641306884,9.73102919861487,10.9767935560446,3.68233641306884,7.47192064921286,9.86382531527404,5.08001598315169,718.058040142953,-0.86085951894291,1.60236247930637,4.08479772911216e-08,9.98015445166863e-07,"B3DK16",3.01e-78,"Polycomb group RING finger protein 5-A","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0006357; GO:0031519; GO:0035102; GO:0046872"
"141","Pocillopora_acuta_HIv2___RNAseq.g10761.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0932707290483,3.68233641306884,3.68233641306884,9.1974039465744,3.68233641306884,7.34242603626167,8.08459101729263,6.36973004382258,3.68233641306884,3.68233641306884,5.94991038383438,5.50200200241548,6.39781876525328,207.157708903374,0.14497319906104,1.0203586957311,0.0226315210216167,0.0821436185838555,"B3DK16",1.32e-80,"Polycomb group RING finger protein 5-A","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0006357; GO:0031519; GO:0035102; GO:0046872"
"142","Pocillopora_acuta_HIv2___RNAseq.g10787.t1",0,NA,NA,0,0,0,0,0,8.33333333333333,NA,1.19047619047619,2.08333333333333,0,NA,NA,NA,NA,NA,NA,7.39792737798653,8.21291850728319,10.455667605344,8.71247567247621,10.6448095403786,9.96235558945678,3.68233641306884,8.11346982294029,8.81015142515567,7.74047756756941,8.37325895216595,9.08440515436102,7.66211274997089,560.049879468571,-0.50720403203006,0.948385439037651,0.233871820952084,0.469170876317745,"Q9LMG7",3.82e-96,"Probable inactive purple acid phosphatase 2","protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]; regulation of carbohydrate metabolic process [GO:0006109]","GO:0003993; GO:0005576; GO:0005739; GO:0005740; GO:0005768; GO:0005794; GO:0005802; GO:0006109; GO:0006626; GO:0009507; GO:0009941; GO:0030943; GO:0045040; GO:0046872"
"143","Pocillopora_acuta_HIv2___RNAseq.g10836.t1",NA,100,NA,NA,12.5,14.2857142857143,50,NA,0,100,46.1309523809524,38.0952380952381,54.1666666666667,NA,NA,NA,NA,NA,NA,11.127950272234,10.8837518842372,11.341936844083,11.1192492562659,11.3717266456193,9.73640256296908,10.2672772798658,11.2011824909613,11.5698372716671,13.3316685192555,11.1950983027158,11.3225267049129,11.0676699005187,2913.0802471855,-0.18216946859232,0.641691303563797,0.692138361229788,0.85904909672647,"Q6A039",7.82e-172,"TBC1 domain family member 12","regulation of autophagosome assembly [GO:2000785]","GO:0005096; GO:0005776; GO:0055037; GO:2000785"
"144","Pocillopora_acuta_HIv2___RNAseq.g10837.t1",NA,0,0,NA,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.91796257251019,10.0465341190243,10.4753974692735,10.4030041672138,9.8418246132622,7.99430979892605,3.68233641306884,9.97907359024988,9.74395528639864,3.68233641306884,8.47667344429962,9.79164270633888,7.16170418226037,715.482527863084,-0.376213917067838,1.02893915102703,0.0977042302153843,0.257084589018613,"A8K8P3",1.66e-93,"Protein SFI1 homolog (hSFI1)","","GO:0005814; GO:0005829; GO:0019902"
"145","Pocillopora_acuta_HIv2___TS.g29013.t1a",0,NA,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.3196046154645,11.2752242515766,11.3705841515508,11.1778943849744,10.4883020091908,10.3276837061931,10.7024868246618,8.26980134459445,12.3574260427299,9.0626023853959,10.6351609716332,10.7611436327061,10.5091783105604,2022.24601375092,-0.0858092786553869,0.736937074562788,0.834900035453848,0.933879368401861,"P57680",5.64e-10,"EvC complex member EVC (Ellis-van Creveld syndrome protein homolog)","cartilage development [GO:0051216]; endochondral bone growth [GO:0003416]; positive regulation of smoothened signaling pathway [GO:0045880]; smoothened signaling pathway [GO:0007224]","GO:0003416; GO:0005737; GO:0005929; GO:0007224; GO:0036064; GO:0045880; GO:0051216; GO:0060170; GO:0098797"
"146","Pocillopora_acuta_HIv2___RNAseq.g10847.t1",NA,NA,26.6666666666667,NA,12.5,20,33.3333333333333,38.4615384615385,0,NA,21.8269230769231,19.4871794871795,24.1666666666667,NA,NA,NA,NA,NA,NA,11.72727707733,11.148959156146,11.4046223220728,10.8315300536769,10.1968040219675,11.6259870858607,10.5977746138779,11.6033009235099,11.8842447881676,10.1992489707214,11.1219749013331,11.3632498266096,10.8806999760566,2388.97259252051,-0.333351430005772,0.63700840882871,0.474940033926113,0.711133337371366,"A1L224",6.35e-49,"Cyclic AMP-responsive element-binding protein 3-like protein 2 (cAMP-responsive element-binding protein 3-like protein 2) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 2]","cartilage development [GO:0051216]; chondrocyte differentiation [GO:0002062]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of extracellular matrix constituent secretion [GO:0003330]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]","GO:0000976; GO:0000981; GO:0002062; GO:0003330; GO:0005634; GO:0005783; GO:0005789; GO:0006357; GO:0006986; GO:0034976; GO:0035497; GO:0051216; GO:0060628"
"147","Pocillopora_acuta_HIv2___RNAseq.g10856.t1",6.66666666666667,NA,NA,NA,7.14285714285714,0,0,20,0,0,4.82993197278912,6.66666666666667,3.45238095238095,NA,NA,NA,NA,NA,NA,3.68233641306884,10.3506709900221,9.93062374535648,4.99561439145868,10.5036117378574,10.259599329331,10.3954312527079,9.31201181857581,3.68233641306884,3.68233641306884,7.67945725045159,7.42218402558547,7.9367304753177,680.012589743658,0.0676650353182763,0.963720686939203,0.814592769117286,0.92278764562033,"A2RSQ0",0,"DENN domain-containing protein 5B (Rab6IP1-like protein)","positive regulation of triglyceride transport [GO:1905885]","GO:0005085; GO:0016020; GO:0031267; GO:1905885"
"148","Pocillopora_acuta_HIv2___RNAseq.g10857.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.283266912285,12.1972010437036,12.5493951476617,11.5775201932448,12.527526835556,12.4972747694648,10.7525798757319,12.156887882164,13.6807813682761,11.870288921447,12.2092722949535,12.6395716291886,11.7789729607184,5332.8095470608,-0.632899518353595,0.600689991484597,0.182431447569306,0.398052263937613,"Q9R1C7",1.68e-145,"Pre-mRNA-processing factor 40 homolog A (Formin-binding protein 11) (FBP-11) (Formin-binding protein 3)","cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]","GO:0000398; GO:0003723; GO:0005634; GO:0005685; GO:0007010; GO:0008360; GO:0016363; GO:0016477; GO:0016607; GO:0032465; GO:0045292; GO:0070064; GO:0071004"
"149","Pocillopora_acuta_HIv2___TS.g29038.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0092102347911,8.07697750564745,8.62521464881705,8.43189622021237,8.98961074851081,8.79818649690832,3.68233641306884,9.98774538530658,10.8665585711123,11.4379609265562,8.8905697150931,9.69566791770757,8.08547151247864,842.268213136391,-0.361710913283951,0.922092953699614,0.365542613720065,0.615274510202997,"O13024",2.97e-44,"Inner centromere protein A (XL-INCENP) (xINC) (xIncenp) (Mitotic phosphoprotein 130)","chromosome segregation [GO:0007059]; mitotic cytokinesis [GO:0000281]; spindle assembly [GO:0051225]","GO:0000281; GO:0000775; GO:0000776; GO:0005634; GO:0005694; GO:0005721; GO:0005737; GO:0005819; GO:0005874; GO:0007059; GO:0019901; GO:0030496; GO:0032133; GO:0051225"
"150","Pocillopora_acuta_HIv2___TS.g29039.t1",NA,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.46246053131994,6.59081673114823,8.11083112805987,8.67673780760658,9.66950672919912,3.68233641306884,8.2746896597434,8.9880943483143,7.65349580332634,7.75155885986295,7.88605280116496,8.77687770804391,6.995227894286,331.071371529842,-0.423964801179507,0.965477674953191,0.246335210068835,0.48542131858796,"Q9Y4D2",2.21e-136,"Diacylglycerol lipase-alpha (DAGL-alpha) (DGL-alpha) (EC 3.1.1.116) (Neural stem cell-derived dendrite regulator) (Sn1-specific diacylglycerol lipase alpha)","arachidonic acid metabolic process [GO:0019369]; cannabinoid biosynthetic process [GO:1901696]; diacylglycerol catabolic process [GO:0046340]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; monoacylglycerol biosynthetic process [GO:0006640]; neuroblast proliferation [GO:0007405]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921]","GO:0004465; GO:0005737; GO:0005886; GO:0006640; GO:0007216; GO:0007405; GO:0019369; GO:0031901; GO:0032590; GO:0032591; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0047372; GO:0098839; GO:0098921; GO:0150077; GO:1901696"
"151","Pocillopora_acuta_HIv2___RNAseq.g10867.t1",0,NA,NA,NA,0,7.01754385964912,0,0,0,NA,1.16959064327485,2.33918128654971,0,NA,NA,NA,NA,NA,NA,6.46401383180475,5.80053168740374,3.68233641306884,10.2041551488552,7.49854836219816,10.3528896084419,4.27277361158612,8.7740530111372,3.68233641306884,3.68233641306884,6.44139745006336,6.02025760625556,6.86253729387116,310.456009011334,0.061645104922113,0.985902074430023,0.65266737679196,0.834959871756345,"Q9EQD2",9.67e-26,"Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor)","cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408]","GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408"
"152","Pocillopora_acuta_HIv2___RNAseq.g10873.t1",NA,0,0,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.18524234540962,10.6512843483523,10.6683973190688,3.68233641306884,10.1564757522655,10.5963780852394,7.48839984654508,9.69970043120983,9.54597865270329,10.3448933957362,9.00190865895989,9.45115890013141,8.55265841778836,890.193429213357,-0.0729858238860096,0.919839158094728,0.78577197324992,0.908941604373548,"E9Q8T7",0,"Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (mDHC7)","cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; sperm axoneme assembly [GO:0007288]","GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005874; GO:0007288; GO:0008569; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060294"
"153","Pocillopora_acuta_HIv2___RNAseq.g10875.t1a",NA,NA,14.2857142857143,0,NA,0,12.5,NA,0,42.8571428571429,11.6071428571429,0,23.2142857142857,NA,NA,NA,NA,NA,NA,6.5907432092831,8.9451651783571,8.5866219774936,8.89632549336012,5.90231870585895,6.49260508637142,3.68233641306884,9.40819335746328,3.68233641306884,11.9610785083067,7.4147724342632,6.83404273263355,7.99550213589284,606.877918744032,0.161636448506452,0.972735735682406,0.518697882778892,0.742890006586185,"A4QMS7",2.36e-12,"Cilia- and flagella-associated protein 90","flagellated sperm motility [GO:0030317]","GO:0005930; GO:0030317; GO:0036064; GO:0036126; GO:0160112"
"154","Pocillopora_acuta_HIv2___TS.g29050.t1",0,12.5,NA,NA,0,21.2121212121212,0,NA,0,NA,5.61868686868687,11.2373737373737,0,NA,NA,NA,NA,NA,NA,6.64356132503947,6.71495757530743,7.29462189187011,6.9069467644944,4.28462663579717,7.32675562721369,3.68233641306884,7.17376781449862,7.93575915157194,3.68233641306884,6.16456696119305,6.66646736375546,5.66266655863064,86.2828691149755,-0.178063140538895,0.980724453939378,0.345672992769278,0.596638952154902,NA,NA,NA,NA,NA
"155","Pocillopora_acuta_HIv2___RNAseq.g10893.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.6670355032052,11.2906412127258,11.4050180295942,11.160047065591,11.3895378351745,11.0400951233883,9.27260817039085,8.49358672130917,11.7411252119871,8.35530533234199,10.5815000205708,10.939260660254,10.2237393808876,2002.00062189785,-0.348116945132135,0.701745259526114,0.459781132789471,0.700776415731614,"P97742",0,"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-)","aflatoxin metabolic process [GO:0046222]; carnitine metabolic process [GO:0009437]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of fatty acid oxidation [GO:0046320]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641]","GO:0001666; GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0005743; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0007584; GO:0009410; GO:0009437; GO:0010883; GO:0014070; GO:0030855; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045471; GO:0046222; GO:0046320; GO:0050796; GO:0071398; GO:0097421; GO:1904772"
"156","Pocillopora_acuta_HIv2___RNAseq.g10898.t1",0,0,0,0,0,1.35135135135135,0,NA,0,NA,0.168918918918919,0.337837837837838,0,NA,NA,NA,NA,NA,NA,9.31015908753573,9.68511491093645,7.88830154420556,10.2867490844354,7.85870855067775,9.79417346752238,9.41540167938653,7.56273982243945,3.68233641306884,9.79721256788863,8.52808971280967,7.26044908358547,9.79573034203388,559.809684486271,1.03095074183585,1.27186756639535,0.0521656314985915,0.160434551136642,NA,NA,NA,NA,NA
"157","Pocillopora_acuta_HIv2___TS.g29154.t1",NA,NA,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.54155064852887,9.85571346358529,10.25076587102,3.68233641306884,9.65230777591215,9.62619799283828,3.68233641306884,10.2524049570521,3.68233641306884,3.68233641306884,7.39082863612121,8.67587313311639,6.10578413912602,555.194782113374,-0.23126105181997,1.01147082314023,0.361394259342333,0.611561347952172,"A0JMD4",3.01e-153,"Two pore channel protein 2 (Two pore calcium channel protein 2) (Voltage-dependent calcium channel protein TPC2)","calcium-mediated signaling [GO:0019722]; endocytosis involved in viral entry into host cell [GO:0075509]; regulation of myotome development [GO:2000290]; skeletal myofibril assembly [GO:0014866]; smooth muscle contraction [GO:0006939]; sodium ion transmembrane transport [GO:0035725]","GO:0005245; GO:0005764; GO:0005765; GO:0006939; GO:0014866; GO:0015280; GO:0019722; GO:0031902; GO:0034702; GO:0035725; GO:0042802; GO:0072345; GO:0075509; GO:0080025; GO:0097682; GO:2000290"
"158","Pocillopora_acuta_HIv2___TS.g29157.t2",0,16.6666666666667,NA,0,0,0,6.25,NA,0,NA,3.27380952380952,4.16666666666667,2.08333333333333,NA,NA,NA,NA,NA,NA,9.54837536055154,8.64829585749115,11.6342686267438,10.0121616018523,10.3407772870995,10.4423186538278,10.6129200248189,9.91140651834197,11.0068016744307,3.68233641306884,9.58396620182265,10.4883258934335,8.6796065102118,1240.68108655269,-0.343291666758173,0.918330270085177,0.374227382486873,0.623716103466422,"O15078",0,"Centrosomal protein of 290 kDa (Cep290) (Bardet-Biedl syndrome 14 protein) (Cancer/testis antigen 87) (CT87) (Nephrocystin-6) (Tumor antigen se2-2)","camera-type eye development [GO:0043010]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; non-motile cilium assembly [GO:1905515]; otic vesicle formation [GO:0030916]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intracellular protein transport [GO:0090316]; pronephros development [GO:0048793]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201]","GO:0001822; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0015031; GO:0016020; GO:0030902; GO:0030916; GO:0032391; GO:0032991; GO:0034451; GO:0035580; GO:0035869; GO:0036038; GO:0036064; GO:0042462; GO:0042802; GO:0043010; GO:0045893; GO:0048793; GO:0060271; GO:0070201; GO:0090316; GO:0097711; GO:1905349; GO:1905515"
"159","Pocillopora_acuta_HIv2___RNAseq.g11012.t1",0,0,NA,NA,0,5.55555555555556,11.1111111111111,0,NA,NA,2.77777777777778,1.85185185185185,3.7037037037037,NA,NA,NA,NA,NA,NA,8.03683150346764,6.90881290542231,8.05127089285979,5.35849991176178,7.28808184092463,7.2119491386412,3.68233641306884,7.54867945930727,7.45952232732554,9.144506977945,7.0690491370724,7.67687720477697,6.46122106936783,170.262719099643,-0.457555411694166,0.986512892779363,0.188451354748133,0.407072938332885,NA,NA,NA,NA,NA
"160","Pocillopora_acuta_HIv2___TS.g29194.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.09390500287516,3.68233641306884,5.66344864002848,7.18297737323777,5.84362177230977,4.51119975925463,5.69873558273438,7.39465756691968,3.68233641306884,10.2092962349992,5.99625147584968,5.73559387904039,6.25690907265896,156.439026344327,-0.118759146881003,0.981108586791344,0.491863576160061,0.723360848002543,"P14381",5.64e-72,"Transposon TX1 uncharacterized 149 kDa protein (ORF 2)","","GO:0003824"
"161","Pocillopora_acuta_HIv2___RNAseq.g11039.t1",0,0,NA,0,0,NA,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.78263567065374,7.91408972240118,9.30096038067748,3.68233641306884,11.5201709467467,4.72257309926916,3.68233641306884,9.93042364169208,10.0266226981465,3.68233641306884,7.32444853987934,9.9121626675833,4.73673441217537,612.291924077895,-8.96476084972654,2.5993162458757,4.59444160525511e-09,1.47791795891781e-07,NA,NA,NA,NA,NA
"162","Pocillopora_acuta_HIv2___RNAseq.g11040.t1",0,0,NA,0,0,NA,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.93088772907051,6.03941460781193,8.37964811069974,9.81820503258106,9.33480806628529,6.53469609022614,3.68233641306884,6.48445350747802,3.68233641306884,3.68233641306884,6.55691223833592,7.16242676532048,5.95139771135136,220.161754150091,-0.530393619830849,1.10101264970555,0.169252268778806,0.377701755435398,NA,NA,NA,NA,NA
"163","Pocillopora_acuta_HIv2___RNAseq.g11090.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.89223359574533,3.68233641306884,6.6530110934117,3.68233641306884,6.98333603148276,6.77526323374519,3.68233641306884,6.26817974381434,3.68233641306884,3.68233641306884,5.19837057635435,6.09581937550459,4.30092177720411,41.2155942732269,-0.351408974368593,1.0855306879794,0.00795820943290437,0.0345046586443431,NA,NA,NA,NA,NA
"164","Pocillopora_acuta_HIv2___RNAseq.g11102.t1",NA,0,NA,NA,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,12.5386550724244,12.0429798362175,11.1423274693528,11.3318531003951,11.4047177664378,11.7732762160888,12.377443435098,12.2665861173661,11.9128262089067,11.1588682430511,11.7949533465338,11.8530225268976,11.7368841661701,3735.34851604072,-0.082878988130818,0.511063319156185,0.843043858536345,0.937478770651933,"Q5M9B7",4.97e-81,"Oligosaccharyltransferase complex subunit ostc-B","protein glycosylation [GO:0006486]","GO:0006486; GO:0008250"
"165","Pocillopora_acuta_HIv2___RNAseq.g11117.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.23176251403244,10.0695988889098,8.58102329781235,3.68233641306884,9.20758094875247,3.68233641306884,3.68233641306884,7.44111104366818,8.8485622865179,3.68233641306884,6.81089846319685,8.66200801815667,4.95978890823703,313.316931679695,-0.805325287022106,1.52168994437892,9.03291359920567e-07,1.43416094729869e-05,"Q9NJ15",3.03e-11,"Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase PC6-like) (aPC6)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0005886; GO:0006508"
"166","Pocillopora_acuta_HIv2___TS.g29293.t2a",93.3333333333333,83.3333333333333,NA,100,71.4285714285714,100,33.3333333333333,NA,NA,NA,80.2380952380952,94.4444444444444,66.031746031746,NA,NA,NA,NA,NA,NA,7.42054337142105,7.23128399729271,6.93658367102579,6.61544894152208,7.93115172111382,8.08524471858609,5.73058915105271,9.95096816916465,10.2097914268884,9.11487041499169,7.9226475583059,8.48980767192274,7.35548744468906,359.268178786536,-0.552857891917114,0.803588969699787,0.259900457323543,0.501650338226899,"P20072",4.01e-123,"Annexin A7 (Annexin VII) (Annexin-7) (Synexin)","","GO:0001786; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0012506; GO:0042584"
"167","Pocillopora_acuta_HIv2___RNAseq.g11120.t1",0,0,0,0,NA,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,9.14885544356701,10.3992716617642,11.4081797883553,11.6565288279829,10.2629424607645,12.0195563902832,7.30046701549876,10.7491316981573,5.38933004445713,3.68233641306884,9.20165997438991,9.39168788706025,9.01163206171958,1494.00758200392,-0.210488239985934,0.873034544910916,0.540907129414903,0.760540557971922,"Q9ULM6",0,"CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (CCR4 carbon catabolite repression 4-like) (Carbon catabolite repressor protein 4 homolog) (Cytoplasmic deadenylase)","miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of translation [GO:0006417]","GO:0000289; GO:0003723; GO:0004532; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0008284; GO:0010606; GO:0016020; GO:0030014; GO:0030374; GO:0035279; GO:0046872; GO:0070966"
"168","Pocillopora_acuta_HIv2___RNAseq.g11124.t1",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.6472692942534,13.6804862585251,10.5953765352336,12.9962266351695,11.609091740522,13.9822064782899,14.0602068603268,13.487998456213,9.61255890373081,13.0234479730961,12.369486913536,11.1904589859906,13.5485148410815,8118.19874141245,2.03182653218577,0.787588810642589,0.000806168082218828,0.00487883478711846,NA,NA,NA,NA,NA
"169","Pocillopora_acuta_HIv2___RNAseq.g11158.t1",0,NA,NA,0,NA,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,10.6069867553506,3.68233641306884,10.427116894031,3.68233641306884,10.1463956452654,3.68233641306884,9.83781369047198,8.88225595732606,3.68233641306884,3.68233641306884,6.83122510077892,8.74901833300838,4.91343186854947,532.931803876032,-0.236472299680935,1.03725768148656,3.23005778194182e-05,0.000313975509126388,NA,NA,NA,NA,NA
"170","Pocillopora_acuta_HIv2___RNAseq.g11180.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.58962569844466,8.10521425400763,10.8286005070126,9.88231773790329,7.92102401319128,9.70812892801873,10.0706676896913,3.68233641306884,3.68233641306884,10.740898754749,8.22111504091562,6.74078460895724,9.70144547287399,689.334301191553,0.408336309572128,1.04838334984898,0.0933314165400925,0.248471490674747,"Q921G8",0,"Gamma-tubulin complex component 2 (GCP-2)","brain development [GO:0007420]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]; spindle assembly [GO:0051225]","GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0001764; GO:0005654; GO:0005737; GO:0005813; GO:0005815; GO:0005874; GO:0007020; GO:0007420; GO:0031122; GO:0043015; GO:0051225; GO:0051321"
"171","Pocillopora_acuta_HIv2___TS.g29359.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.51914456081915,8.72299482239946,7.522982350118,3.68233641306884,9.39930450615898,3.68233641306884,3.68233641306884,3.68233641306884,5.08441990142118,8.50001015528889,6.3478201948481,7.04163754631723,5.65400284337897,226.447580657525,-0.166632047524149,1.00851439982083,0.430024331758714,0.674063474157268,"Q64449",1.41e-24,"C-type mannose receptor 2 (Lectin lambda) (Macrophage mannose receptor 2) (CD antigen CD280)","collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]","GO:0005518; GO:0005886; GO:0006897; GO:0009986; GO:0030246; GO:0030574; GO:0038023"
"172","Pocillopora_acuta_HIv2___TS.g29375.t1",0,NA,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.76452612086534,10.0097403494847,10.5213844049592,9.83089664125353,11.0117577619826,8.66817552643674,6.60024056668087,10.5208506567848,8.58595753502019,6.81941263111671,9.03329421945847,9.68089529592243,8.38569314299451,791.256478962032,-0.72489522716326,0.958333197294694,0.119532804428866,0.297706798465366,"P79102",9.01e-108,"Cytochrome P450 3A28 (EC 1.14.14.1) (CYPIIIA28)","oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]","GO:0005506; GO:0005789; GO:0008202; GO:0020037; GO:0050649; GO:0070330; GO:0070989"
"173","Pocillopora_acuta_HIv2___TS.g29388.t1",61.5384615384615,88.8888888888889,30,14.2857142857143,NA,28.5714285714286,NA,53.8461538461538,50,51.8518518518519,47.3728123728124,47.1184371184371,47.7967711301045,NA,NA,NA,NA,NA,NA,9.63748041795873,6.24196204696702,9.7715225401456,11.6031077239321,8.29996186209569,5.80281783295425,3.68233641306884,10.3260539278436,11.0355052708251,11.6244455913723,8.80251936271632,9.81410480377374,7.7909339216589,1154.32548357891,-0.449158162828037,1.04077560202619,0.102184420966879,0.265683168230261,"Q64512",3.29e-87,"Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (PTP36) (Protein tyrosine phosphatase DPZPTP) (Protein tyrosine phosphatase PTP-BL) (Protein-tyrosine phosphatase RIP)","negative regulation of excitatory synapse assembly [GO:1904890]; negative regulation of protein phosphorylation [GO:0001933]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]","GO:0001933; GO:0004725; GO:0005634; GO:0005737; GO:0005856; GO:0030027; GO:0030496; GO:0036312; GO:0044297; GO:0051896; GO:1904890"
"174","Pocillopora_acuta_HIv2___RNAseq.g11220.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.83459207205508,8.83162439855743,11.9082645399628,9.39351986671286,10.9792727975807,10.8102511101109,8.99577356087328,11.0537269847884,7.94170528458551,12.9534514982057,10.2702182113433,10.3435123357945,10.196924086892,2025.85960571423,-0.253150064744126,0.83826797102661,0.52582532297843,0.749002013070985,"Q14432",4.03e-168,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) (cGMP-inhibited cAMP phosphodiesterase) (cGI-PDE)","apoptotic signaling pathway [GO:0097190]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; regulation of ribonuclease activity [GO:0060700]; response to xenobiotic stimulus [GO:0009410]","GO:0001556; GO:0004114; GO:0004115; GO:0004119; GO:0005829; GO:0006629; GO:0007186; GO:0009410; GO:0016020; GO:0019933; GO:0019934; GO:0030284; GO:0040020; GO:0043066; GO:0043116; GO:0043117; GO:0043951; GO:0046872; GO:0047555; GO:0060282; GO:0060700; GO:0071321; GO:0071560; GO:0097190; GO:0099130; GO:0106072"
"175","Pocillopora_acuta_HIv2___RNAseq.g11285.t1",0,0,0,NA,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.93108274013,9.55221809885684,10.369884726691,12.0436169873589,8.30774756796232,10.771952165572,3.68233641306884,8.95308102090634,11.5334875013139,3.68233641306884,8.7827743634929,9.61905671140071,7.94649201558508,1210.55596001349,-0.0680999092344042,0.964869516350489,0.671207155787233,0.846739413364042,"Q64350",0,"Translation initiation factor eIF2B subunit epsilon (eIF2B GDP-GTP exchange factor subunit epsilon)","astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; cytoplasmic translational initiation [GO:0002183]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413]","GO:0001541; GO:0002183; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0009408; GO:0009749; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0042552; GO:0043065; GO:0043434; GO:0045727; GO:0045948; GO:0048708; GO:0050852"
"176","Pocillopora_acuta_HIv2___TS.g29480.t1",2.08333333333333,1.53846153846154,0,0,0,0,0,0,0,0,0.362179487179487,0.307692307692308,0.416666666666667,NA,NA,NA,NA,NA,NA,5.60860163372973,5.3082414967072,3.68233641306884,3.68233641306884,5.59620788443221,3.68233641306884,5.69873558273438,4.82716794255886,5.59984979127766,6.66207226213774,5.03478858327843,5.06283273301346,5.0067444335434,21.2103787379931,-0.00960412830970324,0.938640470443072,0.998109256561553,0.999597872528976,NA,NA,NA,NA,NA
"177","Pocillopora_acuta_HIv2___RNAseq.g11307.t2",100,66.6666666666667,NA,50,NA,81.8181818181818,100,NA,NA,100,83.0808080808081,66.1616161616162,100,NA,NA,NA,NA,NA,NA,10.6216183931239,8.78706332609212,10.2630429819294,9.4153569016746,11.211080512768,7.4329942219088,10.9845281327748,10.5327500415476,10.7531111443766,3.68233641306884,9.36838820692647,10.6763206147491,8.06045579910383,1147.68859289262,-0.695468836471557,1.11339933354819,0.0750101707519153,0.211903732374161,"Q60520",0,"Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a)","activation of innate immune response [GO:0002218]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cellular response to tert-butyl hydroperoxide [GO:0072736]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; heterochromatin formation [GO:0031507]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; protein localization [GO:0008104]; regulation of axon extension [GO:0030516]; regulation of DNA-templated transcription [GO:0006355]; regulation of hormone levels [GO:0010817]; response to methylglyoxal [GO:0051595]; response to organonitrogen compound [GO:0010243]; rhythmic process [GO:0048511]; type I interferon-mediated signaling pathway [GO:0060337]","GO:0000122; GO:0000776; GO:0000785; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0008104; GO:0010243; GO:0010817; GO:0010971; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031507; GO:0032991; GO:0042754; GO:0043066; GO:0044877; GO:0045666; GO:0045892; GO:0048511; GO:0051595; GO:0060337; GO:0061629; GO:0070822; GO:0071333; GO:0072736; GO:0140416; GO:1900181; GO:1902455; GO:1902459; GO:1903351"
"178","Pocillopora_acuta_HIv2___RNAseq.g11318.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.3491408206833,11.2558755283255,9.83281928207404,12.1348887497844,9.71893451735194,12.8487451321801,10.9347723492552,10.4090936524543,8.93736739175462,13.3695640579772,10.9791201481841,9.84947113286364,12.1087691635045,3151.41830680575,1.67092536915961,0.971473137337822,0.0070398604369687,0.0311771406492086,NA,NA,NA,NA,NA
"179","Pocillopora_acuta_HIv2___RNAseq.g11346.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.4807547713994,10.329330159142,11.0486902196942,8.92706331886005,11.3467929692408,11.6920461453124,10.5174215653963,9.90501134024192,8.51207406275117,9.43568486678976,10.3194869418828,10.4586646726655,10.1803092111001,1588.97874540129,-0.140625556307272,0.651767274113212,0.752248483315958,0.891080291621263,"O97758",9.39e-100,"Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1)","ameloblast differentiation [GO:0036305]; bicellular tight junction assembly [GO:0070830]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to calcium ion [GO:0071277]; establishment of endothelial intestinal barrier [GO:0090557]; positive regulation of blood-brain barrier permeability [GO:1905605]; protein localization to cell-cell junction [GO:0150105]","GO:0005516; GO:0005886; GO:0005911; GO:0005921; GO:0005923; GO:0009986; GO:0031410; GO:0036305; GO:0045216; GO:0050839; GO:0070160; GO:0070830; GO:0071277; GO:0090557; GO:0098609; GO:0150105; GO:1905605"
"180","Pocillopora_acuta_HIv2___RNAseq.g24622.t1",1.171875,0,0,0,1.36054421768707,0.48780487804878,1.10132158590308,0,0.48780487804878,0,0.460935055968772,0.195121951219512,0.726748160718032,NA,NA,NA,NA,NA,NA,5.9511981009209,3.68233641306884,7.23131684908634,9.46505935370887,6.52338418771189,7.14192723638692,9.56829610264504,5.74496152652496,5.98677490518935,3.68233641306884,6.4977591088312,6.28752711388669,6.7079911037757,183.576379244164,0.017090024833908,0.960271423366879,0.922547109333182,0.971054990990861,NA,NA,NA,NA,NA
"181","Pocillopora_acuta_HIv2___RNAseq.g24629.t1",0,0,NA,NA,25,18.1818181818182,66.6666666666667,0,NA,100,29.978354978355,6.06060606060606,47.9166666666667,NA,NA,NA,NA,NA,NA,10.6304874333221,9.89498279200485,6.50448097751675,3.68233641306884,3.68233641306884,10.3719834006956,11.5220305304074,10.3544918634147,5.5336018834485,11.5185442460987,8.36952759530463,7.34107971415418,9.39797547645508,1098.41350292584,0.188063106391971,0.990286873673688,0.339916867397281,0.591074485457355,"Q86VP3",9.28e-178,"Phosphofurin acidic cluster sorting protein 2 (PACS-2) (PACS1-like protein)","apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659]","GO:0000045; GO:0005739; GO:0005783; GO:0006915; GO:0032469; GO:0034497; GO:0044325; GO:0072659; GO:1990456"
"182","Pocillopora_acuta_HIv2___TS.g21030.t2",2.12765957446809,0,NA,0,12.9032258064516,4.28571428571429,0,0,8.33333333333333,0,3.07221477777415,2.52380952380952,3.75772134522992,NA,NA,NA,NA,NA,NA,10.9200878107423,10.5087945900236,10.8368368277509,3.68233641306884,9.76672408408532,3.68233641306884,3.68233641306884,11.3430855331967,8.09359153693876,4.56256470276067,7.70786943247048,10.1920651585428,5.22367370639816,881.776434015257,-1.02859597885404,1.89870552123847,2.65807345086229e-08,6.86542399879859e-07,"Q2I327",1.48e-41,"Doublesex- and mab-3-related transcription factor A2 (Doublesex- and mab-3-related transcription factor 5)","sex differentiation [GO:0007548]","GO:0000978; GO:0000981; GO:0005634; GO:0007548; GO:0046872"
"183","Pocillopora_acuta_HIv2___RNAseq.g24639.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.662286463218,8.9513906682475,11.3190222458149,11.0991588490914,10.2649404061714,11.0244936975363,7.69311517621351,10.786882381711,11.9566785051339,11.6615050995628,10.5419473492701,10.9979620004098,10.0859326981303,1911.0588864324,-0.524167994094011,0.735574353731674,0.275864521664103,0.520561570952328,"Q01728",0,"Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1)","calcium ion export [GO:1901660]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to caffeine [GO:0071313]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; cellular response to reactive oxygen species [GO:0034614]; embryonic heart tube development [GO:0035050]; embryonic placenta development [GO:0001892]; heart morphogenesis [GO:0003007]; intracellular calcium ion homeostasis [GO:0006874]; intracellular sodium ion homeostasis [GO:0006883]; muscle cell development [GO:0055001]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; post-embryonic development [GO:0009791]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of gene expression [GO:0010468]; regulation of heart rate [GO:0002027]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of smooth muscle [GO:0044557]; response to ATP [GO:0033198]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to muscle stretch [GO:0035994]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]; vascular associated smooth muscle contraction [GO:0014829]","GO:0001666; GO:0001892; GO:0002026; GO:0002027; GO:0002028; GO:0003007; GO:0005432; GO:0005509; GO:0005516; GO:0005874; GO:0005886; GO:0006814; GO:0006816; GO:0006874; GO:0006883; GO:0007204; GO:0007584; GO:0008092; GO:0009410; GO:0009749; GO:0009791; GO:0010468; GO:0010763; GO:0010881; GO:0014069; GO:0014704; GO:0014829; GO:0016020; GO:0016323; GO:0021537; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030501; GO:0030506; GO:0033198; GO:0034614; GO:0035050; GO:0035725; GO:0035902; GO:0035994; GO:0036376; GO:0042383; GO:0042542; GO:0042995; GO:0043025; GO:0043197; GO:0043198; GO:0043679; GO:0044325; GO:0044557; GO:0045202; GO:0045211; GO:0051481; GO:0051924; GO:0055001; GO:0055013; GO:0055074; GO:0060048; GO:0060402; GO:0070509; GO:0070588; GO:0071313; GO:0071320; GO:0071456; GO:0071944; GO:0086064; GO:0098703; GO:0098719; GO:0098735; GO:0098794; GO:0099580; GO:1901660; GO:1905060"
"184","Pocillopora_acuta_HIv2___RNAseq.g24675.t1",0,NA,0,0,0,10.8108108108108,0,NA,0,7.14285714285714,2.24420849420849,3.6036036036036,1.42857142857143,NA,NA,NA,NA,NA,NA,5.49100155379421,3.68233641306884,6.59774358746208,3.68233641306884,6.24245863124477,3.68233641306884,3.68233641306884,5.12735228357021,7.7718154974796,3.68233641306884,4.96420536188951,6.24607431071017,3.68233641306884,35.5676223044538,-8.85557699878646,3.73334143438149,6.26995242937074e-05,0.00055739761486428,"Q9GYF0",1.77e-06,"Cholesterol uptake protein 1","cholesterol import [GO:0070508]; RNA transport [GO:0050658]","GO:0003725; GO:0005764; GO:0005768; GO:0005794; GO:0005886; GO:0015485; GO:0031410; GO:0050658; GO:0051033; GO:0070508"
"185","Pocillopora_acuta_HIv2___TS.g21084.t1",NA,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.6677799319535,10.3670538380126,10.874472677274,10.0529689622072,10.3319100159652,10.6738148988579,10.2284685531296,11.2189664354456,10.3579563021529,9.50585499241312,10.4279246607412,10.6902170725582,10.1656322489241,1417.67790453251,-0.396953804210658,0.536771500561297,0.370320472186527,0.620015662658401,"O75506",6.62e-10,"Heat shock factor-binding protein 1 (Nasopharyngeal carcinoma-associated antigen 13) (NPC-A-13)","axonal transport of mitochondrion [GO:0019896]; cellular heat acclimation [GO:0070370]; endodermal cell differentiation [GO:0035987]; negative regulation of transcription by RNA polymerase II [GO:0000122]","GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0019896; GO:0035987; GO:0042802; GO:0070370; GO:1904115"
"186","Pocillopora_acuta_HIv2___RNAseq.g24686.t1",0,NA,NA,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,11.2806982274828,8.61729625855636,8.30346531674014,10.7092240793945,10.3713903671569,9.93308306631932,12.2313564145416,10.6167634878838,11.1798415981385,11.1916688868653,10.4434787703079,10.3504317994804,10.5365257411354,1795.53914263813,0.125915693100933,0.742586349414834,0.78627485443423,0.909450579331203,"Q8CCP0",0,"Ribosome quality control complex subunit NEMF (Nuclear export mediator factor)","CAT tailing [GO:0140708]; nuclear export [GO:0051168]; protein-containing complex assembly [GO:0065003]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]","GO:0000049; GO:0005634; GO:0005829; GO:0022626; GO:0043023; GO:0051168; GO:0065003; GO:0072344; GO:0140708; GO:1904678; GO:1990112; GO:1990116"
"187","Pocillopora_acuta_HIv2___TS.g21128.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.54722453443116,3.68233641306884,9.38843888309567,3.68233641306884,5.66700991799266,3.68233641306884,3.68233641306884,8.7880313257061,8.15626169331613,3.68233641306884,5.89586484198859,8.10939327090834,3.68233641306884,169.891696028128,-12.1287636756343,3.71163637774532,2.76334259211538e-09,9.63108126562814e-08,"Q20JQ7",0,"Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b)","membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; sodium ion transmembrane transport [GO:0035725]","GO:0001518; GO:0005248; GO:0019228; GO:0030424; GO:0035725; GO:0086010"
"188","Pocillopora_acuta_HIv2___RNAseq.2613_t",NA,NA,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.50518110741391,8.13838161065143,10.6591375926194,8.04607565175971,10.4865908543813,8.11280455903221,3.68233641306884,7.54867945930727,12.1067262990233,10.7574260630091,8.90433396102665,10.061263062549,7.74740485950426,1070.23289569044,-1.61131492235569,1.31153053109907,0.0140284860554804,0.0553103335302447,"Q96L93",0,"Kinesin-like protein KIF16B (Sorting nexin-23)","early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]","GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007018; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0080025"
"189","Pocillopora_acuta_HIv2___RNAseq.g24744.t1",8.33333333333333,37.5,27.7777777777778,72.4137931034483,17.9487179487179,19.6078431372549,24.7706422018349,NA,48.7179487179487,NA,32.1337570275395,44.559896239663,19.707617815416,NA,NA,NA,NA,NA,NA,12.1925412034491,11.8715077846691,11.4413523558645,11.2328830263847,12.1549023572767,11.9062563620509,10.8452686207025,11.5046520708902,11.3819938773108,11.1916688868653,11.5723026545464,11.7350883729583,11.4095169361345,3151.106434334,-0.255492022191899,0.481627856573291,0.542294611506255,0.761247898958841,"Q9UBV2",0,"Protein sel-1 homolog 1 (Suppressor of lin-12-like protein 1) (Sel-1L)","ERAD pathway [GO:0036503]; Notch signaling pathway [GO:0007219]; protein secretion [GO:0009306]; protein stabilization [GO:0050821]; retrograde protein transport, ER to cytosol [GO:0030970]; triglyceride metabolic process [GO:0006641]","GO:0000836; GO:0000839; GO:0005783; GO:0005789; GO:0006641; GO:0007219; GO:0009306; GO:0030970; GO:0036503; GO:0036513; GO:0050821"
"190","Pocillopora_acuta_HIv2___RNAseq.g24747.t1",NA,0,NA,NA,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,13.2674582371245,13.5348032451288,12.9698162350479,12.7590903565494,13.3346144776128,12.410143478291,13.3408444048465,12.7293606471905,12.7230793659573,12.2039987748361,12.9273209222585,13.0048657925866,12.8497760519304,8084.53298324372,-0.113859956767027,0.530630909531681,0.797640463330475,0.914734397216585,"P20073",1.49e-75,"Annexin A7 (Annexin VII) (Annexin-7) (Synexin)","autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; negative regulation of gene expression [GO:0010629]","GO:0001786; GO:0003723; GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005737; GO:0005789; GO:0005886; GO:0006914; GO:0010629; GO:0012506; GO:0016020; GO:0030855; GO:0048306; GO:0062023; GO:0070062"
"191","Pocillopora_acuta_HIv2___RNAseq.g24760.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.20203362993825,7.29178752006676,9.66186558338386,3.68233641306884,8.22518700827386,3.68233641306884,3.68233641306884,6.78887433798125,9.07329800973333,3.68233641306884,6.39723917416527,8.39025171386211,4.40422663446842,205.983533024016,-8.955262383749,3.50822779793429,4.53470816445486e-07,7.98334888423673e-06,"Q9TT38",0,"Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)]","arachidonic acid metabolic process [GO:0019369]; glycerol metabolic process [GO:0006071]; leukotriene biosynthetic process [GO:0019370]; monoacylglycerol biosynthetic process [GO:0006640]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylglycerol catabolic process [GO:0034478]; prostaglandin biosynthetic process [GO:0001516]","GO:0000139; GO:0001516; GO:0004622; GO:0005509; GO:0005544; GO:0005635; GO:0005737; GO:0005783; GO:0005829; GO:0006071; GO:0006640; GO:0008374; GO:0010314; GO:0019369; GO:0019370; GO:0032266; GO:0034478; GO:0034638; GO:0047498; GO:0047499; GO:0070273; GO:1902387"
"192","Pocillopora_acuta_HIv2___RNAseq.g24761.t1",0,0,0,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,12.7597922387224,10.0260453652334,12.6259042184441,9.95202367904912,12.4256925995306,9.26473150967485,3.68233641306884,12.3503233543504,13.0492868983681,8.51306185052717,10.4649198126969,12.6421998618831,8.28763976351068,3524.0390642244,-2.64910941532483,1.88961733810552,0.00237696012820755,0.0123937820095148,"P79134",7.56e-108,"Annexin A6 (Annexin VI) (Annexin-6)","apoptotic signaling pathway [GO:0097190]; biomineral tissue development [GO:0031214]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; growth plate cartilage chondrocyte differentiation [GO:0003418]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; regulation of muscle contraction [GO:0006937]","GO:0001725; GO:0001786; GO:0003418; GO:0005262; GO:0005509; GO:0005544; GO:0005737; GO:0005886; GO:0005925; GO:0006816; GO:0006937; GO:0008201; GO:0012506; GO:0016020; GO:0019899; GO:0030061; GO:0031214; GO:0031982; GO:0035374; GO:0038024; GO:0042383; GO:0042470; GO:0042584; GO:0048306; GO:0048471; GO:0051015; GO:0051283; GO:0051560; GO:0070509; GO:0070588; GO:0097190"
"193","Pocillopora_acuta_HIv2___RNAseq.g24776.t1",0,NA,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.80924788289796,7.78725998640764,3.68233641306884,3.68233641306884,7.59531148880866,3.68233641306884,3.68233641306884,7.5950193319465,8.09359153693876,3.68233641306884,5.92921122923437,7.35510133073214,4.5033211277366,165.282017153069,-0.528843743630652,1.20892569393373,0.00063542644490673,0.00401170148368876,"Q99PW8",1.69e-57,"Kinesin-like protein KIF17 (MmKIF17)","anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based process [GO:0007017]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192]","GO:0001750; GO:0001917; GO:0003777; GO:0005524; GO:0005815; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007017; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016192; GO:0016887; GO:0030030; GO:0031503; GO:0032391; GO:0032839; GO:0036064; GO:0042073; GO:0043005; GO:0098794; GO:0098971; GO:1990075"
"194","Pocillopora_acuta_HIv2___TS.g21189.t1b",0,0,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0566469316645,7.8149093232653,10.2366057233796,10.5083289489351,10.7311621921112,9.9123633794615,12.0143230870591,8.10391005152801,10.093410055657,3.68233641306884,9.31539961061302,9.84434699086806,8.78645223035797,1189.22732711703,-0.18617072333023,0.927551588225362,0.492924256078427,0.724190598264943,"Q9P2P6",1.22e-14,"StAR-related lipid transfer protein 9 (START domain-containing protein 9) (StARD9)","microtubule-based movement [GO:0007018]; spindle assembly [GO:0051225]","GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005814; GO:0007018; GO:0008017; GO:0008289; GO:0051225"
"195","Pocillopora_acuta_HIv2___RNAseq.g24786.t1",0,0,NA,NA,0,NA,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.2625799735348,7.42370247120592,3.68233641306884,3.68233641306884,6.90261169119261,7.19476462422787,3.68233641306884,9.44140675513951,8.91943765334758,8.02233914012503,6.92138515479798,7.84167449725667,6.0010958123393,293.07772263959,-0.424933843615286,1.03567321614394,0.29012318699629,0.536685225311975,"O76924",1.44e-24,"Potential E3 ubiquitin-protein ligase ariadne-2 (EC 2.3.2.31) (Protein ariadne-2) (RING-type E3 ubiquitin transferase ariadne-2)","protein polyubiquitination [GO:0000209]; regulation of macromolecule metabolic process [GO:0060255]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0006511; GO:0008270; GO:0031624; GO:0060255; GO:0061630"
"196","Pocillopora_acuta_HIv2___RNAseq.g24787.t1",0,0,0,0,4,0,0,0,0,NA,0.444444444444444,0,1,NA,NA,NA,NA,NA,NA,9.76012515963364,3.68233641306884,9.86424558258856,3.68233641306884,9.4233622567257,3.68233641306884,3.68233641306884,7.50078656318923,8.13048054133132,3.68233641306884,6.30906821688126,8.93580002069369,3.68233641306884,282.087472281966,-13.1712934420179,3.74422798977434,2.66492031568301e-11,2.01832501130311e-09,"E7FAM5",1.26e-34,"E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177"
"197","Pocillopora_acuta_HIv2___RNAseq.g24799.t2",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.92442235164643,6.06348383902188,9.05071967176477,3.68233641306884,8.98152926143592,8.78399003293727,6.93604804798219,8.9828962845594,7.23497478454503,6.9219028403352,7.35623035272969,8.23490847079031,6.47755223466908,234.314320934745,-0.604747192880071,1.00058205286453,0.174739737822426,0.386103814216861,"A0A1X7TVA9",2.66e-06,"Death domain-containing ATP nucleosidase (DDAN) (EC 3.5.99.-)","nucleoside metabolic process [GO:0009116]","GO:0009116; GO:0016787"
"198","Pocillopora_acuta_HIv2___RNAseq.g24803.t1",11.1111111111111,0,0,0,0,0,0,NA,0,0,1.23456790123457,0,2.22222222222222,NA,NA,NA,NA,NA,NA,6.09390500287516,6.03941460781193,6.58642216671358,5.11193581531555,5.37766003570327,6.19123426543186,6.36722016743734,5.36237875279434,7.27336735209762,5.00142931435546,5.94049674805361,6.13874666203679,5.74224683407043,46.2901961267572,-0.194647264532336,0.812439715505353,0.63034940058792,0.821106880075553,NA,NA,NA,NA,NA
"199","Pocillopora_acuta_HIv2___TS.g21207.t2",0,0,0,0,9.67741935483871,0,0,16.6666666666667,0,NA,2.92712066905615,3.33333333333333,2.41935483870968,NA,NA,NA,NA,NA,NA,8.13549223134047,9.53988190650151,8.23019614691036,3.68233641306884,9.54785598626827,3.68233641306884,8.50024276910028,9.67521213835954,8.5318877619598,3.68233641306884,7.32077781796468,8.82412885296769,5.81742678296166,344.712123991392,-0.461845552943781,1.11706688942464,3.08294606744906e-05,0.000301703192960644,"D3ZVM4",2.81e-46,"E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; post-transcriptional regulation of gene expression [GO:0010608]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein metabolic process [GO:0051246]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010608; GO:0017148; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0043161; GO:0051246; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0072089; GO:2000177; GO:2000637"
"200","Pocillopora_acuta_HIv2___TS.g21209.t3",NA,NA,0,33.3333333333333,0,0,0,NA,0,NA,5.55555555555556,11.1111111111111,0,NA,NA,NA,NA,NA,NA,12.093685690715,12.3046760533084,12.3741455408023,10.8242956606611,11.662606695083,12.9555942996295,12.7987119933453,12.0910186502549,11.6785851889106,12.0775350673658,12.0860854840076,11.9800083531532,12.192162614862,4656.90842413898,0.165483541541474,0.60686599347778,0.732612637544684,0.881206585400941,"P49756",4.69e-45,"RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa) (RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7)","mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]","GO:0000381; GO:0003723; GO:0003729; GO:0005654; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0042981"
"201","Pocillopora_acuta_HIv2___RNAseq.g24825.t1",0,0,0,0,0,1.47058823529412,0,0,0,NA,0.163398692810458,0.294117647058824,0,NA,NA,NA,NA,NA,NA,7.87755006797665,4.50233927872981,7.63565941754202,7.41397822195162,6.26454768630413,7.41829334707295,7.97606368319034,7.71311973064617,7.86867142286584,3.68233641306884,6.83525592693484,7.47190966506696,6.19860218880271,135.446122573282,-0.335312570967707,0.957200321641342,0.243402100959592,0.481873527002401,NA,NA,NA,NA,NA
"202","Pocillopora_acuta_HIv2___RNAseq.g24829.t1",66.6666666666667,0,NA,0,62.5,55,30.4347826086957,NA,0,NA,30.6573498964803,13.75,53.2004830917874,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,7.18749148714733,3.68233641306884,5.3992335514363,5.80281783295425,3.68233641306884,4.93729786847052,8.53581797749541,3.68233641306884,5.0274340782848,5.94843545952368,4.10643269704592,53.1001256373244,-0.295884654088177,1.06195468712573,0.0277456154107447,0.0970291540863181,"Q8K4H1",2.22e-62,"Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF)","'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; tryptophan catabolic process to kynurenine [GO:0019441]","GO:0004061; GO:0005634; GO:0005737; GO:0005829; GO:0019441; GO:0034354"
"203","Pocillopora_acuta_HIv2___RNAseq.g24836.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.77100616416234,7.34031383953571,10.2294731757435,9.03447004237552,8.73268461805159,7.28680821969973,6.38660816355309,9.18501234043899,9.80053319509882,7.64859764944046,8.44155074080997,9.34374189869905,7.5393595829209,441.333049861554,-1.65205850611552,0.69235649352483,0.00289833104751901,0.0147371711897836,NA,NA,NA,NA,NA
"204","Pocillopora_acuta_HIv2___RNAseq.g24868.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0542518633939,5.71009804948923,10.8824519215204,7.2055975890902,9.43878723022353,10.3040191699584,11.5827746310455,10.6117237118663,7.71735117006754,12.4428342513267,9.59498895879817,9.74091317941433,9.44906473818201,1526.83736535574,-0.0572925822007857,0.899562635985727,0.794424880020112,0.913181392721203,"Q6DFF9",0,"Mitogen-activated protein kinase-binding protein 1","negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; positive regulation of JNK cascade [GO:0046330]","GO:0005737; GO:0043124; GO:0046330"
"205","Pocillopora_acuta_HIv2___RNAseq.g24889.t1a",0,0,0,24.1379310344828,9.09090909090909,10.9090909090909,0,NA,100,NA,18.0172413793103,33.7617554858934,2.27272727272727,NA,NA,NA,NA,NA,NA,6.79100259980268,9.95968923682614,8.77491546959582,5.80116198083551,8.12000563925695,9.5240444131198,3.68233641306884,8.42364395585137,6.16564805667492,3.68233641306884,7.09247841781009,7.65504314423635,6.52991369138383,283.310646187388,-0.283924724890646,1.02630450887193,0.0526688828307265,0.161501530901765,NA,NA,NA,NA,NA
"206","Pocillopora_acuta_HIv2___RNAseq.g24891.t1",NA,NA,NA,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,8.25313388378648,9.48302439493017,9.00756979532748,6.26838653426437,8.89123258164684,3.68233641306884,10.0633351856872,9.68591035817366,3.68233641306884,5.54842281532527,7.45656883752792,7.90403660640066,7.00910106865517,382.976742265143,-0.0364096069410444,0.948542810847998,0.841708352091503,0.937323925653962,"Q567G6",5.54e-06,"Nucleolus and neural progenitor protein","negative regulation of neuron differentiation [GO:0045665]; positive regulation of Notch signaling pathway [GO:0045747]","GO:0005634; GO:0005730; GO:0045665; GO:0045747"
"207","Pocillopora_acuta_HIv2___RNAseq.2795_t",NA,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.93304082057026,3.68233641306884,9.75174260285165,3.68233641306884,10.1607743254365,8.28415117937733,3.68233641306884,9.83561169563209,3.68233641306884,3.68233641306884,6.6377002689212,8.67270117151187,4.60269936633054,408.268006915086,-0.443902649717671,1.14731770240722,3.25382901069368e-05,0.000316073759641863,"Q03049",5.74e-40,"Putative uncharacterized oxidoreductase YDR541C (EC 1.1.1.-)","response to furfural [GO:1901426]","GO:0016616; GO:0033721; GO:1901426"
"208","Pocillopora_acuta_HIv2___RNAseq.g24924.t1",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.82215178013904,6.41823073368408,9.75671308057796,3.68233641306884,3.68233641306884,10.0854578837381,9.95972514426259,9.78277414904477,7.36504895374022,3.68233641306884,7.22371109643933,7.68180487531417,6.76561731756449,412.95606852839,-0.145322367383751,0.995396619121286,0.276539795393887,0.521437187955717,"Q32L53",3.98e-07,"Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit)","endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]","GO:0005783; GO:0005794; GO:0016020; GO:0032469; GO:0044325; GO:1902236; GO:2001234"
"209","Pocillopora_acuta_HIv2___TS.g21325.t1",NA,0,0,0,0,0,3.57142857142857,NA,NA,NA,0.595238095238095,0,1.19047619047619,NA,NA,NA,NA,NA,NA,8.61711068953782,7.93312856127724,10.1419625620785,3.68233641306884,3.68233641306884,3.68233641306884,3.68233641306884,5.53803082388147,11.3511368759178,3.68233641306884,6.1993051578037,7.86611547289689,4.53249484271052,430.223729758472,-0.35179740291047,1.08717510693316,0.00512932506710372,0.0237637917266458,"Q6GNV7",8.95e-46,"Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog)","pyridoxine transport [GO:0031923]","GO:0005765; GO:0022857; GO:0031923"
"210","Pocillopora_acuta_HIv2___RNAseq.g24929.t1",0,NA,0,7.14285714285714,0,0,0,0,NA,NA,1.02040816326531,2.38095238095238,0,NA,NA,NA,NA,NA,NA,9.82197565263159,7.31139692208749,9.37395323909205,3.68233641306884,9.42931448555664,10.7954776614669,7.18545318045339,9.75764091449668,10.7051102282452,5.43369409583605,8.34963527929348,9.81759890400443,6.88167165458253,669.400544451373,-1.06428640670929,1.5882724259342,0.00665305178399549,0.0296547738069987,NA,NA,NA,NA,NA
"211","Pocillopora_acuta_HIv2___RNAseq.2811_t",0,NA,NA,0,0,0,0,4.91803278688525,NA,NA,0.819672131147541,1.63934426229508,0,NA,NA,NA,NA,NA,NA,11.261623011165,10.3329089630365,10.8869917516396,11.0704009070227,10.7417212360535,10.0360344736369,11.6741698251981,12.2058289572308,10.9717309490472,10.7669802648357,10.9948390338866,11.2135791810272,10.776098886746,2203.82818570052,-0.339144380640573,0.514919730846472,0.440626746957662,0.683235984990955,"V5YMB3",6.67e-26,"Dipeptidyl aminopeptidase BIII (DAP BIII) (EC 3.4.14.-)","proteolysis involved in protein catabolic process [GO:0051603]","GO:0004175; GO:0004177; GO:0008236; GO:0008239; GO:0051603"
"212","Pocillopora_acuta_HIv2___RNAseq.g24974.t1",NA,0,NA,14.2857142857143,0,0,0,0,NA,0,2.04081632653061,3.57142857142857,0,NA,NA,NA,NA,NA,NA,7.45015090580822,7.56088992856599,8.22301936314656,5.9757421057541,7.27216983134098,6.67896938259863,8.60506118897161,6.39131141676195,8.50005356838443,6.11483358357707,7.27722012749095,7.56734101708843,6.98709923789348,164.32688236811,-0.348168932950748,0.818012079437146,0.404940034232391,0.651210546938009,"Q8IDX6",1.68e-06,"Reticulocyte-binding protein homolog 2a (PfR2Ha) (PfRH2a) [Cleaved into: Reticulocyte-binding protein homolog 2a 85 kDa form; Reticulocyte-binding protein homolog 2a 285 kDa form]","cell-cell adhesion [GO:0098609]","GO:0005615; GO:0008201; GO:0016020; GO:0016324; GO:0031410; GO:0044647; GO:0046789; GO:0098609; GO:1990225"
"213","Pocillopora_acuta_HIv2___TS.g21379.t1",0,NA,0,0,0,0,NA,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.50571125650928,5.6460547390973,5.29770193163976,6.29014341372585,4.71118491363556,4.65791064633771,4.60654391542428,6.19602632709643,5.31013166644977,3.68233641306884,5.49037452229848,6.00415121906616,4.9765978255308,52.4877633325109,-0.736862489102855,1.11173907220409,0.0760240097332862,0.214265642397165,"Q5RFW0",1.71e-06,"Scavenger receptor class A member 5","endocytosis [GO:0006897]; intracellular iron ion homeostasis [GO:0006879]; iron ion transmembrane transport [GO:0034755]; protein homotrimerization [GO:0070207]","GO:0005886; GO:0006879; GO:0006897; GO:0034755; GO:0070207; GO:0070287"
"214","Pocillopora_acuta_HIv2___RNAseq.g24994.t1",0,NA,NA,0,0,0,NA,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,5.45976149983951,9.8738447349831,7.94179218572159,3.68233641306884,9.36865652315267,3.68233641306884,3.68233641306884,9.59234070921797,8.86739032239913,5.92487398666357,6.80756692011841,8.24598824806617,5.36914559217064,301.733152018913,-0.466547368286135,1.17038238072513,7.81615778371142e-06,9.22128109164779e-05,"Q5TZ18",1.32e-15,"Neuron navigator 3","liver morphogenesis [GO:0072576]; neurogenesis [GO:0022008]; pancreas development [GO:0031016]","GO:0003779; GO:0005524; GO:0005640; GO:0005794; GO:0016887; GO:0022008; GO:0030027; GO:0030175; GO:0031016; GO:0072576"
"215","Pocillopora_acuta_HIv2___RNAseq.g24995.t2a",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.8147627847613,12.4816688883475,11.9843792453223,11.5667233099812,11.8688867095986,12.4006457904556,11.8971489722203,11.7056542217336,12.7958807260938,11.314025454107,11.9829776102621,12.0339127375019,11.9320424830223,4210.96277343203,-0.0552753115792149,0.573181143021328,0.895790052817416,0.959969424609254,"P79403",0,"Neutral alpha-glucosidase AB (EC 3.2.1.207) (Alpha-glucosidase 2) (Glucosidase II subunit alpha)","carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]","GO:0005794; GO:0005975; GO:0006491; GO:0017177; GO:0030246; GO:0033919; GO:0042470; GO:0043231; GO:0090599"
"216","Pocillopora_acuta_HIv2___RNAseq.g25003.t1",62.5,NA,0,NA,NA,0,0,0,0,NA,10.4166666666667,0,20.8333333333333,NA,NA,NA,NA,NA,NA,11.6837864905397,3.68233641306884,8.65482796170777,4.99561439145868,10.9179594844939,4.99187376865589,5.56266578261131,7.30255480670073,10.494328271086,3.68233641306884,7.19682837833917,9.81069140290562,4.58296535377271,714.910070440306,-5.7643670931222,2.72395394341475,6.38856165383553e-07,1.06949254353099e-05,"B3EWY9",0,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020"
"217","Pocillopora_acuta_HIv2___RNAseq.g25026.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.3314482811072,11.538052727677,11.2690312014246,12.3007685802983,8.25502834782754,9.37676410976139,11.184296503851,9.9738453744108,3.68233641306884,11.5505067278458,9.94620782672725,8.7023379235678,11.1900777298867,1884.82272951504,0.64427594979729,1.03550093137811,0.174081924830958,0.385179893032733,"Q6TMK4",3.44e-96,"Peroxinectin A (EC 1.11.1.7)","defense response to bacterium [GO:0042742]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; response to oxidative stress [GO:0006979]","GO:0004447; GO:0004601; GO:0005576; GO:0005783; GO:0006955; GO:0006979; GO:0020037; GO:0036393; GO:0042742; GO:0042744; GO:0140825"
"218","Pocillopora_acuta_HIv2___RNAseq.g25038.t1",13.4615384615385,0,14.1176470588235,0,10.952380952381,1.41509433962264,8.55614973262032,0,0,0,4.85028105449859,0.283018867924528,9.41754324107265,3,22.5742870411914,22.6415094339623,0.0120033760096305,2.47716210470545e-06,0.0307712140968153,3.68233641306884,9.82723619768913,7.00571141948957,9.72803135494874,8.2003019901985,9.71861013633086,10.3075537149121,7.96292728948732,3.68233641306884,7.62467556988766,7.77397204990816,6.10672270506261,9.4412213947537,453.448692552547,1.45287706957925,2.11454280998948,0.0033852883609274,0.0167458313448885,NA,NA,NA,NA,NA
"219","Pocillopora_acuta_HIv2___RNAseq.g25040.t1",0.224215246636771,2.01005025125628,0.892857142857143,0.760456273764259,0.588235294117647,0.450112528132033,0.408997955010225,0,0.253807106598985,0,0.558873179837334,0.694885231950311,0.422861127724357,NA,NA,NA,NA,NA,NA,9.17334923104468,8.36537983138804,6.67451956276615,6.93438880964508,6.55922841464905,6.60213173979051,4.40301213871548,8.06830292342586,9.87680813571447,10.0259033582741,7.66830241454134,8.07044165352004,7.26616317556264,335.45421372042,-0.340811875373394,0.80432267506756,0.448126527653331,0.690130120951637,NA,NA,NA,NA,NA
"220","Pocillopora_acuta_HIv2___RNAseq.g25041.t1",54.3859649122807,30.5389221556886,31.875,36.0714285714286,29.7619047619048,34.2939481268012,48.7046632124352,33.3333333333333,20,53.3333333333333,37.2298498407206,30.8475264374503,43.6121732439908,NA,NA,NA,NA,NA,NA,9.19743370287671,3.68233641306884,9.659213515785,10.6012024804614,10.3989433421584,5.75438588036295,5.66606675070968,8.52016024963916,3.68233641306884,3.68233641306884,7.08444151611998,8.29161744470562,5.87726558753434,459.884491504611,-0.576177301660398,1.1911354592909,0.0464485524353181,0.147202423844093,NA,NA,NA,NA,NA
"221","Pocillopora_acuta_HIv2___TS.g21492.t1a",8.33333333333333,0,0,NA,0,0,0,0,NA,NA,1.19047619047619,0,2.08333333333333,NA,NA,NA,NA,NA,NA,10.2353538757946,9.86892240662565,8.5866219774936,10.4448824227638,9.73919936905002,10.0155381006788,10.4979742033958,9.5437640348021,8.4467722440281,11.4800604420029,9.88590890766354,9.31034230023368,10.4614755150934,1095.18705650758,0.756591172142443,0.747128437803649,0.13938221701903,0.33245139725201,"Q5RFQ0",1.74e-68,"rRNA-processing protein FCF1 homolog","endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; ribosomal small subunit biogenesis [GO:0042274]","GO:0000447; GO:0000480; GO:0005730; GO:0032040; GO:0042274"
"222","Pocillopora_acuta_HIv2___RNAseq.g25095.t1",100,NA,NA,100,33.3333333333333,66.6666666666667,100,66.6666666666667,NA,NA,77.7777777777778,77.7777777777778,77.7777777777778,NA,NA,NA,NA,NA,NA,9.4369428181726,3.68233641306884,10.1951034057103,3.68233641306884,10.0100984606153,3.68233641306884,3.68233641306884,10.0495175949327,3.68233641306884,11.7061749045388,6.98095192493139,8.67479973849995,5.28710411136283,716.996273563743,-0.252151462561068,1.06643977366001,3.93007897733675e-07,7.10558279102483e-06,NA,NA,NA,NA,NA
"223","Pocillopora_acuta_HIv2___RNAseq.g25101.t1",0,10.5263157894737,0,0,0,9.09090909090909,0,0,14.2857142857143,NA,3.76699324067745,6.78058783321941,0,NA,NA,NA,NA,NA,NA,8.10335247870671,9.08762016653491,3.68233641306884,3.68233641306884,6.07686165919975,9.46834519867581,3.68233641306884,4.90193668648245,3.68233641306884,3.68233641306884,5.60497982549438,5.28936473010532,5.92059492088345,150.55441948549,0.0486155667781108,0.983388944801968,0.757336369957836,0.893629732017469,"P70158",4.59e-20,"Cyclic GMP-AMP phosphodiesterase SMPDL3A (2',3'-cGAMP phosphodiesterase SMPDL3A) (EC 3.1.4.-) (Acid sphingomyelinase-like phosphodiesterase 3a) (ASM-like phosphodiesterase 3a) (EC 3.6.1.15)","negative regulation of cGAS/STING signaling pathway [GO:0160049]; nucleoside triphosphate catabolic process [GO:0009143]","GO:0005576; GO:0005615; GO:0008081; GO:0008270; GO:0009143; GO:0016887; GO:0160049"
"224","Pocillopora_acuta_HIv2___RNAseq.g25123.t2",1.75438596491228,0,0,0,0,0.386100386100386,1.86046511627907,0,5.40540540540541,0,0.940635687269714,1.15830115830116,0.72297021623827,NA,NA,NA,NA,NA,NA,8.79990573373047,6.93444911437942,8.13780270981254,9.99776260389347,8.98799807325146,3.68233641306884,3.68233641306884,3.68233641306884,3.68233641306884,8.78459572882484,6.63718596161676,6.65807586858643,6.61629605464708,266.993214414813,0.00133300165032842,0.9869761048978,0.975959814320458,0.992143389306839,NA,NA,NA,NA,NA
"225","Pocillopora_acuta_HIv2___RNAseq.g25124.t1",0,0,0,2.03045685279188,0,1.01010101010101,0,0,0,0,0.304055786289289,0.608111572578578,0,NA,NA,NA,NA,NA,NA,5.39475910818241,3.68233641306884,8.86056856991358,10.7754290089121,8.00011216985104,3.68233641306884,3.68233641306884,8.05182134598013,3.68233641306884,3.68233641306884,5.94943722681835,6.7979195213992,5.10095493223749,265.831832502288,-0.269746963231296,1.05723927142802,0.00984542146090854,0.0411097505804218,NA,NA,NA,NA,NA
"226","Pocillopora_acuta_HIv2___TS.g21530.t1",0.598802395209581,0,0,0,0,0.427350427350427,2.18978102189781,0,0,0,0.321593384445782,0.0854700854700855,0.557716683421478,NA,NA,NA,NA,NA,NA,9.88398215246135,10.9466105953681,11.1241760862422,9.91844146573737,10.2775301957281,9.39368387991493,8.60101178187524,10.6438975823916,7.71735117006754,10.7656192469976,9.9272304156784,9.92938743737816,9.92507339397865,1171.73429280413,-0.0578840591011102,0.753680977505552,0.886616494965062,0.956445479055389,"P79702",3.96e-17,"Protein c-Fos (Cellular oncogene fos) (Transcription factor AP-1 subunit c-Fos)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003677; GO:0003700; GO:0005634; GO:0006357"
"227","Pocillopora_acuta_HIv2___RNAseq.g25129.t2",18.9189189189189,50,14.8936170212766,28,12.5,8.04597701149425,14.2857142857143,0,0,0,14.6644227237404,17.2091954022988,12.119650045182,NA,NA,NA,NA,NA,NA,11.6976625213302,12.963440384335,11.2095639118418,12.4020302533525,11.2360762237196,11.422643289217,12.082275580832,11.0215771233139,12.2459265314441,9.80783233255023,11.6089028151936,11.4821612623299,11.7356443680573,3615.89858614085,0.217825933553932,0.685644450827906,0.651067910902569,0.833687099875156,"Q9ULT8",0,"E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1)","aorta development [GO:0035904]; heart valve development [GO:0003170]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; ventricular septum development [GO:0003281]","GO:0003170; GO:0003281; GO:0016607; GO:0032436; GO:0035904; GO:0043161; GO:0046872; GO:0061630; GO:0070534"
"228","Pocillopora_acuta_HIv2___TS.g21534.t1",0,0,NA,NA,0,0,14.2857142857143,NA,0,NA,2.38095238095238,0,4.76190476190476,NA,NA,NA,NA,NA,NA,9.67849525535295,8.9575893735592,6.67451956276615,11.9150199437545,9.58458771139335,10.9258751133128,9.90334641785777,10.1440908906608,3.68233641306884,3.68233641306884,8.51481970947952,7.95280596664842,9.07683345231062,988.02872870869,0.345468394860007,0.89976898686382,0.397259281150998,0.643487434172672,"B2RYF1",6.59e-138,"Protein phosphatase 1 regulatory subunit 37 (Leucine-rich repeat-containing protein 68)","","GO:0004864"
"229","Pocillopora_acuta_HIv2___RNAseq.g25184.t1",0,0,NA,0,0,0,0,NA,6.94444444444444,NA,0.992063492063492,1.73611111111111,0,NA,NA,NA,NA,NA,NA,3.68233641306884,10.9262237864823,3.68233641306884,10.8689265929414,5.48185943121106,11.3723333248194,8.51323153972519,8.10391005152801,7.32908137351146,12.2480337795338,8.22082727058903,5.65590473647764,10.7857498047004,1197.80217612348,4.61143610292268,3.96563611580368,6.05447435978099e-06,7.41506495680544e-05,"P70191",5.24e-44,"TNF receptor-associated factor 5","apoptotic process [GO:0006915]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0005164; GO:0005737; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0008270; GO:0008284; GO:0009898; GO:0023019; GO:0031625; GO:0031996; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0043123; GO:0048255; GO:0051092; GO:0070534; GO:0097400"
"230","Pocillopora_acuta_HIv2___TS.g21590.t1",0.48780487804878,0,0,2.38095238095238,0,0.91324200913242,0,0,0,NA,0.420222140903731,0.65883887801696,0.121951219512195,NA,NA,NA,NA,NA,NA,6.99679195296993,7.670995659781,5.26676479605173,7.56992190290079,3.68233641306884,8.21380866985901,3.68233641306884,3.68233641306884,3.68233641306884,3.68233641306884,5.41299650469067,4.66211319764564,6.1638798117357,73.6340340133077,0.299297201731345,1.04025621085509,0.290053048158395,0.536678485807815,"Q6IWL4",2.33e-29,"TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6)","innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of DNA-templated transcription [GO:0045893]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; response to bacterium [GO:0009617]; response to virus [GO:0009615]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005938; GO:0008270; GO:0009615; GO:0009617; GO:0031663; GO:0033209; GO:0038061; GO:0042981; GO:0043122; GO:0045087; GO:0045893; GO:0061630; GO:0070534"
"231","Pocillopora_acuta_HIv2___RNAseq.g25188.t1",0,0,NA,2.35294117647059,0,0,0,0,0,0,0.261437908496732,0.470588235294118,0,NA,NA,NA,NA,NA,NA,8.35798836198224,8.27386811086179,7.62478293516472,6.35341254798027,8.73460981274344,6.40437642337467,6.49753832785703,6.83634004906966,5.8614009438957,3.68233641306884,6.86266539259984,7.48302442057115,6.24230636462852,147.143189386311,-0.942482390976849,1.00994569536802,0.0757236268202322,0.213543875673199,"P70191",1.09e-40,"TNF receptor-associated factor 5","apoptotic process [GO:0006915]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0005164; GO:0005737; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0008270; GO:0008284; GO:0009898; GO:0023019; GO:0031625; GO:0031996; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0043123; GO:0048255; GO:0051092; GO:0070534; GO:0097400"
"232","Pocillopora_acuta_HIv2___RNAseq.g25216.t1b",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.2043674132122,6.63867229711208,10.3795825117777,9.65445783249139,10.7479245339226,3.68233641306884,3.68233641306884,6.19602632709643,12.5769081806964,3.68233641306884,7.74449483355153,10.0209617933411,5.468027873762,1114.51152321024,-0.872062302219981,1.55702950928492,2.41970314408176e-05,0.000243383771043105,"Q9NZJ4",0,"Sacsin (DnaJ homolog subfamily C member 29)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084"
"233","Pocillopora_acuta_HIv2___RNAseq.g25220.t1",0,NA,0,11.1111111111111,0,0,0,0,0,0,1.23456790123457,2.77777777777778,0,NA,NA,NA,NA,NA,NA,8.26563007823044,7.60911950749454,8.89706072579295,7.22786336628594,8.83850913797974,3.68233641306884,3.68233641306884,8.05182134598013,6.89589329451837,3.68233641306884,6.68329066954886,8.18978291650033,5.1767984225974,179.732680781666,-0.814527961046765,1.41588766501889,0.000102117696993987,0.000844983048810653,"Q9NZJ4",0,"Sacsin (DnaJ homolog subfamily C member 29)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084"
"234","Pocillopora_acuta_HIv2___RNAseq.g25232.t1",0,46.1538461538462,0,0,NA,0,0,NA,NA,NA,7.69230769230769,15.3846153846154,0,NA,NA,NA,NA,NA,NA,12.0528853294724,11.4529132757433,12.3090359624397,11.3177555551476,11.40562350281,12.7067100687594,12.5003485298835,11.7625910011518,11.4307700965485,11.239512523027,11.8178145844983,11.7921811784845,11.8434479905122,3826.79062672386,0.0347767405262168,0.585333385155787,0.948617730038672,0.980200706925709,"Q6PD03",0,"Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha)","negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of protein dephosphorylation [GO:0035307]; signal transduction [GO:0007165]","GO:0000159; GO:0000775; GO:0004721; GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0007165; GO:0019900; GO:0030018; GO:0031430; GO:0035307; GO:0072542; GO:1903077"
"235","Pocillopora_acuta_HIv2___TS.g21646.t2",0,NA,NA,0,0,3.44827586206897,0,0,NA,0,0.492610837438424,1.14942528735632,0,NA,NA,NA,NA,NA,NA,10.2739457764767,9.95659927842,11.0827280280368,10.2507731660502,8.27899149163462,5.51028908219708,9.00499286498346,9.86415039040134,10.6599603870211,11.1484631896205,9.60308936548418,10.0319552147141,9.17422351625425,1105.75111374507,-0.549711232075882,0.724895772523354,0.250545860395396,0.491109272904052,"P34885",0,"Protein kinase C-like 1B (PKC1B) (EC 2.7.11.13)","associative learning [GO:0008306]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; dauer larval development [GO:0040024]; dense core granule exocytosis [GO:1990504]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of response to drug [GO:2001024]; neuropeptide signaling pathway [GO:0007218]; neurotransmitter secretion [GO:0007269]; positive regulation of positive chemotaxis [GO:0050927]; protein phosphorylation [GO:0006468]; regulation of chemotaxis [GO:0050920]; regulation of locomotion [GO:0040012]; regulation of presynaptic dense core granule exocytosis [GO:0099161]; response to salt [GO:1902074]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of touch [GO:0050975]; sensory processing [GO:0050893]; synaptic vesicle exocytosis [GO:0016079]","GO:0000165; GO:0004674; GO:0004697; GO:0005524; GO:0005737; GO:0005856; GO:0006468; GO:0006935; GO:0007218; GO:0007269; GO:0007606; GO:0007635; GO:0008306; GO:0016020; GO:0016079; GO:0035556; GO:0040012; GO:0040024; GO:0043005; GO:0046872; GO:0048009; GO:0050893; GO:0050920; GO:0050927; GO:0050975; GO:0098793; GO:0098981; GO:0099161; GO:0106310; GO:1902074; GO:1990504; GO:2001024"
"236","Pocillopora_acuta_HIv2___RNAseq.g25254.t1",0,0,0,0,NA,NA,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.0804908776973,11.5641678470103,10.6180831605119,11.3106547823497,11.5713828526716,11.2964185388052,11.8983855780416,10.3704938775999,12.0416117436207,12.3739468331802,11.4125636091488,11.1364125024203,11.6887147158774,2927.26361156363,0.414389616236206,0.55420323864159,0.370165709453429,0.619958235665064,"Q9NS37",1.56e-13,"CREB/ATF bZIP transcription factor (Host cell factor-binding transcription factor Zhangfei) (HCF-binding transcription factor Zhangfei)","ATF6-mediated unfolded protein response [GO:0036500]; integrated stress response signaling [GO:0140467]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]","GO:0000785; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0009615; GO:0036500; GO:0042802; GO:0045814; GO:0045892; GO:0045944; GO:0051090; GO:0090575; GO:0140467"
"237","Pocillopora_acuta_HIv2___RNAseq.g25265.t1",0,NA,0,NA,0,0,1.40845070422535,0,0,0,0.176056338028169,0,0.28169014084507,NA,NA,NA,NA,NA,NA,6.99679195296993,5.1703194305374,8.31025247179496,4.11054575398787,6.42949564407347,8.09909073650838,3.68233641306884,6.96983139271047,10.551678301999,3.68233641306884,6.40026785107192,7.85160995270957,4.94892574943427,229.959330755015,-0.768698069551797,1.41336877860725,8.16164363609096e-05,0.000697283009760305,"Q5S006",7.24e-14,"Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-)","autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein processing [GO:0010955]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein phosphorylation [GO:0006468]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of gene expression [GO:0010468]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of mitochondrial depolarization [GO:0051900]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; synaptic vesicle recycling [GO:0036465]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","GO:0000139; GO:0000287; GO:0001933; GO:0001934; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0005096; GO:0005524; GO:0005525; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0007029; GO:0007030; GO:0007165; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008021; GO:0008104; GO:0008340; GO:0009267; GO:0010468; GO:0010508; GO:0010738; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0022028; GO:0030159; GO:0030182; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031410; GO:0031647; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034614; GO:0035556; GO:0035564; GO:0035641; GO:0035751; GO:0036465; GO:0036479; GO:0040012; GO:0042802; GO:0042803; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0044325; GO:0044753; GO:0044754; GO:0044877; GO:0045121; GO:0045202; GO:0045746; GO:0046039; GO:0048312; GO:0048812; GO:0051018; GO:0051770; GO:0051900; GO:0051966; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070971; GO:0070973; GO:0071287; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:1900242; GO:1900244; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902902; GO:1903215; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377"
"238","Pocillopora_acuta_HIv2___RNAseq.g25269.t1",0,NA,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.21040300974758,9.15119130388458,10.4441610170962,7.85997747624031,9.54456957331464,9.60052067269517,6.24475683147728,9.46768535835086,10.6308921468597,7.58802519842497,8.97421825880913,9.8595422210738,8.08889429654446,661.998252135631,-1.2490302136841,1.00125120323356,0.0261251840266527,0.0922770846792443,"Q3UHC2",2.03e-70,"Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1)","bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0007165; GO:0035556; GO:0036035; GO:0042802; GO:0045453; GO:0046872; GO:0050731; GO:0050732; GO:0090263; GO:0106310; GO:1902533"
"239","Pocillopora_acuta_HIv2___RNAseq.g25270.t1",0,NA,0,0,0,0,NA,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.92681031311096,8.61976434957389,12.6538611673286,10.5248871487813,12.4676289014316,8.68374559313354,9.77578088427009,7.11315142623839,11.8828968106612,9.33308630075984,7.9431840443865,10.7229885571332,1919.36235294777,1.42578864603019,1.91230370025482,0.00407182774013385,0.0195366939140857,"H9JW44",4.16e-64,"Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0046872"
"240","Pocillopora_acuta_HIv2___RNAseq.g25273.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.1608927834812,13.0851334108932,12.2303923833476,13.4208129404052,11.5676111336919,12.5044298148666,12.6308138454882,12.5559760077091,12.1044152849683,13.1096441639226,12.5370121768774,12.1238575186396,12.9501668351152,6323.66502155171,0.661048804979301,0.533863669017315,0.145802022856072,0.342128562392964,"A5D6U8",1.11e-166,"Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form)","","GO:0003993; GO:0005576; GO:0046872"
"241","Pocillopora_acuta_HIv2___RNAseq.g25282.t1",0,NA,NA,0,0,8.57142857142857,0,0,NA,0,1.22448979591837,2.85714285714286,0,NA,NA,NA,NA,NA,NA,12.6029435787827,10.7589554271457,12.2437272369648,11.0111058243485,12.2606356748797,10.8672042106888,11.3172194649211,13.1713157223823,11.937146856482,10.6120274837574,11.6782281480353,12.4431538138983,10.9133024821723,3864.94043646493,-1.32165634119031,0.548289832883486,0.00512767452625834,0.0237637565997439,NA,NA,NA,NA,NA
"242","Pocillopora_acuta_HIv2___RNAseq.g25283.t1",0,0,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.149327547984,10.3125106545534,10.1996728100115,10.6470275697125,9.51688751894074,10.6197292512092,9.9017027610342,10.5285964134916,8.91943765334758,8.63148430779582,9.94263764880805,9.86278438875508,10.022490908861,1055.25369606834,0.116238549718648,0.5460655616078,0.800192422226747,0.915824840917101,NA,NA,NA,NA,NA
"243","Pocillopora_acuta_HIv2___RNAseq.g25309.t1",1.94174757281553,3.64963503649635,40,4.95049504950495,6.62650602409639,8.25396825396825,14.6017699115044,20.5128205128205,12.5,NA,12.5596602623563,9.97338377055801,15.7925058771041,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,9.93501527358037,8.23832351102165,6.9963526566166,9.27694291822544,8.25419413569394,9.56709998910106,7.10251127257172,3.68233641306884,7.04174489960173,7.45666312098772,6.62682667821574,305.470564433627,-0.289143371008423,0.975386696521982,0.4152160744723,0.659965417710697,"A7S8T5",2.24e-23,"Coiled-coil domain-containing protein 42 homolog","","GO:0043232"
"244","Pocillopora_acuta_HIv2___RNAseq.g25310.t1",0,NA,0,0,0,0,0,NA,17.6470588235294,0,2.20588235294118,5.88235294117647,0,NA,NA,NA,NA,NA,NA,8.28212448841977,8.59757696776149,8.77491546959582,3.68233641306884,8.83850913797974,3.68233641306884,7.45274207143932,8.10391005152801,3.68233641306884,10.8919990168344,7.19887864427651,7.53635911211844,6.86139817643458,376.865804783951,-0.109366926521026,0.989841969274884,0.430242650731671,0.674071674629863,NA,NA,NA,NA,NA
"245","Pocillopora_acuta_HIv2___TS.g21718.t2",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.67442609226723,8.92632565796471,8.26904050216647,3.68233641306884,8.08719054818742,8.14430335732205,3.68233641306884,8.99499605715246,8.32937406314622,3.68233641306884,7.04726655174131,8.47100545258396,5.62352765089866,241.388979649768,-0.45505329850997,1.10341669132694,4.89959372019034e-05,0.000450525896813942,NA,NA,NA,NA,NA
"246","Pocillopora_acuta_HIv2___RNAseq.g25317.t1",4.81481481481481,6.18932038834951,4.1343669250646,7.87949015063731,10.966810966811,0.5859375,2.31788079470199,3.6101083032491,4.31578947368421,10.2803738317757,5.50948931490882,4.51612916318403,6.50284946663361,NA,NA,NA,NA,NA,NA,12.4441888884209,5.74095382813731,11.891983058786,4.86458704699243,12.3215694583585,3.68233641306884,3.68233641306884,11.5498513009677,12.3240489417184,3.68233641306884,8.21841917625878,12.1063283296503,4.33051002286725,2252.95465312817,-10.9676173799993,2.31449225069005,7.98166741539946e-15,2.18881340422377e-12,"Q03146",4.64e-09,"Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (Protein-tyrosine kinase MPK-6) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a)","axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell population proliferation [GO:0008283]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; wound healing, spreading of cells [GO:0044319]","GO:0001558; GO:0001952; GO:0005518; GO:0005524; GO:0005886; GO:0005903; GO:0007566; GO:0007595; GO:0008283; GO:0008285; GO:0010715; GO:0010976; GO:0014909; GO:0016323; GO:0038062; GO:0038063; GO:0038083; GO:0043235; GO:0043583; GO:0044319; GO:0046872; GO:0051897; GO:0060444; GO:0060749; GO:0061302; GO:0061564; GO:1990138"
"247","Pocillopora_acuta_HIv2___RNAseq.g25333.t1",1.20481927710843,NA,0,NA,0,0.395256916996047,0,0,0,NA,0.228582313443497,0.131752305665349,0.301204819277108,NA,NA,NA,NA,NA,NA,7.04630611039243,11.3161764684627,9.38362648960403,9.17481900767789,7.73305689382981,9.17839774949258,10.4012587919944,9.26853858917569,3.68233641306884,3.68233641306884,8.08668529267672,7.42277289921416,8.75059768613928,648.704893162652,0.726497397114859,0.97419451048606,0.158233119545381,0.361155670015086,"P82198",1.91e-66,"Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3)","angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]; localization [GO:0051179]","GO:0001525; GO:0002062; GO:0005518; GO:0005604; GO:0005615; GO:0005802; GO:0007155; GO:0030198; GO:0031012; GO:0042802; GO:0050839; GO:0050840; GO:0051179; GO:0062023"
"248","Pocillopora_acuta_HIv2___RNAseq.g25336.t1",0,NA,0,NA,0,0,NA,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.5272605225827,9.37836418991306,13.2198087039517,9.56829066283521,11.1377521836423,3.68233641306884,5.66606675070968,13.7742698699083,12.4611809874505,7.62467556988766,9.90400058539499,12.6240544535071,7.18394671728289,3879.28098932196,-4.64792456726993,1.99588867033443,8.19264255216027e-06,9.61057436126895e-05,NA,NA,NA,NA,NA
"249","Pocillopora_acuta_HIv2___RNAseq.g25338.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.80261710823671,5.06794590568438,8.07140000186773,5.861974049924,6.44879012096401,3.68233641306884,3.68233641306884,8.4984549128176,7.13419520346623,3.68233641306884,5.89323865421672,7.39109146947046,4.39538583896298,89.5428391617885,-4.23707341567048,3.14559744775023,3.41079829107426e-05,0.000329111317425605,NA,NA,NA,NA,NA
"250","Pocillopora_acuta_HIv2___RNAseq.g25351.t1",0,NA,0,NA,100,0,NA,0,0,NA,16.6666666666667,0,33.3333333333333,NA,NA,NA,NA,NA,NA,14.2357092778105,16.5081689195171,12.655306997128,15.8009900043235,13.7012090026282,16.0451611316621,17.0968803307931,14.8548195507112,11.9885355342007,15.7577004145351,14.8644481163309,13.4871160724957,16.2417801601662,48599.9596373917,2.50537894086459,0.65434172119363,9.91457932083311e-06,0.000113273677169455,"A6QLI0",1.15e-31,"Mammalian ependymin-related protein 1 (MERP-1)","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005576; GO:0005764; GO:0007160; GO:0008289; GO:0043202"
"251","Pocillopora_acuta_HIv2___TS.g21811.t1",0,NA,NA,0,0,10,0,NA,0,NA,1.66666666666667,3.33333333333333,0,NA,NA,NA,NA,NA,NA,10.7268663712357,9.54194528213105,9.39003945098149,10.5428971247802,10.2189598266536,12.1908801060424,11.0490497782307,7.79472045485966,3.68233641306884,12.9798063298468,9.81175011378304,8.36258450335986,11.2609157242062,2065.9860857604,0.576309256553622,1.08384812282909,0.123636554381581,0.304854947592089,"P07174",9.61e-18,"Tumor necrosis factor receptor superfamily member 16 (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor) (NGF receptor) (Low-affinity nerve growth factor receptor p75NGFR) (Low-affinity nerve growth factor receptor p75NGR) (p75 ICD) (CD antigen CD271)","axon guidance [GO:0007411]; cellular response to amyloid-beta [GO:1904646]; cellular response to oxidative stress [GO:0034599]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; detection of temperature stimulus [GO:0016048]; dorsal aorta development [GO:0035907]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast proliferation [GO:0048144]; glucose homeostasis [GO:0042593]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; intracellular glucose homeostasis [GO:0001678]; intracellular protein transport [GO:0006886]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration [GO:0030336]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of hair follicle development [GO:0051799]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of myelination [GO:0031643]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; Rho protein signal transduction [GO:0007266]; skeletal muscle cell differentiation [GO:0035914]; skin development [GO:0043588]; spermatogenesis [GO:0007283]","GO:0001540; GO:0001678; GO:0001942; GO:0005035; GO:0005168; GO:0005516; GO:0005635; GO:0005737; GO:0005739; GO:0005886; GO:0005911; GO:0006886; GO:0007266; GO:0007283; GO:0007411; GO:0007417; GO:0007623; GO:0008543; GO:0009897; GO:0009986; GO:0010468; GO:0010976; GO:0010977; GO:0014069; GO:0015026; GO:0016048; GO:0016525; GO:0021675; GO:0030336; GO:0030426; GO:0031069; GO:0031267; GO:0031594; GO:0031625; GO:0031643; GO:0032224; GO:0032496; GO:0032590; GO:0032809; GO:0032922; GO:0034599; GO:0035025; GO:0035907; GO:0035914; GO:0040037; GO:0042475; GO:0042488; GO:0042593; GO:0042734; GO:0042802; GO:0043065; GO:0043066; GO:0043121; GO:0043197; GO:0043204; GO:0043410; GO:0043524; GO:0043588; GO:0044877; GO:0045334; GO:0045471; GO:0045666; GO:0048144; GO:0048146; GO:0048406; GO:0051402; GO:0051799; GO:0051897; GO:0051902; GO:0051968; GO:0061000; GO:0070678; GO:0099171; GO:1900182; GO:1902895; GO:1903588; GO:1904646; GO:2000179; GO:2000377; GO:2000463; GO:2001235"
"252","Pocillopora_acuta_HIv2___RNAseq.g25425.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.5987934777398,7.90768687698613,10.2621695025571,9.49270992195312,10.6488952270285,10.3315903226701,10.4771579508251,10.6139657864067,9.15728013052784,8.53242010463954,9.80226693013339,10.256220824852,9.3483130354148,1031.30408601191,-0.616934946607025,0.655193692403546,0.207808061109826,0.434103956656921,"Q70CQ2",0,"Ubiquitin carboxyl-terminal hydrolase 34 (EC 3.4.19.12) (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34)","positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055]","GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016055; GO:0016579; GO:0071108; GO:0090263"
"253","Pocillopora_acuta_HIv2___RNAseq.g25431.t1",0,0,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.9945966949045,5.21816971328303,13.4366883677703,3.68233641306884,11.5070084534341,4.32783990674728,3.68233641306884,9.90226184449731,13.3962134158858,3.68233641306884,8.18297876357288,12.2473537552984,4.11860377184737,3378.81007684284,-11.7349380030129,1.97733030305288,1.70268411528234e-17,1.8106919873551e-14,NA,NA,NA,NA,NA
"254","Pocillopora_acuta_HIv2___RNAseq.g25453.t1",21.0526315789474,16.6666666666667,0,0,35.1351351351351,0,11.7647058823529,0,0,NA,9.40212658478912,3.33333333333333,16.9881181491089,1,23.0769230769231,23.0769230769231,0.038378451247267,0.038378451247267,0.038378451247267,8.99744577812822,11.2615196837178,9.80429801387735,9.297488533342,10.6148370849317,10.742178729116,9.61318255760876,8.68507515720922,11.8472093158859,11.2877178485026,10.215095270232,9.98977307000648,10.4404174704574,1489.46135946648,0.27774307199343,0.639615708980705,0.56153504139412,0.774224072338466,"Q08DB5",6.2e-121,"Syntaxin-5","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]","GO:0000139; GO:0000149; GO:0005484; GO:0006886; GO:0006888; GO:0006906; GO:0012505; GO:0031201; GO:0033116; GO:0048278"
"255","Pocillopora_acuta_HIv2___TS.g21857.t1",NA,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.62035545127034,5.4315664930872,7.82326486527108,6.15405973004498,7.12625273022203,7.26229034322735,5.73058915105271,9.44014336565161,6.44828135143128,4.90925637683756,6.89460598580961,7.89165955276927,5.89755241884996,165.622742328238,-1.95344921863239,1.15083634532365,0.00357399910308174,0.0175116270416579,"Q7Z443",2.58e-49,"Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3)","cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of mechanical stimulus [GO:0050982]; monoatomic cation transport [GO:0006812]; sensory perception of sour taste [GO:0050915]","GO:0001581; GO:0005262; GO:0005886; GO:0006812; GO:0016020; GO:0030246; GO:0034703; GO:0043235; GO:0050915; GO:0050982; GO:0070062; GO:0071468"
"256","Pocillopora_acuta_HIv2___RNAseq.g25456.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.1414515907013,8.91999067103299,9.57729476136219,8.27067364660478,7.95119516021968,5.59702265161876,7.43457348819984,5.33850173705749,4.9224776128996,3.68233641306884,7.18355177327655,7.58618417244805,6.78091937410504,301.097920376461,-0.606443857049039,0.968082875142417,0.161804451102704,0.366537130892641,"P35556",1.14e-90,"Fibrillin-2 [Cleaved into: Placensin]","anatomical structure morphogenesis [GO:0009653]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0009653; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023"
"257","Pocillopora_acuta_HIv2___RNAseq.g25460.t1",6.10790634543604,4.39115540330115,7.02127659574468,4.28724544480171,2.50696378830084,2.7063599458728,3.73626373626374,3.80129589632829,6.94712053093556,4.26778242677824,4.57733701137631,4.4266354442479,4.72803857850471,NA,NA,NA,NA,NA,NA,3.68233641306884,5.85749282533549,3.68233641306884,6.94791225850548,7.73305689382981,7.9593001767779,4.96878174907288,8.43638570133787,9.11852204697751,3.68233641306884,6.20684608910435,6.53052749365657,5.88316468455212,140.857088632121,0.0077682573686146,0.994315749105814,0.870422231697604,0.949587992171491,NA,NA,NA,NA,NA
"258","Pocillopora_acuta_HIv2___TS.g21863.t2",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.1273808035965,4.8931170245923,10.5322934409015,3.68233641306884,10.340145715209,3.68233641306884,3.68233641306884,10.4181032590217,9.78247035279086,3.68233641306884,7.18228562483872,10.4400787143039,3.92449253537353,714.499186910933,-11.5870231763242,2.25752154264054,3.94089513301514e-14,8.76940110829708e-12,NA,NA,NA,NA,NA
"259","Pocillopora_acuta_HIv2___RNAseq.g25473.t1",NA,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.44918989210843,7.94568219541168,8.77491546959582,10.6884564426115,3.68233641306884,3.68233641306884,8.00704222118106,7.56273982243945,3.68233641306884,3.68233641306884,6.41573716956233,6.03030360205628,6.80117073706838,271.899931503727,0.508313249062283,0.944565159549076,0.315533166433717,0.564694248585689,"Q9UHC1",4.78e-95,"DNA mismatch repair protein Mlh3 (MutL protein homolog 3)","female meiosis I [GO:0007144]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; protein localization [GO:0008104]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130]","GO:0000795; GO:0001673; GO:0003682; GO:0003696; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0006298; GO:0007130; GO:0007131; GO:0007140; GO:0007144; GO:0008104; GO:0016887; GO:0019237; GO:0030983; GO:0032300; GO:0140664"
"260","Pocillopora_acuta_HIv2___RNAseq.g25494.t1",0,0,0,0,0,0,0,0,40,NA,4.44444444444444,8,0,NA,NA,NA,NA,NA,NA,5.9511981009209,5.06794590568438,7.78960555143337,3.68233641306884,9.94512552263226,8.93808545426081,3.68233641306884,8.17562588539884,8.11478681900153,3.68233641306884,6.50293824785386,7.99526837587738,5.01060811983034,218.95501064894,-0.967738383978904,1.60299354033423,2.56900896156098e-05,0.000255910093801777,"Q60803",7.2e-131,"TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3)","apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0001817; GO:0002224; GO:0005164; GO:0005737; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0045087; GO:0050688; GO:0061630; GO:0070534"
"261","Pocillopora_acuta_HIv2___RNAseq.g25518.t1",0,0,0,0,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.99738846276564,7.4680060679803,8.49133772109432,3.68233641306884,8.92196460494675,8.2679069717014,9.37094284064147,8.63291313484657,8.64536259744557,3.68233641306884,7.51604952275597,8.53779330421977,6.49430574129217,284.382866788206,-0.381857543667611,1.00703545849741,0.131603113245376,0.31927330257986,NA,NA,NA,NA,NA
"262","Pocillopora_acuta_HIv2___RNAseq.g25523.t1",0,0,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,11.8354810762162,11.1105575981411,9.97181302537224,7.02644217673873,11.0462402426766,7.07768908530409,7.61470949026634,10.3102398677748,3.68233641306884,12.675131205344,9.23506401809029,9.36922212502174,9.10090591115885,1702.86994756814,-0.334610644348532,1.00998528009925,0.241695610071811,0.479643643946915,"Q9XTL9",0,"Glycogen phosphorylase (EC 2.4.1.1)","defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; glycogen catabolic process [GO:0005980]; insulin receptor signaling pathway [GO:0008286]; negative regulation of innate immune response [GO:0045824]","GO:0005737; GO:0005829; GO:0005980; GO:0008184; GO:0008286; GO:0008340; GO:0030170; GO:0042803; GO:0045824; GO:0050829; GO:0102250; GO:0102499"
"263","Pocillopora_acuta_HIv2___RNAseq.g25525.t2",0,5.55555555555556,NA,0,0,0,0,NA,NA,NA,0.925925925925926,1.85185185185185,0,NA,NA,NA,NA,NA,NA,8.76515600530933,8.71569691288499,7.98913290325087,8.46021241809359,8.85452977473803,7.6114897718209,11.2262630010611,7.94874910879557,9.86593284638692,9.36192392289027,8.87990866652316,8.68470012769614,9.07511720535017,610.16613760813,0.150296213650901,0.71191413424963,0.763646138353861,0.897231695862973,"Q03701",1.44e-166,"CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor)","positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0003713; GO:0003723; GO:0005634; GO:0016602; GO:0045944"
"264","Pocillopora_acuta_HIv2___RNAseq.g25532.t1",0,0,NA,0,0,1.21951219512195,0,NA,NA,NA,0.203252032520325,0.40650406504065,0,NA,NA,NA,NA,NA,NA,9.25906492444599,4.8931170245923,10.2472388453267,3.68233641306884,9.56957603615072,3.68233641306884,3.68233641306884,9.06881000047198,8.76735014635008,3.68233641306884,6.65345026296131,9.38240799054909,3.92449253537353,344.325732515914,-10.562662206619,2.57570300762809,9.3713243516847e-11,5.37884267550665e-09,"Q5REJ1",1.31e-61,"Small ribosomal subunit protein uS5m (28S ribosomal protein S5, mitochondrial) (MRP-S5) (S5mt)","translation [GO:0006412]","GO:0003723; GO:0003735; GO:0005763; GO:0006412"
"265","Pocillopora_acuta_HIv2___RNAseq.g25565.t1",45.8333333333333,41.6666666666667,100,16.2162162162162,25,31.25,15,NA,NA,50,40.620777027027,29.710960960961,47.1666666666667,NA,NA,NA,NA,NA,NA,5.74163829918218,7.09062453168391,9.10045871331929,3.68233641306884,7.84805420942548,3.68233641306884,5.28097201389241,6.35881100040517,3.68233641306884,3.68233641306884,5.61499044201838,6.54625972708019,4.68372115695657,94.7585744318323,-0.243618021851011,1.02644856194826,0.240397750623222,0.478157800172935,"Q9HBF4",0,"Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1)","cellular response to starvation [GO:0009267]; lipid droplet formation [GO:0140042]; macroautophagy [GO:0016236]; positive regulation by host of viral genome replication [GO:0044829]","GO:0000407; GO:0005545; GO:0005547; GO:0005739; GO:0005776; GO:0005783; GO:0005789; GO:0005794; GO:0005795; GO:0005811; GO:0008270; GO:0009267; GO:0016236; GO:0032266; GO:0043325; GO:0044233; GO:0044829; GO:0048471; GO:0097629; GO:0140042; GO:1990462"
"266","Pocillopora_acuta_HIv2___RNAseq.g25582.t1",12.6865671641791,5.94059405940594,4.76190476190476,14.1891891891892,10.2941176470588,9.20245398773006,5,7.69230769230769,9.45945945945946,13.0434782608696,9.22700722221046,9.29680087761847,9.15721356680245,NA,NA,NA,NA,NA,NA,6.46401383180475,3.68233641306884,5.81272994412078,3.68233641306884,8.35860213271442,3.68233641306884,3.68233641306884,5.26380834900594,3.68233641306884,10.9566432161495,5.52674795391396,5.91629813414295,5.13719777368497,237.981108227126,-0.24882709595559,1.06418301005877,0.000145444831621275,0.00113837340074141,"Q9GSB0",7.63e-10,"Crt homolog 1 (Chloroquine resistance transporter paralog 1) (DdCRTp1)","amino acid transport [GO:0006865]","GO:0005774; GO:0006865; GO:0012506; GO:0042910"
"267","Pocillopora_acuta_HIv2___TS.g21988.t1",NA,0,24.2424242424242,0,0,1.17647058823529,0,0,NA,NA,3.63127069009422,0.294117647058824,8.08080808080808,NA,NA,NA,NA,NA,NA,8.01230688519318,8.46454219346938,7.80412787236133,8.92368021251025,8.30256178415943,8.8938269424416,7.42540170510466,8.55094554442137,3.68233641306884,3.68233641306884,7.37420659657989,7.27045569984083,7.47795749331895,245.795773044501,0.151263730898742,0.721415597159768,0.722458686336335,0.87554607785243,"O08807",1.02e-83,"Peroxiredoxin-4 (EC 1.11.1.24) (Antioxidant enzyme AOE372) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372) (Thioredoxin-dependent peroxiredoxin 4)","cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]","GO:0005615; GO:0005737; GO:0005739; GO:0005783; GO:0005790; GO:0005829; GO:0006979; GO:0007283; GO:0008379; GO:0008584; GO:0022417; GO:0030198; GO:0042744; GO:0042802; GO:0045454; GO:0072593; GO:0140313; GO:2000255"
"268","Pocillopora_acuta_HIv2___RNAseq.g4683.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.9240280238003,8.81122891607137,11.1399521376796,5.67021878014534,10.1507243202186,11.2210319456789,11.7959471739488,8.10391005152801,9.87835507531024,3.68233641306884,9.137773283745,10.0393939217074,8.23615264578265,1276.93506500071,-0.263730962395825,0.99342234005531,0.141255018010397,0.335541563557626,"Q9NRH2",3.79e-161,"SNF-related serine/threonine-protein kinase (EC 2.7.11.1) (SNF1-related kinase)","myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468]","GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0006468; GO:0030099; GO:0106310"
"269","Pocillopora_acuta_HIv2___TS.g7777.t2",0,0,0,NA,0,0,0,NA,50,NA,7.14285714285714,16.6666666666667,0,NA,NA,NA,NA,NA,NA,12.12197480371,12.3717343705125,12.2012981305742,11.2956938019177,12.2856140974854,11.444001191071,12.6706806194075,12.4595406448413,10.1661335505736,10.6872769342008,11.7703948144294,11.8469122454369,11.6938773834219,3945.3356219544,-0.103597707800072,0.541581974262693,0.808801381370146,0.92020004563343,"O54972",2.94e-142,"Protein CBFA2T3 (Eight twenty one protein 2) (MTG8-related protein 2) (Protein ETO-2)","DNA-templated transcription [GO:0006351]; granulocyte differentiation [GO:0030851]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glycolytic process [GO:0045820]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of aerobic respiration [GO:1903715]; response to hypoxia [GO:0001666]","GO:0000122; GO:0000139; GO:0001666; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0008285; GO:0030851; GO:0032436; GO:0045820; GO:0045892; GO:0046872; GO:1903715"
"270","Pocillopora_acuta_HIv2___RNAseq.g4720.t2",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.11706711288888,7.4680060679803,10.7665142914902,8.13666062791065,10.0116858654122,9.84015160836879,3.68233641306884,9.78077953154168,6.71123450989494,10.317288961787,8.58317249903435,9.27745626224558,7.88888873582312,673.804804564289,-0.328522364134734,0.977406829035085,0.280425292862567,0.52628408407476,"Q920B9",0,"FACT complex subunit SPT16 (Chromatin-specific transcription elongation factor 140 kDa subunit) (FACT 140 kDa subunit) (FACTp140) (Facilitates chromatin transcription complex subunit SPT16)","DNA repair [GO:0006281]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; transcription elongation by RNA polymerase II [GO:0006368]","GO:0005634; GO:0006260; GO:0006281; GO:0006334; GO:0006337; GO:0006368; GO:0031491; GO:0035101"
"271","Pocillopora_acuta_HIv2___TS.g7828.t1",0,1.75438596491228,40,0,6.25,8.19672131147541,4.34782608695652,NA,NA,NA,8.64984762333489,3.3170357587959,12.6494565217391,NA,NA,NA,NA,NA,NA,10.3627532000089,9.11837381134201,7.71470031930259,11.4226719341005,10.1172009772576,8.01880398001791,9.55789677526016,9.59461356058045,7.81134664147645,12.0009510617682,9.57193122611148,9.1201229397252,10.0237395124978,1179.44602356756,0.242588883982556,0.868935981720343,0.506699365468713,0.734947816099023,"Q9Y2L5",0,"Trafficking protein particle complex subunit 8 (Protein TRS85 homolog)","collagen biosynthetic process [GO:0032964]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; vesicle tethering [GO:0099022]","GO:0005737; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0032964; GO:0048208; GO:0099022; GO:1990072"
"272","Pocillopora_acuta_HIv2___RNAseq.g4740.t1",0,0,0,13.5135135135135,0,0,0,0,0,NA,1.5015015015015,2.7027027027027,0,NA,NA,NA,NA,NA,NA,10.4895898537159,11.402717718028,11.9702765828625,10.6315683716779,9.75823801738914,11.5264046089218,10.2505882117347,11.2317970659643,11.6122814999695,11.3607439053115,11.0234205835575,11.0124366039803,11.0344045631348,2268.77810041467,0.00767063286805774,0.646330764246339,0.995546650286792,0.998584379316794,NA,NA,NA,NA,NA
"273","Pocillopora_acuta_HIv2___RNAseq.g4744.t1",0,0,16.6666666666667,0,0,0,12.1212121212121,0,21.7391304347826,NA,5.61411213585127,4.34782608695652,7.1969696969697,NA,NA,NA,NA,NA,NA,6.37258314463392,7.43267390932227,7.33531323544956,6.74563749188866,3.68233641306884,6.87624067398106,3.68233641306884,7.50564875204671,3.68233641306884,3.68233641306884,5.69974428595975,5.71564359165357,5.68384498026593,67.7387286713044,0.0164322052471979,0.980641632249734,0.85373357210804,0.942579777696177,NA,NA,NA,NA,NA
"274","Pocillopora_acuta_HIv2___RNAseq.g4757.t1",7.54716981132075,4.12371134020619,NA,0.970873786407767,0,0,4.76190476190476,2.32558139534884,0,0,2.19213789946537,1.48403330439256,3.07726864330638,NA,NA,NA,NA,NA,NA,10.792275690822,9.92690969295718,11.0777725575256,3.68233641306884,9.46683765125607,3.68233641306884,3.68233641306884,8.99327372675703,8.22120504548698,3.68233641306884,7.32076200170802,9.71027293436954,4.93125106904651,627.126961368613,-1.08371418108182,2.0756791810416,7.30795896796633e-08,1.63625880050565e-06,"Q92556",0,"Engulfment and cell motility protein 1 (Protein ced-12 homolog)","actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]","GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0048870"
"275","Pocillopora_acuta_HIv2___RNAseq.g4763.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.60860163372973,5.93854123587151,8.89706072579295,9.1576449754935,7.84448509584657,8.28415117937733,8.90018289441995,7.36818091184417,6.28579400236677,5.00142931435546,7.32860719690979,7.20082447391604,7.45638991990355,221.237832306214,0.142204675287786,0.670204501839417,0.774048192789141,0.902952478765331,NA,NA,NA,NA,NA
"276","Pocillopora_acuta_HIv2___RNAseq.g4764.t1",1.17647058823529,0,2.97619047619048,0,0,0.240963855421687,0,11.6666666666667,0,0,1.60602915865141,2.38152610441767,0.830532212885154,NA,NA,NA,NA,NA,NA,9.79927025543996,10.853342618906,9.84687113984658,10.7565498687069,9.53134849743097,9.85379982800419,10.3635491218844,10.0236080487484,8.72667943317388,3.68233641306884,9.34373552252101,9.58555547492796,9.10191557011407,960.974087065903,-0.00681493947385642,0.845757332164666,0.956415843621414,0.983547725712061,"Q17R09",0,"Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38)","mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0003723; GO:0005524; GO:0005681; GO:0016887; GO:0034458; GO:0071013"
"277","Pocillopora_acuta_HIv2___RNAseq.g4765.t1",0,0,0,0,0,0,0,26.6666666666667,NA,0,2.96296296296296,6.66666666666667,0,NA,NA,NA,NA,NA,NA,7.28736510465359,7.1572797975657,5.9646645801927,8.16562923854076,3.68233641306884,9.35964339759873,3.68233641306884,5.81260090257085,7.70340519522265,3.68233641306884,6.24975974555515,6.09007443914173,6.40944505196857,139.980077970881,-0.0186826002706997,0.987183359405535,0.781505052351858,0.906979786344963,"Q9NXS3",1.01e-74,"Kelch-like protein 28 (BTB/POZ domain-containing protein 5)","",""
"278","Pocillopora_acuta_HIv2___RNAseq.g4766.t1",0,0.65359477124183,0,1.21212121212121,0,1.17820324005891,0.421940928270042,2.7027027027027,0,0,0.61685628543947,1.14932438522493,0.0843881856540084,NA,NA,NA,NA,NA,NA,7.72276316531662,9.11283083309763,9.47544161335609,9.84883592081904,9.41977908774909,8.9735396439084,11.0936371117503,8.93345472001888,10.222026178403,7.71805441628311,9.25203626907022,9.15469295296874,9.3493795851717,741.229802526619,0.146285153828304,0.729745419461998,0.755022623417529,0.892419446070369,NA,NA,NA,NA,NA
"279","Pocillopora_acuta_HIv2___RNAseq.g4783.t1",0,0,NA,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.11310426585121,10.7598419145691,6.54019209615733,3.68233641306884,8.71524105562279,7.37325912511382,3.68233641306884,9.48494204430315,3.68233641306884,3.68233641306884,6.37159261538928,6.90716317500066,5.83602205577789,305.068324315626,-0.196194141404577,1.02324788172476,0.324777427211306,0.574206173717678,"Q09225",4.87e-70,"Nose resistant to fluoxetine protein 6 (Protein nrf-6)","lipid transport [GO:0006869]","GO:0006869; GO:0008289; GO:0016020; GO:0016747"
"280","Pocillopora_acuta_HIv2___RNAseq.g4785.t1",0.274725274725275,2.97029702970297,0,1.25,0.681818181818182,0.595829195630586,1.0183299389002,0,0.735294117647059,NA,0.836254859824919,1.11028406859612,0.493718348860915,NA,NA,NA,NA,NA,NA,8.85602140099026,11.5833233701968,7.88830154420556,11.6385970295481,7.77492674167574,10.2606242127503,10.6834833206896,7.95230680857751,6.76651737006592,11.0512778657726,9.44553796644724,7.847614773103,11.0434611597915,1227.37861831238,3.09715388259877,0.71357230572395,5.91632644268238e-07,1.00086252242056e-05,"P12263",1.54e-09,"Coagulation factor VIII (Procoagulant component)","acute-phase response [GO:0006953]; blood coagulation, intrinsic pathway [GO:0007597]","GO:0005507; GO:0005615; GO:0006953; GO:0007597; GO:0016491"
"281","Pocillopora_acuta_HIv2___RNAseq.g4788.t1",0,0,0,0,6.25,0.50251256281407,5.71428571428571,0,NA,NA,1.55834978463747,0.125628140703518,2.99107142857143,NA,NA,NA,NA,NA,NA,6.87035865762029,11.2887998530791,9.57729476136219,9.85061763610282,7.95450868126574,10.0538807398142,9.17797914979448,7.96996419379309,9.90895043431527,8.89833832163736,9.15506924287845,8.45621534567132,9.85392314008559,763.298351469757,0.719344763017298,0.890550196952979,0.143535238645569,0.338456747924601,NA,NA,NA,NA,NA
"282","Pocillopora_acuta_HIv2___RNAseq.g4791.t1",0,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.18458835466292,11.0194835570927,8.8582568221224,9.06242471982068,6.43917658127574,10.857076547835,10.5418954155225,7.88687806037457,3.68233641306884,9.32172647585935,8.58538429476347,7.01024724630089,10.160521343226,744.783624613668,1.83549822249361,1.94093658802434,0.00462605136025544,0.0217597420730844,"O18806",1.36e-09,"Coagulation factor VIII (Procoagulant component)","acute-phase response [GO:0006953]; blood coagulation, intrinsic pathway [GO:0007597]","GO:0005507; GO:0005615; GO:0006953; GO:0007597; GO:0016491"
"283","Pocillopora_acuta_HIv2___RNAseq.g4796.t1",0,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.29400515509404,9.32902717013835,9.93830016638107,5.35849991176178,9.41138356358749,9.36917999536911,6.82811848658939,8.24393212696616,3.68233641306884,3.68233641306884,7.51371194020251,8.11399148501952,6.91343239538549,385.386027075044,-0.496141283411074,0.939028929432395,0.328585198107248,0.578699158039927,"Q15393",0,"Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (STAF130) (Spliceosome-associated protein 130) (SAP 130)","mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; U2-type prespliceosome assembly [GO:1903241]","GO:0000124; GO:0000375; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0005730; GO:0006282; GO:0008380; GO:0030620; GO:0042177; GO:0043484; GO:0044877; GO:0045893; GO:0071005; GO:0071013; GO:1903241"
"284","Pocillopora_acuta_HIv2___TS.g7901.t1",NA,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,3.68233641306884,7.43323357003778,5.90231870585895,7.00052008311504,6.51519156656932,5.92312243117937,3.68233641306884,3.68233641306884,5.11860684221047,4.57449007524897,5.66272360917196,39.3971149315443,0.223718737066755,1.00670032465065,0.459787623430104,0.700776415731614,NA,NA,NA,NA,NA
"285","Pocillopora_acuta_HIv2___TS.g7920.t1",66.6666666666667,18.75,NA,NA,21.4285714285714,52.9411764705882,53.8461538461538,NA,33.3333333333333,NA,41.1609836242189,35.0081699346405,47.3137973137973,NA,NA,NA,NA,NA,NA,5.29008743000815,4.75675715543394,5.83271376384282,5.63527227912703,5.16318610945075,3.68233641306884,4.27277361158612,5.40874075538327,7.21538268069822,3.68233641306884,5.0939586611668,5.78202214787664,4.40589517445695,24.8335216438796,-0.915639277625153,1.377501825633,0.0213234377276422,0.078081570453827,NA,NA,NA,NA,NA
"286","Pocillopora_acuta_HIv2___RNAseq.g4836.t1",0,0,5.37634408602151,0,0.523560209424084,0.754716981132076,0,0,0.510204081632653,0,0.716482535821032,0.252984212552946,1.17998085908912,NA,NA,NA,NA,NA,NA,8.34234621569247,5.50727693310996,8.54696605901073,10.7688493782254,9.5983885551017,10.3227855093321,9.01110645875676,9.77978118726281,9.58250315800121,9.51560621722274,9.09756096717159,9.16999703501378,9.02512489932939,718.764477934197,-0.0760449066773552,0.75354148643418,0.851776768446798,0.941559311367103,"A4IFB6",0,"CCR4-NOT transcription complex subunit 10","mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]","GO:0006402; GO:0017148; GO:0030014"
"287","Pocillopora_acuta_HIv2___RNAseq.g4846.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.30247991645527,3.68233641306884,10.0788732474779,3.68233641306884,9.79003779613237,3.68233641306884,9.53050218005083,10.4598352012188,3.68233641306884,3.68233641306884,6.65734104066794,8.46271251487064,4.85196956646524,430.333056441341,-0.367784693008481,1.08848480247549,9.47964864257848e-05,0.000793941157882196,"P41044",8.97e-58,"Calbindin-32","regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]","GO:0005509; GO:0005634; GO:0005829; GO:0030425; GO:0043195; GO:0045202; GO:0061175; GO:0097467; GO:0099509; GO:1900271"
"288","Pocillopora_acuta_HIv2___RNAseq.g4860.t2",6.52173913043478,19.4968553459119,4.90196078431373,15.625,7.86240786240786,4.03587443946188,4.42176870748299,7.07070707070707,5.26315789473684,14.0350877192982,8.92345589547554,10.2983189501635,7.54859284078752,1,-35,-35,0.0364355315649229,0.0364355315649229,0.0364355315649229,8.31855930028477,10.204652046276,6.6530110934117,9.72609145270854,7.72531093337751,9.73934674066842,9.93583218846854,7.63990457163417,6.72526102529218,3.68233641306884,8.03503057651907,7.41240938480007,8.65765176823807,457.288241666845,0.55007181728974,1.03046753887714,0.185267460831756,0.402358641662241,NA,NA,NA,NA,NA
"289","Pocillopora_acuta_HIv2___RNAseq.g4863.t1",0,0,6.49350649350649,0,0,0,0,1.33333333333333,0,NA,0.86964886964887,0.266666666666667,1.62337662337662,NA,NA,NA,NA,NA,NA,8.68376069653767,9.48517070370788,7.47530043029133,10.9258013458456,6.36993744999328,10.0912303871701,3.68233641306884,7.43091797997457,3.68233641306884,11.9059348496889,7.9732726669347,6.72845059397314,9.21809473989626,823.411240174534,0.351777365429307,1.05463189802453,0.119130667161452,0.29708723617642,NA,NA,NA,NA,NA
"290","Pocillopora_acuta_HIv2___RNAseq.g4864.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.1560443063542,11.3263850253088,11.4030384056837,8.13079615140025,10.5215486650891,8.84543390622772,6.75620037889345,9.4898348250539,8.82628061242514,10.2052857239394,9.56608480003757,10.0793493629212,9.05282023715392,1083.55816144831,-0.507834593354808,0.873559411190578,0.231174108880275,0.46563184944218,"Q14703",0,"Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1) (SKI-1)","ATF6-mediated unfolded protein response [GO:0036500]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein maturation [GO:0051604]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976]","GO:0000139; GO:0004252; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0007040; GO:0007095; GO:0008203; GO:0016485; GO:0030968; GO:0031293; GO:0034976; GO:0036500; GO:0045540; GO:0051604; GO:0060627"
"291","Pocillopora_acuta_HIv2___RNAseq.3686_t",0,0,0,1.81818181818182,0,0,0,0,0,NA,0.202020202020202,0.363636363636364,0,NA,NA,NA,NA,NA,NA,3.68233641306884,10.3052418196045,9.08670395153231,8.43665445634566,8.00331478228558,7.13292658472672,3.68233641306884,7.661829922175,6.16564805667492,3.68233641306884,6.78393288125512,6.91996662514733,6.64789913736291,265.282281962102,-0.182627160649589,0.997790781537258,0.281244681282857,0.527047147540515,NA,NA,NA,NA,NA
"292","Pocillopora_acuta_HIv2___RNAseq.g4879.t1",0,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,13.7982198166222,9.71650978260157,13.7408287611307,8.68475656126926,14.0901119869741,4.78285319113451,3.68233641306884,14.9314507612788,12.5294627996223,8.1532745878894,10.4109804661592,13.8180148251256,7.00394610719272,8387.62210612352,-5.08977068239278,2.28320045042381,8.8559135973328e-06,0.000102802515466952,"O93429",8.28e-60,"Serotransferrin","antibacterial humoral response [GO:0019731]; iron ion transport [GO:0006826]","GO:0005615; GO:0005769; GO:0005886; GO:0006826; GO:0019731; GO:0046872; GO:0055037"
"293","Pocillopora_acuta_HIv2___TS.g7980.t2",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.66253495264651,6.051458458319,3.68233641306884,9.38222197390182,9.73345236192127,10.2736450832837,6.78080511148754,10.3140543443293,3.68233641306884,7.32451815250957,7.2421752602213,7.40686104479783,484.13425168983,0.0265727936172743,0.992538925621211,0.998715707250911,0.999737786244172,"Q8VCC1",2.28e-54,"15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1)","ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001822; GO:0004957; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0030728; GO:0032355; GO:0032496; GO:0042802; GO:0043065; GO:0045471; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707; GO:1905828"
"294","Pocillopora_acuta_HIv2___RNAseq.g4897.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.13549223134047,7.04438020601615,8.15299070698312,5.26613946623341,8.09020491054116,3.68233641306884,9.10840683033364,7.06558112980681,3.68233641306884,7.82681714880406,6.80546854561965,7.02532107834808,6.58561601289122,172.594574447874,-0.0784839097275957,0.974863990787003,0.572678762760726,0.782248146621129,"Q5RD73",1.99e-50,"Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Vaccinia H1-related phosphatase) (VHR)","dephosphorylation [GO:0016311]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of mitotic cell cycle [GO:0045931]","GO:0004725; GO:0005634; GO:0005829; GO:0008138; GO:0016311; GO:0016791; GO:0017018; GO:0033549; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0070373"
"295","Pocillopora_acuta_HIv2___TS.g7995.t1",0,0,0,0,0,0,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.30651664995697,3.68233641306884,7.53465822665543,3.68233641306884,7.77492674167574,8.54222383928769,3.68233641306884,8.66357016691129,3.68233641306884,10.370189451734,6.59214307284965,7.19240163965365,5.99188450604564,267.195960515848,-0.155517567996565,1.02084674538357,0.000508432496044155,0.0033140908620021,"P98160",4.35e-19,"Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]","angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of endothelial cell proliferation [GO:0001938]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224]","GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031100; GO:0043202; GO:0050750; GO:0062023; GO:0070052; GO:0070062; GO:0072359; GO:0098797"
"296","Pocillopora_acuta_HIv2___RNAseq.g4912.t1",0,0,NA,0,14.2857142857143,0,0,NA,NA,NA,2.38095238095238,0,4.76190476190476,NA,NA,NA,NA,NA,NA,11.0609418566409,10.7464870595693,10.9507205812245,9.71830564126848,10.5911458310036,11.0853336029576,10.3515597695083,10.2581505772724,12.0997821210777,7.40334154893872,10.4265768589462,10.9921481934438,9.86100552444848,1722.62808269592,-0.455947212025208,0.789509843343942,0.330310038143178,0.580722546700247,"Q11076",2.76e-60,"Probable ubiquitin-conjugating enzyme protein 17","negative regulation of apoptotic process [GO:0043066]","GO:0004869; GO:0005634; GO:0016874; GO:0043066; GO:0061631"
"297","Pocillopora_acuta_HIv2___TS.g8003.t2",0,NA,NA,0,15,10.3448275862069,0,NA,0,NA,4.22413793103448,3.44827586206897,5,NA,NA,NA,NA,NA,NA,6.4190560364177,7.61700196810264,4.89801104097743,9.4995404937589,8.94542213631147,9.66697234898041,8.09615847586979,3.68233641306884,3.68233641306884,11.8530915844204,7.43599269109764,5.52543240796886,9.34655297422643,611.884373249548,0.886268404453224,1.47503972432377,0.000318997073110297,0.00222682126711744,NA,NA,NA,NA,NA
"298","Pocillopora_acuta_HIv2___TS.g8019.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0839080917428,10.1007224689175,10.1400619443676,10.5428971247802,9.3980910154067,8.55900084391515,10.4716296923852,9.83465061058417,9.5653173540479,10.0327092302727,9.87289883764199,9.80440580322983,9.94139187205415,973.87914529804,0.107673886352493,0.53421908148098,0.816851259116338,0.924197169263041,"Q6NRC9",0,"Leucine-rich repeat and coiled-coil domain-containing protein 1","cell division [GO:0051301]","GO:0005737; GO:0005814; GO:0051301"
"299","Pocillopora_acuta_HIv2___RNAseq.g4933.t1",0,95.8333333333333,28.5714285714286,60,100,78.6885245901639,77.6119402985075,NA,62.5,100,67.0228029770481,74.2554644808743,61.2366737739872,NA,NA,NA,NA,NA,NA,7.78785518405689,8.80092184181281,10.4153793457256,9.38124371415315,9.9690177998091,11.3728072978904,9.92616305965734,9.64920785490901,10.6563587296534,11.9840811750509,9.99430360027186,9.6955637828308,10.2930434177129,1353.99873314731,0.436773131388431,0.628408674171147,0.362036868370015,0.612241466632046,"Q6PGV1",0,"V-type proton ATPase subunit d 1 (V-ATPase subunit d 1) (Vacuolar proton pump subunit d 1)","apical protein localization [GO:0045176]; cellular response to increased oxygen levels [GO:0036295]; cilium assembly [GO:0060271]; eye pigment granule organization [GO:0008057]; heart looping [GO:0001947]; intracellular iron ion homeostasis [GO:0006879]; left/right axis specification [GO:0070986]; melanosome organization [GO:0032438]; neuromast hair cell development [GO:0035675]; pronephric duct development [GO:0039022]; response to copper ion [GO:0046688]; retina development in camera-type eye [GO:0060041]; retinal pigment epithelium development [GO:0003406]; vacuolar acidification [GO:0007035]; vacuolar transport [GO:0007034]","GO:0001947; GO:0003406; GO:0005765; GO:0005769; GO:0006879; GO:0007034; GO:0007035; GO:0008057; GO:0016471; GO:0032438; GO:0033179; GO:0033181; GO:0035675; GO:0036295; GO:0039022; GO:0045176; GO:0046688; GO:0046961; GO:0060041; GO:0060271; GO:0070986"
"300","Pocillopora_acuta_HIv2___RNAseq.g4938.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.16911426736902,3.68233641306884,9.44342769799349,3.68233641306884,9.25259323416196,3.68233641306884,3.68233641306884,6.48445350747802,6.80659519587517,3.68233641306884,5.65678659682219,7.63123678057553,3.68233641306884,145.737455678457,-11.7812447777536,3.91826391475229,3.67061093718495e-08,9.1222880748184e-07,"E7FAM5",1.12e-121,"E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177"
"301","Pocillopora_acuta_HIv2___RNAseq.g4951.t1",15.7894736842105,8.10810810810811,4.65116279069767,NA,NA,0,0,NA,1.53846153846154,1.86915887850467,4.5651949999975,3.21552321552322,5.57744883835322,NA,NA,NA,NA,NA,NA,9.66128498702246,6.74434409930028,7.71470031930259,3.68233641306884,9.48523925506133,4.32783990674728,3.68233641306884,7.59957177400187,3.68233641306884,10.4969911658076,6.70769807464499,7.62862654969142,5.78676959959857,333.507916199498,-0.382382214931282,1.1160268044062,0.00115641843149155,0.00662958231989451,"A0A2R8QPS5",2.7e-09,"Guanine nucleotide exchange factor subunit RIC1 (Protein RIC1 homolog) (RAB6A-GEF complex partner 1)","intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000139; GO:0005085; GO:0005829; GO:0006886; GO:0034066; GO:0042147"
"302","Pocillopora_acuta_HIv2___RNAseq.g4955.t2",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.16748500850389,9.12389555183141,8.54696605901073,8.87896121308284,7.67793404886523,11.5745848005937,8.49151799840897,7.14279562628233,6.41379501761528,11.0590760386195,8.60770113628139,7.38979515205549,9.82560712050728,727.131161895092,1.86566408802407,1.12059453172838,0.00430604443787178,0.0205079442704569,"O14841",0,"5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase)","glutathione metabolic process [GO:0006749]","GO:0005524; GO:0005829; GO:0006749; GO:0017168; GO:0042802"
"303","Pocillopora_acuta_HIv2___RNAseq.g4974.t1",0,0,0.869565217391304,1.08695652173913,1.14942528735632,0.239234449760766,1.18110236220472,0,0,0,0.452628383845225,0.265238194299979,0.64001857339047,NA,NA,NA,NA,NA,NA,7.89376064460252,6.39972611558308,9.93830016638107,8.80365534365502,9.97146697368041,6.58890355943315,5.40984312721881,8.37945792237163,9.05425581488638,11.0411893009257,8.34805589687378,9.0474483043844,7.64866348936315,561.797676632089,-0.937306302828172,1.05152707058093,0.0582489930303567,0.175159994717741,"P29120",9.28e-146,"Neuroendocrine convertase 1 (NEC 1) (EC 3.4.21.93) (Prohormone convertase 1) (Proprotein convertase 1) (PC1)","cell-cell signaling [GO:0007267]; insulin processing [GO:0030070]; neurogenesis [GO:0022008]; pancreas development [GO:0031016]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; pituitary gland development [GO:0021983]; positive regulation of protein secretion [GO:0050714]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to chlorate [GO:0010157]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]","GO:0004252; GO:0005615; GO:0005802; GO:0006508; GO:0007267; GO:0009410; GO:0009749; GO:0010157; GO:0016020; GO:0016486; GO:0016540; GO:0021983; GO:0022008; GO:0030070; GO:0030133; GO:0030425; GO:0031016; GO:0031667; GO:0032496; GO:0034774; GO:0042802; GO:0043005; GO:0043043; GO:0043204; GO:0043434; GO:0043679; GO:0048471; GO:0048678; GO:0050714; GO:0051384; GO:0051592; GO:0070542; GO:0070555"
"304","Pocillopora_acuta_HIv2___RNAseq.g4985.t2",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.1902578621426,11.3878855650619,9.7970786794685,11.8076940481584,10.515967297692,10.2316485653212,6.24475683147728,9.23395771615791,6.89589329451837,13.4910652461136,9.97962051061118,9.32663096999588,10.6326100512265,2304.7761383971,0.332790344152271,0.906431392187065,0.384889513690785,0.633510529733452,"Q5TJ56",9.48e-45,"Formin-F (Diaphanous-related formin dia1)","'de novo' actin filament nucleation [GO:0070060]; actin filament polymerization [GO:0030041]; positive phototaxis [GO:0046956]","GO:0005522; GO:0015629; GO:0030041; GO:0031143; GO:0031267; GO:0046956; GO:0051015; GO:0070060"
"305","Pocillopora_acuta_HIv2___RNAseq.g4992.t1",0,0,NA,NA,0,5.88235294117647,0,0,NA,NA,0.980392156862745,1.96078431372549,0,NA,NA,NA,NA,NA,NA,7.42800305042402,9.56444963996905,7.58605044178411,9.96688426318284,9.32334629709623,11.0777947867179,8.73637313689673,8.82530251522673,3.68233641306884,10.0706807206,8.62612212649664,7.36900774351999,9.8832365094733,665.223682990035,0.909392886440957,1.21978095954043,0.0636796579899139,0.18746545363141,"Q12955",3.93e-06,"Ankyrin-3 (ANK-3) (Ankyrin-G)","axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]","GO:0000281; GO:0005200; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0008093; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259"
"306","Pocillopora_acuta_HIv2___TS.g8089.t1",0,1.66666666666667,0,0,0,1.28205128205128,0,NA,NA,0,0.368589743589744,0.982905982905983,0,NA,NA,NA,NA,NA,NA,10.7669055946387,7.05608360716548,7.66780142801844,3.68233641306884,9.30921256533115,3.68233641306884,3.68233641306884,8.15725975832439,8.69188709951876,3.68233641306884,6.63784957052723,8.91861328916629,4.35708585188817,326.160840258056,-9.25641987628543,2.85813492854415,2.78849516182933e-08,7.1639065756127e-07,"Q02290",8.03e-07,"Endo-1,4-beta-xylanase B (Xylanase B) (EC 3.2.1.8) (1,4-beta-D-xylan xylanohydrolase B)","xylan catabolic process [GO:0045493]","GO:0005576; GO:0030248; GO:0031176; GO:0045493"
"307","Pocillopora_acuta_HIv2___TS.g8093.t1",0,0,0,0,0,2.04081632653061,0,0,NA,NA,0.255102040816327,0.510204081632653,0,NA,NA,NA,NA,NA,NA,9.99054168790246,3.68233641306884,10.2907186412599,5.76965417569396,9.55658330803566,3.68233641306884,3.68233641306884,10.6389518816945,10.0853962493077,8.52599624145614,7.59048514245568,10.11243835364,5.06853193127132,595.165127859721,-6.04337276233989,4.96989664572947,5.05870778565905e-08,1.19557433679367e-06,NA,NA,NA,NA,NA
"308","Pocillopora_acuta_HIv2___RNAseq.g5014.t1",0,NA,0,5.47945205479452,0,0,0,0,0,NA,0.684931506849315,1.36986301369863,0,NA,NA,NA,NA,NA,NA,3.68233641306884,5.50727693310996,4.89801104097743,3.68233641306884,3.68233641306884,3.68233641306884,7.16350359739089,5.53803082388147,3.68233641306884,6.48472759049682,4.80032320512008,4.29661022081308,5.30403618942707,24.1989606142953,0.166916778456989,1.02347446527522,0.269192090578262,0.51286436367041,NA,NA,NA,NA,NA
"309","Pocillopora_acuta_HIv2___RNAseq.g5075.t1",NA,0,0,0,NA,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,6.01423630021445,10.1650455930785,9.64989267794005,9.08379841403673,9.49094192144715,9.40299864939199,11.2024318375091,9.82306735152005,9.02939732787342,8.340733370963,9.22025434439744,8.80150711579902,9.63900157299586,781.230421824854,0.326325809739205,0.7806898519641,0.480116343927975,0.715254176390383,"A0A061ACU2",0,"Piezo-type mechanosensitive ion channel component 1","cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; flagellated sperm motility [GO:0030317]; monoatomic cation transmembrane transport [GO:0098655]; positive regulation of brood size [GO:0090727]; positive regulation of ovulation [GO:0060279]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612]","GO:0005261; GO:0005886; GO:0008381; GO:0009612; GO:0030317; GO:0042391; GO:0050982; GO:0060279; GO:0071260; GO:0090727; GO:0098655"
"310","Pocillopora_acuta_HIv2___RNAseq.g5079.t1",9.88142292490119,2.14285714285714,18.3006535947712,0,1.18043844856661,1.66320166320166,1.57142857142857,0,0,0,3.47400023457264,0.761211761211761,6.18678870793352,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,8.55269852129508,3.68233641306884,7.98722978398025,5.84950698471885,6.86956709787897,3.68233641306884,8.55530966566589,3.68233641306884,5.62259941188832,6.49198215941578,4.75321666436087,105.745055325676,-0.132967845337943,1.01929553145272,0.0186778248865297,0.0702251258535911,"Q5RED8",2.01e-19,"Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD)","innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-18-mediated signaling pathway [GO:2000493]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of mitotic cell cycle [GO:0007346]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; Wnt signaling pathway [GO:0016055]","GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006508; GO:0007346; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0032088; GO:0036064; GO:0045087; GO:0046329; GO:0048471; GO:0050727; GO:0050728; GO:0061578; GO:0070266; GO:0070536; GO:0090090; GO:0097542; GO:1901223; GO:1902017; GO:1903753; GO:1990108; GO:2000493; GO:2001238; GO:2001242"
"311","Pocillopora_acuta_HIv2___TS.g8173.t1",0,0,0,0,2.89017341040462,0,0.403225806451613,0,NA,NA,0.41167490210703,0,0.823349804214059,NA,NA,NA,NA,NA,NA,5.17503271827961,7.72302631647394,5.20227553025741,4.62642457401022,6.49588007341306,3.68233641306884,8.40588239640505,6.77268923679108,3.68233641306884,4.90925637683756,5.66751400486056,5.465642794362,5.86938521535912,69.8130645768855,0.195246066780789,0.97529912405065,0.438717983770194,0.681737958449945,NA,NA,NA,NA,NA
"312","Pocillopora_acuta_HIv2___RNAseq.g5081.t1",0,0,0,0,0,6.81818181818182,6.34920634920635,0,0,NA,1.4630431297098,1.36363636363636,1.58730158730159,NA,NA,NA,NA,NA,NA,11.712166077951,11.578307051093,12.0539056150695,11.740109330033,11.9833179360984,12.341097361691,12.1623482262854,12.3878191716497,12.6172960888138,11.0116418662505,11.9588008724935,12.1509009779165,11.7667007670706,4135.77864981168,-0.267074129100274,0.556620248332458,0.554125818470991,0.769170975395394,"O16118",0,"Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein)","G protein-coupled receptor signaling pathway [GO:0007186]","GO:0003924; GO:0005525; GO:0007186; GO:0031683; GO:0046872"
"313","Pocillopora_acuta_HIv2___TS.g8177.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.7792912387703,11.0451620213554,10.1314780341863,9.47664493676885,9.17960049617192,6.13692185768316,3.68233641306884,7.47126058053414,10.5143627559046,11.479230379932,8.58962887143755,8.81519862111345,8.36405912176165,897.697425410493,-0.171805850251231,0.93710651196779,0.481740813929743,0.71600950319277,"Q1RMU2",8.94e-121,"Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD)","innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-18-mediated signaling pathway [GO:2000493]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of mitotic cell cycle [GO:0007346]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; Wnt signaling pathway [GO:0016055]","GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006508; GO:0007346; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0032088; GO:0036064; GO:0045087; GO:0046329; GO:0048471; GO:0050727; GO:0050728; GO:0061578; GO:0070266; GO:0070536; GO:0090090; GO:0097542; GO:1901223; GO:1902017; GO:1903753; GO:1990108; GO:2000493; GO:2001238; GO:2001242"
"314","Pocillopora_acuta_HIv2___RNAseq.g5089.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.28621869280214,8.07697750564745,8.0390565812867,4.7918870276047,7.40935653522263,5.16559618031706,4.96878174907288,5.98234595970336,7.91172507704905,3.68233641306884,6.43142817217748,7.52574056921278,5.33711577514219,120.491178273966,-1.78681823734613,1.78483550423186,0.00504835888600837,0.0234487677993658,"Q1RMU2",3.22e-20,"Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD)","innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-18-mediated signaling pathway [GO:2000493]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of mitotic cell cycle [GO:0007346]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; Wnt signaling pathway [GO:0016055]","GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006508; GO:0007346; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0032088; GO:0036064; GO:0045087; GO:0046329; GO:0048471; GO:0050727; GO:0050728; GO:0061578; GO:0070266; GO:0070536; GO:0090090; GO:0097542; GO:1901223; GO:1902017; GO:1903753; GO:1990108; GO:2000493; GO:2001238; GO:2001242"
"315","Pocillopora_acuta_HIv2___RNAseq.g5108.t1b",0.371195248700817,1.89035916824197,0.143266475644699,1.38713745271122,0.70871722182849,0.396712949844149,1.13250283125708,0.376647834274953,0.132275132275132,0,0.653881431477851,0.836626507469485,0.471136355486217,NA,NA,NA,NA,NA,NA,9.66285807248096,3.68233641306884,9.75795302770781,3.68233641306884,9.66042696044772,3.68233641306884,6.20136626305352,8.4984549128176,10.1027035643825,3.68233641306884,6.86131084531655,9.53647930756732,4.18614238306578,386.986622824301,-10.2663913509797,3.00881082304973,2.44700714970129e-09,8.6748802483528e-08,NA,NA,NA,NA,NA
"316","Pocillopora_acuta_HIv2___RNAseq.g5138.t1",NA,0,0,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.663504731815,14.1143573490247,12.6649211793184,13.2677354282252,11.9393793522627,14.2279442657808,13.9563802059406,13.0399184271271,11.9315706798258,14.3662441174693,13.117195573679,12.2478588740698,13.9865322732881,10953.8344849687,1.41574067207943,0.705028151398732,0.00937401433483359,0.0394144602729747,"Q90XW6",8.82e-46,"Iroquois-class homeodomain protein irx-4-A (Iroquois homeobox protein 4-A)","brain development [GO:0007420]; cell differentiation [GO:0030154]; dorsal/ventral pattern formation [GO:0009953]; heart development [GO:0007507]; proximal/distal pattern formation [GO:0009954]","GO:0000981; GO:0003677; GO:0005634; GO:0007420; GO:0007507; GO:0009953; GO:0009954; GO:0030154"
"317","Pocillopora_acuta_HIv2___TS.g8258.t1",0,0,0,0,0.446428571428571,0.423728813559322,0,0,0,0,0.0870157384987894,0.0847457627118644,0.0892857142857143,NA,NA,NA,NA,NA,NA,3.68233641306884,8.08833890508173,3.68233641306884,6.52744462229308,3.68233641306884,6.20886511492185,8.13031222455182,6.36973004382258,3.68233641306884,6.66207226213774,5.67161088250842,4.21981513921959,7.12340662579724,75.7322744331064,7.17538386167691,3.33160106177021,6.26401379830199e-06,7.63291453905982e-05,"Q8NDA2",9.73e-30,"Hemicentin-2","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808]","GO:0005509; GO:0005576; GO:0005886; GO:0007156; GO:0008046; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023"
"318","Pocillopora_acuta_HIv2___TS.g8259.t1b",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.64536487564891,3.68233641306884,9.9420308665761,5.59620788443221,7.1685916905325,11.7928474271363,7.26282800372101,3.68233641306884,9.2495397382469,7.17044197255005,4.78120902547195,9.55967491962814,611.373388321682,5.97373148141043,4.26389540590176,4.88877282869855e-08,1.16492932774787e-06,"P13590",6.63e-23,"Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1)","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synaptic membrane adhesion [GO:0099560]","GO:0005886; GO:0007156; GO:0099560"
"319","Pocillopora_acuta_HIv2___TS.g8276.t1",0,0,0,NA,0,0,0,NA,1.92307692307692,0,0.240384615384615,0.641025641025641,0,NA,NA,NA,NA,NA,NA,5.32602117141484,6.08712839408766,5.59369902756585,3.68233641306884,5.31048131328141,4.78285319113451,3.68233641306884,5.82897333870066,5.8874486244384,3.68233641306884,4.98636142998298,5.58932469508023,4.38339816488574,18.5682820673503,-0.501786916511702,1.13529249685166,0.0111712184283641,0.0456348322571862,"Q92626",3.34e-31,"Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"320","Pocillopora_acuta_HIv2___RNAseq.g5181.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.1872802948014,9.58860577091688,3.68233641306884,9.49726723019594,3.68233641306884,8.3121442893771,10.4848620901078,6.87470680484115,5.56716625041612,9.49603736829695,7.3372742925091,5.19876523523927,9.47578334977893,400.629188017808,4.75293978589626,2.10748942807356,1.38046414224945e-05,0.000150886667255231,"Q9HCK4",3.69e-30,"Roundabout homolog 2","aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; chemotaxis [GO:0006935]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway [GO:0045747]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]","GO:0001656; GO:0001657; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0006935; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016199; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035904; GO:0042802; GO:0045747; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609"
"321","Pocillopora_acuta_HIv2___RNAseq.g5202.t1",NA,NA,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.50166901119502,10.1743848517553,10.3161909914033,9.06242471982068,9.68451377027625,10.1565556541113,11.1782003734031,9.76774683316931,8.61224937819785,9.9983540869364,9.84522896702685,9.57647399684835,10.1139839372054,1000.26730699935,0.390753009322304,0.635858472577919,0.418210008406194,0.662830326713477,"Q4G0P3",0,"Hydrocephalus-inducing protein homolog","axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591]","GO:0002064; GO:0003341; GO:0005930; GO:0021591; GO:0060438; GO:1904158; GO:1990716; GO:1990718"
"322","Pocillopora_acuta_HIv2___RNAseq.g5214.t1",50,31.5789473684211,NA,100,20,52.1739130434783,55.5555555555556,NA,0,NA,44.1869165667793,45.9382151029748,41.8518518518519,NA,NA,NA,NA,NA,NA,8.65873266372766,9.48517070370788,9.80909090305916,8.98339297918665,7.35505011416575,7.3029219250034,9.86337220250049,10.9151468479371,8.17655864680531,10.9362221458046,9.1485659131898,8.982915835139,9.3142159912406,770.427127926059,0.15765044238222,0.689215243256794,0.74704595430353,0.888775652112255,"Q4G0P3",0,"Hydrocephalus-inducing protein homolog","axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591]","GO:0002064; GO:0003341; GO:0005930; GO:0021591; GO:0060438; GO:1904158; GO:1990716; GO:1990718"
"323","Pocillopora_acuta_HIv2___RNAseq.g5218.t1",0.606060606060606,0,0,0,0,0.847457627118644,0.772200772200772,NA,0,NA,0.278214875672503,0.211864406779661,0.344565344565345,NA,NA,NA,NA,NA,NA,3.68233641306884,4.50233927872981,5.16860104011765,5.67021878014534,5.420425513227,5.65167313584929,5.08305273412487,5.09793447691117,3.68233641306884,3.68233641306884,4.76412541983117,4.6103267712787,4.91792406838363,12.2956666404034,0.263956020171131,0.938396950907885,0.498373513126963,0.728342348441257,"Q3UQ28",2.12e-34,"Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment]","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"324","Pocillopora_acuta_HIv2___TS.g8323.t1a",0,0,0,0,0,1.34228187919463,1.61290322580645,0,0,0,0.295518510500108,0.268456375838926,0.32258064516129,NA,NA,NA,NA,NA,NA,8.72954703693815,3.68233641306884,8.36993710353355,3.68233641306884,5.88788892518078,7.57885102301497,3.68233641306884,7.03212376687759,3.68233641306884,3.68233641306884,5.60100299208892,6.74036664911978,4.46163933505807,101.400367445183,-0.247732204472083,1.05218052899672,0.00168029677709568,0.00916087922499508,"Q924N4",0,"Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3)","ammonium import across plasma membrane [GO:0140157]; cell volume homeostasis [GO:0006884]; cellular hypotonic salinity response [GO:0071477]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]","GO:0005886; GO:0006884; GO:0007268; GO:0008519; GO:0015379; GO:0016323; GO:0019901; GO:0030424; GO:0045202; GO:0046872; GO:0055064; GO:0055075; GO:0071333; GO:0071477; GO:0071805; GO:0140157; GO:1902476; GO:1990573"
"325","Pocillopora_acuta_HIv2___RNAseq.g5305.t1",NA,NA,0,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,11.0459535970524,8.11079559888894,10.0649158870878,9.76817785219478,8.79673915149935,10.1027065430965,9.27768752474152,10.2401189869899,10.3117665360118,7.95689430964936,9.56757559872124,10.0918988317282,9.04325236571422,897.367921887969,-0.627024808366964,0.8009181644595,0.197799889459802,0.419763826400599,"Q6NX12",0,"Nuclear pore complex protein Nup93 (93 kDa nucleoporin) (Nucleoporin Nup93)","mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; protein transport [GO:0015031]","GO:0005643; GO:0015031; GO:0017056; GO:0031965; GO:0034399; GO:0051028; GO:0051292"
"326","Pocillopora_acuta_HIv2___RNAseq.g5308.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.08456176348129,8.28377980671824,10.9523459690686,12.0420587772463,10.0329465630023,11.8677678450425,12.4949090082924,10.3081643228335,8.73353815082632,11.84988427246,10.5649956478971,9.8223113538424,11.3076799419519,2274.00311547086,1.04474400618369,0.837702547023246,0.055626236282287,0.168669368714904,NA,NA,NA,NA,NA
"327","Pocillopora_acuta_HIv2___RNAseq.g5373.t1a",0,0,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.4789151142086,8.96990734667213,11.046662763583,7.87410110018827,9.4411457231109,8.34735281558066,3.68233641306884,9.51164915960992,7.5245035367715,10.3265492624993,8.72031232352931,9.60057525945678,7.84004938760184,726.963735690017,-0.473825468756745,1.02832805811862,0.157839665859932,0.360491540659727,"Q9WVQ0",2.41e-13,"Polyamine-modulated factor 1-binding protein 1 (PMF-1-binding protein) (Sperm tail-associated protein)","gene expression [GO:0010467]; spermatogenesis [GO:0007283]","GO:0005737; GO:0007283; GO:0010467; GO:0036126; GO:0061827; GO:0120212"
"328","Pocillopora_acuta_HIv2___RNAseq.g5374.t1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.1060459154971,9.02407102554429,8.61976434957389,3.68233641306884,6.77213038688595,9.21058628392639,8.43802838106897,9.30647549390172,10.0678787236912,3.68233641306884,7.89096533862272,8.97445897390997,6.80747170333547,456.934112061687,-0.321812841722771,1.01298162762199,0.137597975364521,0.329309017050552,"Q2TAA8",6.17e-141,"Translin-associated factor X-interacting protein 1 (Trax-interacting protein 1)","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","GO:0005737; GO:0007283; GO:0030154; GO:0048471"
"329","Pocillopora_acuta_HIv2___RNAseq.g5375.t1",0,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.16247966683365,8.62510896041202,8.41155266821539,9.72414893728774,9.53024124923402,3.68233641306884,9.664489285844,6.01099506072748,10.4534046860541,11.6334270822408,8.5898184009918,8.51373466621293,8.66590213577068,783.589952020058,0.20556143063253,0.924884523550047,0.570899375374132,0.781014420052931,"Q2NL00",1.83e-21,"Glutathione S-transferase theta-1 (EC 2.5.1.18) (GST class-theta-1)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0005737; GO:0006749"
"330","Pocillopora_acuta_HIv2___RNAseq.g5376.t1",0,0,46.1538461538462,30.7692307692308,19.047619047619,5.15463917525773,3.07692307692308,2.38095238095238,17.1428571428571,NA,13.7473408607429,11.0895358936596,17.0695970695971,NA,NA,NA,NA,NA,NA,10.8235492440787,10.9015337779651,11.3990709896644,11.6544907244619,11.3420695460764,9.84015160836879,10.0470712442348,12.4554833534096,11.796574352664,3.68233641306884,10.3942331253993,11.5633494971786,9.22511675361989,2316.35628711321,-0.478942659197458,0.983925201282132,0.222919611529107,0.454377924449802,"Q6YHK3",0,"CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109)","hair follicle development [GO:0001942]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]; stem cell proliferation [GO:0072089]","GO:0001933; GO:0001942; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0043616; GO:0045616; GO:0061045; GO:0072089; GO:0072675; GO:0098552; GO:2000647"
"331","Pocillopora_acuta_HIv2___RNAseq.g5391.t1",0,0,NA,33.3333333333333,0,0,1.75438596491228,NA,NA,NA,5.84795321637427,11.1111111111111,0.584795321637427,NA,NA,NA,NA,NA,NA,11.7418594607215,9.35273167949696,11.6709262322165,10.5384829892554,11.5505152947794,9.49994033464024,3.68233641306884,11.3997340429005,11.1985351081285,3.68233641306884,9.43173979682767,11.5123140277493,7.35116556590606,1739.7692521094,-0.764324604562705,1.30581874678715,0.0153615632169616,0.0596482282872838,"Q98ST7",1.87e-113,"DBH-like monooxygenase protein 1 (EC 1.14.17.-) (DBH-related protein) (Monooxygenase X)","dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]","GO:0004500; GO:0005507; GO:0005615; GO:0005789; GO:0006589; GO:0030667; GO:0042420; GO:0042421"
"332","Pocillopora_acuta_HIv2___RNAseq.g5401.t1",0,NA,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.479807699286,8.38852445472299,8.64412982733272,3.68233641306884,6.64499589542844,3.68233641306884,3.68233641306884,4.6568497180018,7.07010303635839,3.68233641306884,6.06137562834057,7.49917723528147,4.62357402139967,227.927050314172,-6.31303870888089,3.64327945057109,2.64472233152734e-05,0.000262728460186892,"O00750",0,"Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.137) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta)","autophagosome organization [GO:1905037]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]","GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005942; GO:0009267; GO:0016303; GO:0030139; GO:0035005; GO:0035091; GO:0036092; GO:0043231; GO:0043491; GO:0048015; GO:1905037"
"333","Pocillopora_acuta_HIv2___RNAseq.g5465.t1",0,0.657894736842105,0.852878464818763,5.74712643678161,1.03626943005181,0.723025583982202,0.56232427366448,0.554016620498615,1.66389351081531,0,1.17974290574549,1.86919137778397,0.490294433707011,1,30.3030303030303,30.3030303030303,0.0172532241619244,0.0172532241619244,0.0172532241619244,10.5349554106923,7.72302631647394,9.41226279448059,11.5081104367935,9.16254772113993,10.1838255393267,12.071718289926,9.20746648653389,5.77998567012395,3.68233641306884,8.92662350785596,8.81944361659413,9.0338033991178,1174.99106477125,0.0354219579267829,0.89352564824784,0.98340641915517,0.994152138938443,"Q587J7",4.97e-83,"Putative ATP-dependent RNA helicase TDRD12 (EC 3.6.4.13) (ES cell-associated transcript 8 protein) (Tudor domain-containing protein 12)","fertilization [GO:0009566]; germ-line stem cell division [GO:0042078]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; retrotransposon silencing by piRNA-directed DNA methylation [GO:0141196]; spermatogenesis [GO:0007283]","GO:0003676; GO:0003724; GO:0005524; GO:0007140; GO:0007283; GO:0009566; GO:0016887; GO:0034587; GO:0042078; GO:0141196; GO:1990923"
"334","Pocillopora_acuta_HIv2___TS.g8582.t1b",0,2.88461538461538,0.478468899521531,0.440528634361233,0.448430493273543,0.26281208935611,0.184842883548983,0,0,NA,0.522188709408532,0.717591221666546,0.277935569086014,NA,NA,NA,NA,NA,NA,6.88133858134906,6.30327276432217,6.31061316215391,9.0438486539023,5.73407006217363,7.74686409685486,5.7616711601265,6.22050512179836,4.79801079550852,3.68233641306884,6.24825308112581,5.9889075445967,6.50759861765493,101.853973515773,0.0753600212673859,0.848482173281086,0.856640815517106,0.943675000429507,"Q9FR62",5.45e-08,"Co-chaperone protein p23-1 (Bnp23-1)","chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein complex assembly [GO:0051131]; response to heat [GO:0009408]","GO:0005634; GO:0005829; GO:0009408; GO:0051085; GO:0051087; GO:0051131; GO:0051879; GO:0101031"
"335","Pocillopora_acuta_HIv2___RNAseq.g5476.t1",7.90710533591374,7.15542521994135,5.63469452358341,12.4082721814543,4.35052827843381,7.01058201058201,11.1111111111111,7.36040609137056,6.05045769144898,4.4708545557442,7.34594369995835,7.99702863895944,6.69485876095725,NA,NA,NA,NA,NA,NA,7.94132135187028,10.6655458331297,8.36016008697007,5.9757421057541,8.41494494217581,3.68233641306884,11.1270752637137,9.0104050821451,8.26923806364654,3.68233641306884,7.7129105555543,8.39921390536156,7.02660720574704,546.357182530011,-0.199366108752953,0.999255649207538,0.0913530053379899,0.244600123881652,"Q5EA80",4.31e-38,"Geranylgeranyl transferase type-2 subunit alpha (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit alpha) (Rab geranyl-geranyltransferase subunit alpha) (Rab GG transferase alpha) (Rab GGTase alpha) (Rab geranylgeranyltransferase subunit alpha)","protein geranylgeranylation [GO:0018344]","GO:0004663; GO:0005737; GO:0005968; GO:0008270; GO:0018344; GO:0031267"
"336","Pocillopora_acuta_HIv2___RNAseq.g5488.t1",0,0,0,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,9.1622672676774,3.68233641306884,5.16860104011765,3.68233641306884,8.41254060050376,3.68233641306884,3.68233641306884,8.09750134092551,5.63170286483936,3.68233641306884,5.48842951794079,7.29452262281274,3.68233641306884,115.404113864968,-11.3812288045092,3.91587754613935,3.27315165930979e-07,6.0079778680529e-06,"Q5KQT7",1.69e-101,"Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152)","estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]","GO:0004497; GO:0005506; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0008210; GO:0020037; GO:0030544; GO:0042572; GO:0043231; GO:0051879; GO:0070330; GO:0101020; GO:0101021; GO:0106256"
"337","Pocillopora_acuta_HIv2___RNAseq.g5540.t1",0,NA,0,0,0,1.53846153846154,4.80769230769231,0,0,0,0.705128205128205,0.384615384615385,0.961538461538461,NA,NA,NA,NA,NA,NA,3.68233641306884,11.0965911932198,8.20855739098366,8.71247567247621,10.8089895528795,9.56445070014912,11.5432669348635,8.57418642766176,9.15217221381277,3.68233641306884,8.5025362912184,8.08524839968131,8.91982418275549,918.75929893907,0.104321189257546,0.967480491598257,0.704767911951226,0.865325786650226,"O00338",6.57e-54,"Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2)","amine metabolic process [GO:0009308]; sulfation [GO:0051923]","GO:0004062; GO:0005737; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051923"
"338","Pocillopora_acuta_HIv2___TS.g8659.t1",0,NA,NA,0,0,0,16.6666666666667,0,NA,NA,2.77777777777778,0,5.55555555555556,NA,NA,NA,NA,NA,NA,10.5141945984794,3.68233641306884,9.8078941733148,7.39445938623252,8.5214140541948,9.43240780992137,8.15816625667422,10.400027417117,10.6989962301111,11.1006887747474,8.97105851138615,9.98850529464342,7.95361172812887,885.244058491956,-0.458812327958443,0.998038123916546,0.194862903180549,0.415287427045322,NA,NA,NA,NA,NA
"339","Pocillopora_acuta_HIv2___RNAseq.g5553.t1",0,0,1.31578947368421,0,0,0.803212851405622,0,0,0,0,0.211900232508983,0.160642570281124,0.263157894736842,NA,NA,NA,NA,NA,NA,10.2129821054169,11.4540091335566,10.3844070631917,10.8898686838026,10.3223484844245,8.69877104860872,12.0570285638492,10.1906523728812,10.0266226981465,3.68233641306884,9.79190265669468,10.2274025448122,9.35640276857719,1516.54431635903,-0.060320618411183,0.886531927917699,0.816271526423495,0.923685757955675,"Q69YN4",0,"Protein virilizer homolog","mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006397; GO:0008380; GO:0016556; GO:0016604; GO:0016607; GO:0036396"
"340","Pocillopora_acuta_HIv2___RNAseq.g5557.t3",0,0,NA,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.1974199446679,9.3480218580176,10.9871203536313,9.47664493676885,10.5209914991668,10.2626717974782,10.3358231240985,11.1238418954248,10.8342483670769,6.9219028403352,10.1008686616666,10.9327244119935,9.26901291133967,1365.68341268589,-1.12603327654918,0.84093572737091,0.0410265047484299,0.133530010054296,"O35242",0,"Protein FAN (Factor associated with neutral sphingomyelinase activation) (Factor associated with N-SMase activation)","positive regulation of amide metabolic process [GO:0034250]; positive regulation of apoptotic process [GO:0043065]; positive regulation of lipid metabolic process [GO:0045834]; regulation of membrane lipid metabolic process [GO:1905038]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0005123; GO:0005886; GO:0016230; GO:0033209; GO:0034250; GO:0035591; GO:0043065; GO:0045834; GO:1905038"
"341","Pocillopora_acuta_HIv2___RNAseq.g5567.t1",6.06060606060606,0,0,4.76190476190476,0,0,0,0,0,0,1.08225108225108,0.952380952380952,1.21212121212121,NA,NA,NA,NA,NA,NA,5.04675156217379,6.52433724544485,7.33531323544956,3.68233641306884,5.02357447611079,6.67896938259863,6.56684266342844,4.86526991710116,4.97930611778461,3.68233641306884,5.43850374262295,5.45004306172398,5.42696442352192,39.8762691275686,0.0578359749689686,0.97132062907285,0.797670305383411,0.914734397216585,NA,NA,NA,NA,NA
"342","Pocillopora_acuta_HIv2___RNAseq.g5575.t1",0,0,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.6864574233578,8.45141583990641,10.7378991718396,11.011902059359,11.3246167971182,12.2153991219015,11.9754016293808,10.0692617346372,11.0965791967951,10.6285930634844,10.819752603778,10.7829628647496,10.8565423428064,2170.96030213658,0.0656475445637886,0.683010718252184,0.897052620739814,0.960539614034695,"Q8NDA8",0,"Maestro heat-like repeat-containing protein family member 1 (HEAT repeat-containing protein 7A)","","GO:0005737"
"343","Pocillopora_acuta_HIv2___RNAseq.g5578.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.9429221268269,11.704758466395,12.0714616810255,11.1058867872069,11.7438747389637,11.6453399140241,7.84499398146353,10.4937126170725,10.4678603795067,12.8023645801317,11.0823175272617,11.1439663086791,11.0206687458442,2842.33453021887,-0.0414999689675255,0.723924435512243,0.88469828258379,0.955539567782169,"A1L3F5",1.24e-118,"C-Maf-inducing protein (c-Mip)","","GO:0005634; GO:0005737"
"344","Pocillopora_acuta_HIv2___TS.g8704.t2",0,0,NA,NA,0,0,NA,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,11.1848861250956,7.95812695172856,8.94794988124528,8.59824589332789,10.4289528707817,10.1242628281368,10.7388387272635,9.8074768435804,11.8749778337758,3.68233641306884,9.33460543680044,10.4488487108958,8.22036216270512,1208.47312650517,-0.370851337659831,0.957853680752781,0.274632182647434,0.519388060906444,"A1L1W9",9.28e-60,"Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10)","aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327]","GO:0005302; GO:0005886; GO:0008028; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0070327"
"345","Pocillopora_acuta_HIv2___RNAseq.g5591.t1",9.3167701863354,9.89010989010989,16.4179104477612,8.92857142857143,14.8936170212766,7.72946859903382,16.9230769230769,1.38888888888889,0,NA,9.49871259833935,5.5874077613208,14.3878436446125,NA,NA,NA,NA,NA,NA,6.64356132503947,5.74095382813731,4.70263489215087,8.32815545810949,7.16703565314199,9.30702637687573,8.19089365558311,7.70891506725395,8.4129752332032,9.10628966610116,7.53084411555963,6.9270244341579,8.13466379696136,242.980872323599,0.612515195222042,0.901948753943337,0.18754201107109,0.405660085326445,NA,NA,NA,NA,NA
"346","Pocillopora_acuta_HIv2___TS.g8755.t2",NA,0,0,NA,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,7.22868826190456,9.35273167949696,9.7739760643699,7.52579662532212,9.83197441647724,8.22647481831577,3.68233641306884,6.95560773578551,9.4617986842675,9.15286382224581,8.11922485212542,8.65040903256094,7.5880406716899,424.696500036664,-0.461306158694968,0.963345791086192,0.2175842767988,0.447800082472658,"Q502K2",0,"Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-)","dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA damage response [GO:0006974]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]; swimming behavior [GO:0036269]","GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0036269; GO:0045087; GO:0045088; GO:0045540; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0106375; GO:0110025"
"347","Pocillopora_acuta_HIv2___TS.g8763.t3",0,NA,NA,0,0,0,NA,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.26800230477324,7.70956455612337,3.68233641306884,7.3849279187597,3.68233641306884,8.83273967313198,6.26817974381434,11.0103328445133,3.68233641306884,6.52030926933913,7.21106829525591,5.82955024342235,343.929420255801,-0.0922222676910525,1.01625027340585,0.000406761623679193,0.00274796829747587,"Q9JLV6",2.19e-146,"Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase (EC 3.1.3.32) (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase (EC 2.7.1.78)]","DNA damage response [GO:0006974]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; protein K63-linked ubiquitination [GO:0070534]","GO:0003690; GO:0005524; GO:0005634; GO:0006281; GO:0006303; GO:0006974; GO:0019005; GO:0035861; GO:0046403; GO:0046404; GO:0051103; GO:0070534; GO:1990756"
"348","Pocillopora_acuta_HIv2___RNAseq.g5682.t1",NA,NA,5.88235294117647,0,0,2.1505376344086,0,0,NA,NA,1.33881509593085,0.716845878136201,1.96078431372549,NA,NA,NA,NA,NA,NA,9.59361608358773,9.19643964049858,8.89254944096462,10.9359055436427,10.5496824891043,11.0882226895941,9.50690853612286,9.07044442039475,3.68233641306884,3.68233641306884,8.61984416700473,8.35772576942405,8.88196256458542,853.101317419395,0.359285218981831,0.733755857500821,0.463013765652433,0.703514433497958,"Q08CH8",6.97e-117,"Zinc finger TRAF-type-containing protein 1 (Cysteine and histidine-rich protein 1)","","GO:0005634; GO:0046872; GO:0048471"
"349","Pocillopora_acuta_HIv2___TS.g15118.t1",NA,0,0,0,0,0,NA,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,6.16911426736902,6.4545116118486,6.91875970696607,7.01365304638253,6.46781886708255,7.36561316342335,6.47965727105891,6.79689746336218,6.93249648929894,6.11483358357707,6.67133554703692,6.65701735881575,6.68565373525809,81.5152298472939,0.0210698877178532,0.605666149004252,0.966581382729522,0.988072828120568,NA,NA,NA,NA,NA
"350","Pocillopora_acuta_HIv2___TS.g15122.t3",100,NA,NA,NA,33.3333333333333,94.1176470588235,100,100,100,NA,87.9084967320262,98.0392156862745,77.7777777777778,NA,NA,NA,NA,NA,NA,11.596782423551,11.2131491024136,10.6404378898442,11.4634065206801,11.6381539103022,12.3220802610011,3.68233641306884,11.8467355418596,3.68233641306884,3.68233641306884,9.17677548888583,9.88088923572517,8.4726617420465,2170.31064710154,-0.110499329044859,0.937612594532573,0.718432027881847,0.87263231628434,"O14733",1.01e-148,"Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2)","apoptotic process [GO:0006915]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular senescence [GO:0090398]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of motor neuron apoptotic process [GO:2000671]; response to heat [GO:0009408]; response to osmotic stress [GO:0006970]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]","GO:0000287; GO:0004707; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0006970; GO:0007165; GO:0007254; GO:0008545; GO:0009408; GO:0009411; GO:0009611; GO:0019899; GO:0019901; GO:0019903; GO:0032212; GO:0034612; GO:0038095; GO:0043507; GO:0045893; GO:0046330; GO:0051403; GO:0051973; GO:0070374; GO:0071222; GO:0071347; GO:0090398; GO:0106310; GO:0140677; GO:1904355; GO:2000671"
"351","Pocillopora_acuta_HIv2___RNAseq.g12514.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,13.0459707178741,11.3554118337419,13.0303167127282,12.2378442615101,12.7276558755178,11.4888553023277,11.1666146979004,13.2757199960767,12.5424471073206,11.4051229474772,12.2275959452475,12.9244220819035,11.5307698085915,5456.73388872381,-1.16034548711337,0.584857377177073,0.0173457423517652,0.0660407521389662,"O94910",4.82e-40,"Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1) (CIRL-1) (Latrophilin-1) (Lectomedin-2)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]","GO:0004930; GO:0005886; GO:0007157; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0016524; GO:0030246; GO:0030424; GO:0030426; GO:0042734; GO:0043005; GO:0045202; GO:0050839"
"352","Pocillopora_acuta_HIv2___RNAseq.g12554.t1",0,0,0,NA,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.30369490384351,3.68233641306884,9.93830016638107,8.46021241809359,8.52364332124565,3.68233641306884,9.16980564251118,7.16762719725138,3.68233641306884,10.9216312188617,7.25319241073946,7.32312040035809,7.18326442112083,434.268680705853,-0.0730839949623687,0.994035645027488,0.421347892022774,0.665770429087244,"Q9Y5Q8",1.79e-105,"General transcription factor 3C polypeptide 5 (TF3C-epsilon) (Transcription factor IIIC 63 kDa subunit) (TFIIIC 63 kDa subunit) (TFIIIC63) (Transcription factor IIIC subunit epsilon)","5S class rRNA transcription by RNA polymerase III [GO:0042791]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase III [GO:0006383]; transcription initiation at RNA polymerase III promoter [GO:0006384]; tRNA transcription by RNA polymerase III [GO:0042797]","GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0006383; GO:0006384; GO:0035914; GO:0042791; GO:0042797"
"353","Pocillopora_acuta_HIv2___TS.g15172.t1",0,NA,0,0,0,4.16666666666667,0,NA,0,0,0.520833333333333,1.38888888888889,0,NA,NA,NA,NA,NA,NA,9.49638477355247,10.1542975772308,4.6464169258196,11.5232676637826,9.84716922454259,10.3880167369263,10.4151495719967,8.88968241462995,3.68233641306884,9.96316056953122,8.90058818710811,7.31239795032269,10.4887784238935,970.61626019358,0.713141941449391,1.17706738059904,0.035921700498057,0.119634233480059,"B3EWZ9",0,"Hephaestin-like protein (EC 1.-.-.-)","copper ion transport [GO:0006825]","GO:0005507; GO:0005576; GO:0006825; GO:0016020; GO:0016491"
"354","Pocillopora_acuta_HIv2___RNAseq.g12565.t1",0,0,0,NA,0,8.88888888888889,0,0,NA,NA,1.26984126984127,2.96296296296296,0,NA,NA,NA,NA,NA,NA,9.94213735529933,10.8715009604294,10.8881244803146,10.1545383623825,10.3602201009733,9.86327730578312,12.1743081485845,8.21463177346149,9.40066610869537,10.9313748828438,10.2800779478767,9.76115596374882,10.7989999320047,1543.08240232567,0.515884406228514,0.789492656784162,0.290215448607126,0.53674706167489,"Q5XJS0",1.06e-72,"Mitoguardin 1 (Protein FAM73A)","mitochondrial fusion [GO:0008053]","GO:0005741; GO:0005886; GO:0008053; GO:0042803; GO:0046982"
"355","Pocillopora_acuta_HIv2___RNAseq.g12566.t1",NA,0,0,0,0,0,83.3333333333333,NA,NA,0,11.9047619047619,0,20.8333333333333,NA,NA,NA,NA,NA,NA,5.04675156217379,3.68233641306884,8.84664210352288,8.44139700777491,8.69560822347282,3.68233641306884,7.50590027949662,6.88225628497292,9.15217221381277,3.68233641306884,6.56177369144332,7.72468607759104,5.39886130529561,195.342167222802,-0.462957393587007,1.09978681961796,0.00265184652801032,0.0136275577499665,"Q8CHT3",3.83e-91,"Integrator complex subunit 5 (Int5)","snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]","GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016180; GO:0031965; GO:0032039; GO:0034472"
"356","Pocillopora_acuta_HIv2___RNAseq.g12569.t1",NA,0,0,NA,22.5,0,4.59770114942529,NA,0,NA,4.51628352490421,0,9.03256704980843,NA,NA,NA,NA,NA,NA,9.03438621557752,10.5503767541488,8.83493297084932,3.68233641306884,10.4507647622978,3.68233641306884,11.5975692632984,10.1479644702126,9.04876864790721,3.68233641306884,8.07117723234982,9.50336341336889,6.63899105133074,846.502286990954,-0.247772667081235,1.02227326649045,2.03030774774328e-05,0.000210059880281537,"Q3MQ24",3.34e-122,"Autophagy protein 5","apoptotic process [GO:0006915]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; immune system process [GO:0002376]; piecemeal microautophagy of the nucleus [GO:0034727]; regulation of cilium assembly [GO:1902017]","GO:0000422; GO:0002376; GO:0005776; GO:0005930; GO:0006914; GO:0006915; GO:0006995; GO:0034045; GO:0034274; GO:0034727; GO:0044233; GO:0061908; GO:1902017"
"357","Pocillopora_acuta_HIv2___TS.g15186.t1",NA,0,0,11.1111111111111,10.8108108108108,0,0,0,0,0,2.43576910243577,2.22222222222222,2.7027027027027,NA,NA,NA,NA,NA,NA,12.9212617274458,12.2665141743197,11.5106505262482,12.7581416042878,12.3061310355203,12.4977094202047,12.9643257258812,12.1316825330077,12.0546667063963,12.529179888076,12.3940263341388,12.1848785057237,12.6031741625539,5576.50981672967,0.31014959729693,0.556495574200933,0.501307186391862,0.730643661067707,"E7F9T0",6.71e-163,"[F-actin]-monooxygenase mical1 (EC 1.14.13.225) (EC 1.6.3.1) (Molecule interacting with CasL protein 1) (MICAL-1)","actin filament depolymerization [GO:0030042]; sulfur oxidation [GO:0019417]","GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0010008; GO:0016709; GO:0019417; GO:0030042; GO:0030496; GO:0046872; GO:0071949; GO:0106294; GO:0120501"
"358","Pocillopora_acuta_HIv2___RNAseq.g12621.t1",13.3333333333333,NA,NA,75,15.625,16.2790697674419,3.125,NA,0,NA,20.5604005167959,30.4263565891473,10.6944444444444,NA,NA,NA,NA,NA,NA,9.36724482897074,9.74723568233672,9.73168757660773,10.206939492691,9.60891542560473,8.79252469198216,9.75830246376734,9.11388729818905,10.5043802956267,9.46282056401988,9.62939383197961,9.66522308499979,9.59356457895942,810.003503781629,-0.0397301674267185,0.568313265673942,0.918015291122734,0.969230866556771,"Q32PA4",3.29e-42,"14 kDa phosphohistidine phosphatase (EC 3.9.1.3) (Phosphohistidine phosphatase 1) (PHPT1) (Protein histidine phosphatase) (PHP)","actin cytoskeleton organization [GO:0030036]; lamellipodium organization [GO:0097581]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of cell motility [GO:2000147]","GO:0005829; GO:0005886; GO:0016604; GO:0019855; GO:0030036; GO:0044325; GO:0050860; GO:0051015; GO:0061851; GO:0097581; GO:0101006; GO:2000147"
"359","Pocillopora_acuta_HIv2___TS.g15232.t1a",0,0,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.29145478155565,3.68233641306884,8.82075519995976,7.96266298558189,7.21225398492597,5.28004943464804,3.68233641306884,6.412559699967,9.6346965901594,3.68233641306884,6.26614419160042,7.67434405131356,4.85794433188729,167.812907590762,-1.48565225389899,2.73304463843714,0.000137004202941665,0.00108285726303183,NA,NA,NA,NA,NA
"360","Pocillopora_acuta_HIv2___RNAseq.g12651.t1",0,32.258064516129,10,33.3333333333333,20.7792207792208,26.219512195122,12.0481927710843,NA,25.9259259259259,52.5423728813559,23.6785136002413,29.4342089926276,19.0739572863322,NA,NA,NA,NA,NA,NA,9.64386682611512,3.68233641306884,7.39425081166534,5.44417644206312,6.47723594994632,8.99587939680118,3.68233641306884,7.8942970441198,3.68233641306884,3.68233641306884,6.05790521229862,7.01839740898308,5.09741301561416,170.309694256399,-0.257382724254128,1.04388001580761,0.143025968519259,0.337751446312255,NA,NA,NA,NA,NA
"361","Pocillopora_acuta_HIv2___RNAseq.g12660.t1",0,0,0,0.704225352112676,0.840336134453782,0.357142857142857,0,0,NA,NA,0.237713042963664,0.265342052313883,0.210084033613445,NA,NA,NA,NA,NA,NA,9.54667220861534,3.68233641306884,6.32442317864339,3.68233641306884,8.9782839318944,3.68233641306884,3.68233641306884,7.94160713666065,10.5370635857156,3.68233641306884,6.17397321068736,8.66561000830588,3.68233641306884,293.90661207509,-12.9532495234309,3.75528344883728,1.02073269319043e-10,5.78975595070839e-09,NA,NA,NA,NA,NA
"362","Pocillopora_acuta_HIv2___TS.g15302.t3",NA,71.4285714285714,33.3333333333333,NA,100,40,100,NA,100,NA,74.1269841269841,70.4761904761905,77.7777777777778,NA,NA,NA,NA,NA,NA,11.4122798967315,10.7093400833737,9.83517078723544,11.3590158658063,10.6816693124077,11.5412392209169,11.6425407253287,10.9060271563443,10.8093290598463,9.21404180429631,10.8110653912287,10.728895242513,10.8932355399444,1981.12225235341,0.120593860738282,0.64506952349083,0.806077573007078,0.918848640939783,"Q1LXK4",0,"Putative helicase mov-10-B.1 (EC 3.6.4.13)","miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]","GO:0000932; GO:0003723; GO:0005524; GO:0005829; GO:0016887; GO:0032574; GO:0035194; GO:0035279; GO:0043186"
"363","Pocillopora_acuta_HIv2___RNAseq.g12694.t1",6.84931506849315,0,NA,0,0,3.38983050847458,0,NA,0,0,1.27989319712097,0.847457627118644,1.71232876712329,NA,NA,NA,NA,NA,NA,5.71611892316596,9.03583582322898,9.07878473870429,7.27137545289193,8.50571174096725,3.68233641306884,3.68233641306884,6.75631530397046,9.49243024680909,3.68233641306884,6.69035814689445,7.90987219072341,5.47084410306549,229.184043789694,-0.431988401680956,1.12556818494839,0.00014708302130033,0.00114932945439652,"Q5ZKD7",0,"Putative helicase MOV-10 (EC 3.6.4.13)","3'-UTR-mediated mRNA destabilization [GO:0061158]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of neuron projection arborization [GO:0150011]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; retrotransposon silencing [GO:0010526]","GO:0000932; GO:0003723; GO:0005524; GO:0005634; GO:0005829; GO:0010494; GO:0010526; GO:0016887; GO:0032574; GO:0035194; GO:0035195; GO:0035279; GO:0036464; GO:0043186; GO:0061014; GO:0061158; GO:0150011"
"364","Pocillopora_acuta_HIv2___RNAseq.g12709.t2",NA,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.0416620056765,9.22240750215676,9.7727498240567,10.72678999947,9.44937019642127,10.8945291075908,9.25468814015051,10.1103415379879,11.2538007050692,10.96970445574,10.069604347432,9.92558485384231,10.2136238410216,1220.51198038348,0.199233951124529,0.592949153804724,0.670115938224982,0.845992234856721,"Q96AE4",3.91e-79,"Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V)","positive regulation of gene expression [GO:0010628]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0010628"
"365","Pocillopora_acuta_HIv2___TS.g15327.t1",8.33333333333333,0,NA,NA,0,0,0,NA,0,NA,1.38888888888889,0,2.77777777777778,NA,NA,NA,NA,NA,NA,9.24862510846095,6.30327276432217,9.24191127662603,9.38124371415315,10.6856520644931,10.1794968566583,9.13384148117489,10.4796423635456,6.37842387115414,3.68233641306884,8.47144459136572,9.20685093685596,7.73603824587547,661.355530464271,-0.90186554259219,1.05936568635327,0.0686724607721682,0.198854549070799,"Q5ZKK5",2.18e-103,"Outer dense fiber protein 2 (Cenexin) (Outer dense fiber of sperm tails protein 2)","cell differentiation [GO:0030154]; regulation of cilium assembly [GO:1902017]; spermatogenesis [GO:0007283]","GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0005874; GO:0007283; GO:0030154; GO:0036126; GO:1902017"
"366","Pocillopora_acuta_HIv2___TS.g15329.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.7643762797943,10.3088808158993,11.1959076905283,3.68233641306884,12.7426670024329,9.67160374147396,3.68233641306884,10.4441693617032,11.5500796392181,3.68233641306884,8.87246937702566,11.5394399947354,6.20549875931596,1897.50989366451,-0.794666584253187,1.4517563349696,1.04907911243713e-07,2.25131754930129e-06,"D3Z5L6",2.65e-57,"MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT)","serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; spermine transport [GO:0000296]","GO:0000296; GO:0015311; GO:0015312; GO:0015848; GO:0022857; GO:0030667; GO:0030672; GO:0051610"
"367","Pocillopora_acuta_HIv2___RNAseq.g12721.t1",NA,NA,0,0,0,10,0,0,NA,0,1.42857142857143,3.33333333333333,0,NA,NA,NA,NA,NA,NA,6.9558930465414,9.45263567244939,6.84512099725677,3.68233641306884,7.22884663559278,3.68233641306884,3.68233641306884,8.25836134479414,7.40876851237578,9.20201218832341,6.63986476365402,7.33939810731217,5.94033141999586,198.105109587338,-0.237379827890137,1.03110627044264,0.000497162472456165,0.00325530013653507,"D3Z5L6",1.9e-59,"MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT)","serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; spermine transport [GO:0000296]","GO:0000296; GO:0015311; GO:0015312; GO:0015848; GO:0022857; GO:0030667; GO:0030672; GO:0051610"
"368","Pocillopora_acuta_HIv2___RNAseq.g12730.t1",0,0,NA,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.45976149983951,4.8931170245923,6.91875970696607,5.76965417569396,6.35975560497307,4.51119975925463,6.58364178294652,5.95306534505293,7.65349580332634,5.54842281532527,5.96508735179706,6.46896759203158,5.46120711156254,53.5074634576825,-0.955725567741886,0.960602943147885,0.0732903733580345,0.208046651068775,NA,NA,NA,NA,NA
"369","Pocillopora_acuta_HIv2___RNAseq.g12733.t1",0,0,0,0,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,10.1199527693601,9.11971727471937,9.82024586341649,3.68233641306884,3.68233641306884,9.27847035822101,9.9595177447525,3.68233641306884,6.67095860758137,8.57210462976379,4.76981258539895,406.247467279723,-0.404251325750484,1.11607562438593,5.63547000812995e-05,0.000506282224829761,"Q68FK8",0,"ATP-dependent RNA helicase A protein (EC 3.6.4.13) (DEAH box protein 9) (Nuclear DNA helicase II) (NDH II)","alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to tumor necrosis factor [GO:0071356]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription termination [GO:0006353]; G-quadruplex DNA unwinding [GO:0044806]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; RISC complex assembly [GO:0070922]; RNA secondary structure unwinding [GO:0010501]","GO:0000380; GO:0000978; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0006260; GO:0006353; GO:0010501; GO:0015629; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0031490; GO:0032508; GO:0033679; GO:0034458; GO:0035195; GO:0035613; GO:0036464; GO:0043022; GO:0043138; GO:0044806; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0050684; GO:0051028; GO:0051092; GO:0061676; GO:0070063; GO:0070578; GO:0070922; GO:0070937; GO:0071356; GO:0097165; GO:1905172; GO:1990518; GO:1990825; GO:1990841; GO:2000373; GO:2000765; GO:2000767"
"370","Pocillopora_acuta_HIv2___RNAseq.g12744.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.6819031016316,7.87523677967013,8.13398049066195,9.27642972485254,7.22884663559278,3.68233641306884,8.65669248600545,7.27429212882864,10.0083719470739,3.68233641306884,7.25004261204547,7.86547886075777,6.63460636333316,277.733396523621,-0.0905340413332451,0.955046008831689,0.61181379242296,0.80838616225093,"Q6NT16",2.06e-77,"MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT)","serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; spermine transport [GO:0000296]","GO:0000296; GO:0015311; GO:0015312; GO:0015848; GO:0022857; GO:0030667; GO:0030672; GO:0051610"
"371","Pocillopora_acuta_HIv2___RNAseq.g12752.t1",0,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.8221712433205,9.98871829916894,11.3510017324616,6.15405973004498,11.578896836012,3.68233641306884,3.68233641306884,11.8009783930101,10.7698744631722,3.68233641306884,8.45127099363968,11.4645845335953,5.43795745368409,1551.67452238722,-6.72709701147309,5.18011600131841,4.42572272073625e-09,1.44174895118759e-07,"Q9UKP5",3.14e-146,"A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-)","aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508]","GO:0001822; GO:0003279; GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976"
"372","Pocillopora_acuta_HIv2___TS.g15376.t1",0,0,0.760456273764259,0,0.294985250737463,0.434310532030402,0.4,0.591715976331361,0,NA,0.275718670318165,0.205205301672353,0.36386038112543,NA,NA,NA,NA,NA,NA,7.04630611039243,5.3082414967072,5.59369902756585,3.68233641306884,4.99332554465423,3.68233641306884,3.68233641306884,5.72748248273486,3.68233641306884,5.70282560183315,4.91012259161631,5.40862991568324,4.41161526754937,22.3224877335459,-0.315917440668796,1.07642087513079,0.0333115839074813,0.112811695068558,"O88279",5.9e-11,"Slit homolog 1 protein (Slit-1) (Multiple epidermal growth factor-like domains protein 4) (Multiple EGF-like domains protein 4)","axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; dorsal/ventral axon guidance [GO:0033563]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of synapse assembly [GO:0051964]; neuron projection morphogenesis [GO:0048812]; nuclear migration [GO:0007097]; olfactory bulb development [GO:0021772]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; telencephalon cell migration [GO:0022029]","GO:0005509; GO:0005615; GO:0007097; GO:0007409; GO:0007411; GO:0008045; GO:0008201; GO:0021510; GO:0021772; GO:0022028; GO:0022029; GO:0031290; GO:0033563; GO:0043395; GO:0048495; GO:0048812; GO:0048843; GO:0048846; GO:0050919; GO:0051964"
"373","Pocillopora_acuta_HIv2___TS.g15392.t1a",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.45976149983951,5.57859373890424,7.66249431030622,6.94791225850548,3.68233641306884,3.68233641306884,8.97715607484468,7.49590776567488,3.68233641306884,7.20738205486765,6.03762169421492,5.59656728039166,6.47867610803818,108.207806367443,0.291879135109804,0.958212405760753,0.430177923428813,0.674063474157268,NA,NA,NA,NA,NA
"374","Pocillopora_acuta_HIv2___TS.g15396.t2",0,0,0,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.40558854265871,3.68233641306884,8.38342770668208,7.75224048005619,3.68233641306884,9.27260817039085,8.19075369338027,3.68233641306884,3.68233641306884,5.94163006585123,5.3980006825286,6.48525944917386,150.445302137084,0.132002185353426,1.01181566884965,0.0421789919474543,0.136421498105541,NA,NA,NA,NA,NA
"375","Pocillopora_acuta_HIv2___RNAseq.g12798.t1",0,NA,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.3848412180554,9.85902705887729,11.5534015064331,10.563681756568,10.1492828715432,10.1740676704813,10.326053001257,11.0537269847884,11.1615379910272,7.71805441628311,10.2943674475314,10.8605581143695,9.72817678069334,1473.13350109755,-0.689858355593652,0.727132095065591,0.168960881404713,0.377397813652211,"A7S4N4",2.4e-139,"Probable serine incorporator","phospholipid biosynthetic process [GO:0008654]","GO:0005789; GO:0008654; GO:0016020"
"376","Pocillopora_acuta_HIv2___RNAseq.g12843.t2",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.92912467288902,7.00867790939819,10.5567193448022,3.68233641306884,9.49888794950866,10.5231132613958,3.68233641306884,10.9921458865601,6.54686386219783,7.92790638063269,8.03481120935222,9.50474834319156,6.56487407551287,697.787907402756,-0.302898495963406,1.02704715685797,0.0623486100072846,0.184948788996178,"Q4LDE5",2.58e-96,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)","epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of complement activation, classical pathway [GO:0045959]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]","GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0045959; GO:0048014; GO:0098640; GO:0120193"
"377","Pocillopora_acuta_HIv2___RNAseq.g12848.t1",22.5806451612903,17.6470588235294,0,16.6666666666667,100,8.10810810810811,20.6185567010309,NA,0,NA,23.2026294325782,10.605458399576,35.7998004655803,NA,NA,NA,NA,NA,NA,3.68233641306884,5.96448686545822,6.28256793029396,10.7460600496327,8.4852679818335,8.73759746419133,7.98231310981293,8.78405134588346,3.68233641306884,7.40334154893872,7.17503591221825,6.18331201682972,8.16675980760678,330.824635654949,0.708554643420744,1.2381701136926,0.00421578517291862,0.0201111862602556,"A2RT67",6.29e-134,"DENN domain-containing protein 3","endosome to lysosome transport [GO:0008333]; protein catabolic process [GO:0030163]; regulation of Rab protein signal transduction [GO:0032483]","GO:0005085; GO:0008333; GO:0030163; GO:0031410; GO:0032483"
"378","Pocillopora_acuta_HIv2___RNAseq.g12849.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.92950120283598,6.30327276432217,9.38523240637552,7.03911674882672,6.91639049961058,8.95084805180528,10.3346054717124,7.89799219483693,10.0583573359346,3.68233641306884,7.6497653089329,8.03749472791872,7.26203588994708,392.975990664569,-0.0153781958115087,0.918762495201668,0.904532951850255,0.964124142635378,"Q3TCX3",1.74e-73,"KH homology domain-containing protein 4 (Brings lots of money 7) (Pre-mRNA splicing factor protein Khdc4)","mRNA splice site recognition [GO:0006376]","GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006376"
"379","Pocillopora_acuta_HIv2___RNAseq.g12864.t1",0,NA,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.032025494136,9.90303102349715,11.2991480655333,11.146333880112,10.6059327252493,10.2960439200976,8.81886365032418,10.2667263205096,10.5603765816926,9.41499257009444,10.3343474231246,10.7528418374242,9.91585300882507,1427.46064538859,-0.656059540665235,0.564938579370662,0.15705635851472,0.359326663960282,"Q9TXQ1",2.5e-63,"Poly [ADP-ribose] polymerase tankyrase (EC 2.4.2.30) (Poly ADP-ribose metabolism enzyme 5) (Protein poly-ADP-ribosyltransferase tankyrase) (EC 2.4.2.-)","DNA damage response [GO:0006974]; double-strand break repair [GO:0006302]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of programmed cell death [GO:0043069]; response to gamma radiation [GO:0010332]","GO:0003950; GO:0005634; GO:0005694; GO:0005730; GO:0006302; GO:0006974; GO:0008630; GO:0010332; GO:0016779; GO:0043069; GO:1990404"
"380","Pocillopora_acuta_HIv2___RNAseq.g12885.t1",0,NA,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.69445347943463,8.89759623765196,4.98269171864354,4.99561439145868,5.23920445324911,5.38419442015382,9.63906410638121,5.38578475744502,8.19657290837461,5.30690658460733,6.47220830573999,6.09974146342938,6.8446751480506,166.83965311161,0.296897240715204,0.893653680440376,0.452910160337645,0.694024002449804,NA,NA,NA,NA,NA
"381","Pocillopora_acuta_HIv2___RNAseq.g12895.t1",8.33333333333333,0,0,0,0,0,0,0,0,NA,0.925925925925926,0,2.08333333333333,NA,NA,NA,NA,NA,NA,11.4807547713994,8.9451651783571,10.1276465030556,11.531064715231,11.3714176195052,10.1118221718936,10.781464031939,11.1892035516889,10.2097914268884,9.86742335056167,10.561575332052,10.8757627745075,10.2473878895965,1714.28033188797,-0.377945245978565,0.69329871952283,0.418863397038112,0.663472560248936,NA,NA,NA,NA,NA
"382","Pocillopora_acuta_HIv2___RNAseq.g12909.t1",11.1111111111111,NA,0,0,NA,0,0,0,0,NA,1.58730158730159,0,3.7037037037037,NA,NA,NA,NA,NA,NA,3.68233641306884,8.9760270652654,5.26676479605173,7.26062158020419,6.08938798535807,3.68233641306884,3.68233641306884,6.59039256814693,4.97930611778461,3.68233641306884,5.38918457650863,5.32163757608204,5.45673157693522,75.2386163613873,-0.107169325733222,1.01802122901265,0.0228566957418401,0.0827739727616361,NA,NA,NA,NA,NA
"383","Pocillopora_acuta_HIv2___RNAseq.g12914.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.976490469328,4.68019422250907,6.25393493464119,5.05535826649939,6.57680970301896,6.02125060905816,5.73058915105271,5.74496152652496,5.77998567012395,5.16462945902469,5.79842040117811,6.26643646072741,5.3304043416288,39.5220825239563,-0.876128673853894,0.884048559333345,0.104795257238312,0.270864653447988,NA,NA,NA,NA,NA
"384","Pocillopora_acuta_HIv2___RNAseq.g12934.t1",9.52380952380952,0,1.38888888888889,8.92857142857143,0,0,0,0,NA,0,2.20458553791887,2.23214285714286,2.18253968253968,NA,NA,NA,NA,NA,NA,6.53584217462236,5.12032714986833,8.71228771296583,3.68233641306884,7.37006729746139,8.70179514693884,9.9691725844652,8.05513282929674,8.19159541342709,3.68233641306884,7.00208931351835,7.77298508555468,6.23119354148201,249.374360824594,-0.248986571465446,0.995480812653158,0.122698589266554,0.303162349701304,NA,NA,NA,NA,NA
"385","Pocillopora_acuta_HIv2___RNAseq.g12971.t1",20.8333333333333,0,0,0,0,3.75,0,0,0,NA,2.73148148148148,0.75,5.20833333333333,NA,NA,NA,NA,NA,NA,10.282155921959,11.8710976396963,9.81744031918741,12.3383896305023,9.66345990704555,12.5422127634153,12.5221712273571,11.6215222121205,3.68233641306884,11.3389470879744,10.5679733122327,9.01338295467626,12.1225636697891,2924.0927601783,1.0811646425523,1.35513947765786,0.0419271860255056,0.135910985807466,"Q24372",5.99e-06,"Lachesin","cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity, open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]","GO:0005886; GO:0005918; GO:0007156; GO:0007424; GO:0016331; GO:0019991; GO:0035151; GO:0035160; GO:0042803; GO:0043005; GO:0061343; GO:0098552"
"386","Pocillopora_acuta_HIv2___RNAseq.g12986.t2",NA,NA,0,0,0,0,0,8,NA,NA,1.33333333333333,2.66666666666667,0,NA,NA,NA,NA,NA,NA,10.4636560469528,8.64445721468089,10.3128205564996,10.8014514701922,10.6210895853263,9.82775678901632,9.52196727713861,10.0536533061418,11.2040962499493,12.3537097573789,10.3804658253277,10.531063148974,10.2298685016814,1648.86432554869,-0.194877858773057,0.630040676242299,0.67013386451822,0.845992234856721,"Q5RCU0",5.21e-32,"Transcription initiation factor IIA subunit 1 (General transcription factor IIA subunit 1) [Cleaved into: Transcription initiation factor IIA alpha chain (TFIIA p35 subunit); Transcription initiation factor IIA beta chain (TFIIA p19 subunit)]","transcription initiation at RNA polymerase II promoter [GO:0006367]","GO:0005672; GO:0006367"
"387","Pocillopora_acuta_HIv2___RNAseq.g12997.t1",NA,0,0,0,5.55555555555556,0,0,NA,4.76190476190476,NA,1.47392290249433,1.19047619047619,1.85185185185185,NA,NA,NA,NA,NA,NA,11.0142701017267,11.1278275800924,11.0582819138602,11.5260571650908,10.4086144883031,11.6790741071694,10.664226121919,11.8940869239368,11.2496238648971,12.2055051994954,11.2827567466491,11.1249754585448,11.4405380347534,2635.66580990778,0.228863004399533,0.597045233022925,0.625011619809184,0.817375051439425,"Q8NDI1",1.44e-26,"EH domain-binding protein 1","endocytosis [GO:0006897]; protein transport [GO:0015031]","GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0015031"
"388","Pocillopora_acuta_HIv2___TS.g15620.t2",0,NA,33.3333333333333,0,0,0,NA,0,18.75,NA,7.44047619047619,4.6875,11.1111111111111,NA,NA,NA,NA,NA,NA,9.82338294001358,10.8009040195926,9.85152482990564,11.3583899476459,8.28951490702634,10.9672654646731,3.68233641306884,8.6015890511538,5.35039375113526,11.5994542255178,9.03247555497329,8.38328109584693,9.68167001409965,1186.1162176088,0.348144328455381,0.997099538803189,0.274761492767988,0.519496762274011,"P97390",0,"Vacuolar protein sorting-associated protein 45 (mVps45)","intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005794; GO:0006886; GO:0008021; GO:0010008; GO:0016020; GO:0016192"
"389","Pocillopora_acuta_HIv2___RNAseq.g13003.t1",0,NA,33.3333333333333,0,NA,0,100,NA,0,NA,22.2222222222222,0,44.4444444444444,NA,NA,NA,NA,NA,NA,8.82261501056029,8.68612969094628,8.68645353480887,3.68233641306884,10.317222965734,8.25560222341749,10.2073355353107,7.80263062623775,4.79801079550852,11.6673472633423,8.2925684058935,8.08538658656989,8.49975022521712,732.158303495602,0.0208406008063534,0.946505808875451,0.985428724385064,0.994712894794163,"Q6TGY8",2.37e-113,"ER membrane protein complex subunit 2 (Tetratricopeptide repeat protein 35) (TPR repeat protein 35)","protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]","GO:0005737; GO:0005783; GO:0005789; GO:0042406; GO:0045050; GO:0071816; GO:0072546"
"390","Pocillopora_acuta_HIv2___RNAseq.g13032.t1",0,0,0,NA,0,0,13.0434782608696,0,0,NA,1.6304347826087,0,3.26086956521739,NA,NA,NA,NA,NA,NA,10.8479506674469,6.38096952478058,7.90186235669204,3.68233641306884,6.90951792457399,10.259599329331,3.68233641306884,9.00528702817479,3.68233641306884,7.97589929907695,7.03280953692828,7.66939087799131,6.39622819586524,410.288923296239,-0.126887359771387,1.02147237615106,0.0361360370989238,0.120154400137663,"Q8N1B4",0,"Vacuolar protein sorting-associated protein 52 homolog (SAC2 suppressor of actin mutations 2-like protein)","ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein targeting [GO:0006605]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle-mediated cholesterol transport [GO:0090119]","GO:0000938; GO:0005794; GO:0005829; GO:0006605; GO:0006896; GO:0007041; GO:0010008; GO:0010668; GO:0015031; GO:0016020; GO:0019905; GO:0032456; GO:0032588; GO:0042147; GO:0048471; GO:0048611; GO:0055037; GO:0090119; GO:1990745"
"391","Pocillopora_acuta_HIv2___TS.g15651.t1",0,0,0,0.917431192660551,0,0,0.478468899521531,0,0,NA,0.155100010242454,0.18348623853211,0.119617224880383,NA,NA,NA,NA,NA,NA,7.66090630254611,3.68233641306884,5.59369902756585,3.68233641306884,6.11409578894442,3.68233641306884,3.68233641306884,5.49643519805837,5.56716625041612,9.03573981459597,5.41973880344022,6.08646051350617,4.75301709337427,79.732600662613,-0.500367721601692,1.20475661298247,0.000903499052286693,0.0053845118633188,"A0A1L8GXM0",9.45e-20,"DNA repair protein RAD50.L (EC 3.6.-.-)","DNA double-strand break processing [GO:0000729]; DNA strand resection involved in replication fork processing [GO:0110025]; meiotic cell cycle [GO:0051321]; metaphase chromosome alignment [GO:0051310]; R-loop processing [GO:0062176]; telomere maintenance [GO:0000723]","GO:0000723; GO:0000729; GO:0000781; GO:0005524; GO:0016887; GO:0030870; GO:0035861; GO:0043539; GO:0046872; GO:0051310; GO:0051321; GO:0062176; GO:0110025"
"392","Pocillopora_acuta_HIv2___TS.g15652.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.31179009778251,6.62290225491721,6.79706037552057,3.68233641306884,5.98573247127087,3.68233641306884,6.69588727094146,7.32476780740362,7.40876851237578,3.68233641306884,5.91939180294185,6.96562385287067,4.87315975301304,69.6575382645353,-0.738442077578638,1.30318931280044,0.000748225441066273,0.00458767816006044,"Q8N1B4",9.74e-83,"Vacuolar protein sorting-associated protein 52 homolog (SAC2 suppressor of actin mutations 2-like protein)","ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein targeting [GO:0006605]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle-mediated cholesterol transport [GO:0090119]","GO:0000938; GO:0005794; GO:0005829; GO:0006605; GO:0006896; GO:0007041; GO:0010008; GO:0010668; GO:0015031; GO:0016020; GO:0019905; GO:0032456; GO:0032588; GO:0042147; GO:0048471; GO:0048611; GO:0055037; GO:0090119; GO:1990745"
"393","Pocillopora_acuta_HIv2___RNAseq.g13037.t1",0.8,0,0,0,0,1.88679245283019,0,0,0,NA,0.29853249475891,0.377358490566038,0.2,NA,NA,NA,NA,NA,NA,9.9473097302821,6.74434409930028,6.0846563529576,9.46273102313318,7.88326508084658,9.06559390088364,6.44318664815124,9.72481765936628,10.6893358542496,3.68233641306884,7.97275767622393,8.86587693554043,7.07963841690744,500.080038879506,-0.302508042280955,1.01346218745012,0.141935372994631,0.33627407616615,"A0A1L8GXM0",0,"DNA repair protein RAD50.L (EC 3.6.-.-)","DNA double-strand break processing [GO:0000729]; DNA strand resection involved in replication fork processing [GO:0110025]; meiotic cell cycle [GO:0051321]; metaphase chromosome alignment [GO:0051310]; R-loop processing [GO:0062176]; telomere maintenance [GO:0000723]","GO:0000723; GO:0000729; GO:0000781; GO:0005524; GO:0016887; GO:0030870; GO:0035861; GO:0043539; GO:0046872; GO:0051310; GO:0051321; GO:0062176; GO:0110025"
"394","Pocillopora_acuta_HIv2___RNAseq.g13044.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.8270605347317,5.39185996804635,9.3642146422635,3.68233641306884,10.846827927867,3.68233641306884,3.68233641306884,10.8940847061302,10.2805206150351,3.68233641306884,7.23339140463492,10.4425416852055,4.02424112406434,735.671212256975,-11.5629589999316,2.62249052307267,2.43220555764648e-12,2.77003316423612e-10,"Q9UGM3",2.37e-79,"Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031]","GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062"
"395","Pocillopora_acuta_HIv2___TS.g15672.t1",NA,NA,1.69491525423729,0,NA,0,0,NA,0,0,0.282485875706215,0,0.564971751412429,NA,NA,NA,NA,NA,NA,8.73254831273344,3.68233641306884,8.81361363638465,3.68233641306884,8.94042757522744,4.51119975925463,3.68233641306884,9.98081212559619,8.51207406275117,3.68233641306884,6.42200211242229,8.99589514253858,3.848109082306,261.983130716057,-10.1969377833642,2.32611901132807,7.95259007870656e-11,4.67586434546389e-09,"Q91VN0",1.9e-41,"Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7)","adipose tissue development [GO:0060612]; amino acid transport [GO:0006865]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; blood vessel morphogenesis [GO:0048514]; bone development [GO:0060348]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; glucose catabolic process [GO:0006007]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mesodermal cell migration [GO:0008078]; negative regulation of osteoblast differentiation [GO:0045668]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; osteoblast proliferation [GO:0033687]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; retina morphogenesis in camera-type eye [GO:0060042]; retina vasculature development in camera-type eye [GO:0061298]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055]","GO:0001702; GO:0001944; GO:0002053; GO:0002076; GO:0005739; GO:0005783; GO:0005886; GO:0006007; GO:0006865; GO:0006897; GO:0007399; GO:0008078; GO:0008203; GO:0008217; GO:0009952; GO:0010467; GO:0015026; GO:0016055; GO:0017147; GO:0033687; GO:0033690; GO:0035019; GO:0035108; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0043434; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048514; GO:0048539; GO:0051091; GO:0060033; GO:0060042; GO:0060070; GO:0060348; GO:0060349; GO:0060444; GO:0060603; GO:0060612; GO:0060764; GO:0060856; GO:0061178; GO:0061298; GO:0061299; GO:0061304; GO:0098609; GO:0110135; GO:1902262; GO:1990963"
"396","Pocillopora_acuta_HIv2___RNAseq.g13070.t1",83.3333333333333,100,100,100,NA,97.1428571428571,77.7777777777778,100,NA,NA,94.0362811791383,99.2857142857143,87.037037037037,NA,NA,NA,NA,NA,NA,11.1505466244135,7.13540753184008,10.0003803232797,8.62766417813255,10.851267094397,9.25653271652549,8.22289232821536,10.3046984305219,10.2183666375874,7.88832156922198,9.3656077434135,10.5050518220399,8.22616366478709,903.146272180001,-1.95953536058461,0.794838486951665,0.00126243005916109,0.00712716173915147,"A7SKE9",6.57e-147,"Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4)","formation of cytoplasmic translation initiation complex [GO:0001732]","GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0016282; GO:0033290"
"397","Pocillopora_acuta_HIv2___RNAseq.g13086.t1",NA,0,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.401894606079,3.68233641306884,10.9934495751791,11.3633897054336,10.6127468810728,3.68233641306884,4.90654184690663,9.078588829153,3.68233641306884,3.68233641306884,7.20859570960995,8.95380326091055,5.46338815830935,801.495374381545,-0.38541300873408,1.09810313116595,0.00739928388370423,0.0325100978414028,"Q9BZC7",0,"ATP-binding cassette sub-family A member 2 (EC 7.6.2.-) (ATP-binding cassette transporter 2) (ATP-binding cassette 2)","central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; ganglioside metabolic process [GO:0001573]; glycosphingolipid metabolic process [GO:0006687]; intracellular sphingolipid homeostasis [GO:0090156]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; negative regulation of steroid metabolic process [GO:0045939]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of steroid metabolic process [GO:0019218]; response to cholesterol [GO:0070723]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin metabolic process [GO:0006684]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]","GO:0000166; GO:0001573; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005768; GO:0005815; GO:0005886; GO:0006629; GO:0006684; GO:0006687; GO:0006869; GO:0007626; GO:0009410; GO:0010008; GO:0016020; GO:0016887; GO:0019218; GO:0031410; GO:0032289; GO:0032383; GO:0032384; GO:0032805; GO:0042626; GO:0042632; GO:0042986; GO:0043190; GO:0043231; GO:0045939; GO:0046512; GO:0048545; GO:0055085; GO:0060049; GO:0061135; GO:0070723; GO:0071072; GO:0090155; GO:0090156; GO:0090370; GO:0099038; GO:0099040; GO:0140359; GO:0150104; GO:1901873; GO:1902004; GO:1902993; GO:1904375; GO:1905598; GO:1905601; GO:2000008"
"398","Pocillopora_acuta_HIv2___RNAseq.g13131.t1",100,NA,NA,100,83.3333333333333,100,100,NA,100,NA,97.2222222222222,100,94.4444444444444,NA,NA,NA,NA,NA,NA,11.7522387028653,11.8273702463139,10.9733110274847,11.5215913702954,11.7773829905608,12.058083218339,12.4236951263658,11.6826089253834,11.2995424238775,10.81250701639,11.6128331047876,11.4970168140343,11.7286493955408,3265.28718834963,0.181399222301123,0.512727778349104,0.686753418327617,0.855493101444154,"P23438",1.03e-66,"Translocon-associated protein subunit beta (TRAP-beta) (Glycoprotein 25H) (gp25H) (Signal sequence receptor subunit beta) (SSR-beta)","","GO:0005789"
"399","Pocillopora_acuta_HIv2___RNAseq.g13135.t1",0,0,0,NA,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.98240028630582,9.02996543118087,9.47694849689073,10.2412977289499,8.65755186968006,9.50686843186566,10.8392712561022,8.64393716395537,10.0349688537915,3.68233641306884,8.9095545931791,9.1591613341247,8.65994785223349,713.536236094699,0.0673568917595972,0.877034365089407,0.888526379472249,0.95700943091771,"Q810V0",7.11e-106,"U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10)","ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]","GO:0005694; GO:0005732; GO:0006364; GO:0032040; GO:0034457; GO:0042274"
"400","Pocillopora_acuta_HIv2___TS.g15764.t1",0,0,0,0,0,0,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.7792912387703,3.68233641306884,9.18772117787148,9.98484168345047,8.81322848684602,6.83225437178457,9.47410023669497,3.68233641306884,3.68233641306884,10.079471757194,7.21979181918183,6.4289827459251,8.01060089243857,388.766290218987,0.0910541240971577,0.993900565760716,0.57228693131286,0.781914632399983,"Q28WQ1",0,"Kinesin-like protein unc-104","synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]","GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005875; GO:0008017; GO:0047496; GO:0048489"
"401","Pocillopora_acuta_HIv2___RNAseq.g13150.t3",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.510705226198,11.0031056773872,10.927770737027,8.25997094939533,11.8955655386127,10.3634224580614,11.2163811480042,10.8533888899991,10.4450787773973,13.0652551069656,10.8540644509048,10.9265018338468,10.7816270679627,2483.23433110537,-0.0700679857133102,0.747324303332314,0.8569326575105,0.943780854201772,"Q6ZSZ5",4.22e-88,"Rho guanine nucleotide exchange factor 18 (114 kDa Rho-specific guanine nucleotide exchange factor) (p114-Rho-GEF) (p114RhoGEF) (Septin-associated RhoGEF) (SA-RhoGEF)","actin cytoskeleton organization [GO:0030036]; negative regulation of stress fiber assembly [GO:0051497]; protein localization to cell-cell junction [GO:0150105]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase-mediated signal transduction [GO:0007264]","GO:0005085; GO:0005829; GO:0005856; GO:0005886; GO:0007264; GO:0008360; GO:0016324; GO:0030036; GO:0030054; GO:0035023; GO:0045177; GO:0046872; GO:0051497; GO:0070062; GO:0150105"
"402","Pocillopora_acuta_HIv2___RNAseq.g13151.t1",0,0,NA,NA,0,0,7.69230769230769,0,0,NA,1.0989010989011,0,2.56410256410256,NA,NA,NA,NA,NA,NA,11.8186481503012,11.0986947933922,11.6436883942777,11.5459839125283,11.0161134179769,10.8799313484727,12.2066125112127,10.8075990710745,10.7016196887572,12.3487194370861,11.4067610725079,11.1975337444775,11.6159884005384,2909.45799437516,0.276806213160535,0.614665792178061,0.560345784588431,0.773584177559136,"Q9W3Y4",7.93e-23,"GAS2-like protein pickled eggs","actin crosslink formation [GO:0051764]; follicle cell of egg chamber development [GO:0030707]; follicle cell of egg chamber stalk formation [GO:0030713]; microtubule bundle formation [GO:0001578]; negative regulation of Notch signaling pathway [GO:0045746]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization or depolymerization [GO:0031110]","GO:0001578; GO:0005737; GO:0005884; GO:0005938; GO:0008017; GO:0008093; GO:0030707; GO:0030713; GO:0031110; GO:0045746; GO:0051015; GO:0051764; GO:1904825"
"403","Pocillopora_acuta_HIv2___RNAseq.g13155.t1",50,100,NA,100,0,57.1428571428571,100,NA,NA,NA,67.8571428571429,85.7142857142857,50,NA,NA,NA,NA,NA,NA,10.5663874816626,10.2137391355779,11.2131838430102,10.513960796677,8.86335373547257,10.935532681151,3.68233641306884,10.1853849679769,9.25104178284357,10.5952694538431,9.60201902912837,10.0158703621932,9.18816769606357,1205.55126134145,-0.057124002802084,0.886131865922181,0.86164575187271,0.946039236969346,"E9Q634",0,"Unconventional myosin-Ie (Unconventional myosin 1E)","actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerulus development [GO:0032835]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]","GO:0000146; GO:0001570; GO:0001701; GO:0001822; GO:0003094; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0006897; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030097; GO:0032437; GO:0032835; GO:0032836; GO:0032991; GO:0035091; GO:0035166; GO:0044877; GO:0045334; GO:0048008; GO:0051015; GO:0072015"
"404","Pocillopora_acuta_HIv2___TS.g15832.t1",0,0,0,0,0,0,25,NA,0,NA,3.125,0,6.25,NA,NA,NA,NA,NA,NA,11.4519353997864,14.2659524030713,10.0609031348299,13.6457401778364,10.6432744195211,14.0615225737083,12.5823958908559,11.9021356939584,10.2377777653204,13.6276774191721,12.247931487806,10.8592052826832,13.6366576929288,7865.30278436561,2.46920800611594,0.827823818262245,0.000121364437379741,0.000980131335712214,"P02466",7.07e-153,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096"
"405","Pocillopora_acuta_HIv2___RNAseq.g13228.t1",3.63636363636364,0,0,0,0,0,0,0,0,0,0.363636363636364,0,0.727272727272727,NA,NA,NA,NA,NA,NA,11.571467336827,9.41934944775207,11.9544135151139,11.7878419649086,10.6766753588206,9.07728000736896,11.7610249289238,11.4464003110511,10.1482935425103,11.4965621692588,10.9339308582535,11.1594500128646,10.7084117036424,2343.95697314489,-0.26124152988476,0.680165611351944,0.56550126160791,0.776772103314038,"C9D7C2",0,"Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein)","calcium ion import across plasma membrane [GO:0098703]; chemical synaptic transmission [GO:0007268]","GO:0005509; GO:0005891; GO:0007268; GO:0008331; GO:0045202; GO:0098703"
"406","Pocillopora_acuta_HIv2___TS.g15865.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.92037767491365,7.0676910766358,10.9887052642677,3.68233641306884,7.22884663559278,7.72318369733628,3.68233641306884,8.91537760875694,7.99414001711824,3.68233641306884,6.88853312138279,8.60948944012986,5.16757680263572,333.266030060209,-0.508869218878219,1.14198274617767,2.21405968948108e-05,0.000225840333911526,"Q63HN8",0,"E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (E3 ubiquitin-lipopolysaccharide ligase RNF213) (EC 2.3.2.-) (Mysterin) (RING finger protein 213)","angiogenesis [GO:0001525]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0001525; GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005737; GO:0005811; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0051865; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"407","Pocillopora_acuta_HIv2___RNAseq.g13253.t1",0,0,0,0,0,0,0,0,2.27272727272727,0,0.227272727272727,0.454545454545455,0,NA,NA,NA,NA,NA,NA,13.4474977611667,12.1492957528202,13.6574281108963,12.6530958106737,13.4707325517355,13.3001428611767,11.783954131004,12.941038706958,13.2777126746321,13.0977957826803,12.9778694143744,13.3588819610777,12.596856867671,8634.62471508607,-0.584501578176552,0.547317696874288,0.197614963971,0.419515625454169,"Q7TSC1",3.82e-26,"Protein PRRC2A (HLA-B-associated transcript 2) (Proline-rich and coiled-coil-containing protein 2A)","cell differentiation [GO:0030154]","GO:0005654; GO:0005829; GO:0005886; GO:0030154"
"408","Pocillopora_acuta_HIv2___RNAseq.5329_t",0,0,NA,0,0,0,NA,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,11.701110774875,11.0689615317584,10.686740338667,10.460132672188,10.1435026277827,9.71711747698019,3.68233641306884,10.5521719264524,8.43419122002346,9.91485876324018,9.63611237450362,10.3035433775601,8.96868137144712,1309.06011936114,-0.203261444520379,0.8878157998836,0.59529040943202,0.798101456519962,"Q8JGM4",1.53e-90,"Sulfhydryl oxidase 1 (EC 1.8.3.2) (Quiescin Q6)","protein folding [GO:0006457]","GO:0000139; GO:0003756; GO:0005615; GO:0006457; GO:0016971"
"409","Pocillopora_acuta_HIv2___TS.g15897.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.29030127202732,8.37003864502086,7.91083219305282,7.49865221587083,7.75604655926288,6.40437642337467,6.36722016743734,7.72981600275591,7.92379244270732,7.71805441628311,7.59691303377931,7.92215769396125,7.27166837359736,186.731689883299,-0.544017434764706,0.620189805807643,0.258634421940401,0.500654212921033,NA,NA,NA,NA,NA
"410","Pocillopora_acuta_HIv2___TS.g15906.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.07520399501629,6.41823073368408,5.54494604997642,5.21704338441576,6.41974631692761,6.22627004598424,3.68233641306884,5.09793447691117,5.42703766936634,5.49240068675675,5.66011497721075,5.91297370163957,5.40725625278193,38.3480557940092,-0.449575635342721,0.835907865046376,0.350603367228086,0.60205711784246,"P22770",3.44e-83,"Neuronal acetylcholine receptor subunit alpha-7","calcium ion transport [GO:0006816]; cognition [GO:0050890]; intracellular calcium ion homeostasis [GO:0006874]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]","GO:0001540; GO:0001666; GO:0005737; GO:0005886; GO:0005892; GO:0006816; GO:0006874; GO:0007165; GO:0008284; GO:0015464; GO:0015643; GO:0017081; GO:0022848; GO:0030424; GO:0030425; GO:0032720; GO:0035094; GO:0042166; GO:0042803; GO:0043005; GO:0043204; GO:0043410; GO:0045202; GO:0045211; GO:0045766; GO:0050890"
"411","Pocillopora_acuta_HIv2___TS.g15907.t1a",89.1666666666667,88.5964912280702,92.5233644859813,58.4,81.4432989690722,83.3333333333333,81.5533980582524,85.4545454545455,88.5350318471338,85.4368932038835,83.4443023246939,80.8638803726165,86.0247242767712,NA,NA,NA,NA,NA,NA,9.240218470119,11.0165195577879,9.31113427393304,3.68233641306884,10.0722701246562,9.67928982548085,3.68233641306884,10.2372128980074,11.5926294871198,10.2815474300357,8.87954948932776,10.0906930507671,7.66840592788843,1054.3992398436,-0.327113640205885,1.01083904708038,0.145097596679703,0.340973458712464,"A2AWA9",0,"Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA)","","GO:0005096; GO:0005813; GO:0005829; GO:0031267"
"412","Pocillopora_acuta_HIv2___RNAseq.g13303.t1",0,NA,0,0,0,18.1818181818182,0,0,0,0,2.02020202020202,4.54545454545455,0,NA,NA,NA,NA,NA,NA,8.25313388378648,10.2368463969586,11.5690237764612,10.9333861213988,10.9310196717941,10.8053434189733,11.0791696174905,9.30230925171207,11.6589220864784,8.50001015528889,10.3269164380342,10.3428817340465,10.310951142022,1638.31089865984,0.0457590825372571,0.752961610701666,0.931635439856325,0.974855443149612,"Q80YT7",2.17e-40,"Myomegalin (Phosphodiesterase 4D-interacting protein)","centrosome cycle [GO:0007098]; positive regulation of microtubule nucleation [GO:0090063]; protein-containing complex assembly [GO:0065003]; regulation of Golgi organization [GO:1903358]","GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0007098; GO:0019899; GO:0030016; GO:0060090; GO:0065003; GO:0090063; GO:1903358"
"413","Pocillopora_acuta_HIv2___RNAseq.g13319.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.1582762928233,7.13540753184008,10.249884922824,10.0683617088321,9.79003779613237,10.8081498580417,11.3410618269977,11.3019607249313,8.65623322700102,10.300469111268,9.98098430006916,10.0312785927424,9.93069000739592,1278.23021659242,0.0121133435558659,0.71603620497178,0.990599570920567,0.99657031670488,"Q6DFQ7",1.14e-21,"Transmembrane protein 198","Wnt signaling pathway [GO:0016055]","GO:0005886; GO:0012506; GO:0016055; GO:0031410"
"414","Pocillopora_acuta_HIv2___RNAseq.g13340.t1",0,NA,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.4307998357874,6.19950000251922,7.19489022163491,3.68233641306884,7.95781456870118,10.4540135325916,3.68233641306884,6.94123935458015,3.68233641306884,3.68233641306884,6.39076031680898,7.2414160787545,5.54010455486347,322.61269125966,-0.363734989586734,1.09523540991604,0.0221456512505814,0.0806634851897279,"P62288",0,"Abnormal spindle-like microcephaly-associated protein homolog","cell division [GO:0051301]; establishment of meiotic spindle localization [GO:0051295]; mitotic cell cycle [GO:0000278]; spindle organization [GO:0007051]","GO:0000278; GO:0000922; GO:0005516; GO:0005634; GO:0005737; GO:0007051; GO:0051295; GO:0051301"
"415","Pocillopora_acuta_HIv2___RNAseq.g13360.t1",0.940438871473354,0,2.07253886010363,1.66666666666667,0,0.3584229390681,0,0,0,0,0.503806733731175,0.405017921146953,0.602595546315396,NA,NA,NA,NA,NA,NA,9.46246053131994,3.68233641306884,6.79706037552057,8.98987751007651,6.46781886708255,9.46479150362545,8.7252565949708,3.68233641306884,3.68233641306884,6.07894006001887,6.70332146818212,6.01840252001215,7.38824041635209,243.828626106593,0.354245193918275,1.08274419172488,0.0450864252050306,0.143735960803518,"A0A0R4IBK5",3e-131,"E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"416","Pocillopora_acuta_HIv2___RNAseq.g13365.t1",0,0,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.8277617684126,10.3635588582823,10.2958492252449,8.16562923854076,10.8823983854506,10.4250537487197,9.56206551104259,8.19376023911409,10.3712001078503,11.9455370769841,10.1032814159642,10.1141939452145,10.0923688867139,1400.44887469428,0.00979882010712985,0.684885723634054,0.996403207957735,0.998998670844531,"E9Q555",1.41e-177,"E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase RNF213) (EC 2.3.2.-) (Mysterin) (RING finger protein 213)","angiogenesis [GO:0001525]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0001525; GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005737; GO:0005811; GO:0005829; GO:0006511; GO:0016567; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0051865; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"417","Pocillopora_acuta_HIv2___RNAseq.g13367.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.8507133006031,11.5333946998326,10.6235343856195,9.79803262595041,10.9994114995311,9.1163185259133,10.7156418727795,9.47140064731794,10.8665585711123,3.68233641306884,9.76573425417286,10.5623236808368,8.96914482750893,1390.95193499432,-0.260077461873247,0.911150751309012,0.457033869666881,0.697978169677375,"A0A0R4IBK5",5.4e-44,"E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"418","Pocillopora_acuta_HIv2___RNAseq.g13376.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.6872680306761,10.4627150022039,11.2275734111489,10.5937760058621,12.2682909048877,12.1762920091571,10.0485573863072,11.4423057778626,11.7937085050515,11.7300964548505,11.3430583488008,11.6838293259254,11.0022873716762,2874.6989515295,-0.514679971825619,0.55770392950309,0.260734632936604,0.502567394828763,"A0A0R4IBK5",0,"E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha)","blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0046872; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"419","Pocillopora_acuta_HIv2___TS.g16008.t2",0,21.4285714285714,0,0,NA,0,0,NA,NA,NA,3.57142857142857,7.14285714285714,0,NA,NA,NA,NA,NA,NA,10.8122553324231,3.68233641306884,10.3262552984313,3.68233641306884,10.7668459843973,3.68233641306884,3.68233641306884,10.7744082682329,11.553472106528,3.68233641306884,7.26449190553568,10.8466473980025,3.68233641306884,945.362231842888,-15.1356859473163,3.79729136104194,6.03941798624965e-16,2.64709520463985e-13,"Q40778",1.37e-29,"Allene oxide synthase (EC 4.2.1.92) (Cytochrome P450 74A2) (Rubber particle protein) (RPP)","fatty acid biosynthetic process [GO:0006633]; oxylipin biosynthetic process [GO:0031408]","GO:0004497; GO:0005506; GO:0006633; GO:0009978; GO:0016705; GO:0020037; GO:0031408"
"420","Pocillopora_acuta_HIv2___TS.g12014.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.31416944308529,8.68239073149247,9.8198170145748,9.96852602668137,10.5343044406255,9.90713660932484,6.32760358191934,9.99722452017996,10.9065231202139,3.68233641306884,8.91400319011663,10.1144077077359,7.71359867249737,819.060127406002,-0.563645374022452,1.03386086147064,0.13481222623563,0.324824927581569,"P17972",4.72e-104,"Potassium voltage-gated channel protein Shaw (Shaw2)","action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; sleep [GO:0030431]","GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0022843; GO:0030431; GO:0032590; GO:0032809; GO:0042734; GO:0043679; GO:0045211; GO:0051260; GO:0071805"
"421","Pocillopora_acuta_HIv2___RNAseq.g13608.t1",0,NA,1.35135135135135,8.95522388059701,1.44927536231884,5.55555555555556,3.8961038961039,13.953488372093,4.34782608695652,0,4.3898693894418,8.20302347380053,1.33934612195482,NA,NA,NA,NA,NA,NA,10.6779269146882,11.8491913854414,9.00756979532748,9.05625926668333,10.1550400429261,8.23067218564411,10.0895595506413,7.07874584792092,6.03378121970174,10.7696984542469,9.29484446632215,8.59061276411289,9.99907616853141,1060.01052522198,0.589678602684562,0.950238531747581,0.166201929222604,0.373109530385806,"Q2PPJ7",0,"Ral GTPase-activating protein subunit alpha-2 (250 kDa substrate of Akt) (AS250) (p220)","activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]","GO:0005096; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0046982; GO:0051056; GO:0090630"
"422","Pocillopora_acuta_HIv2___RNAseq.g13614.t1",0,0,NA,NA,0,0,6.12244897959184,NA,0,NA,1.02040816326531,0,2.04081632653061,NA,NA,NA,NA,NA,NA,7.55601247066455,3.68233641306884,6.83563938186455,3.68233641306884,3.68233641306884,3.68233641306884,11.2419345060035,6.51415705597779,3.68233641306884,9.1694335319027,5.97288590117573,5.65409634692891,6.29167545542254,326.762467924701,0.0504464593631683,1.01416101775619,0.508981310093757,0.736485160984003,"P41636",1.27e-144,"4-coumarate--CoA ligase (4CL) (EC 6.2.1.12) (4-coumaroyl-CoA synthase)","phenylpropanoid metabolic process [GO:0009698]","GO:0005524; GO:0009698; GO:0016207"
"423","Pocillopora_acuta_HIv2___RNAseq.g13616.t2",0,NA,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.0197234869908,6.4723009311231,9.45264729857135,6.22380314819221,8.68966579358277,10.4232243109699,3.68233641306884,8.9828962845594,3.68233641306884,3.68233641306884,7.0311270493196,7.96545385535463,6.09680024328458,350.097566122973,-0.460799897770719,1.1014825154817,0.146166116448528,0.342545665290335,"A8C750",0,"tRNA (32-2'-O)-methyltransferase regulator THADA (Thyroid adenoma-associated protein homolog)","tRNA methylation [GO:0030488]; tRNA nucleoside ribose methylation [GO:0002128]","GO:0002128; GO:0030488"
"424","Pocillopora_acuta_HIv2___TS.g12097.t1c",0,0,0,0,0,6.25,0,NA,0,NA,0.78125,1.5625,0,NA,NA,NA,NA,NA,NA,9.69550253756889,8.79746969413494,10.8520091984731,10.6934283051192,11.24757186031,9.27288393234448,9.68947391961565,11.1614984836736,9.88298596294877,9.2879829379479,10.0580806832137,10.5679136085949,9.54824775783243,1225.90415092619,-0.799914937074391,0.607961407538545,0.102098156845784,0.265554350048089,"Q15643",6.58e-52,"Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230)","cartilage development [GO:0051216]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; inner ear receptor cell stereocilium organization [GO:0060122]; protein glycosylation [GO:0006486]; protein transmembrane transport [GO:0071806]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]; vesicle tethering to Golgi [GO:0099041]","GO:0000139; GO:0002079; GO:0002081; GO:0003281; GO:0003413; GO:0003713; GO:0005793; GO:0005794; GO:0005801; GO:0005856; GO:0006366; GO:0006486; GO:0006888; GO:0007030; GO:0030133; GO:0031267; GO:0033116; GO:0051216; GO:0060122; GO:0071806; GO:0090161; GO:0099041"
"425","Pocillopora_acuta_HIv2___RNAseq.g13681.t1",0,0,0,NA,0,4,0,0,NA,NA,0.571428571428571,1.33333333333333,0,NA,NA,NA,NA,NA,NA,10.1957009590357,10.2881373815788,9.6064986712494,11.4639885027722,11.5461410416261,10.2819802372667,6.92300023156823,11.2126929978797,11.2010093737278,12.741015951494,10.5460165348199,10.7524086087037,10.339624460936,2170.32803927726,-0.0781241279857,0.793402250685107,0.844265445080517,0.938115955876515,"Q1LV17",7.8e-79,"Interferon regulatory factor 2-binding protein 1 (IRF-2-binding protein 1) (IRF-2BP1)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003714; GO:0005634; GO:0006357"
"426","Pocillopora_acuta_HIv2___RNAseq.g13682.t1",0,NA,NA,0,NA,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,7.3358031916585,3.68233641306884,9.15231611817143,3.68233641306884,9.07867187279407,3.68233641306884,3.68233641306884,9.3393789223552,8.32028448910829,3.68233641306884,6.16381366594317,8.6452909188175,3.68233641306884,211.268369190467,-12.6748681240331,3.6749042823021,1.27217240451148e-10,7.02316857208168e-09,"Q1G7G9",1.61e-47,"TALPID3 protein","centrosome localization [GO:0051642]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458]; smoothened signaling pathway [GO:0007224]","GO:0005737; GO:0005813; GO:0005814; GO:0007224; GO:0036064; GO:0044458; GO:0051642; GO:0060271"
"427","Pocillopora_acuta_HIv2___RNAseq.g13713.t1",0,NA,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.39636529404302,6.06348383902188,8.60052414500046,7.93599079599327,8.94375920571282,9.29106003099674,3.68233641306884,9.26283241636544,3.68233641306884,11.3407761209591,7.71994646742304,7.77716349483812,7.66272944000797,516.330715304444,-0.119271225965385,0.966410990962486,0.597597869772719,0.799598111784699,"Q5ZM55",2.78e-115,"Protein fem-1 homolog B (FEM1b) (FEM1-beta)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"428","Pocillopora_acuta_HIv2___RNAseq.g13716.t1",0.8,0.65359477124183,0,3.97350993377483,0.269541778975741,0.16260162601626,0.50251256281407,0,3.27868852459016,0,0.96404491974129,1.61367897112462,0.314410868357962,NA,NA,NA,NA,NA,NA,10.7901185096658,6.54125763453179,11.3854995733775,3.68233641306884,11.0677621148641,3.68233641306884,3.68233641306884,10.9165098426662,11.7313163303888,10.2487997064811,8.37282729511818,11.1782412741925,5.56741331604388,1305.77810102607,-1.09325812237931,2.04131748248088,9.25293290339535e-09,2.69827462731271e-07,"D2IYS2",7.39e-70,"Tyrosine-protein kinase receptor torso (EC 2.7.10.1)","cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0043235; GO:0046872"
"429","Pocillopora_acuta_HIv2___RNAseq.g13719.t1",NA,40,78.9473684210526,60,100,33.3333333333333,49.1803278688525,NA,94.4444444444444,0,56.9881842584604,56.9444444444444,57.0319240724763,NA,NA,NA,NA,NA,NA,6.87035865762029,9.42383226557013,10.2214066729534,10.6377719459533,8.96522901752289,9.77851578964601,3.68233641306884,9.60028006405261,10.3897564219137,11.1702277822657,9.07397150305669,9.20940616681258,8.9385368393008,916.306190048544,0.103014979246759,0.887111493456863,0.788735853886303,0.910767634569015,"F8W2M1",6.47e-51,"E3 ubiquitin-protein ligase HACE1 (EC 2.3.2.26) (HECT domain and ankyrin repeat-containing E3 ubiquitin-protein ligase 1) (HECT-type E3 ubiquitin transferase HACE1)","atrioventricular valve formation [GO:0003190]; cardiac ventricle morphogenesis [GO:0003208]; Golgi organization [GO:0007030]; heart looping [GO:0001947]; membrane fusion [GO:0061025]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell migration [GO:0030334]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000139; GO:0000209; GO:0001947; GO:0003190; GO:0003208; GO:0004842; GO:0005634; GO:0005737; GO:0005783; GO:0006511; GO:0007030; GO:0016567; GO:0030334; GO:0031267; GO:0032580; GO:0061025; GO:0061630; GO:0070936; GO:1903427"
"430","Pocillopora_acuta_HIv2___RNAseq.g13756.t1",0,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.4600992077576,12.2375335766166,12.2097031756779,11.8757571111285,11.6831701759334,11.4304050384162,12.2947115966378,11.483657158521,12.1617434760564,11.2924509582251,11.8129231474971,11.7996746387893,11.8261716562048,3691.14197698255,0.0197302894673064,0.551084311465245,0.967979783171171,0.988724779511621,"Q9Y4D1",0,"Disheveled-associated activator of morphogenesis 1","actin cytoskeleton organization [GO:0030036]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001725; GO:0003779; GO:0005829; GO:0005886; GO:0016020; GO:0030036; GO:0031267; GO:0031514; GO:0036064; GO:0042802; GO:0048471; GO:0060071"
"431","Pocillopora_acuta_HIv2___RNAseq.g13758.t1",NA,NA,0,NA,0,0,16.6666666666667,0,0,NA,2.77777777777778,0,5.55555555555556,NA,NA,NA,NA,NA,NA,5.04675156217379,3.68233641306884,6.22468762788833,3.68233641306884,8.07202310239185,7.28680821969973,10.9507545351841,7.59957177400187,8.90432383990027,3.68233641306884,6.51319299004465,7.16947158127122,5.85691439881807,301.587392429128,-0.372797758292123,1.06771250185038,0.00614038239364329,0.0277112296229817,"Q6ZMV9",0,"Kinesin-like protein KIF6","microtubule-based movement [GO:0007018]","GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887"
"432","Pocillopora_acuta_HIv2___RNAseq.g13760.t1",2.5,0,0,0,0,0.480769230769231,0,0,0,NA,0.331196581196581,0.0961538461538462,0.625,NA,NA,NA,NA,NA,NA,10.7522055180806,11.267141842698,5.87178581315921,10.2748565348586,9.43524224082924,3.68233641306884,3.68233641306884,9.43507870724526,9.43471449346097,3.68233641306884,7.75180343895384,8.98580535455506,6.51780152335262,738.751177242547,-0.236546849589554,1.03356517313788,2.08165247795518e-05,0.000214451719666265,"F6R2G2",5.34e-12,"NLR family CARD domain-containing protein 4 (Ice protease-activating factor) (Ipaf)","apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of apoptotic process [GO:0042981]","GO:0005524; GO:0005829; GO:0006915; GO:0006954; GO:0016045; GO:0042742; GO:0042981; GO:0045087"
"433","Pocillopora_acuta_HIv2___RNAseq.g13774.t1",0,NA,NA,NA,57.1428571428571,0,66.6666666666667,0,0,NA,20.6349206349206,0,41.2698412698413,NA,NA,NA,NA,NA,NA,6.34070533074306,4.8931170245923,8.45506275286555,8.24376600771061,6.54142192988087,6.5620639848483,3.68233641306884,7.8530093336639,8.76735014635008,3.68233641306884,6.50211693367923,7.59150989870069,5.41272396865778,142.719888977241,-0.580387185451217,1.12447590671841,0.0355901996533109,0.118913524551972,NA,NA,NA,NA,NA
"434","Pocillopora_acuta_HIv2___RNAseq.g13790.t1b",0,NA,NA,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,13.2510845239732,11.0083370178073,11.9295995581267,13.3564476037148,12.8671206979302,13.0760349513031,12.4932731444405,12.1946381178009,13.4749939619107,12.8864739272383,12.6538003504246,12.7434873719483,12.5641133289008,7145.96453471235,-0.0818872971193258,0.648753690957275,0.849826363756694,0.940807790142563,"Q9NQC3",1.09e-52,"Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5)","apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; brain development [GO:0007420]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell adhesion involved in sprouting angiogenesis [GO:0120078]; cell migration involved in vasculogenesis [GO:0035441]; cellular response to hypoxia [GO:0071456]; central nervous system vasculogenesis [GO:0022009]; cerebral cortex radial glia-guided migration [GO:0021801]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; intracellular sphingolipid homeostasis [GO:0090156]; leukocyte migration involved in inflammatory response [GO:0002523]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of vasculogenesis [GO:2001213]; neuron differentiation [GO:0030182]; nuclear pore complex assembly [GO:0051292]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration [GO:1905523]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334]","GO:0001825; GO:0002523; GO:0003723; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0007029; GO:0007413; GO:0007420; GO:0010634; GO:0014069; GO:0021801; GO:0022009; GO:0030054; GO:0030182; GO:0030308; GO:0030334; GO:0030517; GO:0031625; GO:0033601; GO:0034165; GO:0035022; GO:0035441; GO:0042803; GO:0042981; GO:0043005; GO:0045202; GO:0045296; GO:0045766; GO:0046872; GO:0050804; GO:0050821; GO:0051292; GO:0051897; GO:0060317; GO:0060907; GO:0061462; GO:0070161; GO:0071456; GO:0071782; GO:0071786; GO:0071787; GO:0090156; GO:0098826; GO:0098978; GO:0120078; GO:1902430; GO:1902624; GO:1905523; GO:1905552; GO:1905580; GO:1905653; GO:1990809; GO:2000172; GO:2000347; GO:2001213"
"435","Pocillopora_acuta_HIv2___RNAseq.g13791.t1",NA,100,100,33.3333333333333,100,100,100,NA,NA,NA,88.8888888888889,77.7777777777778,100,NA,NA,NA,NA,NA,NA,10.5486317891533,9.00922864981069,7.56912417164875,9.64832458021464,8.94042757522744,10.2748966375874,7.369096855117,8.96718861917064,8.36958085695223,10.4904146766501,9.11869144115322,8.87899060243047,9.35839227987597,691.797627571149,0.271786005406401,0.774341659353691,0.537806350339481,0.758090009006934,"O94806",0,"Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu)","intracellular signal transduction [GO:0035556]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148]","GO:0004674; GO:0004697; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006468; GO:0007200; GO:0007205; GO:0016301; GO:0030148; GO:0035556; GO:0046872; GO:0106310"
"436","Pocillopora_acuta_HIv2___TS.g12279.t1",0,NA,NA,0,NA,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,6.86389470932694,3.68233641306884,4.71118491363556,6.19123426543186,8.11901762584766,6.29140637299107,6.66829119218775,5.84054469821112,5.57325830168385,5.64342272024203,5.50309388312566,56.8519030138588,0.0277371771151371,0.953572013474722,0.958023860924154,0.984472733402787,"Q96AY4",2.4e-16,"Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"437","Pocillopora_acuta_HIv2___RNAseq.g13816.t1",0,0,0,0,0,0,0,8.33333333333333,0,0,0.833333333333333,1.66666666666667,0,NA,NA,NA,NA,NA,NA,11.6465151825514,9.68137605324305,11.1811971412154,10.7190093196417,11.4206359871676,12.2915729358868,11.2070966107122,12.302474612039,11.0089214135471,5.00142931435546,10.646022857036,11.5119488673041,9.78009684676784,2504.66704081552,-0.605175446228844,0.928133612364628,0.180909865181223,0.395627500753131,"Q96L93",0,"Kinesin-like protein KIF16B (Sorting nexin-23)","early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]","GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007018; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0080025"
"438","Pocillopora_acuta_HIv2___RNAseq.g13823.t1",0,NA,0,0,NA,20,0,0,NA,NA,3.33333333333333,6.66666666666667,0,NA,NA,NA,NA,NA,NA,9.06802994240702,10.3197430425328,9.25426777814093,11.8040212620391,5.91659193355748,12.4828573331532,13.4976977295206,9.12808203182104,3.68233641306884,11.7181852614336,9.68718127276746,7.40986161979906,11.9645009257359,2705.40623241689,2.72371496563779,2.56816871477126,0.00058254889715202,0.00372831294177293,"B3EWY9",0,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020"
"439","Pocillopora_acuta_HIv2___RNAseq.g13833.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.7674813525361,6.0149040413723,6.84512099725677,8.36357359719131,8.18628850344862,7.92341504315593,6.44318664815124,8.3847272779716,7.54029722811113,9.18988132487375,7.56588760140688,7.54478307186484,7.58699213094891,209.746225028826,-0.000357393894514015,0.722408526722317,0.996833261377492,0.998998670844531,"Q5TYV4",9.17e-86,"Spermatogenesis-defective protein 39 homolog (hSPE-39) (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction)","cell differentiation [GO:0030154]; hepaticobiliary system development [GO:0061008]; intracellular protein transport [GO:0006886]; spermatogenesis [GO:0007283]; vacuolar transport [GO:0007034]","GO:0005737; GO:0005769; GO:0005770; GO:0006886; GO:0007034; GO:0007283; GO:0030154; GO:0055037; GO:0061008"
"440","Pocillopora_acuta_HIv2___RNAseq.g13851.t1",0,0,NA,NA,0,15,0,NA,0,NA,2.5,5,0,NA,NA,NA,NA,NA,NA,8.54038827674961,8.27386811086179,6.85453915175415,4.99561439145868,9.58991137188566,10.1276371932802,10.7081393985828,8.22348476192202,9.34132069519273,11.2227487774443,8.78776521291319,8.50992885150083,9.06560157432555,748.134479209838,0.237091386288601,0.771509878016723,0.59998305579935,0.800857926605757,"P47990",0,"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]","urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115]","GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0009115; GO:0030151; GO:0034418; GO:0043546; GO:0050660; GO:0051537; GO:0070674; GO:0071949"
"441","Pocillopora_acuta_HIv2___RNAseq.g13855.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.90744172849562,6.5579743664166,6.33809542335038,5.80116198083551,5.94468313522804,5.44887968569328,3.68233641306884,4.82716794255886,6.6827526322222,8.31113887526226,5.95016321831316,5.94002817237102,5.9602982642553,63.7697005817204,-0.147061295468514,0.806043286123255,0.713756662299518,0.870794610227523,"W0LYS5",3.32e-61,"Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (MnCaMKI)","molting cycle process [GO:0022404]; protein phosphorylation [GO:0006468]","GO:0004683; GO:0005516; GO:0005524; GO:0006468; GO:0022404; GO:0106310"
"442","Pocillopora_acuta_HIv2___RNAseq.g13868.t1",0,NA,NA,0,0,0,15.3846153846154,0,0,NA,2.1978021978022,0,5.12820512820513,NA,NA,NA,NA,NA,NA,8.37730481268766,10.2406618713503,10.9072460173797,8.27599526498432,10.5182024368373,10.2819802372667,10.6068809291793,7.51532375783955,10.1470107726101,3.68233641306884,9.05529425132038,9.49301755947086,8.61757094316989,913.232137979624,-0.0734436445792713,0.924436531894685,0.740821577247018,0.885080892510422,"Q80XK6",0,"Autophagy-related protein 2 homolog B","autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of peroxisome [GO:0030242]; glycophagy [GO:0061723]; piecemeal microautophagy of the nucleus [GO:0034727]; reticulophagy [GO:0061709]","GO:0000045; GO:0000407; GO:0000422; GO:0005789; GO:0005811; GO:0030242; GO:0032266; GO:0034045; GO:0034727; GO:0043495; GO:0061709; GO:0061723; GO:0061908; GO:0120013"
"443","Pocillopora_acuta_HIv2___RNAseq.g13875.t1c",100,NA,100,85.7142857142857,100,57.1428571428571,40,NA,50,NA,76.1224489795918,64.2857142857143,85,NA,NA,NA,NA,NA,NA,3.68233641306884,11.2633961722817,3.68233641306884,9.44396776168801,9.38589959524714,8.10367657356437,3.68233641306884,7.93442943737751,3.68233641306884,3.68233641306884,6.45430516055029,5.67346765436623,7.23514266673435,421.687123869037,0.0428914296708706,1.00685050386549,0.0514896078436023,0.158726702440295,NA,NA,NA,NA,NA
"444","Pocillopora_acuta_HIv2___RNAseq.g13878.t1",0,0,NA,61.5384615384615,50,65.9574468085106,46.1538461538462,NA,NA,NA,37.2749590834697,42.4986361156574,32.0512820512821,NA,NA,NA,NA,NA,NA,12.2727484118664,12.8190923221497,12.9362620064693,12.6923655726048,13.281166794333,12.7817966123194,11.6784950897953,12.5583061974934,13.2549726611792,12.3418865160485,12.6617092184259,12.8606912142683,12.4627272225835,6764.83738877886,-0.294112756990403,0.535460918626115,0.504131632785418,0.732987528810644,"Q96PC5",1.94e-16,"Melanoma inhibitory activity protein 2 (MIA protein 2) (CTAGE family member 5 ER export factor) (Cutaneous T-cell lymphoma-associated antigen 5) (Meningioma-expressed antigen 6/11)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; lipoprotein transport [GO:0042953]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459]","GO:0005783; GO:0005789; GO:0006888; GO:0008047; GO:0009306; GO:0016020; GO:0032527; GO:0035459; GO:0038024; GO:0042953; GO:0070971; GO:0070973"
"445","Pocillopora_acuta_HIv2___TS.g12358.t3",11.1111111111111,0,0,0,0,0,0,0,0,NA,1.23456790123457,0,2.77777777777778,NA,NA,NA,NA,NA,NA,7.47915669776618,6.36195368411057,9.03852241960073,9.83989417518581,5.79780043227059,3.68233641306884,3.68233641306884,5.4533793909793,8.17655864680531,7.23934222464913,6.67512804975053,7.18908351748442,6.16117258201664,204.923786654245,-0.693641450742488,1.11376645459902,0.063770922377893,0.187628686182637,NA,NA,NA,NA,NA
"446","Pocillopora_acuta_HIv2___RNAseq.g13890.t1",0,NA,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,7.72880437482727,8.41581523654483,7.66249431030622,5.7042294826067,6.02555167782084,6.22627004598424,8.0131585029338,5.36237875279434,7.84981669252407,6.3425338234262,6.93310528997685,6.92580916165455,6.94040141829915,132.031782273454,-0.0142589693481729,0.790942570161521,0.955055204154273,0.983074901998732,NA,NA,NA,NA,NA
"447","Pocillopora_acuta_HIv2___RNAseq.g13921.t1",0,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.826193401567,9.33617954018857,10.0232461409959,8.6359601564125,9.71211578395195,10.3315903226701,3.68233641306884,10.0782215844611,3.68233641306884,3.68233641306884,7.89905161694536,8.66442266480896,7.13368056908177,602.275097540513,-0.276227156138452,0.965221966145108,0.521954396316992,0.745422189573617,"Q99698",0,"Lysosomal-trafficking regulator (Beige homolog)","defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein localization [GO:0008104]; protein transport [GO:0015031]","GO:0005829; GO:0006909; GO:0008104; GO:0015031; GO:0015630; GO:0016020; GO:0019901; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607"
"448","Pocillopora_acuta_HIv2___RNAseq.g13930.t1",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.90744172849562,10.0908921719085,6.48015208458943,3.68233641306884,5.81325426851759,5.28004943464804,7.06029841987015,6.30287333300819,6.6827526322222,6.11483358357707,6.34148840699056,6.23729480936661,6.44568200461452,150.755753127608,-0.059840225217798,0.893249023984284,0.831182287884903,0.931717169547978,NA,NA,NA,NA,NA
"449","Pocillopora_acuta_HIv2___TS.g12420.t2",0,NA,100,0,NA,72.7272727272727,100,NA,87.5,NA,60.0378787878788,53.4090909090909,66.6666666666667,NA,NA,NA,NA,NA,NA,3.68233641306884,10.5554912439425,9.9206936395711,3.68233641306884,10.6048815306726,8.51152342055849,3.68233641306884,6.8518124665155,3.68233641306884,9.11914170613723,7.02928896596728,6.94841209257938,7.11016583935518,491.655426890613,-0.0342009074526642,1.01001460796462,0.440019784832616,0.682838274651121,"Q99NB1",0,"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)","acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]","GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218"
"450","Pocillopora_acuta_HIv2___TS.g12436.t1a",0,0,0,0,0,0,2.02020202020202,NA,0,NA,0.252525252525253,0,0.505050505050505,NA,NA,NA,NA,NA,NA,7.39792737798653,6.22089677820832,8.25503642196764,3.68233641306884,6.01241040467731,3.68233641306884,3.68233641306884,7.70469802058325,5.26843329136292,3.68233641306884,5.55887479470613,6.92770110331553,4.19004848609674,71.7747898860387,-6.13874355926303,4.52520580175407,5.33861667447518e-05,0.000484123834354915,NA,NA,NA,NA,NA
"451","Pocillopora_acuta_HIv2___RNAseq.g13969.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.81697116993508,10.6945801848703,10.4632879845348,12.0952433378348,7.85161446036259,3.68233641306884,10.803634121434,9.63602771225377,3.68233641306884,3.68233641306884,8.14083682104319,8.09004754803102,8.19162609405536,1053.14891127435,0.122141891338529,0.93855760857425,0.718261770851335,0.87263231628434,"Q6PCN3",8.57e-137,"Tau-tubulin kinase 1 (EC 2.7.11.1)","learning or memory [GO:0007611]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of protein polymerization [GO:0032273]; signal transduction [GO:0007165]","GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005875; GO:0007165; GO:0007611; GO:0010628; GO:0010629; GO:0018105; GO:0018107; GO:0018108; GO:0032273; GO:0043025; GO:0048156; GO:0048471; GO:0050321; GO:0106310; GO:1903980"
"452","Pocillopora_acuta_HIv2___RNAseq.g13974.t1",60,NA,NA,0,0,0,0,0,NA,NA,10,0,20,NA,NA,NA,NA,NA,NA,5.17503271827961,7.90768687698613,3.68233641306884,5.16572759476787,3.68233641306884,5.5398789997613,3.68233641306884,7.7380917079869,3.68233641306884,3.68233641306884,4.9938099963126,4.79202673309461,5.1955932595306,45.7954015693914,0.146922511304954,1.02566165958957,0.0432818111089759,0.139086450984276,"Q76L87",6.13e-37,"Doublesex- and mab-3-related transcription factor A2 (Doublesex- and mab-3-related transcription factor 5) (Ola-DMRT5)","germ cell development [GO:0007281]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007281; GO:0007548; GO:0046872"
"453","Pocillopora_acuta_HIv2___RNAseq.g13977.t1",0.145348837209302,0.505050505050505,0.490196078431373,1.35440180586907,0,0.115473441108545,1.07238605898123,0,0,0,0.368285672665003,0.394985150405625,0.341586194924382,NA,NA,NA,NA,NA,NA,9.86906939763232,6.54125763453179,11.0757855931493,3.68233641306884,10.5331997097019,6.32627630066865,3.68233641306884,11.4946491380107,11.3572503880057,3.68233641306884,7.82444974009069,10.8659908453,4.78290863488139,1008.24770555451,-6.8096960985414,4.81754665064603,2.01375874384446e-09,7.35530466438543e-08,"B3EWY9",0,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020"
"454","Pocillopora_acuta_HIv2___RNAseq.g14013.t1b",2.98782736997418,4.17002959375841,9.10047343503419,4.3585021485574,5.39125077017868,3.42298288508557,6.18090452261307,3.77358490566038,3.23614226209548,4.01686089759484,4.66385587905522,3.79224835903145,5.53546339907899,NA,NA,NA,NA,NA,NA,9.53812614030127,9.1859200648479,10.2586702858024,7.82404749521597,8.50119371632014,8.4115941178289,9.33241012445229,9.59120293861953,10.4963442877127,3.68233641306884,8.68218455841699,9.67710747375121,7.68726164308278,611.273518790503,-0.473575484010628,0.960228998874444,0.242225366273423,0.480266990785304,"Q9JI19",6.42e-115,"Acidic fibroblast growth factor intracellular-binding protein (aFGF intracellular-binding protein) (FGF-1 intracellular-binding protein)","","GO:0005634; GO:0012505; GO:0016020; GO:0017134"
"455","Pocillopora_acuta_HIv2___RNAseq.g14020.t1",NA,NA,NA,0,0,0,2.7027027027027,NA,0,0,0.45045045045045,0,0.900900900900901,NA,NA,NA,NA,NA,NA,5.71611892316596,3.68233641306884,5.38589367603326,3.68233641306884,8.62678029365544,3.68233641306884,3.68233641306884,10.2078253562803,8.523994985793,3.68233641306884,5.68722953002722,7.69212264698559,3.68233641306884,192.015211131491,-11.9896405696236,3.95585920903051,4.73958310998545e-08,1.13311289426164e-06,"G8HTB6",3.1e-10,"ZP domain-containing protein","","GO:0016020"
"456","Pocillopora_acuta_HIv2___RNAseq.g14021.t1",0,0,0,0,NA,8.69565217391304,0,0,NA,NA,1.24223602484472,2.17391304347826,0,NA,NA,NA,NA,NA,NA,11.6945904724411,3.68233641306884,11.0737958882402,3.68233641306884,11.1165194441176,3.68233641306884,3.68233641306884,10.8178469048317,12.1470623157204,3.68233641306884,7.52614970906952,11.3699630050702,3.68233641306884,1390.28685695327,-15.7443142439334,3.85317969026011,3.14334444562964e-17,2.67443141538748e-14,"G8HTB6",2.38e-12,"ZP domain-containing protein","","GO:0016020"
"457","Pocillopora_acuta_HIv2___RNAseq.g14027.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.76666095136545,4.59616451822093,6.14868956725197,5.11193581531555,5.79780043227059,4.78285319113451,6.15654274228627,4.93729786847052,4.86223652345053,5.70282560183315,5.38630072115995,5.50253706856181,5.27006437375808,23.6106028011666,-0.207463832069481,0.843421799924426,0.590312584870675,0.795158014654498,NA,NA,NA,NA,NA
"458","Pocillopora_acuta_HIv2___RNAseq.g14056.t1",0,40.9090909090909,0,NA,71.4285714285714,5.40540540540541,10.2564102564103,NA,22.2222222222222,NA,21.4602428888143,22.8455728455728,20.4212454212454,NA,NA,NA,NA,NA,NA,10.654402181314,7.31139692208749,9.4859568732607,9.56177886745259,11.0279260679275,3.68233641306884,3.68233641306884,9.46022593424953,10.6482219701047,8.64340140185018,8.41579830443844,10.2553466053713,6.57625000350559,783.754467971248,-0.721146927659341,1.28325468652036,0.00815125697386485,0.0352149883124197,"O96005",0,"Putative lipid scramblase CLPTM1 (Cleft lip and palate transmembrane protein 1)","cell differentiation [GO:0030154]; regulation of T cell differentiation in thymus [GO:0033081]","GO:0005886; GO:0009897; GO:0012505; GO:0016020; GO:0030154; GO:0033081; GO:0050811"
"459","Pocillopora_acuta_HIv2___RNAseq.g14060.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.6941688973881,8.63287949292383,9.54173891909105,7.22786336628594,10.4979603966585,3.68233641306884,3.68233641306884,10.9708747265551,8.69891314311557,3.68233641306884,7.73114081812246,10.0807312165617,5.38155041968326,664.041919546602,-1.07490696576404,1.89638776489099,6.97752596874686e-07,1.14946395913388e-05,"A7UKY7",9.87e-67,"Insulinoma-associated protein 1 (Zinc finger protein IA-1)","endocrine pancreas development [GO:0031018]; endodermal cell differentiation [GO:0035987]; gland development [GO:0048732]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; pancreatic A cell differentiation [GO:0003310]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309]","GO:0000122; GO:0000978; GO:0003309; GO:0003310; GO:0003700; GO:0005634; GO:0007399; GO:0017053; GO:0031018; GO:0031490; GO:0035987; GO:0046872; GO:0048732; GO:0060290"
"460","Pocillopora_acuta_HIv2___RNAseq.g14088.t1",0,NA,0,NA,0,0,NA,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.67849525535295,8.74107941055535,8.57540275734067,8.19402536505928,7.87629173226137,9.5544547891103,5.36842592176402,9.13590799889864,3.68233641306884,3.68233641306884,7.44887560564803,7.78968683138449,7.10806437991156,331.380001382891,-0.275605694516491,0.885560380026704,0.586429564306727,0.792869435233922,"Q6P158",0,"Putative ATP-dependent RNA helicase DHX57 (EC 3.6.4.13) (DEAH box protein 57)","","GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0016887; GO:0046872"
"461","Pocillopora_acuta_HIv2___RNAseq.g14147.t1",25,42.8571428571429,33.3333333333333,12.1212121212121,11.1111111111111,20.2380952380952,26.9230769230769,29.6296296296296,11.1111111111111,9.52380952380952,22.1848521848522,23.1914381914382,21.1782661782662,NA,NA,NA,NA,NA,NA,13.0067228316905,13.3095181319558,13.626458058787,13.2076712143555,13.3199565277648,12.3889779790525,12.0481423915867,13.3897726297095,13.7284035776021,14.4604150801779,13.2486038422682,13.4142627251108,13.0829449594257,10690.6391355295,-0.22996191280819,0.575788451729505,0.614214284637394,0.810213899953969,"Q5R452",7.59e-41,"Scaffold attachment factor B1 (SAF-B1)","estrogen receptor signaling pathway [GO:0030520]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0003682; GO:0003723; GO:0005634; GO:0006357; GO:0030520; GO:0050684"
"462","Pocillopora_acuta_HIv2___RNAseq.g14155.t1",0,0,0,0,NA,5.88235294117647,12.5,NA,0,NA,2.62605042016807,1.47058823529412,4.16666666666667,NA,NA,NA,NA,NA,NA,8.87243848970605,11.9470038574432,10.6187656912887,11.1821450860092,10.2589382482347,10.3767176162424,3.68233641306884,9.56246291518841,3.68233641306884,3.68233641306884,8.38654811433192,8.59898835149734,8.1741078771665,1144.52454644194,0.0021919141188385,0.940927883248016,0.917837347448114,0.969230866556771,"Q5ZIF1",1.34e-86,"Adipocyte plasma membrane-associated protein","biosynthetic process [GO:0009058]","GO:0004064; GO:0009058; GO:0009986; GO:0016020; GO:0016844"
"463","Pocillopora_acuta_HIv2___RNAseq.g14161.t1",0,0,NA,0,0,9.375,0,0,0,NA,1.171875,1.875,0,NA,NA,NA,NA,NA,NA,9.27561293388969,10.4173638270967,10.1362531787915,11.1877932741535,11.092721731243,9.49820309610088,10.2126478888416,9.07207698868077,9.24145448746359,11.9473388872404,10.2081466293502,9.76362386401371,10.6526693946866,1437.68010961893,0.586477043679693,0.748710804414225,0.23729745788748,0.474005031195209,"Q07889",0,"Son of sevenless homolog 1 (SOS-1)","axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; leukocyte migration [GO:0050900]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; myelination [GO:0042552]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ischemia [GO:0002931]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; vitellogenesis [GO:0007296]","GO:0001782; GO:0001942; GO:0002931; GO:0003209; GO:0003344; GO:0005085; GO:0005096; GO:0005154; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0007165; GO:0007173; GO:0007265; GO:0007296; GO:0007411; GO:0008286; GO:0008543; GO:0014044; GO:0017124; GO:0019221; GO:0033081; GO:0035264; GO:0038095; GO:0042110; GO:0042127; GO:0042129; GO:0042552; GO:0043025; GO:0045742; GO:0046982; GO:0048009; GO:0048011; GO:0048514; GO:0050853; GO:0050900; GO:0051057; GO:0060021; GO:0061029; GO:0061384; GO:0140693; GO:1904693; GO:1905360; GO:2000973"
"464","Pocillopora_acuta_HIv2___RNAseq.g14225.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.65339371441214,7.07920420214897,9.0628145473811,6.0027184570797,9.87621569438081,5.84950698471885,7.06029841987015,6.01099506072748,6.83269238753983,9.82623079424669,7.72540702625057,8.28722228088827,7.16359177161287,351.263257147188,-0.430212861265318,0.989003876426502,0.159778052019472,0.363540938242826,"Q06HQ7",6.58e-71,"Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3)","phospholipid metabolic process [GO:0006644]","GO:0004622; GO:0004623; GO:0004806; GO:0006644; GO:0016324; GO:0031526; GO:0050253"
"465","Pocillopora_acuta_HIv2___RNAseq.g14232.t1",NA,0,0,0,1,0.955414012738854,0,0,0,0,0.21726822363765,0.191082802547771,0.25,NA,NA,NA,NA,NA,NA,5.8152979608059,3.68233641306884,6.23938980254995,3.68233641306884,7.62893522143865,5.20504317817844,10.6939662146835,8.40820338836075,3.68233641306884,3.68233641306884,5.87201814182925,6.35483255724482,5.38920372641369,221.989933124019,-0.321074448163572,1.0539634342641,0.069534968984059,0.200727147664791,"Q9BUD6",9.54e-33,"Spondin-2 (Differentially expressed in cancerous and non-cancerous lung cells 1) (DIL-1) (Mindin)","cell adhesion [GO:0007155]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; mast cell mediated immunity [GO:0002448]; opsonization [GO:0008228]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760]","GO:0001530; GO:0002448; GO:0003823; GO:0007155; GO:0008228; GO:0031012; GO:0032755; GO:0032760; GO:0043152; GO:0045087; GO:0046872; GO:0050832; GO:0051607; GO:0060907; GO:0070062; GO:0071222"
"466","Pocillopora_acuta_HIv2___RNAseq.g14247.t1",NA,0,14.2857142857143,NA,0,0,0,0,0,NA,2.04081632653061,0,4.76190476190476,NA,NA,NA,NA,NA,NA,9.68315353364293,3.68233641306884,8.59497937886371,6.82126065609372,6.6113197353918,9.73787540319901,3.68233641306884,8.37681598814162,6.60889967998377,3.68233641306884,6.74813136145231,7.97503366320477,5.52122905969985,252.992431059164,-0.454124941193334,1.13719805521411,0.000297631227095983,0.00209792303543679,"Q5VRY0",2.99e-81,"DEAD-box ATP-dependent RNA helicase 39 (EC 3.6.4.13)","mitochondrial large ribosomal subunit assembly [GO:1902775]","GO:0003723; GO:0003724; GO:0005524; GO:0005739; GO:0016887; GO:1902775"
"467","Pocillopora_acuta_HIv2___RNAseq.g14253.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,11.1077751133991,3.68233641306884,11.5371615431696,3.68233641306884,9.75978937480268,11.6066764064713,3.68233641306884,3.68233641306884,10.8217044235796,7.32447889267665,3.68233641306884,10.9666213722845,1084.62610850225,15.9449806203823,3.72600215228243,1.43614754593446e-17,1.73103650869967e-14,"Q96RW7",2.16e-33,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711"
"468","Pocillopora_acuta_HIv2___RNAseq.g14262.t1",0,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.71747898877637,3.68233641306884,8.35688625658826,8.54637216698988,8.22244318725274,9.94077684233322,5.32551295827119,8.31743074307846,9.84393309855325,3.68233641306884,7.46355070679811,8.69163445484982,6.23546695874639,348.371393346057,-0.403177648717739,1.06490989211596,0.0180328109494185,0.0682294256590564,"O43683",5.89e-66,"Mitotic checkpoint serine/threonine-protein kinase BUB1 (hBUB1) (EC 2.7.11.1) (BUB1A)","apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic spindle assembly checkpoint signaling [GO:0007094]; positive regulation of maintenance of mitotic sister chromatid cohesion, centromeric [GO:2000720]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]","GO:0000776; GO:0000940; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0007059; GO:0007063; GO:0007094; GO:0016020; GO:0043231; GO:0051301; GO:0051754; GO:0051983; GO:0106310; GO:0140995; GO:2000720"
"469","Pocillopora_acuta_HIv2___RNAseq.g14263.t1",0,0,0,0,2.00803212851406,0.503778337531486,0,0,0,0,0.251181046604554,0.100755667506297,0.401606425702811,NA,NA,NA,NA,NA,NA,8.97735000601738,10.5565119694172,10.7584847848644,9.6235273196098,10.0492686683601,9.3672777161168,9.28779285166949,8.76196265975048,6.5309125696871,7.52477285154048,9.14378613970332,9.01559573773589,9.27197654167075,733.46537957858,0.199454938128531,0.638456195098134,0.67878738501639,0.850974565191095,"Q8R081",2.86e-129,"Heterogeneous nuclear ribonucleoprotein L (hnRNP L)","mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]","GO:0000381; GO:0000785; GO:0000976; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0035770; GO:0043484; GO:0045120; GO:0045202; GO:0045892; GO:0048471; GO:0097157; GO:1990715; GO:1990904"
"470","Pocillopora_acuta_HIv2___RNAseq.g14330.t3",0,NA,NA,0,0,11.7647058823529,0,0,0,NA,1.68067226890756,2.94117647058824,0,NA,NA,NA,NA,NA,NA,12.329054635867,3.68233641306884,12.5772255288155,3.68233641306884,11.7571823547894,3.68233641306884,3.68233641306884,11.4768983739164,12.0508997718712,3.68233641306884,7.86029427306037,12.0382521330519,3.68233641306884,2168.32101516159,-16.5174777038239,3.9256044314038,6.66109003173888e-19,1.60576677031785e-15,"B8V7S0",6.57e-97,"CUB and peptidase domain-containing protein 1","acrosome reaction [GO:0007340]; proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508; GO:0007340"
"471","Pocillopora_acuta_HIv2___TS.g12824.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.29030127202732,10.0275185395206,8.63875080150635,10.160296006229,8.75751361004584,7.36561316342335,9.27006176547777,10.1182609907078,10.2353656124814,7.33112792163665,9.01948096830561,9.20803845735374,8.83092347925747,634.020786382749,-0.181833237069104,0.767794649703277,0.656305645836971,0.836591597901291,"A0A1B0GTI8",8.47e-08,"Transmembrane protein 272","","GO:0016020"
"472","Pocillopora_acuta_HIv2___RNAseq.g14346.t2",0,9.75609756097561,NA,0,5.76923076923077,0,0,NA,2.67857142857143,NA,2.60055710839683,3.10866724738676,1.92307692307692,NA,NA,NA,NA,NA,NA,3.68233641306884,4.0964559233504,10.0294198662122,3.68233641306884,7.46633298736113,8.28415117937733,10.1209772337929,8.43130253662536,9.51846116743841,3.68233641306884,6.89941101333643,7.82557059414119,5.97325143253166,357.532472279318,-0.0358118888840801,0.972271255239958,0.743545833213029,0.88654248879674,"Q498L0",4.65e-17,"Centrosomal protein of 170 kDa protein B (Centrosomal protein 170B) (Cep170B)","","GO:0005737; GO:0005874"
"473","Pocillopora_acuta_HIv2___RNAseq.g14347.t1",NA,0,NA,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,8.03683150346764,11.9747560412869,5.46801386253237,12.9238292323692,3.68233641306884,12.3174096719603,14.2858769510049,4.5021858093707,3.68233641306884,8.57660183412294,8.54501777322526,5.07434080030168,12.0156947461488,3739.22928222091,9.62610416816493,2.39824238395586,3.7544566919172e-12,3.851380254744e-10,"A2AX52",3.5e-14,"Collagen alpha-4(VI) chain","cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]","GO:0005518; GO:0005576; GO:0005581; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023"
"474","Pocillopora_acuta_HIv2___TS.g12841.t3",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.63634872160117,8.01283033727209,3.68233641306884,7.89502910942778,9.13949221401296,7.47620947122109,9.75466481053707,9.47016328114007,8.49602432054186,9.60052087012192,7.91636195489449,7.28487299007298,8.54785091971599,377.446188576662,0.449937894080078,0.976207206142541,0.224572341493476,0.456980071378958,"Q8C033",4.55e-22,"Rho guanine nucleotide exchange factor 10","actin cytoskeleton organization [GO:0030036]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]","GO:0005085; GO:0005813; GO:0019894; GO:0022011; GO:0030036; GO:0051298; GO:0051496; GO:0090307"
"475","Pocillopora_acuta_HIv2___RNAseq.g14360.t1",0,0,0,0,0,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,7.26251363937259,11.4955789244052,8.79439451891213,11.5678066417933,7.12625273022203,11.1739423298494,10.9315545537716,8.98463105695635,3.68233641306884,12.0637586955533,9.30827695039047,7.17002567170639,11.4465282290746,1548.37344868615,2.77204457416013,1.95617523045798,0.00171554051179113,0.00932490716367789,NA,NA,NA,NA,NA
"476","Pocillopora_acuta_HIv2___TS.g12846.t1",6.15384615384615,6.25,0,0,0,1.11111111111111,0,0,12.7272727272727,NA,2.91580333247,4.01767676767677,1.53846153846154,NA,NA,NA,NA,NA,NA,6.75557122368885,10.1160359714394,3.68233641306884,11.0261596457802,5.44125113471119,10.594753640271,9.54952297022754,7.63103948792328,9.66548769017027,10.2350962200009,8.46972543972815,6.63513718991249,10.3043136895438,763.407221878272,1.50561250980919,2.03962028821958,0.00405115385680931,0.0194864946408014,"Q9JMH4",7.32e-06,"Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog]","extracellular matrix organization [GO:0030198]; hemidesmosome assembly [GO:0031581]","GO:0005581; GO:0005604; GO:0005615; GO:0016020; GO:0030020; GO:0030056; GO:0030198; GO:0031581"
"477","Pocillopora_acuta_HIv2___RNAseq.g14375.t1",10.840108401084,4.13223140495868,25.1748251748252,10.5691056910569,3.33988212180747,12.8895184135977,21.8921892189219,0,13.302752293578,NA,11.34895696887,8.17872156063826,15.3117512291596,NA,NA,NA,NA,NA,NA,8.65557334666683,13.2558622594059,3.68233641306884,12.222792804741,8.5258691405565,12.6528942068119,14.178934702952,5.38578475744502,7.72427355322418,8.78459572882484,9.5068916913697,6.79476744219227,12.2190159405471,4079.04011946024,3.74259698423301,2.83932625300744,8.6067966789733e-05,0.000728856599324765,"A6H584",7.12e-09,"Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain)","cell adhesion [GO:0007155]","GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023"
"478","Pocillopora_acuta_HIv2___RNAseq.g14376.t1",0,NA,0,0,0,0,NA,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.3452278570412,11.3119518573299,3.68233641306884,10.3115381216252,8.55449583697651,10.4727072260591,11.0198035414493,9.0222769824781,3.68233641306884,10.8579186263614,8.92605928754584,7.0573347005267,10.794783874565,1115.91531480395,0.721712881568982,1.25545691662252,0.0224653052111123,0.0816468615015135,NA,NA,NA,NA,NA
"479","Pocillopora_acuta_HIv2___RNAseq.g15181.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.4637127903118,8.59360048686995,10.6180831605119,10.2399389993143,10.078342394476,8.83169776111066,3.68233641306884,8.82530251522673,10.6858068883111,8.75744269627528,9.17762641054766,10.3342495497675,8.02100327132781,983.298192254273,-1.00874707633008,1.2199394101131,0.0504275207900692,0.156352338844065,"Q0IID7",1.03e-59,"Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48)","","GO:0005634; GO:0005737; GO:0005829; GO:0008330; GO:0017017; GO:0017018; GO:0033549; GO:0033550"
"480","Pocillopora_acuta_HIv2___RNAseq.g15187.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.07521991576182,3.68233641306884,10.5044953177362,7.08871005249906,8.32830568999878,10.6458494303827,11.229541966792,9.51285144365387,3.68233641306884,3.68233641306884,7.64319830560309,8.0206417560439,7.26575485516229,673.699746866567,-0.081011339196245,0.96688559646268,0.708394812985739,0.86692804594515,"Q8NG31",2.9e-21,"Kinetochore scaffold 1 (ALL1-fused gene from chromosome 15q14 protein) (AF15q14) (Bub-linking kinetochore protein) (Blinkin) (Cancer susceptibility candidate gene 5 protein) (Cancer/testis antigen 29) (CT29) (Kinetochore-null protein 1) (Protein CASC5) (Protein D40/AF15q14)","acrosome assembly [GO:0001675]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; homologous chromosome orientation in meiotic metaphase I [GO:0031619]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of meiosis I spindle assembly checkpoint [GO:1905326]; protein localization to kinetochore [GO:0034501]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]","GO:0000070; GO:0000776; GO:0000940; GO:0001669; GO:0001675; GO:0005634; GO:0005654; GO:0005829; GO:0008017; GO:0008608; GO:0016604; GO:0031619; GO:0034501; GO:0051301; GO:0090266; GO:0180019; GO:1905326"
"481","Pocillopora_acuta_HIv2___RNAseq.g15191.t1b",NA,NA,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.94650984920337,9.52117743052283,3.68233641306884,3.68233641306884,6.46781886708255,9.7096309157654,9.19418840935092,8.10391005152801,3.68233641306884,3.68233641306884,6.56725811757284,5.97658231879032,7.15793391635537,261.796203201869,0.708323694577284,1.09447564583762,0.181140921936459,0.395893365803709,NA,NA,NA,NA,NA
"482","Pocillopora_acuta_HIv2___RNAseq.g15193.t1",11.1111111111111,NA,NA,0,0,0,0,NA,0,NA,1.85185185185185,0,3.7037037037037,NA,NA,NA,NA,NA,NA,9.69857333489125,9.10447618528001,9.99408075617354,9.88579734114222,9.14673675868645,7.06826986579421,4.51171232812315,9.44140675513951,3.68233641306884,3.68233641306884,7.6215726151368,8.39262680359192,6.85051842668169,457.074866072021,-0.625865606895511,1.04355745325205,0.217762716288891,0.447976095633982,"O75962",2.46e-80,"Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein)","axon guidance [GO:0007411]; cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; negative regulation of fat cell differentiation [GO:0045599]; neuron projection morphogenesis [GO:0048812]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of small GTPase mediated signal transduction [GO:0051056]","GO:0004674; GO:0005085; GO:0005524; GO:0005737; GO:0005829; GO:0007185; GO:0007411; GO:0019898; GO:0042995; GO:0045599; GO:0048786; GO:0048812; GO:0051056; GO:0098794; GO:0098978; GO:0099170; GO:0106310"
"483","Pocillopora_acuta_HIv2___RNAseq.g15195.t1",100,NA,100,NA,NA,83.3333333333333,100,100,100,NA,97.2222222222222,94.4444444444444,100,NA,NA,NA,NA,NA,NA,9.87451007638384,9.27049355188922,10.3395660614826,3.68233641306884,10.1679102671288,3.68233641306884,9.64103588504612,9.70707159107185,11.4084627325663,3.68233641306884,8.14560594047752,10.2995041457267,5.99170773522837,817.638368987451,-0.46384587345172,1.10975368073939,4.60018931882064e-07,8.07489542565797e-06,NA,NA,NA,NA,NA
"484","Pocillopora_acuta_HIv2___TS.g27802.t1b",11.1111111111111,NA,NA,0,0,NA,NA,0,0,0,1.85185185185185,0,3.7037037037037,NA,NA,NA,NA,NA,NA,11.0179616039827,8.48185977946417,7.41968306595897,3.68233641306884,8.83312908347376,5.67813700336456,11.4955825567095,7.82610252698821,3.68233641306884,3.68233641306884,7.17994648591484,7.7558425386945,6.60405043313518,605.018757409905,-0.314423588764307,1.03878950948238,0.181909163897705,0.397212280588226,"Q6PB66",3.8e-53,"Leucine-rich PPR motif-containing protein, mitochondrial (130 kDa leucine-rich protein) (LRP 130) (mLRP130)","autophagy [GO:0006914]; mitochondrial RNA catabolic process [GO:0000957]; mRNA transport [GO:0051028]; negative regulation of mitochondrial RNA catabolic process [GO:0000961]; regulation of mitochondrial translation [GO:0070129]","GO:0000794; GO:0000957; GO:0000961; GO:0003697; GO:0003723; GO:0003730; GO:0005634; GO:0005637; GO:0005640; GO:0005654; GO:0005737; GO:0005739; GO:0005856; GO:0005874; GO:0006914; GO:0031625; GO:0042645; GO:0048471; GO:0048487; GO:0051028; GO:0070129; GO:1990904"
"485","Pocillopora_acuta_HIv2___TS.g27807.t1",NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.6662125030454,3.68233641306884,10.4541386866215,3.68233641306884,10.2834556415788,3.68233641306884,10.1558676751971,10.7024868426096,9.95072196450141,3.68233641306884,7.69422289658292,10.4114031276713,4.97704266549449,791.766086285611,-1.01248086185269,1.8634243776278,1.38961734597492e-11,1.15513938460812e-09,"Q86UK0",0,"Glucosylceramide transporter ABCA12 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 12) (ATP-binding cassette transporter 12) (ATP-binding cassette 12)","cellular homeostasis [GO:0019725]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; cholesterol efflux [GO:0033344]; corneocyte desquamation [GO:0003336]; establishment of skin barrier [GO:0061436]; intracellular protein transport [GO:0006886]; keratinization [GO:0031424]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lung alveolus development [GO:0048286]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of intracellular lipid transport [GO:0032379]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of keratinocyte differentiation [GO:0045616]; secretion by cell [GO:0032940]; surfactant homeostasis [GO:0043129]","GO:0000139; GO:0003336; GO:0005102; GO:0005319; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006672; GO:0006869; GO:0006886; GO:0010875; GO:0016020; GO:0016887; GO:0019725; GO:0030658; GO:0031424; GO:0032379; GO:0032940; GO:0033344; GO:0033700; GO:0034040; GO:0034191; GO:0035627; GO:0042626; GO:0043129; GO:0043231; GO:0045055; GO:0045616; GO:0048286; GO:0055088; GO:0061178; GO:0061436; GO:0072659; GO:0097209; GO:0097234; GO:0140326; GO:0140359; GO:2000010"
"486","Pocillopora_acuta_HIv2___RNAseq.g15220.t1",3.33333333333333,0,0,0,1.28205128205128,0,0,0,2.8436018957346,0.995024875621891,0.84540113867411,0.568720379146919,1.1220818982013,NA,NA,NA,NA,NA,NA,10.5888997172487,7.60119336455739,9.56317746462796,6.9069467644944,10.1391521920756,3.68233641306884,3.68233641306884,10.2809068844409,11.760545136994,9.29177146431641,8.3497265814893,10.4665362790774,6.23291688390118,887.67403368448,-1.6846991541624,2.76881401715949,0.00159773749419597,0.00876694807133934,NA,NA,NA,NA,NA
"487","Pocillopora_acuta_HIv2___RNAseq.g15230.t1",0,0,1.13636363636364,12.9032258064516,0,1.10803324099723,0,0,0,0,1.51476226838125,2.80225180948977,0.227272727272727,NA,NA,NA,NA,NA,NA,8.90472182012517,6.38096952478058,9.85500526885573,9.57261557877701,9.30533373847221,9.86462616105422,6.96178732346706,9.47510638685879,8.18158840441916,5.54842281532527,8.40501770221352,9.14435112374621,7.66568428068083,474.064937930114,-1.11022329167233,0.963899204880536,0.0406688216533363,0.132574675770533,"Q8K4L3",6.22e-177,"Supervillin (Archvillin) (p205/p250)","actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; muscle cell differentiation [GO:0042692]; positive regulation of cytokinesis [GO:0032467]","GO:0002102; GO:0005546; GO:0005654; GO:0005737; GO:0005925; GO:0008154; GO:0015629; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0042383; GO:0042692; GO:0042995; GO:0043034; GO:0051014; GO:0051015; GO:0051016; GO:0071944"
"488","Pocillopora_acuta_HIv2___RNAseq.g15231.t1",17.3076923076923,0,0,0,0,0,0,0,0,0,1.73076923076923,0,3.46153846153846,NA,NA,NA,NA,NA,NA,7.59625454638105,4.68019422250907,4.85281479041193,3.68233641306884,6.45833723334534,7.87591744416405,3.68233641306884,6.8048750249239,3.68233641306884,3.68233641306884,5.29977389140107,5.87892360162621,4.72062418117593,54.56649813611,-0.40985248844482,1.10762433571798,0.061654380178791,0.183265301049329,NA,NA,NA,NA,NA
"489","Pocillopora_acuta_HIv2___RNAseq.g15236.t1",3.98009950248756,1.11524163568773,1.35746606334842,1.36518771331058,5.35714285714286,0.265486725663717,3.75234521575985,0,0,NA,1.91032996815563,0.549183214932406,3.61176340968467,NA,NA,NA,NA,NA,NA,7.0560044049994,9.88851171132952,5.20227553025741,8.45083546887512,3.68233641306884,9.63886719450755,9.85490292833965,6.8048750249239,3.68233641306884,8.16986448347084,7.24308095728411,5.28556555726368,9.20059635730454,339.408054364753,3.80130780951967,2.33425060635168,0.000125235576585775,0.00100243905906843,"Q2TBT8",6.44e-19,"RING finger protein 151","protein ubiquitination [GO:0016567]","GO:0008270; GO:0016567; GO:0061630"
"490","Pocillopora_acuta_HIv2___RNAseq.g15240.t1",5.07246376811594,0,0,0,8.17843866171004,5.92255125284738,9.60526315789474,0,2.66666666666667,0,3.14453835072348,1.71784358390281,4.57123311754414,NA,NA,NA,NA,NA,NA,6.52177114709796,6.71495757530743,5.49419692800081,3.68233641306884,5.81325426851759,7.34242603626167,9.11976657352626,6.23258115521575,6.97986927123753,8.2422364900311,6.61433958582649,6.20833455401393,7.02034461763906,130.52950198638,0.311075073757236,0.902751210438315,0.449393923931117,0.691051851556418,NA,NA,NA,NA,NA
"491","Pocillopora_acuta_HIv2___TS.g27837.t2",7.6499388004896,3.3886085075703,6.46041856232939,4.40867739678097,4.9338146811071,4.24746075715605,5.0125313283208,2.42656449553001,3.57894736842105,1.70940170940171,4.3816363607107,3.61005170509168,5.15322101632972,NA,NA,NA,NA,NA,NA,12.0740208895089,11.2979832378096,11.8053034962762,10.9053781203294,11.3785085259913,12.249092020977,9.95021540894791,12.4460765938625,11.1997727713897,12.0436867129568,11.5350037778049,11.7807364554057,11.2892711002041,3274.40622615358,-0.278475790067164,0.674072059826192,0.549975078275064,0.766731521173062,"Q8K4L3",0,"Supervillin (Archvillin) (p205/p250)","actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; muscle cell differentiation [GO:0042692]; positive regulation of cytokinesis [GO:0032467]","GO:0002102; GO:0005546; GO:0005654; GO:0005737; GO:0005925; GO:0008154; GO:0015629; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0042383; GO:0042692; GO:0042995; GO:0043034; GO:0051014; GO:0051015; GO:0051016; GO:0071944"
"492","Pocillopora_acuta_HIv2___RNAseq.g15256.t1",0,0,NA,NA,0,4.76190476190476,0,0,0,NA,0.680272108843537,1.19047619047619,0,NA,NA,NA,NA,NA,NA,5.17503271827961,4.75675715543394,5.29770193163976,5.05535826649939,5.16318610945075,6.88702586188914,4.10128477526701,5.26380834900594,4.79801079550852,3.68233641306884,5.01805023760429,5.13954798077692,4.89655249443166,18.7874116929631,-0.377543523963487,0.948855384601213,0.305706561736795,0.554116480846262,NA,NA,NA,NA,NA
"493","Pocillopora_acuta_HIv2___RNAseq.g15266.t1",0,NA,2.85714285714286,0,NA,1.02040816326531,0,0,0,NA,0.553935860058309,0.255102040816327,0.952380952380952,NA,NA,NA,NA,NA,NA,9.47146564108512,9.57657829148525,5.92829418692211,3.68233641306884,9.46683765125607,8.56897397659836,9.55789677526016,5.47509710266606,8.25499591993224,11.2810652973715,8.12635412556457,7.71933810037232,8.53337015075682,599.12110456108,0.138453513470303,0.915801636096274,0.682369373378593,0.852971422768017,"O95236",4.32e-11,"Apolipoprotein L3 (Apolipoprotein L-III) (ApoL-III) (TNF-inducible protein CG12-1) (CG12_1)","inflammatory response [GO:0006954]; lipoprotein metabolic process [GO:0042157]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]","GO:0005319; GO:0005576; GO:0005737; GO:0006954; GO:0008289; GO:0016020; GO:0042157; GO:0043123"
"494","Pocillopora_acuta_HIv2___RNAseq.g15279.t1",0,0,0,21.6216216216216,0,0,0,NA,0,0,2.4024024024024,5.40540540540541,0,NA,NA,NA,NA,NA,NA,3.68233641306884,11.6964485579303,8.818378610946,11.5154282424326,5.84362177230977,11.4623777725802,12.7934043095426,7.33026734222755,3.68233641306884,11.0411893009257,8.78657887350324,5.8713881103242,11.7017696366823,1874.32537199299,5.71543099625217,2.58606287650892,1.66946264018255e-06,2.44899671679518e-05,"O95236",1.64e-12,"Apolipoprotein L3 (Apolipoprotein L-III) (ApoL-III) (TNF-inducible protein CG12-1) (CG12_1)","inflammatory response [GO:0006954]; lipoprotein metabolic process [GO:0042157]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]","GO:0005319; GO:0005576; GO:0005737; GO:0006954; GO:0008289; GO:0016020; GO:0042157; GO:0043123"
"495","Pocillopora_acuta_HIv2___RNAseq.g15287.t1",0,NA,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.3240843789281,10.6702684999175,10.857802496282,11.0480617653817,11.1260762339145,11.7358144219856,12.145783131723,11.1541994537849,12.5023861861422,11.2007612678013,11.3765237835861,11.3929097498103,11.3601378173618,2852.26160627535,-0.0125144629828227,0.584663522747102,0.970279553744024,0.990201331076946,"Q9Y4K4",0,"Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5)","intracellular signal transduction [GO:0035556]","GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0008349; GO:0035556; GO:0106310"
"496","Pocillopora_acuta_HIv2___RNAseq.g15289.t1",100,NA,100,100,NA,42.1052631578947,100,NA,0,NA,73.6842105263158,47.3684210526316,100,NA,NA,NA,NA,NA,NA,12.0338684014723,13.0092616942713,12.6149997707275,12.9818723492892,11.9855407013133,12.0648455592852,13.4290514704616,12.4923564622815,11.7496007973034,10.5310342501758,12.2892431456581,12.1752732266196,12.4032130646966,5659.84096757322,0.177005478532257,0.579382410142984,0.716066231128388,0.871743284827961,"O17389",5.15e-12,"Thymosin beta (Tetrathymosin beta)","actin filament organization [GO:0007015]","GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0070161"
"497","Pocillopora_acuta_HIv2___RNAseq.g15290.t1",0,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.80261710823671,11.6335175483349,9.35604858635213,12.1922104414234,7.78985378200311,12.3335692724509,12.7629529136474,8.86728718993316,3.68233641306884,13.0713265957794,9.84917198512299,7.29962861591879,12.3987153543272,2980.34601632217,3.85008031211467,1.7922489894581,0.000224802196768984,0.00165472721326544,"P00734",3.01e-53,"Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain]","acute-phase response [GO:0006953]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blood coagulation [GO:0007596]; cell surface receptor signaling pathway [GO:0007166]; cytolysis by host of symbiont cells [GO:0051838]; fibrinolysis [GO:0042730]; G protein-coupled receptor signaling pathway [GO:0007186]; ligand-gated ion channel signaling pathway [GO:1990806]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of platelet activation [GO:0010544]; negative regulation of proteolysis [GO:0045861]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid kinase activity [GO:0090218]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; proteolysis [GO:0006508]; regulation of blood coagulation [GO:0030193]; regulation of cell shape [GO:0008360]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to wounding [GO:0009611]","GO:0001530; GO:0001934; GO:0004252; GO:0005102; GO:0005509; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006508; GO:0006953; GO:0007166; GO:0007186; GO:0007596; GO:0008083; GO:0008201; GO:0008284; GO:0008360; GO:0009611; GO:0010544; GO:0030168; GO:0030193; GO:0030194; GO:0030307; GO:0032024; GO:0032967; GO:0042730; GO:0045861; GO:0046427; GO:0048712; GO:0051281; GO:0051480; GO:0051838; GO:0051897; GO:0051918; GO:0061844; GO:0062023; GO:0070053; GO:0070062; GO:0070945; GO:0072562; GO:0090218; GO:1900016; GO:1900182; GO:1900738; GO:1990806; GO:2000379"
"498","Pocillopora_acuta_HIv2___TS.g27885.t3",0,0,0,NA,0,7.69230769230769,0,NA,0,0,0.961538461538462,2.56410256410256,0,NA,NA,NA,NA,NA,NA,3.68233641306884,6.71495757530743,3.68233641306884,5.44417644206312,8.40771982830346,5.08222717563762,5.02746360037266,9.49714300378788,3.68233641306884,9.22200612986786,6.04427029945465,5.79037441425957,6.29816618464974,171.103705219011,0.121839177781063,1.02228354330158,0.00439134699048069,0.0208250632361681,"Q05941",1.57e-76,"Neuronal acetylcholine receptor subunit alpha-7","acetylcholine receptor signaling pathway [GO:0095500]; associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to ethanol [GO:0048149]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; cognition [GO:0050890]; dendrite arborization [GO:0140059]; dendritic spine organization [GO:0097061]; dopamine biosynthetic process [GO:0042416]; endocytosis [GO:0006897]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; generation of ovulation cycle rhythm [GO:0060112]; intracellular calcium ion homeostasis [GO:0006874]; learning or memory [GO:0007611]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; modulation of excitatory postsynaptic potential [GO:0098815]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of tumor necrosis factor production [GO:0032720]; neuronal action potential [GO:0019228]; ovulation cycle [GO:0042698]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure [GO:0001988]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of inflammatory response [GO:0050727]; regulation of membrane potential [GO:0042391]; regulation of norepinephrine secretion [GO:0014061]; regulation of response to drug [GO:2001023]; regulation of synapse structural plasticity [GO:0051823]; regulation of synaptic transmission, dopaminergic [GO:0032225]; response to acetylcholine [GO:1905144]; response to amyloid-beta [GO:1904645]; response to carbamate [GO:0046681]; response to cold [GO:0009409]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory processing [GO:0050893]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; synaptic transmission, cholinergic [GO:0007271]; T cell activation [GO:0042110]","GO:0001540; GO:0001666; GO:0001933; GO:0001934; GO:0001988; GO:0005216; GO:0005886; GO:0005892; GO:0006811; GO:0006816; GO:0006874; GO:0006897; GO:0007165; GO:0007271; GO:0007611; GO:0007613; GO:0008179; GO:0008284; GO:0008306; GO:0009409; GO:0009897; GO:0010628; GO:0014061; GO:0015464; GO:0015643; GO:0016020; GO:0016324; GO:0017081; GO:0019228; GO:0019901; GO:0022848; GO:0030317; GO:0030424; GO:0030425; GO:0030426; GO:0030673; GO:0032094; GO:0032225; GO:0032279; GO:0032691; GO:0032715; GO:0032720; GO:0033138; GO:0034220; GO:0035094; GO:0035095; GO:0042110; GO:0042113; GO:0042166; GO:0042391; GO:0042416; GO:0042698; GO:0042734; GO:0042803; GO:0043005; GO:0043025; GO:0043197; GO:0043198; GO:0043410; GO:0044853; GO:0045202; GO:0045211; GO:0045471; GO:0045766; GO:0046681; GO:0048149; GO:0050727; GO:0050728; GO:0050804; GO:0050808; GO:0050890; GO:0050893; GO:0051117; GO:0051247; GO:0051649; GO:0051823; GO:0060112; GO:0070373; GO:0070374; GO:0095500; GO:0097061; GO:0097110; GO:0098690; GO:0098815; GO:0098897; GO:0098981; GO:0099171; GO:0099634; GO:0140059; GO:1900273; GO:1902004; GO:1902430; GO:1902991; GO:1904315; GO:1904645; GO:1905144; GO:1905906; GO:2000463; GO:2001023"
"499","Pocillopora_acuta_HIv2___RNAseq.g15293.t1",NA,0,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,5.55119387333227,10.5045696779552,3.68233641306884,11.2115543799172,7.66178680263729,12.5068069659376,10.7733986483215,9.53668895846901,6.76651737006592,12.5807792214168,9.07756323111216,6.63970468351467,11.5154217787097,1839.70464286307,4.55560970233435,1.97527404388184,1.71919000213356e-05,0.000182840913168087,NA,NA,NA,NA,NA
"500","Pocillopora_acuta_HIv2___TS.g27890.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.8664965805024,10.14889338463,10.4571949052158,8.64831517435104,8.94542213631147,10.207403830872,3.68233641306884,8.56956817466497,7.36504895374022,3.68233641306884,8.25730159664256,9.24074615008697,7.27385704319814,682.67253692864,-0.49210962358601,1.06738752644018,0.0646700445398693,0.189695299984723,"P55786",0,"Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)","cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]","GO:0000209; GO:0004177; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0016020; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955"
"501","Pocillopora_acuta_HIv2___TS.g27891.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,8.43347218433143,3.68233641306884,8.15784478818576,7.07768908530409,3.68233641306884,9.257103564871,9.69563501714361,4.69373610443143,6.20448263965427,7.84527839352013,4.56368688578841,208.84514954706,-0.628336908286695,1.28049128012545,0.00089612690981636,0.00534939315872218,"P55786",0,"Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)","cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]","GO:0000209; GO:0004177; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0016020; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955"
"502","Pocillopora_acuta_HIv2___TS.g27914.t3",5,6.66666666666667,7.65432098765432,5.74712643678161,6.72451193058568,5.22875816993464,3.55648535564854,14.7222222222222,6.61040787623066,12.3919308357349,7.43024304814592,7.79503627436716,7.06544982192468,NA,NA,NA,NA,NA,NA,8.15801681521248,9.73646584632699,9.26651925387568,9.9319683320312,8.56319071864553,4.72257309926916,8.05525808108825,10.2660136194659,10.0638058232344,10.156269086582,8.89200806757316,9.2635092460868,8.52050688905952,659.70060283766,-0.270066829346666,0.840386746216664,0.493987839938099,0.725237527087359,"O46470",4.14e-178,"Regulator of G-protein signaling 7 (RGS7)","G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]","GO:0001965; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0008277; GO:0035556; GO:0043005; GO:0045744"
"503","Pocillopora_acuta_HIv2___RNAseq.g15354.t1",0,0,NA,15.3846153846154,0,0,10,NA,0,NA,3.62637362637363,3.84615384615385,3.33333333333333,NA,NA,NA,NA,NA,NA,9.34193381939614,3.68233641306884,8.88802398442584,11.4304350200666,7.75984255308614,3.68233641306884,6.7263683879903,10.3109310529274,3.68233641306884,3.68233641306884,6.91868804701678,7.99661356458087,5.84076252945268,532.462972378524,-0.301549634925806,1.06353228513727,0.0511556944267037,0.157865578021729,"Q8NHU2",0,"Cilia- and flagella-associated protein 61","cilium movement [GO:0003341]; cilium organization [GO:0044782]; sperm flagellum assembly [GO:0120316]","GO:0003341; GO:0005930; GO:0031514; GO:0044782; GO:0120316"
"504","Pocillopora_acuta_HIv2___RNAseq.g15356.t1",0,0,NA,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,6.50755595230566,9.88363927434569,10.6511530986102,10.0089742248952,10.4104206315422,5.77882859435006,3.68233641306884,10.4110290254906,7.71039516097916,3.68233641306884,7.87266687886564,9.13811077378556,6.60722298394573,646.187257624179,-0.429915599674466,1.10153274005944,0.00402193685332967,0.0193523934286628,"C0HL13",0,"Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)","coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]","GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005886; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167"
"505","Pocillopora_acuta_HIv2___TS.g27953.t1",0,0,0,0,6.97674418604651,9.93788819875776,4.28571428571429,NA,0,NA,2.65004333381482,2.48447204968944,2.8156146179402,NA,NA,NA,NA,NA,NA,7.31983953124869,5.1703194305374,7.94616100538062,3.68233641306884,6.55922841464905,6.2434550875973,8.76198281060728,7.84537306431718,5.8076943734674,5.96509637913949,6.53014865100133,7.09565927781259,5.96463802419006,118.085756874621,-0.366634811657807,0.934628568240758,0.299210630502804,0.547335596255541,NA,NA,NA,NA,NA
"506","Pocillopora_acuta_HIv2___RNAseq.g15369.t2",NA,NA,0,NA,NA,1.8348623853211,4.22535211267606,0,0,0,1.01003574966619,0.611620795107034,1.40845070422535,NA,NA,NA,NA,NA,NA,8.1263825815683,4.8931170245923,7.94616100538062,11.3216140229217,8.4101322337256,8.71382842796993,5.56266578261131,9.41206495467091,4.86223652345053,3.68233641306884,7.293053896996,7.75139545975919,6.83471233423282,441.894155605233,-0.55496003384132,1.09439956093709,0.0511420130896975,0.157857037415575,"P97259",8.73e-175,"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]","positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0000139; GO:0004864; GO:0005576; GO:0018279; GO:0030144; GO:0030145; GO:0030335; GO:1904894"
"507","Pocillopora_acuta_HIv2___RNAseq.g15370.t1",0,0,NA,NA,0,17.3913043478261,0,0,NA,NA,2.89855072463768,5.79710144927536,0,NA,NA,NA,NA,NA,NA,8.24894423055902,7.72302631647394,9.17663430799615,3.68233641306884,9.02306655574417,3.68233641306884,3.68233641306884,8.01488187929588,9.27002716506419,3.68233641306884,6.61859261074087,8.74671082773188,4.49047439374986,233.924568565192,-1.30608032061532,2.93813892654512,1.57167048777198e-07,3.19727734671362e-06,"P97259",5.31e-175,"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]","positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0000139; GO:0004864; GO:0005576; GO:0018279; GO:0030144; GO:0030145; GO:0030335; GO:1904894"
"508","Pocillopora_acuta_HIv2___RNAseq.g15398.t1a",0,0,0,0,1.13636363636364,0,0,0,0,NA,0.126262626262626,0,0.284090909090909,NA,NA,NA,NA,NA,NA,12.3161200410387,13.2800074970946,11.9525198286385,13.1099153884464,12.4673506077544,13.0173742805555,11.4569382774709,12.2538830948116,11.8353135806579,11.5933299506654,12.3282752547134,12.1650374305802,12.4915130788466,5598.71790017977,0.228141545345558,0.573268355675396,0.612292043164579,0.80871081292416,"Q7SIA2",0,"Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Glutamyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)]","cellular response to insulin stimulus [GO:0032869]; cellular response to type II interferon [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; regulation of long-chain fatty acid import into cell [GO:0140212]","GO:0004818; GO:0004827; GO:0005524; GO:0005829; GO:0005886; GO:0006424; GO:0006433; GO:0008270; GO:0017101; GO:0017148; GO:0032869; GO:0035613; GO:0042803; GO:0051020; GO:0071346; GO:0097452; GO:0140212; GO:1990904"
"509","Pocillopora_acuta_HIv2___RNAseq.g15411.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.891555324353,11.4708893363693,12.1601641528606,12.0602623070409,11.6854093954318,11.8181666875296,6.61664389412953,12.1228539821964,12.4583399689716,3.68233641306884,10.5966621461952,12.0636645647627,9.12965972762763,3234.68522071402,-0.441092522303186,1.00840094467655,0.152778883686429,0.353016246037443,NA,NA,NA,NA,NA
"510","Pocillopora_acuta_HIv2___RNAseq.g15415.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.60860163372973,5.74095382813731,9.63916598990574,5.56232777220043,10.2175850149719,7.87591744416405,6.28680786951883,10.4870004861829,9.67085381264757,9.76759841671554,8.0856812268174,9.12464138748757,7.04672106614723,532.937631469826,-1.18591246928169,1.21658865592699,0.0219485265157168,0.0800260870994019,"Q9Y253",2.95e-150,"DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein)","cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; pyrimidine dimer repair [GO:0006290]; regulation of DNA repair [GO:0006282]; response to radiation [GO:0009314]; response to UV-C [GO:0010225]","GO:0000731; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005657; GO:0005829; GO:0006260; GO:0006281; GO:0006282; GO:0006290; GO:0009314; GO:0010225; GO:0035861; GO:0042276; GO:0046872; GO:0070987; GO:0071494"
"511","Pocillopora_acuta_HIv2___TS.g28031.t1",0,0,0,NA,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.57535569075717,6.15566643149668,10.4480067543397,7.80204913956429,8.12589230930502,7.72318369733628,9.74369646773466,10.8862223827632,8.82628061242514,10.8203940930755,9.01067475787976,9.57235154991805,8.44899796584148,770.584334947599,-0.624040687990158,0.892977557761451,0.174810551188832,0.386142304886264,"A0A452G813",1.02e-156,"CSC1-like protein 1 (Transmembrane protein 63A)","regulation of cytokine production [GO:0001817]; regulation of mononuclear cell proliferation [GO:0032944]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of phagocytosis [GO:0050764]; surfactant secretion [GO:0160069]","GO:0001817; GO:0003676; GO:0005227; GO:0005765; GO:0005886; GO:0031901; GO:0032944; GO:0045428; GO:0050764; GO:0160069; GO:1990760"
"512","Pocillopora_acuta_HIv2___TS.g28034.t1b",0,NA,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.8200293857855,10.579791488724,10.6424530637285,6.54549673248371,10.775747464678,10.0252197465304,12.765891650722,10.6887260043387,11.1602670715797,8.88334678396301,10.2886969392534,10.8174445980221,9.75994928048462,1894.78258470457,-0.466625639491857,0.852209442780666,0.265895401353429,0.509527170797032,"O75165",0,"DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8)","endosome organization [GO:0007032]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954]","GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0070062; GO:1902954; GO:2000641"
"513","Pocillopora_acuta_HIv2___RNAseq.g15447.t3",NA,NA,0,0,0,0,0,NA,7.14285714285714,NA,1.19047619047619,2.38095238095238,0,NA,NA,NA,NA,NA,NA,11.9233955846825,10.761613256759,11.9920378384489,11.4587421924606,11.4384471529971,11.2104639310663,10.0351266550074,11.8144443400031,10.5651863909684,11.8530915844204,11.3052548926814,11.54670226142,11.0638075239427,2726.27520231893,-0.325816434750002,0.636995495368941,0.486848049256996,0.720533120275575,"Q9BUJ2",5.92e-133,"Heterogeneous nuclear ribonucleoprotein U-like protein 1 (Adenovirus early region 1B-associated protein 5) (E1B-55 kDa-associated protein 5) (E1B-AP5)","response to virus [GO:0009615]; RNA processing [GO:0006396]","GO:0003723; GO:0005634; GO:0005654; GO:0006396; GO:0009615; GO:0019899; GO:0045202; GO:1990904"
"514","Pocillopora_acuta_HIv2___RNAseq.g15452.t1",0,0,0,NA,0,0,NA,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.63967192774965,8.36070587859545,9.75795302770781,3.68233641306884,8.32830568999878,10.2779367267377,10.5773301510084,8.71465256445696,9.07869273752916,11.0778407893248,8.84954259061776,8.90385518948847,8.79522999174704,757.817578336856,0.175581001169678,0.910259085874688,0.658989423943082,0.839262883443475,"Q6U6G5",7.36e-123,"Zinc finger CCCH domain-containing protein 15 (p48ZnF)","cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic translation [GO:0002181]","GO:0002181; GO:0005634; GO:0005829; GO:0019221; GO:0046872"
"515","Pocillopora_acuta_HIv2___RNAseq.g15474.t1",58.3333333333333,33.3333333333333,75,25,78.2608695652174,38.3333333333333,75,NA,NA,NA,54.7515527950311,32.2222222222222,71.6485507246377,1,36.5025079799362,36.5025079799362,0.022251954867208,0.022251954867208,0.022251954867208,6.05466314442104,3.68233641306884,4.80540103069894,3.68233641306884,7.30902487906021,5.70406148794036,3.68233641306884,5.63630898316489,7.69638093712164,4.40467075915833,5.26575204607719,6.30035579489334,4.23114829726104,42.8208233604579,-4.59034339230563,2.19592182033759,0.000189961909229498,0.00142510843106611,NA,NA,NA,NA,NA
"516","Pocillopora_acuta_HIv2___RNAseq.g15485.t1",8.69565217391304,0,NA,0,83.3333333333333,0,7.14285714285714,NA,0,NA,14.1674060928719,0,33.0572808833678,NA,NA,NA,NA,NA,NA,5.55119387333227,6.03941460781193,3.68233641306884,3.68233641306884,5.71763198038475,5.03801277448085,6.97448315103256,5.72748248273486,3.68233641306884,9.58825213595967,5.56834802449434,4.87219623251791,6.26449981647077,98.5706718521109,0.265978424206797,0.976227297484089,0.430190813740718,0.674063474157268,NA,NA,NA,NA,NA
"517","Pocillopora_acuta_HIv2___RNAseq.g15493.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.39030830812648,8.32275715627176,4.89801104097743,6.50915460878185,3.68233641306884,7.12386846770193,7.58210311844481,6.73139027483494,3.68233641306884,7.08949304564378,6.30117588469207,5.27687649001531,7.32547527936883,99.062493072462,0.951540858698655,1.41595704110947,0.0121938598414448,0.0490876673383404,NA,NA,NA,NA,NA
"518","Pocillopora_acuta_HIv2___RNAseq.6617_t",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.52146481986391,9.41034177695492,3.68233641306884,9.2085650750469,8.26572797413929,9.69757097951174,10.505568252482,5.89248396905691,3.68233641306884,3.68233641306884,6.95487320862622,5.40886991783956,8.50087649941288,379.729722087825,1.66274273727593,3.19351782865406,0.00514457278950082,0.0238191744005569,NA,NA,NA,NA,NA
"519","Pocillopora_acuta_HIv2___TS.g28105.t1",0,71.4285714285714,100,16.6666666666667,0,33.3333333333333,NA,0,0,NA,27.6785714285714,24.2857142857143,33.3333333333333,NA,NA,NA,NA,NA,NA,7.67349335418918,10.0866585901723,8.05935642606527,3.68233641306884,6.87464331873483,6.00096166566855,3.68233641306884,7.68770451693644,3.68233641306884,3.68233641306884,6.11121635240419,6.79550680579891,5.42692589900947,179.815843363876,-0.224428774152756,1.0197241143846,0.311474239822769,0.560622623792501,"Q9UHL4",4.22e-39,"Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase)","lysosomal protein catabolic process [GO:1905146]; proteolysis [GO:0006508]","GO:0004177; GO:0005576; GO:0005794; GO:0006508; GO:0008236; GO:0008239; GO:0031982; GO:0035578; GO:0043231; GO:0070008; GO:0070062; GO:1905146"
"520","Pocillopora_acuta_HIv2___TS.g28111.t1",0,NA,0,0,3.33333333333333,0,0,NA,0,NA,0.476190476190476,0,0.833333333333333,NA,NA,NA,NA,NA,NA,10.7792839491339,3.68233641306884,8.36342648242998,3.68233641306884,9.35245829625253,5.80281783295425,7.35949268040431,8.69570839559952,8.76735014635008,3.68233641306884,7.01675470223311,9.1916454539532,4.84186395051302,363.677410884631,-3.86336023344185,5.28405561606445,1.11484755812862e-06,1.7264620000827e-05,"Q7TPD1",0,"F-box only protein 11","negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004842; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0042981; GO:0043161; GO:0045732; GO:1904878; GO:1990756"
"521","Pocillopora_acuta_HIv2___RNAseq.g15532.t1",NA,0,0,0,3.2258064516129,2.1978021978022,0,0,0,0,0.602623183268345,0.43956043956044,0.806451612903226,NA,NA,NA,NA,NA,NA,8.95182961008951,7.50248485470253,9.1218115418135,3.68233641306884,9.26329684055916,6.3101085141422,7.30046701549876,9.04406860791353,7.90565311294572,7.78429754414113,7.68663540548749,8.85733194266428,6.51593886831069,284.883927090036,-0.994584464451845,1.25844191807644,0.0452847779709095,0.14420938541859,"Q7TPD1",0,"F-box only protein 11","negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004842; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0042981; GO:0043161; GO:0045732; GO:1904878; GO:1990756"
"522","Pocillopora_acuta_HIv2___RNAseq.g15534.t1",0,2.27272727272727,0,0,16.8316831683168,10.5882352941176,8.57142857142857,0,0,NA,4.25156381184337,2.57219251336898,6.35077793493635,NA,NA,NA,NA,NA,NA,11.204456402568,11.0768082414398,11.0436162266729,10.3473099496798,10.8979302450151,11.0777947867179,10.5238461884376,10.0879329004692,10.8626568297032,10.1992489707214,10.7321600741425,10.8193185208857,10.6450016273993,1734.55325195812,-0.132675842111124,0.517320421237469,0.76464285792789,0.897564867478413,"Q6PB44",3.39e-166,"Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48)","cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]","GO:0004725; GO:0005634; GO:0005737; GO:0005768; GO:0005769; GO:0010633; GO:0016604; GO:0019901; GO:0032456; GO:0036064; GO:0043162; GO:0043328; GO:0045022; GO:0060271; GO:0061357; GO:1903387; GO:1903393; GO:2000643"
"523","Pocillopora_acuta_HIv2___RNAseq.g15537.t1",0,NA,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.94988897797731,6.50720798490726,5.94660437537211,3.68233641306884,4.99332554465423,8.88054669016886,3.68233641306884,8.32567457524134,9.08406734514233,3.68233641306884,6.473432473267,7.65991216367746,5.28695278285653,233.966203595379,-0.531505409824735,1.22067869871967,0.000342223176761523,0.00236951461401564,NA,NA,NA,NA,NA
"524","Pocillopora_acuta_HIv2___RNAseq.g15540.t1",0,0,0,3.44827586206897,0,0,0.746268656716418,NA,0,NA,0.524318064848173,0.862068965517241,0.186567164179104,NA,NA,NA,NA,NA,NA,10.1515699447021,8.82146275665632,9.11214491294523,12.0548639574258,9.93428534594616,9.33649482458345,11.6985099460909,9.64153408656845,11.7630590065302,3.68233641306884,9.61962611945174,10.1205186593384,9.11873357956506,1539.12749633378,-0.0307745935684818,0.914759686569261,0.862355668082228,0.946151284467978,"P30173",1.89e-96,"Actin-101 (EC 3.6.4.-)","","GO:0005524; GO:0005737; GO:0005856; GO:0016787"
"525","Pocillopora_acuta_HIv2___TS.g28123.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.9273033334323,11.3518887513916,10.5953765352336,9.81820503258106,10.3520985468545,10.1902943022416,12.0116591653174,9.58664285699348,3.68233641306884,3.68233641306884,9.21981413501832,9.02875153711654,9.4108767329201,1418.00839161953,0.224785849362021,0.755189818960527,0.63745611234547,0.825330128707018,"Q497V6",1.44e-48,"Bromo adjacent homology domain-containing 1 protein (BAH domain-containing protein 1)","heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892]","GO:0000976; GO:0003682; GO:0005677; GO:0005694; GO:0031507; GO:0045892"
"526","Pocillopora_acuta_HIv2___RNAseq.g15543.t1",NA,0,0,0,0,0,1.88679245283019,NA,NA,NA,0.314465408805031,0,0.628930817610063,NA,NA,NA,NA,NA,NA,6.84813858621154,7.95191806449918,8.06338218429842,5.16572759476787,7.04098991334845,9.04193347949468,9.98633377815029,9.09794963906472,6.26649149846874,3.68233641306884,7.31452011513727,7.46339036427837,7.16564986599617,274.469074261095,-0.103680664261378,0.899185857187465,0.672921842436963,0.847897979608382,"Q8N6G5",2.56e-121,"Chondroitin sulfate N-acetylgalactosaminyltransferase 2 (EC 2.4.1.174) (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 2) (Beta4GalNAcT-2) (GalNAcT-2)","chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050652]; proteoglycan biosynthetic process [GO:0030166]","GO:0000139; GO:0008376; GO:0016020; GO:0030166; GO:0030206; GO:0032580; GO:0046872; GO:0047237; GO:0047238; GO:0050650; GO:0050651; GO:0050652; GO:0050653"
"527","Pocillopora_acuta_HIv2___TS.g28126.t1",NA,0,0,NA,0,0,0,NA,2.63157894736842,NA,0.43859649122807,0.87719298245614,0,NA,NA,NA,NA,NA,NA,7.57627509210327,10.9948464778304,3.68233641306884,10.9942825582306,3.68233641306884,7.89192537626846,11.9529634766188,3.68233641306884,3.68233641306884,12.7330300814074,7.68726687147343,4.46112414887573,10.9134095940711,1512.9378096092,12.929109809701,3.46196080968917,1.85049746227984e-11,1.48075276254721e-09,NA,NA,NA,NA,NA
"528","Pocillopora_acuta_HIv2___RNAseq.g15566.t1",0,0,NA,0,0,0,0,31.25,NA,NA,4.46428571428571,7.8125,0,NA,NA,NA,NA,NA,NA,6.73144313448199,8.88138435854897,10.4449309852361,3.68233641306884,9.35245829625253,9.86597375590646,3.68233641306884,9.84423275958734,9.10007193547525,3.68233641306884,7.52675044646952,9.09462742220664,5.95887347073239,484.978056746126,-0.285423306679457,1.04160032585282,1.21211482051248e-05,0.0001347580996456,"A0JJX5",1.11e-16,"Synaptotagmin-4 (NTMC2T2.2) (Synaptotagmin D)","lipid transport [GO:0006869]","GO:0006869; GO:0008289; GO:0012505; GO:0016020; GO:0046872"
"529","Pocillopora_acuta_HIv2___RNAseq.g15572.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0494497618359,7.93941910765684,7.46922666954589,3.68233641306884,8.39802954700685,9.96738636171993,6.75620037889345,6.47440906252077,3.68233641306884,3.68233641306884,6.81011301283861,7.21469029079565,6.40553573488158,284.389742282879,-0.197893117346271,0.950709705949677,0.594279242088068,0.7976502494113,"P24043",1.86e-08,"Laminin subunit alpha-2 (Laminin M chain) (Laminin-12 subunit alpha) (Laminin-2 subunit alpha) (Laminin-4 subunit alpha) (Merosin heavy chain)","axon guidance [GO:0007411]; cell adhesion [GO:0007155]; maintenance of blood-brain barrier [GO:0035633]; muscle organ development [GO:0007517]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037]","GO:0005102; GO:0005198; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007517; GO:0014037; GO:0030334; GO:0031594; GO:0032224; GO:0035633; GO:0042383; GO:0043083; GO:0043197; GO:0045785; GO:0045995; GO:0051149; GO:0062023; GO:0098637; GO:0110011; GO:2001046"
"530","Pocillopora_acuta_HIv2___TS.g28160.t1",0,NA,NA,NA,0,0,0,7.69230769230769,0,NA,1.28205128205128,2.56410256410256,0,NA,NA,NA,NA,NA,NA,10.2790825912764,9.22240750215676,10.2708805838484,3.68233641306884,9.26196322835042,9.67622030634226,9.16158551815153,10.4857767360106,10.011194831212,7.33112792163665,8.93825756320539,10.0617795941396,7.81473553227121,747.862301781432,-0.633457158281668,1.05070711870167,0.132071756497487,0.320088117623937,NA,NA,NA,NA,NA
"531","Pocillopora_acuta_HIv2___TS.g28195.t1",0,0,0,0,0.72992700729927,0.344827586206897,0,0,0,0,0.107475459350617,0.0689655172413793,0.145985401459854,NA,NA,NA,NA,NA,NA,8.00237851673687,10.3483153191188,8.78954939914064,11.1368754981025,8.70152623039769,8.4115941178289,3.68233641306884,8.3311443253598,9.52834923764886,4.56256470276067,8.14946337601636,8.67058954185677,7.62833721017594,587.405624246781,-0.13208308400158,0.954446910090727,0.487084294500446,0.720651975040335,"Q1ZXD6",8.07e-13,"Probable serine/threonine-protein kinase roco5 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 5)","signal transduction [GO:0007165]; sorocarp development [GO:0030587]","GO:0004672; GO:0004674; GO:0005085; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0007165; GO:0030587; GO:0106310"
"532","Pocillopora_acuta_HIv2___TS.g28196.t1",0,0,0,0,2.7027027027027,4.3010752688172,0,0,0,0,0.700377797151991,0.860215053763441,0.540540540540541,NA,NA,NA,NA,NA,NA,8.27801859226,3.68233641306884,5.02254961121426,3.68233641306884,5.48185943121106,3.68233641306884,3.68233641306884,6.4540987163944,5.93804482828044,3.68233641306884,4.95862532447044,6.23491423587203,3.68233641306884,42.2064226824668,-8.90105831999768,4.02629172085902,8.14022034678344e-05,0.000695863753521723,"Q1ZXD6",1.41e-17,"Probable serine/threonine-protein kinase roco5 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 5)","signal transduction [GO:0007165]; sorocarp development [GO:0030587]","GO:0004672; GO:0004674; GO:0005085; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0007165; GO:0030587; GO:0106310"
"533","Pocillopora_acuta_HIv2___RNAseq.g15612.t1",0,0,6.59340659340659,0,0,0,0,0,0,0,0.659340659340659,0,1.31868131868132,NA,NA,NA,NA,NA,NA,8.92322498633793,10.8894335707445,9.80549773037901,11.0627367685167,9.08321023189442,10.288024328398,6.58364178294652,8.12611802033816,7.63156149414641,7.17468652710151,8.95681354408032,8.71392249261919,9.19970459554145,767.563614028955,0.282978640552796,0.703937429359317,0.550993341209127,0.767263664893502,"Q55E58",8.89e-19,"Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)","cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856]","GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310"
"534","Pocillopora_acuta_HIv2___TS.g28199.t1",5.28700906344411,1.17056856187291,23.2851985559567,14.5394006659267,18.7654320987654,27.1523178807947,22.5888324873096,10.5065666041276,2.5,1.00250626566416,12.6797832183862,11.1737707425444,14.185795694228,NA,NA,NA,NA,NA,NA,9.88667707233352,10.7669142700443,8.43657645863972,11.3125948255412,10.542563063904,11.6283708155471,11.4103120657564,10.2538435092189,9.58440010859563,11.2971685897925,10.5119420779373,9.74081204253835,11.2830721133363,1720.7983821566,1.24609946335226,0.671376198138362,0.0183281717388087,0.0691802390475286,"Q1ZXD6",2.31e-16,"Probable serine/threonine-protein kinase roco5 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 5)","signal transduction [GO:0007165]; sorocarp development [GO:0030587]","GO:0004672; GO:0004674; GO:0005085; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0007165; GO:0030587; GO:0106310"
"535","Pocillopora_acuta_HIv2___TS.g28200.t1",NA,0,5.55555555555556,NA,0,0,0,0,NA,NA,0.925925925925926,0,1.85185185185185,NA,NA,NA,NA,NA,NA,6.03460261738071,10.4681493452698,6.76741458562017,3.68233641306884,9.24855880113618,3.68233641306884,3.68233641306884,10.1143066998765,5.91298961818613,3.68233641306884,6.32753673197448,7.61557446443994,5.03949899950903,322.122675866226,-0.474099431427022,1.18918742279399,7.94931602284557e-08,1.76890626083751e-06,"Q96I24",4.65e-07,"Far upstream element-binding protein 3 (FUSE-binding protein 3)","DNA-templated transcription [GO:0006351]; intracellular mRNA localization [GO:0008298]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005840; GO:0006351; GO:0006357; GO:0008298; GO:0010628; GO:0016020; GO:0043025; GO:0043198; GO:0045893; GO:0045944"
"536","Pocillopora_acuta_HIv2___RNAseq.g15621.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.2511238974403,10.4396645161572,10.6584739035372,3.68233641306884,10.3922566146874,8.97603901233876,10.0185396303794,11.2358060946617,11.6517048942819,3.68233641306884,9.09882813896215,10.8378730809217,7.35978319700261,1253.33714929343,-0.461537473122414,1.06501921847605,0.0728871178417849,0.207295895830388,"Q8WXX0",0,"Dynein axonemal heavy chain 7 (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2)","cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]","GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005829; GO:0005858; GO:0005874; GO:0005929; GO:0008569; GO:0016887; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729"
"537","Pocillopora_acuta_HIv2___RNAseq.g15648.t1",NA,NA,NA,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,8.29030127202732,3.68233641306884,9.10631365859813,7.38459886133705,6.83162092158167,6.34225560108856,8.6913826025105,11.1246283278797,9.22695290674866,3.68233641306884,7.43627269779093,8.9159634173671,5.95658197821476,427.239154680997,-0.917436845785021,1.40278191246123,0.011025451363455,0.0450868330565489,"Q8IV61",1.89e-135,"Ras guanyl-releasing protein 3 (Calcium and DAG-regulated guanine nucleotide exchange factor III) (Guanine nucleotide exchange factor for Rap1)","MAPK cascade [GO:0000165]; Ras protein signal transduction [GO:0007265]; small GTPase-mediated signal transduction [GO:0007264]","GO:0000165; GO:0005085; GO:0005096; GO:0005509; GO:0005886; GO:0007264; GO:0007265; GO:0019900; GO:0019992; GO:0031267; GO:0032045; GO:0048471"
"538","Pocillopora_acuta_HIv2___RNAseq.6765_t",0,NA,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.83459207205508,11.2221821979439,10.7003461375956,10.8485677147326,10.1834861612394,10.4186405396332,11.0144908738544,10.1914032914316,11.0554683961342,3.68233641306884,9.91515137976888,10.3930592116912,9.43724354784659,1447.76540256476,-0.0154468229127375,0.86959434230885,0.94494627044876,0.979358127252709,"Q62136",3.97e-64,"Tyrosine-protein phosphatase non-receptor type 21 (EC 3.1.3.48) (Protein-tyrosine phosphatase PTP-RL10)","","GO:0004725; GO:0005737; GO:0005856"
"539","Pocillopora_acuta_HIv2___RNAseq.g15654.t1",100,100,100,100,100,94.1176470588235,100,0,NA,NA,86.7647058823529,73.5294117647059,100,NA,NA,NA,NA,NA,NA,13.4720379459495,13.0703821109186,13.0148445743028,12.5195038169349,13.3107996821098,13.0755982972746,13.1522763337724,13.6028575886221,12.6588356650962,13.0858492878167,13.0962985302798,13.2118750912161,12.9807219693434,8935.64480909478,-0.173445973797884,0.497669782300574,0.677905080661728,0.850833406886062,"Q9IA79",4.53e-80,"Probable Bax inhibitor 1 (BI-1) (Testis-enhanced gene transcript protein homolog) (Transmembrane BAX inhibitor motif-containing protein 6)","apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; response to unfolded protein [GO:0006986]","GO:0005789; GO:0006915; GO:0006986; GO:0043066"
"540","Pocillopora_acuta_HIv2___RNAseq.6831_t",NA,0,63.265306122449,12.5,60.8695652173913,14.6666666666667,59.1549295774648,100,NA,NA,44.3509239405674,31.7916666666667,61.0966003057684,NA,NA,NA,NA,NA,NA,3.68233641306884,9.71101894540186,6.72688650906576,3.68233641306884,7.71361286554099,9.88337885312858,3.68233641306884,9.22077296187623,8.03919311016556,3.68233641306884,6.60242088974543,7.07656037194348,6.12828140754739,280.771048847092,-0.119350687304039,1.01955395677939,0.00109245064520117,0.00631543010878885,"Q9Y580",6.17e-24,"RNA-binding protein 7 (RNA-binding motif protein 7)","meiotic cell cycle [GO:0051321]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; snRNA catabolic process [GO:0016076]","GO:0000381; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0016076; GO:0017069; GO:0051321; GO:0071889; GO:0097157"
"541","Pocillopora_acuta_HIv2___RNAseq.g17404.t1",0,0,10.4838709677419,42.8571428571429,4.57142857142857,5.83941605839416,9.45945945945946,0,8.57142857142857,0,8.17827464855955,11.4535974973931,4.90295179972599,NA,NA,NA,NA,NA,NA,13.3709078225338,12.6388194706035,13.290580987615,13.0074484310113,13.3606915122026,13.0265904640676,11.2548652890157,12.9690034247895,13.2132987978161,12.5667821562712,12.8698988355926,13.2408965089914,12.4989011621939,7985.82980364357,-0.563126227707129,0.548853582740907,0.218819518208811,0.449702402866189,"Q61879",2.88e-32,"Myosin-10 (Cellular myosin heavy chain, type B) (Myosin heavy chain 10) (Myosin heavy chain, non-muscle IIb) (Non-muscle myosin heavy chain B) (NMMHC-B) (Non-muscle myosin heavy chain IIb) (NMMHC II-b) (NMMHC-IIB)","actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; adult heart development [GO:0007512]; aorta development [GO:0035904]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cardiac muscle cell proliferation [GO:0060038]; cardiac myofibril assembly [GO:0055003]; cardiac septum development [GO:0003279]; cell adhesion [GO:0007155]; cerebellar Purkinje cell layer development [GO:0021680]; coronary vasculature development [GO:0060976]; exocytosis [GO:0006887]; fourth ventricle development [GO:0021592]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lateral ventricle development [GO:0021670]; mitotic cytokinesis [GO:0000281]; modification of postsynaptic actin cytoskeleton [GO:0098885]; myofibril assembly [GO:0030239]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; nuclear migration [GO:0007097]; plasma membrane repair [GO:0001778]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; retina development in camera-type eye [GO:0060041]; substrate-dependent cell migration, cell extension [GO:0006930]; third ventricle development [GO:0021678]; ventricular cardiac muscle cell development [GO:0055015]","GO:0000146; GO:0000281; GO:0001701; GO:0001725; GO:0001764; GO:0001778; GO:0003279; GO:0005516; GO:0005524; GO:0005737; GO:0005819; GO:0005829; GO:0005903; GO:0005938; GO:0006887; GO:0006930; GO:0007097; GO:0007155; GO:0007409; GO:0007411; GO:0007420; GO:0007507; GO:0007512; GO:0008360; GO:0009898; GO:0016459; GO:0016460; GO:0016528; GO:0021592; GO:0021670; GO:0021678; GO:0021680; GO:0030027; GO:0030036; GO:0030048; GO:0030239; GO:0030424; GO:0030426; GO:0031032; GO:0031175; GO:0031594; GO:0032982; GO:0035904; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043531; GO:0050885; GO:0051015; GO:0051017; GO:0055003; GO:0055015; GO:0060038; GO:0060041; GO:0060976; GO:0070650; GO:0098871; GO:0098885; GO:0098974; GO:0098978; GO:1905274"
"542","Pocillopora_acuta_HIv2___RNAseq.g17416.t1",NA,NA,16.6666666666667,0,16.6666666666667,16,0,NA,0,NA,8.22222222222222,5.33333333333333,11.1111111111111,NA,NA,NA,NA,NA,NA,10.8150871106705,13.4922330175198,11.3709893053018,13.251478133751,11.2326776469333,12.959701651391,13.4681614942123,9.69122985054748,11.9456553513681,12.581552868591,12.0808766430286,11.0111278529642,13.150625433093,5807.49046974574,1.73660590374684,0.803840359585646,0.00363448173492567,0.0177598458830962,"Q8CAL5",1.62e-40,"Glypican-5 [Cleaved into: Secreted glypican-5]","cell migration [GO:0016477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of protein localization to membrane [GO:1905475]","GO:0005576; GO:0005796; GO:0005886; GO:0009986; GO:0016477; GO:0062023; GO:0090263; GO:0098552; GO:1905475"
"543","Pocillopora_acuta_HIv2___RNAseq.g17428.t1",0,0,NA,0,0,0,11.1111111111111,NA,NA,NA,1.85185185185185,0,3.7037037037037,NA,NA,NA,NA,NA,NA,12.3103617703054,10.9674809174796,11.6369662709033,11.0893849841582,11.5686897742832,12.9193905799436,11.7409457434093,10.2459136581504,10.4303917876009,9.32172647585935,11.2231251962093,11.2384646522486,11.20778574017,2963.05404141349,-0.0266151380337997,0.6559402878575,0.943258052172952,0.978833896473357,"P21333",7.44e-150,"Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)","actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]","GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003723; GO:0005080; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0045022; GO:0045184; GO:0045216; GO:0045296; GO:0046332; GO:0048471; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051220; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224"
"544","Pocillopora_acuta_HIv2___RNAseq.g17438.t1",0,NA,0,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.18019374494757,7.33073994748753,6.99725313095895,9.08984740627795,7.67391428326733,3.68233641306884,8.676067861736,7.99087022978053,3.68233641306884,3.68233641306884,6.69858958436624,6.90491356040464,6.49226560832783,181.663294548001,-0.0568764623962714,0.933293918219072,0.888432179993407,0.95700943091771,"Q0VBY0",1.99e-10,"Cx9C motif-containing protein 4 (Mature T-cell proliferation 1 neighbor protein)","","GO:0005758"
"545","Pocillopora_acuta_HIv2___RNAseq.g17439.t1",3.39943342776204,1.76056338028169,0,0,0.89126559714795,0.342172797262618,0.894187779433681,0,0.427350427350427,0,0.771497340923841,0.506017320978947,1.03697736086873,NA,NA,NA,NA,NA,NA,8.63967192774965,6.95962792177575,9.99092062400641,10.0744731019821,7.63308315590689,3.68233641306884,8.62114586341104,8.99843455391061,10.0446453819402,3.68233641306884,7.83266753568203,9.06135112870275,6.60398394266131,457.739939537694,-0.508386054756302,1.0731059681934,0.0594374103877449,0.178029137264101,"Q20CR4",2.06e-87,"Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5)","cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of kinase activity [GO:0033674]","GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0033674; GO:0043066; GO:0044344; GO:0045743; GO:0070161; GO:0070374; GO:0106310"
"546","Pocillopora_acuta_HIv2___TS.g22683.t1",0,4.44444444444444,0,NA,12.8205128205128,1.11111111111111,0,0,0,0,2.04178537511871,1.38888888888889,2.56410256410256,NA,NA,NA,NA,NA,NA,9.2296407510666,3.68233641306884,8.19761460836865,3.68233641306884,4.82690108855957,6.34225560108856,8.44708254939947,8.84835480854831,3.68233641306884,3.68233641306884,6.06211950593065,6.95696953392239,5.16726947793891,166.880347925217,-0.158585623631806,0.999763605572834,0.429113279202055,0.673396383896987,"P16649",1.2e-11,"General transcriptional corepressor TUP1 (Flocculation suppressor protein) (Glucose repression regulatory protein TUP1) (Repressor AER2)","carbon catabolite repression of transcription from RNA polymerase II promoter by glucose [GO:0000433]; DNA damage response [GO:0006974]; hyperosmotic response [GO:0006972]; mitotic cell cycle [GO:0000278]; negative regulation of dipeptide transport [GO:2000879]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000278; GO:0000433; GO:0003714; GO:0005634; GO:0006357; GO:0006972; GO:0006974; GO:0017053; GO:0036033; GO:0042304; GO:0042393; GO:0042826; GO:0045892; GO:0045944; GO:0080025; GO:2000879"
"547","Pocillopora_acuta_HIv2___RNAseq.g17459.t1",NA,0,0,NA,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,4.72947037839729,6.36195368411057,7.21685803447454,10.1774323056122,7.39474963887568,3.68233641306884,8.94558215164935,6.83634004906966,4.86223652345053,11.0535102199453,7.1260469398654,6.20793092485354,8.04416295487725,413.251218234005,0.573565003055012,1.15494479754372,0.0723973134308933,0.206498667218387,NA,NA,NA,NA,NA
"548","Pocillopora_acuta_HIv2___RNAseq.g17477.t1",0,0,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.6833612538092,8.04817444370993,10.12188005377,12.0899745465781,10.6886319288275,10.1186212833894,10.6911147902997,7.39465756691968,11.0257681203533,10.0618357719368,10.0924019759594,9.98285978473594,10.2019441671828,1486.61671660954,0.070214390756116,0.79522142516564,0.882386366947414,0.954287059391454,"Q92542",1.52e-126,"Nicastrin","adult behavior [GO:0030534]; amyloid precursor protein biosynthetic process [GO:0042983]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; cellular response to calcium ion [GO:0071277]; central nervous system myelination [GO:0022010]; cerebellum development [GO:0021549]; epithelial cell proliferation [GO:0050673]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; glutamate receptor signaling pathway [GO:0007215]; learning or memory [GO:0007611]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; myeloid cell homeostasis [GO:0002262]; neuron apoptotic process [GO:0051402]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of endopeptidase activity [GO:0010950]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of long-term synaptic potentiation [GO:1900271]; short-term synaptic potentiation [GO:1990926]; T cell proliferation [GO:0042098]","GO:0000139; GO:0002262; GO:0005765; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005925; GO:0006508; GO:0006509; GO:0007212; GO:0007215; GO:0007219; GO:0007220; GO:0007611; GO:0008021; GO:0010008; GO:0010950; GO:0016020; GO:0016485; GO:0021549; GO:0022010; GO:0030534; GO:0030674; GO:0031293; GO:0034205; GO:0035577; GO:0042098; GO:0042383; GO:0042470; GO:0042500; GO:0042734; GO:0042982; GO:0042983; GO:0042986; GO:0042987; GO:0050673; GO:0051117; GO:0051402; GO:0070062; GO:0070765; GO:0070851; GO:0071277; GO:1900271; GO:1990926"
"549","Pocillopora_acuta_HIv2___RNAseq.g17483.t1",0,0,NA,NA,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,6.93499074257248,3.68233641306884,8.7199484436706,3.68233641306884,7.39963524616139,7.92859676822119,3.68233641306884,7.82610252698821,9.69914067840575,3.68233641306884,6.3237760058295,8.11596352755969,4.53158848409931,186.495747274366,-0.852812062522371,1.5927540700992,1.93974834720876e-06,2.78338492996305e-05,"P09884",6.29e-161,"DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (DNA polymerase alpha catalytic subunit p180)","DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of primer [GO:0006269]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]; regulation of type I interferon production [GO:0032479]","GO:0000166; GO:0000731; GO:0000785; GO:0003677; GO:0003682; GO:0003688; GO:0003697; GO:0003887; GO:0005634; GO:0005635; GO:0005654; GO:0005658; GO:0005730; GO:0005829; GO:0006260; GO:0006269; GO:0006270; GO:0006271; GO:0006272; GO:0006273; GO:0006281; GO:0006303; GO:0008270; GO:0016363; GO:0019901; GO:0032479; GO:1902975"
"550","Pocillopora_acuta_HIv2___TS.g22706.t1",0,0,0,0,0,0,NA,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,7.48631699375706,7.0676910766358,6.3783135818283,6.54549673248371,7.90740821600663,3.68233641306884,5.32551295827119,6.97688987348655,3.68233641306884,3.68233641306884,5.87346386716758,6.48625301562948,5.26067471870568,72.8476802431074,-0.35842258117096,0.997189635710614,0.380385837168328,0.629580129168406,"Q9DE46",0,"DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (DNA polymerase alpha catalytic subunit p180)","DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of primer [GO:0006269]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]","GO:0000166; GO:0000785; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005635; GO:0005654; GO:0005658; GO:0005730; GO:0006260; GO:0006269; GO:0006270; GO:0006271; GO:0006272; GO:0006273; GO:0006303; GO:0016363; GO:0046872; GO:1902975"
"551","Pocillopora_acuta_HIv2___RNAseq.g17491.t1",0,4.76190476190476,NA,0,0,0,0,NA,NA,NA,0.793650793650794,1.58730158730159,0,NA,NA,NA,NA,NA,NA,5.71611892316596,3.68233641306884,7.18005401377357,6.29014341372585,6.81698272709732,3.68233641306884,3.68233641306884,8.32841205079342,3.68233641306884,4.19574235723263,5.32567991380641,6.34478082557982,4.306579002033,59.1647217376862,-0.389109053837575,1.09411977217666,0.00308384242625106,0.015530883305465,"Q96AY4",1.27e-79,"Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"552","Pocillopora_acuta_HIv2___RNAseq.g17495.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.90446679638468,6.22089677820832,11.0075896026566,3.68233641306884,10.5611093850037,3.68233641306884,3.68233641306884,9.49835744016707,11.285621892778,3.68233641306884,7.12073875474737,10.051429023398,4.19004848609674,695.276104890953,-11.6905800405212,3.24805223587447,7.68641968685419e-10,3.26030423315716e-08,"Q6AX80",2.12e-90,"Bis(5'-adenosyl)-triphosphatase enpp4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4)","blood coagulation [GO:0007596]","GO:0005886; GO:0007596; GO:0046872; GO:0047710"
"553","Pocillopora_acuta_HIv2___RNAseq.g17519.t1",3.33333333333333,1.61290322580645,2.46913580246914,2.12765957446809,2.22222222222222,1.38888888888889,6.66666666666667,3.2258064516129,1.6,4.83870967741935,2.9485325842887,1.99105162815527,3.90601354042214,NA,NA,NA,NA,NA,NA,6.16911426736902,12.2212138398626,3.68233641306884,12.2919456866291,3.68233641306884,10.79122873678,9.36618220150096,9.09955135998982,7.78511408192754,12.0830089909065,8.71720319911032,6.08369050708481,11.3507158911358,1719.95496711286,1.08058068214725,1.94626640985696,3.80116312024801e-05,0.000359581578621761,"Q9VBW3",4.3e-76,"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303"
"554","Pocillopora_acuta_HIv2___RNAseq.g17534.t1",0,NA,NA,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.6385031493097,10.541124724867,7.03078696493316,5.89135073914645,9.52023756429125,6.40437642337467,6.66472726798925,10.2364854599648,8.19657290837461,3.68233641306884,7.88065016153197,9.12451720937471,6.63678311368924,547.211464427983,-1.60925019684577,1.62921973011713,0.00790519461658103,0.0343262488544665,"Q8JFV8",7.59e-39,"Synaptic vesicle membrane protein VAT-1 homolog (EC 1.-.-.-)","negative regulation of mitochondrial fusion [GO:0010637]","GO:0005741; GO:0008270; GO:0010637; GO:0016491"
"555","Pocillopora_acuta_HIv2___TS.g22765.t2",NA,0,0,0,0,0,35,31.5789473684211,NA,0,8.32236842105263,7.89473684210526,8.75,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,5.26676479605173,3.68233641306884,9.95835638677832,7.13292658472672,3.68233641306884,7.85681227116004,8.21631227375645,3.68233641306884,5.68428543778175,6.99611642816308,4.37245444740042,158.1447787579,-0.677821952464349,1.36242773957653,0.0031466127807753,0.0158084776870906,NA,NA,NA,NA,NA
"556","Pocillopora_acuta_HIv2___RNAseq.g17557.t1",16.6666666666667,0,0,NA,NA,0,0,0,NA,NA,2.77777777777778,0,5.55555555555556,NA,NA,NA,NA,NA,NA,9.93564569040583,8.23862894808587,10.535911529181,3.68233641306884,9.93261037080372,3.68233641306884,7.67004118536774,8.5033066912864,10.6253760328443,3.68233641306884,7.64885296871814,9.90657006290425,5.39113587453203,571.209461613994,-0.684777291067238,1.28993661852536,3.11240317324876e-07,5.76412285504097e-06,"P14629",4.96e-92,"DNA excision repair protein ERCC-5 homolog (EC 3.1.-.-) (DNA repair protein complementing XP-G cells homolog) (Xeroderma pigmentosum group G-complementing protein homolog)","nucleotide-excision repair [GO:0006289]","GO:0003697; GO:0004519; GO:0005634; GO:0005694; GO:0006289; GO:0046872"
"557","Pocillopora_acuta_HIv2___RNAseq.g17564.t1",0,NA,0,NA,0,22.6890756302521,0,8.33333333333333,0,NA,4.43177270908363,10.3408029878618,0,1,-29.2682926829268,-29.2682926829268,0.0144321591009956,0.0144321591009956,0.0144321591009956,9.68004968742157,3.68233641306884,9.48894720073031,4.62642457401022,10.7142027780422,9.61982140299553,3.68233641306884,11.1088176393981,9.08406734514233,8.96155721209108,8.0648560665969,10.0152169301469,6.1144952030469,708.272784259612,-0.708528097286472,1.28599516025178,0.000119229012241967,0.00096450136077618,"Q8BLJ3",1.01e-63,"PI-PLC X domain-containing protein 3","lipid catabolic process [GO:0016042]; signal transduction [GO:0007165]","GO:0005737; GO:0007165; GO:0008081; GO:0016042; GO:0045202; GO:0098978"
"558","Pocillopora_acuta_HIv2___RNAseq.g17578.t1",NA,NA,0,0,38.9312977099237,0,3.84615384615385,NA,0,6.55737704918033,7.04783265789398,0,12.3337071513145,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,7.93301443586595,3.68233641306884,7.56522790027118,10.9464003299576,6.66472726798925,9.97471806094529,3.68233641306884,3.68233641306884,6.14957700603735,6.56752664464402,5.73162736743067,338.979106164281,-0.142228254735098,1.01420422819939,0.643292457134272,0.828526016268465,"P16333",2.13e-88,"SH2/SH3 adapter protein NCK1 (Cytoplasmic protein NCK1) (NCK adapter protein 1) (Nck-1) (SH2/SH3 adapter protein NCK-alpha)","actin filament organization [GO:0007015]; antiviral innate immune response [GO:0140374]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; lamellipodium assembly [GO:0030032]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine dephosphorylation [GO:1902310]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cell migration [GO:0030334]; response to endoplasmic reticulum stress [GO:0034976]; signal complex assembly [GO:0007172]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell activation [GO:0042110]","GO:0000122; GO:0000164; GO:0004860; GO:0005102; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005840; GO:0005886; GO:0005911; GO:0006930; GO:0007015; GO:0007172; GO:0008093; GO:0010976; GO:0012506; GO:0016477; GO:0019904; GO:0030032; GO:0030159; GO:0030334; GO:0030674; GO:0030838; GO:0030971; GO:0033137; GO:0034976; GO:0035591; GO:0036493; GO:0042102; GO:0042110; GO:0045296; GO:0045944; GO:0046627; GO:0046875; GO:0048013; GO:0071074; GO:0140374; GO:0140693; GO:1902237; GO:1902310; GO:1903676; GO:1903679; GO:1903898; GO:1903912"
"559","Pocillopora_acuta_HIv2___RNAseq.g17580.t1",0.490196078431373,NA,NA,1.40845070422535,0,0.65359477124183,5.55555555555556,2,0,0,1.26347463868176,1.0155113688668,1.51143790849673,NA,NA,NA,NA,NA,NA,5.58022760055378,11.3004222992996,9.50528405059666,5.7042294826067,8.47838834006635,3.68233641306884,3.68233641306884,9.97034933806169,10.8166081501005,3.68233641306884,7.24025185004918,8.8701714958758,5.61033220422256,634.007661051212,-0.462990310574411,1.17653724193858,2.15250386090831e-06,3.04041170353298e-05,"Q01484",2.35e-25,"Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)","atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]","GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259"
"560","Pocillopora_acuta_HIv2___RNAseq.g17588.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.28736510465359,8.68612969094628,7.18005401377357,7.24978579672844,8.40530337063089,8.42630172396256,8.26447842049562,7.58587073740623,7.16518700660512,3.68233641306884,7.39328122782711,7.52475604661388,7.26180640904035,196.762008836507,-0.0442190724017688,0.833653814070307,0.899171072165571,0.961882285911014,"Q9NRX2",4.74e-27,"Large ribosomal subunit protein bL17m (39S ribosomal protein L17, mitochondrial) (L17mt) (MRP-L17) (LYST-interacting protein 2)","mitochondrial translation [GO:0032543]","GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0019904; GO:0032543"
"561","Pocillopora_acuta_HIv2___TS.g22806.t1",0,0,0,NA,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,6.13203366284608,7.0676910766358,7.63565941754202,7.3031579212903,6.90951792457399,6.98055169899496,8.07292963864076,7.56273982243945,3.68233641306884,3.68233641306884,6.5028953989101,6.38445744809408,6.62133334972613,107.012922071532,0.205831719605816,0.707403502578284,0.662060708929926,0.840593933809906,"O57429",4.3e-117,"Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2)","protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; rhythmic process [GO:0048511]","GO:0004843; GO:0005737; GO:0006508; GO:0016579; GO:0046872; GO:0048471; GO:0048511"
"562","Pocillopora_acuta_HIv2___RNAseq.g17618.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.4263463087757,11.5918112849377,8.81361363638465,9.87708254069058,8.61009583438926,8.480153777931,10.4174517521108,10.9607810999679,8.88597544105649,8.73534553831225,9.47986572145563,9.1393624641148,9.82036897879647,957.490792111194,0.355306896246357,0.700536166451041,0.460070930786203,0.700912781008177,"Q9H095",8.83e-90,"Dynein regulatory complex protein 9 (IQ domain-containing protein G)","cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286]","GO:0002177; GO:0005516; GO:0005737; GO:0005829; GO:0007286; GO:0007288; GO:0015629; GO:0030544; GO:0031514; GO:0036126; GO:0044782; GO:0070062"
"563","Pocillopora_acuta_HIv2___TS.g22844.t2",0.488997555012225,0,0.226244343891403,0,1.63551401869159,0.49813200498132,0.281293952180028,1.63398692810458,0.28735632183908,NA,0.561280569411136,0.483895050984995,0.658012467443811,NA,NA,NA,NA,NA,NA,9.51217973805621,8.57758379751783,9.46939828011841,7.90881337201514,9.41977908774909,9.46656944606883,3.68233641306884,9.11705378794119,10.8973983126193,7.03580592350913,8.5086918158664,9.68316184129684,7.33422179043595,582.036790274258,-0.830859115218336,1.1749042130171,0.0572856310981207,0.172800702440713,NA,NA,NA,NA,NA
"564","Pocillopora_acuta_HIv2___RNAseq.g17637.t1",6.49641577060932,0.182648401826484,0.626959247648903,0.392541707556428,3.74787052810903,0.930108955620516,3.39512601541346,1.98928844682479,0.120627261761158,0,1.78815863353701,0.723042954717875,2.85327431235614,7,15.152192484316,14.2857142857143,0.0095156394840387,0.000615288596295692,0.0226286615837963,5.09121097465794,5.06794590568438,5.54494604997642,5.21704338441576,5.21442834742072,5.08222717563762,4.90654184690663,4.82716794255886,5.91298961818613,5.54842281532527,5.24129240607697,5.31814858656001,5.16443622559393,17.5765367538472,-0.159994278959105,0.666641848556253,0.749712867976945,0.889440481792665,"P14381",1.06e-127,"Transposon TX1 uncharacterized 149 kDa protein (ORF 2)","","GO:0003824"
"565","Pocillopora_acuta_HIv2___TS.g22862.t1",7.14285714285714,6.38297872340426,18.3333333333333,0,7.9646017699115,0.404858299595142,8.6734693877551,4.25531914893617,0,NA,5.90637975619918,2.20863123438711,10.5285654084643,NA,NA,NA,NA,NA,NA,6.9558930465414,9.41034177695492,8.47934738650483,7.13662644726567,8.06897029611317,9.0371544164843,9.36618220150096,7.00477647110157,7.27336735209762,3.68233641306884,7.64149958076333,7.55647091047172,7.72652825105494,281.480546949461,0.0977668133161281,0.899554148127762,0.796681878130672,0.914249975030311,NA,NA,NA,NA,NA
"566","Pocillopora_acuta_HIv2___RNAseq.g17650.t1",0,0,66.6666666666667,0,0.398406374501992,2.64550264550265,0,NA,0,0,7.74561952074126,0.661375661375661,13.4130146082337,NA,NA,NA,NA,NA,NA,12.3562830447617,10.5013928532478,12.1334289716589,8.68874925379205,12.0616386408987,3.68233641306884,3.68233641306884,13.2565653267432,12.8805075375821,3.68233641306884,9.2925574867891,12.5376847043289,6.04743026924927,3302.1444056893,-0.829738088850736,1.52228517371681,1.05589784984941e-09,4.29002991579266e-08,"Q8I030",1.68e-24,"Cystatin-B (Stefin-B)","","GO:0004869; GO:0005634; GO:0005829"
"567","Pocillopora_acuta_HIv2___TS.g22868.t1b",0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.54038827674961,8.75182214721387,9.31619441972494,9.94870042879352,9.99813690438824,6.52080719718656,9.77455929505308,9.95892833498957,8.48793182105935,8.22646580754358,8.95239346327023,9.26031595138234,8.64447097515812,582.105925613417,-0.271090515535163,0.716209396785014,0.559803394232095,0.773482503186389,"Q66HG5",0,"Transmembrane 9 superfamily member 2","ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688]; protein localization to membrane [GO:0072657]; regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010908]","GO:0005794; GO:0005815; GO:0006672; GO:0006688; GO:0010008; GO:0010908; GO:0016020; GO:0072657"
"568","Pocillopora_acuta_HIv2___RNAseq.g17662.t1",0,57.6923076923077,0,48.936170212766,100,NA,24.3243243243243,82.3529411764706,88.8888888888889,NA,50.2743290368447,69.4675769926083,31.0810810810811,NA,NA,NA,NA,NA,NA,6.9558930465414,7.78026348768243,7.9286053405087,9.97670692696191,10.0608152494315,6.41947826134799,9.61117229371725,8.40820338836075,3.68233641306884,10.0394831369025,8.08629575445233,7.40717068758224,8.76542082132242,469.78820968159,0.334160245502632,0.971065558959994,0.321294451450942,0.571260349820089,"B8WI85",1.96e-49,"Uncharacterized skeletal organic matrix protein 7 (Uncharacterized SOMP-7)","","GO:0005576"
"569","Pocillopora_acuta_HIv2___TS.g22883.t1",3.28947368421053,0,2.1505376344086,2.5974025974026,0,0,0,0,0.512820512820513,5.26315789473684,1.38133923235791,0.622044622044622,2.14063384267119,NA,NA,NA,NA,NA,NA,10.0578429759644,10.2111486609453,8.75765247046186,11.594628873247,9.17818711259379,12.283529175626,13.6162936387806,5.03658612426137,5.75167028831017,11.0756457984546,9.75631851186451,7.75638779431832,11.7562492294107,2589.67808780979,2.58015124215372,1.95484028431713,0.000805465966420186,0.00487662609388931,NA,NA,NA,NA,NA
"570","Pocillopora_acuta_HIv2___RNAseq.g17673.t1",4.02684563758389,0,0,0,1.63934426229508,3.06122448979592,2.5,0,0,0,1.12274143896749,0.612244897959184,1.6332379799758,NA,NA,NA,NA,NA,NA,7.52854090287646,7.54444492362095,6.50448097751675,8.86138506883246,7.22884663559278,6.17337120454021,6.42458387407815,8.16952988842414,6.89589329451837,6.58881646192222,7.19198932319225,7.2654583397857,7.1185203065988,149.470463674077,-0.161569859983761,0.731354815207813,0.719715781753986,0.873539403145897,"B6LI37",7.16e-09,"Cilia- and flagella-associated protein HOATZ","cilium assembly [GO:0060271]","GO:0060271"
"571","Pocillopora_acuta_HIv2___RNAseq.g17679.t1",NA,NA,0,0,0,0,6.25,0,NA,NA,1.04166666666667,0,2.08333333333333,NA,NA,NA,NA,NA,NA,7.88837745147468,10.0156907956448,8.91718848910675,6.68205791477539,7.02837946581971,5.44887968569328,5.69873558273438,7.63547889605305,6.30482766574162,7.43123314299026,7.30508490900339,7.55485039363916,7.05531942436762,229.303338833917,-0.354906215104052,0.84978074625928,0.376196784984756,0.625662220325142,"Q7RTR2",8.31e-73,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223"
"572","Pocillopora_acuta_HIv2___RNAseq.g17733.t1",0,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.09414687449084,7.28188058444009,8.65482796170777,3.68233641306884,7.11438186546373,3.68233641306884,3.68233641306884,7.51532375783955,9.91950728835734,3.68233641306884,6.23094139845747,8.05963754957185,4.40224524734309,183.613078962382,-0.925567859019205,1.7166608172656,1.4500666221169e-06,2.17570162057042e-05,"Q7RTR2",5.85e-80,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223"
"573","Pocillopora_acuta_HIv2___RNAseq.g17735.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.550332255092,7.71570812917624,10.6043642848145,11.8131857547208,9.87185214354798,10.8067473209896,12.2102682820616,11.129337940634,10.6068351386127,12.2323552762784,10.7540986525928,10.5525443525402,10.9556529526453,2268.81144676447,0.329965981516814,0.737802399233463,0.496950340461872,0.727141358277533,"Q7TN22",2.08e-50,"Thioredoxin domain-containing protein 16","","GO:0005576; GO:0005788"
"574","Pocillopora_acuta_HIv2___RNAseq.g17741.t1",6.66666666666667,0,0,NA,NA,0,NA,0,NA,0,1.11111111111111,0,2.22222222222222,NA,NA,NA,NA,NA,NA,3.68233641306884,7.28188058444009,6.79706037552057,6.26838653426437,6.85329648854777,8.29621501861494,4.51171232812315,6.15845931147545,6.51477584410355,6.7316772345674,6.30958001327261,6.00118568654324,6.61797434000199,85.4271718515625,0.132231809279386,0.900840267067595,0.709025108361302,0.867405833319621,"Q10751",4.77e-46,"Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II)","angiotensin maturation [GO:0002003]; bradykinin catabolic process [GO:0010815]; cell population proliferation [GO:0008283]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of blood pressure [GO:0008217]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; substance P catabolic process [GO:0010814]","GO:0001822; GO:0002003; GO:0003081; GO:0003084; GO:0004180; GO:0004222; GO:0005737; GO:0005886; GO:0008217; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0010814; GO:0010815; GO:0016020; GO:0031404; GO:0042445; GO:0042447; GO:0048167; GO:0060319; GO:0070573"
"575","Pocillopora_acuta_HIv2___RNAseq.g17742.t1",12.8712871287129,0,5.24017467248908,33.9622641509434,5.96330275229358,9.00277008310249,8.35443037974684,2.24719101123596,15.3409090909091,0,9.29823292694333,12.1106268672382,6.48583898664847,NA,NA,NA,NA,NA,NA,9.05130626338527,7.25173910022888,7.57478855646541,7.32395877248941,7.95450868126574,8.15759426901582,7.56551680110738,7.71731208381075,3.68233641306884,8.41911171979209,7.46981726606296,7.1960503995992,7.74358413252672,208.517100034957,0.076578924708043,0.86463928564995,0.851896059618161,0.941559311367103,"A7RR04",7.45e-27,"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1)","mitochondrial translational elongation [GO:0070125]","GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125"
"576","Pocillopora_acuta_HIv2___RNAseq.g17750.t1",0,0,0,0,2.56410256410256,1.84049079754601,0,0,0,NA,0.489399262405397,0.368098159509202,0.641025641025641,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,7.98913290325087,8.33326890870578,7.18982473243499,8.81782936174425,8.73267714959777,6.8048750249239,8.88904978253325,3.68233641306884,6.78036671023973,6.91104377124237,6.6496896492371,201.030979757003,0.0808856802125977,0.940363050072932,0.830306937932624,0.931233314818069,"Q10751",1.06e-42,"Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II)","angiotensin maturation [GO:0002003]; bradykinin catabolic process [GO:0010815]; cell population proliferation [GO:0008283]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of blood pressure [GO:0008217]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; substance P catabolic process [GO:0010814]","GO:0001822; GO:0002003; GO:0003081; GO:0003084; GO:0004180; GO:0004222; GO:0005737; GO:0005886; GO:0008217; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0010814; GO:0010815; GO:0016020; GO:0031404; GO:0042445; GO:0042447; GO:0048167; GO:0060319; GO:0070573"
"577","Pocillopora_acuta_HIv2___RNAseq.g17753.t1",0,NA,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.71444610781529,8.62120790929901,5.81272994412078,9.16052156343084,5.82852651465621,3.68233641306884,3.68233641306884,6.99090193750695,3.68233641306884,3.68233641306884,5.98576796291044,6.20578818343361,5.76574774238727,148.049031972809,-0.153793484426092,1.00276625462652,0.476446761674842,0.712429025210888,NA,NA,NA,NA,NA
"578","Pocillopora_acuta_HIv2___RNAseq.g17775.t1",0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,5.54344824250154,8.60052414500046,3.68233641306884,6.86044811883467,7.49032865096105,3.68233641306884,6.87470680484115,3.68233641306884,3.68233641306884,5.37811380274831,5.94007037896279,4.81615722653382,72.7482847874034,-0.0702133300002231,1.00662714850138,0.730020651392358,0.880038772322399,"A7RR04",9.99e-33,"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1)","mitochondrial translational elongation [GO:0070125]","GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125"
"579","Pocillopora_acuta_HIv2___RNAseq.g17808.t1",0,0,0,NA,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.80261710823671,10.2782715717676,8.93265128434894,6.82126065609372,9.46452084851023,8.66507991130275,5.08305273412487,8.21758883240833,9.84709654165207,10.2910392978817,8.44031787863269,8.65289492303126,8.22774083423413,532.612066041711,-0.266424014048108,0.863881721517621,0.464986487444988,0.705133629105085,"O95140",0,"Mitofusin-2 (EC 3.6.5.-) (Transmembrane GTPase MFN2)","aerobic respiration [GO:0009060]; apoptotic process [GO:0006915]; blastocyst formation [GO:0001825]; camera-type eye morphogenesis [GO:0048593]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization to phagophore assembly site [GO:0034497]; protein targeting to mitochondrion [GO:0006626]; response to unfolded protein [GO:0006986]","GO:0001825; GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005829; GO:0006626; GO:0006915; GO:0006986; GO:0007006; GO:0008053; GO:0009060; GO:0015630; GO:0031625; GO:0034497; GO:0046580; GO:0048593; GO:0048662; GO:0051646; GO:0061734; GO:0120162; GO:1904707; GO:1905461"
"580","Pocillopora_acuta_HIv2___RNAseq.g17840.t1",0,0,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.2017697847733,9.00624173972253,8.90604113392728,8.49712083958253,8.67570400163745,9.17405111396715,9.91479986072618,9.30786156975193,8.71286321148442,9.77031588357191,9.11667691391447,8.96084794031488,9.27250588751406,556.898538557952,0.237674285527773,0.545764196145201,0.603521954931993,0.802845723915786,NA,NA,NA,NA,NA
"581","Pocillopora_acuta_HIv2___RNAseq.g17841.t1",35.2941176470588,38.3561643835616,NA,100,66.6666666666667,52.4271844660194,39.7959183673469,NA,50.4761904761905,NA,54.7166060009777,60.3148848314429,47.2522342270241,NA,NA,NA,NA,NA,NA,8.88597790678716,8.90081683482051,7.99757501876817,8.68475656126926,7.43337380008681,7.80440718073399,6.98706591615137,8.25548706414865,8.5318877619598,8.9327235568929,8.24140716016186,8.22086031035012,8.26195400997361,305.508990846974,0.03862419486937,0.581072325081938,0.938006679307134,0.976536811102885,"P35251",3.23e-27,"Replication factor C subunit 1 (Activator 1 140 kDa subunit) (A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (DNA-binding protein PO-GA) (Replication factor C 140 kDa subunit) (RF-C 140 kDa subunit) (RFC140) (Replication factor C large subunit)","DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; telomere maintenance via telomerase [GO:0007004]","GO:0000122; GO:0003677; GO:0003689; GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006261; GO:0006281; GO:0007004; GO:0008047; GO:0016887; GO:0019904; GO:0031391; GO:0043565; GO:0045893; GO:0061860; GO:0070062; GO:0140297"
"582","Pocillopora_acuta_HIv2___RNAseq.g17848.t1",1.50375939849624,0,0,0,0,3.90070921985816,0.467289719626168,0,0,NA,0.652417593108952,0.780141843971631,0.492762279530602,NA,NA,NA,NA,NA,NA,10.2097576224312,3.68233641306884,9.79828441445335,3.68233641306884,8.16643717532466,10.6591229296084,3.68233641306884,9.38605571860119,9.02660861504717,3.68233641306884,7.19756121277413,9.31742870917151,5.07769371637675,501.708782020924,-0.577145224162058,1.26892338137661,1.45088425108858e-09,5.60403232138336e-08,"Q5F364",0,"Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)","cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908]","GO:0005524; GO:0006869; GO:0008559; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0070729"
"583","Pocillopora_acuta_HIv2___TS.g25180.t1",0.418410041841004,0,4.49438202247191,2.46913580246914,1.44927536231884,3.68421052631579,0,2.22222222222222,2.40963855421687,NA,1.90525272576175,2.1570414210448,1.59051685665794,NA,NA,NA,NA,NA,NA,7.26251363937259,7.23128399729271,7.94179218572159,9.08379841403673,7.69786528086486,4.42568256259181,9.18880555237845,7.19203195048682,4.79801079550852,5.00142931435546,6.98232136926095,6.97844277039088,6.98619996813103,187.840874898943,0.0860538194423727,0.813428704891178,0.861476744928693,0.946039236969346,NA,NA,NA,NA,NA
"584","Pocillopora_acuta_HIv2___RNAseq.g25645.t1",2.1243115656963,1.20764844012076,1.6180735765532,0.785193494111049,2.84401967152269,1.32293080054274,1.0184692559094,0.336531576686238,0.820593525179856,1.38294838893641,1.34607202952587,0.89457956732813,1.7975644917236,NA,NA,NA,NA,NA,NA,9.76306151863784,9.21725122285112,9.51705019487359,8.67673780760658,9.92673259075288,7.2119491386412,8.51753520883539,9.97209841556107,8.70938834370297,9.01296535174887,9.05247697932115,9.57766621270567,8.52728774593663,578.058173022756,-0.73175115882609,0.707673306381055,0.146730409874658,0.343306783464705,NA,NA,NA,NA,NA
"585","Pocillopora_acuta_HIv2___RNAseq.g25653.t1",0,3.07692307692308,0,0,0,0,1.44927536231884,0,0,NA,0.502910937693546,0.615384615384615,0.36231884057971,NA,NA,NA,NA,NA,NA,8.77392235631032,7.493942887935,9.03033317993431,5.59933054873005,9.30921256533115,7.33461237882746,9.02022848696174,9.02733514890453,6.78000415386907,3.68233641306884,7.60512581198725,8.58416148086988,6.62609014310462,291.341176889144,-1.34089311031614,1.33300673899137,0.0167432149531206,0.0639994347468121,"C3VPR6",6.08e-17,"Protein NLRC5","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of type II interferon-mediated signaling pathway [GO:0060335]; response to bacterium [GO:0009617]","GO:0000978; GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0009617; GO:0032088; GO:0035556; GO:0045087; GO:0045345; GO:0045944; GO:0051607; GO:0060335; GO:0060339; GO:0060340"
"586","Pocillopora_acuta_HIv2___RNAseq.g25711.t1",NA,0,0,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.07994710962842,10.4374498983513,9.99723397921297,11.3028684140633,8.15784478818576,10.7567791366271,9.35901163515975,9.9447464103728,6.16564805667492,10.6464502481542,9.48479796764305,8.46908406881497,10.5005118664711,1028.6142079924,1.37348252271964,1.07684970752209,0.0190420024279981,0.0713717344178712,"B3EWY9",0,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020"
"587","Pocillopora_acuta_HIv2___TS.g25258.t1",3.3457249070632,0,0,1.28205128205128,2.28310502283105,0.125470514429109,0,3.73831775700935,0,0,1.0774669483384,1.02916791069795,1.12576598597885,NA,NA,NA,NA,NA,NA,11.6409402440774,5.57859373890424,12.0885603475555,7.66245516740606,12.4827389045586,3.68233641306884,3.68233641306884,12.5631003601748,9.90591994198763,3.68233641306884,8.29693179438707,11.7362519596708,4.85761162910336,2035.87614383464,-8.9547478641339,3.54944236857939,2.8382141518927e-10,1.37297423053431e-08,"B3EWY9",0,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020"
"588","Pocillopora_acuta_HIv2___TS.g25259.t2",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.7492808170571,3.68233641306884,12.1767123986503,8.77389895020823,11.8914765009055,3.68233641306884,3.68233641306884,12.7526942746561,6.34211912572884,3.68233641306884,7.84155277194814,10.9824566233996,4.70064892049672,1914.03784261248,-12.3400369326509,4.0425085176402,4.96638195725482e-10,2.23781148379233e-08,"B3EWY9",0,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020"
"589","Pocillopora_acuta_HIv2___RNAseq.g25717.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.89912370929782,7.58520805892439,9.50232744987269,3.68233641306884,8.8367180183084,6.71585965723107,3.68233641306884,7.77876790621937,6.49844915574363,3.68233641306884,6.58634631948039,8.10307724788838,5.0696153910724,185.488429850844,-0.900082593119451,1.53258337032094,0.000126262980181169,0.00100954546453313,"B3EWY9",0,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020"
"590","Pocillopora_acuta_HIv2___RNAseq.g25723.t1",0,13.3333333333333,20.8333333333333,NA,0,0,0,0,33.3333333333333,NA,8.4375,11.6666666666667,5.20833333333333,NA,NA,NA,NA,NA,NA,9.4090917269635,9.66253495264651,10.5884245732404,7.03911674882672,9.61623877302633,3.68233641306884,7.7818636248628,10.241569838729,11.5883832853916,3.68233641306884,8.32918963498245,10.2887416394702,6.36963763049474,825.38946599796,-0.764228244783888,1.34243391437175,0.00456938186453573,0.0215352034176099,"A7RU46",0,"Nck-associated protein 1 homolog","cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; neuron projection morphogenesis [GO:0048812]","GO:0000902; GO:0007155; GO:0016477; GO:0030031; GO:0030866; GO:0031209; GO:0048812"
"591","Pocillopora_acuta_HIv2___RNAseq.g25730.t1",0,0,0,NA,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0470427019229,10.2137391355779,10.0966222150354,10.9699037998223,11.8376841144322,8.89118066805287,10.1682244459953,9.72896165700826,11.3104683648549,9.91240068109365,10.3176227783796,10.6041558106507,10.0310897461084,1472.84648102783,-0.281441163465684,0.703236281458701,0.54112348617872,0.760724305455825,"Q63HN8",3.68e-06,"E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (E3 ubiquitin-lipopolysaccharide ligase RNF213) (EC 2.3.2.-) (Mysterin) (RING finger protein 213)","angiogenesis [GO:0001525]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792]","GO:0001525; GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005737; GO:0005811; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0051865; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051"
"592","Pocillopora_acuta_HIv2___RNAseq.g25734.t1",0,NA,NA,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.1902578621426,9.76324110902348,8.45506275286555,11.1302908695784,9.33734279728797,9.72605034463364,10.5227774030865,10.1899010631818,3.68233641306884,11.881012637225,9.48782732520938,8.37098017770935,10.6046744727094,1230.51803319162,0.414229457411077,0.965078049098614,0.287998738692369,0.534432301851344,"O00468",3.16e-50,"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","clustering of voltage-gated sodium channels [GO:0045162]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; synapse organization [GO:0050808]","GO:0002162; GO:0005200; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005886; GO:0007165; GO:0007213; GO:0007528; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0043547; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0050808; GO:0051491; GO:0062023; GO:0070062"
"593","Pocillopora_acuta_HIv2___RNAseq.g25750.t1",0,NA,0,0,0,0,NA,NA,3.84615384615385,NA,0.641025641025641,1.28205128205128,0,NA,NA,NA,NA,NA,NA,7.88837745147468,9.78952827616794,8.10303102571058,8.94051685607582,3.68233641306884,10.9037422638277,10.7277507796709,8.43384636390068,3.68233641306884,3.68233641306884,7.58338022560348,6.35798553344472,8.80877491776224,566.838061362892,0.571390699124691,1.11958831739626,0.160619495116514,0.364652390105989,"B8JKP6",4.69e-06,"GREB1-like protein","kidney development [GO:0001822]; pronephros development [GO:0048793]","GO:0001822; GO:0016020; GO:0048793"
"594","Pocillopora_acuta_HIv2___RNAseq.g25761.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.93499074257248,11.9011377423029,8.22661223412292,10.9181764799988,8.69955626266974,10.1675255555355,10.6767725045696,8.98982287729276,6.71123450989494,10.7255805571714,9.3951409466131,7.91244332531057,10.8778385679156,1143.87904687794,2.57273208064203,1.00933725086846,0.000255962166196069,0.00184374341228085,"A6NMZ7",1.41e-45,"Collagen alpha-6(VI) chain","cell adhesion [GO:0007155]","GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023"
"595","Pocillopora_acuta_HIv2___RNAseq.g25768.t1",NA,0,0,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.27801859226,8.52843578779114,7.89735631637503,8.17135353059522,7.7407611868036,9.26268617920698,3.68233641306884,7.60410977031447,7.84981669252407,3.68233641306884,7.26972108820082,7.87401251165543,6.6654296647462,225.919442803554,-0.22014036925941,0.960804288254799,0.336341594681205,0.587187138474883,"P07700",3.36e-18,"Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor) (Beta-T)","adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; positive regulation of heart contraction [GO:0045823]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]","GO:0004940; GO:0005769; GO:0005886; GO:0016020; GO:0042802; GO:0045187; GO:0045823; GO:0071880"
"596","Pocillopora_acuta_HIv2___RNAseq.g25785.t1b",0,2.41935483870968,NA,NA,0,0.366300366300366,0,0,0,NA,0.397950743572863,0.696413801252511,0,NA,NA,NA,NA,NA,NA,7.14950277613762,7.94568219541168,7.25273306942338,5.9757421057541,8.35860213271442,7.39595400278476,7.99473091893197,6.44383053581276,6.54686386219783,7.64859764944046,7.2712239248609,7.1503064752572,7.39214137446459,149.227133504578,0.169919610556324,0.70445818492341,0.72192608994403,0.875307817685881,"F6R2G2",6.72e-20,"NLR family CARD domain-containing protein 4 (Ice protease-activating factor) (Ipaf)","apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of apoptotic process [GO:0042981]","GO:0005524; GO:0005829; GO:0006915; GO:0006954; GO:0016045; GO:0042742; GO:0042981; GO:0045087"
"597","Pocillopora_acuta_HIv2___RNAseq.g25792.t1",27.9661016949153,29.8507462686567,48.4848484848485,14.2857142857143,33.75,26.8292682926829,30.7317073170732,26.865671641791,31.6666666666667,0,27.0430724652349,25.8996134311023,28.1865314993674,NA,NA,NA,NA,NA,NA,7.24570151093955,8.9513906682475,5.59369902756585,3.68233641306884,7.46167087377179,7.24570716972782,3.68233641306884,5.70976195638337,3.68233641306884,10.1247656214996,6.3379706067342,5.93863395634588,6.73730725712252,202.238764117684,-0.041076723415443,0.979452075169629,0.68299744504567,0.85324538306621,"Q96J02",1.08e-08,"E3 ubiquitin-protein ligase Itchy homolog (Itch) (EC 2.3.2.26) (Atrophin-1-interacting protein 4) (AIP4) (HECT-type E3 ubiquitin transferase Itchy homolog) (NFE2-associated polypeptide 1) (NAPP1)","apoptotic process [GO:0006915]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of cytoplasmic pattern recognition receptor signaling pathway [GO:0039532]; negative regulation of defense response to virus [GO:0050687]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0035872]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of T cell anergy [GO:0002669]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein branched polyubiquitination [GO:0141198]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; receptor internalization [GO:0031623]; regulation of cell growth [GO:0001558]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of necroptotic process [GO:0060544]; regulation of protein deubiquitination [GO:0090085]; symbiont entry into host cell [GO:0046718]; T cell anergy [GO:0002870]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001558; GO:0002669; GO:0002870; GO:0004842; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005938; GO:0006511; GO:0006513; GO:0006915; GO:0006954; GO:0016020; GO:0016567; GO:0016874; GO:0019787; GO:0031410; GO:0031623; GO:0031901; GO:0032088; GO:0032480; GO:0032991; GO:0034450; GO:0035519; GO:0035739; GO:0035872; GO:0039532; GO:0043021; GO:0043066; GO:0043161; GO:0043231; GO:0044389; GO:0045087; GO:0045236; GO:0045732; GO:0046329; GO:0046718; GO:0050687; GO:0051607; GO:0051865; GO:0060544; GO:0061630; GO:0070062; GO:0070534; GO:0070936; GO:0090085; GO:0141198; GO:1902036; GO:1990763; GO:2000562; GO:2000646"
"598","Pocillopora_acuta_HIv2___RNAseq.g25793.t1",0,0,0,0,1.4367816091954,0.573613766730402,0,2.27272727272727,0,0,0.428312264865308,0.569268207891535,0.28735632183908,NA,NA,NA,NA,NA,NA,10.0434245629354,9.03876207521893,10.1996728100115,9.61516588688094,10.8697638429844,9.76557729216204,8.92630023762092,9.28692917524323,9.80216410803438,6.07894006001887,9.36267000511106,10.0403908998418,8.68494911038034,810.223612639006,-0.853739592768266,0.792371569093322,0.103188605941392,0.267572606012242,"F6R2G2",5e-22,"NLR family CARD domain-containing protein 4 (Ice protease-activating factor) (Ipaf)","apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of apoptotic process [GO:0042981]","GO:0005524; GO:0005829; GO:0006915; GO:0006954; GO:0016045; GO:0042742; GO:0042981; GO:0045087"
"599","Pocillopora_acuta_HIv2___RNAseq.g25815.t3",0,NA,0,0,0,1.37931034482759,0,0,0,0,0.153256704980843,0.344827586206897,0,NA,NA,NA,NA,NA,NA,6.54977203526203,11.2330754556614,7.74513402854738,11.5988745276666,9.72475359252705,10.7436454377606,12.229064856821,10.835727356224,9.82480531429808,3.68233641306884,9.4167189017837,8.93603846537171,9.89739933819569,1568.52951002504,0.381264329715428,1.01202219346606,0.22673486611656,0.459892455968297,"Q8TEU7",0,"Rap guanine nucleotide exchange factor 6 (PDZ domain-containing guanine nucleotide exchange factor 2) (PDZ-GEF2) (RA-GEF-2)","microvillus assembly [GO:0030033]; positive regulation of GTPase activity [GO:0043547]; protein localization to plasma membrane [GO:0072659]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087]","GO:0005085; GO:0005813; GO:0005829; GO:0005886; GO:0007265; GO:0016324; GO:0030033; GO:0030139; GO:0030742; GO:0031267; GO:0043087; GO:0043547; GO:0070300; GO:0072659"
"600","Pocillopora_acuta_HIv2___RNAseq.g25835.t1",14.8148148148148,0,0,NA,0,0,0,0,0,NA,1.85185185185185,0,3.7037037037037,NA,NA,NA,NA,NA,NA,8.63326185632858,10.0363261246451,9.59821487799019,3.68233641306884,8.13467733294935,9.04907248628624,10.0139825914324,9.59120293861953,4.79801079550852,3.68233641306884,7.72194218298976,8.15107356027923,7.29281080570028,466.87301570517,-0.161448960767092,0.932971498989419,0.512033925659836,0.738540375831426,"A4L691",1.22e-46,"PIN2/TERF1-interacting telomerase inhibitor 1 (Pin2-interacting protein X1)","mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein localization to nucleolus [GO:1904751]; protein localization to chromosome, telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; telomere maintenance via telomerase [GO:0007004]","GO:0000228; GO:0000776; GO:0000781; GO:0005730; GO:0005819; GO:0007004; GO:0007080; GO:0010521; GO:0010972; GO:0031397; GO:0031647; GO:0032211; GO:0044877; GO:0070034; GO:0070198; GO:1902570; GO:1904751"
"601","Pocillopora_acuta_HIv2___RNAseq.g25839.t1",0,NA,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.3255022112939,3.68233641306884,9.3787979777414,3.68233641306884,8.59533660496169,3.68233641306884,3.68233641306884,5.40874075538327,10.9042473236794,3.68233641306884,6.30243069384039,8.92252497461193,3.68233641306884,417.103348683199,-13.4598536536592,3.82287936511623,5.51073155962331e-11,3.52686819815892e-09,"Q9UDY8",8.87e-39,"Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase)","B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]","GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043280; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051092; GO:0051168; GO:0051603; GO:2000321"
"602","Pocillopora_acuta_HIv2___RNAseq.g25845.t1",0,NA,NA,NA,0,14.7368421052632,30.9090909090909,0,0,NA,7.60765550239234,4.91228070175439,10.3030303030303,NA,NA,NA,NA,NA,NA,7.66090630254611,5.6784794012365,4.27948719681471,3.68233641306884,5.48185943121106,8.57558454812183,3.68233641306884,6.95560773578551,5.03316817358995,7.72930987565577,5.87590754910991,5.88220576798947,5.86960933023036,88.6654027480912,-0.136502870865271,0.986386570790642,0.401494021251836,0.647688775786327,NA,NA,NA,NA,NA
"603","Pocillopora_acuta_HIv2___TS.g25420.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.80069986429418,3.68233641306884,9.71134969819812,3.68233641306884,9.74302726041473,9.19565437983657,10.5669982229049,10.8680217084164,10.1250272989223,3.68233641306884,8.10577876721937,10.0496251660491,6.1619323683896,749.760738237616,-0.497170150858703,1.12542154289682,2.05262039470001e-06,2.92466595394987e-05,NA,NA,NA,NA,NA
"604","Pocillopora_acuta_HIv2___RNAseq.g25875.t1",0,0,0,0,NA,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.5689062615058,10.0260453652334,10.185920938408,8.16562923854076,10.1975015671922,7.87054151223103,9.55371595176991,9.68377705445435,6.6827526322222,3.68233641306884,8.66171269346265,9.46377169075651,7.85965369616879,687.139508920873,-0.999824796298791,1.07360123850074,0.0576466419855769,0.173708547849872,"Q9CWF6",0,"BBSome complex member BBS2 (Bardet-Biedl syndrome 2 protein homolog)","adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; response to leptin [GO:0044321]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601]","GO:0005737; GO:0005902; GO:0007288; GO:0007601; GO:0008104; GO:0010467; GO:0010629; GO:0014824; GO:0016020; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0032420; GO:0033210; GO:0033365; GO:0034451; GO:0034464; GO:0036064; GO:0038108; GO:0040015; GO:0040018; GO:0042311; GO:0043001; GO:0043005; GO:0044321; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0060170; GO:0060271; GO:0060296; GO:0061629; GO:1905515"
"605","Pocillopora_acuta_HIv2___RNAseq.g25877.t1",0,0,NA,0,0,6,0,0,0,0,0.666666666666667,1.2,0,NA,NA,NA,NA,NA,NA,9.65339371441214,6.50720798490726,8.79197399641058,3.68233641306884,8.98638359098042,9.68845937260027,3.68233641306884,10.2559986509068,3.68233641306884,3.68233641306884,6.86127629624928,8.27401727315576,5.44853531934281,374.36433938678,-0.369140627631311,1.08253777068499,0.0588121998584536,0.176375629017763,"P08836",5.93e-141,"Farnesyl pyrophosphate synthase (FPP synthase) (FPS) (EC 2.5.1.10) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Geranyltranstransferase)","cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]","GO:0004161; GO:0004337; GO:0005737; GO:0006695; GO:0033384; GO:0045337; GO:0046872"
"606","Pocillopora_acuta_HIv2___RNAseq.g25890.t1",26.3157894736842,57.6923076923077,0,20.1005025125628,29.3423271500843,25.1497005988024,70.6349206349206,0,0,42.8571428571429,27.2092690919505,20.5885021607346,33.8300360231664,NA,NA,NA,NA,NA,NA,9.32811847350323,11.6796837482755,11.6705971420302,12.4932311124039,10.538164349676,11.2696902193008,12.5423509665282,10.6212285545536,9.05425581488638,12.917749898453,11.2115070279611,10.2424728669299,12.1805411889923,3245.87267948305,1.4720704391473,0.8302478168261,0.0117121343110786,0.0474011340885834,"B3EWZ5",2.83e-80,"MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1)","","GO:0005576; GO:0016020"
"607","Pocillopora_acuta_HIv2___TS.g25474.t1",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.83894995413197,3.68233641306884,8.73766657024434,3.68233641306884,8.38337062067286,9.54438909557558,3.68233641306884,7.17376781449862,3.68233641306884,9.47286620608927,6.3880355913488,6.76321827452333,6.01285290817427,227.100771306857,-0.141994636958537,1.01791475336126,0.00238790790106006,0.012437414433177,NA,NA,NA,NA,NA
"608","Pocillopora_acuta_HIv2___RNAseq.g25935.t1",0,0,0,NA,NA,1.69491525423729,11.4285714285714,0,0,NA,1.87478381182982,0.423728813559322,3.80952380952381,NA,NA,NA,NA,NA,NA,12.4548949619687,16.0208259110725,11.6227470270793,16.2741865974186,12.8359917395608,16.793806421224,15.5636605285907,13.4798011537779,10.785621183678,16.2393864693419,14.2070921993712,12.2358112132129,16.1783731855295,41416.6959166268,3.66254966164606,0.839729123943442,1.56159025853877e-07,3.1812452816204e-06,"B3EWZ6",0,"MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2)","","GO:0005576; GO:0016020"
"609","Pocillopora_acuta_HIv2___TS.g25486.t1",0,NA,0,0,3.57142857142857,0.505050505050505,6.59340659340659,0,0,NA,1.33373570873571,0.126262626262626,2.54120879120879,NA,NA,NA,NA,NA,NA,13.8271746616323,13.8659438500791,13.373896637669,13.7821997044314,13.4522228900768,13.7587323263143,14.1368589376666,13.3154369542136,14.2441091732102,14.442960503046,13.8199535638339,13.6425680633604,13.9973390643075,14886.5598663043,0.276800132409076,0.49028710607867,0.517821386534715,0.7425169559669,"G1T1F0",4.56e-86,"Small ribosomal subunit protein uS11 (40S ribosomal protein S14)","ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]","GO:0000028; GO:0003735; GO:0005730; GO:0006412; GO:0022627"
"610","Pocillopora_acuta_HIv2___RNAseq.g25940.t1",0,0,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.5350053136646,12.335327791996,11.8900055676741,9.36387956026705,11.4670739591076,11.9759224017927,10.2761843539662,11.6667683637721,11.3852611747322,9.62774969672687,11.1523178183699,11.5888228757901,10.7158127609498,2715.00449590428,-0.536759786132121,0.728929663763499,0.262713864187706,0.50517061042422,"Q92903",0,"Phosphatidate cytidylyltransferase 1 (EC 2.7.7.41) (CDP-DAG synthase 1) (CDP-DG synthase 1) (CDP-diacylglycerol synthase 1) (CDS 1) (CDP-diglyceride pyrophosphorylase 1) (CDP-diglyceride synthase 1) (CTP:phosphatidate cytidylyltransferase 1)","CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042]; phosphatidylinositol biosynthetic process [GO:0006661]; phototransduction [GO:0007602]; positive regulation of fat cell differentiation [GO:0045600]; signal transduction [GO:0007165]","GO:0004142; GO:0004605; GO:0005783; GO:0005789; GO:0006661; GO:0007165; GO:0007602; GO:0016020; GO:0016024; GO:0045600; GO:0140042"
"611","Pocillopora_acuta_HIv2___RNAseq.g25943.t1",0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.7732326587915,3.68233641306884,10.1371262287482,5.35568868274662,10.8739166989822,3.68233641306884,7.16145990783134,7.04807821226724,7.51177934837273,6.69082909769463,5.38597992579658,7.99567826959269,354.90115300574,0.289357668447815,1.05191337831889,0.00389734010511683,0.0188653525649075,"Q9H694",0,"Protein bicaudal C homolog 1 (Bic-C)","determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; kidney development [GO:0001822]; negative regulation of canonical Wnt signaling pathway [GO:0090090]","GO:0001822; GO:0003723; GO:0005737; GO:0007368; GO:0007507; GO:0090090"
"612","Pocillopora_acuta_HIv2___RNAseq.g25951.t2",NA,50,47.6190476190476,50,62.5,52.3809523809524,42.8571428571429,NA,NA,NA,50.8928571428571,50.7936507936508,50.9920634920635,NA,NA,NA,NA,NA,NA,12.6609520989154,12.1513238906422,12.2870923970897,11.8040212620391,12.4342985231292,12.2890640751706,11.2373812097767,11.9721857378907,12.3026092042281,12.6895561244873,12.1828484523369,12.3314275922506,12.0342693124232,4797.18210435091,-0.226134912916567,0.507818725577537,0.599952757213112,0.800857926605757,"Q4KM31",1.12e-35,"LIM domain-containing protein 2","actin filament bundle assembly [GO:0051017]","GO:0005634; GO:0005737; GO:0005886; GO:0015629; GO:0046872; GO:0051015; GO:0051017"
"613","Pocillopora_acuta_HIv2___RNAseq.g25983.t1",0,0,NA,0,0,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,11.2221655470454,8.99724367835348,11.2948839594093,11.4984846449866,11.3423849225543,10.4112760722302,9.26495542064035,11.3850408657148,11.3144729432997,12.3532568045251,10.9084164858759,11.3117896476047,10.5050433241471,2307.73099069103,-0.500922890267008,0.717278120105434,0.294524467086307,0.541613903558093,"Q60HH8",1.33e-178,"Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Fatty aldehyde dehydrogenase)","fatty acid metabolic process [GO:0006631]; hexadecanal metabolic process [GO:0046458]","GO:0005789; GO:0006631; GO:0043878; GO:0046458; GO:0050061; GO:0052814"
"614","Pocillopora_acuta_HIv2___RNAseq.g26000.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.554028475323,7.09062453168391,8.05935642606527,7.49865221587083,7.72918915039274,7.81564362332017,7.61470949026634,7.46627967311383,7.48423808046673,8.36973113590363,7.76824528024065,7.85861836107231,7.67787219940898,203.102135004287,-0.123794076286718,0.608158966692193,0.786902584174317,0.909885600567377,"Q9C0H5",6.79e-106,"Rho GTPase-activating protein 39","postsynapse organization [GO:0099173]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]","GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007165; GO:0051056; GO:0098978; GO:0099173"
"615","Pocillopora_acuta_HIv2___RNAseq.g26017.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.8122553324231,11.3924655678014,9.71262925374832,3.68233641306884,10.6676424416293,10.6149288911509,10.8915427649337,9.39129524057586,9.86749148923332,3.68233641306884,9.07149238076336,10.090262751522,8.05272201000474,1182.1271958435,-0.189434442723686,0.963337962799353,0.347041404214295,0.598427142412441,"E7F1U2",6.9e-104,"Dynamin-binding protein (Scaffold protein Tuba)","cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]","GO:0001822; GO:0005085; GO:0005737; GO:0005794; GO:0005795; GO:0005856; GO:0005911; GO:0035556; GO:0045202; GO:0060271; GO:0098793"
"616","Pocillopora_acuta_HIv2___TS.g25570.t1",1.64981373070782,2.22016651248844,1.16144018583043,0.7145859604876,1.13458528951487,0.531914893617021,1.8037518037518,1.14068441064639,2.2470011826322,0.900277008310249,1.35042209779868,1.37087059197433,1.32997360362303,NA,NA,NA,NA,NA,NA,8.44477204554908,3.68233641306884,6.72688650906576,3.68233641306884,5.7009801482996,8.78399003293727,6.74136374297954,5.49643519805837,8.10422827110476,3.68233641306884,6.10456651872009,6.89466043441551,5.31447260302467,120.613344810133,-0.209578542989351,1.02648561326989,0.00068226403765819,0.00425539760271154,NA,NA,NA,NA,NA
"617","Pocillopora_acuta_HIv2___RNAseq.g26025.t1",NA,0,0,NA,0,2.32558139534884,0,0,NA,NA,0.387596899224806,0.775193798449612,0,NA,NA,NA,NA,NA,NA,8.03683150346764,7.69352644314077,8.59497937886371,7.85286315275548,9.46683765125607,6.3891072326092,11.4719668117056,7.82997741321486,7.61674954260043,3.68233641306884,7.86351755426826,8.30907509788054,7.41796001065598,491.860957923886,-0.312838309781145,0.951429093341223,0.273825567395542,0.518676402148915,"P53461",1.54e-175,"Actin, nonmuscle (EC 3.6.4.-) [Cleaved into: Actin, nonmuscle, intermediate form]","","GO:0005524; GO:0005737; GO:0005856; GO:0016787"
"618","Pocillopora_acuta_HIv2___RNAseq.g26028.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.4009524664638,10.8665713102687,10.329594522555,8.41752635455256,10.5756693408269,9.63571031451302,10.0895595506413,10.2977415611361,11.8156704283865,8.11950883152966,10.0548504680874,10.6839256638737,9.42577527230105,1314.59558391157,-0.731295632372016,0.799835520359099,0.146290547637628,0.342718898773996,"Q6GQ69",2.6e-119,"FAS-associated factor 2-B (UBX domain-containing protein 8-B)","stress granule disassembly [GO:0035617]","GO:0005783; GO:0005811; GO:0030674; GO:0035617"
"619","Pocillopora_acuta_HIv2___RNAseq.g26031.t1a",0,0,NA,0,0,4.65116279069767,0,NA,0,0,0.581395348837209,1.16279069767442,0,NA,NA,NA,NA,NA,NA,14.6846547264384,11.8616319787725,14.0435620869392,8.48798210411924,14.1267326870422,3.68233641306884,3.68233641306884,12.661890185664,15.1679245765499,11.0756457984546,10.9474696970118,14.1369528525267,7.7579865414968,11043.6237038499,-3.07564727927596,4.91351753417192,0.000137372505370465,0.00108407882487095,"Q505H7",1.53e-11,"Protein IWS1 homolog (IWS1-like protein)","mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]","GO:0005634; GO:0006397; GO:0008380; GO:0051028"
"620","Pocillopora_acuta_HIv2___RNAseq.7766_t",2.39234449760766,0,0,2.9585798816568,1.5,0.163398692810458,1.34228187919463,0,0,NA,0.928511661252172,0.624395714893452,1.30865659420057,NA,NA,NA,NA,NA,NA,6.80261710823671,3.68233641306884,7.72999801151893,7.45223252512044,7.57819845214682,8.43359952480108,11.1221439689528,9.02058697355857,3.68233641306884,3.68233641306884,6.91863858035419,6.96274739170597,6.8745297690024,360.94126684897,0.00461156950618675,0.916547917187623,0.996146299046706,0.998998670844531,NA,NA,NA,NA,NA
"621","Pocillopora_acuta_HIv2___RNAseq.g26117.t1b",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.60860163372973,3.68233641306884,8.97166705922816,9.7756996894191,7.63308315590689,4.21083509301726,3.68233641306884,4.74601725290823,5.8874486244384,3.68233641306884,5.78803617478543,6.56936354524228,5.00670880432858,157.327138404517,-3.46982121210275,4.13029940609561,0.000569692463816763,0.00365735987423243,NA,NA,NA,NA,NA
"622","Pocillopora_acuta_HIv2___RNAseq.g26118.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.89740667346111,9.01518395889101,10.2630429819294,3.68233641306884,10.7915406146931,3.68233641306884,3.68233641306884,9.73515540992119,11.1423556233323,3.68233641306884,7.55740309145035,10.3659002606674,4.74890592223327,743.19810752368,-1.20752581076459,2.48962691333417,2.26654201616777e-09,8.13480489375947e-08,"C9D7C2",0,"Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein)","calcium ion import across plasma membrane [GO:0098703]; chemical synaptic transmission [GO:0007268]","GO:0005509; GO:0005891; GO:0007268; GO:0008331; GO:0045202; GO:0098703"
"623","Pocillopora_acuta_HIv2___TS.g25674.t1",9.75609756097561,6.46766169154229,12.1739130434783,12.2137404580153,5.69476082004556,8.96551724137931,7.11206896551724,2.99145299145299,5.97826086956522,NA,7.92816373799686,7.32332665039102,8.68421009750417,NA,NA,NA,NA,NA,NA,8.48805428837023,10.5297355025519,10.3119767157659,10.537377341562,10.8565761248705,11.5721104433635,9.40150960197363,9.79171594359522,3.68233641306884,3.68233641306884,8.88537287881906,8.62613189713414,9.14461386050397,1085.22917796731,0.350035693559276,0.734724436315057,0.468694772044996,0.707466028137282,"Q9BPX6",8.75e-70,"Calcium uptake protein 1, mitochondrial (Atopy-related autoantigen CALC) (ara CALC) (Calcium-binding atopy-related autoantigen 1) (allergen Hom s 4)","calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; cellular response to calcium ion [GO:0071277]; cellular response to calcium ion starvation [GO:0072732]; defense response [GO:0006952]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of cristae formation [GO:1903852]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein homooligomerization [GO:0051260]; regulation of cellular hyperosmotic salinity response [GO:1900069]","GO:0005509; GO:0005739; GO:0005743; GO:0005758; GO:0006851; GO:0006952; GO:0019855; GO:0031966; GO:0034704; GO:0036444; GO:0042802; GO:0044284; GO:0046982; GO:0051260; GO:0051560; GO:0051561; GO:0061891; GO:0070509; GO:0071277; GO:0072732; GO:1900069; GO:1903852; GO:1990246"
"624","Pocillopora_acuta_HIv2___RNAseq.g26129.t1",0,0.763358778625954,7.95454545454545,4.85436893203883,1.6304347826087,0,1.13636363636364,0,2.67857142857143,NA,2.11307144586156,1.65925982784724,2.68033596837945,NA,NA,NA,NA,NA,NA,9.29400515509404,9.1859200648479,8.91273989231603,10.1760120312495,10.6631046828266,9.77708389813906,8.67221358884646,10.2335720335027,8.05023889764809,5.49240068675675,9.04572909312271,9.43073213227749,8.66072605396793,701.923512194907,-0.50065024202333,0.761084573695966,0.292935647843671,0.539885475332678,"Q08BI9",1.23e-121,"Calcium uniporter protein, mitochondrial","actin filament organization [GO:0007015]; calcium import into the mitochondrion [GO:0036444]; calcium-mediated signaling [GO:0019722]; chordate embryonic development [GO:0043009]; convergent extension involved in gastrulation [GO:0060027]; establishment of localization in cell [GO:0051649]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein complex oligomerization [GO:0051259]; regulation of heart contraction [GO:0008016]","GO:0005262; GO:0005743; GO:0006851; GO:0007015; GO:0008016; GO:0015292; GO:0019722; GO:0032024; GO:0034704; GO:0036444; GO:0042593; GO:0042802; GO:0043009; GO:0046872; GO:0051259; GO:0051560; GO:0051561; GO:0051649; GO:0060027; GO:1990246"
"625","Pocillopora_acuta_HIv2___RNAseq.g26136.t1",0.514018691588785,0.169635284139101,0.368324125230203,0.872515753756665,0.630828304991772,0.81769436997319,0.503220611916264,0.766016713091922,1.44491270319085,1.64383561643836,0.773100217431711,0.814154964830345,0.732045470033076,NA,NA,NA,NA,NA,NA,6.53584217462236,9.25296372067976,9.41226279448059,9.56177886745259,8.6534867942961,7.98936040530523,3.68233641306884,4.1247493465216,8.17151122259478,8.94721251437447,7.63315042533963,7.37957046650309,7.88673038417618,337.902455414447,0.196766267100436,0.747997956752229,0.693731885635878,0.859455074418616,"O43426",0,"Synaptojanin-1 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1)","inositol phosphate metabolic process [GO:0043647]; learning [GO:0007612]; membrane organization [GO:0061024]; neurotransmitter transport [GO:0006836]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation of endosome organization [GO:1904980]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191]","GO:0003723; GO:0004438; GO:0004439; GO:0005829; GO:0006661; GO:0006836; GO:0007612; GO:0012506; GO:0016082; GO:0016191; GO:0017124; GO:0030117; GO:0030132; GO:0034595; GO:0034596; GO:0043195; GO:0043647; GO:0043812; GO:0043813; GO:0046488; GO:0046856; GO:0048471; GO:0048488; GO:0048489; GO:0052629; GO:0052658; GO:0061024; GO:0097060; GO:0098793; GO:1904980"
"626","Pocillopora_acuta_HIv2___RNAseq.g26137.t1",5.23690773067332,12.7272727272727,23.3644859813084,10.0502512562814,11.8279569892473,10.1010101010101,16.8449197860963,8.69565217391304,8.16326530612245,0,10.7011722051925,9.94749031291995,11.4548540974651,NA,NA,NA,NA,NA,NA,11.4677672806166,11.8163346435566,10.6841341446797,10.9130707535776,11.6301683379825,11.0702163664886,11.913142755309,11.1242351652427,11.0215748519355,5.96509637913949,10.7605740678528,11.1855759560914,10.3355721796143,2330.88367799602,-0.211966937773635,0.777132775938406,0.618107803445719,0.8130512249035,"Q15428",5.04e-125,"Splicing factor 3A subunit 2 (SF3a66) (Spliceosome-associated protein 62) (SAP 62)","mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241]","GO:0000245; GO:0000389; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0006397; GO:0008270; GO:0010976; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241"
"627","Pocillopora_acuta_HIv2___RNAseq.g2472.t1",0,NA,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,4.95179328310793,3.68233641306884,7.38136255625802,7.3342463704392,6.10179861046554,6.61523549873737,3.68233641306884,6.0528465675844,7.47604694481752,3.68233641306884,5.69603390706165,6.39276959244668,4.99929822167662,60.5284652634564,-0.50518977633272,1.11646852394038,0.00895327504866738,0.0379543289284657,"P35601",1.65e-46,"Replication factor C subunit 1 (A1-P145) (Activator 1 140 kDa subunit) (A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (Differentiation-specific element-binding protein) (ISRE-binding protein) (Replication factor C 140 kDa subunit) (RF-C 140 kDa subunit) (RFC140) (Replication factor C large subunit)","DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]","GO:0000122; GO:0003677; GO:0003689; GO:0003690; GO:0005524; GO:0005634; GO:0005663; GO:0006261; GO:0006281; GO:0016887; GO:0019904; GO:0031391; GO:0032991; GO:0043565; GO:0045892; GO:0045893; GO:0061860; GO:0140297"
"628","Pocillopora_acuta_HIv2___RNAseq.g2507.t1",0,0,0,0,NA,9.09090909090909,0,0,NA,NA,1.2987012987013,2.27272727272727,0,NA,NA,NA,NA,NA,NA,13.6241863411786,13.833050015725,12.7249480411237,13.6676314050467,13.0191548406818,13.4994003691185,13.7769688719522,12.838000046606,13.4518081848116,13.8671544532545,13.4302302569499,13.1316194908803,13.7288410230194,11413.4773715878,0.475547067150003,0.505216142040032,0.280157741641456,0.525986704971706,"Q962Q6",5.24e-74,"Small ribosomal subunit protein eS24 (40S ribosomal protein S24)","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412; GO:1990904"
"629","Pocillopora_acuta_HIv2___TS.g9184.t1",0,0,NA,0,0,3.2258064516129,0,0,3.2258064516129,0,0.716845878136201,1.29032258064516,0,NA,NA,NA,NA,NA,NA,11.3953507171612,9.81704961377314,11.6992734766,9.48584683553142,10.6826660318026,10.6292823116145,9.99714916713232,11.139100527246,9.42204039542079,10.6210868293653,10.4888845905647,10.8676862296461,10.1100829514833,1614.83196797112,-0.488635550027047,0.69791799207091,0.30743503478314,0.555887657779777,"P97499",2.18e-43,"Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog)","telomere maintenance via recombination [GO:0000722]","GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904"
"630","Pocillopora_acuta_HIv2___RNAseq.g2519.t1",0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,11.7618101617432,8.31311141953989,13.0697845115291,7.73395220400599,12.4834539851833,6.61523549873737,3.68233641306884,11.7511783132839,10.9608223059771,12.0481713495695,9.84198561626382,12.0054098555433,7.67856137698432,2787.3644931296,-1.83447772980934,4.0407641061666,0.000445549640412367,0.00296440177851899,"O75899",1.2e-86,"Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]","GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712"
"631","Pocillopora_acuta_HIv2___RNAseq.g2520.t1",0,NA,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.97481821212063,10.5266136805201,10.1822315202725,8.98339297918665,9.35496220863709,9.71711747698019,10.3050691195705,9.38998714424826,10.1623292239684,3.68233641306884,9.12788579785732,9.61286566184938,8.64290593386526,799.555138980526,-0.0896358248854223,0.877687321172234,0.785122950224934,0.908824058658276,"Q9UBQ7",3.68e-129,"Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81)","carboxylic acid metabolic process [GO:0019752]; dicarboxylic acid metabolic process [GO:0043648]; glyoxylate metabolic process [GO:0046487]","GO:0005737; GO:0005782; GO:0005829; GO:0008465; GO:0016618; GO:0019752; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0051287; GO:0070062; GO:0070402; GO:1902494"
"632","Pocillopora_acuta_HIv2___RNAseq.g2543.t1",100,66.6666666666667,30,NA,100,58.3333333333333,NA,NA,100,NA,75.8333333333333,75,76.6666666666667,NA,NA,NA,NA,NA,NA,7.8556469288185,8.80092184181281,7.26683347298246,8.97033570352069,6.51427663130281,9.34811557506063,3.68233641306884,9.54963352679001,3.68233641306884,3.68233641306884,6.93527729194944,6.97374539459252,6.89680918930636,265.079626561741,0.113626777026332,0.961856071315511,0.604719229416494,0.803793391691069,"A0A974CYQ5",7.9e-127,"E3 ubiquitin-protein ligase rfwd3.S (EC 2.3.2.27) (RING finger and WD repeat domain-containing protein 3.S)","interstrand cross-link repair [GO:0036297]; protein ubiquitination [GO:0016567]","GO:0005737; GO:0016567; GO:0016605; GO:0036297; GO:0046872; GO:0061630"
"633","Pocillopora_acuta_HIv2___RNAseq.g2567.t1",NA,0,0,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.46426605855417,3.68233641306884,9.4904400418801,3.68233641306884,9.17535618054152,3.68233641306884,3.68233641306884,8.54625199406914,10.4398505740941,3.68233641306884,6.55278469144832,9.42323296982781,3.68233641306884,363.961123913796,-13.5037175528493,3.67728355424626,1.52955486368694e-12,1.82838690482379e-10,"P0C7M7",9.38e-55,"Acyl-coenzyme A synthetase ACSM4, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 4)","acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]","GO:0004321; GO:0005524; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0046872; GO:0102391"
"634","Pocillopora_acuta_HIv2___RNAseq.g2577.t1",0,0,0,83.3333333333333,0,0,0,NA,NA,NA,11.9047619047619,27.7777777777778,0,NA,NA,NA,NA,NA,NA,9.60184042606426,11.2615196837178,9.93501527358037,11.4842113613197,8.18346933366442,11.7082866628727,13.106999305035,8.95485204357217,5.49910115103059,11.686891706309,10.1422186947166,8.43485564558236,11.8495817438508,2312.20319626339,2.78787327555219,1.24098440740164,0.000300130608768607,0.00211245212906527,"B2RVL6",9.01e-80,"Zinc finger CCHC domain-containing protein 24","","GO:0003676; GO:0008270"
"635","Pocillopora_acuta_HIv2___RNAseq.g2602.t1",NA,0,0,0,28.5714285714286,0,0,0,NA,NA,4.08163265306122,0,9.52380952380952,NA,NA,NA,NA,NA,NA,9.01726512697266,11.9705505213532,9.59266579118102,3.68233641306884,8.46916401890907,10.0912303871701,12.4962708126464,10.464191318518,10.7531111443766,3.68233641306884,9.02191219472647,9.65927947999147,8.38454490946148,1546.09546521936,0.0155220799657429,0.971232271170249,0.942249489935446,0.978510670765816,"Q9U3S9",5.61e-45,"Zinc metalloproteinase nas-6 (EC 3.4.24.-) (Nematode astacin 6)","nematode pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465]; proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270; GO:0043050; GO:0060465"
"636","Pocillopora_acuta_HIv2___RNAseq.g2625.t1",0,0,0,0,0,0,1.0989010989011,0,NA,NA,0.137362637362637,0,0.274725274725275,NA,NA,NA,NA,NA,NA,8.54038827674961,3.68233641306884,8.31025247179496,3.68233641306884,8.45988018243229,9.8124614492482,3.68233641306884,9.68377705445435,5.98677490518935,3.68233641306884,6.55228799921441,8.19621457812411,4.90836142030471,267.72441808795,-0.699789987385819,1.38455685105791,4.70650285904948e-06,5.97147871520102e-05,NA,NA,NA,NA,NA
"637","Pocillopora_acuta_HIv2___RNAseq.g2626.t1",4.75257226849584,2.12264150943396,2.64719306252853,2.12435233160622,5.67970204841713,0.994504056529704,7.12219007344758,2.93378038558257,1.34715025906736,3.87096774193548,3.35950537370444,1.90448570844396,4.81452503896491,2,15.2717860224331,15.2717860224331,0.0393266166853818,0.0356457019867086,0.0430075313840551,3.68233641306884,7.51097603982434,3.68233641306884,5.92008485977766,3.68233641306884,3.68233641306884,10.9759633526356,5.72748248273486,4.57231842518309,7.45858994505755,5.68947607574885,4.26936202942489,7.1095901220728,237.041366217848,5.69051302814439,2.2676242913625,0.0001246384152025,0.00100042732380075,NA,NA,NA,NA,NA
"638","Pocillopora_acuta_HIv2___RNAseq.g2666.t1",7,25.531914893617,19.6969696969697,14.2857142857143,22.1374045801527,22.9219143576826,39.0625,22.1153846153846,42.5925925925926,0,21.5344395022114,25.4895041489982,17.5793748554245,NA,NA,NA,NA,NA,NA,6.09390500287516,5.93854123587151,4.75546742395967,6.35341254798027,6.06421730587923,6.82103953412585,7.86543438598675,6.95560773578551,7.36504895374022,8.70723856771838,6.69199126939225,6.24684928444796,7.13713325433655,112.234319332152,0.839930767163111,0.739059795529061,0.11247353571854,0.284753747885849,NA,NA,NA,NA,NA
"639","Pocillopora_acuta_HIv2___TS.g9361.t1",8.33333333333333,NA,0,0,0,0,0,0,0,0,0.925925925925926,0,1.66666666666667,NA,NA,NA,NA,NA,NA,11.4637127903118,10.845847820776,11.6830500936672,10.3485712516589,10.8521532907798,10.1653382397688,10.1010635017712,10.831398412177,12.2027524373764,9.86233816861592,10.8356226006903,11.4066134048624,10.2646317965182,2056.32038678139,-0.886224298316334,0.616226333794296,0.0722174982285511,0.206181530020375,"Q8IVV2",0,"Lipoxygenase homology domain-containing protein 1","sensory perception of sound [GO:0007605]","GO:0007605; GO:0032420"
"640","Pocillopora_acuta_HIv2___RNAseq.g2694.t1",0,0,0,NA,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.88128218725479,7.57714788864859,8.77980998601604,9.16339242140137,8.65552076666099,3.68233641306884,3.68233641306884,8.45403667001078,3.68233641306884,11.3901867435856,7.49483859027847,7.89059720460229,7.09907997595465,540.787440588702,-0.160143777751822,1.00611949211116,0.199035578876397,0.42174781905482,"Q5THR3",2.89e-41,"EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein) (DJBP)","flagellated sperm motility [GO:0030317]","GO:0005509; GO:0005654; GO:0030317; GO:0036126; GO:0160111"
"641","Pocillopora_acuta_HIv2___RNAseq.g2695.t1",NA,0,0,NA,0,15.7894736842105,0,NA,0,NA,2.63157894736842,5.26315789473684,0,NA,NA,NA,NA,NA,NA,10.3373699399139,8.97907720476769,6.00006370517053,8.40301150528128,9.64311871243438,9.02272138448691,8.2176084435896,10.3941688867645,8.26923806364654,10.4194883806257,8.9685866226681,8.92879186158597,9.00838138375024,659.071507106909,0.0338031421588923,0.782194507398826,0.936796830757542,0.976536811102885,"A2CEI6",0,"Piwi-like protein 2 (EC 3.1.26.-)","gamete generation [GO:0007276]; germ-line stem cell population maintenance [GO:0030718]; meiotic cell cycle [GO:0051321]; negative regulation of SMAD protein signal transduction [GO:0060392]; oogenesis [GO:0048477]; piRNA processing [GO:0034587]; positive regulation of gene expression [GO:0010628]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; retrotransposon silencing by heterochromatin formation [GO:0141005]; retrotransposon silencing by piRNA-directed DNA methylation [GO:0141196]; rhythmic process [GO:0048511]; secondary piRNA processing [GO:0140965]; spermatogenesis [GO:0007283]","GO:0004521; GO:0005634; GO:0005737; GO:0006417; GO:0007276; GO:0007283; GO:0010628; GO:0030718; GO:0031047; GO:0034584; GO:0034587; GO:0043186; GO:0046872; GO:0048477; GO:0048511; GO:0051321; GO:0060392; GO:0071546; GO:0140965; GO:0141005; GO:0141196; GO:1990923"
"642","Pocillopora_acuta_HIv2___RNAseq.g2703.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.45745779544039,9.68324669387319,9.64989267794005,8.73581748555832,9.07107603424614,7.66842603524761,10.7323811196821,8.9441931046482,8.93141557112441,3.68233641306884,8.45562429308293,8.81080703667984,8.10044154948601,542.346355364827,-0.110566277431129,0.897965100538615,0.692482121763139,0.85904909672647,"Q8TC84",7.62e-105,"Fibronectin type 3 and ankyrin repeat domains protein 1","negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of apoptotic process [GO:0042981]","GO:0000785; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005929; GO:0036064; GO:0042981; GO:0043065; GO:0043066; GO:0045893; GO:0051091; GO:0097546"
"643","Pocillopora_acuta_HIv2___RNAseq.g2716.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.91745501028,12.2343481451765,9.89387414869397,12.3412433262277,10.9132966553252,12.9439992168773,12.2398361881826,10.937696988756,6.44828135143128,12.3801853518858,11.1250216382836,9.82212083089729,12.42792244567,3466.38289277091,1.73401999096258,1.0683149350344,0.00807361704085409,0.0349421893713086,"O88818",0,"Plastin-3 (T-plastin)","actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]","GO:0005509; GO:0005737; GO:0005884; GO:0032432; GO:0051015; GO:0051017; GO:0051639"
"644","Pocillopora_acuta_HIv2___TS.g9396.t2",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.8801079058254,10.5887995686885,11.3198619124328,10.8574547269828,11.616151541917,9.10266065664967,10.5565917574143,11.8393291948301,12.4673602216522,12.0487309502011,11.2277048436594,11.8245621553315,10.6308475319873,2822.42994371131,-0.897514146298658,0.646310770419525,0.0722300951471314,0.206181530020375,"F1M3L7",5.61e-73,"Epidermal growth factor receptor kinase substrate 8","actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]","GO:0003779; GO:0005886; GO:0005903; GO:0005938; GO:0007266; GO:0008344; GO:0008360; GO:0010458; GO:0014069; GO:0016601; GO:0017146; GO:0030036; GO:0030426; GO:0030832; GO:0031267; GO:0032420; GO:0032421; GO:0032426; GO:0032587; GO:0035023; GO:0036336; GO:0045202; GO:0048149; GO:0051016; GO:0051017; GO:0051764; GO:0070358; GO:0098978; GO:0099072; GO:1900029; GO:1990830"
"645","Pocillopora_acuta_HIv2___RNAseq.g2736.t1",29.4117647058824,16.6666666666667,0,0,19.8630136986301,31.0160427807487,33.3333333333333,0,40,NA,18.9212023539179,17.5365418894831,20.6520279344615,NA,NA,NA,NA,NA,NA,3.68233641306884,6.92168924401968,3.68233641306884,11.3905828666783,6.43917658127574,10.6237173843944,9.85150124291419,6.18361936369477,8.4467722440281,6.40118305541264,7.36229148085555,5.68684820302726,9.03773475868384,570.345812410374,0.80893434492599,1.48968287521945,0.00101952697980967,0.00594614444998673,NA,NA,NA,NA,NA
"646","Pocillopora_acuta_HIv2___TS.g9450.t1",0,NA,NA,0,0,0,0,0,4.54545454545455,NA,0.649350649350649,1.13636363636364,0,NA,NA,NA,NA,NA,NA,9.63267198068178,7.68605551526567,7.99336016744145,9.6605651080147,7.2343347596764,3.68233641306884,3.68233641306884,4.6568497180018,8.03919311016556,3.68233641306884,6.59500395984539,7.5112819471934,5.67872597249738,233.313540451089,-0.608625170564723,1.21577325952478,0.00490162595699039,0.0228774178257209,"Q9NX57",2e-39,"Ras-related protein Rab-20","cellular response to type II interferon [GO:0071346]; intracellular protein transport [GO:0006886]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385]","GO:0003924; GO:0005525; GO:0005794; GO:0006886; GO:0012505; GO:0030670; GO:0043231; GO:0045335; GO:0071346; GO:0090383; GO:0090385"
"647","Pocillopora_acuta_HIv2___RNAseq.g2771.t1",0,0,NA,NA,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,7.76452612086534,3.68233641306884,3.68233641306884,3.68233641306884,7.6080131969712,3.68233641306884,7.80321753215623,9.67521213835954,6.94448951749643,10.9530604396272,6.54778645977513,7.13491547735227,5.96065744219799,340.899230911722,-0.218572092228744,1.0267870753039,0.222972748539269,0.454377924449802,"P79101",0,"Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73)","mRNA 3'-end processing [GO:0031124]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]","GO:0003723; GO:0004521; GO:0004534; GO:0005847; GO:0006398; GO:0031124; GO:0046872; GO:1900087; GO:1990904"
"648","Pocillopora_acuta_HIv2___RNAseq.g2776.t1",0,NA,NA,0,1.36986301369863,0,0,0,7.63888888888889,0,1.12609398782344,1.90972222222222,0.342465753424658,NA,NA,NA,NA,NA,NA,6.79100259980268,6.66968775908682,6.63116616429788,3.68233641306884,6.67787875313474,4.42568256259181,3.68233641306884,6.92672320941957,3.68233641306884,3.68233641306884,5.28514867006089,6.14182142794474,4.42847591217703,41.8555488705291,-0.49611551236068,1.15600738150972,0.0269794729154773,0.0949236429699499,"A0A1X7TVA9",8.67e-18,"Death domain-containing ATP nucleosidase (DDAN) (EC 3.5.99.-)","nucleoside metabolic process [GO:0009116]","GO:0009116; GO:0016787"
"649","Pocillopora_acuta_HIv2___RNAseq.g2783.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,6.17776049751523,6.31061316215391,9.18615571464577,8.53915224815171,7.32675562721369,3.68233641306884,8.0781018333054,3.68233641306884,3.68233641306884,6.03478847352611,6.05850801394974,6.01106893310247,138.972007935951,0.0347315373847225,0.991729275792783,0.701534063213521,0.864029036971656,"Q7M6Z4",0,"Kinesin-like protein KIF27","cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591]","GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0021591; GO:0051649; GO:0060271"
"650","Pocillopora_acuta_HIv2___RNAseq.g2786.t1",23.8003838771593,15.9770114942529,0.924024640657084,8.21917808219178,16.5413533834586,1.95227765726681,29.2682926829268,2.54452926208651,0,68.7861271676301,16.801317824763,5.7385992991596,27.8640363503664,NA,NA,NA,NA,NA,NA,8.82261501056029,8.25383733794239,9.09850176686563,3.68233641306884,6.12628170656021,7.85429172457537,6.13356155741209,9.49471105790083,3.68233641306884,3.68233641306884,6.68308094010233,7.44488919099116,5.92127268921351,222.620939589121,-0.282381669693955,1.00537372268564,0.381812144898228,0.630641870938446,"O96019",0,"Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (ArpNbeta) (BRG1-associated factor 53A) (BAF53A) (INO80 complex subunit K)","blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of cell differentiation [GO:0045596]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; telomere maintenance [GO:0000723]","GO:0000723; GO:0000776; GO:0000785; GO:0000786; GO:0001825; GO:0003407; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005886; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0006355; GO:0006357; GO:0007165; GO:0007399; GO:0008284; GO:0016363; GO:0016514; GO:0016586; GO:0021510; GO:0030071; GO:0031011; GO:0032991; GO:0033044; GO:0035060; GO:0035267; GO:0042981; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:0070316; GO:0071564; GO:0140288; GO:1902459; GO:1904507; GO:1905168; GO:2000045; GO:2000779; GO:2000781; GO:2000819"
"651","Pocillopora_acuta_HIv2___RNAseq.g2807.t2",0,0,0,5.37634408602151,0,0.558659217877095,2.24719101123596,1.21951219512195,0,NA,1.04463405669517,1.43090309980411,0.561797752808989,NA,NA,NA,NA,NA,NA,6.34070533074306,4.82737711805479,9.75298682935183,9.45806305114617,10.3539768144967,10.5119675260977,7.61470949026634,8.20572391788316,9.56147030832383,3.68233641306884,8.03093167994324,8.84297264015972,7.21889071972677,547.04735665688,-0.516711552994187,0.970874633170873,0.210133879899794,0.437005958140994,"Q56UN5",9.66e-95,"Mitogen-activated protein kinase kinase kinase 19 (EC 2.7.11.1) (Regulated in COPD, protein kinase) (SPS1/STE20-related protein kinase YSK4)","","GO:0004674; GO:0005524; GO:0106310"
"652","Pocillopora_acuta_HIv2___RNAseq.g2808.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.63967192774965,10.8332693040481,7.77493455161284,7.85286315275548,9.97960097788862,11.0299133064128,3.68233641306884,10.0478599841669,3.68233641306884,9.65741286982199,8.31801989005941,8.02488077089737,8.61115900922144,743.730952441686,0.154483897516347,0.965234477024257,0.54945506056279,0.766333568422033,"Q7Z4S6",0,"Kinesin-like protein KIF21A (Kinesin-like protein KIF2) (Renal carcinoma antigen NY-REN-62)","cortical microtubule organization [GO:0043622]; microtubule-based movement [GO:0007018]; regulation of axon guidance [GO:1902667]; regulation of microtubule depolymerization [GO:0031114]; regulation of microtubule polymerization [GO:0031113]","GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008574; GO:0016887; GO:0030425; GO:0031113; GO:0031114; GO:0043622; GO:0044295; GO:0071532; GO:1902667"
"653","Pocillopora_acuta_HIv2___RNAseq.g2813.t4",0,0,0,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,11.6830116726173,10.5947738543468,11.8524892555304,3.68233641306884,10.8167278430369,3.68233641306884,3.68233641306884,11.2408924343796,11.9408523695773,3.68233641306884,8.28580930817636,11.5067947150283,5.06482390132443,1653.40829342614,-1.17478950087872,2.37215679410957,3.83425428687377e-13,5.65904632707574e-11,"Q3UP38",3.52e-55,"EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46)","activation of store-operated calcium channel activity [GO:0032237]; adaptive immune response [GO:0002250]; endosomal transport [GO:0016197]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of JNK cascade [GO:0046330]; response to histamine [GO:0034776]; store-operated calcium entry [GO:0002115]; T-helper 1 cell differentiation [GO:0045063]","GO:0000139; GO:0001772; GO:0002115; GO:0002250; GO:0003924; GO:0005509; GO:0005525; GO:0005737; GO:0005815; GO:0005886; GO:0016197; GO:0031982; GO:0032237; GO:0032588; GO:0033093; GO:0034776; GO:0045063; GO:0046330; GO:0051928"
"654","Pocillopora_acuta_HIv2___RNAseq.g2816.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.0704532581148,10.7704374874807,11.4180158568209,8.21634508872886,9.61415018064534,11.0389009858035,3.68233641306884,10.6865972524278,6.85831417532123,3.68233641306884,8.70378871114808,9.92950614466601,7.47807127763015,1137.99434529145,-0.485837364022812,1.09198323568464,0.0314383485237775,0.107525247824053,"P97393",0,"Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B)","cell migration [GO:0016477]; epithelial cell migration [GO:0010631]; mammary gland development [GO:0030879]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of mesenchymal cell proliferation [GO:0002053]; regulation of cell size [GO:0008361]; Rho protein signal transduction [GO:0007266]","GO:0002053; GO:0005096; GO:0005783; GO:0005829; GO:0005886; GO:0007266; GO:0008361; GO:0010631; GO:0010634; GO:0016477; GO:0030879; GO:0042169"
"655","Pocillopora_acuta_HIv2___TS.g9512.t1a",0,50,NA,NA,0,100,0,0,100,NA,35.7142857142857,62.5,0,NA,NA,NA,NA,NA,NA,10.8814337395365,10.1863042918386,10.0995592566082,6.58091230054222,10.1650601256556,3.68233641306884,10.9218578761921,10.2350294823344,8.69188709951876,3.68233641306884,8.51267169983641,10.0145939407307,7.01074945894212,874.878436699894,-0.546824249175266,1.128082410782,0.0113258804234501,0.0461198013639591,NA,NA,NA,NA,NA
"656","Pocillopora_acuta_HIv2___RNAseq.g2844.t1",NA,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0744842795252,9.98417343006573,3.68233641306884,3.68233641306884,10.1607743254365,10.8359179848373,3.68233641306884,10.5118612536943,3.68233641306884,3.68233641306884,6.99788933389032,7.62235853695874,6.37342013082191,639.602627785543,-0.117113816371529,0.981255952285837,0.560634124815783,0.773786017793461,"Q8R2Q6",5.21e-57,"Tectonic-3","apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; positive regulation of apoptotic process [GO:0043065]; smoothened signaling pathway [GO:0007224]","GO:0005634; GO:0006915; GO:0007224; GO:0016020; GO:0043065; GO:0060271"
"657","Pocillopora_acuta_HIv2___RNAseq.g2884.t1",0,0,0,0,0,0.851063829787234,0.671140939597315,0,0,NA,0.16913386326495,0.170212765957447,0.167785234899329,NA,NA,NA,NA,NA,NA,8.43743004364942,11.3004222992996,8.366685476763,11.3893578707247,3.68233641306884,10.3461466174199,10.8706928896995,7.60410977031447,3.68233641306884,11.0185144182393,8.66980322122476,6.35457962337291,10.9850268190766,1112.13170716239,2.03916322252795,3.49290729945891,0.00109061258131659,0.00630984815046525,"A9Y006",1.15e-87,"Aquaporin-3 (Aquaglyceroporin-3)","glycerol transmembrane transport [GO:0015793]; polyol transmembrane transport [GO:0015791]; water transport [GO:0006833]","GO:0005886; GO:0006833; GO:0015166; GO:0015204; GO:0015250; GO:0015254; GO:0015791; GO:0015793; GO:0016323"
"658","Pocillopora_acuta_HIv2___RNAseq.g2904.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.17113964469582,7.45925468652246,10.9711747335947,3.68233641306884,10.5943272365909,8.93551931166073,3.68233641306884,10.0100510222653,9.72516495278771,3.68233641306884,7.79136408273241,10.0943715179869,5.48835664747794,649.548599348627,-0.84084333519008,1.47734066840067,4.73793412091732e-07,8.29001056031251e-06,"P49746",1.13e-160,"Thrombospondin-3","bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931]","GO:0003417; GO:0005509; GO:0005576; GO:0007160; GO:0008201; GO:0043931; GO:0048471; GO:0060346; GO:0062023"
"659","Pocillopora_acuta_HIv2___TS.g9589.t1",0,60,12.5,0,0,5.88235294117647,30,0,0,0,10.8382352941176,13.1764705882353,8.5,NA,NA,NA,NA,NA,NA,9.51043326269363,8.6133739503026,9.20964230287049,8.28657977290827,9.29884574270951,8.11734689253391,8.43802838106897,8.27548738836759,9.54012609905474,3.68233641306884,8.29722002055786,9.16690695913919,7.42753308197652,410.647011229613,-0.514772930499671,0.946304088546589,0.245496365653917,0.484098082183811,"Q68F72",3.78e-95,"Solute carrier family 15 member 4","dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; mast cell homeostasis [GO:0033023]; peptide transport [GO:0015833]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]","GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015833; GO:0015835; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0140206"
"660","Pocillopora_acuta_HIv2___RNAseq.g2917.t2",100,NA,NA,83.3333333333333,100,55.5555555555556,100,NA,100,NA,89.8148148148148,79.6296296296296,100,NA,NA,NA,NA,NA,NA,9.69550253756889,8.82485794222327,9.91514722632609,10.1342036597556,9.69936623805711,5.41697153692495,7.37863675084551,9.49349354493113,9.53621115700866,3.68233641306884,8.377672700671,9.66794414077838,7.08740126056363,565.107676942071,-0.887982347514778,1.26348612491573,0.0292280642822234,0.101404346792535,"P48597",3.99e-98,"Eukaryotic translation initiation factor 4E (eIF-4E) (eIF4E) (eIF-4F 25 kDa subunit) (mRNA cap-binding protein)","mRNA export from nucleus [GO:0006406]; regulation of translation [GO:0006417]; translational initiation [GO:0006413]","GO:0000932; GO:0003723; GO:0003743; GO:0005634; GO:0005737; GO:0006406; GO:0006413; GO:0006417; GO:0016281; GO:0016607; GO:0032991"
"661","Pocillopora_acuta_HIv2___RNAseq.g2926.t1",0,NA,0,0,0,2.5,0,NA,0,NA,0.357142857142857,0.833333333333333,0,NA,NA,NA,NA,NA,NA,7.01680604467962,6.63867229711208,7.25980074116243,9.17481900767789,3.68233641306884,8.74641067247364,5.56266578261131,5.84514254962292,5.1802014623539,3.68233641306884,6.27891913838315,5.79685744217754,6.76098083458875,134.099540350169,0.073028739489143,0.937153521549421,0.821227357486836,0.926620983558223,NA,NA,NA,NA,NA
"662","Pocillopora_acuta_HIv2___RNAseq.g2929.t1",0,0,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.24036347909427,8.82824514368289,6.36503790894442,8.84359181865699,6.13835848329068,8.82616641444346,10.2350096220892,5.70976195638337,8.72323778524158,3.68233641306884,7.35921090248957,6.63535192259086,8.08306988238828,305.660104392482,0.654273355975328,1.20625322234955,0.0661460223672792,0.19292923321644,NA,NA,NA,NA,NA
"663","Pocillopora_acuta_HIv2___RNAseq.g2931.t1",0,0,0.793650793650794,0,1.14503816793893,0.24330900243309,1.26849894291755,0,4.10958904109589,0,0.756008594803625,0.870579608705796,0.641437580901454,NA,NA,NA,NA,NA,NA,11.7403705971663,11.0393328262598,11.4390356202991,10.3231332418684,11.4206359871676,11.9652760399258,11.9180284588548,10.9435027394055,10.9238526305647,3.68233641306884,10.5395504554581,11.2934795149206,9.78562139599553,2387.47768482065,-0.229903647462085,0.889926334183952,0.534483817711014,0.755401010296278,NA,NA,NA,NA,NA
"664","Pocillopora_acuta_HIv2___RNAseq.g2935.t1",0,NA,NA,0,0,1.14942528735632,0,0,0,0,0.14367816091954,0.28735632183908,0,NA,NA,NA,NA,NA,NA,9.68315353364293,9.98113554103772,10.6491500504398,10.1135781611451,11.6603317728832,8.46598915268982,9.93422516211088,10.0066417599351,8.26923806364654,9.1694335319027,9.79328767294338,10.0537030361095,9.53287230977724,1077.38393668418,-0.233999819709798,0.693372483068466,0.620310764089068,0.814353603443988,"Q9D6Y9",0,"1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme)","glycogen biosynthetic process [GO:0005978]; negative regulation of neuron apoptotic process [GO:0043524]","GO:0003844; GO:0004553; GO:0005737; GO:0005829; GO:0005978; GO:0030246; GO:0043169; GO:0043524; GO:0102752"
"665","Pocillopora_acuta_HIv2___RNAseq.g2959.t1",0,NA,NA,0,0,0,11.3636363636364,0,NA,NA,1.89393939393939,0,3.78787878787879,NA,NA,NA,NA,NA,NA,10.2054470677565,3.68233641306884,10.2700118393353,3.68233641306884,10.1347885945528,3.68233641306884,4.40301213871548,9.36357282676523,9.06788301037402,3.68233641306884,6.81740611297747,9.80834066775677,3.82647155819817,461.103525953368,-11.1507652600138,2.22458646138477,7.44245468326434e-13,9.78615132170322e-11,NA,NA,NA,NA,NA
"666","Pocillopora_acuta_HIv2___TS.g9644.t2",0,NA,NA,NA,5.35714285714286,0,0,0,0,NA,0.892857142857143,0,1.78571428571429,NA,NA,NA,NA,NA,NA,8.84774215549785,8.03648948185279,7.99336016744145,4.41872232712587,7.03469873460773,3.68233641306884,3.68233641306884,6.47440906252077,5.59984979127766,3.68233641306884,5.94522809595306,7.19001198226909,4.70044420963704,110.413699532373,-5.11316588001749,2.71325394017689,4.64397543876265e-05,0.000428656418291404,"Q68EL3",2.24e-29,"BET1-like protein","protein transport [GO:0015031]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000139; GO:0005484; GO:0005829; GO:0015031; GO:0031201; GO:0042147; GO:2000156"
"667","Pocillopora_acuta_HIv2___TS.g9656.t1",0,0,14.2857142857143,0,0,11.5384615384615,0,0,0,NA,2.86935286935287,2.30769230769231,3.57142857142857,NA,NA,NA,NA,NA,NA,7.5005307699032,8.05398145875441,6.58642216671358,8.82557602331017,6.550353694785,8.33960285299818,7.37863675084551,8.45654065286637,5.69309697015473,3.68233641306884,7.10670777534,6.95738885088458,7.25602669979542,176.319111055682,0.0638248197337505,0.855021599366437,0.871817228348904,0.949769848164727,"Q55E58",1.08e-13,"Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)","cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856]","GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310"
"668","Pocillopora_acuta_HIv2___RNAseq.g2983.t1",NA,6.81818181818182,0,0,0,1.06951871657754,2.66666666666667,NA,0,NA,1.50776674306086,1.97192513368984,0.888888888888889,NA,NA,NA,NA,NA,NA,6.50755595230566,3.68233641306884,8.19761460836865,3.68233641306884,7.42381535912268,5.20504317817844,3.68233641306884,8.87666088123616,7.57903434039062,3.68233641306884,5.85190699718776,7.71693622828475,3.98687776609076,110.937925636901,-8.32178226729748,3.03464313937734,6.33704239336554e-07,1.0620971167745e-05,NA,NA,NA,NA,NA
"669","Pocillopora_acuta_HIv2___TS.g9659.t2",0,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.60413655354371,7.51941704937578,8.34701981445792,6.22380314819221,9.28446852155977,9.66851779987458,3.68233641306884,9.66226861550215,8.7024133505095,5.84054469821112,7.55349259642956,8.52006137111461,6.58692382174451,318.081137825972,-0.519640533914796,1.0432131783682,0.12458101478793,0.306869856589341,"Q55E58",2.51e-13,"Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)","cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856]","GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310"
"670","Pocillopora_acuta_HIv2___RNAseq.g2988.t1",0,3.84615384615385,4.14201183431953,0,3.91304347826087,2.18068535825545,1.20481927710843,0,0,0,1.52867137940981,1.20536784088186,1.85197491793777,NA,NA,NA,NA,NA,NA,9.82056699060689,7.04438020601615,9.98669631442607,8.32302376070083,10.9034981269597,9.03475892805987,10.65742490462,9.72689114677241,9.70786772550865,11.6549042613927,9.68600123650633,10.0291040608547,9.34289841215791,1108.07653128905,-0.37306837258961,0.804124682446801,0.378699334616427,0.627722573446252,"Q63663",3.5e-13,"Guanylate-binding protein 2 (EC 3.6.5.-) (GTP-binding protein 2) (GBP-2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2) (p67)","activation of innate immune response [GO:0002218]; adhesion of symbiont to host [GO:0044406]; cellular response to interferon-beta [GO:0035458]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to type II interferon [GO:0071346]; cytolysis in another organism [GO:0051715]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; positive regulation of AIM2 inflammasome complex assembly [GO:0140973]; positive regulation of pyroptotic inflammatory response [GO:0140639]; protein localization to nucleus [GO:0034504]; protein targeting [GO:0006605]; response to bacterium [GO:0009617]","GO:0000139; GO:0002218; GO:0003924; GO:0004866; GO:0005525; GO:0005634; GO:0005737; GO:0005794; GO:0006605; GO:0009617; GO:0030659; GO:0031410; GO:0034504; GO:0035458; GO:0042742; GO:0042802; GO:0042803; GO:0042832; GO:0044406; GO:0048471; GO:0050830; GO:0051607; GO:0051715; GO:0071222; GO:0071346; GO:0071347; GO:0071356; GO:0106139; GO:0140639; GO:0140678; GO:0140973"
"671","Pocillopora_acuta_HIv2___RNAseq.g16688.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.4215387053808,9.95195189222917,10.4579579491534,11.3991288359782,10.7993728198656,9.27288393234448,9.05910328121731,9.48126153138428,10.1787426538223,12.0055703168181,10.3027511918194,10.2677747319213,10.3377276517175,1513.38026516805,0.0366463715532762,0.649193541589891,0.949021967422802,0.980200706925709,"Q8IYT8",2.57e-123,"Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2)","autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axon extension [GO:0048675]; collateral sprouting [GO:0048668]; negative regulation of collateral sprouting [GO:0048671]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165]","GO:0000045; GO:0000407; GO:0000422; GO:0004674; GO:0005524; GO:0005737; GO:0005776; GO:0005829; GO:0006914; GO:0007165; GO:0010508; GO:0030659; GO:0034045; GO:0034727; GO:0042594; GO:0046777; GO:0048668; GO:0048671; GO:0048675; GO:0061709; GO:0106310"
"672","Pocillopora_acuta_HIv2___RNAseq.g16697.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.55601247066455,3.68233641306884,8.21218654876206,3.68233641306884,5.44125113471119,3.68233641306884,5.32551295827119,6.025091802042,3.68233641306884,3.68233641306884,5.09717369797952,6.18337567384973,4.01097172210931,51.6904942392307,-0.380440049861878,1.10068325593014,0.00755600687896317,0.0330081798542202,"P20735",1.91e-149,"Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]","glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; zymogen activation [GO:0031638]","GO:0002682; GO:0002951; GO:0005886; GO:0006536; GO:0006750; GO:0006751; GO:0031179; GO:0031638; GO:0036374; GO:0050727; GO:0103068"
"673","Pocillopora_acuta_HIv2___RNAseq.g16716.t1",NA,NA,NA,52.7777777777778,10.2564102564103,45.8333333333333,30.1369863013699,NA,37.5,55.5555555555556,38.6766772040745,45.3703703703704,31.9829840377786,NA,NA,NA,NA,NA,NA,7.3358031916585,7.30162598186706,7.26683347298246,7.84571335344804,7.78613657441435,7.56558401776789,8.78357722964491,7.80263062623775,3.68233641306884,3.68233641306884,6.90525772741586,6.77474805567238,7.03576739915935,157.863753498722,0.209489630246677,0.688972201010837,0.659747151748626,0.839397813590047,"Q1LZC0",2.04e-40,"Zinc finger protein 22","negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cytokine production [GO:0001817]; regulation of immune system process [GO:0002682]","GO:0000122; GO:0000978; GO:0001227; GO:0001817; GO:0002682; GO:0005654; GO:0046872"
"674","Pocillopora_acuta_HIv2___RNAseq.g16720.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.1633810366296,8.57355162319954,8.58941317266829,3.68233641306884,10.6267973332866,8.7108295217711,7.82425794137397,10.1687039117748,9.1444762339614,8.96155721209108,8.74453043998252,9.93855433766414,7.55050654230091,727.390438991627,-1.20893581854018,1.33529629692181,0.030492121019037,0.10495907625401,"Q91ZQ0",5.54e-162,"Vacuole membrane protein 1","autophagosome assembly [GO:0000045]; autophagosome membrane docking [GO:0016240]; autophagy [GO:0006914]; cell junction assembly [GO:0034329]; cell-cell adhesion [GO:0098609]; embryo implantation [GO:0007566]; Golgi organization [GO:0007030]; lipoprotein transport [GO:0042953]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; organelle localization by membrane tethering [GO:0140056]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]","GO:0000045; GO:0000407; GO:0000421; GO:0005783; GO:0005789; GO:0005886; GO:0006914; GO:0007030; GO:0007566; GO:0012505; GO:0016020; GO:0016240; GO:0017128; GO:0033116; GO:0034329; GO:0042953; GO:0098609; GO:0140056; GO:1901896; GO:1990456"
"675","Pocillopora_acuta_HIv2___RNAseq.g16730.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.13128978447547,7.95812695172856,8.10693637131199,5.40210328953245,7.51213554915338,8.76098054746593,7.98853544336584,7.09178937521457,7.59423998853345,8.51954357677332,7.6065680877555,7.48727821373777,7.72585796177322,202.784551192633,0.217762085101194,0.750003964314628,0.638820518577133,0.826023599204331,"Q6GVH4",4.33e-36,"Gametogenetin-binding protein 2 (Protein ZNF403)","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","GO:0005634; GO:0005737; GO:0007283; GO:0030154"
"676","Pocillopora_acuta_HIv2___RNAseq.g16735.t1",0,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.16247966683365,9.6472827895905,8.55840824321401,6.35341254798027,8.79120048715284,9.98485714344735,7.52318888932451,6.5527975076299,7.35614181332736,8.43291462578709,8.13626837142875,7.88420554363155,8.38833119922594,354.191084937776,0.388764763074117,0.736061654977658,0.419242877161009,0.663885370621506,NA,NA,NA,NA,NA
"677","Pocillopora_acuta_HIv2___RNAseq.g16739.t1",0,0,0,0,0.719424460431655,0.591715976331361,6.97674418604651,0,0,NA,0.920876069201059,0.118343195266272,1.92404216161954,NA,NA,NA,NA,NA,NA,9.7304279548272,10.3076688369308,9.86884363171282,8.28657977290827,8.47838834006635,10.8604603418902,10.7544021787229,9.60930040420826,7.57903434039062,11.2915055777796,9.6766611379437,9.05319893424105,10.3001233416464,1053.23370246862,0.697306800958046,0.876544856070151,0.154953974895184,0.356093786603741,"Q5SV77",0,"Gametogenetin-binding protein 2 (Dioxin-inducible factor 3) (DIF-3) (Protein ZNF403)","cell differentiation [GO:0030154]; labyrinthine layer blood vessel development [GO:0060716]; labyrinthine layer development [GO:0060711]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; spermatogenesis [GO:0007283]","GO:0005634; GO:0005737; GO:0007283; GO:0008285; GO:0010629; GO:0030154; GO:0031410; GO:0033140; GO:0042532; GO:0060711; GO:0060716"
"678","Pocillopora_acuta_HIv2___RNAseq.g16758.t1",0,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.94408450251095,3.68233641306884,8.71739939235853,3.68233641306884,9.09374448295069,3.68233641306884,3.68233641306884,6.86711664385428,6.71123450989494,3.68233641306884,5.87452615969136,8.06671590631388,3.68233641306884,155.698026509265,-12.1495462920676,3.73639300600648,3.06955235000376e-09,1.05709536167748e-07,NA,NA,NA,NA,NA
"679","Pocillopora_acuta_HIv2___RNAseq.g16773.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.78785518405689,9.58059860906612,3.68233641306884,6.15405973004498,6.6198153124932,10.2358237523939,9.92777908965568,8.26409272361492,3.68233641306884,10.7546846278643,7.66893818553277,6.00728720926054,9.330589161805,517.173950836484,1.68698099126525,2.42179763749289,0.00215341310947972,0.0113550737205668,NA,NA,NA,NA,NA
"680","Pocillopora_acuta_HIv2___TS.g17168.t1",0,1.69491525423729,0,0,0,4.14201183431953,10,0,0,0,1.58369270885568,1.16738541771136,2,NA,NA,NA,NA,NA,NA,7.82778893403375,8.58961299098714,7.66249431030622,8.082997992935,8.06284514577596,8.1794761914649,3.68233641306884,7.79472045485966,8.03363818715033,8.30364409849442,7.62195547190762,7.87629740642518,7.36761353739006,221.813231622808,-0.0937720793088009,0.842657265820403,0.81324923958843,0.922358425578848,NA,NA,NA,NA,NA
"681","Pocillopora_acuta_HIv2___RNAseq.g16798.t1",0,0,0,0,1.66666666666667,2.02702702702703,1.2987012987013,0,1.5625,NA,0.728321665821666,0.717905405405405,0.741341991341991,NA,NA,NA,NA,NA,NA,5.63634872160117,8.0939860793811,6.14868956725197,7.39445938623252,6.19717517834132,6.82103953412585,6.3073577041051,5.00453269325268,3.68233641306884,3.68233641306884,5.89682616904294,5.3338165147032,6.45983582338268,67.26398634005,1.14752248827355,1.03599447332006,0.0656953688614159,0.19204078722949,NA,NA,NA,NA,NA
"682","Pocillopora_acuta_HIv2___RNAseq.g16828.t1",100,0,NA,NA,100,29.0322580645161,0,71.4285714285714,NA,NA,50.0768049155146,33.4869431643625,66.6666666666667,NA,NA,NA,NA,NA,NA,5.66349904727606,3.68233641306884,6.78724783184476,6.63240153016127,6.56804683919999,5.44887968569328,8.52182604658521,7.2278706159692,5.46360254994476,3.68233641306884,5.96780469728122,6.34205337684695,5.59355601771549,77.2282934483994,-0.49736512872314,1.02278754690098,0.116445653764764,0.292103700321461,NA,NA,NA,NA,NA
"683","Pocillopora_acuta_HIv2___RNAseq.8540_t",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.61059914302406,9.37836418991306,8.82786152927722,3.68233641306884,10.4820178260325,7.87591744416405,3.68233641306884,8.52016024963916,6.79336260184968,3.68233641306884,7.15352922231062,8.64680026996452,5.66025817465673,347.805431619623,-0.748118912515432,1.37234517005601,8.44527709268826e-05,0.000718121621802722,"Q5SPX3",9.49e-41,"RING finger protein 215","ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005737; GO:0006511; GO:0016020; GO:0046872; GO:0061630"
"684","Pocillopora_acuta_HIv2___TS.g17246.t2",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.9020590034213,3.68233641306884,3.68233641306884,3.68233641306884,8.5868343169114,7.99430979892605,11.0667571292541,8.75384566644966,3.68233641306884,3.68233641306884,6.37154879803067,6.72148236258401,6.02161523347733,356.806618819112,-0.017807546723197,0.976872927878546,0.928753290992884,0.97358222937535,"Q5SSZ7",1.13e-105,"E3 ubiquitin-protein ligase ZNRF3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNRF3) (Zinc/RING finger protein 3)","limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055]","GO:0004842; GO:0005109; GO:0005886; GO:0006511; GO:0016055; GO:0016567; GO:0030178; GO:0038018; GO:0046872; GO:0060173; GO:0060828; GO:0061630; GO:0072089; GO:0090090; GO:2000051; GO:2000095"
"685","Pocillopora_acuta_HIv2___RNAseq.g16865.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.290319599264,9.14848487511614,9.01381374020038,3.68233641306884,7.71361286554099,5.12470250408451,3.68233641306884,4.44278995465828,3.68233641306884,3.68233641306884,6.04630691911397,7.0285745145465,5.06403932368143,246.300841157895,-0.681147545076744,1.27318590226266,0.0708798147139052,0.20353335716741,"Q8HZ57",3.44e-38,"Coiled-coil alpha-helical rod protein 1 (Alpha-helical coiled-coil rod protein)","cell differentiation [GO:0030154]","GO:0005634; GO:0005737; GO:0005814; GO:0030154"
"686","Pocillopora_acuta_HIv2___RNAseq.g16867.t1",1.2987012987013,NA,0,0,NA,0,3.125,0,0,0,0.552962662337662,0,1.10592532467532,NA,NA,NA,NA,NA,NA,9.20393294375456,3.68233641306884,7.82326486527108,9.13149400401155,9.49548786985419,9.40855875885978,3.68233641306884,9.33394690804175,3.68233641306884,3.68233641306884,6.91260310020683,7.90779379999808,5.91741240041557,327.183254319664,-0.19722863432609,1.00527618559001,0.412055694666809,0.657761126549026,"Q567Y6",3.38e-66,"Intraflagellar transport protein 22 homolog (Rab-like protein 5)","intracellular protein transport [GO:0006886]","GO:0003924; GO:0005525; GO:0006886; GO:0012505; GO:0030992"
"687","Pocillopora_acuta_HIv2___RNAseq.g16871.t1",0,NA,0,NA,0,3.03030303030303,0,0,0,NA,0.432900432900433,1.01010101010101,0,NA,NA,NA,NA,NA,NA,6.69445347943463,4.68019422250907,4.37026367592069,3.68233641306884,5.26345523824995,9.15211910193021,7.49717686805367,4.22313318099817,5.49910115103059,3.68233641306884,5.47445697442647,5.21008134512681,5.73883260372613,83.03466770149,-0.102497832064958,0.997900267401303,0.302280357268397,0.550514113262415,"O00222",3.86e-121,"Metabotropic glutamate receptor 8 (mGluR8)","adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; regulation of synaptic transmission, glutamatergic [GO:0051966]; visual perception [GO:0007601]","GO:0001642; GO:0004930; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007601; GO:0008066; GO:0051966"
"688","Pocillopora_acuta_HIv2___RNAseq.g16885.t1",NA,NA,NA,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,4.21445057288855,5.1703194305374,5.79243403424225,9.81090221863081,4.35452149648907,10.0609578710212,5.73058915105271,7.75450104011765,4.72904561334115,3.68233641306884,6.13000578413896,5.36899055141573,6.89102101686219,219.623772012786,0.257204208255875,1.00861425418882,0.146142043497205,0.342545665290335,"P16157",2.18e-89,"Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)","cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]","GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014"
"689","Pocillopora_acuta_HIv2___RNAseq.g16888.t1b",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.9809505516008,10.2733132454309,10.6958251151148,9.18615571464577,11.5529699961018,9.5544547891103,11.1707143927521,11.2082482060691,11.6602712996328,11.9934130835014,10.927631639396,11.4196530337039,10.4356102450881,2300.71652427673,-0.697280530330006,0.671233046085568,0.156178902946141,0.357998677054357,"Q5RFV4",2.04e-81,"Probable E3 ubiquitin-protein ligase RNF144A-A (EC 2.3.2.31) (RING finger protein 144A-A)","protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0005737; GO:0005794; GO:0006511; GO:0008270; GO:0016020; GO:0031624; GO:0061630"
"690","Pocillopora_acuta_HIv2___RNAseq.g16917.t1",0,0,0,0,0,5.55555555555556,0,0,NA,NA,0.694444444444444,1.38888888888889,0,NA,NA,NA,NA,NA,NA,8.64286629266806,5.6460547390973,10.9222522497408,5.76965417569396,8.49211488943272,9.89001758390583,9.46966884239544,8.59705801932093,6.76651737006592,3.68233641306884,7.78785405753898,8.68416176424569,6.89154635083227,473.746473172723,-0.587096551280903,1.11585435363516,0.021465235842338,0.0785014339376934,"Q502K3",3.97e-79,"Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C)","",""
"691","Pocillopora_acuta_HIv2___RNAseq.g16928.t3",0,NA,NA,NA,0,0,0,5,0,NA,0.833333333333333,1.66666666666667,0,NA,NA,NA,NA,NA,NA,10.7683673967548,12.5945387185909,11.0451402993581,12.44422797134,10.4336969827541,13.2284973424965,13.7144548523922,11.5996288849099,5.77998567012395,13.4935336390579,11.5102071757778,9.92536384678017,13.0950505047755,5447.65606021035,1.8262702741519,1.26901918317798,0.00851650480399188,0.0364122747516815,"O70521",4.34e-40,"Regulator of G-protein signaling 19 (RGS19) (G-alpha-interacting protein) (GAIP)","negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to ethanol [GO:0045471]","GO:0000139; GO:0001965; GO:0005096; GO:0005903; GO:0008277; GO:0009968; GO:0030136; GO:0045471"
"692","Pocillopora_acuta_HIv2___RNAseq.g16932.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.08465879531668,3.68233641306884,7.28772548725058,6.85040600762403,7.2010836147454,7.37325912511382,3.68233641306884,7.01166301889941,3.68233641306884,3.68233641306884,5.85381417012253,6.65349346585618,5.05413487438887,83.7520727815154,-0.291469865181088,1.02507958273089,0.274497646223292,0.519303975079406,NA,NA,NA,NA,NA
"693","Pocillopora_acuta_HIv2___RNAseq.g16937.t1",NA,0,0,NA,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,7.28736510465359,3.68233641306884,8.11858910456873,3.68233641306884,8.67369836228592,3.68233641306884,8.00704222118106,8.6083589701606,3.68233641306884,10.5501326925932,6.59745321077185,7.27406959094754,5.92083683059616,283.856704659229,-0.202778177479446,1.02921100046778,0.000484575069800064,0.00318586082254006,"P0C7B7",2.7e-16,"Cys-loop ligand-gated ion channel (ELIC)","regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]","GO:0004888; GO:0005230; GO:0005886; GO:0007165; GO:0042391; GO:0042802; GO:0043005"
"694","Pocillopora_acuta_HIv2___TS.g17329.t1",0,0,NA,0,0,1.2987012987013,0,0,NA,NA,0.185528756957328,0.324675324675325,0,NA,NA,NA,NA,NA,NA,9.826193401567,9.39215581386235,9.46484909801949,9.16339242140137,8.18910215367686,10.9380971503962,9.46522378565555,9.61042398934139,7.51654073656363,10.980303658088,9.45462822085718,8.92142187583367,9.98783456588069,855.169186424318,0.51611055947073,0.809394605051877,0.26962970422409,0.513215428595504,"Q8LGG0",2.99e-25,"Peptidyl-prolyl cis-trans isomerase FKBP12 (PPIase FKBP12) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FK506-binding protein 12) (AtFKBP12) (FKBP-12) (Immunophilin FKBP12) (Rotamase)","","GO:0003755; GO:0005829; GO:0009536"
"695","Pocillopora_acuta_HIv2___RNAseq.g16961.t1",0,0,3.75,1.09289617486339,0,0.563607085346216,0.846023688663283,0,0,NA,0.694725216541432,0.331300652041921,1.14900592216582,NA,NA,NA,NA,NA,NA,8.40391932812593,11.4066850717962,6.89159417457077,7.64607003834505,8.96686736539284,9.12535238881659,8.71029977567072,8.22348476192202,8.71632971421491,3.68233641306884,8.17729390319239,8.24043906884529,8.11414873753948,534.349987489832,0.0814523165901343,0.877411507154147,0.83540934174676,0.934087872528226,"Q8N157",0,"Jouberin (Abelson helper integration site 1 protein homolog) (AHI-1)","cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; Kupffer's vesicle development [GO:0070121]; left/right axis specification [GO:0070986]; morphogenesis of a polarized epithelium [GO:0001738]; motile cilium assembly [GO:0044458]; negative regulation of apoptotic process [GO:0043066]; otic vesicle development [GO:0071599]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of polarized epithelial cell differentiation [GO:0030862]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric duct morphogenesis [GO:0039023]; pronephric nephron tubule morphogenesis [GO:0039008]; protein localization [GO:0008104]; regulation of behavior [GO:0050795]; retina layer formation [GO:0010842]; specification of axis polarity [GO:0065001]; vesicle-mediated transport [GO:0016192]","GO:0001738; GO:0001947; GO:0002092; GO:0005813; GO:0005814; GO:0005829; GO:0005911; GO:0005912; GO:0005929; GO:0007169; GO:0007417; GO:0008104; GO:0010842; GO:0016192; GO:0030862; GO:0030902; GO:0035844; GO:0035845; GO:0036038; GO:0036064; GO:0039008; GO:0039023; GO:0042802; GO:0043066; GO:0044458; GO:0045944; GO:0050795; GO:0060271; GO:0065001; GO:0070121; GO:0070986; GO:0071599; GO:0097730"
"696","Pocillopora_acuta_HIv2___RNAseq.g16987.t1",15.3846153846154,0,0,0,0,0,NA,NA,NA,NA,2.56410256410256,0,5.12820512820513,NA,NA,NA,NA,NA,NA,9.62784745505089,10.6184265965957,7.34862272236652,3.68233641306884,7.53892828027555,3.68233641306884,3.68233641306884,7.52971450885446,10.0182279631482,3.68233641306884,6.74111131785667,8.41266818593912,5.06955444977421,378.31881204374,-0.800734267692326,1.51648956879007,2.70309044087263e-06,3.71649240843933e-05,"Q02447",5.2e-43,"Transcription factor Sp3 (SPR-2)","B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; granulocyte differentiation [GO:0030851]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; myeloid progenitor cell differentiation [GO:0002318]; natural killer cell differentiation [GO:0001779]; negative regulation of DNA-templated transcription [GO:0045892]; ossification [GO:0001503]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation [GO:0030217]; trophectodermal cell differentiation [GO:0001829]","GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001503; GO:0001779; GO:0001829; GO:0001889; GO:0001892; GO:0002318; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0016605; GO:0017053; GO:0030183; GO:0030217; GO:0030219; GO:0030224; GO:0030324; GO:0030851; GO:0032993; GO:0043353; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048596; GO:0048706; GO:0060136; GO:0060216; GO:0061629; GO:1990837"
"697","Pocillopora_acuta_HIv2___RNAseq.g16988.t1",0,NA,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.40345635662408,3.68233641306884,9.62835890729581,3.68233641306884,8.8981187997471,4.21083509301726,3.68233641306884,9.47510638685879,10.2640485699225,3.68233641306884,6.66092697657409,9.53381780408966,3.78803614905852,376.1632002207,-11.0459394646824,2.06633961195377,2.28780837165495e-13,3.71807418961991e-11,NA,NA,NA,NA,NA
"698","Pocillopora_acuta_HIv2___RNAseq.g16993.t1",0,0,NA,3.75,0,0,2.14285714285714,NA,0,NA,0.841836734693878,0.9375,0.714285714285714,NA,NA,NA,NA,NA,NA,9.32811847350323,9.9488452939956,9.29071417090254,6.22380314819221,9.45404891591861,9.47189015592548,9.67991560671025,9.98860970391727,10.9095519414227,11.315886337997,9.56113837484849,9.79420864113287,9.32806810856411,979.976066901975,-0.215480596458611,0.696593739048024,0.637238097901292,0.825290116547415,"Q90655",5.98e-35,"Homeobox protein AKR (Avian knotted-related protein)","negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]","GO:0000122; GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0045892"
"699","Pocillopora_acuta_HIv2___RNAseq.g17016.t1",NA,0,0,NA,0,5.40540540540541,0,0,NA,NA,0.900900900900901,1.8018018018018,0,NA,NA,NA,NA,NA,NA,7.8556469288185,5.88506810849203,3.68233641306884,3.68233641306884,7.14387482575766,3.68233641306884,3.68233641306884,5.26380834900594,7.68222817588062,5.08610646190246,5.36460785021326,6.32557893850631,4.4036367619202,57.048190847576,-0.971332618777589,1.69596775323003,0.0169586836936445,0.0647545937024484,"P0CI65",6.26e-30,"Nephrocystin-3","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"700","Pocillopora_acuta_HIv2___TS.g17408.t1",0.448430493273543,0,0,0,0,0.214132762312634,0.651465798045603,0,0,NA,0.146003228181309,0.0428265524625268,0.274974072829786,NA,NA,NA,NA,NA,NA,5.76666095136545,3.68233641306884,6.0681601509144,7.93599079599327,3.68233641306884,3.68233641306884,3.68233641306884,6.88225628497292,8.26923806364654,3.68233641306884,5.33339883122368,6.13373037279363,4.53306728965373,67.2630004973524,-0.256683097409204,1.0548635003409,0.00995089356552051,0.0414902636297747,"A0JM23",5.84e-39,"Nephrocystin-3","cilium assembly [GO:0060271]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]","GO:0005929; GO:0016055; GO:0060271; GO:0090090; GO:2000095"
"701","Pocillopora_acuta_HIv2___RNAseq.g17038.t1",NA,0,0,0,0,5,14.2857142857143,NA,NA,NA,3.21428571428571,1.66666666666667,4.76190476190476,NA,NA,NA,NA,NA,NA,9.66756705827265,10.2317433465825,7.24563010395376,3.68233641306884,9.22411214945276,8.51152342055849,8.73267714959777,8.79793342285728,3.68233641306884,10.3079688251133,8.00838283025262,7.72351582952106,8.29324983098418,506.623101017538,1.89709809385956e-05,0.935536064709982,0.966428133409495,0.988072828120568,"Q5ZM19",2.84e-37,"Nuclear cap-binding protein subunit 3","7-methylguanosine mRNA capping [GO:0006370]; mRNA transport [GO:0051028]","GO:0000339; GO:0000340; GO:0003729; GO:0005634; GO:0005737; GO:0006370; GO:0051028"
"702","Pocillopora_acuta_HIv2___RNAseq.g17040.t1",NA,NA,0,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,11.8048252856168,11.2073121010672,11.6666421931478,3.68233641306884,11.8000626971248,11.7041494825396,10.4174517521108,11.8338094878378,11.2692096582138,10.8005949528483,10.6186394023576,11.6749098643882,9.56236894032695,2513.48657606949,-0.408818698717864,0.936731056819648,0.325723628215195,0.575500980001202,"Q0V9T6",1.76e-18,"BICD family-like cargo adapter 1 (Bicaudal D-related protein 1) (BICD-related protein 1) (BICDR-1) (Coiled-coil domain-containing protein 64A)","Golgi to secretory granule transport [GO:0055107]; neuron projection development [GO:0031175]","GO:0005737; GO:0005813; GO:0031175; GO:0031267; GO:0034452; GO:0055107"
"703","Pocillopora_acuta_HIv2___RNAseq.g17047.t1",33.3333333333333,0,0,0,0,11.1111111111111,0,NA,NA,NA,6.34920634920635,3.7037037037037,8.33333333333333,NA,NA,NA,NA,NA,NA,7.31983953124869,3.68233641306884,8.26555224992641,3.68233641306884,7.63721909911156,3.68233641306884,3.68233641306884,7.57203714587225,7.08098834013476,4.69373610443143,5.72987181230005,7.57512727325873,3.88461635134136,87.493730148627,-8.60610870903766,2.71478311373168,2.08404813642824e-07,4.07346922233758e-06,"P32456",2.12e-09,"Guanylate-binding protein 2 (EC 3.6.5.-) (GTP-binding protein 2) (GBP-2) (HuGBP-2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2)","activation of innate immune response [GO:0002218]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to type II interferon [GO:0071346]; cytolysis in another organism [GO:0051715]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; immune response [GO:0006955]; positive regulation of AIM2 inflammasome complex assembly [GO:0140973]; positive regulation of pyroptotic inflammatory response [GO:0140639]; protein localization to nucleus [GO:0034504]","GO:0000139; GO:0002218; GO:0003924; GO:0004866; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0030659; GO:0031410; GO:0034504; GO:0042742; GO:0042802; GO:0042803; GO:0042832; GO:0048471; GO:0050830; GO:0051607; GO:0051715; GO:0071222; GO:0071346; GO:0071347; GO:0071356; GO:0140639; GO:0140678; GO:0140973"
"704","Pocillopora_acuta_HIv2___RNAseq.g17057.t2",5.65217391304348,0,43.3628318584071,13.3333333333333,32.7731092436975,22.7397260273973,15.2542372881356,11.7647058823529,2.32558139534884,NA,16.3561887713018,10.0326693276865,24.2605880758209,NA,NA,NA,NA,NA,NA,8.79417202436679,10.275794539183,9.59821487799019,9.06549758242751,10.3732436969655,8.72872998755956,10.5524080588503,8.76600406492611,9.65830165477501,9.76759841671554,9.55799649037595,9.43798726380472,9.67800571694718,810.752201200841,0.15397951974037,0.675936924040327,0.750167581674292,0.889524832049267,"Q5SPL2",5.93e-52,"PHD finger protein 12 (PHD factor 1) (Pf1)","negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]","GO:0000122; GO:0001222; GO:0003714; GO:0005634; GO:0017053; GO:0035091; GO:0045892; GO:0046872; GO:0070822"
"705","Pocillopora_acuta_HIv2___TS.g17458.t1",0,0,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.30412255695062,7.5932230481983,10.6350502889735,9.97507445513319,9.27127270636853,9.06089279347407,3.68233641306884,8.6015890511538,6.34211912572884,3.68233641306884,7.81480168521185,8.83083074583506,6.79877262458865,484.255252357092,-0.69285327127237,1.15810268928926,0.0436286324291476,0.139859162113296,"Q7T0Q5",0,"Nucleolar protein 10","","GO:0005730"
"706","Pocillopora_acuta_HIv2___RNAseq.g17078.t5b",0,NA,NA,0,0,0,4.47761194029851,0,0,NA,0.639658848614072,0,1.49253731343284,NA,NA,NA,NA,NA,NA,10.2097576224312,9.24538517898188,10.7087049141458,9.94370115096223,9.76954171190692,10.3079903194372,9.0292931299507,9.68804051051928,12.0416117436207,3.68233641306884,9.46263626950248,10.4835313005248,8.44174123848017,1192.37750133242,-0.357049825655039,0.922993485281247,0.383999142193943,0.632880992786372,"Q76I76",1.07e-146,"Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (hSSH-2L)","actin cytoskeleton organization [GO:0030036]; cell differentiation [GO:0030154]; negative regulation of actin filament polymerization [GO:0030837]; protein dephosphorylation [GO:0006470]; spermatogenesis [GO:0007283]","GO:0001669; GO:0003779; GO:0004721; GO:0004725; GO:0005615; GO:0005737; GO:0005856; GO:0005925; GO:0006470; GO:0007283; GO:0017018; GO:0030036; GO:0030154; GO:0030837"
"707","Pocillopora_acuta_HIv2___RNAseq.g17078.t5a",0,NA,NA,1.76211453744493,2.6525198938992,5.46075085324232,0,NA,5.52147239263804,0.680272108843537,2.29673282658115,4.24811259444176,0.833198000685685,NA,NA,NA,NA,NA,NA,7.77623813175386,10.1596815966852,3.68233641306884,9.76629124656936,7.74842426135321,9.28905174554863,11.2110830172452,9.69016752079256,3.68233641306884,11.65637372659,8.46619840726757,6.51590054800746,10.4164962665277,929.622935474918,0.792623031109221,1.32827419954013,0.0156098939160434,0.0604178500405813,"Q8NDA2",2.97e-24,"Hemicentin-2","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808]","GO:0005509; GO:0005576; GO:0005886; GO:0007156; GO:0008046; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023"
"708","Pocillopora_acuta_HIv2___RNAseq.g17097.t2",NA,NA,100,71.4285714285714,NA,100,16.6666666666667,100,NA,100,81.3492063492064,90.4761904761905,72.2222222222222,NA,NA,NA,NA,NA,NA,10.1515699447021,9.37141858256409,9.55606664229875,3.68233641306884,10.4277644007908,10.8805980974842,9.11125517176571,10.8595433141207,11.4355056970198,3.68233641306884,8.91583946768838,10.4860899997864,7.34558893559034,1079.18998459858,-0.456884441238533,1.06173462693253,0.0728053070845258,0.207131385065024,"P27591",5.57e-11,"23 kDa integral membrane protein (Sj23)","","GO:0016020"
"709","Pocillopora_acuta_HIv2___RNAseq.g17106.t1",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.58092710309753,9.29027002952589,8.09125087353016,11.3350379656932,7.99690239617268,10.010672796331,3.68233641306884,8.86163355661156,6.48192780096359,7.43123314299026,8.17621920779847,8.0025283460751,8.34991006952184,565.356510822496,0.255511623385006,0.928712492236792,0.48230457982626,0.716300795010475,"Q9Z265",8.75e-154,"Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Checkpoint kinase 2)","cell division [GO:0051301]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic spindle assembly [GO:0090307]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of anoikis [GO:2000210]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein catabolic process [GO:0042176]; response to gamma radiation [GO:0010332]; signal transduction in response to DNA damage [GO:0042770]; thymocyte apoptotic process [GO:0070242]","GO:0000077; GO:0000086; GO:0000781; GO:0001934; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006974; GO:0006978; GO:0008630; GO:0010332; GO:0016301; GO:0016605; GO:0019901; GO:0030163; GO:0031573; GO:0031625; GO:0042176; GO:0042770; GO:0042771; GO:0042803; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0070242; GO:0071480; GO:0090307; GO:0106310; GO:2000002; GO:2000210"
"710","Pocillopora_acuta_HIv2___RNAseq.g17112.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.83894995413197,9.98265528542106,8.43967404947304,3.68233641306884,6.86044811883467,3.68233641306884,10.8132820482782,6.0800375531696,3.68233641306884,11.0789370336008,7.01409932821159,6.18028921773562,7.84790943868755,539.042899389212,0.127782911805752,1.02387967432892,0.143244201189952,0.338042631039049,"O18835",0,"Beta-glucuronidase (EC 3.2.1.31)","carbohydrate metabolic process [GO:0005975]; glucuronoside catabolic process [GO:0019391]","GO:0004566; GO:0005102; GO:0005615; GO:0005764; GO:0005975; GO:0019391; GO:0030246"
"711","Pocillopora_acuta_HIv2___RNAseq.g17117.t1",0,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.2553002786236,3.68233641306884,11.5487532735825,3.68233641306884,10.8085330640331,3.68233641306884,3.68233641306884,8.6015890511538,12.0031411529228,3.68233641306884,7.162899888566,10.6434633640632,3.68233641306884,1037.72978148286,-15.1578340719951,3.85908239440274,2.19017396969699e-15,7.54254197564221e-13,"O19132",0,"Nitric oxide synthase 1 (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Nitric oxide synthase, brain) (bNOS) (Peptidyl-cysteine S-nitrosylase NOS1)","nitric oxide biosynthetic process [GO:0006809]","GO:0004517; GO:0005516; GO:0006809; GO:0010181; GO:0020037; GO:0042383; GO:0043197; GO:0046872; GO:0050660; GO:0050661"
"712","Pocillopora_acuta_HIv2___RNAseq.g17166.t2",100,100,NA,NA,100,100,100,NA,100,NA,100,100,100,NA,NA,NA,NA,NA,NA,8.13094462683116,9.25799403543053,9.27520698974103,6.20095146371302,9.4481981402695,7.1685916905325,10.4012587919944,8.44649846873451,3.68233641306884,11.4608471284744,8.34728277487899,7.79663692772901,8.89792862202897,672.245165455821,0.104530269361001,0.941876922534303,0.720968180971848,0.874472433507489,"P51659",0,"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]","androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]","GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0004303; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006635; GO:0008209; GO:0008210; GO:0016020; GO:0016853; GO:0018812; GO:0033989; GO:0036111; GO:0036112; GO:0042803; GO:0044594; GO:0060009; GO:0106386"
"713","Pocillopora_acuta_HIv2___RNAseq.g17168.t1",0,NA,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.8256570439174,8.93891267109463,10.4441610170962,10.6012024804614,9.81843297423533,10.1432806817205,10.4837640148158,10.9572536528786,10.6680313866794,12.3921411276162,10.5272837050515,10.5427072149614,10.5118601951417,1745.31299858065,-0.0125904603180901,0.64508116420045,0.970670619054095,0.990404923253695,"Q9BUZ4",1.89e-88,"TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich domain associated with RING and Traf domains protein 1) (Metastatic lymph node gene 62 protein) (MLN 62) (RING finger protein 83)","apoptotic process [GO:0006915]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323]; signal transduction [GO:0007165]","GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007165; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699"
"714","Pocillopora_acuta_HIv2___RNAseq.g17193.t1",50,36.8421052631579,NA,0,50,66.6666666666667,78.5714285714286,NA,100,100,60.2600250626566,50.8771929824561,69.6428571428571,NA,NA,NA,NA,NA,NA,10.5847572048645,8.58561441878371,9.148538169335,3.68233641306884,9.28709325024985,3.68233641306884,7.70829378208802,9.32164951581864,8.9343945549374,6.14979536860625,7.70848090908211,9.45528653904108,5.96167527912313,432.085193715848,-1.23647585340386,1.86034617040344,0.0033371121372759,0.0165641695104868,NA,NA,NA,NA,NA
"715","Pocillopora_acuta_HIv2___RNAseq.g17204.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.83894995413197,7.37797883176631,9.83986232575552,10.5841711540003,7.46633298736113,3.68233641306884,3.68233641306884,9.84423275958734,3.68233641306884,6.9219028403352,6.89204400921443,7.33434288798096,6.4497451304479,371.934944695685,-0.023068940874413,0.9864826904875,0.905687133420138,0.964810500134212,"P67999",0,"Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA)","apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to nutrient [GO:0031670]; cellular response to organic cyclic compound [GO:0071407]; cellular response to type II interferon [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; regulation of glucose import [GO:0046324]; response to amino acid [GO:0043200]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to L-leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929]","GO:0000082; GO:0001662; GO:0003009; GO:0004672; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0006915; GO:0007281; GO:0007584; GO:0007616; GO:0009410; GO:0009612; GO:0009636; GO:0009749; GO:0009986; GO:0014070; GO:0014732; GO:0014878; GO:0014911; GO:0016477; GO:0018105; GO:0030165; GO:0031667; GO:0031670; GO:0031929; GO:0032496; GO:0032868; GO:0032869; GO:0032870; GO:0033574; GO:0033762; GO:0034612; GO:0042277; GO:0042802; GO:0043005; GO:0043066; GO:0043200; GO:0043201; GO:0043434; GO:0044539; GO:0045202; GO:0045471; GO:0045727; GO:0045931; GO:0045948; GO:0046324; GO:0046627; GO:0048471; GO:0048633; GO:0048661; GO:0050804; GO:0051384; GO:0051721; GO:0071346; GO:0071363; GO:0071407; GO:0071549; GO:0098794; GO:0098978; GO:0106310; GO:1904263; GO:2001237"
"716","Pocillopora_acuta_HIv2___RNAseq.g17214.t1",0.417536534446764,0,2.4390243902439,0.767263427109974,0,0.355239786856128,0,3.84615384615385,1.46341463414634,0,0.928863261895696,1.28641433885326,0.571312184938133,NA,NA,NA,NA,NA,NA,3.68233641306884,8.97907720476769,8.44276498562665,5.92008485977766,5.52116216212419,10.4423186538278,5.63253479849075,7.66617496800159,6.59364800818146,3.68233641306884,6.65624384669355,6.38121730740055,6.93127038598655,250.742740262704,-0.0735153539597995,0.996009997884999,0.505282906323488,0.73378484968849,"Q9D2N9",1.12e-84,"Vacuolar protein sorting-associated protein 33A","autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; pigmentation [GO:0043473]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; vesicle-mediated transport [GO:0016192]","GO:0005764; GO:0005765; GO:0005769; GO:0005776; GO:0006886; GO:0008333; GO:0016192; GO:0030123; GO:0030136; GO:0030220; GO:0030897; GO:0031902; GO:0032400; GO:0032418; GO:0033263; GO:0035751; GO:0043473; GO:0044877; GO:0048070; GO:0048471; GO:0071439; GO:0097352"
"717","Pocillopora_acuta_HIv2___TS.g17630.t1",18.75,NA,0,0,NA,0,0,NA,0,NA,3.125,0,6.25,NA,NA,NA,NA,NA,NA,12.5244518343428,11.4507190596355,12.1064323033747,9.41776294647851,11.3493058188741,11.264591131045,3.68233641306884,10.4435391753337,7.44280416944215,12.6003787751745,10.228232162677,10.7733066602735,9.68315766508047,2640.0602892839,-0.229987441979982,0.955175039353856,0.409082027220508,0.654898230173517,"P26818",0,"G protein-coupled receptor kinase 3 (EC 2.7.11.15) (Beta-adrenergic receptor kinase 2) (Beta-ARK-2)","desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0001664; GO:0002029; GO:0004703; GO:0005524; GO:0007186; GO:0042995; GO:0047696; GO:0098793; GO:0098794"
"718","Pocillopora_acuta_HIv2___TS.g17647.t1",0,NA,NA,0,0,0,33.3333333333333,0,NA,NA,5.55555555555556,0,11.1111111111111,NA,NA,NA,NA,NA,NA,10.2974251099662,11.2752242515766,11.4195834228804,10.528501517952,10.7426773275979,10.7748242589595,9.02325637500585,11.2589129251475,10.9490947730461,11.9176237530997,10.8187123715232,10.9335387117276,10.7038860313187,1997.96047685668,-0.11444822813605,0.656862092824226,0.799427712975618,0.915686828675195,"O88664",0,"Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Thousand and one amino acid protein 1)","central nervous system neuron development [GO:0021954]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; execution phase of apoptosis [GO:0097194]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of microtubule depolymerization [GO:0007026]; neuron cellular homeostasis [GO:0070050]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein acetylation [GO:1901985]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule cytoskeleton organization [GO:0070507]","GO:0000226; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006281; GO:0006974; GO:0007026; GO:0007095; GO:0015630; GO:0016301; GO:0019901; GO:0021954; GO:0030295; GO:0031489; GO:0032874; GO:0032956; GO:0043014; GO:0043539; GO:0046330; GO:0046777; GO:0048471; GO:0048487; GO:0051493; GO:0070050; GO:0070507; GO:0097194; GO:0106310; GO:1901985"
"719","Pocillopora_acuta_HIv2___RNAseq.g17259.t1",0,0,0,NA,0,0,NA,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.45339882191563,9.15389265986356,9.90398999480587,3.68233641306884,9.66547833317844,11.3518037497941,10.0139825914324,9.36490510064536,10.6884544217997,10.4953498523358,9.37735919388397,9.815245334469,8.93947305329894,1021.19711035322,-0.0877193280383694,0.871494400416029,0.814954411797355,0.922969773254981,"Q5E9N3",5.12e-65,"E3 ubiquitin-protein ligase RNF25 (EC 2.3.2.27) (RING finger protein 25)","positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]","GO:0004842; GO:0005634; GO:0005829; GO:0016567; GO:0046872; GO:0051059; GO:0051092; GO:0061630; GO:0072344"
"720","Pocillopora_acuta_HIv2___RNAseq.g21696.t1",0,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.07521991576182,10.0724562222335,9.28039460830977,6.68205791477539,9.47146011767165,3.68233641306884,3.68233641306884,8.15725975832439,9.05972216677657,7.75155885986295,7.59148023898537,8.80881131336884,6.3741491646019,361.459405611875,-0.494737341340351,1.11013627661515,0.027280137093204,0.0957485811492605,"Q3KP44",5.09e-68,"Ankyrin repeat domain-containing protein 55","",""
"721","Pocillopora_acuta_HIv2___RNAseq.g21723.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.1622672676774,7.82173911168432,3.68233641306884,7.48026504127711,3.68233641306884,3.68233641306884,3.68233641306884,9.58550057964849,8.79055491568583,3.68233641306884,6.12520089813173,6.98059911782988,5.26980267843359,206.300200953445,-0.134470431138752,1.01766956469123,0.027721929226645,0.0969697664653428,"H9D1R1",4.14e-43,"Thioredoxin domain-containing protein 12 (EC 1.8.4.2)","defense response to virus [GO:0051607]","GO:0005788; GO:0009055; GO:0019153; GO:0051607"
"722","Pocillopora_acuta_HIv2___TS.g6778.t1",0,0,NA,0,NA,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,8.32373142797256,8.98013973691163,8.11113015643725,9.45765772696193,7.19630206472076,5.06769837305767,3.68233641306884,12.3837381448915,7.05674068701598,5.77344655672103,8.34003481731093,715.736355011116,0.513767038321138,1.09587177433743,0.0998035355020431,0.261041290687442,"Q6DCX5",1.51e-68,"Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1)","","GO:0005542; GO:0005768; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324"
"723","Pocillopora_acuta_HIv2___TS.g6789.t1",0,NA,0,0,NA,25,0,NA,0,NA,4.16666666666667,8.33333333333333,0,NA,NA,NA,NA,NA,NA,9.6083862909531,9.62214869763182,10.4648072413128,10.7451026363834,11.0216380274019,9.87403298760182,11.8574312515107,10.1063654450881,12.190665055737,3.68233641306884,9.91729140466895,10.6783724120986,9.15621039723932,1697.32234665152,-0.133024938391288,0.891423091518607,0.683389933111784,0.853511318721997,"O75643",0,"U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD)","cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]","GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0016020; GO:0016887; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013"
"724","Pocillopora_acuta_HIv2___RNAseq.g21748.t2",0,0,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.9471456487842,12.0290761158836,11.7450026084975,11.8775055892664,12.1777034688805,11.4962697583854,9.27515008487114,11.8880786335008,9.86593284638692,12.3908175904288,11.4692682344885,11.52477264121,11.4137638277671,3330.21671350593,-0.0628124715267153,0.715562372447674,0.883583882880388,0.955164598805513,"Q8BVE8",0,"Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.357) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (Wolf-Hirschhorn syndrome candidate 1 protein homolog)","atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; bone development [GO:0060348]; membranous septum morphogenesis [GO:0003149]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of establishment of protein localization [GO:0070201]","GO:0000122; GO:0000785; GO:0003149; GO:0003289; GO:0003290; GO:0003682; GO:0005634; GO:0005654; GO:0006355; GO:0032259; GO:0042054; GO:0043565; GO:0046872; GO:0046975; GO:0048298; GO:0060348; GO:0070201; GO:0140954; GO:0140955; GO:2001032"
"725","Pocillopora_acuta_HIv2___RNAseq.g21757.t1",0,0,0,1.15606936416185,0.833333333333333,1.22591943957968,1.32013201320132,0,0,NA,0.503939350030688,0.476397760748307,0.538366336633663,NA,NA,NA,NA,NA,NA,6.15070113667054,6.4898644287519,5.49419692800081,7.55243492849436,5.35568868274662,6.09946079805647,3.68233641306884,3.68233641306884,3.68233641306884,3.68233641306884,5.18716925549961,4.87305191471113,5.50128659628808,36.4292563778609,0.347333322075706,0.963605829698256,0.407628744707412,0.653507222727555,"Q8R4V5",1.6e-22,"Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein)","renal system process [GO:0003014]","GO:0003014; GO:0005509; GO:0005635"
"726","Pocillopora_acuta_HIv2___RNAseq.g21759.t1",0,0,NA,0,NA,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,6.27463595648141,8.5816047084155,6.40448673657577,9.23609553638554,6.39007772316546,9.05144431720124,3.68233641306884,6.09342916571462,3.68233641306884,10.3521662211497,6.97486131912269,5.76899319900122,8.18072943924416,294.230931584547,0.480852168192004,1.11959556861629,0.0887165202452222,0.239134504067628,"Q8IZP9",2.35e-25,"Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Human epididymis-specific protein 6) (He6)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; spermatogenesis [GO:0007283]","GO:0004930; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007283; GO:0009986; GO:0016020; GO:0016324; GO:0070062"
"727","Pocillopora_acuta_HIv2___RNAseq.9044_t",0,0,7.79220779220779,36.8421052631579,11.2359550561798,13.7254901960784,62.7450980392157,100,7.69230769230769,NA,26.6703515599053,31.6519806303088,20.4433152219008,NA,NA,NA,NA,NA,NA,9.49814833887089,8.27883249990586,9.61199487853286,7.90193779854914,9.29884574270951,7.04924140340958,10.788595599767,8.52732321941403,10.1937295001371,3.68233641306884,8.48309853943648,9.42600833593288,7.54018874294008,589.945934669623,-0.486182294835149,1.01257426048703,0.167124779964653,0.374541806230049,"P55440",2.41e-09,"Uncharacterized protein y4fB","","GO:0003676; GO:0016787; GO:0046872"
"728","Pocillopora_acuta_HIv2___TS.g6825.t1",0,3.65853658536585,25.5639097744361,18.1818181818182,4.16666666666667,3.37552742616034,16.2011173184358,0,4.91803278688525,NA,8.45173430441868,6.02678299604592,11.4829234398846,1,17.6470588235294,17.6470588235294,0.00950260677850795,0.00950260677850795,0.00950260677850795,9.30412255695062,9.11837381134201,10.5409616549701,10.4740681401082,9.45054130051746,9.92922073171484,8.5846992726593,9.60930040420826,11.3433183839171,5.96509637913949,9.43197026355274,10.0496488601127,8.81429166699277,934.827605631768,-0.416107082362646,0.815053713202026,0.364277065996819,0.61487962219372,NA,NA,NA,NA,NA
"729","Pocillopora_acuta_HIv2___RNAseq.g21787.t1",66.6666666666667,0,0,0,54.5454545454545,0,15.3846153846154,NA,0,NA,17.0745920745921,0,34.1491841491842,NA,NA,NA,NA,NA,NA,8.00735128423171,8.9760270652654,7.73506114401181,3.68233641306884,6.98333603148276,9.62141819605509,10.2711013344143,4.93729786847052,9.13155756557981,3.68233641306884,7.30278233156491,7.35892077875532,7.24664388437449,351.897225248205,0.0407887425737111,0.983321645631001,0.916795185301307,0.969178193941354,NA,NA,NA,NA,NA
"730","Pocillopora_acuta_HIv2___RNAseq.g21788.t1",NA,NA,38.4615384615385,0,28.2051282051282,25.4901960784314,20,16.6666666666667,18.75,NA,21.0819327731092,15.2267156862745,28.8888888888889,NA,NA,NA,NA,NA,NA,4.72947037839729,7.02067905064675,6.54019209615733,7.26062158020419,6.86756360488365,3.68233641306884,3.68233641306884,6.0528465675844,7.04807821226724,3.68233641306884,5.65664607293474,6.24763017185798,5.06566197401149,55.4021151659819,-0.250371980685971,1.033650153658,0.00337613884398115,0.0167120028197616,NA,NA,NA,NA,NA
"731","Pocillopora_acuta_HIv2___RNAseq.g21793.t1b",0,0,0,0,8.60215053763441,11.7977528089888,14.4329896907216,3.33333333333333,23.5294117647059,NA,6.85507090393156,7.7320995814056,5.75878505708901,NA,NA,NA,NA,NA,NA,7.31983953124869,8.84506269345107,3.68233641306884,7.58719755490047,7.68992605650028,9.03954592923249,3.68233641306884,6.92672320941957,3.68233641306884,3.68233641306884,6.21376406270279,5.86023232466124,6.56729580074434,151.696768178249,0.125321411235268,0.990508557613851,0.539994892992786,0.759848830844212,NA,NA,NA,NA,NA
"732","Pocillopora_acuta_HIv2___RNAseq.g21801.t1",2.89855072463768,0,0,0,0.833333333333333,0.82135523613963,1.5748031496063,0,0,NA,0.680893604857438,0.164271047227926,1.32667180189433,NA,NA,NA,NA,NA,NA,9.56529713715211,5.06794590568438,7.00571141948957,7.85997747624031,8.35108764351216,8.19674494829501,9.84979738652842,8.9828962845594,9.65830165477501,9.28418442824534,8.38219442844817,8.71265882789765,8.05173002899869,438.455711932518,-0.164603478520718,0.786929261598471,0.705133956821313,0.865394905604821,NA,NA,NA,NA,NA
"733","Pocillopora_acuta_HIv2___TS.g6874.t1",0,3.7037037037037,0,NA,NA,0,0,NA,0,NA,0.617283950617284,1.23456790123457,0,NA,NA,NA,NA,NA,NA,7.27084577869145,8.46454219346938,8.49133772109432,3.68233641306884,5.05297917362319,10.1027065430965,9.9738731979895,7.27998974034641,3.68233641306884,10.9398469341571,7.49407941086055,6.35549776536484,8.63266105635626,492.871945224278,0.360209737155538,1.06606723485783,0.0813385961925086,0.224605088837045,"Q6DCX5",2.6e-51,"Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1)","","GO:0005542; GO:0005768; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324"
"734","Pocillopora_acuta_HIv2___RNAseq.g21833.t1",0,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.2693866317545,11.2105577948722,12.0853543154279,11.0825794606604,11.421830264072,8.91742718084503,11.7482796410879,12.1580406418337,6.20688780213667,3.68233641306884,9.97826801457591,10.628299931045,9.32823609810687,2243.57784283962,-0.808909228112889,0.957361721647547,0.105178576962623,0.271564251550764,"O88783",1.57e-19,"Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]","blood circulation [GO:0008015]; blood coagulation [GO:0007596]; response to vitamin K [GO:0032571]","GO:0005507; GO:0005576; GO:0005615; GO:0007596; GO:0008015; GO:0031091; GO:0032571"
"735","Pocillopora_acuta_HIv2___RNAseq.g21842.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,10.1174200793621,3.68233641306884,9.1018697478511,7.60379181609188,11.6897654213985,9.25983092208202,5.87689277444549,3.68233641306884,3.68233641306884,6.83789164135064,4.90553876594878,8.77024451675251,568.044443915798,0.856287515669757,1.60739004826631,0.00261375330920449,0.0134586428851313,"Q9VCA2",9.75e-66,"Organic cation transporter protein","apoptotic process [GO:0006915]; monoatomic ion transport [GO:0006811]","GO:0006811; GO:0006915; GO:0016020; GO:0022857"
"736","Pocillopora_acuta_HIv2___TS.g6907.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.2333228569042,5.21816971328303,11.9359116359619,3.68233641306884,12.4599578331679,3.68233641306884,4.40301213871548,12.6583645097617,13.2712520202334,7.75155885986295,8.62962223940282,12.3117617712058,4.94748270759983,2839.24667072626,-9.38615985394496,2.37136527850434,6.54535927476237e-13,8.84785762151055e-11,NA,NA,NA,NA,NA
"737","Pocillopora_acuta_HIv2___RNAseq.g21861.t1",0,NA,0,NA,0,0,NA,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.44975813022123,9.67950298274677,8.98019559995231,11.2592755517594,7.90398397731598,9.40299864939199,9.85490292833965,9.66443395376021,3.68233641306884,10.6655492872534,9.05429374738098,7.93614161486371,10.1724458798982,852.496103217263,0.5956518772835,1.02399311955679,0.173793451272099,0.384682585838447,"Q9CXR1",1e-88,"Dehydrogenase/reductase SDR family member 7 (EC 1.1.1.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1) (Protein SDR34C1)","","GO:0004090; GO:0005789; GO:0016616; GO:0052650"
"738","Pocillopora_acuta_HIv2___RNAseq.g21880.t1",0,NA,0,0,0,0,0,1.69491525423729,0,NA,0.211864406779661,0.423728813559322,0,NA,NA,NA,NA,NA,NA,6.82556204308159,7.47670412910099,5.98248205022216,9.26578381504101,6.08938798535807,9.07027972171358,9.24952694379838,7.80656939979663,7.69638093712164,6.53774712136497,7.6000424146599,6.88007648311602,8.32000834620379,246.366634875874,0.914429202036549,0.987825734231331,0.0732996220856248,0.208046651068775,"P12111",6.58e-08,"Collagen alpha-3(VI) chain","cell adhesion [GO:0007155]; muscle organ development [GO:0007517]; neuron apoptotic process [GO:0051402]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; response to glucose [GO:0009749]; response to UV [GO:0009411]","GO:0004867; GO:0005576; GO:0005589; GO:0005615; GO:0005788; GO:0007155; GO:0007517; GO:0009411; GO:0009749; GO:0030020; GO:0031012; GO:0042383; GO:0043491; GO:0051402; GO:0062023; GO:0070062; GO:1903561"
"739","Pocillopora_acuta_HIv2___RNAseq.g21915.t1",0,NA,0,0,6.25,0,0,0,NA,NA,0.892857142857143,0,1.5625,NA,NA,NA,NA,NA,NA,7.67974561220581,3.68233641306884,8.11858910456873,3.68233641306884,8.39315981742328,3.68233641306884,3.68233641306884,9.00186486460695,10.2146977882004,3.68233641306884,6.18197392523494,8.68161143740103,3.68233641306884,239.410855885202,-12.660871521048,3.65206415889139,7.99187129250739e-11,4.67993629047882e-09,"Q6IND7",3.85e-110,"LRP2-binding protein","","GO:0005737"
"740","Pocillopora_acuta_HIv2___RNAseq.9201_t",0,0,0,NA,0,0,NA,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.36720372069137,8.13290662201816,7.51710843450505,3.68233641306884,9.14673675868645,9.19350856641533,3.68233641306884,8.28115103341985,11.4886231587967,3.68233641306884,7.21742475337394,8.76016462121988,5.674684885528,478.98484149048,-0.410052479429184,1.08169435646501,4.26574772715057e-05,0.000398451233014426,"O17185",5.26e-46,"Two pore potassium channel protein sup-9 (Suppressor of unc-93 protein 9) (n2P38)","potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937]; stabilization of membrane potential [GO:0030322]","GO:0005267; GO:0005886; GO:0006813; GO:0006937; GO:0015271; GO:0022841; GO:0030322; GO:0036195; GO:0055120; GO:0071805"
"741","Pocillopora_acuta_HIv2___TS.g6999.t2",NA,11.1111111111111,NA,0,0,0,0,NA,NA,0,1.85185185185185,3.7037037037037,0,NA,NA,NA,NA,NA,NA,12.1199724462959,12.6390603791608,12.3900239151904,12.1135340347224,12.1000063968617,11.5083993399059,10.0048250884397,11.2296056180844,13.0449895385707,11.6983498745668,11.8848766631799,12.1769195830006,11.5928337433591,4287.91619060987,-0.426313505406885,0.57438691623996,0.354369518320315,0.605408744596291,"Q9W735",1.07e-106,"Prominin-1-A (Prominin-like protein 1)","","GO:0005783; GO:0005793; GO:0005886; GO:0005902; GO:0005929; GO:0009986; GO:0015485; GO:0016324; GO:0031528; GO:0071914"
"742","Pocillopora_acuta_HIv2___RNAseq.g21938.t1",0,NA,0,0,0,5.47945205479452,0,0,0,0,0.60882800608828,1.36986301369863,0,NA,NA,NA,NA,NA,NA,14.3171765509684,14.2213586282428,14.5804067202284,13.3205866666459,14.6083067496762,14.3587134330431,14.2616581466184,14.0425134092137,14.9158000115599,14.4350632683625,14.3061583584559,14.4928406883293,14.1194760285825,20954.878543237,-0.271587188429804,0.526746527441836,0.53444342459292,0.755401010296278,"D3ZAT9",5.92e-42,"Failed axon connections homolog","","GO:0005737; GO:0016020"
"743","Pocillopora_acuta_HIv2___RNAseq.g21949.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.1832432212793,10.0767316363486,10.0867886550736,6.77637728594488,10.5654387881933,11.599907690554,5.28097201389241,10.7713983615365,10.7732038768591,10.6552966218828,9.77693581515645,10.6760145805884,8.87785704972454,1412.11588524477,-0.676890548701748,0.996249058190783,0.111197761585303,0.282508655570131,"Q8WY21",3.4e-124,"VPS10 domain-containing receptor SorCS1 (hSorCS)","neuropeptide signaling pathway [GO:0007218]; post-Golgi vesicle-mediated transport [GO:0006892]","GO:0005794; GO:0006892; GO:0007218; GO:0008188; GO:0016020"
"744","Pocillopora_acuta_HIv2___RNAseq.g21953.t1",0,NA,NA,NA,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.3165368930797,10.4385576322723,10.7099865916098,10.2628651147657,10.5906149139052,10.6914020035541,10.3149819247529,10.8386061186741,10.3690012341191,7.25505688810043,10.1787609314833,10.5649491502776,9.79257271268909,1308.7994160762,-0.432920105385077,0.686971371612659,0.365313017148345,0.615274510202997,"O93309",0,"Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3)","cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275]","GO:0000775; GO:0000785; GO:0005524; GO:0005634; GO:0006275; GO:0006281; GO:0016887; GO:0030893; GO:0051276; GO:0051301; GO:0051321"
"745","Pocillopora_acuta_HIv2___TS.g7018.t1",14.2857142857143,12.7272727272727,2.30769230769231,18.0722891566265,22.6993865030675,4.95867768595041,18.1818181818182,16.6666666666667,6.83760683760684,14.1104294478528,13.0847553800268,11.8525026148246,14.317008145229,NA,NA,NA,NA,NA,NA,7.21146895076296,6.06348383902188,7.55772762038829,8.51522602698091,7.64955567509537,6.71585965723107,8.18549058728256,8.09750134092551,9.69914067840575,3.68233641306884,7.33777907891631,8.04307885311558,6.63247930471705,224.91333640569,-0.34018314320866,0.91356532056996,0.383022485443304,0.631919382850684,"Q60997",1.82e-59,"Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Apactin) (CRP-ductin) (Deleted in malignant brain tumors 1 protein) (Glycoprotein 300) (gp300) (Hensin) (Mucin-like glycoprotein) (Muclin) (Vomeroglandin) (p80)","blastocyst development [GO:0001824]; columnar/cuboidal epithelial cell differentiation [GO:0002065]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; response to bacterium [GO:0009617]","GO:0001824; GO:0001833; GO:0002065; GO:0005615; GO:0006952; GO:0009617; GO:0015031; GO:0030658; GO:0030858; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830; GO:0062023"
"746","Pocillopora_acuta_HIv2___TS.g7019.t1",0,NA,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,5.32602117141484,9.72015875967158,7.26683347298246,10.6894521869591,3.68233641306884,8.98599335443773,9.57036699782278,3.68233641306884,8.51207406275117,3.68233641306884,7.11179092452462,5.69392030665723,8.52966154239201,414.808455994647,0.399736013028266,1.12562729761523,0.00443864006805831,0.0210148903254977,"Q9UGM3",1.67e-58,"Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031]","GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062"
"747","Pocillopora_acuta_HIv2___RNAseq.g21967.t1",NA,NA,0,0,NA,3.44827586206897,0,0,NA,0,0.574712643678161,1.14942528735632,0,NA,NA,NA,NA,NA,NA,9.52780354200312,11.1790935120415,8.87893019756678,11.3615168262805,9.05422290374872,11.7202550724805,12.0742736839209,8.9441931046482,9.78412181036285,10.775119515433,10.3299530168486,9.23785431166593,11.4220517220313,1724.85187375922,1.92530210663041,0.714976180431075,0.000829625684291578,0.00500404749691134,"P53634",5.21e-171,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005813; GO:0006508; GO:0006955; GO:0008234; GO:0008239; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0043231; GO:0051087; GO:0051603; GO:0062023; GO:0070062; GO:1903052; GO:1903980; GO:2001235"
"748","Pocillopora_acuta_HIv2___RNAseq.g22041.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.9029126230743,11.080360867007,11.7092411149873,12.2701486940873,12.0808555643943,10.9716528695184,9.05614986436118,11.3484813187382,11.6178475391625,10.2092962349992,11.224694669033,11.7318676320713,10.7175217059946,2783.35715316997,-0.727083478662372,0.668280594837968,0.141485661521086,0.335758590359474,"Q5R416",0,"Catenin alpha-2 (Alpha N-catenin)","axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of synapse structural plasticity [GO:0051823]","GO:0005198; GO:0005634; GO:0005737; GO:0005912; GO:0007409; GO:0008013; GO:0010975; GO:0015629; GO:0016342; GO:0021942; GO:0030424; GO:0034316; GO:0045296; GO:0048813; GO:0048854; GO:0051015; GO:0051823; GO:0060134; GO:0098609; GO:2001222"
"749","Pocillopora_acuta_HIv2___RNAseq.g22045.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.22289842159741,3.68233641306884,10.6531533692359,3.68233641306884,8.31033346353542,7.4619492718124,9.23654251700305,9.20449273482584,3.68233641306884,3.68233641306884,6.58187154302854,7.61464288045268,5.54910020560439,322.223252457961,-0.300751680536637,1.0222020961915,0.223904320705399,0.455813102699915,"Q32N22",2.94e-27,"TATA box-binding protein-associated factor RNA polymerase I subunit B (RNA polymerase I-specific TBP-associated factor 63 kDa) (TAFI63) (TATA box-binding protein-associated factor 1B) (TBP-associated factor 1B)","RNA polymerase I preinitiation complex assembly [GO:0001188]","GO:0001164; GO:0001188; GO:0046872; GO:0070860"
"750","Pocillopora_acuta_HIv2___RNAseq.g22047.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.13094462683116,7.88178580013571,9.8480359709801,7.38459886133705,9.44232352428482,9.68082213827152,3.68233641306884,6.644948255539,11.363890258525,3.68233641306884,7.7742022262042,9.08602852723202,6.46237592517639,565.619700146394,-0.538527845390893,1.10067881327707,0.041136126661336,0.133796477632013,"Q9R0D8",1.7e-82,"WD repeat-containing protein 54","cilium assembly [GO:0060271]; negative regulation of receptor internalization [GO:0002091]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of MAPK cascade [GO:0043408]","GO:0002091; GO:0005930; GO:0031982; GO:0042058; GO:0042803; GO:0043231; GO:0043408; GO:0060271"
"751","Pocillopora_acuta_HIv2___TS.g7113.t1",0,NA,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.3690968921852,9.86068100578687,12.2771834965576,7.26062158020419,10.8875942751652,9.66697234898041,6.88311649774628,11.4029789697531,11.1979158780825,13.0165991864622,10.3822760130924,11.4269539023487,9.33759812383599,2460.75590384971,-0.947458779373736,1.16289140132574,0.0376550071385784,0.124404299509456,"Q86UK5",2.87e-29,"Limbin (Ellis-van Creveld syndrome protein 2) (EVC2)","smoothened signaling pathway [GO:0007224]","GO:0005634; GO:0005737; GO:0005856; GO:0005929; GO:0007224; GO:0060170; GO:0098797"
"752","Pocillopora_acuta_HIv2___TS.g7121.t1",1.05633802816901,0,0,0,0,0.387596899224806,1.51515151515152,0,0,NA,0.328787382505037,0.0775193798449612,0.642872385830132,NA,NA,NA,NA,NA,NA,9.09858249926947,9.76500857347088,8.56409540488861,9.70063232790689,8.61219199715842,10.0923821206271,10.1953107149535,9.00015073007664,8.38273717370072,8.80595549305352,9.22170470351058,8.73155156101877,9.71185784600238,632.402892403617,0.818663394130886,0.556465353175809,0.0801561770786594,0.222743313211475,NA,NA,NA,NA,NA
"753","Pocillopora_acuta_HIv2___RNAseq.g22076.t2a",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.8766977630804,10.8188797887622,8.26555224992641,3.68233641306884,7.65364434417167,8.33960285299818,3.68233641306884,9.65466422234158,8.04472662528376,3.68233641306884,7.47007770857707,8.89905704096076,6.04109837619338,541.2867319357,-0.445233420590169,1.09827337369022,4.26715265444791e-05,0.000398451233014426,"Q6P1B1",0,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)","bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508]","GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0043069; GO:0070006"
"754","Pocillopora_acuta_HIv2___RNAseq.g22100.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.18019374494757,7.73755144868966,9.89500164195794,9.0958711139735,7.78985378200311,10.0179646119109,9.93100572731929,10.4672947963297,3.68233641306884,3.68233641306884,8.04794096932694,8.00293607566143,8.09294586299244,545.038216601357,0.0199969241294358,0.752378474095164,0.924073380599532,0.971563376971115,"Q8CAI1",8.8e-24,"Coiled-coil domain-containing protein 142","",""
"755","Pocillopora_acuta_HIv2___TS.g7156.t2",NA,100,100,100,100,60,100,NA,NA,NA,93.3333333333333,86.6666666666667,100,NA,NA,NA,NA,NA,NA,9.33602916180979,10.4462880415136,11.0215923755122,9.85772256597646,10.3873739962792,11.9331786724209,12.0470277616195,10.1579873592673,10.1875038944462,12.0096000677938,10.7384303896639,10.2180973574629,11.2587634218649,2070.63439291507,0.753877774165107,0.722463948022232,0.138649634807939,0.33120203432899,"Q5EAJ7",0,"Major vault protein (MVP)","","GO:0005634; GO:0005737; GO:1990904"
"756","Pocillopora_acuta_HIv2___RNAseq.g22105.t1",0,NA,100,0,NA,66.6666666666667,42.8571428571429,NA,100,NA,51.5873015873016,55.5555555555556,47.6190476190476,NA,NA,NA,NA,NA,NA,8.72653949301279,3.68233641306884,8.45199815117828,3.68233641306884,6.08938798535807,10.288024328398,3.68233641306884,7.94874910879557,8.43419122002346,3.68233641306884,6.46682359390415,7.93017319167363,5.00347399613467,253.560788647882,-0.474670866965879,1.19066777067125,1.3183545248958e-07,2.74764839309695e-06,"A6H779",1.1e-11,"F-box/LRR-repeat protein 2 (F-box and leucine-rich repeat protein 2)","negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]","GO:0005516; GO:0010506; GO:0016020; GO:0016567; GO:0019005; GO:0031146; GO:0050727; GO:0051896; GO:1900226; GO:1990756"
"757","Pocillopora_acuta_HIv2___RNAseq.g22113.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.86634134176067,8.54911845570323,9.760429728062,9.22789147001793,9.87969705385302,9.91887031580272,3.68233641306884,10.3355956721066,8.93141557112441,3.68233641306884,8.38340324345683,9.75469587338134,7.01211061353231,626.188823808274,-0.474584050302549,1.05903146252261,0.0837104880813699,0.229177258819533,"Q0P5M9",4.82e-119,"Major facilitator superfamily domain-containing protein 10 (Tetracycline transporter-like protein)","apoptotic process [GO:0006915]","GO:0005637; GO:0006915; GO:0022857; GO:0031526"
"758","Pocillopora_acuta_HIv2___RNAseq.g22119.t1",0.872093023255814,8.19672131147541,2.41935483870968,0.955414012738854,6.34005763688761,1.95439739413681,0.630252100840336,0.99009900990099,1.21951219512195,0,2.35779015230674,2.6632287846748,2.05235151993869,NA,NA,NA,NA,NA,NA,6.87035865762029,3.68233641306884,5.70790219953855,3.68233641306884,6.46781886708255,3.68233641306884,3.68233641306884,5.12735228357021,8.23094090625512,3.68233641306884,5.08160549794109,6.48087458281334,3.68233641306884,47.6485687071175,-9.44111453476717,3.7076379732913,1.46733270979203e-05,0.000159096704006237,NA,NA,NA,NA,NA
"759","Pocillopora_acuta_HIv2___RNAseq.g23527.t1",25.5474452554745,45.4545454545455,32.6530612244898,7.14285714285714,38.0952380952381,18.6252771618625,24.2290748898678,12.9032258064516,0,NA,22.7389694478652,16.8251811131433,30.1312048662675,1,31.3725490196078,31.3725490196078,0.00450009011896794,0.00450009011896794,0.00450009011896794,8.26147673713321,6.32311345750654,6.35163274692994,8.50166853559975,8.40771982830346,7.79875575103921,6.90983061090606,8.92625107149489,7.53242220357841,5.79624808010018,7.48091190225917,7.89590051748798,7.06592328703035,199.586649864359,-0.609202587601617,0.85948468201338,0.200301400992574,0.423375634072277,NA,NA,NA,NA,NA
"760","Pocillopora_acuta_HIv2___RNAseq.g23532.t1",0,NA,0,NA,NA,0,5,0,0,NA,0.833333333333333,0,1.66666666666667,NA,NA,NA,NA,NA,NA,5.63634872160117,6.13320531664763,6.41738916037693,8.48798210411924,5.21442834742072,6.65382384584395,3.68233641306884,5.4533793909793,7.56366523702835,3.68233641306884,5.8924894950155,6.05704217148129,5.7279368185497,74.8613263742984,-0.0536249659189149,0.952502815685793,0.747170792558866,0.888813088541117,"Q9VGA4",6.06e-06,"Protein MBD-R2","chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000785; GO:0000791; GO:0003677; GO:0005634; GO:0005700; GO:0005705; GO:0006325; GO:0006357; GO:0044545; GO:0045944; GO:0046872; GO:1990841"
"761","Pocillopora_acuta_HIv2___RNAseq.g23539.t1",2.19512195121951,0,0.286532951289398,1.61290322580645,7.22610722610723,0.861393891934221,3.30827067669173,0,9.58333333333333,28.5714285714286,5.36450918278104,2.4115260902148,8.31749227534729,NA,NA,NA,NA,NA,NA,9.94472586158724,10.4307855706764,10.9759769536931,9.4129468346543,8.6473675796025,7.12386846770193,11.3893561601552,8.30358512279268,8.35184978893498,10.3228522733328,9.49033146131311,9.2447010613221,9.73596186130413,995.476958758638,0.213316983348929,0.780513435263483,0.629713152853064,0.820680633826485,"Q9WUU9",7.52e-177,"Germinal-center associated nuclear protein (GANP) (EC 2.3.1.48) (GC-associated DNA primase)","mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446]","GO:0003676; GO:0003682; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006406; GO:0010484; GO:0015031; GO:0016446; GO:0016973; GO:0031965; GO:0034728; GO:0042393; GO:0044615; GO:0070390"
"762","Pocillopora_acuta_HIv2___RNAseq.g23549.t1",0,NA,0,0,NA,8,0,NA,0,NA,1.33333333333333,2.66666666666667,0,NA,NA,NA,NA,NA,NA,3.68233641306884,5.39185996804635,3.68233641306884,6.39402768922764,5.88788892518078,7.50430960043243,6.11018217243107,5.12735228357021,3.68233641306884,3.68233641306884,5.11449662911638,4.4124500895915,5.81654316864127,33.3517049622877,0.610544884961173,1.21169268783059,0.0582572075340415,0.175159994717741,NA,NA,NA,NA,NA
"763","Pocillopora_acuta_HIv2___TS.g23869.t1",0,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.47868055454933,4.68019422250907,8.05935642606527,8.62766417813255,6.46781886708255,4.83944927859506,3.68233641306884,7.05229290628527,8.25021701133413,3.68233641306884,6.18203462706909,7.26167315306331,5.10239610107487,114.476451354839,-1.06893434167633,1.66687454728319,0.00382025201502348,0.0185602183903334,"Q4UMH6",9.68e-57,"Putative ankyrin repeat protein RF_0381","guanosine tetraphosphate metabolic process [GO:0015969]","GO:0015969"
"764","Pocillopora_acuta_HIv2___RNAseq.g23588.t1",2.65957446808511,0,1.66666666666667,4.6242774566474,2.43161094224924,2.00860832137733,0.29585798816568,3.84615384615385,0,0,1.75327496893453,2.09580792483572,1.41074201303334,NA,NA,NA,NA,NA,NA,8.19333746262727,9.53367400315034,9.30096038067748,11.5165507713109,8.60589432994897,11.3986388792359,10.9120955780169,8.09750134092551,6.32360023828538,11.0734474626853,9.4955700446864,8.10425875049292,10.8868813388799,1186.7343084127,2.45067569509182,0.89613203462696,0.000273405604145979,0.00195285859672466,"Q01484",3.68e-69,"Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)","atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]","GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259"
"765","Pocillopora_acuta_HIv2___TS.g23889.t2",0,0,11.1111111111111,NA,NA,23.0769230769231,NA,0,NA,0,5.6980056980057,7.69230769230769,3.7037037037037,NA,NA,NA,NA,NA,NA,3.68233641306884,6.28314015845146,6.50448097751675,7.24978579672844,5.10947276732146,6.91889492578439,8.19089365558311,4.74601725290823,7.05913344033601,3.68233641306884,5.94264918007675,5.42028817023026,6.46501018992325,74.2482632879357,0.396364936485528,1.06505917495307,0.101299682939891,0.263952191324552,NA,NA,NA,NA,NA
"766","Pocillopora_acuta_HIv2___RNAseq.g23594.t1",3.125,7.57575757575758,11.5384615384615,7.56013745704467,5.28301886792453,4.67289719626168,5.30503978779841,0,0,0,4.50603124232484,3.96175844581279,5.0503040388369,NA,NA,NA,NA,NA,NA,6.22289842159741,6.88270198298439,7.5288322148278,8.7925686150577,7.10241079320388,8.70782435704477,9.13103747490332,6.025091802042,7.45118772687036,6.58881646192222,7.44333698504539,6.86608419170829,8.02058977838248,202.859411439735,0.796720326517696,0.838177642397801,0.125947153198462,0.309304566531497,"Q59002",8.48e-09,"Uncharacterized glycosyltransferase MJ1607 (EC 2.4.-.-)","","GO:0016757"
"767","Pocillopora_acuta_HIv2___RNAseq.g23595.t1",1.63934426229508,0,0,2.53164556962025,9.31372549019608,6.64739884393064,9.71223021582734,0,31.25,NA,6.78826048687438,8.08580888271018,5.16632499207963,NA,NA,NA,NA,NA,NA,8.25731136237857,7.67854539303102,9.19872341498392,9.58551303159016,7.13802507858311,8.6369157235529,9.86506010515632,6.65383698875806,6.80659519587517,11.0035822873193,8.48241085812285,7.61089840811577,9.35392330812994,535.401080018047,1.0327710286139,1.02436421545626,0.0501084630157195,0.155596566994282,NA,NA,NA,NA,NA
"768","Pocillopora_acuta_HIv2___TS.g23892.t2",0,0,0,0,0,0.256410256410256,0,0,0,NA,0.0284900284900285,0.0512820512820513,0,NA,NA,NA,NA,NA,NA,10.1593909921548,9.98871829916894,11.168201196538,9.43449375631599,11.5676111336919,11.9840110530908,10.3611592105732,10.9873979563785,11.257965486836,8.64340140185018,10.5552350486598,11.0281133531198,10.0823567441998,1817.79236686312,-0.614279682142951,0.693854373539834,0.209052581724487,0.435600233417006,NA,NA,NA,NA,NA
"769","Pocillopora_acuta_HIv2___RNAseq.g23598.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.8094179843483,8.90723650973111,11.1899496098501,7.74936704245489,10.7205252877362,10.2809704218275,9.84979738652842,10.5333424418278,12.05569234743,8.92298266183496,10.1019281693569,11.0617855342385,9.14207080447538,1465.03271846977,-1.44263208620473,0.881780455669214,0.0134107433278457,0.0532453998061926,"Q4UMH6",9.53e-68,"Putative ankyrin repeat protein RF_0381","guanosine tetraphosphate metabolic process [GO:0015969]","GO:0015969"
"770","Pocillopora_acuta_HIv2___RNAseq.g23610.t1",5.02183406113537,0,5.24861878453039,6.86813186813187,5.03875968992248,3.63636363636364,10.7438016528926,1.14285714285714,25,NA,6.96670742620372,7.32947052947053,6.5132535471202,NA,NA,NA,NA,NA,NA,5.76666095136545,8.71935049078991,8.05935642606527,8.98663889257869,6.02555167782084,3.68233641306884,7.42540170510466,8.22348476192202,7.68932204596019,5.3719891395326,6.99500925042085,7.15287517262675,6.83714332821494,181.581027934707,-0.217752787178927,0.926367282471805,0.446329773333038,0.688389191884097,NA,NA,NA,NA,NA
"771","Pocillopora_acuta_HIv2___RNAseq.g23611.t1",1.76767676767677,1.89274447949527,1.90839694656489,1.01522842639594,1.09289617486339,0.327332242225859,0.539083557951482,0.403225806451613,0,0,0.89465844016252,0.727706190913736,1.0616106894113,NA,NA,NA,NA,NA,NA,9.61164811340314,10.0566703714662,9.69201885455244,9.5131053164886,8.41254060050376,9.38994105485423,5.32551295827119,8.81168297583991,7.36504895374022,10.598330884716,8.87765000838357,8.77858789960789,8.97671211715924,637.178546154387,0.120327859028734,0.808785352193168,0.77866451446445,0.905466524937074,"Q7Z7M1",5.42e-08,"Adhesion G protein-coupled receptor D2 (G-protein coupled receptor 144) (G-protein coupled receptor PGR24)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020"
"772","Pocillopora_acuta_HIv2___RNAseq.g23618.t1",0,0,2.38095238095238,1.41843971631206,1.68067226890756,0,0,0,0,0,0.5480064366172,0.283687943262411,0.812324929971989,NA,NA,NA,NA,NA,NA,8.47017797120283,5.57859373890424,8.49431975897384,7.78719371610229,8.34100685813099,5.87223972230221,3.68233641306884,7.1302149901151,4.72904561334115,3.68233641306884,6.37674651952103,7.43295303835278,5.32054000068928,134.379815296173,-2.32520428140584,1.88197677119144,0.00339532579456278,0.016784002834093,NA,NA,NA,NA,NA
"773","Pocillopora_acuta_HIv2___RNAseq.g23622.t1",0.212765957446809,0.198412698412698,0.525394045534151,0.362976406533575,0.564174894217207,0.940438871473354,0.199600798403194,0,0,0,0.300376367202099,0.300365595283926,0.300387139120272,NA,NA,NA,NA,NA,NA,7.79362858270644,5.77108626594745,7.91529616546613,6.58091230054222,6.87464331873483,6.78684792853876,3.68233641306884,7.86438802095663,3.68233641306884,9.44592069888342,6.63973961079136,6.82605850018657,6.45342072139614,157.64585013085,-0.19112951406721,0.975802843091781,0.436863041779325,0.680097625260592,"Q9DBN1",3.23e-06,"Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2)","establishment of localization in cell [GO:0051649]; retinol transport [GO:0034633]; vitamin A import into cell [GO:0071939]","GO:0005886; GO:0034632; GO:0034633; GO:0038023; GO:0051649; GO:0071939"
"774","Pocillopora_acuta_HIv2___RNAseq.g23623.t1",0,1.5625,0,0.273972602739726,1.94174757281553,0.584307178631052,0.732600732600733,0,0,0,0.509512808678704,0.484155956274156,0.534869661083253,NA,NA,NA,NA,NA,NA,7.57627509210327,9.69997414692601,3.68233641306884,9.73961628300052,3.68233641306884,10.030036306245,9.37568781042739,3.68233641306884,3.68233641306884,3.68233641306884,6.48332717040464,4.46112414887573,8.50553019193355,346.060402414297,0.488784689458364,1.17999280032262,9.87129751509202e-06,0.00011286833775359,NA,NA,NA,NA,NA
"775","Pocillopora_acuta_HIv2___RNAseq.g23626.t1",0.952380952380952,0,0,0,0,0.829875518672199,1.63934426229508,0,0,NA,0.380177859260915,0.16597510373444,0.647931303669009,NA,NA,NA,NA,NA,NA,8.74746157828316,8.08266943966032,7.90186235669204,10.6734372030406,3.68233641306884,9.2970681539981,3.68233641306884,8.5033066912864,9.30496451622884,3.68233641306884,7.3557779178396,7.62798631111186,7.08356952456734,402.067205259053,-0.047515748115418,0.993696992786766,0.648725036658306,0.832430707081772,NA,NA,NA,NA,NA
"776","Pocillopora_acuta_HIv2___TS.g23937.t1",0,NA,0,0,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.4285572532014,11.8987252258906,11.5537584432361,9.3886219429448,12.0382741902901,10.794770375877,12.5352141316803,12.1844916003199,12.0308734438519,9.93921187072951,11.4792498478022,12.0471909861799,10.9113087094244,3449.10633029718,-0.810827685028945,0.688545015364538,0.104772765035713,0.270854919298759,"P25708",0,"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (NDUFV1) (EC 7.1.1.2) (Complex I-51kD) (CI-51kD) (NADH dehydrogenase flavoprotein 1) (NADH-ubiquinone oxidoreductase 51 kDa subunit)","mitochondrial electron transport, NADH to ubiquinone [GO:0006120]","GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0010181; GO:0045271; GO:0046872; GO:0051287; GO:0051539"
"777","Pocillopora_acuta_HIv2___RNAseq.g23673.t1",4.61538461538461,0,3.125,NA,0,4.04858299595142,0,0,0,NA,1.473620951417,1.01214574898785,1.93509615384615,NA,NA,NA,NA,NA,NA,8.47017797120283,7.97046471243864,7.19489022163491,3.68233641306884,3.68233641306884,5.87223972230221,3.68233641306884,7.44111104366818,3.68233641306884,9.86742335056167,6.15456526740838,6.09417041252872,6.21496012228804,177.053702653465,-0.0124965734983635,1.00306533458589,0.83623444050655,0.934576954681405,"Q09575",8.49e-38,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0005737; GO:0008270; GO:0015074; GO:0019899; GO:0042575"
"778","Pocillopora_acuta_HIv2___RNAseq.g11410.t1",6.38297872340426,10.8108108108108,16.2162162162162,5.11627906976744,8.10810810810811,9.61098398169336,10.2040816326531,0,21.1538461538462,0,8.76033046964994,9.33838400322355,8.18227693607633,NA,NA,NA,NA,NA,NA,9.5174065067491,7.93312856127724,12.1125022937718,8.51522602698091,9.20758094875247,9.5051395260767,5.18636982781747,10.699850702439,10.2933322492624,3.68233641306884,8.66528730561959,10.366134540195,6.96444007104423,981.941658430094,-1.19298006768991,1.70234082789368,0.00406069144504185,0.0195129040070051,"Q6Q759",2.1e-100,"Sperm-associated antigen 17 (Projection protein PF6 homolog)","axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283]","GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0031514; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953"
"779","Pocillopora_acuta_HIv2___TS.g6.t1",0,NA,0,0,0,0,4.41176470588235,0,0,0,0.490196078431373,0,0.882352941176471,NA,NA,NA,NA,NA,NA,9.31216565992877,9.85737121293262,9.33126914756743,10.4981358781327,8.68569050529328,11.0256998158614,3.68233641306884,7.16762719725138,11.8184930212478,3.68233641306884,8.50611252643531,9.26304910625773,7.74917594661288,970.293128351292,-0.0940781946528926,0.9587460547611,0.576121831742687,0.785496726478169,"Q8N5D0",0,"WD and tetratricopeptide repeats protein 1","cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; intracellular chemical homeostasis [GO:0055082]; multicellular organism growth [GO:0035264]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell size [GO:0008361]","GO:0000122; GO:0001701; GO:0004857; GO:0005654; GO:0005737; GO:0005829; GO:0006006; GO:0008361; GO:0016567; GO:0032869; GO:0035264; GO:0042393; GO:0042826; GO:0045717; GO:0055082; GO:0080008"
"780","Pocillopora_acuta_HIv2___RNAseq.g11414.t1",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.0657053962733,3.68233641306884,7.73506114401181,9.34630370156166,10.3571018356201,3.68233641306884,9.97543667073592,9.85848765320023,8.79383957244156,11.9237379769533,8.64203467769356,9.5620391203094,7.72203023507771,1037.95224708326,-0.07284342645891,0.970812438441152,0.618560871051604,0.813351312626399,"P35738",0,"2-oxoisovalerate dehydrogenase subunit beta, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component beta chain) (BCKDE1B) (BCKDH E1-beta)","branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]","GO:0003863; GO:0005654; GO:0005730; GO:0005739; GO:0005759; GO:0006629; GO:0007584; GO:0009083; GO:0044877; GO:0045252; GO:0046872; GO:0047101; GO:0051384; GO:0051591; GO:0160157"
"781","Pocillopora_acuta_HIv2___RNAseq.g11417.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.8347554206896,9.46138372062901,10.7240103933728,10.1298086724271,10.7426773275979,10.9310338608378,9.93904087906803,11.2886896155079,7.78511408192754,11.1017677997916,10.2938281771849,10.2750493678191,10.3126069865507,1465.56006142224,-0.0676717191272468,0.727357350859898,0.870163354067204,0.949587992171491,"Q6ZTR5",0,"Cilia- and flagella-associated protein 47","cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288]","GO:0005737; GO:0005856; GO:0005929; GO:0007288; GO:0031514; GO:0060271; GO:0120212"
"782","Pocillopora_acuta_HIv2___RNAseq.9567_t",NA,NA,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.79927025543996,3.68233641306884,9.65522624623916,10.4775310724004,7.60379181609188,5.03801277448085,3.68233641306884,8.81168297583991,3.68233641306884,3.68233641306884,6.61148607927675,7.91046154133595,5.31251061721755,365.250164924742,-0.371556494085908,1.08519124619892,0.046673772958035,0.147743106751646,"Q2PZL6",9.18e-128,"Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)","branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]","GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307; GO:0098609"
"783","Pocillopora_acuta_HIv2___TS.g29.t1",7.31707317073171,0,50,0,62.5,0,0,0,0,NA,13.3130081300813,0,29.9542682926829,NA,NA,NA,NA,NA,NA,9.89205185128076,10.9574699274803,6.69570208705218,9.70063232790689,3.68233641306884,9.79558849868479,11.5662714889301,9.29533864401342,8.69891314311557,10.0728835082764,9.03571878898092,7.65286842770615,10.4185691502557,968.857989442098,1.17294489609122,1.40358757079625,0.0344945068423922,0.116029894643805,"B1WAZ6",0,"Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)]","phospholipid catabolic process [GO:0009395]","GO:0004622; GO:0004623; GO:0005509; GO:0009395; GO:0031410"
"784","Pocillopora_acuta_HIv2___RNAseq.g11443.t1",0,0,NA,0,NA,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,11.4569298808919,9.414852647401,11.3794713550362,10.9417671402062,10.8631850539718,11.0093315120182,3.68233641306884,11.5466274151546,10.9666505126535,3.68233641306884,9.49434883434711,11.2425728435416,7.74612482515262,1683.68421932826,-0.445953083231664,1.06250910219866,0.0714305099950551,0.204709906195458,"Q5TCS8",0,"Adenylate kinase 9 (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2)","","GO:0004017; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016887; GO:0031514; GO:0031965; GO:0036430; GO:0036431; GO:0047506; GO:0050145"
"785","Pocillopora_acuta_HIv2___TS.g45.t1",0,13.3333333333333,NA,NA,0,0,0,NA,0,NA,2.22222222222222,4.44444444444444,0,NA,NA,NA,NA,NA,NA,10.0909357614407,10.2253390392709,10.2463557396584,6.37387005840579,10.3514719137318,10.3050129827859,8.90018289441995,8.44145097007129,10.3254392697161,10.0098969691881,9.52699555986889,9.89113073092366,9.16286038881413,904.350169352576,-0.294272576733834,0.732969237408798,0.525917066146911,0.749002013070985,NA,NA,NA,NA,NA
"786","Pocillopora_acuta_HIv2___RNAseq.g11465.t1",0,16.2162162162162,2.38095238095238,0,7.40740740740741,6.94444444444444,0,50,0,0,8.29490204490205,14.6321321321321,1.95767195767196,NA,NA,NA,NA,NA,NA,13.1668610670737,13.5987473490531,12.6347037920734,14.2716038978834,12.2475615036978,13.6523641287383,13.7156244918516,12.1464713843773,12.9900743594086,14.1883648771326,13.261237685129,12.6371344213262,13.8853409489318,11001.3267553643,1.03081526842883,0.568269398219131,0.0310804286883237,0.106628871097702,"Q5GN48",0,"Dystrophin","muscle cell development [GO:0055001]; neuron development [GO:0048666]; regulation of muscle system process [GO:0090257]; skeletal muscle tissue development [GO:0007519]; synaptic signaling [GO:0099536]","GO:0003779; GO:0005737; GO:0005856; GO:0007519; GO:0008270; GO:0042383; GO:0045211; GO:0048666; GO:0055001; GO:0090257; GO:0099536; GO:0120025"
"787","Pocillopora_acuta_HIv2___RNAseq.g11487.t1",NA,0,0,NA,0,7.14285714285714,0,0,NA,NA,1.19047619047619,2.38095238095238,0,NA,NA,NA,NA,NA,NA,11.3116060806256,10.9135333325746,10.2604209553186,11.1686413390668,10.9343709362459,11.1459312675097,10.8873968282888,10.7465795096556,10.8093290598463,10.8769514882826,10.9054760797415,10.8124613083384,10.9984908511445,1925.3505206174,0.141252512548371,0.511704524413859,0.747619054968983,0.888880403661994,"Q32L63",3.88e-86,"Vacuolar protein sorting-associated protein VTA1 homolog","late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; protein transport [GO:0015031]","GO:0005771; GO:0010008; GO:0015031; GO:0032511"
"788","Pocillopora_acuta_HIv2___RNAseq.g11510.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.9635087971394,12.9638250995005,12.0134757178926,13.0116342022769,12.6908549697138,12.9037327622161,12.7193046896886,12.7496388289271,12.5837975071144,12.4424084377879,12.7042181012257,12.6002551641575,12.808181038294,6772.34139281415,0.155879648038129,0.507911804912848,0.721966056391592,0.875307817685881,"O00299",5.47e-26,"Chloride intracellular channel protein 1 (Chloride channel ABP) (Glutaredoxin-like oxidoreductase CLIC1) (EC 1.8.-.-) (Glutathione-dependent dehydroascorbate reductase CLIC1) (EC 1.8.5.1) (Nuclear chloride ion channel 27) (NCC27) (Regulatory nuclear chloride ion channel protein) (hRNCC)","chloride transport [GO:0006821]; platelet aggregation [GO:0070527]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of mitochondrial membrane potential [GO:0051881]; signal transduction [GO:0007165]","GO:0005254; GO:0005615; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005783; GO:0005886; GO:0005903; GO:0006821; GO:0007165; GO:0016020; GO:0016491; GO:0031965; GO:0031982; GO:0034707; GO:0045296; GO:0045669; GO:0048471; GO:0051881; GO:0070062; GO:0070527; GO:0072562"
"789","Pocillopora_acuta_HIv2___RNAseq.g11533.t2c",0,11.4285714285714,NA,NA,NA,0,0,NA,0,3.57142857142857,2.5,3.80952380952381,1.19047619047619,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,6.0846563529576,3.68233641306884,5.31048131328141,3.68233641306884,5.63253479849075,9.07044442039475,5.91298961818613,3.68233641306884,5.04227885686548,6.01218162357775,4.07237609015322,63.9602247010522,-1.14538919123842,2.34811424968059,0.00390542935878589,0.0188923512526686,"Q505D9",8.52e-16,"Tripartite motif-containing protein 67","negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]","GO:0005737; GO:0005856; GO:0008270; GO:0010976; GO:0046580; GO:2000060"
"790","Pocillopora_acuta_HIv2___RNAseq.g11565.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.65557334666683,9.82723619768913,3.68233641306884,11.6334324516652,6.90951792457399,3.68233641306884,6.81402638403065,8.46899561793879,3.68233641306884,3.68233641306884,6.70381275748399,6.27975194306346,7.12787357190453,492.562477353305,-0.0126079887330397,0.985373108864886,0.887528876880656,0.956724719019482,"P18956",3.81e-23,"Glutathione hydrolase proenzyme (EC 3.4.19.13) (Gamma-glutamyltranspeptidase proenzyme) (GGT) (EC 2.3.2.2) [Cleaved into: Glutathione hydrolase large chain; Glutathione hydrolase small chain]","amino acid salvage [GO:0043102]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; self proteolysis [GO:0097264]","GO:0006750; GO:0006751; GO:0030288; GO:0034722; GO:0036374; GO:0042597; GO:0043102; GO:0097264; GO:0103068"
"791","Pocillopora_acuta_HIv2___TS.g157.t1",0,NA,0,0,0,3.33333333333333,0,0,0,NA,0.416666666666667,0.833333333333333,0,NA,NA,NA,NA,NA,NA,4.51677976470286,7.99482653437196,6.45538792833035,10.8405223221634,3.68233641306884,7.8972218944009,9.81877863446637,9.39911899079698,3.68233641306884,3.68233641306884,6.79696453084393,5.54719190199357,8.04673715969429,384.73011053613,0.990926735158703,1.64211885473636,0.00598889702632709,0.0271042445666613,"Q68UT7",1.92e-119,"Hormonally up-regulated neu tumor-associated kinase (EC 2.7.11.1)","intracellular signal transduction [GO:0035556]","GO:0004674; GO:0005524; GO:0005737; GO:0035556; GO:0106310"
"792","Pocillopora_acuta_HIv2___RNAseq.g11588.t1",NA,NA,0,0,0,0,0,NA,7.14285714285714,NA,1.19047619047619,2.38095238095238,0,NA,NA,NA,NA,NA,NA,9.74386743028599,3.68233641306884,10.5524388361805,3.68233641306884,10.5098027467542,3.68233641306884,3.68233641306884,12.4727257968189,11.629834121183,3.68233641306884,7.33203509965668,10.9817337862445,3.68233641306884,1254.25173047322,-15.4699309222934,3.89022465385711,3.01703869785162e-16,1.67840183560484e-13,"B3EWY9",3.43e-26,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020"
"793","Pocillopora_acuta_HIv2___TS.g184.t1a",NA,33.3333333333333,0,0,0,0,0,NA,0,NA,4.76190476190476,8.33333333333333,0,NA,NA,NA,NA,NA,NA,9.96908769287778,7.976594044287,10.1476494340533,7.15999107231523,3.68233641306884,9.80404965107117,3.68233641306884,9.97733295665498,3.68233641306884,3.68233641306884,6.97640505035348,7.49174858194475,6.46106151876222,428.193018888281,-0.166965288956496,1.01589660432436,0.260701838615533,0.502567394828763,"P52430",6.67e-53,"Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (Serum aryldialkylphosphatase 1)","blood circulation [GO:0008015]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of cholesterol efflux [GO:0010875]; response to fluoride [GO:1902617]; response to toxic substance [GO:0009636]","GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005615; GO:0008015; GO:0008035; GO:0008203; GO:0009636; GO:0010875; GO:0034366; GO:0042803; GO:0046395; GO:0046434; GO:0046470; GO:0102007; GO:1902617"
"794","Pocillopora_acuta_HIv2___RNAseq.g11595.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.89223359574533,6.80133194180119,7.34198352049247,3.68233641306884,9.45404891591861,3.68233641306884,9.1450032675314,10.2328427564565,11.5529879564924,8.07615398838481,7.68612587689604,9.09481934902106,6.27743240477102,593.776916162781,-0.781005132977747,1.2919392867002,0.00858645387570064,0.0366774378727399,"P82933",1.38e-55,"Small ribosomal subunit protein uS9m (28S ribosomal protein S9, mitochondrial) (MRP-S9) (S9mt)","mitochondrial translation [GO:0032543]","GO:0003723; GO:0003735; GO:0005730; GO:0005739; GO:0005743; GO:0005763; GO:0032543"
"795","Pocillopora_acuta_HIv2___RNAseq.g11601.t1",0,0,NA,NA,2.4390243902439,NA,0,16.6666666666667,0,NA,3.18428184281843,5.55555555555556,0.813008130081301,NA,NA,NA,NA,NA,NA,10.1605048306613,9.17532314507704,9.84103282948696,8.54196377296752,8.76695038679216,9.45407755796135,9.09695683207791,6.88976552797531,4.97930611778461,11.4574794047148,8.8363360405499,8.12751193854007,9.54516014255972,741.135977785956,0.346928337724976,0.897583874742076,0.374484819513304,0.623954432604589,"Q9UBI9",4.4e-86,"Headcase protein homolog (hHDC)","negative regulation of mitotic cell cycle [GO:0045930]; respiratory tube development [GO:0030323]","GO:0005634; GO:0005737; GO:0016020; GO:0030323; GO:0045930"
"796","Pocillopora_acuta_HIv2___TS.g201.t2",0,NA,NA,0,0,1.53846153846154,0,0,0,NA,0.21978021978022,0.384615384615385,0,NA,NA,NA,NA,NA,NA,8.5775921357841,6.19950000251922,11.0313653300437,10.0483189203131,8.85983063482945,6.67896938259863,8.89357890031265,10.9752413270382,9.96389559993161,9.35831557623055,9.05866078096012,9.88158500552541,8.23573655639483,806.722490334943,-1.44723147039158,0.730793968336179,0.00898099209551194,0.0380272452194042,"Q8TE73",0,"Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)","cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158]","GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097728; GO:0097729"
"797","Pocillopora_acuta_HIv2___RNAseq.g11610.t1",33.3333333333333,0,0,14.2857142857143,NA,0,66.6666666666667,NA,NA,NA,19.047619047619,4.76190476190476,33.3333333333333,NA,NA,NA,NA,NA,NA,9.3380000695129,9.25799403543053,10.1996728100115,8.15988205155278,8.90154960422363,9.11178026958758,3.68233641306884,9.33122320578472,9.24385729623082,10.0372287011931,8.72635244565964,9.40286059715271,8.04984429416657,582.558005084141,-0.303419859805765,0.906593966187252,0.427081725277051,0.671446747218182,"Q6NXD2",5.51e-73,"Charged multivesicular body protein 2b (Chromatin-modifying protein 2b) (CHMP2b)","endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031]","GO:0000815; GO:0005771; GO:0005829; GO:0015031; GO:0031902; GO:0032509; GO:0045324"
"798","Pocillopora_acuta_HIv2___RNAseq.g11633.t1",0,0,0,NA,2.63157894736842,0,0,NA,0,NA,0.37593984962406,0,0.657894736842105,NA,NA,NA,NA,NA,NA,10.5855866595958,6.24196204696702,10.9797009928376,9.5354335501256,10.7229496625435,10.4665028741481,10.8202584138372,9.79961792515197,3.68233641306884,11.203779371026,9.40381279093016,9.15403833063954,9.65358725122078,1230.89819279507,-0.0152174754787988,0.918734242097297,0.923519777188841,0.971401373709041,"Q9Y6R4",0,"Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4)","chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]","GO:0000165; GO:0001890; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048471; GO:0051973; GO:0060718; GO:0106310; GO:1900745; GO:1904355"
"799","Pocillopora_acuta_HIv2___RNAseq.g11646.t1",0,0,0,0,23.3333333333333,0,0,0,NA,NA,2.91666666666667,0,5.83333333333333,NA,NA,NA,NA,NA,NA,7.70448509956555,8.65975075825696,10.8432753932948,10.8069671589742,6.93680958615949,8.1794761914649,9.22080521374798,9.63492390961611,4.57231842518309,10.4986306138309,8.7057442350094,7.93836248276381,9.47312598725499,727.050927628191,0.511096129001498,0.897324495577907,0.265574276821738,0.509124924499284,"Q709C8",0,"Intermembrane lipid transfer protein VPS13C (Vacuolar protein sorting-associated protein 13C)","Golgi to endosome transport [GO:0006895]; lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868]","GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005770; GO:0005789; GO:0005811; GO:0005829; GO:0006623; GO:0006869; GO:0006895; GO:0007005; GO:0031902; GO:0032127; GO:0032868; GO:0045053; GO:0070062; GO:1905090"
"800","Pocillopora_acuta_HIv2___RNAseq.g11653.t1",42.8571428571429,0,33.3333333333333,29.4117647058824,28,18.9189189189189,26.8292682926829,25,0,NA,22.7056031231067,14.6661367249603,32.7549361207898,NA,NA,NA,NA,NA,NA,9.2296407510666,10.6955071162667,10.1438606785498,8.22187128010793,8.50796544529402,10.1827445859578,7.86543438598675,8.95130781857065,7.03693597958341,11.3416897685827,9.21769578099664,8.7739421346129,9.66144942738038,841.702385198604,0.343640882699898,0.846382836954477,0.40498056344769,0.651210546938009,"Q6ZV70",2.87e-121,"LanC-like protein 3","carbohydrate metabolic process [GO:0005975]; peptide modification [GO:0031179]","GO:0005886; GO:0005975; GO:0031179"
"801","Pocillopora_acuta_HIv2___RNAseq.g11666.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.6224727084592,12.2714953831408,12.0826359430074,12.1031106203288,12.1359254666639,12.8374572168696,13.1779613980639,13.2098070313346,11.4961981108853,11.1039234316454,12.3040987310399,12.3094078520701,12.2987896100097,5538.17438282008,-0.00855852474000694,0.503221256700364,0.98181203112349,0.993697377242332,"P08289",1.59e-141,"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1)","bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cellular homeostasis [GO:0019725]; cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; futile creatine cycle [GO:0140651]; inhibition of non-skeletal tissue mineralization [GO:0140928]; phosphate ion homeostasis [GO:0055062]; positive regulation of cold-induced thermogenesis [GO:0120162]; pyridoxal phosphate metabolic process [GO:0042822]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to macrophage colony-stimulating factor [GO:0036005]; response to organic cyclic compound [GO:0014070]; response to sodium phosphate [GO:1904383]; response to vitamin B6 [GO:0034516]; response to vitamin D [GO:0033280]","GO:0001958; GO:0003006; GO:0004035; GO:0004427; GO:0005509; GO:0005615; GO:0005758; GO:0005886; GO:0014070; GO:0016462; GO:0016887; GO:0019725; GO:0030282; GO:0031012; GO:0031966; GO:0032496; GO:0032868; GO:0033280; GO:0033883; GO:0034516; GO:0036005; GO:0042822; GO:0043262; GO:0046677; GO:0050187; GO:0051384; GO:0052732; GO:0055062; GO:0055074; GO:0065010; GO:0071407; GO:0071529; GO:0098552; GO:0120162; GO:0140651; GO:0140928; GO:1904383"
"802","Pocillopora_acuta_HIv2___RNAseq.g11668.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,6.35163274692994,6.61544894152208,6.93003600424895,6.3891072326092,3.68233641306884,3.68233641306884,7.47604694481752,6.99884884928982,5.54904663716929,5.62447770442682,5.47361556991176,54.6581715751444,-0.0835345367579746,0.862374753206913,0.948087300338075,0.980070334383826,"B8VIU6",6.15e-27,"Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","","GO:0005576"
"803","Pocillopora_acuta_HIv2___RNAseq.g11694.t1",36.8421052631579,NA,100,33.3333333333333,0,52.7777777777778,53.8461538461538,100,50,NA,53.3499212775529,59.0277777777778,47.6720647773279,NA,NA,NA,NA,NA,NA,11.2141428753028,13.0659092286266,12.6309874437546,13.0126290270338,12.5883543826665,13.0154025421583,13.1380394117809,12.0666724826024,13.0685528487377,12.9498609176946,12.6750551160358,12.3137420066128,13.0363682254588,6954.68692875654,0.531495480370588,0.582090410853344,0.261973787201567,0.504176315851773,"Q9Z0R4",0,"Intersectin-1 (EH and SH3 domains protein 1)","clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of postsynapse organization [GO:0099175]; small GTPase-mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488]","GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0007264; GO:0015031; GO:0016197; GO:0019209; GO:0030027; GO:0030139; GO:0042734; GO:0043025; GO:0043197; GO:0043524; GO:0044305; GO:0048488; GO:0051402; GO:0051897; GO:0055037; GO:0060090; GO:0060124; GO:0060999; GO:0097440; GO:0097708; GO:0098833; GO:0098871; GO:0098978; GO:0099175; GO:0150007; GO:1905274; GO:2001288"
"804","Pocillopora_acuta_HIv2___TS.g305.t1",NA,0,0,0,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.07985770650919,8.05976508509743,8.87207198518165,3.68233641306884,9.13949221401296,7.79875575103921,4.40301213871548,8.69146451830397,10.104026333542,3.68233641306884,7.35131185585396,9.17738255150995,5.52524116019796,340.354574462484,-1.11982884047201,1.79830203091573,6.59973035102417e-05,0.000582419156785928,"O75899",4.3e-126,"Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]","GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712"
"805","Pocillopora_acuta_HIv2___TS.g314.t3a",0,0,0,0,0,1.0989010989011,0,8.33333333333333,NA,NA,1.1790293040293,2.35805860805861,0,NA,NA,NA,NA,NA,NA,11.5384362732991,12.3754985174211,11.7393651116767,12.1985188861883,11.4803176141269,12.2756937797193,13.2351941561287,11.6673081897742,10.7698744631722,10.2052857239394,11.7485492715446,11.4390603304098,12.0580382126794,3978.84343164174,0.466454106137621,0.581497581920592,0.331075212840638,0.581444776811666,"E2RYF7",5.88e-12,"Protein PBMUCL2 (HLA complex group 22) (Panbronchiolitis-related mucin-like protein 2)","","GO:0005576"
"806","Pocillopora_acuta_HIv2___RNAseq.g11721.t1",0,0,0,NA,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.05466314442104,9.05619588384409,3.68233641306884,8.0335541792819,3.68233641306884,3.68233641306884,3.68233641306884,8.20274232164201,3.68233641306884,7.93763424012006,5.76964718346533,5.06088294105391,6.47841142587675,127.689849630959,0.149321761289814,1.02604258141074,0.0117203697491377,0.0474011340885834,"P14318",8.03e-35,"Muscle-specific protein 20","actin filament organization [GO:0007015]; myoblast fusion [GO:0007520]; regulation of myoblast fusion [GO:1901739]","GO:0005737; GO:0007015; GO:0007520; GO:0015629; GO:0051015; GO:1901739"
"807","Pocillopora_acuta_HIv2___RNAseq.g11724.t1",0,0,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.3480218580176,3.68233641306884,8.86844128137914,3.68233641306884,8.23485733216397,9.59702142127278,8.00121015687543,3.68233641306884,3.68233641306884,6.24612341150531,4.54611116183016,7.94613566118047,232.460657708625,0.470154376767109,1.15521022884653,5.10093215759804e-05,0.000465488219100934,"Q24799",5.35e-44,"Myophilin","actin filament organization [GO:0007015]","GO:0007015; GO:0015629; GO:0051015"
"808","Pocillopora_acuta_HIv2___RNAseq.g11768.t1",0,0,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.54496704248403,3.68233641306884,6.86389470932694,3.68233641306884,8.61009583438926,7.58543864250144,3.68233641306884,8.73335074317926,6.6827526322222,3.68233641306884,6.27498452563785,8.08701219232034,4.46295685895536,182.547353640695,-8.06497807906387,3.89967796454282,2.73659231556318e-06,3.74499337972649e-05,NA,NA,NA,NA,NA
"809","Pocillopora_acuta_HIv2___RNAseq.g11785.t1",0,NA,28.5714285714286,11.1111111111111,0,0,NA,0,NA,NA,6.61375661375661,3.7037037037037,9.52380952380952,NA,NA,NA,NA,NA,NA,8.28212448841977,3.68233641306884,8.05127089285979,3.68233641306884,9.8084211406149,3.68233641306884,3.68233641306884,4.70256513311627,8.89517885241835,3.68233641306884,5.81512425727733,7.94791210148582,3.68233641306884,185.500463514639,-12.1556665010683,3.87596408226079,2.12751003187747e-08,5.59496456383194e-07,"P79888",7.01e-51,"S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain]","spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597]","GO:0004014; GO:0006597; GO:0008295"
"810","Pocillopora_acuta_HIv2___RNAseq.g11790.t1",100,0,0,NA,NA,0,28.5714285714286,NA,0,NA,21.4285714285714,0,42.8571428571429,NA,NA,NA,NA,NA,NA,3.68233641306884,10.1407489385924,8.37964811069974,3.68233641306884,6.81698272709732,9.79982528033928,9.36140578909401,5.95306534505293,6.24691203794079,3.68233641306884,6.7745597468023,6.21578892677192,7.33333056683267,308.937536825337,0.104108004963198,1.01228994753365,0.369462509337763,0.61915255880679,"Q4QRH7",9.48e-98,"Peroxisomal membrane protein PEX16 (Peroxin-16) (Peroxisomal biogenesis factor 16)","peroxisome organization [GO:0007031]","GO:0005778; GO:0007031"
"811","Pocillopora_acuta_HIv2___RNAseq.g11805.t1",0,0,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,5.74163829918218,6.06348383902188,6.11705336350933,5.80116198083551,5.78216020895349,5.89458481577045,5.32551295827119,6.92672320941957,6.83269238753983,6.07894006001887,6.05639511225223,6.28005349372088,5.83273673078358,47.2650958312847,-0.361171719809274,0.693311506048295,0.460966124672823,0.701575180056449,"P96202",0,"Phenolphthiocerol/phthiocerol polyketide synthase subunit C (EC 2.3.1.292) ((Phenol)carboxyphthiodiolenone synthase subunit C) (Beta-ketoacyl-acyl-carrier-protein synthase I) (Phthiocerol synthesis polyketide synthase type I PpsC)","Actinobacterium-type cell wall biogenesis [GO:0071766]; DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; phenolic phthiocerol biosynthetic process [GO:0097041]; phthiocerol biosynthetic process [GO:0097040]","GO:0004312; GO:0004315; GO:0005737; GO:0005829; GO:0005886; GO:0006633; GO:0016491; GO:0031177; GO:0034081; GO:0071766; GO:0071770; GO:0097040; GO:0097041"
"812","Pocillopora_acuta_HIv2___RNAseq.g11806.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.60347968030327,9.76500857347088,9.8916165142805,6.50915460878185,8.426906743025,9.64986216290798,10.2570299565429,5.28924211491062,3.68233641306884,3.68233641306884,7.67569731803607,7.37871629311765,7.97267834295449,490.128143451126,0.185166823424339,0.9283964078748,0.593866086068285,0.797408008623438,"Q8BH60",1.8e-158,"Golgi-associated PDZ and coiled-coil motif-containing protein (CFTR-associated ligand) (PDZ protein interacting specifically with TC10) (PIST)","autophagy [GO:0006914]; negative regulation of protein localization to cell surface [GO:2000009]; protein transport [GO:0015031]; spermatid nucleus differentiation [GO:0007289]","GO:0000139; GO:0005109; GO:0005737; GO:0005794; GO:0005886; GO:0006914; GO:0007289; GO:0014069; GO:0015031; GO:0016020; GO:0019905; GO:0030140; GO:0030425; GO:0030695; GO:0032991; GO:0042802; GO:0042803; GO:0044325; GO:0045202; GO:2000009"
"813","Pocillopora_acuta_HIv2___TS.g412.t1",0,NA,0,0,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.5503852146925,10.2633451638186,12.2890231597774,3.68233641306884,12.5755340767861,9.91105846175298,3.68233641306884,11.283417227019,13.5017067716982,3.68233641306884,9.34214793147513,12.4400132899946,6.24428257295562,3321.11237024044,-0.79783661612157,1.46716828413927,6.49579880180192e-09,1.99480326686333e-07,"P11533",3.86e-83,"Dystrophin","muscle cell development [GO:0055001]; neuron development [GO:0048666]; regulation of muscle system process [GO:0090257]; skeletal muscle tissue development [GO:0007519]; synaptic signaling [GO:0099536]","GO:0003779; GO:0005737; GO:0005856; GO:0007519; GO:0008270; GO:0042383; GO:0045211; GO:0048666; GO:0055001; GO:0090257; GO:0099536; GO:0120025"
"814","Pocillopora_acuta_HIv2___TS.g431.t1",0,0,0,0,0,0,0,35,0,NA,3.88888888888889,7,0,NA,NA,NA,NA,NA,NA,9.87722273799593,10.3185401600712,10.9860627783326,11.0441749816257,10.4745555942227,7.66842603524761,11.2097554386639,10.6662158712946,10.2425900027011,3.68233641306884,9.61698800132242,10.4493293969094,8.78464660573545,1295.93312735881,-0.312036119004169,0.9215956121735,0.366422673491257,0.615881456756069,"Q5U2Y9",4.62e-27,"Lebercilin (Leber congenital amaurosis 5 protein homolog)","intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031]","GO:0005929; GO:0005930; GO:0015031; GO:0032391; GO:0036064; GO:0042073; GO:0043005; GO:0044877; GO:0045494"
"815","Pocillopora_acuta_HIv2___RNAseq.g11843.t1",6.81818181818182,3.6697247706422,22.2222222222222,4.63576158940397,2.45901639344262,1.48148148148148,4.59770114942529,37.5,NA,0,9.26489882497773,11.8217419603819,7.21942431665439,NA,NA,NA,NA,NA,NA,7.63539511754732,7.10195357481188,9.46180831578392,10.3883613733396,11.315649989109,10.551025452212,3.68233641306884,10.9381444154546,10.1724518809532,10.2546330075388,9.15017595398192,9.90468994376961,8.39566196419422,1054.04291945022,-0.242021744458617,0.893599654660148,0.543358750467078,0.761839954125224,"Q63358",0,"Unconventional myosin-IXb (Unconventional myosin-9b)","actin filament-based movement [GO:0030048]; establishment of cell polarity [GO:0030010]; lamellipodium morphogenesis [GO:0072673]; macrophage chemotaxis [GO:0048246]; monocyte chemotaxis [GO:0002548]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]","GO:0000146; GO:0001726; GO:0002548; GO:0003779; GO:0005096; GO:0005516; GO:0005524; GO:0005737; GO:0005884; GO:0005938; GO:0007266; GO:0008270; GO:0016459; GO:0016887; GO:0030010; GO:0030027; GO:0030048; GO:0031267; GO:0032433; GO:0035023; GO:0035385; GO:0043008; GO:0043531; GO:0048246; GO:0048471; GO:0048495; GO:0051015; GO:0072673; GO:0098871"
"816","Pocillopora_acuta_HIv2___RNAseq.g11852.t1",0,0,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.3358031916585,9.69812509453545,10.8444429603472,3.68233641306884,9.24855880113618,3.68233641306884,3.68233641306884,8.41594438720861,7.78511408192754,3.68233641306884,6.80573341690888,8.72597268445561,4.88549414936216,385.001906001498,-0.555389454067417,1.24749286690366,4.59805780913312e-09,1.47791795891781e-07,"Q8BLA8",1.82e-109,"Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor)","calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832]","GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014070; GO:0014832; GO:0015267; GO:0015278; GO:0016020; GO:0016324; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0071244; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760"
"817","Pocillopora_acuta_HIv2___RNAseq.g11866.t1",0,0,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.9894156865248,8.02470864440337,10.4632879845348,9.95864729437138,10.5686773345239,10.057423646276,10.6456905476175,9.67198713358832,11.0985711262546,8.5388154229039,10.0017224820999,10.5583878530853,9.44505711111443,1201.24687232886,-0.648884333765613,0.7920208158263,0.180489206357823,0.395125757644855,"P31029",1.84e-149,"Alanine--glyoxylate aminotransferase (AGT) (EC 2.6.1.44) (Serine--pyruvate aminotransferase, mitochondrial) (SPT) (EC 2.6.1.51)","glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate metabolic process [GO:0046487]","GO:0004760; GO:0005759; GO:0005777; GO:0008453; GO:0019265; GO:0042803; GO:0046487"
"818","Pocillopora_acuta_HIv2___RNAseq.g11868.t1",0,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.76012515963364,8.01283033727209,9.99197477094589,3.68233641306884,9.71309186500894,3.68233641306884,3.68233641306884,8.14177326309749,6.63891135226464,3.68233641306884,6.69880524004981,8.84917528219012,4.54843519790949,321.45389292764,-9.21450130744796,3.77447422455384,2.33127420265777e-07,4.48995340442637e-06,"Q8IYF3",1.8e-155,"Testis-expressed protein 11 (Protein ZIP4 homolog) (ZIP4H)","apoptotic process [GO:0006915]; chiasma assembly [GO:0051026]; ectopic germ cell programmed cell death [GO:0035234]; fertilization [GO:0009566]; male gonad development [GO:0008584]; male meiosis chromosome segregation [GO:0007060]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130]","GO:0000712; GO:0000801; GO:0005694; GO:0006311; GO:0006915; GO:0007060; GO:0007130; GO:0007131; GO:0008584; GO:0009566; GO:0035234; GO:0043066; GO:0051026; GO:0051093; GO:2000242"
"819","Pocillopora_acuta_HIv2___RNAseq.g11877.t2b",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.36960933384197,12.3647592680512,7.94179218572159,12.1060964313481,8.71328977413245,13.1636909606331,10.5618043744986,9.47387219836032,7.23497478454503,12.865981205155,10.2795870516287,8.34670765532027,12.2124664479372,2944.03655162024,3.66283992835838,1.01501714130256,1.90875456337301e-06,2.7416311821874e-05,"Q8IUL8",7.39e-55,"Cartilage intermediate layer protein 2 (CILP-2) [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2]","","GO:0005615; GO:0070062"
"820","Pocillopora_acuta_HIv2___RNAseq.g20012.t1",0,0,0,0,0,0.448430493273543,0,0,0,NA,0.049825610363727,0.0896860986547085,0,NA,NA,NA,NA,NA,NA,5.90744172849562,8.47754988276052,7.00571141948957,3.68233641306884,5.6496780876982,3.68233641306884,3.68233641306884,5.61726033607325,3.68233641306884,3.68233641306884,5.10693235198614,5.5724855969651,4.64137910700718,52.7020330911363,-0.231302447833201,1.04924641605644,0.0253069170734377,0.0899801495944452,NA,NA,NA,NA,NA
"821","Pocillopora_acuta_HIv2___TS.g5618.t1",0,0,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.2194095260223,13.3063362421304,8.18289340538931,14.1490279938221,9.19645386528744,14.4739216383471,14.883603814972,7.94160713666065,3.68233641306884,14.0766032186083,11.0112193254308,7.84454006928571,14.177898581576,10064.3811847063,5.38580158297742,1.8586447586047,3.92183971139004e-06,5.10580464316342e-05,"Q9UGM3",3.42e-55,"Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031]","GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062"
"822","Pocillopora_acuta_HIv2___RNAseq.g20032.t1",0,0,NA,NA,0,14.2857142857143,0,NA,0,NA,2.38095238095238,4.76190476190476,0,NA,NA,NA,NA,NA,NA,8.64286629266806,7.96430909081604,8.0390565812867,8.80733203620861,9.24855880113618,3.68233641306884,8.63705281123079,6.87470680484115,9.88298596294877,3.68233641306884,7.5461541207274,8.53763488857617,6.55467335287862,322.737376937835,-0.199351475099084,0.973259302791061,0.30471400500167,0.553552294441617,"Q9DBW0",9.45e-164,"Cytochrome P450 4V2 (Docosahexaenoic acid omega-hydroxylase CYP4V2) (EC 1.14.14.79) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80)","fatty acid omega-oxidation [GO:0010430]","GO:0005506; GO:0005789; GO:0010430; GO:0020037; GO:0102033"
"823","Pocillopora_acuta_HIv2___RNAseq.g20059.t1",0,0,NA,0,0,0,12.5,NA,0,NA,1.78571428571429,0,4.16666666666667,NA,NA,NA,NA,NA,NA,9.96399297305885,11.1644397918278,9.72536274785199,10.5362708457496,10.3633316397084,9.96864131762035,10.8141559412887,9.77878215135658,7.51654073656363,3.68233641306884,9.35138545580947,9.46960204970789,9.23316886191106,1057.77197649399,-0.0099766565826435,0.836302819064336,0.951011518423856,0.981064633023038,"B4JWR9",1.98e-92,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial","iron-sulfur cluster assembly [GO:0016226]","GO:0005506; GO:0005739; GO:0016226; GO:0051536"
"824","Pocillopora_acuta_HIv2___TS.g5666.t1",NA,0,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.581064614067,10.6693252026772,11.6692800300669,10.7082418946914,11.3941086096273,9.33260033023362,11.565233747213,11.7841539180423,11.6220080207676,9.9983540869364,11.0324370454323,11.6101230385142,10.4547510523503,2343.42295303029,-0.900504378948229,0.613097649648208,0.0647678810053389,0.189866767503288,NA,NA,NA,NA,NA
"825","Pocillopora_acuta_HIv2___RNAseq.g20070.t1",0,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.16748500850389,8.42479831485514,9.9184776332861,3.68233641306884,8.93541563926212,8.95592160273647,8.47390813977053,7.64871506591188,3.68233641306884,3.68233641306884,7.05717306435326,7.47048595200657,6.64386017669996,282.157083873392,-0.0259230667486706,0.92857075726156,0.885427656364615,0.955675039482623,"Q6IML7",1.57e-133,"DnaJ homolog subfamily C member 27 (Rab and DnaJ domain-containing protein)","intracellular protein transport [GO:0006886]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]","GO:0003924; GO:0005525; GO:0005634; GO:0006886; GO:0043410; GO:0070374"
"826","Pocillopora_acuta_HIv2___RNAseq.10263_t",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.82556204308159,12.1237004883984,9.56459543055032,11.6867598238052,10.0753094552239,12.4616259167367,13.084359921001,11.7252296085226,5.1802014623539,11.6251961883249,10.4352540337999,8.67417959994646,12.1963284676532,3036.53535946797,2.56160162030553,1.44101571243952,0.000673743214496699,0.00421133182993961,"Q8IWU5",1.83e-153,"Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form]","bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; liver regeneration [GO:0097421]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelin production [GO:1904472]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of hepatocyte proliferation [GO:2000345]; response to wounding [GO:0009611]","GO:0001822; GO:0002063; GO:0003094; GO:0004065; GO:0005509; GO:0005539; GO:0005576; GO:0005615; GO:0005783; GO:0005795; GO:0005886; GO:0008449; GO:0009611; GO:0009986; GO:0010575; GO:0014846; GO:0030177; GO:0030201; GO:0032836; GO:0035860; GO:0040037; GO:0048706; GO:0051216; GO:0060348; GO:0060384; GO:0090263; GO:0097421; GO:1904472; GO:2000345"
"827","Pocillopora_acuta_HIv2___TS.g5712.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.7208742321479,10.7913979771575,10.6431241632456,9.08682608399983,11.1532943936139,10.700493465382,6.86956709787897,11.2855284952784,11.7969832951245,10.9602171165329,10.5008306320362,11.3199609158821,9.68170034819024,1914.17097038703,-0.986117000954042,0.849665395671422,0.0686891847030435,0.198863164040196,"P78536",7.18e-80,"Disintegrin and metalloproteinase domain-containing protein 17 (ADAM 17) (EC 3.4.24.86) (Snake venom-like protease) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD antigen CD156b)","amyloid precursor protein catabolic process [GO:0042987]; B cell differentiation [GO:0030183]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell motility [GO:0048870]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; commissural neuron axon guidance [GO:0071679]; defense response to Gram-positive bacterium [GO:0050830]; germinal center formation [GO:0002467]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neutrophil mediated immunity [GO:0002446]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of mast cell apoptotic process [GO:0033025]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410]; signal release [GO:0023061]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; wound healing, spreading of epidermal cells [GO:0035313]","GO:0000139; GO:0001666; GO:0002446; GO:0002467; GO:0002690; GO:0004175; GO:0004222; GO:0005112; GO:0005138; GO:0005178; GO:0005737; GO:0005788; GO:0005829; GO:0005886; GO:0006508; GO:0006509; GO:0007155; GO:0007219; GO:0007220; GO:0008233; GO:0008237; GO:0008284; GO:0009410; GO:0009986; GO:0010820; GO:0015629; GO:0016020; GO:0016324; GO:0016485; GO:0017124; GO:0019955; GO:0023061; GO:0030165; GO:0030183; GO:0030307; GO:0030335; GO:0030512; GO:0032496; GO:0032722; GO:0032760; GO:0033025; GO:0033077; GO:0033627; GO:0035313; GO:0042987; GO:0043120; GO:0043536; GO:0045121; GO:0045737; GO:0045741; GO:0045742; GO:0046872; GO:0048536; GO:0048870; GO:0050830; GO:0071403; GO:0071679; GO:0120163; GO:1900087; GO:1902945; GO:1903265; GO:1905564"
"828","Pocillopora_acuta_HIv2___TS.g5714.t1a",0,0,0,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.50758496116064,8.25383733794239,9.24545252766718,7.92924455308051,10.2009842421002,7.6114897718209,8.11333685089601,8.37416919248697,7.39144121826992,7.15805210680923,8.17855927622339,8.54392642833698,7.81319212410981,337.984529322092,-0.467216989638719,0.696717963476092,0.343431843674987,0.594557047301527,"Q5XIT9",0,"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)","coenzyme A metabolic process [GO:0015936]; L-leucine catabolic process [GO:0006552]","GO:0002169; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0015936; GO:1905202"
"829","Pocillopora_acuta_HIv2___RNAseq.g20146.t1",NA,0,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.5512301858611,10.6636524286472,11.80110036263,8.67673780760658,11.6117105117299,10.4323483850471,10.6088967715824,11.3005695013024,12.3797111098522,9.2495397382469,10.8275496802506,11.7288643342751,9.92623502622604,2287.86053169587,-1.34771166114902,0.808582782314941,0.0167124144549946,0.0639154845788054,NA,NA,NA,NA,NA
"830","Pocillopora_acuta_HIv2___RNAseq.g4312.t1",0,NA,0,0,NA,2.94117647058824,0,NA,7.69230769230769,NA,1.77224736048265,3.54449472096531,0,NA,NA,NA,NA,NA,NA,8.97481821212063,9.95350268552663,8.96738378287857,9.13442321085644,9.52691439362008,10.1729793765768,8.81886365032418,9.48126153138428,7.98840764607209,7.78429754414113,9.08028520335008,8.98775711321513,9.17281329348504,583.680917704416,0.135198510675547,0.549922919691327,0.766723399056013,0.899008213489835,"Q9Y4B6",0,"DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein)","B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]","GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756"
"831","Pocillopora_acuta_HIv2___TS.g29566.t1",0.709219858156028,0,0.884955752212389,1.23456790123457,3.97727272727273,1.61662817551963,0,9.72222222222222,0,0,1.81448666366176,2.51468365979528,1.11428966752823,NA,NA,NA,NA,NA,NA,8.35409374540166,9.47007900817922,8.99920222213776,8.84000664084059,8.71718969660388,9.01545029148707,9.53687036455819,9.04240397932938,8.07748726595138,7.96642826417093,8.80192114786601,8.63807538188481,8.9657669138472,448.227594886703,0.254409433493615,0.535671401023049,0.575626456580052,0.785088266664203,"Q9Y4B6",0,"DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein)","B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]","GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756"
"832","Pocillopora_acuta_HIv2___TS.g29571.t2",0,0,0,0,0,0,1.25,4.08163265306122,NA,NA,0.666454081632653,1.02040816326531,0.3125,NA,NA,NA,NA,NA,NA,9.04649220287259,9.82554342269253,9.48894720073031,8.21634508872886,8.71133584495369,8.94320406797548,9.00192631322108,9.36623614442491,9.55954292947827,5.49240068675675,8.76519739018345,9.23451086449195,8.29588391587494,508.543991969734,-0.405774806423877,0.794938921069642,0.374641071445456,0.624070995898546,"Q5XPI3",6.88e-165,"E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123)","protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; proteolysis involved in protein catabolic process [GO:0051603]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0031965; GO:0046872; GO:0051603; GO:0051604; GO:0061630"
"833","Pocillopora_acuta_HIv2___RNAseq.g4321.t1",NA,NA,33.3333333333333,0,0,0,0,NA,0,NA,5.55555555555556,0,11.1111111111111,NA,NA,NA,NA,NA,NA,7.75271757526413,3.68233641306884,8.8419698660937,3.68233641306884,7.14970055854672,7.47620947122109,3.68233641306884,6.09342916571462,8.24542216327784,3.68233641306884,6.02887944523935,7.6166478657794,4.44111102469929,121.847451423517,-0.895657244741189,1.65689459133964,7.97634908947686e-06,9.38729969326227e-05,NA,NA,NA,NA,NA
"834","Pocillopora_acuta_HIv2___TS.g29582.t1",5.22875816993464,5.65371024734982,8.33333333333333,2.70935960591133,4.47368421052632,6.73575129533679,4.60992907801418,4.57746478873239,5.08259212198221,4.05529953917051,5.14598823902915,4.95177561186251,5.3402008661958,NA,NA,NA,NA,NA,NA,9.68470295498949,8.48185977946417,6.64213136387843,3.68233641306884,9.36493459277662,7.94403059481423,3.68233641306884,10.1150984258175,10.8493114115044,3.68233641306884,7.41290783624514,9.33123574979329,5.49457992269698,496.365387899189,-0.783119101450291,1.38679581063606,2.78528899968515e-05,0.000275368558383089,"Q9NU19",0,"TBC1 domain family member 22B","","GO:0005096; GO:0071889"
"835","Pocillopora_acuta_HIv2___TS.g29592.t2",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.56279864080063,8.59360048686995,9.57729476136219,3.68233641306884,6.56804683919999,3.68233641306884,8.04931890392619,8.63733288117018,5.93804482828044,3.68233641306884,6.59734465808161,7.65670359016269,5.53798572600053,198.584167729846,-0.475428705704522,1.10991040266035,0.00141492349439025,0.00788042103306147,"Q08BB2",1.7e-148,"N-fatty-acyl-amino acid synthase/hydrolase PM20D1.2 (EC 3.5.1.114) (EC 3.5.1.14) (Peptidase M20 domain-containing protein 1.2)","adaptive thermogenesis [GO:1990845]; amide biosynthetic process [GO:0043604]; amide catabolic process [GO:0043605]; amino acid metabolic process [GO:0006520]; cellular lipid metabolic process [GO:0044255]; energy homeostasis [GO:0097009]; fatty acid metabolic process [GO:0006631]; proteolysis [GO:0006508]; respiratory electron transport chain [GO:0022904]","GO:0004046; GO:0004181; GO:0005615; GO:0006508; GO:0006520; GO:0006631; GO:0016811; GO:0016829; GO:0022904; GO:0043604; GO:0043605; GO:0044255; GO:0046872; GO:0097009; GO:1990845"
"836","Pocillopora_acuta_HIv2___RNAseq.g4348.t1",0,0,10,6.25,26.3157894736842,42.8571428571429,11.1111111111111,NA,NA,NA,13.7905776345626,16.3690476190476,11.8567251461988,NA,NA,NA,NA,NA,NA,8.441105727868,6.59081673114823,7.04726048369553,8.74351476367351,8.35108764351216,3.68233641306884,3.68233641306884,6.71452383453295,10.2781789514423,3.68233641306884,6.72134973750792,8.16643132821019,5.27626814680565,250.442974430094,-0.535855974713275,1.18220792682856,7.71186335618334e-05,0.000665936666172154,NA,NA,NA,NA,NA
"837","Pocillopora_acuta_HIv2___RNAseq.g4349.t1",NA,0,7.14285714285714,0,0,0,0,NA,0,NA,1.02040816326531,0,2.38095238095238,NA,NA,NA,NA,NA,NA,10.2108332512412,9.0960728204644,6.3914623546344,3.68233641306884,9.91405609767921,8.79252469198216,8.39656433331989,7.63547889605305,8.061200365156,8.25783603172818,8.04383652553273,8.44260619295277,7.64506685811269,410.789613729123,-0.408559983602531,0.869444165614788,0.348401298238866,0.599978071693962,"Q8VC12",0,"Urocanate hydratase (Urocanase) (EC 4.2.1.49) (Imidazolonepropionate hydrolase)","L-histidine catabolic process [GO:0006548]; L-histidine catabolic process to glutamate and formamide [GO:0019556]; L-histidine catabolic process to glutamate and formate [GO:0019557]","GO:0006548; GO:0016153; GO:0019556; GO:0019557"
"838","Pocillopora_acuta_HIv2___RNAseq.g4350.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.36865548890326,3.68233641306884,10.198570284277,6.17395423718631,9.23999388563156,3.68233641306884,7.55806838583083,3.68233641306884,3.68233641306884,5.89509243471732,4.95580637244473,6.8343784969899,208.187844913815,0.160233600291981,1.02862821116244,0.00981445322452749,0.0409922758993837,"A7YWP4",0,"Histidine ammonia-lyase (Histidase) (EC 4.3.1.3)","L-histidine catabolic process [GO:0006548]; L-histidine catabolic process to glutamate and formamide [GO:0019556]; L-histidine catabolic process to glutamate and formate [GO:0019557]","GO:0004397; GO:0005737; GO:0006548; GO:0019556; GO:0019557"
"839","Pocillopora_acuta_HIv2___RNAseq.g4352.t1",0,0,0,2.54237288135593,0,0.263852242744063,1.53061224489796,0,0,0,0.433683736899795,0.561245024819999,0.306122448979592,NA,NA,NA,NA,NA,NA,8.43005038277679,8.10521425400763,7.59722431946636,5.80116198083551,8.04431136120609,5.84950698471885,8.90347357338541,9.64701951365487,5.69309697015473,3.68233641306884,7.17533957532751,7.88234050945177,6.46833864120325,230.469109024221,-1.28121996748709,1.06826234523204,0.0295685581611273,0.102277539530665,"A0A0G2K2P5",2.75e-13,"Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1)","actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; ameloblast differentiation [GO:0036305]; blastocyst formation [GO:0001825]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to glucose stimulus [GO:0071333]; establishment of endothelial intestinal barrier [GO:0090557]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]","GO:0001825; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005921; GO:0005923; GO:0007605; GO:0008013; GO:0008284; GO:0009410; GO:0014704; GO:0016020; GO:0016301; GO:0016323; GO:0016324; GO:0016327; GO:0019904; GO:0030036; GO:0030054; GO:0030335; GO:0031032; GO:0032496; GO:0032991; GO:0034334; GO:0036305; GO:0043066; GO:0043116; GO:0043296; GO:0044325; GO:0045177; GO:0045216; GO:0045471; GO:0046581; GO:0050839; GO:0051493; GO:0051497; GO:0070160; GO:0071000; GO:0071253; GO:0071333; GO:0071896; GO:0090557; GO:0098609; GO:0150105; GO:1901888; GO:1902396; GO:1903672; GO:1905605; GO:2000049; GO:2000810"
"840","Pocillopora_acuta_HIv2___RNAseq.g4354.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.35941821610709,3.68233641306884,5.9646645801927,3.68233641306884,6.11409578894442,5.08222717563762,3.68233641306884,8.32567457524134,7.63156149414641,3.68233641306884,5.52069874825449,7.07908293092639,3.9623145655826,70.7119686645363,-7.42621619544129,3.48330274338104,9.22562846384446e-06,0.000106411076635603,NA,NA,NA,NA,NA
"841","Pocillopora_acuta_HIv2___TS.g29608.t1b",0,0,0,0,0,2.20588235294118,0,0,0,NA,0.245098039215686,0.441176470588235,0,NA,NA,NA,NA,NA,NA,7.99238100110728,7.10195357481188,6.03454572419577,10.1760120312495,3.68233641306884,6.5620639848483,8.29489711500127,5.67356605113577,3.68233641306884,3.68233641306884,6.28824287215563,5.4130331205153,7.16345262379596,190.430633757283,0.69967755222408,1.27215790811734,0.0373133976814614,0.123473114633873,"A0A0G2K2P5",3.11e-12,"Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1)","actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; ameloblast differentiation [GO:0036305]; blastocyst formation [GO:0001825]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to glucose stimulus [GO:0071333]; establishment of endothelial intestinal barrier [GO:0090557]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]","GO:0001825; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005921; GO:0005923; GO:0007605; GO:0008013; GO:0008284; GO:0009410; GO:0014704; GO:0016020; GO:0016301; GO:0016323; GO:0016324; GO:0016327; GO:0019904; GO:0030036; GO:0030054; GO:0030335; GO:0031032; GO:0032496; GO:0032991; GO:0034334; GO:0036305; GO:0043066; GO:0043116; GO:0043296; GO:0044325; GO:0045177; GO:0045216; GO:0045471; GO:0046581; GO:0050839; GO:0051493; GO:0051497; GO:0070160; GO:0071000; GO:0071253; GO:0071333; GO:0071896; GO:0090557; GO:0098609; GO:0150105; GO:1901888; GO:1902396; GO:1903672; GO:1905605; GO:2000049; GO:2000810"
"842","Pocillopora_acuta_HIv2___RNAseq.g4365.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.49100155379421,3.68233641306884,3.68233641306884,3.68233641306884,6.85329648854777,5.41697153692495,7.76744882370521,3.68233641306884,9.92998742717084,3.68233641306884,5.38703878954872,5.9277916591301,4.84628591996734,127.819707798633,-0.109601659432818,1.01270451732933,0.0666725170500049,0.194229866386963,"O75581",0,"Low-density lipoprotein receptor-related protein 6 (LRP-6)","canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]","GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909"
"843","Pocillopora_acuta_HIv2___RNAseq.g4369.t1",0,0.854700854700855,0,0,0,1.07913669064748,2.29885057471264,0,0,NA,0.470298680006776,0.386767509069667,0.574712643678161,NA,NA,NA,NA,NA,NA,9.45884267933463,4.68019422250907,10.9458334004992,5.11193581531555,9.90212332314931,3.68233641306884,3.68233641306884,10.6924437777966,10.7421095850801,3.68233641306884,7.2580492042891,10.348270553172,4.16782785540623,689.301300641021,-9.45232308526084,2.1061942528058,3.51028570943061e-12,3.64409775583172e-10,"O75096",0,"Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395"
"844","Pocillopora_acuta_HIv2___TS.g29624.t2",0,0,0,1.0989010989011,0,0.367647058823529,0,0,0,0,0.146654815772463,0.293309631544926,0,NA,NA,NA,NA,NA,NA,10.550332255092,8.75893970845155,8.61429333751661,9.5153537643326,10.2106912311769,4.32783990674728,3.68233641306884,8.91901122257894,7.60178260564003,3.68233641306884,7.58629168576736,9.1792221304009,5.99336124113382,474.515985673538,-0.824016189058465,1.42367095300409,2.74052866012445e-05,0.000271500044794795,"O88572",0,"Low-density lipoprotein receptor-related protein 6 (LRP-6)","anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesenchymal cell proliferation [GO:0010463]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of developmental process [GO:0051093]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of morphogenesis of an epithelium [GO:1905331]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell proliferation [GO:2000648]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of anatomical structure morphogenesis [GO:0022603]; regulation of cell development [GO:0060284]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation [GO:0050678]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244]","GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003151; GO:0003344; GO:0003401; GO:0005041; GO:0005769; GO:0005783; GO:0005886; GO:0006355; GO:0007204; GO:0007268; GO:0007399; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0010463; GO:0010976; GO:0016020; GO:0017147; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0022603; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0034185; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042475; GO:0042733; GO:0042813; GO:0043025; GO:0043065; GO:0045121; GO:0045202; GO:0045444; GO:0045599; GO:0045778; GO:0045780; GO:0045893; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050678; GO:0050680; GO:0051091; GO:0051093; GO:0051593; GO:0055008; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060412; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071542; GO:0072089; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0098609; GO:0110135; GO:1905331; GO:1990963; GO:2000051; GO:2000149; GO:2000151; GO:2000164; GO:2000166; GO:2000168; GO:2000648"
"845","Pocillopora_acuta_HIv2___RNAseq.g4373.t1",49.7175141242938,73.0769230769231,43.7908496732026,41.6666666666667,44.2528735632184,42.3684210526316,37.0656370656371,22.6666666666667,30.9090909090909,62.2641509433962,44.7778793741727,42.1375536743958,47.4182050739496,NA,NA,NA,NA,NA,NA,5.69008050215398,5.6784794012365,6.88242140054137,7.19433250046938,7.63721909911156,7.67461468239209,3.68233641306884,7.65747164433661,7.35614181332736,7.92790638063269,6.73810038372704,7.04466689189418,6.4315338755599,116.191503051626,-0.151655298345823,0.848929021768814,0.715610815430681,0.871555644525882,NA,NA,NA,NA,NA
"846","Pocillopora_acuta_HIv2___RNAseq.g4374.t1",0,1.47058823529412,0,0,0,0.316455696202532,0.442477876106195,0,2.77777777777778,NA,0.556366620597847,0.912964341854885,0.110619469026549,NA,NA,NA,NA,NA,NA,6.5907432092831,5.01287713650611,6.10095238771267,3.68233641306884,6.68597998145865,4.05708008052864,3.68233641306884,5.26380834900594,3.68233641306884,4.40467075915833,4.916312114286,5.66476406810584,4.16786016046615,22.9578795799454,-0.510174061217815,1.17728917990697,0.0126537681862582,0.0506711248743185,NA,NA,NA,NA,NA
"847","Pocillopora_acuta_HIv2___RNAseq.g4375.t1",0.111482720178372,0.744416873449132,0,0.527983104540655,0.971599402092676,0.687409551374819,0.46583850931677,0.666666666666667,0.449438202247191,0,0.462483502986628,0.615182879655693,0.309784126317564,NA,NA,NA,NA,NA,NA,10.7033685777805,11.1147212881966,10.8704664430172,9.5131053164886,10.4230007044188,9.65454874838883,8.89357890031265,9.98081212559619,10.7723722435692,11.7935722739328,10.3719546621701,10.5500040188764,10.1939053054639,1519.63040735812,-0.24894768669021,0.612182457500228,0.589170575101287,0.794597838681766,"Q96AY4",7.28e-49,"Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"848","Pocillopora_acuta_HIv2___RNAseq.g4376.t1",33.3333333333333,32.258064516129,12.5,NA,43.3333333333333,24.1935483870968,51.2820512820513,39.1304347826087,NA,NA,33.7186808049361,31.8606825619448,35.1121794871795,NA,NA,NA,NA,NA,NA,6.38824903660035,6.34267098328276,9.52435557149753,6.50915460878185,8.23338718506561,6.90835173973027,9.44279057789572,8.24682958013343,6.8455615954538,6.61366512258304,7.50550160010244,7.84767659375014,7.16332660645473,238.120440277867,-0.385916141964638,0.74824841775347,0.400842517500041,0.64709944784739,"Q5R613",2.17e-14,"Sorting nexin-6 [Cleaved into: Sorting nexin-6, N-terminally processed]","intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0005634; GO:0005829; GO:0006886; GO:0030904; GO:0031901; GO:0034452; GO:0035091; GO:0042147; GO:0097422"
"849","Pocillopora_acuta_HIv2___TS.g29630.t1",0,0,0,0,3.27868852459016,0.597014925373134,0.416666666666667,0,0,NA,0.476930012958885,0.119402985074627,0.923838797814208,NA,NA,NA,NA,NA,NA,5.17503271827961,5.21816971328303,6.03454572419577,7.99532088114034,7.11438186546373,6.13692185768316,5.1359206776867,3.68233641306884,4.79801079550852,8.61342163913137,5.99040622854411,5.36086150330329,6.61995095378492,85.3269225904918,0.718218902599612,1.13145285041556,0.0524362870910139,0.161027273138944,NA,NA,NA,NA,NA
"850","Pocillopora_acuta_HIv2___RNAseq.g4377.t1",1.22525918944392,0.15015015015015,0.376884422110553,1.21546961325967,0.649350649350649,0.395048722675797,0.251730648206419,1.19521912350598,0.710479573712256,1.13314447592068,0.730273656833607,0.733273436660769,0.727273877006444,NA,NA,NA,NA,NA,NA,10.9002236764635,10.216324966058,11.4042265059806,11.7817859944921,10.8067056627321,10.4824033227849,10.5184943249931,9.88193709365152,10.4963442877127,11.9829104307127,10.8471356265581,10.6978874453081,10.9963838078082,2020.07707828094,0.208527242711585,0.576257397256738,0.654903445838878,0.83627785450436,"P0CI65",8.28e-48,"Nephrocystin-3","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"851","Pocillopora_acuta_HIv2___TS.g29671.t1",0,NA,NA,NA,85.7142857142857,9.09090909090909,NA,62.5,100,37.5,49.1341991341991,57.1969696969697,41.0714285714286,NA,NA,NA,NA,NA,NA,8.62035545127034,8.08833890508173,10.3060559673519,10.0121616018523,9.91575274839834,7.84883394633985,8.06117279526697,9.71231373137442,5.75167028831017,3.68233641306884,8.19989918483149,8.86122963734103,7.53856873232194,509.564869808356,-1.04847395504775,0.961178768886837,0.0607722828913379,0.180981126911513,"Q8VC31",9.23e-20,"Coiled-coil domain-containing protein 9","","GO:0003723; GO:0035145"
"852","Pocillopora_acuta_HIv2___RNAseq.g4420.t3",NA,NA,0,0,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,8.58561441878371,9.48145972078632,8.34344158691074,6.35975560497307,8.34348305453574,3.68233641306884,7.64431660005706,3.68233641306884,11.8740828710419,7.16791630962951,6.17004095039083,8.16579166886819,560.929893409819,0.153193567511311,1.00579482880806,0.239056853443852,0.476288317655649,"Q7S8J7",9.37e-26,"Dicer-like protein 1 [Includes: Endoribonuclease dcl-1 (EC 3.1.26.-); ATP-dependent helicase dcl-1 (EC 3.6.4.-)]","defense response to virus [GO:0051607]; regulation of defense response to virus [GO:0050688]; siRNA processing [GO:0030422]","GO:0003677; GO:0003723; GO:0004386; GO:0004525; GO:0005524; GO:0005634; GO:0005737; GO:0030422; GO:0046872; GO:0050688; GO:0051607"
"853","Pocillopora_acuta_HIv2___RNAseq.g4448.t1",100,NA,NA,100,100,100,100,NA,100,NA,100,100,100,NA,NA,NA,NA,NA,NA,10.9698545976018,11.1671151999311,10.5081837169286,11.2871684539518,10.2582697974068,10.0264253953009,10.5998032133256,9.62939218636709,11.5201740868902,11.2127959793537,10.7179182627058,10.5771748770389,10.8586616483726,1792.7092384129,0.215730277503795,0.532133843476607,0.637207757387781,0.825290116547415,"O08663",0,"Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M)","N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein processing [GO:0016485]","GO:0004177; GO:0004239; GO:0005737; GO:0008235; GO:0016485; GO:0018206; GO:0031365; GO:0046872; GO:0070006"
"854","Pocillopora_acuta_HIv2___TS.g29705.t1",8.33333333333333,0,0,NA,0,0,0,NA,0,NA,1.19047619047619,0,2.08333333333333,NA,NA,NA,NA,NA,NA,5.32602117141484,7.78026348768243,6.9541853393125,8.81465738438183,6.01241040467731,5.38419442015382,4.76881142028858,6.67144653115387,5.98677490518935,5.30690658460733,6.30056716488619,6.19016767034957,6.4109666594228,94.3450136092878,-0.0236929601486926,0.830238395991469,0.946329101822666,0.979700213448218,"Q96AY4",1.33e-65,"Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"855","Pocillopora_acuta_HIv2___RNAseq.g4455.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.50755595230566,3.68233641306884,8.52380512707497,3.68233641306884,7.58678057169964,3.68233641306884,7.24933793434975,8.47394757343443,7.07010303635839,9.68071174217242,6.61392511766018,7.63243845217462,5.59541178314574,194.043113911417,-0.448997335381677,1.11905198865897,0.000262823501092838,0.00188940314105706,NA,NA,NA,NA,NA
"856","Pocillopora_acuta_HIv2___RNAseq.g4465.t1",NA,NA,0,0,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.7229071005402,9.54606319595285,10.12188005377,10.496998855681,10.2155203372714,8.68049185815881,10.196651767454,10.0353668033868,11.3018495087215,10.0213482021832,10.033907768312,10.279504760738,9.78831077588597,1128.31356581589,-0.340344095339705,0.592256030375243,0.459571284608237,0.70065991201051,"Q7TQ20",0,"DnaJ homolog subfamily C member 2 (Gliosarcoma-related antigen MIDA1) (Zuotin-related factor 1)","'de novo' cotranslational protein folding [GO:0051083]; DNA replication [GO:0006260]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA biosynthetic process [GO:2000279]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of translational fidelity [GO:0006450]","GO:0003682; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006260; GO:0006450; GO:0030308; GO:0030544; GO:0042393; GO:0043022; GO:0045893; GO:0051083; GO:0061649; GO:2000279"
"857","Pocillopora_acuta_HIv2___RNAseq.g4468.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.1499860079363,9.74365466666222,11.123695320414,9.99776260389347,11.0117577619826,9.81106288583418,8.44708254939947,11.8959306057631,11.9315706798258,10.5968009814441,10.5709304063155,11.4225880751844,9.71927273744669,1870.60138023069,-1.32751794195854,0.723485680911757,0.0152333324304368,0.059243220890276,"Q28728",2.07e-176,"Sodium/myo-inositol cotransporter 2 (Na(+)/myo-inositol cotransporter 2) (Sodium-dependent glucose cotransporter) (Sodium/glucose cotransporter KST1) (rKST1) (Sodium/myo-inositol transporter 2) (SMIT2) (Solute carrier family 5 member 11)","apoptotic process [GO:0006915]; myo-inositol transport [GO:0015798]","GO:0005365; GO:0005412; GO:0005886; GO:0006915; GO:0015798; GO:0016324"
"858","Pocillopora_acuta_HIv2___RNAseq.g4479.t1",NA,NA,0,0,2.94117647058824,0,10.3448275862069,NA,2.77777777777778,NA,2.67729697242882,0.925925925925926,4.42866801893171,NA,NA,NA,NA,NA,NA,3.68233641306884,5.4315664930872,5.64062457406066,5.05535826649939,5.3333020303659,5.28004943464804,3.68233641306884,4.1247493465216,5.66277130452222,5.54842281532527,4.9441517091168,4.88875673370784,4.99954668452575,15.1599407074999,-0.0143132002595141,0.898800873120815,0.941204551512103,0.977846762898366,NA,NA,NA,NA,NA
"859","Pocillopora_acuta_HIv2___TS.g29736.t1",0,0,0,3.44827586206897,0,0,NA,0,0,NA,0.431034482758621,0.689655172413793,0,NA,NA,NA,NA,NA,NA,12.0012948672449,11.9582461092036,12.4699247091438,12.4615253282698,12.1649222143218,12.7125259431945,10.2812495236594,10.2872429359234,12.2174915182407,11.0276271847905,11.7582050333992,11.8281752489749,11.6882348178236,3978.4051577546,-0.0948119182316693,0.534510557366145,0.826504146828497,0.929736815968843,"Q7Z6Z7",0,"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)","base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006284; GO:0006511; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:0140852; GO:1903955; GO:1904813"
"860","Pocillopora_acuta_HIv2___RNAseq.g4500.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.5089573696174,11.4907814857026,11.4117285036514,10.9096568688752,10.8832656677496,10.3757720153788,11.2917221435825,10.4542150791468,11.8197010153973,11.5848663953336,11.0730666544435,11.0155735271125,11.1305597817745,2254.11469816084,0.0836699113005901,0.552718437590583,0.86055731792091,0.945397314781106,NA,NA,NA,NA,NA
"861","Pocillopora_acuta_HIv2___RNAseq.g4511.t1",2.45398773006135,3.44827586206897,4.54545454545455,5.33333333333333,5.68181818181818,1.62162162162162,1.3986013986014,0,1.35135135135135,0,2.58344440243107,2.35091643367505,2.8159723711871,NA,NA,NA,NA,NA,NA,9.1078544423473,10.5697160886399,10.8006009319828,11.7766417807278,11.1961517378994,10.3247467845534,8.33935160288026,11.0375328428721,11.1923308140379,12.2024907755397,10.6547417801481,10.6668941538279,10.6425894064682,2021.63132758478,0.0424049850925096,0.710026790162588,0.932172767051108,0.97497067561138,"Q9D504",2.88e-43,"Ankyrin repeat domain-containing protein 7","blastocyst hatching [GO:0001835]","GO:0001835; GO:0005634"
"862","Pocillopora_acuta_HIv2___RNAseq.g4531.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.18458835466292,10.0067558946003,9.12758054862443,8.62349819294917,9.15825281380541,10.6606765182317,11.2024318375091,9.34614028220726,9.8215925383836,10.8919990168344,9.70235159978083,9.12763090753672,10.2770722920249,1002.1773508969,0.887436321373073,0.683710451493327,0.0841163784232862,0.230122810197543,"Q2M389",0,"WASH complex subunit 4 (Strumpellin and WASH-interacting protein) (SWIP) (WASH complex subunit SWIP)","endosomal transport [GO:0016197]; endosome organization [GO:0007032]; nuclear envelope budding [GO:0140591]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]","GO:0005654; GO:0005768; GO:0007032; GO:0015031; GO:0016197; GO:0031901; GO:0034315; GO:0071203; GO:0140591"
"863","Pocillopora_acuta_HIv2___RNAseq.g4536.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.39792737798653,9.55221809885684,8.01846561668189,9.0531666196555,8.75372151717615,8.33571215430193,8.64100223739937,8.68079977744435,5.96263381334191,8.39815582913653,8.2793803041981,7.76270962052617,8.79605098787003,342.41942505724,0.722295910042572,0.773912125582745,0.153647706632106,0.354121965035925,"A4IIM3",6.78e-132,"Target of rapamycin complex 2 subunit MAPKAP1 (TORC2 subunit MAPKAP1) (Mitogen-activated protein kinase 2-associated protein 1) (Stress-activated map kinase-interacting protein 1) (SAPK-interacting protein 1)","","GO:0031932"
"864","Pocillopora_acuta_HIv2___RNAseq.g4558.t1",0,1.58730158730159,NA,0,2.17391304347826,0,0,NA,0,NA,0.537316375825693,0.396825396825397,0.72463768115942,NA,NA,NA,NA,NA,NA,10.4815912141722,10.2608423423611,11.4168390634593,8.24376600771061,11.5640999715729,9.11405118415396,10.51312253111,11.5478005710102,11.5855455249521,12.1138198698741,10.6841478280376,11.3191752690333,10.049120387042,2098.13992209414,-0.782064789491271,0.799448036745687,0.121230182433209,0.300664156158081,"Q6PHU5",3.29e-145,"Sortilin (Neurotensin receptor 3) (NTR3) (mNTR3)","endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; glucose import [GO:0046323]; Golgi to endosome transport [GO:0006895]; Golgi to lysosome transport [GO:0090160]; maintenance of synapse structure [GO:0099558]; myotube differentiation [GO:0014902]; negative regulation of fat cell differentiation [GO:0045599]; neuropeptide signaling pathway [GO:0007218]; neurotrophin TRK receptor signaling pathway [GO:0048011]; ossification [GO:0001503]; plasma membrane to endosome transport [GO:0048227]; positive regulation of epithelial cell apoptotic process [GO:1904037]; protein targeting to lysosome [GO:0006622]; regulation of gene expression [GO:0010468]; response to insulin [GO:0032868]; vesicle organization [GO:0016050]","GO:0001503; GO:0005764; GO:0005765; GO:0005769; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006622; GO:0006895; GO:0006897; GO:0007218; GO:0008333; GO:0008625; GO:0009986; GO:0010008; GO:0010465; GO:0010468; GO:0014902; GO:0016020; GO:0016050; GO:0019899; GO:0030140; GO:0030379; GO:0030425; GO:0030659; GO:0031965; GO:0032509; GO:0032580; GO:0032868; GO:0043025; GO:0045599; GO:0046323; GO:0048011; GO:0048227; GO:0048406; GO:0048471; GO:0090160; GO:0099558; GO:0150053; GO:1904037; GO:1905394"
"865","Pocillopora_acuta_HIv2___RNAseq.g4562.t1",27.2727272727273,0,5.88235294117647,1.75438596491228,16.5289256198347,2.09205020920502,7.90960451977401,0,7.40740740740741,NA,7.64971710389302,2.25076871630494,14.3984025883781,1,47.8260869565217,47.8260869565217,0.000462049531742044,0.000462049531742044,0.000462049531742044,3.68233641306884,6.36195368411057,4.52101710263,10.0105687938888,6.34949773762474,3.68233641306884,5.44987995888088,5.84514254962292,3.68233641306884,3.68233641306884,5.32674054790333,4.81606604320307,5.83741505260359,118.342434386423,0.0957884331461891,1.00229210244092,0.450724655596943,0.692439350411838,NA,NA,NA,NA,NA
"866","Pocillopora_acuta_HIv2___RNAseq.g4563.t1",60,0,0,0,57.1428571428571,26.4705882352941,34.8484848484849,NA,0,NA,22.3077412783295,6.61764705882353,37.9978354978355,NA,NA,NA,NA,NA,NA,3.68233641306884,8.83835921732124,6.3914623546344,8.47878496008449,8.21693978182662,7.99430979892605,10.4837640148158,8.16647216468735,3.68233641306884,3.68233641306884,6.96171015315025,6.02790942545721,7.89551088084328,299.517216651899,0.563435585772139,1.10851226946995,0.14794580189644,0.345421804460066,"Q6PFL8",1.44e-89,"Thymocyte nuclear protein 1","","GO:0005634"
"867","Pocillopora_acuta_HIv2___RNAseq.g4569.t1",1.36024572180781,0.919540229885057,1.53429602888087,0.897531787584144,1.24925639500297,0.841750841750842,1.83374083129584,0.416088765603329,2.64623955431755,5.53846153846154,1.723715169459,1.14423023582818,2.30320010308981,NA,NA,NA,NA,NA,NA,9.1667102834738,5.88506810849203,9.73672754175274,8.66056507040527,9.63387071442544,6.86537227239914,9.48292237233824,8.44397693284445,10.7497349769724,11.0833136991553,8.97082619722588,9.54620408989377,8.395448304558,750.75580490474,-0.616063285878472,0.870823312373339,0.174484222536637,0.385774960985924,"G5E8P0",3.61e-132,"Gamma-tubulin complex component 6 (GCP-6)","cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225]","GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0000931; GO:0005737; GO:0005813; GO:0005874; GO:0007020; GO:0008017; GO:0031122; GO:0043015; GO:0051225; GO:0051321"
"868","Pocillopora_acuta_HIv2___RNAseq.g4576.t1",0,NA,NA,0,0,28.5714285714286,0,66.6666666666667,NA,0,13.6054421768707,31.7460317460317,0,NA,NA,NA,NA,NA,NA,12.0913516981545,11.6450783990732,12.1434238848529,11.388744982454,12.3505490259851,11.1020103300989,13.4454998510166,12.3972868833616,10.5908858110344,12.4938626509516,11.9648693516983,11.9146994606777,12.0150392427189,4579.69432389691,0.0562480412034207,0.647318511416352,0.924561526240866,0.971740311916873,"P05631",8.03e-120,"ATP synthase subunit gamma, mitochondrial (ATP synthase F1 subunit gamma) (F-ATPase gamma subunit)","proton motive force-driven ATP synthesis [GO:0015986]","GO:0000275; GO:0005739; GO:0015986; GO:0045259; GO:0046933"
"869","Pocillopora_acuta_HIv2___RNAseq.g24110.t1",NA,NA,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.11283993360409,7.22094502716092,9.50084687279806,6.59828765874778,3.68233641306884,3.68233641306884,10.7580398930646,8.19376023911409,9.81352914429953,3.68233641306884,7.02452580079956,7.66066252057692,6.3883890810222,385.874535745739,-0.149481654492744,0.968887115434374,0.545824964858738,0.763595346911383,NA,NA,NA,NA,NA
"870","Pocillopora_acuta_HIv2___TS.g549.t1",NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.1924375664416,10.111875660246,9.70107217275744,3.68233641306884,10.4996581250342,3.68233641306884,8.60101178187524,10.4623260217092,7.71735117006754,3.68233641306884,7.83327417373377,9.714569011202,5.95197933626555,638.863259083191,-0.637496343091707,1.2425244354159,1.50006037433653e-05,0.000162158992932763,"Q1LY46",3.82e-168,"Mitochondrial proton/calcium exchanger protein (Electroneutral mitochondrial K(+)/H(+)exchanger) (KHE) (Leucine zipper-EF-hand-containing transmembrane protein 1)","calcium export from the mitochondrion [GO:0099093]; calcium ion transport [GO:0006816]; inner mitochondrial membrane organization [GO:0007007]; intracellular monoatomic cation homeostasis [GO:0030003]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; potassium ion transport [GO:0006813]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]","GO:0005509; GO:0005743; GO:0006813; GO:0006816; GO:0006851; GO:0007007; GO:0015369; GO:0030003; GO:0034214; GO:0043022; GO:0051260; GO:0051560; GO:0099093"
"871","Pocillopora_acuta_HIv2___TS.g562.t1",0,0.847457627118644,1.33333333333333,4.3859649122807,0,0.917431192660551,0,2.18978102189781,0.446927374301676,0.835654596100279,1.0956550057693,1.75751242565188,0.433797585886722,NA,NA,NA,NA,NA,NA,5.92950120283598,7.70835234963412,6.22468762788833,3.68233641306884,6.90951792457399,8.13537395015294,9.06205065734861,7.12388258861865,9.71654227425836,3.68233641306884,6.81745814014487,7.18082632363506,6.45408995665467,206.553016932047,-0.0240506503935008,0.958841626953227,0.833315720883106,0.932873300782672,NA,NA,NA,NA,NA
"872","Pocillopora_acuta_HIv2___TS.g563.t1",5.55555555555556,NA,0,0,0,0,0,0,0,NA,0.694444444444444,0,1.38888888888889,NA,NA,NA,NA,NA,NA,7.72880437482727,8.39310902442961,8.73766657024434,3.68233641306884,8.5995689912383,3.68233641306884,3.68233641306884,8.69146451830397,6.03378121970174,3.68233641306884,6.29137403510206,7.95825713486312,4.62449093534099,169.29698820035,-0.791457260058413,1.49521314204708,3.78358754038343e-06,4.9525620076114e-05,NA,NA,NA,NA,NA
"873","Pocillopora_acuta_HIv2___TS.g568.t1",0,NA,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.21146895076296,9.47656623090312,3.68233641306884,8.01456480640263,5.54035303062331,9.27694291822544,11.3561407084669,6.18361936369477,3.68233641306884,10.5246114944297,7.49489403296465,5.26002283424374,9.72976523168556,575.612194494433,4.98242595253981,2.30187593578235,7.63572099507108e-06,9.05271053054985e-05,"P28741",7.63e-61,"Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A)","anterior/posterior pattern specification [GO:0009952]; anterograde axonal transport [GO:0008089]; anterograde dendritic transport [GO:0098937]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dentate gyrus development [GO:0021542]; determination of left/right symmetry [GO:0007368]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; forebrain development [GO:0030900]; heart development [GO:0007507]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; inner ear receptor cell stereocilium organization [GO:0060122]; keratinocyte proliferation [GO:0043616]; kidney development [GO:0001822]; microtubule anchoring at centrosome [GO:0034454]; motile cilium assembly [GO:0044458]; neural precursor cell proliferation [GO:0061351]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of axo-dendritic protein transport [GO:1905128]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of establishment or maintenance of cell polarity regulating cell shape [GO:2000771]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of receptor-mediated endocytosis [GO:0048260]; smoothened signaling pathway [GO:0007224]","GO:0001701; GO:0001822; GO:0001947; GO:0003341; GO:0003777; GO:0005524; GO:0005814; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007224; GO:0007368; GO:0007507; GO:0008017; GO:0008089; GO:0008544; GO:0009952; GO:0009953; GO:0010457; GO:0010838; GO:0016887; GO:0016939; GO:0019894; GO:0021542; GO:0021904; GO:0021915; GO:0030507; GO:0030900; GO:0031514; GO:0032391; GO:0032839; GO:0034454; GO:0036334; GO:0043005; GO:0043025; GO:0043616; GO:0044458; GO:0044877; GO:0048260; GO:0050679; GO:0060122; GO:0060271; GO:0061351; GO:0090316; GO:0098794; GO:0098937; GO:0098971; GO:0098978; GO:0120170; GO:1904115; GO:1905128; GO:1905515; GO:2000771"
"874","Pocillopora_acuta_HIv2___RNAseq.g24146.t1",0,NA,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.1876201471498,11.0120621087635,10.4169498816057,8.98987751007651,10.9098960151954,3.68233641306884,3.68233641306884,11.1072269980395,10.3071800043549,10.7546846278643,9.20501701191873,10.7857746092691,7.6242594145684,1319.35252373063,-0.364730240266854,1.02334201582378,0.126549579975872,0.310134382373943,"A0A1L8GXY4",0,"Cilia- and flagella-associated protein 43","epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; regulation of cilium beat frequency [GO:0003356]","GO:0003351; GO:0003356; GO:0005576; GO:0005737; GO:0005856; GO:0042995"
"875","Pocillopora_acuta_HIv2___RNAseq.g24162.t1",NA,0,28.2051282051282,11.1111111111111,2.85714285714286,9.52380952380952,23.1578947368421,18.1818181818182,0,NA,11.6296130769815,7.76334776334776,18.0733885997044,NA,NA,NA,NA,NA,NA,7.8556469288185,8.1492693916892,5.0980278924796,8.59399377233369,6.71792376881781,8.8938269424416,8.20698204111156,7.49101224450391,8.23094090625512,3.68233641306884,7.29199603015198,7.07871034817499,7.50528171212898,207.234673477552,0.237768981251786,0.935312318575374,0.481186831232655,0.715964029106997,"A0A2B4SII1",4.66e-37,"Stimulator of interferon genes protein 7 (Sp-STING7)","activation of innate immune response [GO:0002218]; autophagosome assembly [GO:0000045]; innate immune response [GO:0045087]; positive regulation of macroautophagy [GO:0016239]; positive regulation of type I interferon production [GO:0032481]; reticulophagy [GO:0061709]","GO:0000045; GO:0002218; GO:0005776; GO:0005789; GO:0016239; GO:0032481; GO:0035438; GO:0045087; GO:0061507; GO:0061709; GO:0140703"
"876","Pocillopora_acuta_HIv2___RNAseq.g24163.t1",0,NA,0,NA,100,66.6666666666667,100,28.5714285714286,58.3333333333333,NA,50.5102040816327,51.1904761904762,50,NA,NA,NA,NA,NA,NA,8.4737710451535,5.6784794012365,6.80680485095045,8.19402536505928,8.64122224584178,3.68233641306884,3.68233641306884,7.87192395769485,4.25049936715761,3.68233641306884,6.09637354723005,7.20884429335964,4.98390280110046,129.985787637678,-0.589707773254172,1.21749427127058,0.00915956015051033,0.0386250373227351,"A0A2B4SJA1",7.19e-45,"Stimulator of interferon genes protein 2 (Sp-STING2)","activation of innate immune response [GO:0002218]; autophagosome assembly [GO:0000045]; innate immune response [GO:0045087]; positive regulation of macroautophagy [GO:0016239]; positive regulation of type I interferon production [GO:0032481]; reticulophagy [GO:0061709]","GO:0000045; GO:0002218; GO:0005776; GO:0005789; GO:0016239; GO:0032481; GO:0035438; GO:0045087; GO:0061507; GO:0061709"
"877","Pocillopora_acuta_HIv2___RNAseq.g24188.t1",0,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.7574004548766,9.11560498715579,9.51851423438926,10.9384205734352,11.0938460626221,11.2574219921158,10.9642015487847,11.0454450076735,11.6887579484752,10.5845029879522,10.796411579748,11.0207927416073,10.5720304178887,2003.86748776566,-0.237379079359008,0.688059434032318,0.605064667337544,0.803793391691069,"Q62824",0,"Exocyst complex component 4 (Exocyst complex component Sec8) (rSec8)","chemical synaptic transmission [GO:0007268]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; Golgi to transport vesicle transport [GO:0055108]; membrane biogenesis [GO:0044091]; oligodendrocyte differentiation [GO:0048709]; paraxial mesoderm formation [GO:0048341]; positive regulation of calcium-mediated signaling [GO:0050850]; protein targeting to membrane [GO:0006612]; protein transmembrane transport [GO:0071806]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]; vesicle tethering involved in exocytosis [GO:0090522]","GO:0000145; GO:0005768; GO:0005813; GO:0005902; GO:0006612; GO:0006887; GO:0006893; GO:0006903; GO:0006904; GO:0007268; GO:0008021; GO:0014069; GO:0030010; GO:0030165; GO:0030425; GO:0030426; GO:0031252; GO:0032584; GO:0032991; GO:0035255; GO:0035748; GO:0043005; GO:0043025; GO:0043198; GO:0044091; GO:0044877; GO:0045202; GO:0048341; GO:0048709; GO:0050850; GO:0051223; GO:0055108; GO:0071806; GO:0090522; GO:0090543; GO:0098685; GO:0098696; GO:0099092"
"878","Pocillopora_acuta_HIv2___RNAseq.g24197.t1",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.6524645204062,10.8541729756763,11.5124879455455,12.5947707605393,12.1557998221248,13.137432869233,8.40588239640505,11.3012652808241,11.1384883504712,11.2463590184,11.3999123939625,11.5521011838744,11.2477236040507,3504.22004540948,-0.119403914856861,0.693280041960822,0.788068992246367,0.91044191380161,"A7SK48",0,"Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10)","formation of cytoplasmic translation initiation complex [GO:0001732]; translation reinitiation [GO:0002188]","GO:0001732; GO:0002188; GO:0003729; GO:0003743; GO:0016282; GO:0033290; GO:0043614; GO:0071540; GO:0071541"
"879","Pocillopora_acuta_HIv2___RNAseq.g24245.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.17555543509735,3.68233641306884,8.60328853964979,7.49865221587083,3.68233641306884,5.31580014468035,3.68233641306884,7.91267833663967,8.25975899506637,3.68233641306884,6.14950793192797,7.5267235439044,4.77229231995154,158.823505709693,-0.271206556595459,1.05325037562908,0.000639753500959878,0.00403461349754981,NA,NA,NA,NA,NA
"880","Pocillopora_acuta_HIv2___RNAseq.g24254.t1",11.1111111111111,0,0,NA,28.5714285714286,3.125,NA,NA,0,NA,7.13458994708995,1.04166666666667,13.2275132275132,NA,NA,NA,NA,NA,NA,4.72947037839729,4.59616451822093,5.02254961121426,3.68233641306884,4.71118491363556,6.11832151256475,7.95079023411305,4.78747788616564,6.20688780213667,3.68233641306884,5.14875196825858,5.09151411830988,5.20598981820728,35.8004963759575,-0.0390581618526639,0.967256482897124,0.68638672760744,0.855123664842091,NA,NA,NA,NA,NA
"881","Pocillopora_acuta_HIv2___RNAseq.g24327.t1",NA,NA,0,0,0,NA,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.79783922794957,3.68233641306884,9.44958064460795,9.55523752978023,8.62470528020048,3.68233641306884,3.68233641306884,8.91719556124791,3.68233641306884,3.68233641306884,6.47562403091303,8.09433142541495,4.85691663641112,309.284280518046,-0.333067857766142,1.07779851258078,0.000150870972304842,0.00117322459323507,"Q9UHC3",6.16e-41,"Acid-sensing ion channel 3 (ASIC3) (hASIC3) (Amiloride-sensitive cation channel 3) (Neuronal amiloride-sensitive cation channel 3) (Testis sodium channel 1) (hTNaC1)","detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; response to acidic pH [GO:0010447]; response to heat [GO:0009408]; sensory perception [GO:0007600]; sensory perception of sour taste [GO:0050915]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]","GO:0005261; GO:0005272; GO:0005886; GO:0007165; GO:0007600; GO:0009408; GO:0010447; GO:0015280; GO:0035725; GO:0042931; GO:0048471; GO:0050915; GO:0050965; GO:0050966; GO:0050968; GO:0160128"
"882","Pocillopora_acuta_HIv2___RNAseq.g21354.t2",83.3333333333333,100,71.4285714285714,100,NA,83.3333333333333,68.75,NA,NA,NA,84.4742063492064,94.4444444444444,74.5039682539683,NA,NA,NA,NA,NA,NA,8.09403604863606,7.75193075643614,9.89048637036369,5.16572759476787,5.54035303062331,6.2434550875973,3.68233641306884,10.1253515086319,5.03316817358995,3.68233641306884,6.52091813967839,7.73667902636898,5.3051572529878,255.746503012906,-0.603436217994327,1.17386418725784,0.0113465247048678,0.0461908621815951,"Q8K4Q7",5.19e-91,"Ceramide kinase (mCERK) (EC 2.7.1.138) (Acylsphingosine kinase)","ceramide metabolic process [GO:0006672]","GO:0000287; GO:0001729; GO:0005524; GO:0005739; GO:0005886; GO:0006672; GO:0016020; GO:0102773"
"883","Pocillopora_acuta_HIv2___RNAseq.g21356.t1",0,0,NA,0,NA,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,7.14950277613762,3.68233641306884,9.05071967176477,10.0483189203131,7.37999157022098,3.68233641306884,3.68233641306884,9.0737077095255,9.4199171707923,7.82681714880406,7.09959842067649,8.41476777968823,5.78442906166474,317.276200132538,-0.574225554946295,1.19546377258482,8.42856656403288e-05,0.000717122275189245,"A8E657",0,"Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase (LKR) (LOR) (EC 1.5.1.8); Saccharopine dehydrogenase (SDH) (EC 1.5.1.9)]","L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554]","GO:0004753; GO:0005737; GO:0005739; GO:0006554; GO:0019878; GO:0033512; GO:0047130; GO:0047131"
"884","Pocillopora_acuta_HIv2___RNAseq.g21359.t2",1.75438596491228,0,3.33333333333333,6.52173913043478,4.93827160493827,3.44827586206897,0,3.84615384615385,0,NA,2.64912886020461,2.76323376773152,2.50649772579597,NA,NA,NA,NA,NA,NA,7.91509363256345,6.81522472615292,3.68233641306884,7.94938886197888,7.66178680263729,8.8938269424416,5.90680277481292,9.19253599087313,3.68233641306884,8.966307214974,7.06656397725719,6.42681785044231,7.70631010407206,222.653217953421,0.173003957145582,0.985351938672925,0.295053167686972,0.542130210546795,"Q8IVH2",2.59e-73,"Forkhead box protein P4 (Fork head-related protein-like A)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872"
"885","Pocillopora_acuta_HIv2___TS.g2251.t1",0,0,3.7037037037037,0,0,0,0.602409638554217,0,0,0,0.430611334225792,0,0.861222668451584,NA,NA,NA,NA,NA,NA,7.92037767491365,8.63287949292383,10.1005369428845,3.68233641306884,10.4336969827541,8.3741534738921,7.96348259476953,9.1865202157142,10.340106589463,3.68233641306884,8.03164267934526,9.59624768114589,6.46703767754463,537.805146508717,-0.506613335861674,1.09760609424704,0.0469784119540103,0.14849120421827,"Q8R151",1.02e-54,"NFX1-type zinc finger-containing protein 1","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"886","Pocillopora_acuta_HIv2___TS.g2252.t1",0.574712643678161,0,4.16666666666667,7.07070707070707,0,1.98863636363636,0,1.35135135135135,0,0,1.51520740960396,2.08213895713896,0.948275862068966,NA,NA,NA,NA,NA,NA,8.56080040423262,3.68233641306884,8.51795618392323,9.3027055138069,6.74915512039247,5.75438588036295,3.68233641306884,7.86816093962977,7.58665737684829,3.68233641306884,6.53868306584028,7.85654600500528,5.22082012667527,179.071040286739,-0.589494737740976,1.20010644712356,8.34552531609088e-05,0.00071173159299492,"Q96I24",2.47e-08,"Far upstream element-binding protein 3 (FUSE-binding protein 3)","DNA-templated transcription [GO:0006351]; intracellular mRNA localization [GO:0008298]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005840; GO:0006351; GO:0006357; GO:0008298; GO:0010628; GO:0016020; GO:0043025; GO:0043198; GO:0045893; GO:0045944"
"887","Pocillopora_acuta_HIv2___RNAseq.g21371.t1",NA,0,NA,NA,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.87179230269972,6.36195368411057,8.06739668855565,7.66245516740606,8.4806852104889,7.85429172457537,9.13664004250746,9.86603303904193,10.5709370719373,3.68233641306884,8.15545213443918,9.3713688625447,6.93953540633366,487.012038189887,-0.6642546129371,1.07257781718694,0.103557203625593,0.26819183406277,"Q5A761",7.39e-25,"CCR4-Not complex 3'-5'-exoribonuclease subunit Ccr4 (EC 3.1.13.4) (Carbon catabolite repressor protein 4) (Cytoplasmic deadenylase) (Glucose-repressible alcohol dehydrogenase transcriptional effector)","cellular response to starvation [GO:0009267]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; filamentous growth [GO:0030447]; filamentous growth of a population of unicellular organisms in response to biotic stimulus [GO:0036180]; filamentous growth of a population of unicellular organisms in response to starvation [GO:0036170]; fungal-type cell wall biogenesis [GO:0009272]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; phospholipid homeostasis [GO:0055091]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; transcription elongation by RNA polymerase II [GO:0006368]; traversing start control point of mitotic cell cycle [GO:0007089]","GO:0000076; GO:0000289; GO:0000932; GO:0003723; GO:0004535; GO:0005634; GO:0005737; GO:0006260; GO:0006368; GO:0007089; GO:0009267; GO:0009272; GO:0016593; GO:0030014; GO:0030015; GO:0030447; GO:0032968; GO:0036170; GO:0036180; GO:0046872; GO:0055091"
"888","Pocillopora_acuta_HIv2___RNAseq.g21380.t1",100,100,0,NA,NA,100,0,NA,0,NA,50,66.6666666666667,33.3333333333333,NA,NA,NA,NA,NA,NA,7.82215178013904,9.09326077426548,10.2915750069164,8.21634508872886,10.6575390776806,7.38842911034179,3.68233641306884,10.4784123523042,9.28176728780022,11.5591736690877,8.84709905603331,9.70628910096809,7.98790901109853,894.486843259697,-0.303370068421224,0.982152028006199,0.253648191727219,0.494848214552261,"F1MNN4",1.19e-79,"F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7)","DNA damage response [GO:0006974]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin recycling [GO:0010992]","GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006281; GO:0006974; GO:0010992; GO:0019005; GO:0031146; GO:0043130; GO:0043161; GO:0050816; GO:0070534; GO:1990756"
"889","Pocillopora_acuta_HIv2___TS.g2282.t1",0,NA,NA,NA,70,45.4545454545455,16.6666666666667,100,0,NA,38.6868686868687,48.4848484848485,28.8888888888889,NA,NA,NA,NA,NA,NA,5.86218072811404,5.50727693310996,6.17960196289983,6.39402768922764,5.44125113471119,5.4799700608392,6.03750049456639,5.47509710266606,5.98677490518935,5.75038415558079,5.81140651669044,5.78898116671609,5.8338318666648,34.9023624513742,0.0446790085283405,0.621296700331824,0.930947167686254,0.974540047290582,"P0C1F8",5.68e-49,"DELTA-stichotoxin-Hcr4b (DELTA-SHTX-Hcr4b) (Cytolysin RTX-S II) (RTX-SII)","cytolysis in another organism [GO:0051715]; monoatomic cation transport [GO:0006812]; pore complex assembly [GO:0046931]","GO:0005576; GO:0006812; GO:0015267; GO:0042151; GO:0044218; GO:0046930; GO:0046931; GO:0051715; GO:0090729"
"890","Pocillopora_acuta_HIv2___RNAseq.g21394.t1",0,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0661876289089,3.68233641306884,9.95785393579384,9.10485972724127,8.35359683810296,8.32397650160948,3.68233641306884,10.0074948313467,7.56366523702835,3.68233641306884,7.4424643939238,9.18975969423615,5.69516909361145,430.620536754144,-0.553044560199135,1.16829457116849,2.59499494300793e-05,0.000258143100795506,"P18294",0,"Creatine kinase, flagellar (EC 2.7.3.2)","cell projection organization [GO:0030030]; phosphocreatine biosynthetic process [GO:0046314]","GO:0004111; GO:0005524; GO:0005615; GO:0005737; GO:0005856; GO:0030030; GO:0031514; GO:0046314"
"891","Pocillopora_acuta_HIv2___RNAseq.g21424.t1",0,5.63380281690141,2.04081632653061,1.61290322580645,8.23529411764706,6.38297872340426,6.19469026548673,0,0,0,3.01004854757765,2.72593695322242,3.29416014193288,NA,NA,NA,NA,NA,NA,5.69008050215398,5.4315664930872,5.85239579733235,3.68233641306884,3.68233641306884,3.68233641306884,3.68233641306884,4.97146452269528,3.68233641306884,7.85789910219586,4.82150884828089,4.77572272966386,4.86729496689792,30.3370686045758,-0.0845438324357193,1.00749043891999,0.60159408765611,0.802051514780899,NA,NA,NA,NA,NA
"892","Pocillopora_acuta_HIv2___TS.g2315.t1",0,NA,NA,0,0,0,NA,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,13.7100750769315,13.1689400347671,12.6330157295178,11.7596767593406,12.6000070805985,12.5409480572568,11.1079609539399,12.3288169835578,13.4348280844266,13.1841192765657,12.6468388036902,12.9413485910064,12.352329016374,7207.41275962092,-0.454026281200884,0.524938449989025,0.307459987710054,0.555887657779777,"D3ZHA0",0,"Filamin-C (FLN-C) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin)","muscle cell development [GO:0055001]; sarcomere organization [GO:0045214]","GO:0005737; GO:0005829; GO:0005856; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0043034; GO:0045171; GO:0045214; GO:0051015; GO:0055001"
"893","Pocillopora_acuta_HIv2___RNAseq.g21468.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.70689227093755,4.39481510491619,5.75086179528365,6.98772252729676,6.32874911315906,7.17736970220031,5.1359206776867,4.22313318099817,3.68233641306884,3.68233641306884,5.40701371986161,5.33839455468945,5.47563288503376,41.0295379024828,0.19201005275214,0.927081390857354,0.566046944290963,0.777226409932076,"M9NDE3",5.92e-28,"Protein bark beetle (Protein anakonda)","cell-cell junction maintenance [GO:0045217]; liquid clearance, open tracheal system [GO:0035002]; regulation of tube length, open tracheal system [GO:0035159]; response to endoplasmic reticulum stress [GO:0034976]; tricellular tight junction assembly [GO:1904274]","GO:0005912; GO:0005918; GO:0016020; GO:0016328; GO:0030246; GO:0034976; GO:0035002; GO:0035159; GO:0045217; GO:0061689; GO:1904274"
"894","Pocillopora_acuta_HIv2___RNAseq.g21475.t1",NA,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.93941910765684,8.62521464881705,8.98987751007651,8.5610219174009,3.68233641306884,7.93798460463687,3.68233641306884,3.68233641306884,11.376878080178,6.81597415210415,5.64664916108489,7.98529914312341,427.958259639559,0.210938932349037,1.0323032121961,7.70619028947547e-05,0.000665844303147988,"P24821",4.14e-51,"Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)","bud outgrowth involved in lung branching [GO:0060447]; cell adhesion [GO:0007155]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to retinoic acid [GO:0071300]; cellular response to vitamin D [GO:0071305]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell adhesion [GO:0007162]; neuromuscular junction development [GO:0007528]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to wounding [GO:0009611]","GO:0001558; GO:0001649; GO:0002009; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007162; GO:0007528; GO:0008284; GO:0009611; GO:0009612; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0042475; GO:0045471; GO:0045545; GO:0050727; GO:0060447; GO:0060739; GO:0060740; GO:0062023; GO:0071300; GO:0071305; GO:0071774; GO:0071799; GO:0090733; GO:0098966"
"895","Pocillopora_acuta_HIv2___RNAseq.g21482.t1",0,0,0,0,0,0,12,0,0,NA,1.33333333333333,0,3,NA,NA,NA,NA,NA,NA,6.44918989210843,3.68233641306884,6.59774358746208,9.34377528002283,5.02357447611079,3.68233641306884,3.68233641306884,6.71452383453295,7.22521248378998,5.49240068675675,5.78934294799903,6.40204885480085,5.17663704119722,100.169709027917,-0.608121310744042,1.24450620163166,0.00321085072898559,0.0160642493753191,"M9NDE3",6.25e-37,"Protein bark beetle (Protein anakonda)","cell-cell junction maintenance [GO:0045217]; liquid clearance, open tracheal system [GO:0035002]; regulation of tube length, open tracheal system [GO:0035159]; response to endoplasmic reticulum stress [GO:0034976]; tricellular tight junction assembly [GO:1904274]","GO:0005912; GO:0005918; GO:0016020; GO:0016328; GO:0030246; GO:0034976; GO:0035002; GO:0035159; GO:0045217; GO:0061689; GO:1904274"
"896","Pocillopora_acuta_HIv2___RNAseq.g21490.t1",NA,0,0,0,NA,3.33333333333333,0,NA,NA,0,0.555555555555556,1.11111111111111,0,NA,NA,NA,NA,NA,NA,10.6078035293718,7.55269107778438,9.25426777814093,10.5830999897292,9.78168821355153,9.7096309157654,3.68233641306884,10.403919926329,3.68233641306884,7.97589929907695,8.32336735558869,8.74600317209242,7.90073153908495,701.420484417843,-0.05832773511172,0.962297738856025,0.779011714347134,0.905466524937074,"A8WIP6",0,"Cyclin-dependent kinase 20 (EC 2.7.11.22) (Cell cycle-related kinase) (Cell division protein kinase 20)","cell division [GO:0051301]; cilium assembly [GO:0060271]","GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005929; GO:0051301; GO:0060271; GO:0106310"
"897","Pocillopora_acuta_HIv2___RNAseq.g21491.t1",NA,0,0,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.58022760055378,6.11036395750361,8.28979413555857,4.52967082297852,7.2010836147454,7.03963041141765,3.68233641306884,3.99577996562374,6.83269238753983,3.68233641306884,5.69439157220588,6.37991554080426,5.00886760360749,68.3861754165777,-0.528557812380445,1.08018159218426,0.0937385493139797,0.249142663961301,"Q6PF45",1.08e-67,"Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter) (xVIAAT)","beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836]","GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800"
"898","Pocillopora_acuta_HIv2___RNAseq.g21501.t1",NA,0,NA,4.16666666666667,0,NA,0,0,NA,0,0.694444444444445,1.38888888888889,0,NA,NA,NA,NA,NA,NA,11.1073064408783,8.50745155353574,8.0143117467574,11.0111058243485,8.73075684616717,9.2970681539981,11.1782003734031,7.57666323111741,9.51846116743841,3.68233641306884,8.8623661750713,8.98949988647174,8.73523246367086,895.985610949847,0.0494884937548605,0.9385459333076,0.903193889265621,0.963547277327752,"Q24270",0,"Voltage-dependent calcium channel type D subunit alpha-1 (DmCa1D)","calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; epithelial fluid transport [GO:0042045]; locomotion [GO:0040011]; muscle contraction [GO:0006936]; neuron remodeling [GO:0016322]","GO:0005245; GO:0005891; GO:0006816; GO:0006936; GO:0008331; GO:0016322; GO:0016323; GO:0016324; GO:0019722; GO:0040011; GO:0042045; GO:0046872; GO:0050965; GO:0070588; GO:0098703"
"899","Pocillopora_acuta_HIv2___RNAseq.g21510.t1",6.45161290322581,NA,4.16666666666667,0,8.33333333333333,3.81679389312977,NA,0,NA,NA,3.79473446605926,1.27226463104326,6.31720430107527,NA,NA,NA,NA,NA,NA,6.71922149999791,3.68233641306884,6.28256793029396,7.18297737323777,5.23920445324911,4.21083509301726,3.68233641306884,8.57649000955297,3.68233641306884,3.68233641306884,5.29406420116243,6.09996406123256,4.48816434109231,63.1014795460405,-0.348875394982502,1.07264567549517,0.0858596959276191,0.233391212534689,NA,NA,NA,NA,NA
"900","Pocillopora_acuta_HIv2___RNAseq.g21516.t1",0,0,0,2.7027027027027,2.85714285714286,3.38983050847458,0,0,NA,0,0.994408452035571,1.52313330279432,0.571428571428571,NA,NA,NA,NA,NA,NA,3.68233641306884,10.0171745790842,5.20227553025741,10.2628651147657,3.68233641306884,8.58544382875616,11.5569048300592,9.67413793798634,3.68233641306884,3.68233641306884,7.00281474731844,5.18468454149005,8.82094495314682,636.706584008716,0.719285490840763,1.37148539889112,0.000915021384258034,0.00544420785763398,"B8VIW9",0,"Fibronectin type III domain-containing protein (Neuroglian-like protein)","axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]","GO:0005886; GO:0007411; GO:0030424; GO:0098609"
"901","Pocillopora_acuta_HIv2___RNAseq.g21532.t1",NA,NA,71.4285714285714,100,41.1764705882353,77.7777777777778,66.6666666666667,100,NA,NA,76.1749144102085,92.5925925925926,59.7572362278245,NA,NA,NA,NA,NA,NA,10.6408992041451,10.2745544258692,11.784772586033,11.4428878079333,11.8287080285144,9.8605758045342,9.33971390028441,10.7249609630063,11.8830896689945,11.2599552952668,10.9040117684581,11.3724860901387,10.4355374467776,2202.89783724734,-0.709020120454866,0.595789073251647,0.136736864025629,0.328095886076094,"P51572",8.63e-57,"B-cell receptor-associated protein 31 (BCR-associated protein 31) (Bap31) (6C6-AG tumor-associated antigen) (Protein CDM) (p28)","apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein targeting to mitochondrion [GO:0006626]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]","GO:0000139; GO:0005783; GO:0005789; GO:0005811; GO:0005829; GO:0005886; GO:0006626; GO:0006886; GO:0006888; GO:0006915; GO:0007283; GO:0016020; GO:0030136; GO:0032580; GO:0033116; GO:0034976; GO:0042288; GO:0044233; GO:0044877; GO:0070973; GO:0097038; GO:0098553; GO:1904154; GO:1904294; GO:2000060; GO:2001244"
"902","Pocillopora_acuta_HIv2___TS.g2429.t1",NA,0,NA,0,0,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,9.01233578841319,9.79818524877428,10.7963838905747,7.95604127232808,11.2210622276358,10.9291014917576,10.7323811196821,9.47263695245158,11.5403426844974,9.08023654260957,10.0538707218724,10.4085523087145,9.69918913503033,1344.7176306099,-0.33916360775979,0.766583502756917,0.445537118639487,0.687606932743248,"P53590",0,"Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial (EC 6.2.1.4) (GTP-specific succinyl-CoA synthetase subunit beta) (G-SCS) (GTPSCS) (Succinyl-CoA synthetase beta-G chain) (SCS-betaG)","succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]","GO:0004776; GO:0005524; GO:0005525; GO:0005739; GO:0006099; GO:0006104; GO:0042709; GO:0046872"
"903","Pocillopora_acuta_HIv2___RNAseq.g21538.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.9619637175816,3.68233641306884,8.41470454910082,3.68233641306884,7.53892828027555,3.68233641306884,3.68233641306884,9.22811270986501,5.59984979127766,3.68233641306884,5.71552411134448,7.74871180962013,3.68233641306884,130.209241528971,-11.7363044492385,3.69491252831839,1.63038141426813e-08,4.46625696514663e-07,"O43704",2.35e-56,"Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase)","3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; biogenic amine metabolic process [GO:0006576]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]","GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006576; GO:0006805; GO:0008146; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923"
"904","Pocillopora_acuta_HIv2___RNAseq.g21609.t1",0,NA,NA,33.3333333333333,0,0,0,NA,0,NA,5.55555555555556,11.1111111111111,0,NA,NA,NA,NA,NA,NA,6.3567367124764,4.39481510491619,5.16860104011765,8.73581748555832,4.82690108855957,10.398297080943,3.68233641306884,4.60853003661057,3.68233641306884,3.68233641306884,5.55367077883882,4.92862105816661,6.17872049951104,181.541258898979,0.0417815924392562,1.00203341954064,0.723249124117733,0.875685160888514,NA,NA,NA,NA,NA
"905","Pocillopora_acuta_HIv2___RNAseq.g21610.t1",NA,0,0,0,0,8.33333333333333,0,NA,NA,NA,1.38888888888889,2.77777777777778,0,NA,NA,NA,NA,NA,NA,6.24036347909427,3.68233641306884,7.19489022163491,6.37387005840579,8.00651026551819,7.51815502630389,3.68233641306884,10.2816122661808,12.3873352160951,3.68233641306884,6.90497457724395,8.82214228970465,4.98780686478324,717.497554579552,-0.583867292849207,1.19630498003501,9.13174009062713e-05,0.000767915631807156,"Q9BYN7",2.49e-39,"Zinc finger protein 341","regulation of DNA-templated transcription [GO:0006355]","GO:0000978; GO:0000981; GO:0001216; GO:0003677; GO:0005634; GO:0006355; GO:0046872"
"906","Pocillopora_acuta_HIv2___RNAseq.11056_t",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.6180172093456,3.68233641306884,10.5631163849172,3.68233641306884,11.8178624817277,3.68233641306884,3.68233641306884,10.9083124899354,12.4735131020256,3.68233641306884,7.57925037332957,11.4761643335903,3.68233641306884,1574.73889068724,-15.9358651320797,3.89078629777836,1.75260562935366e-17,1.8106919873551e-14,NA,NA,NA,NA,NA
"907","Pocillopora_acuta_HIv2___RNAseq.g21627.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.56697844314971,6.4898644287519,10.1941877851581,3.68233641306884,9.76578365008145,3.68233641306884,5.7616711601265,9.59120293861953,11.9147116536215,3.68233641306884,7.43314092987152,10.2065728941261,4.65970896561698,740.285196352006,-6.31854132516727,4.12038898810744,7.97322897407702e-09,2.37770057832293e-07,"Q96N23",0,"Cilia- and flagella-associated protein 54","cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283]","GO:0005576; GO:0005930; GO:0007283; GO:0051649; GO:0060271; GO:0060294; GO:0090660; GO:0120197; GO:0120316"
"908","Pocillopora_acuta_HIv2___RNAseq.11061_t",0,0,0,0,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.64286629266806,3.68233641306884,8.21218654876206,6.2462771951713,5.37766003570327,3.68233641306884,3.68233641306884,8.3635330345621,3.68233641306884,3.68233641306884,5.5254205172211,6.85571646495287,4.19512456948933,102.23628635199,-0.510617827243978,1.19691855730721,0.0034011993626479,0.0168072933315132,"Q9LQV2",1.8e-133,"RNA-dependent RNA polymerase 1 (AtRDRP1) (EC 2.7.7.48) (RNA-directed RNA polymerase 1)","defense response [GO:0006952]; positive regulation of post-transcriptional gene silencing [GO:0060148]; response to salicylic acid [GO:0009751]; response to virus [GO:0009615]; siRNA processing [GO:0030422]; wax biosynthetic process [GO:0010025]","GO:0003723; GO:0003968; GO:0006952; GO:0009615; GO:0009751; GO:0010025; GO:0030422; GO:0060148"
"909","Pocillopora_acuta_HIv2___RNAseq.g8148.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.91003273324489,12.712554284057,6.91875970696607,11.3028684140633,3.68233641306884,11.4923492054476,10.7625741737278,8.22053982023861,9.12895987737672,12.9859553074136,9.61169299356044,7.37212571017903,11.8512602769419,2320.13158146332,3.40378680496231,1.75761567003207,0.000578447403880108,0.00370698416026667,"Q96RW7",0,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711"
"910","Pocillopora_acuta_HIv2___RNAseq.g8158.t1",0,0,0,NA,0,0.869565217391304,0,NA,0,NA,0.124223602484472,0.289855072463768,0,NA,NA,NA,NA,NA,NA,10.9887888063355,10.6464990143766,10.7993973204244,11.5470829248038,10.8758770944983,11.1641180588156,10.462740171673,11.416207382663,10.340106589463,10.7478081596833,10.8988625522737,10.8840754386768,10.9136496658705,1948.75451489874,0.0203925276992796,0.542388044547118,0.956189970405086,0.98345528919428,"P10731",1.1e-160,"Peptidyl-glycine alpha-amidating monooxygenase (PAM) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase (PHM) (EC 1.14.17.3); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase (EC 4.3.2.5) (Peptidylamidoglycolate lyase) (PAL)]","fatty acid primary amide biosynthetic process [GO:0062112]; peptide amidation [GO:0001519]","GO:0001519; GO:0004504; GO:0004598; GO:0005507; GO:0005509; GO:0005576; GO:0008270; GO:0030658; GO:0030667; GO:0031418; GO:0062112"
"911","Pocillopora_acuta_HIv2___RNAseq.g8175.t3",0,0,0,NA,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.4220642786067,9.93478219149317,10.2890043831317,11.9880526515298,10.0949105061944,8.2719852622556,9.34939505871154,9.76068013332758,6.56263408610192,3.68233641306884,9.13558449644212,9.62585867747246,8.64531031541179,1182.53142062266,-0.513258663772732,0.92616964226328,0.221403015864398,0.45250434102906,"Q26473",1.14e-60,"Semaphorin-1A (Fasciclin IV) (Fasciclin-4) (Semaphorin-I) (Sema I)","axon guidance [GO:0007411]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]","GO:0001755; GO:0007411; GO:0016020; GO:0030215; GO:0030335; GO:0045499; GO:0048843; GO:0071526"
"912","Pocillopora_acuta_HIv2___TS.g29982.t2",0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.1152663980642,8.08266943966032,10.3682620712297,9.2388198810257,11.0388646147143,9.70361355517205,3.68233641306884,10.9808982190689,10.5477954995481,9.1735463642302,9.29320724557823,10.610217360525,7.97619713063142,1011.02417576374,-0.839455667072587,1.14643419755738,0.0958431828910663,0.253293586211654,"Q0IH87",6.99e-68,"Paired box protein Pax-3-B (xPax3-B) (Paired-domain transcription factor Pax3-B)","fibroblast growth factor receptor signaling pathway [GO:0008543]; hatching gland development [GO:0048785]; nervous system development [GO:0007399]; neural crest cell fate commitment [GO:0014034]; neural crest formation [GO:0014029]; positive regulation of DNA-templated transcription [GO:0045893]; Wnt signaling pathway [GO:0016055]","GO:0000981; GO:0003677; GO:0005634; GO:0007399; GO:0008543; GO:0014029; GO:0014034; GO:0016055; GO:0045893; GO:0048785"
"913","Pocillopora_acuta_HIv2___TS.g29998.t1",4.34782608695652,26.6666666666667,NA,6.66666666666667,0,36.2068965517241,32.6923076923077,NA,9.52380952380952,NA,16.5863104554473,19.7660098522167,12.3467112597547,NA,NA,NA,NA,NA,NA,8.72954703693815,10.2733132454309,10.288146489449,9.91503983174146,9.23774477837523,10.4566989385027,9.86168232199218,8.69358802044517,10.3151968891565,9.17764749349489,9.69486050455262,9.45284464287281,9.93687636623243,882.992975042991,0.339214045600301,0.651027087705785,0.481317474509387,0.71600950319277,"Q5XIG5",4.19e-13,"G kinase-anchoring protein 1","positive regulation of insulin receptor signaling pathway [GO:0046628]; signal transduction [GO:0007165]","GO:0005794; GO:0007165; GO:0042802; GO:0046628"
"914","Pocillopora_acuta_HIv2___TS.g30000.t3",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.6401009613325,10.9340989997391,10.5974556072494,10.4589652832632,11.3889273029289,10.1609536317461,12.108157553898,11.4495420629608,9.56339511422562,8.60735003386347,10.5908946551207,10.7278842097394,10.453905100502,1843.86922694566,-0.183318124965045,0.57215705890765,0.666722832214552,0.844004607883395,"Q9JJP9",5.17e-163,"Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1)","aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000045; GO:0000502; GO:0005634; GO:0005737; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0006511; GO:0016235; GO:0016236; GO:0016241; GO:0019900; GO:0019904; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0034140; GO:0034976; GO:0035973; GO:0036503; GO:0042802; GO:0048471; GO:0071456; GO:0097352; GO:1901340; GO:1902175; GO:1904294"
"915","Pocillopora_acuta_HIv2___TS.g30004.t1",1.5660985720866,1.80430256766135,1.76884767302078,1.70785353862078,1.68470241023119,1.79833012202954,2.13781255964879,1.32661628883291,1.20533485486057,1.4264388787527,1.64263374657452,1.56848747440103,1.71678001874801,NA,NA,NA,NA,NA,NA,9.74980056058326,8.17613327516216,10.5510091725968,9.57907872589277,10.0077140726582,10.3345133570957,3.68233641306884,9.25279193447333,7.46780854522067,3.68233641306884,8.24835224698206,9.40582485710645,7.09087963685766,632.030038040849,-0.576351321540612,1.10605689093915,0.0529514689140252,0.162230469470972,"A2CEA7",1.92e-71,"Ras-specific guanine nucleotide-releasing factor 2 (Ras-GRF2) (Ras guanine nucleotide exchange factor 2)","Ras protein signal transduction [GO:0007265]","GO:0005085; GO:0005516; GO:0005789; GO:0005886; GO:0007265"
"916","Pocillopora_acuta_HIv2___RNAseq.g8215.t1",4.16666666666667,0,0,0,0,4,3.44827586206897,27.906976744186,NA,NA,4.94023990911521,7.97674418604651,1.90373563218391,NA,NA,NA,NA,NA,NA,3.68233641306884,6.74434409930028,9.16171788928747,7.96925428521777,9.34617942162719,3.68233641306884,3.68233641306884,8.49602287564832,3.68233641306884,9.34013710890754,6.57870013322639,6.87371860254013,6.28368166391265,243.996030299961,-0.0342067402397671,1.00681788460232,0.637485356603623,0.825330128707018,"Q5VW36",0,"Focadhesin","regulation of post-transcriptional gene silencing [GO:0060147]","GO:0005829; GO:0005925; GO:0060147"
"917","Pocillopora_acuta_HIv2___RNAseq.g8229.t1",100,100,NA,100,NA,100,100,NA,NA,100,100,100,100,NA,NA,NA,NA,NA,NA,10.6630725264778,11.1577294831685,11.5523301658408,10.465955487095,10.3849264751925,11.5930084302261,10.4254805695805,11.7532138453618,11.2797817914839,3.68233641306884,10.2957835187496,11.1266649608714,9.46490207662779,1983.32623248152,-0.263379235676205,0.907634147167356,0.47640528080978,0.712429025210888,"E9PV86",0,"Multiple C2 and transmembrane domain-containing protein 1","negative regulation of cell migration [GO:0030336]; negative regulation of endocytosis [GO:0045806]; negative regulation of response to oxidative stress [GO:1902883]; regulation of neurotransmitter secretion [GO:0046928]","GO:0005509; GO:0005789; GO:0030336; GO:0030672; GO:0045806; GO:0046928; GO:0055037; GO:1902883"
"918","Pocillopora_acuta_HIv2___RNAseq.g8230.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.98667766036915,9.15389265986356,3.68233641306884,3.68233641306884,7.16128077648109,3.68233641306884,4.27277361158612,5.74496152652496,9.67975321112738,3.68233641306884,5.77286850982276,6.65100191751428,4.89473510213124,159.319856711547,-0.300185033048973,1.06228918528461,0.057102796595095,0.17235702211007,"P07942",1.37e-97,"Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta)","cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]","GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005788; GO:0007155; GO:0021812; GO:0030335; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043257; GO:0043259; GO:0045785; GO:0048471; GO:0050679; GO:0051149; GO:0062023; GO:0070062; GO:0098637; GO:0110011; GO:2001046"
"919","Pocillopora_acuta_HIv2___RNAseq.g8261.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.45976149983951,9.92058060602293,8.36993710353355,8.84716809532974,9.9860753119605,9.35004329185677,10.7415974484405,7.88315412751572,6.44828135143128,3.68233641306884,8.06889352489993,7.62944187885611,8.50834517094376,528.363161508599,0.194152411571905,0.926004598793567,0.56531039907511,0.776688619198524,"Q9H267",0,"Vacuolar protein sorting-associated protein 33B (hVPS33B)","collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; lysosome localization [GO:0032418]; megakaryocyte development [GO:0035855]; melanosome localization [GO:0032400]; membrane fusion [GO:0061025]; peptidyl-lysine hydroxylation [GO:0017185]; phagosome-lysosome fusion [GO:0090385]; platelet alpha granule organization [GO:0070889]; protein transport [GO:0015031]; regulation of platelet aggregation [GO:0090330]; skin morphogenesis [GO:0043589]; vesicle-mediated transport [GO:0016192]","GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005794; GO:0005829; GO:0006886; GO:0007032; GO:0010008; GO:0015031; GO:0016192; GO:0017185; GO:0030136; GO:0030199; GO:0030897; GO:0031091; GO:0031901; GO:0031902; GO:0032400; GO:0032418; GO:0032963; GO:0033263; GO:0035855; GO:0043589; GO:0044877; GO:0046907; GO:0048471; GO:0055037; GO:0061025; GO:0070889; GO:0090330; GO:0090385; GO:0099023"
"920","Pocillopora_acuta_HIv2___RNAseq.g8275.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.5159361243912,10.3137185736982,11.8267282747023,10.3822160641749,9.87534403980389,11.1487016230529,3.68233641306884,10.5380729060245,10.8294587521669,11.5755764419689,10.0688089213053,10.7171080194178,9.42050982319275,1704.21006112319,-0.180770144929194,0.891338103033699,0.617732834452314,0.812853686091546,"Q3UHD6",0,"Sorting nexin-27","endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; endosome to plasma membrane protein transport [GO:0099638]; establishment of protein localization to plasma membrane [GO:0061951]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport to plasma membrane [GO:0098877]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; signal transduction [GO:0007165]","GO:0001772; GO:0005768; GO:0005769; GO:0005829; GO:0006886; GO:0007165; GO:0008333; GO:0016197; GO:0030904; GO:0031901; GO:0032266; GO:0032456; GO:0035091; GO:0035255; GO:0048306; GO:0061951; GO:0071203; GO:0098685; GO:0098794; GO:0098837; GO:0098842; GO:0098877; GO:0098978; GO:0099072; GO:0099638; GO:1904719"
"921","Pocillopora_acuta_HIv2___TS.g30082.t2",0,6.38297872340426,0,6.25,0,0,0,0,0,0,1.26329787234043,2.52659574468085,0,NA,NA,NA,NA,NA,NA,9.74535300296951,8.48615680610434,9.61747021527548,10.1444068470491,9.8310755988393,8.16199739230414,10.3125101028695,9.68484410081867,10.5213096002864,4.69373610443143,9.11988597709479,9.88001050363787,8.3597614505517,767.359491444098,-0.478145934038142,0.899113415199187,0.260291944417871,0.502249557638752,"Q00174",3.02e-167,"Laminin subunit alpha (Laminin A chain)","animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]","GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0007411; GO:0007498; GO:0007507; GO:0008021; GO:0009887; GO:0009888; GO:0030155; GO:0030334; GO:0030424; GO:0033627; GO:0034446; GO:0035001; GO:0035011; GO:0036062; GO:0045886; GO:0045995; GO:0062023; GO:0071711"
"922","Pocillopora_acuta_HIv2___RNAseq.g8305.t1",39.1304347826087,0,NA,0,0,13.6363636363636,0,NA,10.7142857142857,0,7.93513551665726,6.08766233766234,9.78260869565217,NA,NA,NA,NA,NA,NA,8.78263567065374,5.3082414967072,9.68290833754419,8.5197169563895,7.77492674167574,3.68233641306884,11.8721916173512,7.59045235107559,5.38933004445713,3.68233641306884,7.2285076041992,7.84405062908128,6.61296457931712,567.675432758923,-0.480004919935767,1.11166647268601,0.0166695676486457,0.0637773834327145,"C0H906",0,"Nuclear cap-binding protein subunit 1 (80 kDa nuclear cap-binding protein) (CBP80) (NCBP 80 kDa subunit)","7-methylguanosine mRNA capping [GO:0006370]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; RNA splicing [GO:0008380]","GO:0000184; GO:0000339; GO:0005634; GO:0005737; GO:0005846; GO:0006370; GO:0006406; GO:0006417; GO:0008380; GO:0031047"
"923","Pocillopora_acuta_HIv2___RNAseq.11263_t",100,NA,50,NA,NA,70.5882352941177,100,100,100,NA,86.7647058823529,90.1960784313726,83.3333333333333,NA,NA,NA,NA,NA,NA,8.7768326555933,6.34267098328276,9.19689553123884,9.23609553638554,9.03872893471114,8.23067218564411,5.66606675070968,8.90625327520324,5.8076943734674,3.68233641306884,7.48842466393049,8.34528095404278,6.63156837381819,290.184899198178,-1.43495487425256,1.28695979517182,0.015506902329152,0.0601318593267706,"Q9UBB5",2.08e-58,"Methyl-CpG-binding domain protein 2 (Demethylase) (DMTase) (Methyl-CpG-binding protein MBD2)","cellular response to organic cyclic compound [GO:0071407]; chromatin remodeling [GO:0006338]; DNA methylation-dependent heterochromatin formation [GO:0006346]; embryonic organ development [GO:0048568]; maternal behavior [GO:0042711]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]; ventricular cardiac muscle tissue development [GO:0003229]; Wnt signaling pathway [GO:0016055]","GO:0000122; GO:0000785; GO:0000792; GO:0003229; GO:0003682; GO:0003696; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006346; GO:0008327; GO:0009612; GO:0016055; GO:0016581; GO:0019904; GO:0030177; GO:0031667; GO:0032355; GO:0032991; GO:0035197; GO:0042127; GO:0042711; GO:0042802; GO:0045892; GO:0045893; GO:0048568; GO:0060090; GO:0065003; GO:0070742; GO:0071407"
"924","Pocillopora_acuta_HIv2___RNAseq.g8316.t1",0,0,NA,0,0,0,2.77777777777778,0,0,NA,0.347222222222222,0,0.925925925925926,NA,NA,NA,NA,NA,NA,10.1072017045513,3.68233641306884,7.93741002328246,7.35460134587828,8.73845249809789,3.68233641306884,3.68233641306884,8.64393716395537,8.03919311016556,3.68233641306884,6.55501414982062,8.69323890001052,4.41678939963073,245.116187540382,-1.20454420236632,2.4697999306103,1.86796635393928e-07,3.71052965768015e-06,"Q9Z160",0,"Conserved oligomeric Golgi complex subunit 1 (COG complex subunit 1) (Component of oligomeric Golgi complex 1) (Low density lipoprotein receptor defect B-complementing protein)","glycosylation [GO:0070085]; Golgi organization [GO:0007030]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]","GO:0000139; GO:0000301; GO:0005794; GO:0007030; GO:0015031; GO:0017119; GO:0070085"
"925","Pocillopora_acuta_HIv2___TS.g30120.t1",0,0,NA,0,3.75,0,0,NA,0,NA,0.535714285714286,0,1.25,NA,NA,NA,NA,NA,NA,7.30369490384351,8.60944092617983,8.8419698660937,3.68233641306884,8.08719054818742,3.68233641306884,3.68233641306884,8.98636374320206,4.57231842518309,3.68233641306884,6.1130324064965,7.55830749730196,4.66775731569104,166.599138727316,-0.590825910312262,1.2551799836585,2.27687621191263e-05,0.000230898112656506,"Q7SY06",2.82e-70,"Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase) (HACD) (Protein-tyrosine phosphatase-like A domain-containing protein 1)","fatty acid elongation [GO:0030497]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761]","GO:0005783; GO:0005789; GO:0018812; GO:0030148; GO:0030497; GO:0042761; GO:0102158"
"926","Pocillopora_acuta_HIv2___RNAseq.g8342.t1",NA,NA,100,100,57.8947368421053,100,100,NA,50,NA,84.6491228070175,83.3333333333333,85.9649122807018,NA,NA,NA,NA,NA,NA,8.69918513939989,5.35078960182194,6.50448097751675,8.11305770165279,7.76362851520386,9.51032003628689,3.68233641306884,9.88193709365152,3.68233641306884,3.68233641306884,6.68704083047402,7.30631362776817,6.06776803317986,254.250716797257,-0.137754334213768,0.985319986831214,0.654469617845685,0.836093318540892,"Q9D2K4",0,"IQ domain-containing protein H","",""
"927","Pocillopora_acuta_HIv2___TS.g30160.t2",NA,NA,0,0,0,0,37.5,0,NA,NA,6.25,0,12.5,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,3.68233641306884,8.61512988089867,4.75140430725689,11.0172357338788,3.68233641306884,7.94160713666065,3.68233641306884,10.6829575074375,6.14200166314767,4.74800413662481,7.53599918967053,426.047654519673,0.19113009550352,1.0410578970289,0.000165576159285087,0.00126713945391508,NA,NA,NA,NA,NA
"928","Pocillopora_acuta_HIv2___RNAseq.11323_t",0,NA,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,8.59219896615401,11.5672650775763,6.77213038688595,11.0305142302604,7.37863675084551,8.74568266445487,3.68233641306884,12.2165045104956,7.73499418258792,6.2949369687265,9.17505139644933,1080.01712041107,0.434643859559087,1.09586600496942,0.0326396267064468,0.111044720663227,NA,NA,NA,NA,NA
"929","Pocillopora_acuta_HIv2___TS.g30173.t1",0,NA,0,2.56410256410256,0,28.5714285714286,0,0,0,NA,3.89194139194139,7.78388278388278,0,NA,NA,NA,NA,NA,NA,8.39257334917541,8.38852445472299,10.3187136592403,10.1180228085228,8.5214140541948,5.93816758953943,3.68233641306884,7.83769590517856,3.68233641306884,8.78996544050039,7.56697500872124,7.75054667617158,7.38340334127089,395.986439389058,-0.130818409704254,0.958991129189043,0.569460532415816,0.78006223514181,"Q5VT52",1.73e-56,"Regulation of nuclear pre-mRNA domain-containing protein 2","mRNA 3'-end processing [GO:0031124]","GO:0000993; GO:0005654; GO:0031124; GO:0097550; GO:0099122"
"930","Pocillopora_acuta_HIv2___RNAseq.g8376.t1",0,0,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.98231336343907,9.81192921118201,9.48445938050496,9.82547105153167,9.67151671481472,9.52745519154259,8.85670563922031,8.89153306233129,3.68233641306884,9.19797990095922,8.69316999285947,7.94243178683178,9.44390819888716,562.623431913321,0.407185845733351,0.923430251123288,0.334631143998675,0.58547294868717,"A1L314",3.66e-166,"Macrophage-expressed gene 1 protein (Macrophage gene 1 protein) (Mpg-1) (Perforin-2) (P-2) (PFN2) (mPFN2) (Protein MPS1) [Cleaved into: Macrophage-expressed gene 1 protein, processed form]","adaptive immune response [GO:0002250]; antibacterial innate immune response [GO:0140367]; antigen processing and presentation of exogenous peptide antigen [GO:0002478]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dendritic cell antigen processing and presentation [GO:0002468]","GO:0002250; GO:0002468; GO:0002478; GO:0022829; GO:0030670; GO:0031410; GO:0036019; GO:0042590; GO:0042742; GO:0045335; GO:0050829; GO:0050830; GO:0061474; GO:0140367; GO:0140911"
"931","Pocillopora_acuta_HIv2___RNAseq.g8389.t1",0,NA,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.8444899192752,10.8239748471342,9.77029421085801,10.3397188881214,9.92336307241252,10.9316774090766,9.50690853612286,10.0757835039426,8.07207879611671,10.1870991334773,10.0475388316537,9.73720190052101,10.3578757627865,1173.17598810112,0.42395001303264,0.631286767122604,0.378355024684817,0.62742111255418,"Q25197",0,"Putative insulin-like peptide receptor (EC 2.7.10.1)","cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0004714; GO:0005524; GO:0007169; GO:0016020; GO:0043235; GO:0043548; GO:0043560; GO:0046872"
"932","Pocillopora_acuta_HIv2___RNAseq.g8391.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.29197312541099,8.79054047643763,9.27693827115082,9.59829614094612,8.95535961344266,8.08059955791897,6.49753832785703,8.2783219996615,9.34803656828488,3.68233641306884,8.17999404941794,9.03012591559017,7.32986218324572,405.834285244046,-0.527971653984802,0.962904345347967,0.221691579889288,0.452774217949543,"B7E321",4.16e-11,"Double-stranded RNA-binding protein 5 (dsRNA-binding protein 2) (OsDRB2) (dsRNA-binding protein 5)","","GO:0003725"
"933","Pocillopora_acuta_HIv2___RNAseq.g8407.t1",0,0,0,NA,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.3393384360934,9.11837381134201,9.56459543055032,8.43665445634566,10.0100984606153,9.67160374147396,9.75284253707505,10.5833997236546,10.7318792854864,9.27272846903697,9.74815143516737,10.24586226728,9.25044060305473,926.346935428197,-0.821816876780591,0.554493790158082,0.0770296722130934,0.216719933649131,"Q3T8J9",1.27e-41,"GON-4-like protein (GON-4 homolog)","regulation of DNA-templated transcription [GO:0006355]","GO:0003712; GO:0005634; GO:0005654; GO:0006355; GO:0016604"
"934","Pocillopora_acuta_HIv2___RNAseq.g8410.t1",0,0,0,71.4285714285714,NA,0,0,NA,NA,NA,11.9047619047619,23.8095238095238,0,NA,NA,NA,NA,NA,NA,7.88297397736584,8.26388760970949,10.019115593321,3.68233641306884,9.68550870833796,8.61140980842975,10.1979915742431,5.4533793909793,9.07869273752916,11.0219384551445,8.38972342681289,8.42393408150665,8.35551277211914,640.93813603427,0.0824876817825895,0.92851270598463,0.814456402372874,0.92278764562033,"P50904",0,"Ras GTPase-activating protein 1 (GAP) (GTPase-activating protein) (RasGAP) (Ras p21 protein activator) (p120GAP)","actin cytoskeleton organization [GO:0030036]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; male genitalia development [GO:0030539]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of glucose import [GO:0046326]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; regulation of actin filament polymerization [GO:0030833]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570]","GO:0000281; GO:0001570; GO:0001726; GO:0001784; GO:0001934; GO:0001953; GO:0005096; GO:0005102; GO:0005161; GO:0005737; GO:0005886; GO:0007155; GO:0007162; GO:0007165; GO:0009410; GO:0030036; GO:0030539; GO:0030833; GO:0030971; GO:0031965; GO:0032868; GO:0036120; GO:0043066; GO:0043422; GO:0043524; GO:0044325; GO:0044344; GO:0044877; GO:0046326; GO:0048146; GO:0048514; GO:0050731; GO:0051020; GO:0071364; GO:1990782"
"935","Pocillopora_acuta_HIv2___RNAseq.g6874.t1",0,0.490196078431373,0,0,0.413223140495868,0.237812128418549,0,0,0,NA,0.126803483038421,0.145601641369984,0.103305785123967,NA,NA,NA,NA,NA,NA,10.2469353884651,12.3462875397868,10.8496853491749,10.0851061215896,9.29624234581273,6.77526323374519,10.5711398787438,9.73926984828918,10.2921722461698,11.7706886469175,10.1972790598695,10.0848610355823,10.3096970841566,1696.20507649956,0.146462752860261,0.741820959659678,0.749450532232615,0.889440481792665,"Q9CYL5",7.42e-31,"Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2)","positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]","GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070374"
"936","Pocillopora_acuta_HIv2___TS.g16797.t3a",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.116414824804,10.6589080159293,10.2838493505339,12.0892202888581,10.8845656143213,11.6928055860638,3.68233641306884,10.1214166361866,8.21140278976863,3.68233641306884,9.14232559326033,9.92352984312289,8.36112134339778,1473.79159662611,-0.145765920218075,0.95838538482423,0.469041935445586,0.707721943906213,"Q9P2K1",0,"Coiled-coil and C2 domain-containing protein 2A","axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; heart development [GO:0007507]; kidney development [GO:0001822]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224]","GO:0001822; GO:0001843; GO:0005829; GO:0005856; GO:0007224; GO:0007368; GO:0007507; GO:0035082; GO:0035869; GO:0036038; GO:0043010; GO:0044458; GO:0060271; GO:1904491; GO:1905515; GO:1990403"
"937","Pocillopora_acuta_HIv2___TS.g16801.t1",0,1.42857142857143,0,0,0,0.18348623853211,0.284900284900285,1.22699386503067,0,0,0.31239518170345,0.567810306426843,0.056980056980057,NA,NA,NA,NA,NA,NA,9.06327152006495,7.80115133184057,8.30346531674014,6.96130739864265,8.68569050529328,3.68233641306884,9.25468814015051,7.39989440691108,9.03495861440668,8.66109410707429,7.8847857754193,8.49745607268323,7.27211547815537,309.358847673993,-0.337658335013309,0.926447621665429,0.355450935563306,0.606431382275847,"Q8IY17",0,"Patatin-like phospholipase domain-containing protein 6 (EC 3.1.1.5) (Neuropathy target esterase)","glycerophospholipid catabolic process [GO:0046475]; phosphatidylcholine metabolic process [GO:0046470]","GO:0004622; GO:0005783; GO:0005789; GO:0005829; GO:0016020; GO:0046470; GO:0046475"
"938","Pocillopora_acuta_HIv2___TS.g16802.t1",0,0,0,0,0.816326530612245,0.403551251008878,0,0,0,3.53535353535354,0.475523131697466,0.0807102502017756,0.870336013193156,NA,NA,NA,NA,NA,NA,13.0805064418451,7.90768687698613,12.4136168608284,3.68233641306884,12.6419887163761,3.68233641306884,4.27277361158612,11.938815988088,13.2755134276465,4.69373610443143,8.75893108539255,12.6700882869568,4.84777388382827,3444.71837581509,-10.7029757939764,1.99183805886875,2.39520092444236e-15,7.88997550901037e-13,NA,NA,NA,NA,NA
"939","Pocillopora_acuta_HIv2___RNAseq.g6896.t1",0,NA,0,0,16.6666666666667,0,0,0,0,NA,2.08333333333333,0,4.16666666666667,NA,NA,NA,NA,NA,NA,8.84219610301059,3.68233641306884,10.4043374520596,6.29014341372585,9.21999709027669,3.68233641306884,6.66472726798925,10.4623260217092,11.8265272749775,10.3098376764733,8.13847651263597,10.1510767884067,6.12587623686522,870.17172066181,-3.50754416962333,2.75612308479577,0.000104319093680754,0.000857954961797028,"Q5BK26",0,"Patatin-like phospholipase domain-containing protein 7 (EC 3.1.1.-) (EC 3.1.1.5) (Liver NTE-related protein 1) (NTE-related esterase)","phosphatidylcholine catabolic process [GO:0034638]","GO:0004622; GO:0005783; GO:0005789; GO:0005811; GO:0034638"
"940","Pocillopora_acuta_HIv2___RNAseq.g6913.t1",0,0,0,NA,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.9159935093723,9.09326077426548,10.0345445262805,10.646002094899,9.70231846201278,6.58890355943315,8.85330624588099,9.96684480650805,11.7343087085051,7.75155885986295,9.42870415470203,10.2708020025357,8.58660630686831,992.581873630031,-1.01081890841344,0.962474583193939,0.053391881008912,0.163234023866604,NA,NA,NA,NA,NA
"941","Pocillopora_acuta_HIv2___TS.g16828.t1a",28.8461538461538,48.0769230769231,46.1538461538462,0,33.3333333333333,12.5,25,53.3333333333333,0,NA,27.47150997151,22.7820512820513,33.3333333333333,NA,NA,NA,NA,NA,NA,9.71534681575676,7.8420353800155,10.6357248405362,11.6370495965824,10.8248763322764,10.8951891451109,3.68233641306884,10.2306527103193,11.0683994736437,10.570541251442,9.7102151958752,10.4950000345065,8.92543035724393,1420.45958314117,-0.316117944141123,0.916274883193768,0.40543767386192,0.651511000415378,"Q921M4",8.51e-67,"Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein) (GM130)","asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; centrosome cycle [GO:0007098]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi localization [GO:0051645]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; meiotic spindle assembly [GO:0090306]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; positive regulation of axonogenesis [GO:0050772]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225]","GO:0000137; GO:0000139; GO:0000922; GO:0005794; GO:0005801; GO:0005874; GO:0006486; GO:0006888; GO:0007020; GO:0007030; GO:0007098; GO:0007409; GO:0008017; GO:0008356; GO:0015031; GO:0019901; GO:0032580; GO:0032991; GO:0033116; GO:0043025; GO:0044877; GO:0048471; GO:0050772; GO:0051225; GO:0051289; GO:0051645; GO:0061676; GO:0072686; GO:0090161; GO:0090166; GO:0090306; GO:0090307"
"942","Pocillopora_acuta_HIv2___RNAseq.g6927.t2",2.33644859813084,0,0.738007380073801,0,0,1.68,0.147058823529412,0.510204081632653,0.292397660818713,4.375,1.00791165441854,0.496520348490273,1.51930296034681,NA,NA,NA,NA,NA,NA,11.5864610527407,11.2060117761069,11.3846972648525,11.65754680101,9.73728160620186,11.5638318004898,10.029117058254,9.41977709659751,10.8158011737625,11.5161182686348,10.8916643898651,10.588803638831,11.1945251408991,2142.81879330019,0.439763603531363,0.585191915051319,0.351774999550112,0.603337346566078,"Q9QW30",0,"Neurogenic locus notch homolog protein 2 (Notch 2) [Cleaved into: Notch 2 extracellular truncation; Notch 2 intracellular domain]","animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cell population proliferation [GO:0008283]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; embryonic limb morphogenesis [GO:0030326]; glial cell differentiation [GO:0010001]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; liver morphogenesis [GO:0072576]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; placenta development [GO:0001890]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246]; wound healing [GO:0042060]","GO:0000122; GO:0000987; GO:0001228; GO:0001701; GO:0001709; GO:0001889; GO:0001890; GO:0001947; GO:0002011; GO:0002052; GO:0002315; GO:0002437; GO:0003184; GO:0004888; GO:0005509; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0005929; GO:0006357; GO:0006915; GO:0006959; GO:0007219; GO:0007368; GO:0008283; GO:0008284; GO:0009887; GO:0009986; GO:0010001; GO:0010629; GO:0010838; GO:0019899; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0042060; GO:0042246; GO:0042742; GO:0043011; GO:0043065; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:0072576; GO:0098839; GO:0098978; GO:1902895; GO:1990705; GO:2001204"
"943","Pocillopora_acuta_HIv2___TS.g16836.t1",0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,11.2806982274828,9.68511491093645,12.3235515191813,10.9062348859255,10.8441578560175,11.2445306676754,11.143160417677,11.7719075995245,12.5685494237063,10.3773361565077,11.2145241664634,11.7577729251825,10.6712754077444,2752.78913006132,-0.791262142718645,0.668214064330978,0.111827850964555,0.28361880349839,"Q709C8",0,"Intermembrane lipid transfer protein VPS13C (Vacuolar protein sorting-associated protein 13C)","Golgi to endosome transport [GO:0006895]; lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868]","GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005770; GO:0005789; GO:0005811; GO:0005829; GO:0006623; GO:0006869; GO:0006895; GO:0007005; GO:0031902; GO:0032127; GO:0032868; GO:0045053; GO:0070062; GO:1905090"
"944","Pocillopora_acuta_HIv2___TS.g16837.t2",0,0,0,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,8.57355162319954,8.57821577086389,10.5745019192293,9.97960097788862,7.57223291016523,8.4783308492366,7.6265862610439,3.68233641306884,3.68233641306884,7.24300295508336,6.70981516718682,7.7761907429799,386.58511283418,0.249661301214499,0.979284161950044,0.404161664163772,0.650761918119202,"Q709C8",0,"Intermembrane lipid transfer protein VPS13C (Vacuolar protein sorting-associated protein 13C)","Golgi to endosome transport [GO:0006895]; lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868]","GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005770; GO:0005789; GO:0005811; GO:0005829; GO:0006623; GO:0006869; GO:0006895; GO:0007005; GO:0031902; GO:0032127; GO:0032868; GO:0045053; GO:0070062; GO:1905090"
"945","Pocillopora_acuta_HIv2___TS.g16838.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.3322702455229,11.8926762252327,11.8976181431309,9.80540073625351,11.8940603991036,12.2665408825136,10.7342291021008,11.7093285145334,11.46719921731,11.4883349000484,11.548765836575,11.8600953039202,11.2374363692298,3290.26066255161,-0.416768083429911,0.611871916958355,0.373662562523539,0.62323382212016,"G9G127",2.42e-44,"Ninein-like protein","eye photoreceptor cell development [GO:0042462]; photoreceptor cell outer segment organization [GO:0035845]","GO:0005509; GO:0005737; GO:0005813; GO:0005874; GO:0035845; GO:0036064; GO:0042462"
"946","Pocillopora_acuta_HIv2___RNAseq.g6937.t1",0,0,0,NA,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.32215683786057,10.2406618713503,8.41784953959255,9.35134727937557,9.8129805924651,7.68691227964876,9.05910328121731,7.74631987145943,8.1511423388877,4.56256470276067,8.4351038594618,8.69008983605307,8.18011788287052,476.075741193028,-0.153554454772282,0.830719552553033,0.675072862923961,0.849091786487324,NA,NA,NA,NA,NA
"947","Pocillopora_acuta_HIv2___RNAseq.g6941.t1",0,0,0,NA,9.30232558139535,0,0,0,0,0,1.03359173126615,0,1.86046511627907,NA,NA,NA,NA,NA,NA,12.0314355170867,11.7143932463031,12.2715525607969,13.6701554721301,13.1443472663627,9.55779446517573,9.13103747490332,12.7332329202637,13.2552702950917,5.3719891395326,11.2881208357647,12.6871677119203,9.88907395960897,5227.07623052176,-0.849663085724898,1.23038781792477,0.0278581055308152,0.097287105267421,NA,NA,NA,NA,NA
"948","Pocillopora_acuta_HIv2___RNAseq.g6946.t1",NA,0,37.5,83.3333333333333,0,66.6666666666667,61.5384615384615,NA,50,NA,42.7197802197802,50,33.0128205128205,NA,NA,NA,NA,NA,NA,9.16004061292812,10.9736071730413,9.61610332903238,10.3834472223055,9.71990599536876,11.4290383489338,3.68233641306884,8.69782565298042,10.1013795809663,3.68233641306884,8.74460207416943,9.4590510342552,8.03015311408366,961.395132467228,-0.0831932138588974,0.958768135156541,0.624113853085008,0.816717883924867,"Q8ILR9",1.64e-07,"Protein PF3D7_1417600","","GO:0003677; GO:0016020"
"949","Pocillopora_acuta_HIv2___RNAseq.g6951.t1",0,NA,NA,0,4.8780487804878,2.64550264550265,0,0,0,0,0.940443928248806,0.661375661375661,1.21951219512195,NA,NA,NA,NA,NA,NA,10.9095276551114,10.600723498744,10.8801766375245,11.2280943693032,9.97797784290129,9.46834519867581,12.3050054844614,11.9199130262172,8.79055491568583,11.4413744701726,10.7521693098797,10.495630015488,11.0087086042714,2138.01987623843,0.291974823230578,0.649058270844296,0.545090943735124,0.763306748977136,NA,NA,NA,NA,NA
"950","Pocillopora_acuta_HIv2___RNAseq.g6962.t1",NA,0,NA,7.14285714285714,25,81.25,87.5,0,NA,0,28.6989795918367,22.0982142857143,37.5,NA,NA,NA,NA,NA,NA,11.9749491578888,11.6503463181437,11.9160592831616,12.651308397895,11.8246504972421,13.0364962046386,13.0448894841168,11.5354345937384,10.9615521208267,11.0378107063507,11.9633496764002,11.6425291305715,12.284170222229,4482.61076032235,0.470664309920528,0.579750007653324,0.314933620356798,0.564265130608122,"Q0VCX2",0,"Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein)","chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of cell migration [GO:0030335]; post-translational protein targeting to membrane, translocation [GO:0031204]; protein refolding [GO:0042026]","GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005788; GO:0005829; GO:0009986; GO:0016020; GO:0016887; GO:0030335; GO:0030968; GO:0031072; GO:0031204; GO:0031333; GO:0034663; GO:0035437; GO:0036503; GO:0042026; GO:0042470; GO:0043231; GO:0044183; GO:0051085; GO:0140662; GO:1903895"
"951","Pocillopora_acuta_HIv2___TS.g16873.t1",0,NA,NA,0,0,0,0,12.5,NA,NA,2.08333333333333,4.16666666666667,0,NA,NA,NA,NA,NA,NA,9.74831956497812,8.86498795418406,7.79930343134751,3.68233641306884,8.20586934810711,8.72278785521071,3.68233641306884,9.03572616822344,9.62182427894246,8.28092248874476,7.76444139158759,8.88220855831973,6.64667422485544,368.847349297496,-0.504954870398283,1.07084118145566,0.0713765374432177,0.20463632063007,NA,NA,NA,NA,NA
"952","Pocillopora_acuta_HIv2___RNAseq.g6990.t1",0,NA,NA,8.33333333333333,0,3.03030303030303,0,NA,0,NA,1.89393939393939,3.78787878787879,0,NA,NA,NA,NA,NA,NA,6.4342051856516,6.97205094875064,5.49419692800081,5.05535826649939,5.05297917362319,5.03801277448085,5.52620649542623,5.43126625005349,5.83482419616881,3.68233641306884,5.45214366317238,5.64949434669958,5.25479297964519,30.371933093576,-0.254433202487488,0.841919906766061,0.555636011585967,0.770243365112079,"Q96NT0",1.17e-12,"Coiled-coil domain-containing protein 115","cellular response to increased oxygen levels [GO:0036295]; intracellular iron ion homeostasis [GO:0006879]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]","GO:0005764; GO:0005768; GO:0005783; GO:0005793; GO:0006879; GO:0007042; GO:0016020; GO:0016471; GO:0030137; GO:0036295; GO:0051082; GO:0070072; GO:1905146"
"953","Pocillopora_acuta_HIv2___TS.g16920.t1",21.6666666666667,75,0,25,21.875,12.7777777777778,26.6666666666667,3.84615384615385,31.5789473684211,0,21.8411212325686,29.6405757984705,14.0416666666667,NA,NA,NA,NA,NA,NA,8.21926968797241,8.29362364263554,7.18749148714733,3.68233641306884,5.46172465639773,8.20102990912141,3.68233641306884,6.39131141676195,3.68233641306884,3.68233641306884,5.84837964523117,6.18842673226965,5.50833255819269,103.427371954044,-0.143281287168929,1.00083406000227,0.500174495253182,0.729801664414609,"Q6DFB8",0,"Tetratricopeptide repeat protein 37 (TPR repeat protein 37) (Thespin homolog)","RNA catabolic process [GO:0006401]","GO:0000791; GO:0005634; GO:0005737; GO:0006401; GO:0055087"
"954","Pocillopora_acuta_HIv2___RNAseq.g7018.t1",1.37058513442277,0.0866551126516465,0.891861761426979,0.539707016191211,0.80338266384778,0.720268006700168,0.717547292889759,0.728597449908925,0.56044835868695,0,0.641905279672619,0.52713518882778,0.756675370517458,NA,NA,NA,NA,NA,NA,6.1872802948014,3.68233641306884,5.9646645801927,3.68233641306884,8.79489529560833,9.62619799283828,8.1019074575871,8.9880943483143,3.68233641306884,3.68233641306884,6.23923856216175,6.72345418639711,5.75502293792638,200.461762054247,-0.335781717847648,1.02595784256999,0.226094308056611,0.458786205349441,NA,NA,NA,NA,NA
"955","Pocillopora_acuta_HIv2___RNAseq.g7019.t1",11.7647058823529,11.1111111111111,0,0,5.71428571428571,7.92079207920792,26.9230769230769,100,0,NA,18.1593301900038,23.8063806380638,11.1005171299289,NA,NA,NA,NA,NA,NA,10.3491408206833,8.47322703846654,9.00548245314794,6.08052100501175,10.2589382482347,9.72307886629111,3.68233641306884,9.31752696165462,9.66010152373951,8.65522066322507,8.52055739935234,9.71823800149201,7.32287679721266,593.559069207192,-0.979279181961651,1.24063756744082,0.0486734629465746,0.152548855484129,NA,NA,NA,NA,NA
"956","Pocillopora_acuta_HIv2___RNAseq.g7037.t1",NA,0,0,0,0,3.125,0,NA,2.08333333333333,1.92307692307692,0.891426282051282,1.30208333333333,0.480769230769231,NA,NA,NA,NA,NA,NA,12.5752344273846,11.8979201563926,12.8971346148375,11.4990526494285,12.8694203091085,12.0683611940165,11.2791189686886,12.5791102530794,12.7146626103242,11.3371157331036,12.1717130916364,12.7271124429468,11.616313740326,4987.63632944993,-0.924640520121356,0.537474661726788,0.0451100617920062,0.143779624010484,NA,NA,NA,NA,NA
"957","Pocillopora_acuta_HIv2___RNAseq.g7041.t1a",0,0,0,0,0,0,2.08333333333333,0,0,NA,0.231481481481482,0,0.520833333333333,NA,NA,NA,NA,NA,NA,9.37109968628948,10.1352936453215,9.38523240637552,3.68233641306884,8.42452232618469,7.19476462422787,9.26751085422486,3.68233641306884,3.68233641306884,9.1694335319027,7.39948663137331,6.90910544899747,7.88986781374915,396.084151441958,0.101768641001531,0.991794717664943,0.521960449115155,0.745422189573617,"O00471",0,"Exocyst complex component 5 (Exocyst complex component Sec10) (hSec10)","epithelial cell apoptotic process [GO:1904019]; establishment of planar polarity [GO:0001736]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; non-motile cilium assembly [GO:1905515]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]","GO:0000145; GO:0000281; GO:0001736; GO:0005737; GO:0005829; GO:0006887; GO:0006892; GO:0006893; GO:0006904; GO:0015031; GO:0030496; GO:0031267; GO:0072659; GO:0090148; GO:0090522; GO:1904019; GO:1905515"
"958","Pocillopora_acuta_HIv2___TS.g16955.t1",0,NA,NA,NA,0,0,25,0,0,NA,4.16666666666667,0,8.33333333333333,NA,NA,NA,NA,NA,NA,7.74081087897825,9.2504419648408,9.54317811531685,9.0716237196073,10.6615889188819,10.2585737171619,10.3050691195705,9.75966777191805,9.13415057995656,3.68233641306884,8.94074411993009,9.36787925301032,8.51360898684987,741.711892904619,-0.130733396879641,0.862643353490312,0.718460394261,0.87263231628434,"P50430",2.05e-152,"Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S)","anterior head development [GO:0097065]; autophagy [GO:0006914]; colon epithelial cell migration [GO:0061580]; dermatan sulfate catabolic process [GO:0030209]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268]","GO:0003943; GO:0004065; GO:0005764; GO:0006914; GO:0007584; GO:0008484; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0030209; GO:0043627; GO:0043890; GO:0046872; GO:0051597; GO:0061580; GO:0097065"
"959","Pocillopora_acuta_HIv2___TS.g16961.t1",0,NA,0,0,NA,2.12765957446809,0,0,0,0,0.265957446808511,0.531914893617021,0,NA,NA,NA,NA,NA,NA,6.46401383180475,8.79054047643763,9.37395323909205,8.15411178501296,8.55012861972864,10.4085046743068,3.68233641306884,8.89338133565296,5.56716625041612,3.68233641306884,7.35664730385896,7.7697286553389,6.94356595237901,353.843515785823,-0.207267846658945,0.977916260932561,0.323478023028381,0.573096847682363,"Q6JAN0",0,"Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1)","cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]","GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007194; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0090037; GO:0097264"
"960","Pocillopora_acuta_HIv2___RNAseq.g7058.t1",0,NA,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.7792912387703,7.69352644314077,5.51983254007951,3.68233641306884,4.28462663579717,8.59523604015312,9.83781369047198,4.1247493465216,3.68233641306884,9.1276464974367,6.33273952585088,4.87816723484748,7.78731181685428,208.0178328076,0.439903277568209,1.1241192781947,0.000612456787463423,0.00388069711124117,"Q8TE59",0,"A disintegrin and metalloproteinase with thrombospondin motifs 19 (ADAM-TS 19) (ADAM-TS19) (ADAMTS-19) (EC 3.4.24.-)","aortic valve morphogenesis [GO:0003180]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; mitral valve morphogenesis [GO:0003183]; proteolysis [GO:0006508]; pulmonary valve morphogenesis [GO:0003184]; tricuspid valve morphogenesis [GO:0003186]; ventricular septum morphogenesis [GO:0060412]","GO:0003180; GO:0003183; GO:0003184; GO:0003186; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0030199; GO:0031012; GO:0046872; GO:0060412"
"961","Pocillopora_acuta_HIv2___TS.g16967.t1",NA,NA,0,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.2086811908784,7.60911950749454,9.60374269128844,6.66570112997648,9.26861898501721,10.7042647282841,6.0123691187043,8.14177326309749,8.38273717370072,8.34803780681849,8.49450455952602,9.12111066079645,7.86789845825558,530.056638778656,-0.804566677681014,0.93575110974991,0.096431813929076,0.254445294217536,"P22105",1.78e-11,"Tenascin-X (TN-X) (Hexabrachion-like protein)","actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; neuron projection development [GO:0031175]; positive regulation of cell fate determination [GO:1905935]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; triglyceride metabolic process [GO:0006641]","GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0008284; GO:0010718; GO:0030036; GO:0030155; GO:0030199; GO:0030334; GO:0031012; GO:0031175; GO:0032963; GO:0043231; GO:0045595; GO:0048251; GO:0062023; GO:0070062; GO:0090733; GO:0098609; GO:0098633; GO:1900748; GO:1904028; GO:1905935"
"962","Pocillopora_acuta_HIv2___RNAseq.g7074.t1",0,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.49100155379421,6.13320531664763,4.80540103069894,6.80645827979764,5.3333020303659,7.59199605080199,9.75648478416772,6.14570161823912,3.68233641306884,6.94153598059022,6.26874230581722,5.0915485292334,7.44593608240104,133.808489773768,2.81524127784733,1.41761971734184,0.000759943296134389,0.00464966998108621,NA,NA,NA,NA,NA
"963","Pocillopora_acuta_HIv2___RNAseq.g7076.t1",0,0,0,5.97014925373134,0,1.22950819672131,0.917431192660551,0,0,0,0.811708864311321,1.43993149009053,0.18348623853211,NA,NA,NA,NA,NA,NA,7.25413241344069,10.7194006119987,7.83273839746458,11.1679271019374,6.9963526566166,10.2190499955671,12.3439499495049,8.31190848209697,3.68233641306884,10.7885837038212,8.9316379725517,6.81549367253754,11.0477822725659,1274.53713067447,3.52724602254572,1.51679449388979,0.000296367042252799,0.00209207071700561,NA,NA,NA,NA,NA
"964","Pocillopora_acuta_HIv2___RNAseq.g7100.t1",0,NA,0,0,NA,0,14.2857142857143,NA,0,NA,2.38095238095238,0,4.76190476190476,NA,NA,NA,NA,NA,NA,9.09858249926947,5.88506810849203,8.67336052685824,3.68233641306884,7.53005307756441,5.65167313584929,3.68233641306884,9.95185480479357,10.0638058232344,3.68233641306884,6.79014072152679,9.06353134634402,4.51675009670957,313.96233441298,-5.11112889948071,4.42094096442309,2.74715481849791e-07,5.16708027239971e-06,"Q9DBN1",1.28e-72,"Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2)","establishment of localization in cell [GO:0051649]; retinol transport [GO:0034633]; vitamin A import into cell [GO:0071939]","GO:0005886; GO:0034632; GO:0034633; GO:0038023; GO:0051649; GO:0071939"
"965","Pocillopora_acuta_HIv2___TS.g17019.t1",100,100,53.8461538461538,66.6666666666667,31.25,36.3636363636364,61.1111111111111,100,100,100,74.9237567987568,80.6060606060606,69.241452991453,NA,NA,NA,NA,NA,NA,8.80561670821774,8.11079559888894,7.91974629023079,3.68233641306884,8.45053605559721,6.19123426543186,3.68233641306884,8.43384636390068,8.00553653590004,3.68233641306884,6.69643210573738,8.32305639076929,5.06980782070546,181.750723558608,-0.943361228417467,1.61913855281524,3.38281893673185e-05,0.000326882135095362,NA,NA,NA,NA,NA
"966","Pocillopora_acuta_HIv2___TS.g17020.t1",0,0,0,0,0,0.763358778625954,0,0,0,NA,0.0848176420695505,0.152671755725191,0,NA,NA,NA,NA,NA,NA,4.66441148952732,5.61277682111054,6.11705336350933,5.44417644206312,5.21442834742072,5.70406148794036,5.28097201389241,5.76220623405517,4.86223652345053,5.60202388220197,5.42643466051715,5.32406719159261,5.52880212944168,23.0514813907406,0.247580230322745,0.754890376040839,0.603233253178115,0.802756994568798,"P46023",5.69e-28,"G-protein coupled receptor GRL101","","GO:0004930; GO:0005886"
"967","Pocillopora_acuta_HIv2___RNAseq.g7113.t1",2.05949656750572,1.44927536231884,0.43859649122807,0,1.875,0.874125874125874,0.204498977505112,0.843881856540084,0,NA,0.860541681024856,0.63345661859696,1.14439800905973,NA,NA,NA,NA,NA,NA,5.71611892316596,3.68233641306884,6.0846563529576,7.54361055218435,5.61428486132265,3.68233641306884,3.68233641306884,5.28924211491062,3.68233641306884,3.68233641306884,4.86595948698854,5.27732773308513,4.45459124089194,28.0747639828578,-0.253291455255786,1.05056121698048,0.0431373383316855,0.138838108951825,"P46023",4.21e-68,"G-protein coupled receptor GRL101","","GO:0004930; GO:0005886"
"968","Pocillopora_acuta_HIv2___RNAseq.g14588.t1",28.5714285714286,0,NA,NA,14.2857142857143,11.1111111111111,0,0,0,NA,7.70975056689342,2.77777777777778,14.2857142857143,NA,NA,NA,NA,NA,NA,4.95179328310793,3.68233641306884,3.68233641306884,3.68233641306884,6.10179861046554,3.68233641306884,8.0131585029338,6.50432644188691,6.94448951749643,9.35107167391803,5.6595983682084,5.63694885320513,5.68224788321167,108.26973328231,-0.0647124622832146,0.983534634930776,0.678897208362266,0.850988525228431,"Q68CL5",2.58e-76,"Tubulin polyglutamylase complex subunit 2 (PGs2)","","GO:0005737; GO:0005874; GO:0034451"
"969","Pocillopora_acuta_HIv2___TS.g19887.t1",3.84615384615385,NA,0,0,0,0,0,NA,0,NA,0.549450549450549,0,0.961538461538462,NA,NA,NA,NA,NA,NA,6.65645919844107,9.13760804836959,3.68233641306884,9.65241631227825,3.68233641306884,10.2158830832681,9.24434720056294,3.68233641306884,3.68233641306884,11.0679369222053,7.07039964174006,4.27716097014329,9.86363831333684,525.99718908866,11.8141915649243,3.14995187800814,2.77126132917192e-10,1.34508469346116e-08,"Q92051",2.1e-38,"Carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase)","carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539]; one-carbon metabolic process [GO:0006730]; regulation of pH [GO:0006885]","GO:0004089; GO:0005737; GO:0006730; GO:0006885; GO:0008270; GO:0015670; GO:0042539"
"970","Pocillopora_acuta_HIv2___RNAseq.g14639.t1",0,100,NA,NA,NA,0,0,0,NA,0,16.6666666666667,33.3333333333333,0,NA,NA,NA,NA,NA,NA,7.96707824409319,3.68233641306884,6.82609342317979,9.06549758242751,9.19645386528744,3.68233641306884,3.68233641306884,9.91868073623623,3.68233641306884,3.68233641306884,6.13854859165684,7.5181285363731,4.75896864694057,232.852712499723,-0.239399065651045,1.05076610088039,0.000381447880188892,0.00260248214106233,"P48508",4.73e-65,"Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit)","apoptotic mitochondrial changes [GO:0008637]; blood vessel diameter maintenance [GO:0097746]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]","GO:0004357; GO:0006534; GO:0006536; GO:0006749; GO:0006750; GO:0006979; GO:0007584; GO:0008637; GO:0009410; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035729; GO:0035733; GO:0043524; GO:0044344; GO:0044752; GO:0044877; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1990830; GO:2001237"
"971","Pocillopora_acuta_HIv2___RNAseq.g14653.t1",NA,0,0,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,15.4833147129496,17.3637175016167,15.1446300832446,16.1453912642874,15.658509593276,15.961275420869,15.7267003089589,16.2222112574369,13.8183711456372,16.9666667552357,15.8490788043512,15.2654073585089,16.4327502501935,71163.7074554405,0.738198954394797,0.746392788073016,0.146802575755614,0.343306783464705,"P19615",3.63e-78,"Major yolk protein (MYP) (Vitellogenin)","iron ion transport [GO:0006826]; protein targeting to ER [GO:0045047]","GO:0005576; GO:0005785; GO:0006826; GO:0045047; GO:0045735; GO:0046872"
"972","Pocillopora_acuta_HIv2___RNAseq.g14659.t1",0,0,0,0,0,0,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.2507191294519,7.02067905064675,8.26904050216647,3.68233641306884,7.09638713862687,10.3786069602969,3.68233641306884,8.19075369338027,3.68233641306884,5.3719891395326,6.66251848533083,7.29784737533887,6.02718959532279,267.745502240106,-0.11113821788208,1.00735610374023,0.244858030871586,0.483622229073531,"Q5T1B0",1.51e-148,"Axonemal dynein light chain domain-containing protein 1","manchette assembly [GO:1905198]; spermatogenesis [GO:0007283]","GO:0005737; GO:0007283; GO:1905198"
"973","Pocillopora_acuta_HIv2___TS.g19929.t1",0,NA,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.79100259980268,6.88270198298439,5.92829418692211,7.5168056772214,5.16318610945075,8.51152342055849,10.2749152774125,5.76220623405517,3.68233641306884,3.68233641306884,6.41953083145452,5.46540510865991,7.37365655424912,197.609548947408,1.4059633523682,1.58937654695159,0.0229017318308435,0.0828126623003301,"Q9H0J9",2.11e-64,"Protein mono-ADP-ribosyltransferase PARP12 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Poly [ADP-ribose] polymerase 12) (PARP-12) (Zinc finger CCCH domain-containing protein 1)","protein auto-ADP-ribosylation [GO:0070213]","GO:0003723; GO:0003950; GO:0005634; GO:0016779; GO:0046872; GO:0070213; GO:0140803; GO:1990404"
"974","Pocillopora_acuta_HIv2___RNAseq.g14711.t1",0,0,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.8281408264362,11.800483145051,12.0727075483929,9.43686810066797,11.8528164465482,12.5888562528075,10.1531072901146,11.8536298059648,13.2151359580653,12.7396302761206,11.7541375650169,12.1644861170815,11.3437890129523,4299.51642348152,-0.499338035306042,0.695628362037245,0.297823415390323,0.545626077290137,NA,NA,NA,NA,NA
"975","Pocillopora_acuta_HIv2___RNAseq.g14714.t2",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.915830956231,10.0245706846539,11.4262266411067,6.79149831683273,11.5778258029588,9.80123477931317,3.68233641306884,11.1568928685664,12.0519280934875,10.5422057153613,9.89705502715803,11.6257408724701,8.16836918184599,1950.8880563561,-1.33512254711704,1.6172423299345,0.0149667522379794,0.058381635482776,"P50211",1.25e-136,"Insulin gene enhancer protein ISL-1 (Islet-1)","atrial septum morphogenesis [GO:0060413]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cell population proliferation [GO:0008283]; endocardial cushion morphogenesis [GO:0003203]; heart development [GO:0007507]; innervation [GO:0060384]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuron fate specification [GO:0048665]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type II interferon production [GO:0032729]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; sinoatrial node cell development [GO:0060931]; spinal cord motor neuron cell fate specification [GO:0021520]; transcription by RNA polymerase II [GO:0006366]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524]","GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001755; GO:0003139; GO:0003148; GO:0003203; GO:0003215; GO:0003266; GO:0005634; GO:0006366; GO:0007409; GO:0007507; GO:0008283; GO:0008284; GO:0010575; GO:0021520; GO:0021524; GO:0021559; GO:0021983; GO:0031016; GO:0031290; GO:0032024; GO:0032725; GO:0032729; GO:0032730; GO:0032731; GO:0032735; GO:0032755; GO:0032760; GO:0042531; GO:0043425; GO:0043524; GO:0045597; GO:0045665; GO:0045766; GO:0045892; GO:0045944; GO:0046872; GO:0048665; GO:0048880; GO:0048936; GO:0050728; GO:0055010; GO:0060037; GO:0060070; GO:0060379; GO:0060384; GO:0060413; GO:0060913; GO:0060931; GO:0061629; GO:0071657; GO:0086091; GO:0090090; GO:1990841"
"976","Pocillopora_acuta_HIv2___RNAseq.g14724.t1",0,0,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.7125457883795,9.17797968831809,11.6059788119831,3.68233641306884,11.1028093061317,4.42568256259181,3.68233641306884,12.4427696838306,10.7748657064941,7.12418674957952,8.57314911234461,11.5277938593638,5.61850436532542,1653.60689603483,-5.15080113578471,4.23876854574933,8.70451601166438e-08,1.91340607283759e-06,NA,NA,NA,NA,NA
"977","Pocillopora_acuta_HIv2___TS.g19988.t1",0,0,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.39030830812648,3.68233641306884,7.13459198279071,3.68233641306884,6.78724087838546,3.68233641306884,3.68233641306884,8.09750134092551,9.72344453692796,3.68233641306884,5.75447691125003,7.82661740943122,3.68233641306884,141.406931162774,-11.5771967021503,3.63121254349769,7.11864158189104e-09,2.16310991261496e-07,NA,NA,NA,NA,NA
"978","Pocillopora_acuta_HIv2___RNAseq.g14728.t1",0,0,NA,0,0,4,0,NA,NA,NA,0.666666666666667,1.33333333333333,0,NA,NA,NA,NA,NA,NA,9.37109968628948,3.68233641306884,10.511127660802,3.68233641306884,9.93009425494798,8.19674494829501,3.68233641306884,6.412559699967,10.6272170822356,3.68233641306884,6.97781889848124,9.37041967684841,4.58521812011407,490.644217686924,-9.91311613157699,3.64820688177323,4.94065503587648e-08,1.17535582958746e-06,NA,NA,NA,NA,NA
"979","Pocillopora_acuta_HIv2___TS.g19991.t2",NA,NA,0,0,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,11.646996232413,3.68233641306884,11.1743425413731,3.68233641306884,10.3786069602969,11.1583801893778,3.68233641306884,3.68233641306884,8.95200996673904,7.1722017955544,3.68233641306884,10.66206717804,950.24838269187,15.739017006898,3.72381145194001,1.16154272214417e-16,8.40027696654667e-14,NA,NA,NA,NA,NA
"980","Pocillopora_acuta_HIv2___TS.g19996.t1",8.33333333333333,NA,NA,NA,0,5.55555555555556,0,0,0,NA,2.31481481481481,1.85185185185185,2.77777777777778,NA,NA,NA,NA,NA,NA,10.0054958071947,12.1195627742658,3.68233641306884,10.1745903569617,7.40935653522263,11.921239180876,12.8722985089251,9.67950095548207,9.08674715072376,5.65342752976771,9.26045552124883,7.9726873723384,10.5482236701593,1936.81236750379,0.684659662977813,1.25213836842764,0.0298896618714729,0.103253897613801,NA,NA,NA,NA,NA
"981","Pocillopora_acuta_HIv2___RNAseq.g14749.t1",0,0,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,9.79224563301464,8.13666062791065,9.63180752401316,7.02995371519419,8.91981515587807,8.1725811194537,10.4048608561378,3.68233641306884,7.31349338708087,8.33676630913763,6.29022046502412,404.426210303575,-0.401922463081216,1.02981176732818,0.245127455461391,0.483723702868609,"B2RUR8",3.9e-77,"OTU domain-containing protein 7B (EC 3.4.19.12) (Cellular zinc finger anti-NF-kappa-B protein) (Zinc finger A20 domain-containing protein 1) (Zinc finger protein Cezanne)","adaptive immune response [GO:0002250]; in utero embryonic development [GO:0001701]; mucosal immune response [GO:0002385]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]","GO:0000122; GO:0001701; GO:0002250; GO:0002385; GO:0003677; GO:0004843; GO:0005634; GO:0005737; GO:0008234; GO:0008270; GO:0032717; GO:0035871; GO:0043124; GO:0070530; GO:0070536; GO:0071108; GO:0071947; GO:1900181; GO:1990380"
"982","Pocillopora_acuta_HIv2___RNAseq.g14752.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.759574281299,9.61039891316526,9.52581221552609,8.56821385139866,11.1775360212756,10.3050129827859,10.9736186511845,9.35555322338958,5.8614009438957,8.99912586528872,9.5136246949209,9.33597533707719,9.69127405276461,1019.69747047368,0.135230210629391,0.760706172139122,0.762207308229216,0.896233355518038,"Q9EPU0",0,"Regulator of nonsense transcripts 1 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (mUpf1)","3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone mRNA catabolic process [GO:0071044]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]","GO:0000184; GO:0000781; GO:0000785; GO:0000932; GO:0003682; GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006281; GO:0006449; GO:0008270; GO:0016887; GO:0032201; GO:0032204; GO:0032508; GO:0035145; GO:0036121; GO:0042162; GO:0044530; GO:0044770; GO:0048471; GO:0061158; GO:0071044; GO:0071222; GO:0071347; GO:1905746"
"983","Pocillopora_acuta_HIv2___RNAseq.g14783.t1",0,0,0,0,NA,4.65116279069767,0,NA,0,NA,0.664451827242525,1.16279069767442,0,NA,NA,NA,NA,NA,NA,11.8154699936227,12.222822001193,11.9216012843283,12.4843661347518,12.0834992102189,12.7419927171001,9.71590497179537,11.8159057772335,13.1815471286727,13.2708537393475,12.1253962958264,12.1636046788152,12.0871879128376,5254.87745596801,-0.0119260978155423,0.615119928020438,0.973814551410532,0.991634839421231,"P40201",0,"Chromodomain-helicase-DNA-binding protein 1 (CHD-1) (EC 3.6.4.12) (ATP-dependent helicase CHD1)","chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; nucleosome organization [GO:0034728]; positive regulation by host of viral transcription [GO:0043923]","GO:0000228; GO:0000785; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0006325; GO:0006338; GO:0016887; GO:0034728; GO:0035064; GO:0042393; GO:0043923; GO:0140658"
"984","Pocillopora_acuta_HIv2___RNAseq.g14788.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.67130106083343,9.14577335445078,3.68233641306884,3.68233641306884,8.35108764351216,6.0412356346892,3.68233641306884,8.18774084464288,3.68233641306884,11.7955740983568,6.69220582887606,6.51496047502523,6.86945118272689,506.319990306539,-0.0605349347011352,0.991768552450603,0.625354561359403,0.817424650911444,NA,NA,NA,NA,NA
"985","Pocillopora_acuta_HIv2___RNAseq.g14799.t1",NA,0,0,0,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.71837568779606,10.2954927053144,10.4449309852361,9.43211549519643,10.0600483466198,8.43723459037635,4.69145782511396,10.4845519467578,10.0692338052739,7.87825228538505,9.15116936730698,10.1554281543367,8.14691058027724,811.812326105481,-0.875358005455181,1.05179223223184,0.0794026763123307,0.221329795756707,"Q3KR37",2.9e-32,"Protein Aster-B (GRAM domain-containing protein 1B)","cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]; intracellular sterol transport [GO:0032366]","GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0032366; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268"
"986","Pocillopora_acuta_HIv2___RNAseq.g14805.t1",NA,0,0,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.4369428181726,10.4229714053591,10.3085964074684,9.37134696530092,10.2305931181874,10.9096340858006,11.0601423174024,10.4193857640818,10.449247738916,3.68233641306884,9.62911970337581,10.1689531693652,9.08928623738637,1179.45580096576,-0.103172190344632,0.870646981441971,0.764114022159352,0.897382989710658,NA,NA,NA,NA,NA
"987","Pocillopora_acuta_HIv2___RNAseq.g14858.t1",28.5714285714286,0,NA,100,66.6666666666667,68.75,88.8888888888889,NA,NA,NA,58.8128306878307,56.25,61.3756613756614,NA,NA,NA,NA,NA,NA,6.64356132503947,3.68233641306884,7.48134846227682,3.68233641306884,6.67787875313474,9.21270684105873,7.57383401319275,8.16340792044239,3.68233641306884,9.56025974049047,6.63600062948419,6.52970657479245,6.74229468417593,203.297085499293,-0.0410198112008793,0.989971197361304,0.655325787491782,0.836374498392406,NA,NA,NA,NA,NA
"988","Pocillopora_acuta_HIv2___RNAseq.g14859.t1",0,0,0,NA,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.3393384360934,4.26601370117446,8.05531935028899,3.68233641306884,9.12195526713125,8.41528513965604,8.94558215164935,9.03572616822344,7.83071070883202,3.68233641306884,7.33746037491866,8.87660998611382,5.79831076372351,353.093968182254,-0.75633889845947,1.30848491628772,3.13416163614212e-05,0.000305887408266934,"Q91348",1.98e-127,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]","fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]","GO:0003873; GO:0004331; GO:0005524; GO:0005829; GO:0006000; GO:0006003; GO:0043540"
"989","Pocillopora_acuta_HIv2___TS.g20127.t1b",0,0,0,0.78125,0.909090909090909,1.07398568019093,0.476190476190476,2.17391304347826,0,0,0.541443010895058,0.805829744733838,0.277056277056277,NA,NA,NA,NA,NA,NA,11.3991299627684,9.66632291868463,11.6510467316778,3.68233641306884,10.645320884506,3.68233641306884,5.52620649542623,10.8115115967451,11.814055035236,3.68233641306884,8.25606028642507,11.2642128421867,5.24790773066348,1359.92324999169,-7.33150203079188,4.62074853151005,2.07382251333833e-09,7.53662533490593e-08,"Q5PQM2",1.52e-10,"Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8)","microtubule-based movement [GO:0007018]","GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0019894"
"990","Pocillopora_acuta_HIv2___RNAseq.g14865.t1",0,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.21468966089253,3.68233641306884,7.55199508843038,3.68233641306884,5.7009801482996,3.68233641306884,9.18069338409004,7.661829922175,11.4682266518592,3.68233641306884,6.15077605080221,7.51954429433134,4.78200780727308,374.844452283932,-0.578379032130116,1.24257248893671,0.000125009769559884,0.00100118566274317,NA,NA,NA,NA,NA
"991","Pocillopora_acuta_HIv2___RNAseq.g14866.t1",30,71.4285714285714,33.3333333333333,100,NA,58.3333333333333,56.25,NA,NA,NA,58.2242063492063,76.5873015873016,39.8611111111111,NA,NA,NA,NA,NA,NA,10.5469293162604,9.43053046458547,10.1024903294605,10.2013654196764,9.87795742461386,9.254475710825,10.4082209030856,8.74976994917191,8.74036435685052,9.32911896855345,9.66412228430831,9.60350227527144,9.72474229334518,862.026192332135,0.0792407138432518,0.615393058080493,0.871947898722431,0.949769848164727,"Q91447",4.4e-63,"Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK1)","regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]","GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005739; GO:0005769; GO:0005770; GO:0005813; GO:0005816; GO:0005925; GO:0032872; GO:0090170; GO:0106310; GO:2000641"
"992","Pocillopora_acuta_HIv2___RNAseq.g14867.t1",0,1.03092783505155,0.862068965517241,0,0.617283950617284,0.598802395209581,0,0,0,NA,0.34545368293285,0.325946046052225,0.369838229033631,NA,NA,NA,NA,NA,NA,9.23388115827767,6.97205094875064,8.59775443158888,3.68233641306884,8.09621472284577,3.68233641306884,3.68233641306884,8.62180403992444,9.51448687321297,3.68233641306884,6.57655378268757,8.81282824516995,4.3402793202052,236.324861356435,-9.42908796526981,3.22435878895887,1.74279908654176e-07,3.48656237728077e-06,"Q5PQM2",1.36e-07,"Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8)","microtubule-based movement [GO:0007018]","GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0019894"
"993","Pocillopora_acuta_HIv2___RNAseq.g14868.t1b",1.9047619047619,0,9.52380952380952,4.6875,0,2.1978021978022,0,7.35294117647059,0,12,3.76668148028442,2.84764867485456,4.68571428571429,NA,NA,NA,NA,NA,NA,9.62623568600215,6.78730040748609,9.66979264516464,3.68233641306884,8.5258691405565,3.68233641306884,3.68233641306884,7.8942970441198,10.1341199325359,3.68233641306884,6.73669605081404,9.1700628896758,4.30332921195229,329.465398600593,-9.922223921731,3.01192208934665,1.11348572621954e-08,3.18289674783387e-07,"P46825",2.56e-08,"Kinesin light chain (KLC)","microtubule-based movement [GO:0007018]","GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0019894"
"994","Pocillopora_acuta_HIv2___RNAseq.g14886.t1",NA,0,6.66666666666667,0,0,0,0,0,0,NA,0.833333333333333,0,2.22222222222222,NA,NA,NA,NA,NA,NA,11.1211017668145,6.80133194180119,10.6043642848145,5.56232777220043,10.7626102449412,3.68233641306884,3.68233641306884,10.5064405980701,11.4057839702252,3.68233641306884,7.78109698180736,10.8800601729731,4.68213379064163,967.371642145282,-8.45773589656948,3.44235948409806,3.88326162515849e-10,1.79448869476973e-08,"Q9Y2U5",5.86e-73,"Mitogen-activated protein kinase kinase kinase 2 (EC 2.7.11.25) (MAPK/ERK kinase kinase 2) (MEK kinase 2) (MEKK 2)","cellular response to mechanical stimulus [GO:0071260]; intracellular signal transduction [GO:0035556]","GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0019901; GO:0035556; GO:0046872; GO:0071260; GO:0106310"
"995","Pocillopora_acuta_HIv2___RNAseq.g14897.t1",NA,NA,100,100,83.3333333333333,100,100,100,NA,NA,97.2222222222222,100,94.4444444444444,NA,NA,NA,NA,NA,NA,10.8733053779702,11.5967809470437,10.5765287976511,10.4901578350496,10.7822714799651,10.4549092234992,10.865643756664,10.7506608466593,9.6868333951625,12.0676293588202,10.8144721018485,10.5339199794816,11.0950242242153,1955.29889459297,0.349564727871394,0.626483827584947,0.462229786201742,0.702993549126977,"Q5T6F2",5.64e-22,"Ubiquitin-associated protein 2 (UBAP-2) (RNA polymerase II degradation factor UBAP2)","regulation of gene expression [GO:0010468]","GO:0000932; GO:0003723; GO:0005634; GO:0005694; GO:0005737; GO:0010468; GO:0045296"
"996","Pocillopora_acuta_HIv2___RNAseq.g14922.t1",0,100,0,0,0,100,100,NA,NA,NA,42.8571428571429,66.6666666666667,25,NA,NA,NA,NA,NA,NA,8.29437229214579,9.42606845816916,9.5097076147004,3.68233641306884,10.0646436586121,6.17337120454021,10.3730693650492,8.13553162203908,4.9224776128996,3.68233641306884,7.42639146542932,8.18534656007939,6.66743637077925,431.58128134445,-0.327281146197328,1.02427927900771,0.0530941704650914,0.162461197716751,"Q98TA5",1.54e-47,"Chromatin assembly factor 1 subunit A-A (CAF-1 subunit A) (Chromatin assembly factor I p150 subunit A) (CAF-I 150 kDa subunit A) (CAF-I p150-A) (xp150)","DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; nucleosome assembly [GO:0006334]","GO:0005634; GO:0006260; GO:0006281; GO:0006334; GO:0006335; GO:0033186"
"997","Pocillopora_acuta_HIv2___TS.g20189.t3",0,0,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.738846139113,6.60695183817265,8.24798289162422,3.68233641306884,6.68597998145865,3.68233641306884,10.098196104762,6.71452383453295,6.12311189824512,3.68233641306884,6.62626019271151,7.70208894899479,5.55043143642823,331.247158686293,-0.642991581073392,1.31403264716957,0.000267015985334992,0.00191478394243199,"Q9Z1N9",0,"Protein unc-13 homolog B (Munc13-2) (munc13)","cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; innervation [GO:0060384]; negative regulation of synaptic plasticity [GO:0031914]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; phagosome maturation [GO:0090382]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of exocytosis [GO:0045921]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic vesicle priming [GO:0010808]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of presynaptic dense core granule exocytosis [GO:0099161]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]","GO:0001566; GO:0005509; GO:0005516; GO:0005543; GO:0005794; GO:0005829; GO:0005886; GO:0007268; GO:0007528; GO:0010808; GO:0016079; GO:0016081; GO:0016082; GO:0017075; GO:0019905; GO:0019992; GO:0030672; GO:0031594; GO:0031914; GO:0032009; GO:0035249; GO:0042734; GO:0043195; GO:0044305; GO:0045921; GO:0048172; GO:0048786; GO:0050714; GO:0060384; GO:0061669; GO:0061789; GO:0071333; GO:0090382; GO:0097060; GO:0097151; GO:0097470; GO:0098686; GO:0098793; GO:0098831; GO:0098978; GO:0099011; GO:0099161; GO:0099525; GO:1900426"
"998","Pocillopora_acuta_HIv2___RNAseq.g14932.t2",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.82778893403375,3.68233641306884,9.06482052714005,3.68233641306884,9.6078661902075,3.68233641306884,3.68233641306884,10.6950934761179,7.091790659748,3.68233641306884,6.26990418525914,8.85747195744944,3.68233641306884,321.144066743527,-13.2779203617806,3.81869379185273,4.23984293854962e-11,2.88672720218757e-09,"P0C6Y7",5.95e-49,"Histone-lysine N-methyltransferase PRDM9 (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)","chromatin remodeling [GO:0006338]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiosis I [GO:0007127]; meiotic gene conversion [GO:0006311]; methylation [GO:0032259]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fertilization [GO:1905516]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]","GO:0000785; GO:0000976; GO:0005634; GO:0006311; GO:0006338; GO:0007127; GO:0007129; GO:0007283; GO:0007292; GO:0008270; GO:0010468; GO:0010844; GO:0010845; GO:0032259; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0045944; GO:0046975; GO:0048232; GO:0060903; GO:0140941; GO:0140944; GO:0140949; GO:0140955; GO:0140999; GO:1905516; GO:1990918"
"999","Pocillopora_acuta_HIv2___RNAseq.g9956.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.3882378356132,10.995599271188,11.1475394725346,11.353372801749,10.9978107089865,9.49123313358272,9.86674603458582,8.78205722401949,9.7113438093812,8.5388154229039,10.2272755714544,10.405397810107,10.0491533328019,1470.0804994206,-0.238751321657564,0.617056410329248,0.602677763482712,0.802608523249604,"A8C750",4.25e-75,"tRNA (32-2'-O)-methyltransferase regulator THADA (Thyroid adenoma-associated protein homolog)","tRNA methylation [GO:0030488]; tRNA nucleoside ribose methylation [GO:0002128]","GO:0002128; GO:0030488"
"1000","Pocillopora_acuta_HIv2___RNAseq.g10025.t1",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.24036347909427,3.68233641306884,5.79243403424225,3.68233641306884,5.82852651465621,7.4256627193897,4.96878174907288,5.36237875279434,5.69309697015473,3.68233641306884,5.23582534586109,5.78335995018836,4.68829074153382,32.5707844606897,-0.464219494374525,1.11278818748178,0.00846874761332285,0.0362509516067185,NA,NA,NA,NA,NA
"1001","Pocillopora_acuta_HIv2___RNAseq.g10032.t1",NA,0,0,NA,NA,40,0,0,NA,0,6.66666666666667,13.3333333333333,0,NA,NA,NA,NA,NA,NA,6.64356132503947,3.68233641306884,9.46028551627977,8.14831825205188,9.20202814468338,10.1129575852632,9.6051246313482,9.3965157888877,10.8571766014012,3.68233641306884,8.07906406710925,9.1119134752583,7.04621465896019,589.02367641168,-0.357187490561237,1.00367016823672,0.138680525869601,0.331221123873499,"A5D6U8",5.32e-109,"Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form)","","GO:0003993; GO:0005576; GO:0046872"
"1002","Pocillopora_acuta_HIv2___RNAseq.g10057.t1",0,0,0,NA,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.31455627883993,3.68233641306884,7.49336821421169,9.14026382408328,7.53005307756441,7.55219272909506,3.68233641306884,9.30508808399463,3.68233641306884,3.68233641306884,6.40648678600644,7.2650804135359,5.54789315847697,191.762755281842,-0.182967900545121,1.00415084970684,0.4430720501358,0.685831026054283,"Q8IXR9",2.3e-55,"Uncharacterized protein C12orf56","",""
"1003","Pocillopora_acuta_HIv2___RNAseq.g10095.t1",0,0,0,NA,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.26050262500135,3.68233641306884,11.468635926672,3.68233641306884,3.68233641306884,11.0979492177119,7.86060514912441,3.68233641306884,7.25505688810043,6.53544318719543,4.51799016027995,8.5528962141109,589.820674496794,0.586953786802516,1.2689936506305,9.73260120276493e-05,0.000812304349664119,NA,NA,NA,NA,NA
"1004","Pocillopora_acuta_HIv2___RNAseq.g10110.t1",0,0,0,0,0,1.89873417721519,3.57142857142857,0,0,NA,0.607795860960418,0.379746835443038,0.892857142857143,NA,NA,NA,NA,NA,NA,8.06094425102857,8.41581523654483,5.90972641462649,8.19402536505928,6.10179861046554,3.68233641306884,3.68233641306884,6.38056304735675,5.26843329136292,3.68233641306884,5.93783154556509,6.34429312296805,5.53136996816213,98.5401584187091,-0.354956939772594,1.05668966453836,0.0117952037231471,0.0476467444986824,NA,NA,NA,NA,NA
"1005","Pocillopora_acuta_HIv2___RNAseq.g10112.t1",0.900900900900901,0,0,0.680272108843537,0,0.866551126516464,0.623700623700624,0,0,0,0.307142475996153,0.309364647072,0.304920304920305,NA,NA,NA,NA,NA,NA,9.92388654585986,9.04168239678785,9.5097076147004,7.65428605382399,8.88084113857379,8.53884484296528,6.89653683871883,9.13278270983045,7.97107187406358,9.74013832856918,8.72897783438932,9.08365797660562,8.37429769217303,480.685174827583,-0.466682395080879,0.753714350414296,0.32181205895916,0.571776684522036,"A3AVH5",5.85e-45,"DEAD-box ATP-dependent RNA helicase 13 (EC 3.6.4.13)","","GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016887"
"1006","Pocillopora_acuta_HIv2___RNAseq.g10119.t1",10.2564102564103,23.8095238095238,NA,12.5,25,28.9473684210526,39.622641509434,25,100,100,40.5706604440467,38.0513784461153,43.7197629414611,NA,NA,NA,NA,NA,NA,4.51677976470286,6.0149040413723,5.26676479605173,5.76965417569396,6.29702506358452,3.68233641306884,3.68233641306884,5.06769837305767,3.68233641306884,3.68233641306884,4.76621718667384,4.96612088209312,4.56631349125456,16.2785646072153,-0.0908031379481482,0.998570266005606,0.669031594370866,0.845215563016876,NA,NA,NA,NA,NA
"1007","Pocillopora_acuta_HIv2___TS.g25875.t1",8.98876404494382,0,NA,0,4.54545454545455,0.829875518672199,1.70212765957447,25.531914893617,NA,NA,5.94259095175172,6.59044760307231,5.07878208332428,NA,NA,NA,NA,NA,NA,7.46472747091322,6.65426612666998,7.67835698968189,6.82126065609372,6.40992758448011,5.77882859435006,4.96878174907288,6.92672320941957,8.5821620479674,4.69373610443143,6.59787705330803,7.41237946049244,5.78337464612361,106.377233087809,-1.2806611253427,1.07448119841678,0.0286839662091196,0.0998279324467533,"Q54TD7",2.9e-37,"ATP-dependent RNA helicase ddx24 (EC 3.6.4.13) (DEAD box protein 24)","","GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016887"
"1008","Pocillopora_acuta_HIv2___RNAseq.g10125.t1",0,0,NA,NA,0,1.73913043478261,0,0,0,NA,0.248447204968944,0.434782608695652,0,NA,NA,NA,NA,NA,NA,5.60860163372973,7.93941910765684,6.9801832069997,7.12479826629565,7.90055154479321,7.15087115891671,5.93399417379984,7.01851619965034,6.89589329451837,9.09765751970712,7.16504861060675,6.88074917593827,7.44934804527523,155.616000634276,0.289459111488098,0.779244444868444,0.512147693703138,0.738540375831426,NA,NA,NA,NA,NA
"1009","Pocillopora_acuta_HIv2___RNAseq.12179_t",0,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.05134768622769,6.30327276432217,7.34862272236652,6.61544894152208,7.8046269361412,7.40343939604643,4.40301213871548,7.72566014842227,7.54029722811113,3.68233641306884,6.68780643749438,7.69411094425376,5.681501930735,120.261730878358,-1.13078951352649,1.39208499555264,0.0184305718045044,0.0694982156878572,NA,NA,NA,NA,NA
"1010","Pocillopora_acuta_HIv2___RNAseq.g26552.t1",NA,0,0,NA,NA,2.38095238095238,0,0,0,0,0.340136054421769,0.595238095238095,0,NA,NA,NA,NA,NA,NA,11.7110263466517,4.954754005646,7.58605044178411,3.68233641306884,10.5030475990408,3.68233641306884,4.40301213871548,16.3728461088533,7.30149687833185,5.16462945902469,7.53615358041856,10.6948934749324,4.37741368590477,8991.89050197275,-9.29147018709163,2.72468032469546,1.86341146782557e-10,9.76535632993807e-09,"Q9U6Y6",3.32e-59,"GFP-like fluorescent chromoprotein amFP486","bioluminescence [GO:0008218]; generation of precursor metabolites and energy [GO:0006091]","GO:0006091; GO:0008218"
"1011","Pocillopora_acuta_HIv2___RNAseq.g26586.t1",0,0,0,0.909090909090909,3.75,0,0,NA,0,NA,0.582386363636364,0.227272727272727,0.9375,NA,NA,NA,NA,NA,NA,9.55007650304825,3.68233641306884,9.50823460080548,3.68233641306884,10.2196467413965,3.68233641306884,3.68233641306884,10.0643509813812,7.63156149414641,3.68233641306884,6.5385552386122,9.39477406415557,3.68233641306884,381.247139568541,-13.7468056008106,3.76496147885094,2.01677859548392e-12,2.3151337781809e-10,"Q7TM99",4.51e-38,"Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9)","carnitine transmembrane transport [GO:1902603]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]; urate metabolic process [GO:0046415]","GO:0005308; GO:0005886; GO:0008028; GO:0015226; GO:0015718; GO:0015881; GO:0046415; GO:1902603"
"1012","Pocillopora_acuta_HIv2___RNAseq.g26589.t1",NA,NA,26.6666666666667,0,0,0,0,0,NA,NA,4.44444444444444,0,8.88888888888889,NA,NA,NA,NA,NA,NA,10.6118804767262,13.5921679549534,10.0416885962955,12.3651187277232,11.2643125213469,13.320063856936,13.968303347256,11.9296204816832,10.1597874201218,13.5444175855133,12.0797360968555,10.8014578992347,13.3580142944764,6569.48131392173,2.33793737589324,0.635532028240099,2.27801166178674e-05,0.000230898112656506,"Q5VXJ0",5.57e-109,"Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2)","cornification [GO:0070268]; lipid catabolic process [GO:0016042]","GO:0004465; GO:0005576; GO:0016042; GO:0043231; GO:0070268"
"1013","Pocillopora_acuta_HIv2___RNAseq.g26597.t2",NA,0,NA,0,0,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,11.4668672670152,7.23128399729271,11.3148165662244,8.07079571851333,10.9196513288888,9.14102665616845,3.68233641306884,10.5885392576883,10.9095519414227,12.8439040945104,9.61687732407931,11.0398852722479,8.19386937591075,1888.53445774707,-0.817763453584965,1.31794461816317,0.0238562266939425,0.085749618017193,NA,NA,NA,NA,NA
"1014","Pocillopora_acuta_HIv2___RNAseq.g26604.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,11.5406340369197,4.70263489215087,13.3605166020007,3.68233641306884,12.9292522401817,13.0265336584598,3.68233641306884,6.43114589272003,13.0220238212523,8.60597503828916,4.43615800481548,12.7757920717628,3789.9648726559,12.3051226483064,2.53307531075201,2.56133742617023e-16,1.6107471535707e-13,"Q9GLK0",3.7e-171,"Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1)","keratinization [GO:0031424]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]","GO:0003810; GO:0010838; GO:0016020; GO:0031424; GO:0045787; GO:0046872"
"1015","Pocillopora_acuta_HIv2___RNAseq.g26608.t1",NA,0,0,0,0,0,5.55555555555556,NA,NA,NA,0.925925925925926,0,1.85185185185185,NA,NA,NA,NA,NA,NA,11.2136064408415,7.71570812917624,10.5884245732404,9.3412424159987,10.9760243542821,9.34618527701393,8.45608009706679,12.2035977231723,11.6992970739741,8.09365327011805,9.96338193548841,11.3361900331021,8.59057383787474,1585.09370711908,-2.44978651781069,0.8598964792555,0.000169323080395762,0.00129103270155208,"P22735",5.1e-173,"Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1)","cell envelope organization [GO:0043163]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]; protein modification process [GO:0036211]","GO:0001533; GO:0003810; GO:0005829; GO:0005886; GO:0010838; GO:0016020; GO:0018149; GO:0030216; GO:0031424; GO:0036211; GO:0042802; GO:0043163; GO:0045787; GO:0046872; GO:0070062"
"1016","Pocillopora_acuta_HIv2___RNAseq.g26609.t2",NA,NA,0,0,50,28.5714285714286,100,71.4285714285714,NA,NA,41.6666666666667,33.3333333333333,50,NA,NA,NA,NA,NA,NA,13.1721162726264,13.0248323573971,13.1915307465948,13.7452116044342,13.6839548577576,13.0860416896532,12.8473308463295,12.7537113202352,14.0764546279175,12.8795704672573,13.2460754790203,13.3755535650263,13.1165973930143,10133.7866037904,-0.182210849218148,0.54152349330362,0.67827126054391,0.850843224386686,"Q54G05",1.42e-08,"Putative leucine-rich repeat-containing protein DDB_G0290503","",""
"1017","Pocillopora_acuta_HIv2___RNAseq.g26611.t1",0,0,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.43743004364942,3.68233641306884,7.98913290325087,8.07079571851333,3.68233641306884,7.51124908779255,3.68233641306884,8.19075369338027,10.6040333350374,3.68233641306884,6.55327404338992,7.78073727767736,5.32581080910248,274.994638128596,-0.19094795945363,1.02725190018508,0.000136966620530051,0.00108285726303183,"F6YVB9",8.02e-66,"Transcription factor E2F7 (E2F-7)","chorionic trophoblast cell differentiation [GO:0060718]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; hepatocyte differentiation [GO:0070365]; negative regulation of cytokinesis [GO:0032466]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA endoreduplication [GO:0032877]; sprouting angiogenesis [GO:0002040]","GO:0000122; GO:0000978; GO:0001217; GO:0002040; GO:0003700; GO:0005634; GO:0005667; GO:0006977; GO:0032466; GO:0032877; GO:0060718; GO:0070365; GO:2000134"
"1018","Pocillopora_acuta_HIv2___TS.g1815.t1",1.11111111111111,0,0,0,0,0.934579439252336,0,8.92857142857143,NA,NA,1.37178274736686,2.46578771695594,0.277777777777778,NA,NA,NA,NA,NA,NA,6.46401383180475,6.86946281647337,7.60277868691723,8.24918797675221,6.73362645085059,5.77882859435006,8.07292963864076,6.33670898571414,7.2828057670621,3.68233641306884,6.7072679161634,6.88398674446976,6.53054908785705,115.28430453909,-0.0843702807811292,0.863430775767658,0.800106836205248,0.915824840917101,NA,NA,NA,NA,NA
"1019","Pocillopora_acuta_HIv2___RNAseq.g26619.t1",0,5.0314465408805,0.476190476190476,0,0,0,0,0,0,0,0.550763701707098,1.0062893081761,0.0952380952380952,NA,NA,NA,NA,NA,NA,7.16748500850389,6.63867229711208,7.97209823383322,6.87896002582645,6.46781886708255,6.64107926124897,7.95715044700245,6.29140637299107,8.3607426458759,10.3339149347773,7.47093280942539,7.25191022565733,7.68995539319345,250.176270508914,0.265957731741506,0.703801464945251,0.575316004288629,0.784960917463516,NA,NA,NA,NA,NA
"1020","Pocillopora_acuta_HIv2___RNAseq.g26623.t1",0,NA,0,0,0,2.53164556962025,0,0,NA,NA,0.361663652802893,0.843881856540084,0,NA,NA,NA,NA,NA,NA,6.60413655354371,5.26408513103678,6.72688650906576,6.58091230054222,4.99332554465423,6.43441652940609,5.32551295827119,6.2798424236602,4.4808124149756,9.27655724722162,6.19664876123774,5.8170006891799,6.57629683329558,98.9481612848448,0.145940518747817,0.878489320177036,0.681617064579406,0.85240439409273,NA,NA,NA,NA,NA
"1021","Pocillopora_acuta_HIv2___TS.g1823.t1",30.7692307692308,0,NA,0,10.7142857142857,1.49253731343284,22.5,0,0,NA,8.18450672461866,0.298507462686567,21.3278388278388,NA,NA,NA,NA,NA,NA,8.8338367793067,8.45580461001357,9.06682371837974,9.40083569211753,8.7893495224103,9.30504022818365,9.8701119921893,8.48134369958496,10.2991183123735,8.91808740451969,9.14203519590789,9.09409440641104,9.18997598540475,587.791379570823,0.075655888807322,0.611218931504643,0.877694426962905,0.952970326228554,"Q75UR0",1.32e-58,"Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein homolog) (Transmembrane protein 16E)","chloride transmembrane transport [GO:1902476]; plasma membrane repair [GO:0001778]","GO:0001778; GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0031982; GO:0046983; GO:1902476"
"1022","Pocillopora_acuta_HIv2___RNAseq.g26634.t1",0.402414486921529,0.496277915632754,0.836820083682008,2.20440881763527,0.671140939597315,0.550614146548073,0.4720692368214,0.176056338028169,0,NA,0.645533551651836,0.685471443568853,0.595611186755563,NA,NA,NA,NA,NA,NA,7.80510606841379,6.62290225491721,8.21941748892048,7.77970785255746,7.85870855067775,9.75543314052869,9.23131581756164,8.68720809600232,8.83587213672297,8.11094191681231,8.29066133231146,8.28126246814746,8.30006019647546,343.258653497247,-0.0253775544825736,0.65422376720526,0.945989914071738,0.979675840287514,"Q75V66",1.32e-119,"Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E)","chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220]; plasma membrane repair [GO:0001778]","GO:0001778; GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0031982; GO:0034220; GO:0046983; GO:1902476"
"1023","Pocillopora_acuta_HIv2___TS.g1832.t1",0.866089273817455,0.388726919339164,0.254452926208651,0.19893899204244,0.466804979253112,0.666920731707317,0.448796409628723,0.125628140703518,0.843170320404722,8.33333333333333,1.25928620264384,0.444677020839432,2.07389538444826,NA,NA,NA,NA,NA,NA,7.4130444802169,5.39185996804635,5.9646645801927,7.97581545078448,4.28462663579717,3.68233641306884,3.68233641306884,6.9839132704192,4.57231842518309,9.86488300095535,5.98157986377329,5.84371347836181,6.11944624918477,144.856721520897,-0.150235106058464,0.993742342281553,0.317256834553052,0.566588820221675,NA,NA,NA,NA,NA
"1024","Pocillopora_acuta_HIv2___TS.g1833.t1",1.14329268292683,3.28638497652582,0.551343900758098,3.86343216531896,2.10930009587728,1.82717929196802,1.96404793608522,2.81195079086116,1.45586897179254,27.5862068965517,4.65990077086656,2.6489632392933,6.67083830243983,NA,NA,NA,NA,NA,NA,9.17334923104468,8.70098919034049,9.4341487594456,9.87358182133739,8.51470545911468,9.26268617920698,8.63705281123079,8.02842462874741,10.4398505740941,8.63148430779582,9.06962729623579,9.11809573048929,9.02115886198229,579.483770783681,-0.035246704957189,0.615270958464548,0.933764336574791,0.975723693412641,"Q9BYT9",1.91e-13,"Anoctamin-3 (Transmembrane protein 16C)","calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; chloride transmembrane transport [GO:1902476]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048]; establishment of localization in cell [GO:0051649]; monoatomic ion transmembrane transport [GO:0034220]","GO:0005254; GO:0005886; GO:0016048; GO:0017128; GO:0034220; GO:0046983; GO:0050982; GO:0051649; GO:0061590; GO:0061591; GO:1902476"
"1025","Pocillopora_acuta_HIv2___RNAseq.g26645.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.27801859226,8.27386811086179,8.64144282653843,8.27067364660478,8.426906743025,9.53085792045677,9.62518563914564,8.18774084464288,9.94482816676589,9.03121362741376,8.82107361177149,8.69578743464644,8.94635978889655,474.92492797412,0.17525503954576,0.612084248564506,0.715590953340205,0.871555644525882,"Q75UR0",3.7e-59,"Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein homolog) (Transmembrane protein 16E)","chloride transmembrane transport [GO:1902476]; plasma membrane repair [GO:0001778]","GO:0001778; GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0031982; GO:0046983; GO:1902476"
"1026","Pocillopora_acuta_HIv2___RNAseq.g26649.t1",0.921658986175115,1.02827763496144,0.550795593635251,0.765794511805999,0.0942063118228921,0.916546068499759,0.736126840317101,0,2.10409745293466,0.226757369614512,0.734426076976673,0.962943133640372,0.505909020312974,NA,NA,NA,NA,NA,NA,10.060232093121,10.7402122282195,9.29071417090254,10.6274177841879,8.88950587151703,10.6784235513167,10.7081393985828,10.0478599841669,9.6346965901594,8.08493028034454,9.87621319525183,9.58460174197337,10.1678246485303,1064.26740206137,0.409947760565542,0.676207924020583,0.401964753251067,0.648234830084004,"Q75V66",0,"Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E)","chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220]; plasma membrane repair [GO:0001778]","GO:0001778; GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0031982; GO:0034220; GO:0046983; GO:1902476"
"1027","Pocillopora_acuta_HIv2___RNAseq.g26673.t1",50,37.5,0,33.3333333333333,NA,28.5714285714286,100,NA,NA,NA,41.5674603174603,33.1349206349206,50,NA,NA,NA,NA,NA,NA,8.34627273025484,8.04817444370993,9.73168757660773,8.59399377233369,9.06497040377488,10.1794968566583,3.68233641306884,9.59574864416972,10.0692338052739,3.68233641306884,8.09942510589207,9.36158263201621,6.83726757976792,516.728190064558,-0.352520106855049,1.01316810087661,0.141628144621814,0.33587628854073,NA,NA,NA,NA,NA
"1028","Pocillopora_acuta_HIv2___RNAseq.g26701.t1",0,0,0,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,10.6941688973881,5.39185996804635,10.0160099007508,7.66245516740606,10.7054025323253,9.44689043769908,9.08830923418343,10.6537384030532,11.7466400031764,5.84054469821112,9.12460192422398,10.7631919473388,7.48601190110921,1070.5255059844,-2.36452991581157,1.4562340827908,0.000915716468771726,0.00544610320901079,"Q8CQD9",2.31e-10,"Accumulation-associated protein","","GO:0005576"
"1029","Pocillopora_acuta_HIv2___RNAseq.g26703.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.43005038277679,6.06348383902188,5.13387918792038,7.03911674882672,6.67787875313474,8.50114266775195,7.70072459344644,8.04517538076324,7.54029722811113,3.68233641306884,6.88140851948221,7.16545618654126,6.59736085242317,148.36286883333,-0.11186798852849,0.917332635182051,0.676877421310233,0.850108312242743,NA,NA,NA,NA,NA
"1030","Pocillopora_acuta_HIv2___TS.g1918.t1",0,0,NA,NA,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,7.94132135187028,10.7084220010456,8.76754236452289,10.5184504965765,9.23366851108143,10.9859753927791,12.3244558006968,9.79171594359522,10.7267367992903,11.3270015126798,10.2325290174138,9.29219699407202,11.1728610407556,1647.6018770717,1.61667016718238,0.708313873301286,0.00382137239812035,0.0185602183903334,"P53199",5.91e-08,"Sterol-4-alpha-carboxylate 3-dehydrogenase ERG26, decarboxylating (EC 1.1.1.170) (C-3 sterol dehydrogenase ERG26) (C-4 decarboxylase ERG26) (Ergosterol biosynthetic protein 26)","ergosterol biosynthetic process [GO:0006696]","GO:0000252; GO:0005783; GO:0005789; GO:0006696; GO:0047012; GO:0103066; GO:0103067"
"1031","Pocillopora_acuta_HIv2___RNAseq.g26735.t1",0,NA,NA,0,13.5135135135135,0,6.38297872340426,0,0,0,2.48706152961472,0,4.97412305922944,NA,NA,NA,NA,NA,NA,8.63004608615769,10.6027012727726,5.20227553025741,11.0182561673887,9.69542051393351,10.6245136896032,11.3477159604749,7.51049444605365,4.4808124149756,7.58802519842497,8.67002612800422,7.10380979827557,10.2362424577329,923.096739732059,2.97024315759188,1.40956323770441,0.000181650647835667,0.00137272464487727,NA,NA,NA,NA,NA
"1032","Pocillopora_acuta_HIv2___RNAseq.g26740.t1",0,0,0,0,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.01726512697266,8.37003864502086,9.84919986202388,6.15405973004498,7.37006729746139,9.44869057947134,9.40150960197363,7.98045527622875,7.03693597958341,7.34586633953267,8.19740884383136,8.25078470845402,8.1440329792087,368.059848425312,0.0528258528923898,0.784716419549295,0.916108387581401,0.969168333631514,"Q7TNK0",1.15e-117,"Serine incorporator 1 (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2)","membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665]","GO:0005789; GO:0005886; GO:0006658; GO:0006665; GO:0008654; GO:0016020; GO:0019899; GO:0030674; GO:0044091; GO:1904219; GO:1904222"
"1033","Pocillopora_acuta_HIv2___RNAseq.g26742.t1",0,0,0,0,0,3.94736842105263,0,0,3.7037037037037,0,0.765107212475634,1.53021442495127,0,NA,NA,NA,NA,NA,NA,12.5196861771521,12.4263534171161,12.5844057855214,11.6452834581959,12.5998751908842,12.2090429225771,12.2139148125083,12.8634276047561,12.9637260631634,11.6438353017835,12.3669550733658,12.7062241642954,12.0276859824362,5479.86958335853,-0.525796899151414,0.531204267906576,0.240883416481253,0.478721865345541,"P02752",5.06e-39,"Riboflavin-binding protein (RBP) [Cleaved into: Riboflavin-binding protein, plasma form; Riboflavin-binding protein, yolk major form; Riboflavin-binding protein, yolk minor form]","negative regulation of sensory perception of bitter taste [GO:1904661]; negative regulation of sensory perception of sweet taste [GO:1904657]; riboflavin transport [GO:0032218]","GO:0009897; GO:0032217; GO:0032218; GO:0038023; GO:1902444; GO:1904657; GO:1904661"
"1034","Pocillopora_acuta_HIv2___RNAseq.g26743.t1",37.5,NA,NA,NA,28.5714285714286,60,100,33.3333333333333,61.5384615384615,NA,53.4905372405372,51.6239316239316,55.3571428571429,NA,NA,NA,NA,NA,NA,9.88802264615702,7.41467425941368,10.960983909315,5.56232777220043,8.71524105562279,6.43441652940609,9.12259257331817,10.0919600624666,7.91777144829032,3.68233641306884,7.97903266692589,9.51479582437035,6.44326950948144,533.321382848229,-2.37707499282495,1.74040126193548,0.00111879303973831,0.00644967019799716,"P27545",1.95e-75,"Ceramide synthase 1 (CerS1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1) (Sphingoid base N-stearoyltransferase CERS1) (EC 2.3.1.299)","brain development [GO:0007420]; ceramide biosynthetic process [GO:0046513]; negative regulation of glucose import [GO:0046325]","GO:0005783; GO:0005789; GO:0007420; GO:0016410; GO:0043231; GO:0046325; GO:0046513; GO:0050291"
"1035","Pocillopora_acuta_HIv2___RNAseq.g26745.t1b",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.15354005906022,3.68233641306884,7.93741002328246,3.68233641306884,6.550353694785,5.38419442015382,10.5649229271308,9.31339258377614,8.61967397173629,3.68233641306884,6.75704969191313,8.11487406652802,5.39922531729823,303.776736354036,-0.547733194613131,1.16905910649603,3.3552373050529e-05,0.000324616403881506,NA,NA,NA,NA,NA
"1036","Pocillopora_acuta_HIv2___RNAseq.g26746.t1",3.05676855895197,8.30324909747292,1.92,2.38095238095238,30.2593659942363,0.216450216450216,4.23162583518931,5.3475935828877,1.41342756183746,NA,6.3477148031087,3.53233456792014,9.8669400970944,1,43.3333333333333,43.3333333333333,0.0370400757516178,0.0370400757516178,0.0370400757516178,9.81633272974479,9.82892698801727,10.3884152324546,10.9509303680179,10.9310196717941,11.2445306676754,8.88361579571106,9.00699506687624,11.8357116895437,3.68233641306884,9.65688146229039,10.3956948780827,8.91806804649809,1392.19410017678,-0.145910917631254,0.874477917978536,0.704168825243429,0.865231270206016,"Q9HCE0",0,"Ectopic P granules protein 5 homolog","autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; nucleotide transport [GO:0006862]; toll-like receptor 9 signaling pathway [GO:0034162]","GO:0005737; GO:0005764; GO:0006862; GO:0008333; GO:0032456; GO:0034162; GO:0048471; GO:0097352; GO:1990786"
"1037","Pocillopora_acuta_HIv2___RNAseq.g26750.t1a",0,0,0,NA,NA,6.52173913043478,0,NA,0,NA,1.08695652173913,2.17391304347826,0,NA,NA,NA,NA,NA,NA,8.74449125457864,3.68233641306884,8.0143117467574,6.69822557197013,7.77867310521305,10.398297080943,3.68233641306884,9.6535745993527,3.68233641306884,3.68233641306884,6.60169190110903,7.57467742379413,5.62870637842393,301.550236813064,-0.221791978014849,1.02469503665442,0.285460141181732,0.531377769036214,"Q4A3R3",1.2e-14,"Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin)","cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031]; zymogen activation [GO:0031638]","GO:0004252; GO:0005576; GO:0005886; GO:0015031; GO:0030154; GO:0030658; GO:0031012; GO:0031638; GO:0035375; GO:0042589; GO:0050829; GO:0050830"
"1038","Pocillopora_acuta_HIv2___TS.g1941.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.5315987481135,3.68233641306884,10.1414990084124,6.06421730587923,7.69910513380005,11.3513325928471,8.50814216729098,3.68233641306884,3.68233641306884,6.80252406086186,5.12387374247535,8.48117437924838,497.124197302094,0.569685967493775,1.20938137856944,0.0293763367441962,0.101821072290451,"Q8TER0",3.88e-73,"Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1)","cell-matrix adhesion [GO:0007160]","GO:0005112; GO:0005509; GO:0005576; GO:0007160; GO:0031012"
"1039","Pocillopora_acuta_HIv2___TS.g1945.t1b",0,0,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.05370727604774,9.42830118760175,9.98775355235779,9.49726723019594,8.59109173818164,9.41225362088906,8.90018289441995,9.77878215135658,10.6554569084619,3.68233641306884,8.89871329725812,9.61335832528113,8.18406826923511,676.571016513662,-0.228895435865191,0.884342829002806,0.557999618174159,0.77196618625261,"Q0KHY3",5.12e-85,"Protein mesh","cell-matrix adhesion [GO:0007160]; smooth septate junction assembly [GO:0090528]","GO:0005615; GO:0005920; GO:0007160; GO:0016327; GO:0090528"
"1040","Pocillopora_acuta_HIv2___RNAseq.g26775.t1",0,0,0,0,NA,0,NA,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,10.8347554206896,10.3809496844774,11.0871734436828,3.68233641306884,9.48638159423404,10.0070130168686,5.18636982781747,10.2174421391784,10.4616828128354,3.68233641306884,8.50264407659214,10.417487082124,6.58780107106023,951.888012913307,-0.543043238424,1.15011760547589,0.000562645829387964,0.00361854569865163,"Q9D687",0,"Sodium-dependent neutral amino acid transporter B(0)AT1 (Solute carrier family 6 member 19) (System B(0) neutral amino acid transporter AT1)","neutral amino acid transport [GO:0015804]; response to nutrient [GO:0007584]; sodium ion transmembrane transport [GO:0035725]","GO:0005886; GO:0007584; GO:0015175; GO:0015293; GO:0015804; GO:0016324; GO:0031526; GO:0035725"
"1041","Pocillopora_acuta_HIv2___TS.g1976.t1b",0,0,0,0,0,1.69491525423729,0,0,0,NA,0.188323917137476,0.338983050847458,0,NA,NA,NA,NA,NA,NA,9.95117687411115,10.8222784930746,10.9625977806723,9.52654370688352,10.9013591763912,10.1902943022416,10.6583984725598,10.7270338874188,8.82948488900972,7.14122045145112,9.97103880338138,10.2743305215206,9.66774708524213,1226.77200018516,-0.425214986609405,0.640093462235415,0.364181894257036,0.614790723451654,"O77633",0,"Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c)","membrane protein ectodomain proteolysis [GO:0006509]; Notch signaling pathway [GO:0007219]","GO:0000139; GO:0004175; GO:0004222; GO:0005886; GO:0005912; GO:0006509; GO:0007219; GO:0017124; GO:0030136; GO:0030424; GO:0030425; GO:0046872; GO:0097060; GO:1902945"
"1042","Pocillopora_acuta_HIv2___RNAseq.12432_t",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.56529713715211,3.68233641306884,8.73009976547052,3.68233641306884,9.46567971525477,9.62460648707743,10.40009516611,8.70836549291351,9.15982731622767,3.68233641306884,7.67009803194125,9.12585388540372,6.21434217847879,484.23561549526,-0.318174271374482,1.0427736095821,2.1584293807388e-05,0.000221572197040497,"P19492",3.39e-87,"Glutamate receptor 3 (GluR-3) (AMPA-selective glutamate receptor 3) (GluR-C) (GluR-K3) (Glutamate receptor ionotropic, AMPA 3)","long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; protein heterotetramerization [GO:0051290]; protein homotetramerization [GO:0051289]; regulation of receptor recycling [GO:0001919]; response to fungicide [GO:0060992]; response to lithium ion [GO:0010226]; synaptic transmission, glutamatergic [GO:0035249]","GO:0001540; GO:0001919; GO:0004970; GO:0004971; GO:0005886; GO:0008328; GO:0010226; GO:0014069; GO:0016020; GO:0022849; GO:0030425; GO:0032279; GO:0032281; GO:0032991; GO:0035249; GO:0042734; GO:0043025; GO:0043083; GO:0043195; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0048787; GO:0050804; GO:0051289; GO:0051290; GO:0060291; GO:0060992; GO:0098688; GO:0098839; GO:0098978; GO:0099507; GO:1904315"
"1043","Pocillopora_acuta_HIv2___RNAseq.g20376.t1a",33.3333333333333,NA,NA,0,14.2857142857143,17.6470588235294,NA,33.3333333333333,NA,78.5714285714286,29.5284780578898,16.9934640522876,42.0634920634921,NA,NA,NA,NA,NA,NA,9.1147694605826,3.68233641306884,6.0846563529576,8.11899488820735,8.30774756796232,3.68233641306884,3.68233641306884,6.17109778065781,5.03316817358995,9.87501766027578,6.37524611234399,6.94228786715006,5.80820435753793,209.257347571474,-0.151347775021503,1.0223417984187,0.00123056761530447,0.0069799725442211,"Q641M3",4.15e-29,"Transmembrane protein 18","fat cell differentiation [GO:0045444]","GO:0003677; GO:0031965; GO:0045444"
"1044","Pocillopora_acuta_HIv2___TS.g14329.t2",0,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.5772197832221,7.48534952228994,6.80680485095045,9.92013927871722,6.17395423718631,7.49032865096105,3.68233641306884,7.25706111290644,3.68233641306884,3.68233641306884,6.275786667544,6.09947527946683,6.45209805562118,158.930123681761,0.137088608774685,0.957594059403002,0.602575000693092,0.802545562617392,"P16092",1.8e-43,"Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331)","angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cementum mineralization [GO:0071529]; central nervous system neuron development [GO:0021954]; chondrocyte differentiation [GO:0002062]; diphosphate metabolic process [GO:0071344]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; motogenic signaling involved in postnatal olfactory bulb interneuron migration [GO:0021837]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of postsynaptic density assembly [GO:0099151]; regulation of stem cell proliferation [GO:0072091]; response to sodium phosphate [GO:1904383]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; stem cell proliferation [GO:0072089]; ureteric bud development [GO:0001657]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640]","GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001837; GO:0002053; GO:0002062; GO:0005007; GO:0005102; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007420; GO:0007435; GO:0007605; GO:0008201; GO:0008283; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010468; GO:0010629; GO:0010763; GO:0010966; GO:0010976; GO:0017134; GO:0018108; GO:0019827; GO:0021769; GO:0021837; GO:0021847; GO:0021954; GO:0030031; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0035607; GO:0042127; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042803; GO:0043235; GO:0043406; GO:0043536; GO:0043583; GO:0044877; GO:0045597; GO:0045666; GO:0045668; GO:0045787; GO:0045944; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048471; GO:0048514; GO:0048699; GO:0048762; GO:0048863; GO:0050678; GO:0050839; GO:0051174; GO:0051897; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0060979; GO:0070640; GO:0071344; GO:0071529; GO:0072089; GO:0072091; GO:0090080; GO:0090272; GO:0090722; GO:0098794; GO:0098978; GO:0099151; GO:1903465; GO:1904383; GO:1905564; GO:2000491; GO:2000546; GO:2000648; GO:2000830; GO:2001239"
"1045","Pocillopora_acuta_HIv2___RNAseq.g20379.t1",0,0.699300699300699,1.44927536231884,0.531914893617021,0,1.25588697017268,0.740740740740741,0,0,0,0.467711866614999,0.497420512618081,0.438003220611916,NA,NA,NA,NA,NA,NA,10.3034878116813,11.0567502202934,11.0648080983251,8.0335541792819,10.1090677488525,9.74375176711507,3.68233641306884,10.6908516194428,11.2662591522673,8.89833832163736,9.48492053319656,10.6868948861138,8.28294618027931,1212.3728188641,-0.604924281990552,1.07179132499729,0.111929378757978,0.283776780780962,"P11362",2.19e-65,"Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331)","angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cementum mineralization [GO:0071529]; chondrocyte differentiation [GO:0002062]; chordate embryonic development [GO:0043009]; diphosphate metabolic process [GO:0071344]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung-associated mesenchyme development [GO:0060484]; MAPK cascade [GO:0000165]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell differentiation [GO:0045595]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; response to sodium phosphate [GO:1904383]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; ureteric bud development [GO:0001657]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640]","GO:0000122; GO:0000165; GO:0001501; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001764; GO:0001837; GO:0002053; GO:0002062; GO:0004713; GO:0005007; GO:0005524; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0006468; GO:0007605; GO:0008201; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010518; GO:0010966; GO:0010976; GO:0016020; GO:0016477; GO:0017134; GO:0018108; GO:0021847; GO:0030031; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0035607; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0043009; GO:0043235; GO:0043406; GO:0043410; GO:0043536; GO:0044344; GO:0045595; GO:0045597; GO:0045666; GO:0046777; GO:0048015; GO:0048339; GO:0048378; GO:0048469; GO:0048705; GO:0048863; GO:0051897; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0070640; GO:0071344; GO:0071529; GO:0072089; GO:0090080; GO:0090272; GO:0090722; GO:1903465; GO:1904383; GO:1905564; GO:2000648; GO:2000830; GO:2001028; GO:2001239"
"1046","Pocillopora_acuta_HIv2___TS.g14331.t2",0,0,0,0,1.28617363344051,0.597907324364723,1.0840108401084,1.47058823529412,0,0,0.443868003320776,0.413699111931768,0.474036894709783,NA,NA,NA,NA,NA,NA,5.25300700550269,5.4315664930872,5.72956178137413,6.61544894152208,5.68410831247026,6.82103953412585,3.68233641306884,6.025091802042,5.96263381334191,3.68233641306884,5.48871305096038,5.7308805429462,5.24654555897456,34.1729595310767,-0.16300311016774,0.949285593376944,0.483254733916111,0.716930817545357,"Q02763",9.04e-64,"Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b)","angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endochondral ossification [GO:0001958]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; response to cAMP [GO:0051591]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to peptide hormone [GO:0043434]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]","GO:0001525; GO:0001666; GO:0001934; GO:0001935; GO:0001938; GO:0001958; GO:0002040; GO:0004672; GO:0004714; GO:0005524; GO:0005576; GO:0005737; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016323; GO:0016324; GO:0016525; GO:0019838; GO:0032878; GO:0034446; GO:0034451; GO:0035022; GO:0035025; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0043434; GO:0043627; GO:0045121; GO:0045766; GO:0048014; GO:0050728; GO:0051591; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0072012; GO:1902533; GO:2000351; GO:2000352"
"1047","Pocillopora_acuta_HIv2___RNAseq.g20395.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.42029681044045,8.26388760970949,7.95918821835721,5.31323081329325,9.33607598889781,9.58095808206829,9.38513115247525,9.64811409941554,10.1787426538223,3.68233641306884,8.27679618415484,9.30848355418666,7.24510881412302,509.899359560557,-0.57457796324879,1.02504633540088,0.1381693327624,0.330218312801611,"Q9HCD6",7.47e-06,"Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)","dense core granule cytoskeletal transport [GO:0099519]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]","GO:0030424; GO:0043197; GO:0060998; GO:0061001; GO:0099519"
"1048","Pocillopora_acuta_HIv2___RNAseq.g20399.t1",12.9032258064516,NA,100,19.7368421052632,26.0869565217391,10.4895104895105,0,0,100,NA,33.6520668653705,32.5565881486934,34.7475455820477,NA,NA,NA,NA,NA,NA,10.5486317891533,8.9513906682475,10.1333899895593,10.1859247070722,10.0676990859755,8.36654696487216,10.0530066464751,9.89398176528497,10.5103780578533,3.68233641306884,9.23932860875622,10.2308161375653,8.24784107994716,892.725152876592,-0.484491507474176,0.962083917617098,0.237987612501115,0.474858991201012,"Q5HYA8",0,"Meckelin (Meckel syndrome type 3 protein) (Transmembrane protein 67)","cilium assembly [GO:0060271]; ERAD pathway [GO:0036503]; negative regulation of centrosome duplication [GO:0010826]; non-canonical Wnt signaling pathway [GO:0035567]","GO:0005789; GO:0005813; GO:0010826; GO:0030659; GO:0031005; GO:0035567; GO:0035869; GO:0036038; GO:0036503; GO:0051082; GO:0060170; GO:0060271"
"1049","Pocillopora_acuta_HIv2___RNAseq.g20407.t1",0,0,0,0,NA,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.7087080876747,9.1859200648479,10.1467031778113,8.22187128010793,9.89955340382098,9.62141819605509,9.38513115247525,9.95892833498957,7.49238249684073,3.68233641306884,8.83029526076923,9.64125510022746,8.019335421311,704.662635882695,-0.814778929436858,1.01697990561539,0.103714174145722,0.268502204196119,"Q9H0I2",1.74e-44,"Enkurin domain-containing protein 1","establishment of mitotic spindle orientation [GO:0000132]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]","GO:0000132; GO:0000922; GO:0005813; GO:0005814; GO:0005881; GO:0008017; GO:0015630; GO:0036064; GO:0043014; GO:0044458; GO:0097546; GO:0097731; GO:1905515"
"1050","Pocillopora_acuta_HIv2___RNAseq.g20410.t1",39.6907216494845,21.6783216783217,42.2413793103448,24.3697478991597,43.5483870967742,28.051391862955,42.8571428571429,25.3521126760563,7.40740740740741,50,32.5196612437647,21.37179630478,43.6675261827493,1,61.2244897959184,61.2244897959184,0.00359050866677279,0.00359050866677279,0.00359050866677279,8.87515657260048,7.88830505095858,7.99336016744145,9.60253211680803,9.08923922973774,8.96349858670414,3.68233641306884,8.81753569748032,3.68233641306884,3.68233641306884,7.22766366609373,7.69152561606577,6.76380171612169,305.694393300929,-0.16959863053022,0.943045346427558,0.700846487621624,0.863535530876495,"Q2HJF4",3.29e-103,"Phenazine biosynthesis-like domain-containing protein (EC 5.1.-.-)","biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]","GO:0005737; GO:0009058; GO:0016853; GO:0030277; GO:0030512; GO:0042802"
"1051","Pocillopora_acuta_HIv2___RNAseq.g20411.t2",62.5,31.5789473684211,62.5,NA,NA,23.5294117647059,70,NA,14.2857142857143,NA,44.0656789031402,23.1313578062804,65,NA,NA,NA,NA,NA,NA,10.5847572048645,11.1014948304754,10.4874061403855,11.6432293943302,10.6726677104594,10.9847355855556,9.9801169451547,10.6537384030532,11.4265475838792,9.0626023853959,10.6597296183554,10.7650234085284,10.5544358281824,1767.8580678726,-0.0932049411155433,0.655280620716531,0.833970207556515,0.933344559122364,"Q5U2X2",6e-125,"Sperm-associated antigen 1 (HSD-3.8) (Infertility-related sperm protein Spag-1)","axonemal dynein complex assembly [GO:0070286]; single fertilization [GO:0007338]","GO:0005525; GO:0005737; GO:0005829; GO:0007338; GO:0016787; GO:0070286; GO:0101031; GO:0120293"
"1052","Pocillopora_acuta_HIv2___RNAseq.g20416.t1",0,0.426439232409382,0.483091787439614,0.589390962671906,1.16472545757072,0.498442367601246,0,0,0,0,0.316208980769286,0.302854512536507,0.329563449002066,NA,NA,NA,NA,NA,NA,7.38264830809177,6.13320531664763,6.46782542466738,3.68233641306884,6.64499589542844,7.18609379060864,6.77088171065989,5.84514254962292,5.8076943734674,6.75413069443622,6.26749544766991,6.42966131025558,6.10532958508424,68.7670091052787,-0.0969422608460118,0.863481860340412,0.783292155806934,0.907961030741424,"P07897",1.4e-16,"Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)","cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; cellular response to growth factor stimulus [GO:0071363]; central nervous system development [GO:0007417]; chondroblast differentiation [GO:0060591]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; glial cell differentiation [GO:0010001]; heart development [GO:0007507]; negative regulation of cell migration [GO:0030336]; ossification [GO:0001503]; positive regulation of neuroblast proliferation [GO:0002052]; proteoglycan biosynthetic process [GO:0030166]; response to acidic pH [GO:0010447]; response to glucose [GO:0009749]; response to gravity [GO:0009629]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; skeletal system development [GO:0001501]; spinal cord development [GO:0021510]","GO:0001501; GO:0001502; GO:0001503; GO:0002052; GO:0002063; GO:0005509; GO:0005540; GO:0005604; GO:0005615; GO:0007155; GO:0007417; GO:0007507; GO:0009410; GO:0009612; GO:0009629; GO:0009749; GO:0010001; GO:0010447; GO:0014070; GO:0021510; GO:0030166; GO:0030199; GO:0030246; GO:0030336; GO:0031012; GO:0043025; GO:0045202; GO:0060591; GO:0071363; GO:0072534; GO:0098966; GO:0098978; GO:0098982"
"1053","Pocillopora_acuta_HIv2___TS.g14372.t1a",0,NA,0,50,0,0,16.6666666666667,NA,0,NA,9.52380952380952,16.6666666666667,4.16666666666667,NA,NA,NA,NA,NA,NA,11.2853002555731,11.4463205898996,9.8102866405211,9.93700837533857,11.130830991617,8.45527342080496,9.90334641785777,11.0799142486844,8.40009381532483,11.1763863987958,10.2624761154417,10.3412851903441,10.1836670405393,1527.73302441043,-0.0945304350108772,0.742862476227618,0.818991232036911,0.925460092201709,"Q9EQW7",0,"Kinesin-like protein KIF13A","cell division [GO:0051301]; cytoskeleton-dependent intracellular transport [GO:0030705]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459]","GO:0000139; GO:0003777; GO:0005524; GO:0005813; GO:0005871; GO:0005874; GO:0006886; GO:0007018; GO:0008017; GO:0008333; GO:0010008; GO:0016887; GO:0030496; GO:0030705; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383"
"1054","Pocillopora_acuta_HIv2___TS.g14378.t2",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.34070533074306,5.57859373890424,5.29770193163976,6.54549673248371,8.426906743025,3.68233641306884,7.56551680110738,8.93883391709639,6.60889967998377,7.87825228538505,6.68632435734372,7.1226095204976,6.25003919418984,140.322637091664,-0.17793674041735,0.906229862589218,0.59899038726791,0.800794617011096,NA,NA,NA,NA,NA
"1055","Pocillopora_acuta_HIv2___RNAseq.g20430.t1",0,0,0,0,8.45070422535211,0,0,0,0,0,0.845070422535211,0,1.69014084507042,NA,NA,NA,NA,NA,NA,9.83039885085637,12.3209845324138,8.55555621349218,10.6033173266544,8.50796544529402,10.9011159321961,8.67991184486442,11.6422647221667,8.60104019303021,11.4833759225171,10.1125930983485,9.4274450849679,10.7977411117292,1683.88699191278,0.954793746536544,1.04177225979486,0.0651626407536551,0.190742679268766,"P18075",4.52e-104,"Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1) (Eptotermin alfa)","allantois development [GO:1905069]; ameloblast differentiation [GO:0036305]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cellular response to BMP stimulus [GO:0071773]; cellular response to hypoxia [GO:0071456]; chorio-allantoic fusion [GO:0060710]; dendrite development [GO:0016358]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial to mesenchymal transition [GO:0001837]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:1901145]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; mesonephros development [GO:0001823]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; metanephros development [GO:0001656]; monocyte aggregation [GO:0070487]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of dendrite development [GO:1900006]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of phosphorylation [GO:0042325]; regulation of removal of superoxide radicals [GO:2000121]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; skeletal system development [GO:0001501]; ureteric bud development [GO:0001657]","GO:0001501; GO:0001503; GO:0001656; GO:0001657; GO:0001707; GO:0001823; GO:0001837; GO:0003272; GO:0003344; GO:0005125; GO:0005576; GO:0005615; GO:0007411; GO:0008083; GO:0008201; GO:0009880; GO:0010628; GO:0010664; GO:0010718; GO:0016358; GO:0021502; GO:0030326; GO:0030501; GO:0030509; GO:0030858; GO:0030902; GO:0031982; GO:0032088; GO:0032355; GO:0033280; GO:0034116; GO:0036305; GO:0042325; GO:0042475; GO:0043065; GO:0043434; GO:0045665; GO:0045666; GO:0045669; GO:0045746; GO:0045786; GO:0045839; GO:0045892; GO:0045893; GO:0045944; GO:0048596; GO:0048738; GO:0048754; GO:0048762; GO:0048812; GO:0050768; GO:0051216; GO:0060037; GO:0060272; GO:0060391; GO:0060411; GO:0060445; GO:0060485; GO:0060686; GO:0060687; GO:0060710; GO:0061384; GO:0062023; GO:0070487; GO:0070700; GO:0071456; GO:0071773; GO:0072040; GO:0072125; GO:0072133; GO:0072134; GO:0072136; GO:0090336; GO:1900006; GO:1900106; GO:1901145; GO:1901223; GO:1905069; GO:1905312; GO:2000121"
"1056","Pocillopora_acuta_HIv2___TS.g14383.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,8.21218654876206,8.0769098149547,3.68233641306884,10.6489836127232,3.68233641306884,9.14988853214494,7.7718154974796,3.68233641306884,6.22714660714087,6.49971268090486,5.95458053337688,283.281469423601,-0.0883437084565708,1.00862278596063,0.07935782695904,0.221329795756707,"Q9V3L1",0,"Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase) (Sulfateless) [Includes: Heparan sulfate N-deacetylase (EC 3.-.-.-); Heparan sulfate N-sulfotransferase (EC 2.8.2.-)]","epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]","GO:0000137; GO:0000139; GO:0005783; GO:0005794; GO:0006024; GO:0006790; GO:0007283; GO:0007367; GO:0007427; GO:0007474; GO:0007509; GO:0008146; GO:0008543; GO:0008587; GO:0015012; GO:0015014; GO:0015016; GO:0016055; GO:0019213; GO:0030210; GO:0045570; GO:0102140"
"1057","Pocillopora_acuta_HIv2___RNAseq.g20434.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.4677672806166,11.9891905923913,10.0045647998289,11.0931520037171,11.2347177536375,10.9983152106973,10.9331643487143,10.5064405980701,11.8788463014533,9.66619412162829,10.9772353010755,11.0184673467213,10.9360032554297,2229.767859511,-0.0147631413833757,0.637362319621949,0.972625547944211,0.991336475615888,"P34642",4.69e-27,"Signal recognition particle 9 kDa protein (SRP9)","negative regulation of translational elongation [GO:0045900]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]","GO:0005786; GO:0006614; GO:0008312; GO:0045900"
"1058","Pocillopora_acuta_HIv2___RNAseq.g20448.t1",34.6153846153846,NA,66.6666666666667,37.5,15.3846153846154,13.1147540983607,13.8461538461538,0,NA,NA,25.8753678015973,16.8715846994536,32.6282051282051,NA,NA,NA,NA,NA,NA,6.22289842159741,7.73030729659763,6.4923699430376,7.11287062487384,6.36993744999328,7.48328651223368,6.71121078207718,6.18361936369477,8.77401831832923,3.68233641306884,6.67628551255035,6.80856869933046,6.54400232577023,117.441906572361,0.123164849561661,0.878203939496841,0.758456499813921,0.894224443650557,"Q9P215",7.04e-28,"Pogo transposable element with KRAB domain","regulation of DNA-templated transcription [GO:0006355]","GO:0003677; GO:0005634; GO:0005654; GO:0006355"
"1059","Pocillopora_acuta_HIv2___RNAseq.g20450.t1",49.5726495726496,7.46268656716418,18.6440677966102,63.7254901960784,62.2222222222222,25.4988913525499,30.3258145363409,29.0322580645161,13.1487889273356,NA,33.292541026163,27.7736230215289,40.1911885319557,NA,NA,NA,NA,NA,NA,3.68233641306884,6.17776049751523,8.09518833552696,5.35849991176178,7.36507912989583,9.43240780992137,5.40984312721881,7.07874584792092,9.35694267211217,9.43568486678976,7.13924886117317,7.11565847970494,7.16283924264139,255.123515244816,0.0362254436713714,0.908692987353929,0.910606257127928,0.966688018314516,NA,NA,NA,NA,NA
"1060","Pocillopora_acuta_HIv2___TS.g14424.t1",1.6,0,0,0,0,0.239234449760766,0,0,0,NA,0.204359383306752,0.0478468899521531,0.4,NA,NA,NA,NA,NA,NA,6.11310426585121,3.68233641306884,5.85239579733235,7.48948822201648,8.7480145898251,6.93974781619552,6.20136626305352,8.37945792237163,7.123712339569,3.68233641306884,6.42119600423525,7.24333698298986,5.59905502548064,121.186352577915,-0.723920475552031,1.25068788704111,0.0209726339441587,0.0770701670143067,"P07897",7.6e-19,"Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)","cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; cellular response to growth factor stimulus [GO:0071363]; central nervous system development [GO:0007417]; chondroblast differentiation [GO:0060591]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; glial cell differentiation [GO:0010001]; heart development [GO:0007507]; negative regulation of cell migration [GO:0030336]; ossification [GO:0001503]; positive regulation of neuroblast proliferation [GO:0002052]; proteoglycan biosynthetic process [GO:0030166]; response to acidic pH [GO:0010447]; response to glucose [GO:0009749]; response to gravity [GO:0009629]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; skeletal system development [GO:0001501]; spinal cord development [GO:0021510]","GO:0001501; GO:0001502; GO:0001503; GO:0002052; GO:0002063; GO:0005509; GO:0005540; GO:0005604; GO:0005615; GO:0007155; GO:0007417; GO:0007507; GO:0009410; GO:0009612; GO:0009629; GO:0009749; GO:0010001; GO:0010447; GO:0014070; GO:0021510; GO:0030166; GO:0030199; GO:0030246; GO:0030336; GO:0031012; GO:0043025; GO:0045202; GO:0060591; GO:0071363; GO:0072534; GO:0098966; GO:0098978; GO:0098982"
"1061","Pocillopora_acuta_HIv2___RNAseq.g20479.t1",0,0,0,NA,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.12393817219713,9.17266169627307,4.80540103069894,9.88405858895679,8.88431328824717,9.78422918013371,10.5281134283633,8.86540510987046,6.28579400236677,10.4384040196278,8.77723185167351,7.59297032067609,9.96149338267093,662.402718967454,1.30230539405393,1.28310373191107,0.017445366523367,0.0663327501035701,NA,NA,NA,NA,NA
"1062","Pocillopora_acuta_HIv2___RNAseq.g20480.t1",NA,0,0,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.71060374849395,3.68233641306884,5.16860104011765,3.68233641306884,9.50228002981965,7.48328651223368,11.1326904650979,9.02058697355857,8.91943765334758,3.68233641306884,6.99844956618755,8.06430188906748,5.93259724330762,422.596062249527,-0.531457898390053,1.16432610659256,0.00146562859411498,0.00812216551160115,NA,NA,NA,NA,NA
"1063","Pocillopora_acuta_HIv2___TS.g14436.t2",100,NA,100,85.7142857142857,33.3333333333333,100,NA,100,100,NA,88.4353741496599,96.4285714285714,77.7777777777778,NA,NA,NA,NA,NA,NA,12.137894392751,12.3403736928626,11.9641134028565,11.0534857291541,11.7880729817037,12.6415319029558,12.3345403609315,12.0251596396822,12.1198615432367,11.1189233321029,11.9523956978237,12.007020392046,11.8977710036014,4149.10494570339,-0.0673447080710688,0.562851397771545,0.86776503710407,0.948202273677818,"Q01518",1.29e-133,"Adenylyl cyclase-associated protein 1 (CAP 1)","actin filament organization [GO:0007015]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cAMP-mediated signaling [GO:0019933]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]","GO:0000902; GO:0001667; GO:0003779; GO:0005576; GO:0005737; GO:0005886; GO:0005925; GO:0006898; GO:0007015; GO:0007163; GO:0007165; GO:0007190; GO:0008179; GO:0019933; GO:0030864; GO:0035578; GO:0070062"
"1064","Pocillopora_acuta_HIv2___RNAseq.g20492.t1",13.0434782608696,0,0,0,0,0,2.17391304347826,0,0,NA,1.69082125603865,0,3.80434782608696,NA,NA,NA,NA,NA,NA,7.07520399501629,7.90125532391943,8.07937330513335,7.23886682728914,3.68233641306884,3.68233641306884,3.68233641306884,6.42306225265296,3.68233641306884,3.68233641306884,5.51294437693554,5.78846247578806,5.23742627808302,75.8404222773413,-0.14536414682328,0.984807873514947,0.780481946280843,0.906275064711769,"P78504",1e-19,"Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339)","angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; aortic valve morphogenesis [GO:0003180]; blood vessel remodeling [GO:0001974]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; endothelial cell differentiation [GO:0045446]; hemopoiesis [GO:0030097]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; keratinocyte differentiation [GO:0030216]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; myoblast differentiation [GO:0045445]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; nervous system development [GO:0007399]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; podocyte development [GO:0072015]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of reproductive process [GO:2000241]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456]","GO:0001525; GO:0001709; GO:0001953; GO:0001974; GO:0002011; GO:0002085; GO:0002456; GO:0003180; GO:0003184; GO:0003215; GO:0005112; GO:0005198; GO:0005509; GO:0005543; GO:0005576; GO:0005886; GO:0005912; GO:0007219; GO:0007399; GO:0008083; GO:0016020; GO:0016324; GO:0022408; GO:0030097; GO:0030216; GO:0030336; GO:0032495; GO:0035909; GO:0042127; GO:0042491; GO:0045445; GO:0045446; GO:0045599; GO:0045602; GO:0045639; GO:0045665; GO:0045669; GO:0045747; GO:0045944; GO:0050678; GO:0060090; GO:0060411; GO:0061073; GO:0061101; GO:0061156; GO:0061309; GO:0061444; GO:0062043; GO:0072006; GO:0072015; GO:0072017; GO:0072070; GO:0097150; GO:2000241; GO:2000737"
"1065","Pocillopora_acuta_HIv2___RNAseq.g20495.t1",0.728155339805825,0.331491712707182,0.576368876080692,0.41592394533571,0.952380952380952,0.63028993336935,0.831183720263686,0.586854460093897,0.0750750750750751,0,0.512772401511237,0.407927025316243,0.617617777706231,NA,NA,NA,NA,NA,NA,5.99355402052038,7.51097603982434,6.16423403991286,6.1299899042818,3.68233641306884,3.68233641306884,3.68233641306884,6.26817974381434,3.68233641306884,3.68233641306884,5.04786158136979,5.15812812607705,4.93759503666253,34.68428035889,-0.0591276253453361,0.984509654510319,0.97621228585517,0.992143389306839,"Q90Y54",3.71e-41,"Protein jagged-1b (Jagged1b) (Jagged3)","auditory receptor cell development [GO:0060117]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cranial skeletal system development [GO:1904888]; dorsal/ventral pattern formation [GO:0009953]; exocrine pancreas development [GO:0031017]; face morphogenesis [GO:0060325]; fin regeneration [GO:0031101]; inner ear morphogenesis [GO:0042472]; intrahepatic bile duct development [GO:0035622]; liver development [GO:0001889]; Notch signaling pathway [GO:0007219]; otolith morphogenesis [GO:0032474]; pancreas development [GO:0031016]; semicircular canal development [GO:0060872]; semicircular canal morphogenesis [GO:0048752]; thyroid gland development [GO:0030878]","GO:0001889; GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0009953; GO:0016020; GO:0030878; GO:0031016; GO:0031017; GO:0031101; GO:0032474; GO:0035622; GO:0042472; GO:0048752; GO:0060117; GO:0060325; GO:0060351; GO:0060872; GO:1904888"
"1066","Pocillopora_acuta_HIv2___RNAseq.g20523.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.9875342281228,9.59458209611622,9.95461332949861,11.1441566742614,8.81868324725634,11.4538908904809,11.2064311373306,10.2255296337226,6.80659519587517,6.3122422615894,9.6504258694254,9.3585911268951,9.9422606119557,1281.54260512001,0.32114329712427,0.715612425237985,0.498142520672927,0.728181929668648,"Q62825",0,"Exocyst complex component 3 (Exocyst complex component Sec6) (rSec6)","exocyst localization [GO:0051601]; exocytosis [GO:0006887]; protein transport [GO:0015031]","GO:0000145; GO:0000149; GO:0005794; GO:0006887; GO:0015031; GO:0030426; GO:0030496; GO:0042734; GO:0048471; GO:0051601"
"1067","Pocillopora_acuta_HIv2___RNAseq.g20528.t1",0,0,0,NA,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.97416447868051,8.91362770448972,10.4449309852361,9.31824411792278,7.75224048005619,10.2698155398593,8.97089640132859,9.44266903847303,9.57106874526941,10.448618036784,9.51062755280996,9.43701474554305,9.58424036007688,807.22423060018,0.0491923610631887,0.689268333328174,0.922694323825413,0.971054990990861,"Q91YR7",0,"Pre-mRNA-processing factor 6 (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein)","mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244]","GO:0000244; GO:0000398; GO:0003713; GO:0003723; GO:0005634; GO:0005682; GO:0006403; GO:0016607; GO:0030674; GO:0042802; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013"
"1068","Pocillopora_acuta_HIv2___RNAseq.g20545.t1",0,1.90839694656489,0.431034482758621,0.419287211740042,0.120481927710843,0.998751560549313,1.15942028985507,1.2012012012012,1.42045454545455,0,0.765902816583452,1.189618293102,0.342187340064907,NA,NA,NA,NA,NA,NA,9.96271647603787,10.3137185736982,10.9955531598066,9.25774746444326,9.56309430682896,10.651329788673,11.3870088237132,11.4808960273771,11.3167562927131,10.3228522733328,10.5251673186624,10.6638032525527,10.3865313847721,1640.17350946412,-0.168836214074238,0.62008593094982,0.705899791452145,0.865999540590656,"Q9UKV8",0,"Protein argonaute-2 (Argonaute2) (hAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (PAZ Piwi domain protein) (PPD) (Protein slicer)","miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of translational initiation [GO:0045947]; P-body assembly [GO:0033962]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; regulation of synapse maturation [GO:0090128]; regulatory ncRNA-mediated gene silencing [GO:0031047]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; RISC complex assembly [GO:0070922]; RNA secondary structure unwinding [GO:0010501]; siRNA processing [GO:0030422]; siRNA-mediated gene silencing by mRNA destabilization [GO:0090625]; translation [GO:0006412]","GO:0000340; GO:0000932; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0003743; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0009791; GO:0010501; GO:0010586; GO:0016020; GO:0016442; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0033962; GO:0035194; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035925; GO:0036464; GO:0042985; GO:0045727; GO:0045766; GO:0045944; GO:0045947; GO:0046872; GO:0060213; GO:0070062; GO:0070551; GO:0070578; GO:0070922; GO:0090128; GO:0090624; GO:0090625; GO:0098794; GO:0098808; GO:0098978; GO:1900153; GO:1901165"
"1069","Pocillopora_acuta_HIv2___TS.g14497.t1a",1.90735694822888,0,0,0,0,2.38970588235294,0.555555555555556,1.44927536231884,1.171875,NA,0.830418749828469,1.00217124893436,0.61572812594611,NA,NA,NA,NA,NA,NA,3.68233641306884,8.62120790929901,7.89735631637503,6.41389448441836,5.95850798619116,3.68233641306884,3.68233641306884,6.17109778065781,7.07010303635839,9.62774969672687,6.28069264492331,6.15588030653025,6.40550498331638,160.687488639737,-0.0837198672332971,0.996203983080541,0.387301176265573,0.634994809964323,NA,NA,NA,NA,NA
"1070","Pocillopora_acuta_HIv2___RNAseq.g20555.t1",0,0,0,10.6060606060606,0,2.12765957446809,5.83941605839416,0,7.69230769230769,0,2.62654439312305,4.08520557456728,1.16788321167883,NA,NA,NA,NA,NA,NA,6.98667766036915,6.26270646445638,7.12687135132875,3.68233641306884,7.04098991334845,3.68233641306884,3.68233641306884,6.10668867658604,7.08098834013476,3.68233641306884,5.53342680584989,6.86844318835343,4.19841042334635,53.4795269263418,-6.59573507305144,3.73391808861867,3.94031797711964e-05,0.000371530373018634,NA,NA,NA,NA,NA
"1071","Pocillopora_acuta_HIv2___RNAseq.g20556.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.976490469328,4.8931170245923,9.93939347008632,3.68233641306884,7.95781456870118,3.68233641306884,3.68233641306884,7.78676637931927,6.37842387115414,3.68233641306884,5.86613514354566,7.80777775171778,3.92449253537353,154.652189714123,-8.69243147569365,3.27570819153819,4.01113179770388e-07,7.2340411872804e-06,"Q9HB75",6.98e-08,"p53-induced death domain-containing protein 1 (EC 3.4.21.-) (Leucine-rich repeat and death domain-containing protein) [Cleaved into: PIDD-N; PIDD-C; PIDD-CC]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoprocessing [GO:0016540]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; signal transduction [GO:0007165]","GO:0004175; GO:0005123; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0006977; GO:0007165; GO:0008625; GO:0016540; GO:0043065; GO:0043066; GO:0043122; GO:0051092; GO:1905369"
"1072","Pocillopora_acuta_HIv2___RNAseq.g20561.t1b",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,4.72947037839729,3.68233641306884,7.26683347298246,5.16572759476787,7.67391428326733,5.4799700608392,3.68233641306884,7.93082707738892,9.71307871410632,3.68233641306884,5.90068308209559,7.46282478522846,4.33854137896272,138.612186869492,-3.67855542560669,3.09561581792526,0.000242959168802936,0.00177125071449882,"Q9ULJ7",2.78e-80,"Ankyrin repeat domain-containing protein 50","endocytic recycling [GO:0032456]; protein transport [GO:0015031]","GO:0005768; GO:0015031; GO:0032456"
"1073","Pocillopora_acuta_HIv2___RNAseq.g20562.t1",2.84090909090909,0,4.57142857142857,1.15606936416185,0,0.704225352112676,1.64533820840951,6.25,0,0,1.71679705870217,1.62205894325491,1.81153517414943,NA,NA,NA,NA,NA,NA,9.1799577376633,8.76602226627005,9.50823460080548,9.92691061350274,8.91179326619723,7.77015937692672,8.62513910796068,8.65051128999095,8.33389739635467,3.68233641306884,8.33549620687407,8.91687885820233,7.75411355554581,430.870709559816,-0.365117194719249,0.88156355410398,0.392870655737941,0.639630928027193,"O77503",0,"Protein argonaute-2 (Argonaute2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Protein slicer)","miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of translational initiation [GO:0045947]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; pre-miRNA processing [GO:0031054]; regulation of DNA-templated transcription [GO:0006355]; regulatory ncRNA-mediated gene silencing [GO:0031047]","GO:0000340; GO:0000932; GO:0003727; GO:0005634; GO:0005737; GO:0006355; GO:0016442; GO:0031047; GO:0031054; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0045947; GO:0046872; GO:0060213; GO:0070551; GO:0070578; GO:0098808; GO:1900153"
"1074","Pocillopora_acuta_HIv2___RNAseq.g20565.t1c",0,NA,0,7.5,0,0,0,0,0,NA,0.9375,1.875,0,NA,NA,NA,NA,NA,NA,7.56955274651392,6.54125763453179,6.64213136387843,6.58091230054222,6.02555167782084,7.3029219250034,4.84014736901689,6.35881100040517,5.22517199274777,4.40467075915833,6.14911287696188,6.36424375627323,5.93398199765053,64.3831808013797,-0.458013411905215,0.803963047289575,0.330502491820324,0.58084909376539,"Q8C8R3",1.45e-54,"Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin)","atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cardiac muscle contraction [GO:0060048]; endocytosis [GO:0006897]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; T-tubule organization [GO:0033292]","GO:0002027; GO:0005200; GO:0005737; GO:0005739; GO:0005764; GO:0005769; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0015031; GO:0015459; GO:0019901; GO:0030018; GO:0030315; GO:0030674; GO:0031234; GO:0031430; GO:0031647; GO:0031672; GO:0033010; GO:0033292; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043034; GO:0043268; GO:0044325; GO:0045211; GO:0048471; GO:0050821; GO:0051117; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060048; GO:0070972; GO:0072659; GO:0086004; GO:0086014; GO:0086015; GO:0086036; GO:0086066; GO:0086070; GO:0086091; GO:0098904; GO:0098907; GO:0098910; GO:1901018; GO:1901019; GO:1901021; GO:2001259"
"1075","Pocillopora_acuta_HIv2___RNAseq.g20569.t1",0,0,1.3745704467354,0,0,0.169348010160881,1.04347826086957,0.735294117647059,0,NA,0.369187870601433,0.180928425561588,0.60451217690124,NA,NA,NA,NA,NA,NA,10.0227485386077,8.77307016386335,10.6847861347406,11.8461506207659,10.3210688112375,9.46834519867581,10.3491498938418,9.64701951365487,9.87835507531024,3.68233641306884,9.46730303637666,10.1107956147102,8.82381045804314,1161.08848591737,-0.240831072623965,0.8899805815988,0.512770963062222,0.738569927278628,"Q8CJG0",0,"Protein argonaute-2 (Argonaute2) (mAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Piwi/argonaute family protein meIF2C2) (Protein slicer)","cell differentiation [GO:0030154]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of post-transcriptional gene silencing by RNA [GO:1900370]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; regulation of mRNA stability [GO:0043488]; regulatory ncRNA-mediated gene silencing [GO:0031047]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; RISC complex assembly [GO:0070922]; RNA secondary structure unwinding [GO:0010501]; siRNA processing [GO:0030422]; siRNA-mediated gene silencing by mRNA destabilization [GO:0090625]","GO:0000340; GO:0000932; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0009791; GO:0010494; GO:0010501; GO:0010586; GO:0010628; GO:0016020; GO:0016442; GO:0030154; GO:0030422; GO:0030425; GO:0030544; GO:0031047; GO:0031054; GO:0033391; GO:0035194; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035925; GO:0036464; GO:0042985; GO:0043186; GO:0043488; GO:0045727; GO:0045766; GO:0045944; GO:0045947; GO:0046872; GO:0051879; GO:0060213; GO:0070062; GO:0070551; GO:0070578; GO:0070922; GO:0071546; GO:0090624; GO:0090625; GO:0098808; GO:1900153; GO:1900370; GO:1901165; GO:1905172; GO:1990904"
"1076","Pocillopora_acuta_HIv2___RNAseq.g20598.t1",NA,NA,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.64181568123354,9.20688299394651,10.1141554158039,9.74728818393302,9.30533373847221,9.8713515781131,8.98649488768758,10.3157600972897,8.60852267251487,7.75155885986295,9.15491641088574,9.19711752106284,9.11271530070863,646.212091525606,-0.0627928104208544,0.635044978783996,0.890462223539618,0.957808105992194,NA,NA,NA,NA,NA
"1077","Pocillopora_acuta_HIv2___RNAseq.g20601.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.69611344064921,9.35037869220396,9.39003945098149,10.5240430413247,7.5076208322678,8.79535837652911,3.68233641306884,7.55806838583083,8.07748726595138,10.4315542713025,8.40130001701098,8.24586587513614,8.55673415888582,544.963964673678,0.204368933648887,0.88415535386507,0.623111170087615,0.816170996172051,"Q9D361",7.74e-22,"U11/U12 small nuclear ribonucleoprotein 48 kDa protein (U11/U12 snRNP 48 kDa protein)","mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","GO:0005654; GO:0005689; GO:0005829; GO:0006397; GO:0008380; GO:0046872"
"1078","Pocillopora_acuta_HIv2___RNAseq.g20607.t1",28.5714285714286,33.3333333333333,NA,0,0,0,0,NA,NA,NA,10.3174603174603,11.1111111111111,9.52380952380952,NA,NA,NA,NA,NA,NA,9.34781439012174,8.19726855485875,10.6538195102097,10.3346358947883,9.88230256942176,3.68233641306884,9.664489285844,9.627173541364,8.66702239556097,3.68233641306884,8.37391989683069,9.63562648133563,7.11221331232575,659.671807631483,-0.433920683905111,1.03313554445907,0.098074403016252,0.257824094007101,"Q5ZIJ9",0,"E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2)","Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]","GO:0005737; GO:0007219; GO:0008270; GO:0016567; GO:0061630"
"1079","Pocillopora_acuta_HIv2___RNAseq.g20610.t1",0,0,NA,0,NA,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,7.02670788736903,8.54088102005396,8.0991150332705,9.62768992369247,7.95781456870118,7.15087115891671,3.68233641306884,7.89059234920551,3.68233641306884,3.68233641306884,6.73406811804159,6.93131325032301,6.53682298576016,202.146725502175,-0.0538045145994723,0.935615165171262,0.946437859767614,0.979700213448218,"Q12788",0,"Transducin beta-like protein 3 (WD repeat-containing protein SAZD)","endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; ribosomal small subunit biogenesis [GO:0042274]","GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0030686; GO:0032040; GO:0034511; GO:0042274"
"1080","Pocillopora_acuta_HIv2___RNAseq.g20623.t1",0,0,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.94548057967938,6.68494107039366,6.89159417457077,3.68233641306884,7.12625273022203,4.99187376865589,3.68233641306884,7.03212376687759,3.68233641306884,3.68233641306884,5.44016117426747,6.33555753288372,4.54476481565121,50.5175625318514,-0.489159121411907,1.14236800668869,0.052946376390038,0.162230469470972,NA,NA,NA,NA,NA
"1081","Pocillopora_acuta_HIv2___RNAseq.g20640.t1",NA,NA,NA,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,9.0197234869908,10.6036891438365,9.99723397921297,10.9902479347067,10.194709359937,9.42511157114,9.48731327895194,10.0627103409456,10.4314458320834,6.63807857080278,9.68502634986077,9.94116459983395,9.42888809988758,1000.49957807997,-0.177854476431847,0.762933485560014,0.676812078142221,0.850108312242743,"Q1L8L9",2.35e-120,"Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase)","ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; leukocyte differentiation [GO:0002521]","GO:0002244; GO:0002521; GO:0004017; GO:0005524; GO:0005737; GO:0005739; GO:0005758; GO:0006172; GO:0046033; GO:0046034; GO:0060218"
"1082","Pocillopora_acuta_HIv2___TS.g14591.t1",1.93726937269373,0,1.41129032258065,0.361663652802893,1.13935144609991,1.09335576114382,0.0683994528043776,0.142045454545455,2.7027027027027,0.465116279069767,0.93211944444433,0.859953514238974,1.00428537464969,NA,NA,NA,NA,NA,NA,7.99238100110728,9.65302127291306,9.62835890729581,7.82404749521597,7.94454507494712,9.50686843186566,9.34456260645596,8.91719556124791,6.37842387115414,6.51149074430832,8.37008949665112,8.17218088315045,8.56799811015179,410.998503682573,0.282975738404832,0.691593472057338,0.553322273595545,0.768804357856481,"Q6QNK2",2.79e-46,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0016607"
"1083","Pocillopora_acuta_HIv2___RNAseq.g20645.t1",0,0,2.01005025125628,0,1.23203285420945,0.703605980650836,0.411522633744856,0,0,0,0.435721171986142,0.140721196130167,0.730721147842117,NA,NA,NA,NA,NA,NA,7.38264830809177,7.50248485470253,8.70458600931018,7.62113507079819,7.48941789276043,8.14874733571589,9.45853039827569,8.56725347973517,3.68233641306884,6.75413069443622,7.53112704568949,7.16524842059328,7.8970056707857,239.234010278672,0.340358565150104,0.868829064656528,0.43779958713623,0.681042506812049,"Q6QNK2",7.16e-52,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0016607"
"1084","Pocillopora_acuta_HIv2___RNAseq.g20646.t1",0,0,NA,NA,0,2.63157894736842,10.7142857142857,NA,0,NA,2.22431077694236,0.87719298245614,3.57142857142857,NA,NA,NA,NA,NA,NA,7.42800305042402,9.11005132858626,8.818378610946,9.37630383238908,6.43917658127574,9.61020333126859,8.85670563922031,8.86163355661156,3.68233641306884,8.88836131768024,8.10711536614706,7.04590564246523,9.1683250898289,388.57332795423,0.78480317012007,1.13237811855861,0.0757188018087558,0.213543875673199,"Q6QNK2",2.18e-71,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0016607"
"1085","Pocillopora_acuta_HIv2___RNAseq.g20660.t1",0,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.70530894887322,8.14383581458983,10.0427062950968,3.68233641306884,4.41738064913951,3.68233641306884,3.68233641306884,10.1602904759134,9.40066610869537,3.68233641306884,6.55995339445835,8.54527049554366,4.57463629337304,345.179086075557,-0.852272734004349,1.55340889200482,1.82177305169838e-06,2.640293128233e-05,"O18598",2.16e-31,"Glutathione S-transferase (EC 2.5.1.18) (GST class-sigma) (Major allergen Bla g 5) (allergen Bla g 5)","","GO:0004364"
"1086","Pocillopora_acuta_HIv2___TS.g3432.t2",0,11.4285714285714,0,NA,12.1212121212121,2.77777777777778,0,0,0,0,2.92528459195126,3.5515873015873,2.42424242424242,NA,NA,NA,NA,NA,NA,7.19403844897667,7.45044931999893,7.3151128988556,7.72618212191993,9.00723206100263,7.65596787775879,9.01415355586542,7.78676637931927,7.92978827359902,11.0734474626853,8.21531383999816,7.84658761235064,8.58404006764567,429.533909172935,0.419125245281154,0.743618879523487,0.384987591420236,0.633571569268665,"Q91W89",0,"Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1) (Neutral/cytosolic alpha-mannosidase)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0005654; GO:0005829; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"1087","Pocillopora_acuta_HIv2___RNAseq.g3643.t1",0,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.759974421673,11.5514253803248,10.9387447803736,11.459326058881,11.3493058188741,10.8137464095308,11.6081886898457,11.6069636392119,11.4407493074199,10.7615284718526,11.3289952977987,11.4191475935105,11.238843002087,2615.79855142068,-0.136541789332876,0.51200924619959,0.752613810849717,0.891080291621263,"Q4LDD4",8.39e-69,"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 (Centaurin-delta-2) (Cnt-d2)","negative regulation of stress fiber assembly [GO:0051497]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of receptor recycling [GO:0001921]; regulation of cell shape [GO:0008360]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0000976; GO:0001921; GO:0003700; GO:0005096; GO:0005547; GO:0005654; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0007179; GO:0008360; GO:0031702; GO:0032580; GO:0045893; GO:0046872; GO:0051491; GO:0051497; GO:0061629; GO:0070412"
"1088","Pocillopora_acuta_HIv2___RNAseq.g3653.t1",NA,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.6184225229589,7.34031383953571,11.2515349991164,3.68233641306884,11.8392492035967,3.68233641306884,3.68233641306884,9.89213527384446,11.5162056602782,3.68233641306884,7.81872071516057,11.2235095319589,4.41393189836221,1313.49523169237,-12.3179792384906,3.02749038011501,1.00487127143437e-11,8.86247443294316e-10,"P29145",1.58e-161,"PC3-like endoprotease variant B (EC 3.4.21.-) (SPC3)","proteolysis [GO:0006508]","GO:0004252; GO:0006508"
"1089","Pocillopora_acuta_HIv2___RNAseq.g3666.t1c",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.35018855407922,6.54125763453179,8.92162339142109,11.9896702653621,8.95039944272719,9.02272138448691,11.9155876753131,10.3362748160354,11.0458655107004,7.89832065319794,9.49719093278551,9.52087034299266,9.47351152257837,1324.22244389585,-0.0223908486745446,0.810514448245032,0.919238351605125,0.969611032821436,"Q6ZWJ1",1.65e-77,"Syntaxin-binding protein 4 (Syntaxin 4-interacting protein) (STX4-interacting protein) (Synip)","cellular response to type II interferon [GO:0071346]; DNA damage response [GO:0006974]; insulin receptor signaling pathway [GO:0008286]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of keratinocyte proliferation [GO:0010838]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of glucose transmembrane transport [GO:0010827]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]","GO:0006605; GO:0006974; GO:0008286; GO:0010827; GO:0010838; GO:0019905; GO:0031410; GO:0045335; GO:0050821; GO:0061178; GO:0070062; GO:0071346; GO:0098685; GO:0099072; GO:1902808"
"1090","Pocillopora_acuta_HIv2___RNAseq.g3681.t1",0,0,NA,0,8.88888888888889,0,0,NA,0,0,1.11111111111111,0,2.22222222222222,NA,NA,NA,NA,NA,NA,8.17578565497786,9.67010096007007,9.45417818289505,7.67057791575813,9.4017284276406,9.60859406341681,10.3406834804403,9.86509202193393,7.61674954260043,9.37626766476269,9.11797579144959,8.90270676600957,9.3332448168896,630.320197359473,0.300625068123661,0.691053861258197,0.530596144973845,0.751710387795533,"P51610",0,"Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6]","chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein-containing complex assembly [GO:0043254]; release from viral latency [GO:0019046]","GO:0000122; GO:0000123; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0010628; GO:0016020; GO:0019046; GO:0030674; GO:0032991; GO:0035097; GO:0042802; GO:0043025; GO:0043254; GO:0044545; GO:0044665; GO:0045296; GO:0045787; GO:0045893; GO:0045944; GO:0048188; GO:0050821; GO:0071339; GO:0140297"
"1091","Pocillopora_acuta_HIv2___TS.g3527.t1",NA,0,0,0,0,0,9.09090909090909,0,NA,NA,1.2987012987013,0,3.03030303030303,NA,NA,NA,NA,NA,NA,10.2687906023586,9.97045225272625,8.59219896615401,10.8671676176034,9.76390094017949,7.47620947122109,10.1572458891639,5.90789232542808,5.49910115103059,3.68233641306884,8.21852956289342,8.00637679703015,8.4306823287567,656.278209508213,-0.0101764227081749,0.90516878285693,0.90562788034816,0.964810500134212,"Q9UIJ5",1.58e-76,"Palmitoyltransferase ZDHHC2 (EC 2.3.1.225) (Acyltransferase ZDHHC2) (EC 2.3.1.-) (Reduced expression associated with metastasis protein) (Ream) (Reduced expression in cancer protein) (Rec) (Zinc finger DHHC domain-containing protein 2) (DHHC-2) (Zinc finger protein 372)","peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; protein localization to membrane raft [GO:1903044]; protein localization to plasma membrane [GO:0072659]; protein localization to postsynaptic membrane [GO:1903539]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of cell-cell adhesion [GO:0022407]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of protein catabolic process [GO:0042176]; regulation of protein localization to plasma membrane [GO:1903076]; synapse assembly [GO:0007416]","GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006612; GO:0007416; GO:0014069; GO:0016409; GO:0018230; GO:0018345; GO:0019705; GO:0019706; GO:0022407; GO:0042176; GO:0042803; GO:0048168; GO:0055038; GO:0072659; GO:0098837; GO:0098944; GO:0140439; GO:1900273; GO:1903044; GO:1903076; GO:1903539; GO:1904719; GO:1905751"
"1092","Pocillopora_acuta_HIv2___RNAseq.g3709.t1",NA,NA,0,37.5,0,0,0,0,NA,NA,6.25,12.5,0,NA,NA,NA,NA,NA,NA,11.9247071327526,10.7029012027161,10.9272198373129,10.6284565512232,11.1348420437604,10.1365970946579,10.9202354074089,11.4554926071155,10.2073319733984,8.00394309746693,10.6041726947813,11.129918718868,10.0784266706946,1838.89986842911,-0.80191023488087,0.61863545750726,0.0985656291757728,0.258739248711139,"Q92545",0,"Transmembrane protein 131 (Protein RW1)","collagen biosynthetic process [GO:0032964]","GO:0005518; GO:0016020; GO:0032964"
"1093","Pocillopora_acuta_HIv2___RNAseq.g3721.t1",0,0,NA,43.75,0,0,0,NA,NA,NA,7.29166666666667,14.5833333333333,0,NA,NA,NA,NA,NA,NA,8.52315420649741,9.42159259903707,10.5044953177362,8.38342770668208,8.5782815116387,9.59565485098009,11.1036787150444,5.74496152652496,8.61224937819785,3.68233641306884,8.41498322254076,8.39262838811902,8.4373380569625,641.620507606061,0.0242449393598223,0.924798671897149,0.998169682876992,0.999597872528976,"O15050",0,"TPR and ankyrin repeat-containing protein 1 (Lupus brain antigen 1 homolog)","",""
"1094","Pocillopora_acuta_HIv2___RNAseq.g3723.t1",NA,NA,0,0,0,0,NA,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.4187487316035,6.26270646445638,10.6330247395968,10.0729476797117,9.31179266359222,3.68233641306884,3.68233641306884,9.913228515426,10.5545835603731,3.68233641306884,7.82140415939662,10.1662756421183,5.47653267667492,703.784720849938,-0.99019633456501,1.78815642288413,2.67396441091951e-07,5.06233262297642e-06,"A6QLU6",3.82e-31,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"1095","Pocillopora_acuta_HIv2___RNAseq.g3731.t1",0,NA,NA,66.6666666666667,0,20.6896551724138,1.50375939849624,0,0,NA,12.6942973196538,21.8390804597701,0.50125313283208,NA,NA,NA,NA,NA,NA,7.3358031916585,3.68233641306884,7.5288322148278,6.73001114537384,3.68233641306884,3.68233641306884,7.68546509718932,6.92672320941957,7.68222817588062,3.68233641306884,5.8618408686625,6.63118464097107,5.09249709635394,83.7645691407509,-0.258160095706085,1.01213048701423,0.25976478806277,0.501650338226899,NA,NA,NA,NA,NA
"1096","Pocillopora_acuta_HIv2___TS.g3599.t1",0,0,0,0,0,2.39520958083832,6.95652173913043,0,0,0,0.935173131996876,0.479041916167665,1.39130434782609,NA,NA,NA,NA,NA,NA,11.1392926904349,3.68233641306884,11.1733207176873,8.67271162187297,10.6158810521823,9.93949739325492,3.68233641306884,10.7337503929961,11.8124378312474,3.68233641306884,8.51339009388824,11.0949365369096,5.93184365086688,1264.50738023587,-0.687602968420427,1.31103634981997,6.00205161832019e-08,1.37799483503783e-06,"Q2TBA3",1.39e-06,"Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog (EC 3.4.22.-) (Paracaspase)","B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; cellular response to lipopolysaccharide [GO:0071222]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; nuclear export [GO:0051168]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]","GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005829; GO:0006508; GO:0009620; GO:0019209; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0050870; GO:0051168; GO:0051603; GO:0071222; GO:2000321"
"1097","Pocillopora_acuta_HIv2___RNAseq.g3778.t1",0,0,0,0,0,1.20724346076459,0.380228136882129,0,0,NA,0.176385733071857,0.241448692152917,0.0950570342205323,NA,NA,NA,NA,NA,NA,9.53812614030127,7.61700196810264,9.80069286428888,6.05508630481337,9.46103864881457,6.89772912952247,3.68233641306884,6.79689746336218,11.6494420971123,11.3759864553139,8.28743374847004,9.44923944277584,7.12562805416424,847.937059955879,-1.92771431035045,1.50194805606289,0.00445952492200387,0.0210930570542394,"Q9UDY8",6.11e-11,"Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase)","B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]","GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0043280; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051092; GO:0051168; GO:0051603; GO:2000321"
"1098","Pocillopora_acuta_HIv2___RNAseq.g3779.t1",NA,0,0,0,NA,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,9.87722273799593,9.68884409943706,10.0355672768324,10.206939492691,9.79741927901131,9.83877965531544,9.63906410638121,10.1425385412752,8.94033410692654,8.80064517556696,9.69673544714331,9.75861638840828,9.63485450587833,841.307813899134,-0.0971091321146175,0.488960109686212,0.817509781270391,0.92454355065102,NA,NA,NA,NA,NA
"1099","Pocillopora_acuta_HIv2___RNAseq.g3781.t1a",16.6666666666667,NA,NA,NA,0,2.56410256410256,0,0,0,NA,3.20512820512821,0.854700854700855,5.55555555555556,NA,NA,NA,NA,NA,NA,11.0822549949646,10.9214779393958,10.8710394438307,12.2419220964625,11.0137392360816,11.0478330162456,13.283633248771,10.7486216215638,11.2549918701189,11.9545237085926,11.4420037176027,10.9941294333119,11.8898780018935,3285.79983402782,0.607737701097781,0.659569536606968,0.221382129134371,0.45250434102906,"B2KI97",0,"THO complex subunit 2 (Tho2)","generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; neuron development [GO:0048666]; RNA splicing [GO:0008380]","GO:0000347; GO:0003723; GO:0006397; GO:0006406; GO:0008380; GO:0016607; GO:0048666; GO:0048699"
"1100","Pocillopora_acuta_HIv2___RNAseq.g3813.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.4789151142086,9.06483432593658,9.04869395259803,9.60675568484633,9.75634542385889,8.86983362963277,10.2672772798658,8.80972677177386,8.29266586896935,10.370189451734,9.45652375034242,9.27726942628175,9.6357780744031,766.880075630389,0.220781073499235,0.694474025269949,0.643390778119981,0.828526016268465,"Q460N5",3.46e-141,"Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)","innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212]","GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:1902216; GO:1990404"
"1101","Pocillopora_acuta_HIv2___TS.g3673.t1",0,0,10,0,23.4042553191489,25,44,14.2857142857143,66.6666666666667,0,18.335663627153,21.1904761904762,15.4808510638298,NA,NA,NA,NA,NA,NA,12.014905351764,10.8222784930746,12.6071109749448,12.1716935216457,11.7493552300387,12.766367381646,11.4569382774709,12.4157166852942,11.4692533551979,11.3589400298171,11.8832559300894,12.0512683194479,11.7152435407309,4069.23878815984,-0.247836418435923,0.579648147901537,0.598352496523299,0.80025000822734,"Q9WTN3",0,"Sterol regulatory element-binding protein 1 (SREBP-1) (Sterol regulatory element-binding transcription factor 1) [Cleaved into: Processed sterol regulatory element-binding protein 1 (Transcription factor SREBF1)]","cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol biosynthetic process [GO:0006695]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; insulin secretion [GO:0030073]; lipid biosynthetic process [GO:0008610]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of triglyceride metabolic process [GO:0090209]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of innate immune response [GO:0045089]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of DNA-templated transcription [GO:0006355]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; regulation of mitophagy [GO:1901524]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to fructose [GO:0009750]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; SREBP signaling pathway [GO:0032933]; transcription by RNA polymerase II [GO:0006366]","GO:0000122; GO:0000139; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0003062; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0006355; GO:0006357; GO:0006366; GO:0006695; GO:0007584; GO:0007623; GO:0008203; GO:0008286; GO:0008610; GO:0009267; GO:0009410; GO:0009749; GO:0009750; GO:0010867; GO:0010883; GO:0012507; GO:0016020; GO:0019217; GO:0019901; GO:0030073; GO:0030324; GO:0031647; GO:0032094; GO:0032526; GO:0032570; GO:0032810; GO:0032933; GO:0032991; GO:0033762; GO:0042789; GO:0043565; GO:0044877; GO:0045089; GO:0045444; GO:0045471; GO:0045542; GO:0045723; GO:0045893; GO:0045944; GO:0046676; GO:0046889; GO:0046983; GO:0050796; GO:0051591; GO:0071398; GO:0090209; GO:1901524; GO:1902895; GO:1903214"
"1102","Pocillopora_acuta_HIv2___RNAseq.g3862.t1",0,NA,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.70448509956555,3.68233641306884,11.3571498410552,8.781395882489,10.5469484054255,11.9668466173288,3.68233641306884,10.4359553854445,9.04601720904466,3.68233641306884,8.08858076795597,9.81811118810708,6.35905034780486,1050.68134198,-0.596708901081304,1.23476184060094,1.37143609754514e-05,0.000150162389968909,"P18460",1.97e-104,"Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Tyrosine kinase receptor CEK2)","apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; regulation of macromolecule metabolic process [GO:0060255]","GO:0005007; GO:0005524; GO:0005886; GO:0006915; GO:0008284; GO:0017134; GO:0030154; GO:0043235; GO:0043410; GO:0060255"
"1103","Pocillopora_acuta_HIv2___RNAseq.g3865.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.9574346304241,12.7846642892623,10.8089982105771,12.524812998733,11.7574188787347,10.7170137713798,10.4504269336355,11.9761125872564,9.89067121680312,10.8870005939923,11.3754554110798,11.2781271047591,11.4727837174006,3188.04557098128,0.132649004217543,0.6648034514982,0.78280007352319,0.907681598800659,"Q3KQW7",5.99e-27,"LIM and calponin homology domains-containing protein 1","actomyosin structure organization [GO:0031032]; negative regulation of cell migration [GO:0030336]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; regulation of focal adhesion assembly [GO:0051893]","GO:0001725; GO:0001934; GO:0003779; GO:0005737; GO:0030336; GO:0031032; GO:0046872; GO:0051496; GO:0051893"
"1104","Pocillopora_acuta_HIv2___RNAseq.g3884.t1",0,0,0,0,2.1505376344086,0.427350427350427,0,NA,NA,NA,0.368269723108433,0.142450142450142,0.537634408602151,NA,NA,NA,NA,NA,NA,6.11310426585121,5.88506810849203,5.16860104011765,4.86458704699243,5.66700991799266,5.08222717563762,5.59808714140454,5.12735228357021,5.69309697015473,6.4574369061227,5.56565708563358,5.55383289553729,5.57748127572986,28.1049655796419,-0.0103419339793656,0.67916736392247,0.978269552178658,0.992220049005353,NA,NA,NA,NA,NA
"1105","Pocillopora_acuta_HIv2___RNAseq.13044_t",0,0,0,NA,0,3.77358490566038,3.44827586206897,0,0,NA,0.902732595966168,0.943396226415094,0.862068965517241,NA,NA,NA,NA,NA,NA,7.43542392964019,8.84171485494338,10.6002230501379,10.027993673575,5.95850798619116,3.68233641306884,10.7268229254561,9.078588829153,6.34211912572884,11.2512295548405,8.39449603427349,7.88297258417022,8.90601948437676,782.019555916938,0.215075748105476,0.919732124677235,0.545019634075425,0.763306748977136,"Q6IFT6",5.11e-71,"Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G)","calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; establishment of localization in cell [GO:0051649]","GO:0005229; GO:0005254; GO:0005783; GO:0005886; GO:0017128; GO:0046983; GO:0051649; GO:0061588; GO:0061589; GO:0061590; GO:0061591; GO:1902476"
"1106","Pocillopora_acuta_HIv2___RNAseq.g3902.t1",NA,NA,NA,100,100,100,85.7142857142857,100,NA,100,97.6190476190476,100,95.2380952380952,NA,NA,NA,NA,NA,NA,13.5590651178066,14.6062158356888,13.4424825310203,14.866022703371,13.1710477175421,15.1682936618533,14.4994962254894,13.2752774149069,10.6554569084619,15.2483853569082,13.8491743473048,12.8206659379476,14.8776827566621,19740.7329294039,1.46359273395438,0.866879674135073,0.0139486580889479,0.0550787307121327,"Q32Q86",9.01e-159,"Cryptochrome-1","circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein ubiquitination [GO:0031398]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; regulation of gluconeogenesis [GO:0006111]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]; signal transduction in response to DNA damage [GO:0042770]","GO:0000122; GO:0003677; GO:0003690; GO:0005634; GO:0005737; GO:0005739; GO:0006094; GO:0006111; GO:0007623; GO:0009416; GO:0009881; GO:0014823; GO:0016922; GO:0019900; GO:0019901; GO:0019902; GO:0019915; GO:0031397; GO:0031398; GO:0032868; GO:0032922; GO:0033762; GO:0042593; GO:0042752; GO:0042754; GO:0042770; GO:0042826; GO:0043153; GO:0045721; GO:0045722; GO:0045744; GO:0045892; GO:0070888; GO:0071949; GO:0140297; GO:2000001; GO:2000323; GO:2000850"
"1107","Pocillopora_acuta_HIv2___TS.g22198.t1",NA,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.34371843387449,3.68233641306884,8.09125087353016,11.0999079491544,4.82690108855957,9.53932977438237,3.68233641306884,3.68233641306884,3.68233641306884,3.68233641306884,5.93127901848452,5.52530864442038,6.33724939254866,328.181574517527,0.108380300204811,1.01202173208598,0.50449198560466,0.733340677314533,"P19643",1.02e-07,"Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B)","negative regulation of serotonin secretion [GO:0014063]; phenylethylamine catabolic process [GO:0019607]; positive regulation of dopamine metabolic process [GO:0045964]; response to aluminum ion [GO:0010044]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to steroid hormone [GO:0048545]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]","GO:0005739; GO:0005741; GO:0008131; GO:0009410; GO:0009636; GO:0010044; GO:0010269; GO:0014063; GO:0019607; GO:0030425; GO:0032496; GO:0042802; GO:0043025; GO:0045471; GO:0045964; GO:0048545; GO:0050660; GO:0051412; GO:0052595; GO:0097621"
"1108","Pocillopora_acuta_HIv2___RNAseq.g2322.t1b",0,0,0,0,0,1.76991150442478,0,0,NA,NA,0.221238938053097,0.442477876106195,0,NA,NA,NA,NA,NA,NA,7.45015090580822,8.43372565070379,7.63565941754202,9.4533799163338,9.66547833317844,7.26229034322735,8.01924883694224,8.89891197015975,3.68233641306884,3.68233641306884,7.41835182000333,7.46650740795145,7.3701962320552,292.230097925768,-0.0259091979638592,0.817051657101848,0.991280688700472,0.996626742584487,"Q6DFF6",4.98e-172,"Kelch-like protein 20","Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]","GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390"
"1109","Pocillopora_acuta_HIv2___RNAseq.g2329.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.81697116993508,9.47440706498007,10.1352994137747,9.21134190495212,9.87882750154072,10.2636945008505,10.8228658771435,10.4523368285118,3.68233641306884,11.6229432248627,9.436102389962,8.59315426536623,10.2790505145578,1118.75877454574,0.252375975176038,0.899342500031152,0.537131557860467,0.757521187418802,"A0A2D0TC04",4.88e-145,"Venom phosphodiesterase (PDE) (EC 3.6.1.-)","","GO:0003676; GO:0005576; GO:0043262; GO:0046872; GO:0090729"
"1110","Pocillopora_acuta_HIv2___RNAseq.g2368.t1b",0,0,0,NA,0,3.2258064516129,NA,NA,0,NA,0.537634408602151,1.0752688172043,0,NA,NA,NA,NA,NA,NA,9.33602916180979,9.82723619768913,9.69978231634291,10.9633326114345,10.851267094397,8.87787588494184,3.68233641306884,10.0236080487484,11.9581419156968,6.61366512258304,9.18332747667123,10.373765707399,7.99288924594347,1159.04175838375,-0.462894942877134,1.04001722694208,0.0977425971852812,0.257118286933781,"H9D1R1",4.35e-55,"Thioredoxin domain-containing protein 12 (EC 1.8.4.2)","defense response to virus [GO:0051607]","GO:0005788; GO:0009055; GO:0019153; GO:0051607"
"1111","Pocillopora_acuta_HIv2___RNAseq.g2384.t1",0,0,0,0,NA,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,7.69216879492937,5.74095382813731,8.8419698660937,3.68233641306884,8.43876990824882,3.68233641306884,3.68233641306884,9.98774538530658,10.6216868699097,8.59512945492368,7.09654333467557,9.11646816489763,5.0766185044535,386.949675165107,-1.40928926124706,2.74135234291718,9.90624185355386e-07,1.55743350184568e-05,"P02597",2.19e-39,"Calmodulin, striated muscle","","GO:0005509; GO:0005737"
"1112","Pocillopora_acuta_HIv2___TS.g22351.t2",1.73913043478261,0,0,5.04201680672269,0,0.869565217391304,0,0,0,NA,0.850079162099622,1.1823164048228,0.434782608695652,NA,NA,NA,NA,NA,NA,6.66923905548191,10.6964334524209,8.67861202552873,9.9319683320312,3.68233641306884,11.1869381432193,10.1531072901146,6.35881100040517,3.68233641306884,10.7656192469976,8.18054013723371,5.8142669815107,10.5468132929567,823.990219553825,1.52467469676117,3.05481771540953,0.000445562048292332,0.00296440177851899,"P04927",6.84e-11,"S-antigen protein","","GO:0020003"
"1113","Pocillopora_acuta_HIv2___RNAseq.g2445.t1",0,0,0,0,NA,10.5263157894737,0,0,0,NA,1.31578947368421,2.10526315789474,0,NA,NA,NA,NA,NA,NA,8.87243848970605,11.8845712339512,9.0767981169388,9.84883592081904,9.80201359261142,12.3684482871838,12.0981474433347,10.7491316981573,6.6827526322222,11.6976363990679,10.3080773813992,9.03662690592715,11.5795278568713,2116.81954437018,1.9328643526859,1.02983188081347,0.00326555006042997,0.016270381010699,"Q9HCI5",9.11e-15,"Melanoma-associated antigen E1 (Alpha-dystrobrevin-associated MAGE Protein) (DAMAGE) (Hepatocellular carcinoma-associated protein 1) (MAGE-E1 antigen)","negative regulation of transcription by RNA polymerase II [GO:0000122]","GO:0000122; GO:0005634; GO:0005886; GO:0030425; GO:0045211; GO:0048471"
"1114","Pocillopora_acuta_HIv2___RNAseq.g2451.t1",0,0,NA,77.7777777777778,50,20.5882352941176,0,NA,NA,NA,24.7276688453159,32.7886710239651,16.6666666666667,NA,NA,NA,NA,NA,NA,7.96707824409319,8.58961299098714,7.43223115439203,3.68233641306884,8.71328977413245,6.19123426543186,3.68233641306884,6.63600256149146,3.68233641306884,3.68233641306884,6.02587946428035,6.88618762943559,5.1655712991251,125.271854448619,-0.428150184597375,1.10167080645332,0.0719254287014807,0.20555807167323,"P05205",5.88e-10,"Heterochromatin protein 1 (HP1) (Non-histone chromosomal protein C1A9 antigen)","chromosome organization [GO:0051276]; heterochromatin formation [GO:0031507]; mitotic cell cycle [GO:0000278]; negative regulation of DNA-templated transcription [GO:0045892]; pericentric heterochromatin formation [GO:0031508]; positive regulation of DNA methylation-dependent heterochromatin formation [GO:0090309]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to euchromatin [GO:1905632]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein localization to chromatin [GO:1905634]; telomere maintenance [GO:0000723]","GO:0000182; GO:0000278; GO:0000723; GO:0000775; GO:0000779; GO:0000781; GO:0000791; GO:0000792; GO:0000793; GO:0003682; GO:0003696; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005694; GO:0005700; GO:0005701; GO:0005703; GO:0005721; GO:0006355; GO:0010369; GO:0030544; GO:0030674; GO:0031507; GO:0031508; GO:0035064; GO:0042393; GO:0044877; GO:0045892; GO:0045893; GO:0045944; GO:0051276; GO:0070063; GO:0090309; GO:0099122; GO:1905632; GO:1905634; GO:1905646"
"1115","Pocillopora_acuta_HIv2___RNAseq.g20215.t1",0,0,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.91377419539293,3.68233641306884,6.89159417457077,6.83590881275217,3.68233641306884,8.52865999346697,10.1266167339502,7.62211912839311,6.81970434483651,9.73179728955948,7.08348474990598,6.38590565125243,7.78106384855953,280.291014986573,0.279360623813349,1.00825758460423,0.266488085418623,0.510324859988741,"Q09575",5.81e-08,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0005737; GO:0008270; GO:0015074; GO:0019899; GO:0042575"
"1116","Pocillopora_acuta_HIv2___RNAseq.g20266.t1",NA,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.9511981009209,6.22089677820832,5.89089308266057,5.67021878014534,5.85854445871868,5.82637165358479,6.63285646347393,5.84514254962292,3.68233641306884,4.40467075915833,5.59831290395626,5.44562292099838,5.75100288691414,33.7253184770117,0.347363917151714,0.750984435126967,0.497799283198941,0.727877965243579,"Q80TR8",1.87e-44,"DDB1- and CUL4-associated factor 1 (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1)","B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]","GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0008180; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756"
"1117","Pocillopora_acuta_HIv2___RNAseq.g30981.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0685629745122,10.1311885917524,10.5409616549701,10.6592767396735,10.4372448551981,9.77851578964601,8.74740452298089,9.19703140164984,3.68233641306884,9.97498742121413,9.3217510364666,8.78522745987982,9.85827461305339,936.080852249893,0.152247656600452,0.867529049973195,0.718136584974,0.87263231628434,"Q5RBB1",3.64e-91,"Sentrin-specific protease 1 (EC 3.4.22.-) (Sentrin/SUMO-specific protease SENP1)","protein desumoylation [GO:0016926]; proteolysis [GO:0006508]","GO:0005634; GO:0005737; GO:0006508; GO:0016926; GO:0016929; GO:0070139"
"1118","Pocillopora_acuta_HIv2___RNAseq.g30984.t1",NA,NA,0,0,0,0,NA,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,11.127950272234,9.69812509453545,10.7652818881293,9.49270992195312,10.0851432782511,9.94460839326245,3.68233641306884,10.7873791095714,9.81029112020909,11.2267107494913,9.66205362407061,10.515209133679,8.80889811446223,1243.30598310738,-0.321555553458857,0.926240458675318,0.388046100643318,0.63556774993828,"Q5EA61",8.63e-95,"Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain) (Creatine phosphokinase M-type) (CPK-B)","brain development [GO:0007420]; futile creatine cycle [GO:0140651]; intracellular chloride ion homeostasis [GO:0030644]; phosphocreatine biosynthetic process [GO:0046314]","GO:0004111; GO:0005524; GO:0005615; GO:0005739; GO:0005829; GO:0005886; GO:0007420; GO:0030644; GO:0031625; GO:0046314; GO:0140651"
"1119","Pocillopora_acuta_HIv2___RNAseq.g30986.t1",0,NA,12.5,0,NA,10,0,0,0,NA,3.21428571428571,2.5,4.16666666666667,NA,NA,NA,NA,NA,NA,9.35561802083288,7.7732326587915,7.45700107032243,3.68233641306884,9.30144444624961,3.68233641306884,3.68233641306884,9.27847035822101,7.78511408192754,8.63745518523718,7.06353450607887,8.63552959551069,5.49153941664704,274.427804339854,-0.554595913947569,1.18306612909149,2.46036046449921e-05,0.000246795069454252,"Q704V6",1.45e-11,"Toll-like receptor 6 (CD antigen CD286)","cellular response to diacyl bacterial lipopeptide [GO:0071726]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; toll-like receptor signaling pathway [GO:0002224]","GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0032731; GO:0035355; GO:0035663; GO:0038023; GO:0042802; GO:0045087; GO:0045121; GO:0061809; GO:0071723; GO:0071726; GO:1900227"
"1120","Pocillopora_acuta_HIv2___RNAseq.g31038.t1",0,NA,0,0,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.51914456081915,6.54125763453179,11.3542839840558,7.96925428521777,11.5176597483509,3.68233641306884,4.69145782511396,9.28692917524323,11.8605736252752,7.92790638063269,8.43508036323093,10.7077182187489,6.16244250771301,1101.92807608059,-4.00047789167036,1.76129237883341,8.68956301757238e-05,0.000734146258680881,"P50549",1.41e-68,"ETS translocation variant 1 (Ets-related protein 81)","axon guidance [GO:0007411]; mechanosensory behavior [GO:0007638]; muscle organ development [GO:0007517]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]","GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0007411; GO:0007517; GO:0007638; GO:0045944; GO:0048935; GO:1990837"
"1121","Pocillopora_acuta_HIv2___RNAseq.g31040.t1",0,0,NA,0,0,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,11.5592747028611,11.3855900994701,10.1189881605459,10.6562241847351,11.8037318827734,11.8593366771151,11.7391064287247,11.9459524640008,6.63891135226464,8.33339164675596,10.6040507599247,10.4133717124892,10.7947298073602,2324.15505969681,0.285250587857779,0.585695032370918,0.542170204743292,0.761247898958841,"Q5R526",1.46e-08,"DAZ-associated protein 2 (Deleted in azoospermia-associated protein 2) (Proline-rich transcript in brain protein)","positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1905636]; protein destabilization [GO:0031648]; stress granule assembly [GO:0034063]","GO:0002039; GO:0005634; GO:0005737; GO:0010494; GO:0016604; GO:0016607; GO:0030971; GO:0031435; GO:0031625; GO:0031648; GO:0032991; GO:0034063; GO:0042802; GO:0043539; GO:0050699; GO:0120283; GO:0140297; GO:1905636"
"1122","Pocillopora_acuta_HIv2___RNAseq.g31061.t1",NA,NA,NA,NA,0,0,38.8888888888889,0,0,0,6.48148148148148,0,12.962962962963,NA,NA,NA,NA,NA,NA,9.44975813022123,3.68233641306884,7.63565941754202,3.68233641306884,8.23065898728289,7.78738559023813,3.68233641306884,5.65507448014406,6.28579400236677,3.68233641306884,5.97736762600705,7.45138900351139,4.5033462485027,140.156502876075,-1.04002659353816,1.92464224367362,3.86731806229354e-05,0.000365123292774242,NA,NA,NA,NA,NA
"1123","Pocillopora_acuta_HIv2___TS.g14968.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.26147673713321,8.39310902442961,7.07161686373946,3.68233641306884,3.68233641306884,3.68233641306884,9.54321054616989,10.1440908906608,3.68233641306884,3.68233641306884,6.18251861274772,6.56837146353423,5.7966657619612,252.945483620343,-0.158324428310071,0.97134045797825,0.722876850054154,0.875577315928563,NA,NA,NA,NA,NA
"1124","Pocillopora_acuta_HIv2___RNAseq.g31067.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.62894561063038,3.68233641306884,7.35523113293712,3.68233641306884,6.98985932682562,3.68233641306884,8.16915841609588,9.64153408656845,9.35694267211217,3.68233641306884,6.3871016897445,8.19450256581475,4.57970081367425,208.117822889682,-7.47050926616739,3.35331412459462,1.19750234814313e-06,1.8290046424015e-05,NA,NA,NA,NA,NA
"1125","Pocillopora_acuta_HIv2___RNAseq.g31076.t1",NA,0,NA,0,0,0,0,NA,NA,11.5384615384615,1.92307692307692,0,3.84615384615385,NA,NA,NA,NA,NA,NA,11.6381446750964,11.0194835570927,11.3398686740765,10.1283406955416,11.5370770382901,11.4399357827754,11.5395730587414,11.9275940866871,12.2341969756994,12.4096732356487,11.5213887779649,11.7353762899699,11.30740126596,3159.96265874663,-0.320894565509256,0.527811906389326,0.467501773437205,0.706798960070631,"P16951",3.2e-84,"Cyclic AMP-dependent transcription factor ATF-2 (cAMP-dependent transcription factor ATF-2) (Activating transcription factor 2) (MXBP protein) (cAMP response element-binding protein CRE-BP1)","abducens nucleus development [GO:0021742]; adipose tissue development [GO:0060612]; amelogenesis [GO:0097186]; apoptotic process [GO:0006915]; apoptotic process involved in development [GO:1902742]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; cellular lipid metabolic process [GO:0044255]; cellular response to anisomycin [GO:0072740]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; cellular response to virus [GO:0098586]; detection of cell density [GO:0060245]; DNA damage response [GO:0006974]; facial nucleus development [GO:0021754]; gene expression [GO:0010467]; growth plate cartilage chondrocyte differentiation [GO:0003418]; growth plate cartilage chondrocyte proliferation [GO:0003419]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; hepatocyte apoptotic process [GO:0097284]; hypoglossal nucleus development [GO:0021743]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; JNK cascade [GO:0007254]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; motor neuron apoptotic process [GO:0097049]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of angiogenesis [GO:0016525]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurofilament cytoskeleton organization [GO:0060052]; NK T cell differentiation [GO:0001865]; outflow tract morphogenesis [GO:0003151]; p38MAPK cascade [GO:0038066]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; protein import into nucleus [GO:0006606]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to organic cyclic compound [GO:0014070]; response to osmotic stress [GO:0006970]; transcription initiation-coupled chromatin remodeling [GO:0045815]; vacuole organization [GO:0007033]; white fat cell differentiation [GO:0050872]","GO:0000122; GO:0000165; GO:0000978; GO:0000981; GO:0001228; GO:0001701; GO:0001865; GO:0001889; GO:0001934; GO:0002244; GO:0003151; GO:0003360; GO:0003418; GO:0003419; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0006355; GO:0006357; GO:0006606; GO:0006915; GO:0006970; GO:0006974; GO:0007033; GO:0007254; GO:0007507; GO:0008140; GO:0010467; GO:0010485; GO:0014070; GO:0016020; GO:0016525; GO:0016602; GO:0019901; GO:0021742; GO:0021743; GO:0021754; GO:0030509; GO:0031573; GO:0032915; GO:0034599; GO:0035497; GO:0035861; GO:0038066; GO:0042789; GO:0042803; GO:0043522; GO:0043525; GO:0043565; GO:0044013; GO:0044255; GO:0044877; GO:0045815; GO:0045944; GO:0046872; GO:0046982; GO:0050680; GO:0050872; GO:0051091; GO:0060052; GO:0060245; GO:0060612; GO:0061629; GO:0072740; GO:0097049; GO:0097186; GO:0097284; GO:0098586; GO:0110024; GO:1902110; GO:1902562; GO:1902742; GO:1990144; GO:1990253; GO:1990841"
"1126","Pocillopora_acuta_HIv2___RNAseq.g31081.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.34627273025484,11.1610885391398,8.52963039598,12.676132875212,7.94454507494712,11.9218870912431,11.5521985958481,9.38342879926144,3.68233641306884,13.3970718037389,9.85945923186941,7.57724268270245,12.1416757810364,2788.55766565212,2.58240351982175,2.06520360452336,0.00301254861546487,0.0152195260824603,"Q29121",9.66e-164,"Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form]","protein O-linked glycosylation [GO:0006493]","GO:0004653; GO:0005576; GO:0005794; GO:0006493; GO:0030145; GO:0030246; GO:0032580"
"1127","Pocillopora_acuta_HIv2___RNAseq.g3907.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,6.5579743664166,7.09556155255397,3.68233641306884,5.31048131328141,3.68233641306884,10.51312253111,9.59120293861953,9.68329764860644,3.68233641306884,6.34809860028633,7.07257597322604,5.62362122734662,317.913878064101,-0.145189283536096,1.01125667781706,0.0024524586678268,0.012732362588459,"Q96RW7",3.51e-36,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711"
"1128","Pocillopora_acuta_HIv2___RNAseq.g3920.t1",0,0,0,6.66666666666667,0,0,0,NA,0,NA,0.833333333333333,1.66666666666667,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.17882016274784,5.89089308266057,8.23286033009443,3.68233641306884,8.88587349129514,8.46055785917695,6.84409752428356,3.68233641306884,3.68233641306884,6.02224481025338,4.75639996923013,7.28808965127664,129.795146933022,0.610322504550404,1.2340073064957,0.0273223322898113,0.0958038268233247,"O00468",8.74e-08,"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","clustering of voltage-gated sodium channels [GO:0045162]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; synapse organization [GO:0050808]","GO:0002162; GO:0005200; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005886; GO:0007165; GO:0007213; GO:0007528; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0043547; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0050808; GO:0051491; GO:0062023; GO:0070062"
"1129","Pocillopora_acuta_HIv2___RNAseq.g3923.t2",4.8780487804878,12.9175946547884,1.70940170940171,1.75438596491228,6.31313131313131,0,1.12219451371571,3.58974358974359,4.34782608695652,3.25814536340852,3.98904719765459,4.52191005928016,3.45618433602901,NA,NA,NA,NA,NA,NA,3.68233641306884,9.52743925559399,7.40065151733208,10.3908121849062,3.68233641306884,11.3551657459418,11.3537386537724,9.89674707718608,3.68233641306884,8.9082467043071,7.98798103782462,5.66888156674494,10.3070805089043,874.224738607362,0.943362717610533,1.65373531935658,4.12146164710307e-07,7.39613167043409e-06,"O00468",1.47e-08,"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","clustering of voltage-gated sodium channels [GO:0045162]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; synapse organization [GO:0050808]","GO:0002162; GO:0005200; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005886; GO:0007165; GO:0007213; GO:0007528; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0043547; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0050808; GO:0051491; GO:0062023; GO:0070062"
"1130","Pocillopora_acuta_HIv2___RNAseq.g3924.t1",0,NA,NA,0,0,1.75438596491228,0,0,NA,NA,0.292397660818713,0.584795321637427,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.36865548890326,3.68233641306884,7.96925428521777,3.68233641306884,8.70481290756462,8.65669248600545,6.6888369593493,3.68233641306884,8.23437277660538,6.23519705559211,4.28363652232493,8.1867575888593,149.157933080526,8.91231671251361,3.22644584993891,1.58558517539448e-07,3.21653632214666e-06,NA,NA,NA,NA,NA
"1131","Pocillopora_acuta_HIv2___RNAseq.g3928.t1",0,NA,NA,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.5469293162604,9.16464773428985,9.43569940235883,10.299849035045,10.5480426608377,10.4094290653816,10.1599983725359,10.4759491787879,10.7446558637447,6.9219028403352,9.87071034695771,10.3502552843979,9.39116540951751,1103.15458062284,-0.459532848633401,0.768373311335866,0.324721793077235,0.574206173717678,"P84169",4.92e-140,"26S proteasome non-ATPase regulatory subunit 13 (26S proteasome regulatory subunit RPN9) (26S proteasome regulatory subunit S11) (26S proteasome regulatory subunit p40.5)","ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005198; GO:0005634; GO:0005829; GO:0006511; GO:0008541; GO:0022624"
"1132","Pocillopora_acuta_HIv2___RNAseq.g3937.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.134781163883,13.0274112076315,11.4582290137318,11.696697665819,11.8806601646331,12.1402770114974,12.4621127962613,11.5510218391502,13.6157414008875,11.9852509700835,12.1952183233578,12.1280867164571,12.2623499302585,5225.83432326707,0.113794718317377,0.600094508400699,0.809090708118685,0.920312047989042,"Q925B0",5.17e-06,"PRKC apoptosis WT1 regulator protein (Prostate apoptosis response 4 protein) (Par-4)","actin filament bundle assembly [GO:0051017]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; calcium ion import across plasma membrane [GO:0098703]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of calcium ion import [GO:0090281]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of action potential [GO:0045760]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cellular senescence [GO:2000774]; positive regulation of gene expression [GO:0010628]; positive regulation of hindgut contraction [GO:0060450]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of relaxation of smooth muscle [GO:1901082]","GO:0000122; GO:0000785; GO:0003779; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0008157; GO:0010628; GO:0010629; GO:0010719; GO:0015629; GO:0030424; GO:0030889; GO:0042130; GO:0042986; GO:0043025; GO:0043065; GO:0043522; GO:0043525; GO:0045760; GO:0048147; GO:0050860; GO:0050965; GO:0050966; GO:0051017; GO:0060450; GO:0090281; GO:0097190; GO:0098703; GO:1901082; GO:1901300; GO:1903238; GO:1904457; GO:2000391; GO:2000774"
"1133","Pocillopora_acuta_HIv2___RNAseq.g3939.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,10.5421556634766,3.68233641306884,8.02725225421589,4.78991773661312,10.6403481717807,10.3223720760532,3.68233641306884,3.68233641306884,10.639036600694,6.96904281551089,3.9038526777777,10.0342329532441,610.379215541957,11.7790085610348,2.42993105057754,1.37363023364899e-13,2.4528626789505e-11,"Q9W770",1.17e-71,"Spondin-1 (F-spondin)","cell adhesion [GO:0007155]","GO:0005576; GO:0007155; GO:0031012; GO:0046872"
"1134","Pocillopora_acuta_HIv2___TS.g12914.t1",0,0,NA,0,0,50,0,0,NA,NA,7.14285714285714,12.5,0,NA,NA,NA,NA,NA,NA,12.1939015967731,12.3941733286883,12.3705031064191,12.3731967547213,11.6471170699612,13.0246312899161,13.0584125069401,12.5064536675223,11.5295555786067,12.5988511415826,12.3696796041131,12.0495062038565,12.6898530043697,5546.132714461,0.49042196728691,0.545954257557447,0.285736034556019,0.531697671917953,"O60293",9.29e-132,"Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2)","RNA processing [GO:0006396]","GO:0000178; GO:0005615; GO:0005634; GO:0006396; GO:0046872"
"1135","Pocillopora_acuta_HIv2___RNAseq.g3968.t1",0,0,0,NA,28.5714285714286,22.5806451612903,0,NA,28.5714285714286,NA,11.3890717577354,17.0506912442396,7.14285714285714,NA,NA,NA,NA,NA,NA,7.95167965288704,6.43649034287553,7.38136255625802,3.68233641306884,5.46172465639773,8.29220497476352,6.93604804798219,7.74631987145943,3.68233641306884,3.68233641306884,6.125283934183,6.44468463001421,5.80588323835178,102.582989879879,-0.186011588332261,0.970250639376635,0.586096849000155,0.792641872270991,NA,NA,NA,NA,NA
"1136","Pocillopora_acuta_HIv2___TS.g12944.t1",0,0,NA,0,0,0,0,NA,21.4285714285714,NA,3.06122448979592,5.35714285714286,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.21207643129142,9.0262210408604,9.84883592081904,9.77047969910791,3.68233641306884,10.2888140826913,10.4200265892518,3.68233641306884,3.68233641306884,7.32957994162972,7.31628003107156,7.34287985218789,537.816939062797,0.0369471793567589,0.975693481650474,0.878127470326224,0.952980997782933,NA,NA,NA,NA,NA
"1137","Pocillopora_acuta_HIv2___RNAseq.g3995.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.42800305042402,3.68233641306884,7.76011177582932,6.92073451612509,10.1252885991919,10.9011159321961,10.3321670788441,7.33026734222755,7.45952232732554,3.68233641306884,7.56218834483013,8.02063861899967,7.10373807066059,496.543020150035,-0.195823995610277,0.968925601765571,0.274125491780305,0.518972658784075,"P11862",1.76e-67,"Growth arrest-specific protein 2 (GAS-2)","actin crosslink formation [GO:0051764]; antral ovarian follicle growth [GO:0001547]; apoptotic process [GO:0006915]; basement membrane organization [GO:0071711]; initiation of primordial ovarian follicle growth [GO:0001544]; ovulation [GO:0030728]; regulation of cell cycle [GO:0051726]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593]","GO:0001544; GO:0001547; GO:0001725; GO:0005737; GO:0005884; GO:0006915; GO:0008017; GO:0008093; GO:0008360; GO:0008593; GO:0016020; GO:0030728; GO:0051015; GO:0051726; GO:0051764; GO:0071711"
"1138","Pocillopora_acuta_HIv2___RNAseq.g4000.t1",0,NA,NA,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,7.58296597751871,10.4778798658706,9.31619441972494,10.101658367495,6.77970596320737,11.4134580311963,11.5563826726702,9.56709998910106,3.68233641306884,3.68233641306884,8.41600181129219,7.38566055252418,9.44634307006019,975.972924326337,1.64440000951637,1.29823853631852,0.0179736562692134,0.0680908759240185,"P70627",9.02e-155,"Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase)","folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]","GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493"
"1139","Pocillopora_acuta_HIv2___RNAseq.g4004.t2",NA,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.887021138101,12.0686041401928,12.0001798993129,10.5105843273305,11.9697048143814,12.9688222836819,10.6119152630067,12.6519692245881,12.2971268414779,11.4181747419774,11.9384102674051,12.3612003835723,11.5156201512379,4496.76562926697,-0.589466595033054,0.667299673343237,0.225684487626076,0.458376160755734,"P00516",0,"cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI)","cGMP-mediated signaling [GO:0019934]; collateral sprouting [GO:0048668]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; protein kinase A signaling [GO:0010737]; regulation of GTPase activity [GO:0043087]; relaxation of vascular associated smooth muscle [GO:0060087]","GO:0001764; GO:0004692; GO:0005246; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0010737; GO:0016358; GO:0019934; GO:0030553; GO:0030900; GO:0042802; GO:0043087; GO:0048668; GO:0060087; GO:0090331; GO:0106310; GO:1904706; GO:1904753"
"1140","Pocillopora_acuta_HIv2___TS.g12990.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.2507191294519,3.68233641306884,8.58382535959455,5.56232777220043,4.28462663579717,3.68233641306884,3.68233641306884,8.30079992882404,10.4346033520377,9.22992668983972,6.6693838106952,8.17091488114107,5.16785274024933,319.323234430846,-1.41512964106404,2.54470302310449,0.00104180566577002,0.00606385398378171,"P57769",1.16e-43,"Sorting nexin-16","early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]","GO:0005764; GO:0005769; GO:0005770; GO:0006622; GO:0008333; GO:0010008; GO:0031901; GO:0031902; GO:0035091; GO:0042802; GO:0045022"
"1141","Pocillopora_acuta_HIv2___RNAseq.g4039.t1",0,6.97674418604651,25.7142857142857,0,10,8,16.9230769230769,30.4347826086957,0,NA,10.8943210480116,9.08230535894843,13.1593406593407,NA,NA,NA,NA,NA,NA,7.66090630254611,3.68233641306884,6.14868956725197,3.68233641306884,7.54334529587741,3.68233641306884,3.68233641306884,6.34780447458004,3.68233641306884,11.001271255734,5.71136989613337,6.27661641066487,5.14612338160187,246.886532181351,-0.251528062130955,1.0657327297534,7.41510906385312e-05,0.000644156981979409,"Q14191",0,"Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN (DNA helicase, RecQ-like type 3) (RecQ protein-like 2) (Werner syndrome protein) [Includes: 3'-5' exonuclease (EC 3.1.-.-); ATP-dependent helicase (EC 5.6.2.4) (DNA 3'-5' helicase WRN)]","base-excision repair [GO:0006284]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; cellular senescence [GO:0090398]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of growth rate [GO:0040009]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820]","GO:0000287; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000731; GO:0000781; GO:0003677; GO:0003678; GO:0003682; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006259; GO:0006260; GO:0006268; GO:0006284; GO:0006302; GO:0006974; GO:0006979; GO:0008340; GO:0008408; GO:0009267; GO:0009378; GO:0010225; GO:0016607; GO:0016853; GO:0016887; GO:0030145; GO:0031297; GO:0032201; GO:0032405; GO:0032508; GO:0040009; GO:0042803; GO:0043138; GO:0044806; GO:0044877; GO:0051345; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0070337; GO:0071480; GO:0090398; GO:0090399; GO:0090656; GO:0098530; GO:1902570; GO:1905773"
"1142","Pocillopora_acuta_HIv2___RNAseq.g4071.t1",0,0,NA,NA,14.2857142857143,0,0,NA,0,NA,2.38095238095238,0,4.76190476190476,NA,NA,NA,NA,NA,NA,9.18434663461896,7.1572797975657,9.67505324614081,10.0775191149871,10.2387487258947,3.68233641306884,9.93100572731929,10.0420432976576,10.8866792377836,10.1141096757426,9.09891218707792,10.0053742284191,8.19245014573671,863.427391499539,-0.412226326093502,0.944172270535321,0.293295098625985,0.540187454535961,NA,NA,NA,NA,NA
"1143","Pocillopora_acuta_HIv2___RNAseq.g4080.t1",0,21.8181818181818,8.95522388059701,0,0,21.0526315789474,10.2040816326531,0,0,14.2857142857143,7.63158331960935,8.57416267942584,6.68900395979287,NA,NA,NA,NA,NA,NA,9.91203073243211,11.1091670266276,6.86389470932694,10.7555993946047,4.99332554465423,10.9527550278495,12.709240432965,7.94518256625855,7.50048072915978,13.1482763540262,9.58899525179046,7.44298285636632,11.7350076472146,2298.64897734108,4.29749234339526,1.23188118616822,6.5370679501242e-07,1.08805697158339e-05,NA,NA,NA,NA,NA
"1144","Pocillopora_acuta_HIv2___TS.g13052.t1",NA,44,10.3448275862069,0,0,23.8805970149254,12.1951219512195,0,NA,NA,12.9172209360503,16.9701492537313,7.51331651247547,NA,NA,NA,NA,NA,NA,6.5907432092831,6.81522472615292,8.075392186735,9.59404768410316,7.10840896269092,8.32789903644394,3.68233641306884,7.64431660005706,3.68233641306884,3.68233641306884,6.52030416446726,6.62023947436698,6.42036885456754,173.776167691338,0.00752846131959259,0.925978428489214,0.912760404195807,0.967643845446301,"Q9H5L6",3.55e-09,"DNA transposase THAP9 (EC 2.7.7.-) (THAP domain-containing protein 9) (hTh9)","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; DNA transposition [GO:0006313]","GO:0003677; GO:0004803; GO:0006310; GO:0006313; GO:0015074; GO:0016740; GO:0043565; GO:0046872"
"1145","Pocillopora_acuta_HIv2___RNAseq.g4083.t2c",0,0,NA,33.3333333333333,0,0,NA,NA,NA,50,13.8888888888889,11.1111111111111,16.6666666666667,NA,NA,NA,NA,NA,NA,10.49047585975,9.17797968831809,9.44342769799349,9.24153908615506,8.88950587151703,10.8025315094018,11.4183800769187,10.3253699532732,9.67085381264757,3.68233641306884,9.31423999690438,9.76392663903626,8.8645533547725,1018.54938583529,-0.110390357223,0.881263985851363,0.7302369946945,0.880064197052006,"Q3UPL0",0,"Protein transport protein Sec31A (SEC31-like protein 1) (SEC31-related protein A)","COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; protein transport [GO:0015031]; response to calcium ion [GO:0051592]","GO:0005198; GO:0005768; GO:0005789; GO:0005829; GO:0007029; GO:0015031; GO:0030120; GO:0030127; GO:0030134; GO:0048306; GO:0048471; GO:0051592; GO:0070971; GO:0090110"
"1146","Pocillopora_acuta_HIv2___TS.g13057.t2",15.3846153846154,0,0,22.2222222222222,66.6666666666667,43.5897435897436,50,0,NA,0,21.9848053181387,16.4529914529915,26.4102564102564,NA,NA,NA,NA,NA,NA,9.6597101835665,10.3400400420598,10.6084936645476,10.0089742248952,11.4110460116886,10.8604603418902,11.0571926368419,10.2430192325518,7.56366523702835,3.68233641306884,9.54349379881388,9.89718686587657,9.18980073175119,1258.15971440327,-0.217709090209943,0.841636601654976,0.581605349866331,0.789434218425641,"Q66HV4",0,"Coatomer subunit beta (Beta-coat protein) (Beta-COP)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; notochord development [GO:0030903]; somite development [GO:0061053]","GO:0000139; GO:0005198; GO:0006886; GO:0006888; GO:0006891; GO:0030126; GO:0030903; GO:0061053"
"1147","Pocillopora_acuta_HIv2___TS.g13061.t1",20.8333333333333,0,NA,0,0,4,0,0,NA,NA,3.54761904761905,1,6.94444444444444,NA,NA,NA,NA,NA,NA,14.108328257471,14.8044403568914,14.030862561252,14.6361851783423,14.5471359674651,14.8758601363843,14.6695001568417,14.3028910968061,13.3130241472467,14.2011320429742,14.3489359901675,14.0604484060482,14.6374235742868,21751.056876849,0.463350564750518,0.493084178173007,0.285211381453331,0.531232003953715,"P07602",3.46e-56,"Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)]","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; ganglioside GM1 transport to membrane [GO:1905572]; lysosomal transport [GO:0007041]; positive regulation of beta-galactosidase activity [GO:1903771]; prostate gland growth [GO:0060736]; regulation of autophagy [GO:0010506]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665]","GO:0002020; GO:0005543; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0006665; GO:0007041; GO:0007193; GO:0008047; GO:0010506; GO:0019216; GO:0035577; GO:0042802; GO:0042803; GO:0043202; GO:0043231; GO:0060736; GO:0060742; GO:0062023; GO:0070062; GO:0097110; GO:1903771; GO:1905572; GO:1905573; GO:1905574; GO:1905575; GO:1905576; GO:1905577"
"1148","Pocillopora_acuta_HIv2___RNAseq.g4095.t1",0,2.31660231660232,0,0,0.974658869395711,0.593667546174143,0.585365853658537,1.14068441064639,0.340136054421769,NA,0.661235005655429,0.878218065568923,0.390006180763562,NA,NA,NA,NA,NA,NA,12.0170588660422,12.1339931500218,11.8939578430141,11.6162569645403,12.3140317045229,12.2698527979297,11.2341200339142,12.1566956659686,12.354650773122,11.7955740983568,11.9786191897433,12.147278970534,11.8099594089526,4112.57495885784,-0.264763372263061,0.50659366699997,0.552221950683827,0.767939457234004,"Q8BY87",0,"Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47)","base-excision repair [GO:0006284]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; response to xenobiotic stimulus [GO:0009410]","GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006284; GO:0006508; GO:0006974; GO:0008630; GO:0009410; GO:0010972; GO:0016579; GO:0019005; GO:0030307; GO:0034644; GO:0035520; GO:0043154; GO:0045892; GO:0071987; GO:0090263; GO:1902230"
"1149","Pocillopora_acuta_HIv2___RNAseq.g4097.t1",9.09090909090909,NA,29.1666666666667,1.75438596491228,12.1495327102804,67.741935483871,7.14285714285714,NA,76,0,25.3807858824371,48.4987738162611,11.5099931221427,NA,NA,NA,NA,NA,NA,16.8511865122996,13.7317615897778,16.8685530687252,11.4064138736274,16.4430392631283,5.70406148794036,9.48072189413458,15.3014750775115,17.9028439782046,13.8865354005629,13.7576592145912,16.6734195799738,10.8418988492086,64440.9190646108,-4.71876609414254,1.41949085292693,1.18772689219487e-06,1.81983917041383e-05,NA,NA,NA,NA,NA
"1150","Pocillopora_acuta_HIv2___RNAseq.g4106.t1",2.9585798816568,0.694444444444444,10.7142857142857,9.33333333333333,1.85873605947955,7.15835140997831,0.884955752212389,12.5,0,0,4.61026865953905,5.93722583755122,3.28331148152689,NA,NA,NA,NA,NA,NA,12.6135546602293,9.69812509453545,10.71126713132,10.2735290673131,11.6796800225465,10.0312379370277,9.59905149700857,14.8617637403744,11.3196054066106,10.6713754009125,11.1459189957878,12.2371741922162,10.0546637993595,4881.93073334362,-1.32353852501361,1.02300465961855,0.0234199925394992,0.0843913233909606,"Q9U6Y6",2.54e-12,"GFP-like fluorescent chromoprotein amFP486","bioluminescence [GO:0008218]; generation of precursor metabolites and energy [GO:0006091]","GO:0006091; GO:0008218"
"1151","Pocillopora_acuta_HIv2___TS.g7387.t1b",13.0434782608696,6.06060606060606,NA,0,5.12820512820513,14.9253731343284,0,NA,26.6666666666667,NA,9.4034756072394,11.9131614654003,6.05722779635823,NA,NA,NA,NA,NA,NA,6.75557122368885,6.08712839408766,8.98019559995231,7.14835683950801,5.75030036476101,9.22326308025137,9.88682493808577,7.78277272362825,5.26843329136292,3.68233641306884,7.0565182868395,6.90745464067867,7.20558193300033,246.283221386442,-0.0528590236056879,0.890413752074721,0.805891288250651,0.918848640939783,NA,NA,NA,NA,NA
"1152","Pocillopora_acuta_HIv2___TS.g7403.t1",83.3333333333333,66.6666666666667,0,NA,NA,26.3157894736842,75,22.2222222222222,60,NA,47.6482873851295,43.8011695906433,52.7777777777778,NA,NA,NA,NA,NA,NA,7.13128978447547,3.68233641306884,7.80412787236133,9.57477318172048,8.03495398222209,3.68233641306884,8.79070401255391,4.30559910501959,5.93804482828044,3.68233641306884,6.26265020058398,6.64280311447178,5.88249728669618,174.693303106362,-0.155434969001938,1.01681272913041,0.00501336525899132,0.0233210666682895,NA,NA,NA,NA,NA
"1153","Pocillopora_acuta_HIv2___TS.g7418.t3",1.07913669064748,0,0,5.26315789473684,0.4,0.537634408602151,2.27272727272727,0,0,0,0.955265626671375,1.1601584606678,0.750372792674951,NA,NA,NA,NA,NA,NA,11.751130206258,9.36676951686655,12.3187292097382,11.5018893218997,11.6846633750455,12.5201326880156,10.8554921615126,11.9497294067174,11.9705213329426,12.8958348140906,11.6814892033087,11.9349547061403,11.428023700477,3846.87675668127,-0.293465062165373,0.676519459522068,0.52366041362885,0.747112272906657,"Q9NR09",0,"Baculoviral IAP repeat-containing protein 6 (EC 2.3.2.27) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON)","apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]","GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0051301; GO:0060711; GO:0060712; GO:0061631; GO:0090543; GO:2001237"
"1154","Pocillopora_acuta_HIv2___TS.g7422.t2",50,NA,NA,0,33.3333333333333,0,0,0,0,NA,11.9047619047619,0,27.7777777777778,NA,NA,NA,NA,NA,NA,6.56356363373408,7.88830505095858,6.69570208705218,8.32815545810949,9.8883638617591,6.76358212736915,6.68039407196693,9.18199184901398,10.6554569084619,7.69527455782698,8.03407896062524,8.59701566800425,7.47114225324623,406.880025655105,-0.502202621169184,0.94200496845302,0.189934064698506,0.408976739304076,"Q58D06",5.56e-79,"WD repeat-containing protein 74","blastocyst formation [GO:0001825]; ribosomal large subunit biogenesis [GO:0042273]; RNA metabolic process [GO:0016070]; rRNA processing [GO:0006364]","GO:0001825; GO:0005634; GO:0005730; GO:0006364; GO:0016070; GO:0030687; GO:0042273"
"1155","Pocillopora_acuta_HIv2___TS.g7432.t1b",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.87857715777996,8.80780141347791,8.96523736015115,8.59824589332789,3.68233641306884,8.63375208709472,3.68233641306884,8.1198078417103,3.68233641306884,9.29555005973397,7.33459810524824,6.86565903715582,7.80353717334067,340.346153401654,0.0600194744790541,0.984340879114639,0.707937851106004,0.866776216459524,"P16671",1.4e-11,"Platelet glycoprotein 4 (Fatty acid translocase) (FAT) (Glycoprotein IIIb) (GPIIIB) (Leukocyte differentiation antigen CD36) (PAS IV) (PAS-4) (Platelet collagen receptor) (Platelet glycoprotein IV) (GPIV) (Thrombospondin receptor) (CD antigen CD36)","amyloid fibril formation [GO:1990000]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; apoptotic cell clearance [GO:0043277]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to hydroperoxide [GO:0071447]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cGMP-mediated signaling [GO:0019934]; cholesterol import [GO:0070508]; cholesterol transport [GO:0030301]; defense response to Gram-positive bacterium [GO:0050830]; energy homeostasis [GO:0097009]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; intestinal absorption [GO:0050892]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; lipid transport across blood-brain barrier [GO:1990379]; lipoprotein transport [GO:0042953]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid transport [GO:0015909]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle mediated signaling [GO:0055096]; MAPK cascade [GO:0000165]; negative regulation of angiogenesis [GO:0016525]; negative regulation of gene expression [GO:0010629]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nitric oxide-cGMP-mediated signaling [GO:0038060]; oxidised low-density lipoprotein particle clearance [GO:0150024]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood microparticle formation [GO:2000334]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of tumor necrosis factor production [GO:0032760]; production of molecular mediator involved in inflammatory response [GO:0002532]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of action potential [GO:0098900]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of protein-containing complex assembly [GO:0043254]; regulation of removal of superoxide radicals [GO:2000121]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to fatty acid [GO:0070542]; response to linoleic acid [GO:0070543]; response to lipid [GO:0033993]; response to stilbenoid [GO:0035634]; sensory perception of taste [GO:0050909]; short-chain fatty acid transport [GO:0015912]; triglyceride transport [GO:0034197]","GO:0000122; GO:0000165; GO:0001540; GO:0001954; GO:0002532; GO:0005041; GO:0005044; GO:0005324; GO:0005615; GO:0005737; GO:0005794; GO:0005886; GO:0005901; GO:0006629; GO:0006631; GO:0006898; GO:0006910; GO:0006911; GO:0007155; GO:0007166; GO:0007204; GO:0007596; GO:0008035; GO:0008289; GO:0009897; GO:0009986; GO:0010628; GO:0010629; GO:0010744; GO:0010886; GO:0015636; GO:0015908; GO:0015909; GO:0015911; GO:0015912; GO:0016020; GO:0016324; GO:0016525; GO:0019915; GO:0019934; GO:0030169; GO:0030194; GO:0030299; GO:0030301; GO:0030666; GO:0031092; GO:0031526; GO:0031623; GO:0031664; GO:0032731; GO:0032735; GO:0032755; GO:0032760; GO:0033993; GO:0034121; GO:0034197; GO:0034381; GO:0034383; GO:0035325; GO:0035579; GO:0035634; GO:0038024; GO:0038060; GO:0042308; GO:0042953; GO:0043123; GO:0043235; GO:0043254; GO:0043277; GO:0044539; GO:0044877; GO:0045121; GO:0045335; GO:0045429; GO:0050431; GO:0050731; GO:0050830; GO:0050892; GO:0050909; GO:0055096; GO:0060100; GO:0060907; GO:0070053; GO:0070374; GO:0070508; GO:0070542; GO:0070543; GO:0070892; GO:0071222; GO:0071223; GO:0071404; GO:0071447; GO:0071726; GO:0071813; GO:0071944; GO:0097009; GO:0098900; GO:0120162; GO:0140052; GO:0150024; GO:0150025; GO:0150094; GO:1900227; GO:1901480; GO:1903428; GO:1904646; GO:1990000; GO:1990379; GO:2000121; GO:2000334"
"1156","Pocillopora_acuta_HIv2___RNAseq.g29539.t1",0,0,0,NA,0,0,0,42.8571428571429,0,NA,5.35714285714286,10.7142857142857,0,NA,NA,NA,NA,NA,NA,13.1710115032628,9.45044034127388,13.0508178923185,5.89135073914645,12.5457172710077,3.68233641306884,3.68233641306884,13.0388758772252,13.5393441099503,3.68233641306884,9.17345669733914,13.0691533307529,5.27776006392537,4459.14029207164,-10.1825247936247,4.40508550940885,3.35183545493173e-12,3.53875532993668e-10,NA,NA,NA,NA,NA
"1157","Pocillopora_acuta_HIv2___RNAseq.g29544.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.6806872070788,11.7239641068348,12.8695875203679,12.7433555953861,12.5751316007,11.2262870626073,11.1521733146073,12.3405413042352,12.6035691226911,9.03573981459597,11.8951036649104,12.6139033510146,11.1763039788063,4674.20137391612,-0.964335536685676,0.754829896122759,0.0670558874860497,0.19507167268669,"O88379",3.97e-102,"Bromodomain adjacent to zinc finger domain protein 1A (Cbp146)","chromatin remodeling [GO:0006338]; nucleosome assembly [GO:0006334]; positive regulation of DNA replication [GO:0045740]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated transcription [GO:0006355]; regulation of heterochromatin formation [GO:0031445]","GO:0000228; GO:0003677; GO:0005634; GO:0005721; GO:0006275; GO:0006334; GO:0006338; GO:0006355; GO:0008623; GO:0016590; GO:0031445; GO:0045740; GO:0046872"
"1158","Pocillopora_acuta_HIv2___RNAseq.g29551.t1",NA,NA,0,4.16666666666667,0,0,0,0,0,NA,0.595238095238095,1.04166666666667,0,NA,NA,NA,NA,NA,NA,10.5979715846068,8.68985896662406,9.4993647737521,9.5153537643326,9.54127565247577,10.18490568319,5.66606675070968,8.58795294428508,10.8571766014012,12.1989659683956,9.53388926897729,9.81674831130419,9.25103022665039,1206.81699598371,-0.282862955981954,0.766443993069843,0.514139903070033,0.739510695903437,"Q5ND34",3.48e-134,"WD repeat-containing protein 81","aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; protein stabilization [GO:0050821]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000421; GO:0005739; GO:0005765; GO:0005829; GO:0006511; GO:0007005; GO:0010008; GO:0031901; GO:0031902; GO:0035014; GO:0035973; GO:0045022; GO:0050821; GO:0070530; GO:0141039"
"1159","Pocillopora_acuta_HIv2___RNAseq.g29560.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.6699738570485,9.37373750516401,13.2671562103822,5.44417644206312,13.7118050787211,7.72914060428487,3.68233641306884,9.86603303904193,12.9709927648313,9.76214807201436,9.84774999866202,12.497192190005,7.19830780731904,4031.65016075501,-5.11792369589211,1.90042231644463,5.72919450920375e-07,9.72618185224449e-06,"Q8T882",9.23e-164,"Tauropine dehydrogenase (TaDH) (EC 1.5.1.23) (NAD: tauropine oxidoreductase)","","GO:0050325"
"1160","Pocillopora_acuta_HIv2___RNAseq.g21178.t3a",3.77358490566038,20,57.9365079365079,10,6.07734806629834,43.9024390243902,43.5897435897436,4.28571428571429,0,5.625,19.5190337808315,15.6376306620209,23.400436899642,NA,NA,NA,NA,NA,NA,11.8048252856168,12.1455700787192,12.1990180657928,12.4518761063199,11.6903730301354,11.405604314733,12.3333217378098,11.853155395765,12.5840344843077,12.3244302065006,12.07922087057,12.0262812523235,12.1321604888165,4430.35339051276,0.0830553387317461,0.492994828096266,0.848731735630022,0.94018961661581,"Q8WXA9",6.06e-49,"Splicing regulatory glutamine/lysine-rich protein 1 (Serine/arginine-rich-splicing regulatory protein 86) (SRrp86) (Splicing factor, arginine/serine-rich 12) (Splicing regulatory protein 508) (SRrp508)","mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","GO:0003723; GO:0005654; GO:0005681; GO:0006397; GO:0008380; GO:0016607"
"1161","Pocillopora_acuta_HIv2___RNAseq.g21225.t1",NA,0,0,NA,0,0,NA,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,5.42769788077612,8.47754988276052,3.68233641306884,10.1076305780412,8.50796544529402,8.45527342080496,8.86348045355243,7.69197184048926,3.68233641306884,3.68233641306884,6.8578578740925,5.79846159853942,7.91725414964559,271.717572224858,0.477051967727076,1.07446194827535,0.156171678442307,0.357998677054357,NA,NA,NA,NA,NA
"1162","Pocillopora_acuta_HIv2___RNAseq.g21230.t1",0,0,0,0,0,1.53061224489796,6.93877551020408,0,0,0,0.846938775510204,0.306122448979592,1.38775510204082,NA,NA,NA,NA,NA,NA,9.39401484257848,10.093707671639,9.37395323909205,5.56232777220043,9.80933418495054,9.61982140299553,10.5152736498159,10.1951520311791,8.38709600717497,3.68233641306884,8.66330172146948,9.43191006099503,7.89469338194394,690.51401104116,-0.394830928914477,0.954435247196662,0.219692308906644,0.450791538661611,"O75694",0,"Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155)","atrial cardiac muscle cell action potential [GO:0086014]; miRNA processing [GO:0035196]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]","GO:0000972; GO:0005635; GO:0005643; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006998; GO:0016020; GO:0017056; GO:0031965; GO:0035196; GO:0036228; GO:0044611; GO:0086014"
"1163","Pocillopora_acuta_HIv2___RNAseq.g21232.t1",7.14285714285714,0,0,0,5.15463917525773,1.6304347826087,0,10.8695652173913,8.33333333333333,0,3.31308296514482,4.16666666666667,2.45949926362298,NA,NA,NA,NA,NA,NA,9.59855631613624,9.03290361665377,7.79930343134751,8.77013579887542,9.42574609802483,11.376120756289,10.5141984914507,8.41336867966569,9.62367023097523,10.4553874206811,9.50093908400995,8.9721289512299,10.02974921679,904.663964545125,0.788427872577648,0.692359377691526,0.122986795884586,0.303718800695689,"Q9WVM6",9.04e-07,"Tolloid-like protein 2 (EC 3.4.24.-)","cell differentiation [GO:0030154]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of skeletal muscle tissue growth [GO:0048632]; protein processing [GO:0016485]","GO:0004222; GO:0005509; GO:0005615; GO:0008270; GO:0009953; GO:0016485; GO:0030154; GO:0048632"
"1164","Pocillopora_acuta_HIv2___RNAseq.g21234.t1",0,0,NA,0,0,0,0.595238095238095,NA,0.8,0,0.174404761904762,0.2,0.148809523809524,NA,NA,NA,NA,NA,NA,11.2683538931755,11.0553067759082,9.98881001584275,10.043653837661,10.6396861048595,11.1525712046374,9.93743742612801,10.1417617395941,11.0547845916316,10.9756025132505,10.6257968102689,10.6186792690207,10.632914351517,1653.36442579668,0.0135058087625878,0.488589305212635,0.980635518280382,0.993248398161815,"Q0JRZ9",6.82e-84,"F-BAR domain only protein 2","clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488]","GO:0001786; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098835"
"1165","Pocillopora_acuta_HIv2___RNAseq.g21247.t1",0,NA,NA,NA,7.14285714285714,0,0,0,0,NA,1.19047619047619,0,2.38095238095238,NA,NA,NA,NA,NA,NA,8.84497179844843,10.3269393472936,7.97637589315786,11.6757485431828,9.39930450615898,11.2599864906804,8.02531344350215,9.54846153832699,6.95638151601114,8.11950883152966,9.2132991908292,8.54509905042068,9.88149933123772,955.449293254627,0.838409450977816,0.89101771125794,0.103278770530186,0.267626213007513,"Q9Z139",1.23e-122,"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (mROR1) (Neurotrophic tyrosine kinase, receptor-related 1)","astrocyte development [GO:0014002]; inner ear development [GO:0048839]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; sensory perception of sound [GO:0007605]","GO:0001725; GO:0004714; GO:0005524; GO:0005886; GO:0007605; GO:0009986; GO:0010976; GO:0014002; GO:0017147; GO:0042813; GO:0043123; GO:0043235; GO:0043679; GO:0048839; GO:0051092; GO:0051897"
"1166","Pocillopora_acuta_HIv2___RNAseq.g21249.t1",100,NA,NA,100,NA,88.2352941176471,100,NA,100,100,98.0392156862745,96.078431372549,100,NA,NA,NA,NA,NA,NA,8.75928198563692,9.48731382210407,8.76013131833378,10.5296139872324,7.49399042417554,6.78684792853876,3.68233641306884,9.62049705008046,10.4963442877127,3.68233641306884,7.92986936299523,9.02604901318788,6.83368971280258,538.356985202755,-0.223084124359836,0.980548350295487,0.279074700276114,0.524525898686191,"Q99KY4",0,"Cyclin-G-associated kinase (EC 2.7.11.1) (DnaJ homolog subfamily C member 26)","clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; epidermal cell differentiation [GO:0009913]; epithelial cell development [GO:0002064]; establishment of skin barrier [GO:0061436]; forebrain morphogenesis [GO:0048853]; Golgi organization [GO:0007030]; intracellular transport [GO:0046907]; intrahepatic bile duct development [GO:0035622]; keratinocyte differentiation [GO:0030216]; negative regulation of neuron projection development [GO:0010977]; neural precursor cell proliferation [GO:0061351]; neuroepithelial cell differentiation [GO:0060563]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of clathrin coat assembly [GO:1905443]; stem cell differentiation [GO:0048863]","GO:0002064; GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0005925; GO:0007029; GO:0007030; GO:0009913; GO:0010977; GO:0030136; GO:0030216; GO:0030276; GO:0030332; GO:0031982; GO:0035622; GO:0043231; GO:0046907; GO:0048471; GO:0048853; GO:0048863; GO:0060563; GO:0061351; GO:0061436; GO:0072318; GO:0072583; GO:0106310; GO:1905443; GO:2000179"
"1167","Pocillopora_acuta_HIv2___RNAseq.g21256.t1",0,0,0,0,NA,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.64181568123354,10.3878477275597,8.3000596879337,8.58972905395168,7.95119516021968,10.202078872845,8.67991184486442,8.90075080666568,10.975348908932,10.1727937458949,9.18015314901003,8.75383404899692,9.60647224902314,746.806355874271,0.492103549949702,0.750636909192497,0.305250586597035,0.553953223234029,"X1WGX5",1.76e-155,"Pumilio homolog 3","germ cell migration [GO:0008354]; regulation of translation [GO:0006417]","GO:0003677; GO:0003729; GO:0005654; GO:0005694; GO:0005730; GO:0006417; GO:0008354"
"1168","Pocillopora_acuta_HIv2___TS.g19040.t1",NA,NA,66.6666666666667,0,0,14.2857142857143,0,NA,100,NA,30.1587301587302,38.0952380952381,22.2222222222222,NA,NA,NA,NA,NA,NA,5.76666095136545,3.68233641306884,7.22410582422696,3.68233641306884,8.53252601853795,3.68233641306884,3.68233641306884,8.26980134459445,4.97930611778461,3.68233641306884,5.31840823218536,6.95448005130188,3.68233641306884,79.63900163295,-10.6841537430057,3.89809326061503,1.76201164230983e-06,2.56395738373937e-05,"Q9UIJ7",1.38e-58,"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (Adenylate kinase 3 alpha-like 1) (Adenylate kinase isozyme 3)","ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; blood coagulation [GO:0007596]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; UTP metabolic process [GO:0046051]","GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006172; GO:0007596; GO:0009142; GO:0046033; GO:0046039; GO:0046041; GO:0046051; GO:0046899"
"1169","Pocillopora_acuta_HIv2___RNAseq.g21314.t1",NA,NA,50,0,31.25,12.8205128205128,21.6216216216216,0,NA,NA,19.2820224070224,4.27350427350427,34.2905405405405,1,53.125,53.125,0.00225809429407775,0.00225809429407775,0.00225809429407775,10.6440877654689,3.68233641306884,7.74513402854738,10.491300260595,3.68233641306884,3.68233641306884,9.22869534326832,7.99087022978053,3.68233641306884,3.68233641306884,6.45117696930043,6.7489529699869,6.15340096861397,398.211291750693,0.0499615676889342,0.98605689277978,0.859867281870805,0.945104931288288,"B1AS42",2.32e-89,"NADH-cytochrome b5 reductase-like (EC 1.6.2.2)","","GO:0004128; GO:0005654"
"1170","Pocillopora_acuta_HIv2___TS.g19102.t1",0,0,NA,0,0,NA,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.66721366552832,10.1941962115377,7.46922666954589,9.86655478583399,10.0638787893195,9.72456537084841,5.08305273412487,10.0544790271901,8.21631227375645,8.77379586949444,8.71132753971797,8.69422208506805,8.72843299436788,598.593913664784,0.165128114195183,0.857910953699957,0.661521596143692,0.840239762140965,"Q8NBS3",0,"Solute carrier family 4 member 11 (Sodium borate cotransporter 1) (NaBC1)","bicarbonate transport [GO:0015701]; borate transport [GO:0046713]; cellular hypotonic response [GO:0071476]; cellular response to oxidative stress [GO:0034599]; fluid transport [GO:0042044]; intracellular monoatomic cation homeostasis [GO:0030003]; monoatomic anion transport [GO:0006820]; monoatomic ion homeostasis [GO:0050801]; proton transmembrane transport [GO:1902600]; regulation of mesenchymal stem cell differentiation [GO:2000739]; regulation of mitochondrial membrane potential [GO:0051881]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]","GO:0005272; GO:0005372; GO:0005452; GO:0005886; GO:0006814; GO:0006820; GO:0012506; GO:0015078; GO:0015106; GO:0015252; GO:0015293; GO:0015701; GO:0016323; GO:0016324; GO:0022857; GO:0030003; GO:0034599; GO:0042044; GO:0046713; GO:0046715; GO:0046983; GO:0050801; GO:0051881; GO:0055085; GO:0071476; GO:1902600; GO:2000739"
"1171","Pocillopora_acuta_HIv2___RNAseq.g21317.t1",42.5,6.45161290322581,77.9069767441861,85.7142857142857,50.3246753246753,54.8599670510708,57.649667405765,62.406015037594,50.3597122302158,0,48.8172912411018,51.9583185872784,45.6762638949253,NA,NA,NA,NA,NA,NA,9.98048543283414,10.4918201832092,10.4821646439135,11.0079164821899,10.1650601256556,10.6300755515804,10.6505914687018,10.1174709993649,8.7024133505095,10.5548680532442,10.2782866291203,9.88951891045553,10.6670543477851,1305.66854884187,0.597011535611898,0.565973026125008,0.200421350966228,0.423505393772902,"Q9EPB1",7.5e-85,"Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase)","lysosomal protein catabolic process [GO:1905146]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]","GO:0004177; GO:0005576; GO:0005764; GO:0006508; GO:0008239; GO:0030163; GO:0031410; GO:0031982; GO:0070008; GO:1905146"
"1172","Pocillopora_acuta_HIv2___RNAseq.g21321.t1a",35.2941176470588,63.1944444444444,50.3875968992248,50.2958579881657,48.8986784140969,43.108504398827,59.0785907859079,27.6315789473684,62.2950819672131,0,44.0184451492307,49.3050935492037,38.7317967492577,NA,NA,NA,NA,NA,NA,7.22868826190456,6.92168924401968,8.06338218429842,3.68233641306884,6.38004444217139,8.78113387066434,3.68233641306884,7.17988199284164,9.4535191481937,3.68233641306884,6.50553483833002,7.66110320588194,5.34996647077811,173.512795660605,-0.360968287101136,1.07049451083513,0.000143741855940117,0.0011280966925219,NA,NA,NA,NA,NA
"1173","Pocillopora_acuta_HIv2___RNAseq.g21321.t1b",56.25,57.1428571428571,50,NA,50,54.5454545454545,45,54.5454545454545,75,NA,55.3104707792208,60.3084415584416,50.3125,NA,NA,NA,NA,NA,NA,10.4009524664638,11.5426957639836,11.287605927096,11.6360170517082,10.9047799766297,11.497139547341,10.8698525938353,10.9647391950506,10.9080383257347,11.335282050444,11.1347102898287,10.893223178195,11.3761974014624,2294.48355231106,0.373476349459569,0.51847322984259,0.398807433179027,0.645012939002734,"Q9EPB1",2.62e-148,"Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase)","lysosomal protein catabolic process [GO:1905146]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]","GO:0004177; GO:0005576; GO:0005764; GO:0006508; GO:0008239; GO:0030163; GO:0031410; GO:0031982; GO:0070008; GO:1905146"
"1174","Pocillopora_acuta_HIv2___RNAseq.g21334.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.93889786916176,10.1703897148266,3.68233641306884,9.3886219429448,9.66547833317844,3.68233641306884,3.68233641306884,9.52601081978479,7.56366523702835,11.0116418662505,7.73117150223818,7.87527773444444,7.58706527003192,593.890216028068,0.0317397681947772,0.99807298972669,0.79378072644641,0.912813245883888,"Q99P31",1.3e-48,"Hsp70-binding protein 1 (HspBP1) (Heat shock protein-binding protein 1) (Hsp70-interacting protein 1)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]","GO:0000774; GO:0005615; GO:0005783; GO:0031398; GO:0031625; GO:0032436; GO:0140313"
"1175","Pocillopora_acuta_HIv2___RNAseq.g21339.t1",0,0,NA,0,0,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,10.0852446302197,3.68233641306884,7.39445938623252,6.78724087838546,8.57558454812183,10.6378142744836,6.57172203937157,4.37599570701945,3.68233641306884,6.54750707030407,5.01992629018283,8.0750878504253,328.883790494002,0.506553191396379,1.16246693138707,0.0103268082193587,0.0427373259183989,"P47799",2.74e-111,"Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of protein kinase A signaling [GO:0010738]","GO:0004963; GO:0005886; GO:0007186; GO:0007189; GO:0008528; GO:0008584; GO:0009755; GO:0010738; GO:0016020; GO:0042699; GO:0043235; GO:0051897; GO:0070374; GO:0071372"
"1176","Pocillopora_acuta_HIv2___RNAseq.g29594.t1",NA,0,0,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.34371843387449,8.46454219346938,9.21507088400397,5.59933054873005,7.95781456870118,9.12084253590371,3.68233641306884,9.60592438604238,3.68233641306884,3.68233641306884,6.83542527899317,7.56097293713817,6.10987762084816,256.966842570163,-0.201407351200126,0.987097255289357,0.514989009107897,0.739989238220648,"P70610",1.83e-103,"Double C2-like domain-containing protein beta (Doc2-beta)","calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vesicle fusion [GO:0031340]; protein localization [GO:0008104]; regulation of calcium ion-dependent exocytosis [GO:0017158]; spontaneous neurotransmitter secretion [GO:0061669]","GO:0005509; GO:0005544; GO:0005737; GO:0005886; GO:0006887; GO:0008104; GO:0017158; GO:0019905; GO:0031340; GO:0032024; GO:0045202; GO:0045956; GO:0048791; GO:0061669; GO:0098850; GO:0098978; GO:0099502"
"1177","Pocillopora_acuta_HIv2___RNAseq.g29611.t1",0,0,0,0,NA,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,13.3987810138971,14.9204210351972,13.774676770486,15.5475541145663,13.5349845822271,15.1084361834489,15.8230717863648,14.2664344516117,13.1629485842832,15.3772788107088,14.4914587332791,13.627565080501,15.3553523860572,28007.0215218009,1.51696408996071,0.552298659037667,0.00159627956767401,0.0087622723593309,NA,NA,NA,NA,NA
"1178","Pocillopora_acuta_HIv2___TS.g7543.t1",0,0,NA,NA,0,2.7027027027027,0,NA,0,NA,0.45045045045045,0.900900900900901,0,NA,NA,NA,NA,NA,NA,5.92950120283598,8.42926890719667,6.62011409682418,8.77389895020823,9.09074254630947,9.54775214054269,9.34698085750427,5.63630898316489,6.37842387115414,7.0539287087459,7.68069202644864,6.73101814005773,8.63036591283955,290.825295473673,1.62181125042837,0.998781716763303,0.00904072988867669,0.0382316119336685,"A1ZAY1",1.88e-42,"SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains)","establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251]","GO:0001736; GO:0005737; GO:0005929; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219"
"1179","Pocillopora_acuta_HIv2___RNAseq.g29613.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.39475910818241,9.21466614941496,6.75739185036896,7.18297737323777,5.3333020303659,6.76358212736915,3.68233641306884,4.60853003661057,7.57903434039062,11.0355539059463,6.75521333349555,5.93460347318369,7.5758231938074,314.245742848658,0.646711714390394,1.06130394729738,0.119562242738422,0.297706798465366,"F1NZI4",1.16e-151,"Protein-glucosylgalactosylhydroxylysine glucosidase (EC 3.2.1.107) (Acid trehalase-like protein 1)","carbohydrate metabolic process [GO:0005975]","GO:0005829; GO:0005975; GO:0047402"
"1180","Pocillopora_acuta_HIv2___RNAseq.g29614.t1",0,83.3333333333333,100,0,30,36.8421052631579,0,0,100,NA,38.9083820662768,44.0350877192982,32.5,NA,NA,NA,NA,NA,NA,12.7694962736058,12.706819794289,12.8490854595825,13.0663141599837,12.3533682805427,12.7102774173669,12.229064856821,11.8677900501777,12.9148253700055,14.0815338212019,12.7548575483577,12.5509130867828,12.9588020099325,7489.84970617977,0.313372528983188,0.513842278698588,0.48071551422174,0.715754462983782,"Q80U40",1.1e-48,"RIMS-binding protein 2 (RIM-BP2)","neuromuscular synaptic transmission [GO:0007274]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of presynaptic membrane potential [GO:0099505]","GO:0005886; GO:0007274; GO:0044305; GO:0098831; GO:0098882; GO:0098978; GO:0099505; GO:0099508; GO:0099626; GO:0150037"
"1181","Pocillopora_acuta_HIv2___RNAseq.g29670.t2",0,0,0,NA,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.2129821054169,3.68233641306884,9.2975530633082,3.68233641306884,6.71000591019696,3.68233641306884,3.68233641306884,5.36237875279434,7.97687376171105,3.68233641306884,5.79714756587717,7.91195871868549,3.68233641306884,209.219227652221,-12.2128084332167,3.94915574031289,1.39167103572882e-08,3.86214850837327e-07,"Q16281",1.33e-122,"Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3)","inorganic cation import across plasma membrane [GO:0098659]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic cation transport [GO:0006812]; response to cAMP [GO:0051591]; response to magnesium ion [GO:0032026]; signal transduction [GO:0007165]; visual perception [GO:0007601]","GO:0005222; GO:0005223; GO:0005262; GO:0005272; GO:0005886; GO:0006812; GO:0007165; GO:0007601; GO:0015276; GO:0017022; GO:0017071; GO:0030425; GO:0030553; GO:0032026; GO:0043194; GO:0043204; GO:0044877; GO:0045296; GO:0051591; GO:0097386; GO:0098655; GO:0098659; GO:1902495"
"1182","Pocillopora_acuta_HIv2___RNAseq.g29671.t1",0,NA,NA,NA,83.3333333333333,0,0,0,0,NA,13.8888888888889,0,27.7777777777778,NA,NA,NA,NA,NA,NA,7.39030830812648,6.5579743664166,10.327090829469,9.90478652318717,9.00882336383711,3.68233641306884,3.68233641306884,7.91996540694884,9.7008903182286,3.68233641306884,7.18568483554203,8.86941564532201,5.50195402576206,391.926230293297,-0.638951160341789,1.23184725694372,1.00778521208681e-05,0.00011466185210526,"Q9P2R3",0,"Rabankyrin-5 (Rank-5) (Ankyrin repeat and FYVE domain-containing protein 1) (Ankyrin repeats hooked to a zinc finger motif)","endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0005765; GO:0005768; GO:0005769; GO:0005829; GO:0006897; GO:0010008; GO:0016020; GO:0016197; GO:0031267; GO:0034058; GO:0042147; GO:0043231; GO:0044354; GO:0046872; GO:0048549; GO:0070062; GO:0090160; GO:1901981"
"1183","Pocillopora_acuta_HIv2___RNAseq.g29688.t1",33.3333333333333,0,NA,0,NA,0,0,NA,0,0,4.76190476190476,0,11.1111111111111,NA,NA,NA,NA,NA,NA,5.00035332017132,8.96067875392427,6.17960196289983,9.16052156343084,5.50166800055048,8.92779334496856,11.1284811144547,5.89248396905691,8.5821620479674,3.68233641306884,7.30160804904931,6.23125386012919,8.37196223796944,417.292447836812,0.867459258681306,1.53122304866236,0.0101598675764611,0.0421791976538269,NA,NA,NA,NA,NA
"1184","Pocillopora_acuta_HIv2___RNAseq.g29696.t1",0,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.38495933952552,8.47322703846654,8.56409540488861,10.6222126988446,8.90838679889222,8.45527342080496,8.03736634147278,6.2798424236602,9.90591994198763,8.88334678396301,8.65146301925061,8.40864078179084,8.89428525671038,499.66417716293,0.312694300196428,0.697832994923544,0.508891337915044,0.736451625547888,"Q96LW2",4.91e-69,"Ribosomal protein S6 kinase-related protein (EC 2.7.11.1) (Sugen kinase 494)","","GO:0004672; GO:0004674; GO:0005524; GO:0106310"
"1185","Pocillopora_acuta_HIv2___RNAseq.14228_t",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.84571475096462,10.4318984323623,10.9908157734171,11.5812800928524,11.3596253040469,10.6583455073896,12.0902333392115,11.1414337500042,12.1444937496732,10.8655619313849,11.1109402631307,11.0964166656212,11.1254638606401,2440.12721679521,0.0279262268020024,0.589098396449389,0.951016815515488,0.981064633023038,"Q4R7K7",0,"E3 ubiquitin-protein ligase BRE1B (BRE1-B) (EC 2.3.2.27) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B)","chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]","GO:0000151; GO:0004842; GO:0005634; GO:0006325; GO:0016567; GO:0031625; GO:0033503; GO:0042803; GO:0045944; GO:0046872"
"1186","Pocillopora_acuta_HIv2___TS.g19186.t1",15.6862745098039,0,0,0,7.98004987531172,NA,0,NA,0,0,2.95829054813946,0,4.73326487702313,NA,NA,NA,NA,NA,NA,5.74163829918218,3.68233641306884,5.79243403424225,4.86458704699243,4.93003625965001,7.46909717663739,6.34755478695309,5.61726033607325,5.8874486244384,6.8613079844839,5.71937009617217,5.59376351071722,5.84497668162713,44.8265199691447,0.0425566489424921,0.90179810048845,0.913187119077849,0.967643845446301,NA,NA,NA,NA,NA
"1187","Pocillopora_acuta_HIv2___TS.g19206.t1",3.57142857142857,0,0,4.23728813559322,1.42857142857143,2.22222222222222,0.719424460431655,0,0,NA,1.35321497980523,1.29190207156309,1.42985611510791,NA,NA,NA,NA,NA,NA,6.47868055454933,3.68233641306884,6.74729698008972,3.68233641306884,4.99332554465423,3.68233641306884,8.5388626032004,5.93817869271292,3.68233641306884,6.81941263111671,5.42451026585987,5.56796363701501,5.28105689470473,63.3738628658331,-0.0855064389123848,1.0135275826234,0.0336090212650346,0.113553114594128,"Q7ZWU7",2.51e-11,"Extended synaptotagmin-2-B (E-Syt2-B)","endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]","GO:0005509; GO:0005789; GO:0006869; GO:0006897; GO:0008429; GO:0009898; GO:0031210; GO:0035091; GO:0044232; GO:0061817; GO:0140268"
"1188","Pocillopora_acuta_HIv2___TS.g19214.t1",1.21951219512195,0,0.980392156862745,2.97029702970297,0,0.900900900900901,0,0,0,NA,0.674566920287619,0.774239586120774,0.549976087996174,NA,NA,NA,NA,NA,NA,5.29008743000815,6.52433724544485,5.77181515294413,7.31359632654781,6.17395423718631,7.06826986579421,5.73058915105271,7.01166301889941,3.68233641306884,3.68233641306884,5.82489852540153,5.58597125042137,6.06382580038168,54.597424953981,0.356027997271496,0.871627032154182,0.414200369218132,0.659242173820208,NA,NA,NA,NA,NA
"1189","Pocillopora_acuta_HIv2___RNAseq.g20989.t1",33.3333333333333,NA,33.3333333333333,13.3333333333333,NA,38.4615384615385,25,NA,33.3333333333333,NA,29.465811965812,28.3760683760684,30.5555555555556,NA,NA,NA,NA,NA,NA,6.60413655354371,6.06348383902188,5.90972641462649,3.68233641306884,4.78991773661312,5.28004943464804,8.62912130682098,4.93729786847052,5.49910115103059,8.52599624145614,5.99211669593003,5.54803594485689,6.43619744700318,92.7127092818266,0.248021166111853,0.957417398159803,0.410751884744416,0.656201701679441,NA,NA,NA,NA,NA
"1190","Pocillopora_acuta_HIv2___RNAseq.g21015.t1",0,40,60,14.5161290322581,11.6666666666667,0.531914893617021,10.2803738317757,16.6666666666667,13.0434782608696,16.2790697674419,18.2984299119296,16.9516377706823,19.6452220531768,NA,NA,NA,NA,NA,NA,5.13391848923153,3.68233641306884,5.0980278924796,5.73735826925806,5.90231870585895,4.51119975925463,4.27277361158612,4.78747788616564,3.68233641306884,6.63807857080278,4.9445826010775,4.92081587736091,4.96834932479409,18.5192130532738,-0.135989381125974,0.97349860581241,0.511186205216779,0.738198609450428,"P22792",4.71e-26,"Carboxypeptidase N subunit 2 (Carboxypeptidase N 83 kDa chain) (Carboxypeptidase N large subunit) (Carboxypeptidase N polypeptide 2) (Carboxypeptidase N regulatory subunit)","protein stabilization [GO:0050821]","GO:0005576; GO:0005615; GO:0030234; GO:0031012; GO:0050821; GO:0070062; GO:0072562"
"1191","Pocillopora_acuta_HIv2___RNAseq.14358_t",NA,NA,NA,26.9230769230769,0,0,0,0,NA,0,4.48717948717949,8.97435897435897,0,NA,NA,NA,NA,NA,NA,5.25300700550269,9.52952050180834,3.68233641306884,11.5492784408392,3.68233641306884,3.68233641306884,10.1654876310695,8.91355735930819,3.68233641306884,3.68233641306884,6.38225330038721,5.04271472080348,7.72179187997094,528.151999542194,0.36190231741798,1.07353755454593,0.01021322839875,0.0423399643334822,"Q96PQ7",1.8e-168,"Kelch-like protein 5","","GO:0003779; GO:0005737; GO:0005829; GO:0005856"
"1192","Pocillopora_acuta_HIv2___RNAseq.g15095.t1",NA,NA,0,0,0,0,10,NA,0,NA,1.66666666666667,0,3.33333333333333,NA,NA,NA,NA,NA,NA,11.1026785262305,12.1553716326832,12.1734643537203,11.4142647033032,11.8765285997117,12.1200928234831,10.6058719505919,11.364548632295,11.9668913418881,10.1952103860815,11.4974922949988,11.6968222907691,11.2981622992286,3143.54263527491,-0.260982343113813,0.618446835085156,0.569259690902965,0.77986763081517,"O43149",0,"Zinc finger ZZ-type and EF-hand domain-containing protein 1","","GO:0005509; GO:0008270; GO:0035064; GO:0070577; GO:0140566"
"1193","Pocillopora_acuta_HIv2___RNAseq.g15137.t1",0,0,0,0,NA,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.40373863593062,3.68233641306884,7.51710843450505,3.68233641306884,9.06955205015327,3.68233641306884,3.68233641306884,10.0668084480556,6.97986927123753,3.68233641306884,5.84487589052263,8.00741536797641,3.68233641306884,188.012888832924,-12.228248186123,3.85203860749756,4.58990802901236e-09,1.47791795891781e-07,"Q9Z2E3",0,"Serine/threonine-protein kinase/endoribonuclease IRE2 (Endoplasmic reticulum-to-nucleus signaling 2) (Inositol-requiring protein 2) (Ire1-beta) (IRE1b) (mIre1) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)]","apoptotic chromosome condensation [GO:0030263]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; rRNA catabolic process [GO:0016075]","GO:0000287; GO:0004521; GO:0004674; GO:0005524; GO:0005829; GO:0006355; GO:0006397; GO:0006468; GO:0016075; GO:0030263; GO:0034976; GO:0036498; GO:0043507; GO:0044322; GO:0045892; GO:0051082; GO:0070059; GO:0106310; GO:1990604"
"1194","Pocillopora_acuta_HIv2___RNAseq.g15159.t1",0,0,0,0,0,0,0,1.23456790123457,0,NA,0.137174211248285,0.246913580246914,0,NA,NA,NA,NA,NA,NA,8.8338367793067,3.68233641306884,10.1840774090003,3.68233641306884,9.87272591058301,5.77882859435006,3.68233641306884,8.15725975832439,8.18660061915389,3.68233641306884,6.57426747229937,9.04690009527366,4.10163484932508,303.969221846213,-9.72739026390008,2.75572129056373,3.55145439937474e-09,1.18633340490892e-07,"Q7TN88",1.45e-54,"Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"1195","Pocillopora_acuta_HIv2___RNAseq.g15163.t1",0,NA,20,0,NA,4.76190476190476,0,NA,0,NA,4.12698412698413,1.58730158730159,6.66666666666667,NA,NA,NA,NA,NA,NA,7.08470708623522,10.6992088970635,3.68233641306884,9.70063232790689,6.01241040467731,11.1602793674972,11.2097554386639,9.2030035550118,3.68233641306884,12.1868151132451,8.46214850164386,5.9329587744124,10.9913382288753,1240.28670083128,3.52429969620495,3.47407239279441,6.17266380381759e-05,0.000549424056974877,"Q9W740",2.52e-25,"Noggin-2","cartilage development [GO:0051216]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell differentiation [GO:0045596]; osteoblast differentiation [GO:0001649]","GO:0001649; GO:0005615; GO:0009953; GO:0030514; GO:0045596; GO:0051216"
"1196","Pocillopora_acuta_HIv2___RNAseq.g9675.t1",0,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,6.75880950091271,3.68233641306884,10.1943673985451,6.54142192988087,3.68233641306884,3.68233641306884,7.32476780740362,6.83269238753983,3.68233641306884,5.60637410896263,5.6127109901924,5.60003722773287,152.495027094156,-0.0633651180328322,1.02069029605148,0.0076859884208816,0.0335051647135719,"Q91YT7",2.29e-10,"YTH domain-containing family protein 2","embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; gamete generation [GO:0007276]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; organelle assembly [GO:0070925]; positive regulation of cap-independent translational initiation [GO:1903679]; regulation of cell adhesion [GO:0030155]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]; regulation of rRNA processing [GO:2000232]; spermatogonial cell division [GO:0007284]; stress granule assembly [GO:0034063]","GO:0000932; GO:0001556; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0007276; GO:0007284; GO:0010494; GO:0030155; GO:0034063; GO:0034451; GO:0043488; GO:0045087; GO:0045746; GO:0048598; GO:0050767; GO:0060339; GO:0061157; GO:0062153; GO:0070925; GO:0071425; GO:0098508; GO:1902036; GO:1903538; GO:1903679; GO:1990247; GO:2000232; GO:2000737"
"1197","Pocillopora_acuta_HIv2___RNAseq.g9692.t1",0,0,0,0,NA,0,22.2222222222222,NA,NA,NA,3.7037037037037,0,7.40740740740741,NA,NA,NA,NA,NA,NA,9.44610822163855,8.9482812858533,9.88141319404927,11.4893660267433,7.84090707511663,9.41961505704584,11.2090911909473,8.0845974933492,10.90120733259,13.3387786736272,10.0559365550961,9.23084666334873,10.8810264468434,2058.12441897345,1.26057427826126,0.84201596116573,0.0266500619055004,0.0939474763346718,NA,NA,NA,NA,NA
"1198","Pocillopora_acuta_HIv2___RNAseq.g9707.t1",NA,0,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.67754435585556,5.88506810849203,7.41336738893051,9.89791026061459,6.44879012096401,9.13656566211361,10.3825271848027,8.88782938643167,3.68233641306884,3.68233641306884,7.40942752943424,7.02197353305012,7.79688152581835,385.343455894642,0.428634636196425,0.971411382749769,0.284764046123484,0.530776696279648,"Q80TY5",0,"Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1 homolog) (Vacuolar protein sorting-associated protein 13B)","acrosome assembly [GO:0001675]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; lipid transport [GO:0006869]; maintenance of lens transparency [GO:0036438]; nervous system development [GO:0007399]; slow endocytic recycling [GO:0032458]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0001675; GO:0002080; GO:0005765; GO:0006869; GO:0007030; GO:0007399; GO:0007417; GO:0016192; GO:0031901; GO:0032266; GO:0032458; GO:0032588; GO:0033106; GO:0033116; GO:0036438; GO:0055038; GO:0060612; GO:0090168"
"1199","Pocillopora_acuta_HIv2___TS.g31246.t1a",7.64790764790765,2.53929866989117,12.9934210526316,16.3989856297549,25.8764607679466,3.82513661202186,9.33734939759036,0.523560209424084,18.0432020330368,3.95778364116095,10.1143105661366,8.26603663082576,11.9625845014474,NA,NA,NA,NA,NA,NA,5.88500629885129,9.41934944775207,6.74729698008972,3.68233641306884,6.56804683919999,3.68233641306884,3.68233641306884,7.2278706159692,8.94329472564692,3.68233641306884,5.95202105597845,7.07430309195142,4.82973902000549,144.19688785503,-0.500327217192074,1.20818453627747,1.11691545967084e-06,1.72781446082129e-05,"Q04962",2.96e-09,"Coagulation factor XII (EC 3.4.21.38) (Hageman factor) (HAF) [Cleaved into: Coagulation factor XIIa heavy chain; Coagulation factor XIIa light chain]","blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; zymogen activation [GO:0031638]","GO:0004252; GO:0005509; GO:0005615; GO:0005791; GO:0007596; GO:0031638; GO:0042730"
"1200","Pocillopora_acuta_HIv2___RNAseq.g9715.t1",0,0,0,0,0,0.689655172413793,0,0,0,NA,0.0766283524904215,0.137931034482759,0,NA,NA,NA,NA,NA,NA,8.06571859090574,7.21053030663599,8.86056856991358,5.52419073768572,8.75751361004584,5.16559618031706,7.28023528800867,8.7740530111372,6.14454741514326,3.68233641306884,6.94652901228619,8.12048023942912,5.77257778514326,184.285875622447,-2.53664245765143,1.42072036500444,0.000912979107407433,0.00543429210269182,NA,NA,NA,NA,NA
"1201","Pocillopora_acuta_HIv2___RNAseq.g9733.t1",0,NA,NA,0,0,31.0344827586207,0,NA,0,NA,5.17241379310345,10.3448275862069,0,NA,NA,NA,NA,NA,NA,11.6389439620259,11.5727688788573,11.69571995289,11.3608919925169,11.4560410962149,11.1755732234181,6.96178732346706,11.2520916292403,12.4424828798346,11.4583220729758,11.1014623011441,11.6970559040411,10.505868698247,2799.37173839057,-0.580708059614669,0.775178734336412,0.237905869574988,0.474826010057354,"E9QAT4",4.17e-55,"Protein transport protein Sec16A (SEC16 homolog A) (p250)","autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; Golgi to plasma membrane transport [GO:0006893]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976]","GO:0000139; GO:0005789; GO:0005829; GO:0006893; GO:0006914; GO:0007029; GO:0007030; GO:0012507; GO:0031090; GO:0032527; GO:0034976; GO:0048208; GO:0048471; GO:0050821; GO:0070971; GO:0070973; GO:0072659"
"1202","Pocillopora_acuta_HIv2___TS.g31270.t3",1.92307692307692,16.6666666666667,2.22222222222222,0,0,0,0,0,0,7.14285714285714,2.7954822954823,3.33333333333333,2.25763125763126,NA,NA,NA,NA,NA,NA,10.6716910690569,10.8624503607221,11.069808226509,8.29184295024184,10.7058928458596,10.9011159321961,8.43347983997092,10.2240625491161,8.59728431793216,10.9167345955548,10.067436268716,10.2537478016948,9.88112473573715,1314.60489417885,-0.181032977640895,0.753867948015658,0.662745555445226,0.841094297969619,"Q6GN42",0,"Choline transporter-like protein 4 (Solute carrier family 44 member 4)","acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]","GO:0008292; GO:0015220; GO:0015297; GO:0015871; GO:0016324; GO:0030307; GO:0032475; GO:0035675; GO:0061526"
"1203","Pocillopora_acuta_HIv2___RNAseq.g9737.t1",0,NA,NA,0,71.4285714285714,50,NA,NA,100,0,36.9047619047619,50,23.8095238095238,NA,NA,NA,NA,NA,NA,9.32215683786057,4.82737711805479,10.5445580934716,9.29487294560875,9.4691507370047,6.72794348889772,10.4649676931234,9.72377979654519,10.1093053120379,7.49866657067739,8.7982778593282,9.83379015538399,7.76276556327241,690.221175815964,-1.31937863850084,1.21550609425527,0.0174301234800678,0.0662922182528796,"Q52I78",0,"Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1 homolog) (PBEF) (Visfatin)","circadian regulation of gene expression [GO:0032922]; NAD biosynthetic process [GO:0009435]","GO:0005125; GO:0005615; GO:0005634; GO:0005737; GO:0009435; GO:0032922; GO:0047280"
"1204","Pocillopora_acuta_HIv2___RNAseq.g9740.t1",0,0,NA,NA,0,0,NA,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,9.58865886660743,12.8030564254832,11.7862922042821,9.43449375631599,10.4566036870437,10.2482772849251,7.70829378208802,10.3578402875325,10.5823701099235,3.68233641306884,9.66482228172704,10.5543530310778,8.77529153237623,1758.75273363843,-0.390177321466642,1.00094525609556,0.202041052060324,0.425622163850935,"E9Q309",1.26e-76,"Centrosome-associated protein 350 (Cep350)","microtubule anchoring [GO:0034453]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]","GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0008017; GO:0034453; GO:0042995; GO:0071539; GO:1905515"
"1205","Pocillopora_acuta_HIv2___RNAseq.g9742.t1",0,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.2882830075676,11.6421968601936,10.9239100136842,11.1288235282662,11.2020722901829,10.2274612573272,11.2954817251008,10.3504634670115,8.95800724344856,3.68233641306884,9.96990358058514,10.344547204379,9.59525995679133,1627.0045702917,-0.10573241735748,0.860430234999811,0.763800737773838,0.897231695862973,"F1NVK6",8.89e-29,"Transmembrane protein 237","cilium assembly [GO:0060271]; regulation of Wnt signaling pathway [GO:0030111]","GO:0016020; GO:0030111; GO:0035869; GO:0060271"
"1206","Pocillopora_acuta_HIv2___RNAseq.g9769.t1",NA,NA,0,0,0,NA,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.4856506357416,8.57758379751783,11.0339261938982,9.62976672813264,9.83556409551191,9.09807911724003,11.2406350300413,10.3012241900631,13.000586922821,9.3142958773975,10.3517312588365,11.1313904076072,9.57207211006586,1985.87850677406,-0.935874879429913,0.907453768160444,0.0685021635986622,0.198440876084729,"Q92963",3.82e-81,"GTP-binding protein Rit1 (EC 3.6.5.2) (Ras-like protein expressed in many tissues) (Ras-like without CAAX protein 1)","Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165]","GO:0003924; GO:0003925; GO:0005516; GO:0005525; GO:0005886; GO:0007165; GO:0007265; GO:0019003"
"1207","Pocillopora_acuta_HIv2___RNAseq.g9789.t1",0,NA,NA,NA,0,0,14.2857142857143,0,0,NA,2.38095238095238,0,4.76190476190476,NA,NA,NA,NA,NA,NA,6.61740237719946,3.68233641306884,9.02416056226861,7.97581545078448,6.88168762658974,3.68233641306884,3.68233641306884,5.28924211491062,10.3690012341191,3.68233641306884,6.08866550181474,7.63629878301751,4.54103222061197,220.438535080701,-6.7014419337882,4.26029685908355,1.93000113881693e-05,0.000200975784534544,"Q8C0S1",0,"DIS3-like exonuclease 1 (EC 3.1.13.1)","mRNA catabolic process [GO:0006402]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]","GO:0000175; GO:0000177; GO:0003723; GO:0005813; GO:0005829; GO:0005886; GO:0006396; GO:0006401; GO:0006402; GO:0008859; GO:0016075; GO:0019899"
"1208","Pocillopora_acuta_HIv2___RNAseq.g31296.t2",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.66188506348893,8.82146275665632,7.63565941754202,3.68233641306884,6.36993744999328,3.68233641306884,3.68233641306884,9.37684048226265,8.84540021481888,9.144506977945,6.99027016019136,8.17794452562115,5.80259579476157,265.45074144582,-0.461978703320728,1.10483054095757,0.000217373368232782,0.00160390774104997,"P46531",0,"Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]","animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]","GO:0000122; GO:0000139; GO:0000987; GO:0001228; GO:0001554; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010008; GO:0010614; GO:0010628; GO:0010629; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027"
"1209","Pocillopora_acuta_HIv2___RNAseq.g31304.t1",0,NA,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.7425695051014,11.1243900838266,10.9100367522316,12.2186604612176,11.3701808526563,11.8460848695684,11.3398486800985,11.1480241279641,10.3744921461413,12.9795128666591,11.4053800345465,10.9090606768189,11.901699392274,3097.40186011164,0.697274177806352,0.649248594580452,0.162108468428285,0.366995912873176,"A1Z1Q3",1.67e-73,"ADP-ribose glycohydrolase MACROD2 (MACRO domain-containing protein 2) (O-acetyl-ADP-ribose deacetylase MACROD2) (EC 3.5.1.-) ([Protein ADP-ribosylaspartate] hydrolase MACROD2) (EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD2) (EC 3.2.2.-)","brain development [GO:0007420]; DNA damage response [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]; response to bacterium [GO:0009617]","GO:0005634; GO:0005654; GO:0005730; GO:0006974; GO:0007420; GO:0009617; GO:0016798; GO:0019213; GO:0042278; GO:0051725; GO:0140291; GO:0140293"
"1210","Pocillopora_acuta_HIv2___TS.g16143.t1",0,0,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.43542392964019,10.4907526211391,10.6782529351508,3.68233641306884,7.86576771623041,10.7451106566308,10.6169320880769,9.84518748203157,11.0403493100787,11.6319340447858,9.40320471968331,9.37299627462633,9.43341316474029,1274.14659997897,0.234251466991699,0.940404752633218,0.497094424132207,0.727141358277533,"D4A8G9",5.43e-175,"Zinc finger FYVE domain-containing protein 26","autophagosome organization [GO:1905037]; double-strand break repair via homologous recombination [GO:0000724]; lysosome organization [GO:0007040]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465]","GO:0000281; GO:0000724; GO:0005764; GO:0005769; GO:0005770; GO:0005813; GO:0007040; GO:0019901; GO:0030496; GO:0032266; GO:0032465; GO:0046872; GO:1905037"
"1211","Pocillopora_acuta_HIv2___TS.g16150.t1",0,0,0,0,0,2.5,0,NA,NA,NA,0.357142857142857,0.833333333333333,0,NA,NA,NA,NA,NA,NA,7.01680604467962,5.35078960182194,5.35722166815878,5.21704338441576,5.23920445324911,5.67813700336456,3.68233641306884,3.68233641306884,5.96263381334191,3.68233641306884,5.08688452082382,5.45164047849965,4.72212856314799,24.4088354403799,-0.306891370612497,0.97245816386532,0.466061720424295,0.705968424146217,"K0E4E1",7.18e-14,"Putative glycosyl hydrolase ecdE (EC 3.2.1.-)","carbohydrate metabolic process [GO:0005975]","GO:0004553; GO:0005975"
"1212","Pocillopora_acuta_HIv2___TS.g16172.t3",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.52315420649741,3.68233641306884,7.91083219305282,3.68233641306884,9.86484288334115,4.65791064633771,3.68233641306884,9.10753336965743,11.5246255570989,3.68233641306884,6.63182445082608,9.38619764192954,3.87745125972261,491.815198073264,-10.5417770706884,2.39237961317866,2.0601320371816e-11,1.63723899921949e-09,"Q05973",0,"Sodium channel protein 1 brain (Sodium channel protein I brain)","membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]","GO:0001518; GO:0005248; GO:0019228; GO:0086010"
"1213","Pocillopora_acuta_HIv2___TS.g16229.t1",1.58730158730159,1.31578947368421,NA,6.99300699300699,0,1.96078431372549,0,3.84615384615385,0,6.25,2.43922624598579,2.82314692531411,1.9593253968254,NA,NA,NA,NA,NA,NA,12.9158309556542,9.27049355188922,12.0046254678725,3.68233641306884,12.0035994597745,3.68233641306884,3.68233641306884,12.8235430127173,13.9477539687345,10.5084283637784,9.45212840196271,12.7390705729506,6.16518623097483,4088.82997827338,-1.04959815531206,2.01739901469895,1.94271775765158e-09,7.14999227650699e-08,NA,NA,NA,NA,NA
"1214","Pocillopora_acuta_HIv2___RNAseq.g9836.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.42800305042402,9.2326650509977,10.7510330525267,10.1342036597556,9.8120698546016,9.8713515781131,11.2848040268522,8.81558743150869,9.27708270669759,8.26557278173816,9.48723731932154,9.21675521915172,9.75771941949135,907.658847235901,0.306655805153385,0.71115990056839,0.520296983083011,0.744295872150397,"P50851",0,"Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) (CDC4-like protein)","mitophagy [GO:0000423]; protein localization [GO:0008104]; protein localization to phagophore assembly site [GO:0034497]","GO:0000423; GO:0005765; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0008104; GO:0016020; GO:0019901; GO:0034497"
"1215","Pocillopora_acuta_HIv2___TS.g13451.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,8.60944092617983,3.68233641306884,7.67057791575813,3.68233641306884,8.75225632267961,6.03750049456639,8.60384923015434,3.68233641306884,3.68233641306884,5.80853069546825,4.66663897648594,6.95042241445056,135.643515111258,0.211751480131336,1.04035555384081,0.000450144822273465,0.00299213911275891,"Q8T882",2.28e-124,"Tauropine dehydrogenase (TaDH) (EC 1.5.1.23) (NAD: tauropine oxidoreductase)","","GO:0050325"
"1216","Pocillopora_acuta_HIv2___TS.g13460.t1",0,NA,0,NA,0,0,NA,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,4.90080178660296,6.26270646445638,5.32783859183311,6.50915460878185,4.82690108855957,5.35049164323153,4.76881142028858,4.78747788616564,4.86223652345053,4.80766789501754,5.24040879083877,4.94105117532236,5.53976640635518,20.9287870128251,0.596181776752583,0.803790490382242,0.253863605854976,0.49499638650396,"Q460N5",4.85e-135,"Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)","innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212]","GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:1902216; GO:1990404"
"1217","Pocillopora_acuta_HIv2___TS.g13467.t1",0,0,4.25531914893617,0,2.54237288135593,0.33112582781457,0.772200772200772,0,0,0,0.790101863030744,0.0662251655629139,1.51397856049857,NA,NA,NA,NA,NA,NA,10.8500231381597,8.10521425400763,10.4814143014956,9.5040762963169,11.7122564337689,8.32397650160948,5.7616711601265,11.2696181502223,8.61596646138199,7.98530824364536,9.26095249407344,10.5858556970057,7.93604929114117,1087.05815970966,-1.84890260290849,1.21744272349154,0.00483225366335344,0.0226003961086342,NA,NA,NA,NA,NA
"1218","Pocillopora_acuta_HIv2___RNAseq.g9897.t1",0,14.2857142857143,NA,NA,0,0,0,0,NA,NA,2.38095238095238,4.76190476190476,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.670995659781,7.8421497361785,7.96925428521777,5.78216020895349,8.2053021325804,7.91855927919823,6.65383698875806,3.68233641306884,3.68233641306884,6.3089267529874,5.52856395200555,7.08928955396925,120.501668130977,0.576820004216291,1.10262054042998,0.143771518926339,0.338736811334558,NA,NA,NA,NA,NA
"1219","Pocillopora_acuta_HIv2___TS.g13522.t1a",0,0,0,0,0,0,0,NA,9.52380952380952,NA,1.19047619047619,2.38095238095238,0,NA,NA,NA,NA,NA,NA,5.92950120283598,7.23128399729271,10.1495400861607,9.49042585449224,9.21587024901567,9.47189015592548,11.1782003734031,10.0387089138489,5.72271821572966,5.70282560183315,8.41309646505376,8.21126773351818,8.61492519658934,659.950966132359,0.32680046671971,0.609207189074196,0.489373322952674,0.721945685711072,"Q502W6",0,"von Willebrand factor A domain-containing protein 3B (VWA domain-containing protein 3B)","","GO:0005654; GO:0005829"
"1220","Pocillopora_acuta_HIv2___RNAseq.g22211.t1",0,0,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.41143390216431,3.68233641306884,8.66279971671285,10.3089487208653,7.42381535912268,3.68233641306884,3.68233641306884,3.68233641306884,6.37842387115414,3.68233641306884,5.95971036353635,6.91176185244456,5.00765887462813,214.47904191579,-0.29319659774094,1.06111419641211,0.00476484245857508,0.0223037803627282,"Q96QP1",5.08e-48,"Alpha-protein kinase 1 (EC 2.7.11.1) (Chromosome 4 kinase) (Lymphocyte alpha-protein kinase)","cilium assembly [GO:0060271]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]","GO:0000922; GO:0002753; GO:0004674; GO:0005524; GO:0005813; GO:0005829; GO:0005929; GO:0043123; GO:0045087; GO:0048029; GO:0060271; GO:0106310"
"1221","Pocillopora_acuta_HIv2___RNAseq.g22212.t1",0,NA,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.3952866693647,9.88201146362094,10.1024903294605,10.7335638373809,9.13221106882038,8.51840255502147,9.95339229312721,10.682330301053,8.49602432054186,11.2820175421177,9.91777303805087,9.76166853784809,10.0738775382536,1125.14213653992,0.131908235842922,0.67423108941442,0.785289893772851,0.908824058658276,"O00418",0,"Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase)","cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; myosin II filament disassembly [GO:0031037]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; regulation of translation at postsynapse [GO:0140245]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414]","GO:0002931; GO:0004672; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006414; GO:0008135; GO:0014069; GO:0031037; GO:0031952; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:0098978; GO:0140245; GO:1990416; GO:1990637"
"1222","Pocillopora_acuta_HIv2___RNAseq.14918_t",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.28790045227443,8.90403024817267,10.0739039669374,9.36387956026705,10.8609854401271,8.2095616944569,3.68233641306884,8.44649846873451,10.3590646089358,3.68233641306884,8.28704972660436,9.80567058740185,6.76842886580686,645.581084974312,-0.659137840415057,1.18548072541479,0.0227026043370283,0.0823189945176177,"Q96RR1",6.42e-169,"Twinkle mtDNA helicase (EC 5.6.2.3) (Progressive external ophthalmoplegia 1 protein) (T7 gp4-like protein with intramitochondrial nucleoid localization) (T7-like mitochondrial DNA helicase) (Twinkle protein, mitochondrial)","cellular response to glucose stimulus [GO:0071333]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214]","GO:0002020; GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006264; GO:0006268; GO:0006390; GO:0008289; GO:0016853; GO:0016887; GO:0034214; GO:0042645; GO:0042802; GO:0043139; GO:0071333"
"1223","Pocillopora_acuta_HIv2___RNAseq.g22261.t1",0,0,0,0,0,0.564971751412429,0,11.1111111111111,NA,NA,1.45951035781544,2.91902071563088,0,NA,NA,NA,NA,NA,NA,3.68233641306884,5.35078960182194,3.68233641306884,11.0923993863337,3.68233641306884,11.4018936014545,12.8626166766326,3.68233641306884,3.68233641306884,8.02233914012503,6.7141720471712,3.68233641306884,9.74600768127355,1251.45084902703,15.9238331848865,4.19119276665777,3.16396184787707e-12,3.40818088944317e-10,"B3EWY8",1.14e-104,"Skeletal aspartic acid-rich protein 2","","GO:0016020"
"1224","Pocillopora_acuta_HIv2___RNAseq.g22262.t1",1.11111111111111,0,NA,0,0,0,0,0,0,NA,0.138888888888889,0,0.37037037037037,NA,NA,NA,NA,NA,NA,5.00035332017132,7.36865548890326,3.68233641306884,4.99561439145868,5.88788892518078,6.76358212736915,7.93153867530596,3.68233641306884,3.68233641306884,6.04206022209894,5.50367023896946,4.38705029691172,6.6202901810272,54.6132730203529,2.6855092768733,4.44188126556818,0.000540597532277771,0.00348915783438897,"P54422",4.68e-26,"Glutathione hydrolase proenzyme (EC 3.4.19.13) (Gamma-glutamyltranspeptidase proenzyme) (EC 2.3.2.2) [Cleaved into: Glutathione hydrolase large chain; Glutathione hydrolase small chain]","glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; proteolysis [GO:0006508]","GO:0005576; GO:0006508; GO:0006750; GO:0006751; GO:0036374; GO:0103068"
"1225","Pocillopora_acuta_HIv2___TS.g20378.t1b",NA,0,0,0,0,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,8.51271382672152,8.3082641794478,9.00548245314794,10.0009748275365,9.96328683412873,9.58750848005358,3.68233641306884,9.58892470050005,10.3479430321913,8.74643649917212,8.77438712459684,9.48367016933791,8.06510407985577,626.28489264781,-0.321993401192995,0.907598664496174,0.416826566818174,0.661289839032364,"Q8BVV7",4.27e-66,"Centrosomal protein of 95 kDa (Cep95) (Coiled-coil domain-containing protein 45)","","GO:0000922; GO:0005737; GO:0005813"
"1226","Pocillopora_acuta_HIv2___TS.g20384.t2",NA,0,NA,0,0,0,14.2857142857143,NA,NA,0,2.38095238095238,0,4.76190476190476,NA,NA,NA,NA,NA,NA,11.0136539319076,7.8947948031256,11.6797834087524,11.085608102096,10.655002140973,11.848131549044,8.84648329724399,11.1937073184915,11.3589132229122,3.68233641306884,9.92584141876151,11.1802120046073,8.67147083291569,1825.80615117828,-0.578828487305639,1.0672005374447,0.111333210923995,0.282711299649696,"A4IHD9",1.26e-57,"Mediator of RNA polymerase II transcription subunit 25 (Mediator complex subunit 25)","","GO:0005634"
"1227","Pocillopora_acuta_HIv2___RNAseq.g22280.t1",NA,NA,0,NA,0,0,NA,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.07521991576182,8.21809751775082,6.51648711029815,8.33326890870578,8.47147564881472,8.73759746419133,10.5366102229555,9.40948504545145,6.43114589272003,9.69222151298885,8.44216092396385,7.78076272260923,9.10355912531846,459.23746234981,0.940531899522019,0.805788903954665,0.078539847102037,0.219591340214947,"Q949P2",0,"Probable cytosolic oligopeptidase A (EC 3.4.24.70) (Thimet metalloendopeptidase 2) (Zincin-like metalloproteases family protein 2)","proteolysis [GO:0006508]","GO:0004222; GO:0005829; GO:0005886; GO:0006508; GO:0046872; GO:0048046"
"1228","Pocillopora_acuta_HIv2___RNAseq.g22284.t1",0,NA,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.34781439012174,8.60549712734851,8.38608588282561,8.02092254567833,8.83312908347376,9.7096309157654,3.68233641306884,9.91504821357591,9.97116262302611,3.68233641306884,8.01539636079531,9.29064803860463,6.74014468298598,469.52450872044,-0.344578441672121,1.00717244669375,0.162541645564643,0.367458949897937,NA,NA,NA,NA,NA
"1229","Pocillopora_acuta_HIv2___RNAseq.g22287.t1",NA,NA,100,0,100,100,62.5,NA,0,NA,60.4166666666667,33.3333333333333,87.5,NA,NA,NA,NA,NA,NA,13.4357019319824,13.4266234627956,13.1105080380049,13.452096494525,13.0543284131052,13.7142629771246,13.2809493171125,13.3851859210145,12.9931112673184,12.9152971697377,13.2768064992721,13.1957671142851,13.3578458842591,10036.2026893509,0.12501238581053,0.490172020639297,0.770530262445857,0.901092058485246,"Q8MPM1",3.44e-125,"Gelsolin-like protein 2 (Actin-modulator) (EWAM-P2)","actin filament capping [GO:0051693]","GO:0005737; GO:0005856; GO:0051015; GO:0051693"
"1230","Pocillopora_acuta_HIv2___RNAseq.g22291.t1",0,NA,NA,100,NA,57.1428571428571,100,33.3333333333333,NA,71.4285714285714,60.3174603174603,63.4920634920635,57.1428571428571,NA,NA,NA,NA,NA,NA,11.72727707733,10.8747780597501,11.3460643104064,11.7192981988901,10.1664859003986,11.4871051724481,12.5697744857766,10.3416964864517,8.55530966566589,9.97498742121413,10.8762776778332,10.4273666880505,11.3251886676158,2376.73476794467,0.635673166696434,0.686254499314095,0.205575003125316,0.430954486445433,"Q13136",0,"Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1)","cell-matrix adhesion [GO:0007160]; cortical microtubule organization [GO:0043622]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; signal transduction [GO:0007165]; synapse organization [GO:0050808]","GO:0005737; GO:0005829; GO:0005925; GO:0005938; GO:0007160; GO:0007165; GO:0030424; GO:0032991; GO:0043622; GO:0048786; GO:0050808; GO:0051497; GO:0097444; GO:0098685; GO:0099072; GO:1903077"
"1231","Pocillopora_acuta_HIv2___TS.g31606.t1",0,NA,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.88133858134906,3.68233641306884,6.44283750088468,8.82194566568818,5.44125113471119,6.3101085141422,3.68233641306884,6.13282228848601,6.26649149846874,3.68233641306884,5.73438044229366,6.23294820077994,5.23581268380738,76.1679291951908,-0.28018351050024,1.03777490037855,0.0040128466727449,0.0193150796254849,"O35474",1.13e-11,"EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005576; GO:0007155; GO:0010811"
"1232","Pocillopora_acuta_HIv2___RNAseq.g23742.t1",100,NA,NA,NA,100,100,100,100,100,NA,100,100,100,NA,NA,NA,NA,NA,NA,9.88398215246135,10.2020451848776,10.2743503389081,7.96925428521777,9.83556409551191,9.05853647603373,7.55715091401747,8.24102882196059,6.43114589272003,7.98530824364536,8.74383664053539,8.9332142603124,8.55445902075839,563.81824016557,-0.209295620485896,0.694232368108752,0.650130985673758,0.833126125346438,"P20673",0,"Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)","amino acid metabolic process [GO:0006520]; ammonia assimilation cycle [GO:0019676]; arginine biosynthetic process [GO:0006526]; arginine biosynthetic process via ornithine [GO:0042450]; arginine metabolic process [GO:0006525]; argininosuccinate metabolic process [GO:0000053]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to type II interferon [GO:0071346]; diaphragm development [GO:0060539]; kidney development [GO:0001822]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; midgut development [GO:0007494]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; post-embryonic development [GO:0009791]; response to amine [GO:0014075]; response to growth hormone [GO:0060416]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to peptide hormone [GO:0043434]; response to steroid hormone [GO:0048545]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050]","GO:0000050; GO:0000053; GO:0001822; GO:0001889; GO:0004056; GO:0005741; GO:0005829; GO:0006520; GO:0006525; GO:0006526; GO:0007494; GO:0007584; GO:0007626; GO:0009410; GO:0009636; GO:0009791; GO:0010043; GO:0014075; GO:0019676; GO:0032496; GO:0042450; GO:0042802; GO:0043025; GO:0043204; GO:0043434; GO:0045429; GO:0048471; GO:0048545; GO:0060416; GO:0060539; GO:0070852; GO:0071242; GO:0071320; GO:0071346; GO:0071356; GO:0071377; GO:0071385; GO:0071456; GO:0071549"
"1233","Pocillopora_acuta_HIv2___RNAseq.g23745.t2",0,0,0,0,NA,0,20.8333333333333,NA,NA,NA,3.47222222222222,0,6.94444444444444,NA,NA,NA,NA,NA,NA,3.68233641306884,9.44824166214109,7.03904768963524,3.68233641306884,6.89567146066421,9.61502038656193,3.68233641306884,8.71255992242008,3.68233641306884,3.68233641306884,6.01222231867667,6.00239037977144,6.02205425758191,202.791862316898,-0.0218734040188845,1.01119798241902,0.257301961358784,0.499143719030774,"Q8BHR2",8.38e-31,"Ecto-NOX disulfide-thiol exchanger 1 (Constitutive Ecto-NOX) (cNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)]","ultradian rhythm [GO:0007624]","GO:0003723; GO:0003756; GO:0003954; GO:0005576; GO:0005886; GO:0007624; GO:0009897"
"1234","Pocillopora_acuta_HIv2___RNAseq.g23752.t1",0,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.13549223134047,10.3924281641343,9.148538169335,10.4507669995119,10.1016338937644,11.1679465626912,10.2913268119751,10.9563704417273,3.68233641306884,11.0434373093046,9.53702769968531,8.4048742298472,10.6691811695234,1211.32629150291,0.55067131411942,1.01533968417258,0.185921638250091,0.403355418576468,"Q2KHS5",1.09e-106,"2-acylglycerol O-acyltransferase 2-A (EC 2.3.1.20) (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2-A) (MGAT2-A) (Monoacylglycerol O-acyltransferase 2-A)","glycerol metabolic process [GO:0006071]; monoacylglycerol biosynthetic process [GO:0006640]; triglyceride biosynthetic process [GO:0019432]","GO:0003846; GO:0004144; GO:0006071; GO:0006640; GO:0019432; GO:1990578"
"1235","Pocillopora_acuta_HIv2___RNAseq.g23755.t1",0.833333333333333,0,0,1.73913043478261,0,0.378787878787879,0.518134715025907,0,0,NA,0.385487373547747,0.423583662714097,0.33786701208981,NA,NA,NA,NA,NA,NA,7.83899717282492,8.60944092617983,8.08730258783991,3.68233641306884,7.94454507494712,3.68233641306884,8.5346223329741,7.27998974034641,9.05972216677657,3.68233641306884,6.84016292410954,8.04211134854699,5.63821449967209,202.224213101399,-0.313900392450469,1.04152764498079,7.49140765563184e-05,0.000650004321122129,"D4G3R4",1.18e-22,"tRNA(Glu)-specific nuclease WapA (EC 3.1.-.-) (Cell wall-associated protein) (RNase WapA) (Toxin WapA)","tRNA decay [GO:0016078]","GO:0004519; GO:0004549; GO:0005576; GO:0016078; GO:0016798; GO:0090729"
"1236","Pocillopora_acuta_HIv2___RNAseq.g23772.t1",0,NA,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.3598470565961,7.45925468652246,9.17291965128782,10.0683617088321,9.58352061654031,9.10037170762349,9.07960943095631,3.68233641306884,3.68233641306884,3.68233641306884,7.58708940975651,7.29619203011238,7.87798678940064,482.071319658375,0.0843681027971438,0.9488962418111,0.776875554547474,0.904218879936804,"Q5XG48",4.7e-52,"Mediator of RNA polymerase II transcription subunit 4 (Mediator complex subunit 4)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003712; GO:0006357; GO:0016592"
"1237","Pocillopora_acuta_HIv2___RNAseq.g23779.t1",0,NA,0,0,0,1.78571428571429,2.94117647058824,NA,0,NA,0.675270108043217,0.595238095238095,0.735294117647059,NA,NA,NA,NA,NA,NA,7.86664031724252,9.03583582322898,6.51648711029815,10.4017895958435,7.89020468744546,8.74933646359489,6.90983061090606,5.15600352509361,9.46592069005936,8.45337382475563,8.04454226484682,7.37905126602782,8.71003326366581,383.781433351579,0.891335398624929,0.931175529163108,0.0834163544141797,0.228482522349853,NA,NA,NA,NA,NA
"1238","Pocillopora_acuta_HIv2___TS.g29845.t2",0,NA,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.28790045227443,10.08948235831,7.38136255625802,8.88245085387777,9.26994645638407,11.6132069099037,8.76921698621586,9.48861318561759,3.68233641306884,3.68233641306884,8.21468525849791,7.82203181272059,8.60733870427523,705.532748029731,0.530179076912668,0.818338432816735,0.287012797282804,0.533379946510729,"Q8WZ42",5.83e-08,"Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)","cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]","GO:0000794; GO:0002020; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0030018; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0045214; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0070062; GO:0097493; GO:0106310"
"1239","Pocillopora_acuta_HIv2___TS.g29856.t1",NA,NA,NA,0,8.33333333333333,0,0,NA,0,0,1.38888888888889,0,2.77777777777778,NA,NA,NA,NA,NA,NA,8.47735516942381,3.68233641306884,7.95918821835721,3.68233641306884,3.68233641306884,3.68233641306884,8.85330624588099,8.82142434140143,8.40009381532483,3.68233641306884,6.09230498557325,7.46807959151522,4.71653037963127,173.191960063773,-0.32788386798116,1.0665010467339,0.000648766562171515,0.00407989545880382,"Q96M69",1.67e-164,"Leucine-rich repeat and guanylate kinase domain-containing protein","axoneme assembly [GO:0035082]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","GO:0001669; GO:0002177; GO:0004385; GO:0005524; GO:0005829; GO:0007283; GO:0030154; GO:0035082; GO:0042995"
"1240","Pocillopora_acuta_HIv2___RNAseq.g23857.t1",13.3333333333333,28.5714285714286,NA,NA,62.5,66.6666666666667,100,NA,0,NA,45.1785714285714,31.7460317460317,58.6111111111111,NA,NA,NA,NA,NA,NA,8.59088589524056,3.68233641306884,9.85847732838945,3.68233641306884,7.38984723548559,3.68233641306884,3.68233641306884,8.71465256445696,6.18642473237091,3.68233641306884,5.91519698212877,8.14805755118869,3.68233641306884,185.042253771809,-12.3184133060373,3.75077027443383,1.67428472251211e-09,6.29009200686107e-08,NA,NA,NA,NA,NA
"1241","Pocillopora_acuta_HIv2___RNAseq.15128_t",0,NA,0,NA,0,0,NA,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.87210556722981,7.93312856127724,6.0681601509144,3.68233641306884,6.16219278122378,3.68233641306884,3.68233641306884,5.98234595970336,6.24691203794079,3.68233641306884,5.49941907105647,6.46634329940243,4.53249484271052,61.342460158374,-1.19035843982154,2.32759012027961,0.000257302725920995,0.00185247716661089,NA,NA,NA,NA,NA
"1242","Pocillopora_acuta_HIv2___RNAseq.g23871.t1",100,100,100,100,NA,100,100,NA,NA,NA,100,100,100,NA,NA,NA,NA,NA,NA,8.91268086580113,10.4473890114854,8.99920222213776,8.83280940348506,9.18101249508214,7.60502134296842,9.72708592498973,6.89723497020019,3.68233641306884,3.68233641306884,7.79671090622875,7.53449339325801,8.05892841919949,438.620371085343,0.274008774934193,0.84638718300512,0.529213593450144,0.751034675791099,"Q80Y56",4.08e-93,"Rabenosyn-5 (FYVE finger-containing Rab5 effector protein rabenosyn-5) (RAB effector RBSN) (Zinc finger FYVE domain-containing protein 20)","early endosome to Golgi transport [GO:0034498]; Golgi to lysosome transport [GO:0090160]; protein transport [GO:0015031]; regulation of Golgi organization [GO:1903358]","GO:0005829; GO:0005886; GO:0015031; GO:0031267; GO:0031901; GO:0034498; GO:0046872; GO:0090160; GO:1903358"
"1243","Pocillopora_acuta_HIv2___RNAseq.g23879.t1",NA,NA,0,NA,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.15557695652597,6.26270646445638,9.53452131036586,7.03911674882672,9.62144705661849,3.68233641306884,3.68233641306884,8.93525001822804,8.91642754872211,3.68233641306884,7.05120553429501,9.23264457809209,4.86976649049792,310.566223860072,-4.44062049346011,4.33692170551255,6.99074384856052e-07,1.1503312744662e-05,"Q60HG9",0,"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)","carnitine metabolic process [GO:0009437]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid metabolic process [GO:0001676]","GO:0001676; GO:0004095; GO:0005743; GO:0006635; GO:0008458; GO:0009437; GO:0016746"
"1244","Pocillopora_acuta_HIv2___RNAseq.g23883.t2",1.93370165745856,5.12820512820513,4.22535211267606,0,0,0.286532951289398,0.284090909090909,0,0,NA,1.31754252874667,1.08294761589891,1.61078616980638,NA,NA,NA,NA,NA,NA,9.8947317476966,4.50233927872981,10.9860627783326,3.68233641306884,10.3331801113346,3.68233641306884,3.68233641306884,10.4542150791468,9.69914067840575,3.68233641306884,7.05990153259215,10.2734660789833,3.84633698620103,638.102436356512,-11.7250240512866,2.34846475679245,1.36354125222061e-13,2.4528626789505e-11,"Q5VU97",8.26e-146,"VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1)","","GO:0005245; GO:0005891"
"1245","Pocillopora_acuta_HIv2___RNAseq.g23886.t1",0,0,0,0,0,6.25,0,0,NA,NA,0.78125,1.5625,0,NA,NA,NA,NA,NA,NA,7.09414687449084,10.8034857415427,5.87178581315921,9.84347752922993,7.50309180060618,11.4394833627379,12.3909775504387,10.9930074701943,3.68233641306884,10.0706807206,8.96924732760686,7.02887367430387,10.9096209809098,1411.88130779252,3.25612129754305,1.73408726541336,0.000367754357226617,0.00251975320839687,"P07942",0,"Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta)","cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]","GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005788; GO:0007155; GO:0021812; GO:0030335; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043257; GO:0043259; GO:0045785; GO:0048471; GO:0050679; GO:0051149; GO:0062023; GO:0070062; GO:0098637; GO:0110011; GO:2001046"
"1246","Pocillopora_acuta_HIv2___RNAseq.g23898.t1",NA,0,0,NA,0,0,0,2.17391304347826,NA,NA,0.36231884057971,0.72463768115942,0,NA,NA,NA,NA,NA,NA,8.72050549546643,11.3341431147141,5.20227553025741,10.1717427975498,7.28808184092463,10.6707342634831,10.0485573863072,10.1823663629647,3.68233641306884,7.37489358856917,8.46756367933054,7.0151131285364,9.92001423012467,814.369081255654,2.37519512332793,2.03803539183503,0.000975246179458144,0.00573180038182958,"Q9JHA8",2.31e-27,"von Willebrand factor A domain-containing protein 7 (Protein G7c)","","GO:0005576"
"1247","Pocillopora_acuta_HIv2___TS.g29912.t2",0,0,0,2.77777777777778,0,0,0,0,0,0,0.277777777777778,0.555555555555556,0,NA,NA,NA,NA,NA,NA,8.67130106083343,11.1367269241162,5.54494604997642,11.7780465682608,5.3992335514363,10.88259649749,10.3635491218844,9.48371625031575,10.3690012341191,10.2272068030226,9.3856324061455,7.8936396293362,10.8776251829548,1245.44592349205,1.38573706311438,1.52895180141379,0.00672647302760166,0.0299635681771575,"E7FDW2",1.57e-61,"E3 ubiquitin-protein ligase PDZRN3-B (EC 2.3.2.27) (PDZ domain-containing RING finger protein 3-B)","neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567]","GO:0005737; GO:0007528; GO:0016567; GO:0045202; GO:0046872; GO:0061630"
"1248","Pocillopora_acuta_HIv2___RNAseq.g23907.t1",4.12371134020619,0,0,0,0,0,3.84615384615385,NA,0,NA,0.996233148295004,0,1.99246629659001,NA,NA,NA,NA,NA,NA,9.84016413468959,12.0800059868133,10.8403523345863,10.198570284277,9.36617630423823,10.5392498145142,11.1129408862005,10.4802569760706,6.78000415386907,9.82623079424669,10.1063951669505,9.46139078069076,10.7513995532103,1480.96219631498,0.866399435004557,0.805997329303453,0.0973469380729037,0.256237691043945,"O35161",1.08e-178,"Cadherin EGF LAG seven-pass G-type receptor 1","anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; neural tube closure [GO:0001843]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060]","GO:0001736; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007266; GO:0007626; GO:0009952; GO:0016020; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0045176; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090179; GO:0090251; GO:0097475; GO:0098609"
"1249","Pocillopora_acuta_HIv2___TS.g29914.t1",0,8.33333333333333,8.64197530864197,0,14.8648648648649,4.76190476190476,4.7244094488189,0,1.88679245283019,NA,4.80147557448822,2.99640610961366,7.05781240558143,NA,NA,NA,NA,NA,NA,6.03460261738071,9.91740561622851,7.48134846227682,8.77013579887542,8.66766462690904,7.91299510525976,8.87693523789752,7.56273982243945,5.5336018834485,5.08610646190246,7.58435356326182,7.0559914824909,8.11271564403273,279.297253256415,0.491225791390423,0.827860203739153,0.296237886925084,0.543745953529436,"Q80TR8",2.8e-63,"DDB1- and CUL4-associated factor 1 (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1)","B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]","GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0008180; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756"
"1250","Pocillopora_acuta_HIv2___RNAseq.g23910.t1",NA,NA,0,0,0,7.14285714285714,0,NA,0,NA,1.19047619047619,2.38095238095238,0,NA,NA,NA,NA,NA,NA,4.5939750356694,4.8931170245923,4.02873527760674,5.59933054873005,4.35452149648907,3.68233641306884,5.59808714140454,5.4533793909793,6.20688780213667,5.79624808010018,5.02066182107771,4.92749980057624,5.11382384157918,17.6021403844297,0.0721573975934568,0.876077529807552,0.858934103977234,0.944762196192145,NA,NA,NA,NA,NA
"1251","Pocillopora_acuta_HIv2___RNAseq.g23911.t1",0,1.88679245283019,1.63934426229508,0.709219858156028,0,0.328947368421053,1.90114068441065,0,0,NA,0.718382736234778,0.584991935881454,0.885121236676432,NA,NA,NA,NA,NA,NA,7.77623813175386,6.86946281647337,7.43846405649506,7.08871005249906,7.04098991334845,10.1827445859578,5.79202165087362,6.44383053581276,8.9343945549374,9.144506977945,7.67113632760964,7.52678343846951,7.81548921674977,289.179084928701,0.0405365698260501,0.712116868570701,0.937324757496807,0.976536811102885,"Q9Y4B6",0,"DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein)","B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]","GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756"
"1252","Pocillopora_acuta_HIv2___RNAseq.g23913.t1",0,0,5.71428571428571,0,0,1.32450331125828,0,0,20,0,2.7038789025544,4.26490066225166,1.14285714285714,NA,NA,NA,NA,NA,NA,5.88500629885129,8.03061114627924,7.24563010395376,5.21704338441576,7.32966434275371,7.18609379060864,7.54027079080636,8.42364395585137,7.79829038226439,11.0811270261657,7.57373812219502,7.3364470167349,7.81102922765514,349.112037691479,0.144292455785591,0.822959256447593,0.716565240143778,0.871975483339755,"Q9NYQ6",8.4e-73,"Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2)","apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001736; GO:0001764; GO:0001843; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007266; GO:0007417; GO:0016020; GO:0032956; GO:0042249; GO:0045176; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0098609"
"1253","Pocillopora_acuta_HIv2___RNAseq.g23916.t1",1.9047619047619,0.404858299595142,0,0,0,0.925925925925926,3.58744394618834,2.4390243902439,0,NA,1.02911271852391,0.753961723152994,1.37305146273756,NA,NA,NA,NA,NA,NA,6.976490469328,8.66733703951336,7.62478293516472,6.89302286053367,7.30381793138361,6.61523549873737,6.53262293348038,7.42579401114328,8.46337762414405,6.00413425515518,7.25066155585836,7.55885259423273,6.94247051748399,154.210670399032,-0.440218297322856,0.761203298284092,0.352351808304374,0.603626264990461,"Q9Y4B6",0,"DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein)","B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]","GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756"
"1254","Pocillopora_acuta_HIv2___RNAseq.g18722.t1",0,NA,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,10.2457335208979,10.948550544706,3.68233641306884,7.57819845214682,9.41961505704584,10.1039252094994,9.81431843929869,7.60178260564003,3.68233641306884,7.67591330684412,7.92503729097208,7.42678932271616,608.418723269126,-0.0183198904553349,0.986198520953657,0.810394872654294,0.920910068781073,"Q62371",4.25e-103,"Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b)","biomineral tissue development [GO:0031214]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endochondral bone growth [GO:0003416]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of neuron projection development [GO:0010976]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of wound healing [GO:0090303]; regulation of bone mineralization [GO:0030500]; regulation of tissue remodeling [GO:0034103]; response to muscle stretch [GO:0035994]","GO:0001503; GO:0003416; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0007169; GO:0008284; GO:0010763; GO:0010976; GO:0015629; GO:0016324; GO:0018108; GO:0030199; GO:0030500; GO:0031214; GO:0032967; GO:0034103; GO:0035988; GO:0035994; GO:0038062; GO:0038063; GO:0043066; GO:0043235; GO:0045669; GO:0045860; GO:0048146; GO:0051091; GO:0051897; GO:0071456; GO:0071560; GO:0090091; GO:0090303; GO:1900087; GO:1901299; GO:1904385; GO:1904707; GO:1904754; GO:1904899; GO:2000491"
"1255","Pocillopora_acuta_HIv2___TS.g27659.t1",NA,NA,NA,0,0,0,7.29166666666667,NA,4.76190476190476,0,2.00892857142857,1.58730158730159,2.43055555555556,NA,NA,NA,NA,NA,NA,10.7064221459714,10.5328505828977,9.96538715305399,11.485358435262,10.4454894450376,11.9049461245411,11.6640268236356,10.4359553854445,7.54812909326947,11.1702277822657,10.5858792971379,9.82027664455539,11.3514819497204,1911.5426725936,1.05458452816349,0.806470092029794,0.0524820725239479,0.161101876543201,"Q8N5H7",4.44e-26,"SH2 domain-containing protein 3C (Cas/HEF1-associated signal transducer) (Chat-H) (Novel SH2-containing protein 3) (SH2 domain-containing Eph receptor-binding protein 1) (SHEP1)","JNK cascade [GO:0007254]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase-mediated signal transduction [GO:0007264]","GO:0001784; GO:0005085; GO:0005829; GO:0007254; GO:0007264; GO:0030424; GO:0032587; GO:0033138"
"1256","Pocillopora_acuta_HIv2___TS.g27662.t3b",0,0,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,11.0591514661772,12.0711060055669,11.3970831825515,7.85997747624031,11.0169039444261,9.10037170762349,3.68233641306884,10.8481607132278,11.7032294806736,10.370189451734,9.91085098412897,11.2049057574112,8.61679621084671,1825.87349697724,-0.676552158881381,1.12455928577209,0.0815802149616486,0.225100387105167,"Q13698",0,"Voltage-dependent L-type calcium channel subunit alpha-1S (Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle) (Voltage-gated calcium channel subunit alpha Cav1.1)","calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular response to caffeine [GO:0071313]; endoplasmic reticulum organization [GO:0007029]; extraocular skeletal muscle development [GO:0002074]; muscle contraction [GO:0006936]; myoblast fusion [GO:0007520]; neuromuscular junction development [GO:0007528]; positive regulation of muscle contraction [GO:0045933]; release of sequestered calcium ion into cytosol [GO:0051209]; skeletal muscle adaptation [GO:0043501]; skeletal muscle fiber development [GO:0048741]; skeletal system development [GO:0001501]; striated muscle contraction [GO:0006941]","GO:0001501; GO:0002074; GO:0005245; GO:0005516; GO:0005737; GO:0005886; GO:0005891; GO:0006816; GO:0006936; GO:0006941; GO:0007029; GO:0007520; GO:0007528; GO:0008331; GO:0016529; GO:0030315; GO:0031674; GO:0036094; GO:0043501; GO:0045933; GO:0046872; GO:0048741; GO:0051209; GO:0070588; GO:0071313; GO:0098703; GO:0140677; GO:1990454"
"1257","Pocillopora_acuta_HIv2___RNAseq.g18756.t2",0,0,0,NA,8.33333333333333,0,0,0,0,NA,1.04166666666667,0,2.08333333333333,NA,NA,NA,NA,NA,NA,6.16911426736902,3.68233641306884,9.35440980955537,3.68233641306884,6.70204301475986,3.68233641306884,3.68233641306884,8.59705801932093,7.72427355322418,3.68233641306884,5.69585807295736,7.70937973284587,3.68233641306884,130.629689073319,-11.5644527315142,3.71131525503225,1.67546854554832e-08,4.53819794809192e-07,"O75382",1.34e-10,"Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97)","negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]","GO:0000209; GO:0005737; GO:0005769; GO:0005794; GO:0007399; GO:0008270; GO:0015031; GO:0017148; GO:0030371; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061630; GO:0070534"
"1258","Pocillopora_acuta_HIv2___RNAseq.g18760.t2",0,NA,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.5375792980568,12.5235040018549,12.1386730374529,11.7544529573954,12.4651801920158,11.9108328449725,11.8751256544507,11.5842749567325,11.6539641478084,10.4838080665767,11.7927395157317,11.8759343264133,11.70954470505,3755.4862476434,-0.112302582860967,0.566731011490408,0.793124917376452,0.912629976526094,"Q6GN42",0,"Choline transporter-like protein 4 (Solute carrier family 44 member 4)","acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]","GO:0008292; GO:0015220; GO:0015297; GO:0015871; GO:0016324; GO:0030307; GO:0032475; GO:0035675; GO:0061526"
"1259","Pocillopora_acuta_HIv2___RNAseq.g18771.t2",0,0,0,3.33333333333333,0,0,0,50,0,NA,5.92592592592593,10.6666666666667,0,NA,NA,NA,NA,NA,NA,9.89740667346111,9.55016938248,11.2444766677838,8.68874925379205,10.9098960151954,9.76990303595308,9.44279057789572,10.7943153995415,10.9767935560446,3.68233641306884,9.49568369752161,10.7645776624053,8.22678973263794,1159.68723792259,-0.73877049856726,1.09017990595833,0.109162789964248,0.27876599471096,"Q5VVW2",0,"GTPase-activating Rap/Ran-GAP domain-like protein 3","regulation of small GTPase mediated signal transduction [GO:0051056]","GO:0005096; GO:0005737; GO:0051056"
"1260","Pocillopora_acuta_HIv2___TS.g2568.t1",2.17391304347826,0,NA,0,0,2.7972027972028,0,0,0,NA,0.621389480085132,0.559440559440559,0.72463768115942,NA,NA,NA,NA,NA,NA,9.31015908753573,7.58520805892439,9.41698069478445,3.68233641306884,8.5369468928593,6.53469609022614,3.68233641306884,7.75450104011765,8.74715835856478,9.58516857155362,7.48354916207037,8.75314921477238,6.21394910936837,318.784171921762,-0.633208728317997,1.17863899272204,0.024176767857079,0.0867723995743897,"P07949",8.02e-57,"Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0006468; GO:0006919; GO:0007156; GO:0007158; GO:0007165; GO:0007411; GO:0007497; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0038023; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:0160144; GO:2001241"
"1261","Pocillopora_acuta_HIv2___RNAseq.g31.t1",0,0,6.66666666666667,NA,0,1.81818181818182,0,NA,0,NA,1.21212121212121,0.606060606060606,1.66666666666667,NA,NA,NA,NA,NA,NA,11.1633810366296,8.93577621236778,11.5774742445992,4.7130258565198,12.0887720129178,3.68233641306884,3.68233641306884,11.8661451654861,11.9263467305692,10.3060975492254,8.99416916344526,11.7244238380404,6.26391448885013,1891.4383734855,-1.04735870853319,1.79310615646222,1.40000200917997e-06,2.10714142151708e-05,"G8HTB6",3.14e-49,"ZP domain-containing protein","","GO:0016020"
"1262","Pocillopora_acuta_HIv2___RNAseq.g35.t1",0,NA,0,14.2857142857143,0,0,NA,NA,0,NA,2.38095238095238,4.76190476190476,0,NA,NA,NA,NA,NA,NA,10.3344121493503,9.1938169358223,9.29071417090254,9.99936961001568,10.6881357120485,7.0963417398513,3.68233641306884,10.5034202974165,10.2816900227706,3.68233641306884,8.47525734643154,10.2196744704977,6.73084022236539,780.666769971966,-0.580331692269463,1.16617167801497,0.0110831620916544,0.0453100216206017,"G8HTB6",1.44e-55,"ZP domain-containing protein","","GO:0016020"
"1263","Pocillopora_acuta_HIv2___RNAseq.g50.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.63634872160117,4.8931170245923,3.68233641306884,3.68233641306884,5.23920445324911,5.12470250408451,9.24434720056294,4.44278995465828,5.72271821572966,3.68233641306884,5.13502373136845,4.94467955166141,5.32536791107549,68.235299385266,-0.0431744642577292,0.960169990962434,0.80398322914341,0.917677827204095,NA,NA,NA,NA,NA
"1264","Pocillopora_acuta_HIv2___RNAseq.g55.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.20278042680075,8.98212090096353,6.3783135818283,3.68233641306884,7.59531148880866,3.68233641306884,3.68233641306884,7.41549053134096,9.16744197358883,3.68233641306884,6.14708045556064,7.5518676004735,4.74229331064778,152.678704455298,-0.672174742609878,1.36087419934629,1.47566243079191e-05,0.000159760339812681,NA,NA,NA,NA,NA
"1265","Pocillopora_acuta_HIv2___RNAseq.g20175.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.30806921954879,7.66340589212872,8.0991150332705,8.11899488820735,7.59105239200954,8.42263889455193,3.68233641306884,5.98234595970336,3.68233641306884,3.68233641306884,6.32326315186267,6.33258380352021,6.31394250020514,126.164858982505,-0.0268585616896186,0.907976373478946,0.998294196535765,0.999597872528976,NA,NA,NA,NA,NA
"1266","Pocillopora_acuta_HIv2___TS.g15102.t1",0,0.50761421319797,0.952380952380952,1.30434782608696,0,0.40595399188092,0.173010380622837,0,0,NA,0.371478596018848,0.443583206233169,0.281347833250947,NA,NA,NA,NA,NA,NA,7.55601247066455,5.1703194305374,7.46922666954589,8.37848981204756,7.1954653265099,7.88127329890854,8.20698204111156,7.91267833663967,7.59423998853345,3.68233641306884,7.10470237875674,7.54552455837869,6.66388019913478,162.594820229838,-0.268089613947223,0.908400217589137,0.416444834178374,0.661046760486831,"Q54TD7",4.38e-25,"ATP-dependent RNA helicase ddx24 (EC 3.6.4.13) (DEAD box protein 24)","","GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016887"
"1267","Pocillopora_acuta_HIv2___RNAseq.g20177.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.0744275437907,7.50248485470253,7.20957309746076,6.97457669156694,7.18982473243499,8.17076336729223,4.10128477526701,6.69745174704333,4.37599570701945,5.3719891395326,6.36683716561105,6.30945456554985,6.42421976567226,91.3617275867669,0.165087680714392,0.852438442553583,0.676644840063236,0.850108312242743,NA,NA,NA,NA,NA
"1268","Pocillopora_acuta_HIv2___RNAseq.g20178.t1",0,0,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.28621869280214,4.68019422250907,6.80680485095045,8.74351476367351,5.37766003570327,5.31580014468035,3.68233641306884,5.9967476145607,8.09891974992475,3.68233641306884,6.06705329009419,6.91327018878826,5.22083639140012,111.250086229052,-0.501646392918802,1.12019042369872,0.00509802527134015,0.0236414996872921,NA,NA,NA,NA,NA
"1269","Pocillopora_acuta_HIv2___RNAseq.g20183.t1",0,0,0,0,1.91082802547771,1.80995475113122,0.462962962962963,0,0,0,0.418374573957189,0.361990950226244,0.474758197688134,NA,NA,NA,NA,NA,NA,10.1571607313348,8.69357860865382,10.3650112737923,9.98970060408642,9.03561004855938,9.69908399890452,7.03630624529082,9.17896501427429,8.68836117951372,9.93679498219623,9.27805726866063,9.4850216494949,9.07109288782636,709.762179802852,-0.248845635727448,0.691682298846026,0.587499174972614,0.793573782854304,"A3AVH5",2.38e-56,"DEAD-box ATP-dependent RNA helicase 13 (EC 3.6.4.13)","","GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016887"
"1270","Pocillopora_acuta_HIv2___TS.g15111.t1",0,0,0,2.61437908496732,0,0.432900432900433,2.30414746543779,0,0,NA,0.59460299814506,0.609455903573551,0.576036866359447,NA,NA,NA,NA,NA,NA,7.63539511754732,6.89581790443942,6.67451956276615,9.32851090790566,7.27749362716997,7.46909717663739,3.68233641306884,7.93082707738892,7.16518700660512,11.8626709581229,7.59218557516517,7.3366844782955,7.84768667203484,528.3809211211,0.119524047434875,0.927168927353589,0.69593506183254,0.860176735737152,"Q54TD7",3.77e-55,"ATP-dependent RNA helicase ddx24 (EC 3.6.4.13) (DEAD box protein 24)","","GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016887"
"1271","Pocillopora_acuta_HIv2___RNAseq.g20189.t1",0,0,NA,0,0.704225352112676,0.854700854700855,0,0,0,0,0.173214022979281,0.170940170940171,0.176056338028169,NA,NA,NA,NA,NA,NA,9.2017697847733,9.11560498715579,8.50618649773748,8.64009028753399,7.98722978398025,9.41040737357254,7.53175536625655,8.74772775685289,8.40440045007422,8.43291462578709,8.59780869137241,8.56946285468363,8.62615452806119,388.74853990406,0.0354817485278132,0.601650389300474,0.943489619499741,0.978833896473357,"A3AVH5",1.6e-59,"DEAD-box ATP-dependent RNA helicase 13 (EC 3.6.4.13)","","GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016887"
"1272","Pocillopora_acuta_HIv2___RNAseq.g20190.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.74355908835771,4.39481510491619,4.89801104097743,3.68233641306884,4.4748864375616,5.35049164323153,8.00704222118106,5.49643519805837,7.65349580332634,3.68233641306884,5.43834093637479,5.85327751365629,5.02340435909329,55.0836221430551,-0.235660835658008,1.01587519928486,0.0532585487028807,0.162929705676495,"A7RKF6",8.96e-177,"RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase)","tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]","GO:0003972; GO:0005525; GO:0005634; GO:0006388; GO:0046872; GO:0072669; GO:0170057"
"1273","Pocillopora_acuta_HIv2___TS.g19140.t1a",NA,0,NA,0,33.3333333333333,0,0,NA,NA,0,5.55555555555556,0,11.1111111111111,NA,NA,NA,NA,NA,NA,7.34371843387449,7.60911950749454,9.64989267794005,3.68233641306884,7.69390117206977,5.41697153692495,10.5607633569118,6.66266950447494,8.9343945549374,4.90925637683756,7.24630235345343,8.05691526865933,6.43568943824754,332.505867202625,-0.346281962449727,1.02812086260619,0.0711829116768281,0.204202624849988,"Q9H0J4",1.48e-27,"Glutamine-rich protein 2","cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]","GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059"
"1274","Pocillopora_acuta_HIv2___RNAseq.g4291.t1",0,NA,NA,0,83.3333333333333,0,100,NA,0,NA,30.5555555555556,0,61.1111111111111,NA,NA,NA,NA,NA,NA,11.7133049095452,12.0213346023917,11.134235333279,9.99615380517827,10.4911494307121,12.2363864477093,10.0866691684174,11.5303990256198,10.2473862382045,10.6360604402051,11.0093079401262,11.0232949874721,10.9953208927804,2364.48194186478,-0.0214182267080418,0.643037377081274,0.958167801647952,0.984472733402787,NA,NA,NA,NA,NA
"1275","Pocillopora_acuta_HIv2___RNAseq.g9797.t1",NA,0,13.953488372093,23.0769230769231,2.73972602739726,0,8.33333333333333,NA,0,NA,6.87192440139239,5.76923076923077,8.34218257760787,NA,NA,NA,NA,NA,NA,10.4261767031427,10.8566611820395,11.6056345659308,10.3422536834405,10.3946917399871,10.1106858639992,8.29489711500127,10.9115058867735,11.3309459246838,12.3925820369862,10.6666034701985,10.9337909641036,10.3994159762933,2003.44411352058,-0.302848764274184,0.687387919764994,0.522140607713212,0.745532255672646,"Q9PVV4",3.05e-106,"Pericentriolar material 1 protein (PCM-1) (xPCM-1)","cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring at centrosome [GO:0034454]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]","GO:0005737; GO:0005813; GO:0005929; GO:0034451; GO:0034454; GO:0035735; GO:0042802; GO:0060271; GO:0071539; GO:0090316"
"1276","Pocillopora_acuta_HIv2___RNAseq.g9818.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.1414515907013,9.28288560999927,10.3819968045945,10.6284565512232,10.3369837010006,10.3422792794948,9.81529055841039,8.88968241462995,10.6152080444998,8.82176997594444,9.92560045304982,10.0730645110852,9.77813639501442,1040.28682133343,-0.184647837167051,0.614618572545364,0.687254118417936,0.855680775483948,"Q5U317",4.73e-36,"Pre-mRNA 3'-end-processing factor FIP1 (FIP1-like 1 protein)","mRNA processing [GO:0006397]","GO:0003723; GO:0005634; GO:0005847; GO:0006397"
"1277","Pocillopora_acuta_HIv2___RNAseq.g9821.t1",0,NA,NA,0,0,1.36986301369863,0,NA,0,NA,0.228310502283105,0.45662100456621,0,NA,NA,NA,NA,NA,NA,3.68233641306884,6.5579743664166,7.44466985220172,3.68233641306884,4.28462663579717,6.47828580769909,6.66472726798925,5.33850173705749,3.68233641306884,3.68233641306884,5.14981313194367,4.88649421023881,5.41313205364852,38.3638837305758,0.189291012640814,1.02312184747637,0.284697994242465,0.530776696279648,NA,NA,NA,NA,NA
"1278","Pocillopora_acuta_HIv2___RNAseq.g23920.t2",1.06382978723404,0,1.38888888888889,0.409836065573771,1.38751238850347,1.29060970182466,0.0836820083682008,0,0.288184438040346,0,0.591254327843337,0.397726041087754,0.78478261459892,NA,NA,NA,NA,NA,NA,5.76666095136545,7.25173910022888,6.63116616429788,6.86475539414292,6.40992758448011,6.57554848939467,7.31047606804878,6.94844182343232,6.57822744878171,5.08610646190246,6.54230494860752,6.46688479447149,6.61772510274354,77.772774045573,0.0981181523095719,0.70507507275044,0.840657191533152,0.936985618829446,"Q9Y4B6",0,"DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein)","B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]","GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756"
"1279","Pocillopora_acuta_HIv2___RNAseq.g4603.t1",71.4285714285714,0,66.6666666666667,30,35.7142857142857,28.5714285714286,8.33333333333333,NA,NA,NA,34.3877551020408,19.5238095238095,45.5357142857143,NA,NA,NA,NA,NA,NA,4.4307132106762,6.52433724544485,6.051458458319,7.63780657485539,6.05145252438901,6.46381683615196,7.10709703926101,5.09793447691117,7.95939725468383,3.68233641306884,6.10063500337613,5.91819118499584,6.28307882175641,74.7386415148867,0.351047009460153,0.985931563534911,0.288246438849745,0.534718031489381,NA,NA,NA,NA,NA
"1280","Pocillopora_acuta_HIv2___RNAseq.g3156.t1",0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.89404089377115,3.68233641306884,7.00571141948957,3.68233641306884,6.64499589542844,8.18381287343643,3.68233641306884,7.50078656318923,3.68233641306884,3.68233641306884,5.6641029710659,6.74557423698945,4.58263170514236,105.260791780322,-0.266259701471086,1.05656510906297,0.00228398432567859,0.0119694019154402,"Q2VLG4",7.39e-49,"Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)]","acute-phase response [GO:0006953]","GO:0005576; GO:0006953; GO:0009897"
"1281","Pocillopora_acuta_HIv2___RNAseq.g3159.t1",NA,0,0,0,9.52380952380952,0,0,NA,NA,NA,1.58730158730159,0,3.17460317460317,NA,NA,NA,NA,NA,NA,9.92257403600907,3.68233641306884,8.39887563080906,9.0250299895197,8.99443797260713,8.34348305453574,3.68233641306884,8.53445071536131,8.94033410692654,3.68233641306884,7.32061947449751,8.95813449234262,5.68310445665239,334.873062380951,-0.470100162346274,1.11601223742452,1.56874315730177e-05,0.000168325675276059,"Q5G266",6.26e-52,"Neurotrypsin (EC 3.4.21.-) (Serine protease 12)","exocytosis [GO:0006887]; proteolysis [GO:0006508]","GO:0004252; GO:0005886; GO:0006508; GO:0006887; GO:0030424; GO:0030425; GO:0043083; GO:0043195"
"1282","Pocillopora_acuta_HIv2___RNAseq.g1.t1",0,0,0,0,0,1.55440414507772,0,0,0,NA,0.172711571675302,0.310880829015544,0,NA,NA,NA,NA,NA,NA,5.17503271827961,3.68233641306884,6.59774358746208,5.861974049924,4.41738064913951,8.36654696487216,3.68233641306884,6.11981883186139,3.68233641306884,5.75038415558079,5.33358901963261,5.19846243996229,5.46871559930293,50.8946816583968,-0.0365218633718478,0.996575615885994,0.674606513011049,0.848848073439914,NA,NA,NA,NA,NA
"1283","Pocillopora_acuta_HIv2___RNAseq.g22602.t1",NA,NA,33.3333333333333,100,83.3333333333333,64.2857142857143,85.7142857142857,NA,100,NA,77.7777777777778,88.0952380952381,67.4603174603175,NA,NA,NA,NA,NA,NA,12.4057271275116,8.47754988276052,11.3148165662244,11.8709378407474,10.6726677104594,11.583211782231,12.082638250982,11.3925694073522,10.9571676831123,3.68233641306884,10.443962266445,11.348589698932,9.53933483395795,2555.99858079933,-0.227898984384038,0.927403306836665,0.420530110209584,0.664904625499719,"Q5RA77",0,"Coatomer subunit delta (Archain) (Delta-coat protein) (Delta-COP)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi localization [GO:0051645]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0006888; GO:0006890; GO:0015031; GO:0030126; GO:0051645"
"1284","Pocillopora_acuta_HIv2___RNAseq.g22624.t1a",0,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.71444610781529,5.85749282533549,8.4581208410883,6.50915460878185,6.85329648854777,8.25560222341749,3.68233641306884,8.8233647335454,3.68233641306884,6.94153598059022,6.77776866352595,7.30631291681312,6.24922441023878,172.174220779731,-0.163093825438643,0.987720974786113,0.387260979001901,0.634994809964323,"Q96L58",1.23e-97,"Beta-1,3-galactosyltransferase 6 (Beta-1,3-GalTase 6) (Beta3Gal-T6) (Beta3GalT6) (EC 2.4.1.134) (GAG GalTII) (Galactosyltransferase II) (Galactosylxylosylprotein 3-beta-galactosyltransferase) (UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6)","chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein O-linked glycosylation [GO:0006493]; proteoglycan biosynthetic process [GO:0030166]","GO:0000139; GO:0005794; GO:0005797; GO:0006024; GO:0006493; GO:0015012; GO:0016020; GO:0030166; GO:0030203; GO:0030206; GO:0032580; GO:0035250; GO:0047220"
"1285","Pocillopora_acuta_HIv2___RNAseq.g22638.t1",0,0,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.3216065289306,15.2329324484483,11.9026709681334,14.8665730242114,12.020646933195,14.9942522958874,14.6009612228161,13.8858571346708,9.78081700181806,14.5139800585842,13.4120297616695,11.9823197133496,14.8417398099895,17813.0516537474,2.41770323775597,0.90968773764325,0.000265595347889803,0.00190743352129002,"P08120",0,"Collagen alpha-1(IV) chain (Collagen type IV alpha 1)","basement membrane organization [GO:0071711]; cardiac muscle cell development [GO:0055013]; dorsal closure [GO:0007391]; extracellular matrix organization [GO:0030198]; intestinal epithelial structure maintenance [GO:0060729]; post-embryonic digestive tract morphogenesis [GO:0048621]","GO:0005201; GO:0005587; GO:0005604; GO:0005615; GO:0007391; GO:0030020; GO:0030198; GO:0048621; GO:0055013; GO:0060729; GO:0062023; GO:0071711"
"1286","Pocillopora_acuta_HIv2___TS.g24066.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.537529628211,13.845838568067,10.2769471886171,12.8856780416339,10.2148314540704,13.673197356607,13.3482536963568,11.8476884358809,10.674277758594,12.5640446634702,11.9868286791508,10.7102548930747,13.263402465227,6081.75958151818,2.27236467624306,0.712818520657562,0.000109710959209108,0.000896981370589127,"P27393",8.24e-154,"Collagen alpha-2(IV) chain","extracellular matrix organization [GO:0030198]","GO:0005581; GO:0005604; GO:0005615; GO:0030020; GO:0030198"
"1287","Pocillopora_acuta_HIv2___RNAseq.g22675.t2",18.4210526315789,0,0,0,0,0,0,4.41176470588235,0,NA,2.53697970416237,0.882352941176471,4.60526315789474,NA,NA,NA,NA,NA,NA,11.2574652661922,8.11635534182104,11.985967120978,6.58091230054222,11.4965613396419,7.15087115891671,9.40615518432746,13.2830470788959,12.5728542614571,9.81837446375526,10.1668563516528,12.119179013433,8.21453368987254,2729.83046484347,-3.7602530151549,0.8114117270991,4.51931736578655e-08,1.08945677297894e-06,NA,NA,NA,NA,NA
"1288","Pocillopora_acuta_HIv2___RNAseq.g22694.t1",0,NA,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.7573676019567,11.074672459014,11.6159263814894,10.1559799295237,11.5727275089537,11.9010082570379,8.51753520883539,11.1363736559175,11.5339782390054,11.6911991911802,10.9956768432914,11.3232746774645,10.6680790091182,2367.16866761265,-0.378155860869958,0.676865993017871,0.422718818240488,0.666834440727496,"Q9UPV0",5e-44,"Centrosomal protein of 164 kDa (Cep164)","cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281]","GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0043231; GO:0051301; GO:0060271; GO:0097539"
"1289","Pocillopora_acuta_HIv2___TS.g24153.t1",0,0,NA,2.77777777777778,0,3.27868852459016,0,NA,50,0,7.00705828779599,14.014116575592,0,NA,NA,NA,NA,NA,NA,8.75928198563692,6.15566643149668,9.68942171787145,3.68233641306884,8.23065898728289,5.87223972230221,7.95079023411305,8.1510851760415,8.07748726595138,3.68233641306884,7.02513043468338,8.58158702655683,5.46867384280992,229.374719532268,-1.04838548981297,1.61873095465919,0.00394678142523139,0.0190327993779926,NA,NA,NA,NA,NA
"1290","Pocillopora_acuta_HIv2___RNAseq.g22725.t1",0,NA,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.569744878372,10.2495255894261,10.3069032779743,11.2246641417134,7.95781456870118,11.578288397269,3.68233641306884,11.2101018672325,8.43419122002346,9.07144643747077,9.42850167912516,9.69575116246069,9.16125219578962,1272.73963779211,0.0593141914093936,0.904947636221209,0.862014182719089,0.946091768548938,"Q9NUK0",1.7e-70,"Muscleblind-like protein 3 (Cys3His CCG1-required protein) (Muscleblind-like X-linked protein) (Protein HCHCR)","mRNA processing [GO:0006397]; negative regulation of myoblast differentiation [GO:0045662]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]","GO:0003723; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0008380; GO:0043484; GO:0045662; GO:0046872"
"1291","Pocillopora_acuta_HIv2___RNAseq.g22748.t1",0,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.3128681908177,12.7525153011628,12.4485861915489,12.7201578975719,12.2636360391517,12.4092196222603,12.0135624683678,12.8762087732756,13.0227842399811,11.699062997385,12.4518601721523,12.584816686955,12.3189036573496,5772.64684927805,-0.183758000943268,0.560867131465247,0.686866799437981,0.855493101444154,"Q8CHG3",1.28e-97,"GRIP and coiled-coil domain-containing protein 2 (185 kDa Golgi coiled-coil protein) (GCC185)","Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]","GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0006622; GO:0016020; GO:0031023; GO:0034067; GO:0034453; GO:0034499; GO:0042802; GO:0070861; GO:0071955; GO:0090161"
"1292","Pocillopora_acuta_HIv2___TS.g24198.t1",1.48698884758364,2.18120805369128,3.51437699680511,1.07296137339056,3.10262529832936,0,1.78571428571429,5.40540540540541,0.230149597238205,1.2,1.99794298581578,1.77794488594509,2.21794108568648,NA,NA,NA,NA,NA,NA,13.9388905816579,13.8724130753056,14.0317596601013,14.4608321247493,13.6622665700507,13.6186920222769,14.0776870392743,13.6826554721237,14.146160256942,14.0451187791564,13.9536475581638,13.8923465081751,14.0149486081525,16076.1452576397,0.0987021271997233,0.48199999272187,0.821964740426144,0.926807266713194,"Q95209",0,"Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA)","adaptive thermogenesis [GO:1990845]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of insulin receptor signaling pathway [GO:0046628]; post-Golgi vesicle-mediated transport [GO:0006892]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; regulation of smooth muscle cell migration [GO:0014910]","GO:0000139; GO:0002024; GO:0005615; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006897; GO:0010897; GO:0014910; GO:0016020; GO:0030514; GO:0030658; GO:0031901; GO:0032585; GO:0038020; GO:0045053; GO:0046628; GO:0055038; GO:1904179; GO:1990845"
"1293","Pocillopora_acuta_HIv2___TS.g24210.t1",NA,0,0,NA,NA,0,0,100,NA,0,16.6666666666667,33.3333333333333,0,NA,NA,NA,NA,NA,NA,10.1902578621426,11.0545845117419,9.36258512748144,11.1686413390668,10.9555541555132,11.7086621825204,9.82051951382199,10.7358107343358,10.2232439649257,9.77302823921283,10.4992887630763,10.2934903688797,10.7050871572728,1601.27942503016,0.273811573782372,0.625182277607203,0.563940842593308,0.775733746768389,"P53356",0,"Tyrosine-protein kinase HTK16 (EC 2.7.10.2)","","GO:0004715; GO:0005524"
"1294","Pocillopora_acuta_HIv2___RNAseq.g22785.t1",0,NA,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.45934460031867,9.4438342190206,9.102413005967,9.11379262397548,10.2622758634889,9.43785585853975,11.1136509038199,10.154910805139,3.68233641306884,10.8243215192948,9.15947358126329,8.33225613759648,9.98669102493011,901.383242673395,0.316465767210501,0.911916126941733,0.446903606851133,0.688980363408099,"Q9NR80",1.3e-147,"Rho guanine nucleotide exchange factor 4 (APC-stimulated guanine nucleotide exchange factor 1) (Asef) (Asef1)","filopodium assembly [GO:0046847]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; regulation of small GTPase mediated signal transduction [GO:0051056]","GO:0005085; GO:0005829; GO:0019904; GO:0030032; GO:0032587; GO:0035556; GO:0046847; GO:0051056"
"1295","Pocillopora_acuta_HIv2___TS.g24249.t2",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.3627532000089,9.55221809885684,9.08670395153231,10.5351635005157,8.00331478228558,9.77134207182996,12.8048797114352,10.4372221225786,4.4808124149756,10.9386396831017,9.59730495371204,8.4741612942762,10.7204486131479,1550.52942682761,0.899167167906526,1.11576794412376,0.0698306663872648,0.20136179398433,"P97360",2.91e-12,"Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel)","cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; mesenchymal cell apoptotic process [GO:0097152]; neurogenesis [GO:0022008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; vitellogenesis [GO:0007296]","GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005730; GO:0005829; GO:0006355; GO:0006357; GO:0007296; GO:0019904; GO:0022008; GO:0030154; GO:0045944; GO:0071425; GO:0097152"
"1296","Pocillopora_acuta_HIv2___TS.g24258.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.33446087899792,4.82737711805479,9.37395323909205,8.23832351102165,8.60589432994897,8.64322221697842,3.68233641306884,8.88782938643167,3.68233641306884,3.68233641306884,6.7958069919732,7.77689484950789,5.81471913443851,240.836505490007,-0.510952611993314,1.10003608902227,0.154569161382237,0.355523793530491,NA,NA,NA,NA,NA
"1297","Pocillopora_acuta_HIv2___RNAseq.g22824.t1",2.27272727272727,0,0,0,22.2222222222222,0,0,NA,0,0,2.72166105499439,0,4.8989898989899,NA,NA,NA,NA,NA,NA,8.44842904443638,5.01287713650611,8.43657645863972,7.5168056772214,7.3142128553038,8.82893474292791,8.46055785917695,7.69622648191018,9.32325721750938,10.3154297460229,8.13533072196547,8.24374041155989,8.02692103237105,375.286569249596,-0.0332535980266265,0.783959808676295,0.924913500702405,0.971740311916873,"B2IZD3",2.04e-08,"Bacterial dynamin-like protein (BDLP) (EC 3.6.5.5)","mitochondrial fusion [GO:0008053]","GO:0003924; GO:0005525; GO:0005886; GO:0008053; GO:0008289; GO:0042802"
"1298","Pocillopora_acuta_HIv2___RNAseq.g22839.t1",0,7.69230769230769,NA,0,0,0,0,0,0,0,0.854700854700855,1.53846153846154,0,NA,NA,NA,NA,NA,NA,8.84774215549785,7.70095858672402,7.33531323544956,8.22737630653289,6.33916264969108,10.5468308940351,11.3639198787226,3.68233641306884,3.68233641306884,7.48543228611298,7.52114088189038,5.97737817335523,9.06490359042552,532.213093124493,0.580607239510926,1.17926481462257,0.00619337074420768,0.0279242252008167,"Q01887",4.12e-117,"Tyrosine-protein kinase RYK (EC 2.7.10.1) (Kinase VIK) (Met-related kinase) (NYK-R)","axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; chemorepulsion of axon [GO:0061643]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of cell proliferation in midbrain [GO:1904935]; positive regulation of MAPK cascade [GO:0043410]; skeletal system morphogenesis [GO:0048705]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0007409; GO:0007411; GO:0016020; GO:0016055; GO:0017147; GO:0022038; GO:0030182; GO:0031175; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048787; GO:0048843; GO:0048846; GO:0050919; GO:0060071; GO:0061643; GO:0071679; GO:0098839; GO:0098978; GO:1904935; GO:1904948"
"1299","Pocillopora_acuta_HIv2___TS.g24278.t2",0,NA,NA,0,NA,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,10.550332255092,11.1883416980689,9.95569434085864,11.1133256565269,9.84894636904332,10.4450259000383,5.28097201389241,10.3618481630113,8.44259078107913,11.4276715639264,9.86147487415373,9.83188238181688,9.89106736649058,1356.40282910201,0.195588988879518,0.840661412223257,0.636643483835685,0.824756950308942,"Q32LQ6",0,"Lysosomal dipeptide transporter MFSD1 (Major facilitator superfamily domain-containing protein 1)","dipeptide transmembrane transport from lysosomal lumen to cytosol [GO:0141204]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]","GO:0005764; GO:0005765; GO:0042803; GO:0050821; GO:0061462; GO:0141204; GO:0160178"
"1300","Pocillopora_acuta_HIv2___RNAseq.g22847.t1",NA,NA,0,0,0,0,3.03030303030303,0,NA,NA,0.505050505050505,0,1.01010101010101,NA,NA,NA,NA,NA,NA,8.38877138209431,7.10195357481188,7.90186235669204,7.21677407670513,9.25795497256134,7.0963417398513,3.68233641306884,7.93442943737751,8.95507673447494,3.68233641306884,7.12178371007061,8.48761897664003,5.7559484435012,215.103582981192,-0.874494252709079,1.34811379830462,0.015002445456435,0.0584893183509098,NA,NA,NA,NA,NA
"1301","Pocillopora_acuta_HIv2___RNAseq.g22852.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,13.4747266075772,13.7275764472462,13.9809082173664,15.1014052753821,13.6408242896897,14.6225107073738,15.0222112390703,13.8556835283846,13.6407895488012,15.6344105286771,14.2701046389569,13.7185864383638,14.8216228395499,22575.1473167538,0.888882273758769,0.591788401466084,0.0699142270329486,0.201532940710802,NA,NA,NA,NA,NA
"1302","Pocillopora_acuta_HIv2___RNAseq.g22873.t1",0,0,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.85400082282646,10.8853775079859,4.52101710263,9.9099222895395,6.74915512039247,11.3850762541291,3.68233641306884,9.73515540992119,5.66277130452222,10.2232458527863,8.2608058077802,7.30441995205847,9.21719166350193,846.412595029802,0.478978508075227,1.12489928261881,0.0240305324919025,0.0863332394343959,"P69525",2.53e-86,"Transmembrane protease serine 9 (EC 3.4.21.-) (Polyserase-I) (Polyserine protease 1) (Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3]","plasminogen activation [GO:0031639]; proteolysis [GO:0006508]","GO:0004252; GO:0005886; GO:0006508; GO:0008236; GO:0031639"
"1303","Pocillopora_acuta_HIv2___RNAseq.g22880.t1",0,0,0,0,6.25,2.41935483870968,0,NA,0,NA,1.08366935483871,0.604838709677419,1.5625,NA,NA,NA,NA,NA,NA,8.02707186966077,8.23352351804856,7.8137283068138,4.41872232712587,7.85516589283234,3.68233641306884,3.68233641306884,5.26380834900594,8.21631227375645,8.72416849554478,6.59171738589262,7.43521733841386,5.74821743337138,160.864323915894,-0.625936965859822,1.17812981779166,0.00504101613810698,0.0234221835597749,"Q7RTR2",1.57e-19,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223"
"1304","Pocillopora_acuta_HIv2___RNAseq.g22881.t1",28.5714285714286,NA,NA,70,37.9310344827586,23.0769230769231,38.0952380952381,100,22.2222222222222,NA,45.6995494926529,53.8247863247863,34.8659003831418,NA,NA,NA,NA,NA,NA,5.88500629885129,7.54444492362095,5.32783859183311,7.40425219505693,5.48185943121106,6.11832151256475,5.82167741730566,5.90789232542808,6.48192780096359,6.9219028403352,6.28951233371706,5.81690488965743,6.7621197777767,66.3649917577926,0.832301054225116,0.787740214209033,0.117375611939807,0.293977636553656,"Q9P215",4.52e-37,"Pogo transposable element with KRAB domain","regulation of DNA-templated transcription [GO:0006355]","GO:0003677; GO:0005634; GO:0005654; GO:0006355"
"1305","Pocillopora_acuta_HIv2___TS.g24323.t1",1.35062128579146,0.666666666666667,1.39103554868624,1.28398791540786,2.22057735011103,0.663439124977587,1.28350320875802,1.92102454642476,0.922131147540984,0,1.17029867943646,1.09144988020357,1.24914747866935,NA,NA,NA,NA,NA,NA,5.52146481986391,6.97205094875064,8.36342648242998,3.68233641306884,6.29702506358452,5.67813700336456,3.68233641306884,5.95306534505293,3.68233641306884,3.68233641306884,5.35145153153219,5.96346362480004,4.73943943826434,55.1922037737322,-0.220386901636832,1.01488484261267,0.34494441051483,0.596019108073886,"Q7RTR2",7.77e-64,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223"
"1306","Pocillopora_acuta_HIv2___RNAseq.g22897.t1",0,14.2857142857143,0,7.14285714285714,0,0,0,0,0,0,2.14285714285714,4.28571428571429,0,NA,NA,NA,NA,NA,NA,8.51271382672152,9.54811775094958,8.57258423570792,10.0295673639255,8.94542213631147,8.38924687130923,7.9120252782838,9.79567234675235,9.23422193434221,9.37626766476269,9.03158394090663,9.01212289596709,9.05104498584616,551.124599227463,0.038574354806575,0.66040812928949,0.937289859734662,0.976536811102885,"Q5F364",0,"Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)","cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908]","GO:0005524; GO:0006869; GO:0008559; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0070729"
"1307","Pocillopora_acuta_HIv2___RNAseq.g22898.t1",2.77777777777778,NA,NA,0,4.54545454545455,0,0,NA,0,NA,1.22053872053872,0,2.44107744107744,NA,NA,NA,NA,NA,NA,10.2469353884651,9.75792568064723,9.71390767490975,3.68233641306884,10.5692163860579,5.24316029637619,4.90654184690663,8.37681598814162,9.87835507531024,11.2715081186103,8.36467028684938,9.75704610257692,6.97229447112184,803.380039699802,-0.711378162758336,1.24797680106873,0.00393618655032525,0.0190093496707527,"Q5F364",0,"Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)","cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908]","GO:0005524; GO:0006869; GO:0008559; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0070729"
"1308","Pocillopora_acuta_HIv2___TS.g24370.t1",0,8.33333333333333,NA,0,0,3.36134453781513,0,NA,0,0,1.46183473389356,2.92366946778712,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,6.00006370517053,9.45572338525138,3.68233641306884,6.75180294683743,8.69518597124527,8.23228355748136,3.68233641306884,3.68233641306884,5.75467416313302,5.05587130037168,6.45347702589435,146.608000034806,0.335778524551931,1.04821893153709,0.242995043275956,0.481199384712956,"Q811B3",2.49e-105,"A disintegrin and metalloproteinase with thrombospondin motifs 12 (ADAM-TS 12) (ADAM-TS12) (ADAMTS-12) (EC 3.4.24.-)","cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of cellular response to hepatocyte growth factor stimulus [GO:2001113]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of hepatocyte growth factor receptor signaling pathway [GO:1902203]; ossification [GO:0001503]; ossification involved in bone maturation [GO:0043931]; proteoglycan catabolic process [GO:0030167]; proteoglycan metabolic process [GO:0006029]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of inflammatory response [GO:0050727]","GO:0001503; GO:0002062; GO:0004222; GO:0005576; GO:0006029; GO:0007160; GO:0016477; GO:0030167; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0050727; GO:0051603; GO:0071347; GO:0071356; GO:0071773; GO:1901509; GO:1902203; GO:1902548; GO:2001113"
"1309","Pocillopora_acuta_HIv2___TS.g24371.t1",0,0,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.78489567390366,8.70836182932305,10.2586702858024,8.25997094939533,8.75751361004584,11.4641581403301,3.68233641306884,9.83079985253019,9.96097850686524,10.7791719837094,9.1486857244974,9.71857158582947,8.57879986316534,952.585234640067,-0.207207570513805,0.92376629159677,0.507878604115982,0.735846552131981,"Q811B3",3.27e-102,"A disintegrin and metalloproteinase with thrombospondin motifs 12 (ADAM-TS 12) (ADAM-TS12) (ADAMTS-12) (EC 3.4.24.-)","cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of cellular response to hepatocyte growth factor stimulus [GO:2001113]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of hepatocyte growth factor receptor signaling pathway [GO:1902203]; ossification [GO:0001503]; ossification involved in bone maturation [GO:0043931]; proteoglycan catabolic process [GO:0030167]; proteoglycan metabolic process [GO:0006029]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of inflammatory response [GO:0050727]","GO:0001503; GO:0002062; GO:0004222; GO:0005576; GO:0006029; GO:0007160; GO:0016477; GO:0030167; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0050727; GO:0051603; GO:0071347; GO:0071356; GO:0071773; GO:1901509; GO:1902203; GO:1902548; GO:2001113"
"1310","Pocillopora_acuta_HIv2___RNAseq.g22940.t1",2.43243243243243,0.895522388059702,0,0,2.42290748898678,0.989345509893455,0.61576354679803,0,1.7921146953405,0,0.91480860615109,0.735396518658732,1.09422069364345,NA,NA,NA,NA,NA,NA,9.31416944308529,6.65426612666998,7.44466985220172,6.37387005840579,9.26329684055916,9.32477963456415,9.98788380820886,9.23687135489802,3.68233641306884,3.68233641306884,7.49644799447306,7.78826878076261,7.20462720818352,366.938810105735,-0.337119988117899,0.813135768235137,0.516760370697908,0.741548472726029,"Q54RB7",2.88e-29,"Dual specificity protein kinase shkA (EC 2.7.11.1) (SH2 domain-containing protein 1) (SH2 domain-containing protein A)","actin cytoskeleton organization [GO:0030036]; chemotaxis [GO:0006935]; negative regulation of signal transduction [GO:0009968]; phagocytosis [GO:0006909]","GO:0004674; GO:0004713; GO:0005524; GO:0005737; GO:0005938; GO:0006909; GO:0006935; GO:0009968; GO:0016020; GO:0030036; GO:0106310"
"1311","Pocillopora_acuta_HIv2___RNAseq.16039_t",0,0,19.047619047619,7.14285714285714,37.037037037037,4.47761194029851,3.63636363636364,28.5714285714286,0,0,9.9912917375604,8.03837953091685,11.9442039442039,NA,NA,NA,NA,NA,NA,9.00491001710773,9.73285795229738,3.68233641306884,10.7903564175182,5.97219005110571,11.329025132283,3.68233641306884,7.03212376687759,3.68233641306884,3.68233641306884,6.8590808989465,5.87477933224574,7.84338246564725,575.244846146767,0.150008399349128,1.01027354442467,0.149478312352215,0.347932782404641,"Q8RWL6",5.14e-28,"Serine/threonine-protein kinase STY17 (EC 2.7.11.1) (Serine/threonine/tyrosine-protein kinase 17)","chloroplast organization [GO:0009658]","GO:0004674; GO:0004712; GO:0005524; GO:0005829; GO:0009658; GO:0106310"
"1312","Pocillopora_acuta_HIv2___RNAseq.g22945.t1a",1.05263157894737,0.442477876106195,0,0,0,0,0,0,2.30414746543779,NA,0.422139657832372,0.549325068308796,0.263157894736842,NA,NA,NA,NA,NA,NA,8.89939125569339,6.85609801113518,5.70790219953855,12.5353731047808,8.79304907618526,10.0082339755232,3.68233641306884,5.40874075538327,3.68233641306884,3.68233641306884,6.92557976174462,6.49828393997386,7.35287558351537,792.758271732304,-0.023627979180487,0.967412944936031,0.953704094455798,0.982365476585149,"Q54IP4",4.09e-29,"Dual specificity protein kinase shkB (EC 2.7.11.1) (SH2 domain-containing protein 2) (SH2 domain-containing protein B)","","GO:0004674; GO:0004713; GO:0005524; GO:0005737; GO:0016020; GO:0106310"
"1313","Pocillopora_acuta_HIv2___RNAseq.g22946.t1",0,NA,0,0,0,0,4.16666666666667,2.85714285714286,0,NA,0.87797619047619,0.714285714285714,1.04166666666667,NA,NA,NA,NA,NA,NA,8.4263463087757,6.94709464914545,6.40448673657577,8.33326890870578,9.57710140984208,8.34348305453574,3.68233641306884,9.89121114080339,8.95214025271258,3.68233641306884,7.42398052872342,8.6502571697419,6.19770388770493,320.830226697257,-0.40788820724653,1.0545817787386,0.0781176578566763,0.218675015142049,"Q96DT5",0,"Dynein axonemal heavy chain 11 (Axonemal beta dynein heavy chain 11) (Ciliary dynein heavy chain 11)","cardiac septum morphogenesis [GO:0060411]; cilium movement involved in cell motility [GO:0060294]; determination of left/right asymmetry in nervous system [GO:0035545]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; learning or memory [GO:0007611]; protein localization to motile cilium [GO:0120229]; regulation of cilium beat frequency [GO:0003356]","GO:0003356; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007368; GO:0007611; GO:0008569; GO:0016887; GO:0030286; GO:0030317; GO:0031514; GO:0035545; GO:0045505; GO:0051959; GO:0060287; GO:0060294; GO:0060411; GO:0097728; GO:0097729; GO:0120134; GO:0120229"
"1314","Pocillopora_acuta_HIv2___RNAseq.g22947.t1",24.5901639344262,0,0,0,0,4.05405405405405,5.55555555555556,33.3333333333333,NA,NA,8.44163835967115,9.34684684684685,7.53642987249545,NA,NA,NA,NA,NA,NA,10.5747663668499,6.43649034287553,5.23497525321289,6.15405973004498,8.82411742802113,3.68233641306884,3.68233641306884,8.44649846873451,6.56263408610192,3.68233641306884,6.32805509150474,7.92859832058407,4.72751186242541,244.883789681208,-0.838784269722339,1.55609192002127,4.65714361978503e-05,0.000429323934458705,"Q6ING7",1.38e-144,"FAD synthase (EC 2.7.7.2) (FAD pyrophosphorylase) (FMN adenylyltransferase) (Flavin adenine dinucleotide synthase) [Includes: Molybdenum cofactor biosynthesis protein-like region; FAD synthase region]","FAD biosynthetic process [GO:0006747]","GO:0003919; GO:0005524; GO:0005737; GO:0006747"
"1315","Pocillopora_acuta_HIv2___RNAseq.g22957.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,8.82786152927722,3.68233641306884,7.30902487906021,8.18813650796672,8.95512719247895,7.53922844514113,4.4808124149756,5.3719891395326,6.17191893476389,6.3678527363046,5.97598513322319,148.553294554818,0.100472532900767,0.945932930185298,0.778937830499215,0.905466524937074,"Q9EQS5",6.69e-133,"Lathosterol oxidase (EC 1.14.19.20) (C-5 sterol desaturase) (Delta(7)-sterol 5-desaturase) (Delta(7)-sterol C5(6)-desaturase) (Lathosterol 5-desaturase) (Sterol-C5-desaturase)","cholesterol biosynthetic process via lathosterol [GO:0033490]; fatty acid metabolic process [GO:0006631]; negative regulation of ferroptosis [GO:0110076]","GO:0000248; GO:0005506; GO:0005789; GO:0006631; GO:0016020; GO:0033490; GO:0050046; GO:0110076"
"1316","Pocillopora_acuta_HIv2___RNAseq.g22964.t1",0,NA,NA,0,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.4913613219064,3.68233641306884,10.9620600241402,6.43347906989454,11.8537016599652,3.68233641306884,6.36722016743734,11.1206918713478,11.9712462363983,9.09332197909593,8.56577551563234,11.2798122227516,5.8517388085131,1389.15835526996,-4.62397155044648,2.60268282723946,2.04723262063318e-05,0.000211659561292626,"Q6QNK2",6.08e-29,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0016607"
"1317","Pocillopora_acuta_HIv2___RNAseq.g22975.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.3567367124764,7.73030729659763,10.282988384378,4.7130258565198,8.44584113692867,5.28004943464804,3.68233641306884,8.39520843214021,6.49844915574363,10.0075957715061,7.13925385940073,7.99584476433338,6.28266295446808,319.580142036546,-0.310977551391938,1.04159676593726,0.0203962594301984,0.0753926645536389,"Q14692",0,"Ribosome biogenesis protein BMS1 homolog (Ribosome assembly protein BMS1 homolog)","endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]","GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005524; GO:0005525; GO:0005654; GO:0005694; GO:0005730; GO:0030686; GO:0032040; GO:0034511; GO:0042274"
"1318","Pocillopora_acuta_HIv2___RNAseq.g22998.t1",0,0,NA,0,15.4761904761905,1.66666666666667,4.6875,0,33.3333333333333,NA,6.89546130952381,7,6.72123015873016,1,25.8064516129032,25.8064516129032,0.0328108334770168,0.0328108334770168,0.0328108334770168,8.97735000601738,3.68233641306884,7.85615191270033,9.99776260389347,9.97797784290129,6.3891072326092,3.68233641306884,7.02533634129515,6.05667785981469,3.68233641306884,6.7327373038438,7.97869879254577,5.48677581514184,287.461684649445,-0.753554732652097,1.43048039880473,0.00025455875173839,0.00183637794770278,"Q2KIN5",9.8e-122,"Porphobilinogen deaminase (EC 2.5.1.61) (Hydroxymethylbilane synthase) (HMBS)","heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]","GO:0004418; GO:0005737; GO:0006782; GO:0006783"
"1319","Pocillopora_acuta_HIv2___RNAseq.g23006.t1",NA,0,0,0,100,0,0,NA,0,0,12.5,0,25,NA,NA,NA,NA,NA,NA,6.3567367124764,8.89436842442846,8.88575591384507,6.80645827979764,8.65958011145385,8.62102755951409,3.68233641306884,3.68233641306884,3.68233641306884,7.79504629209236,6.70659825328144,6.2533491127826,7.15984739378028,198.897222031121,0.222394354546356,0.970002610632669,0.398483260622578,0.644847333355021,NA,NA,NA,NA,NA
"1320","Pocillopora_acuta_HIv2___RNAseq.g23008.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.43326027943365,3.68233641306884,7.07161686373946,11.0863642699884,7.60379181609188,8.92261958639937,3.68233641306884,9.24123079958091,8.27395426385003,3.68233641306884,7.26798471182902,8.32477080453919,6.21119861911886,441.850535830667,-0.214284297907547,1.02921497924072,7.10574044497916e-05,0.00062101166039987,"Q86BN8",2.86e-63,"Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 (EC 3.1.3.27) (PTEN-like phosphatase) (PTEN-like protein) (Protein-tyrosine phosphatase mitochondrial 1-like protein) (EC 3.1.3.16, EC 3.1.3.48)","dephosphorylation [GO:0016311]; liquid clearance, open tracheal system [GO:0035002]; phosphatidylglycerol biosynthetic process [GO:0006655]","GO:0004439; GO:0004725; GO:0005739; GO:0005743; GO:0006655; GO:0008962; GO:0016311; GO:0017018; GO:0035002"
"1321","Pocillopora_acuta_HIv2___TS.g24454.t1",0,0,0,0,0,0,0,0,1.88679245283019,10,1.18867924528302,0.377358490566038,2,NA,NA,NA,NA,NA,NA,8.00237851673687,9.18063134406443,9.20419319850278,8.01456480640263,10.3583499508171,8.13088834820294,3.68233641306884,8.28115103341985,8.9343945549374,3.68233641306884,7.74712245792217,8.9560934508828,6.53815146496154,387.653148061406,-0.550837293861285,1.11908396236822,0.0359962942196815,0.119827479768348,NA,NA,NA,NA,NA
"1322","Pocillopora_acuta_HIv2___RNAseq.g23030.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.25300700550269,5.21816971328303,7.78960555143337,7.22786336628594,4.28462663579717,3.68233641306884,9.91316921308074,3.68233641306884,3.68233641306884,11.329766976364,6.20632177009535,4.93838240377418,7.47426113641651,384.369881541324,0.141386621346284,0.987828916669231,0.540653912060256,0.760337999852907,NA,NA,NA,NA,NA
"1323","Pocillopora_acuta_HIv2___TS.g24486.t2",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.11310426585121,3.68233641306884,3.68233641306884,9.11082113977338,7.94120843891926,6.77526323374519,7.64658910810218,3.68233641306884,3.68233641306884,3.68233641306884,5.59986682517354,5.0202643887954,6.17946926155169,105.508948480569,0.0709685866006215,1.00804267285226,0.588427313030547,0.794234103739626,"Q9I9D5",1.16e-31,"Retinal homeobox protein Rx1","positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000978; GO:0000981; GO:0005634; GO:0045944"
"1324","Pocillopora_acuta_HIv2___RNAseq.g23050.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.60511707305,9.85405380645264,6.51648711029815,8.64420860433498,9.31950536570595,9.04907248628624,11.5031887266311,11.0705578285903,9.69387898533967,11.5047427848359,9.67608127715249,9.24110927259681,10.1110532817082,1189.88133994515,0.626759366384659,0.677637191805186,0.209215681930383,0.435785660057755,NA,NA,NA,NA,NA
"1325","Pocillopora_acuta_HIv2___RNAseq.g23052.t1",0,0,0,50,35.2941176470588,0,0,NA,0,NA,10.6617647058824,12.5,8.82352941176471,NA,NA,NA,NA,NA,NA,8.2447423312731,8.66733703951336,9.30266102387004,9.58122668632785,10.2455100155001,9.13656566211361,3.68233641306884,8.6128546266769,8.07748726595138,6.51149074430832,8.20622118086035,8.8966510526543,7.5157913090664,441.067909644657,-0.42966816843806,0.929487602522547,0.296973802238862,0.544433798969148,"P57080",0,"Ubiquitin carboxyl-terminal hydrolase 25 (EC 3.4.19.12) (Deubiquitinating enzyme 25) (Ubiquitin thioesterase 25) (Ubiquitin-specific-processing protease 25) (mUSP25)","immune response [GO:0006955]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA metabolic process [GO:0016071]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; response to oxidative stress [GO:0006979]; stress-activated protein kinase signaling cascade [GO:0031098]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000502; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0006955; GO:0006979; GO:0016071; GO:0016579; GO:0031098; GO:0031647; GO:0032183; GO:0097400"
"1326","Pocillopora_acuta_HIv2___RNAseq.g23057.t1",0,0,NA,0,0,4.76190476190476,0,NA,NA,NA,0.793650793650794,1.58730158730159,0,NA,NA,NA,NA,NA,NA,7.56279864080063,3.68233641306884,7.24563010395376,5.40210328953245,8.02238185013316,5.87223972230221,9.33484883040155,8.65269601142557,5.31013166644977,9.31801596440613,7.04031824924741,7.35872765455258,6.72190884394224,221.115041588175,-0.266041152563487,0.971587132921327,0.270977180776858,0.514784238138366,NA,NA,NA,NA,NA
"1327","Pocillopora_acuta_HIv2___RNAseq.g23069.t1b",0,0,0,0,0,0,0.403225806451613,0,0,7.69230769230769,0.809553349875931,0,1.61910669975186,NA,NA,NA,NA,NA,NA,8.53695793266372,3.68233641306884,7.86078908225553,7.24978579672844,7.87978264491838,3.68233641306884,6.40572683292009,7.92721564972577,6.43114589272003,10.3844476264272,7.00405242844968,7.72717824045669,6.28092661644268,254.496623396675,-0.312489913872851,1.02364265166096,0.111183259382115,0.282508655570131,"P00542",4.36e-29,"Tyrosine-protein kinase transforming protein Fes (EC 2.7.10.2)","","GO:0004715; GO:0005524"
"1328","Pocillopora_acuta_HIv2___RNAseq.g23078.t1",0,0,0,0,20,0,NA,NA,NA,NA,3.33333333333333,0,6.66666666666667,NA,NA,NA,NA,NA,NA,12.7197433540338,12.7653727168471,12.2911654254095,12.7500519191511,12.0912135643966,12.3432755983371,13.112692861909,12.5413264259373,11.7529771380841,13.0630409423609,12.5430859946466,12.2792851815723,12.806886807721,6173.99417182848,0.402597660212302,0.522586659440154,0.364825785233672,0.614986399605068,"Q61210",7.45e-93,"Rho guanine nucleotide exchange factor 1 (Lbc's second cousin) (Lymphoid blast crisis-like 2)","G protein-coupled receptor signaling pathway [GO:0007186]; microtubule depolymerization [GO:0007019]","GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007019; GO:0007186"
"1329","Pocillopora_acuta_HIv2___RNAseq.g23082.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.09158918263054,3.68233641306884,3.68233641306884,9.94703592761197,9.79096255038713,8.77253124101927,3.68233641306884,9.01380704641068,10.762355066967,3.68233641306884,7.2107626667302,8.46821005189284,5.95331528156755,495.71215485216,-0.213709863410756,1.03614602750108,7.11269659979143e-05,0.00062124422475473,"Q5F415",0,"TBC1 domain family member 23","embryonic brain development [GO:1990403]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle tethering to Golgi [GO:0099041]","GO:0005802; GO:0005829; GO:0042147; GO:0099041; GO:1990403"
"1330","Pocillopora_acuta_HIv2___TS.g24552.t2",2.22222222222222,0,0,0,0,1.0989010989011,0,0,0,0,0.332112332112332,0.21978021978022,0.444444444444444,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,5.46801386253237,3.68233641306884,5.13665622490825,3.68233641306884,7.82425794137397,3.68233641306884,5.77998567012395,5.96509637913949,4.85856921434222,4.74986571674045,4.967272711944,30.9893926436856,-0.0262768074047491,1.00142066987864,0.280831416009664,0.526841193406456,"Q9UGM3",0,"Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031]","GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006952; GO:0015031; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0051607; GO:0070062"
"1331","Pocillopora_acuta_HIv2___RNAseq.g23134.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.041007417848,10.0156907956448,10.3001108152778,11.8308907850944,10.4687890313064,7.52502774190946,7.80321753215623,10.3585090406035,8.96385044000221,3.68233641306884,9.09894300129116,10.0264533490076,8.17143265357475,1040.09813894818,-0.568266518461812,1.05040043824518,0.109544320372613,0.27949357027156,"Q9WVR3",2.43e-177,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1) (INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2) (SH2 domain-containing inositol phosphatase 2) (SHIP-2)","actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cellular lipid metabolic process [GO:0044255]; endochondral ossification [GO:0001958]; endocytosis [GO:0006897]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; immune system process [GO:0002376]; inositol trisphosphate metabolic process [GO:0032957]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; post-embryonic development [GO:0009791]; regulation of actin filament organization [GO:0110053]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]; ruffle assembly [GO:0097178]","GO:0000132; GO:0000922; GO:0001958; GO:0002376; GO:0003779; GO:0004445; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006006; GO:0006661; GO:0006897; GO:0006915; GO:0007015; GO:0007155; GO:0008156; GO:0008285; GO:0009410; GO:0009791; GO:0009925; GO:0010467; GO:0010629; GO:0010642; GO:0010977; GO:0016607; GO:0017124; GO:0030027; GO:0030175; GO:0032868; GO:0032880; GO:0032957; GO:0034485; GO:0042169; GO:0043491; GO:0043569; GO:0044255; GO:0046627; GO:0046856; GO:0050776; GO:0070371; GO:0097178; GO:0110053"
"1332","Pocillopora_acuta_HIv2___TS.g24596.t1",0,33.3333333333333,NA,33.3333333333333,100,100,62.5,NA,28.5714285714286,NA,51.1054421768708,48.8095238095238,54.1666666666667,NA,NA,NA,NA,NA,NA,5.86218072811404,8.85837677707325,8.47633412667938,3.68233641306884,7.57819845214682,6.79833783139352,3.68233641306884,7.87942050012176,3.68233641306884,3.68233641306884,6.01821940678041,6.69569404402617,5.34074476953466,126.896174542188,-0.182788091135458,1.01432922604643,0.381696073451964,0.630594175489345,"O04714",9.6e-18,"G-protein coupled receptor 1","abscisic acid-activated signaling pathway [GO:0009738]; blue light signaling pathway [GO:0009785]; brassinosteroid mediated signaling pathway [GO:0009742]; cell surface receptor signaling pathway [GO:0007166]; cytokinin-activated signaling pathway [GO:0009736]; flower development [GO:0009908]; gibberellic acid mediated signaling pathway [GO:0009740]; L-phenylalanine biosynthetic process [GO:0009094]; lipid metabolic process [GO:0006629]; maintenance of seed dormancy [GO:0010231]; mitotic cell cycle [GO:0000278]; negative regulation of abscisic acid-activated signaling pathway [GO:0009788]; positive regulation of gibberellic acid mediated signaling pathway [GO:0009939]; regulation of inositol trisphosphate biosynthetic process [GO:0032960]; response to cytokinin [GO:0009735]; response to low fluence blue light stimulus by blue low-fluence system [GO:0010244]; tyrosine biosynthetic process [GO:0006571]","GO:0000278; GO:0000325; GO:0004930; GO:0005794; GO:0005886; GO:0006571; GO:0006629; GO:0007166; GO:0009094; GO:0009735; GO:0009736; GO:0009738; GO:0009740; GO:0009742; GO:0009785; GO:0009788; GO:0009908; GO:0009939; GO:0010231; GO:0010244; GO:0032960"
"1333","Pocillopora_acuta_HIv2___RNAseq.g23157.t1",5.38461538461539,0,0,1.81818181818182,0,0.936768149882904,0,0,0,NA,0.90439615029779,0.550989993612944,1.34615384615385,NA,NA,NA,NA,NA,NA,5.32602117141484,3.68233641306884,7.03904768963524,7.91565614756502,5.13665622490825,7.33461237882746,8.46947179477713,4.44278995465828,4.25049936715761,3.68233641306884,5.72794275550815,5.23900288155484,6.21688262946146,82.7966295426796,0.131517773544691,0.964062815474224,0.645986420984983,0.830611395957578,NA,NA,NA,NA,NA
"1334","Pocillopora_acuta_HIv2___RNAseq.g23165.t1",37.5,100,NA,NA,100,57.1428571428571,100,100,NA,NA,82.4404761904762,85.7142857142857,79.1666666666667,NA,NA,NA,NA,NA,NA,10.3981223497779,10.7275800828976,8.16052492200176,11.8349458877488,8.84386917251937,10.5316286813788,8.75471211329172,9.96508934210381,3.68233641306884,3.68233641306884,8.65811453778574,8.20998843989434,9.10624063567715,1015.20040752929,0.41717562993439,0.8825675270382,0.338815423180737,0.589726387591597,"Q80U62",2.77e-90,"Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (Rubicon)","autophagy [GO:0006914]; endocytosis [GO:0006897]; immune system process [GO:0002376]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]","GO:0002376; GO:0005654; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006897; GO:0006914; GO:0045806; GO:0051898; GO:0141039; GO:1901097; GO:1901981"
"1335","Pocillopora_acuta_HIv2___RNAseq.g23174.t1",0,0,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.23599669296538,7.493942887935,7.79930343134751,10.2880644463572,9.2659603691155,9.38618848726225,3.68233641306884,10.571912548711,9.57870175344783,12.9480622707619,9.02504693009724,9.29037495911744,8.75971890107704,1350.21190633609,0.00620007569808517,0.925862163381102,0.988975572432127,0.995926959444672,"O35343",0,"Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4)","NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; response to hydrogen peroxide [GO:0042542]","GO:0001673; GO:0005634; GO:0005654; GO:0005829; GO:0006606; GO:0006607; GO:0008139; GO:0042542; GO:0042564; GO:0061608"
"1336","Pocillopora_acuta_HIv2___RNAseq.g23180.t2",0,0,0,0,0,0,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.16748500850389,3.68233641306884,7.77493455161284,8.42233227527333,8.65144994445038,3.68233641306884,9.55162098517574,7.51049444605365,3.68233641306884,3.68233641306884,6.38076628633452,6.95734007273792,5.80419249993112,189.060715374523,-0.102356341465145,0.987423607053861,0.534564240978274,0.755439720807572,"P97479",0,"Unconventional myosin-VIIa","actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; auditory receptor cell stereocilium organization [GO:0060088]; cell projection organization [GO:0030030]; cochlea development [GO:0090102]; endocytosis [GO:0006897]; equilibrioception [GO:0050957]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mechanoreceptor differentiation [GO:0042490]; phagocytosis [GO:0006909]; phagolysosome assembly [GO:0001845]; pigment granule localization [GO:0051875]; pigment granule transport [GO:0051904]; protein localization [GO:0008104]; sensory organ development [GO:0007423]; sensory perception [GO:0007600]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601]","GO:0000146; GO:0001750; GO:0001845; GO:0001917; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005737; GO:0005765; GO:0005829; GO:0005902; GO:0005938; GO:0006886; GO:0006897; GO:0006909; GO:0007015; GO:0007040; GO:0007423; GO:0007600; GO:0007601; GO:0007605; GO:0008104; GO:0015629; GO:0016020; GO:0016324; GO:0016459; GO:0019904; GO:0030030; GO:0030048; GO:0030507; GO:0031477; GO:0032391; GO:0032420; GO:0042470; GO:0042472; GO:0042490; GO:0042491; GO:0042802; GO:0043531; GO:0044877; GO:0045202; GO:0048839; GO:0050953; GO:0050957; GO:0051015; GO:0051875; GO:0051904; GO:0060088; GO:0060113; GO:0060122; GO:0090102; GO:0120044; GO:1990435"
"1337","Pocillopora_acuta_HIv2___RNAseq.g23202.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.49100155379421,3.68233641306884,5.81272994412078,6.10548275003066,5.94468313522804,3.68233641306884,3.68233641306884,5.33850173705749,6.26649149846874,3.68233641306884,4.96882362709753,5.77068157373385,4.1669656804612,21.2901662951648,-0.691694430051211,1.35098402862768,0.00231203786954701,0.0120901358442256,"P32004",5.28e-07,"Neural cell adhesion molecule L1 (N-CAM-L1) (NCAM-L1) (CD antigen CD171)","axon development [GO:0061564]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; chemotaxis [GO:0006935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; synapse organization [GO:0050808]","GO:0005886; GO:0005925; GO:0006935; GO:0007155; GO:0007156; GO:0007160; GO:0007399; GO:0007411; GO:0008046; GO:0009986; GO:0016477; GO:0019904; GO:0030424; GO:0030425; GO:0031175; GO:0043025; GO:0044295; GO:0045773; GO:0050808; GO:0061564; GO:0062023"
"1338","Pocillopora_acuta_HIv2___RNAseq.g23206.t1",0,0,NA,NA,37.5,11.5384615384615,50,0,100,NA,28.4340659340659,27.8846153846154,29.1666666666667,NA,NA,NA,NA,NA,NA,8.03683150346764,8.58961299098714,3.68233641306884,3.68233641306884,8.38827354634219,5.62464424494188,3.68233641306884,7.52971450885446,9.267667622457,3.68233641306884,6.21660900693257,7.38096471883803,5.05225329502711,168.541259068622,-0.412776611298473,1.1012626997421,0.0498195657657122,0.155114107940926,"B3MH43",1.46e-09,"Tyrosine-protein kinase-like otk (Tyrosine-protein kinase-like 7 homolog)","cell adhesion [GO:0007155]; imaginal disc-derived female genitalia morphogenesis [GO:0048804]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; internal genitalia morphogenesis [GO:0035260]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; photoreceptor cell axon guidance [GO:0072499]; retinal ganglion cell axon guidance [GO:0031290]","GO:0004672; GO:0004714; GO:0005524; GO:0005886; GO:0007155; GO:0017147; GO:0030424; GO:0031290; GO:0035260; GO:0038023; GO:0042803; GO:0046982; GO:0048803; GO:0048804; GO:0050839; GO:0072499; GO:0090090"
"1339","Pocillopora_acuta_HIv2___RNAseq.g23212.t1",NA,0,0,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.99626139826451,6.36503790894442,10.0185153009457,7.2010836147454,8.30420171157497,3.68233641306884,8.55562383905727,10.8166081501005,3.68233641306884,7.23043411628393,7.32413798518329,7.13673024738457,460.879958447929,0.039007896249261,0.999600478953147,0.759728008959089,0.894772894844415,"P30205",9.45e-50,"Antigen WC1.1","","GO:0005576; GO:0009897"
"1340","Pocillopora_acuta_HIv2___TS.g24712.t1",18.75,0,NA,0,7.14285714285714,23.3333333333333,4.8780487804878,66.6666666666667,0,NA,15.0963632404181,18,10.256968641115,NA,NA,NA,NA,NA,NA,6.50755595230566,5.57859373890424,7.27383161333198,6.29014341372585,7.65364434417167,7.14192723638692,6.06216801367023,6.40197652230091,6.03378121970174,7.49866657067739,6.64422886251766,6.77415793036239,6.51429979467293,87.3630074002407,-0.24733699876431,0.681440042116245,0.602039168458055,0.802201246667647,NA,NA,NA,NA,NA
"1341","Pocillopora_acuta_HIv2___TS.g24743.t1",0,0,NA,0,0,4.25531914893617,0,0,0,0,0.472813238770686,0.851063829787234,0,NA,NA,NA,NA,NA,NA,5.21468966089253,5.4315664930872,4.89801104097743,6.54549673248371,5.26345523824995,8.87787588494184,9.13103747490332,6.43348545126895,4.4808124149756,7.27059983815277,6.35470302299333,5.25809076127289,7.45131528471377,131.030297610325,2.64964622543993,1.1383810671547,0.000428400215095739,0.00287002348825603,"Q8NDA2",7.89e-19,"Hemicentin-2","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse organization [GO:0050808]","GO:0005509; GO:0005576; GO:0005886; GO:0007156; GO:0008046; GO:0030424; GO:0032154; GO:0043025; GO:0050808; GO:0062023"
"1342","Pocillopora_acuta_HIv2___RNAseq.g23290.t1",0,NA,0,0,0,17.3913043478261,0,NA,0,NA,2.48447204968944,5.79710144927536,0,NA,NA,NA,NA,NA,NA,6.0744275437907,5.6460547390973,5.98248205022216,6.17770847719114,6.76451369627749,8.01880398001791,8.97402963750492,6.35881100040517,6.01048531358257,6.24956979519673,6.62568862332861,6.23814392085562,7.0132333258016,110.972633841434,0.515217735951333,0.733514676280755,0.305588413078635,0.554096879374374,"Q9VBW3",5.76e-78,"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303"
"1343","Pocillopora_acuta_HIv2___RNAseq.g23291.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.7680840551955,9.41259897644459,9.13332655422424,8.05229567757085,9.22137008246158,8.18813650796672,8.15816625667422,9.07207698868077,10.2425900027011,9.30307766519526,8.95517227671148,9.28748953665264,8.62285501677033,524.706451165334,-0.518391588650272,0.592033258259984,0.269795935697227,0.51346426499009,"O73792",1.74e-53,"Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)","angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell-cell adhesion [GO:0071603]; heart development [GO:0007507]; positive regulation of angiogenesis [GO:0045766]; vasculature development [GO:0001944]","GO:0001525; GO:0001568; GO:0001944; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0007507; GO:0043235; GO:0045766; GO:0071603"
"1344","Pocillopora_acuta_HIv2___RNAseq.g23306.t1",0,0.384615384615385,0,0,0,0.480769230769231,1.91082802547771,0,0,NA,0.308468071206925,0.173076923076923,0.477707006369427,NA,NA,NA,NA,NA,NA,10.3452278570412,10.7019790119452,10.304359851432,10.7875692692137,10.4253845191282,9.76413248923,10.0910025725106,10.2516851425837,10.6698188260747,3.68233641306884,9.70234959522281,10.399295239252,9.00540395119367,1195.23927996476,-0.209838282337066,0.874371752439277,0.59012516172978,0.795116007383283,"O73792",5.7e-39,"Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)","angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell-cell adhesion [GO:0071603]; heart development [GO:0007507]; positive regulation of angiogenesis [GO:0045766]; vasculature development [GO:0001944]","GO:0001525; GO:0001568; GO:0001944; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0007507; GO:0043235; GO:0045766; GO:0071603"
"1345","Pocillopora_acuta_HIv2___RNAseq.g23329.t1",0,1.36986301369863,0,0.869565217391304,0,1.19760479041916,1.59680638722555,4.47761194029851,0.571428571428571,0,1.00828799204617,1.69721470664723,0.31936127744511,NA,NA,NA,NA,NA,NA,5.39475910818241,5.71009804948923,7.74513402854738,6.97457669156694,6.70204301475986,5.65167313584929,5.87903781356616,6.17109778065781,4.65430837654882,9.33280104707855,6.42155290462464,6.13346846173926,6.70963734751003,115.91872026027,0.072856585915382,0.8182483102592,0.870715115324199,0.949587992171491,"Q9VBW3",6.01e-71,"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303"
"1346","Pocillopora_acuta_HIv2___RNAseq.g23331.t1",2.63157894736842,9.52380952380952,0,0,0,0,0,3.57142857142857,0,NA,1.74742411584517,2.61904761904762,0.657894736842105,NA,NA,NA,NA,NA,NA,6.71922149999791,6.59081673114823,6.64213136387843,6.66570112997648,3.68233641306884,3.68233641306884,9.43144170330301,7.91632649873513,6.07918960036691,3.68233641306884,6.10918377666126,6.20784107520944,6.01052647811308,123.299418202825,-0.0890394594418441,0.898966745979566,0.818893771010099,0.925422259855463,"P35546",9.59e-88,"Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","anatomical structure morphogenesis [GO:0009653]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797"
"1347","Pocillopora_acuta_HIv2___RNAseq.g23350.t1",0,28.5714285714286,0,0,0,6.97674418604651,0,NA,0,NA,4.44352159468439,8.88704318936877,0,NA,NA,NA,NA,NA,NA,9.1147694605826,9.39672385697905,10.2682727790021,8.29184295024184,9.30662784079128,10.7596815684173,3.68233641306884,9.38605571860119,7.03693597958341,8.28092248874476,8.55241690560124,9.02253235571212,8.08230145549036,602.606380122444,-0.126599883401766,0.894658210136294,0.704427487747987,0.865235532315007,"Q9VBW3",6.31e-79,"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303"
"1348","Pocillopora_acuta_HIv2___TS.g24829.t1a",0,0,0,0,0,2.06896551724138,0,0,0,NA,0.229885057471264,0.413793103448276,0,NA,NA,NA,NA,NA,NA,11.8105122357585,10.6096022051787,12.5007968869181,10.9266460707242,12.1377435825101,10.530779397943,9.50690853612286,11.1865698464545,12.6059049390431,10.2719926854212,11.2087456386074,12.0483054981369,10.369185779078,2915.50267882844,-1.46126955674555,0.576426351166875,0.00292594376876384,0.0148546334402949,NA,NA,NA,NA,NA
"1349","Pocillopora_acuta_HIv2___RNAseq.g23376.t1b",0,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.90737972402627,3.68233641306884,8.92383573348383,3.68233641306884,8.92365286826578,8.39299560414697,3.68233641306884,3.68233641306884,8.60852267251487,6.28126538983346,6.47669976445465,7.80914548227192,5.14425404663739,210.569928538017,-0.463261778820352,1.11515588410115,0.072656538784679,0.206993141024542,"G3V9H8",5.69e-72,"Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144"
"1350","Pocillopora_acuta_HIv2___TS.g24838.t1",0,0,0,0,0,0,NA,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,5.83894995413197,9.45044034127388,3.68233641306884,10.4821354211709,3.68233641306884,11.274264039477,7.42540170510466,8.58337871854158,3.68233641306884,3.68233641306884,6.77839158319753,5.09386758237601,8.46291558401906,507.010941055385,0.306303689954958,1.05905298149976,0.0357919832012054,0.119312109938289,"Q9VBW3",1.02e-57,"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303"
"1351","Pocillopora_acuta_HIv2___RNAseq.g23389.t1",6.45161290322581,0,NA,0,0,0,0,NA,NA,NA,1.0752688172043,0,2.1505376344086,NA,NA,NA,NA,NA,NA,8.69611344064921,3.68233641306884,8.31025247179496,9.44868151980265,3.68233641306884,3.68233641306884,9.74002173568032,6.84409752428356,3.68233641306884,3.68233641306884,6.14508487575549,6.24302725257308,6.0471424989379,227.538156823141,0.0693749030726366,0.988251012259766,0.810072914651835,0.920777574658086,"Q9VBW3",9.46e-88,"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303"
"1352","Pocillopora_acuta_HIv2___TS.g24850.t1",33.3333333333333,0,0,2.94117647058824,0,23.8095238095238,46.3414634146341,NA,0,9.52380952380952,12.8832562835432,6.68767507002801,17.8397212543554,NA,NA,NA,NA,NA,NA,5.9511981009209,4.8931170245923,6.3783135818283,7.76461776481731,5.98573247127087,3.68233641306884,3.68233641306884,5.03658612426137,7.45952232732554,8.78459572882484,5.96183559499791,6.1622705211214,5.76140066887443,91.9902991670934,-0.33042474506884,0.989908822042045,0.174112182248192,0.385187917411723,NA,NA,NA,NA,NA
"1353","Pocillopora_acuta_HIv2___RNAseq.g23394.t1",0,0,0,0,0,0,2.29885057471264,0,0,NA,0.255427841634738,0,0.574712643678161,NA,NA,NA,NA,NA,NA,9.67849525535295,9.59458209611622,10.3178732600859,9.52877131159572,9.51128675433427,9.22536508227238,9.73079372695072,9.29952505223405,8.87980700480875,10.6944473604787,9.64609469042297,9.53739746536318,9.75479191548275,828.939754198667,0.136176363348522,0.6013094316464,0.776639985883812,0.904017443732774,"Q5SZT7",1.76e-64,"NKAP-like protein","cell differentiation [GO:0030154]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]","GO:0003682; GO:0005634; GO:0007283; GO:0010468; GO:0030154"
"1354","Pocillopora_acuta_HIv2___RNAseq.g23395.t1",NA,NA,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.50758496116064,6.92168924401968,7.72999801151893,3.68233641306884,6.08938798535807,3.68233641306884,3.68233641306884,6.61793724077436,3.68233641306884,3.68233641306884,5.32782795081759,6.32544892237617,4.33020697925901,56.0587525402538,-0.394695332679408,1.10857647928819,0.00557349487039265,0.0254707835088023,NA,NA,NA,NA,NA
"1355","Pocillopora_acuta_HIv2___RNAseq.g23397.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.78785518405689,7.45925468652246,8.0267374734725,3.68233641306884,7.5076208322678,3.68233641306884,3.68233641306884,7.03887879464293,3.68233641306884,3.68233641306884,5.62320290363068,6.80868573950179,4.43772006775956,84.7328653636552,-0.370083357512945,1.09504648234214,0.00150552194851707,0.00831457406008053,NA,NA,NA,NA,NA
"1356","Pocillopora_acuta_HIv2___RNAseq.g23419.t1",79.3103448275862,81.0810810810811,62.5,54.2857142857143,51.7241379310345,20,62.5,59.2592592592593,69.0476190476191,70.3296703296703,61.0037826761965,56.7347347347347,65.2728306176582,NA,NA,NA,NA,NA,NA,6.6819031016316,3.68233641306884,9.61883580699266,8.72029839140143,8.80041979687758,6.44919487895889,3.68233641306884,8.41078835226626,3.68233641306884,3.68233641306884,6.34107859804038,7.43885669416739,5.24330050191337,203.513340056834,-0.564898226436661,1.18600204329431,0.0514507256889083,0.158674476836753,NA,NA,NA,NA,NA
"1357","Pocillopora_acuta_HIv2___RNAseq.g23453.t1",0,0,0,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,6.38824903660035,8.28377980671824,6.88242140054137,7.47098189621969,6.82432087263943,8.57228305726721,5.08305273412487,8.0781018333054,6.94448951749643,4.56256470276067,6.90902448576737,7.0235165321166,6.79453243941814,139.944657650597,-0.0873165847039357,0.876595760745537,0.776129091417364,0.903786424463469,NA,NA,NA,NA,NA
"1358","Pocillopora_acuta_HIv2___RNAseq.g23455.t1",60.4166666666667,NA,0,NA,NA,38.0952380952381,0,14.2857142857143,85.7142857142857,NA,33.0853174603175,46.031746031746,20.1388888888889,NA,NA,NA,NA,NA,NA,4.4307132106762,7.670995659781,4.80540103069894,7.55243492849436,4.52813742588667,6.22627004598424,6.84207077851515,5.96778646100673,3.68233641306884,8.45337382475563,6.01595197788678,4.68287490826748,7.34902904750608,86.4851502214077,3.34483539430924,1.82321886865254,0.000270228816578083,0.00193303145548239,"P27401",5.78e-07,"Pro-Pol polyprotein (Pr125Pol) [Cleaved into: Protease/Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (EC 3.4.23.-) (p87Pro-RT-RNaseH); Protease/Reverse transcriptase (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.4.23.-) (p65Pro-RT); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p42In)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; proteolysis [GO:0006508]; symbiont entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; viral penetration into host nucleus [GO:0075732]","GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0006508; GO:0015074; GO:0030430; GO:0042025; GO:0043657; GO:0044423; GO:0044826; GO:0046718; GO:0046872; GO:0075713; GO:0075732"
"1359","Pocillopora_acuta_HIv2___RNAseq.g7259.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.7018393663106,11.9035462310789,9.42480971363826,10.8476759948571,9.77141707659714,10.115225734055,10.1953107149535,10.9466192616109,10.1648665563073,9.68935267154801,10.3760663320957,10.2019103948928,10.5502222692985,1487.41900781016,0.240194774998618,0.60191606837051,0.611431530737462,0.808090795009745,"P82094",7.42e-146,"TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa)","acrosome assembly [GO:0001675]; androgen receptor signaling pathway [GO:0030521]; defense response to bacterium [GO:0042742]; epithelial cell apoptotic process [GO:1904019]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid nucleus differentiation [GO:0007289]","GO:0000139; GO:0001675; GO:0001819; GO:0003677; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0007289; GO:0010629; GO:0030317; GO:0030374; GO:0030521; GO:0032275; GO:0033327; GO:0042742; GO:0045944; GO:0050681; GO:0061136; GO:1904019; GO:1904036; GO:2000845"
"1360","Pocillopora_acuta_HIv2___RNAseq.g7273.t1",0,50,0,0,0,3.92156862745098,0,NA,0,NA,6.74019607843137,13.4803921568627,0,NA,NA,NA,NA,NA,NA,11.5516547017015,12.0312803681411,11.3165003096455,11.4298393404834,12.0510653209384,12.2614307352903,9.25983092208202,11.532474623954,13.04154241043,12.6678642965028,11.7143483029169,11.8986474733339,11.5300491324999,3990.80938759761,-0.210329965672058,0.616825416983982,0.648567236409385,0.832430707081772,"Q7Z6E9",3.54e-87,"E3 ubiquitin-protein ligase RBBP6 (EC 2.3.2.27) (Proliferation potential-related protein) (Protein P2P-R) (RING-type E3 ubiquitin transferase RBBP6) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis)","DNA damage response [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; protein ubiquitination [GO:0016567]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001701; GO:0003723; GO:0004842; GO:0005634; GO:0005694; GO:0005730; GO:0005813; GO:0005829; GO:0006260; GO:0006275; GO:0006511; GO:0006974; GO:0008270; GO:0016567; GO:0016607; GO:0019901; GO:0032991; GO:0035264; GO:0048568; GO:0061053; GO:0061630"
"1361","Pocillopora_acuta_HIv2___TS.g5828.t1",0.25062656641604,0,0,1.9047619047619,0.573613766730402,0.3003003003003,1.74050632911392,0,0,0,0.476980886732257,0.441012441012441,0.512949332452073,NA,NA,NA,NA,NA,NA,7.93088772907051,10.3340999271669,8.57821577086389,10.8252019463658,8.46684866936864,5.38419442015382,11.4326759605095,8.6284797783327,8.75054337765242,7.67212637019187,8.8003273949676,8.47099506505763,9.12965972487758,767.228432744782,0.31877665897371,0.888436364650531,0.412707463640975,0.658488721278313,"Q8N8E3",0,"Centrosomal protein of 112 kDa (Cep112) (Coiled-coil domain-containing protein 46)","receptor localization to synapse [GO:0097120]","GO:0005737; GO:0005813; GO:0005886; GO:0060077; GO:0097120"
"1362","Pocillopora_acuta_HIv2___RNAseq.g7295.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.8520926356948,9.5315987481135,11.1270573214068,10.126871223039,10.95679059296,10.2285092245124,11.6192305923128,10.8940847061302,10.5429272527025,11.3196009199822,10.7198763216854,10.8745905017789,10.565162141592,1797.1491361885,-0.213641500496137,0.603243545958099,0.64284257865532,0.828492036577996,NA,NA,NA,NA,NA
"1363","Pocillopora_acuta_HIv2___RNAseq.g7301.t1",0,NA,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.13203366284608,3.68233641306884,3.68233641306884,6.58091230054222,7.85161446036259,3.68233641306884,5.48863783836819,7.98045527622875,3.68233641306884,3.68233641306884,5.2445335603692,5.86575524511502,4.62331187562339,57.502741178461,-0.167959182952781,1.03014355690375,0.0289329170320564,0.100525032897349,"F5H4B4",4.39e-30,"Protein FAM227A","",""
"1364","Pocillopora_acuta_HIv2___RNAseq.g7311.t1",0,0,NA,11.1111111111111,0,0,0,NA,NA,NA,1.85185185185185,3.7037037037037,0,NA,NA,NA,NA,NA,NA,8.79417202436679,3.68233641306884,7.46312695790699,3.68233641306884,3.68233641306884,8.99341423801164,7.35949268040431,8.16952988842414,3.68233641306884,3.68233641306884,5.91914178544581,6.35830033936712,5.47998323152449,145.701209823891,-0.0948808086958303,1.00751331929299,0.0556361696722074,0.168669368714904,"Q9D2E1",4.12e-70,"Testis-specific serine/threonine-protein kinase 3 (TSK-3) (TSSK-3) (Testis-specific kinase 3) (EC 2.7.11.1) (Serine/threonine-protein kinase 22C)","intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; sperm capacitation [GO:0048240]; spermatogenesis [GO:0007283]","GO:0000287; GO:0004674; GO:0005524; GO:0006468; GO:0007283; GO:0035556; GO:0048240; GO:0106310"
"1365","Pocillopora_acuta_HIv2___RNAseq.g7315.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.32448441960038,6.60695183817265,5.70790219953855,4.62642457401022,4.52813742588667,6.92935989231271,4.51171232812315,5.26380834900594,4.25049936715761,5.16462945902469,5.39139098528326,5.21496635223783,5.56781561832868,30.5755478370862,0.153922042305999,0.876542816339203,0.665704005073552,0.843491750152,"C9JTQ0",2.84e-22,"Ankyrin repeat domain-containing protein 63","",""
"1366","Pocillopora_acuta_HIv2___RNAseq.g7321.t1",NA,NA,0,0,20,0,0,NA,0,NA,3.33333333333333,0,6.66666666666667,NA,NA,NA,NA,NA,NA,9.1330489210328,10.8853775079859,10.3860116676742,10.3320876652069,10.3904275690686,10.398297080943,12.4959985545931,8.9880943483143,11.0972434789336,7.47207419844448,10.1578660992197,9.9989651970047,10.3167670014347,1617.02458228269,0.192829543301979,0.815337959965991,0.667543480362378,0.844575854120982,"O60303",0,"Katanin-interacting protein","cerebrospinal fluid circulation [GO:0090660]","GO:0005615; GO:0005737; GO:0005856; GO:0042995; GO:0090660"
"1367","Pocillopora_acuta_HIv2___RNAseq.g7330.t2",NA,0,0,NA,0,20,0,NA,0,NA,3.33333333333333,6.66666666666667,0,NA,NA,NA,NA,NA,NA,8.01230688519318,6.52433724544485,8.47633412667938,10.3141228822159,7.33477781291543,8.93294859018828,9.28274904352691,8.92805536322963,6.14454741514326,3.68233641306884,7.76325157776057,7.77920432063218,7.74729883488896,358.65859834049,-0.0592839237256003,0.851800134939573,0.845236560047062,0.938618165414257,"Q8VBT9",4.46e-83,"Tether containing UBX domain for GLUT4 (Alveolar soft part sarcoma chromosomal region candidate gene 1 protein homolog)","glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; positive regulation of protein modification process [GO:0031401]; regulation of glucose import [GO:0046324]","GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006886; GO:0009898; GO:0012505; GO:0012506; GO:0030659; GO:0031401; GO:0033116; GO:0042593; GO:0046324; GO:0048471"
"1368","Pocillopora_acuta_HIv2___RNAseq.g7337.t1",0,0,0,0,0.254452926208651,0.337268128161889,1.60213618157543,0,0,0,0.219385723594597,0.0674536256323778,0.371317821556817,NA,NA,NA,NA,NA,NA,8.91268086580113,10.6455400396638,9.11214491294523,9.25505869336016,9.65738762109318,10.4250537487197,5.85067236387506,8.31743074307846,7.47604694481752,3.68233641306884,8.33343523464231,8.6951382175471,7.97173225173751,575.988513250371,-0.226208781571958,0.898726368432846,0.490892973567734,0.722782631865996,"P35546",1.34e-77,"Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]","anatomical structure morphogenesis [GO:0009653]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]","GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797"
"1369","Pocillopora_acuta_HIv2___TS.g5881.t1",0,0,2.10970464135021,0.469483568075117,0,0.554938956714761,0.102459016393443,0,0,NA,0.35962068694817,0.204884504957976,0.553040914435913,NA,NA,NA,NA,NA,NA,8.18896956663764,3.68233641306884,8.16052492200176,3.68233641306884,4.89684440866119,4.58790998118372,4.51171232812315,6.24455097845002,3.68233641306884,5.92487398666357,5.35623954109276,6.23464525776389,4.47783382442162,63.7091093394013,-0.277618547200791,1.04295559627772,0.0594635556003406,0.178070573126983,NA,NA,NA,NA,NA
"1370","Pocillopora_acuta_HIv2___RNAseq.g7343.t1",0,0,NA,0,0,3.84615384615385,0,0,0,NA,0.480769230769231,0.769230769230769,0,NA,NA,NA,NA,NA,NA,9.91335286831058,3.68233641306884,10.6880416720604,3.68233641306884,9.94927322149745,11.2247125365912,8.30489533367289,8.79595844217485,8.4214992092383,7.34586633953267,8.2008272449216,9.55362508265632,6.84802940718689,705.961837742059,-0.335297549357332,1.01106638390622,0.142572266412531,0.337010175092474,"O70239",1.61e-35,"Axin-1 (Axis inhibition protein 1) (rAxin)","adult walking behavior [GO:0007628]; apoptotic process [GO:0006915]; axial mesoderm development [GO:0048318]; axial mesoderm formation [GO:0048320]; canonical Wnt signaling pathway [GO:0060070]; cell development [GO:0048468]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal joint morphogenesis [GO:0060272]; epigenetic programming in the zygotic pronuclei [GO:0044725]; erythrocyte homeostasis [GO:0034101]; head development [GO:0060322]; hemoglobin metabolic process [GO:0020027]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; negative regulation of Wnt signaling pathway [GO:0030178]; nervous system process [GO:0050877]; nucleocytoplasmic transport [GO:0006913]; positive regulation of JNK cascade [GO:0046330]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; post-anal tail morphogenesis [GO:0036342]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; protein-containing complex assembly [GO:0065003]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein phosphorylation [GO:0001932]; response to quercetin [GO:1905235]; sensory perception of sound [GO:0007605]; Wnt signaling pathway [GO:0016055]","GO:0000209; GO:0001701; GO:0001932; GO:0001934; GO:0002039; GO:0005102; GO:0005634; GO:0005737; GO:0005886; GO:0005938; GO:0006913; GO:0006915; GO:0007605; GO:0007628; GO:0008013; GO:0009950; GO:0009953; GO:0010629; GO:0010800; GO:0015630; GO:0016055; GO:0016328; GO:0019899; GO:0019901; GO:0019904; GO:0020027; GO:0030163; GO:0030178; GO:0030511; GO:0030877; GO:0031122; GO:0031398; GO:0031410; GO:0031625; GO:0032436; GO:0032991; GO:0033138; GO:0034101; GO:0034244; GO:0036342; GO:0042802; GO:0042803; GO:0044725; GO:0045202; GO:0045599; GO:0045732; GO:0046330; GO:0046332; GO:0048318; GO:0048320; GO:0048468; GO:0048471; GO:0050877; GO:0051248; GO:0060070; GO:0060090; GO:0060272; GO:0060322; GO:0060828; GO:0065003; GO:0070016; GO:0070411; GO:0070412; GO:0071944; GO:0090090; GO:1905235; GO:1990756; GO:1990909; GO:2000060"
"1371","Pocillopora_acuta_HIv2___RNAseq.g7344.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.58022760055378,8.92316164654114,8.68645353480887,9.8218426182336,9.8364601208679,3.68233641306884,10.7231055289726,8.63953767662881,9.51647538970022,3.68233641306884,7.90919369424446,8.45183086451192,7.366556523977,538.599966567777,0.00831852196832252,0.974351710599535,0.938094490384583,0.976536811102885,"Q6DBY0",0,"Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (Nucleoporin Nup85) (Pericentrin-1)","mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; positive regulation of DNA-templated transcription [GO:0045893]; protein import into nucleus [GO:0006606]","GO:0006406; GO:0006606; GO:0017056; GO:0031080; GO:0031965; GO:0045893; GO:0072006"
"1372","Pocillopora_acuta_HIv2___RNAseq.g7395.t1a",0,0,0,15.625,0,0,NA,NA,NA,NA,2.60416666666667,5.20833333333333,0,NA,NA,NA,NA,NA,NA,13.8758737145859,14.661929246972,13.105769111537,14.2650234727066,12.9951867281425,14.3662902674059,14.7637689391643,13.4186750121471,14.0520792368506,15.0879036452538,14.0592499374766,13.4895167606526,14.6289831143005,18906.8536188998,0.95772769291991,0.524019333931715,0.0350436778110129,0.117385770231239,"Q8IDX6",1.07e-06,"Reticulocyte-binding protein homolog 2a (PfR2Ha) (PfRH2a) [Cleaved into: Reticulocyte-binding protein homolog 2a 85 kDa form; Reticulocyte-binding protein homolog 2a 285 kDa form]","cell-cell adhesion [GO:0098609]","GO:0005615; GO:0008201; GO:0016020; GO:0016324; GO:0031410; GO:0044647; GO:0046789; GO:0098609; GO:1990225"
"1373","Pocillopora_acuta_HIv2___RNAseq.g7399.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,6.73712889964964,3.68233641306884,6.01241040467731,4.94358885541907,8.15816625667422,7.55806838583083,3.68233641306884,3.68233641306884,5.18210448675953,5.53445610325909,4.82975287025996,55.8647081028259,-0.149795050313714,0.986376869553256,0.635377822223428,0.823997929339533,"Q1LW01",4.87e-38,"Hatching enzyme 1.2 (EC 3.4.24.67) (Choriolysin H homolog 1) (High choriolytic enzyme 1 homolog) (zHCE-1)","hatching [GO:0035188]; proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0008270; GO:0035188"
"1374","Pocillopora_acuta_HIv2___RNAseq.g7401.t1",0,NA,0,0,0,2.27272727272727,0,NA,0,0,0.284090909090909,0.757575757575758,0,NA,NA,NA,NA,NA,NA,13.5788807365964,12.0168921571918,13.6673580873253,11.677756855647,13.0955099338684,12.2789847734371,10.6279080687105,12.9281460390389,13.4660214954582,13.0454846179257,12.6382942765199,13.3471832584574,11.9294052945824,7527.93108154458,-1.12234154787478,0.64969097464717,0.0277905650748089,0.0971393748772442,NA,NA,NA,NA,NA
"1375","Pocillopora_acuta_HIv2___RNAseq.g7413.t1",0,0,NA,0,0,1.38888888888889,0,NA,0,0,0.173611111111111,0.347222222222222,0,NA,NA,NA,NA,NA,NA,3.68233641306884,8.91681270067311,8.44276498562665,8.58545166315126,8.83133125715271,5.72947039629047,3.68233641306884,8.14488394461492,3.68233641306884,3.68233641306884,6.33800605997845,6.55673060270639,6.1192815172505,185.824798170081,-0.0966088588328661,0.997645062653829,0.431555640946041,0.675104995743407,"Q3MHQ7",2.49e-61,"Lysoplasmalogenase TMEM86A (EC 3.3.2.2) (Transmembrane protein 86A)","lipid metabolic process [GO:0006629]","GO:0005789; GO:0006629; GO:0016020; GO:0016787; GO:0047408"
"1376","Pocillopora_acuta_HIv2___TS.g5985.t1",2.27272727272727,0,0,0,0,0,NA,0,NA,NA,0.324675324675325,0,0.757575757575758,NA,NA,NA,NA,NA,NA,6.71922149999791,3.68233641306884,3.68233641306884,3.68233641306884,8.26038811490452,8.52865999346697,9.51338155041335,9.14524340688818,7.22521248378998,3.68233641306884,6.41214527017363,7.00648038372989,5.81781015661737,207.80936916672,-0.239993365218655,0.995292924908323,0.314062981572973,0.563528962346046,"Q566Y1",1.35e-92,"Elongator complex protein 4 (ELP4)","regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098]","GO:0002098; GO:0005737; GO:0006357; GO:0008023; GO:0008607; GO:0033588"
"1377","Pocillopora_acuta_HIv2___RNAseq.g7454.t2",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.74163829918218,3.68233641306884,6.17960196289983,4.2857336656916,5.66700991799266,3.68233641306884,5.18636982781747,5.90789232542808,6.05667785981469,5.30690658460733,5.16965032695715,5.91056407306349,4.42873658085082,22.4460646048048,-1.20190268797013,1.7452914087835,0.00810365711441764,0.0350407463386956,"P0CI65",3.24e-37,"Nephrocystin-3","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"1378","Pocillopora_acuta_HIv2___RNAseq.g7465.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.6716910690569,10.6368804573566,9.97181302537224,9.81820503258106,10.224446006473,9.71412751504697,11.0076314257217,10.5196553015693,4.97930611778461,11.780155317388,9.93239112683504,9.27338230405121,10.5913999496189,1399.17827861175,0.258535511070358,0.829425062418262,0.557311896500309,0.771531323792158,"Q8CIS0",1.57e-13,"Caspase recruitment domain-containing protein 11 (CARD-containing MAGUK protein 1) (Carma 1)","B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; canonical NF-kappaB signal transduction [GO:0007249]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; homeostasis of number of cells [GO:0048872]; lymphocyte activation [GO:0046649]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein homooligomerization [GO:0051260]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of immune response [GO:0050776]; regulation of T cell differentiation [GO:0045580]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]; thymic T cell selection [GO:0045061]; TORC1 signaling [GO:0038202]","GO:0001772; GO:0005737; GO:0005886; GO:0007165; GO:0007249; GO:0030183; GO:0030890; GO:0031295; GO:0032449; GO:0032743; GO:0035739; GO:0038202; GO:0042100; GO:0042110; GO:0042981; GO:0043123; GO:0045061; GO:0045121; GO:0045577; GO:0045580; GO:0046649; GO:0048872; GO:0050700; GO:0050776; GO:0050862; GO:0050870; GO:0051092; GO:0051260; GO:2000563"
"1379","Pocillopora_acuta_HIv2___TS.g6012.t1",0.75187969924812,0,0,2.94117647058824,15.1111111111111,1.76991150442478,5.12820512820513,NA,NA,NA,3.67175484479677,1.57036265833767,5.24779898464109,NA,NA,NA,NA,NA,NA,7.66721366552832,6.32311345750654,5.89089308266057,4.86458704699243,4.93003625965001,7.69302168712282,5.73058915105271,6.19602632709643,6.65367853148855,3.68233641306884,5.96314956221672,6.26756957328478,5.65872955114867,62.9729269680882,-0.358925852783324,0.958435886656338,0.298492939013437,0.546299110450507,"P21328",1.25e-34,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)","","GO:0003964"
"1380","Pocillopora_acuta_HIv2___RNAseq.g7467.t1",0,NA,0,0,0,5.26315789473684,0,0,0,NA,0.657894736842105,1.31578947368421,0,NA,NA,NA,NA,NA,NA,10.5880721659329,10.2176161449399,9.41068672381548,9.37382752931313,7.82650501859209,5.98035870671382,3.68233641306884,8.43892056480132,3.68233641306884,3.68233641306884,7.28829960933152,7.98930417724213,6.58729504142091,453.606164166754,-0.402889951395368,1.00185554956188,0.35101606024966,0.602570849621001,NA,NA,NA,NA,NA
"1381","Pocillopora_acuta_HIv2___RNAseq.g7479.t3a",0,8.33333333333333,0,0,NA,0,0,NA,NA,NA,1.38888888888889,2.77777777777778,0,NA,NA,NA,NA,NA,NA,10.4966627107004,8.93891267109463,9.58709526639691,3.68233641306884,7.04098991334845,9.98485714344735,3.68233641306884,8.95485204357217,10.8477332144327,3.68233641306884,7.68981122021991,9.38546662969013,5.9941558107497,601.157305074041,-0.39727102460329,1.10077702309088,5.90338095488751e-06,7.27932669492694e-05,"Q5ZIE8",1.26e-18,"Activating transcription factor 7-interacting protein 1 (MBD1-containing chromatin-associated factor 1)","positive regulation of DNA methylation-dependent heterochromatin formation [GO:0090309]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein stability [GO:0031647]","GO:0003712; GO:0005634; GO:0005667; GO:0006355; GO:0031647; GO:0050821; GO:0090309"
"1382","Pocillopora_acuta_HIv2___RNAseq.16864_t",100,100,NA,100,100,60,95,NA,NA,NA,92.5,86.6666666666667,98.3333333333333,NA,NA,NA,NA,NA,NA,5.39475910818241,6.94709464914545,7.87001867442991,10.8270128114338,6.86756360488365,3.68233641306884,10.2685530915312,8.61060855334333,6.12311189824512,7.95689430964936,7.45479531139131,6.97321236781688,7.93637825496573,405.528666263129,0.467324915933428,0.998354867469903,0.244840144545133,0.483622229073531,"Q801S4",1.28e-87,"Uncharacterized protein KIAA0930 homolog","",""
"1383","Pocillopora_acuta_HIv2___RNAseq.g7508.t1",0,NA,0,NA,NA,0,8.82352941176471,23.8095238095238,0,4.91803278688525,5.36444085831054,7.93650793650794,3.43539054966249,NA,NA,NA,NA,NA,NA,11.471361730617,10.5767762510676,11.8562561566809,10.6864628895108,11.1373887370428,11.578288397269,11.4172302627223,11.8231908386234,10.5341227895252,3.68233641306884,10.4763414466128,11.3644640504979,9.58821884272771,2264.34200712053,-0.381972663597767,0.912938721735333,0.345786185571085,0.596689499892647,"Q14008",0,"Cytoskeleton-associated protein 5 (Colonic and hepatic tumor overexpressed gene protein) (Ch-TOG)","cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; positive regulation of microtubule nucleation [GO:0090063]; RNA transport [GO:0050658]; spindle organization [GO:0007051]","GO:0000776; GO:0000922; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007019; GO:0007051; GO:0007052; GO:0007098; GO:0008017; GO:0016020; GO:0030951; GO:0032991; GO:0043021; GO:0045296; GO:0046785; GO:0050658; GO:0051010; GO:0051298; GO:0051301; GO:0061863; GO:0090063"
"1384","Pocillopora_acuta_HIv2___RNAseq.g7520.t1",NA,NA,0,0,0,0,NA,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.24052811387302,9.69627366810145,8.9738039318025,8.38342770668208,9.22958068330455,5.12470250408451,3.68233641306884,9.1421383182884,11.0159647992677,3.68233641306884,7.71710925515419,9.32040316930723,6.11381534100114,504.130441381808,-0.501369790204707,1.12842040862479,0.00243387158206824,0.0126404016384327,NA,NA,NA,NA,NA
"1385","Pocillopora_acuta_HIv2___RNAseq.g7530.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.31855930028477,9.41710280084655,3.68233641306884,3.68233641306884,3.68233641306884,10.0656567391257,7.20706873415218,5.90789232542808,8.36516854001352,8.25783603172818,6.85862937107855,5.99125859837281,7.72600014378429,274.428481085907,0.368127491007189,1.00254479851231,0.321401802975615,0.571301257129035,NA,NA,NA,NA,NA
"1386","Pocillopora_acuta_HIv2___TS.g6081.t1",21.0526315789474,NA,NA,0,0,0,0,0,NA,NA,3.50877192982456,0,7.01754385964912,NA,NA,NA,NA,NA,NA,8.49160305648387,6.59081673114823,3.68233641306884,3.68233641306884,7.42860258406594,3.68233641306884,3.68233641306884,5.28924211491062,5.42703766936634,8.9804639821468,5.69371117903972,6.06376436757912,5.32365799050031,107.328888798609,-0.237996381056734,1.03504089996822,0.219756519787227,0.45079539103708,"Q02496",1.47e-12,"Mucin-1 (MUC-1) (Episialin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)]","","GO:0005634; GO:0005737; GO:0009986; GO:0016324; GO:0062023"
"1387","Pocillopora_acuta_HIv2___RNAseq.g7535.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.50921680081805,8.65975075825696,9.53885620978072,9.86479266389506,8.38827354634219,3.68233641306884,3.68233641306884,9.07044442039475,9.04326050652363,3.68233641306884,7.41216041452179,8.91001029677187,5.91431053227171,366.792998134007,-0.432487497575919,1.09162356493029,1.85894258224606e-05,0.000194980025450377,NA,NA,NA,NA,NA
"1388","Pocillopora_acuta_HIv2___RNAseq.g7541.t1",0,0,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.24052811387302,8.0939860793811,8.50322897424329,10.3359083233811,7.89020468744546,8.18381287343643,8.8668559495874,8.21758883240833,6.46520689288117,8.1532745878894,8.29505953145267,7.86335150017025,8.72676756273509,364.618699462369,0.667072612400746,0.652595759240352,0.178384254839324,0.392000890610146,NA,NA,NA,NA,NA
"1389","Pocillopora_acuta_HIv2___RNAseq.g7549.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.4726515055344,11.2451537182291,10.3723152923693,3.68233641306884,10.4917182411411,10.6528917886822,10.8715326963735,9.37022191784003,3.68233641306884,3.68233641306884,8.45234943993762,8.87784867399073,8.0268502058845,1058.01364751434,-0.0084375897650008,0.927680640046795,0.906260931129538,0.964970414300474,"Q5R834",8.07e-173,"Fatty acyl-CoA reductase 1 (EC 1.2.1.84)","ether lipid biosynthetic process [GO:0008611]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025]","GO:0005778; GO:0008611; GO:0010025; GO:0035336; GO:0080019; GO:0102965"
"1390","Pocillopora_acuta_HIv2___RNAseq.g7553.t1",2.66159695817491,0,0,2.11640211640212,0,0.34965034965035,1.67714884696017,0,0,NA,0.756088696798615,0.493210493210493,1.08468645128377,NA,NA,NA,NA,NA,NA,8.22781082278327,3.68233641306884,9.74800346912972,3.68233641306884,5.35568868274662,3.68233641306884,3.68233641306884,8.87104398910152,7.90565311294572,3.68233641306884,5.8519882142051,8.02164001534137,3.68233641306884,178.606610751168,-12.123627689548,3.76147299332261,4.53001804665599e-09,1.47240856240073e-07,"Q14517",2.69e-09,"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]","actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cellular response to angiotensin [GO:1904385]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]","GO:0002088; GO:0003382; GO:0003412; GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062; GO:0098609; GO:1904385; GO:1904754"
"1391","Pocillopora_acuta_HIv2___TS.g6104.t1",0,0,0,NA,2.10526315789474,0,0,NA,2.38095238095238,NA,0.640887934121017,0.793650793650794,0.526315789473684,NA,NA,NA,NA,NA,NA,11.2082310965692,6.93444911437942,10.5567193448022,3.68233641306884,9.49435272580464,3.68233641306884,3.68233641306884,9.50199462372655,11.638074565073,3.68233641306884,7.40631671226304,10.4798744711951,4.33275895333096,847.604023362473,-11.395630384939,2.89324084650418,7.13078758060371e-11,4.3336013262963e-09,"Q5HY64",3.55e-18,"Putative protein FAM47C","",""
"1392","Pocillopora_acuta_HIv2___RNAseq.g7565.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.19403844897667,9.91581549631341,10.3354196278013,9.64422120430262,10.4751309846154,11.6140089964049,7.94440170487039,9.47757159886023,6.73914848420464,10.7505626817625,9.40903192281121,8.84426182889165,9.97380201673076,1029.89598942962,0.49849171082372,0.882214762881311,0.245092668812158,0.483723702868609,"O75581",0,"Low-density lipoprotein receptor-related protein 6 (LRP-6)","canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]","GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909"
"1393","Pocillopora_acuta_HIv2___TS.g6119.t1b",0,33.3333333333333,30.3030303030303,NA,0,50,29.7297297297297,80,23.0769230769231,NA,30.8053770553771,46.6025641025641,15.00819000819,NA,NA,NA,NA,NA,NA,3.68233641306884,9.05330485701912,6.96290456783844,10.2788316229672,5.68410831247026,7.8972218944009,3.68233641306884,7.27429212882864,3.68233641306884,9.9584025386264,6.81560751613575,5.457195567055,8.17401946521649,316.502305575792,0.362221518544304,1.09021048048891,0.0262767689232631,0.0927671920200334,"O75581",4.2e-173,"Low-density lipoprotein receptor-related protein 6 (LRP-6)","canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]","GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909"
"1394","Pocillopora_acuta_HIv2___RNAseq.g7578.t1",0,NA,NA,0,0,10,0,NA,0,NA,1.66666666666667,3.33333333333333,0,NA,NA,NA,NA,NA,NA,10.0506517870049,10.3786429865617,9.64855619765768,11.5377145247185,8.99443797260713,11.3618663240492,10.3406834804403,9.44896393042823,7.56366523702835,3.68233641306884,9.30075188535648,9.14125502494526,9.46024874576771,1126.53565244587,0.19810661697605,0.879353142414178,0.640444077952519,0.826966699938375,"Q552M5",1.8e-30,"Ras guanine nucleotide exchange factor Y (RasGEF domain-containing protein Y)","Ras protein signal transduction [GO:0007265]","GO:0005085; GO:0005886; GO:0007265"
"1395","Pocillopora_acuta_HIv2___RNAseq.g7610.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0470427019229,11.0098282086761,10.8710394438307,11.6015217306309,11.1536538554782,11.3083609266413,11.0475643075791,9.77678200082257,12.3938382484834,10.0816611694157,10.9291292593481,10.8484712501076,11.0097872685886,2211.78448566723,0.157871259192532,0.66430483356444,0.744557321398171,0.887121835820779,"Q6ZQ03",1.03e-34,"Formin-binding protein 4 (Formin-binding protein 30)","",""
"1396","Pocillopora_acuta_HIv2___RNAseq.g7624.t1",7.69230769230769,NA,NA,NA,0,0,0,0,0,NA,1.28205128205128,0,2.56410256410256,NA,NA,NA,NA,NA,NA,9.43326027943365,8.28377980671824,9.7970786794685,7.47098189621969,8.2003019901985,10.5273772550477,3.68233641306884,8.03179044943754,3.68233641306884,3.68233641306884,7.27915795957303,7.82895356232141,6.72936235682466,392.523143847351,-0.294906161164483,0.996102658268609,0.409311393858448,0.654898230173517,NA,NA,NA,NA,NA
"1397","Pocillopora_acuta_HIv2___RNAseq.g7640.t1",11.8518518518519,23.3333333333333,37.1794871794872,23.5955056179775,23.4567901234568,21.8855218855219,12.5,18.1818181818182,21.7391304347826,0,19.3723438608229,21.7470618906867,16.9976258309592,NA,NA,NA,NA,NA,NA,6.34070533074306,3.68233641306884,9.50823460080548,6.63240153016127,9.08622788371448,3.68233641306884,3.68233641306884,7.89059234920551,6.10133000554887,10.0662650265849,6.66727659659701,7.78541803400348,5.54913515919054,265.784772937705,-0.509515496147961,1.19453419075711,0.000209553805484022,0.00155435191924148,"Q498Z6",2.7e-53,"Small ribosomal subunit protein uS7m (28S ribosomal protein S7, mitochondrial) (MRP-S7) (S7mt)","mitochondrial translation [GO:0032543]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]","GO:0000028; GO:0003729; GO:0003735; GO:0005763; GO:0005840; GO:0006412; GO:0019843; GO:0032543"
"1398","Pocillopora_acuta_HIv2___RNAseq.g7644.t1",0,0,0,NA,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.7680840551955,6.17776049751523,8.27599171875922,3.68233641306884,10.6891279749702,3.68233641306884,3.68233641306884,9.61826466553278,11.363338101745,3.68233641306884,6.96219126659933,9.74296130324054,4.18142122995812,573.932030486125,-11.0482363339345,3.23094399036347,1.40554192347152e-09,5.47971924018656e-08,"Q9BYK8",0,"3'-5' exoribonuclease HELZ2 (EC 3.1.13.1) (ATP-dependent RNA helicase PRIC285) (EC 3.6.4.13) (Helicase with zinc finger 2, transcriptional coactivator) (Helicase with zinc finger domain 2) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein)","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]","GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0008859; GO:0016020; GO:0016887; GO:0030374; GO:0035194; GO:0043186; GO:0045944; GO:0046872"
"1399","Pocillopora_acuta_HIv2___RNAseq.g7648.t1",0,0,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.53983941110886,10.2954927053144,11.4696236623907,11.0063191630172,11.3335282148822,9.2503528719535,10.0910025725106,11.4592382384734,10.8820608535631,6.56351623590136,10.1890973929115,10.9368580760837,9.44133670973941,1571.79786931813,-0.816553930578162,0.893696504820286,0.109610348765604,0.279584483777638,"Q9BYK8",0,"3'-5' exoribonuclease HELZ2 (EC 3.1.13.1) (ATP-dependent RNA helicase PRIC285) (EC 3.6.4.13) (Helicase with zinc finger 2, transcriptional coactivator) (Helicase with zinc finger domain 2) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein)","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]","GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0008859; GO:0016020; GO:0016887; GO:0030374; GO:0035194; GO:0043186; GO:0045944; GO:0046872"
"1400","Pocillopora_acuta_HIv2___TS.g6226.t1",0,NA,0,0,0,11.7647058823529,0,0,NA,NA,1.68067226890756,3.92156862745098,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.48302439493017,9.11408343284851,10.3218494885675,10.0592810358057,7.78738559023813,3.68233641306884,10.6356453024019,9.68506660558398,7.43123314299026,8.18822418195038,8.63528255794179,7.74116580595898,622.164650165222,-0.141974446751599,0.981329061661595,0.492331795654665,0.723540651529066,"Q7TN88",3.45e-96,"Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"1401","Pocillopora_acuta_HIv2___RNAseq.g7667.t1",0,0,0,NA,0,0,0,0,6.25,NA,0.78125,1.5625,0,NA,NA,NA,NA,NA,NA,10.1141170561699,7.7732326587915,10.7208351161006,10.5439985513089,10.1194111937256,6.47828580769909,5.93399417379984,8.82530251522673,9.08674715072376,3.68233641306884,8.32782606366148,9.77328260638932,6.88236952093363,654.3126396625,-1.9218318692877,1.78833212514393,0.00455461216814751,0.021486598304007,"Q8IV36",0,"Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog)","","GO:0000138; GO:0005737; GO:0005794; GO:0005797; GO:0005829; GO:0005881; GO:0016020; GO:0070062; GO:0098548"
"1402","Pocillopora_acuta_HIv2___RNAseq.g7668.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.2724804189951,8.70836182932305,12.3090359624397,10.3611239791526,11.7085914002488,3.68233641306884,3.68233641306884,11.0912233700517,12.1178988645314,3.68233641306884,8.86157250639489,11.6998460032533,6.02329900953643,1907.61122060162,-0.836585506441693,1.50585743001614,1.26694449638438e-08,3.57214136368491e-07,"P22105",7.8e-78,"Tenascin-X (TN-X) (Hexabrachion-like protein)","actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; fatty acid metabolic process [GO:0006631]; neuron projection development [GO:0031175]; positive regulation of cell fate determination [GO:1905935]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell migration [GO:0030334]; triglyceride metabolic process [GO:0006641]","GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0008284; GO:0010718; GO:0030036; GO:0030155; GO:0030199; GO:0030334; GO:0031012; GO:0031175; GO:0032963; GO:0043231; GO:0045595; GO:0048251; GO:0062023; GO:0070062; GO:0090733; GO:0098609; GO:0098633; GO:1900748; GO:1904028; GO:1905935"
"1403","Pocillopora_acuta_HIv2___RNAseq.g7710.t1",11.1111111111111,NA,NA,0,13.8888888888889,0,0,NA,0,NA,4.16666666666667,0,8.33333333333333,NA,NA,NA,NA,NA,NA,9.46787034384102,11.2426193162773,7.03078696493316,10.5218086246593,9.55767051833452,3.68233641306884,4.10128477526701,7.86060514912441,10.4973512404023,3.68233641306884,7.76446697589767,8.88285684332708,6.64607710846826,698.777475410817,-0.228975009184386,1.03052576096136,0.000317754285362254,0.00221921679549959,"P49656",5.35e-103,"Inward rectifier potassium channel 2 (Inward rectifier K(+) channel Kir2.1) (IRK-1) (Potassium channel, inwardly rectifying subfamily J member 2)","cardiac muscle cell action potential involved in contraction [GO:0086002]; magnesium ion transport [GO:0015693]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of skeletal muscle contraction via regulation of action potential [GO:0014861]; relaxation of cardiac muscle [GO:0055119]; relaxation of skeletal muscle [GO:0090076]","GO:0005242; GO:0005546; GO:0006813; GO:0008076; GO:0014861; GO:0015693; GO:0016020; GO:0034765; GO:0042802; GO:0051289; GO:0055119; GO:0060306; GO:0086002; GO:0086008; GO:0086091; GO:0090076; GO:1990573"
"1404","Pocillopora_acuta_HIv2___RNAseq.g7752.t1b",0,NA,NA,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.90744172849562,3.68233641306884,4.89801104097743,3.68233641306884,8.1749784885011,3.68233641306884,5.59808714140454,4.70256513311627,3.68233641306884,3.68233641306884,4.76927655978392,5.47306656083185,4.06548655873598,34.3523252719551,-0.210056735589772,1.0344898409171,0.0542537356298412,0.165309886696866,"Q8BLA8",4.76e-104,"Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor)","calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832]","GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014070; GO:0014832; GO:0015267; GO:0015278; GO:0016020; GO:0016324; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0071244; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760"
"1405","Pocillopora_acuta_HIv2___RNAseq.g7777.t1",1.61290322580645,NA,NA,3.57142857142857,2.08333333333333,9.78260869565217,3.57142857142857,NA,0,NA,3.43695039960818,4.45134575569358,2.42255504352279,NA,NA,NA,NA,NA,NA,9.70163760674945,3.68233641306884,7.98489315249426,6.93438880964508,9.77047969910791,3.68233641306884,9.91805563520427,7.74631987145943,10.1184972855934,3.68233641306884,7.32212812994603,9.06436552308089,5.57989073681117,419.929981957287,-0.377209857152214,1.07853129743264,3.19937328373761e-06,4.28479029407229e-05,"O75521",1.24e-134,"Enoyl-CoA delta isomerase 2 (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1)","fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]","GO:0000062; GO:0004165; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006635; GO:0009062; GO:0016020; GO:0043231"
"1406","Pocillopora_acuta_HIv2___TS.g6353.t2",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.01518395889101,7.43223115439203,10.0025782604341,10.2346766863355,11.7265731335225,10.1804762525579,8.53207880317425,7.1955167311206,7.23934222464913,8.52409936181459,7.41536795761824,9.63283076601093,791.13272650773,0.89516729127432,1.17205417429263,0.0727269120749379,0.20711204100254,"A8KBE0",1.96e-33,"Oxidation resistance protein 1","","GO:0005739"
"1407","Pocillopora_acuta_HIv2___RNAseq.g7808.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0566469316645,3.68233641306884,5.92829418692211,6.47183417987439,9.39566096527514,7.44754517716341,3.68233641306884,8.12926274614067,3.68233641306884,9.80783233255023,6.8284085758797,7.43844024861425,6.21837690314514,306.601994206791,-0.144825660144281,1.00271637670674,0.257293197146218,0.499143719030774,"Q8CGC6",1.46e-115,"RNA-binding protein 28 (RNA-binding motif protein 28)","mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","GO:0003723; GO:0005681; GO:0005730; GO:0006397; GO:0008380"
"1408","Pocillopora_acuta_HIv2___TS.g6363.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.8256570439174,10.7853158981201,11.5292832955399,11.9294196474777,11.3223803147979,12.0592615569145,9.52624104391385,10.7789113854355,11.8373030273947,10.991989927513,11.1585763141025,11.2587070134171,11.0584456147878,2519.86935664483,-0.135766798187743,0.571055632972224,0.760224432806253,0.89499317891174,NA,NA,NA,NA,NA
"1409","Pocillopora_acuta_HIv2___RNAseq.g7812.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.16748500850389,10.738414394501,3.68233641306884,3.68233641306884,9.99493032998455,8.19674494829501,3.68233641306884,9.52720119243602,9.15217221381277,3.68233641306884,6.95062937398086,7.90482503156121,5.99643371640051,432.118908456058,-0.216395713221361,1.02884961031799,0.248834447969806,0.488748160705495,"Q9VCA2",2.18e-81,"Organic cation transporter protein","apoptotic process [GO:0006915]; monoatomic ion transport [GO:0006811]","GO:0006811; GO:0006915; GO:0016020; GO:0022857"
"1410","Pocillopora_acuta_HIv2___RNAseq.g7815.t1",0,NA,5.71428571428571,0,0,0,0,0,0,0,0.634920634920635,0,1.14285714285714,NA,NA,NA,NA,NA,NA,9.78345030358105,9.01815240881009,9.65389470251962,3.68233641306884,9.52246661131694,9.94460839326245,8.45608009706679,8.35818531483881,9.64017831110097,7.61256283194379,8.56719153875093,9.39163504867148,7.74274802883039,537.125340374793,-0.410200337336317,0.935527761881965,0.303244172712904,0.551644285513702,"Q6DFQ7",3.04e-24,"Transmembrane protein 198","Wnt signaling pathway [GO:0016055]","GO:0005886; GO:0012506; GO:0016055; GO:0031410"
"1411","Pocillopora_acuta_HIv2___RNAseq.g7831.t1",0,NA,0,0,NA,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,10.6957062575989,10.8641001534851,10.6016047831151,11.0023181100486,9.99573264220259,8.02848582028765,8.56404519101346,10.5250266164875,9.11590073433909,12.1313615361461,10.1524281844724,10.1867942067486,10.1180621621962,1504.81798411358,-0.0721175757808017,0.752032487601605,0.841746928913453,0.937323925653962,"Q2V2M9",4.16e-157,"FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2)","cardiac myofibril assembly [GO:0055003]; cortical actin cytoskeleton organization [GO:0030866]; sarcomere organization [GO:0045214]","GO:0005737; GO:0005856; GO:0030018; GO:0030866; GO:0045214; GO:0051015; GO:0055003"
"1412","Pocillopora_acuta_HIv2___RNAseq.g7832.t1a",100,NA,NA,100,100,100,85.7142857142857,100,NA,NA,97.6190476190476,100,95.2380952380952,NA,NA,NA,NA,NA,NA,6.84813858621154,8.30340054455653,5.90972641462649,3.68233641306884,10.7956923728502,9.41593903755035,3.68233641306884,9.89398176528497,6.46520689288117,3.68233641306884,6.86790948531678,7.98254920637087,5.75326976426268,381.904886706675,-0.553701417749008,1.17615942884149,0.00135317310560778,0.00757148773675473,"Q642H7",7.33e-76,"Synembryn-A (Protein Ric-8A)","G protein-coupled receptor signaling pathway [GO:0007186]","GO:0001965; GO:0005085; GO:0005737; GO:0005886; GO:0007186"
"1413","Pocillopora_acuta_HIv2___RNAseq.g7833.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.7213982112356,9.38297607345041,9.03238485718131,3.68233641306884,9.80567853399987,6.52080719718656,3.68233641306884,6.79689746336218,7.65349580332634,3.68233641306884,6.99606473789488,8.60197097382106,5.3901585019687,316.008295885859,-1.32961499841588,2.53041448308311,3.63778143738246e-05,0.000346163623094078,"Q86U44",0,"N6-adenosine-methyltransferase catalytic subunit (EC 2.1.1.348) (Methyltransferase-like protein 3) (hMETTL3) (N6-adenosine-methyltransferase 70 kDa subunit) (MT-A70)","cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA destabilization [GO:0061157]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oogenesis [GO:0048477]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]","GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006397; GO:0006974; GO:0007283; GO:0007623; GO:0008173; GO:0009048; GO:0016556; GO:0016604; GO:0016607; GO:0019827; GO:0021861; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0045087; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0048477; GO:0051445; GO:0060339; GO:0061157; GO:0098508; GO:1902036; GO:1903679; GO:1904047; GO:1990204"
"1414","Pocillopora_acuta_HIv2___RNAseq.g7835.t1",0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.96654258263855,10.7571808162937,10.3229083259399,10.8369321384471,9.4065640784219,11.1241379427471,9.29030815292959,10.4548406195931,8.14084858207735,10.6987325699935,10.0998995809082,9.65834083773416,10.5414583240822,1247.09962038549,0.573387946740232,0.725394804126365,0.24408552581645,0.482697982691979,"Q5EA11",1.34e-22,"Tetratricopeptide repeat protein 4 (TPR repeat protein 4)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; protein folding [GO:0006457]","GO:0005634; GO:0005654; GO:0005737; GO:0006457; GO:0030544; GO:0045087; GO:0051607; GO:0051879"
"1415","Pocillopora_acuta_HIv2___TS.g6400.t1",100,0,NA,100,100,NA,100,100,NA,NA,83.3333333333333,66.6666666666667,100,NA,NA,NA,NA,NA,NA,8.60733229148948,3.68233641306884,7.34198352049247,9.99293081393562,8.74228495705164,3.68233641306884,3.68233641306884,8.45152832190879,8.06664988114209,3.68233641306884,6.59320554382955,8.24195579441689,4.9444552932422,246.667469664859,-0.566862215736902,1.2607479120936,3.20010350159735e-08,8.09200997326994e-07,"Q60848",0,"Lymphocyte-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein)","apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; chromosomal DNA methylation maintenance following DNA replication [GO:0141119]; DNA methylation-dependent heterochromatin formation [GO:0006346]; heterochromatin formation [GO:0031507]; kidney development [GO:0001822]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin formation [GO:0031508]; urogenital system development [GO:0001655]","GO:0000775; GO:0001655; GO:0001822; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006338; GO:0006346; GO:0006915; GO:0016787; GO:0030098; GO:0031507; GO:0031508; GO:0043066; GO:0044027; GO:0046651; GO:0051301; GO:0140658; GO:0141119; GO:1990830; GO:2001243"
"1416","Pocillopora_acuta_HIv2___RNAseq.g7864.t2",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.60184042606426,10.1298176400947,10.1692437272259,10.8069671589742,8.69560822347282,8.89118066805287,5.93399417379984,9.19403601956843,8.31113709628057,6.14979536860625,8.78836205021398,9.1943730985224,8.38235100190557,651.569911703004,-0.413821905118825,0.79936077241886,0.351566244442489,0.60324252359393,"Q9R1X5",0,"ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP)","cAMP transport [GO:0070730]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; transmembrane transport [GO:0055085]","GO:0005524; GO:0005796; GO:0005886; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0022884; GO:0030213; GO:0034634; GO:0035351; GO:0042626; GO:0048471; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0140359; GO:1901505"
"1417","Pocillopora_acuta_HIv2___RNAseq.g7894.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.72592015084728,12.704519600838,8.74519382368357,6.50915460878185,9.52691439362008,8.21380866985901,9.37805445150441,10.6865972524278,8.34738265562321,9.90747191218317,9.37450175193684,9.40640165524039,9.34260184863329,1242.35160979218,-0.104912898667886,0.789077054006716,0.790696154324537,0.911581851260126,"Q63722",4.53e-21,"Protein jagged-1 (Jagged1) (CD antigen CD339)","animal organ morphogenesis [GO:0009887]; animal organ regeneration [GO:0031100]; aorta morphogenesis [GO:0035909]; blood vessel remodeling [GO:0001974]; camera-type eye development [GO:0043010]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; podocyte development [GO:0072015]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of gene expression [GO:0010628]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456]; wound healing [GO:0042060]","GO:0001709; GO:0001953; GO:0001974; GO:0002011; GO:0002085; GO:0002456; GO:0003184; GO:0003215; GO:0005112; GO:0005509; GO:0005543; GO:0005886; GO:0005912; GO:0007219; GO:0009887; GO:0010628; GO:0016020; GO:0016324; GO:0022408; GO:0030182; GO:0030336; GO:0031100; GO:0032495; GO:0035909; GO:0042060; GO:0042127; GO:0042491; GO:0043010; GO:0045177; GO:0045596; GO:0045599; GO:0045602; GO:0045639; GO:0045665; GO:0045669; GO:0045747; GO:0045944; GO:0048018; GO:0048839; GO:0050678; GO:0060090; GO:0060411; GO:0061073; GO:0061101; GO:0061156; GO:0061309; GO:0061444; GO:0062043; GO:0072006; GO:0072015; GO:0072017; GO:0072070; GO:0097150; GO:2000737"
"1418","Pocillopora_acuta_HIv2___RNAseq.g7925.t1",100,73.3333333333333,92.3076923076923,NA,69.5652173913043,85,100,NA,100,NA,88.6008918617614,86.1111111111111,90.4682274247492,NA,NA,NA,NA,NA,NA,10.1682777083416,12.1363842416873,11.8603018498984,10.8741906866815,10.6184876695994,11.5285332015024,9.84809151468804,10.5908176302988,10.8477332144327,10.9943158638065,10.9467133580937,10.8171236145142,11.0763031016731,2186.48993580218,0.155522444382471,0.634929257043533,0.746050428291007,0.88813772796717,NA,NA,NA,NA,NA
"1419","Pocillopora_acuta_HIv2___TS.g6492.t2",66.6666666666667,NA,NA,0,50,42.8571428571429,NA,66.6666666666667,NA,100,54.3650793650794,36.5079365079365,72.2222222222222,NA,NA,NA,NA,NA,NA,7.59625454638105,8.46018003415581,7.86541130395348,7.34446020722041,7.60379181609188,7.85429172457537,5.44987995888088,5.43126625005349,3.68233641306884,3.68233641306884,6.497020866745,6.43581206590975,6.55822966758026,126.098046509729,0.0911732115700685,0.693592924680201,0.815896818704075,0.923478487028386,"Q6GQX6",4.53e-98,"Ankyrin repeat and SAM domain-containing protein 6 (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6)","determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]","GO:0001701; GO:0001822; GO:0005737; GO:0007368; GO:0007507; GO:0042802; GO:0097543"
"1420","Pocillopora_acuta_HIv2___RNAseq.g7952.t1",0,NA,0,0,0,0,NA,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.62300673298873,5.47000929073246,9.75671308057796,9.22239603472545,9.49094192144715,3.68233641306884,3.68233641306884,9.00528702817479,7.68222817588062,9.43568486678976,7.70509399574546,9.11163538781385,6.29855260367707,422.717510834845,-0.475219670802418,1.11246226533023,0.00364880038688539,0.0178117613216032,"O35218",0,"Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit) (CPSF 100 kDa subunit)","mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]","GO:0003723; GO:0005847; GO:0006398; GO:0098794; GO:0098978"
"1421","Pocillopora_acuta_HIv2___RNAseq.g7959.t1",8.29493087557604,7.84313725490196,8.30258302583026,12.2719734660033,10.7705779334501,8.6185967467832,8.57868020304569,14.1158989598811,8.44772967265047,0,8.72441081381221,10.259467220044,7.18935440758041,1,-13.6986301369863,-13.6986301369863,0.0114603664633809,0.0114603664633809,0.0114603664633809,8.4844967469423,7.12434365571459,7.874611289381,3.68233641306884,6.73362645085059,7.15087115891671,8.2746896597434,7.54396176493916,3.68233641306884,3.68233641306884,6.42336099656943,6.86380653303638,5.98291546010248,130.396010245559,-0.186419622771356,0.937328401496108,0.630533332204035,0.821106880075553,NA,NA,NA,NA,NA
"1422","Pocillopora_acuta_HIv2___RNAseq.g7960.t1",1.14942528735632,NA,0,8.06451612903226,1.19047619047619,2.20820189274448,1.53061224489796,0,16.2790697674419,NA,3.80278768899363,6.63794694730465,0.967628430682618,NA,NA,NA,NA,NA,NA,5.00035332017132,3.68233641306884,6.59774358746208,3.68233641306884,3.68233641306884,4.32783990674728,8.4243393880191,6.18361936369477,3.68233641306884,7.88832156922198,5.31515627875919,5.02927781949317,5.60103473802521,66.6548557429443,0.0944285412979956,1.01065154877577,0.392586379541101,0.639384010098242,NA,NA,NA,NA,NA
"1423","Pocillopora_acuta_HIv2___RNAseq.g7969.t1b",4.12371134020619,3.77358490566038,5.91397849462366,2.22222222222222,1.44927536231884,5.48780487804878,12.7659574468085,0,4.05405405405405,0,3.97905887039426,3.10753321199709,4.85058452879144,NA,NA,NA,NA,NA,NA,8.57089893133007,7.11319280397558,9.26826099503974,8.73195336304879,7.30381793138361,10.0538807398142,7.7818636248628,8.78205722401949,6.18642473237091,3.68233641306884,7.7474686758914,8.02229196282876,7.47264538895404,329.040868394499,-0.366512777442418,0.899997502542084,0.35102751513458,0.602570849621001,NA,NA,NA,NA,NA
"1424","Pocillopora_acuta_HIv2___TS.g6544.t2",0.497512437810945,0.641025641025641,0.249376558603491,1.4308426073132,1.14155251141553,0.826446280991736,0.708103855232101,0,2.30179028132992,0,0.779665017372256,1.0400209621321,0.519309072612413,NA,NA,NA,NA,NA,NA,6.50755595230566,10.738414394501,6.59774358746208,7.10084180733574,8.86335373547257,9.07728000736896,3.68233641306884,8.88597397159546,3.68233641306884,7.53764925099809,7.26734855331772,6.90739273198092,7.62730437465453,349.958755017548,0.192083948470434,0.979119198377237,0.382186116058799,0.630899336073324,"B3EWZ5",3.61e-89,"MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1)","","GO:0005576; GO:0016020"
"1425","Pocillopora_acuta_HIv2___TS.g6583.t1",NA,0,NA,NA,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,12.3005449097452,11.5473239049448,12.1517004070504,12.3980768141122,12.0823668122907,9.7970021427311,12.7547834916345,11.5556945173654,11.6453600966525,9.89756355121408,11.6130416647741,11.9471333486208,11.2789499809273,3703.4353754674,-0.400270473429942,0.695608444994398,0.386779932530635,0.634571794932294,"Q6V0I7",0,"Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)","cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008]","GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609"
"1426","Pocillopora_acuta_HIv2___RNAseq.g8030.t1",0,0,NA,NA,0,0,14.2857142857143,NA,0,NA,2.38095238095238,0,4.76190476190476,NA,NA,NA,NA,NA,NA,8.91796257251019,6.81522472615292,7.25980074116243,7.64607003834505,3.68233641306884,10.9678930543473,11.3060809715833,3.68233641306884,8.37836509164591,8.73534553831225,7.7391415560197,6.38416024629124,9.09412286574816,604.311271830533,0.246696821041808,0.996561328507808,0.278156977591415,0.523657753987015,NA,NA,NA,NA,NA
"1427","Pocillopora_acuta_HIv2___RNAseq.g8054.t1",0,NA,NA,0,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.79704173223452,10.3340999271669,8.67336052685824,9.74153808809013,9.5401760045045,7.9593001767779,11.0674902395356,6.92672320941957,9.19253747569013,8.69584034710088,9.09281077273784,8.62596778974139,9.55965375573428,700.821416021019,0.411491605147013,0.820899341233859,0.369554533077015,0.619235028547954,"Q8TEX9",0,"Importin-4 (Imp4) (Importin-4b) (Imp4b) (Ran-binding protein 4) (RanBP4)","protein import into nucleus [GO:0006606]; protein localization to nucleus [GO:0034504]","GO:0000785; GO:0005634; GO:0005737; GO:0006606; GO:0008139; GO:0016020; GO:0031267; GO:0032991; GO:0034504; GO:0061608"
"1428","Pocillopora_acuta_HIv2___RNAseq.g8078.t1",NA,0,0,NA,16.6666666666667,0,0,0,NA,NA,2.77777777777778,0,5.55555555555556,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,5.02254961121426,7.88111108983815,7.83011911983456,8.88852952366543,3.68233641306884,6.93399994628221,6.83269238753983,3.68233641306884,5.81183473306498,6.06033949558794,5.56332997054202,106.158717575242,-0.0921732052369448,0.998414611877759,0.599444428951024,0.800857926605757,"Q8R151",0,"NFX1-type zinc finger-containing protein 1","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"1429","Pocillopora_acuta_HIv2___RNAseq.g8086.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.49160305648387,3.68233641306884,11.0075896026566,3.68233641306884,11.1020644925947,7.87591744416405,3.68233641306884,7.2040788754888,11.363338101745,3.68233641306884,7.17739372254084,9.83373482579379,4.52105261928788,748.221244176246,-10.3278309560828,3.41325636329624,7.14108869365371e-09,2.16538169528317e-07,"Q8R151",1.86e-146,"NFX1-type zinc finger-containing protein 1","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"1430","Pocillopora_acuta_HIv2___RNAseq.g8087.t1",0,0,0,8,0,0,0,0,0,NA,0.888888888888889,1.6,0,NA,NA,NA,NA,NA,NA,7.76452612086534,10.0552266895744,6.52839021051498,11.2143242475693,7.18982473243499,10.2169394934919,12.3454618939037,9.21043411544989,3.68233641306884,11.6349185761061,8.98423824929794,6.87510231846681,11.0933741801291,1383.60419693104,2.96107099656306,1.83112173115437,0.00120793806426801,0.00687588199983174,"Q8R151",5.27e-143,"NFX1-type zinc finger-containing protein 1","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"1431","Pocillopora_acuta_HIv2___RNAseq.g8091.t1",0,0,0,0,0,NA,NA,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.9751069475382,11.7198700819014,12.2477037760452,12.3986857411379,13.0425371794059,10.9710269137678,12.0101347128748,12.8391982854376,13.2241347900982,12.6506415845229,12.407904001273,12.865736195705,11.950071806841,5932.79161345012,-0.670627915634146,0.610686634213619,0.162081080550966,0.366991350827985,"Q05975",3.74e-143,"Ras-related protein Rab-2","protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0003924; GO:0005525; GO:0005789; GO:0015031; GO:0016192; GO:0033116"
"1432","Pocillopora_acuta_HIv2___TS.g6681.t1",0,0,0,3.88349514563107,0,0.968992248062015,0.4739336492891,0,0,0,0.532642104298218,0.970497478738617,0.0947867298578199,NA,NA,NA,NA,NA,NA,11.6277134446641,10.4038160218463,11.4801780752198,3.68233641306884,11.3499333479666,3.68233641306884,3.68233641306884,9.27422226230349,11.6891986193149,3.68233641306884,8.05544074235906,11.0842491498938,5.02663233482433,1375.40247079999,-1.27187675055683,2.77233006310273,5.6631550296787e-10,2.48972262459796e-08,"Q6NYL5",2.28e-110,"Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2)","2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]","GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853"
"1433","Pocillopora_acuta_HIv2___TS.g6682.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.6163982052495,10.953600971981,12.0571822225163,3.68233641306884,12.2184774227461,3.68233641306884,3.68233641306884,10.5404323334107,12.302897173332,5.00142931435546,8.67374268827976,11.9470774714509,5.4004079051086,2368.98413027754,-9.97149425826053,3.34049894649836,1.36887255754588e-10,7.52827858264015e-09,"Q6GM82",2.43e-154,"Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2)","2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851]","GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853"
"1434","Pocillopora_acuta_HIv2___RNAseq.g415.t1",29.9382716049383,20.4545454545455,24.3303571428571,16.7539267015707,20.462850182704,12.2417355371901,30.9398099260824,20.4225352112676,9.09090909090909,19.7183098591549,20.435325071122,15.7927303990966,25.0779197431473,2,22.8896103896104,22.8896103896104,0.00867987675992868,0.00132637948652095,0.0160333740333364,3.68233641306884,3.68233641306884,7.71470031930259,7.13662644726567,4.99332554465423,4.89289037263117,5.59808714140454,6.17109778065781,5.13335110137444,3.68233641306884,5.2687087946497,5.53896223181158,4.99845535748781,41.1271430976038,-0.409245850809689,0.93540180504415,0.402967367485717,0.649389286262421,NA,NA,NA,NA,NA
"1435","Pocillopora_acuta_HIv2___TS.g4022.t1a",2.77777777777778,0,0,7.5,7.14285714285714,6.38297872340426,NA,0,NA,NA,3.40051623486274,3.47074468085106,3.30687830687831,NA,NA,NA,NA,NA,NA,8.15801681521248,9.14848487511614,8.13780270981254,3.68233641306884,9.66345990704555,8.2514771251046,8.74740452298089,9.16526503885951,7.04807821226724,8.61342163913137,8.06157472585992,8.43452453663946,7.68862491508037,355.18344940231,-0.169242421380311,0.880376507624997,0.635808721857734,0.823997929339533,"Q5JU00",1.08e-136,"Dynein regulatory complex subunit 5 (T-complex-associated testis-expressed protein 1) (Tcte-1)","flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018]","GO:0005737; GO:0005856; GO:0007018; GO:0030317; GO:0036126"
"1436","Pocillopora_acuta_HIv2___TS.g4027.t1",NA,0,NA,0,0,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,9.84155379289543,9.83903031122011,10.6657577426425,8.84359181865699,9.5983885551017,10.3060061113473,9.79063490060094,9.44519029441824,6.10133000554887,10.4315542713025,9.48630378037346,9.13044407812135,9.84216348262557,873.82036872435,0.252957120237412,0.785592987121189,0.57046180001465,0.781014402677303,"Q9Y5A7",7.29e-95,"NEDD8 ultimate buster 1 (Negative regulator of ubiquitin-like proteins 1) (Renal carcinoma antigen NY-REN-18)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to tumor necrosis factor [GO:0034612]; response to type II interferon [GO:0034341]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005654; GO:0005730; GO:0005829; GO:0006511; GO:0016567; GO:0032436; GO:0034341; GO:0034612; GO:2000058"
"1437","Pocillopora_acuta_HIv2___RNAseq.g507.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.03654092012575,8.77307016386335,7.38136255625802,6.87896002582645,6.35975560497307,7.8972218944009,9.26495542064035,6.412559699967,3.68233641306884,3.68233641306884,6.73690991121926,6.17451103887854,7.29930878355998,167.763398623859,0.821934266044628,0.991803267223687,0.132546271061614,0.320918957476592,"Q6DKE2",2.08e-140,"Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3)","ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; Wnt signaling pathway [GO:0016055]","GO:0005737; GO:0008013; GO:0016055; GO:0032053; GO:0035556; GO:0060271"
"1438","Pocillopora_acuta_HIv2___RNAseq.g592.t1",0,0,0,0,0,1.72413793103448,0,0,NA,NA,0.21551724137931,0.431034482758621,0,NA,NA,NA,NA,NA,NA,11.5350053136646,13.1088089106169,13.8087959033937,13.8306133063693,12.5842269337013,13.2991457878719,12.0588729803699,12.5094674106917,11.8730397030132,13.7365762169669,12.8344552466659,12.4621070528929,13.206803440439,8418.24008591177,0.519798659357611,0.627016077515721,0.28133152455033,0.527095747551292,"Q8NF91",6.17e-78,"Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1)","cardiac muscle cell differentiation [GO:0055007]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of mini excitatory postsynaptic potential [GO:0061886]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of dendrite morphogenesis [GO:0048814]; regulation of nucleus organization [GO:1903353]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; response to light stimulus [GO:0009416]; spermatogenesis [GO:0007283]","GO:0000932; GO:0002053; GO:0003723; GO:0003779; GO:0005102; GO:0005521; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005856; GO:0006997; GO:0007030; GO:0007283; GO:0009416; GO:0016020; GO:0019899; GO:0030017; GO:0030496; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0044327; GO:0045211; GO:0048260; GO:0048471; GO:0048814; GO:0051015; GO:0055007; GO:0061886; GO:0090292; GO:0099149; GO:0140444; GO:1903353; GO:2001054"
"1439","Pocillopora_acuta_HIv2___RNAseq.g610.t1",0,NA,NA,0.909090909090909,0,0,0,NA,0,NA,0.151515151515152,0.303030303030303,0,NA,NA,NA,NA,NA,NA,7.89376064460252,5.39185996804635,7.41336738893051,7.56992190290079,6.92322974996165,3.68233641306884,3.68233641306884,8.40042050975166,6.81970434483651,3.68233641306884,6.14592737482365,7.49009652761657,4.80175822203073,104.253915296151,-0.991772465223853,1.72742695472362,0.00011932107668094,0.000964706569655183,"Q05609",7.44e-21,"Serine/threonine-protein kinase CTR1 (EC 2.7.11.1) (Protein CONSTITUTIVE TRIPLE RESPONSE1)","ethylene-activated signaling pathway [GO:0009873]; gibberellin biosynthetic process [GO:0009686]; negative regulation of ethylene-activated signaling pathway [GO:0010105]; protein autophosphorylation [GO:0046777]; regulation of post-embryonic root development [GO:2000069]; regulation of stem cell division [GO:2000035]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; response to ethylene [GO:0009723]; response to fructose [GO:0009750]; response to hypoxia [GO:0001666]; response to sucrose [GO:0009744]; sugar mediated signaling pathway [GO:0010182]","GO:0001666; GO:0004674; GO:0004712; GO:0005524; GO:0005789; GO:0009686; GO:0009723; GO:0009744; GO:0009750; GO:0009873; GO:0010105; GO:0010182; GO:0046777; GO:0048510; GO:0106310; GO:2000035; GO:2000069"
"1440","Pocillopora_acuta_HIv2___RNAseq.g616.t1",NA,0,NA,NA,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.39211909700571,10.6301091018162,10.3312612401762,12.7196706235089,9.6078661902075,11.641017944537,11.6581986427739,11.0441985999302,11.2370202905546,6.9608997877233,10.5222361518234,10.3224930835748,10.7219792200719,2189.18315803046,0.353368618950057,0.839479355798048,0.4165853549622,0.661128313381275,"Q6NZ04",1.5e-121,"Homeobox protein six1b (Homeobox protein six1a) (Sine oculis homeobox homolog 1a) (Sine oculis homeobox homolog 1b)","adenohypophysis development [GO:0021984]; apoptotic process [GO:0006915]; chordate pharyngeal muscle development [GO:0043282]; extraocular skeletal muscle development [GO:0002074]; inner ear development [GO:0048839]; peripheral nervous system neuron development [GO:0048935]; regulation of skeletal muscle cell proliferation [GO:0014857]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle fiber development [GO:0048741]; striated muscle cell differentiation [GO:0051146]","GO:0000978; GO:0000981; GO:0002074; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0006915; GO:0014857; GO:0021984; GO:0043282; GO:0048741; GO:0048839; GO:0048935; GO:0051146"
"1441","Pocillopora_acuta_HIv2___TS.g4178.t2",0,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.17503271827961,5.71009804948923,3.68233641306884,5.11193581531555,7.2560778700207,3.68233641306884,3.68233641306884,8.71674216983619,8.82306919173889,3.68233641306884,5.55223014669555,6.73065167258885,4.37380862080226,100.980884947288,-0.189078393984418,1.02813715391157,0.000821226410068754,0.00496166198631348,"Q90WM5",1.15e-29,"Doublesex- and mab-3-related transcription factor 3","male sex differentiation [GO:0046661]","GO:0000978; GO:0000981; GO:0005634; GO:0046661; GO:0046872"
"1442","Pocillopora_acuta_HIv2___RNAseq.g626.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0874262069357,9.09044323014377,10.9211460144645,7.13662644726567,9.63387071442544,7.90249892642914,5.79202165087362,9.36889455076052,11.5587870607191,3.68233641306884,8.51740512150863,10.3140249094611,6.72078533355621,825.478450901913,-1.72411650826137,1.95716554225192,0.00611687178254395,0.0276482604570987,"Q9VXE5",2.68e-145,"Serine/threonine-protein kinase PAK mbt (EC 2.7.11.1) (Protein mushroom bodies tiny) (p21-activated kinase-related protein)","compound eye development [GO:0048749]; compound eye photoreceptor cell differentiation [GO:0001751]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; positive regulation of compound eye photoreceptor development [GO:0045315]; positive regulation of developmental growth [GO:0048639]; protein phosphorylation [GO:0006468]; regulation of cell-cell adhesion mediated by cadherin [GO:2000047]; regulation of MAPK cascade [GO:0043408]","GO:0001751; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0005912; GO:0006468; GO:0007010; GO:0007030; GO:0016319; GO:0031267; GO:0035556; GO:0043408; GO:0045315; GO:0045792; GO:0048639; GO:0048749; GO:0106310; GO:2000047"
"1443","Pocillopora_acuta_HIv2___TS.g4194.t1",NA,NA,100,NA,100,85.7142857142857,0,85.7142857142857,100,NA,78.5714285714286,90.4761904761905,66.6666666666667,NA,NA,NA,NA,NA,NA,6.74355908835771,3.68233641306884,7.23131684908634,7.83130589073456,8.65755186968006,8.45527342080496,3.68233641306884,3.68233641306884,10.8996849312922,3.68233641306884,6.45480377022312,7.44288983029703,5.46671771014921,300.066939496792,-0.251433689138992,1.00723797482433,0.354875328330527,0.605902901424,"Q5U4C9",5.08e-21,"Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1)","intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]; smoothened signaling pathway [GO:0007224]","GO:0000151; GO:0000287; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007224; GO:0030145; GO:0042771; GO:0045725; GO:0070885; GO:0106310; GO:1990904"
"1444","Pocillopora_acuta_HIv2___TS.g4220.t1",23.2558139534884,100,50,46.6666666666667,15.2173913043478,36.5671641791045,23.6641221374046,15.8730158730159,28.2051282051282,0,33.9449302319156,45.462394984783,22.4274654790482,NA,NA,NA,NA,NA,NA,8.05615398516961,8.76602226627005,8.78225102071592,7.98234675797472,8.90326194741471,7.46909717663739,7.91855927919823,8.52493952181678,8.88904978253325,3.68233641306884,7.89740181507995,8.63113125153005,7.16367237862985,290.873740718111,-0.455497439601403,0.928720498674395,0.285228687963534,0.531232003953715,"Q9V3D5",1.01e-30,"Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) (Protein smell impaired at 35A) (dDyrk2)","olfactory behavior [GO:0042048]; positive regulation of Wnt signaling pathway [GO:0030177]; response to light stimulus [GO:0009416]; sensory perception of smell [GO:0007608]","GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007608; GO:0009416; GO:0030177; GO:0042048; GO:0106310"
"1445","Pocillopora_acuta_HIv2___RNAseq.g672.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.01233578841319,3.68233641306884,10.6531533692359,3.68233641306884,10.4934233278643,8.87787588494184,3.68233641306884,8.82917027527558,9.87525953500156,3.68233641306884,7.24705638330077,9.7726684591581,4.72144430744344,528.012808858935,-10.3692294338882,3.25299962860475,1.33628368017687e-08,3.73849267893196e-07,"B3EWZ3",2.84e-96,"Coadhesin","","GO:0016020"
"1446","Pocillopora_acuta_HIv2___RNAseq.g675.t1",NA,NA,0,0,0,4,0,0,0,NA,0.571428571428571,1,0,NA,NA,NA,NA,NA,NA,7.57627509210327,5.91207600133758,8.79439451891213,8.28129725885401,10.3940833439597,7.35792596442826,3.68233641306884,8.78006033731957,3.68233641306884,3.68233641306884,6.8143121756121,7.8454299410727,5.78319441015151,278.173594814363,-0.688671372630479,1.19914799904069,0.12705986821669,0.311121370219435,"Q7T199",1.08e-06,"Potassium voltage-gated channel subfamily A member 10","action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]","GO:0001508; GO:0005251; GO:0008076; GO:0016020; GO:0051260; GO:0071805"
"1447","Pocillopora_acuta_HIv2___RNAseq.g680.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,4.75675715543394,6.9541853393125,9.90821239873394,5.21442834742072,7.45476539457999,3.68233641306884,6.19602632709643,3.68233641306884,3.68233641306884,5.52137206148529,5.14586256799347,5.89688155497711,125.895666801197,0.256060742807734,1.03326182365264,0.234910044272077,0.470600952957247,"Q0P5W1",0,"Vacuolar protein sorting-associated protein 8 homolog","endosomal vesicle fusion [GO:0034058]; protein targeting to vacuole [GO:0006623]","GO:0005769; GO:0005770; GO:0006623; GO:0030897; GO:0033263; GO:0034058; GO:0046872"
"1448","Pocillopora_acuta_HIv2___RNAseq.g682.t1",NA,0,0,NA,0,0,0,16.6666666666667,0,NA,2.38095238095238,4.16666666666667,0,NA,NA,NA,NA,NA,NA,7.83899717282492,11.5957883832487,9.22407332995664,10.8583404243995,7.96768678089113,12.3957567982905,13.2368244086835,10.5196553015693,3.68233641306884,10.0006700658224,9.73201290787554,7.84654979966217,11.6174760160889,2333.47091477811,2.80410290032967,1.73737822301744,0.00116327260653293,0.00666359405183852,"O55005",1.77e-28,"Roundabout homolog 1","aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hypoxia [GO:0071456]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; coronary vasculature development [GO:0060976]; endocardial cushion formation [GO:0003272]; heart development [GO:0007507]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; kidney development [GO:0001822]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; neuron projection extension [GO:1990138]; olfactory bulb interneuron development [GO:0021891]; oligodendrocyte development [GO:0014003]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; regulation of dendrite morphogenesis [GO:0048814]; Roundabout signaling pathway [GO:0035385]; spinal cord development [GO:0021510]; synapse organization [GO:0050808]; ventricular septum development [GO:0003281]; ventricular septum morphogenesis [GO:0060412]","GO:0001822; GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0003281; GO:0005737; GO:0005886; GO:0007156; GO:0007411; GO:0007507; GO:0008046; GO:0008285; GO:0009986; GO:0010628; GO:0010629; GO:0014003; GO:0016199; GO:0021510; GO:0021836; GO:0021891; GO:0030275; GO:0030336; GO:0030424; GO:0030425; GO:0030673; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043025; GO:0045747; GO:0048814; GO:0050772; GO:0050808; GO:0050925; GO:0051964; GO:0060412; GO:0060763; GO:0060976; GO:0070100; GO:0071456; GO:1900748; GO:1990138"
"1449","Pocillopora_acuta_HIv2___RNAseq.g688.t1",0,NA,0,0,0,0,NA,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,14.5451664025447,14.2756690803407,14.5408935711031,14.2136085954891,14.335359382799,13.9086899369288,14.3718496836259,14.2779236656082,14.6228841481442,13.9280352928353,14.3020079759419,14.4644454340398,14.139570517844,20425.358617746,-0.260098913828773,0.488403066150831,0.552084973469863,0.767932032877992,"Q01082",0,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)","actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; central nervous system development [GO:0007417]; central nervous system formation [GO:0021556]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390]","GO:0000281; GO:0003723; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007009; GO:0007417; GO:0008091; GO:0014069; GO:0014731; GO:0021556; GO:0030036; GO:0030054; GO:0030506; GO:0030673; GO:0030864; GO:0031430; GO:0032437; GO:0032743; GO:0042995; GO:0043001; GO:0045296; GO:0051015; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:0098978; GO:1903076; GO:1903078"
"1450","Pocillopora_acuta_HIv2___RNAseq.g707.t1",0,0,0,0,NA,10.7142857142857,0,NA,0,NA,1.53061224489796,2.67857142857143,0,NA,NA,NA,NA,NA,NA,7.49344156505009,8.03648948185279,7.07964346771683,3.68233641306884,7.77117055688731,3.68233641306884,3.68233641306884,7.82997741321486,8.17151122259478,3.68233641306884,6.1111579359592,7.66914884509277,4.55316702682563,116.3085811622,-0.901964211171995,1.67913427114091,6.0125872677489e-06,7.38455152171618e-05,"Q9U1S7",1.42e-12,"Polycystin-2 (CePc2) (Polycystic kidney disease 2 protein homolog)","calcium ion transport [GO:0006816]; detection of mechanical stimulus [GO:0050982]; male mating behavior [GO:0060179]; mating behavior [GO:0007617]; neuronal signal transduction [GO:0023041]; regulation of male mating behavior [GO:1902435]; response to hermaphrodite contact [GO:0034606]; vulval location [GO:0034608]","GO:0005262; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0005929; GO:0006816; GO:0007617; GO:0016020; GO:0023041; GO:0030424; GO:0030425; GO:0031090; GO:0034606; GO:0034608; GO:0043025; GO:0043204; GO:0048471; GO:0050982; GO:0060170; GO:0060179; GO:0071683; GO:0097730; GO:1902435"
"1451","Pocillopora_acuta_HIv2___RNAseq.g709.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.4587417773011,14.8562841593308,10.2804023981289,14.8684425464091,10.4571862816704,15.0355482073806,14.751960507443,12.8532628533479,11.11964897415,14.5430663864355,13.0224544091597,11.2338484569197,14.8110603613998,15945.586082239,3.31465641464002,0.790318860940209,5.64701751738139e-07,9.63189402964674e-06,NA,NA,NA,NA,NA
"1452","Pocillopora_acuta_HIv2___RNAseq.g710.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.2065259147445,7.40558854265871,10.6119258073171,3.68233641306884,10.6273151013105,3.68233641306884,3.68233641306884,10.9861003496417,9.44727814294713,3.68233641306884,7.4014079510895,10.3758290631922,4.42698683898681,707.193089478224,-11.5349722935492,3.15334887896313,3.43878267074491e-10,1.59418437659149e-08,"Q7TN88",1e-49,"Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"1453","Pocillopora_acuta_HIv2___TS.g4267.t1",0,0,0,4.54545454545455,5.55555555555556,0,0,0,0,NA,1.12233445566779,0.909090909090909,1.38888888888889,NA,NA,NA,NA,NA,NA,6.74355908835771,9.34329659846683,7.7198177287158,8.83280940348506,7.81560771910048,9.45765772696193,9.66254934004683,8.20572391788316,3.68233641306884,7.72930987565577,7.91926678117424,6.8334089734252,9.00512458892328,344.414275999994,1.37508527700789,1.30278355132787,0.0261159173609532,0.0922668853709886,NA,NA,NA,NA,NA
"1454","Pocillopora_acuta_HIv2___RNAseq.g713.t1",0,0,0,0,6.12244897959184,0.469483568075117,1.49253731343284,100,14.2857142857143,NA,13.5966871274238,22.9510395707579,1.90374657325617,NA,NA,NA,NA,NA,NA,9.9779603745956,9.66443017950663,9.68942171787145,9.12561766872391,9.01041291121026,9.92664008348448,9.09408006132084,9.81236700742792,6.01048531358257,10.8243215192948,9.31357368370185,8.90012946493756,9.72701790246613,776.416551612461,0.24035125029221,0.783037750552562,0.596702004708188,0.79884221219394,"Q28IT1",8.07e-108,"Endoplasmic reticulum lectin 1 (ER lectin) (Erlectin)","endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; retrograde protein transport, ER to cytosol [GO:0030970]","GO:0005788; GO:0030968; GO:0030970; GO:0036503"
"1455","Pocillopora_acuta_HIv2___RNAseq.g715.t1",0,NA,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.63634872160117,10.0067558946003,8.20127146777352,8.81099936724135,5.95850798619116,10.4797653899461,8.50024276910028,6.25641654278035,3.68233641306884,7.15805210680923,7.46906966591123,5.94697622628301,8.99116310553945,367.339410568285,3.23660279393445,1.7147788168189,0.000176940377331449,0.00134415211014815,"Q9JHA8",9.6e-26,"von Willebrand factor A domain-containing protein 7 (Protein G7c)","","GO:0005576"
"1456","Pocillopora_acuta_HIv2___RNAseq.g726.t1",37.9746835443038,32.8358208955224,75,50,63.3333333333333,22.6851851851852,84.6153846153846,3.84615384615385,NA,33.8983050847458,44.9098740560699,27.3417899817154,58.9643413155535,3,56.9392047406232,56.4223798266351,0.00147790054083945,0.000202878805222504,0.00304683834284148,9.68934125489244,7.4680060679803,7.44466985220172,10.4878702659836,7.04098991334845,7.9593001767779,9.95656219468619,8.67436281040448,10.6581606824114,3.68233641306884,8.30615996317553,8.7015049026517,7.91081502369937,578.529326162957,0.00531271479703767,0.918370298223619,0.949127282221403,0.980233988579105,"D3YVL2",0,"Cilia- and flagella-associated protein 70 (Tetratricopeptide repeat protein 18) (TPR repeat protein 18)","cilium assembly [GO:0060271]; cilium movement [GO:0003341]","GO:0003341; GO:0005930; GO:0031514; GO:0036126; GO:0036157; GO:0060271"
"1457","Pocillopora_acuta_HIv2___RNAseq.g727.t1",0,0,0,0,1.94174757281553,0,1.42857142857143,0,0,NA,0.374479889042996,0,0.842579750346741,NA,NA,NA,NA,NA,NA,5.9511981009209,3.68233641306884,6.4923699430376,3.68233641306884,6.54142192988087,3.68233641306884,3.68233641306884,5.87689277444549,6.96817420778911,3.68233641306884,5.02417390214182,6.36601139121479,3.68233641306884,31.1027796244483,-8.9761424403908,3.6430763474576,5.21588244060854e-05,0.000474481280634981,NA,NA,NA,NA,NA
"1458","Pocillopora_acuta_HIv2___RNAseq.g745.t1",0.932400932400932,0,0,1.00200400801603,0,0.603318250377074,0,0,0,0,0.253772319079404,0.321064451678621,0.186480186480186,NA,NA,NA,NA,NA,NA,10.7033685777805,10.3125106545534,10.8209101573891,9.84168696518138,9.45871250106622,9.34231690943149,10.7184452712346,10.2055969633557,8.72323778524158,10.7505626817625,10.0877348466996,9.98236519696662,10.1931044964327,1177.44492613342,0.12211978729376,0.624209805495135,0.801671891239997,0.916329010177088,"Q9QZ05",0,"eIF-2-alpha kinase GCN2 (Eukaryotic translation initiation factor 2-alpha kinase 4) (EC 2.7.11.1) (GCN2-like protein) (mGCN2)","adaptive immune response [GO:0002250]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to starvation [GO:0009267]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endoplasmic reticulum unfolded protein response [GO:0030968]; GCN2-mediated signaling [GO:0140469]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of cytoplasmic translational initiation in response to stress [GO:1990625]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cytoplasmic translational initiation in response to stress [GO:1990611]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; regulation of translational initiation in response to stress [GO:0043558]; response to endoplasmic reticulum stress [GO:0034976]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081]","GO:0000049; GO:0000077; GO:0001934; GO:0002230; GO:0002250; GO:0002286; GO:0002821; GO:0004674; GO:0004694; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006446; GO:0006468; GO:0007612; GO:0007616; GO:0009267; GO:0010628; GO:0010998; GO:0017148; GO:0019081; GO:0022626; GO:0030968; GO:0032057; GO:0032792; GO:0034198; GO:0034644; GO:0034976; GO:0036492; GO:0043558; GO:0044828; GO:0045665; GO:0045947; GO:0046777; GO:0051607; GO:0060259; GO:0070417; GO:0071074; GO:0071264; GO:0106310; GO:0140469; GO:1900273; GO:1990138; GO:1990611; GO:1990625"
"1459","Pocillopora_acuta_HIv2___RNAseq.g758.t1",0,0,0,0,0,1.16279069767442,0,0,20.5882352941176,NA,2.41678066575467,4.35020519835841,0,NA,NA,NA,NA,NA,NA,9.07749990721811,12.7191778610334,9.25426777814093,12.9533499285784,9.53907551722316,12.8011181018262,12.4609973457113,11.4213369635835,8.2015332238684,10.5100548714747,10.8938411498658,9.49874267800682,12.2889396217248,3358.4593161405,2.5213848731154,0.807327722843834,7.99130349775865e-05,0.000686786772380162,NA,NA,NA,NA,NA
"1460","Pocillopora_acuta_HIv2___RNAseq.g763.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.82778893403375,4.954754005646,5.51983254007951,4.7918870276047,7.16128077648109,4.65791064633771,4.96878174907288,6.7397479573644,9.07599789807544,3.68233641306884,5.93803179477643,7.26492962120684,4.61113396834603,97.7345988190866,-2.95569297577162,1.64826941977381,0.000804509992123635,0.00487349716402162,"O70277",2.65e-20,"Tripartite motif-containing protein 3 (EC 2.3.2.27) (Brain-expressed RING finger protein) (RING finger protein 22)","negative regulation of translation [GO:0017148]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252]","GO:0000209; GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0017148; GO:0030371; GO:0030425; GO:0034141; GO:0042802; GO:0043161; GO:0061630; GO:0070534; GO:0098794; GO:0098978; GO:0140252"
"1461","Pocillopora_acuta_HIv2___RNAseq.g769.t1",0,NA,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.92564232622162,6.84260510118125,7.78960555143337,9.39840120632391,7.05348901017515,9.83877965531544,10.233703779222,8.24102882196059,9.52440214338623,3.68233641306884,8.05299940082884,8.10683357063539,7.99916523102229,431.997216438814,0.130684304738095,0.919739501183183,0.70205180512183,0.864357959591603,"O13046",0,"WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)","","GO:0003677; GO:0005654; GO:0005737"
"1462","Pocillopora_acuta_HIv2___RNAseq.g773.t1",0,NA,NA,0,0,0,2.08333333333333,0,0,NA,0.297619047619048,0,0.694444444444445,NA,NA,NA,NA,NA,NA,11.9260174895568,10.6096022051787,11.6247869483858,9.56829066283521,11.5207283977073,10.169709559239,3.68233641306884,11.3202688858478,11.5789022950432,3.68233641306884,9.56829792699315,11.5941408033082,7.54245505067812,1887.24247736876,-0.664833172442713,1.20863377907331,0.0275984154790699,0.0966311986175907,"Q8NE09",1.76e-15,"Regulator of G-protein signaling 22 (RGS22)","negative regulation of signal transduction [GO:0009968]","GO:0001650; GO:0001965; GO:0005634; GO:0005737; GO:0005829; GO:0009968; GO:0015629"
"1463","Pocillopora_acuta_HIv2___RNAseq.g780.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.84294211329491,6.63867229711208,10.6022951535975,10.2588457181211,10.0061222878786,10.5751162583205,3.68233641306884,10.2766673344905,10.4091475164068,3.68233641306884,8.59744815053597,10.2274348811337,6.96746141993827,874.915518432809,-0.500050211061867,1.10536763517946,0.0206004717175081,0.0759534088508888,"Q6AX60",0,"Protein PTHB1 (Bardet-Biedl syndrome 9 protein homolog) (Parathyroid hormone-responsive B1 gene protein homolog)","","GO:0005737; GO:0005929; GO:0034451; GO:0034464; GO:0060170"
"1464","Pocillopora_acuta_HIv2___RNAseq.g783.t1",NA,0,0,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.13540753184008,6.11705336350933,9.23336603275199,6.15032817604227,3.68233641306884,3.68233641306884,3.68233641306884,3.68233641306884,7.8681118031009,5.49159489725888,4.66287815575162,6.32031163876613,99.5029763098785,0.200300491950644,1.03762914460673,0.0129182961865072,0.0516303498318982,"Q9QYP2",1.34e-31,"Cadherin EGF LAG seven-pass G-type receptor 2 (Multiple epidermal growth factor-like domains protein 3) (Multiple EGF-like domains protein 3)","cerebrospinal fluid secretion [GO:0033326]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dendrite morphogenesis [GO:0048813]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; motor neuron migration [GO:0097475]; neural plate anterior/posterior regionalization [GO:0021999]; regulation of cell-cell adhesion [GO:0022407]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein localization [GO:0032880]; spermatogenesis [GO:0007283]; ventricular system development [GO:0021591]; Wnt signaling pathway [GO:0016055]","GO:0003341; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0006355; GO:0007156; GO:0007283; GO:0016055; GO:0021591; GO:0021999; GO:0022407; GO:0032880; GO:0033326; GO:0048813; GO:0060271; GO:0097475"
"1465","Pocillopora_acuta_HIv2___RNAseq.17885_t",NA,NA,0,0,11.1111111111111,0,0,0,NA,0,1.58730158730159,0,2.77777777777778,NA,NA,NA,NA,NA,NA,11.9670143586842,9.45044034127388,11.5990782349065,10.6357070507529,11.4705405640114,9.90975236225717,6.0123691187043,10.2823173031312,9.87835507531024,8.84774761108544,10.0053322020117,11.0394611072087,8.97120329681474,1565.4831661472,-1.52251649198073,0.923219313028571,0.0115549098960642,0.0469335065253223,NA,NA,NA,NA,NA
"1466","Pocillopora_acuta_HIv2___RNAseq.g795.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.7087080876747,8.13290662201816,8.12245243794858,9.51759871126021,9.63695997539792,9.81664901985577,8.51753520883539,9.10753336965743,3.68233641306884,9.1276464974367,8.63703263431537,8.25159805674949,9.02246721188125,591.319036028991,0.136210787558554,0.894128947516405,0.706525760099718,0.866207781611742,"Q96PB1",0,"N-acetylneuraminate (7)9-O-acetyltransferase (EC 2.3.1.45) (CAS1 domain-containing protein 1) (CAS1 protein) (Cas1p) (Sialate O-acetyltransferase) (SOAT)","carbohydrate metabolic process [GO:0005975]","GO:0000139; GO:0005975; GO:0047186"
"1467","Pocillopora_acuta_HIv2___RNAseq.g800.t1",79.1666666666667,0,41.6666666666667,28.5714285714286,65.2173913043478,19.3181818181818,37.8378378378378,59.2592592592593,21.7391304347826,0,35.2776562559171,25.7776000167305,44.7777124951038,1,79.4642857142857,79.4642857142857,4.99988101252545e-09,4.99988101252545e-09,4.99988101252545e-09,3.68233641306884,6.08712839408766,8.24089458168747,3.68233641306884,7.43812911505959,6.89772912952247,8.34420722057997,8.2783219996615,3.68233641306884,3.68233641306884,6.0015756092874,6.26440370450925,5.73874751406556,115.090405108651,-0.018239078476184,0.969628888159102,0.99078492824858,0.99657031670488,"P08953",1.45e-12,"Protein toll","antifungal innate immune response [GO:0061760]; cell adhesion [GO:0007155]; cell competition in a multicellular organism [GO:0035212]; defense response to Gram-positive bacterium [GO:0050830]; defense response to oomycetes [GO:0002229]; detection of virus [GO:0009597]; dorsal/ventral axis specification [GO:0009950]; heart development [GO:0007507]; innate immune response [GO:0045087]; larval somatic muscle development [GO:0007526]; negative regulation of cell growth [GO:0030308]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of antifungal peptide production [GO:0002804]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of hemocyte proliferation [GO:0035208]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of embryonic pattern specification [GO:1902875]; response to tumor cell [GO:0002347]; response to wounding [GO:0009611]; synapse assembly [GO:0007416]; synaptic target inhibition [GO:0016201]; Toll signaling pathway [GO:0008063]","GO:0002225; GO:0002229; GO:0002347; GO:0002804; GO:0004888; GO:0004896; GO:0005769; GO:0005886; GO:0007155; GO:0007416; GO:0007507; GO:0007526; GO:0008063; GO:0009597; GO:0009611; GO:0009897; GO:0009950; GO:0009986; GO:0016201; GO:0019955; GO:0030308; GO:0032154; GO:0035208; GO:0035212; GO:0038023; GO:0040015; GO:0042802; GO:0045087; GO:0045944; GO:0046627; GO:0046790; GO:0050830; GO:0061760; GO:0061809; GO:0070976; GO:1902875"
"1468","Pocillopora_acuta_HIv2___TS.g4359.t1",3.03030303030303,0,0,21.6216216216216,0,0,0,NA,0,NA,3.08149058149058,5.40540540540541,0.757575757575758,NA,NA,NA,NA,NA,NA,3.68233641306884,9.4548276658549,3.68233641306884,8.0017642298512,3.68233641306884,8.56897397659836,8.71405356980917,7.78277272362825,3.68233641306884,3.68233641306884,6.09340742310861,4.50242367518072,7.68439117103649,185.207155986944,0.416265337497104,1.11685125778525,9.3531692525486e-05,0.000785622764627543,"P13590",1.16e-10,"Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1)","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synaptic membrane adhesion [GO:0099560]","GO:0005886; GO:0007156; GO:0099560"
"1469","Pocillopora_acuta_HIv2___RNAseq.g804.t1",57.5757575757576,0,10.5263157894737,23.0769230769231,26.2295081967213,21.9178082191781,44.4444444444444,100,NA,NA,35.4713446628123,36.2486828240253,34.6940065015993,NA,NA,NA,NA,NA,NA,4.5939750356694,8.66733703951336,3.68233641306884,6.47183417987439,4.93003625965001,7.6243395295462,8.0131585029338,7.80263062623775,3.68233641306884,3.68233641306884,5.91503204126314,4.93826294953897,6.89180113298732,106.585860403258,0.999502007543431,1.62414202164765,0.00848447977672688,0.0362968102604489,"A2ASS6",2.09e-09,"Titin (EC 2.7.11.1) (Connectin)","adult heart development [GO:0007512]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of relaxation of cardiac muscle [GO:1901897]; sarcomere organization [GO:0045214]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591]","GO:0001701; GO:0001756; GO:0003007; GO:0004674; GO:0004713; GO:0005200; GO:0005516; GO:0005524; GO:0005634; GO:0005859; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0021591; GO:0030017; GO:0030018; GO:0030506; GO:0031430; GO:0031672; GO:0031674; GO:0035995; GO:0043056; GO:0045214; GO:0046872; GO:0048738; GO:0055002; GO:0055003; GO:0055008; GO:0060419; GO:0106310; GO:1901897"
"1470","Pocillopora_acuta_HIv2___RNAseq.g809.t1",0,0,NA,0,11.1111111111111,0,0,NA,NA,1.42857142857143,1.79138321995465,0,3.13492063492063,NA,NA,NA,NA,NA,NA,10.3867460258848,10.9293790326978,9.93391864454255,9.67270260293903,9.75445034317874,11.0928332270176,10.2925815370269,10.1951520311791,10.1482935425103,6.56351623590136,9.89695732228782,10.0837121174591,9.71020252711654,1153.33802961703,-0.103589180858148,0.727926181777683,0.807989811722094,0.91985958908904,"P05455",2.67e-89,"Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B)","histone mRNA metabolic process [GO:0008334]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; positive regulation of translation [GO:0045727]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]","GO:0000049; GO:0000781; GO:0001682; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006400; GO:0006409; GO:0008033; GO:0008266; GO:0008334; GO:0010494; GO:0042780; GO:0045727; GO:0071045; GO:0075522; GO:1903608; GO:1990825; GO:1990904"
"1471","Pocillopora_acuta_HIv2___RNAseq.g815.t1",0,0,NA,0,0,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,8.45571527498275,7.83530183461159,9.17848805228091,10.4821354211709,8.17213702136549,3.68233641306884,9.84979738652842,8.8597440704686,9.16490822195571,10.3247019523716,8.60052656488048,8.76619852821069,8.43485460155027,589.349114351695,-0.000688828896459809,0.863152031901277,0.971718673644239,0.99090093736536,"Q15542",0,"Transcription initiation factor TFIID subunit 5 (Transcription initiation factor TFIID 100 kDa subunit) (TAF(II)100) (TAFII-100) (TAFII100)","DNA-templated transcription initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation at RNA polymerase II promoter [GO:0006367]","GO:0000785; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006352; GO:0006357; GO:0006367; GO:0015629; GO:0016251; GO:0033276; GO:0042789; GO:0042802; GO:0045893; GO:0051123; GO:0060261"
"1472","Pocillopora_acuta_HIv2___RNAseq.g820.t1",0,1.78571428571429,NA,0,0,0,0,NA,0,1.5625,0.418526785714286,0.446428571428571,0.390625,NA,NA,NA,NA,NA,NA,9.25281011275677,8.95449335454389,7.50528764594476,3.68233641306884,7.11438186546373,6.73992398508141,8.49151799840897,4.37784214571138,9.6181252701695,3.68233641306884,6.94190552042181,7.57368940800923,6.31012163283439,250.72889088946,-0.176959564442088,0.981917228998486,0.306257237446732,0.554851114368444,"Q96EZ8",1.36e-139,"Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2)","chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein modification process [GO:0036211]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]","GO:0000123; GO:0000723; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0008266; GO:0010521; GO:0030425; GO:0031011; GO:0033044; GO:0034046; GO:0036211; GO:0043204; GO:0044545; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0051726; GO:0051974; GO:0060382; GO:0071339; GO:1904357; GO:1904507; GO:1904751"
"1473","Pocillopora_acuta_HIv2___RNAseq.g821.t1",0,NA,0,0,0,0,11.1111111111111,NA,0,NA,1.58730158730159,0,2.77777777777778,NA,NA,NA,NA,NA,NA,9.52780354200312,9.38757325024469,10.8089982105771,10.1444068470491,11.2962456427827,10.2738818489705,10.3575669025636,10.8689606836303,10.2110195827546,11.5716879022269,10.4448144412803,10.5426055323496,10.347023350211,1524.26074533802,-0.143684904141682,0.586069970226734,0.743303710439003,0.886473026697702,"Q9NRC6",0,"Spectrin beta chain, non-erythrocytic 5 (Beta-V spectrin)","actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041]","GO:0002046; GO:0003779; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0007030; GO:0007041; GO:0008091; GO:0016020; GO:0019894; GO:0030036; GO:0030054; GO:0030507; GO:0030864; GO:0032029; GO:0032391; GO:0034452; GO:0042802; GO:0042995; GO:0045179; GO:0045505; GO:0051015; GO:0051693; GO:0097381"
"1474","Pocillopora_acuta_HIv2___TS.g4383.t2",0,NA,18.1818181818182,36.8421052631579,0,27.0833333333333,36.3636363636364,NA,0,NA,16.9244133059923,21.3084795321637,13.6363636363636,NA,NA,NA,NA,NA,NA,8.4809303886018,7.56904202048958,10.8875582271572,3.68233641306884,9.60471389524798,9.94077684233322,10.0455835692342,9.24557709905535,11.1038695305923,3.68233641306884,8.42427243988493,9.86452982813093,6.98401505163894,786.468326956727,-0.278963349552802,0.989140662537743,0.200024404137984,0.423161179091969,"Q8BW94",0,"Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3)","cilium movement involved in cell motility [GO:0060294]","GO:0005524; GO:0005874; GO:0008569; GO:0016887; GO:0030286; GO:0036156; GO:0045505; GO:0051959; GO:0060294; GO:0097729"
"1475","Pocillopora_acuta_HIv2___TS.g4404.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.1572797975657,4.5861709679923,8.56387194917703,4.89684440866119,9.77277967313263,3.68233641306884,7.16145990783134,3.68233641306884,5.43369409583605,5.86191100394028,4.8018296221245,6.92199238575605,147.554993204648,0.547119968289481,1.24118875534411,0.000919700751875322,0.005465304714513,NA,NA,NA,NA,NA
"1476","Pocillopora_acuta_HIv2___TS.g4421.t1",0.353356890459364,2,1.36363636363636,0.613496932515337,0.239234449760766,0.529450694904037,0.827966881324747,0.540540540540541,0.583090379008746,NA,0.783419236905545,0.853315709393732,0.69604864629531,NA,NA,NA,NA,NA,NA,9.10322592755727,9.59855259577554,9.6816021235649,8.0017642298512,9.09823569548282,9.62619799283828,7.95079023411305,9.09474084660914,8.3607426458759,8.67276960055201,8.91886218922201,9.06770944781801,8.77001493062602,501.908078807561,-0.188521136226044,0.620888416646305,0.678343895691695,0.850843224386686,"Q9BYW2",1.94e-43,"Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2) (hSET2) (p231HBP)","angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of autophagy [GO:0010508]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of ossification [GO:0045778]; regulation of cytokinesis [GO:0032465]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; response to alkaloid [GO:0043279]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation by RNA polymerase II [GO:0006368]","GO:0001525; GO:0001763; GO:0001843; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006298; GO:0006355; GO:0006368; GO:0010038; GO:0010468; GO:0010508; GO:0010569; GO:0010793; GO:0014070; GO:0016279; GO:0018023; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0043279; GO:0045778; GO:0046872; GO:0046975; GO:0048332; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0140938; GO:0140955; GO:1902850; GO:1905634"
"1477","Pocillopora_acuta_HIv2___RNAseq.g861.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.27463595648141,3.68233641306884,5.85239579733235,3.68233641306884,5.90231870585895,6.76358212736915,3.68233641306884,3.68233641306884,7.8434762799534,3.68233641306884,5.10480909323395,5.91103263053899,4.2985855559289,41.4930651293096,-0.295154022903338,1.06017148041843,0.0147702454706676,0.0578334679176329,"Q6AZW2",1.24e-89,"Aldo-keto reductase family 1 member A1-A (Alcohol dehydrogenase [NADP(+)] A) (EC 1.1.1.2) (Aldehyde reductase-A) (S-nitroso-CoA reductase) (ScorR) (EC 1.6.-.-)","aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; glucose homeostasis [GO:0042593]; sprouting angiogenesis [GO:0002040]","GO:0002040; GO:0004032; GO:0005829; GO:0016324; GO:0042593; GO:0046185; GO:0110095; GO:0160163"
"1478","Pocillopora_acuta_HIv2___TS.g4427.t1",0,NA,85.7142857142857,100,0,53.5714285714286,60,33.3333333333333,0,NA,41.5773809523809,46.7261904761905,36.4285714285714,NA,NA,NA,NA,NA,NA,8.2320624332994,7.20003870083844,8.6574901205839,7.94270546705381,8.58470087504098,9.85651404028125,3.68233641306884,8.52016024963916,8.90128195642838,3.68233641306884,7.5259626669303,8.57913912699836,6.47278620686224,305.25427961062,-0.399785468901506,1.02665670348787,0.109191170356476,0.278789247667445,"Q9BYW2",1.17e-35,"Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2) (hSET2) (p231HBP)","angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of autophagy [GO:0010508]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of ossification [GO:0045778]; regulation of cytokinesis [GO:0032465]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; response to alkaloid [GO:0043279]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation by RNA polymerase II [GO:0006368]","GO:0001525; GO:0001763; GO:0001843; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006298; GO:0006355; GO:0006368; GO:0010038; GO:0010468; GO:0010508; GO:0010569; GO:0010793; GO:0014070; GO:0016279; GO:0018023; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0043279; GO:0045778; GO:0046872; GO:0046975; GO:0048332; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0140938; GO:0140955; GO:1902850; GO:1905634"
"1479","Pocillopora_acuta_HIv2___RNAseq.g867.t4",0,3.8961038961039,0,0,1.41843971631206,1.68067226890756,0,0,9.52380952380952,0,1.6519025405133,3.0201171377642,0.283687943262411,NA,NA,NA,NA,NA,NA,11.3389172459934,6.4723009311231,12.0870815256912,11.3369455153538,11.274264457318,10.4186405396332,3.68233641306884,11.9356826445453,11.6398994001884,3.68233641306884,9.38684050859841,11.6551690547473,7.11851196244956,2036.78388884006,-0.674672432994504,1.25162819133103,0.00182943044452306,0.00985507707619423,"P10894",0,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-beta-1) (PLC-beta-1)","G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; memory [GO:0007613]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; release of sequestered calcium ion into cytosol [GO:0051209]","GO:0004435; GO:0005509; GO:0005516; GO:0005737; GO:0005829; GO:0007186; GO:0007613; GO:0016042; GO:0016607; GO:0031965; GO:0046488; GO:0048015; GO:0051209"
"1480","Pocillopora_acuta_HIv2___RNAseq.g871.t1",1.05820105820106,0,0,8.51063829787234,3.84615384615385,4.25531914893617,7.40740740740741,0,1.52671755725191,NA,2.95604859064697,2.85853500081208,3.07794057794058,NA,NA,NA,NA,NA,NA,9.23599669296538,7.86865771480162,7.6518206655359,10.8933296641357,8.80958046944986,9.73197499492653,12.5510260897518,9.3965157888877,8.60852267251487,3.68233641306884,8.84297611660382,8.74048725787074,8.9454649753369,1107.64389936107,0.140300326265418,0.927483624684751,0.692928912066725,0.85904909672647,"Q15147",0,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-4) (Phospholipase C-beta-4) (PLC-beta-4)","G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating endothelin receptor signaling pathway [GO:0160135]; release of sequestered calcium ion into cytosol [GO:0051209]","GO:0004435; GO:0004629; GO:0005509; GO:0005829; GO:0005886; GO:0007186; GO:0016042; GO:0046488; GO:0048015; GO:0051209; GO:0160135"
"1481","Pocillopora_acuta_HIv2___RNAseq.g874.t1",0,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,4.79011450555827,7.670995659781,6.73712889964964,3.68233641306884,6.62825944060524,7.22892834819183,8.33447953584917,7.54867945930727,6.92040066231401,3.68233641306884,6.32236593373941,6.52491659348689,6.11981527399194,102.665727323778,-0.0735364380317123,0.958221573418788,0.642131037695766,0.828253434138378,NA,NA,NA,NA,NA
"1482","Pocillopora_acuta_HIv2___TS.g4435.t1",32,0,NA,0,44.1860465116279,2.85714285714286,17.2413793103448,NA,12.5,0,13.5980710848894,3.83928571428571,23.3568564554932,1,56.5217391304348,56.5217391304348,0.00573619721043529,0.00573619721043529,0.00573619721043529,10.2882830075676,10.0022676006658,10.4356641298345,9.24696215526144,10.1435026277827,9.35004329185677,9.43144170330301,6.60881604930705,7.7718154974796,3.68233641306884,8.69611324761273,9.04961626239429,8.34261023283117,683.16844162104,-0.228930540726129,0.890247265023322,0.509245949208776,0.736573340935573,"Q7RTR2",3.5e-40,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223"
"1483","Pocillopora_acuta_HIv2___RNAseq.g876.t1",0,0,23.0769230769231,4.89510489510489,6.5359477124183,5.68181818181818,3.2258064516129,1.04166666666667,0,NA,4.939696331616,2.32371794871795,8.20966931023857,NA,NA,NA,NA,NA,NA,10.5228812781129,10.2620942959526,9.60512133972004,9.85949334258542,9.65434186196239,9.0371544164843,6.89653683871883,9.11388729818905,11.1991540724883,7.45858994505755,9.36092546892714,10.0190771700945,8.70277376775974,868.561154290426,-0.76974370673222,0.829391808770533,0.126186127888887,0.309570276440494,"Q28G87",6.54e-51,"La-related protein 7 (La ribonucleoprotein domain family member 7)","box C/D sno(s)RNA 3'-end processing [GO:0000494]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U6 2'-O-snRNA methylation [GO:1990438]","GO:0000494; GO:0005634; GO:0005654; GO:0006397; GO:0007283; GO:0008380; GO:0017070; GO:0030154; GO:0048024; GO:0097322; GO:1904871; GO:1905382; GO:1990438; GO:1990904"
"1484","Pocillopora_acuta_HIv2___RNAseq.g885.t1",0,NA,NA,0,0,0,NA,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,7.15852236535678,9.8917508811719,7.28079550540564,7.62949510756941,5.3992335514363,8.34735281558066,3.68233641306884,8.91901122257894,3.68233641306884,3.68233641306884,6.56731706883062,6.4879798115693,6.64665432609193,212.654786991019,0.125687425955715,0.973867607413091,0.555130603353668,0.769960936565513,NA,NA,NA,NA,NA
"1485","Pocillopora_acuta_HIv2___RNAseq.g899.t2",0,0,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.1106635249423,10.0494374675554,10.6174003066377,9.68673508505278,8.87387163126569,11.3147886775587,11.2948558081877,9.02733514890453,9.81837258898811,7.44497709434963,9.82384373334425,9.68952864014767,9.95815882654084,1143.3993251679,0.130021777716709,0.767977078713972,0.780742881642456,0.906313406105656,"Q9Y2I7",1.46e-143,"1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1)","1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0012506; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031410; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043813; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:0106310; GO:1903100; GO:1903426; GO:1904562; GO:2000785"
"1486","Pocillopora_acuta_HIv2___RNAseq.g930.t1",0,0,NA,0,10,0,0,NA,NA,NA,1.66666666666667,0,3.33333333333333,NA,NA,NA,NA,NA,NA,10.0614251692564,9.17797968831809,9.1390497414879,10.2426551798511,9.09374448295069,7.4619492718124,8.40588239640505,8.70836549291351,3.68233641306884,10.2012640304251,8.61746518664891,8.13698425993547,9.09794611336235,585.261963238793,0.0937105913530777,0.885420895208262,0.810853466418945,0.921158069296546,"Q5ZIP4",0,"5'-3' exoribonuclease 2 (EC 3.1.13.-)","mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process [GO:0000956]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]","GO:0000956; GO:0001147; GO:0003723; GO:0004534; GO:0005634; GO:0005654; GO:0005730; GO:0006369; GO:0006397; GO:0007283; GO:0008409; GO:0016235; GO:0042802; GO:0046872"
"1487","Pocillopora_acuta_HIv2___RNAseq.g932.t1",NA,NA,100,50,100,100,100,NA,100,NA,91.6666666666667,83.3333333333333,100,NA,NA,NA,NA,NA,NA,9.11706711288888,7.80115133184057,9.47091148992293,9.08984740627795,8.41974160401277,8.70782435704477,6.40572683292009,9.38342879926144,3.68233641306884,6.81941263111671,7.88974479783549,8.01469708383097,7.76479251184002,343.403482009314,-0.0810508539289505,0.875245408761419,0.826260278484516,0.929607083696332,"Q5ZIP4",4.41e-105,"5'-3' exoribonuclease 2 (EC 3.1.13.-)","mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process [GO:0000956]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]","GO:0000956; GO:0001147; GO:0003723; GO:0004534; GO:0005634; GO:0005654; GO:0005730; GO:0006369; GO:0006397; GO:0007283; GO:0008409; GO:0016235; GO:0042802; GO:0046872"
"1488","Pocillopora_acuta_HIv2___TS.g4500.t2",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.7768326555933,8.25887125628039,9.05071967176477,10.7782396895718,8.8773605998122,9.57931582229337,11.3098033664791,10.4485729741405,3.68233641306884,9.07584819219609,8.98379006412004,8.16716446287592,9.80041566536415,851.36753134238,0.493589485230036,0.950023406789503,0.25635352761836,0.498105510944649,"Q9JJZ8",4.2e-149,"Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3) (Gustatory cyclic nucleotide-gated cation channel) (CNGgust)","inorganic cation import across plasma membrane [GO:0098659]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic ion transmembrane transport [GO:0034220]; response to cAMP [GO:0051591]; response to magnesium ion [GO:0032026]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; visual perception [GO:0007601]","GO:0001750; GO:0005221; GO:0005222; GO:0005223; GO:0005262; GO:0005272; GO:0005886; GO:0007601; GO:0017022; GO:0017071; GO:0030425; GO:0030553; GO:0032026; GO:0034220; GO:0043025; GO:0043194; GO:0043204; GO:0044877; GO:0045296; GO:0046549; GO:0051591; GO:0060041; GO:0097386; GO:0098655; GO:0098659; GO:0120199"
"1489","Pocillopora_acuta_HIv2___RNAseq.g938.t1",0,NA,NA,0,NA,0,11.1111111111111,12.5,3.84615384615385,0,3.92246642246642,4.08653846153846,3.7037037037037,NA,NA,NA,NA,NA,NA,3.68233641306884,9.23010749922258,3.68233641306884,10.9384205734352,3.68233641306884,12.1461112623502,11.4653067838243,9.02733514890453,3.68233641306884,3.68233641306884,7.1218963333081,4.75133616023598,9.49245650638022,1031.71969072538,0.470439473940588,1.16426745577085,6.0931545529181e-06,7.45612415003446e-05,"P42586",4.58e-40,"Homeobox protein Nkx-2.2 (Homeobox protein NK-2 homolog B)","astrocyte differentiation [GO:0048708]; cell development [GO:0048468]; cell differentiation [GO:0030154]; digestive tract development [GO:0048565]; endocrine pancreas development [GO:0031018]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuron fate specification [GO:0048665]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; optic nerve development [GO:0021554]; pancreatic A cell fate commitment [GO:0003326]; pancreatic PP cell fate commitment [GO:0003329]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell differentiation [GO:0003309]; type B pancreatic cell fate commitment [GO:0003327]; ventral spinal cord interneuron fate determination [GO:0060580]","GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003309; GO:0003323; GO:0003326; GO:0003327; GO:0003329; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007224; GO:0007399; GO:0009749; GO:0010628; GO:0014003; GO:0021522; GO:0021529; GO:0021530; GO:0021554; GO:0030154; GO:0030182; GO:0030858; GO:0031018; GO:0032570; GO:0043565; GO:0045665; GO:0045666; GO:0045944; GO:0048468; GO:0048565; GO:0048665; GO:0048708; GO:0048709; GO:0048714; GO:0060580; GO:0061101"
"1490","Pocillopora_acuta_HIv2___TS.g4508.t5",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.25760738373578,9.9581450851561,5.38589367603326,3.68233641306884,9.3723688690179,7.94913853085304,6.22323459566748,9.90042593084862,3.68233641306884,3.68233641306884,6.60938233105187,6.91972645454088,6.29903820756286,288.319110454741,-0.347657083711384,1.03733040456421,0.27433471148873,0.519261595483308,"Q61851",8.16e-11,"Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Heparin-binding growth factor receptor) (CD antigen CD333)","alveolar secondary septum development [GO:0061144]; astrocyte differentiation [GO:0048708]; axonogenesis involved in innervation [GO:0060385]; bone development [GO:0060348]; bone maturation [GO:0070977]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; bone trabecula morphogenesis [GO:0061430]; calcium ion homeostasis [GO:0055074]; cartilage development [GO:0051216]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; central nervous system myelination [GO:0022010]; cochlea development [GO:0090102]; digestive tract morphogenesis [GO:0048546]; endothelial cell proliferation [GO:0001935]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; lens fiber cell development [GO:0070307]; lens morphogenesis in camera-type eye [GO:0002089]; MAPK cascade [GO:0000165]; mitotic nuclear division [GO:0140014]; morphogenesis of an epithelium [GO:0002009]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of developmental growth [GO:0048640]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of gene expression [GO:0010629]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast proliferation [GO:0007405]; neuroepithelial cell differentiation [GO:0060563]; neuron apoptotic process [GO:0051402]; oligodendrocyte development [GO:0014003]; p38MAPK cascade [GO:0038066]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; post-anal tail morphogenesis [GO:0036342]; protein ubiquitination [GO:0016567]; regulation of bone remodeling [GO:0046850]; regulation of collagen metabolic process [GO:0010712]; regulation of ossification [GO:0030278]; regulation of osteoclast differentiation [GO:0045670]; response to axon injury [GO:0048678]; response to sodium phosphate [GO:1904383]; somatic stem cell population maintenance [GO:0035019]; substantia nigra development [GO:0021762]","GO:0000122; GO:0000165; GO:0001935; GO:0001938; GO:0002009; GO:0002089; GO:0004713; GO:0005007; GO:0005524; GO:0005764; GO:0005783; GO:0005886; GO:0007267; GO:0007405; GO:0007406; GO:0008283; GO:0008284; GO:0008285; GO:0008543; GO:0009898; GO:0009986; GO:0010518; GO:0010629; GO:0010712; GO:0014003; GO:0016567; GO:0017134; GO:0021762; GO:0022010; GO:0030278; GO:0030282; GO:0030501; GO:0030900; GO:0031398; GO:0031410; GO:0035019; GO:0035198; GO:0036342; GO:0038066; GO:0042491; GO:0042531; GO:0043235; GO:0043410; GO:0043525; GO:0045597; GO:0045608; GO:0045670; GO:0045839; GO:0045879; GO:0046850; GO:0048471; GO:0048546; GO:0048640; GO:0048678; GO:0048708; GO:0048712; GO:0048839; GO:0050673; GO:0050680; GO:0050731; GO:0051216; GO:0051402; GO:0051897; GO:0055074; GO:0060348; GO:0060349; GO:0060385; GO:0060563; GO:0061144; GO:0061430; GO:0070307; GO:0070371; GO:0070374; GO:0070977; GO:0071864; GO:0072148; GO:0090080; GO:0090102; GO:0090263; GO:0140014; GO:1902178; GO:1904383"
"1491","Pocillopora_acuta_HIv2___RNAseq.g957.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,8.75893970845155,8.366685476763,4.2857336656916,7.96768678089113,8.28010730107237,10.1024950653837,6.93399994628221,3.68233641306884,3.68233641306884,6.57426571837421,6.1266090060148,7.02192243073361,239.794704258093,0.18408879868931,0.9990269897309,0.438045134381324,0.681163913831888,"Q5F478",1.59e-27,"Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44)","",""
"1492","Pocillopora_acuta_HIv2___TS.g4549.t1",0,0,0,NA,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.06571859090574,6.94709464914545,9.18587927859679,10.1195013191381,8.38827354634219,10.0479564866981,11.1910399052278,10.9990241902164,3.68233641306884,8.46685343608961,8.7093677815429,8.06424640382599,9.35448915925981,799.079333177211,0.389079428887655,0.920312734923287,0.3440459912596,0.595177755959676,"Q80UJ7",0,"Rab3 GTPase-activating protein catalytic subunit (RAB3 GTPase-activating protein 130 kDa subunit) (Rab3-GAP p130) (Rab3-GAP)","establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; protein stabilization [GO:0050821]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of Rab protein signal transduction [GO:0032483]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; synaptic vesicle transport [GO:0048489]","GO:0005096; GO:0005737; GO:0010628; GO:0010807; GO:0031267; GO:0032483; GO:0032991; GO:0034389; GO:0043547; GO:0048172; GO:0048489; GO:0050821; GO:0060076; GO:0060079; GO:0061646; GO:0071782; GO:0097051; GO:0098794; GO:1903061; GO:1903233; GO:1903373; GO:2000786"
"1493","Pocillopora_acuta_HIv2___RNAseq.g993.t1",0.956937799043062,0,0.638977635782748,0.818330605564648,0.824499411071849,0.896860986547085,1.11336032388664,1.68776371308017,0.190839694656489,0,0.712757016963269,0.718758999969678,0.70675503395686,NA,NA,NA,NA,NA,NA,11.6033495570606,8.33233862556014,12.20334711241,8.69273090564006,11.1005737108839,3.68233641306884,3.68233641306884,12.8895718556757,11.5211644902011,3.68233641306884,8.7390085496638,11.8636013452463,5.61441575408134,2110.82545169326,-4.03712903750274,5.67440725139538,2.62771892504579e-09,9.20274250166158e-08,"P09917",2.26e-47,"Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34)","arachidonic acid metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426]","GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016525; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301"
"1494","Pocillopora_acuta_HIv2___RNAseq.g994.t1",0,NA,0,0,1.19047619047619,0,0,0,0,NA,0.148809523809524,0,0.297619047619048,NA,NA,NA,NA,NA,NA,10.4744438850929,6.86946281647337,11.0205597814703,7.52579662532212,9.95258281340783,3.68233641306884,3.68233641306884,12.170279770347,10.7698744631722,3.68233641306884,7.98300093944922,10.877548142698,5.0884537362004,1097.04685468941,-5.87548615787894,4.79616469881936,8.84907036962979e-09,2.60148280134807e-07,"P09917",1.46e-46,"Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34)","arachidonic acid metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426]","GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016525; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301"
"1495","Pocillopora_acuta_HIv2___RNAseq.g1008.t1",0,0,0,0,NA,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.99993815660658,3.68233641306884,8.09125087353016,8.53754183487098,9.93846429273508,9.20846260235005,3.68233641306884,8.92625107149489,3.68233641306884,3.68233641306884,6.84312544838631,7.92764816148711,5.75860273528551,306.369671769205,-0.27704380233215,1.02384309206966,0.279075422733011,0.524525898686191,"Q6NRT6",0,"DnaJ homolog subfamily C member 10 (EC 1.8.4.-)","ERAD pathway [GO:0036503]; protein folding in endoplasmic reticulum [GO:0034975]","GO:0005788; GO:0015035; GO:0016671; GO:0034975; GO:0036503"
"1496","Pocillopora_acuta_HIv2___RNAseq.g1018.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.63587938650108,3.68233641306884,10.6578099089562,3.68233641306884,8.47838834006635,3.68233641306884,3.68233641306884,6.83634004906966,8.60852267251487,3.68233641306884,6.26286224224524,8.84338807142163,3.68233641306884,314.664717169831,-13.1724224363217,3.7988285101334,4.03711449927477e-11,2.80734731334184e-09,"Q0VA40",2.36e-89,"Transcription factor Sp9","","GO:0003677; GO:0005634; GO:0046872"
"1497","Pocillopora_acuta_HIv2___RNAseq.g1020.t1",0,NA,0,0,NA,2.63157894736842,0,0,NA,NA,0.43859649122807,0.87719298245614,0,NA,NA,NA,NA,NA,NA,6.15070113667054,10.6407355798853,9.88822342216718,6.2462771951713,9.62352511395515,10.538405007625,10.5947263555771,9.84518748203157,3.68233641306884,7.53764925099809,8.47477669571501,7.83799471357866,9.11155867785136,739.441084056737,0.403545686593272,1.01025096418341,0.164791933872764,0.370576886121837,"Q9NTK5",0,"Obg-like ATPase 1 (DNA damage-regulated overexpressed in cancer 45) (DOC45) (GTP-binding protein 9)","ATP metabolic process [GO:0046034]","GO:0005524; GO:0005525; GO:0005576; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0016020; GO:0016887; GO:0031093; GO:0043023; GO:0045296; GO:0046034; GO:0046872; GO:0070062"
"1498","Pocillopora_acuta_HIv2___RNAseq.g1039.t1",0,0,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.07520399501629,3.68233641306884,6.67451956276615,8.59399377233369,7.43812911505959,8.0712639202594,4.27277361158612,7.9874069688121,7.54029722811113,8.76291441208491,7.00988389990982,7.34311137395305,6.67665642586659,174.36380743707,-0.133508532177059,0.938309666930978,0.560069746349185,0.773521073027609,NA,NA,NA,NA,NA
"1499","Pocillopora_acuta_HIv2___RNAseq.g1040.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.88328018451953,9.42606845816916,9.80189558249984,9.81273139204407,8.8686222828428,9.96361492864384,7.80321753215623,8.86163355661156,10.2341580216316,7.10694600864365,9.07621679477623,9.32991792562107,8.82251566393139,619.59827425321,-0.228690114585589,0.719370062306866,0.605081225111042,0.803793391691069,"E9Q5F9",2.3e-06,"Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2)","angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of autophagy [GO:0010508]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of ossification [GO:0045778]; regulation of cytokinesis [GO:0032465]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; response to alkaloid [GO:0043279]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation by RNA polymerase II [GO:0006368]; vasculogenesis [GO:0001570]","GO:0001525; GO:0001570; GO:0001763; GO:0001843; GO:0005634; GO:0005694; GO:0006298; GO:0006355; GO:0006368; GO:0010038; GO:0010468; GO:0010508; GO:0010569; GO:0010793; GO:0014070; GO:0016279; GO:0018023; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0043279; GO:0045778; GO:0046872; GO:0046975; GO:0048332; GO:0048568; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0140955; GO:1902850; GO:1905634"
"1500","Pocillopora_acuta_HIv2___RNAseq.g1045.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.89223359574533,8.45580461001357,8.66808980443327,8.13079615140025,8.48983620475166,9.12984817307264,8.05525808108825,7.70046851692625,7.45118772687036,6.9608997877233,7.99344226520249,7.84036316974537,8.1465213606596,260.078509581912,0.220238207636596,0.610247219923567,0.645746772782094,0.830524748490149,"Q9BYW2",1.71e-23,"Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2) (hSET2) (p231HBP)","angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of autophagy [GO:0010508]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of ossification [GO:0045778]; regulation of cytokinesis [GO:0032465]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; response to alkaloid [GO:0043279]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation by RNA polymerase II [GO:0006368]","GO:0001525; GO:0001763; GO:0001843; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006298; GO:0006355; GO:0006368; GO:0010038; GO:0010468; GO:0010508; GO:0010569; GO:0010793; GO:0014070; GO:0016279; GO:0018023; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0043279; GO:0045778; GO:0046872; GO:0046975; GO:0048332; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0140938; GO:0140955; GO:1902850; GO:1905634"
"1501","Pocillopora_acuta_HIv2___RNAseq.g1054.t1",0,NA,NA,0,0,0,0,NA,50,NA,8.33333333333333,16.6666666666667,0,NA,NA,NA,NA,NA,NA,8.98743292666405,8.7835777607105,9.0728166383295,8.0335541792819,8.32830568999878,9.5544547891103,7.69311517621351,8.61957189691283,9.25819063713358,5.96509637913949,8.42961160734944,8.85326355780775,8.00595965689114,384.692485955499,-0.472640500582464,0.773375375941121,0.31374234412762,0.563233122187154,"E9Q5F9",9.83e-38,"Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2)","angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of autophagy [GO:0010508]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of ossification [GO:0045778]; regulation of cytokinesis [GO:0032465]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; response to alkaloid [GO:0043279]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation by RNA polymerase II [GO:0006368]; vasculogenesis [GO:0001570]","GO:0001525; GO:0001570; GO:0001763; GO:0001843; GO:0005634; GO:0005694; GO:0006298; GO:0006355; GO:0006368; GO:0010038; GO:0010468; GO:0010508; GO:0010569; GO:0010793; GO:0014070; GO:0016279; GO:0018023; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0043279; GO:0045778; GO:0046872; GO:0046975; GO:0048332; GO:0048568; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0140955; GO:1902850; GO:1905634"
"1502","Pocillopora_acuta_HIv2___TS.g4646.t1",0,NA,0,0,NA,0,11.1111111111111,0,0,NA,1.58730158730159,0,3.7037037037037,NA,NA,NA,NA,NA,NA,11.7163374060217,11.5534717535546,12.2341831224697,11.8966002728994,12.7471995984909,11.8977184699705,13.2343783385055,12.3123447411238,12.8394102301292,13.3173422140362,12.3748986147202,12.3698950196471,12.3799022097932,5769.53634074588,0.00770026292598212,0.542387308553802,0.989660193508985,0.996407478451293,"Q28EW0",1.54e-146,"Transmembrane protein 87A (Elkin1)","cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]","GO:0000139; GO:0005886; GO:0032580; GO:0050976; GO:0071260"
"1503","Pocillopora_acuta_HIv2___RNAseq.g1091.t1",11.6279069767442,NA,0,0,0,0,0,NA,8.33333333333333,NA,2.8516057585825,2.77777777777778,2.90697674418605,NA,NA,NA,NA,NA,NA,6.05466314442104,7.8947948031256,6.19479753228254,5.80116198083551,5.99913827937875,3.68233641306884,5.63253479849075,7.17988199284164,7.5245035367715,3.68233641306884,5.9646148894285,6.59059689713909,5.33863288171791,68.7070221735655,-0.443077884953913,1.05575342652807,0.0770921077821122,0.216769099331351,"P16066",0,"Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A)","blood vessel diameter maintenance [GO:0097746]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114]","GO:0001653; GO:0004016; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016525; GO:0016941; GO:0017046; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620"
"1504","Pocillopora_acuta_HIv2___RNAseq.g1109.t2",0,0,3.44827586206897,8.33333333333333,14.2857142857143,0,0,0,0,NA,2.89636927567962,1.66666666666667,4.43349753694581,NA,NA,NA,NA,NA,NA,8.14454448327006,8.81122891607137,8.24089458168747,3.68233641306884,9.2646292200546,3.68233641306884,4.60654391542428,7.38412583434139,9.55954292947827,3.68233641306884,6.7058519119534,8.51874740976636,4.89295641414043,242.578253147326,-0.884431350712597,1.61390031976728,2.4396490919389e-06,3.39625452028915e-05,"Q6QNK2",3.35e-09,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0016607"
"1505","Pocillopora_acuta_HIv2___RNAseq.g30303.t2",NA,0,0,NA,NA,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,10.3771967325818,6.74434409930028,9.34948227176697,8.2970869323733,8.83312908347376,9.27694291822544,6.64888280067412,8.98115942097522,8.51605868541514,10.6120274837574,8.76363104285434,9.21140523884258,8.31585684686611,576.622196746181,-0.4339542730806,0.856886158056443,0.300827353396083,0.549086807978501,"Q5U249",2.56e-171,"Protein ELYS (Protein MEL-28) (xELYS)","mRNA transport [GO:0051028]; protein transport [GO:0015031]","GO:0003677; GO:0005643; GO:0005654; GO:0005737; GO:0015031; GO:0051028"
"1506","Pocillopora_acuta_HIv2___RNAseq.g30304.t2",1.26582278481013,0,NA,NA,2.53164556962025,0.961538461538462,0,0,0,0,0.594875851996105,0.240384615384615,0.949367088607595,NA,NA,NA,NA,NA,NA,7.97725293850525,12.5388200549313,5.72956178137413,10.6480523160379,3.68233641306884,12.3748508907764,13.1100268046164,6.66266950447494,10.1799975226171,11.0734474626853,9.39770156890876,6.84636363200805,11.9490395058095,2520.38767280819,4.3163272801789,2.36273966012624,5.56644747586354e-05,0.000501014911579902,"D9IQ16",4.06e-39,"Galaxin","","GO:0005576"
"1507","Pocillopora_acuta_HIv2___RNAseq.g30369.t1",0,NA,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.47196031329338,8.26388760970949,7.81850451703104,3.68233641306884,6.64499589542844,8.54559492130511,3.68233641306884,7.88687806037457,8.57835652673245,3.68233641306884,6.6257187083081,7.68013906257198,5.57129835404422,162.901594184823,-0.287483478718266,1.03911430712724,0.000167270311375628,0.00127672706265809,"O76075",1.1e-53,"DNA fragmentation factor subunit beta (EC 3.-.-.-) (Caspase-activated deoxyribonuclease) (CAD) (Caspase-activated DNase) (Caspase-activated nuclease) (CPAN) (DNA fragmentation factor 40 kDa subunit) (DFF-40)","apoptotic chromosome condensation [GO:0030263]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308]; negative regulation of apoptotic DNA fragmentation [GO:1902511]","GO:0000785; GO:0003677; GO:0004520; GO:0004536; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006308; GO:0006309; GO:0019899; GO:0019904; GO:0030263; GO:0032991; GO:0042802; GO:0097718; GO:1902511"
"1508","Pocillopora_acuta_HIv2___RNAseq.g30379.t1",0,NA,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.80679056307722,3.68233641306884,12.7840076037467,8.72107908560905,10.7819795739205,3.68233641306884,5.61726033607325,3.68233641306884,3.68233641306884,6.61227992277709,5.07706973217776,8.14749011337642,1005.60898444693,0.162802727335355,1.02434734949063,0.00628137301194821,0.0282593403560867,"Q80YS6",3.18e-07,"Actin filament-associated protein 1 (110 kDa actin filament-associated protein) (AFAP-110)","regulation of signal transduction [GO:0009966]","GO:0001725; GO:0003779; GO:0005829; GO:0005884; GO:0005925; GO:0009966; GO:0017124; GO:0042169"
"1509","Pocillopora_acuta_HIv2___RNAseq.g30390.t1",2.5,0,NA,0,0,0.956937799043062,0,0,0,NA,0.432117224880383,0.191387559808612,0.833333333333333,NA,NA,NA,NA,NA,NA,10.696474323728,9.86727788990133,6.55189453597217,9.32081767867581,8.54355284690326,9.95730720730454,3.68233641306884,10.6240122190054,3.68233641306884,3.68233641306884,7.6608345940697,8.01965406773553,7.30201512040387,609.545486516556,-0.0151617183366063,0.954300552084163,0.988254740666074,0.99576911106837,"Q5TZ24",3.62e-114,"DBH-like monooxygenase protein 1 homolog (EC 1.14.17.-)","dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]","GO:0004500; GO:0005507; GO:0005615; GO:0005789; GO:0006589; GO:0030667; GO:0042420; GO:0042421"
"1510","Pocillopora_acuta_HIv2___RNAseq.g30424.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.3070873393092,12.5219372895549,9.65122792065155,13.3054045264485,10.7813412822908,12.8460167670899,11.7727598571862,11.9455074670108,11.5452193766574,12.0654188230267,11.7741920649226,11.046076677184,12.5023074526612,4292.69695177914,0.919360157430975,0.802274326162921,0.0779526840354652,0.218333228480408,"Q18DN4",1.29e-08,"Halomucin","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","GO:0005509; GO:0005576; GO:0007156; GO:0016020; GO:0030246"
"1511","Pocillopora_acuta_HIv2___RNAseq.g30479.t1",NA,0,0,5.26315789473684,0,3.125,0,NA,NA,0,1.19830827067669,2.79605263157895,0,NA,NA,NA,NA,NA,NA,8.2320624332994,7.23128399729271,3.68233641306884,6.26838653426437,3.68233641306884,9.23999388563156,3.68233641306884,7.07217878081263,3.68233641306884,3.68233641306884,5.64555876966449,5.27025009066371,6.02086744866526,114.415119231915,0.0441068865427129,1.00534559775039,0.147107285142272,0.343797022507323,"Q96PM5",5.02e-21,"RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2)","error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630; GO:0070987; GO:0072344"
"1512","Pocillopora_acuta_HIv2___RNAseq.g30517.t1",1.28205128205128,0,0,0,2.56410256410256,0,0,0,16.6666666666667,0,2.05128205128205,3.33333333333333,0.769230769230769,NA,NA,NA,NA,NA,NA,8.43374494478076,9.5705267185652,9.62971423045963,8.30231185926826,9.88230256942176,3.68233641306884,3.68233641306884,10.0610678321017,9.86281049793089,3.68233641306884,7.67894878917347,9.57392801493895,5.783969563408,497.93798766626,-0.461540816738888,1.1227243243049,2.39187114284807e-06,3.34908269217371e-05,NA,NA,NA,NA,NA
"1513","Pocillopora_acuta_HIv2___TS.g18522.t1a",1.19156736938588,0.951086956521739,0.906002265005662,0.875,0.075187969924812,0.687757909215956,0.476190476190476,0.200400801603206,1.47368421052632,0,0.683687795837405,0.837585975573443,0.529789616101367,NA,NA,NA,NA,NA,NA,9.23176251403244,5.1703194305374,10.7048530349657,3.68233641306884,10.2065390897294,3.68233641306884,6.81402638403065,10.2752513775017,8.17151122259478,3.68233641306884,7.16212722925986,9.7179834477648,4.60627101075491,495.555808296377,-6.65762847524016,3.06866730763789,6.708057972866e-08,1.52077351911495e-06,NA,NA,NA,NA,NA
"1514","Pocillopora_acuta_HIv2___TS.g18525.t1",NA,0,0,0,NA,NA,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,7.32784372520422,5.61277682111054,4.4496922765333,9.36637299559231,4.62472736042638,7.68691227964876,9.94224244663848,8.37945792237163,3.68233641306884,3.68233641306884,6.47546986536633,5.69281153952087,7.25812819121179,225.395152820402,0.529283408761416,1.11128780418032,0.0844877621681407,0.230746033232626,NA,NA,NA,NA,NA
"1515","Pocillopora_acuta_HIv2___RNAseq.g30542.t1",NA,0,0,NA,14.2857142857143,0,0,0,NA,NA,2.38095238095238,0,4.76190476190476,NA,NA,NA,NA,NA,NA,10.8955490873246,9.35508083244379,10.857802496282,3.68233641306884,11.2244882464545,8.5489581260917,9.74919106734537,10.0168454647865,6.01048531358257,12.5609097265315,9.29016467739114,9.80103412168603,8.77929523309624,1495.92480841356,-0.245852332457762,0.972752124446815,0.351779716253733,0.603337346566078,"Q5ZIJ9",0,"E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2)","Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]","GO:0005737; GO:0007219; GO:0008270; GO:0016567; GO:0061630"
"1516","Pocillopora_acuta_HIv2___RNAseq.g30543.t1b",0,10,NA,0,5.88235294117647,0,0,0,0,NA,1.98529411764706,2,1.96078431372549,NA,NA,NA,NA,NA,NA,10.7208389714464,6.26270646445638,8.87436168578354,7.92924455308051,5.71763198038475,10.0703403482893,3.68233641306884,6.84409752428356,3.68233641306884,3.68233641306884,6.7466230766931,7.16785331499342,6.32539283839277,354.84607868393,-0.249918172510152,1.01820170854504,0.328950620897389,0.579108738754571,"Q2PC93",4.85e-108,"SCO-spondin","cell adhesion [GO:0007155]","GO:0005615; GO:0007155; GO:0031012"
"1517","Pocillopora_acuta_HIv2___RNAseq.g30559.t1",0,0,6.66666666666667,0,NA,0,0,NA,NA,NA,1.11111111111111,0,2.22222222222222,NA,NA,NA,NA,NA,NA,9.5174065067491,9.77381354675143,9.37556996168884,3.68233641306884,8.4434879200832,9.94205515735528,3.68233641306884,9.59688283490894,3.68233641306884,8.9082467043071,7.66044718710504,8.12313672729978,7.1977576469103,468.1288794191,-0.0430401164898387,0.986319775423222,0.748745730057358,0.889440481792665,"Q5QGU6",3.78e-09,"Receptor-transporting protein 3 (Transmembrane protein 7)","detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; protein insertion into membrane [GO:0051205]; protein targeting to membrane [GO:0006612]","GO:0001580; GO:0005737; GO:0006612; GO:0016020; GO:0031849; GO:0046872; GO:0051205"
"1518","Pocillopora_acuta_HIv2___RNAseq.g30564.t1",0,NA,0,0,NA,10,0,0,NA,NA,1.66666666666667,3.33333333333333,0,NA,NA,NA,NA,NA,NA,6.3567367124764,8.52426334690287,5.79243403424225,6.10548275003066,5.23920445324911,8.1794761914649,8.28987181369227,5.51740847876286,5.98677490518935,6.11483358357707,6.61064862695877,5.77851171678399,7.44278553713355,115.868762673729,1.44998363865944,1.06223651792289,0.0164876393816539,0.0631727724546335,NA,NA,NA,NA,NA
"1519","Pocillopora_acuta_HIv2___RNAseq.g30586.t1",0,NA,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,13.2691370608747,12.9539826729868,13.1051604295383,12.1490722522338,13.6452405703057,13.3432246316115,13.8503668944821,13.373820321564,12.7243699041425,14.6267767920644,13.3041151529804,13.223545657285,13.3846846486757,11155.9105007736,0.0964904271889304,0.608434275202685,0.852876934019781,0.942039860531662,"Q5GIS3",0,"Guanine nucleotide-binding protein subunit beta (pfGbeta1) (G protein subunit beta-1)","G protein-coupled receptor signaling pathway [GO:0007186]","GO:0005516; GO:0005737; GO:0005834; GO:0007186; GO:0030159"
"1520","Pocillopora_acuta_HIv2___RNAseq.g30593.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,5.74095382813731,6.051458458319,10.8872674884344,7.99046123582709,8.74641067247364,7.99473091893197,6.7397479573644,3.68233641306884,8.37689014175785,6.98925935273833,5.62926809552963,8.34925060994703,319.597733468068,1.69014866336472,2.44162677316582,0.000789695674822049,0.00479922615152358,"Q2HJI8",3.45e-51,"Ras-related protein Rab-8B","endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; protein secretion [GO:0009306]","GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006887; GO:0008021; GO:0009306; GO:0010008; GO:0019003; GO:0030140; GO:0030670; GO:0032456; GO:0045335"
"1521","Pocillopora_acuta_HIv2___TS.g18589.t1",100,NA,NA,100,100,100,NA,NA,100,100,100,100,100,NA,NA,NA,NA,NA,NA,14.3736687177121,14.3145731515835,15.0275735901034,14.5611328342789,14.7289963590032,14.4903950385774,14.8759346160912,14.6313859916932,14.8178451646612,14.9973177012223,14.6818823164926,14.7158939646346,14.6478706683507,26612.9571813134,-0.0485055967552952,0.484523524961097,0.901465701526985,0.962645303825561,"B0S5G3",6.67e-87,"Calsyntenin-2","homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]","GO:0000139; GO:0005509; GO:0005789; GO:0007156; GO:0009986; GO:0030425; GO:0045211; GO:0050806; GO:0051965"
"1522","Pocillopora_acuta_HIv2___RNAseq.g30618.t1",0,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.42771877417721,3.68233641306884,6.81648221983832,7.88111108983815,5.61428486132265,3.68233641306884,7.17452079654744,5.33850173705749,6.01048531358257,3.68233641306884,5.93101140315703,6.64149458119565,5.22052822511842,116.933342743272,-0.263243118567322,1.02935391911571,0.0057609270350728,0.0261949225511767,NA,NA,NA,NA,NA
"1523","Pocillopora_acuta_HIv2___TS.g18617.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,6.97157030183863,3.68233641306884,6.6113197353918,3.68233641306884,8.92306134574704,6.4540987163944,9.36358632685335,3.68233641306884,5.67353184915694,6.6165822987094,4.73048139960448,133.219716182923,-0.203261914130172,1.03450361989352,0.00346657126152822,0.0170720077380811,NA,NA,NA,NA,NA
"1524","Pocillopora_acuta_HIv2___RNAseq.g30624.t2b",0,0,19.2307692307692,0,0,0,0,0,0,0,1.92307692307692,0,3.84615384615385,NA,NA,NA,NA,NA,NA,11.7847425409918,5.88506810849203,11.2387162354473,8.91348296376329,11.3043625297081,3.68233641306884,3.68233641306884,10.8433913264086,11.9319430962234,3.68233641306884,8.2948716040241,11.4206311457558,5.16911206229237,1458.34037951228,-8.25320622308124,4.24344882427549,8.67986521182632e-10,3.59729428148584e-08,"Q99NH0",5.34e-66,"Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein)","blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]","GO:0000785; GO:0001673; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007492; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246"
"1525","Pocillopora_acuta_HIv2___TS.g18622.t1b",7.69230769230769,NA,NA,0,0,1.42857142857143,34.8837209302326,0,0,9.09090909090909,6.6369386427526,0.357142857142857,12.9167344283623,NA,NA,NA,NA,NA,NA,9.15557695652597,12.6081385186634,8.1263054097228,12.2618054915492,9.51688751894074,13.3292507351962,13.6097658950262,10.0959760111707,3.68233641306884,13.1884424525837,10.5574485402448,8.11541646188581,12.9994806186037,4572.98017033914,3.38243611792493,1.74956122386046,0.000822388464066329,0.00496660824394796,"A2ASQ1",1.54e-86,"Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; enzyme-linked receptor protein signaling pathway [GO:0007167]; motor neuron apoptotic process [GO:0097049]; negative regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903407]; negative regulation of sodium ion export across plasma membrane [GO:1903277]; neuromuscular junction development [GO:0007528]; plasma membrane organization [GO:0007009]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; regulation of synaptic activity [GO:0060025]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416]","GO:0001932; GO:0001934; GO:0002162; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0007009; GO:0007167; GO:0007268; GO:0007416; GO:0007528; GO:0007623; GO:0009986; GO:0015031; GO:0030154; GO:0030548; GO:0032092; GO:0033691; GO:0035022; GO:0035374; GO:0036122; GO:0042030; GO:0042383; GO:0043083; GO:0043087; GO:0043113; GO:0043395; GO:0043547; GO:0044295; GO:0044325; GO:0045202; GO:0045887; GO:0045944; GO:0048018; GO:0050431; GO:0050731; GO:0050807; GO:0051491; GO:0055117; GO:0060025; GO:0061098; GO:0062023; GO:0070507; GO:0071340; GO:0086036; GO:0097049; GO:0098978; GO:1902667; GO:1903277; GO:1903407; GO:1904395; GO:2000541; GO:2000673"
"1526","Pocillopora_acuta_HIv2___RNAseq.g30635.t1",50,0,50,19.047619047619,66.6666666666667,13.3333333333333,50,0,66.6666666666667,NA,35.0793650793651,19.8095238095238,54.1666666666667,NA,NA,NA,NA,NA,NA,9.18215385673275,10.3161313815516,9.41068672381548,10.6418928899969,9.13367024367935,10.2524046821588,9.57862096280873,8.76600406492611,9.30955949992316,9.76759841671554,9.63587227223084,9.16041487781537,10.1113296666463,836.731827164033,0.799345431316839,0.533605493411435,0.080454940999528,0.223226733156562,"Q5ZK62",2.09e-178,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)","cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]","GO:0005096; GO:0010008; GO:0032456; GO:0046872; GO:1990090"
"1527","Pocillopora_acuta_HIv2___TS.g18644.t1",11.4285714285714,0,0,0,0,1.49253731343284,0,0,0,NA,1.43567874911158,0.298507462686567,2.85714285714286,NA,NA,NA,NA,NA,NA,8.1263825815683,9.05908112218842,8.13780270981254,9.61516588688094,8.20586934810711,9.3843085341297,8.74373677536899,8.59251268064315,8.58974304078406,8.14490725316028,8.65995099326435,8.33046207218303,8.98943991434567,407.28666457261,0.502558420949067,0.605615317158971,0.294571654217955,0.541613903558093,NA,NA,NA,NA,NA
"1528","Pocillopora_acuta_HIv2___RNAseq.g30651.t1",NA,0,0,NA,38.0952380952381,0,75,0,0,NA,16.156462585034,0,37.6984126984127,NA,NA,NA,NA,NA,NA,7.27912941077028,8.87484817488002,6.89159417457077,8.27067364660478,6.80219049990908,8.12187490846922,6.74136374297954,6.69745174704333,8.74715835856478,7.88832156922198,7.63146062330138,7.28350483817165,7.97941640843111,207.276269561869,0.533591973006938,0.686053997536874,0.27840017374089,0.523979194923647,"Q15057",4.65e-20,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)","actin filament-based process [GO:0030029]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]","GO:0001726; GO:0005096; GO:0010008; GO:0016020; GO:0030029; GO:0032456; GO:0046872; GO:1990090"
"1529","Pocillopora_acuta_HIv2___RNAseq.g30655.t1",13.3333333333333,0,0,0,0,4.16666666666667,2.22222222222222,1.75438596491228,0,0,2.14766081871345,1.18421052631579,3.11111111111111,NA,NA,NA,NA,NA,NA,6.7792912387703,7.34982382480446,8.17547586494681,8.82557602331017,7.16128077648109,8.67742263793333,7.73817667505897,7.61314279352236,6.97986927123753,8.35530533234199,7.7655364438407,7.34181198899162,8.18926089868978,218.300456478034,0.717537438316917,0.60511578012974,0.139717979127706,0.332874460567145,NA,NA,NA,NA,NA
"1530","Pocillopora_acuta_HIv2___RNAseq.g30656.t1",0,NA,0,0,23.8095238095238,0,0,NA,0,NA,3.40136054421769,0,5.95238095238095,NA,NA,NA,NA,NA,NA,7.29555341930434,8.65594257524443,7.93301443586595,8.32302376070083,7.11438186546373,9.79558849868479,7.29038709687432,8.77003416098,3.68233641306884,3.68233641306884,7.25425986392561,6.95906405893657,7.54945566891464,254.552374345096,0.325890125829251,0.84408162277293,0.448085356296515,0.690130120951637,"G1T469",2.86e-10,"Nucleotide-binding oligomerization domain-containing protein 2 (OcNOD2)","adaptive immune response [GO:0002250]; antibacterial innate immune response [GO:0140367]; biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0002815]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to peptidoglycan [GO:0071224]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; detection of muramyl dipeptide [GO:0032498]; ERK1 and ERK2 cascade [GO:0070371]; establishment of localization in cell [GO:0051649]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; innate immune response in mucosa [GO:0002227]; intestinal stem cell homeostasis [GO:0036335]; JNK cascade [GO:0007254]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type II interferon production [GO:0032689]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; phagocytosis [GO:0006909]; positive regulation of B cell activation [GO:0050871]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of mitophagy [GO:1901526]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type 2 immune response [GO:0002830]; positive regulation of xenophagy [GO:1904417]; regulation of appetite [GO:0032098]; regulation of neutrophil chemotaxis [GO:0090022]; response to endoplasmic reticulum stress [GO:0034976]; response to exogenous dsRNA [GO:0043330]; response to muramyl dipeptide [GO:0032495]; stress-activated MAPK cascade [GO:0051403]; temperature homeostasis [GO:0001659]; toll-like receptor 2 signaling pathway [GO:0034134]; xenophagy [GO:0098792]","GO:0001659; GO:0002227; GO:0002250; GO:0002606; GO:0002710; GO:0002815; GO:0002830; GO:0002862; GO:0002925; GO:0003779; GO:0005524; GO:0005739; GO:0005794; GO:0005829; GO:0005856; GO:0006909; GO:0006965; GO:0007254; GO:0009986; GO:0010936; GO:0016045; GO:0016323; GO:0019897; GO:0019901; GO:0030277; GO:0030544; GO:0032098; GO:0032495; GO:0032498; GO:0032500; GO:0032689; GO:0032695; GO:0032701; GO:0032703; GO:0032720; GO:0032731; GO:0032733; GO:0032735; GO:0032740; GO:0032755; GO:0032757; GO:0032760; GO:0032874; GO:0032991; GO:0034134; GO:0034136; GO:0034976; GO:0036335; GO:0038187; GO:0042742; GO:0042834; GO:0043123; GO:0043130; GO:0043330; GO:0043531; GO:0044877; GO:0045335; GO:0045747; GO:0045944; GO:0046330; GO:0048874; GO:0050679; GO:0050700; GO:0050731; GO:0050766; GO:0050871; GO:0051403; GO:0051649; GO:0051770; GO:0051879; GO:0060907; GO:0070371; GO:0070374; GO:0070431; GO:0071222; GO:0071224; GO:0071225; GO:0071639; GO:0090022; GO:0098792; GO:0140367; GO:1900017; GO:1901224; GO:1901526; GO:1902523; GO:1904417; GO:2000110"
"1531","Pocillopora_acuta_HIv2___RNAseq.g30657.t1",28.5714285714286,0,NA,0,26.0869565217391,16.9811320754717,29.0322580645161,33.3333333333333,NA,NA,19.1435869380698,12.5786163522013,27.8968810525613,NA,NA,NA,NA,NA,NA,8.83662861426627,10.4207309893499,9.34453783310147,11.2335658244948,9.17109932916526,10.0597807581141,9.77276200430013,8.75993769633789,7.50853330341144,10.0327092302727,9.5140285582814,8.72414735525647,10.3039097613063,881.370342871197,1.33668311503062,0.651731941855339,0.0100970059164109,0.0419784689781452,"Q5ZK62",0,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)","cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]","GO:0005096; GO:0010008; GO:0032456; GO:0046872; GO:1990090"
"1532","Pocillopora_acuta_HIv2___RNAseq.g30688.t1",40.8163265306122,3.17460317460317,33.3333333333333,2.7027027027027,26,12.7388535031847,29.8701298701299,21.0526315789474,NA,NA,21.2110725866892,9.91719773985949,32.5049474335189,1,48.3309143686502,48.3309143686502,0.0053220676077301,0.0053220676077301,0.0053220676077301,4.21445057288855,6.30327276432217,6.93658367102579,5.31323081329325,4.52813742588667,6.47828580769909,7.20706873415218,6.68016878280013,5.75167028831017,4.19574235723263,5.76086112176106,5.62220214818226,5.89952009533986,47.7995772154236,0.13093258224223,0.923133087602983,0.644009941585404,0.829236492764719,NA,NA,NA,NA,NA
"1533","Pocillopora_acuta_HIv2___TS.g18687.t1",0.431034482758621,NA,0,0,3.33333333333333,1.5625,0,0.719424460431655,1.28205128205128,NA,0.916042944821861,0.890993935620734,0.941091954022989,NA,NA,NA,NA,NA,NA,5.58022760055378,8.33233862556014,8.17547586494681,8.28657977290827,8.63298744957825,9.51204274481595,5.44987995888088,6.82069555819925,3.68233641306884,3.68233641306884,6.8154900401581,6.57834457726939,7.05263550304682,206.093723939386,0.201915489593039,0.848684475796704,0.601820320749319,0.802201246667647,NA,NA,NA,NA,NA
"1534","Pocillopora_acuta_HIv2___TS.g18688.t1",12.5,26.6666666666667,45.1612903225806,0,42.4242424242424,16.3934426229508,19.1780821917808,33.3333333333333,100,NA,32.8507841735061,35.2786885245902,29.815903734651,NA,NA,NA,NA,NA,NA,9.89606983075715,10.8558322566942,9.92290624605818,10.8671676176034,9.60891542560473,10.6165307867863,10.2376177664449,8.91901122257894,10.1508556647822,9.10198005608807,10.0176886873398,9.69955167795624,10.3358256967234,1111.8240571831,0.476643153668128,0.620769972683798,0.323076558692075,0.572598865938263,"Q5ZK62",6.21e-138,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)","cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]","GO:0005096; GO:0010008; GO:0032456; GO:0046872; GO:1990090"
"1535","Pocillopora_acuta_HIv2___RNAseq.g30694.t1",0,37.037037037037,NA,30.7692307692308,15.3846153846154,24,14.6341463414634,NA,NA,0,17.4035756474781,30.6020892687559,7.5046904315197,NA,NA,NA,NA,NA,NA,8.39257334917541,3.68233641306884,9.31955800906196,8.92706331886005,8.92702347129378,8.58871530612081,9.42687702045085,8.81558743150869,7.08098834013476,3.68233641306884,7.6843059072744,8.50714612023492,6.86146569431388,340.603017329779,-0.380270107504714,0.994890349174437,0.152784962679369,0.353016246037443,NA,NA,NA,NA,NA
"1536","Pocillopora_acuta_HIv2___RNAseq.g30695.t1",3.77358490566038,33.3333333333333,0,0,8.33333333333333,3.36134453781513,25.5813953488372,NA,0,NA,9.29787393237242,9.17366946778712,9.42207839695773,NA,NA,NA,NA,NA,NA,9.57702531549222,10.9933397115807,9.78009167390166,10.9113648211108,8.46220676323956,9.65766469777978,9.52837318614152,9.25853791374079,9.9855877328727,11.1316574092228,9.92858492250825,9.41268987984939,10.4444799651671,1112.1584694539,0.865138553131121,0.554230764572562,0.067340378706736,0.195663165450829,NA,NA,NA,NA,NA
"1537","Pocillopora_acuta_HIv2___RNAseq.g30698.t1",0,0,NA,0,0,0,1.85185185185185,0,0,NA,0.231481481481481,0,0.617283950617284,NA,NA,NA,NA,NA,NA,7.72880437482727,7.70095858672402,6.50448097751675,5.21704338441576,8.426906743025,7.69302168712282,7.95715044700245,6.85948535074232,7.46780854522067,3.68233641306884,6.92379965096659,7.3974971982664,6.45010210366678,142.195386272744,-0.390320766752134,0.908344094703741,0.326771247446582,0.576744273711698,NA,NA,NA,NA,NA
"1538","Pocillopora_acuta_HIv2___RNAseq.g30699.t1",3.96039603960396,0,0,0,0,1.12359550561798,1.86915887850467,0,0,0,0.695315042372661,0.224719101123596,1.16591098362173,NA,NA,NA,NA,NA,NA,4.95179328310793,6.43649034287553,6.46782542466738,8.26533225739722,6.11409578894442,8.08059955791897,3.68233641306884,5.51740847876286,3.68233641306884,3.68233641306884,5.68805543728808,5.34669187771029,6.02941899686588,73.6025326145673,0.235798370013352,0.975650205032002,0.443712462416166,0.686328420103456,"Q96P50",9.27e-94,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 (Centaurin-beta-5) (Cnt-b5)","neuron migration [GO:0001764]; regulation of neuron projection development [GO:0010975]","GO:0001764; GO:0005096; GO:0005737; GO:0010975; GO:0030426; GO:0046872"
"1539","Pocillopora_acuta_HIv2___RNAseq.g30700.t1",NA,0,100,NA,87.5,7.69230769230769,0,NA,50,NA,40.8653846153846,19.2307692307692,62.5,NA,NA,NA,NA,NA,NA,3.68233641306884,6.34267098328276,4.02873527760674,8.30231185926826,6.550353694785,6.60213173979051,7.04835315333773,5.51740847876286,3.68233641306884,3.68233641306884,5.54389744260404,4.69223405545846,6.39556082974962,62.3417734062417,0.59095670327252,1.17712436306983,0.0484481327912156,0.152040310846635,"Q5ZK62",3.05e-43,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)","cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]","GO:0005096; GO:0010008; GO:0032456; GO:0046872; GO:1990090"
"1540","Pocillopora_acuta_HIv2___RNAseq.g30709.t1",0,0,0,0,11.1111111111111,3.81679389312977,0,0,NA,NA,1.86598812553011,0.954198473282443,2.77777777777778,NA,NA,NA,NA,NA,NA,8.69303517526933,10.478956994086,10.0768875893379,10.6201253943745,8.61219199715842,9.57272801418021,8.69518597124527,9.45021961732666,10.0473982215442,9.18581490818331,9.54325438827058,9.3759465201273,9.71056225641386,814.814774405103,0.22095484276872,0.634363400937458,0.64435626862835,0.829348747992372,NA,NA,NA,NA,NA
"1541","Pocillopora_acuta_HIv2___TS.g18709.t1",0,24.1379310344828,30.7692307692308,0,NA,32.258064516129,48.3870967741936,NA,NA,NA,22.592053849006,18.7986651835373,26.3854425144748,NA,NA,NA,NA,NA,NA,6.53584217462236,7.5932230481983,7.28772548725058,6.41389448441836,8.23065898728289,7.6179290796022,6.94897634016548,5.67356605113577,5.8874486244384,3.68233641306884,6.58716006901832,6.723048264946,6.45127187309064,104.128640065521,-0.15651191476713,0.840387590305651,0.681556798143283,0.85240439409273,NA,NA,NA,NA,NA
"1542","Pocillopora_acuta_HIv2___TS.g18711.t1",0,0,0,0,0,1.59453302961276,0.813008130081301,0,0,NA,0.26750457329934,0.318906605922551,0.203252032520325,NA,NA,NA,NA,NA,NA,9.79640677900355,6.06348383902188,9.97181302537224,8.91006777795816,8.24695104246703,9.45048847637882,11.1459396189984,9.6665960453138,10.7007457325655,11.06351328372,9.50160056207994,9.67650252494442,9.32669859921545,1007.56727722794,-0.0749814522942402,0.767450679253505,0.842368309391186,0.937323925653962,NA,NA,NA,NA,NA
"1543","Pocillopora_acuta_HIv2___RNAseq.g30720.t1",2.90846877673225,2.16284987277354,1.41442715700141,1.87074829931973,4.52567449956484,2.37618093329516,2.46406570841889,4.28571428571429,1.41843971631206,0,2.34265692491322,2.42278662148295,2.26252722834348,NA,NA,NA,NA,NA,NA,10.0979293543734,9.40808103785765,8.54121067406901,9.73576497217129,9.75445034317874,9.19779700333832,10.2799848978045,8.36086166010469,10.2208073628337,10.2507467625915,9.58476340683228,9.39505187891191,9.77447493475265,818.089101101606,0.243559032919675,0.63681618362611,0.609945832980646,0.80679072046018,"Q7SY23",0,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)","proline catabolic process to glutamate [GO:0010133]","GO:0003842; GO:0005759; GO:0010133"
"1544","Pocillopora_acuta_HIv2___RNAseq.g30759.t1",0,NA,NA,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.23176251403244,3.68233641306884,10.8368368277509,7.3342463704392,9.86835177181334,7.04924140340958,5.90680277481292,8.60610586611839,6.66829119218775,3.68233641306884,7.28663115467022,9.04226963438056,5.53099267495988,401.229753927853,-3.70407031889035,1.84634656990781,0.00016344823269504,0.00125358703400109,NA,NA,NA,NA,NA
"1545","Pocillopora_acuta_HIv2___TS.g18761.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.62359291611186,7.96430909081604,9.57025339063966,11.6661706921954,9.08923922973774,10.7429122698495,6.81402638403065,7.8530093336639,10.213472761636,3.68233641306884,8.62193224817496,9.06991352635783,8.17395096999209,821.664391369369,-0.0908653423039704,0.895512129731762,0.754260351696192,0.89215158935372,"Q9TT16",0,"H(+)/Cl(-) exchange transporter 6 (Chloride channel protein 6) (ClC-6) (Chloride transport protein 6)","chloride transport [GO:0006821]","GO:0005247; GO:0005524; GO:0005765; GO:0006821; GO:0015297; GO:0031902"
"1546","Pocillopora_acuta_HIv2___RNAseq.g30773.t1",NA,0,NA,NA,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,11.7343997296781,10.6320470204528,8.95012219398314,9.42973330435663,10.265605773447,8.82339275517331,3.68233641306884,9.6954713605788,10.5833187853106,3.68233641306884,8.74787637491181,10.2457835685995,7.24996918122408,1002.19948959758,-0.471147624585309,1.06639199904033,0.0725428213149667,0.206791361351927,"Q5XI57",1.68e-112,"Protein polyglycylase TTLL10 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 10)","protein polyglycylation [GO:0018094]","GO:0005524; GO:0005874; GO:0005929; GO:0005930; GO:0015630; GO:0018094; GO:0046872; GO:0070735; GO:0070737"
"1547","Pocillopora_acuta_HIv2___RNAseq.g30807.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.24894423055902,7.47670412910099,3.68233641306884,11.847489359435,3.68233641306884,7.6179290796022,10.745267555647,7.6791315170708,9.23904766652665,10.079471757194,8.02986581212733,6.50635924805883,9.55337237619584,776.987092525486,0.521142367304534,1.12032636905837,0.0282030518673004,0.0982962673484271,"Q9NXG6",1.93e-51,"Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4)","regulation of erythrocyte differentiation [GO:0045646]","GO:0004656; GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0016706; GO:0031418; GO:0045646; GO:0160082"
"1548","Pocillopora_acuta_HIv2___TS.g18803.t1b",50,0,100,0,100,NA,NA,NA,100,NA,58.3333333333333,33.3333333333333,83.3333333333333,NA,NA,NA,NA,NA,NA,10.4065960957004,7.5932230481983,10.8618440058967,9.72220380163334,9.64209408124392,11.1364720640762,9.76374179605489,9.82306735152005,3.68233641306884,3.68233641306884,8.63139150704615,8.88318758948598,8.37959542460631,887.794062124372,-0.249580587237593,0.816306395450239,0.635741655417895,0.823997929339533,"E0ZS48",0,"Urease (EC 3.5.1.5) (Urea amidohydrolase)","urea catabolic process [GO:0043419]","GO:0009039; GO:0016151; GO:0035550; GO:0043419"
"1549","Pocillopora_acuta_HIv2___RNAseq.g30828.t1",20,NA,0,0,0,0,0,0,0,0,2.22222222222222,0,4,NA,NA,NA,NA,NA,NA,8.08465879531668,9.87220582490995,3.68233641306884,9.26578381504101,8.91519169776851,9.59402925463676,10.4593924264436,9.21930051651831,3.68233641306884,3.68233641306884,7.64575715698413,6.71676476714824,8.57474954682003,490.613538951263,0.506759629799051,1.05106804209914,0.216316464928208,0.446143069830544,NA,NA,NA,NA,NA
"1550","Pocillopora_acuta_HIv2___RNAseq.g30859.t1",NA,NA,NA,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,8.96209207639517,8.32275715627176,10.2160038324386,3.68233641306884,6.27545950462381,5.84950698471885,3.68233641306884,9.16373474950593,11.5027310495125,3.68233641306884,7.13392945926731,9.2240042424952,5.04385467603943,544.533317315152,-0.566543971816954,1.18114227760953,9.60153881167293e-07,1.51446736501676e-05,NA,NA,NA,NA,NA
"1551","Pocillopora_acuta_HIv2___RNAseq.g30861.t1",0,NA,NA,NA,33.3333333333333,4.16666666666667,8.33333333333333,0,0,NA,7.63888888888889,1.38888888888889,13.8888888888889,NA,NA,NA,NA,NA,NA,7.50758496116064,10.0421681081753,8.36993710353355,8.5197169563895,6.13835848329068,3.68233641306884,9.42916116845914,9.56362358250377,9.74055702340423,3.68233641306884,7.66757802130545,8.26401223077857,7.07114381183232,410.579478771725,-0.203592218290755,0.96481686235733,0.331730261946327,0.582158033097753,"B2GUS6",1.99e-12,"Lysine-specific demethylase 8 (EC 1.14.11.27) (JmjC domain-containing protein 5) (Jumonji domain-containing protein 5)","circadian regulation of gene expression [GO:0032922]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of DNA-templated transcription [GO:0045893]","GO:0000086; GO:0003682; GO:0005634; GO:0032922; GO:0045893; GO:0046872; GO:0051864; GO:0140680"
"1552","Pocillopora_acuta_HIv2___RNAseq.g30885.t1",0,NA,0,19.4029850746269,0,0,10.4166666666667,NA,2.38095238095238,NA,4.60008630317799,7.26131248519308,2.60416666666667,NA,NA,NA,NA,NA,NA,10.2708548835234,3.68233641306884,8.50913795563873,9.47433525610994,8.60799661496839,7.89192537626846,9.78172614145459,8.46402656163266,6.72526102529218,3.68233641306884,7.7089936641026,8.51545540821107,6.90253191999413,407.672230445836,-0.231428866401625,0.968376632186552,0.272559969601628,0.516820582107753,"Q59022",1.24e-13,"Uncharacterized protein MJ1628","","GO:0005524"
"1553","Pocillopora_acuta_HIv2___RNAseq.g30886.t1",NA,0,NA,NA,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.43374494478076,8.57758379751783,6.74729698008972,9.44396776168801,8.62262727163695,6.93974781619552,3.68233641306884,9.13746810560362,3.68233641306884,3.68233641306884,6.89494459167189,7.32469474303598,6.46519444030781,243.686607820517,-0.140746658212294,0.962103076936586,0.72367475138619,0.875894560273645,"Q0IIF0",3.55e-122,"Integrin-linked kinase-associated serine/threonine phosphatase 2C (ILKAP) (EC 3.1.3.16)","","GO:0005737; GO:0017018; GO:0046872"
"1554","Pocillopora_acuta_HIv2___RNAseq.g30908.t2",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.27912941077028,7.45925468652246,3.68233641306884,7.00074722714729,5.13665622490825,7.56558401776789,3.68233641306884,3.68233641306884,3.68233641306884,3.68233641306884,5.28530536324604,4.69255897497701,5.87805175151506,56.4446053292354,0.278509869680796,1.03186568145244,0.295682899309636,0.542942421685232,NA,NA,NA,NA,NA
"1555","Pocillopora_acuta_HIv2___TS.g18917.t1",53.3333333333333,84.6153846153846,77.2727272727273,71.4285714285714,56.0975609756098,47.3684210526316,37.5,72.7272727272727,53.7313432835821,85.7142857142857,63.9788900403398,65.9741986214885,61.9835814591912,NA,NA,NA,NA,NA,NA,9.69857333489125,8.80436573511234,8.27599171875922,7.5168056772214,8.99443797260713,7.56558401776789,6.63285646347393,7.12388258861865,10.5728488822128,3.68233641306884,7.88676828037334,8.93314689941781,6.84038966132888,400.751164063258,-0.592223524186988,0.991730549209762,0.197529580373786,0.419416889390258,"Q15427",5.98e-133,"Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (Spliceosome-associated protein 49) (SAP 49)","mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; U2-type prespliceosome assembly [GO:1903241]","GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0006397; GO:0008380; GO:0048026; GO:0071005; GO:1903241; GO:1990935"
"1556","Pocillopora_acuta_HIv2___TS.g18918.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.20520613944672,3.68233641306884,7.56912417164875,5.89135073914645,7.72142218548987,7.67461468239209,8.14708935828997,7.58587073740623,8.92244148182826,3.68233641306884,6.7081792321786,7.60081294316397,5.81554552119324,150.303900599085,-0.499704001175285,1.06303438239748,0.0641046938810094,0.188344280585504,"F1N476",2.05e-58,"Endothelin-converting enzyme 2 (ECE-2) (EC 3.4.24.71)","brain development [GO:0007420]; cardioblast differentiation [GO:0010002]; heart development [GO:0007507]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]","GO:0000139; GO:0004222; GO:0005886; GO:0007420; GO:0007507; GO:0010002; GO:0016485; GO:0016486; GO:0030658; GO:0030659; GO:0046872"
"1557","Pocillopora_acuta_HIv2___RNAseq.g30932.t1",0,NA,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,6.22289842159741,9.48945375959539,8.95661954912388,8.88245085387777,9.00563899882032,3.68233641306884,3.68233641306884,9.48248941326871,9.47412951432438,3.68233641306884,7.25606897498144,8.62835517942694,5.88378277053594,352.699246195066,-0.289131087764971,1.04791042271341,1.90551368566886e-05,0.000198568803670853,"Q18297",1.59e-139,"Transient receptor potential cation channel subfamily A member 1 homolog","","GO:0005216; GO:0005886; GO:0043025; GO:0097730"
"1558","Pocillopora_acuta_HIv2___TS.g18947.t1",4.92753623188406,2.77777777777778,3.47222222222222,2.07715133531157,3.47222222222222,5.92255125284738,5.69105691056911,7.19424460431655,0,6.66666666666667,4.22014292238176,3.59434499405066,4.84594085071286,NA,NA,NA,NA,NA,NA,15.0278869829783,12.0287084128524,15.0972399649395,11.3991288359782,14.6215226030814,10.9628646754004,11.6006113701217,14.4244278871626,15.333947194155,10.6655492872534,13.1161887213923,14.9010049264634,11.3313725163212,17030.606210404,-3.35736836972465,0.664919936067497,1.67047180701767e-08,4.53798385910799e-07,"Q9QWN8",4.06e-57,"Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41)","actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult behavior [GO:0030534]; cellular response to ethanol [GO:0071361]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; multicellular organism growth [GO:0035264]; postsynapse organization [GO:0099173]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of postsynaptic specialization assembly [GO:0099150]; synapse assembly [GO:0007416]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005200; GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0007416; GO:0008021; GO:0008091; GO:0016079; GO:0016081; GO:0016192; GO:0016324; GO:0016363; GO:0017158; GO:0021692; GO:0030036; GO:0030054; GO:0030534; GO:0030864; GO:0033010; GO:0035264; GO:0042995; GO:0043025; GO:0048471; GO:0051015; GO:0051693; GO:0071361; GO:0098688; GO:0098793; GO:0098918; GO:0098978; GO:0099150; GO:0099173; GO:0099186; GO:0099189"
"1559","Pocillopora_acuta_HIv2___RNAseq.g30954.t1",0,0.617283950617284,0,0,0,1.26382306477093,0,0,0,NA,0.209011890598691,0.376221403077643,0,NA,NA,NA,NA,NA,NA,6.74355908835771,10.7038228043165,3.68233641306884,9.06242471982068,6.95026000352262,10.5627057380078,9.10840683033364,3.68233641306884,4.37599570701945,10.1012177424286,7.49730654599447,5.08689752500749,9.90771556698144,542.335819053487,6.470950478046,2.44217177017121,3.99453282313985e-08,9.80932474599231e-07,"A1KZ92",2.07e-33,"Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2)","hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]","GO:0004519; GO:0004601; GO:0005615; GO:0005783; GO:0005886; GO:0006979; GO:0020037; GO:0042744; GO:0046872; GO:0140825"
"1560","Pocillopora_acuta_HIv2___RNAseq.g18943.t1",0,NA,NA,0,0,5.76923076923077,4.34782608695652,0,0,NA,1.44529383659818,1.44230769230769,1.44927536231884,NA,NA,NA,NA,NA,NA,5.45976149983951,8.27386811086179,3.68233641306884,8.68475656126926,6.89567146066421,7.20338285899743,3.68233641306884,6.60881604930705,3.68233641306884,8.91317545679835,6.30864412369441,5.26578436718969,7.35150388019913,144.065324589211,0.259595047383371,1.03420394495065,0.0640509427961023,0.188261092583382,"Q8IS64",1.1e-163,"Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)","proteolysis [GO:0006508]","GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0008270"
"1561","Pocillopora_acuta_HIv2___RNAseq.g18944.t1",0,0,6.25,0,3.65853658536585,0,2.06185567010309,0,0,NA,1.33004358394099,0,2.99259806386724,NA,NA,NA,NA,NA,NA,10.8008723009478,5.21816971328303,6.68515093072166,8.9066444768695,9.09674017930627,8.64636513457533,10.1979915742431,11.3814263229825,6.07918960036691,11.3426028379383,8.83551530712344,8.80867586686503,8.86235474738185,961.231705171011,0.0363122271784017,0.901014797106286,0.906868290195441,0.965363170704455,"Q5XF89",0,"Polyamine-transporting ATPase 13A3 (Putrescine transporting ATPase) (EC 7.6.2.16)","intracellular calcium ion homeostasis [GO:0006874]; polyamine transmembrane transport [GO:1902047]","GO:0005524; GO:0006874; GO:0015203; GO:0015594; GO:0015662; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0046872; GO:0055038; GO:0140358; GO:1902047"
"1562","Pocillopora_acuta_HIv2___RNAseq.g18949.t2",0,NA,16.6666666666667,50,0,43.75,NA,NA,50,NA,26.7361111111111,47.9166666666667,5.55555555555556,1,-79.7962648556876,-79.7962648556876,0.0159894312495054,0.0159894312495054,0.0159894312495054,11.6409402440774,11.1035912974666,11.607354975336,11.1934194343736,11.3732707840189,11.8562893540159,10.9315545537716,10.6212285545536,12.5208237401836,13.7452331620502,11.6593706099847,11.5527236596339,11.7660175603356,4009.69489531873,0.157669414288767,0.550091617815372,0.738918129431703,0.88436541118816,"Q8VE97",2.55e-63,"Serine/arginine-rich splicing factor 4 (Splicing factor, arginine/serine-rich 4)","hematopoietic progenitor cell differentiation [GO:0002244]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; RNA splicing [GO:0008380]","GO:0002244; GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0048025; GO:1990825; GO:1990904"
"1563","Pocillopora_acuta_HIv2___RNAseq.g18958.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.57627509210327,11.209909240041,6.19479753228254,12.1341576182203,8.77445553895457,11.2062149526914,12.8088307943417,10.0887392329396,4.9224776128996,9.50258987334894,9.44184474878229,7.51134900183592,11.3723404957287,1870.13484021893,3.77126416067944,1.09239335597011,2.1118350658632e-06,2.98880453939777e-05,NA,NA,NA,NA,NA
"1564","Pocillopora_acuta_HIv2___RNAseq.g18965.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.5772197832221,9.96431179679802,6.22468762788833,5.11193581531555,9.41858271632398,9.9711479581476,10.2647222661036,8.90625327520324,9.25581162301369,3.68233641306884,7.9377009275085,8.07651100513027,7.79889084988672,499.219316181455,0.00477851727614923,0.907951840233626,0.96570263735466,0.987620939453992,"Q02978",8.29e-155,"Mitochondrial 2-oxoglutarate/malate carrier protein (OGCP) (alpha-oxoglutarate carrier) (Solute carrier family 25 member 11) (SLC25A11)","gluconeogenesis [GO:0006094]; lipid transport [GO:0006869]; malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709]","GO:0003723; GO:0005634; GO:0005739; GO:0005743; GO:0005886; GO:0006094; GO:0006869; GO:0008272; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015367; GO:0015709; GO:0015729; GO:0035435; GO:0071422; GO:0071423"
"1565","Pocillopora_acuta_HIv2___RNAseq.g18970.t1",11.1111111111111,4.44444444444444,1.19047619047619,5.55555555555556,2.7027027027027,0,NA,NA,8.33333333333333,0,4.16720291720292,4.58333333333333,3.7510725010725,NA,NA,NA,NA,NA,NA,7.60285280872257,8.12189365008233,10.2392713616853,7.92246643836188,10.2622758634889,10.7690743424422,11.3573402376426,9.57402775762441,10.2793502584394,3.68233641306884,8.98108891315584,9.59155560999212,8.37062221631957,929.793163016844,-0.150586631887152,0.900392791132867,0.618901475337046,0.813577291581845,"Q5ZIH0",0,"Integrator complex subunit 11 (Int11) (EC 3.1.27.-) (Cleavage and polyadenylation-specific factor 3-like protein) (CPSF3-like protein)","snRNA processing [GO:0016180]","GO:0004521; GO:0005634; GO:0016180; GO:0032039"
"1566","Pocillopora_acuta_HIv2___RNAseq.g18973.t1",5.71428571428571,20,0,5.40540540540541,13.6363636363636,2.5,3.33333333333333,11.1111111111111,9.67741935483871,10.5263157894737,8.19042343448116,9.73878717427105,6.64205969469127,NA,NA,NA,NA,NA,NA,3.68233641306884,7.8947948031256,7.89735631637503,3.68233641306884,8.92702347129378,3.68233641306884,4.60654391542428,10.0627103409456,10.1875038944462,3.68233641306884,6.43052783938858,8.15138608722589,4.70966959155128,307.786571824425,-0.381840712495963,1.12932156753315,1.51851702397001e-05,0.000163664904878556,"Q5ZID0",2.8e-81,"NmrA-like family domain-containing protein 1","","GO:0005634; GO:0048471"
"1567","Pocillopora_acuta_HIv2___TS.g5000.t1",NA,NA,0,0,NA,50,0,33.3333333333333,NA,0,13.8888888888889,27.7777777777778,0,NA,NA,NA,NA,NA,NA,10.792275690822,9.19118944999156,10.8954656157031,8.72807884406084,10.6544942177885,10.2677780783679,8.25419413569394,10.3477716054952,6.93249648929894,3.68233641306884,8.97460805402908,9.92450072382155,8.02471538423662,903.413780970817,-1.3310568884223,1.15646874254502,0.0271758749218279,0.0954521260003201,"Q674X7",6.64e-129,"Kazrin","keratinization [GO:0031424]","GO:0001533; GO:0005654; GO:0005829; GO:0005856; GO:0016607; GO:0030057; GO:0031424"
"1568","Pocillopora_acuta_HIv2___RNAseq.g18981.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.3787786145229,10.9103431983659,8.95661954912388,9.0438486539023,9.48752302902893,9.95983360732126,11.3331580749977,9.0222769824781,5.75167028831017,11.6032687367895,9.54473207348406,8.5193736926928,10.5700904542753,1134.18715203538,0.983187399819827,1.02131822771404,0.0670867375951001,0.195122174256089,"Q5ZMV8",1.83e-127,"Rap1 GTPase-activating protein 2 (Rap1GAP2) (GTPase-activating Rap/Ran-GAP domain-like protein 4)","regulation of small GTPase mediated signal transduction [GO:0051056]","GO:0005096; GO:0005737; GO:0005886; GO:0051056"
"1569","Pocillopora_acuta_HIv2___RNAseq.g19006.t1",0,0,0,0,2.42914979757085,0.248138957816377,1.93050193050193,0,NA,0,0.511976742876573,0.0620347394540943,0.871930345614556,NA,NA,NA,NA,NA,NA,8.95696998053855,6.70002980369271,6.0681601509144,7.52579662532212,8.12295198948429,6.62821723110622,4.10128477526701,6.94844182343232,3.68233641306884,9.37983141108895,6.81140202039154,6.75577207148768,6.8670319692954,182.450834626775,-0.115850093693448,0.958397557913896,0.581793780054734,0.789479804363606,NA,NA,NA,NA,NA
"1570","Pocillopora_acuta_HIv2___RNAseq.g19034.t4",NA,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,11.6436383490796,8.90827751609233,11.0519381050657,10.6027768406081,10.1061316589027,3.68233641306884,8.1725811194537,3.68233641306884,6.48472759049682,7.80170804189055,7.00966166045836,8.59375442332273,866.180181257424,0.180879018631985,1.00549960780502,0.227105746651865,0.460386477865813,"Q05793",0,"Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) [Cleaved into: Endorepellin; LG3 peptide]","angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; brain development [GO:0007420]; cardiac muscle tissue development [GO:0048738]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte differentiation [GO:0002062]; embryonic skeletal system morphogenesis [GO:0048704]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of endothelial cell proliferation [GO:0001938]; protein localization [GO:0008104]; receptor-mediated endocytosis [GO:0006898]; smoothened signaling pathway [GO:0007224]; tissue development [GO:0009888]","GO:0001525; GO:0001938; GO:0001958; GO:0002020; GO:0002062; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0006898; GO:0007162; GO:0007224; GO:0007411; GO:0007420; GO:0008104; GO:0008285; GO:0009887; GO:0009888; GO:0030198; GO:0031012; GO:0048704; GO:0048738; GO:0060351; GO:0062023; GO:0070052"
"1571","Pocillopora_acuta_HIv2___RNAseq.g19051.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.24036347909427,3.68233641306884,6.23938980254995,3.68233641306884,5.91659193355748,3.68233641306884,3.68233641306884,5.86111396217282,6.3603914105578,3.68233641306884,4.90295326532765,6.12357011758646,3.68233641306884,23.5398908061935,-8.37853881696348,3.72142584952847,0.000216582027212655,0.00159991953095191,NA,NA,NA,NA,NA
"1572","Pocillopora_acuta_HIv2___RNAseq.g19053.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.59625454638105,4.39481510491619,4.6464169258196,8.59399377233369,6.75685543042877,5.82637165358479,4.84014736901689,8.12296639568276,3.68233641306884,4.80766789501754,5.92678255062501,6.1609659422762,5.69259915897382,92.7587761204209,-0.095771867982698,0.977219090818057,0.585449560323151,0.792136804538266,NA,NA,NA,NA,NA
"1573","Pocillopora_acuta_HIv2___RNAseq.g19082.t1",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.61628577353322,3.68233641306884,10.7536965655577,3.68233641306884,11.1923187016633,11.0900338177746,3.68233641306884,3.68233641306884,11.1784334421985,7.22424503660715,3.68233641306884,10.7661536601455,922.112612153853,15.7395547637724,3.70510612057295,5.04384777531586e-17,4.05301190123159e-14,NA,NA,NA,NA,NA
"1574","Pocillopora_acuta_HIv2___TS.g5112.t1",2.5,0,0,0,5,2.56410256410256,0,0,11.7647058823529,NA,2.42542316071728,2.8657616892911,1.875,NA,NA,NA,NA,NA,NA,14.1696955811929,12.437753671565,13.1663099383277,8.62349819294917,13.2307821111145,10.0923821206271,6.86956709787897,12.4275550959369,14.5327028818253,12.3645381797592,11.7914784871177,13.5054091216795,10.0775478525559,7861.55930595759,-2.93840328974779,1.03214233744887,5.77456164228064e-05,0.000516212976476806,NA,NA,NA,NA,NA
"1575","Pocillopora_acuta_HIv2___RNAseq.g19089.t1",0,0,0,0,NA,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.19769212363849,9.96123173697161,7.00571141948957,6.1299899042818,5.420425513227,9.74814337849084,3.68233641306884,5.96778646100673,3.68233641306884,5.79624808010018,6.55919014433439,6.05479038608613,7.06358990258265,231.853768287556,0.232503622131581,0.991092250147554,0.272170227721892,0.516352331291901,NA,NA,NA,NA,NA
"1576","Pocillopora_acuta_HIv2___TS.g5115.t2",2.65084075173096,5.79345088161209,2.40224891387682,1.71613163739148,5.93851886353051,1.54620640057533,2.72295321637427,15.2043144575814,2.9359112065879,11.3915751516145,5.23021514808753,5.43920291674964,5.02122737942541,NA,NA,NA,NA,NA,NA,10.7163018364248,14.5654138265258,10.3195535690312,14.9166439807369,5.73407006217363,14.4822916683159,14.7040894651166,8.58566764835236,7.61674954260043,14.5878407227514,11.6228622322029,8.59446853171648,14.6512559326893,13271.9800359766,5.76740772612988,1.17788992556152,1.40212906928712e-10,7.68196774930642e-09,"P07898",1.61e-11,"Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)","cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; glial cell differentiation [GO:0010001]; positive regulation of neuroblast proliferation [GO:0002052]; skeletal system development [GO:0001501]","GO:0001501; GO:0002052; GO:0005509; GO:0005540; GO:0005615; GO:0007155; GO:0007417; GO:0010001; GO:0030246; GO:0045202; GO:0072534"
"1577","Pocillopora_acuta_HIv2___RNAseq.g19126.t1",NA,33.3333333333333,0,0,50,21.4285714285714,30.7692307692308,NA,80,48.8372093023256,33.0460431041826,33.6904761904762,32.4016100178891,NA,NA,NA,NA,NA,NA,10.1605048306613,11.4875743070768,11.266420260318,12.4047609171193,11.5990968289097,11.9199424865446,10.7342291021008,11.9025942701667,9.64017831110097,12.4723331482772,11.3587634462275,10.9137589002313,11.8037679922237,3063.56399771311,0.5519102956295,0.725083283968287,0.258412767797327,0.500426064188049,"Q90687",0,"Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (SH-PTP2) (cSH-PTP2)","cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of ossification [GO:0045778]","GO:0004725; GO:0004726; GO:0005634; GO:0005737; GO:0030971; GO:0032331; GO:0045778; GO:0050839; GO:0070374; GO:0071364"
"1578","Pocillopora_acuta_HIv2___TS.g5158.t1",0,3.40909090909091,14.5833333333333,0,18.2608695652174,0,4.44444444444444,4.16666666666667,0,NA,4.98493387986142,1.51515151515152,9.32216183574879,NA,NA,NA,NA,NA,NA,10.9227158148895,9.81192921118201,9.78982302210454,11.2930759799521,9.26861898501721,3.68233641306884,3.68233641306884,10.5136636216112,9.29341256436314,3.68233641306884,8.19402484383262,9.95764680159712,6.43040288606813,876.21361028343,-0.43218434389556,1.1043312640572,4.80633624161114e-06,6.0609282823595e-05,"Q5F464",5.1e-78,"Lipoma-preferred partner homolog","cell-cell adhesion [GO:0098609]","GO:0001725; GO:0005634; GO:0005737; GO:0005925; GO:0046872; GO:0098609"
"1579","Pocillopora_acuta_HIv2___TS.g5171.t1",0,0,0,0,0,0.869565217391304,0,NA,NA,NA,0.124223602484472,0.289855072463768,0,NA,NA,NA,NA,NA,NA,10.2656886306724,5.93854123587151,9.30435966305754,3.68233641306884,6.77213038688595,3.68233641306884,3.68233641306884,9.28552281498808,8.79055491568583,3.68233641306884,6.50861432994367,8.88365128225796,4.13357737762937,295.198265472461,-9.49528426615781,2.6434138817504,4.02370921627066e-09,1.32270295691224e-07,"P52569",2.27e-146,"Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)","amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-ornithine transmembrane transport [GO:1903352]; transport across blood-brain barrier [GO:0150104]","GO:0000064; GO:0005886; GO:0006865; GO:0015171; GO:0015174; GO:0015179; GO:0015189; GO:0015807; GO:0030054; GO:0061459; GO:0089718; GO:0097638; GO:0150104; GO:1902475; GO:1903352; GO:1903826"
"1580","Pocillopora_acuta_HIv2___RNAseq.g19165.t1",0,NA,NA,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.74081087897825,6.84260510118125,9.05476258699696,8.7085483189017,8.77258291434518,8.32789903644394,7.87890122384497,9.98860970391727,10.3679005389635,11.476737324267,8.915935762784,9.18493332464023,8.64693820092777,720.833495307999,-0.381331975587397,0.655157741141684,0.421498361612819,0.665925975135752,"Q5THJ4",0,"Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D)","lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]","GO:0006623; GO:0006869; GO:0007005; GO:0045053; GO:0070062; GO:1901526"
"1581","Pocillopora_acuta_HIv2___TS.g5202.t1",0,NA,NA,6.66666666666667,0,0,NA,NA,0,6.25,2.15277777777778,2.22222222222222,2.08333333333333,NA,NA,NA,NA,NA,NA,9.24862510846095,9.03876207521893,9.23301989748937,3.68233641306884,9.34617942162719,3.68233641306884,9.74553032813342,5.4533793909793,3.68233641306884,5.75038415558079,6.88628896166965,7.39270804632513,6.37986987701416,317.129361240184,0.00341935661042129,0.994895420754686,0.880250144917207,0.953504426100978,"P35525",0,"Chloride channel protein 2 (ClC-2)","acinar cell differentiation [GO:0090425]; cell differentiation involved in salivary gland development [GO:0060689]; cellular hypotonic response [GO:0071476]; chloride transport [GO:0006821]; lung development [GO:0030324]; phagocytosis, engulfment [GO:0006911]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of aldosterone biosynthetic process [GO:0032347]; regulation of membrane depolarization during action potential [GO:0098902]; retina development in camera-type eye [GO:0060041]","GO:0005247; GO:0005886; GO:0006821; GO:0006911; GO:0008308; GO:0015629; GO:0016323; GO:0030324; GO:0030425; GO:0032347; GO:0032591; GO:0034707; GO:0043194; GO:0043204; GO:0043209; GO:0045211; GO:0048714; GO:0060041; GO:0060689; GO:0071476; GO:0072320; GO:0090425; GO:0097450; GO:0098902"
"1582","Pocillopora_acuta_HIv2___TS.g5231.t1",0,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.29178752006676,3.68233641306884,6.2462771951713,9.08321023189442,3.68233641306884,8.60506118897161,7.08528261834752,10.8720033402508,3.68233641306884,6.39129677469778,6.88103380332608,5.90155974606947,302.550995986613,0.0488647045791023,1.00790431794387,0.538486183530667,0.758389888859548,"P07463",3.44e-21,"Calmodulin (CaM)","","GO:0005509; GO:0030234"
"1583","Pocillopora_acuta_HIv2___RNAseq.g19211.t1",0,0,0,0,0,8.33333333333333,0,0,0,0,0.833333333333333,1.66666666666667,0,NA,NA,NA,NA,NA,NA,9.82899839662404,9.54811775094958,10.8179413795883,3.68233641306884,10.4802991957536,9.84425965372215,7.86543438598675,9.13590799889864,9.74055702340423,10.5100548714747,9.14539070694708,10.0007407988538,8.2900406150404,869.163812628592,-0.328690479908991,0.913828252360651,0.409109810008408,0.654898230173517,"Q4PZA2",2.96e-163,"Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71)","axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; blood vessel diameter maintenance [GO:0097746]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; gene expression [GO:0010467]; neuron projection development [GO:0031175]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of blood pressure [GO:0008217]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to hypoxia [GO:0001666]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492]","GO:0001666; GO:0001921; GO:0004222; GO:0005769; GO:0005794; GO:0005886; GO:0007411; GO:0008217; GO:0008270; GO:0009897; GO:0009986; GO:0010467; GO:0010613; GO:0010814; GO:0010815; GO:0010816; GO:0016485; GO:0016486; GO:0030141; GO:0031175; GO:0031982; GO:0033093; GO:0034959; GO:0035050; GO:0042733; GO:0042802; GO:0042803; GO:0043583; GO:0043950; GO:0045745; GO:0048471; GO:0060037; GO:0060385; GO:0070372; GO:0097492; GO:0097746; GO:1902287"
"1584","Pocillopora_acuta_HIv2___RNAseq.g19215.t1a",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,11.7875014766787,7.78960555143337,10.7782396895718,9.07411917587505,11.0637726139685,9.96445660018503,10.4747160129212,3.68233641306884,11.8330903266589,9.01301742734302,6.94062271327346,11.0854121414126,1405.87983582649,0.568340265777602,1.16482656158428,0.0198533449078516,0.0737249758015831,NA,NA,NA,NA,NA
"1585","Pocillopora_acuta_HIv2___RNAseq.g19240.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.89135824262272,6.36195368411057,7.12687135132875,3.68233641306884,7.49854836219816,3.68233641306884,9.77096247074546,9.06060997845972,10.0069584303551,7.52477285154048,7.36067081974986,8.51686927299289,6.20447236650684,329.905592758262,-0.93065029572931,1.44905855432943,0.00605589906685461,0.0273812204135621,"A6X8Z9",8.37e-08,"Testis-specific expressed protein 55 (Testis-specific conserved, cAMP-dependent type II PK-anchoring protein)","","GO:0005634"
"1586","Pocillopora_acuta_HIv2___RNAseq.g19245.t1",0,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.13758278776356,3.68233641306884,7.47530043029133,9.51085335678529,10.1016338937644,3.68233641306884,3.68233641306884,3.68233641306884,5.22517199274777,3.68233641306884,5.98622245266966,7.12440510352718,4.84803980181213,248.448952484328,-0.251723720858269,1.04888749558236,0.0238995640164302,0.0858840481822725,"Q7TS68",5.78e-142,"tRNA (cytosine(72)-C(5))-methyltransferase NSUN6 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 6)","RNA methylation [GO:0001510]; tRNA C5-cytosine methylation [GO:0002946]; tRNA methylation [GO:0030488]","GO:0000049; GO:0001510; GO:0002946; GO:0005737; GO:0016428; GO:0030488"
"1587","Pocillopora_acuta_HIv2___TS.g5280.t1",0,NA,100,7.14285714285714,40,57.1428571428571,50,NA,72.7272727272727,100,53.3766233766234,45.6709956709957,58,NA,NA,NA,NA,NA,NA,9.1887222074393,3.68233641306884,9.760429728062,11.7563547109936,10.2058459025819,9.78422918013371,10.2376177664449,9.86509202193393,9.65649953639874,8.48020794163491,9.26173354086918,9.73531787928317,8.78814920245519,1004.80087969376,-0.174385971098348,0.884261370676125,0.61954994101624,0.814133764591523,"P56399",0,"Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5)","negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation protein catabolic process at presynapse [GO:0140251]","GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0008270; GO:0016579; GO:0032436; GO:0043130; GO:0098793; GO:0140251; GO:2000059"
"1588","Pocillopora_acuta_HIv2___RNAseq.g19257.t1",NA,NA,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.72441441264566,10.6310783865688,6.88242140054137,3.68233641306884,8.09020491054116,9.53085792045677,5.98675477185165,8.42620134867823,4.97930611778461,3.68233641306884,7.16159120952059,7.62050963803821,6.70267278100298,380.642813690122,-0.464255903823231,1.04218782801628,0.086220840268571,0.234021060920362,"A4II73",1.4e-63,"Esterase OVCA2 (EC 3.1.2.-) (Ovarian cancer-associated gene 2 protein homolog)","","GO:0016787"
"1589","Pocillopora_acuta_HIv2___RNAseq.g19258.t1",0,0,0,0,10.7142857142857,0,0,NA,NA,NA,1.53061224489796,0,2.67857142857143,NA,NA,NA,NA,NA,NA,8.50571125650928,5.6460547390973,7.93741002328246,3.68233641306884,7.39474963887568,3.68233641306884,3.68233641306884,7.96292728948732,6.63891135226464,3.68233641306884,5.8815109951792,7.68794191208388,4.07508007827453,102.97848240713,-8.10117552705426,2.81494843686699,5.77097364783863e-07,9.78562284200913e-06,"Q7VWH8",3.5e-21,"Phosphonoacetaldehyde hydrolase (Phosphonatase) (EC 3.11.1.1) (Phosphonoacetaldehyde phosphonohydrolase)","organic phosphonate catabolic process [GO:0019700]","GO:0000287; GO:0019700; GO:0050194"
"1590","Pocillopora_acuta_HIv2___RNAseq.g19269.t1",0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.0482467340334,3.68233641306884,9.41383714402746,10.0591457883376,9.23910097643923,9.89001758390583,9.98788380820886,9.16373474950593,8.59351861773419,3.68233641306884,8.37601582283302,9.29168764434804,7.46034400131799,613.262737680647,-0.185015131143642,0.958660087939216,0.3808174583133,0.630006144005899,"Q9VBW3",3.52e-57,"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303"
"1591","Pocillopora_acuta_HIv2___RNAseq.g19270.t1",0.568181818181818,0.920598388952819,0.700280112044818,1.7258883248731,1.08214461387113,0.405624661979448,0.741045697818032,1.29496402877698,0.158982511923688,0,0.759771015842183,0.901211583301206,0.618330448383159,NA,NA,NA,NA,NA,NA,8.43374494478076,8.11079559888894,9.29925772874183,9.56177886745259,9.21999709027669,7.79875575103921,8.81187518612058,8.73541341082483,5.8874486244384,3.68233641306884,7.95414036156327,8.3151723598125,7.59310836331403,353.684823912782,-0.464323781282696,0.834366550674049,0.315965027933878,0.564997612407568,"Q07496",3.66e-148,"Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (cEK8)","axon guidance [GO:0007411]; cell adhesion [GO:0007155]; ephrin receptor signaling pathway [GO:0048013]; fasciculation of sensory neuron axon [GO:0097155]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001108]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; segmentation [GO:0035282]; somitogenesis [GO:0001756]","GO:0001756; GO:0004672; GO:0005004; GO:0005005; GO:0005524; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0018108; GO:0030425; GO:0031901; GO:0035282; GO:0043087; GO:0046777; GO:0048013; GO:0097155; GO:0097161; GO:2001108"
"1592","Pocillopora_acuta_HIv2___RNAseq.g19271.t1",0,0,0,0,2.4390243902439,0.467289719626168,0,1.72413793103448,0,0,0.463045204090455,0.43828553013213,0.48780487804878,NA,NA,NA,NA,NA,NA,5.21468966089253,3.68233641306884,5.23497525321289,7.56120515657027,5.88788892518078,7.19476462422787,3.68233641306884,5.00453269325268,3.68233641306884,3.68233641306884,5.08274019656124,5.00488458912154,5.16059580400093,36.6150368553106,-0.0696203629963148,0.992569667781996,0.754269497297029,0.89215158935372,"Q07496",1.63e-77,"Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (cEK8)","axon guidance [GO:0007411]; cell adhesion [GO:0007155]; ephrin receptor signaling pathway [GO:0048013]; fasciculation of sensory neuron axon [GO:0097155]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001108]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; segmentation [GO:0035282]; somitogenesis [GO:0001756]","GO:0001756; GO:0004672; GO:0005004; GO:0005005; GO:0005524; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0018108; GO:0030425; GO:0031901; GO:0035282; GO:0043087; GO:0046777; GO:0048013; GO:0097155; GO:0097161; GO:2001108"
"1593","Pocillopora_acuta_HIv2___RNAseq.g19278.t1",2.61282660332542,0,0.227272727272727,0,2.55681818181818,0.461183704842429,1.90114068441065,2.18340611353712,0,0,0.994264801520652,0.528917963675909,1.45961163936539,NA,NA,NA,NA,NA,NA,9.01480256558103,5.26408513103678,9.0728166383295,8.43665445634566,8.93708822259858,8.44808500512408,7.94440170487039,9.53432286363424,6.30482766574162,3.68233641306884,7.66394206663307,8.57277159117699,6.75511254208915,312.507621670884,-1.20705565825551,1.25660366675676,0.0236778635045905,0.0851720014251174,"Q9VBW3",7.73e-75,"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303"
"1594","Pocillopora_acuta_HIv2___TS.g5308.t2",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.78605088335295,3.68233641306884,8.91006777795816,3.68233641306884,10.7355600227172,11.976963209238,3.68233641306884,4.86223652345053,9.2495397382469,7.02497638072391,3.91831643514518,10.1316363263026,759.035885685081,12.4310654655339,3.01233472419247,3.18103166534035e-12,3.40818088944317e-10,"Q9VBW3",7.83e-67,"Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303"
"1595","Pocillopora_acuta_HIv2___RNAseq.g19298.t1",0,NA,0,0,NA,0,1.63934426229508,0,5.88235294117647,0,0.940212150433944,1.47058823529412,0.409836065573771,NA,NA,NA,NA,NA,NA,3.68233641306884,5.71009804948923,3.68233641306884,10.5505895075146,10.1201471805294,9.35772848411287,11.8797242618596,8.09106390811834,3.68233641306884,3.68233641306884,7.04386970438994,5.85164406557085,8.23609534320903,721.249507689394,0.469031478783463,1.1339038188357,0.0348437602632206,0.116899786518986,"Q9CQ52",1.21e-53,"Chymotrypsin-like elastase family member 3B (EC 3.4.21.70) (Elastase IIIB) (Elastase-3B) (Protease E)","proteolysis [GO:0006508]","GO:0004252; GO:0005615; GO:0006508; GO:0062023"
"1596","Pocillopora_acuta_HIv2___RNAseq.g19306.t1",45.8333333333333,0,50,66.6666666666667,0,45.0980392156863,65.7142857142857,NA,100,NA,46.6640406162465,52.9411764705882,40.3869047619048,NA,NA,NA,NA,NA,NA,7.04630611039243,3.68233641306884,5.64062457406066,9.15187451781258,6.27545950462381,6.46381683615196,3.68233641306884,6.09342916571462,3.68233641306884,3.68233641306884,5.54008563610314,5.74763115357207,5.33254011863421,84.2109371427032,-0.123292358330987,1.00076482357708,0.549676976282168,0.766455118452715,NA,NA,NA,NA,NA
"1597","Pocillopora_acuta_HIv2___TS.g5340.t3b",0,NA,NA,0,0,0,0,16.6666666666667,NA,NA,2.77777777777778,5.55555555555556,0,NA,NA,NA,NA,NA,NA,9.74535300296951,10.7464870595693,9.7837486292929,10.6734372030406,9.678529682526,11.0812791364927,10.9665615938963,9.12651172582184,9.86593284638692,6.94153598059022,9.86093768605863,9.64001517739943,10.0818601947178,1143.90716479083,0.343521205943254,0.760318858664872,0.469339282375579,0.70777371562157,"O70585",9.52e-173,"Dystrobrevin beta (DTN-B) (mDTN-BDTN-B) (Beta-dystrobrevin)","synaptic signaling [GO:0099536]","GO:0003677; GO:0005634; GO:0005737; GO:0005886; GO:0008270; GO:0009925; GO:0014069; GO:0019902; GO:0030425; GO:0045202; GO:0060077; GO:0098794; GO:0098982; GO:0099536"
"1598","Pocillopora_acuta_HIv2___RNAseq.g19326.t1",28.5714285714286,66.6666666666667,NA,0,18.75,0,17.7777777777778,0,0,NA,16.4707341269841,13.3333333333333,21.6997354497354,NA,NA,NA,NA,NA,NA,7.77039409372247,10.8197302158365,10.0538538413808,9.37382752931313,10.0313823995686,8.67126450028949,9.22869534326832,9.3393789223552,3.68233641306884,8.69010722265362,8.7660970481457,8.17546913401918,9.35672496227221,663.877761990604,0.259696584028171,0.919695361986632,0.452057120932797,0.693304442495173,"Q96AE7",3.45e-14,"Tetratricopeptide repeat protein 17 (TPR repeat protein 17)","actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]","GO:0005737; GO:0005829; GO:0005886; GO:0015629; GO:0030041; GO:0044782"
"1599","Pocillopora_acuta_HIv2___RNAseq.19307_t",41.6666666666667,0,33.3333333333333,0,0,57.1428571428571,21.0526315789474,25,NA,NA,22.2744360902256,20.5357142857143,24.0131578947368,NA,NA,NA,NA,NA,NA,6.0744275437907,7.25173910022888,9.8304639363196,9.98808278206217,7.05969742439756,3.68233641306884,3.68233641306884,3.68233641306884,3.68233641306884,3.68233641306884,5.86160928521431,6.06585234612911,5.65736622429951,215.596885982526,-0.0592060388511281,0.97099448550499,0.974948833082989,0.991913908309692,"Q9UPW0",2.66e-73,"Forkhead box protein J3","cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]","GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007141; GO:0007283; GO:0030154; GO:0043565; GO:0045944; GO:1990837"
"1600","Pocillopora_acuta_HIv2___RNAseq.g19334.t1",0,0,0,0,0,NA,NA,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.13094462683116,10.0171745790842,7.13459198279071,6.82126065609372,9.8883638617591,3.68233641306884,9.44955726734836,7.90167785068873,7.76511963037754,8.33339164675596,7.91244185147983,8.16413959048945,7.66074411247022,377.10226336141,0.0533946510880335,0.887280990496051,0.909080934012357,0.96603751551201,"B0DOB4",0,"Nephrocystin-4","negative regulation of canonical Wnt signaling pathway [GO:0090090]","GO:0005737; GO:0005856; GO:0090090; GO:0097730"
"1601","Pocillopora_acuta_HIv2___TS.g5360.t3",16.6666666666667,0,NA,NA,0,0,0,NA,0,NA,2.77777777777778,0,5.55555555555556,NA,NA,NA,NA,NA,NA,9.45703034318526,10.3855520432604,10.9365566401557,11.8122719208055,10.9493560217956,10.3691353949959,5.63253479849075,11.1119936701315,8.10422827110476,10.2052857239394,9.89639448278648,10.1118329892746,9.68095597629839,1436.33599613303,0.0257354879047496,0.816922999178424,0.950409643120921,0.980895974456225,"Q8C033",9.86e-145,"Rho guanine nucleotide exchange factor 10","actin cytoskeleton organization [GO:0030036]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]","GO:0005085; GO:0005813; GO:0019894; GO:0022011; GO:0030036; GO:0051298; GO:0051496; GO:0090307"
"1602","Pocillopora_acuta_HIv2___RNAseq.g19368.t2",NA,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.82759658107764,5.01287713650611,8.86287661369108,7.47098189621969,10.384313945469,7.59199605080199,11.2301968665404,9.27847035822101,12.6441370249182,9.75941515522351,9.20628616286686,10.1994789046754,8.21309342105834,1315.60447397793,-1.08779152682076,1.24032121021739,0.0261111684199293,0.0922668853709886,"Q9I7F7",1.03e-65,"Activated Cdc42 kinase-like (EC 2.7.10.2) (Tyrosine-protein kinase PR2)","dorsal closure, amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; myosin filament assembly [GO:0031034]; protein phosphorylation [GO:0006468]","GO:0004713; GO:0004715; GO:0005524; GO:0005886; GO:0006468; GO:0008258; GO:0031034; GO:0046664"
"1603","Pocillopora_acuta_HIv2___RNAseq.g19392.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.75338390936338,8.60154249448205,9.6064986712494,3.68233641306884,9.0309190252451,3.68233641306884,3.68233641306884,8.74363466371469,10.0140122009672,3.68233641306884,6.94793366172972,9.22968969410795,4.66617762935148,343.308985662354,-1.03447124547342,1.95220516663312,6.10990201326076e-08,1.39831681518677e-06,"A2AP18",8.2e-180,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2)","lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; release of sequestered calcium ion into cytosol [GO:0051209]","GO:0004435; GO:0004629; GO:0005509; GO:0005737; GO:0005886; GO:0007200; GO:0016042; GO:0046488; GO:0048015; GO:0051209"
"1604","Pocillopora_acuta_HIv2___RNAseq.g19394.t1",0,0,NA,NA,0,0,NA,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,7.09414687449084,7.93941910765684,9.25250903568254,3.68233641306884,8.63298744957825,3.68233641306884,3.68233641306884,8.84453828830892,7.98265228961194,3.68233641306884,6.44755986976047,8.3613667875345,4.53375295198644,195.119125347909,-0.780301809094165,1.48947687328996,7.29641342180856e-07,1.19114360872505e-05,"A2AP18",0,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2)","lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; release of sequestered calcium ion into cytosol [GO:0051209]","GO:0004435; GO:0004629; GO:0005509; GO:0005737; GO:0005886; GO:0007200; GO:0016042; GO:0046488; GO:0048015; GO:0051209"
"1605","Pocillopora_acuta_HIv2___RNAseq.g6124.t1",50,0,NA,16.6666666666667,65.2173913043478,45.4545454545455,43.75,NA,50,NA,38.7269433465086,28.030303030303,52.9891304347826,NA,NA,NA,NA,NA,NA,11.0417288267943,10.7757062316007,11.7493721482988,10.8837919156225,11.7185871850089,11.8566282635143,11.7070034615289,11.3457859486681,12.420888402386,12.8442264772731,11.6343718860696,11.6552725022312,11.6134712699079,3479.89374058125,-0.025703400650151,0.518199868369999,0.946587629381325,0.979700213448218,"A7S4N4",1.25e-164,"Probable serine incorporator","phospholipid biosynthetic process [GO:0008654]","GO:0005789; GO:0008654; GO:0016020"
"1606","Pocillopora_acuta_HIv2___RNAseq.g6126.t1",100,100,NA,100,66.6666666666667,100,100,NA,NA,NA,94.4444444444444,100,88.8888888888889,NA,NA,NA,NA,NA,NA,12.3751136636048,11.1590740442766,12.1286450410084,11.4807646569292,12.454424757004,11.1624741559954,13.0147990025294,11.2470446914275,11.7453692288862,11.1926819860112,11.7960391227673,11.9901194763862,11.6019587691484,3906.42272767078,-0.276255018858361,0.643851642612848,0.545440011371628,0.763440817239297,"Q2KJI2",0,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18)","co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0004579; GO:0018279; GO:0035000; GO:0043686; GO:0043687; GO:0046872"
"1607","Pocillopora_acuta_HIv2___TS.g2668.t1a",NA,NA,0,0,0,0,0,0,2.5,0,0.3125,0.625,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,5.79243403424225,3.68233641306884,8.09921022563552,9.46834519867581,9.83092088717402,3.68233641306884,7.91777144829032,3.68233641306884,5.95203638593621,5.83481770686115,6.06925506501127,206.687465998408,0.00344146414822298,1.00318524553331,0.256193483265925,0.49786141904586,"O15050",0,"TPR and ankyrin repeat-containing protein 1 (Lupus brain antigen 1 homolog)","",""
"1608","Pocillopora_acuta_HIv2___TS.g2668.t1b",NA,0,0,NA,13.3333333333333,0,0,0,NA,NA,2.22222222222222,0,4.44444444444444,NA,NA,NA,NA,NA,NA,8.50921680081805,9.67386912869877,8.85362216673741,9.40083569211753,8.96686736539284,10.1598553939212,10.024593370431,9.29394046840886,7.67509897577884,9.71778743968482,9.22756868019893,8.6597491554272,9.79538820497066,642.626406210649,0.936791323297088,0.601494631522023,0.0557310313649468,0.168912053557848,"Q9NSN8",5.12e-83,"Gamma-1-syntrophin (G1SYN) (Syntrophin-4) (SYN4)","cell communication [GO:0007154]","GO:0003779; GO:0005198; GO:0005634; GO:0005737; GO:0005856; GO:0007154; GO:0016010; GO:0016013; GO:0032587"
"1609","Pocillopora_acuta_HIv2___RNAseq.g6142.t1",0,NA,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.44158929104264,3.68233641306884,3.68233641306884,7.21780641711855,3.68233641306884,3.68233641306884,8.01827956207571,8.98123917769104,7.85789910219586,5.7928495615468,6.3163995966046,5.269299526489,119.468084491203,-0.129013497628519,1.01539940013257,0.0481812082285471,0.151399738391854,NA,NA,NA,NA,NA
"1610","Pocillopora_acuta_HIv2___RNAseq.g6154.t1",0,0,NA,3.57142857142857,0,0,0,NA,NA,NA,0.595238095238095,1.19047619047619,0,NA,NA,NA,NA,NA,NA,11.3492102497146,10.2020451848776,9.42168320607397,12.1264582825454,11.600152191738,8.74641067247364,11.0341257862485,10.5556752541588,9.78247035279086,11.5161182686348,10.6334349449256,10.5418382508952,10.725031638956,1963.41192244903,0.117249922347292,0.775835200500097,0.79351645203082,0.91264487612705,"Q92519",1.89e-130,"Tribbles homolog 2 (TRB-2)","negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405]","GO:0004860; GO:0005634; GO:0005737; GO:0005856; GO:0006469; GO:0031434; GO:0031625; GO:0032436; GO:0032693; GO:0043405; GO:0045599; GO:0055106; GO:0061629"
"1611","Pocillopora_acuta_HIv2___RNAseq.g6157.t1",6.95187165775401,4.67289719626168,13.5593220338983,2.66666666666667,11.7021276595745,9.78835978835979,19.047619047619,0,0,0,6.8388864050134,3.42558473025763,10.2521880797692,NA,NA,NA,NA,NA,NA,9.34585686405774,8.8616861583784,7.18005401377357,3.68233641306884,10.7268202071498,3.68233641306884,3.68233641306884,8.34202180783398,10.2036349119119,3.68233641306884,6.93894196153807,9.1596775609454,4.71820636213075,430.777539107758,-1.03162857837977,1.93529269480617,1.69694579854673e-07,3.40897555974721e-06,"Q96DC8",5.6e-121,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial","fatty acid metabolic process [GO:0006631]; positive regulation of cellular response to insulin stimulus [GO:1900078]","GO:0004300; GO:0005739; GO:0006631; GO:0016836; GO:1900078"
"1612","Pocillopora_acuta_HIv2___RNAseq.g6161.t1",0.425531914893617,0,0,1.78041543026706,0.454545454545455,0.604651162790698,0.388726919339164,2.09302325581395,1.06100795755968,0,0.680790209520963,1.10781956128628,0.253760857755647,NA,NA,NA,NA,NA,NA,6.5907432092831,3.68233641306884,8.43036119756512,9.34882769618367,6.69403455193469,8.97853405266249,3.68233641306884,8.03514839820377,8.93736739175462,8.33339164675596,7.27130809704811,7.73753094974826,6.80508524434796,257.692844654148,-0.200982432111608,0.967885569678332,0.329021193166634,0.57916058634078,NA,NA,NA,NA,NA
"1613","Pocillopora_acuta_HIv2___RNAseq.g6169.t1",0.564971751412429,0,0,0,0,0.917431192660551,0.276243093922652,7.46268656716418,0,NA,1.02459251168442,1.67602355196495,0.21030371133377,NA,NA,NA,NA,NA,NA,7.50758496116064,9.51908409750923,8.06338218429842,3.68233641306884,6.12628170656021,8.2679069717014,4.27277361158612,8.17866421370582,3.68233641306884,3.68233641306884,6.29826869857284,6.71164989575879,5.88488750138689,170.436901066703,-0.104073553700088,0.993240484350035,0.67660261329662,0.850108312242743,"Q460N5",1.15e-65,"Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)","innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212]","GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:1902216; GO:1990404"
"1614","Pocillopora_acuta_HIv2___RNAseq.g6170.t1b",1.03550295857988,0.304878048780488,1.06744298884037,0.601001669449082,0.921080175842579,0.892605468382975,0.994575045207957,0.961538461538462,0.43640897755611,0.141242937853107,0.735627673203101,0.639286525141423,0.831968821264779,NA,NA,NA,NA,NA,NA,10.9325284099429,11.081779471148,11.1183962945721,8.32302376070083,10.9435469710229,10.2052762061549,7.7961348588384,9.95716320225835,11.8499709302554,9.24172651454906,10.1449546619443,10.9603211616103,9.32958816227824,1507.38441817583,-1.22794822644881,0.823200265653858,0.0266687509748028,0.0939675552008644,"Q460N5",1.46e-94,"Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)","innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212]","GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:1902216; GO:1990404"
"1615","Pocillopora_acuta_HIv2___RNAseq.g6173.t1",NA,50,50,NA,50,40.5405405405405,NA,NA,56.25,50,49.4650900900901,48.9301801801802,50,NA,NA,NA,NA,NA,NA,9.85124408540131,9.80679056307722,9.87685510969563,11.51823292861,10.6580459300581,10.0033439268811,8.13592639885313,9.7049693874149,9.07869273752916,11.616163146692,10.0250264214213,9.83396145001982,10.2160913928227,1287.58946270667,0.188737350387912,0.715302692700983,0.684601735598444,0.854142974527378,"Q9V3J1",1.97e-171,"V-type proton ATPase subunit H (V-ATPase subunit H) (Vacuolar proton pump subunit H) (Vacuolar proton pump subunit SFD)","determination of adult lifespan [GO:0008340]; dsRNA transport [GO:0033227]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]","GO:0000221; GO:0007042; GO:0008340; GO:0033181; GO:0033227; GO:0046961; GO:1902600"
"1616","Pocillopora_acuta_HIv2___TS.g2710.t1",NA,0,NA,NA,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,15.4446962703948,12.6541570864794,15.4520281588096,12.2426006164124,15.3943198382477,12.4161341648351,12.6529622503228,15.5016363376785,15.4329439219339,12.6335838510591,13.9825062496173,15.4451249054129,12.5198875938218,25241.7068372189,-2.77483874029913,0.545409700186054,4.18372037934555e-08,1.0170307826362e-06,"G8HTB6",2.94e-156,"ZP domain-containing protein","","GO:0016020"
"1617","Pocillopora_acuta_HIv2___RNAseq.g6190.t1",1.78571428571429,13.6363636363636,3.7037037037037,21.875,4.65116279069767,13.0434782608696,0,27.7777777777778,NA,18.4210526315789,11.654917009634,19.0831549187527,5.71232668233892,NA,NA,NA,NA,NA,NA,8.45571527498275,6.13320531664763,8.02260750249222,3.68233641306884,8.89640032871869,8.09909073650838,3.68233641306884,7.01851619965034,3.68233641306884,3.68233641306884,6.13548810112754,7.21511514378257,5.05586105847251,141.331981704788,-0.546564240791808,1.17377569984302,0.0516798544085745,0.159177473203923,"Q8T5T1",1.88e-07,"Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein)","ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0005524; GO:0005654; GO:0005730; GO:0016887"
"1618","Pocillopora_acuta_HIv2___TS.g2727.t1",NA,0,NA,NA,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,10.0862544551206,8.97907720476769,9.63647180323261,11.090892972596,6.77213038688595,10.4700514851442,5.7616711601265,8.63512470404645,3.68233641306884,3.68233641306884,7.87963469980577,7.76246355247089,7.99680584714065,634.878595931601,0.0441478101983008,0.897439095845727,0.83082460412733,0.931554036751759,"Q8IZQ1",0,"WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy)","aggrephagy [GO:0035973]","GO:0000421; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872"
"1619","Pocillopora_acuta_HIv2___RNAseq.g6209.t1",0,NA,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.0744275437907,5.35078960182194,7.04726048369553,3.68233641306884,3.68233641306884,9.80545502921985,3.68233641306884,8.79793342285728,3.68233641306884,3.68233641306884,5.54875481467295,5.85685885529624,5.24065077404966,146.026988021353,-0.117361128170045,1.0150109095304,0.0571827577771727,0.172548896496808,"A0A2B4RNI3",0,"Cyclic GMP-AMP synthase-like receptor 2 (Sp-cGLR2) (EC 2.7.7.86)","innate immune response [GO:0045087]","GO:0005524; GO:0005525; GO:0045087; GO:0046872; GO:0061501"
"1620","Pocillopora_acuta_HIv2___TS.g2780.t1",0.135135135135135,2.24032586558045,3.56294536817102,2.66393442622951,12.2873345935728,0.177935943060498,4.54545454545455,2.60869565217391,0,4.23976608187134,3.24615276112492,1.53817837740887,4.95412714484096,NA,NA,NA,NA,NA,NA,3.68233641306884,6.77312724931675,7.32187822721292,8.26533225739722,7.61222215514669,8.2679069717014,3.68233641306884,6.20832086896029,5.75167028831017,3.68233641306884,6.1247467257252,6.11528559053978,6.13420786091061,103.878845238717,-0.0406434472485414,0.973107356329124,0.759564106918495,0.894772894844415,"Q91VS7",7.4e-12,"Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I)","glutathione metabolic process [GO:0006749]; response to lipopolysaccharide [GO:0032496]; response to organonitrogen compound [GO:0010243]; response to xenobiotic stimulus [GO:0009410]","GO:0004364; GO:0005739; GO:0005741; GO:0005743; GO:0005778; GO:0005783; GO:0005789; GO:0006749; GO:0009410; GO:0010243; GO:0016020; GO:0032496; GO:0042802; GO:0043295; GO:0045177"
"1621","Pocillopora_acuta_HIv2___TS.g2787.t1",0,0,15.625,0,0,1.8018018018018,0,NA,0,NA,2.17835022522523,0.45045045045045,3.90625,NA,NA,NA,NA,NA,NA,11.4825370087006,11.1435354095268,12.1156486244438,11.4292434148356,11.5565083182436,7.35792596442826,5.82167741730566,11.9345619419736,11.7036657538173,13.4516204275017,10.7996924280777,11.7585843294358,9.8408005267196,3375.23961148052,-0.556904242222004,0.987149046854111,0.13330162823359,0.322030616955381,NA,NA,NA,NA,NA
"1622","Pocillopora_acuta_HIv2___RNAseq.g6251.t1",0,0,0,0,0,3.06748466257669,7.40740740740741,0,0,0,1.04748920699841,0.613496932515337,1.48148148148148,NA,NA,NA,NA,NA,NA,10.8671789082419,10.6281685762011,10.9398376070986,7.19433250046938,10.5359599522577,9.71412751504697,9.74736185936645,9.56709998910106,5.46360254994476,11.0668322836412,9.57245017413691,9.4747358013288,9.67016454694502,1144.24694807485,-0.0499251654929342,0.845252595707089,0.877270646441933,0.952758869960664,"P30622",1.3e-06,"CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin)","cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116]","GO:0000278; GO:0000776; GO:0001578; GO:0001726; GO:0005634; GO:0005813; GO:0005829; GO:0005874; GO:0005882; GO:0005886; GO:0005938; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0031122; GO:0042802; GO:0051010"
"1623","Pocillopora_acuta_HIv2___RNAseq.g6253.t1",50,NA,83.3333333333333,0,0,38.4615384615385,NA,NA,0,NA,28.6324786324786,12.8205128205128,44.4444444444444,NA,NA,NA,NA,NA,NA,14.4494327053805,14.2847819621567,14.2270727048962,14.7483491116773,13.8262623597975,14.2916176312547,14.5247387712358,13.9837522895909,14.1808082780705,14.3880771912619,14.2904893005322,14.1334656675471,14.4475129335173,20313.8435276399,0.249127172428718,0.489238232394152,0.566146528309484,0.77728935789923,"P36241",1.26e-100,"Large ribosomal subunit protein eL19 (60S ribosomal protein L19)","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"1624","Pocillopora_acuta_HIv2___RNAseq.g6256.t1",0,NA,0,0,NA,2.08333333333333,4.6875,NA,0,NA,1.12847222222222,0.694444444444445,1.5625,NA,NA,NA,NA,NA,NA,7.88297397736584,3.68233641306884,7.07964346771683,5.56232777220043,9.67952875660758,9.80404965107117,3.68233641306884,9.92320856083833,3.68233641306884,6.21711944007385,6.71958608650805,7.64953823511948,5.78963393789663,300.630775243946,-0.202799250334947,1.00997462418575,0.192938574822084,0.412820051216955,"Q149N8",0,"E3 ubiquitin-protein ligase SHPRH (EC 2.3.2.27) (EC 3.6.4.-) (RING-type E3 ubiquitin transferase SHPRH) (SNF2, histone-linker, PHD and RING finger domain-containing helicase)","DNA damage response [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]","GO:0000209; GO:0000786; GO:0003677; GO:0004386; GO:0004842; GO:0005524; GO:0005654; GO:0006281; GO:0006334; GO:0006974; GO:0016567; GO:0016787; GO:0031625; GO:0046872; GO:0061630; GO:0140658"
"1625","Pocillopora_acuta_HIv2___TS.g2796.t1",NA,0,57.1428571428571,68.4210526315789,4.16666666666667,37.5,53.8461538461538,100,84.6153846153846,0,45.076901655849,58.1072874493927,28.7889194139194,1,-65.5172413793103,-65.5172413793103,0.00469015530954215,0.00469015530954215,0.00469015530954215,12.829892673005,11.8197392135719,13.2379132034993,12.5698452079189,12.7249976771947,12.3257569168916,13.1273566471507,12.2233721431859,11.7805344978491,12.5565880349021,12.5195996215169,12.5593420389468,12.479857204087,6155.61205610198,-0.0529815618344759,0.573226760610025,0.899686829853286,0.962042601550155,"G5E8K5",0,"Ankyrin-3 (ANK-3) (Ankyrin-G)","anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; clustering of voltage-gated sodium channels [GO:0045162]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in cell [GO:0032507]; membrane assembly [GO:0071709]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of endocytosis [GO:0045806]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; regulation of protein targeting [GO:1903533]; signal transduction [GO:0007165]; synapse organization [GO:0050808]","GO:0005764; GO:0005886; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008089; GO:0008092; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0030951; GO:0031594; GO:0032507; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045162; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045806; GO:0045838; GO:0050808; GO:0061564; GO:0071286; GO:0071709; GO:0072659; GO:0090314; GO:0098794; GO:0099612; GO:0140031; GO:1900827; GO:1901224; GO:1902260; GO:1903533; GO:1904115; GO:2000651; GO:2001259"
"1626","Pocillopora_acuta_HIv2___RNAseq.g6259.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.77620164177499,11.1810802633463,9.90398999480587,11.0581186644522,9.94512552263226,7.83785566423622,11.1937284643851,11.0396192025013,6.03378121970174,3.68233641306884,9.16518370509048,9.33974351628323,8.99062389389773,1178.94169144984,-0.194310290288347,0.846228903950664,0.589446477974072,0.79464571324606,"Q8TDM6",1.8e-122,"Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG)","apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; neuroepithelial cell differentiation [GO:0060563]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; postsynapse organization [GO:0099173]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186]","GO:0001837; GO:0005737; GO:0005886; GO:0005912; GO:0007165; GO:0008013; GO:0008092; GO:0008285; GO:0014069; GO:0030011; GO:0030054; GO:0030159; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0035556; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045880; GO:0051965; GO:0060441; GO:0060563; GO:0060999; GO:0065003; GO:0071896; GO:0072205; GO:0098609; GO:0098978; GO:0099173"
"1627","Pocillopora_acuta_HIv2___RNAseq.g6273.t1",0,0,NA,NA,0,6.45161290322581,0,0,NA,NA,1.0752688172043,2.1505376344086,0,NA,NA,NA,NA,NA,NA,9.35756234588217,9.11560498715579,10.2258936316634,9.21411339541792,9.78540510875706,7.22892834819183,7.10709703926101,10.011752636061,10.9557032376031,7.77346755820766,9.07755282882009,10.0672633919933,8.08784226564684,715.748271921282,-1.61798922082397,0.891548399636149,0.00695840087753314,0.030863633944385,"Q5F4A1",1.91e-75,"G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)","apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]","GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872"
"1628","Pocillopora_acuta_HIv2___RNAseq.g6275.t1",60.8695652173913,NA,46.1538461538462,NA,NA,66.6666666666667,57.5757575757576,76.1904761904762,63.1578947368421,NA,61.7690344234967,68.671679197995,54.8663896489983,NA,NA,NA,NA,NA,NA,8.17578565497786,6.97205094875064,8.35688625658826,7.97581545078448,8.53252601853795,6.58890355943315,8.07877216362674,8.87291872100213,7.83710770302699,6.94153598059022,7.83323024573184,8.35504487082664,7.31141562063705,230.310767326532,-0.900135030323875,0.629689014486238,0.0706517736443597,0.203081727740862,"Q5F4A1",2.38e-68,"G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)","apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]","GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872"
"1629","Pocillopora_acuta_HIv2___RNAseq.g6279.t1",0,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.32448441960038,3.68233641306884,7.67308893932296,5.9757421057541,7.39474963887568,4.58790998118372,3.68233641306884,7.1111323359117,6.73914848420464,3.68233641306884,5.68532651440597,7.04852076358307,4.32213226522887,62.0898809323004,-5.03853431846026,2.43214513392916,3.82858265988262e-05,0.000361702283426141,"Q5F4A1",3.47e-68,"G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)","apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]","GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872"
"1630","Pocillopora_acuta_HIv2___TS.g2824.t1",0,9.67741935483871,0,0,1.21951219512195,0.662251655629139,7.07964601769912,0,0,NA,2.07098102480988,2.06793420209357,2.07478955320527,NA,NA,NA,NA,NA,NA,8.03195997917701,7.83530183461159,8.06338218429842,7.43323357003778,7.3142128553038,8.05240858509761,6.36722016743734,6.56229197038834,4.08537762695683,3.68233641306884,6.74277251863776,6.81144492322488,6.67410011405063,133.60384018715,-0.133825345434058,0.650414600633219,0.792849086933276,0.912574068471411,NA,NA,NA,NA,NA
"1631","Pocillopora_acuta_HIv2___TS.g2835.t1",66.6666666666667,NA,NA,NA,80,46.6666666666667,100,75,100,NA,78.0555555555556,73.8888888888889,82.2222222222222,NA,NA,NA,NA,NA,NA,6.5772197832221,6.41823073368408,7.49934036428563,4.62642457401022,7.09033777769384,3.68233641306884,6.64888280067412,8.19376023911409,6.05667785981469,3.68233641306884,6.04755469586364,7.08346720482607,5.01164218690122,79.4348268517831,-1.41273665426048,2.01249421072036,0.0024216567060758,0.01259505307324,"Q5F4A1",3.58e-61,"G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase)","apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]","GO:0004842; GO:0005634; GO:0005730; GO:0005737; GO:0006915; GO:0016567; GO:0046872"
"1632","Pocillopora_acuta_HIv2___RNAseq.g6317.t2",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.69242518691729,6.17776049751523,9.29925772874183,9.6235273196098,9.77141707659714,3.68233641306884,3.68233641306884,10.362515060908,3.68233641306884,3.68233641306884,6.96562485225647,8.56159029324662,5.36965941126631,435.829380084628,-0.384376508032515,1.09245938500462,0.0393157496242883,0.129153532265661,"P55112",1.63e-38,"Zinc metalloproteinase nas-4 (EC 3.4.24.-) (Nematode astacin 4)","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"1633","Pocillopora_acuta_HIv2___RNAseq.g6318.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.68625071326984,8.17613327516216,7.05542591027989,8.64831517435104,8.16357875140148,3.68233641306884,5.96063705750028,8.73747312827691,3.68233641306884,3.68233641306884,6.74748232494481,7.46501298325939,6.02995166663023,224.947739461304,-0.377482398951816,1.03525118835787,0.276544847124468,0.521437187955717,"Q5R941",1.11e-44,"Peptidyl-prolyl cis-trans isomerase FKBP14 (PPIase FKBP14) (EC 5.2.1.8) (FK506-binding protein 14) (FKBP-14) (Rotamase)","","GO:0003755; GO:0005509; GO:0005788"
"1634","Pocillopora_acuta_HIv2___RNAseq.g6321.t1",NA,100,33.3333333333333,NA,NA,100,71.4285714285714,NA,100,100,84.1269841269841,100,68.2539682539683,NA,NA,NA,NA,NA,NA,9.4442797963975,7.69352644314077,9.80069286428888,9.91333600125988,10.0646436586121,9.42144955781877,3.68233641306884,10.2093090411939,7.83710770302699,9.25731083832564,8.73239923171333,9.47120661270387,7.99359185072278,631.280145124083,-0.283344201083312,0.915557784685172,0.44433938443042,0.686868423771978,"Q9UBI4",1.96e-68,"Stomatin-like protein 1 (SLP-1) (EPB72-like protein 1) (Protein unc-24 homolog) (Stomatin-related protein) (STORP)","lipid transport [GO:0006869]","GO:0005886; GO:0006869; GO:0031902; GO:0045121"
"1635","Pocillopora_acuta_HIv2___RNAseq.g6350.t1",0,0,0,0,3.19148936170213,0.91324200913242,9.19540229885057,0,0,0,1.33001336696851,0.182648401826484,2.47737833211054,NA,NA,NA,NA,NA,NA,10.6512363628672,3.68233641306884,11.7314985278322,7.28204866049182,10.8423750585344,3.68233641306884,7.89224278088045,12.317340586911,11.4459739276171,5.70282560183315,8.5230214333105,11.3976848927524,5.64835797386862,1498.34017104801,-5.95294858935764,2.16895566648695,3.36689499083038e-07,6.14883448830437e-06,"B3EWY8",8.13e-08,"Skeletal aspartic acid-rich protein 2","","GO:0016020"
"1636","Pocillopora_acuta_HIv2___RNAseq.g6351.t1",0,0,0,0,0,2.5974025974026,0,0,0,0,0.25974025974026,0.519480519480519,0,NA,NA,NA,NA,NA,NA,11.6008903839305,5.39185996804635,11.5830805148927,5.59933054873005,12.0093705664354,6.06092633439065,5.66606675070968,12.1414290823614,11.5167023110052,6.48472759049682,8.80543840509987,11.770294571725,5.84058223847471,1780.06230928926,-6.55617592440502,0.680641849792378,2.76863968827508e-24,4.00456044512108e-20,"B3EWY8",8.79e-09,"Skeletal aspartic acid-rich protein 2","","GO:0016020"
"1637","Pocillopora_acuta_HIv2___RNAseq.g6359.t1",0,0,1.29198966408269,0,0,0.167084377610693,0,2.25563909774436,0,0,0.371471313943774,0.484544695071011,0.258397932816537,NA,NA,NA,NA,NA,NA,8.22781082278327,6.70002980369271,8.78468792516394,7.80204913956429,8.10518255534107,3.68233641306884,3.68233641306884,10.3987275762744,3.68233641306884,7.47207419844448,6.85375712604707,7.8397490585263,5.86776519356783,269.601580442591,-0.232019032169087,1.02037370199776,0.172643752692983,0.382993748305415,"A6QLU6",8.01e-57,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"1638","Pocillopora_acuta_HIv2___RNAseq.g6360.t1",0.368324125230203,0.399201596806387,0.345337937839171,0.426439232409382,0.507416081186573,0.424757281553398,0.230149597238205,0.196270853778214,1.27737226277372,0.87463556851312,0.504990453732837,0.544808245464221,0.465172662001454,NA,NA,NA,NA,NA,NA,8.13094462683116,7.91408972240118,7.02247773613795,9.66664662601031,7.80829655253983,8.8426971363928,3.68233641306884,8.02842462874741,3.68233641306884,6.21711944007385,7.09953692952722,6.93449599146504,7.2645778675894,228.429224427785,0.185461478445119,0.96193395146468,0.479235139528646,0.714382877269127,"A6QLU6",9.79e-59,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"1639","Pocillopora_acuta_HIv2___RNAseq.g6361.t1",0.760456273764259,0,0.462962962962963,0,2.19123505976096,1,1.16550116550117,0,0,0,0.558015546198934,0.2,0.916031092397869,NA,NA,NA,NA,NA,NA,4.90080178660296,5.91207600133758,4.75546742395967,5.35849991176178,4.66904661341994,5.77882859435006,5.36842592176402,4.93729786847052,4.79801079550852,4.90925637683756,5.13877112940126,4.81212489759232,5.4654173612102,16.0162071258804,0.834250184846597,0.845042718959036,0.137739422600149,0.329555122031125,"Q7SY09",2.55e-51,"Adhesion G protein-coupled receptor L4","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; animal organ development [GO:0048513]; cell surface receptor signaling pathway [GO:0007166]","GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0007189; GO:0048513"
"1640","Pocillopora_acuta_HIv2___RNAseq.g6366.t1",0.184842883548983,0.347826086956522,0.819672131147541,1.83299389002037,0,0.680561463207146,0.309119010819165,0,0,0,0.417501546569972,0.572276288036807,0.262726805103138,NA,NA,NA,NA,NA,NA,5.17503271827961,3.68233641306884,9.07878473870429,3.68233641306884,7.28808184092463,3.68233641306884,3.68233641306884,8.69993980176051,10.1211128397201,3.68233641306884,5.87746340047333,8.07259038787783,3.68233641306884,214.077295911434,-12.2570484263503,3.75647918125757,3.66500733818437e-09,1.21863600320687e-07,"Q7SY09",4.76e-36,"Adhesion G protein-coupled receptor L4","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; animal organ development [GO:0048513]; cell surface receptor signaling pathway [GO:0007166]","GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0007189; GO:0048513"
"1641","Pocillopora_acuta_HIv2___RNAseq.g6374.t1",0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,6.57449245641112,5.89089308266057,3.68233641306884,3.68233641306884,7.06826986579421,3.68233641306884,6.70601381879379,3.68233641306884,6.00413425515518,5.06554855441591,4.72878322813218,5.40231388069964,33.8935503160764,0.0709052553276697,1.02025103030985,0.00755231329733981,0.0330020119434208,NA,NA,NA,NA,NA
"1642","Pocillopora_acuta_HIv2___TS.g2911.t1",0,0,0,3.63636363636364,0,0,0,0,0,NA,0.404040404040404,0.727272727272727,0,NA,NA,NA,NA,NA,NA,6.24036347909427,6.41823073368408,3.68233641306884,7.00074722714729,4.28462663579717,5.87223972230221,3.68233641306884,5.26380834900594,3.68233641306884,5.08610646190246,5.12131318481399,4.63069425800701,5.61193211162098,28.5720747409621,0.278876913769118,1.03546018624997,0.081384977844554,0.224647389225883,NA,NA,NA,NA,NA
"1643","Pocillopora_acuta_HIv2___TS.g2912.t1",0.340136054421769,1.79153094462541,3.10192023633678,0.281293952180028,0.89058524173028,0.714626012386851,0.848056537102474,0.664451827242525,1.1441647597254,0,0.977676556575151,0.919213499232042,1.03613961391826,NA,NA,NA,NA,NA,NA,6.69445347943463,8.31794237534842,3.68233641306884,7.91565614756502,5.71763198038475,8.53206295779152,3.68233641306884,5.69179244239728,7.175369052787,8.91808740451969,6.6327668666366,5.7923166736145,7.4732170596587,157.255142849251,0.425123653559239,1.06085207936345,0.151473023565137,0.350994202634756,"A6QLU6",1.06e-13,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"1644","Pocillopora_acuta_HIv2___RNAseq.g6375.t1",1.34297520661157,0.520833333333333,0.0881834215167548,1.08481262327416,1.25714285714286,0.719942404607631,0.328022492970947,0,1.72143974960876,0,0.706335208906602,0.809405622164778,0.603264795648426,NA,NA,NA,NA,NA,NA,6.93499074257248,8.4470136419494,8.31700774249646,8.0335541792819,7.59105239200954,3.68233641306884,3.68233641306884,10.1921538192403,4.97930611778461,7.37489358856917,6.92346450500415,7.60290216282068,6.24402684718763,241.727673260591,-0.11461821594889,0.975077250458525,0.535215861242704,0.756066238598933,"A6QLU6",7.5e-54,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"1645","Pocillopora_acuta_HIv2___RNAseq.g6377.t1",1.23456790123457,0.932400932400932,0.538599640933573,0.37359900373599,0.424088210347752,0.914285714285714,0.173160173160173,1.21065375302663,1.08108108108108,0,0.688243641020642,0.90240409690607,0.474083185135213,NA,NA,NA,NA,NA,NA,3.68233641306884,5.54344824250154,7.34198352049247,7.18297737323777,3.68233641306884,5.72947039629047,5.73058915105271,6.60881604930705,3.68233641306884,3.68233641306884,5.28666303851574,4.99956176180121,5.57376431523027,41.7470504354028,0.201890452210443,0.996459933600172,0.284142104837746,0.530164009852058,"Q7SY09",7.94e-45,"Adhesion G protein-coupled receptor L4","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; animal organ development [GO:0048513]; cell surface receptor signaling pathway [GO:0007166]","GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0007189; GO:0048513"
"1646","Pocillopora_acuta_HIv2___RNAseq.g6379.t1",0.900900900900901,0,0.45766590389016,0.521739130434783,0.998003992015968,0.495399858457183,1.08481262327416,0.526315789473684,0,0,0.498483819844684,0.30869095567313,0.688276684016238,NA,NA,NA,NA,NA,NA,8.54381046440986,3.68233641306884,9.0965421593809,3.68233641306884,8.73845249809789,3.68233641306884,3.68233641306884,7.60863341305874,7.1955167311206,3.68233641306884,5.95946373314122,8.2365910532136,3.68233641306884,156.421421073687,-12.1917760345026,3.66704969153415,1.20637923813308e-09,4.83353720231493e-08,"A6QLU6",8.77e-21,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"1647","Pocillopora_acuta_HIv2___RNAseq.g6393.t1",0.538599640933573,0.351617440225035,0.951968844655993,0.718562874251497,0.61576354679803,0.527530497856907,0.713079376993808,0.477164280845262,0.638792102206736,0,0.553307860476684,0.542733439077088,0.563882281876281,NA,NA,NA,NA,NA,NA,9.07749990721811,8.03061114627924,8.74519382368357,10.6242969873462,9.1496244106913,10.1197513590544,3.68233641306884,9.64701951365487,7.57903434039062,6.8613079844839,8.35166758858711,8.83967439912769,7.86366077804652,537.238569038846,-0.159493853099545,0.89318783290721,0.65078537818095,0.833595440135429,"Q7SY09",1.31e-20,"Adhesion G protein-coupled receptor L4","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; animal organ development [GO:0048513]; cell surface receptor signaling pathway [GO:0007166]","GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0007189; GO:0048513"
"1648","Pocillopora_acuta_HIv2___RNAseq.g6394.t1",0.464396284829721,0,0.562851782363977,0,1.46892655367232,0.423728813559322,0.137080191912269,0.255754475703325,0.277008310249307,5.17241379310345,0.876216020539369,0.191298319902391,1.56113372117635,NA,NA,NA,NA,NA,NA,5.79120769139532,4.50233927872981,6.40448673657577,9.2085650750469,6.94355081454563,3.68233641306884,3.68233641306884,6.31424499730879,9.09741681661952,8.96155721209108,6.45880414484505,6.91018141128901,6.00742687840109,181.446251793353,-0.4022708804638,1.0521848480256,0.0524176902845248,0.161004347478311,"A6QLU6",6.69e-29,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"1649","Pocillopora_acuta_HIv2___RNAseq.g6397.t1",0,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.03460261738071,4.50233927872981,4.85281479041193,7.14835683950801,6.86044811883467,5.72947039629047,5.02746360037266,5.84514254962292,3.68233641306884,6.42959658710632,5.61125711913263,5.45506889786381,5.76744534040145,40.4458966416662,0.0161973621510791,0.934367086182269,0.958771002578088,0.984709492387237,"A6QLU6",1.76e-13,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"1650","Pocillopora_acuta_HIv2___RNAseq.g6409.t1",0.833031510322347,1.00908173562059,0.741608118657299,0.46242774566474,0.49079754601227,0.549853372434018,0.742115027829313,0.485100485100485,1.04239054899236,0.147275405007364,0.650368149564078,0.709770777562437,0.590965521565719,NA,NA,NA,NA,NA,NA,5.39475910818241,7.87523677967013,7.21685803447454,8.72807884406084,4.89684440866119,6.91889492578439,4.27277361158612,8.04850220834679,4.25049936715761,6.9608997877233,6.45633470756473,5.96149262536451,6.95117678976496,120.354233438063,0.687240478615178,1.17792643855288,0.0596169421934818,0.17827154266829,"B3MFV7",4.23e-10,"Latrophilin Cirl","cell surface receptor signaling pathway [GO:0007166]","GO:0004930; GO:0005886; GO:0007166; GO:0030246"
"1651","Pocillopora_acuta_HIv2___TS.g2949.t1",0.471698113207547,0.711053652230123,0.504731861198738,0.280504908835905,0.27027027027027,0.644122383252818,0.572737686139748,0.801068090787717,0.426257459505541,0,0.468244442542841,0.572601298922421,0.363887586163261,NA,NA,NA,NA,NA,NA,6.56356363373408,5.6460547390973,7.11130286437252,7.92246643836188,6.35975560497307,3.68233641306884,5.18636982781747,4.86526991710116,7.46780854522067,8.84774761108544,6.36526755948324,6.4735401130803,6.25699500588619,110.026344829389,-0.0942697537288458,0.857976144441672,0.800571602052222,0.915824840917101,"Q8IZF2",1.19e-12,"Adhesion G protein-coupled receptor F5 (G-protein coupled receptor 116)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; energy reserve metabolic process [GO:0006112]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; glomerular filtration [GO:0003094]; glucose homeostasis [GO:0042593]; macrophage activation [GO:0042116]; negative regulation of macrophage activation [GO:0043031]; pharyngeal arch artery morphogenesis [GO:0061626]; phospholipid biosynthetic process [GO:0008654]; positive regulation of phospholipid biosynthetic process [GO:0071073]; regulation of lipid metabolic process [GO:0019216]; surfactant homeostasis [GO:0043129]","GO:0003094; GO:0004930; GO:0005886; GO:0006112; GO:0007166; GO:0007186; GO:0007189; GO:0008654; GO:0009986; GO:0016020; GO:0019216; GO:0031410; GO:0042116; GO:0042593; GO:0043031; GO:0043129; GO:0045177; GO:0045444; GO:0048821; GO:0061626; GO:0071073"
"1652","Pocillopora_acuta_HIv2___TS.g2952.t1",0,0,0,0,3.77358490566038,0.819672131147541,0,0,0,NA,0.510361892978658,0.163934426229508,0.943396226415094,NA,NA,NA,NA,NA,NA,8.10335247870671,3.68233641306884,8.40205537874038,3.68233641306884,8.72107908560905,3.68233641306884,3.68233641306884,8.04184082734543,8.73353815082632,3.68233641306884,6.04135479865721,8.40037318424558,3.68233641306884,159.858019637123,-12.2135799475606,3.59782866711428,5.04071234610529e-10,2.26425041534369e-08,"A6QLU6",7.47e-15,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"1653","Pocillopora_acuta_HIv2___TS.g2955.t1",6.80272108843537,13.4969325153374,14.0845070422535,33.1550802139037,25.085910652921,7.36842105263158,19.6245733788396,0,0,NA,13.2909051049247,10.8040867563745,16.3994280406124,NA,NA,NA,NA,NA,NA,8.26147673713321,3.68233641306884,5.0980278924796,3.68233641306884,5.08159533560207,8.25971551899663,3.68233641306884,5.36237875279434,4.4808124149756,3.68233641306884,5.12733523042568,5.65685822659696,4.5978122342544,61.3027248173021,-0.428110707722356,1.14162750205583,0.0117097083213165,0.0474011340885834,"P21328",5.6e-06,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)","","GO:0003964"
"1654","Pocillopora_acuta_HIv2___TS.g9686.t1",0,0,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.75042578815773,8.05398145875441,8.78712071333689,6.20095146371302,9.16967758015488,6.80973452051995,7.70829378208802,7.64431660005706,9.59007603241508,6.7316772345674,7.94462551737644,8.78832334282433,7.10092769192856,293.803093048257,-1.36257226317991,0.912586157670285,0.0185605744951329,0.0699114972650007,"Q5C9Z4",2.24e-147,"Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog)","hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274]","GO:0003723; GO:0005730; GO:0042274; GO:0048820"
"1655","Pocillopora_acuta_HIv2___RNAseq.g3193.t1",0,0,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.30412255695062,8.34659219022148,7.95485894137405,3.68233641306884,8.34353368649726,3.68233641306884,4.60654391542428,3.68233641306884,3.68233641306884,10.9434626372321,6.42284595799751,6.59343760219192,6.25225431380311,337.899805721052,-0.056250718586298,1.00383502489264,0.692159501574553,0.85904909672647,NA,NA,NA,NA,NA
"1656","Pocillopora_acuta_HIv2___RNAseq.g3198.t1",0,NA,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,4.4307132106762,7.40558854265871,6.13296418561106,7.85286315275548,5.61428486132265,10.3069985565844,3.68233641306884,7.84919628280518,3.68233641306884,6.48472759049682,6.34420092090482,5.54189899069679,7.14650285111285,194.07512037947,0.518288773428397,1.17058336726644,0.0160104867517868,0.0616548669802568,"A1DWM3",1.61e-63,"Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog)","antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]","GO:0005886; GO:0042590"
"1657","Pocillopora_acuta_HIv2___RNAseq.g3211.t1",NA,NA,NA,28.5714285714286,100,33.3333333333333,100,NA,100,100,76.984126984127,53.968253968254,100,NA,NA,NA,NA,NA,NA,10.4993061165329,3.68233641306884,7.40065151733208,8.0769098149547,9.98203226037604,3.68233641306884,3.68233641306884,9.27988361263783,7.50048072915978,3.68233641306884,6.74686097032687,8.93247084720773,4.56125109344601,354.945563589144,-0.753937903858825,1.44894400034046,1.54989608759293e-07,3.16634138572657e-06,"E1BD52",2.35e-176,"Transmembrane protein 245","","GO:0016020"
"1658","Pocillopora_acuta_HIv2___TS.g9749.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.27912941077028,3.68233641306884,7.93741002328246,3.68233641306884,5.93071224280985,3.68233641306884,3.68233641306884,8.35818531483881,7.95939725468383,3.68233641306884,5.58765163117294,7.49296684927705,3.68233641306884,91.5713759454203,-11.0317763549549,3.5881984021498,7.59685428176015e-08,1.69308012837255e-06,"P10079",2.84e-72,"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","","GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579"
"1659","Pocillopora_acuta_HIv2___RNAseq.g3222.t1",NA,0,0,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.68779681205199,3.68233641306884,10.1189881605459,3.68233641306884,7.78985378200311,3.68233641306884,3.68233641306884,11.3226696670999,10.2886866289688,3.68233641306884,6.76196771160139,9.84159901013394,3.68233641306884,584.314671432432,-14.2009468635482,3.79712522148022,1.65827329586618e-13,2.87606469873934e-11,"P49013",1.81e-28,"Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III)","","GO:0005509; GO:0005576; GO:0009374"
"1660","Pocillopora_acuta_HIv2___TS.g9752.t3",5.12820512820513,0,0,0,0,0,0,NA,0,0,0.56980056980057,0,1.02564102564103,NA,NA,NA,NA,NA,NA,8.68376069653767,7.80115133184057,11.053746428583,3.68233641306884,9.49775548030301,3.68233641306884,3.68233641306884,10.2759595297477,10.4166186542408,3.68233641306884,7.24583377735281,9.98556815788244,4.50609939682319,593.7277310131,-1.25734445512357,2.71079679172877,3.71341751017224e-09,1.23190070796173e-07,"Q14517",4.66e-21,"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]","actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cellular response to angiotensin [GO:1904385]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]","GO:0002088; GO:0003382; GO:0003412; GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062; GO:0098609; GO:1904385; GO:1904754"
"1661","Pocillopora_acuta_HIv2___RNAseq.g3238.t1",0,9.375,0,23.8095238095238,0,0,8,NA,0,0,4.5760582010582,8.29613095238095,1.6,NA,NA,NA,NA,NA,NA,9.54837536055154,10.8129127198423,9.86078739941063,8.94386070189641,9.76578365008145,10.6403481717807,12.1620050530686,8.0715766610533,6.73914848420464,10.3448933957362,9.68896915976258,8.79713431106031,10.5808040084648,1244.24529111802,1.02886520331691,1.02801491421915,0.0509778357146478,0.15751835415011,"Q76N89",0,"E3 ubiquitin-protein ligase HECW1 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECW1) (NEDD4-like E3 ubiquitin-protein ligase 1) (hNEDL1)","negative regulation of canonical Wnt signaling pathway [GO:0090090]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005737; GO:0005829; GO:0006511; GO:0016567; GO:0048814; GO:0061630; GO:0090090"
"1662","Pocillopora_acuta_HIv2___RNAseq.g3239.t1",0,0,0,0,NA,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.7325287542554,10.9597863298555,9.70107217275744,8.24376600771061,11.1975469966138,11.3363340545967,9.80653327805441,10.9743690636977,10.6554569084619,10.7030050874078,10.5310398653411,10.8521947791572,10.209884951525,1739.62934488616,-0.469539549160384,0.576506711486478,0.300046886114127,0.548241303784075,"Q91V92",0,"ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme)","acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107]","GO:0003878; GO:0005524; GO:0005739; GO:0005829; GO:0006084; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0008610; GO:0046872"
"1663","Pocillopora_acuta_HIv2___TS.g9768.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.3409281476977,9.71518496369293,6.02915908265446,3.68233641306884,10.8095510327815,8.69518597124527,7.02533634129515,8.91943765334758,8.43976673506018,7.63392227539125,6.60492635689467,8.66291819388782,452.538839094166,0.227264331823601,1.00499428553572,0.196992691933503,0.41868077927971,"Q9ER47",0,"Voltage-gated inwardly rectifying potassium channel KCNH7 (Ether-a-go-go-related gene potassium channel 3) (ERG-3) (Eag-related protein 3) (Ether-a-go-go-related protein 3) (Potassium voltage-gated channel subfamily H member 7) (Voltage-gated potassium channel subunit Kv11.3)","circadian rhythm [GO:0007623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential [GO:0042391]","GO:0005242; GO:0005249; GO:0005267; GO:0005886; GO:0006813; GO:0007623; GO:0034702; GO:0042391; GO:0044877; GO:0071805"
"1664","Pocillopora_acuta_HIv2___RNAseq.g3256.t1",0,NA,NA,0,0,0,0,0,12.5,0,1.5625,3.125,0,NA,NA,NA,NA,NA,NA,6.38824903660035,9.46573791965081,8.74519382368357,7.56120515657027,9.19924369978803,3.68233641306884,3.68233641306884,9.40948504545145,3.68233641306884,10.9744248293338,7.27905487502848,7.48490160371845,7.07320814633851,451.303424360496,-0.0542678584321962,1.00009383546242,0.540710499618847,0.760337999852907,"Q5UIP0",3.73e-110,"Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog)","cellular response to leukemia inhibitory factor [GO:1990830]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]; somatic stem cell population maintenance [GO:0035019]; subtelomeric heterochromatin formation [GO:0031509]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]","GO:0000122; GO:0000723; GO:0000785; GO:0000793; GO:0001939; GO:0001940; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006281; GO:0006974; GO:0031509; GO:0031965; GO:0035019; GO:0035861; GO:0043247; GO:0045814; GO:0045830; GO:0051233; GO:0140445; GO:1990830; GO:2000042; GO:2001034"
"1665","Pocillopora_acuta_HIv2___RNAseq.g3258.t1",0,NA,NA,28.5714285714286,NA,47.0588235294118,0,0,NA,100,29.2717086834734,25.2100840336134,33.3333333333333,NA,NA,NA,NA,NA,NA,11.3872867961427,9.75614950833761,10.6262522925126,11.152123749059,11.3916726655678,10.6784235513167,11.2308514691203,11.1214800224437,8.85800706594595,5.88338661330132,10.2085633733748,10.6769397685225,9.74018697822699,1662.68018077013,-0.573150162288819,0.753795609857764,0.241123638330588,0.4789360484501,"Q91WK0",5.24e-60,"Leucine-rich repeat flightless-interacting protein 2 (LRR FLII-interacting protein 2)","MyD88-dependent toll-like receptor 4 signaling pathway [GO:0035660]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of DNA-templated transcription [GO:0006355]; Wnt signaling pathway [GO:0016055]","GO:0002756; GO:0006355; GO:0016055; GO:0032760; GO:0035660"
"1666","Pocillopora_acuta_HIv2___RNAseq.g3277.t1",0,28.5714285714286,NA,NA,100,38.4615384615385,35.7142857142857,NA,100,NA,50.4578754578755,55.6776556776557,45.2380952380952,NA,NA,NA,NA,NA,NA,5.63634872160117,5.01287713650611,5.16860104011765,4.2857336656916,5.50166800055048,4.51119975925463,3.68233641306884,5.06769837305767,3.68233641306884,3.68233641306884,4.62311359359858,5.01133050967916,4.234896677518,9.66462284712619,-0.569198413578533,1.13370505383156,0.200672627859964,0.423850597162166,NA,NA,NA,NA,NA
"1667","Pocillopora_acuta_HIv2___RNAseq.g3311.t3",1.58730158730159,0,0,NA,0,0,0,NA,0,NA,0.226757369614512,0,0.396825396825397,NA,NA,NA,NA,NA,NA,8.20203362993825,9.48731382210407,8.91940764679443,9.3104957527689,9.61728193583181,3.68233641306884,3.68233641306884,8.14177326309749,11.2827047974135,3.68233641306884,7.6008020087155,9.2326402546151,5.9689637628159,551.304042050318,-0.337176002319804,1.05326260463884,1.05776030313662e-05,0.000119154556266106,"D3Z2X2",8.81e-94,"Dynein heavy chain domain-containing protein 1 (Coiled-coil domain-containing protein 35) (Dynein heavy chain domain 1-like protein)","flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316]","GO:0005524; GO:0008569; GO:0030317; GO:0036126; GO:0036156; GO:0045505; GO:0051959; GO:0120316"
"1668","Pocillopora_acuta_HIv2___RNAseq.g3318.t1",0,0,NA,NA,8.33333333333333,0,0,0,0,NA,1.19047619047619,0,2.77777777777778,NA,NA,NA,NA,NA,NA,5.29008743000815,5.6784794012365,5.16860104011765,3.68233641306884,5.52116216212419,3.68233641306884,3.68233641306884,5.36237875279434,6.83269238753983,3.68233641306884,4.8582746826096,5.63498435451683,4.08156501070237,19.435263062631,-0.628725691616106,1.28647093520653,0.00344764413472561,0.0169927920002628,"B8V7S0",4.29e-72,"CUB and peptidase domain-containing protein 1","acrosome reaction [GO:0007340]; proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508; GO:0007340"
"1669","Pocillopora_acuta_HIv2___RNAseq.g3326.t2",9.27152317880795,6.77966101694915,34.7826086956522,4.81927710843374,7.47663551401869,2.38095238095238,20.9459459459459,4.25531914893617,9.09090909090909,0,9.98028320806053,5.46522374923611,14.495342666885,NA,NA,NA,NA,NA,NA,13.5488948375694,13.539198524014,14.0610552553277,12.9773954024464,13.7072209571023,13.1086975581376,13.3887049518508,13.0265165527835,14.087612391138,12.2888708544379,13.3734167284808,13.6862599987842,13.0605734581773,11247.9914903448,-0.447018345808341,0.592354346557661,0.347583383118991,0.598909165631154,"Q13439",1.34e-21,"Golgin subfamily A member 4 (256 kDa golgin) (Golgin-245) (Protein 72.1) (Trans-Golgi p230)","Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle transport [GO:0048193]; positive regulation of axon extension [GO:0045773]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005654; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0016192; GO:0031267; GO:0043001; GO:0045773; GO:0048193; GO:0051020; GO:0070062"
"1670","Pocillopora_acuta_HIv2___RNAseq.19904_t",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.6520284690815,6.68494107039366,8.60328853964979,7.73395220400599,8.74228495705164,4.94358885541907,10.5098898262463,7.30814062619735,10.4872499410802,3.68233641306884,7.93477009021943,9.1585985066121,6.71094167382677,560.362613786223,-0.566576024554248,1.15117696546687,0.0174282465343908,0.0662922182528796,"Q07929",4.39e-10,"63 kDa sperm flagellar membrane protein","","GO:0005509; GO:0005886; GO:0031514; GO:0098552"
"1671","Pocillopora_acuta_HIv2___TS.g9882.t2",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.34234621569247,6.77312724931675,9.50823460080548,6.17770847719114,7.91082430011367,3.68233641306884,7.99473091893197,7.45626541537361,9.22695290674866,3.68233641306884,7.07548629103114,8.48892468774678,5.66204789431551,230.67634044123,-0.773014607471623,1.31408647191915,0.00551663740612495,0.0252428482892095,"B4J6N6",4.01e-24,"Ell-associated factor Eaf","cellular response to heat [GO:0034605]; positive regulation of DNA-templated transcription [GO:0045893]; transcription elongation by RNA polymerase II [GO:0006368]","GO:0005654; GO:0006368; GO:0032783; GO:0034605; GO:0045893"
"1672","Pocillopora_acuta_HIv2___RNAseq.g3359.t1",0,NA,0,NA,0,0,0,0,8.51063829787234,NA,1.21580547112462,2.83687943262411,0,NA,NA,NA,NA,NA,NA,8.38113716776767,9.12939621685935,7.84683233870282,9.08682608399983,6.11409578894442,8.67742263793333,11.4993906545133,5.36237875279434,8.3957742487921,6.9608997877233,8.14541536780305,7.22004365940027,9.07078707620582,529.742145052482,0.725553382723072,1.03619750803139,0.109114658431402,0.27869228669465,"Q84LH3",4.41e-23,"3'-5' exonuclease (EC 3.1.-.-) (Werner Syndrome-like exonuclease)","nucleobase-containing compound metabolic process [GO:0006139]","GO:0003677; GO:0005634; GO:0006139; GO:0008408; GO:0046872"
"1673","Pocillopora_acuta_HIv2___TS.g9888.t1",0.230414746543779,0,0,0,0.619195046439629,0.721649484536082,0.289855072463768,0,0,NA,0.206790483331473,0.144329896907216,0.284866216361794,NA,NA,NA,NA,NA,NA,3.68233641306884,4.59616451822093,7.53465822665543,5.05535826649939,6.05145252438901,3.68233641306884,4.40301213871548,7.05895260351335,3.68233641306884,10.733956095987,5.64805636131871,5.60194723613909,5.69416548649833,201.132527859168,-0.103132915855416,1.01426835902934,0.237571692367333,0.474356289122185,"Q84LH3",1.75e-24,"3'-5' exonuclease (EC 3.1.-.-) (Werner Syndrome-like exonuclease)","nucleobase-containing compound metabolic process [GO:0006139]","GO:0003677; GO:0005634; GO:0006139; GO:0008408; GO:0046872"
"1674","Pocillopora_acuta_HIv2___RNAseq.g3361.t1",100,100,100,100,NA,96.2962962962963,100,NA,NA,NA,99.3827160493827,98.7654320987654,100,NA,NA,NA,NA,NA,NA,9.90938281886409,10.4550723614739,10.212390662486,9.4995404937589,9.6078661902075,9.41961505704584,8.82581837105862,9.64153408656845,10.3501742182439,10.5752101946465,9.84966044543537,9.94426959527399,9.75505129559675,956.939420303406,-0.146565450790736,0.534939797262223,0.745892256899451,0.888038467648244,"B4MR74",8.41e-27,"Ell-associated factor Eaf","cellular response to heat [GO:0034605]; positive regulation of DNA-templated transcription [GO:0045893]; transcription elongation by RNA polymerase II [GO:0006368]","GO:0005654; GO:0006368; GO:0032783; GO:0034605; GO:0045893"
"1675","Pocillopora_acuta_HIv2___RNAseq.g3423.t2",NA,0,0,NA,0,0,NA,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.44477204554908,7.11319280397558,7.7198177287158,3.68233641306884,7.54774870150168,5.89458481577045,3.68233641306884,9.68910440783524,8.17151122259478,3.68233641306884,6.56277409651491,8.31459082123932,4.81095737179051,188.524505033016,-1.13439373613214,1.93425583342978,1.36125520293189e-05,0.000149273656218399,"Q80UG8",0,"Tubulin monoglutamylase TTLL4 (EC 6.3.2.-) (Protein monoglutamylase TTLL4) (Tubulin--tyrosine ligase-like protein 4)","microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]","GO:0000226; GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0036064; GO:0046872; GO:0070739; GO:0070740; GO:0097731; GO:0120222"
"1676","Pocillopora_acuta_HIv2___RNAseq.g3428.t1",0,0,0,0.757575757575758,2.83018867924528,1.2,0,NA,0,NA,0.59847055460263,0.489393939393939,0.707547169811321,NA,NA,NA,NA,NA,NA,6.25760738373578,5.1703194305374,8.1939484205115,5.94820612318409,6.95026000352262,4.21083509301726,8.23862843105155,7.68342443483516,7.24467051682398,8.42602972610564,6.8323929563325,7.26598215188581,6.39880376077919,137.884106177022,-0.55212091936475,0.943033427530728,0.171361668275031,0.380675037617884,"Q5ZKG5",2.38e-42,"Low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) (LMW-PTPase) (EC 3.1.3.48) (Low molecular weight cytosolic acid phosphatase) (EC 3.1.3.2)","","GO:0003993; GO:0004725; GO:0004726; GO:0005829; GO:0009898; GO:0042383"
"1677","Pocillopora_acuta_HIv2___RNAseq.g3430.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0166105136991,9.30735463838075,10.8006009319828,8.34344158691074,10.0005371652592,10.1118221718936,9.40383426438237,9.3393789223552,10.9513009600009,10.5564430586054,9.88313242134701,10.2216856986594,9.54457914403457,1046.51636271518,-0.435865497873685,0.634398675665042,0.358896765235093,0.609139029847499,"G8HTB6",4.91e-19,"ZP domain-containing protein","","GO:0016020"
"1678","Pocillopora_acuta_HIv2___RNAseq.g3434.t1",0,NA,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.5938550798668,9.00624173972253,10.8473577502874,10.4566276672565,10.2913185595025,11.1375881361845,9.87849267546319,10.1007804357344,9.34580141849236,3.68233641306884,9.5340399875579,10.2358226487767,8.83225732633911,1127.38188563535,-0.349170064000431,0.900517717828669,0.386694317622294,0.634571794932294,"Q9CZV8",0,"F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like)","behavioral fear response [GO:0001662]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]","GO:0001662; GO:0005737; GO:0019005; GO:0031146; GO:0045202; GO:0098685; GO:0098793; GO:0098978; GO:0099575; GO:2000300"
"1679","Pocillopora_acuta_HIv2___RNAseq.g3439.t1",0,0,0,0,0,0.293255131964809,0,0,0,0,0.0293255131964809,0.0586510263929619,0,NA,NA,NA,NA,NA,NA,8.21067749582655,3.68233641306884,9.1654614919124,3.68233641306884,8.78192178349322,3.68233641306884,3.68233641306884,8.13553162203908,9.8215925383836,3.68233641306884,6.2526866996999,8.82303698633097,3.68233641306884,237.035201069787,-12.7778919950398,3.63442803291475,4.25105706627456e-11,2.88672720218757e-09,NA,NA,NA,NA,NA
"1680","Pocillopora_acuta_HIv2___RNAseq.g3441.t1",2.17391304347826,8.33333333333333,2.08333333333333,0,0,0,0,0,NA,NA,1.57382246376812,2.08333333333333,1.0643115942029,NA,NA,NA,NA,NA,NA,7.01680604467962,3.68233641306884,8.43347218433143,3.68233641306884,8.42928721457121,3.68233641306884,3.68233641306884,8.02842462874741,9.05425581488638,3.68233641306884,5.93739279525602,8.19244917744321,3.68233641306884,148.744932859109,-11.9986307379577,3.60815116295714,1.49071508954416e-09,5.71928463001769e-08,NA,NA,NA,NA,NA
"1681","Pocillopora_acuta_HIv2___RNAseq.g3464.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.5772197832221,9.02702124234852,3.68233641306884,3.68233641306884,8.74991941285559,8.09909073650838,3.68233641306884,10.464191318518,3.68233641306884,3.68233641306884,6.13291245587968,6.63120066814667,5.63462424361268,260.929867746688,-0.0812774283003532,0.991114913732161,0.648359814326994,0.83233126426073,NA,NA,NA,NA,NA
"1682","Pocillopora_acuta_HIv2___TS.g10002.t1",NA,50,NA,0,0,6.89655172413793,0,NA,NA,0,9.48275862068965,18.9655172413793,0,NA,NA,NA,NA,NA,NA,7.92564232622162,8.51167294945903,7.83745178960705,7.02644217673873,5.59620788443221,6.26042601982666,3.68233641306884,7.69197184048926,6.26649149846874,4.80766789501754,6.56063107933297,7.06355306784378,6.05770909082216,119.043094283073,-0.375807255585521,0.93448669268324,0.318867866581441,0.568413214473005,NA,NA,NA,NA,NA
"1683","Pocillopora_acuta_HIv2___RNAseq.g3490.t1",0,0,0,1.38888888888889,0,0.45662100456621,2.04081632653061,0,0,0,0.388632621998571,0.36910197869102,0.408163265306122,NA,NA,NA,NA,NA,NA,7.22010468013657,3.68233641306884,8.48834949082615,6.05508630481337,9.01517105923397,3.68233641306884,3.68233641306884,9.21487413363796,3.68233641306884,3.68233641306884,5.84052677339922,7.5241671553807,4.15688639141775,156.261551006704,-0.539223827056583,1.22781528711132,0.000252344038813802,0.00182312895974168,"V6CLA2",3.03e-13,"E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26)","determination of adult lifespan [GO:0008340]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of cell fate specification [GO:0042659]; regulation of germ cell proliferation [GO:1905936]; regulation of response to oxidative stress [GO:1902882]; regulation of vulval development [GO:0040028]","GO:0008340; GO:0016607; GO:0032436; GO:0040028; GO:0042659; GO:0043161; GO:0045746; GO:0045747; GO:0046872; GO:0061630; GO:0070534; GO:1902882; GO:1905936"
"1684","Pocillopora_acuta_HIv2___TS.g10039.t1",0.213219616204691,1.09489051094891,0,0,0.33167495854063,0.910470409711684,1.32352941176471,0,5.10204081632653,NA,0.997313969277461,1.42148034739742,0.467105996627507,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,7.08762485888264,5.67021878014534,8.26572797413929,3.68233641306884,3.68233641306884,6.29140637299107,7.01438483963671,3.68233641306884,5.27410448911392,6.46829609174371,4.07991288648414,58.2303202262715,-0.489059906016713,1.17669884591893,0.00373073954610198,0.0181688272036428,"V6CLA2",7.09e-11,"E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26)","determination of adult lifespan [GO:0008340]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; regulation of cell fate specification [GO:0042659]; regulation of germ cell proliferation [GO:1905936]; regulation of response to oxidative stress [GO:1902882]; regulation of vulval development [GO:0040028]","GO:0008340; GO:0016607; GO:0032436; GO:0040028; GO:0042659; GO:0043161; GO:0045746; GO:0045747; GO:0046872; GO:0061630; GO:0070534; GO:1902882; GO:1905936"
"1685","Pocillopora_acuta_HIv2___RNAseq.g3545.t2",0,NA,7.69230769230769,NA,0,0,0,87.5,0,85.7142857142857,22.6133241758242,29.1666666666667,18.6813186813187,NA,NA,NA,NA,NA,NA,8.14002548660679,10.2770335872061,9.6009814336232,10.5218086246593,9.08169903303776,9.71861013633086,10.7379179798863,6.89723497020019,3.68233641306884,9.77843769353736,8.84360853581567,7.48045546730736,10.206761604324,763.137624925489,1.06009694649107,1.34881345493961,0.0339735473664149,0.114543913544948,"Q5T5U3",1.87e-103,"Rho GTPase-activating protein 21 (Rho GTPase-activating protein 10) (Rho-type GTPase-activating protein 21)","establishment of Golgi localization [GO:0051683]; Golgi localization [GO:0051645]; Golgi organization [GO:0007030]; maintenance of Golgi location [GO:0051684]; organelle transport along microtubule [GO:0072384]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]","GO:0000139; GO:0005096; GO:0005794; GO:0005829; GO:0005886; GO:0007030; GO:0007165; GO:0015629; GO:0030054; GO:0030659; GO:0051056; GO:0051645; GO:0051683; GO:0051684; GO:0070161; GO:0072384"
"1686","Pocillopora_acuta_HIv2___RNAseq.g3546.t1",0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,12.0432572661414,11.6764011779485,13.3750079586924,12.1367149592665,12.0089732994015,11.1820784224303,11.7972736007308,12.612429945155,11.9946094774294,11.6746168547356,12.0501362961931,12.4068555893639,11.6934170030223,4598.01164612165,-0.562363400273563,0.518691386395955,0.203016503210417,0.427126213360349,"Q62217",2.77e-79,"Semaphorin-5A (Semaphorin-F) (Sema F)","axon extension [GO:0048675]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; branching morphogenesis of an epithelial tube [GO:0048754]; cell chemotaxis [GO:0060326]; detection of light stimulus involved in visual perception [GO:0050908]; diencephalon development [GO:0021536]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endothelial cell apoptotic process [GO:2000352]; neural crest cell migration [GO:0001755]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; positive chemotaxis [GO:0050918]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; semaphorin-plexin signaling pathway [GO:0071526]; signal clustering [GO:1990256]","GO:0001569; GO:0001755; GO:0001938; GO:0002043; GO:0005886; GO:0007162; GO:0007411; GO:0007413; GO:0008046; GO:0016020; GO:0021536; GO:0030215; GO:0030335; GO:0030836; GO:0035373; GO:0043395; GO:0045499; GO:0045545; GO:0045766; GO:0048675; GO:0048754; GO:0048842; GO:0048843; GO:0050908; GO:0050918; GO:0051897; GO:0060326; GO:0071526; GO:0090091; GO:0090263; GO:0097485; GO:1990138; GO:1990256; GO:2000352; GO:2001028"
"1687","Pocillopora_acuta_HIv2___TS.g10097.t2",0,0,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.61740237719946,9.53988190650151,9.09064729804441,10.0216816847567,9.65637308269729,9.89794393079361,9.8012532695953,8.85595764659669,8.67417051921941,10.0029823316285,9.21582940470329,8.57891018475145,9.85274862465512,672.556538221613,0.949610402936149,0.720209540199084,0.0701737195882316,0.20194840432236,"Q6GNV7",7.07e-67,"Solute carrier family 49 member 4 homolog (Disrupted in renal carcinoma protein 2 homolog)","pyridoxine transport [GO:0031923]","GO:0005765; GO:0022857; GO:0031923"
"1688","Pocillopora_acuta_HIv2___RNAseq.g3564.t1",2.5,0,0,0,0,0,0,0,0,NA,0.277777777777778,0,0.625,NA,NA,NA,NA,NA,NA,4.21445057288855,8.81805954919296,6.94541193766045,9.41053273193755,6.90261169119261,5.77882859435006,7.78901700759002,3.68233641306884,3.68233641306884,3.68233641306884,6.09059213240187,5.08542940557586,7.09575485922789,150.562185543798,0.47056256576426,1.12470526970729,0.0492278503369398,0.153777351980544,"Q9D9D9",1.7e-06,"Cilia- and flagella-associated protein 141","flagellated sperm motility [GO:0030317]","GO:0005879; GO:0030317; GO:0036126; GO:0160111"
"1689","Pocillopora_acuta_HIv2___RNAseq.g3565.t1",0,0,NA,0,0,0,2.85714285714286,NA,NA,NA,0.476190476190476,0,0.952380952380952,NA,NA,NA,NA,NA,NA,6.79100259980268,3.68233641306884,3.68233641306884,7.70261567160669,7.32453244996143,3.68233641306884,5.32551295827119,9.40431133506437,11.697983886123,3.68233641306884,6.29753045531047,7.78003333680406,4.81502757381688,437.304584895654,-0.343248682983916,1.10423998601752,0.00015935859450772,0.001227349686347,"Q4R5T4",2.41e-118,"RING finger protein 32","","GO:0005737; GO:0046872"
"1690","Pocillopora_acuta_HIv2___RNAseq.g3566.t1",0,0,0,0,9.52380952380952,0,0,0,0,NA,1.05820105820106,0,2.38095238095238,NA,NA,NA,NA,NA,NA,9.15109943273746,9.51278580086792,7.99336016744145,3.68233641306884,8.24964852338715,8.78399003293727,3.68233641306884,8.12611802033816,8.20647647853418,3.68233641306884,7.10704876954501,8.34534052448768,5.86875701460234,269.731719654473,-0.426233926109225,1.08659364794731,8.63957271346546e-05,0.000731204094368428,"P79769",1.02e-90,"Translin (EC 3.1.-.-) (Component 3 of promoter of RISC) (C3PO)","RNA metabolic process [GO:0016070]","GO:0003697; GO:0003723; GO:0004519; GO:0005634; GO:0005737; GO:0016070; GO:0043565"
"1691","Pocillopora_acuta_HIv2___RNAseq.g3598.t1",0,NA,0,NA,0,0,NA,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,13.5372597421125,13.6921425009401,14.3346331478661,14.3065799928273,13.9916128563851,14.2350001553976,13.3016592932104,13.6086308659093,13.8025733238938,14.3237589869904,13.9133850865533,13.8549419872334,13.9718281858732,15874.6222196881,0.0975193567304282,0.486961755613229,0.831632278588078,0.931736902945742,"Q70FJ1",3.17e-51,"A-kinase anchor protein 9 (AKAP-9) (Protein kinase A-anchoring protein 9) (PRKA9)","maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein-containing complex localization [GO:0031503]; regulation of Golgi organization [GO:1903358]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]","GO:0000242; GO:0005737; GO:0005794; GO:0005795; GO:0005801; GO:0005813; GO:0007020; GO:0007165; GO:0007283; GO:0015459; GO:0031503; GO:0033138; GO:0034237; GO:0034705; GO:0036064; GO:0043025; GO:0044307; GO:0051661; GO:0060009; GO:0060090; GO:0060307; GO:0097060; GO:0097729; GO:0099147; GO:0120219; GO:1903358"
"1692","Pocillopora_acuta_HIv2___TS.g25899.t2",5.35714285714286,18.1818181818182,24.3243243243243,1.33333333333333,0.591715976331361,3.80710659898477,5.38922155688623,0,7.31707317073171,1.26582278481013,6.75675587843629,6.1278662569736,7.38564549989898,NA,NA,NA,NA,NA,NA,10.5562681492073,10.5868026289435,10.6564810021718,10.8476759948571,11.2435250286229,11.0472392650497,8.66447395195279,10.1417617395941,7.44280416944215,8.47354618139891,9.96605781112403,10.0081680178076,9.9239476044404,1285.20141320701,-0.0435725060801937,0.588184722069735,0.925515213501987,0.97201946326552,"Q5ZJ54",0,"T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta)","protein folding [GO:0006457]","GO:0005524; GO:0005832; GO:0006457; GO:0016887; GO:0051082; GO:0140662"
"1693","Pocillopora_acuta_HIv2___RNAseq.g15792.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.69088404533631,10.1352936453215,7.83745178960705,8.47878496008449,10.169333228625,6.19123426543186,8.14151872004538,9.11863442761243,3.68233641306884,12.0464912441046,8.54919627392375,8.09972798084993,8.99866456699757,860.343353424824,0.0334441367570182,0.916051459450301,0.935449684391326,0.976255136933338,"A3KN83",0,"Protein strawberry notch homolog 1 (Monocyte protein 3) (MOP-3)","regulation of DNA-templated transcription [GO:0006355]","GO:0005634; GO:0006355; GO:0031490; GO:0042393"
"1694","Pocillopora_acuta_HIv2___RNAseq.g15801.t1",NA,NA,0,0,NA,0,0,NA,12.5,0,2.08333333333333,4.16666666666667,0,NA,NA,NA,NA,NA,NA,10.3185340072371,10.779208067072,10.9960785770211,9.18332988672649,10.6504243810181,10.4522204805108,10.4323270221882,10.8318800479752,10.7344436702018,11.6311869462131,10.6009633086164,10.7062721366907,10.4956544805421,1649.11009458047,-0.121137476636942,0.603459907247533,0.780363517028816,0.906275064711769,"Q99PV0",0,"Pre-mRNA-processing-splicing factor 8 (Splicing factor Prp8)","cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]","GO:0000244; GO:0000398; GO:0005634; GO:0005682; GO:0008237; GO:0016607; GO:0017070; GO:0030532; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157"
"1695","Pocillopora_acuta_HIv2___RNAseq.g15824.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.1858885465392,10.371700676942,8.47331454364134,11.1441566742614,9.32206712341433,4.72257309926916,3.68233641306884,7.2512707478268,3.68233641306884,8.78996544050039,7.76256096785323,7.7829754748981,7.74214646080836,617.31635593787,-0.00648112101458721,0.977478132709296,0.863416205166686,0.946309918279226,"Q95ND4",2.6e-72,"Pro-epidermal growth factor (EGF) [Cleaved into: Epidermal growth factor]","epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of MAPK cascade [GO:0043410]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]","GO:0005509; GO:0005886; GO:0007173; GO:0008083; GO:0008284; GO:0043388; GO:0043410; GO:0046425"
"1696","Pocillopora_acuta_HIv2___RNAseq.g15831.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.1555823929053,14.4344806700254,8.51502277407054,12.5144559787309,8.6696786827695,4.78285319113451,11.0520161385141,3.68233641306884,11.9101824397108,13.3212845717275,10.0037893252657,8.786560540505,11.2210181100265,4705.78748115589,0.512164331912786,1.12239280655192,0.0711741447237622,0.204202624849988,"B3EWZ6",2.05e-103,"MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2)","","GO:0005576; GO:0016020"
"1697","Pocillopora_acuta_HIv2___RNAseq.g15832.t1",0,0,0,0,7.14285714285714,0,0,15.625,NA,NA,2.84598214285714,3.90625,1.78571428571429,NA,NA,NA,NA,NA,NA,5.29008743000815,11.342451583815,7.3286115711524,9.17766155518247,7.96111285780312,11.1690385573365,11.4178052843744,7.43091797997457,3.68233641306884,12.2620967297916,8.7062119962507,6.33861325040142,11.0738107421,1352.41797806265,3.3894295209199,2.19647044375059,0.000296963498264218,0.00209423697654493,"B3EWZ5",2.52e-152,"MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1)","","GO:0005576; GO:0016020"
"1698","Pocillopora_acuta_HIv2___RNAseq.g15835.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.30162598186706,9.42480971363826,3.68233641306884,6.95026000352262,8.17076336729223,11.4895780192454,8.9244445172624,3.68233641306884,3.68233641306884,6.69908272551033,6.53283741211219,6.86532803890847,446.776914186273,0.17815392127051,1.00497103665822,0.368353721658502,0.61793878799218,"O35453",1.43e-54,"Serine protease hepsin (EC 3.4.21.106) [Cleaved into: Serine protease hepsin non-catalytic chain; Serine protease hepsin catalytic chain]","basement membrane disassembly [GO:0034769]; cholesterol homeostasis [GO:0042632]; cochlea morphogenesis [GO:0090103]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; epithelium development [GO:0060429]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; pilomotor reflex [GO:0097195]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell growth [GO:0030307]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of thyroid hormone generation [GO:2000611]; potassium ion transmembrane transport [GO:0071805]; proteolysis [GO:0006508]; regulation of cell shape [GO:0008360]; response to thyroid hormone [GO:0097066]; sensory perception of sound [GO:0007605]","GO:0004252; GO:0005576; GO:0005737; GO:0005789; GO:0005886; GO:0005911; GO:0006508; GO:0007605; GO:0008236; GO:0008360; GO:0009986; GO:0010628; GO:0010719; GO:0010756; GO:0016324; GO:0030307; GO:0034769; GO:0042632; GO:0043025; GO:0043066; GO:0043923; GO:0050680; GO:0050910; GO:0060429; GO:0070008; GO:0071805; GO:0090103; GO:0097066; GO:0097195; GO:2000347; GO:2000611"
"1699","Pocillopora_acuta_HIv2___RNAseq.g15840.t1",0,NA,NA,NA,0,20,0,0,0,NA,3.33333333333333,6.66666666666667,0,NA,NA,NA,NA,NA,NA,9.5952647091742,10.0289902105903,8.13014807555559,10.7949897311685,9.59733162875768,9.04669674499447,8.05525808108825,9.68697582768588,9.24865093065445,11.9563143368576,9.61406202765269,9.25167423436556,9.97644982093982,1059.69715893725,0.355695563382481,0.781577614735428,0.429659518061841,0.674034194061439,"Q6JZS3",3.57e-82,"Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1)","","GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0043231; GO:0070330"
"1700","Pocillopora_acuta_HIv2___RNAseq.g15843.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0494497618359,10.4341215832892,8.81361363638465,7.74936704245489,9.43405863799651,9.01301841736928,9.7941830512278,9.20002057155156,10.0308018132118,3.68233641306884,8.82009709283904,9.50558888419608,8.134605301482,661.031356545153,-0.266195810152946,0.884660182273476,0.500073066971122,0.729800912185482,"Q86YT6",0,"E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2)","blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; neuron differentiation [GO:0030182]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0008270; GO:0016567; GO:0030182; GO:0031410; GO:0034451; GO:0045665; GO:0045807; GO:0061630"
"1701","Pocillopora_acuta_HIv2___RNAseq.g15853.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.34627273025484,3.68233641306884,3.68233641306884,3.68233641306884,5.93071224280985,8.2053021325804,9.57449988649168,7.49101224450391,3.68233641306884,3.68233641306884,5.79594813019849,5.82653400874126,5.76536225165572,150.045979471594,0.0883630173206569,0.993216485543595,0.73151473616301,0.880282597737381,"Q8CFG5",3.43e-53,"Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3]","calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of presynapse organization [GO:0099174]","GO:0005245; GO:0005246; GO:0005891; GO:0006816; GO:0046872; GO:0048787; GO:0098982; GO:0099174; GO:1990314"
"1702","Pocillopora_acuta_HIv2___RNAseq.g15862.t2a",0,NA,NA,NA,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,7.15852236535678,3.68233641306884,3.68233641306884,7.29264242014095,5.48185943121106,5.95943109045959,3.68233641306884,5.67356605113577,8.49602432054186,5.70282560183315,5.68118805198857,6.09846171626286,5.26391438771427,70.6395331089546,-0.195286992089599,1.01514714954395,0.114035189234685,0.28755316894883,NA,NA,NA,NA,NA
"1703","Pocillopora_acuta_HIv2___TS.g26004.t1",0,0,0,0,1.86915887850467,0,1.12994350282486,0,0,0,0.299910238132953,0,0.599820476265906,NA,NA,NA,NA,NA,NA,5.83894995413197,10.1174200793621,3.68233641306884,7.2055975890902,7.65772136444679,5.62464424494188,3.68233641306884,7.68342443483516,3.68233641306884,3.68233641306884,5.88571033190835,5.70895371591032,6.06246694790637,162.755228184603,0.018022423987559,1.00460409629715,0.71214965687914,0.869668405991259,"Q8IY21",0,"Probable ATP-dependent RNA helicase DDX60 (EC 3.6.4.13) (DEAD box protein 60)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615]","GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0009615; GO:0016887; GO:0045087; GO:0045111; GO:0051607; GO:1900245; GO:1900246"
"1704","Pocillopora_acuta_HIv2___RNAseq.g15887.t1",0,NA,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.4224674987333,3.68233641306884,9.39163824382052,9.60253211680803,8.01605425720067,5.82637165358479,3.68233641306884,9.20895106476319,3.68233641306884,4.40467075915833,6.79196948332753,8.1442894955173,5.43964947113777,358.250704432067,-0.249313461367766,1.02141732337076,0.117759053333309,0.294498588031378,"Q9CUS9",9.09e-162,"Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin-like protein 4)","membrane protein proteolysis [GO:0033619]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein binding [GO:0032092]; positive regulation of protein dephosphorylation [GO:0035307]; signal peptide processing [GO:0006465]; T cell receptor signaling pathway [GO:0050852]","GO:0005791; GO:0005794; GO:0005886; GO:0006465; GO:0007204; GO:0016020; GO:0030660; GO:0032092; GO:0033116; GO:0033619; GO:0035307; GO:0042500; GO:0042803; GO:0050852; GO:0070886; GO:0098553; GO:0098554"
"1705","Pocillopora_acuta_HIv2___TS.g26021.t1",0,4.16666666666667,0,4.54545454545455,8.33333333333333,5.76923076923077,0,NA,0,NA,2.85183566433566,3.620337995338,2.08333333333333,NA,NA,NA,NA,NA,NA,11.8316408416581,10.102121343569,12.457579211112,10.0820761065368,11.8246504972421,3.68233641306884,8.03736634147278,11.645556021426,13.3026939564541,9.86233816861592,10.2828358901156,12.2124241055785,8.35324767465267,2935.17911250005,-1.90922073365235,1.90838893625173,0.00768894230725631,0.033507942612882,"Q795M8",9.5e-11,"Putative potassium channel protein YugO","","GO:0005267; GO:0005886"
"1706","Pocillopora_acuta_HIv2___TS.g26022.t1",0,1.75438596491228,0,0,0,0.5,0,0,0,NA,0.250487329434698,0.450877192982456,0,NA,NA,NA,NA,NA,NA,6.27463595648141,3.68233641306884,8.87436168578354,6.1299899042818,5.71763198038475,3.68233641306884,3.68233641306884,8.074842953032,3.68233641306884,3.68233641306884,5.34831445453077,6.52476179775011,4.17186711131143,81.9204739499004,-0.67606879105427,1.366270276671,0.0028367577816433,0.014462765087659,"Q9UIX4",5.61e-08,"Voltage-gated potassium channel regulatory subunit KCNG1 (Potassium voltage-gated channel subfamily G member 1) (Voltage-gated potassium channel subunit Kv6.1) (kH2)","action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of potassium ion transmembrane transport [GO:1901379]","GO:0001508; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0015459; GO:0016020; GO:0051260; GO:0071805; GO:1901379"
"1707","Pocillopora_acuta_HIv2___RNAseq.20294_t",0,0,1.14942528735632,0.980392156862745,0,0.87173100871731,0.572519083969466,0,1.63934426229508,NA,0.579267977688992,0.698293485575027,0.430486092831447,NA,NA,NA,NA,NA,NA,3.68233641306884,5.50727693310996,5.51983254007951,5.31323081329325,6.9963526566166,3.68233641306884,8.91656163500511,6.42306225265296,3.68233641306884,3.68233641306884,5.34056624830327,5.26078405509735,5.4203484415092,68.869782744913,0.112821174633801,0.990429699798486,0.634927574055661,0.823862243755368,"Q795M8",1.35e-07,"Putative potassium channel protein YugO","","GO:0005267; GO:0005886"
"1708","Pocillopora_acuta_HIv2___RNAseq.g15902.t1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.47017797120283,3.68233641306884,8.910510431974,3.68233641306884,7.31938199961972,3.68233641306884,7.10709703926101,5.63630898316489,7.32908137351146,3.68233641306884,5.95019034510093,7.53309215189458,4.36728853830727,119.727184475171,-0.620609519455738,1.29789760132816,7.72390688568724e-06,9.13479878941784e-05,NA,NA,NA,NA,NA
"1709","Pocillopora_acuta_HIv2___RNAseq.g15934.t1",0,0,0,0,0,0,0,0,1.42857142857143,NA,0.158730158730159,0.285714285714286,0,NA,NA,NA,NA,NA,NA,7.79362858270644,10.4207309893499,4.70263489215087,8.77389895020823,6.62825944060524,7.31091089691147,9.80301542127397,7.62211912839311,7.62417468898769,6.7979873969628,7.74773603875497,6.87416334656867,8.62130873094127,346.982454716121,1.05548580270881,1.10959701560055,0.0446584475435514,0.142654546216857,NA,NA,NA,NA,NA
"1710","Pocillopora_acuta_HIv2___RNAseq.g15951.t1",NA,NA,16.6666666666667,35.7142857142857,0,0,37.5,NA,0,NA,14.9801587301587,11.9047619047619,18.0555555555556,NA,NA,NA,NA,NA,NA,3.68233641306884,6.15566643149668,5.59369902756585,5.31323081329325,3.68233641306884,5.44887968569328,9.34214029194588,6.40197652230091,3.68233641306884,8.9804639821468,5.82830659936492,4.60853695781466,7.04807624091518,127.817149844781,1.00795286089828,1.7490730043359,0.000298889331451238,0.0021047396738611,NA,NA,NA,NA,NA
"1711","Pocillopora_acuta_HIv2___RNAseq.g15953.t1",0,40,NA,NA,0,0,0,0,NA,NA,6.66666666666667,13.3333333333333,0,NA,NA,NA,NA,NA,NA,7.22868826190456,8.84506269345107,6.13296418561106,9.23609553638554,6.846108336017,7.74098060029849,8.28482888725975,7.60863341305874,4.79801079550852,7.71805441628311,7.44394271257778,6.52288099841998,8.36500442673559,211.507091715162,1.63300135414802,0.99962997703141,0.00872595902169485,0.037154039237502,"Q923Y9",2.14e-06,"Trace amine-associated receptor 1 (TaR-1) (Trace amine receptor 1)","G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cAMP-mediated signaling [GO:0043950]","GO:0001594; GO:0004930; GO:0005886; GO:0007186; GO:0008227; GO:0043950"
"1712","Pocillopora_acuta_HIv2___RNAseq.g15954.t1",0,0,NA,0,0,0,0,0,5.71428571428571,0,0.634920634920635,1.14285714285714,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.72302631647394,5.72956178137413,3.68233641306884,3.68233641306884,8.01393846452208,3.68233641306884,5.65507448014406,5.77998567012395,3.68233641306884,5.13132687779824,4.90585895155596,5.35679480404051,51.0580610439844,-0.0578225811622867,1.01978959598427,0.0844315235802728,0.230635988114271,NA,NA,NA,NA,NA
"1713","Pocillopora_acuta_HIv2___RNAseq.g15961.t1",100,NA,NA,100,100,100,100,NA,100,NA,100,100,100,NA,NA,NA,NA,NA,NA,5.74163829918218,3.68233641306884,6.92769983394193,3.68233641306884,6.93680958615949,3.68233641306884,9.9017027610342,7.96996419379309,4.25049936715761,7.33112792163665,6.01064512021117,6.36532225604686,5.65596798437547,152.166200145858,-0.160089656738001,1.01555302886442,0.00451841954646198,0.0213437035663051,NA,NA,NA,NA,NA
"1714","Pocillopora_acuta_HIv2___RNAseq.g15975.t1",0,0,NA,0,NA,0,18.75,NA,NA,0,3.125,0,6.25,NA,NA,NA,NA,NA,NA,9.25906492444599,9.85239223713684,7.71470031930259,10.0971629246886,10.7009821947483,9.64044304650115,7.44368669316089,11.1457015485468,9.01539947721401,3.68233641306884,8.8551869778814,9.56716969285154,8.14320426291127,803.443099975639,-0.316013723984796,0.960311463884063,0.288070181332665,0.534459607849624,"Q5RA75",1.02e-114,"Protein FAM135A","cellular lipid metabolic process [GO:0044255]","GO:0044255"
"1715","Pocillopora_acuta_HIv2___RNAseq.g15977.t1",100,100,100,100,NA,100,100,NA,100,NA,100,100,100,NA,NA,NA,NA,NA,NA,10.49047585975,3.68233641306884,7.65716743907436,3.68233641306884,9.69443239362342,10.9772742822422,11.5600338117693,7.46627967311383,3.68233641306884,12.8188617560483,8.17115344548279,7.79813835572609,8.5441685352395,1472.91169847357,0.0632145876810308,1.00165798254672,0.733087490163907,0.881440977832293,"Q96DM3",0,"Regulator of MON1-CCZ1 complex (Colon cancer-associated protein Mic1) (Mic-1) (WD repeat-containing protein 98)","autophagy [GO:0006914]; regulation of autophagy [GO:0010506]","GO:0005765; GO:0006914; GO:0010506; GO:0031902; GO:0035658"
"1716","Pocillopora_acuta_HIv2___TS.g26100.t1",2.08333333333333,0,0,0,0,0,9.375,13.5135135135135,4,0,2.89718468468468,3.5027027027027,2.29166666666667,NA,NA,NA,NA,NA,NA,11.4718104078101,11.0718198214329,11.0101929843222,9.81090221863081,10.4554377914001,10.2748966375874,5.98675477185165,10.9060271563443,11.1735562082478,12.0857381836842,10.4247136181311,11.0034049096249,9.84602232663739,1898.21367725555,-0.425580633388213,0.810598248495486,0.341922371011481,0.592764538677031,"Q9ERC5",0,"Otoferlin (Fer-1-like protein 2)","cochlea development [GO:0090102]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]","GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0007009; GO:0007605; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0042995; GO:0044877; GO:0045177; GO:0045178; GO:0048787; GO:0090102; GO:0098683"
"1717","Pocillopora_acuta_HIv2___TS.g26104.t1",0,NA,0,NA,0,0,NA,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.40014726954871,9.85405380645264,8.56693058133701,7.5168056772214,9.7918867120139,9.58914144040642,10.5628446413429,10.1587554735129,9.65649953639874,3.68233641306884,8.77794015513035,9.31484391456225,8.24103639569844,671.691314992171,-0.178360130552715,0.876172423141047,0.623309163157494,0.816170996172051,"Q2KIR8",4.15e-139,"L-threonine 3-dehydrogenase, mitochondrial (EC 1.1.1.103)","L-threonine catabolic process to glycine [GO:0019518]; threonine catabolic process [GO:0006567]","GO:0005739; GO:0006567; GO:0008743; GO:0019518; GO:0042802"
"1718","Pocillopora_acuta_HIv2___RNAseq.g15994.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.52146481986391,7.22094502716092,5.41389330997997,6.02915908265446,5.82852651465621,6.26042601982666,7.70829378208802,6.3255230136643,4.65430837654882,3.68233641306884,5.86448763595121,5.54874320694264,6.18023206495978,54.5500521031671,0.360937158306961,0.823192947939653,0.452154805429801,0.6933072305456,"Q8K2J9",1.73e-31,"BTB/POZ domain-containing protein 6","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"1719","Pocillopora_acuta_HIv2___TS.g26116.t1",1.53061224489796,0,2.24719101123596,0,2.5,2.61324041811847,5.09915014164306,2.98507462686567,0,NA,1.88614093808457,1.11966300899683,2.84423834944424,NA,NA,NA,NA,NA,NA,6.52177114709796,5.06794590568438,5.79243403424225,4.62642457401022,7.52112240205826,9.16969133003891,3.68233641306884,7.27998974034641,3.68233641306884,3.68233641306884,5.70263883726849,6.15953074736274,5.24574692717424,95.9430956241788,-0.404964700616515,1.04638095777717,0.264366926409352,0.507674352573668,"Q8K2J9",2.42e-16,"BTB/POZ domain-containing protein 6","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"1720","Pocillopora_acuta_HIv2___TS.g26127.t2b",10,28.5714285714286,0,0,NA,5,0,14.2857142857143,12.5,0,7.81746031746032,12.0714285714286,2.5,NA,NA,NA,NA,NA,NA,10.9161368059529,12.8320046764275,7.74513402854738,13.2743864808043,5.85854445871868,12.6573752848159,11.6751321163994,8.00121015687543,3.68233641306884,12.336855058618,9.89791154802283,7.24067237263265,12.555150723413,3433.77439236694,4.34232318093989,2.20797704088504,2.81769159550705e-05,0.000278191749060846,"Q27409",2.4e-33,"Adhesive plaque matrix protein (Foot protein 1) (MGFP-1) (MGFP1)","","GO:0005576"
"1721","Pocillopora_acuta_HIv2___RNAseq.g16015.t2",31.1475409836066,0,NA,NA,39.0476190476191,0.666666666666667,0,0,0,NA,10.1231180996989,0.166666666666667,23.3983866770752,2,46.5079365079365,46.5079365079365,0.00688122678228226,0.00450009011896794,0.00926236344559658,9.65022507353947,7.88830505095858,10.1598946035143,3.68233641306884,9.36865652315267,11.0684618320054,3.68233641306884,8.34202180783398,6.66829119218775,8.35530533234199,7.88658342416718,8.83781784004563,6.93534900828873,554.536563055786,-0.224482142075883,0.992794208231663,0.188941926286178,0.407767236914843,"Q0VGW6",0,"Solute carrier family 12 member 9 (Cation-chloride cotransporter-interacting protein 1)","","GO:0005886; GO:0015377"
"1722","Pocillopora_acuta_HIv2___RNAseq.g16050.t1",28.5714285714286,NA,NA,50,62.5,62.5,60,NA,83.3333333333333,NA,57.8174603174603,65.2777777777778,50.3571428571429,NA,NA,NA,NA,NA,NA,10.749247440873,7.43267390932227,10.9577507399571,5.44417644206312,11.2306346510756,10.1365970946579,8.14708935828997,10.7024868426096,11.3489073415189,9.37269508685841,9.55222589072259,10.9978054032068,8.10664637823833,1242.56235257443,-2.28920026484526,1.12566267817173,0.00122506798964609,0.0069542321044902,"Q04859",0,"Serine/threonine-protein kinase MAK (EC 2.7.11.1) (Male germ cell-associated kinase) (Protein kinase RCK)","cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary transport [GO:0042073]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]","GO:0001750; GO:0001917; GO:0003713; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005929; GO:0005930; GO:0006468; GO:0030496; GO:0031514; GO:0032391; GO:0035556; GO:0042073; GO:0045494; GO:0046777; GO:0046872; GO:0060271; GO:0072686; GO:0106310; GO:1902856; GO:1905515"
"1723","Pocillopora_acuta_HIv2___RNAseq.g16070.t1",0,0,0,NA,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,9.57201063003453,3.68233641306884,7.8421497361785,3.68233641306884,7.37006729746139,3.68233641306884,3.68233641306884,6.40197652230091,7.34717865078807,3.68233641306884,5.69450649021076,7.70667656735268,3.68233641306884,127.99356372656,-11.5682470357404,3.76081620419925,2.15157042424418e-08,5.64796998480359e-07,NA,NA,NA,NA,NA
"1724","Pocillopora_acuta_HIv2___RNAseq.g16086.t1",0,0,46.6666666666667,NA,NA,16.6666666666667,30.7692307692308,NA,0,NA,15.6837606837607,5.55555555555556,25.8119658119658,NA,NA,NA,NA,NA,NA,11.8090925985225,11.3583411775631,10.9566714045332,9.5332162226494,11.8695433172168,10.7954776614669,12.5895588541452,11.9574744678975,7.97687376171105,12.1020057982382,11.0948255263944,10.9139311099762,11.2757199428126,2899.44860246457,0.0575365331395868,0.752673125643943,0.912935674362877,0.967643845446301,"P79735",2.92e-138,"GTP-binding nuclear protein Ran (EC 3.6.5.-) (GTPase Ran) (Ras-related nuclear protein)","GTP metabolic process [GO:0046039]; mitotic sister chromatid segregation [GO:0000070]; neural retina development [GO:0003407]; protein import into nucleus [GO:0006606]; retina development in camera-type eye [GO:0060041]; ribosomal subunit export from nucleus [GO:0000054]; snRNA import into nucleus [GO:0061015]","GO:0000054; GO:0000070; GO:0000287; GO:0003407; GO:0003924; GO:0005525; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0006606; GO:0046039; GO:0060041; GO:0061015"
"1725","Pocillopora_acuta_HIv2___RNAseq.g16087.t1",NA,NA,0,50,77.7777777777778,100,17.6470588235294,NA,15.3846153846154,NA,43.4682419976538,55.1282051282051,31.8082788671024,NA,NA,NA,NA,NA,NA,8.63647045954561,9.77381354675143,9.48296033076121,8.41752635455256,8.9066805399295,3.68233641306884,8.75106295318757,8.03514839820377,10.1799975226171,3.68233641306884,7.95483329316864,9.04825145021144,6.86141513612585,446.144064165286,-0.266418323190042,0.985270280072472,0.211443885355983,0.439098974556918,"Q5TX47",8.17e-86,"Syntaxin-1A","exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]","GO:0000149; GO:0005484; GO:0005886; GO:0006886; GO:0006887; GO:0008021; GO:0012505; GO:0030672; GO:0031201; GO:0031629; GO:0048278; GO:0048787"
"1726","Pocillopora_acuta_HIv2___TS.g26208.t2",0,0,0,NA,NA,14.2857142857143,0,0,NA,NA,2.38095238095238,4.76190476190476,0,NA,NA,NA,NA,NA,NA,11.5085724259597,10.8886232700364,10.1960184453842,12.133426115938,11.309210830533,11.5425036895425,3.68233641306884,11.4142790777223,10.7275951544213,3.68233641306884,9.70849018356751,11.0311351868041,8.38584518033092,2021.58041886646,-0.220782770670072,0.981132787707134,0.283530453469586,0.529665828988992,"Q9QZ67",3.2e-94,"Protein phosphatase 1D (EC 3.1.3.16) (Protein phosphatase 2C isoform delta) (PP2C-delta) (Protein phosphatase magnesium-dependent 1 delta) (p53-induced protein phosphatase 1)","cellular response to starvation [GO:0009267]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation-dependent heterochromatin formation [GO:0006346]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of gene expression, epigenetic [GO:0045814]; response to bacterium [GO:0009617]","GO:0000086; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006346; GO:0009267; GO:0009617; GO:0017018; GO:0030330; GO:0045814; GO:0046872; GO:0051019"
"1727","Pocillopora_acuta_HIv2___RNAseq.g16106.t2",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.6461206458767,12.4072447827057,12.3615604696166,12.6768861107216,12.6469760332017,12.7307588986616,12.7550110457994,11.9962327638797,12.1661821620148,12.3832945239453,12.4770267436423,12.3634144149179,12.5906390723667,5754.39883430129,0.177720980662334,0.495769433825815,0.684267316669241,0.853890878080779,"Q6QEF8",2.53e-146,"Coronin-6 (Coronin-like protein E) (Clipin-E)","actin filament organization [GO:0007015]; cell migration [GO:0016477]","GO:0007015; GO:0016477; GO:0051015"
"1728","Pocillopora_acuta_HIv2___TS.g26225.t1",35.7142857142857,28.5714285714286,0,9.61538461538461,5.17241379310345,48.1481481481481,0,33.3333333333333,0,41.1764705882353,20.1731464763919,23.9336589336589,16.4126340191249,NA,NA,NA,NA,NA,NA,8.43005038277679,12.1067295999434,10.1561379196311,11.4094384817553,10.752203551263,9.40485440288825,9.09695683207791,9.36490510064536,12.2287510010988,6.00413425515518,9.89541615272351,10.186409591083,9.60442271436401,1683.75560831849,-0.0622407778980886,0.863674750782997,0.843873438413408,0.937987733990921,"Q9NDJ2",0,"Helicase domino (EC 3.6.4.-)","chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; DNA repair-dependent chromatin remodeling [GO:0140861]; hemopoiesis [GO:0030097]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; somatic stem cell population maintenance [GO:0035019]; transcription initiation-coupled chromatin remodeling [GO:0045815]; wing disc pattern formation [GO:0035222]","GO:0000123; GO:0000381; GO:0000812; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006338; GO:0008094; GO:0010629; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0045815; GO:0048477; GO:0048813; GO:0070983; GO:0140658; GO:0140713; GO:0140849; GO:0140861"
"1729","Pocillopora_acuta_HIv2___RNAseq.g16108.t1",0,0,0,NA,NA,0,NA,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.85050719468541,6.26270646445638,9.67373989401448,3.68233641306884,9.66143865162392,6.88702586188914,7.42540170510466,7.78277272362825,8.08824348486291,3.68233641306884,7.19965088064028,8.81134038976299,5.58796137151757,274.876509956482,-1.14920760859983,1.75121418061937,0.00334369103802223,0.0165854414176795,"Q9DG67",0,"DNA repair and recombination protein RAD54B (EC 3.6.4.-) (RAD54 homolog B)","double-strand break repair via homologous recombination [GO:0000724]; reciprocal meiotic recombination [GO:0007131]","GO:0000724; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0007131; GO:0015616; GO:0016787; GO:0140658"
"1730","Pocillopora_acuta_HIv2___RNAseq.g16133.t1a",0,0,0,0,3.63636363636364,5.03597122302158,3.125,56.5217391304348,0,42.8571428571429,11.1176216846963,12.3115420706913,9.9237012987013,NA,NA,NA,NA,NA,NA,7.54234269767134,8.65212429292871,6.31061316215391,3.68233641306884,3.68233641306884,5.24316029637619,3.68233641306884,6.39131141676195,7.38269797181723,3.68233641306884,5.62515954899847,6.26186033229465,4.98845876570228,81.3402543099767,-0.175484904525264,1.02307342119886,0.0083833635449748,0.035991976941085,"Q9WTN5",7.89e-125,"Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1)","endocytosis involved in viral entry into host cell [GO:0075509]; positive regulation of autophagy [GO:0010508]; sodium ion transmembrane transport [GO:0035725]","GO:0005248; GO:0005765; GO:0010008; GO:0010508; GO:0015280; GO:0016020; GO:0019905; GO:0022832; GO:0031901; GO:0034702; GO:0035725; GO:0036019; GO:0042802; GO:0042803; GO:0055038; GO:0072345; GO:0075509; GO:0080025; GO:0097682"
"1731","Pocillopora_acuta_HIv2___RNAseq.g16146.t1",0,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.27912941077028,8.66733703951336,7.22410582422696,3.68233641306884,8.8474314801625,9.06324526423961,9.5909139884606,8.34472837204077,8.06664988114209,3.68233641306884,7.44482140866938,7.95240899366852,6.93723382367025,287.050159076572,-0.155588289912511,0.950255103436701,0.433972068780895,0.677566062483469,"Q13356",0,"RING-type E3 ubiquitin-protein ligase PPIL2 (EC 2.3.2.27) (CYC4) (Cyclophilin-60) (Cyclophilin-like protein Cyp-60) (Cyp60) (hCyP-60) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2) (PPIase) (Rotamase PPIL2)","mRNA processing [GO:0006397]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; RNA splicing [GO:0008380]","GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005796; GO:0005886; GO:0006397; GO:0006457; GO:0008380; GO:0034450; GO:0061630; GO:0071013; GO:0072659"
"1732","Pocillopora_acuta_HIv2___TS.g26266.t1",0,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.39475910818241,3.68233641306884,8.54983514404054,10.3024548084521,8.35860213271442,3.68233641306884,9.32996728589492,8.19075369338027,3.68233641306884,3.68233641306884,6.485571782494,6.8352572982773,6.13588626671071,279.543157120688,-0.108118900543438,0.982391730202163,0.554023257049006,0.769113388036935,"Q8N9F7",1.43e-92,"Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)","glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]","GO:0004622; GO:0005783; GO:0005789; GO:0008081; GO:0016020; GO:0046475; GO:0046872; GO:0048471; GO:0070291"
"1733","Pocillopora_acuta_HIv2___RNAseq.g16150.t1",0,0,0,NA,18.1818181818182,0,3.57142857142857,0,0,0,2.41702741702742,0,4.35064935064935,NA,NA,NA,NA,NA,NA,10.6551925515086,11.997481898128,10.1877621145204,10.2331260854598,9.40535668548782,12.6089111266817,11.8574312515107,8.68507515720922,9.97116262302611,10.5485507782516,10.6150050271784,9.78090982635043,11.4491002280064,2136.46246620031,1.14738190953099,0.858610556830682,0.0383551904833065,0.126490487055098,"Q96AY4",0,"Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1734","Pocillopora_acuta_HIv2___RNAseq.g16175.t1",37.5,0,0,NA,60.9756097560976,48.4848484848485,0,100,NA,0,30.8700572801183,49.4949494949495,19.6951219512195,NA,NA,NA,NA,NA,NA,12.2227107194873,11.7464995168727,11.7977892882456,10.6367398678305,12.3354192418983,10.6544520991347,13.2247166883937,12.5238463836826,12.5018845888428,11.7328848539909,11.9376943248379,12.2763300444313,11.5990586052445,4455.75437342811,-0.483275711479151,0.604838333251418,0.301549748124465,0.549875889671238,"Q9TTT7",1.32e-32,"Cytochrome c oxidase subunit 6A1, mitochondrial (Cytochrome c oxidase polypeptide VIa-liver)","mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]","GO:0005751; GO:0006123; GO:0016491; GO:0030234"
"1735","Pocillopora_acuta_HIv2___RNAseq.g16182.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.6191900700116,9.101680504721,9.89048637036369,8.70461022469608,11.0462402426766,10.416802944758,3.68233641306884,10.8328428374176,9.59384760678025,9.87501766027578,9.37630548747694,10.3965214254499,8.35608954950394,1027.66018794314,-0.479734031701746,0.963573524895005,0.261908972515174,0.504176315851773,"P62323",7.6e-63,"Small nuclear ribonucleoprotein Sm D3 (Sm-D3) (snRNP core protein D3)","mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]","GO:0000243; GO:0000387; GO:0000398; GO:0005634; GO:0005682; GO:0005684; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0071005; GO:0071007; GO:0071208"
"1736","Pocillopora_acuta_HIv2___RNAseq.g16196.t1",0,NA,NA,NA,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,4.05965798824309,7.32110127300494,5.9646645801927,7.00074722714729,6.97678248710109,6.87624067398106,8.38247307922146,5.70976195638337,9.20984790764022,9.19393630104748,7.06952134739627,6.38414298391209,7.75489971088045,193.941287510038,0.81459365507757,1.04414817747632,0.0847017164777982,0.231243040229308,"D3YXG0",2.47e-51,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]","GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711"
"1737","Pocillopora_acuta_HIv2___RNAseq.g16200.t1",0,10,NA,8.33333333333333,6.66666666666667,NA,NA,0,0,0,3.57142857142857,4.58333333333333,2.22222222222222,NA,NA,NA,NA,NA,NA,10.0862544551206,8.25887125628039,9.52581221552609,8.42712219499703,10.0148554430927,8.28818371605666,9.58478057633476,10.1433149248141,9.55374528622154,3.68233641306884,8.75652764815127,9.86479646495501,7.64825883134754,624.394421438873,-0.834628349915634,1.09412669970774,0.0932027901951076,0.248220430377838,"Q80U12",0,"Small G protein signaling modulator 2 (RUN and TBC1 domain-containing protein 1)","late endosome to Golgi transport [GO:0034499]","GO:0005096; GO:0031267; GO:0034499; GO:0042470"
"1738","Pocillopora_acuta_HIv2___RNAseq.g16204.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,4.66441148952732,7.43267390932227,7.8421497361785,10.1545383623825,8.2947478723639,7.35019707545882,8.25419413569394,7.62211912839311,3.68233641306884,9.43910489187003,7.47364730142592,6.42115292790633,8.52614167494551,302.143111531547,0.697753326592451,1.15197520902422,0.0568313289125703,0.171843861481402,"Q8WYQ5",1.18e-83,"Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8)","DNA damage response [GO:0006974]; positive regulation of pre-miRNA processing [GO:2000633]; primary miRNA processing [GO:0031053]; regulation of stem cell proliferation [GO:0072091]","GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006974; GO:0014069; GO:0016604; GO:0020037; GO:0030674; GO:0031053; GO:0035861; GO:0042802; GO:0042803; GO:0046872; GO:0070877; GO:0070878; GO:0072091; GO:0098978; GO:0140517; GO:2000633"
"1739","Pocillopora_acuta_HIv2___RNAseq.g16231.t1",9.8159509202454,0,0,4.34782608695652,16.3568773234201,28.8770053475936,11.9047619047619,26.3888888888889,28.8888888888889,0,12.6580199360755,17.7005218424656,7.61551802968548,1,-64.8860958366064,-64.8860958366064,1.2968155030185e-10,1.2968155030185e-10,1.2968155030185e-10,11.4587417773011,11.1091670266276,11.4343909578167,11.6391124719055,11.9927913535118,8.46598915268982,3.68233641306884,11.6395162251889,11.8201034554405,10.9265112773894,10.416866011094,11.6691087538518,9.16462326833623,2393.22060683339,-0.506921652862218,1.01162814279686,0.175160409405573,0.386678901349543,"Q91YT2",1.97e-77,"E3 ubiquitin-protein ligase RNF185 (EC 2.3.2.27) (RING finger protein 185)","autophagy [GO:0006914]; defense response to virus [GO:0051607]; ERAD pathway [GO:0036503]; innate immune response [GO:0045087]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein autoubiquitination [GO:0051865]; protein K27-linked ubiquitination [GO:0044314]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005741; GO:0005783; GO:0005789; GO:0006511; GO:0006914; GO:0036503; GO:0043130; GO:0044314; GO:0044390; GO:0044877; GO:0045087; GO:0046872; GO:0051607; GO:0051865; GO:0060340; GO:0061630; GO:1904294"
"1740","Pocillopora_acuta_HIv2___RNAseq.g16232.t1",0.29585798816568,0.495458298926507,1.66919575113809,0.182370820668693,0.588004704037632,0.272656452869385,0.513083632632119,1.44927536231884,0.0794912559618442,1.53061224489796,0.707600651161675,0.495850438149054,0.919350864174296,NA,NA,NA,NA,NA,NA,10.8291632139792,10.9206854447124,12.0404695838633,11.9774937181024,10.5148484280053,9.3538910092679,9.82746209165324,11.6290239185803,11.514714681395,11.3009316186181,10.9908683708177,11.3056439651646,10.6760927764708,2338.94133186286,-0.446253650629254,0.589433786237345,0.337669178427893,0.588510302058205,"E9PVA8",0,"Stalled ribosome sensor GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)","cellular response to amino acid starvation [GO:0034198]; GCN2-mediated signaling [GO:0140469]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]","GO:0005737; GO:0005829; GO:0006417; GO:0019887; GO:0022626; GO:0034198; GO:0043539; GO:0060090; GO:0072344; GO:0140469; GO:0170011"
"1741","Pocillopora_acuta_HIv2___RNAseq.g16247.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.99738846276564,6.86946281647337,5.51983254007951,7.34446020722041,3.68233641306884,9.68082213827152,6.42458387407815,8.75180924963986,3.68233641306884,3.68233641306884,6.3635368527735,5.92674061572454,6.80033308982246,174.803789163988,0.0825665131155466,0.967908148843214,0.647782245156806,0.832069908084707,"Q29599",3.96e-14,"2'-5'-oligoadenylate synthase 1 ((2-5')oligo(A) synthase 1) (2-5A synthase 1) (EC 2.7.7.84) (p42 OAS)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of transformation of host cell by virus [GO:1904188]; negative regulation of viral genome replication [GO:0045071]; regulation of ribonuclease activity [GO:0060700]","GO:0001730; GO:0003725; GO:0005524; GO:0005576; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0016020; GO:0045071; GO:0045087; GO:0046872; GO:0051607; GO:0060700; GO:1904188"
"1742","Pocillopora_acuta_HIv2___RNAseq.g16256.t1",NA,NA,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,13.6380449552837,13.1802409137685,13.3887777051646,13.1256331831103,13.7037272568957,13.2228561382141,13.7191277313731,13.8572812192709,13.7911236576914,13.3042788990318,13.4931091659804,13.6757909588613,13.3104273730996,11695.7320545485,-0.29082396760924,0.478193231789112,0.492049217601395,0.723419382332443,"Q78P75",7.34e-59,"Dynein light chain 2, cytoplasmic (Dynein light chain LC8-type 2)","microtubule-based process [GO:0007017]","GO:0005737; GO:0005813; GO:0005856; GO:0005868; GO:0005874; GO:0007017; GO:0014069; GO:0031475; GO:0042802; GO:0044877; GO:0045505; GO:0097110; GO:0097731; GO:0098794; GO:0098978"
"1743","Pocillopora_acuta_HIv2___TS.g26403.t1",0,NA,NA,NA,0,0,0,0,100,NA,16.6666666666667,33.3333333333333,0,NA,NA,NA,NA,NA,NA,5.39475910818241,6.59081673114823,7.94179218572159,3.68233641306884,6.60277205734412,3.68233641306884,7.30046701549876,7.36282605502715,3.68233641306884,7.20738205486765,5.94478244469964,6.19689716386882,5.69266772553046,78.2981384364491,-0.0468634968666487,0.983810282742198,0.698962268334846,0.862536494257761,"Q5ZHS1",0,"Elongator complex protein 3 (EC 2.3.1.311) (tRNA uridine(34) acetyltransferase)","regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]; tRNA wobble uridine modification [GO:0002098]","GO:0000049; GO:0002098; GO:0002926; GO:0005634; GO:0005737; GO:0006357; GO:0008607; GO:0033588; GO:0046872; GO:0051539; GO:0106261"
"1744","Pocillopora_acuta_HIv2___TS.g26411.t1",4,16.6666666666667,28.5714285714286,10.3448275862069,15.9090909090909,13.0081300813008,21.3333333333333,0,16,NA,13.9814974608919,11.2039248668349,17.4534632034632,NA,NA,NA,NA,NA,NA,11.1488641209673,8.84840276906955,11.3373829499476,8.35856695130629,10.4900111365108,10.7451106566308,3.68233641306884,10.5609143438635,10.4398505740941,11.0253543841931,9.66367942996519,10.7954046250767,8.53195423485372,1355.62030853424,-0.539246526692509,1.03576941995444,0.13965590220894,0.332781378838567,"Q8NFA0",0,"Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32)","positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]","GO:0000139; GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006508; GO:0016579; GO:1904263"
"1745","Pocillopora_acuta_HIv2___RNAseq.g16294.t1",0,0,NA,NA,NA,90,10,NA,10,0,18.3333333333333,33.3333333333333,3.33333333333333,NA,NA,NA,NA,NA,NA,10.5537271849977,11.3065019723497,11.5292832955399,11.7463424191231,11.0882156223581,11.2403809946194,11.6794545011939,11.0299968647344,7.14460118177282,13.0271442018872,11.0345648238576,10.2691648298806,11.7999648178347,2862.86447680411,0.567399773590883,0.83803922582917,0.252149080067595,0.493115778001311,"Q15276",1.3e-92,"Rab GTPase-binding effector protein 1 (Rabaptin-4) (Rabaptin-5) (Rabaptin-5alpha) (Renal carcinoma antigen NY-REN-17)","apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; membrane fusion [GO:0061025]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","GO:0005096; GO:0005768; GO:0005769; GO:0006893; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0031901; GO:0032991; GO:0042803; GO:0043231; GO:0055037; GO:0061025; GO:1903441"
"1746","Pocillopora_acuta_HIv2___RNAseq.g16297.t1",NA,92.3076923076923,81.8181818181818,33.3333333333333,73.3333333333333,60,NA,66.6666666666667,75.7575757575758,86.5384615384615,71.2194055944056,65.6130536130536,80.5633255633256,NA,NA,NA,NA,NA,NA,9.83738079452434,9.5085715992601,9.10045871331929,10.0467655687602,10.344560922123,7.32675562721369,11.0813490128854,9.01210706827363,9.55180754640415,9.3142958773975,9.51240527301613,9.56926300892888,9.45554753710338,852.70897779027,-0.00820741660527717,0.730390160289175,0.963431055845769,0.986832858278677,"Q96RR4",5.15e-136,"Calcium/calmodulin-dependent protein kinase kinase 2 (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta)","calcium-mediated signaling [GO:0019722]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to reactive oxygen species [GO:0034614]; MAPK cascade [GO:0000165]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase activity [GO:0045859]","GO:0000165; GO:0001934; GO:0004674; GO:0004683; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0019722; GO:0034614; GO:0043005; GO:0045859; GO:0045893; GO:0046777; GO:0061762; GO:0106310; GO:1903599"
"1747","Pocillopora_acuta_HIv2___RNAseq.g16304.t1",68.1818181818182,79.4117647058823,77.4193548387097,79.3103448275862,100,44,84.375,82.7586206896552,83.5616438356164,80.2469135802469,77.9265460659515,73.808474811748,82.044617320155,NA,NA,NA,NA,NA,NA,7.36720372069137,5.39185996804635,9.19872341498392,10.3523485534912,9.35245829625253,7.85972880706295,9.82051951382199,7.87192395769485,3.68233641306884,3.68233641306884,7.45794390581828,7.4945291605383,7.42135865109827,392.818434975247,-0.058805877010793,0.840742230031969,0.911703217390517,0.967276119440801,"Q96RR4",1.04e-138,"Calcium/calmodulin-dependent protein kinase kinase 2 (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta)","calcium-mediated signaling [GO:0019722]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to reactive oxygen species [GO:0034614]; MAPK cascade [GO:0000165]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase activity [GO:0045859]","GO:0000165; GO:0001934; GO:0004674; GO:0004683; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0019722; GO:0034614; GO:0043005; GO:0045859; GO:0045893; GO:0046777; GO:0061762; GO:0106310; GO:1903599"
"1748","Pocillopora_acuta_HIv2___TS.g23090.t1",0,NA,6.25,0,0,4.16666666666667,0,0,0,0,1.15740740740741,1.04166666666667,1.25,NA,NA,NA,NA,NA,NA,9.33602916180979,3.68233641306884,8.43347218433143,9.13734647618724,10.9885715308202,3.68233641306884,3.68233641306884,3.68233641306884,11.4318237964315,8.34803780681849,7.2404626608674,8.77444661729235,5.70647870444245,652.307314752918,-0.35039911846832,1.06617470841568,0.0890801788172117,0.239866406088161,"Q9Y6L7",1.9e-28,"Tolloid-like protein 2 (EC 3.4.24.-)","cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of skeletal muscle tissue growth [GO:0048632]; protein processing [GO:0016485]","GO:0004222; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0008270; GO:0009953; GO:0016485; GO:0030154; GO:0030199; GO:0048632"
"1749","Pocillopora_acuta_HIv2___TS.g23121.t2",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,14.2052738722193,14.0817627624269,13.7719948946987,13.047799276884,14.3011302435758,13.1435563516124,14.4714519408509,13.6979930791558,13.5880075137623,13.2143623625026,13.7523332297689,13.9128799206824,13.5917865388554,14548.8927035189,-0.228105109739711,0.553329425092528,0.605190005570439,0.803807393727885,"Q90705",0,"Elongation factor 2 (EF-2) (EC 3.6.5.-)","translational elongation [GO:0006414]","GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0006414; GO:0043022; GO:1990904"
"1750","Pocillopora_acuta_HIv2___RNAseq.g8803.t1a",5.71428571428571,0,NA,0,33.3333333333333,0,0,NA,0,0,4.88095238095238,0,9.76190476190476,NA,NA,NA,NA,NA,NA,12.6049902417491,12.4148623582326,13.1525899589784,11.6747433375631,12.682284960407,12.0904301118823,10.9014446663213,12.5891159897517,12.5311844209267,11.184557201503,12.1826203247315,12.7120331143626,11.6532075351005,5106.425766822,-0.83987203575545,0.589855497239563,0.0823955493171209,0.226679087386639,"Q6P5H6",7.5e-115,"FERM domain-containing protein 5","actomyosin structure organization [GO:0031032]","GO:0005856; GO:0005912; GO:0008092; GO:0031032"
"1751","Pocillopora_acuta_HIv2___TS.g23144.t1",0,NA,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.441105727868,11.9869210324753,7.04726048369553,11.5988745276666,8.14920071011206,12.3574742743654,10.84184460894,9.67091052716981,3.68233641306884,11.8709219396617,9.56468502450232,7.39816277238285,11.7312072766218,1933.98573877367,2.90257623605892,2.09879549999036,0.00105204484463207,0.00610625065519992,"Q00685",6.8e-149,"Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3 gamma chain]","complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]","GO:0004866; GO:0005615; GO:0006954; GO:0006958; GO:0045087"
"1752","Pocillopora_acuta_HIv2___RNAseq.g8820.t1",NA,0,NA,NA,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,6.96622929966615,10.1215644514048,3.68233641306884,9.42973330435663,7.72531093337751,11.7664385604421,12.032458655256,9.30786156975193,3.68233641306884,10.0394831369025,8.47537527372953,6.27281492578665,10.6779356216724,1129.70986215374,3.36507158136878,2.59958601254134,0.000212355299728827,0.00157271226588723,"Q3SYW2",2.58e-53,"Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment]","complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]","GO:0004252; GO:0005576; GO:0006508; GO:0006956; GO:0006958; GO:0009617; GO:0045087; GO:0046872"
"1753","Pocillopora_acuta_HIv2___RNAseq.g8821.t1",1.73913043478261,2.23214285714286,9.46969696969697,5.34351145038168,13.0434782608696,0,0.604229607250755,0,1.59574468085106,0.471698113207547,3.4499632374183,1.83427979767512,5.06564667716149,NA,NA,NA,NA,NA,NA,11.512939013,14.8789507335123,10.7290763437433,14.7198211964714,11.8064776608171,14.9346259806175,15.1405414700809,13.0385629652865,10.6345578723296,14.0682099256626,13.1463763161521,11.5443227710353,14.7484298612689,15967.8005170179,3.00420767847167,0.657280947073452,2.66272779062243e-07,5.05574845802589e-06,"P01026",2.73e-170,"Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2]","amyloid-beta clearance [GO:0097242]; chemotaxis [GO:0006935]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement receptor mediated signaling pathway [GO:0002430]; complement-dependent cytotoxicity [GO:0097278]; complement-mediated synapse pruning [GO:0150062]; fatty acid metabolic process [GO:0006631]; inflammatory response [GO:0006954]; neuron remodeling [GO:0016322]; oviduct epithelium development [GO:0035846]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of developmental growth [GO:0048639]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of lipid storage [GO:0010884]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of type IIa hypersensitivity [GO:0001798]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of triglyceride biosynthetic process [GO:0010866]; response to bacterium [GO:0009617]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to magnesium ion [GO:0032026]; response to progesterone [GO:0032570]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; tolerance induction [GO:0002507]; vascular associated smooth muscle cell differentiation [GO:0035886]; vertebrate eye-specific patterning [GO:0150064]","GO:0001798; GO:0001934; GO:0001970; GO:0002430; GO:0002507; GO:0004866; GO:0005576; GO:0005615; GO:0006631; GO:0006935; GO:0006954; GO:0006956; GO:0006957; GO:0006958; GO:0008289; GO:0009410; GO:0009617; GO:0009986; GO:0010575; GO:0010828; GO:0010866; GO:0010884; GO:0016322; GO:0031715; GO:0032026; GO:0032355; GO:0032570; GO:0032991; GO:0035846; GO:0035886; GO:0043627; GO:0045745; GO:0045766; GO:0048260; GO:0048639; GO:0050766; GO:0051384; GO:0060041; GO:0060100; GO:0070374; GO:0097242; GO:0097278; GO:0150062; GO:0150064; GO:2000427"
"1754","Pocillopora_acuta_HIv2___RNAseq.g8827.t1",0,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.5764363193014,8.86498795418406,10.9139347331224,10.2575034263515,10.4837344110761,9.79417346752238,11.4264032180244,10.5226418343367,10.2640485699225,11.545757266931,10.4649621200772,10.5521591735518,10.3777650666027,1565.36915859745,-0.106189611407573,0.639650258007335,0.804523481920347,0.918222018661398,"Q66I24",0,"Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase)","arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; urea cycle [GO:0000050]","GO:0000050; GO:0000053; GO:0004055; GO:0005524; GO:0005737; GO:0005829; GO:0006526"
"1755","Pocillopora_acuta_HIv2___TS.g23178.t1",0,0,0,NA,0,0,0,2.56410256410256,0,0,0.284900284900285,0.641025641025641,0,NA,NA,NA,NA,NA,NA,11.2152151461771,13.4999465030484,10.6491500504398,13.7680130091235,10.2134526998317,14.0233909629851,11.6162275361774,10.6597193549758,8.40009381532483,14.2181468994211,11.8263355977505,10.2275262133498,13.4251449821511,7125.51468368757,2.60608845419624,1.06948529725725,0.000309803744169721,0.00217102778860021,"A0MSJ1",4.25e-146,"Collagen alpha-1(XXVII) chain B","bone mineralization [GO:0030282]; extracellular matrix organization [GO:0030198]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501]","GO:0001501; GO:0005581; GO:0005615; GO:0030020; GO:0030198; GO:0030282; GO:0046872; GO:0048570; GO:0062023"
"1756","Pocillopora_acuta_HIv2___TS.g23179.t1",0,NA,0,0,83.3333333333333,0,NA,0,NA,NA,13.8888888888889,0,27.7777777777778,NA,NA,NA,NA,NA,NA,3.68233641306884,11.639791173356,3.68233641306884,9.93028439588735,9.15825281380541,10.5476707820176,3.68233641306884,9.16066928766405,3.68233641306884,11.919460742657,7.70854748476628,5.8731862681352,9.54390870139736,1052.76690567051,0.236416221928437,1.04273849164203,2.58128396437066e-06,3.56596860178197e-05,"P43903",3.95e-67,"Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase)","","GO:0003960; GO:0005829; GO:0008270; GO:0035925; GO:0070402"
"1757","Pocillopora_acuta_HIv2___RNAseq.g8864.t1",0,NA,0,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,15.5511480374952,13.2097346061824,15.5665559191477,10.2166425851365,16.2306282920621,8.08059955791897,8.5089149620922,13.1573572666775,16.481367170514,12.2519269260328,12.9254875323259,15.3974113371793,10.4535637274726,28998.8049452589,-4.39943874997544,1.13879091561272,1.969872260458e-07,3.89238147203067e-06,NA,NA,NA,NA,NA
"1758","Pocillopora_acuta_HIv2___RNAseq.g8878.t1",NA,100,100,100,100,100,100,NA,NA,NA,100,100,100,NA,NA,NA,NA,NA,NA,11.2729954057633,12.2900232207619,11.4954947569031,12.4462910764148,11.9077635692086,12.1703061590999,12.9504830490693,11.7332438197984,12.3601959838191,3.68233641306884,11.2309133453907,11.7539387070985,10.7078879836829,4074.94472389766,0.0460479647512046,0.881082908112742,0.935851684750417,0.976255136933338,"Q9YHD3",1.73e-37,"Large proline-rich protein bag6-A (BCL2-associated athanogene 6) (HLA-B-associated transcript 3-A) (Protein Scythe)","brain development [GO:0007420]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ERAD pathway [GO:0036503]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; proteasomal protein catabolic process [GO:0010498]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001822; GO:0005576; GO:0005634; GO:0005829; GO:0006325; GO:0006511; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0018393; GO:0030324; GO:0031593; GO:0032435; GO:0036503; GO:0042771; GO:0043022; GO:0045861; GO:0045995; GO:0050821; GO:0061857; GO:0070059; GO:0070628; GO:0071816; GO:0071818"
"1759","Pocillopora_acuta_HIv2___RNAseq.g8893.t1",NA,NA,4.16666666666667,0,0,0,0,NA,0,NA,0.694444444444445,0,1.38888888888889,NA,NA,NA,NA,NA,NA,3.68233641306884,6.77312724931675,6.19479753228254,3.68233641306884,8.08416984619327,7.69302168712282,7.11855920009515,7.64871506591188,3.68233641306884,3.68233641306884,5.82417362331978,5.85847105410507,5.78987619253448,85.3690334002546,-0.0393630047363137,0.969599827268293,0.928095260855583,0.973456842133079,"P08940",3.53e-19,"Myeloid protein 1 (p33)","granulocyte differentiation [GO:0030851]; response to antibiotic [GO:0046677]","GO:0005615; GO:0030851; GO:0044194; GO:0046677; GO:0046872"
"1760","Pocillopora_acuta_HIv2___RNAseq.g8901.t1",0,NA,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.32811847350323,9.6260441116532,3.68233641306884,9.47202186942336,3.68233641306884,10.9271665307343,6.15654274228627,8.95485204357217,3.68233641306884,9.19393630104748,7.47056913114265,5.86599595125638,9.07514231102892,506.748351229391,0.305927155633517,1.05177659032942,3.7826830465553e-06,4.9525620076114e-05,"D3YXG0",0,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]","GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711"
"1761","Pocillopora_acuta_HIv2___RNAseq.g8905.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.6448838057529,11.0305446294465,9.42480971363826,10.6884564426115,10.4577686410872,10.9200493853018,11.7587572272991,8.70626368761647,10.6554569084619,11.8485993484765,10.6135589789692,9.97783655131135,11.2492814066271,1830.2852148065,0.915902973728356,0.704178766623686,0.079946708848783,0.222374845536307,"Q12904",4.45e-84,"Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) [Cleaved into: Endothelial monocyte-activating polypeptide 2 (EMAP-2) (Endothelial monocyte-activating polypeptide II) (EMAP-II) (Small inducible cytokine subfamily E member 1)]","angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412]","GO:0000049; GO:0001525; GO:0001937; GO:0005125; GO:0005615; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006412; GO:0006915; GO:0006954; GO:0007267; GO:0009986; GO:0016020; GO:0017101; GO:0042803; GO:0050900; GO:0051020; GO:0051607; GO:0070094"
"1762","Pocillopora_acuta_HIv2___TS.g23234.t1",32.8358208955224,4.22535211267606,0,NA,7.36842105263158,3.54609929078014,0,0,0,7.86516853932584,6.204540210104,1.94286285086405,9.61388209749596,NA,NA,NA,NA,NA,NA,10.4966627107004,3.68233641306884,9.99197477094589,9.75872004496075,9.36617630423823,7.39595400278476,9.30779343082827,10.0244511465491,3.68233641306884,3.68233641306884,7.73887416502139,8.71232026910049,6.76542806094229,565.542927879884,-0.376466099049628,0.999509996726751,0.355823939055172,0.606557154330467,"P53676",0,"AP-3 complex subunit mu-1 (AP-3 adaptor complex mu3A subunit) (Adaptor-related protein complex 3 subunit mu-1) (Clathrin assembly protein assembly protein complex 3 mu-1 medium chain) (Clathrin coat assembly protein AP47 homolog 1) (Clathrin coat-associated protein AP47 homolog 1) (Golgi adaptor AP-1 47 kDa protein homolog 1) (HA1 47 kDa subunit homolog 1) (Mu-adaptin 3A) (Mu3A-adaptin) (P47A)","anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; postsynaptic neurotransmitter receptor internalization [GO:0098884]","GO:0005794; GO:0006886; GO:0006897; GO:0008089; GO:0030131; GO:0030659; GO:0031267; GO:0031410; GO:0048490; GO:0098837; GO:0098884; GO:1904115"
"1763","Pocillopora_acuta_HIv2___RNAseq.g8911.t1",0,NA,0,NA,0,0,NA,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.28621869280214,8.99121360085343,9.17848805228091,3.68233641306884,9.04959218039685,9.26473150967485,7.46174035997229,9.45648169920655,9.34580141849236,3.68233641306884,7.83989403398171,9.06331640863576,6.61647165932765,387.278011757956,-0.411041957574344,1.03973859016315,0.0795722153312786,0.221631527547008,"Q6DCP1",3.8e-132,"FAD-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-)","mitochondrial respiratory chain complex I assembly [GO:0032981]","GO:0005743; GO:0016491; GO:0032981; GO:0070469"
"1764","Pocillopora_acuta_HIv2___RNAseq.g8914.t1",0,0,0,0,0,2.29885057471264,0,0,0,0,0.229885057471264,0.459770114942529,0,NA,NA,NA,NA,NA,NA,9.61164811340314,11.9462252908776,8.5120833728374,12.6546261181701,4.35452149648907,12.6624241474921,13.9262855420983,8.09750134092551,3.68233641306884,13.7393520952276,9.91870039305897,6.85161814734479,12.9857826387731,4734.09510362457,4.72764850795015,2.66172640755826,1.03961397003406e-05,0.000117476378613849,"O75096",0,"Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395"
"1765","Pocillopora_acuta_HIv2___RNAseq.g8915.t1",0,NA,NA,3.03030303030303,0,1.86915887850467,0,NA,2.85714285714286,NA,1.29276746099176,2.58553492198352,0,NA,NA,NA,NA,NA,NA,11.036885318939,9.05619588384409,11.7229541587546,8.656493341284,11.7224692684997,10.430528181482,5.1359206776867,11.6982774422184,11.3583591575447,7.53764925099809,9.83557326812513,11.5077890691913,8.16335746705898,1709.59092303431,-2.52152406894803,1.30047168895481,0.000877482631424409,0.00525327350203752,"P10079",9.58e-16,"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","","GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579"
"1766","Pocillopora_acuta_HIv2___RNAseq.g8922.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.40581674802619,3.68233641306884,7.24978579672844,7.42860258406594,9.60052067269517,10.8824059244982,9.14834181996278,6.96817420778911,10.8895019703292,7.89378225502327,6.1819582875911,9.60560622245544,605.533010139431,2.22039676651637,2.77389272206674,0.000758640622794287,0.00464366397295665,"Q00685",0,"Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3 gamma chain]","complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]","GO:0004866; GO:0005615; GO:0006954; GO:0006958; GO:0045087"
"1767","Pocillopora_acuta_HIv2___RNAseq.g8933.t1",NA,0,0,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.1448322685481,3.68233641306884,8.24444310560462,3.68233641306884,10.4837344110761,11.4111525495906,11.74415891213,9.81041293133785,3.68233641306884,3.68233641306884,7.65680798305626,8.4731518259271,6.84046414018542,976.598333236286,-0.0880768082105494,0.985439507064993,0.553699466371175,0.769106797425591,"Q5M7G4",7.6e-168,"Adenylate kinase 8 (AK 8) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 8)","","GO:0004017; GO:0004127; GO:0004550; GO:0005524; GO:0005829"
"1768","Pocillopora_acuta_HIv2___RNAseq.g8940.t1",0,0,0,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.03654092012575,9.17532314507704,3.68233641306884,3.68233641306884,7.65772136444679,8.22647481831577,3.68233641306884,3.68233641306884,8.69188709951876,3.68233641306884,5.91996294128283,6.1501644420458,5.68976144051987,149.935473195418,-0.00956158522929425,0.978804721827426,0.911570058262071,0.967205789517503,"P44659",1.62e-06,"Uncharacterized protein HI_0358","thiamine metabolic process [GO:0006772]","GO:0005829; GO:0006772; GO:0050334"
"1769","Pocillopora_acuta_HIv2___RNAseq.g8958.t1",26.4623955431755,8.15217391304348,8.53333333333333,2.24438902743142,22.1991701244813,4.90196078431373,8.31889081455806,6.61157024793388,50.9433962264151,0,13.8367280014686,14.5706980398275,13.1027579631096,NA,NA,NA,NA,NA,NA,8.69303517526933,9.42383226557013,8.65482796170777,3.68233641306884,8.34857406366281,11.0572999493651,3.68233641306884,8.66140189614823,6.18642473237091,6.3122422615894,7.47023111318214,8.10885276583181,6.83160946053246,431.886321484472,-0.141639030389391,0.964571033804333,0.464451712379748,0.704795396342353,"Q69Z28",4.19e-168,"A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-)","branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073]","GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017"
"1770","Pocillopora_acuta_HIv2___RNAseq.g8962.t1",NA,0,0,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.86971526847046,3.68233641306884,7.60277868691723,3.68233641306884,8.58896460150771,8.62102755951409,11.3579396284139,8.28115103341985,3.68233641306884,3.68233641306884,6.80509224305186,7.40498920067682,6.2051952854269,422.533398223063,-0.0965305436675105,0.99002590784036,0.48829231225361,0.721443179141038,"O94762",0,"ATP-dependent DNA helicase Q5 (EC 5.6.2.4) (DNA 3'-5' helicase RecQ5) (DNA helicase, RecQ-like type 5) (RecQ5) (RecQ protein-like 5)","cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to xenobiotic stimulus [GO:0071466]; chromosome separation [GO:0051304]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; mitotic DNA-templated DNA replication [GO:1990506]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]","GO:0000278; GO:0000724; GO:0000993; GO:0003677; GO:0003678; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005737; GO:0005829; GO:0006259; GO:0006260; GO:0006268; GO:0006281; GO:0009378; GO:0016853; GO:0016887; GO:0034244; GO:0042802; GO:0043138; GO:0046872; GO:0051301; GO:0051304; GO:0071466; GO:0072757; GO:0097550; GO:1990414; GO:1990506; GO:2000042"
"1771","Pocillopora_acuta_HIv2___RNAseq.g8964.t1",0,0,0,0,0,4.23728813559322,0,NA,0,NA,0.529661016949153,1.05932203389831,0,NA,NA,NA,NA,NA,NA,9.45157962526724,9.15389265986356,3.68233641306884,10.5472977938127,8.96686736539284,3.68233641306884,11.4580568870868,9.06881000047198,3.68233641306884,9.96316056953122,7.96566741406329,6.97038596345395,8.96094886467262,743.688422189393,0.190193819020482,1.0124662109772,0.201051151533726,0.424526110333404,"Q9DBQ7",7.63e-103,"Protein-associating with the carboxyl-terminal domain of ezrin (Ezrin-binding protein PACE-1) (SCY1-like protein 3)","inflammatory response [GO:0006954]; neuron development [GO:0048666]; protein localization [GO:0008104]; spinal cord motor neuron differentiation [GO:0021522]","GO:0000139; GO:0004672; GO:0005524; GO:0005783; GO:0005794; GO:0005829; GO:0006954; GO:0008104; GO:0021522; GO:0030027; GO:0042802; GO:0048666"
"1772","Pocillopora_acuta_HIv2___RNAseq.g9000.t1",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.7640099708404,12.1587360972554,11.8261374183221,13.1152971977664,11.7691959050223,10.9653810557966,12.1074448448319,11.2086191288976,11.8313264377979,11.4456300725475,11.8191778129078,11.6798577721761,11.9584978536396,3900.10310277152,0.199706147152457,0.577439041222715,0.673212635867152,0.847897979608382,"Q8BUV8",6.65e-143,"Protein GPR107","clathrin-dependent endocytosis [GO:0072583]","GO:0005654; GO:0005769; GO:0005794; GO:0005886; GO:0016020; GO:0030136; GO:0032050; GO:0072583"
"1773","Pocillopora_acuta_HIv2___RNAseq.20975_t",NA,0,11.1111111111111,0,0,0,0,NA,0,NA,1.58730158730159,0,3.7037037037037,NA,NA,NA,NA,NA,NA,9.82899839662404,8.35601668762938,10.2312596220024,7.02644217673873,8.63092136976072,9.78849941707104,3.68233641306884,9.39911899079698,7.58665737684829,10.0006700658224,8.45309205163628,9.13539115120649,7.77079295206608,551.513452697872,-0.272409823304247,0.960639280327109,0.321212189265402,0.571184301147625,"P35658",6.79e-91,"Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN)","mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405]","GO:0005049; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006913; GO:0008139; GO:0017056; GO:0046822; GO:0051726; GO:1990876"
"1774","Pocillopora_acuta_HIv2___RNAseq.g9032.t1",0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,4.90080178660296,8.96376152408571,9.1654614919124,3.68233641306884,9.12489295101675,4.05708008052864,3.68233641306884,8.69358802044517,9.13932265436363,6.7979873969628,6.82075687320557,8.20481338086818,5.43670036554297,258.064835211333,-0.516096563578773,1.19474642233977,3.09676475015516e-05,0.00030285061086034,"F4JTS8",3.53e-154,"Protein NO VEIN (Protein EMBRYO DEFECTIVE 2597)","auxin polar transport [GO:0009926]; cell fate specification [GO:0001708]; embryo development ending in seed dormancy [GO:0009793]; leaf vascular tissue pattern formation [GO:0010305]; root development [GO:0048364]; stem cell population maintenance [GO:0019827]","GO:0001708; GO:0005634; GO:0009793; GO:0009926; GO:0010305; GO:0019827; GO:0048364"
"1775","Pocillopora_acuta_HIv2___TS.g23369.t3",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.34070533074306,5.77108626594745,3.68233641306884,3.68233641306884,5.84362177230977,8.08524471858609,7.70829378208802,6.22050512179836,3.68233641306884,3.68233641306884,5.46988026437481,5.15390101019777,5.78585951855185,60.584187333333,0.297441044933025,0.959672897858711,0.460257550908261,0.701071824728179,"Q923L3",8.3e-53,"CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)","conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964]","GO:0001964; GO:0007613; GO:0008584; GO:0008585; GO:0016020; GO:0035846; GO:0042593; GO:0060745; GO:1990708"
"1776","Pocillopora_acuta_HIv2___RNAseq.g9041.t1",0,0,0,0,0,0,0,1.5625,0,1.42857142857143,0.299107142857143,0.3125,0.285714285714286,NA,NA,NA,NA,NA,NA,10.1437062561485,9.16732400920039,8.73262645402442,10.7258197064831,8.62054625928763,11.83958449556,8.61312599041619,8.90075080666568,3.68233641306884,11.5833222182013,9.20091426090561,8.01599323783901,10.3858352839722,1159.28482250826,0.465584477633126,1.01635254063105,0.181020559885233,0.395749906012697,"A2AVA0",0,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)","cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of complement activation, classical pathway [GO:0045959]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193]","GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0045959; GO:0048014; GO:0090136; GO:0098640; GO:0120193"
"1777","Pocillopora_acuta_HIv2___RNAseq.g9054.t1",0,0,6.66666666666667,0,0,0,0,0,NA,NA,0.833333333333333,0,1.66666666666667,NA,NA,NA,NA,NA,NA,6.38824903660035,11.2571316948218,3.68233641306884,8.22187128010793,3.68233641306884,11.0631853885191,11.4068404861786,3.68233641306884,3.68233641306884,9.34379118728125,7.24104147257844,4.22351893777514,10.2585640073817,818.346861337894,11.9534081435043,3.18660283846916,3.16059073926246e-11,2.35643218828311e-09,"Q68CP4",2.88e-135,"Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76)","heparan sulfate proteoglycan catabolic process [GO:0030200]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259]","GO:0005765; GO:0005886; GO:0007041; GO:0015019; GO:0016746; GO:0030200; GO:0035579; GO:0043202; GO:0051259; GO:0070821"
"1778","Pocillopora_acuta_HIv2___RNAseq.20998_t",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,10.688074933819,8.26904050216647,6.58091230054222,4.93003625965001,10.1718902608968,9.46522378565555,9.59914854345106,3.68233641306884,9.1570241431435,7.62260235554623,6.03257962628104,9.21262508481141,509.459380939356,0.40619655136975,1.08007362288892,0.000423291847713726,0.00284370333735779,"Q9DBI0",4.71e-41,"Transmembrane protease serine 6 (EC 3.4.21.-) (Matriptase-2)","BMP signaling pathway [GO:0030509]; fibrinolysis [GO:0042730]; intracellular iron ion homeostasis [GO:0006879]; membrane protein proteolysis [GO:0033619]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508]; self proteolysis [GO:0097264]","GO:0000122; GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0006879; GO:0016020; GO:0030509; GO:0030514; GO:0033619; GO:0042730; GO:0045892; GO:0045944; GO:0060586; GO:0097264"
"1779","Pocillopora_acuta_HIv2___RNAseq.g9064.t1",0,NA,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,3.68233641306884,8.18839085032791,3.68233641306884,7.49032865096105,8.14708935828997,7.19203195048682,3.68233641306884,9.39047009487938,5.88199929702893,4.38427552055244,7.37972307350543,144.741752125662,0.418793707033608,1.11904943347806,0.000192327633308755,0.00143986898974008,"Q96PZ7",1.19e-74,"CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)","conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964]","GO:0001964; GO:0007613; GO:0008584; GO:0008585; GO:0016020; GO:0035846; GO:0042593; GO:0060745; GO:1990708"
"1780","Pocillopora_acuta_HIv2___RNAseq.g9084.t1",0,0,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.41843533392233,12.6472274257085,9.17105872651436,12.3747450492547,9.10866107783238,12.5738876677038,12.810802285379,10.6982667028736,4.65430837654882,13.151927028741,10.6609319674478,8.6101460435383,12.7117178913574,3736.00912665436,2.90713894076682,1.40221173412562,0.000692686119785967,0.00431110672830647,"Q8SQ75",1.5e-56,"Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment]","complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]","GO:0004252; GO:0005601; GO:0006508; GO:0006958; GO:0009617; GO:0045087; GO:0046872; GO:0070062"
"1781","Pocillopora_acuta_HIv2___RNAseq.g9085.t1",0,0,0,0,0,0.401606425702811,0,0,8.95522388059701,0,0.935683030629983,1.87136606125997,0,NA,NA,NA,NA,NA,NA,9.77620164177499,13.5166937244974,10.1324343286869,13.8085583887917,10.1304117553122,13.3526261251884,13.5355436325607,11.4778218930556,10.9231034866628,14.2569233869018,12.0910318363432,10.4879946210985,13.694069051588,7563.81025980618,3.02206875535546,0.653308721640851,2.10531730899171e-07,4.1027561729048e-06,"Q96PZ7",8.15e-53,"CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1)","conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964]","GO:0001964; GO:0007613; GO:0008584; GO:0008585; GO:0016020; GO:0035846; GO:0042593; GO:0060745; GO:1990708"
"1782","Pocillopora_acuta_HIv2___RNAseq.g9086.t1",NA,0,NA,0,0,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,8.94667083400464,5.26408513103678,3.68233641306884,4.7918870276047,8.96850385239319,8.28010730107237,3.68233641306884,8.93345472001888,3.68233641306884,3.68233641306884,5.99140545184059,6.84266044651088,5.14015045717031,171.798332110315,-0.182085921105089,1.01164598249496,0.481870385206541,0.71600950319277,"Q8NFG4",3.4e-168,"Folliculin (BHD skin lesion fibrofolliculoma protein) (Birt-Hogg-Dube syndrome protein)","cell proliferation involved in kidney development [GO:0072111]; cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; epithelial cell proliferation [GO:0050673]; ERK1 and ERK2 cascade [GO:0070371]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lysosome localization [GO:0032418]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of glycolytic process [GO:0045820]; negative regulation of lysosome organization [GO:1905672]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of pro-B cell differentiation [GO:2000973]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0000122; GO:0001701; GO:0004857; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0007043; GO:0007179; GO:0009267; GO:0010508; GO:0019899; GO:0030097; GO:0030511; GO:0031929; GO:0032006; GO:0032007; GO:0032008; GO:0032418; GO:0034198; GO:0035024; GO:0035556; GO:0043065; GO:0043491; GO:0044877; GO:0045820; GO:0046578; GO:0050673; GO:0050680; GO:0051898; GO:0070371; GO:0070373; GO:0072111; GO:0072686; GO:0097009; GO:0097193; GO:0120163; GO:1901723; GO:1901874; GO:1903444; GO:1904263; GO:1905672; GO:1990877; GO:2000973; GO:2001244"
"1783","Pocillopora_acuta_HIv2___TS.g23415.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.99355402052038,6.08712839408766,5.35722166815878,5.73735826925806,5.66700991799266,6.6664531765618,6.28680786951883,4.97146452269528,6.16564805667492,6.14979536860625,5.90824412640746,5.6309796372084,6.18550861560652,40.2874180761514,0.56261270978163,0.710896700625449,0.273774535541523,0.518676402148915,NA,NA,NA,NA,NA
"1784","Pocillopora_acuta_HIv2___RNAseq.g9090.t1",NA,NA,0,0,14.2857142857143,37.5,0,NA,0,NA,8.63095238095238,12.5,4.76190476190476,NA,NA,NA,NA,NA,NA,7.27912941077028,6.57449245641112,9.35112665652338,3.68233641306884,9.37113248229241,4.32783990674728,3.68233641306884,7.21602452626304,7.00297301330175,3.68233641306884,6.21697276915158,8.04407721783017,4.38986832047298,169.7101423904,-7.19083392486996,2.68556374688789,8.20640870953439e-07,1.32202400764621e-05,"Q9WUW9",7.37e-52,"Sulfotransferase 1C2A (ST1C2A) (rSULT1C2A) (EC 2.8.2.1) (Sulfotransferase K2)","sulfation [GO:0051923]","GO:0004062; GO:0005737; GO:0005764; GO:0008146; GO:0051923"
"1785","Pocillopora_acuta_HIv2___TS.g23422.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.143804804696,11.1188729954059,11.1198434148897,9.244253171146,11.6511960400953,9.54438909557558,10.9720533969961,10.405862248935,12.5163605694621,10.2291832065801,10.7945818943782,11.3674134156156,10.2217503731407,2145.01741008166,-0.770094333221337,0.746071827210603,0.124635085352096,0.306907112181762,NA,NA,NA,NA,NA
"1786","Pocillopora_acuta_HIv2___RNAseq.g9105.t1",0,NA,0,2.4390243902439,6.75675675675676,2.4390243902439,0,0,9.67741935483871,NA,2.66402811151041,3.63886703383163,1.68918918918919,NA,NA,NA,NA,NA,NA,10.3024791293845,10.390139763992,10.6828292798316,11.8154678102149,9.94761557309954,8.62421925072359,9.45853039827569,10.2196523206063,9.87990035735,8.60125271221105,9.99220865956892,10.2064953320544,9.77792198708345,1220.66590496129,-0.310926046276288,0.621688624010545,0.509986005785747,0.737348819240808,"Q6MG55",1.71e-161,"Phosphatidylserine lipase ABHD16A (EC 3.1.-.-) (Alpha/beta hydrolase domain-containing protein 16A) (Abhydrolase domain-containing protein 16A) (HLA-B-associated transcript 5 homolog) (Monoacylglycerol lipase ABHD16A) (EC 3.1.1.23)","monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; prostaglandin catabolic process [GO:1905344]","GO:0004620; GO:0006660; GO:0016020; GO:0047372; GO:0052651; GO:1905344"
"1787","Pocillopora_acuta_HIv2___RNAseq.g9109.t1",0,0,0,0,0,2.67857142857143,0,NA,NA,NA,0.38265306122449,0.892857142857143,0,NA,NA,NA,NA,NA,NA,9.40533726205741,3.68233641306884,3.68233641306884,10.8088010452442,8.76318309299656,10.5341735356218,3.68233641306884,9.60705060392878,5.98677490518935,3.68233641306884,6.98346660973135,7.48893645544819,6.4779967640145,508.209311952894,-0.119577267954541,1.01799467927854,0.00100876030434987,0.00589047599600991,"P15215",5.37e-142,"Laminin subunit gamma-1 (Laminin B2 chain)","animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; endodermal digestive tract morphogenesis [GO:0061031]; extracellular matrix assembly [GO:0085029]; midgut development [GO:0007494]; salivary gland morphogenesis [GO:0007435]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]","GO:0005576; GO:0005604; GO:0007411; GO:0007435; GO:0007494; GO:0009887; GO:0009888; GO:0033627; GO:0034446; GO:0061031; GO:0070831; GO:0071711; GO:0085029"
"1788","Pocillopora_acuta_HIv2___RNAseq.g9116.t1",NA,0,0,0,0,5.88235294117647,0,NA,NA,NA,0.980392156862745,1.96078431372549,0,NA,NA,NA,NA,NA,NA,8.56754062166566,9.16999532373749,9.6202001066349,3.68233641306884,10.4354720097783,3.68233641306884,7.83811523990364,8.24682958013343,7.40013118083982,5.49240068675675,7.41353575755877,8.85403469981042,5.97303681530711,367.528551006577,-0.451013787048674,1.06909961816848,0.0492528950353867,0.153777351980544,"P62168",3.78e-110,"Neuronal calcium sensor 1 (NCS-1) (Frequenin homolog) (Frequenin-like protein) (Frequenin-like ubiquitous protein)","positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of exocytosis [GO:0045921]; regulation of neuron projection development [GO:0010975]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of synaptic vesicle exocytosis [GO:2000300]","GO:0000287; GO:0005245; GO:0005509; GO:0005737; GO:0005794; GO:0005886; GO:0008048; GO:0008427; GO:0010975; GO:0014069; GO:0019901; GO:0030424; GO:0030425; GO:0031045; GO:0044305; GO:0045921; GO:0048471; GO:0050850; GO:0098794; GO:0098978; GO:0099509; GO:0099523; GO:0099524; GO:2000300"
"1789","Pocillopora_acuta_HIv2___RNAseq.g9134.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,9.16359090608638,3.68233641306884,7.54334529587741,6.60213173979051,3.68233641306884,7.10471396075978,7.1854786141887,3.68233641306884,5.6010942582047,6.93589303799622,4.26629547841317,101.718147278024,-0.444761549960841,1.13997779330313,0.00177113420319296,0.00959823346383778,"Q96AY4",2.13e-63,"Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1790","Pocillopora_acuta_HIv2___RNAseq.g12074.t1",NA,33.3333333333333,62.5,NA,0,0,100,33.3333333333333,NA,NA,38.1944444444444,22.2222222222222,54.1666666666667,NA,NA,NA,NA,NA,NA,9.42029681044045,9.1938169358223,9.38843888309567,3.68233641306884,7.2560778700207,8.69270373175752,3.68233641306884,9.42233866986031,8.76400444678825,3.68233641306884,7.31846865869917,8.85023133604108,5.78670598135727,345.161253750749,-0.376065828717742,1.07204115827342,2.06901581935481e-05,0.000213453957283509,"Q3SZZ0",1.09e-132,"Ribosome biogenesis protein BRX1 homolog (Brix domain-containing protein 2)","ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]","GO:0000027; GO:0003723; GO:0005730; GO:0006364; GO:0019843"
"1791","Pocillopora_acuta_HIv2___RNAseq.g12088.t1",0,0,0,NA,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.74081087897825,7.63263776583099,4.4496922765333,7.47098189621969,5.91659193355748,9.48773547593271,4.10128477526701,3.68233641306884,3.68233641306884,6.9608997877233,6.11253076161804,5.09435358304134,7.13070794019474,135.026335841181,2.38818677070321,2.84108712743999,0.00180794513822563,0.00976844171807826,"Q9EQD2",2.18e-33,"Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor)","cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of MAPK cascade [GO:0043408]","GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0042277; GO:0043408"
"1792","Pocillopora_acuta_HIv2___RNAseq.g12123.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.84219610301059,7.14638580056123,7.82800945720994,7.63780657485539,8.63711073538355,6.88702586188914,7.11855920009515,9.23541527173648,6.28579400236677,9.18581490818331,7.88041179152915,8.16570511394147,7.59511846911684,269.759869566883,-0.404922307350712,0.827191041684441,0.359975350515475,0.61011055423668,"Q8IZF0",0,"Sodium leak channel NALCN (CanIon) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1)","calcium ion transmembrane transport [GO:0070588]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]","GO:0005248; GO:0005261; GO:0005272; GO:0005886; GO:0022840; GO:0032224; GO:0032230; GO:0034220; GO:0034702; GO:0035725; GO:0060075; GO:0070588; GO:0071805"
"1793","Pocillopora_acuta_HIv2___RNAseq.g12154.t1",NA,0,NA,0,0.909090909090909,0,0,NA,1.13636363636364,0,0.292207792207792,0.284090909090909,0.303030303030303,NA,NA,NA,NA,NA,NA,8.64605358581663,8.35601668762938,7.46312695790699,3.68233641306884,9.18383234974313,3.68233641306884,10.9307489821471,8.33659335057371,3.68233641306884,3.68233641306884,6.76457175660923,7.46238853142186,6.0667549817966,361.024821057869,-0.125595230779271,0.991749732657728,0.4295815408381,0.673984966556273,"Q9CZU3",0,"Exosome RNA helicase MTR4 (EC 3.6.4.13) (ATP-dependent helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase)","DNA damage response [GO:0006974]; maturation of 5.8S rRNA [GO:0000460]; mRNA processing [GO:0006397]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]","GO:0000176; GO:0000460; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0006397; GO:0006401; GO:0006974; GO:0008380; GO:0016607; GO:0016887; GO:0031499; GO:0071013"
"1794","Pocillopora_acuta_HIv2___RNAseq.g12160.t1a",0.99009900990099,9.52380952380952,2.67857142857143,0,2.29885057471264,9.2436974789916,1.79640718562874,8,7.14285714285714,20.2380952380952,6.19123875825673,6.78207282913165,5.60040468738181,NA,NA,NA,NA,NA,NA,12.1305249957826,11.9597899120775,12.26611739384,12.6056241345601,12.3485094658974,12.3432755983371,13.0282291705895,12.5724970665857,13.0627830260168,12.8296474573206,12.5146998221007,12.4760863896245,12.553313254577,6006.1680524515,0.0634506962172823,0.486923495970284,0.888528736711416,0.95700943091771,"Q9JHU4",0,"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)","cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]","GO:0002177; GO:0003341; GO:0005524; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005881; GO:0005938; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0016887; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1904115; GO:1905832"
"1795","Pocillopora_acuta_HIv2___RNAseq.g12163.t1",0,0,0,0,0,1.3840830449827,0,0,0.917431192660551,0,0.230151423764325,0.46030284752865,0,NA,NA,NA,NA,NA,NA,7.15852236535678,6.5579743664166,4.94123562252982,8.52419391542848,6.82432087263943,6.71585965723107,3.68233641306884,6.91940874856523,7.98840764607209,8.82176997594444,6.81340295832528,6.76637905103267,6.86042686561789,146.493922139966,-0.00427027458676008,0.892461525108055,0.973261465710362,0.991523900568459,"O15118",5.5e-55,"NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)","adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; cholesterol transport [GO:0030301]; cyclodextrin metabolic process [GO:2000900]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; gene expression [GO:0010467]; intestinal cholesterol absorption [GO:0030299]; intracellular cholesterol transport [GO:0032367]; intracellular lipid transport [GO:0032365]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; macroautophagy [GO:0016236]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of macroautophagy [GO:0016242]; negative regulation of TORC1 signaling [GO:1904262]; neurogenesis [GO:0022008]; programmed cell death [GO:0012501]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to xenobiotic stimulus [GO:0009410]; symbiont entry into host cell [GO:0046718]","GO:0001618; GO:0001889; GO:0004888; GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0009410; GO:0010467; GO:0010878; GO:0012501; GO:0015485; GO:0016020; GO:0016236; GO:0016242; GO:0022008; GO:0030299; GO:0030301; GO:0031579; GO:0031902; GO:0032365; GO:0032367; GO:0033344; GO:0038023; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1904036; GO:1904262; GO:2000900"
"1796","Pocillopora_acuta_HIv2___TS.g3145.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.68934125489244,9.97045225272625,9.12373711115305,8.27599526498432,8.66160550004852,8.31609918735907,10.1252089248128,9.43887886806762,10.2061006721982,9.71496906202053,9.35223880982628,9.42393268127197,9.28054493838059,699.898440281082,-0.11066847347948,0.54154191443918,0.800863512820852,0.915996350580484,"O70244",3.12e-09,"Cubilin (460 kDa receptor) (Glycoprotein 280) (gp280) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor)","cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; endocytic hemoglobin import into cell [GO:0020028]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; response to nutrient [GO:0007584]","GO:0001701; GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007584; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0020028; GO:0030135; GO:0030139; GO:0030492; GO:0030666; GO:0031419; GO:0031526; GO:0031528; GO:0032991; GO:0038024; GO:0042366; GO:0042802; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0045177; GO:0051649; GO:0070062"
"1797","Pocillopora_acuta_HIv2___RNAseq.g12189.t1",7.35434574976122,3.63247863247863,4.47093889716841,0.106609808102345,8.94439967767929,2.03520352035204,3.572929802438,0.591715976331361,0.894454382826476,0,3.16030764471378,1.45209246401817,4.86852282540938,1,14.0350877192982,14.0350877192982,0.0138314075167228,0.0138314075167228,0.0138314075167228,7.02670788736903,9.86398321989598,7.66780142801844,7.96266298558189,8.47147564881472,3.68233641306884,3.68233641306884,6.67144653115387,5.49910115103059,3.68233641306884,6.4210188091071,7.06730652927733,5.77473108893688,184.608272563946,-0.317063484006952,1.04793706546379,0.00523740669654378,0.0241793330542002,NA,NA,NA,NA,NA
"1798","Pocillopora_acuta_HIv2___RNAseq.g12219.t1",NA,NA,NA,100,100,100,85.7142857142857,100,NA,100,97.6190476190476,100,95.2380952380952,NA,NA,NA,NA,NA,NA,10.7321197656005,10.1637064629974,10.5545806782678,10.4740681401082,10.525442812302,10.6213258278604,11.1452453204618,10.6411520645581,11.1647103997183,8.86311224931715,10.4885463721192,10.7236011440893,10.253491600149,1519.12572752916,-0.284222594989187,0.624429237949036,0.541491317172476,0.760770316812306,"B6MFW3",0,"Protein Hook homolog","cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; protein transport [GO:0015031]","GO:0005737; GO:0005813; GO:0005874; GO:0008017; GO:0015031; GO:0030705; GO:0031122; GO:0051959"
"1799","Pocillopora_acuta_HIv2___RNAseq.g12222.t1",NA,NA,0,0,66.6666666666667,0,69.2307692307692,50,NA,NA,30.982905982906,16.6666666666667,45.2991452991453,NA,NA,NA,NA,NA,NA,9.85675230063415,9.56850387027591,11.6035673627975,11.9937063824206,11.7569457920596,10.9834947118782,4.90654184690663,10.8562326564748,7.56366523702835,12.4411302425669,10.1530540403043,10.3274326697989,9.97867541080965,2174.64606521167,-0.0843200139132574,0.873110027977006,0.839573553733611,0.936644186749167,"P50533",0,"Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E)","cell division [GO:0051301]; chromosome condensation [GO:0030261]","GO:0005524; GO:0005634; GO:0005694; GO:0005829; GO:0016887; GO:0030261; GO:0051301"
"1800","Pocillopora_acuta_HIv2___RNAseq.g12223.t1",0,NA,NA,NA,0,0,0,10,0,NA,1.66666666666667,3.33333333333333,0,NA,NA,NA,NA,NA,NA,12.0274733085724,9.66632291868463,11.40778494726,6.20095146371302,11.1348420437604,8.60496209062734,8.94238636689426,10.8036759048509,12.764860117268,3.68233641306884,9.52355955746998,11.6277272643423,7.41939185059762,1942.75963931324,-1.8661158469433,2.06818144990927,0.00474534674739626,0.0222341092822609,"P25228",3.56e-96,"Ras-related protein Rab-3","cytoskeletal matrix organization at active zone [GO:0048789]; exocytosis [GO:0006887]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; symbiont entry into host cell [GO:0046718]; vesicle-mediated transport [GO:0016192]","GO:0000287; GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006887; GO:0007269; GO:0008021; GO:0009306; GO:0016192; GO:0031489; GO:0031630; GO:0031982; GO:0032482; GO:0045202; GO:0046718; GO:0046928; GO:0048172; GO:0048786; GO:0048789; GO:0048790"
"1801","Pocillopora_acuta_HIv2___RNAseq.g12228.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,8.07697750564745,7.98064084080777,5.05535826649939,3.68233641306884,4.65791064633771,3.68233641306884,5.38578475744502,9.48838344510852,3.68233641306884,5.53744011141212,6.0438963738998,5.03098384892445,120.405978196322,-0.0805969372793838,1.01796789920347,0.144214272324737,0.339559699642682,"P35384",1.56e-105,"Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (BoPCaR1) (PCaR1)","calcium ion transport [GO:0006816]; detection of calcium ion [GO:0005513]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874]; JNK cascade [GO:0007254]; ossification [GO:0001503]; positive regulation of cell population proliferation [GO:0008284]; regulation of calcium ion transport [GO:0051924]; vasodilation [GO:0042311]","GO:0001503; GO:0004930; GO:0005509; GO:0005513; GO:0005886; GO:0006816; GO:0006874; GO:0007186; GO:0007254; GO:0008284; GO:0016597; GO:0042311; GO:0042803; GO:0043679; GO:0051924"
"1802","Pocillopora_acuta_HIv2___TS.g3209.t2",0,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,14.7247817962871,13.2694644666984,15.0295317234484,14.3628186666153,14.5602099245225,13.5311695173009,14.0647115416856,14.508434504389,14.3948337368632,14.5486161280123,14.2994572005823,14.643558337102,13.9553560640625,21315.3397420563,-0.51843395301633,0.552263689837749,0.255252823651209,0.496399065600992,"O35889",4.54e-06,"Afadin (Afadin adherens junction formation factor) (Protein Af-6)","adherens junction maintenance [GO:0034334]; bicellular tight junction assembly [GO:0070830]; brain morphogenesis [GO:0048854]; cell-cell adhesion mediated by cadherin [GO:0044331]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; homeostasis of number of cells [GO:0048872]; negative regulation of cell migration [GO:0030336]; neuroepithelial cell differentiation [GO:0060563]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; postsynaptic specialization organization [GO:0099084]; protein localization to cell junction [GO:1902414]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of postsynapse assembly [GO:0150052]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165]; telencephalon development [GO:0021537]","GO:0005737; GO:0005829; GO:0005911; GO:0005912; GO:0007165; GO:0010628; GO:0021537; GO:0021987; GO:0022409; GO:0030054; GO:0030274; GO:0030336; GO:0030424; GO:0031267; GO:0032880; GO:0034334; GO:0036477; GO:0043296; GO:0044291; GO:0044331; GO:0045177; GO:0046930; GO:0046931; GO:0048787; GO:0048854; GO:0048872; GO:0050775; GO:0050839; GO:0051015; GO:0060019; GO:0060076; GO:0060563; GO:0061003; GO:0061885; GO:0061951; GO:0070160; GO:0070445; GO:0070830; GO:0090557; GO:0098686; GO:0098839; GO:0098978; GO:0099084; GO:0140059; GO:0150052; GO:1902414; GO:1903861; GO:2000049"
"1803","Pocillopora_acuta_HIv2___RNAseq.g12259.t1",2.22222222222222,0,5.88235294117647,0,0,0.649350649350649,0,0,0,NA,0.972658423638816,0.12987012987013,2.02614379084967,NA,NA,NA,NA,NA,NA,3.68233641306884,8.76248534121948,7.77493455161284,6.96130739864265,7.84805420942548,10.3069985565844,9.67799631760878,3.68233641306884,3.68233641306884,10.8553618319851,7.32341474462852,5.33399960004897,9.31282988920808,477.079801796246,0.601154593237631,1.23638529560755,8.69840166188959e-07,1.38408890690397e-05,"P18052",3.33e-63,"Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28)","insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of focal adhesion assembly [GO:0051893]","GO:0004725; GO:0005925; GO:0007229; GO:0008286; GO:0016020; GO:0043235; GO:0044877; GO:0048714; GO:0050804; GO:0051893; GO:0097060; GO:0098685"
"1804","Pocillopora_acuta_HIv2___RNAseq.g12266.t1",3.7037037037037,NA,0,0,0,0,0,NA,0,NA,0.529100529100529,0,0.925925925925926,NA,NA,NA,NA,NA,NA,3.68233641306884,8.78706332609212,3.68233641306884,6.58091230054222,3.68233641306884,7.81003641322381,5.69873558273438,4.37784214571138,6.49844915574363,5.16462945902469,5.59646776222788,4.38466010813231,6.80827541632344,80.1516984408818,0.590288005142202,1.24780152145828,6.31281118074648e-05,0.000559831397414574,"O14522",1.71e-45,"Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho)","cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; signal transduction [GO:0007165]","GO:0004725; GO:0005001; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016020; GO:0016790; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0050807; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:0098839; GO:0098978; GO:1904893; GO:1990264"
"1805","Pocillopora_acuta_HIv2___RNAseq.g12281.t1",0,0,33.3333333333333,0,0,0,0,0,NA,NA,4.16666666666667,0,8.33333333333333,NA,NA,NA,NA,NA,NA,3.68233641306884,10.5013928532478,3.68233641306884,9.08076436963003,3.68233641306884,11.1481479773932,11.0318738111082,3.68233641306884,3.68233641306884,10.1972310919072,7.03710921686306,3.68233641306884,10.3918820206573,740.060962879886,15.4019456150839,3.72097169211652,4.02937321358851e-16,2.08145907719087e-13,"P10586",7.23e-48,"Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR)","cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; negative regulation of receptor binding [GO:1900121]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of axon regeneration [GO:0048679]; synaptic membrane adhesion [GO:0099560]","GO:0004721; GO:0004725; GO:0005001; GO:0005886; GO:0007155; GO:0007185; GO:0008201; GO:0016477; GO:0031102; GO:0035335; GO:0035373; GO:0043005; GO:0043025; GO:0044877; GO:0048679; GO:0050839; GO:0070062; GO:0099560; GO:1900121"
"1806","Pocillopora_acuta_HIv2___RNAseq.g12282.t1",0,0,0,NA,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.06770233724501,7.29462189187011,9.43211549519643,3.68233641306884,9.93565222150942,6.66472726798925,5.93817869271292,3.68233641306884,9.84181621110451,6.92218233568342,4.85596196475791,8.98840270660892,327.06843060631,0.815831751200579,1.44857745699293,4.67793814353558e-07,8.20141785552711e-06,"F1NWE3",9.76e-150,"Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha)","negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; peptidyl-tyrosine dephosphorylation [GO:0035335]; synaptic membrane adhesion [GO:0099560]","GO:0004725; GO:0005886; GO:0008201; GO:0030424; GO:0030426; GO:0030517; GO:0030672; GO:0035335; GO:0042803; GO:0043204; GO:0043395; GO:0048671; GO:0048681; GO:0061000; GO:0098839; GO:0099560"
"1807","Pocillopora_acuta_HIv2___TS.g3256.t1",NA,NA,0,59.0909090909091,0,33.8461538461538,0,NA,0,NA,15.4895104895105,30.979020979021,0,1,-55.5555555555556,-55.5555555555556,0.0132730692561142,0.0132730692561142,0.0132730692561142,9.1996033744134,7.8080468355442,8.95661954912388,7.41397822195162,8.83492466866254,6.3891072326092,3.68233641306884,9.07696362560168,9.21230394209822,3.68233641306884,7.42562202761424,9.05608303197994,5.79516102324854,295.295562269589,-1.07198050204221,1.6003151530471,0.0067554270337028,0.0300740217345267,"Q9I929",3.19e-13,"Fucolectin-3","regulation of cellular defense response [GO:0010185]; regulation of complement activation, lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088]","GO:0001868; GO:0005509; GO:0005615; GO:0010185; GO:0030246; GO:0042806; GO:0045088"
"1808","Pocillopora_acuta_HIv2___RNAseq.g12287.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.30369490384351,3.68233641306884,8.54983514404054,3.68233641306884,7.76362851520386,7.34242603626167,4.51171232812315,8.22348476192202,9.08674715072376,3.68233641306884,6.3828538079325,8.18547809514674,4.58022952071827,160.939659886312,-6.29951637698291,3.09906228075976,1.73717789907528e-06,2.53547337358475e-05,"P16621",3.33e-16,"Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124]","GO:0004725; GO:0005001; GO:0005158; GO:0005925; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0009986; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0045467; GO:0046627; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0061484; GO:0120034; GO:1903386"
"1809","Pocillopora_acuta_HIv2___TS.g3265.t1",0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,5.71611892316596,9.29027002952589,6.50448097751675,10.1342036597556,7.65364434417167,11.3546859402075,9.97543667073592,8.59478714399461,3.68233641306884,9.63074362499101,8.25367077271338,6.43027356038357,10.0770679850432,667.550514401953,3.1732606109571,1.66797261715989,0.000455758895001489,0.00302389754922089,"Q64487",3.22e-154,"Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]","GO:0004725; GO:0005102; GO:0007157; GO:0030182; GO:0042734; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099151; GO:0099537; GO:0099545; GO:0099560"
"1810","Pocillopora_acuta_HIv2___RNAseq.g12295.t2",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.52177114709796,5.93854123587151,9.75298682935183,3.68233641306884,7.40935653522263,6.34225560108856,7.23888785936134,8.1198078417103,10.2933322492624,3.68233641306884,6.89816121251042,8.41945092052902,5.37687150449182,275.538810787763,-0.563042100056318,1.1121204875574,0.052998733372641,0.162328780813898,"P35573",0,"Glycogen debranching enzyme (Glycogen debrancher) [Includes: 4-alpha-glucanotransferase (EC 2.4.1.25) (Oligo-1,4-1,4-glucantransferase); Amylo-alpha-1,6-glucosidase (Amylo-1,6-glucosidase) (EC 3.2.1.33) (Dextrin 6-alpha-D-glucosidase)]","glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]","GO:0004133; GO:0004134; GO:0004135; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005978; GO:0005980; GO:0007584; GO:0016234; GO:0016529; GO:0030247; GO:0031593; GO:0034774; GO:0043033; GO:0051384; GO:0102500; GO:1904813"
"1811","Pocillopora_acuta_HIv2___RNAseq.g12306.t1",6.77966101694915,3.84615384615385,0,4.34782608695652,10,0,10.5263157894737,0,NA,NA,4.43749459244165,2.04849498327759,6.82649420160571,NA,NA,NA,NA,NA,NA,3.68233641306884,11.1209443769597,5.79243403424225,9.2388198810257,5.420425513227,7.99430979892605,9.11693502128184,7.84919628280518,3.68233641306884,11.7720448376261,7.56697825722315,5.28534573128242,9.84861078316388,727.113927494196,1.16465052186372,1.97518538626118,0.00136610707952094,0.00762910146648295,"B7ZCC9",1.01e-57,"Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; neurogenesis [GO:0022008]","GO:0004930; GO:0005886; GO:0007166; GO:0007189; GO:0022008"
"1812","Pocillopora_acuta_HIv2___RNAseq.g12309.t1",NA,NA,0,0,2.77777777777778,0,0,5.26315789473684,NA,NA,1.3401559454191,1.75438596491228,0.925925925925926,NA,NA,NA,NA,NA,NA,8.46296479422179,8.08266943966032,8.837282424363,9.24696215526144,9.77422555871129,6.62821723110622,7.7818636248628,8.97942046114956,8.28801074732352,5.92487398666357,8.20064904233235,8.86838079715383,7.53291728751087,351.278658963259,-0.921426834108757,0.865009108388592,0.077723459193825,0.217908919127638,"Q6NYU2",1.19e-112,"Probable helicase with zinc finger domain (EC 3.6.4.-)","regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]","GO:0003677; GO:0003700; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005829; GO:0016787; GO:0035194; GO:0043186; GO:0046872"
"1813","Pocillopora_acuta_HIv2___RNAseq.g12314.t1",0,0,NA,0,0,0,NA,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,8.27801859226,6.03941460781193,8.389293996423,9.56395273519032,8.06284514577596,9.51376339745893,10.653524048807,10.1732724568877,10.8238506944551,11.0355539059463,9.25334895810162,9.14545617716035,9.3612417390429,889.217342543086,0.160457347992976,0.697324206048144,0.740253027543838,0.88487766862761,"P21804",8.16e-82,"Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (Tyrosine kinase receptor CEK1)","epicardial cell to mesenchymal cell transition [GO:0003347]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of MAP kinase activity [GO:0043406]","GO:0003347; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0008201; GO:0008284; GO:0017134; GO:0018108; GO:0031410; GO:0043235; GO:0043406; GO:0045597; GO:0045893"
"1814","Pocillopora_acuta_HIv2___TS.g3288.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.92650798752011,7.4680060679803,9.57729476136219,9.80723689665745,8.7054580990537,10.5443082919376,10.7128330156058,10.5998953042424,10.0280170824319,12.0851927580117,9.94547502648031,9.76743464692206,10.1235154060386,1308.60405244702,0.236765633750978,0.735661639030256,0.615873368677108,0.811549328562477,"P21804",5.06e-82,"Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (Tyrosine kinase receptor CEK1)","epicardial cell to mesenchymal cell transition [GO:0003347]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of MAP kinase activity [GO:0043406]","GO:0003347; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0008201; GO:0008284; GO:0017134; GO:0018108; GO:0031410; GO:0043235; GO:0043406; GO:0045597; GO:0045893"
"1815","Pocillopora_acuta_HIv2___RNAseq.g12323.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.6008903839305,12.8334790571237,11.6001154280382,12.4597757178072,12.5573105652585,12.6223271424947,11.2229765654679,12.4168407042168,9.79235084836367,12.3114311420402,11.9417497554741,11.5935015859615,12.2899979249867,4504.72740485695,0.434673573431761,0.688853448422314,0.367311780780801,0.616777519267701,"Q7T070",2.61e-136,"Ammonium transporter Rh type B (Rhesus blood group family type B glycoprotein) (Rh family type B glycoprotein) (Rh type B glycoprotein)","ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488]","GO:0005886; GO:0008519; GO:0016323; GO:0030659; GO:0072488; GO:0097272"
"1816","Pocillopora_acuta_HIv2___TS.g3304.t1",0,0,31.25,0,0,0,0,NA,0,NA,3.90625,0,7.8125,NA,NA,NA,NA,NA,NA,11.958075261824,11.0202236063382,11.7296041476678,10.720958427566,11.6019972209849,11.3699611207996,11.0022736579714,10.8595433141207,10.2616799891188,3.68233641306884,10.420665315946,11.2821799867432,9.55915064514881,2180.103686852,-0.401360878306916,0.912642168848464,0.344701568313143,0.595820653550928,NA,NA,NA,NA,NA
"1817","Pocillopora_acuta_HIv2___RNAseq.g12340.t1",0,0,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.9892884839846,3.68233641306884,10.6214925895285,3.68233641306884,9.13367024367935,10.4038738120072,11.4513321818433,10.0032244194979,3.68233641306884,3.68233641306884,7.63322273828162,8.68600242995184,6.5804430466114,818.170186803888,-0.0893482430809859,0.986880829462477,0.570400201795243,0.781014402677303,"Q5ZL21",4.76e-83,"Cyanocobalamin reductase / alkylcobalamin dealkylase (Alkylcobalamin:glutathione S-alkyltransferase) (EC 2.5.1.151) (CblC) (Cyanocobalamin reductase (cyanide-eliminating)) (EC 1.16.1.6) (Methylmalonic aciduria and homocystinuria type C protein) (MMACHC)","cobalamin metabolic process [GO:0009235]; demethylation [GO:0070988]; glutathione metabolic process [GO:0006749]","GO:0005737; GO:0005829; GO:0006749; GO:0009235; GO:0016491; GO:0016740; GO:0031419; GO:0032451; GO:0033787; GO:0043295; GO:0070988; GO:0071949"
"1818","Pocillopora_acuta_HIv2___TS.g3312.t1",NA,NA,NA,14.2857142857143,0,0,0,0,NA,0,2.38095238095238,4.76190476190476,0,NA,NA,NA,NA,NA,NA,7.56955274651392,9.89498279200485,7.34862272236652,3.68233641306884,10.2622758634889,9.90713660932484,3.68233641306884,9.3873673854253,8.49602432054186,3.68233641306884,7.39129716788727,8.6127686076673,6.16982572810724,434.744537310439,-0.372395763606233,1.07362658187362,0.00010054625754569,0.000834845619483845,"O75038",1.34e-180,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2)","lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; release of sequestered calcium ion into cytosol [GO:0051209]","GO:0004435; GO:0005509; GO:0005737; GO:0005886; GO:0007200; GO:0016042; GO:0046488; GO:0048015; GO:0051209"
"1819","Pocillopora_acuta_HIv2___RNAseq.g12370.t1",0,0,0,0,0,0,11.1111111111111,NA,0,NA,1.38888888888889,0,2.77777777777778,NA,NA,NA,NA,NA,NA,9.41283643968351,6.36195368411057,9.4075294040383,10.8297248538736,9.87447185807098,8.70179514693884,3.68233641306884,8.03514839820377,7.20548442133826,9.52529193539413,8.30365725547208,8.78709410426696,7.8202204066772,553.888857960732,-0.243579306049563,0.943426505093247,0.36849720742682,0.618036132678748,"Q8VDU0",1.78e-27,"G-protein-signaling modulator 2 (Pins homolog)","cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; regulation of mitotic spindle organization [GO:0060236]","GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0016328; GO:0019904; GO:0032991; GO:0042802; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832"
"1820","Pocillopora_acuta_HIv2___RNAseq.g12390.t1",NA,0,0,NA,0,14.2857142857143,0,NA,0,NA,2.38095238095238,4.76190476190476,0,NA,NA,NA,NA,NA,NA,8.7797370858197,6.88270198298439,6.36503790894442,4.7918870276047,6.89567146066421,3.68233641306884,8.3634674021712,9.59688283490894,10.1250272989223,11.7808291370239,7.72635785521126,8.35247131785191,7.10024439257061,630.676544083863,-0.740945628566497,1.09984677090391,0.0808849429755087,0.223950960030199,"Q8BG58",4.28e-16,"Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4)","regulation of erythrocyte differentiation [GO:0045646]","GO:0004656; GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0016706; GO:0031418; GO:0045646; GO:0160082"
"1821","Pocillopora_acuta_HIv2___RNAseq.g12413.t1",53.5714285714286,0,NA,NA,76.1904761904762,45.7142857142857,44.4444444444444,30,NA,NA,41.6534391534392,25.2380952380952,58.0687830687831,NA,NA,NA,NA,NA,NA,7.88297397736584,6.4545116118486,6.3783135818283,3.68233641306884,6.59417161353813,4.42568256259181,3.68233641306884,6.92672320941957,3.68233641306884,3.68233641306884,5.33917222088676,6.29290375904414,4.38544068272939,50.7943435490584,-0.739588224001306,1.3819752983274,0.0153174962947942,0.0595250581429081,"P32929",5.62e-161,"Cystathionine gamma-lyase (CGL) (CSE) (EC 4.4.1.1) (Cysteine desulfhydrase) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) (Homocysteine desulfhydrase) (EC 4.4.1.2)","cellular response to leukemia inhibitory factor [GO:1990830]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process via cystathionine [GO:0019343]; cysteine metabolic process [GO:0006534]; endoplasmic reticulum unfolded protein response [GO:0030968]; hydrogen sulfide biosynthetic process [GO:0070814]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of aortic smooth muscle cell differentiation [GO:1904831]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; protein homotetramerization [GO:0051289]; protein sulfhydration [GO:0044524]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; transsulfuration [GO:0019346]","GO:0004123; GO:0005516; GO:0005737; GO:0005829; GO:0006534; GO:0006629; GO:0018272; GO:0019343; GO:0019344; GO:0019346; GO:0030170; GO:0030968; GO:0042802; GO:0043123; GO:0044524; GO:0044540; GO:0047982; GO:0051289; GO:0070062; GO:0070814; GO:0080146; GO:0098606; GO:1904831; GO:1990830; GO:2001234"
"1822","Pocillopora_acuta_HIv2___RNAseq.g12424.t1",100,NA,100,NA,NA,100,100,100,80,NA,96.6666666666667,93.3333333333333,100,NA,NA,NA,NA,NA,NA,11.8270891639135,9.66443017950663,11.6176345684356,11.2812366371209,10.4342889011608,9.96361492864384,10.6996522097759,10.1111354429209,10.9394954477745,11.8734512385818,10.8412028717834,10.9859287048411,10.6964770387258,2068.74569350403,-0.160134679982553,0.631839306517801,0.724386298482135,0.876193629473624,"P06180",1.21e-57,"Histone-binding protein N1/N2","","GO:0005634; GO:0061676"
"1823","Pocillopora_acuta_HIv2___RNAseq.g12427.t1",0,0,0,NA,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.82778893403375,8.03648948185279,7.69923743453429,7.28204866049182,6.90951792457399,3.68233641306884,5.40984312721881,9.61490959498112,3.68233641306884,4.19574235723263,6.43402503410569,7.1467580602384,5.72129200797298,163.063334790477,-0.324059123780385,0.976422791124993,0.26695753396545,0.510547900472863,"Q921Y2",3.4e-84,"U3 small nucleolar ribonucleoprotein protein IMP3 (U3 snoRNP protein IMP3)","ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]","GO:0005654; GO:0005730; GO:0006364; GO:0019843; GO:0030515; GO:0030684; GO:0032040; GO:0034457; GO:0042274"
"1824","Pocillopora_acuta_HIv2___TS.g3398.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.95117687411115,8.90723650973111,9.66451278226152,10.7431859014604,9.91150737318821,8.77253124101927,7.72331317186407,9.39260215105686,10.6363872476932,3.68233641306884,8.93847896654546,9.91123728566219,7.96572064742874,764.261000939836,-0.471529340201919,0.968786464710258,0.245172736845255,0.483723702868609,"Q96MR6",0,"Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65)","","GO:0005737; GO:0005856; GO:0042995"
"1825","Pocillopora_acuta_HIv2___TS.g3401.t1",2.5974025974026,2.48447204968944,0,2.63157894736842,0,3.01724137931034,0,1.26582278481013,0,0,1.19965177585809,1.87982303223567,0.519480519480519,NA,NA,NA,NA,NA,NA,8.07047711082789,3.68233641306884,7.38782124613403,3.68233641306884,7.44286863576053,3.68233641306884,3.68233641306884,8.53918284492604,6.07918960036691,3.68233641306884,5.59312215033596,7.50390788760308,3.68233641306884,92.6948107633524,-11.2018977301378,3.63535496649796,6.4636087124388e-08,1.46765520277417e-06,"Q0V8E4",8.22e-94,"Asparagine synthetase domain-containing protein 1","asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541]","GO:0004066; GO:0006529; GO:0006541"
"1826","Pocillopora_acuta_HIv2___RNAseq.g12436.t1",12.5,0,NA,0,0,3.03030303030303,0,0,0,2.08333333333333,1.95707070707071,0.606060606060606,3.64583333333333,NA,NA,NA,NA,NA,NA,9.08925051517136,3.68233641306884,6.17960196289983,10.6232552195465,7.09638713862687,7.13292658472672,8.59287863380852,3.68233641306884,3.68233641306884,3.68233641306884,6.34436457070552,5.94598248856715,6.74274665284388,270.921652834364,0.129227916740039,1.00524031895892,0.28919250108485,0.53564865356528,"Q01063",5.5e-49,"3',5'-cyclic-AMP phosphodiesterase 4D (EC 3.1.4.53) (DPDE3) (cAMP-specific phosphodiesterase 4D)","adrenergic receptor signaling pathway [GO:0071875]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; negative regulation of heart contraction [GO:0045822]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; ovulation from ovarian follicle [GO:0001542]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of heart rate [GO:0010460]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein-containing complex assembly [GO:0065003]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; smooth muscle contraction [GO:0006939]","GO:0001542; GO:0001934; GO:0002027; GO:0004112; GO:0004114; GO:0004115; GO:0005246; GO:0005634; GO:0005813; GO:0005829; GO:0005891; GO:0006198; GO:0006939; GO:0007613; GO:0008277; GO:0010460; GO:0010880; GO:0014911; GO:0016324; GO:0019899; GO:0019933; GO:0022409; GO:0030016; GO:0030545; GO:0030593; GO:0031698; GO:0032991; GO:0033137; GO:0034704; GO:0034705; GO:0035264; GO:0043949; GO:0044325; GO:0045822; GO:0046872; GO:0047555; GO:0048471; GO:0048661; GO:0051117; GO:0061028; GO:0065003; GO:0071222; GO:0071320; GO:0071372; GO:0071872; GO:0071875; GO:0086004; GO:1901844; GO:1901898; GO:1902514; GO:1990266"
"1827","Pocillopora_acuta_HIv2___RNAseq.g9163.t2",0,0,NA,0,0,0.865800865800866,0.719424460431655,NA,2.77777777777778,5.66037735849057,1.25292255781261,0.910894660894661,1.59495045473056,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,6.13296418561106,3.68233641306884,3.68233641306884,5.84950698471885,5.73058915105271,6.14570161823912,8.0112010446212,3.68233641306884,5.02816450495871,5.53090793492181,4.52542107499562,39.2632163193415,-0.0907665334375561,1.00695300130647,0.517877603238786,0.742523954524763,NA,NA,NA,NA,NA
"1828","Pocillopora_acuta_HIv2___RNAseq.g9165.t1",0,0,4.13223140495868,0,0,1.18483412322275,0.900900900900901,0,0,0,0.621796642908233,0.23696682464455,1.00662646117192,NA,NA,NA,NA,NA,NA,8.61059914302406,3.68233641306884,8.77736480701605,3.68233641306884,7.92102401319128,5.80281783295425,3.68233641306884,9.78874150165509,9.49444939613268,3.68233641306884,6.51243423462488,8.91843577220383,4.10643269704592,258.445565897004,-10.0020006940688,3.05394839017297,1.73625888071381e-08,4.69406513096159e-07,NA,NA,NA,NA,NA
"1829","Pocillopora_acuta_HIv2___RNAseq.g9175.t1",0,0,NA,NA,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.11260887285627,3.68233641306884,7.92418265347176,3.68233641306884,9.20619475199154,6.89772912952247,3.68233641306884,3.68233641306884,6.37842387115414,3.68233641306884,5.69308213443404,7.06074931250851,4.32541495635957,118.931341107509,-0.60326684600127,1.27058473313484,0.00182438895362199,0.00983891194078614,"Q5VVJ2",2.3e-126,"Deubiquitinase MYSM1 (2A-DUB) (EC 3.4.19.-) (Myb-like, SWIRM and MPN domain-containing protein 1)","chromatin remodeling [GO:0006338]; immune system process [GO:0002376]; pigmentation [GO:0043473]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508]; regulation of cell migration [GO:0030334]; regulation of hair follicle development [GO:0051797]; regulation of hemopoiesis [GO:1903706]","GO:0002376; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006338; GO:0006508; GO:0030334; GO:0032991; GO:0042393; GO:0043473; GO:0045944; GO:0046872; GO:0051797; GO:0140492; GO:0140950; GO:1903706"
"1830","Pocillopora_acuta_HIv2___RNAseq.g9176.t1",0,0,0,NA,0,0,NA,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.21898483186445,10.2633451638186,9.88709061510058,6.56331726802105,10.2162088916128,9.85515757268537,6.47965727105891,9.9553959065248,11.4307700965485,10.6538259885907,9.45237536058258,10.1416900683302,8.76306065283493,1018.40479206522,-0.724096196478156,0.911850920399538,0.122136184985888,0.301979107630067,"Q6VTH5",8.09e-76,"Radial spoke head 1 homolog (Meichroacidin homolog) (Meichroacidin-like sperm-specific axonemal protein) (Testis-specific gene A2-like protein)","cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; spermatogenesis [GO:0007283]","GO:0001535; GO:0007283; GO:0030154; GO:0036126; GO:0051321; GO:0097729"
"1831","Pocillopora_acuta_HIv2___TS.g30839.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.58022760055378,7.8947948031256,7.25273306942338,8.30231185926826,7.57819845214682,7.51124908779255,3.68233641306884,7.91267833663967,9.21475579861879,9.40453397244757,7.43338193930853,7.50771865147649,7.35904522714056,241.805029967467,0.0530080531601094,0.876853527763939,0.890042522650661,0.957499073828126,NA,NA,NA,NA,NA
"1832","Pocillopora_acuta_HIv2___RNAseq.g9184.t1",0,0,NA,0,0,2.63157894736842,0,NA,0,NA,0.37593984962406,0.657894736842105,0,NA,NA,NA,NA,NA,NA,7.6159587061357,3.68233641306884,7.11130286437252,7.2055975890902,8.83312908347376,5.87223972230221,8.61714151159454,7.07874584792092,9.27238285158771,9.90500119662516,7.51938357861716,7.98230387069812,7.05646328653619,287.8991126693,-0.24079515410349,0.915728993007775,0.430145444428749,0.674063474157268,"Q6DG99",1.08e-18,"BTB/POZ domain-containing protein KCTD6","protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]","GO:0016567; GO:0051260"
"1833","Pocillopora_acuta_HIv2___RNAseq.g9186.t1",0,0,0,0,0,0.719424460431655,1.05263157894737,0,0,NA,0.196895115486558,0.143884892086331,0.263157894736842,NA,NA,NA,NA,NA,NA,8.68995031506986,10.5997335939201,9.46636708751857,8.96046450079683,9.66244963349173,7.06826986579421,3.68233641306884,9.84423275958734,10.2628647657114,3.68233641306884,8.19190053480277,9.58517291227578,6.79862815732976,606.018737233585,-0.404436787952264,1.06024194534434,0.0489763965488459,0.153298982835427,"Q91W43",0,"Glycine dehydrogenase (decarboxylating), mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring))","cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein-containing complex assembly [GO:0065003]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255]","GO:0004375; GO:0005654; GO:0005739; GO:0005886; GO:0005960; GO:0006546; GO:0016594; GO:0016829; GO:0019464; GO:0019899; GO:0030170; GO:0036255; GO:0042803; GO:0065003; GO:0070280; GO:1903442; GO:1990830"
"1834","Pocillopora_acuta_HIv2___RNAseq.g9204.t1",0,0,NA,0,3.17460317460317,0,0,NA,0,NA,0.453514739229025,0,1.05820105820106,NA,NA,NA,NA,NA,NA,7.32784372520422,7.09062453168391,5.66344864002848,3.68233641306884,9.04649674354661,8.53545789500076,7.33028556223127,6.85948535074232,6.46520689288117,3.68233641306884,6.56835221674564,7.07249627048056,6.06420816301072,141.800524716925,-0.478746671334917,1.00425951277993,0.141855787025885,0.336183299247693,"Q7KWX9",2.27e-71,"Putative exosome complex component rrp40 (Exosome component 3) (Ribosomal RNA-processing protein 40)","CUT catabolic process [GO:0071034]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U4 snRNA 3'-end processing [GO:0034475]","GO:0000176; GO:0000177; GO:0000288; GO:0000467; GO:0000956; GO:0003723; GO:0005730; GO:0034475; GO:0071034; GO:0071035; GO:0071038; GO:0071051"
"1835","Pocillopora_acuta_HIv2___RNAseq.g9214.t1",0,0,NA,NA,18.6046511627907,0,0,0,NA,NA,3.10077519379845,0,6.2015503875969,NA,NA,NA,NA,NA,NA,7.58962569844466,9.51278580086792,8.47028861072748,6.56331726802105,7.73305689382981,8.38924687130923,8.15263848176061,7.54396176493916,9.74734556003112,6.14979536860625,7.98520623185373,8.21685570559445,7.75355675811301,307.387547517436,-0.145197641221108,0.805396019959959,0.70545150209882,0.865596413840968,"Q8IDX6",2.99e-07,"Reticulocyte-binding protein homolog 2a (PfR2Ha) (PfRH2a) [Cleaved into: Reticulocyte-binding protein homolog 2a 85 kDa form; Reticulocyte-binding protein homolog 2a 285 kDa form]","cell-cell adhesion [GO:0098609]","GO:0005615; GO:0008201; GO:0016020; GO:0016324; GO:0031410; GO:0044647; GO:0046789; GO:0098609; GO:1990225"
"1836","Pocillopora_acuta_HIv2___RNAseq.g9215.t1",0,0,0,NA,0,3.44827586206897,NA,0,NA,NA,0.574712643678161,1.14942528735632,0,NA,NA,NA,NA,NA,NA,5.74163829918218,9.54811775094958,7.17257738738475,7.65428605382399,7.70969217649592,7.63072138130473,3.68233641306884,8.32841205079342,6.94448951749643,9.21404180429631,7.36263128347961,7.17936188627054,7.54590068068869,237.180447268786,0.175027499790788,0.925661613151903,0.584372578616535,0.791197695133349,NA,NA,NA,NA,NA
"1837","Pocillopora_acuta_HIv2___RNAseq.g9240.t1",NA,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.3161200410387,13.4017089398693,12.6885174893217,13.0919551402673,12.4880221271856,13.4970109812756,14.2362110432527,12.4485910663783,13.2139114445459,13.2614700997163,13.0643518372851,12.631032433694,13.4976712408762,9251.29842960591,0.668180895695045,0.579354935658212,0.162203537988848,0.367123733668985,NA,NA,NA,NA,NA
"1838","Pocillopora_acuta_HIv2___RNAseq.g9250.t1",3.276955602537,0.294550810014728,1.26849894291755,0.575815738963532,0.12531328320802,0.65924073653103,1.81069958847737,1.67224080267559,0.249376558603491,0,0.99326920639283,0.690244929357673,1.29629348342799,NA,NA,NA,NA,NA,NA,8.2739009371264,10.4746436468587,11.6066670577526,7.42363838165424,11.2289299416238,8.01393846452208,9.64889614696393,9.77678200082257,5.03316817358995,11.3084283564579,9.27889931073722,9.18388962218306,9.37390899929137,1168.1384878102,-0.0242156205498129,0.918642799541701,0.899131101918414,0.961882285911014,"Q64487",0,"Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]","GO:0004725; GO:0005102; GO:0007157; GO:0030182; GO:0042734; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099151; GO:0099537; GO:0099545; GO:0099560"
"1839","Pocillopora_acuta_HIv2___RNAseq.g9252.t1",0.345911949685535,0.934579439252336,0.0754432289701999,0.342252644679527,0.549242424242424,0.611951043916487,0.769116994527437,1.33928571428571,0.461361014994233,0.20746887966805,0.563661333422194,0.737885971425659,0.389436695418729,NA,NA,NA,NA,NA,NA,3.68233641306884,7.97046471243864,3.68233641306884,6.59828765874778,5.66700991799266,9.23791312461303,3.68233641306884,7.95230680857751,3.68233641306884,6.56351623590136,5.87188441105463,4.93326519315534,6.81050362895393,119.879323349064,0.351484379381307,1.10229040068336,0.000604273353031028,0.00384243532250732,"Q6V4S5",4.75e-92,"Protein sidekick-2","camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0045202; GO:0060219"
"1840","Pocillopora_acuta_HIv2___RNAseq.g9253.t1",0.542635658914729,0.732741997686078,0.837988826815642,0.565656565656566,0.824742268041237,0.76509511993383,0.73487846240814,0.408496732026144,1.50107219442459,0,0.691330782590695,0.794612521945441,0.58804904323595,NA,NA,NA,NA,NA,NA,7.35158994656897,8.04817444370993,5.87178581315921,8.26533225739722,5.31048131328141,7.47620947122109,8.58879476274176,5.33850173705749,3.68233641306884,8.61342163913137,6.85466277973373,5.51093904462718,8.19838651484027,161.304064460142,2.27589833351754,1.76444788695432,0.003236568372741,0.0161593803739475,"Q64487",8.98e-10,"Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]","GO:0004725; GO:0005102; GO:0007157; GO:0030182; GO:0042734; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099151; GO:0099537; GO:0099545; GO:0099560"
"1841","Pocillopora_acuta_HIv2___TS.g30914.t1",0.86848635235732,0.925925925925926,0.296442687747036,0.723763570566948,1.64634146341463,0.624814043439453,0.754716981132076,0.78125,0.423728813559322,0,0.704546983814271,0.69589647069833,0.713197496930213,NA,NA,NA,NA,NA,NA,3.68233641306884,11.4380371380495,6.45538792833035,8.17135353059522,5.98573247127087,11.0050573856338,10.6603436394388,6.35881100040517,3.68233641306884,12.4479342347335,7.98873301545949,5.23292084522881,10.7445451856902,1235.88291131494,4.10907028017226,3.43635531092144,4.71605679088938e-05,0.000434477996327542,"Q64487",0,"Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48)","heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]","GO:0004725; GO:0005102; GO:0007157; GO:0030182; GO:0042734; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099151; GO:0099537; GO:0099545; GO:0099560"
"1842","Pocillopora_acuta_HIv2___RNAseq.g9285.t1",NA,NA,0,NA,0,0,4.34782608695652,0,0,NA,0.72463768115942,0,1.44927536231884,NA,NA,NA,NA,NA,NA,9.86770601476514,10.7491679399258,9.00339208276961,11.0803037995335,8.57398597632423,7.75272352654359,10.0692041681105,10.1143066998765,6.65367853148855,7.38918851429576,9.12536572536332,8.84261386104481,9.40811758968183,812.973972622984,0.389535147356452,0.643163112199261,0.418122242597999,0.662763848431502,"Q8R1A4",0,"Dedicator of cytokinesis protein 7 (Protein moonlight)","axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; interkinetic nuclear migration [GO:0022027]; negative regulation of cold-induced thermogenesis [GO:0120163]; pigmentation [GO:0043473]; postsynaptic specialization assembly [GO:0098698]; regulation of neurogenesis [GO:0050767]; small GTPase-mediated signal transduction [GO:0007264]","GO:0002244; GO:0005085; GO:0007264; GO:0007409; GO:0022027; GO:0030424; GO:0031267; GO:0031594; GO:0043473; GO:0050767; GO:0098698; GO:0120163"
"1843","Pocillopora_acuta_HIv2___RNAseq.g9295.t1",16.6666666666667,NA,0,0,0,0,12.5,NA,0,NA,4.16666666666667,0,7.29166666666667,NA,NA,NA,NA,NA,NA,6.73144313448199,3.68233641306884,6.51648711029815,7.03911674882672,5.95850798619116,5.20504317817844,3.68233641306884,6.33670898571414,7.50048072915978,6.98000170082845,5.96324623998165,6.60872558916904,5.31776689079426,62.7112520609434,-0.514271639003555,1.05784748929601,0.0886348730422509,0.239048070796777,NA,NA,NA,NA,NA
"1844","Pocillopora_acuta_HIv2___TS.g30962.t1",8.56269113149847,0.383141762452107,4.16666666666667,0.228310502283105,6.45481628599801,1.57415078707539,10.2564102564103,1.49051490514905,1.22137404580153,NA,3.81534181592607,0.979498400552237,7.36014608514335,2,58.547165200391,58.547165200391,0.0177200859931179,1.10629373500259e-09,0.0354401708799421,10.8094179843483,11.2881855438679,10.8721847631024,12.4786177491185,10.5911458310036,9.97239964656168,11.4440115357573,10.6645944830697,10.9571676831123,10.2291832065801,10.9306908426522,10.7789021489273,11.0824795363771,2176.61296467729,0.205988580640881,0.599323029779318,0.665735817905538,0.843491750152,"P18433",5.65e-164,"Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48)","insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; modulation of chemical synaptic transmission [GO:0050804]; regulation of focal adhesion assembly [GO:0051893]","GO:0004725; GO:0005001; GO:0005886; GO:0005925; GO:0007229; GO:0008286; GO:0016020; GO:0043235; GO:0050804; GO:0051893; GO:0070062; GO:0097060; GO:0098685"
"1845","Pocillopora_acuta_HIv2___RNAseq.g9304.t1",3.7542662116041,1.10497237569061,5.47445255474453,2.18068535825545,2.67857142857143,0.624219725343321,3.93120393120393,4.42477876106195,3.97727272727273,12.3595505617978,4.05099736355458,2.46238578952481,5.63960893758435,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,6.19479753228254,3.68233641306884,3.68233641306884,9.08656113641513,8.14151872004538,5.96778646100673,7.091790659748,3.68233641306884,5.4894136574842,5.32380949583499,5.65501781913341,97.6891710075419,0.0101812311565956,1.00735863313928,0.352800164765552,0.60403664573496,NA,NA,NA,NA,NA
"1846","Pocillopora_acuta_HIv2___RNAseq.g9305.t1",2.2508038585209,1.64835164835165,2.63157894736842,0,0.731707317073171,2.36220472440945,1.16009280742459,2.18340611353712,0,NA,1.44090504629837,1.23879249725964,1.69354573259677,NA,NA,NA,NA,NA,NA,8.88328018451953,9.77381354675143,10.344526099162,3.68233641306884,7.53449756950489,9.06793871589801,3.68233641306884,6.54323773344988,11.7726551291774,3.68233641306884,7.49669582176697,9.01563934316274,5.97775230037119,678.594562475785,-0.27992062613985,1.03475056949428,0.000147776115455487,0.00115169767471072,"Q8R151",2.93e-62,"NFX1-type zinc finger-containing protein 1","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"1847","Pocillopora_acuta_HIv2___RNAseq.g9334.t1",0,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,13.1073208591553,12.0176335153574,13.4664722715473,10.3485712516589,13.2005718777351,11.540817484966,10.8622678230637,13.6346735516529,13.00678718059,10.8502346079133,12.203535042364,13.2831651481361,11.1239049365919,6238.79877234631,-1.87172736135396,0.695723994017379,0.000928676521193222,0.00551411215210951,"P16621",0,"Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR)","axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; hematopoietic stem cell homeostasis [GO:0061484]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; negative regulation of insulin receptor signaling pathway [GO:0046627]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic assembly at neuromuscular junction [GO:0051124]","GO:0004725; GO:0005001; GO:0005158; GO:0005925; GO:0007155; GO:0007283; GO:0007399; GO:0007411; GO:0007412; GO:0008045; GO:0008201; GO:0008594; GO:0009925; GO:0009986; GO:0030424; GO:0031252; GO:0031290; GO:0032093; GO:0045467; GO:0046627; GO:0048477; GO:0048675; GO:0048841; GO:0051124; GO:0051491; GO:0060269; GO:0061484; GO:0120034; GO:1903386"
"1848","Pocillopora_acuta_HIv2___RNAseq.g9367.t1",0,NA,0,3.07692307692308,17.1428571428571,2.7972027972028,0,NA,0,NA,3.28814043099757,1.95804195804196,4.28571428571429,NA,NA,NA,NA,NA,NA,4.21445057288855,3.68233641306884,5.51983254007951,7.32395877248941,7.16128077648109,7.58543864250144,3.68233641306884,7.16762719725138,3.68233641306884,9.26504026695003,5.92846380078479,5.54910549995387,6.30782210161571,115.609153865598,0.0141494781070896,0.976582429715738,0.96297660519474,0.986832858278677,NA,NA,NA,NA,NA
"1849","Pocillopora_acuta_HIv2___RNAseq.g9369.t1",0,NA,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.05466314442104,3.68233641306884,10.9960785770211,3.68233641306884,9.38467476357723,9.74081657844215,8.59287863380852,8.64613187640677,10.4760561947713,8.82700311856785,8.00829757131536,9.11152091123949,6.90507423139124,609.709183966396,-0.452644605226958,1.04053212657335,0.0943994179078399,0.250531039334299,NA,NA,NA,NA,NA
"1850","Pocillopora_acuta_HIv2___TS.g31030.t1",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.87857715777996,7.96430909081604,10.1083346657244,8.05848887682085,9.272597737218,7.82122898376461,10.0953229957992,9.71440526324744,8.15626169331613,3.68233641306884,8.47518628775555,9.42603530345719,7.52433727205391,539.794765785344,-0.88007363896508,1.11021053714354,0.0716297747176732,0.205118404576604,"Q8CE72",7.65e-74,"Ciliogenesis and planar polarity effector 1 (Protein C5orf42 homolog) (Protein JBTS17)","cardiac septum development [GO:0003279]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; coronary vasculature development [GO:0060976]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; heart development [GO:0007507]; kidney development [GO:0001822]; protein localization to ciliary transition zone [GO:1904491]; roof of mouth development [GO:0060021]; ventricular septum development [GO:0003281]","GO:0001736; GO:0001822; GO:0003279; GO:0003281; GO:0007507; GO:0016020; GO:0021549; GO:0035869; GO:0042733; GO:0060021; GO:0060271; GO:0060976; GO:1904491"
"1851","Pocillopora_acuta_HIv2___TS.g31039.t1",2.12765957446809,NA,NA,0,0,0,0,0,NA,NA,0.354609929078014,0,0.709219858156028,NA,NA,NA,NA,NA,NA,10.0850817505733,12.6417077216065,10.7665142914902,11.7477770078832,11.0685248462711,10.8482413554794,5.18636982781747,11.1418222538412,3.68233641306884,3.68233641306884,9.08507118811001,9.34885591104893,8.82128646517108,1874.44536417672,-0.00954217542555882,0.901953285754453,0.939801590815036,0.977231503202637,"Q54QR7",5.06e-07,"Granulin","","GO:0005576"
"1852","Pocillopora_acuta_HIv2___RNAseq.g9381.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,8.49897143052232,3.68233641306884,8.49712083958253,3.68233641306884,8.4115941178289,9.12822800244161,6.88225628497292,3.68233641306884,11.0712457718062,6.72187620994298,4.32232038744966,9.12143203243631,374.196229111387,10.1703816261436,3.24703547828754,7.91127017512635e-09,2.36422751679809e-07,"Q60928",3.76e-122,"Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain]","cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638]","GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006536; GO:0006749; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068"
"1853","Pocillopora_acuta_HIv2___TS.g31052.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.85675230063415,3.68233641306884,10.4685983973343,10.3473099496798,9.3723688690179,10.0021188196789,9.15883502508435,9.76169178453478,9.53031874011435,3.68233641306884,8.58626667122162,9.7979460183271,7.37458732411615,731.04342894611,-0.326906188947349,0.994089911078154,0.177200247642364,0.390110255996826,"Q5VYK3",0,"Proteasome adapter and scaffold protein ECM29 (Ecm29 proteasome adapter and scaffold) (Proteasome-associated protein ECM29 homolog)","ERAD pathway [GO:0036503]; proteasome assembly [GO:0043248]","GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005793; GO:0005813; GO:0016020; GO:0030134; GO:0030139; GO:0031410; GO:0036503; GO:0043248; GO:0060090; GO:0070628"
"1854","Pocillopora_acuta_HIv2___RNAseq.g9412.t1",0,0,0,0,0,0,1.01522842639594,0,0,NA,0.112803158488438,0,0.253807106598985,NA,NA,NA,NA,NA,NA,7.55601247066455,9.30005744330105,8.67861202552873,8.85073551501649,8.56319071864553,7.39595400278476,6.40572683292009,8.0781018333054,9.12635749845022,3.68233641306884,7.76370847536857,8.40045490931889,7.12696204141825,292.562624744603,-0.334215547844821,0.92812990530871,0.359193591239322,0.609356803153361,"Q92889",0,"DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein)","cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]","GO:0000014; GO:0000109; GO:0000110; GO:0000712; GO:0000723; GO:0000724; GO:0000781; GO:0001094; GO:0003684; GO:0003697; GO:0004520; GO:0005634; GO:0005654; GO:0006281; GO:0006289; GO:0006303; GO:0009411; GO:0009650; GO:0010506; GO:0032205; GO:0034644; GO:0042802; GO:0061819; GO:0070522; GO:1901255; GO:1904357; GO:1905765; GO:1905768; GO:1990841"
"1855","Pocillopora_acuta_HIv2___RNAseq.g9418.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.2507191294519,9.32902717013835,9.08670395153231,8.01456480640263,8.21693978182662,6.64107926124897,3.68233641306884,7.6176380021177,7.22521248378998,3.68233641306884,7.27465574126461,8.2794426697437,6.26986881278553,259.822438189451,-0.712425562028797,1.18148833403141,0.03454510686116,0.116142175411767,"Q92889",3.47e-113,"DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein)","cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]","GO:0000014; GO:0000109; GO:0000110; GO:0000712; GO:0000723; GO:0000724; GO:0000781; GO:0001094; GO:0003684; GO:0003697; GO:0004520; GO:0005634; GO:0005654; GO:0006281; GO:0006289; GO:0006303; GO:0009411; GO:0009650; GO:0010506; GO:0032205; GO:0034644; GO:0042802; GO:0061819; GO:0070522; GO:1901255; GO:1904357; GO:1905765; GO:1905768; GO:1990841"
"1856","Pocillopora_acuta_HIv2___RNAseq.g9420.t1",0,0,4.34782608695652,0,4.13223140495868,2.12201591511936,0,0.8,0,NA,1.26689704522606,0.584403183023873,2.1200143729788,NA,NA,NA,NA,NA,NA,6.3567367124764,3.68233641306884,7.49336821421169,8.18839085032791,7.38984723548559,6.78684792853876,5.90680277481292,6.3255230136643,3.68233641306884,3.68233641306884,5.94945259687241,6.24956231778136,5.64934287596345,80.3218089019067,-0.252906891078572,0.932821513240119,0.570236173311276,0.780976802459454,"Q9QYM7",9.92e-108,"DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4)","cellular response to UV [GO:0034644]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]","GO:0000110; GO:0000712; GO:0000724; GO:0000781; GO:0001094; GO:0003684; GO:0003697; GO:0005634; GO:0006289; GO:0006303; GO:0009411; GO:0009650; GO:0010506; GO:0032205; GO:0034644; GO:0042802; GO:0061819; GO:0070522; GO:1901255; GO:1904357; GO:1905765; GO:1990599; GO:1990841"
"1857","Pocillopora_acuta_HIv2___RNAseq.g9422.t1",NA,0,50,0,0,8.97435897435897,6.66666666666667,NA,0,20,10.7051282051282,2.24358974358974,19.1666666666667,NA,NA,NA,NA,NA,NA,6.976490469328,3.68233641306884,7.37487447386323,5.16572759476787,7.48022867002046,8.35506124056664,3.68233641306884,3.68233641306884,3.68233641306884,6.90199259960273,5.69837207004243,5.83925328786987,5.55749085221498,80.9033385725621,-0.0565379358594385,0.987724452411642,0.864086598804012,0.946470925036064,"Q9Y573",6.78e-162,"Actin-binding protein IPP (Intracisternal A particle-promoted polypeptide) (IPP) (Kelch-like protein 27)","","GO:0003779; GO:0005737; GO:0015629"
"1858","Pocillopora_acuta_HIv2___RNAseq.g9423.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.07985770650919,7.28188058444009,8.79681098034116,6.56331726802105,9.00882336383711,5.77882859435006,4.40301213871548,6.0800375531696,9.99986999136825,8.31113887526226,7.53035770560142,8.59307991904506,6.46763549215779,299.739005122343,-2.38363007294439,0.799967780267798,0.000188612283211956,0.00141718860487155,NA,NA,NA,NA,NA
"1859","Pocillopora_acuta_HIv2___RNAseq.g9425.t1",0,0,0,0,0,2.4,0,0,0,NA,0.266666666666667,0.48,0,NA,NA,NA,NA,NA,NA,7.40550595771431,8.36537983138804,7.64645383920312,7.49865221587083,6.83162092158167,5.72947039629047,3.68233641306884,7.00477647110157,6.41379501761528,3.68233641306884,6.4260327476903,7.06043044144319,5.7916350539374,106.674831832412,-0.472660725903637,1.03860349175751,0.100261139842906,0.262001287567805,"Q92889",4.42e-167,"DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein)","cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]","GO:0000014; GO:0000109; GO:0000110; GO:0000712; GO:0000723; GO:0000724; GO:0000781; GO:0001094; GO:0003684; GO:0003697; GO:0004520; GO:0005634; GO:0005654; GO:0006281; GO:0006289; GO:0006303; GO:0009411; GO:0009650; GO:0010506; GO:0032205; GO:0034644; GO:0042802; GO:0061819; GO:0070522; GO:1901255; GO:1904357; GO:1905765; GO:1905768; GO:1990841"
"1860","Pocillopora_acuta_HIv2___RNAseq.g9428.t1",2.46913580246914,0,0,0.78740157480315,5.16431924882629,2.9940119760479,8.83534136546185,8.51063829787234,13.7931034482759,1.25,4.38039517137565,5.21703105939985,3.54375928335145,NA,NA,NA,NA,NA,NA,7.58296597751871,9.2976168129029,8.22301936314656,8.19402536505928,7.36507912989583,7.73507283692995,5.08305273412487,7.64871506591188,7.5245035367715,3.68233641306884,7.23363872353303,7.6688566146489,6.79842083241717,198.879629375896,-0.286689401900455,0.924216757640226,0.376171561347168,0.625662220325142,"Q92889",0,"DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein)","cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]","GO:0000014; GO:0000109; GO:0000110; GO:0000712; GO:0000723; GO:0000724; GO:0000781; GO:0001094; GO:0003684; GO:0003697; GO:0004520; GO:0005634; GO:0005654; GO:0006281; GO:0006289; GO:0006303; GO:0009411; GO:0009650; GO:0010506; GO:0032205; GO:0034644; GO:0042802; GO:0061819; GO:0070522; GO:1901255; GO:1904357; GO:1905765; GO:1905768; GO:1990841"
"1861","Pocillopora_acuta_HIv2___RNAseq.21751_t",0,0,0,0,5.55555555555556,1.82481751824818,0,0,0,0,0.738037307380373,0.364963503649635,1.11111111111111,NA,NA,NA,NA,NA,NA,7.73482020810787,3.68233641306884,8.05531935028899,9.44160509056042,6.80219049990908,7.63072138130473,3.68233641306884,4.93729786847052,4.9224776128996,6.53774712136497,6.34268519590439,6.49042110793521,6.19494928387356,144.915901278367,-0.0574649456019664,0.943597789158454,0.739219353544761,0.88436541118816,"Q9Y573",7.58e-175,"Actin-binding protein IPP (Intracisternal A particle-promoted polypeptide) (IPP) (Kelch-like protein 27)","","GO:0003779; GO:0005737; GO:0015629"
"1862","Pocillopora_acuta_HIv2___RNAseq.g9433.t1",1.5625,0,0,3.37078651685393,0.72992700729927,0.404858299595142,1.73913043478261,0,0,0,0.780720225853095,0.755128963289815,0.806311488416376,NA,NA,NA,NA,NA,NA,9.56361386835853,8.85837677707325,9.32458872292201,10.0545156505221,8.70742001466724,8.99834034520203,3.68233641306884,9.73102919861487,10.7748657064941,10.5406150790723,9.02357017759953,9.62030350221135,8.4268368529877,771.733689277666,-0.211537481521212,0.874460417751463,0.591767045789093,0.795816336298635,"P55809",0,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (SCOT) (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) (Succinyl-CoA:3-oxoacid CoA transferase)","cellular ketone body metabolic process [GO:0046950]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]","GO:0005739; GO:0005759; GO:0008260; GO:0042182; GO:0046950; GO:0046952"
"1863","Pocillopora_acuta_HIv2___RNAseq.g9451.t1",55,0,NA,0,11.1111111111111,0,0,0,12.5,0,8.73456790123457,2.5,16.5277777777778,NA,NA,NA,NA,NA,NA,11.7713185360258,11.1442144940706,10.3279258767958,10.7082418946914,10.7984535880624,10.994008270972,10.9884044679326,10.2674386695716,7.98265228961194,12.0670770423316,10.7049735130066,10.2295577920135,11.1803892339996,2009.04416055551,0.440380745609133,0.748238322846589,0.365562866052105,0.615274510202997,"P27986",1.45e-95,"Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha)","B cell differentiation [GO:0030183]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; cytokine-mediated signaling pathway [GO:0019221]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular glucose homeostasis [GO:0001678]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; myeloid leukocyte migration [GO:0097529]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of stress fiber assembly [GO:0051497]; osteoclast differentiation [GO:0030316]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366]","GO:0001678; GO:0001784; GO:0001953; GO:0002687; GO:0005068; GO:0005158; GO:0005159; GO:0005168; GO:0005634; GO:0005737; GO:0005801; GO:0005829; GO:0005886; GO:0005911; GO:0005942; GO:0005943; GO:0006366; GO:0006606; GO:0006955; GO:0008286; GO:0008625; GO:0008630; GO:0010592; GO:0016020; GO:0019209; GO:0019221; GO:0019903; GO:0030183; GO:0030217; GO:0030316; GO:0032760; GO:0032869; GO:0033120; GO:0034143; GO:0034446; GO:0034644; GO:0034976; GO:0035014; GO:0035655; GO:0036312; GO:0042267; GO:0042307; GO:0043066; GO:0043125; GO:0043491; GO:0043548; GO:0043559; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0046982; GO:0048009; GO:0048471; GO:0048661; GO:0050821; GO:0051491; GO:0051497; GO:0052742; GO:0060396; GO:0097529; GO:0120183; GO:0140767; GO:0141038; GO:1900103; GO:1903078; GO:1990578"
"1864","Pocillopora_acuta_HIv2___RNAseq.g9462.t1",0,NA,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.68376069653767,7.02067905064675,7.38136255625802,9.67068676860971,6.12628170656021,8.12638869719274,10.6279080687105,9.71335987651025,9.36579409191446,3.68233641306884,8.03985579260092,8.25411178555612,7.82559979964571,472.903742948237,0.0427333076955096,0.90886392593386,0.922474617468088,0.971054990990861,"Q18593",3.29e-08,"Calcium homeostasis modulator protein","ATP export [GO:1904669]; calcium ion transmembrane transport [GO:0070588]; regulation of locomotion [GO:0040012]","GO:0005245; GO:0005261; GO:0005886; GO:0034702; GO:0040012; GO:0070588; GO:0097730; GO:1904669"
"1865","Pocillopora_acuta_HIv2___RNAseq.g9466.t1",0,NA,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,12.4501212133638,6.88270198298439,13.008999473924,3.68233641306884,12.2646347755261,3.68233641306884,3.68233641306884,13.4375474106493,13.069060844611,8.19439564745621,9.03544705877213,12.8460727436148,5.22482137392942,3868.10737894307,-8.73779242586273,5.46350065581124,7.82097272152185e-12,7.25144547718539e-10,"Q6RI86",1.07e-142,"Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor)","calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832]","GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014070; GO:0014832; GO:0015267; GO:0015278; GO:0016324; GO:0019233; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0070588; GO:0071244; GO:0071313; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760"
"1866","Pocillopora_acuta_HIv2___RNAseq.g9527.t2a",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.92912467288902,8.93577621236778,8.57821577086389,7.78719371610229,8.84029803322418,9.84835603016618,9.85490292833965,8.7880313257061,7.59423998853345,10.2565722104848,9.04127108886773,8.74598195824333,9.33656021949214,597.95042415034,0.342734771465117,0.714958566063791,0.476788259363829,0.7125502911055,"Q7YU29",1.13e-115,"Dystrophin, isoform E (Protein detached)","actin cytoskeleton organization [GO:0030036]; establishment of cell polarity [GO:0030010]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; imaginal disc-derived wing vein specification [GO:0007474]; maintenance of presynaptic active zone structure [GO:0048790]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; muscle organ development [GO:0007517]; neuromuscular synaptic transmission [GO:0007274]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]","GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0007274; GO:0007474; GO:0007517; GO:0008270; GO:0008307; GO:0008586; GO:0016010; GO:0030010; GO:0030018; GO:0030036; GO:0030054; GO:0030864; GO:0031594; GO:0042383; GO:0042995; GO:0045202; GO:0046716; GO:0046928; GO:0048172; GO:0048790; GO:0050699; GO:0051015; GO:0055001"
"1867","Pocillopora_acuta_HIv2___RNAseq.g29795.t1",0,0,0,0,41.6666666666667,NA,0,NA,0,NA,5.95238095238095,0,10.4166666666667,NA,NA,NA,NA,NA,NA,3.68233641306884,9.92216548359899,3.68233641306884,9.31824411792278,3.68233641306884,7.2540229229069,11.1008168108256,3.68233641306884,4.4808124149756,7.53764925099809,6.43430566535033,3.84203161345019,9.02657971725047,402.139504546331,11.3568065538685,3.00752361262481,1.5825777128624e-10,8.5094438806103e-09,"O88799",2.25e-08,"Zonadhesin","binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; regulation of binding of sperm to zona pellucida [GO:2000359]","GO:0005615; GO:0005886; GO:0007155; GO:0007339; GO:0031012; GO:0050840; GO:2000359"
"1868","Pocillopora_acuta_HIv2___RNAseq.g29817.t1",0,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.35798836198224,7.91408972240118,4.6464169258196,8.61512988089867,6.93680958615949,8.70179514693884,8.24902427200567,7.2512707478268,6.63891135226464,3.68233641306884,7.0993772409366,6.76627939481055,7.43247508706264,186.372863642724,0.193954919130588,0.923607589008183,0.558815522239847,0.772725402837204,"P19246",3.2e-09,"Neurofilament heavy polypeptide (NF-H) (200 kDa neurofilament protein) (Neurofilament triplet H protein)","axon development [GO:0061564]; axon regeneration [GO:0031103]; cellular response to leukemia inhibitory factor [GO:1990830]; intermediate filament bundle assembly [GO:0045110]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; neurofilament bundle assembly [GO:0033693]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle atresia [GO:0001552]; peripheral nervous system neuron axonogenesis [GO:0048936]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of organelle transport along microtubule [GO:1902513]; response to sodium arsenite [GO:1903935]","GO:0000226; GO:0001552; GO:0005200; GO:0005737; GO:0005739; GO:0005882; GO:0005883; GO:0014069; GO:0015643; GO:0019901; GO:0030424; GO:0030674; GO:0031103; GO:0033693; GO:0043025; GO:0043204; GO:0043209; GO:0044877; GO:0045104; GO:0045110; GO:0048936; GO:0060052; GO:0061564; GO:0097418; GO:0097440; GO:0098685; GO:0099160; GO:0099170; GO:0099184; GO:0150017; GO:1902513; GO:1903935; GO:1990830"
"1869","Pocillopora_acuta_HIv2___RNAseq.g29841.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.11246813923256,5.01287713650611,10.9436559942555,9.58765143536759,10.5911458310036,3.68233641306884,5.52620649542623,10.1541406401328,11.1640764758461,4.80766789501754,8.05822264558569,10.3930974160941,5.72334787507726,816.002237387024,-5.13519042541937,2.01902238291629,2.07640122060071e-06,2.94441835831065e-05,"O00339",8.25e-51,"Matrilin-2","axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; response to axon injury [GO:0048678]","GO:0001764; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0048678; GO:0062023; GO:0120216"
"1870","Pocillopora_acuta_HIv2___RNAseq.g29875.t1",0,15.4761904761905,30.7692307692308,20.5128205128205,4.86111111111111,11.4285714285714,8.73015873015873,41.8604651162791,25.4545454545455,0,15.9093093598908,22.9465185976814,8.87210012210012,NA,NA,NA,NA,NA,NA,6.4190560364177,9.24791578945223,10.6009140820675,6.02915908265446,9.62144705661849,6.3101085141422,10.0938842922128,10.1331891942759,10.8382276007134,3.68233641306884,8.29762380616235,9.5225667940186,7.07268081830611,700.203719211671,-0.457542315558914,1.07664250930821,0.0398296364541166,0.130486038883883,"Q60649",0,"Mitochondrial disaggregase (EC 3.6.1.-) (Suppressor of potassium transport defect 3) [Cleaved into: Mitochondrial disaggregase, cleaved form]","cellular response to heat [GO:0034605]; granulocyte differentiation [GO:0030851]","GO:0005524; GO:0005737; GO:0005739; GO:0005758; GO:0016887; GO:0030851; GO:0034605; GO:0140545"
"1871","Pocillopora_acuta_HIv2___RNAseq.g29878.t1",16.9491525423729,0,8.16326530612245,0,1.28205128205128,4.56273764258555,13.7614678899083,18.1818181818182,0,0,6.29004928448586,4.54891116488075,8.03118740409097,NA,NA,NA,NA,NA,NA,6.53584217462236,8.31794237534842,7.34862272236652,3.68233641306884,6.56804683919999,6.6664531765618,9.13384148117489,7.05895260351335,5.13335110137444,3.68233641306884,6.41277253002994,6.52896308821533,6.29658197184456,130.904334117805,-0.0948762033094467,0.941402683911323,0.613381261700549,0.80948417602525,"Q60649",2.7e-170,"Mitochondrial disaggregase (EC 3.6.1.-) (Suppressor of potassium transport defect 3) [Cleaved into: Mitochondrial disaggregase, cleaved form]","cellular response to heat [GO:0034605]; granulocyte differentiation [GO:0030851]","GO:0005524; GO:0005737; GO:0005739; GO:0005758; GO:0016887; GO:0030851; GO:0034605; GO:0140545"
"1872","Pocillopora_acuta_HIv2___RNAseq.g29880.t1b",7.3394495412844,7.2463768115942,0,1.58730158730159,27.4509803921569,10.7936507936508,2.58620689655172,0,0,0,5.70039660225396,3.92546583850932,7.4753273659986,NA,NA,NA,NA,NA,NA,7.83340400713327,6.89581790443942,8.99078577225017,3.68233641306884,7.87279230126165,7.32675562721369,8.04335505963054,8.33387141872831,3.68233641306884,3.68233641306884,6.63437913298636,7.34263798248845,5.92612028348427,166.286992149763,-0.328259525274238,0.966363103436436,0.444566301177586,0.686971143553533,"Q60649",5.53e-167,"Mitochondrial disaggregase (EC 3.6.1.-) (Suppressor of potassium transport defect 3) [Cleaved into: Mitochondrial disaggregase, cleaved form]","cellular response to heat [GO:0034605]; granulocyte differentiation [GO:0030851]","GO:0005524; GO:0005737; GO:0005739; GO:0005758; GO:0016887; GO:0030851; GO:0034605; GO:0140545"
"1873","Pocillopora_acuta_HIv2___TS.g11629.t1a",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,8.9513906682475,6.23938980254995,5.94820612318409,3.68233641306884,9.61502038656193,3.68233641306884,8.45152832190879,3.68233641306884,11.28296915872,6.52178501134476,5.14758547273305,7.89598454995647,411.024696874831,0.174509132013613,1.02354630031472,1.72820076513949e-05,0.000183445232414489,"P42674",4.1e-26,"Blastula protease 10 (EC 3.4.24.-)","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0005938; GO:0006508; GO:0008270; GO:0048471"
"1874","Pocillopora_acuta_HIv2___RNAseq.g29902.t1",0,0,NA,NA,0,0,NA,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,6.73144313448199,9.09044323014377,6.22468762788833,10.1091197746935,6.74141228903702,9.72456537084841,9.71777449472389,8.85406069576677,5.56716625041612,3.68233641306884,7.64430092810686,6.82375399951805,8.46484785669568,391.474868223428,0.60321027449665,1.06782262938247,0.121648021877107,0.301403477468644,"Q04671",5.32e-154,"P protein (Melanocyte-specific transporter protein) (Pink-eyed dilution protein homolog)","cell population proliferation [GO:0008283]; lysosomal lumen pH elevation [GO:0035752]; melanin biosynthetic process [GO:0042438]; melanin biosynthetic process from tyrosine [GO:0006583]; melanocyte differentiation [GO:0030318]; spermatid development [GO:0007286]","GO:0005254; GO:0005765; GO:0005789; GO:0006583; GO:0007286; GO:0008283; GO:0010008; GO:0030318; GO:0033162; GO:0035752; GO:0042438"
"1875","Pocillopora_acuta_HIv2___RNAseq.g29914.t1",0,NA,10.2272727272727,0.29940119760479,1.40845070422535,1.88679245283019,10.8108108108108,0,2.92887029288703,0,3.06239979840343,1.2787659858305,4.48930684846178,NA,NA,NA,NA,NA,NA,6.3567367124764,9.20427924097985,8.20127146777352,7.40425219505693,8.85629889639966,10.2950439061706,7.9697869252993,7.661829922175,7.86241401940152,3.68233641306884,7.74942496988016,7.78771020364522,7.7111397361151,331.670706297643,0.0356163083487987,0.881962926524352,0.937589653712423,0.976536811102885,"Q6P1S4",0,"Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)","arginyl-tRNA aminoacylation [GO:0006420]","GO:0004814; GO:0005524; GO:0005829; GO:0006420; GO:0017101"
"1876","Pocillopora_acuta_HIv2___TS.g11659.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.4280277346742,10.6436201755488,10.3892155315085,11.097659480994,10.3738609447703,10.8276435266767,11.8884629241977,10.5303780045418,7.00297301330175,8.31859479180947,10.1500436128023,9.74489104575931,10.5551961798453,1511.78563468886,0.668976274151821,0.560646154740843,0.157490204434706,0.360205299959455,"Q9ULD2",6.52e-24,"Microtubule-associated tumor suppressor 1 (AT2 receptor-binding protein) (Angiotensin-II type 2 receptor-interacting protein) (Mitochondrial tumor suppressor 1)","regulation of macrophage chemotaxis [GO:0010758]","GO:0005615; GO:0005634; GO:0005730; GO:0005739; GO:0005794; GO:0005813; GO:0005819; GO:0005874; GO:0005886; GO:0008017; GO:0010758; GO:0015630"
"1877","Pocillopora_acuta_HIv2___RNAseq.g29925.t1",NA,66.6666666666667,NA,NA,100,82.2222222222222,23.3333333333333,NA,70,0,57.037037037037,72.962962962963,41.1111111111111,NA,NA,NA,NA,NA,NA,11.0441444960377,10.600723498744,11.1318466288976,10.6388032861779,11.0010105156941,11.1793714868581,10.2245296257607,10.3102398677748,11.372696145923,10.1789420078858,10.7682307559754,10.9719875308654,10.5644739810853,1789.2715683939,-0.303939118536591,0.525942344021691,0.487894059761795,0.721195675053102,"P16157",5.97e-40,"Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)","cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]","GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014"
"1878","Pocillopora_acuta_HIv2___TS.g11679.t1",0,0,0,0,0,0.308641975308642,1.72413793103448,0,0,NA,0.225864434038125,0.0617283950617284,0.431034482758621,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,11.6362923326279,3.68233641306884,13.3355652775762,16.1370289323518,15.4071526558592,3.68233641306884,3.68233641306884,15.7603078661494,9.06880291299087,7.20377336988212,10.9338324560996,18441.4783883572,0.18434711007611,1.03342134316038,0.000349022898863016,0.00240737587465649,NA,NA,NA,NA,NA
"1879","Pocillopora_acuta_HIv2___RNAseq.g29939.t1",NA,0,6.52173913043478,0,0,0,0,NA,0,NA,0.93167701863354,0,2.17391304347826,NA,NA,NA,NA,NA,NA,3.68233641306884,9.28288560999927,3.68233641306884,3.68233641306884,7.65772136444679,7.38086429475322,3.68233641306884,3.68233641306884,8.7024133505095,10.7001581489824,6.21357248340354,5.48142879083256,6.94571617597451,294.594555897106,0.220241080684577,1.00365349964441,0.430047407678717,0.674063474157268,NA,NA,NA,NA,NA
"1880","Pocillopora_acuta_HIv2___RNAseq.g29951.t1",NA,NA,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,7.7993788153644,9.85902705887729,5.56956094325591,7.40425219505693,7.18982473243499,10.3823782403765,11.37462225161,7.70891506725395,4.65430837654882,5.08610646190246,7.70283741426813,6.58439758697161,8.82127724156464,553.480578933693,2.32462633234384,0.797927959228109,0.000272580357307374,0.00194792603166692,NA,NA,NA,NA,NA
"1881","Pocillopora_acuta_HIv2___RNAseq.g29967.t1",7.46268656716418,11.9402985074627,0,5.05050505050505,8.75912408759124,3.20855614973262,6.25,3.10077519379845,4.34782608695652,6.36604774535809,5.64858193885688,5.52959219769107,5.7675716800227,NA,NA,NA,NA,NA,NA,9.35756234588217,10.2620942959526,10.7560051486874,12.4291070584113,10.3965153899103,9.16531831784015,8.75471211329172,10.0943709732861,11.1124381476103,3.68233641306884,9.60104602039409,10.3433784010753,8.85871363971292,1455.98901848417,-0.215850624546802,0.909169837046765,0.528762792525703,0.750615863292941,"Q14643",0,"Inositol 1,4,5-trisphosphate-gated calcium channel ITPR1 (IP3 receptor isoform 1) (IP3R 1) (InsP3R1) (Inositol 1,4,5 trisphosphate receptor) (Inositol 1,4,5-trisphosphate receptor type 1) (Type 1 inositol 1,4,5-trisphosphate receptor) (Type 1 InsP3 receptor)","calcium import into the mitochondrion [GO:0036444]; calcium ion transport [GO:0006816]; cell morphogenesis [GO:0000902]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; ligand-gated ion channel signaling pathway [GO:1990806]; negative regulation of calcium-mediated signaling [GO:0050849]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; positive regulation of apoptotic process [GO:0043065]; positive regulation of insulin secretion [GO:0032024]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; regulation of autophagy [GO:0010506]; regulation of cytosolic calcium ion concentration [GO:0051480]; release of sequestered calcium ion into cytosol [GO:0051209]; release of sequestered calcium ion into cytosol by endoplasmic reticulum [GO:1903514]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; voluntary musculoskeletal movement [GO:0050882]","GO:0000902; GO:0001666; GO:0005220; GO:0005509; GO:0005524; GO:0005637; GO:0005730; GO:0005783; GO:0005789; GO:0005886; GO:0005955; GO:0006816; GO:0007165; GO:0007207; GO:0007338; GO:0009791; GO:0010506; GO:0014069; GO:0015085; GO:0015278; GO:0016020; GO:0016529; GO:0019855; GO:0019904; GO:0030658; GO:0030667; GO:0031088; GO:0031094; GO:0031095; GO:0032024; GO:0032469; GO:0035091; GO:0036444; GO:0042045; GO:0043065; GO:0048471; GO:0050849; GO:0050882; GO:0051209; GO:0051289; GO:0051480; GO:0070059; GO:0070679; GO:0098685; GO:0098695; GO:0099105; GO:1903514; GO:1990806"
"1882","Pocillopora_acuta_HIv2___TS.g11718.t1",46.4285714285714,2.7027027027027,66.6666666666667,0,0,0,48.780487804878,NA,0,0,18.2864920669799,0.675675675675676,32.3751451800232,NA,NA,NA,NA,NA,NA,10.7298706531308,9.90463529410206,12.037154753845,10.7847767254118,9.91744740544774,11.8320209718179,11.0608787961232,10.5469009297001,11.2139300994587,10.7015823205283,10.8729197949566,10.8890607683165,10.8567788215967,2065.38494268133,-0.0379813101986586,0.638406932011201,0.925484312251462,0.97201946326552,"Q9UK61",3.35e-42,"Protein TASOR (CTCL tumor antigen se89-1) (Retinoblastoma-associated protein RAP140) (Transgene activation suppressor protein)","anterior/posterior axis specification, embryo [GO:0008595]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin formation [GO:0090309]; protein localization to heterochromatin [GO:0097355]","GO:0000792; GO:0003682; GO:0003723; GO:0005654; GO:0008595; GO:0045814; GO:0045869; GO:0060809; GO:0090309; GO:0097355"
"1883","Pocillopora_acuta_HIv2___RNAseq.g29988.t1",NA,100,16.6666666666667,NA,100,100,35.7142857142857,NA,100,NA,75.3968253968254,100,50.7936507936508,NA,NA,NA,NA,NA,NA,7.84456860244933,3.68233641306884,5.49419692800081,3.68233641306884,7.69786528086486,7.78738559023813,3.68233641306884,7.86816093962977,3.68233641306884,3.68233641306884,5.51038594065271,6.51742563280272,4.5033462485027,81.5358965410091,-0.352374230705225,1.08540753649739,0.00865962444627474,0.0369368351491943,"O18404",1.89e-90,"3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51, EC 1.1.1.62) (3-hydroxyacyl-CoA dehydrogenase type II) (Hydroxysteroid dehydrogenase) (EC 1.1.1.-, EC 1.1.1.53) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Scully protein) (Type II HADH)","acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; steroid metabolic process [GO:0008202]","GO:0003857; GO:0004303; GO:0005739; GO:0006631; GO:0006637; GO:0008202; GO:0008205; GO:0008209; GO:0008210; GO:0016229; GO:0018454; GO:0030678; GO:0035410; GO:0047015; GO:0047022; GO:0047035; GO:0090646; GO:0106282; GO:0106283"
"1884","Pocillopora_acuta_HIv2___RNAseq.22092_t",0,NA,0,0,0,37.5,NA,NA,0,0,5.35714285714286,12.5,0,NA,NA,NA,NA,NA,NA,7.40550595771431,9.74186081854088,6.93658367102579,6.68205791477539,4.2048702631434,7.53867478441361,10.3683170978611,4.5021858093707,3.68233641306884,9.71778743968482,7.07801801695988,5.34629642286461,8.80973961105516,343.233674107457,2.17526836581224,4.26041332854471,5.47984934907335e-05,0.000494451284996862,"Q9JME2",2.7e-41,"Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1)","apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030166; GO:0030204; GO:0030206; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216"
"1885","Pocillopora_acuta_HIv2___RNAseq.g30046.t1",0,0,0,0,0,0,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.0560044049994,10.9254338954227,3.68233641306884,12.2047998657816,7.14387482575766,12.9368048541012,13.3801739468236,3.68233641306884,3.68233641306884,12.1476480165331,8.68417490486258,5.04937769399272,12.3189721157324,2980.31198903644,8.58192239268404,5.69786410913527,1.70561786471129e-11,1.40170777245364e-09,NA,NA,NA,NA,NA
"1886","Pocillopora_acuta_HIv2___RNAseq.g30055.t2",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.5139241004496,11.6992238493077,10.2132948038736,9.57692756088418,9.75823801738914,10.2232617578145,3.68233641306884,9.40301500116485,9.73544456618406,3.68233641306884,8.74880024832053,9.72478329781225,7.77281719882881,939.400691276672,-0.215407672756722,0.97593158096772,0.28961023964921,0.53614776734752,"Q498H0",0,"Sister chromatid cohesion protein PDS5 homolog B-A (Androgen-induced proliferation inhibitor A)","cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]","GO:0003677; GO:0005634; GO:0007064; GO:0008285; GO:0051301"
"1887","Pocillopora_acuta_HIv2___RNAseq.g30087.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.97162831963388,3.68233641306884,6.58642216671358,7.83130589073456,8.04741698510306,8.74641067247364,3.68233641306884,6.14570161823912,3.68233641306884,3.68233641306884,6.20582313051732,6.8867011005517,5.52494516048294,194.461270933378,-0.157673402641271,0.995404712594975,0.494669672675703,0.725766479676139,"A0A2B4RP11",2.32e-16,"Cyclic GMP-AMP synthase-like receptor 1 (Sp-cGLR1) (Cyclic UMP-AMP synthase cGLR1) (EC 2.7.7.-)","innate immune response [GO:0045087]","GO:0003725; GO:0005524; GO:0016779; GO:0045087; GO:0046872"
"1888","Pocillopora_acuta_HIv2___RNAseq.g30132.t1",0,0,0,0,2.08333333333333,0,0,0,0,NA,0.231481481481482,0,0.520833333333333,NA,NA,NA,NA,NA,NA,8.81414093494965,8.22839989032863,9.72155449193117,3.68233641306884,9.2975446319909,9.55110735960129,3.68233641306884,4.82716794255886,10.9372711180906,3.68233641306884,7.24241956086576,8.71953582390424,5.76530329782729,479.075256685507,-0.478568002286718,1.11039050044501,0.0043777245875551,0.0207672707229901,"Q96NL6",1.32e-84,"Sodium channel and clathrin linker 1 (Sodium channel-associated protein 1)","cilium assembly [GO:0060271]; clustering of voltage-gated sodium channels [GO:0045162]","GO:0005813; GO:0005814; GO:0005829; GO:0017080; GO:0030276; GO:0045162; GO:0060271; GO:0071439; GO:0097539"
"1889","Pocillopora_acuta_HIv2___RNAseq.g30139.t1",66.6666666666667,0,NA,0,0,0,0,NA,0,NA,9.52380952380952,0,22.2222222222222,NA,NA,NA,NA,NA,NA,9.5952647091742,7.35927076110737,9.95244887291825,5.05535826649939,9.68948160995363,10.3099718017394,9.66254934004683,11.0705578285903,10.4005614187079,6.58881646192222,8.96842810706595,10.1416628878689,7.79519332626304,821.795906152358,-1.47165100581324,1.32836698973554,0.0102729451630841,0.0425387571826078,"Q921G7",0,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)","electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979]","GO:0004174; GO:0005739; GO:0005743; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0022900; GO:0031966; GO:0033539; GO:0046872; GO:0048039; GO:0051536; GO:0051539"
"1890","Pocillopora_acuta_HIv2___RNAseq.g30148.t1",0,0,0,1.19047619047619,0.595238095238095,0.657894736842105,5.08474576271186,NA,0.847457627118644,0,0.930645823598544,0.673957138609235,1.13599677158999,NA,NA,NA,NA,NA,NA,9.61327626178013,3.68233641306884,8.69684289122575,6.66570112997648,9.47606781113678,8.82339275517331,6.99953765449245,8.6083589701606,6.99146834177293,10.5689815727494,8.01259638015367,8.67720285521524,7.3479899050921,440.430423537365,-0.357802128499265,0.980824848100013,0.266613615546246,0.510401208203379,"Q7Z494",8.13e-37,"Nephrocystin-3","atrial septum development [GO:0003283]; cilium assembly [GO:0060271]; convergent extension [GO:0060026]; convergent extension involved in gastrulation [GO:0060027]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; determination of stomach left/right asymmetry [GO:0071909]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; maintenance of animal organ identity [GO:0048496]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; ureter development [GO:0072189]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001947; GO:0003283; GO:0005576; GO:0005829; GO:0005929; GO:0006629; GO:0007163; GO:0007368; GO:0016055; GO:0030198; GO:0030324; GO:0035469; GO:0045494; GO:0048496; GO:0060026; GO:0060027; GO:0060271; GO:0060287; GO:0060993; GO:0071908; GO:0071909; GO:0071910; GO:0072189; GO:0090090; GO:0097543; GO:0097546; GO:1905515; GO:2000095"
"1891","Pocillopora_acuta_HIv2___RNAseq.g30149.t1",100,NA,33.3333333333333,22.2222222222222,58.6206896551724,2.04081632653061,61.9047619047619,37.5,0,NA,39.4527279302526,15.4407596371882,63.4646962233169,1,37.9310344827586,37.9310344827586,0.00615533573709885,0.00615533573709885,0.00615533573709885,5.42769788077612,6.30327276432217,7.02247773613795,9.29225260325604,7.52112240205826,4.21083509301726,7.12992946871016,5.23780076973312,7.2828057670621,4.40467075915833,6.38328652442315,6.49838091115351,6.26819213769279,121.076886197283,0.0029035982974195,0.928076898277994,0.97739988044516,0.992220049005353,"Q4L235",0,"Beta-alanine-activating enzyme (EC 6.2.1.-) (Acyl-CoA synthetase family member 4) (Protein NRPS998)","amino acid activation for nonribosomal peptide biosynthetic process [GO:0043041]; beta-alanine metabolic process [GO:0019482]; fatty acid metabolic process [GO:0006631]","GO:0005524; GO:0006631; GO:0016878; GO:0019482; GO:0043041"
"1892","Pocillopora_acuta_HIv2___RNAseq.g30151.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.2569830015029,6.24196204696702,8.40522811368302,7.02644217673873,10.0013363653359,8.44447728452823,3.68233641306884,8.9967163312335,3.68233641306884,10.8334441439407,7.65712622900677,8.06852004496483,7.2457324130487,466.559639158531,-0.277517284312336,1.01402689930137,0.248794889417138,0.48873683016834,"P0CI65",3.16e-29,"Nephrocystin-3","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"1893","Pocillopora_acuta_HIv2___RNAseq.g30153.t1",0.961538461538462,0,5.26315789473684,0,2.04081632653061,0.71301247771836,0.286532951289398,0,0.680272108843537,0,0.994533022065721,0.27865691731238,1.71040912681906,NA,NA,NA,NA,NA,NA,8.63967192774965,3.68233641306884,7.72491691603718,5.94820612318409,8.7268935431052,8.44447728452823,3.68233641306884,8.1510851760415,3.68233641306884,10.116247172385,6.87985073822374,7.38498079520047,6.374720681247,266.412272054715,-0.194432132412799,1.0111546903456,0.180594378946261,0.395262601220026,"Q7TNH6",3.07e-29,"Nephrocystin-3","atrial septum development [GO:0003283]; cilium assembly [GO:0060271]; convergent extension [GO:0060026]; convergent extension involved in gastrulation [GO:0060027]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; determination of stomach left/right asymmetry [GO:0071909]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; maintenance of animal organ identity [GO:0048496]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; ureter development [GO:0072189]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001947; GO:0003283; GO:0005929; GO:0006629; GO:0007163; GO:0007368; GO:0016055; GO:0030198; GO:0030324; GO:0035469; GO:0045494; GO:0048496; GO:0060026; GO:0060027; GO:0060271; GO:0060993; GO:0071908; GO:0071909; GO:0071910; GO:0072189; GO:0090090; GO:0097543; GO:0097546; GO:1905515; GO:2000095"
"1894","Pocillopora_acuta_HIv2___TS.g11915.t1",NA,NA,0,20,0,0,0,NA,0,0,2.85714285714286,6.66666666666667,0,NA,NA,NA,NA,NA,NA,8.4844967469423,8.7482501316643,8.18658786747835,6.92073451612509,9.51016398589625,8.75517027377591,11.0534970344177,9.86320814364097,5.69309697015473,8.1532745878894,8.5368480257985,8.34751074282252,8.72618530877448,550.57758998963,0.218782238725288,0.724576892223735,0.644111879289341,0.829236492764719,"P61222",0,"ATP-binding cassette sub-family E member 1 (RNase L inhibitor) (EC 3.6.5.-) (Ribonuclease 4 inhibitor) (RNS4I)","regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosomal subunit export from nucleus [GO:0000054]; ribosome disassembly [GO:0032790]; translational initiation [GO:0006413]; translational termination [GO:0006415]","GO:0000054; GO:0003924; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0006413; GO:0006415; GO:0006417; GO:0016887; GO:0022626; GO:0032790; GO:0043024; GO:0043273; GO:0051539; GO:0060698; GO:0072344"
"1895","Pocillopora_acuta_HIv2___RNAseq.g30235.t1",8.84353741496599,0,22.3880597014925,9.19540229885057,0,1.13636363636364,10,5.88235294117647,6.12244897959184,2.77777777777778,6.63459427502188,4.4673135711965,8.80187497884726,NA,NA,NA,NA,NA,NA,3.68233641306884,10.4451862305697,3.68233641306884,10.0420954508701,5.61428486132265,9.45228413401723,9.49169085368382,3.68233641306884,3.68233641306884,10.2623742252718,7.00372614080107,4.0687261027196,9.93872617888253,499.633037389693,11.6857740726603,2.85719912699997,3.24279837407293e-11,2.37049281344524e-09,"P55115",1.2e-54,"Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"1896","Pocillopora_acuta_HIv2___RNAseq.g1118.t1",0,1.38888888888889,0,0,2.06185567010309,0.571428571428571,0.43859649122807,1.52284263959391,0,0,0.598361226124253,0.696632019982274,0.500090432266233,NA,NA,NA,NA,NA,NA,5.39475910818241,8.15468249800669,5.54494604997642,8.57685856079561,7.90398397731598,3.68233641306884,3.68233641306884,8.16952988842414,6.6827526322222,9.62774969672687,6.7419935237788,6.73919433122423,6.74479271633337,198.299388111433,0.0850521752847095,0.998332179580611,0.519349170306344,0.743675517207302,"P12111",1.85e-92,"Collagen alpha-3(VI) chain","cell adhesion [GO:0007155]; muscle organ development [GO:0007517]; neuron apoptotic process [GO:0051402]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; response to glucose [GO:0009749]; response to UV [GO:0009411]","GO:0004867; GO:0005576; GO:0005589; GO:0005615; GO:0005788; GO:0007155; GO:0007517; GO:0009411; GO:0009749; GO:0030020; GO:0031012; GO:0042383; GO:0043491; GO:0051402; GO:0062023; GO:0070062; GO:1903561"
"1897","Pocillopora_acuta_HIv2___RNAseq.g1119.t1",0,0,NA,0,0,0,NA,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,10.2317433465825,3.68233641306884,10.9633326114345,8.50571174096725,11.8188625707273,10.3149819247529,7.94874910879557,3.68233641306884,9.68647811119288,8.05168686536594,5.50029401779387,10.603079712938,934.210540933629,1.8485101145677,6.732507507849,3.83430698090581e-08,9.49647537188726e-07,"Q8C6K9",5.82e-52,"Collagen alpha-6(VI) chain","cell adhesion [GO:0007155]","GO:0005576; GO:0005581; GO:0007155; GO:0031012; GO:0062023"
"1898","Pocillopora_acuta_HIv2___RNAseq.g1125.t1",NA,0,0,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,11.4507190596355,3.68233641306884,11.5956914588148,8.37845092615746,11.7807961106149,9.19955123775469,7.8144146220943,3.68233641306884,10.6829575074375,8.19495901617157,5.44797495749166,10.9419430748515,1202.4430853272,0.922673435637377,1.64791109677202,1.04055906947964e-08,3.00908168120616e-07,"P12111",1.23e-65,"Collagen alpha-3(VI) chain","cell adhesion [GO:0007155]; muscle organ development [GO:0007517]; neuron apoptotic process [GO:0051402]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; response to glucose [GO:0009749]; response to UV [GO:0009411]","GO:0004867; GO:0005576; GO:0005589; GO:0005615; GO:0005788; GO:0007155; GO:0007517; GO:0009411; GO:0009749; GO:0030020; GO:0031012; GO:0042383; GO:0043491; GO:0051402; GO:0062023; GO:0070062; GO:1903561"
"1899","Pocillopora_acuta_HIv2___RNAseq.g1126.t1",2.3121387283237,0,0,0,0,0.746268656716418,0,0,0,7.21649484536082,1.02749022304009,0.149253731343284,1.9057267147369,NA,NA,NA,NA,NA,NA,8.63967192774965,13.4407879592082,3.68233641306884,13.3951052311537,3.68233641306884,12.7379512538266,11.8582787815525,3.68233641306884,3.68233641306884,12.2596818424028,8.70608226481688,4.673803516005,12.7383610136288,3758.53930256433,14.5774795798716,3.15720134877493,3.83075249892931e-14,8.65750064758024e-12,"B3EWZ3",7.33e-54,"Coadhesin","","GO:0016020"
"1900","Pocillopora_acuta_HIv2___RNAseq.g1130.t1",6.89655172413793,0,0,0,0,0,0,0,0,0,0.689655172413793,0,1.37931034482759,NA,NA,NA,NA,NA,NA,9.52952911540641,4.68019422250907,9.10436465200446,7.48948822201648,8.67369836228592,9.21058628392639,9.7344920197594,7.28566463212703,10.5613398274244,10.8668318875424,8.7136189225002,9.03091931784964,8.39631852715075,663.524407432758,-0.13628868787572,0.847968941078391,0.696621942865215,0.860823561008327,"Q9Z2Z6",5.64e-11,"Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (CACT) (mCAC) (Solute carrier family 25 member 20)","carnitine transmembrane transport [GO:1902603]; in utero embryonic development [GO:0001701]; lipid transport [GO:0006869]; mitochondrial transport [GO:0006839]","GO:0001701; GO:0005739; GO:0005740; GO:0005743; GO:0005829; GO:0006839; GO:0006869; GO:0015227; GO:1902603"
"1901","Pocillopora_acuta_HIv2___RNAseq.g1135.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.4869285656541,10.4128620155513,11.6207042172134,11.4604930832887,11.3618048279567,11.0099410690573,10.0706676896913,11.4623521861536,11.7838392951145,11.6541689671203,11.1323761916801,11.3431258184185,10.9216265649418,2384.95723531178,-0.312787710157263,0.531388499196581,0.482863762192085,0.71668973384775,"P21613",0,"Kinesin heavy chain","microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]","GO:0000278; GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008017; GO:0030424"
"1902","Pocillopora_acuta_HIv2___TS.g16421.t1",0,0,0,0,0,0,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.76666095136545,7.40558854265871,8.64144282653843,8.14250126351214,6.01241040467731,8.85361315525796,10.1858882719055,5.51740847876286,9.77085688999895,6.81941263111671,7.7115783415794,7.1417559102686,8.2814007728902,338.67669372115,0.507205688989123,0.996629069274205,0.16129197158196,0.365705817220322,"Q16515",6.15e-86,"Acid-sensing ion channel 2 (ASIC2) (Amiloride-sensitive brain sodium channel) (Amiloride-sensitive cation channel 1, neuronal) (Amiloride-sensitive cation channel neuronal 1) (Brain sodium channel 1) (BNC1) (BNaC1) (Mammalian degenerin homolog) (MDEG)","cellular response to acidic pH [GO:0071468]; cellular response to xenobiotic stimulus [GO:0071466]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; establishment of localization in cell [GO:0051649]; inorganic cation transmembrane transport [GO:0098662]; negative regulation of apoptotic process [GO:0043066]; peripheral nervous system development [GO:0007422]; phototransduction [GO:0007602]; positive regulation of synapse assembly [GO:0051965]; protein localization to synapse [GO:0035418]; regulation of membrane potential [GO:0042391]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback [GO:0003026]; regulation of vasoconstriction [GO:0019229]; sensory perception of sound [GO:0007605]; sensory perception of sour taste [GO:0050915]; sodium ion transmembrane transport [GO:0035725]; synapse assembly [GO:0007416]","GO:0003026; GO:0005248; GO:0005886; GO:0007268; GO:0007416; GO:0007417; GO:0007422; GO:0007602; GO:0007605; GO:0015280; GO:0019229; GO:0022839; GO:0034765; GO:0035418; GO:0035725; GO:0042391; GO:0043025; GO:0043066; GO:0043197; GO:0050915; GO:0050974; GO:0051649; GO:0051965; GO:0071466; GO:0071468; GO:0098662"
"1903","Pocillopora_acuta_HIv2___RNAseq.g1172.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.00035332017132,5.21816971328303,5.72956178137413,3.68233641306884,7.68593987239162,6.82103953412585,3.68233641306884,7.38412583434139,9.81191104106353,3.68233641306884,5.86981103359574,7.1223783698684,4.61724369732308,134.354290508583,-0.588880636920863,1.1907980952273,0.000732238087777062,0.0045126083091638,"A6QLU6",1.1e-15,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"1904","Pocillopora_acuta_HIv2___RNAseq.g1182.t1",0,0,0,0,0,0.72992700729927,3.16901408450704,0,0,0,0.389894109180631,0.145985401459854,0.633802816901408,NA,NA,NA,NA,NA,NA,7.97725293850525,8.0939860793811,7.88375263086711,8.55514865369028,8.2003019901985,3.68233641306884,3.68233641306884,7.34663969472793,3.68233641306884,3.68233641306884,6.27864276396455,7.01805673347353,5.53922879445558,144.435939726955,-0.226062258264935,1.00604524297659,0.370660373592596,0.62022578015309,"Q80T32",7.77e-10,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; neurogenesis [GO:0022008]","GO:0004930; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016607; GO:0022008"
"1905","Pocillopora_acuta_HIv2___RNAseq.g1187.t1",100,NA,0,0,0,0,NA,NA,0,NA,16.6666666666667,0,33.3333333333333,NA,NA,NA,NA,NA,NA,9.11016313708943,3.68233641306884,9.1895607263034,3.68233641306884,9.07259840835275,3.68233641306884,3.68233641306884,8.97069404020915,10.8334512014618,7.55041065829872,6.94562238239906,9.43529350268331,4.45595126211482,403.69447428007,-10.0847271118013,3.24266838327992,5.38614935756441e-08,1.25249621073652e-06,NA,NA,NA,NA,NA
"1906","Pocillopora_acuta_HIv2___TS.g16482.t1",0,0,NA,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.3914970695504,3.68233641306884,9.74300282796309,3.68233641306884,10.1614895104307,3.68233641306884,9.23654251700305,10.6801920829196,9.00693502697906,3.68233641306884,7.39490046871213,9.99662330356857,4.79317763385568,595.102737753852,-9.74808962474393,3.51750000348824,1.02931023277695e-08,2.98954682869192e-07,"P31649",0,"Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13)","amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734]","GO:0005283; GO:0005308; GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0015185; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0089718"
"1907","Pocillopora_acuta_HIv2___TS.g16484.t1",0,0,NA,NA,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,7.69834019107527,3.68233641306884,8.28979413555857,3.68233641306884,8.74991941285559,5.77882859435006,7.07214377630121,8.59705801932093,7.56366523702835,3.68233641306884,6.47967586056965,8.17975539916774,4.77959632197156,154.454617079156,-3.45319763065609,4.27696613619078,1.77846990998386e-05,0.000187764881591289,"P31649",0,"Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13)","amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734]","GO:0005283; GO:0005308; GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0015185; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0089718"
"1908","Pocillopora_acuta_HIv2___TS.g16486.t1",0,0,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.07994710962842,3.68233641306884,8.343715901752,3.68233641306884,9.28446852155977,3.68233641306884,3.68233641306884,9.92230413243012,11.0724590073308,6.37217112046895,6.78044114454454,9.34057893454022,4.22030335454886,427.524815118564,-10.0799047814824,2.66569622520285,7.32287066712196e-10,3.13366867838024e-08,NA,NA,NA,NA,NA
"1909","Pocillopora_acuta_HIv2___RNAseq.g1207.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,5.64062457406066,9.31824411792278,8.18346933366442,7.88660922674629,3.68233641306884,8.09428623094977,6.30482766574162,5.54842281532527,6.20234932036173,6.38110884349706,6.0235897972264,144.607265905808,-0.108734016837229,0.959811649727726,0.758524746168658,0.894224443650557,NA,NA,NA,NA,NA
"1910","Pocillopora_acuta_HIv2___RNAseq.g1208.t1",2.9673590504451,3.69230769230769,0,0.367647058823529,1.25786163522013,3.23383084577114,7.14285714285714,3.43137254901961,0,3.56744704570792,2.56606830201523,2.14503162918439,2.98710497484606,NA,NA,NA,NA,NA,NA,3.68233641306884,7.96430909081604,3.68233641306884,11.4076244779492,3.68233641306884,7.22892834819183,11.1964120222501,6.79689746336218,3.68233641306884,3.68233641306884,6.30058534679135,4.30524862312751,8.2959220704552,544.930217628386,0.733212507585855,1.45768227720166,4.64932925281502e-05,0.000428876902504569,"Q05360",1.57e-176,"Protein white","","GO:0005524; GO:0016020; GO:0016887; GO:0031409; GO:0140359"
"1911","Pocillopora_acuta_HIv2___RNAseq.g1211.t1",NA,0,0,0,NA,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,8.92584900242764,3.68233641306884,6.88242140054137,9.45806305114617,7.52559471763287,7.71720190845086,3.68233641306884,8.37151751743006,3.68233641306884,10.1141096757426,7.00417665125781,7.07754381022016,6.93080949229546,296.639030680845,-0.0106412945171986,0.991414724170635,0.881237000342401,0.953843595970402,"P10090",0,"Protein white (EC 7.6.2.-) (EC 7.6.2.6) (ATP-binding cassette transporter sub-family G member white) (Broad substrate specificity ATP-binding cassette transporter white)","aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; guanine transport [GO:0015854]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; riboflavin transport [GO:0032218]; transmembrane transport [GO:0055085]; tryptophan transport [GO:0015827]; xanthine transport [GO:0042906]","GO:0005275; GO:0005524; GO:0005886; GO:0006856; GO:0007613; GO:0008049; GO:0008558; GO:0015196; GO:0015208; GO:0015827; GO:0015842; GO:0015854; GO:0016887; GO:0022857; GO:0030659; GO:0031409; GO:0031410; GO:0032217; GO:0032218; GO:0042332; GO:0042401; GO:0042441; GO:0042626; GO:0042906; GO:0042907; GO:0048072; GO:0048770; GO:0051615; GO:0055085; GO:0070731; GO:0090741; GO:0098793; GO:1905948"
"1912","Pocillopora_acuta_HIv2___TS.g16495.t2b",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.54234269767134,3.68233641306884,9.760429728062,8.05848887682085,9.05422290374872,8.18381287343643,10.8529430609663,9.06717372470269,8.87671285340396,3.68233641306884,7.876079954495,8.86017638151774,6.89198352747225,479.663039261401,-0.425204974994755,1.04135889139574,0.06951347552479,0.200727147664791,"P80193",5.06e-52,"Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)","carnitine biosynthetic process [GO:0045329]","GO:0005506; GO:0005737; GO:0008336; GO:0045329"
"1913","Pocillopora_acuta_HIv2___RNAseq.g1235.t1",4.34782608695652,66.6666666666667,0,0,0,6.41025641025641,0,0,0,NA,8.60274990709773,14.6153846153846,1.08695652173913,NA,NA,NA,NA,NA,NA,5.8152979608059,9.64919815594458,5.98248205022216,6.45278967965745,7.83011911983456,5.51028908219708,8.92306134574704,6.13282228848601,3.68233641306884,6.8405162461847,6.68189123421483,5.88861156648349,7.47517090194617,173.843285732127,0.667232575775301,1.17375274018552,0.0401061162201388,0.131124517406891,"A8HYJ1",9.46e-15,"Translocase of chloroplast 34 homolog, chloroplastic (Cr-TOC34) (TOC34p) (EC 3.6.5.-)","protein transport [GO:0015031]","GO:0005525; GO:0009707; GO:0015031; GO:0016787; GO:0046872"
"1914","Pocillopora_acuta_HIv2___TS.g16547.t2a",NA,NA,15.625,NA,3.2258064516129,2.32558139534884,0,0,3.125,NA,4.05023130782696,1.81686046511628,6.28360215053763,NA,NA,NA,NA,NA,NA,5.76666095136545,4.0964559233504,6.55189453597217,5.52419073768572,6.55922841464905,6.92935989231271,7.61470949026634,5.95306534505293,6.75289969255109,3.68233641306884,5.94308013962747,6.31674978791814,5.5694104913368,58.8429340482055,-0.38115193876221,0.980658192509362,0.188827516498096,0.407702821111876,NA,NA,NA,NA,NA
"1915","Pocillopora_acuta_HIv2___TS.g16549.t1",NA,100,50,50,69.2307692307692,62.7906976744186,100,NA,NA,NA,72.0035778175313,70.9302325581395,73.0769230769231,NA,NA,NA,NA,NA,NA,10.6401009613325,10.1663834810023,10.809596149854,7.07647355201382,9.98041186087074,10.038426773231,11.4286873722819,9.93312001810279,10.4048608561378,8.76291441208491,9.92409754369118,10.3536179692596,9.49457711812279,1200.68380090046,-0.394898272653176,0.782225978784968,0.373052330483745,0.622787270096594,"Q9Z1G4",0,"V-type proton ATPase 116 kDa subunit a 1 (V-ATPase 116 kDa subunit a 1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1)","regulation of macroautophagy [GO:0016241]; synaptic vesicle lumen acidification [GO:0097401]; vacuolar acidification [GO:0007035]","GO:0000220; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0008021; GO:0016241; GO:0016471; GO:0016607; GO:0030665; GO:0030672; GO:0042470; GO:0043229; GO:0046961; GO:0048471; GO:0051117; GO:0097401"
"1916","Pocillopora_acuta_HIv2___RNAseq.g1264.t1",2.52844500632111,4.72972972972973,1.07142857142857,2.54988913525499,12.481426448737,5.01766784452297,3.01507537688442,0,7.6103500761035,0,3.90040121889823,3.98152735712224,3.81927508067422,NA,NA,NA,NA,NA,NA,3.68233641306884,7.13540753184008,7.91083219305282,3.68233641306884,8.10219949446545,7.87591744416405,3.68233641306884,6.01099506072748,5.72271821572966,10.5230013271025,6.43280805062886,6.28581627540885,6.57979982584886,230.889062831735,0.00186847681573528,0.994193738488169,0.883891104548584,0.955164598805513,"Q08AG5",7.13e-06,"Zinc finger protein 844","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"1917","Pocillopora_acuta_HIv2___RNAseq.g1270.t1",0,NA,NA,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.80850548108783,3.68233641306884,9.14898060176948,3.68233641306884,10.8932081258691,3.68233641306884,7.84537306431718,3.68233641306884,7.03580592350913,6.31435552618969,4.51494374331851,8.11376730906088,360.164241768108,0.293463327045632,1.07987550548284,1.73810598577492e-07,3.48198960917569e-06,"Q5RA50",4.16e-23,"Protein FAM124A","",""
"1918","Pocillopora_acuta_HIv2___RNAseq.g1315.t1",0,0,14.2857142857143,NA,NA,0,0,0,0,NA,2.04081632653061,0,4.76190476190476,NA,NA,NA,NA,NA,NA,5.55119387333227,7.42370247120592,3.68233641306884,9.18897601303468,7.41901201626945,8.50807148292514,11.6217283726507,7.41031074864208,3.68233641306884,7.95689430964936,7.24445621138473,5.5490378928763,8.93987452989316,470.976544572365,1.99011042152131,3.01855813013709,0.000744743776629451,0.00457408661790589,"Q0V9P1",3.74e-22,"Histamine N-methyltransferase (HMT) (EC 2.1.1.8)","histamine catabolic process [GO:0001695]; methylation [GO:0032259]","GO:0001695; GO:0005737; GO:0032259; GO:0046539"
"1919","Pocillopora_acuta_HIv2___RNAseq.g1321.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.5797704355276,10.0171745790842,10.4263373553083,10.3231332418684,11.1507756494974,11.7552123394465,10.9961260293741,11.3178641026058,9.41352867039381,3.68233641306884,9.9662258816175,10.5776552426666,9.35479652056841,1600.14827185299,-0.26243008907329,0.868219641721174,0.518694328651512,0.742890006586185,"Q15032",1.46e-58,"R3H domain-containing protein 1","","GO:0003723"
"1920","Pocillopora_acuta_HIv2___RNAseq.g1325.t1",0,0,NA,0,0,0,5,NA,0,NA,0.714285714285714,0,1.66666666666667,NA,NA,NA,NA,NA,NA,8.66816923205416,7.493942887935,4.98269171864354,5.92008485977766,8.0811427777168,6.97046070240566,3.68233641306884,7.26282800372101,8.02806168915246,3.68233641306884,6.4772054697544,7.40457868425759,5.5498322552512,129.752665289833,-0.468792748237654,1.06130308939474,0.0789703542238444,0.220549759315251,"Q96ND8",3.15e-102,"Zinc finger protein 583 (Zinc finger protein L3-5)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"1921","Pocillopora_acuta_HIv2___RNAseq.g1346.t1",30.7692307692308,100,NA,NA,NA,24.2424242424242,80.9523809523809,0,0,87.5,46.2091479948623,31.0606060606061,66.4072039072039,NA,NA,NA,NA,NA,NA,7.87755006797665,3.68233641306884,8.80883284594724,7.39445938623252,7.73691422051336,3.68233641306884,3.68233641306884,6.6888369593493,4.57231842518309,11.0127895676863,6.5138710712095,7.13689050379393,5.89085163862507,309.009160286381,-0.342659019593118,1.0805209369984,0.00030912857545086,0.00216875505495022,NA,NA,NA,NA,NA
"1922","Pocillopora_acuta_HIv2___TS.g16637.t1",1.81818181818182,0,2.52427184466019,0.492610837438424,0.828729281767956,0.525812619502868,0.684345594525235,0.742574257425743,1.13314447592068,0,0.874967072942292,0.578828438057543,1.17110570782704,NA,NA,NA,NA,NA,NA,6.6819031016316,3.68233641306884,4.75546742395967,3.68233641306884,6.07686165919975,7.04924140340958,3.68233641306884,6.09342916571462,7.40876851237578,3.68233641306884,5.27950169185664,6.20328597257628,4.35571741113699,42.8559766658433,-0.65911956672911,1.32233324221096,0.000804612225365294,0.00487349716402162,"Q55E58",7.67e-21,"Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)","cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856]","GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310"
"1923","Pocillopora_acuta_HIv2___RNAseq.g1367.t1",0.903405142460042,1.23318385650224,0.928074245939675,0.285714285714286,0.374331550802139,0.848234754699679,0.751366120218579,0.970873786407767,1.14068441064639,0,0.74358681533908,0.895738218794072,0.591435411884087,NA,NA,NA,NA,NA,NA,7.75863401495251,6.63867229711208,7.84683233870282,7.72618212191993,7.14387482575766,7.4619492718124,6.63285646347393,7.19203195048682,7.27336735209762,6.75413069443622,7.2428531330752,7.44294809639949,7.04275816975091,133.863550960977,-0.343550099967628,0.580134485838185,0.466833629578344,0.706157876827146,NA,NA,NA,NA,NA
"1924","Pocillopora_acuta_HIv2___RNAseq.g1391.t1",0,NA,NA,0,0,NA,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.6069867553506,10.786186338134,9.61747021527548,10.8315300536769,10.6935847309383,11.673313857469,10.829796158423,10.9678102227372,10.4272250248985,5.54842281532527,10.1982326172228,10.46261538984,9.93384984460563,1584.97570369127,-0.0595842727314335,0.780706765329697,0.877237907275788,0.952758869960664,"Q9HD67",0,"Unconventional myosin-X (Unconventional myosin-10)","cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165]","GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005547; GO:0005730; GO:0005829; GO:0005886; GO:0005938; GO:0007165; GO:0008360; GO:0016459; GO:0022409; GO:0030027; GO:0030175; GO:0030507; GO:0030705; GO:0031527; GO:0032433; GO:0043005; GO:0043025; GO:0051015; GO:0051489; GO:0060002"
"1925","Pocillopora_acuta_HIv2___RNAseq.g1397.t1",NA,0,0,NA,NA,15.3846153846154,0,NA,0,0,2.56410256410256,5.12820512820513,0,NA,NA,NA,NA,NA,NA,11.2253621648634,11.1929436527818,11.4187998527656,8.16562923854076,10.6766753588206,9.97365024959269,10.7071988397689,10.235757654864,11.1359043969493,10.3791173136602,10.5111038722607,10.9384998856526,10.0837078588689,1660.6911032735,-0.473631858400659,0.70295038013064,0.32233100611833,0.571838056236419,"P15690",0,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)","apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]","GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0008637; GO:0032981; GO:0045271; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593"
"1926","Pocillopora_acuta_HIv2___RNAseq.g18273.t1",2.32558139534884,1.29645635263613,2.05787781350482,1.97044334975369,5.53077609277431,3.99543378995434,8.62337662337662,11.2169312169312,4.12371134020619,0.882658359293873,4.202324633378,4.52059520989631,3.88405405685969,NA,NA,NA,NA,NA,NA,11.2274893150459,7.00867790939819,10.7879126431045,3.68233641306884,10.5670589702203,3.68233641306884,3.68233641306884,10.6956228322301,10.9975799741825,3.68233641306884,7.60136872964569,10.8551327469567,4.34760471233471,936.232722120782,-11.9192591881192,2.97944918262866,5.4312481887146e-11,3.50703454471285e-09,"Q8IS64",0,"Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-)","proteolysis [GO:0006508]","GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0008270"
"1927","Pocillopora_acuta_HIv2___RNAseq.g18287.t2",0,0,0,0,0,8,0,NA,0,0,0.888888888888889,2,0,NA,NA,NA,NA,NA,NA,7.9619637175816,7.83530183461159,8.1939484205115,9.16052156343084,9.53576900667435,9.87000900145959,10.8486845245564,8.43384636390068,6.72526102529218,3.68233641306884,8.22476418710876,8.17015770679206,8.27937066742545,509.020645141988,0.056125610975877,0.841712632982928,0.92733088286666,0.972937319728955,"Q8N2I9",3.92e-177,"Serine/threonine-protein kinase 40 (EC 2.7.11.1) (SINK-homologous serine/threonine-protein kinase) (Sugen kinase 495) (SgK495)","glycogen metabolic process [GO:0005977]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; regulation of gene expression [GO:0010468]; regulation of MAPK cascade [GO:0043408]; respiratory system process [GO:0003016]","GO:0003016; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0005977; GO:0010468; GO:0035264; GO:0043066; GO:0043408; GO:0048286; GO:0060425; GO:0106310"
"1928","Pocillopora_acuta_HIv2___TS.g20586.t1",NA,0,0,0,0,0.78125,0,0,0,0,0.0868055555555556,0.15625,0,NA,NA,NA,NA,NA,NA,9.1330489210328,8.84506269345107,8.34040438161525,6.94791225850548,6.01241040467731,5.89458481577045,3.68233641306884,9.07533658711014,4.57231842518309,4.80766789501754,6.7311082795432,7.42670374392372,6.03551281516268,197.405444640606,-0.353337451257251,0.913727925013191,0.401062578965792,0.647285108475922,"C0HK24",7.08e-06,"L-rhamnose-binding lectin ELEL-1","","GO:0030246"
"1929","Pocillopora_acuta_HIv2___TS.g20588.t1",0,0,28.5714285714286,NA,NA,0,0,0,NA,NA,4.76190476190476,0,9.52380952380952,NA,NA,NA,NA,NA,NA,8.45934460031867,13.7272365786651,8.09125087353016,11.0931520037171,8.3359398435869,11.7639112323536,10.2033383904447,11.2984801470108,3.68233641306884,11.2424507149295,9.78974407976254,7.97347037550307,11.606017784022,2606.30839091533,1.21825258975417,1.85534475927568,0.005187389651186,0.0239943728540947,NA,NA,NA,NA,NA
"1930","Pocillopora_acuta_HIv2___TS.g20625.t1",71.4285714285714,33.3333333333333,14.2857142857143,100,NA,50,85.7142857142857,NA,NA,NA,59.1269841269841,61.1111111111111,57.1428571428571,NA,NA,NA,NA,NA,NA,6.87035865762029,4.82737711805479,6.22468762788833,5.59933054873005,8.7480145898251,7.03963041141765,5.1359206776867,7.51049444605365,3.68233641306884,3.68233641306884,5.93204869034142,6.60717834689124,5.25691903379161,86.2308723635886,-1.48660438437145,1.21045654765557,0.0395938099918824,0.129848899111948,"P51635",1.95e-51,"Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (EC 1.1.1.372) (EC 1.1.1.54) (3-DG-reducing enzyme) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (EC 1.1.1.19) (Glucuronolactone reductase) (EC 1.1.1.20) (S-nitroso-CoA reductase) (ScorR) (EC 1.6.-.-)","aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; D-glucuronate catabolic process [GO:0042840]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; L-ascorbic acid biosynthetic process [GO:0019853]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]","GO:0004032; GO:0005829; GO:0006629; GO:0016324; GO:0019640; GO:0019853; GO:0042840; GO:0043066; GO:0044597; GO:0044598; GO:0045202; GO:0046185; GO:0047655; GO:0047939; GO:0047941; GO:0047956; GO:0080007; GO:0110095; GO:0160163; GO:1990002"
"1931","Pocillopora_acuta_HIv2___RNAseq.g18328.t2",0,NA,0,NA,0,5.55555555555556,0,0,0,NA,0.793650793650794,1.85185185185185,0,NA,NA,NA,NA,NA,NA,8.1263825815683,3.68233641306884,5.83271376384282,6.94791225850548,7.2010836147454,7.67461468239209,3.68233641306884,7.17988199284164,6.14454741514326,3.68233641306884,6.01541455482455,6.89692187362828,5.13390723602082,85.7566349418846,-0.362156074881249,1.06083642557933,0.00168404468290685,0.00917586394998457,NA,NA,NA,NA,NA
"1932","Pocillopora_acuta_HIv2___RNAseq.g18333.t1",25,25.531914893617,4.81927710843374,10.8108108108108,4.86486486486486,4.49438202247191,9.33333333333333,7.5,14.4736842105263,NA,11.869807471562,12.5621583874852,11.004368826658,NA,NA,NA,NA,NA,NA,8.49160305648387,9.67574952683565,9.53162411990669,9.32338665305123,9.3723688690179,8.73759746419133,10.3467359852038,9.87166628355461,10.1250272989223,10.5937362984599,9.60694955556273,9.47845792557707,9.73544118554838,829.49065524304,0.1927905231613,0.556884809627136,0.680171738724327,0.851596707856172,"O08807",9.62e-116,"Peroxiredoxin-4 (EC 1.11.1.24) (Antioxidant enzyme AOE372) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372) (Thioredoxin-dependent peroxiredoxin 4)","cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]","GO:0005615; GO:0005737; GO:0005739; GO:0005783; GO:0005790; GO:0005829; GO:0006979; GO:0007283; GO:0008379; GO:0008584; GO:0022417; GO:0030198; GO:0042744; GO:0042802; GO:0045454; GO:0072593; GO:0140313; GO:2000255"
"1933","Pocillopora_acuta_HIv2___TS.g20643.t2",0,NA,NA,0,0,5.88235294117647,0,0,3.33333333333333,NA,1.31652661064426,2.30392156862745,0,NA,NA,NA,NA,NA,NA,13.6304291499411,12.3040684807384,14.0555208137908,13.3918975468289,13.5324991037681,12.9218218357026,12.8145188782138,14.0200246332804,12.8696622178896,13.7127630843625,13.3253205744516,13.621627183734,13.0290139651692,10959.3834993855,-0.428579263188886,0.59151539490928,0.356560370860137,0.607091706531764,NA,NA,NA,NA,NA
"1934","Pocillopora_acuta_HIv2___RNAseq.g18396.t1",8.33333333333333,NA,NA,0,0,0,NA,NA,0,0,1.38888888888889,0,2.77777777777778,NA,NA,NA,NA,NA,NA,5.63634872160117,3.68233641306884,8.31363407389494,6.15405973004498,6.91639049961058,3.68233641306884,8.92306134574704,6.01099506072748,8.6380696427894,3.68233641306884,6.16395683136221,7.10308759972471,5.22482606299971,133.929890560647,-0.509977376839474,1.17170506803036,0.000934027791503145,0.00553679425258258,NA,NA,NA,NA,NA
"1935","Pocillopora_acuta_HIv2___RNAseq.g18400.t1",0,NA,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.234296385117,11.0516918334622,9.49639599719956,11.0047200732305,8.84208470956863,3.68233641306884,3.68233641306884,9.00186486460695,11.1885953891658,3.68233641306884,8.18666584915572,9.75264746913159,6.62068422917984,923.138940555112,-0.291237191761541,1.03696749023387,9.1233446052188e-06,0.000105399406046234,"Q9NU22",0,"Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein)","ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit export from nucleus [GO:0000055]","GO:0000027; GO:0000055; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887; GO:0030687; GO:0045111"
"1936","Pocillopora_acuta_HIv2___RNAseq.g18401.t1",0,NA,NA,0,100,7.14285714285714,40,NA,0,NA,24.5238095238095,2.38095238095238,46.6666666666667,NA,NA,NA,NA,NA,NA,8.40014726954871,3.68233641306884,7.74513402854738,10.6874600104457,8.48983620475166,3.68233641306884,3.68233641306884,7.6265862610439,3.68233641306884,11.2981102676246,6.89766196942373,7.1888080353921,6.60651590345536,512.532917863183,-0.0932049250850672,1.0185211477984,0.000524986665648622,0.0034097023493227,"A7S2N8",0,"E3 UFM1-protein ligase 1 homolog (EC 2.3.2.-) (E3 UFM1-protein transferase 1 homolog)","protein K69-linked ufmylation [GO:1990592]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; response to endoplasmic reticulum stress [GO:0034976]","GO:0005789; GO:0032434; GO:0034976; GO:0061666; GO:0071568; GO:1990592"
"1937","Pocillopora_acuta_HIv2___RNAseq.g18425.t1",0,0,0,0,2.91666666666667,0.795755968169761,1.70940170940171,0,0,0,0.542182434423814,0.159151193633952,0.925213675213675,NA,NA,NA,NA,NA,NA,9.07513824389395,11.3418597060151,9.70878717586238,11.6927307401584,9.06190786006613,11.8454019973247,11.6102026048393,9.3965157888877,9.4617986842675,11.7132519237298,10.4907594725045,9.34082955059553,11.6406893944135,1910.41124896392,2.14946155697096,0.567510331836371,2.30744563399628e-05,0.00023339086468617,"Q0EEE2",1.85e-99,"Patched domain-containing protein 3 (RND-type protein RNDEu-3)","","GO:0005783; GO:0005789; GO:0005886; GO:0016020; GO:0097225"
"1938","Pocillopora_acuta_HIv2___TS.g20752.t1",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.1777533229141,12.7627219468284,9.39003945098149,10.7996082106947,9.58884821107998,11.0743020006815,9.67222307503986,9.359568601715,8.02806168915246,8.66109410707429,10.0514220616162,9.50885425516861,10.5939898680637,1652.99239240897,0.889096960561755,0.581793245196639,0.0646109943949575,0.189598990247244,"Q13009",3.56e-166,"Rho guanine nucleotide exchange factor TIAM1 (T-lymphoma invasion and metastasis-inducing protein 1) (TIAM-1)","activation of GTPase activity [GO:0090630]; cardiac muscle hypertrophy [GO:0003300]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; ephrin receptor signaling pathway [GO:0048013]; neuron projection extension [GO:1990138]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein binding [GO:0032092]; positive regulation of Schwann cell chemotaxis [GO:1904268]; protein localization to membrane [GO:0072657]; protein-containing complex assembly [GO:0065003]; Rac protein signal transduction [GO:0016601]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to cocaine [GO:0042220]; small GTPase-mediated signal transduction [GO:0007264]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0003300; GO:0005085; GO:0005829; GO:0005874; GO:0005886; GO:0005911; GO:0007160; GO:0007264; GO:0008017; GO:0008284; GO:0008289; GO:0010717; GO:0010718; GO:0016477; GO:0016601; GO:0019900; GO:0030335; GO:0030971; GO:0032092; GO:0032587; GO:0042220; GO:0043025; GO:0043197; GO:0044291; GO:0044295; GO:0044304; GO:0045202; GO:0048013; GO:0050772; GO:0051056; GO:0060071; GO:0061003; GO:0061178; GO:0065003; GO:0070372; GO:0072657; GO:0090630; GO:0098978; GO:0099147; GO:1904268; GO:1904338; GO:1905274; GO:1990138; GO:2000050"
"1939","Pocillopora_acuta_HIv2___RNAseq.g18449.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.133065399255,9.76500857347088,9.51705019487359,3.68233641306884,10.0851432782511,10.0831423978554,9.57036699782278,9.92320856083833,9.17753267009788,7.78429754414113,9.07211520296749,9.96720002066318,8.17703038527181,832.145864594108,-0.517236068728767,0.956483682418326,0.231622748943731,0.466146019301813,"Q9V5N8",1.03e-26,"Protocadherin-like wing polarity protein stan (Protein flamingo) (Protein starry night)","axon guidance [GO:0007411]; axonogenesis [GO:0007409]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; morphogenesis of a polarized epithelium [GO:0001738]; mushroom body development [GO:0016319]; ommatidial rotation [GO:0016318]; positive regulation of axon extension [GO:0045773]; positive regulation of axon guidance [GO:1902669]; R3/R4 development [GO:0048057]; regulation of axonogenesis [GO:0050770]; regulation of synapse assembly [GO:0051963]; regulation of tube length, open tracheal system [GO:0035159]; segment polarity determination [GO:0007367]","GO:0001736; GO:0001737; GO:0001738; GO:0004888; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007166; GO:0007367; GO:0007409; GO:0007411; GO:0016020; GO:0016318; GO:0016319; GO:0016324; GO:0016339; GO:0016358; GO:0035159; GO:0042067; GO:0045773; GO:0048057; GO:0048813; GO:0050770; GO:0050839; GO:0051963; GO:0070593; GO:0098609; GO:1902669"
"1940","Pocillopora_acuta_HIv2___TS.g20762.t1",0,0,0,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,6.91377419539293,6.88270198298439,10.3892155315085,9.11675799391177,8.97340219038424,10.5693379670847,3.68233641306884,9.15759729182091,3.68233641306884,3.68233641306884,7.3049796392294,7.82326512443508,6.78669415402371,455.223018762462,-0.18808923931122,0.950227008115309,0.677257377511968,0.850334262876138,"E9PYK3",0,"Protein mono-ADP-ribosyltransferase PARP4 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (Poly [ADP-ribose] polymerase 4) (PARP-4) (Vault poly(ADP-ribose) polymerase) (VPARP) (mVparp)","inflammatory response [GO:0006954]; protein modification process [GO:0036211]","GO:0003950; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0005876; GO:0006954; GO:0016779; GO:0019899; GO:0036211; GO:1990404; GO:1990904"
"1941","Pocillopora_acuta_HIv2___RNAseq.g18499.t1",0,NA,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.19308453685806,7.56088992856599,5.56956094325591,4.62642457401022,8.83133125715271,7.79875575103921,3.68233641306884,8.19975452707599,9.13415057995656,11.5940969083294,7.61903854193129,8.18557636885985,7.05250071500273,525.415639715931,-0.486610454293948,0.996167859756784,0.1956016515286,0.416484953291575,"Q9UA35",2.4e-166,"Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (hfCNT)","purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]","GO:0005886; GO:0015389; GO:0015860; GO:0015864"
"1942","Pocillopora_acuta_HIv2___RNAseq.g18504.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0349467724641,10.9766605721249,8.13014807555559,9.90135249013246,10.0638787893195,9.91105846175298,11.8830595205932,9.79468426310321,10.6733870740416,4.69373610443143,9.6062912123519,9.7394089948968,9.47317342980699,1240.93567563339,0.145231232321856,0.852785760531399,0.738544852249469,0.88436541118816,"P14184",6.59e-10,"Lipopolysaccharide cholinephosphotransferase LicD (EC 2.7.8.-)","glycoprotein metabolic process [GO:0009100]; lipopolysaccharide biosynthetic process [GO:0009103]","GO:0009100; GO:0009103; GO:0016740"
"1943","Pocillopora_acuta_HIv2___RNAseq.g18521.t2",NA,NA,NA,0,0,5.26315789473684,0,0,NA,0,0.87719298245614,1.75438596491228,0,NA,NA,NA,NA,NA,NA,9.43141547668008,8.16544791369456,10.44261984671,7.595757733073,6.26454768630413,7.52502774190946,6.49753832785703,10.5034202974165,6.72526102529218,8.52599624145614,8.16770322903931,8.67345286648058,7.66195359159804,459.214562912,-0.359518573516234,0.890196836002817,0.337375107410112,0.588227327055481,"Q8K078",1.02e-99,"Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12)","monoatomic ion transport [GO:0006811]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone metabolic process [GO:0042403]","GO:0006811; GO:0008514; GO:0015132; GO:0015347; GO:0015349; GO:0016323; GO:0042403; GO:0043252"
"1944","Pocillopora_acuta_HIv2___RNAseq.g18548.t1",40,0,NA,0,0,8.06451612903226,0,4.34782608695652,0,50,11.3791491351099,2.48246844319776,22.5,1,44.0350877192982,44.0350877192982,0.0124852138344469,0.0124852138344469,0.0124852138344469,5.45976149983951,5.57859373890424,6.82609342317979,3.68233641306884,5.95850798619116,3.68233641306884,3.68233641306884,5.03658612426137,3.68233641306884,3.68233641306884,4.72712248377203,5.39265708930813,4.06158787823592,18.8209244859723,-0.272648863024113,1.05379374680024,0.0455675284263909,0.144950237774207,NA,NA,NA,NA,NA
"1945","Pocillopora_acuta_HIv2___RNAseq.g18550.t3",0.921658986175115,2.98507462686567,0,3.26797385620915,20.9876543209877,5.88235294117647,4.18848167539267,5.12820512820513,0,7.31707317073171,5.06784747057436,3.45272131049128,6.68297363065743,NA,NA,NA,NA,NA,NA,10.2032869499014,7.64039204480993,8.96738378287857,3.68233641306884,8.35359683810296,10.4223087212612,3.68233641306884,3.68233641306884,3.68233641306884,3.68233641306884,6.39986504022983,6.97778807940412,5.82194200105553,345.189926818627,-0.147886689452538,1.00262655586506,0.716919989428905,0.871987230130241,"Q9Z2A5",4.89e-134,"Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1)","proteasomal protein catabolic process [GO:0010498]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004057; GO:0005634; GO:0005737; GO:0006511; GO:0010498"
"1946","Pocillopora_acuta_HIv2___RNAseq.g18557.t1",0,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.52780354200312,9.43275629978818,9.31113427393304,7.53473134849954,9.93846429273508,9.54775214054269,6.49753832785703,9.05731685974099,7.75163327373382,11.0601866300936,8.96593169889271,9.11727044842921,8.81459294935621,670.169676594345,-0.239609082099979,0.796492309839306,0.567872689818829,0.778944666525444,"Q9HCF6",0,"Transient receptor potential cation channel subfamily M member 3 (Long transient receptor potential channel 3) (LTrpC-3) (LTrpC3) (Melastatin-2) (MLSN2)","calcium ion transmembrane transport [GO:0070588]; metal ion transport [GO:0030001]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic cation transport [GO:0006812]; protein tetramerization [GO:0051262]","GO:0005261; GO:0005262; GO:0005886; GO:0006812; GO:0030001; GO:0051262; GO:0070588; GO:0098655"
"1947","Pocillopora_acuta_HIv2___RNAseq.g18568.t1",0,NA,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.116414824804,9.66253495264651,10.4926286597177,10.2893786098516,10.7649649688476,10.028833673479,11.6479423246095,10.9368017188231,10.8805181005619,8.62548856369012,10.3445506397031,10.6382656545509,10.0508356248553,1459.16748889461,-0.37762735088783,0.63140961271703,0.417891372967694,0.66254311285813,"O08807",6.39e-135,"Peroxiredoxin-4 (EC 1.11.1.24) (Antioxidant enzyme AOE372) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372) (Thioredoxin-dependent peroxiredoxin 4)","cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283]","GO:0005615; GO:0005737; GO:0005739; GO:0005783; GO:0005790; GO:0005829; GO:0006979; GO:0007283; GO:0008379; GO:0008584; GO:0022417; GO:0030198; GO:0042744; GO:0042802; GO:0045454; GO:0072593; GO:0140313; GO:2000255"
"1948","Pocillopora_acuta_HIv2___TS.g20877.t2",19.5121951219512,23.0769230769231,0,8.88888888888889,24.6031746031746,10.7883817427386,19.375,17.7777777777778,15.7894736842105,0,13.9811814895665,15.2642890341078,12.6980739450252,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,3.68233641306884,7.32395877248941,5.26345523824995,7.84335531322265,7.59849923149008,7.22195991090184,3.68233641306884,8.20248052335186,5.81830546419812,4.70648487767166,6.93012605072457,92.0464007045203,0.495328931908463,1.14295242750064,0.0318206802420718,0.108627405952638,"Q5R5M0",2e-42,"Mitochondrial carrier homolog 2","lipid homeostasis [GO:0055088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of stem cell differentiation [GO:2000738]; protein insertion into mitochondrial outer membrane [GO:0045040]; regulation of mitochondrial fusion [GO:0010635]","GO:0005741; GO:0010635; GO:0032977; GO:0043065; GO:0045040; GO:0055088; GO:2000738"
"1949","Pocillopora_acuta_HIv2___RNAseq.g18572.t1",22.5,0,0,12.5,8.66666666666667,8.72093023255814,8.25688073394495,44.4444444444444,0,0,10.5088922077614,13.1330749354005,7.88470948012232,NA,NA,NA,NA,NA,NA,8.55741842239411,7.86204832692584,6.03454572419577,8.05848887682085,8.191910306003,10.2063404108222,3.68233641306884,8.902587299027,10.145726860829,6.51149074430832,7.81528933843949,8.36643772248978,7.26414095438921,389.424480585589,-0.17607304814892,0.945889688293966,0.472834194560455,0.710014077672907,"Q13315",0,"Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated) (A-T mutated)","brain development [GO:0007420]; cellular response to gamma radiation [GO:0071480]; cellular response to nitrosative stress [GO:0071500]; cellular response to reactive oxygen species [GO:0034614]; cellular response to retinoic acid [GO:0071300]; cellular response to X-ray [GO:0071481]; cellular senescence [GO:0090398]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; histone mRNA catabolic process [GO:0071044]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lipoprotein catabolic process [GO:0042159]; male meiotic nuclear division [GO:0007140]; meiotic telomere clustering [GO:0045141]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic spindle assembly checkpoint signaling [GO:0007094]; multicellular organism growth [GO:0035264]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of telomere capping [GO:1904354]; negative regulation of TORC1 signaling [GO:1904262]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; pexophagy [GO:0000425]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA catabolic process [GO:1903626]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; reciprocal meiotic recombination [GO:0007131]; regulation of apoptotic process [GO:0042981]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of cell cycle [GO:0051726]; regulation of cellular response to heat [GO:1900034]; regulation of microglial cell activation [GO:1903978]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere maintenance via telomerase [GO:0032210]; replicative senescence [GO:0090399]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; somitogenesis [GO:0001756]; telomere maintenance [GO:0000723]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]","GO:0000077; GO:0000425; GO:0000723; GO:0000724; GO:0000729; GO:0001541; GO:0001666; GO:0001756; GO:0002331; GO:0003677; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005782; GO:0005813; GO:0005819; GO:0005829; GO:0006302; GO:0006303; GO:0006468; GO:0006974; GO:0006977; GO:0007094; GO:0007095; GO:0007131; GO:0007140; GO:0007143; GO:0007165; GO:0007420; GO:0007507; GO:0008340; GO:0008630; GO:0009791; GO:0010212; GO:0010506; GO:0010628; GO:0016303; GO:0018105; GO:0030335; GO:0030889; GO:0031410; GO:0032210; GO:0032212; GO:0033151; GO:0034614; GO:0035264; GO:0035861; GO:0035979; GO:0036289; GO:0042159; GO:0042770; GO:0042802; GO:0042981; GO:0043065; GO:0043231; GO:0043517; GO:0043525; GO:0044877; GO:0045141; GO:0045785; GO:0045944; GO:0046777; GO:0048538; GO:0048599; GO:0051402; GO:0051726; GO:0071044; GO:0071300; GO:0071480; GO:0071481; GO:0071500; GO:0090398; GO:0090399; GO:0097694; GO:0097695; GO:0106310; GO:1900034; GO:1901796; GO:1903626; GO:1903978; GO:1904262; GO:1904354; GO:1904358; GO:1904884; GO:1990391; GO:2000785"
"1950","Pocillopora_acuta_HIv2___TS.g20880.t1",0,0,0,NA,NA,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,7.53545846369506,3.68233641306884,5.20227553025741,3.68233641306884,7.62893522143865,3.68233641306884,3.68233641306884,7.46128132600845,8.21140278976863,3.68233641306884,5.44510353965124,7.20787066623364,3.68233641306884,77.2218040403559,-10.7330721197711,3.64042070084216,4.13977587846933e-07,7.41979161167043e-06,"Q8R1U2",2.51e-08,"Cell growth regulator with EF hand domain protein 1 (Cell growth regulatory gene 11 protein) (Hydrophobestin)","cell adhesion [GO:0007155]; negative regulation of cell growth [GO:0030308]; regulation of cell cycle [GO:0051726]","GO:0005509; GO:0005576; GO:0007155; GO:0030308; GO:0051726"
"1951","Pocillopora_acuta_HIv2___RNAseq.g18575.t2",0,83.3333333333333,NA,57.1428571428571,0,25,50,NA,NA,NA,35.9126984126984,55.1587301587302,16.6666666666667,NA,NA,NA,NA,NA,NA,8.89404089377115,9.18327813028454,10.0487974534996,9.20299531426771,10.1636329401126,8.60496209062734,10.2647222661036,10.306085786976,10.4678603795067,9.62774969672687,9.67641249518761,9.97608349077321,9.37674149960201,869.112193391169,-0.442529792134344,0.580260649661164,0.339576895233178,0.590625326196812,"Q9D554",3.44e-152,"Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61)","mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]","GO:0000398; GO:0003723; GO:0005681; GO:0005686; GO:0008270; GO:0016607; GO:0071005; GO:0071013; GO:1903241"
"1952","Pocillopora_acuta_HIv2___RNAseq.g18601.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.89939125569339,6.38096952478058,9.64989267794005,3.68233641306884,9.59415619334413,11.034114526078,11.2638483649208,10.5684484820708,3.68233641306884,10.8282382818966,8.5583732132862,8.47884500442344,8.63790142214896,982.743530332336,0.00912503985247347,0.962253088454972,0.968862333246999,0.989313433680522,"Q29486",3e-140,"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1)","bone mineralization [GO:0030282]; dephosphorylation [GO:0016311]; positive regulation of cold-induced thermogenesis [GO:0120162]","GO:0004035; GO:0004427; GO:0005509; GO:0005758; GO:0005886; GO:0016311; GO:0016462; GO:0016887; GO:0030282; GO:0031966; GO:0033883; GO:0043262; GO:0050187; GO:0052732; GO:0098552; GO:0120162"
"1953","Pocillopora_acuta_HIv2___TS.g20912.t1b",0,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0932707290483,9.99174027462837,11.0945521629659,10.3282568599752,10.660071560528,10.5988113278154,8.59695095174466,10.2003839519985,9.63103049773579,3.68233641306884,9.48774047295089,10.3358617804553,8.63961916544649,1087.89096033382,-0.46689574345374,0.931624281834087,0.279742164941518,0.525342855584799,"Q6PAM1",8.78e-83,"Alpha-taxilin","B cell activation [GO:0042113]; exocytosis [GO:0006887]","GO:0005737; GO:0006887; GO:0019905; GO:0042113"
"1954","Pocillopora_acuta_HIv2___RNAseq.g18629.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.83894995413197,8.13838161065143,3.68233641306884,7.07647355201382,7.64545528991859,3.68233641306884,3.68233641306884,7.06558112980681,8.1664460067515,9.32911896855345,6.43074157510341,6.47975375873554,6.38172939147128,156.649651479053,0.0270764577607882,0.991074453552289,0.872399057356584,0.949787452964802,NA,NA,NA,NA,NA
"1955","Pocillopora_acuta_HIv2___TS.g20943.t3",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.93088772907051,9.68324669387319,7.87001867442991,10.3523485534912,9.05576317721685,9.00814232133484,8.08459101729263,6.54323773344988,3.68233641306884,3.68233641306884,7.58929087262967,7.0164487454472,8.16213299981214,381.849117009078,0.935285927274119,0.91090271856894,0.102390816350883,0.266028519435812,"Q5XIN9",1.24e-75,"Coiled-coil domain-containing protein 81","","GO:0003677; GO:0005737; GO:0005813"
"1956","Pocillopora_acuta_HIv2___RNAseq.g18637.t1",0,0,0,NA,0,6.45161290322581,0,NA,0,NA,0.921658986175115,2.1505376344086,0,NA,NA,NA,NA,NA,NA,7.27912941077028,4.59616451822093,7.39425081166534,7.01365304638253,8.3561016627567,7.02021039294225,8.56819978450712,6.47440906252077,3.68233641306884,7.33112792163665,6.77155830244714,6.63724547215639,6.9058711327379,134.806695626506,0.0372639613084509,0.919636354280019,0.919380609644907,0.969611032821436,"Q90W04",2.62e-16,"Neuroglobin (Nitrite reductase) (EC 1.7.-.-)","cellular response to hypoxia [GO:0071456]","GO:0005092; GO:0005759; GO:0005829; GO:0019825; GO:0020037; GO:0046872; GO:0071456; GO:0098809"
"1957","Pocillopora_acuta_HIv2___TS.g20947.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.99744577812822,7.27190420218942,8.80643648684297,9.95533928922177,8.6473675796025,3.68233641306884,7.69311517621351,8.59251268064315,6.07918960036691,3.68233641306884,7.34079836193461,8.22459042511675,6.45700629875248,296.827891888243,-0.546030413808335,1.08866245583213,0.062544759977305,0.185416562474224,"Q9DCC4",8.21e-73,"Pyrroline-5-carboxylate reductase 3 (P5C reductase 3) (P5CR 3) (EC 1.5.1.2) (Pyrroline-5-carboxylate reductase-like protein)","cytidine deamination [GO:0009972]; L-proline biosynthetic process [GO:0055129]","GO:0004126; GO:0004735; GO:0005829; GO:0009972; GO:0045171; GO:0055129; GO:0072686"
"1958","Pocillopora_acuta_HIv2___RNAseq.g18643.t1",NA,NA,55.5555555555556,50,41.6666666666667,40.9090909090909,53.3333333333333,NA,53.3333333333333,NA,49.1329966329966,48.0808080808081,50.1851851851852,NA,NA,NA,NA,NA,NA,7.82778893403375,10.5109024146563,10.5694851811016,7.50775778510704,9.55222625029589,10.062134024013,3.68233641306884,10.3012241900631,3.68233641306884,11.4473288047184,8.51435204101268,8.38661219371264,8.64209188831272,905.902168402813,0.0199215223987062,0.976104491255972,0.92073197808174,0.970228529825123,"P59808",1.09e-23,"SAM and SH3 domain-containing protein 1","positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; protein polyubiquitination [GO:0000209]; regulation of protein autoubiquitination [GO:1902498]; regulation of protein K63-linked ubiquitination [GO:1900044]","GO:0000209; GO:0005737; GO:0010595; GO:0016020; GO:0019901; GO:0031435; GO:0031666; GO:0032991; GO:0045766; GO:0060090; GO:1900044; GO:1900745; GO:1901224; GO:1902498"
"1959","Pocillopora_acuta_HIv2___RNAseq.g18645.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.49100155379421,3.68233641306884,9.2717381762647,3.68233641306884,8.73845249809789,7.35019707545882,3.68233641306884,7.54396176493916,3.68233641306884,3.68233641306884,5.6807033133899,6.94549808123296,4.41590854554684,131.781571492324,-0.472169766824873,1.15987506975205,0.00465346516342552,0.0218744621786762,"E7F5E1",1.73e-123,"Centrosomal protein of 162 kDa (Cep162)","cilium assembly [GO:0060271]; heart looping [GO:0001947]","GO:0001947; GO:0005813; GO:0005814; GO:0005879; GO:0060271"
"1960","Pocillopora_acuta_HIv2___RNAseq.g18657.t1",0,NA,0,NA,0,0,NA,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.93499074257248,10.6683812881874,9.28039460830977,8.22187128010793,7.89711087890415,9.05617629930348,7.85865324267667,7.71731208381075,9.89983978596418,3.68233641306884,8.12170666229057,8.34592961991227,7.89748370466886,461.262147981822,0.00232010584322323,0.903580587379176,0.987696403557639,0.995622428922686,"P22311",2.46e-07,"Puff II/9-1 protein","",""
"1961","Pocillopora_acuta_HIv2___TS.g17854.t1",0,1.19047619047619,NA,0,1.68539325842697,0,0,NA,0,NA,0.410838492700451,0.297619047619048,0.561797752808989,NA,NA,NA,NA,NA,NA,12.4066660759176,8.48615680610434,11.0901294618992,3.68233641306884,12.1278984241118,3.68233641306884,3.68233641306884,7.81832118912028,12.7558431296685,10.4738410672634,8.62058653932916,11.2397716561435,6.00140142251485,2083.02089718451,-1.45836171212632,3.4326981538466,4.73993275261231e-07,8.29001056031251e-06,NA,NA,NA,NA,NA
"1962","Pocillopora_acuta_HIv2___RNAseq.g26846.t1c",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.3155372981104,11.7415718419864,10.226789350849,11.185677794254,11.3558812993437,9.89266454295479,11.1171957595139,10.7347809315094,10.6972446032706,7.53764925099809,10.480499267279,10.6660466966166,10.2949518379414,1731.42840634531,-0.130268920414951,0.738136180224885,0.754294924378224,0.89215158935372,"Q98925",3.62e-40,"Interferon regulatory factor 2 (IRF-2)","immune system process [GO:0002376]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0002376; GO:0005634; GO:0006357"
"1963","Pocillopora_acuta_HIv2___TS.g17908.t1",0,0,0,0,7.14285714285714,1.88679245283019,5.88235294117647,0,0,NA,1.65688917076264,0.377358490566038,3.2563025210084,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,8.42098766983566,3.68233641306884,7.92440786583197,10.6316607240922,3.68233641306884,9.5751791564872,3.68233641306884,7.40334154893872,6.23672590305299,6.6570495036585,5.81640230244749,297.837977650013,-0.0328801434711863,1.01087578660508,0.161748432244486,0.366467625937383,"Q0VG85",1.18e-146,"Coiled-coil domain-containing protein 162","",""
"1964","Pocillopora_acuta_HIv2___TS.g17915.t1",0,NA,12.7659574468085,16.6666666666667,25,11.4285714285714,0,0,0,0,7.31791061578296,7.02380952380952,7.5531914893617,NA,NA,NA,NA,NA,NA,5.90744172849562,7.5932230481983,4.85281479041193,10.3346358947883,7.07203319964235,4.94358885541907,7.04835315333773,6.5996347665023,9.35472129914556,3.68233641306884,6.738878314901,6.75732915683955,6.72042747296245,241.085591411167,0.00688480026908374,0.953218720443889,0.99685756473307,0.998998670844531,NA,NA,NA,NA,NA
"1965","Pocillopora_acuta_HIv2___RNAseq.g26860.t1",0,0,2.66666666666667,0,1.0958904109589,1.09529025191676,0,0,2.42424242424242,NA,0.809121083753861,0.703906535231836,0.940639269406393,NA,NA,NA,NA,NA,NA,9.39401484257848,3.68233641306884,10.5081837169286,6.05508630481337,9.9860753119605,7.83233483651014,7.52318888932451,9.45021961732666,10.5033782395171,7.93763424012006,8.28724524121483,9.96837434566227,6.60611613676738,579.249932008465,-2.41427572152666,1.71463310462274,0.00215500311845284,0.0113593167293374,NA,NA,NA,NA,NA
"1966","Pocillopora_acuta_HIv2___RNAseq.g26862.t1",0,0,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.177758267203,7.63263776583099,9.44496839822344,3.68233641306884,8.38091287670807,3.68233641306884,6.74136374297954,9.59914854345106,9.71481153406314,3.68233641306884,7.17386103676658,9.26351992392974,5.08420214960341,335.489418510941,-1.3747499963128,2.67798118432658,1.12704535696264e-06,1.74162222682774e-05,NA,NA,NA,NA,NA
"1967","Pocillopora_acuta_HIv2___RNAseq.g26880.t1",0,0,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.55516792120583,11.7093544826796,10.0808561756384,10.5117106955051,10.383088105134,10.0324385674958,10.9767440736671,10.731687104698,11.9135806825133,10.1583450521984,10.6052972860736,10.5328759978379,10.6777185743092,1748.73769681016,0.0870907806754447,0.660219959803331,0.860094378019167,0.94521887111443,"Q9HBI1",8.35e-120,"Beta-parvin (Affixin)","actin cytoskeleton organization [GO:0030036]; cell projection assembly [GO:0030031]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; lamellipodium assembly [GO:0030032]; substrate adhesion-dependent cell spreading [GO:0034446]","GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007163; GO:0015629; GO:0030018; GO:0030027; GO:0030031; GO:0030032; GO:0030036; GO:0034446; GO:0071963"
"1968","Pocillopora_acuta_HIv2___RNAseq.g26885.t1",2.5,NA,0,0,0,0,0,NA,0,NA,0.357142857142857,0,0.625,NA,NA,NA,NA,NA,NA,5.29008743000815,4.8931170245923,5.38589367603326,5.67021878014534,5.21442834742072,5.44887968569328,5.52620649542623,5.28924211491062,5.93804482828044,5.75038415558079,5.44065025380911,5.42353927933064,5.45776122828759,22.4646212894707,0.0358974078488529,0.654895969990688,0.945901252273077,0.979675840287514,"Q5R6B1",1.02e-21,"Leucine-rich repeat transmembrane neuronal protein 1","","GO:0005615; GO:0031012; GO:0045211"
"1969","Pocillopora_acuta_HIv2___RNAseq.g26889.t1",0,0,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.24862510846095,3.68233641306884,7.48737098476787,9.45572338525138,5.88788892518078,9.93179677040757,3.68233641306884,8.13553162203908,7.175369052787,3.68233641306884,6.83693150881011,7.58695713864714,6.08690587897309,277.799212502699,-0.184984933154538,1.02572351516609,0.000487206504117222,0.00320170598616606,"F8J3H2",1.58e-31,"Holothin acyltransferase (EC 2.3.1.-)","response to antibiotic [GO:0046677]","GO:0016747; GO:0046677"
"1970","Pocillopora_acuta_HIv2___TS.g17954.t1a",NA,0,0,25,0,0,0,NA,NA,NA,4.16666666666667,8.33333333333333,0,NA,NA,NA,NA,NA,NA,9.87586704499619,12.8632733784537,12.0368994511647,11.5775201932448,11.4604062586264,13.2518751399257,11.449083629436,11.5375029649654,12.1263845881596,12.5183116015103,11.8697124250483,11.4074120615825,12.3320127885141,4407.15934179772,0.546586011746569,0.717856597762731,0.266273365820748,0.510048730397471,"Q3TZZ7",7.74e-116,"Extended synaptotagmin-2 (E-Syt2)","endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]","GO:0005509; GO:0005544; GO:0005789; GO:0005829; GO:0006869; GO:0006897; GO:0008429; GO:0009898; GO:0031210; GO:0035091; GO:0044232; GO:0061817; GO:0140268"
"1971","Pocillopora_acuta_HIv2___TS.g18002.t1",0,NA,22.2222222222222,0,66.6666666666667,2.85714285714286,0,33.3333333333333,NA,NA,17.8684807256236,12.0634920634921,22.2222222222222,NA,NA,NA,NA,NA,NA,8.51620237562004,3.68233641306884,6.82609342317979,8.57685856079561,5.6496780876982,3.68233641306884,4.10128477526701,6.0800375531696,3.68233641306884,3.68233641306884,5.44795004280056,6.15086957054729,4.74503051505383,86.0058611266653,-0.351336617624098,1.08669518945106,0.0229133438517332,0.0828339428821469,"A0A2J6RX17",3.83e-06,"Nucleotide-binding leucine-rich repeat (NLR)-like protein (EC 3.5.99.-)","nucleoside metabolic process [GO:0009116]","GO:0009116; GO:0016787; GO:0043531"
"1972","Pocillopora_acuta_HIv2___RNAseq.g26950.t1",0.581395348837209,0.533333333333333,0.235849056603774,0,0.88809946714032,0.569395017793594,0.91264667535854,2.67857142857143,0,2.4390243902439,0.88383147178821,0.756259955939671,1.01140298763675,NA,NA,NA,NA,NA,NA,6.20520613944672,5.85749282533549,6.62011409682418,5.40210328953245,5.98573247127087,6.20886511492185,4.96878174907288,5.77922341645693,5.13335110137444,3.68233641306884,5.58432066173047,5.94472544507463,5.2239158783863,32.8444748252273,-0.680780189043469,0.920540372118935,0.18111092736322,0.395887630857128,NA,NA,NA,NA,NA
"1973","Pocillopora_acuta_HIv2___RNAseq.g26956.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.92650798752011,9.02407102554429,9.02209713307019,8.13666062791065,10.2058459025819,10.1773276339239,10.6348495492947,7.66617496800159,10.5555506809777,3.68233641306884,8.90314219218939,9.4752353344303,8.33104904994848,770.384105675411,-0.16540346224493,0.902524747001445,0.602810210426398,0.802633425315071,"Q3U0J8",3.39e-177,"TBC1 domain family member 2B","endocytosis [GO:0006897]","GO:0005096; GO:0005769; GO:0005829; GO:0006897"
"1974","Pocillopora_acuta_HIv2___RNAseq.g26961.t1",0,0,0,NA,NA,0.87719298245614,0,0,NA,NA,0.146198830409357,0.292397660818713,0,NA,NA,NA,NA,NA,NA,13.1322275375791,12.8220660480038,12.3308590268396,12.1562921092082,12.4243525845315,11.9724865805705,11.0475643075791,12.6503318325158,13.3860563436162,13.0454846179257,12.4967720988369,12.7847654650164,12.2087787326575,6290.03875137987,-0.426188457868342,0.541218463543511,0.342957880425333,0.593934720123565,NA,NA,NA,NA,NA
"1975","Pocillopora_acuta_HIv2___TS.g18041.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.55347277866168,7.52780847854544,9.47694849689073,6.29014341372585,9.55440642495853,8.49766570970123,3.68233641306884,8.43892056480132,3.68233641306884,9.16530892946231,7.58693476228848,8.14121693567622,7.03265258890073,356.084733664382,-0.302704295701358,1.02057081447616,0.212583181616933,0.440768798581897,"Q92095",3.35e-91,"Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1)","hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]","GO:0004508; GO:0005506; GO:0005789; GO:0020037; GO:0042446; GO:0042448; GO:0070330"
"1976","Pocillopora_acuta_HIv2___RNAseq.g26985.t1",NA,0,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.43719768727532,6.64213136387843,11.0893849841582,7.65364434417167,11.1291964724294,3.68233641306884,9.06717372470269,3.68233641306884,5.00142931435546,7.10671671301777,6.14552445177809,8.06790897425744,581.025468775651,0.415153890085482,1.1259994901786,0.0153801943549547,0.0596885245908409,"Q9Z139",6.63e-73,"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (mROR1) (Neurotrophic tyrosine kinase, receptor-related 1)","astrocyte development [GO:0014002]; inner ear development [GO:0048839]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; sensory perception of sound [GO:0007605]","GO:0001725; GO:0004714; GO:0005524; GO:0005886; GO:0007605; GO:0009986; GO:0010976; GO:0014002; GO:0017147; GO:0042813; GO:0043123; GO:0043235; GO:0043679; GO:0048839; GO:0051092; GO:0051897"
"1977","Pocillopora_acuta_HIv2___RNAseq.g26986.t1",0,0,0,33.3333333333333,0,0,0,NA,0,NA,4.16666666666667,8.33333333333333,0,NA,NA,NA,NA,NA,NA,7.43542392964019,9.16464773428985,7.65716743907436,9.52877131159572,8.62054625928763,8.08987490428564,7.09554146303979,9.78077953154168,7.50853330341144,9.96316056953122,8.48444464456975,8.20049009259106,8.76839919654844,429.924627989508,0.350075418761231,0.821028243635913,0.413757541577429,0.658950570510453,"O15146",1.72e-87,"Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor)","cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; memory [GO:0007613]; neuromuscular junction development [GO:0007528]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]","GO:0001934; GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0007528; GO:0007613; GO:0008582; GO:0010628; GO:0010976; GO:0017147; GO:0030154; GO:0031594; GO:0043235; GO:0045211; GO:0046777; GO:0046872; GO:0051897; GO:0071340; GO:2000541"
"1978","Pocillopora_acuta_HIv2___TS.g18047.t1",0,NA,NA,0,2.7027027027027,4.34782608695652,2,0,NA,NA,1.5084214649432,1.44927536231884,1.56756756756757,NA,NA,NA,NA,NA,NA,7.56279864080063,3.68233641306884,6.87318851603749,8.67271162187297,8.30515701379396,8.42630172396256,7.65444924775928,9.41464025531832,3.68233641306884,9.34379118728125,7.36177110329641,7.16762416780385,7.55591803878898,270.800724746439,0.0151078436419859,0.95308288067487,0.957796745974432,0.984407882738164,"Q62838",1.3e-87,"Muscle, skeletal receptor tyrosine protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine protein kinase receptor) (MuSK) (Muscle-specific kinase receptor)","cell differentiation [GO:0030154]; cochlea development [GO:0090102]; enzyme-linked receptor protein signaling pathway [GO:0007167]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; motor neuron apoptotic process [GO:0097049]; negative regulation of gene expression [GO:0010629]; neuromuscular junction development [GO:0007528]; positive regulation of gene expression [GO:0010628]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; receptor clustering [GO:0043113]; regulation of DNA-templated transcription [GO:0006355]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to muscle activity [GO:0014850]; retina development in camera-type eye [GO:0060041]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]","GO:0001934; GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0006355; GO:0007167; GO:0007528; GO:0007613; GO:0008582; GO:0009897; GO:0010628; GO:0010629; GO:0010976; GO:0014850; GO:0016020; GO:0017147; GO:0019901; GO:0030154; GO:0030165; GO:0031594; GO:0032224; GO:0035022; GO:0042995; GO:0043113; GO:0043235; GO:0045202; GO:0045211; GO:0045887; GO:0046872; GO:0048678; GO:0050731; GO:0051602; GO:0051897; GO:0060041; GO:0060291; GO:0071340; GO:0090102; GO:0097049; GO:1904395; GO:2000541; GO:2000673"
"1979","Pocillopora_acuta_HIv2___RNAseq.g27015.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.78633959701262,4.50233927872981,11.1853496675002,10.441340118995,9.55331674969778,9.96109514965795,9.26751085422486,10.2552806280766,5.91298961818613,9.65447386203721,9.05200355241182,9.33865525209467,8.76535185272897,883.232174385537,-0.136730414500267,0.873826309102118,0.69222504372401,0.85904909672647,"Q704V6",9.55e-16,"Toll-like receptor 6 (CD antigen CD286)","cellular response to diacyl bacterial lipopeptide [GO:0071726]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; toll-like receptor signaling pathway [GO:0002224]","GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0032731; GO:0035355; GO:0035663; GO:0038023; GO:0042802; GO:0045087; GO:0045121; GO:0061809; GO:0071723; GO:0071726; GO:1900227"
"1980","Pocillopora_acuta_HIv2___RNAseq.g27027.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.10798813166413,3.68233641306884,8.9414132214938,3.68233641306884,3.68233641306884,10.3432470864987,6.54983813759369,7.52013679887341,10.3299681972773,3.68233641306884,6.65219372256764,7.7163685524755,5.58801889265978,348.0774974041,-0.217562510437001,1.03795179948719,0.000158329213435437,0.00122072161147663,"Q63ZU0",2.53e-109,"Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)","adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]","GO:0004000; GO:0005764; GO:0005886; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0046103; GO:0046936; GO:0060205; GO:0070161"
"1981","Pocillopora_acuta_HIv2___TS.g18097.t2",0,0,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.78263567065374,8.83162439855743,10.9144907287105,7.45223252512044,9.64311871243438,3.68233641306884,7.19630206472076,10.4302412615725,9.22695290674866,9.37269508685841,8.55326297684457,9.79948785602396,7.30703809766518,636.21006172158,-0.749007715524369,1.18188193036813,0.0466906624005653,0.147743106751646,"Q6DFX2",1.9e-69,"Anthrax toxin receptor 2","collagen fibril organization [GO:0030199]; single fertilization [GO:0007338]; uterus development [GO:0060065]","GO:0004888; GO:0005886; GO:0007338; GO:0009897; GO:0009986; GO:0016020; GO:0030199; GO:0046872; GO:0060065"
"1982","Pocillopora_acuta_HIv2___RNAseq.g27044.t1",2.88461538461538,5.06329113924051,1.5748031496063,1.62162162162162,3.74531835205992,2.39808153477218,1.86915887850467,7.19424460431655,3.81679389312977,1.72413793103448,3.18920664889014,4.01880655861613,2.35960673916415,NA,NA,NA,NA,NA,NA,11.7522387028653,11.8669897640001,11.2918915680383,11.7975713007622,11.6389243669392,11.4349513416722,3.68233641306884,9.63271376622945,12.2893001015037,9.1570241431435,10.4543941468223,11.3210137011152,9.58777459252937,2534.96270831999,-0.387362481083675,0.943329590030466,0.284605627377252,0.530686579139432,"Q2EMV9",1.06e-54,"Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14)","innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]","GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016779; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:1902216; GO:1990404"
"1983","Pocillopora_acuta_HIv2___RNAseq.g27045.t1a",0,NA,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.52117743052283,6.75739185036896,3.68233641306884,6.89567146066421,3.68233641306884,3.68233641306884,4.86526991710116,9.01539947721401,3.68233641306884,5.54665922012154,6.24321382368344,4.85010461655964,138.940980986185,-0.2558883197139,1.06674202640116,7.2775342174203e-05,0.000633728205423041,"Q460N5",7.22e-87,"Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)","innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212]","GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:1902216; GO:1990404"
"1984","Pocillopora_acuta_HIv2___RNAseq.g27048.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.6650305762357,8.51167294945903,9.78009167390166,10.528501517952,8.52364332124565,9.61502038656193,7.78901700759002,9.91504821357591,11.1910867468092,10.92772871689,9.54468411102211,9.61498010635362,9.4743881156906,949.807917020245,-0.0628549699859947,0.644236059051795,0.886790990013164,0.956520022271903,"Q6PAV2",0,"Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4)","cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001650; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630"
"1985","Pocillopora_acuta_HIv2___RNAseq.g27050.t1",NA,0,NA,0,0,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,8.25503642196764,3.68233641306884,7.04098991334845,7.10557681894167,7.32041525669233,6.94123935458015,3.68233641306884,3.68233641306884,5.50749398308744,5.92038770320678,5.0946002629681,73.4613612376441,-0.0808815124593226,0.972984955620456,0.833326969410793,0.932873300782672,"C0LGV1",1.23e-06,"LRR receptor-like serine/threonine-protein kinase RGI2 (EC 2.7.11.1) (Protein RECEPTOR OF RGF1 3) (Protein RGF1 INSENSITIVE 2) (Protein ROOT CLAVATA-HOMOLOG1 1)","maintenance of meristem identity [GO:0010074]; maintenance of root meristem identity [GO:0010078]; regulation of root development [GO:2000280]; regulation of root meristem growth [GO:0010082]; root meristem growth [GO:0010449]","GO:0001653; GO:0004674; GO:0005524; GO:0010074; GO:0010078; GO:0010082; GO:0010449; GO:0016020; GO:0042277; GO:0106310; GO:2000280"
"1986","Pocillopora_acuta_HIv2___RNAseq.g27063.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.98240028630582,10.3088808158993,9.74425461490202,10.9608606781467,10.6309342831123,8.74933646359489,7.55715091401747,9.56594211796048,6.34211912572884,10.3485343922418,9.31904136919096,9.05313008560189,9.58495265278003,872.01219245086,0.188732004956186,0.8285907816939,0.634922303206719,0.823862243755368,"Q8NBS9",8.33e-97,"Thioredoxin domain-containing protein 5 (EC 1.8.4.-) (EC 5.3.4.1) (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Thioredoxin-like protein p46)","negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457]","GO:0003756; GO:0005576; GO:0005783; GO:0005788; GO:0006457; GO:0015035; GO:0035578; GO:0043066; GO:0043202; GO:0070062"
"1987","Pocillopora_acuta_HIv2___TS.g1447.t2",0,NA,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0054958071947,8.59360048686995,9.82337472948014,5.63527227912703,10.1252885991919,8.52524896388594,6.54983813759369,7.59957177400187,9.61069866280851,10.9590267999277,8.74274162400814,9.43288591453542,8.05259733348086,666.620298359253,-0.785406567121709,0.92188193632029,0.11294430378665,0.28537534372514,"Q6PF21",0,"Methionine--tRNA ligase, cytoplasmic (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)","methionyl-tRNA aminoacylation [GO:0006431]","GO:0000049; GO:0004825; GO:0005524; GO:0005730; GO:0005829; GO:0006431; GO:0017101"
"1988","Pocillopora_acuta_HIv2___RNAseq.g86.t1",NA,NA,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,8.22839989032863,9.00548245314794,3.68233641306884,4.28462663579717,8.42630172396256,3.68233641306884,8.03179044943754,7.82428504101232,3.68233641306884,6.05302318459615,6.56570419849276,5.54034217069954,152.281642068522,-0.0829310042457202,1.02250213964063,0.000954449711253243,0.00563016338644654,"O75899",8.41e-154,"Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]","GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712"
"1989","Pocillopora_acuta_HIv2___TS.g1462.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,10.705664243014,3.68233641306884,10.901945960376,6.43917658127574,11.4189762009414,11.3085636350849,9.38605571860119,6.41379501761528,7.79504629209236,8.17338964751385,5.92074002872598,10.4260392663017,972.093848949411,1.1141471088388,1.83547536309369,0.000545099010656696,0.00351664232387977,"P98133",0,"Fibrillin-1 (MP340) [Cleaved into: Asprosin]","anatomical structure morphogenesis [GO:0009653]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0008201; GO:0009653; GO:0031012"
"1990","Pocillopora_acuta_HIv2___RNAseq.g110.t1",7.14285714285714,NA,1.81818181818182,0,0,0.917431192660551,0,0,0,NA,1.23480876921244,0.229357798165138,2.24025974025974,NA,NA,NA,NA,NA,NA,11.1859803557763,8.74466923423128,8.91940764679443,3.68233641306884,9.60471389524798,6.17337120454021,3.68233641306884,9.41464025531832,9.95659177437717,10.9252928095773,8.22893400020007,9.81626678550284,6.64160121489729,751.282739029886,-0.78616552205253,1.36749613864366,0.00353352259785396,0.0173367947270555,"Q55E58",1.18e-21,"Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)","cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856]","GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310"
"1991","Pocillopora_acuta_HIv2___RNAseq.g138.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.0791176412267,3.68233641306884,3.68233641306884,6.27545950462381,4.89289037263117,3.68233641306884,5.12735228357021,3.68233641306884,8.08493028034454,5.18714321477406,4.48996420548011,5.88432222406802,83.9435907423345,0.0376567440004011,1.00993169972113,0.682593329777048,0.852971422768017,NA,NA,NA,NA,NA
"1992","Pocillopora_acuta_HIv2___TS.g1506.t1b",NA,NA,100,33.3333333333333,0,57.1428571428571,62.5,100,NA,NA,58.8293650793651,63.4920634920635,54.1666666666667,NA,NA,NA,NA,NA,NA,3.68233641306884,8.7482501316643,6.11705336350933,9.9099222895395,5.99913827937875,5.82637165358479,3.68233641306884,8.89522724068867,7.45952232732554,9.14031031390876,6.94604684257373,6.43065552479423,7.46143816035324,260.317209690586,0.212049611957018,0.993819568237712,0.306736453566208,0.555343104816827,"E7FE40",1.88e-60,"Nuclear envelope integral membrane protein 1","erythrocyte enucleation [GO:0043131]; erythrocyte maturation [GO:0043249]; oocyte maturation [GO:0001556]","GO:0001556; GO:0005635; GO:0005637; GO:0043131; GO:0043249"
"1993","Pocillopora_acuta_HIv2___TS.g1507.t1",0,0,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.25281011275677,10.70750333404,8.33375837790739,8.71639234395652,8.52364332124565,10.1061316589027,10.576300281983,10.7587890414231,3.68233641306884,5.60202388220197,8.62596887674859,8.11026745328035,9.14167030021684,757.811840131977,0.762706064664375,0.913003741580927,0.137606726981024,0.329309017050552,"Q29496",6.78e-121,"Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24)","oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]","GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0020037; GO:0050649; GO:0070330; GO:0070989"
"1994","Pocillopora_acuta_HIv2___RNAseq.g145.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.42800305042402,6.52433724544485,6.43017198544678,5.92008485977766,7.23980178218474,8.48367325464854,8.26447842049562,8.45403667001078,8.48793182105935,3.68233641306884,7.09148555025612,7.60798906182513,6.5749820386871,171.668321025783,-0.298360082887778,0.887278793852744,0.451813246516037,0.693219701537134,"Q64459",5.16e-28,"Cytochrome P450 3A11 (EC 1.14.14.1) (CYPIIIA11) (Cytochrome P-450IIIAM1) (Cytochrome P-450UT)","oxidative demethylation [GO:0070989]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]","GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0009617; GO:0020037; GO:0032451; GO:0050649; GO:0070330; GO:0070989"
"1995","Pocillopora_acuta_HIv2___RNAseq.g167.t1",0,NA,0,0,0,5.45454545454545,0,0,0,0,0.606060606060606,1.36363636363636,0,NA,NA,NA,NA,NA,NA,6.92442235164643,8.57758379751783,8.34040438161525,6.79149831683273,9.30403847333871,6.62821723110622,7.42540170510466,7.6791315170708,8.1511423388877,7.67212637019187,7.74939664833122,8.07982781251178,7.41896548415066,228.662758741349,-0.401221663352678,0.763882573194603,0.385186069243089,0.633753987661476,"A6QQC6",7.48e-08,"HEPACAM family member 2 (Mitotic kinetics regulator)","cell division [GO:0051301]; centrosome cycle [GO:0007098]","GO:0000139; GO:0005794; GO:0005813; GO:0005819; GO:0007098; GO:0030496; GO:0051301"
"1996","Pocillopora_acuta_HIv2___RNAseq.g175.t1",0,NA,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.4997994003029,9.50434504394073,11.8504568428133,3.68233641306884,10.8153652752776,3.68233641306884,3.68233641306884,11.0920277820511,10.0405062455606,5.3719891395326,8.12214989686854,11.0596311092011,5.18466868453597,1221.92043470924,-6.88012450345106,5.22499098911887,3.30571019558463e-09,1.11976094306642e-07,NA,NA,NA,NA,NA
"1997","Pocillopora_acuta_HIv2___RNAseq.g183.t1",0,0,0,0,5.33333333333333,1.94174757281553,1.63934426229508,0,0,NA,0.990491685382661,0.388349514563107,1.7431693989071,NA,NA,NA,NA,NA,NA,3.68233641306884,8.28871014884914,6.29666242793451,9.24153908615506,6.34949773762474,8.79252469198216,10.664226121919,5.72748248273486,3.68233641306884,8.66694368835129,7.13922592116884,5.14766309488636,9.13078874745133,340.729076017681,4.63795977653563,2.19184090236558,1.18103317458375e-05,0.000131606038807237,"B7WFQ1",7.31e-42,"Uncharacterized skeletal organic matrix protein 2 (Uncharacterized SOMP-2)","","GO:0016020"
"1998","Pocillopora_acuta_HIv2___RNAseq.g204.t1",85.7142857142857,NA,16.6666666666667,50,NA,36.3636363636364,15.7894736842105,NA,60,NA,44.0890104047999,48.7878787878788,39.390142021721,NA,NA,NA,NA,NA,NA,4.95179328310793,8.60154249448205,6.26832651907503,7.85997747624031,7.40935653522263,6.85441933218098,3.68233641306884,5.79601957132358,4.9224776128996,3.68233641306884,6.00285856506698,5.86959470432575,6.1361224258082,91.4373661784377,-0.101214735585734,0.955621200323716,0.581522677021997,0.789434218425641,NA,NA,NA,NA,NA
"1999","Pocillopora_acuta_HIv2___TS.g1567.t1",100,NA,NA,100,100,100,100,NA,100,NA,100,100,100,NA,NA,NA,NA,NA,NA,12.4827652789041,12.5294940199724,12.2503487257937,11.5812800928524,12.2965602121621,11.2701991382452,11.5802084270075,11.6834097494922,12.3212086523051,12.1863065999209,12.0181780896656,12.2068585237314,11.8294976555997,4294.55894448378,-0.287545643666825,0.513180854433356,0.511963599275519,0.738540375831426,"Q8NEZ4",0,"Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3)","methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to electrical stimulus [GO:0051602]","GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0016746; GO:0032259; GO:0035097; GO:0042054; GO:0042800; GO:0044666; GO:0045944; GO:0046872; GO:0051602; GO:0140945; GO:0140999"
"2000","Pocillopora_acuta_HIv2___RNAseq.g237.t1",0,0,0,8.06451612903226,0,0,0,0,NA,NA,1.00806451612903,2.01612903225806,0,NA,NA,NA,NA,NA,NA,9.58202262090556,6.94709464914545,9.98775355235779,6.43347906989454,9.5246922175557,6.57554848939467,6.13356155741209,5.98234595970336,10.0446453819402,6.51149074430832,7.77226342426177,9.02429194649252,6.52023490203101,386.013334923639,-2.35227937923947,1.04669819146138,0.00073398218414125,0.00451859368732133,"A0JM23",2.01e-36,"Nephrocystin-3","cilium assembly [GO:0060271]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]","GO:0005929; GO:0016055; GO:0060271; GO:0090090; GO:2000095"
"2001","Pocillopora_acuta_HIv2___RNAseq.g239.t1",0,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.12180600315947,9.70734673737317,8.11858910456873,8.77013579887542,7.89020468744546,7.59199605080199,3.68233641306884,8.92625107149489,3.68233641306884,8.28092248874476,7.47719247686016,7.34783745594748,7.60654749777284,285.553448765738,0.10030970779276,0.947582827549434,0.709692453582211,0.867855229000093,"Q96AY4",1.06e-44,"Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"2002","Pocillopora_acuta_HIv2___RNAseq.g242.t1",0,46,NA,25.3333333333333,0,4.76190476190476,0,NA,3.2258064516129,NA,11.3315777924073,19.8302611367127,0,NA,NA,NA,NA,NA,NA,7.02670788736903,5.91207600133758,5.35722166815878,3.68233641306884,4.96216975216306,3.68233641306884,3.68233641306884,5.55831526900334,6.28579400236677,3.68233641306884,4.98316302326739,5.8380417158122,4.12828433072259,25.2777026865998,-1.48693754924487,3.42671098422308,0.00200822035749902,0.0106948274587065,NA,NA,NA,NA,NA
"2003","Pocillopora_acuta_HIv2___RNAseq.g251.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.71611892316596,3.68233641306884,8.366685476763,10.7735521747439,7.81560771910048,8.42630172396256,3.68233641306884,7.43602361342634,10.5718932938033,3.68233641306884,7.01531921641721,7.98126580525182,6.0493726275826,422.403082103959,-0.300270923550943,1.04223638134873,0.00130470397690302,0.00733718441754484,"Q6P5F6",4.24e-53,"Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10)","epithelial to mesenchymal transition [GO:0001837]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577]","GO:0001837; GO:0002903; GO:0005385; GO:0005886; GO:0006882; GO:0016324; GO:0030003; GO:0030890; GO:0050861; GO:0071577; GO:0071578; GO:0140410"
"2004","Pocillopora_acuta_HIv2___RNAseq.g252.t1",1.03092783505155,0,0,0,2.95566502463054,1.91082802547771,3.90625,0,0.956937799043062,NA,1.19562318713365,0.573553164904154,1.97321071492052,NA,NA,NA,NA,NA,NA,10.4993061165329,5.93854123587151,10.5765287976511,9.3886219429448,11.0030067966588,11.3647285004813,11.5220305304074,11.8512561933555,10.5331411902998,10.116247172385,10.2793408476588,10.8926478188996,9.666033876418,1736.97214919332,-0.542279876371296,0.808209459946162,0.254696574618591,0.495809824475873,"Q9UJS0",0,"Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial (Calcium-binding mitochondrial carrier protein Aralar2) (ARALAR-related gene 2) (ARALAR2) (Citrin) (Mitochondrial aspartate glutamate carrier 2) (Solute carrier family 25 member 13)","aspartate transmembrane transport [GO:0015810]; ATP biosynthetic process [GO:0006754]; cellular respiration [GO:0045333]; gluconeogenesis [GO:0006094]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; response to calcium ion [GO:0051592]","GO:0000514; GO:0000515; GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0005886; GO:0006094; GO:0006754; GO:0006839; GO:0015183; GO:0015810; GO:0015813; GO:0042802; GO:0043490; GO:0045333; GO:0051592"
"2005","Pocillopora_acuta_HIv2___RNAseq.g263.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.24652804093718,10.6964334524209,8.77000426265141,10.299849035045,8.8077529900687,3.68233641306884,9.79595385817412,9.24557709905535,9.57489030030249,3.68233641306884,8.38016618647928,9.12895053860303,7.63138183435554,646.715779716468,-0.113279354348054,0.956815060557406,0.531524810639297,0.752395269239264,"Q9JLI7",0,"Sperm-associated antigen 6 (Axoneme central apparatus protein) (Protein PF16 homolog)","cell division [GO:0051301]; cerebrospinal fluid circulation [GO:0090660]; ear development [GO:0043583]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of localization in cell [GO:0051649]; fibroblast migration [GO:0010761]; filopodium assembly [GO:0046847]; flagellated sperm motility [GO:0030317]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; neuron projection extension [GO:1990138]; non-motile cilium assembly [GO:1905515]; protein localization [GO:0008104]; regulation of cilium beat frequency [GO:0003356]; regulation of establishment of planar polarity [GO:0090175]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]; stress fiber assembly [GO:0043149]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; ventricular system development [GO:0021591]","GO:0001669; GO:0002177; GO:0003351; GO:0003356; GO:0005576; GO:0005829; GO:0005874; GO:0005930; GO:0006931; GO:0007283; GO:0007288; GO:0008017; GO:0008104; GO:0010761; GO:0015630; GO:0021591; GO:0030317; GO:0031410; GO:0043149; GO:0043583; GO:0044458; GO:0045198; GO:0046847; GO:0051301; GO:0051649; GO:0090175; GO:0090660; GO:0097228; GO:0120197; GO:0120249; GO:1905515; GO:1990138; GO:1990716"
"2006","Pocillopora_acuta_HIv2___TS.g1633.t2",0,0,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.52146481986391,3.68233641306884,6.03454572419577,6.58091230054222,4.99332554465423,3.68233641306884,8.9582948718601,7.7626357514571,3.68233641306884,3.68233641306884,5.45805246648487,5.59886165064797,5.31724328232177,81.3675358105187,-0.169992664842114,0.977343904107256,0.460857727912261,0.701575180056449,"Q55E58",1.43e-11,"Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)","cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856]","GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310"
"2007","Pocillopora_acuta_HIv2___RNAseq.g278.t1",0,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.31179009778251,11.1119468305237,7.78473188899765,7.62949510756941,8.03182125486859,9.90320406275014,3.68233641306884,7.79868099805539,3.68233641306884,3.68233641306884,7.06186794797539,6.9218721305546,7.20186376539619,405.707717133832,0.0801190400985466,0.956219005214547,0.715966800614738,0.871743284827961,NA,NA,NA,NA,NA
"2008","Pocillopora_acuta_HIv2___RNAseq.g279.t1",0,0,NA,0,0,0,8.21917808219178,0,3.125,NA,1.41802226027397,0.625,2.73972602739726,NA,NA,NA,NA,NA,NA,3.68233641306884,6.92168924401968,5.23497525321289,9.96852602668137,7.89020468744546,8.44086049489064,3.68233641306884,3.68233641306884,3.68233641306884,11.0920273956598,6.42776287541852,4.83443783597297,8.02108791486407,378.152348796865,0.594189352745361,1.229849495226,0.00351153593686969,0.0172523287333163,"Q7SYB2",6.74e-06,"THO complex subunit 1","apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]","GO:0000445; GO:0003677; GO:0003723; GO:0005654; GO:0005829; GO:0006397; GO:0006406; GO:0006915; GO:0007165; GO:0008380; GO:0016363; GO:0042981"
"2009","Pocillopora_acuta_HIv2___RNAseq.g281.t1",0,0,NA,0,0,0,14.2857142857143,NA,NA,NA,2.38095238095238,0,4.76190476190476,NA,NA,NA,NA,NA,NA,3.68233641306884,9.73285795229738,8.27945476463715,9.16052156343084,5.88788892518078,7.51124908779255,3.68233641306884,7.86060514912441,5.13335110137444,3.68233641306884,6.46129377830441,6.16872727067712,6.75386028593169,207.342695770081,0.00500937674712885,0.983139315038118,0.986091977270396,0.9951046088913,"Q8R2H2",4.63e-166,"Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa)","apolipoprotein A-I-mediated signaling pathway [GO:0038027]; apoptotic cell clearance [GO:0043277]; blood coagulation, fibrin clot formation [GO:0072378]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to xenobiotic stimulus [GO:0071466]; embryo implantation [GO:0007566]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; maintenance of postsynaptic specialization structure [GO:0098880]; mesodermal cell differentiation [GO:0048333]; negative chemotaxis [GO:0050919]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:1900731]; positive regulation of angiogenesis [GO:0045766]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell migration [GO:2000406]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of extracellular matrix organization [GO:1903053]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of postsynaptic neurotransmitter receptor diffusion trapping [GO:0150054]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein localization [GO:0032880]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of serotonin uptake [GO:0051611]; regulation of trophoblast cell migration [GO:1901163]; response to activity [GO:0014823]; response to platelet-derived growth factor [GO:0036119]; smooth muscle cell migration [GO:0014909]; substrate adhesion-dependent cell spreading [GO:0034446]; symbiont entry into host cell [GO:0046718]","GO:0001938; GO:0001954; GO:0001968; GO:0002020; GO:0002687; GO:0003756; GO:0005080; GO:0005178; GO:0005634; GO:0005654; GO:0005886; GO:0005911; GO:0005925; GO:0007044; GO:0007155; GO:0007160; GO:0007229; GO:0007566; GO:0008277; GO:0008305; GO:0009897; GO:0009986; GO:0010595; GO:0010628; GO:0010745; GO:0010763; GO:0010888; GO:0014823; GO:0014909; GO:0014911; GO:0016324; GO:0017134; GO:0019899; GO:0019960; GO:0030168; GO:0030335; GO:0031258; GO:0031527; GO:0031528; GO:0031589; GO:0031994; GO:0032369; GO:0032587; GO:0032880; GO:0032956; GO:0032991; GO:0033627; GO:0033630; GO:0033690; GO:0034113; GO:0034446; GO:0034683; GO:0035866; GO:0035867; GO:0035868; GO:0036119; GO:0036120; GO:0038027; GO:0038132; GO:0042470; GO:0042802; GO:0043184; GO:0043235; GO:0043277; GO:0045202; GO:0045211; GO:0045766; GO:0045780; GO:0046718; GO:0046872; GO:0048008; GO:0048146; GO:0048333; GO:0048661; GO:0050731; GO:0050748; GO:0050839; GO:0050840; GO:0050919; GO:0051279; GO:0051611; GO:0070374; GO:0070442; GO:0070527; GO:0071133; GO:0071260; GO:0071466; GO:0072126; GO:0072378; GO:0097060; GO:0098690; GO:0098880; GO:0098978; GO:0099149; GO:0150054; GO:1900026; GO:1900731; GO:1901163; GO:1903053; GO:1990314; GO:2000352; GO:2000406"
"2010","Pocillopora_acuta_HIv2___RNAseq.g293.t1",NA,0,0,0,0,5.88235294117647,0,0,NA,NA,0.840336134453782,1.47058823529412,0,NA,NA,NA,NA,NA,NA,6.84813858621154,7.05608360716548,9.71518496369293,8.88245085387777,5.10947276732146,3.68233641306884,3.68233641306884,3.68233641306884,6.95638151601114,3.68233641306884,5.92970579465557,6.46230284926118,5.39710874004995,157.474085404666,-0.408756550879863,1.04706260989112,0.2139892283001,0.442756418274236,"Q8IYE1",1.17e-62,"Coiled-coil domain-containing protein 13","cytoplasmic microtubule organization [GO:0031122]; DNA damage response [GO:0006974]; non-motile cilium assembly [GO:1905515]","GO:0005654; GO:0005813; GO:0005829; GO:0006974; GO:0031122; GO:0034451; GO:0042995; GO:1905515"
"2011","Pocillopora_acuta_HIv2___RNAseq.g297.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.22868826190456,3.68233641306884,8.33375837790739,7.35460134587828,3.68233641306884,9.88204743185983,10.5195662873777,9.71962085934648,5.66277130452222,3.68233641306884,6.9748063108003,6.9254350433499,7.0241775782507,376.824270650678,-0.104039954622695,0.981455798728977,0.416079620844433,0.66065579172225,"Q9JLC8",0,"Sacsin (DnaJ homolog subfamily C member 29)","","GO:0005737; GO:0030544; GO:0050750"
"2012","Pocillopora_acuta_HIv2___RNAseq.g299.t1",NA,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.58425436173005,3.68233641306884,10.4685983973343,3.68233641306884,8.83133125715271,3.68233641306884,3.68233641306884,9.84614157284758,9.59007603241508,3.68233641306884,6.57320836868239,9.46408032429594,3.68233641306884,382.035799448043,-13.6026371780005,3.70602855079907,1.25548226802591e-12,1.56278007698963e-10,"Q9NZJ4",0,"Sacsin (DnaJ homolog subfamily C member 29)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084"
"2013","Pocillopora_acuta_HIv2___TS.g1685.t2",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.8603410638964,10.6683812881874,11.3139739570026,8.5725426957775,11.1388419743666,10.1038491523604,3.68233641306884,11.2735235801945,10.3265728354391,3.68233641306884,9.16226993733622,10.9826506821798,7.3418891924926,1332.37823049195,-0.592174359503253,1.15566051070459,0.0264240073708326,0.093241483925768,"Q6P9R2",0,"Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)","cell volume homeostasis [GO:0006884]; cellular hyperosmotic response [GO:0071474]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; renal sodium ion absorption [GO:0070294]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]","GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006884; GO:0006979; GO:0007231; GO:0009410; GO:0010820; GO:0018107; GO:0019901; GO:0035556; GO:0038116; GO:0038146; GO:0042802; GO:0046777; GO:0070294; GO:0071474; GO:0071476; GO:0106310; GO:1901017; GO:1901380; GO:1990869"
"2014","Pocillopora_acuta_HIv2___RNAseq.g326.t1",0,0,0,0,NA,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.6273107333231,11.4285913659353,12.4543328842856,10.160296006229,11.6296516187038,11.3765934868408,3.68233641306884,10.731687104698,12.885515284195,11.3715200460994,10.7347834943379,11.8656995250411,9.60386746363467,3019.04409299031,-0.575939399958817,1.0110581308606,0.176902200421943,0.389572689845156,NA,NA,NA,NA,NA
"2015","Pocillopora_acuta_HIv2___TS.g1727.t1",NA,25,33.3333333333333,NA,33.3333333333333,8.33333333333333,66.6666666666667,0,0,NA,23.8095238095238,8.33333333333333,44.4444444444444,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,3.68233641306884,6.39402768922764,6.550353694785,3.68233641306884,5.90680277481292,5.53803082388147,8.48793182105935,3.68233641306884,5.12888288691106,5.5881978331727,4.66956794064942,52.5399395521075,-0.0536770300099936,1.00413237124954,0.663380906107363,0.841752910425204,NA,NA,NA,NA,NA
"2016","Pocillopora_acuta_HIv2___RNAseq.g362.t1",0,0,0,0,NA,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,8.40768152179436,8.48185977946417,5.44125591099677,3.68233641306884,9.66143865162392,7.80440718073399,3.68233641306884,9.44770714891909,11.7697413213542,3.68233641306884,7.2061100754093,8.94556491093767,5.46665523988094,579.021504628521,-0.63752861216748,1.24465618474747,0.000536063819490865,0.00346763286454198,"Q864U1",5.32e-28,"Breast cancer type 1 susceptibility protein homolog (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BRCA1)","chordate embryonic development [GO:0043009]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of fatty acid biosynthetic process [GO:0045717]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; regulation of transcription by RNA polymerase II [GO:0006357]; sex-chromosome dosage compensation [GO:0007549]","GO:0000724; GO:0003677; GO:0003713; GO:0004842; GO:0005634; GO:0005694; GO:0005737; GO:0006357; GO:0006633; GO:0007095; GO:0007549; GO:0008270; GO:0031436; GO:0043009; GO:0045717; GO:0045893; GO:0045944; GO:0051865; GO:0070063; GO:0070531; GO:0085020"
"2017","Pocillopora_acuta_HIv2___RNAseq.g363.t1",0,0,NA,0,4.76190476190476,0,5.55555555555556,NA,NA,NA,1.71957671957672,0,3.43915343915344,NA,NA,NA,NA,NA,NA,8.35409374540166,11.2040590883835,11.1579073252146,7.96266298558189,10.3426703452311,11.0226826271646,9.03830110607458,10.2100503117186,5.49910115103059,7.56305912788741,9.23545878136885,9.11276457571931,9.3581529870184,1029.4035593014,0.197416369401233,0.83084909834474,0.627830556760721,0.819357680500502,"Q9NYL2",0,"Mitogen-activated protein kinase kinase kinase 20 (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase 7) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK)","cell death [GO:0008219]; cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cellular response to UV-B [GO:0071493]; chromosome segregation [GO:0007059]; cytoskeleton organization [GO:0007010]; DNA damage checkpoint signaling [GO:0000077]; embryonic digit morphogenesis [GO:0042733]; GCN2-mediated signaling [GO:0140469]; inflammatory response [GO:0006954]; JNK cascade [GO:0007254]; limb development [GO:0060173]; MAPK cascade [GO:0000165]; negative regulation of stress-activated protein kinase signaling cascade [GO:0070303]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitotic DNA damage checkpoint [GO:1904291]; positive regulation of programmed cell death [GO:0043068]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; pyroptotic inflammatory response [GO:0070269]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; stress-activated MAPK cascade [GO:0051403]; stress-activated protein kinase signaling cascade [GO:0031098]","GO:0000077; GO:0000165; GO:0000287; GO:0003723; GO:0004674; GO:0004706; GO:0004709; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007010; GO:0007059; GO:0007254; GO:0008219; GO:0030071; GO:0030154; GO:0030295; GO:0031098; GO:0038066; GO:0042733; GO:0043022; GO:0043065; GO:0043068; GO:0046777; GO:0051403; GO:0060173; GO:0070181; GO:0070269; GO:0070303; GO:0071480; GO:0071493; GO:0106310; GO:0140469; GO:0170011; GO:1902010; GO:1904291"
"2018","Pocillopora_acuta_HIv2___TS.g1731.t1",0,0,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.89740667346111,8.01283033727209,8.66279971671285,3.68233641306884,9.17818711259379,3.68233641306884,3.68233641306884,8.97069404020915,11.3550302891229,3.68233641306884,7.08062938216472,9.61282356641996,4.54843519790949,516.555249517255,-10.4115190790971,3.2530603570357,1.04654179872768e-08,3.00937983634138e-07,"P10079",5.83e-76,"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","","GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579"
"2019","Pocillopora_acuta_HIv2___RNAseq.g22294.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.3579063696545,9.2927231201274,10.3779707353214,10.9870120916072,9.36617630423823,11.1695842448419,9.19149949379049,10.4943212648746,3.68233641306884,11.3795496530862,9.62990796906108,8.85574221743151,10.4040737206906,1272.49835405185,0.208002124108517,0.912033094928731,0.560532198720421,0.773767677256363,"Q14108",2.35e-84,"Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36)","aminophospholipid transport [GO:0015917]; endosome to plasma membrane protein transport [GO:0099638]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of carbohydrate catabolic process [GO:0043470]; regulation of endosome organization [GO:1904978]; regulation of glucosylceramide catabolic process [GO:2000752]; regulation of lysosome organization [GO:1905671]; sensory perception of sound [GO:0007605]","GO:0000139; GO:0001618; GO:0001786; GO:0004888; GO:0005044; GO:0005737; GO:0005765; GO:0005789; GO:0005886; GO:0005925; GO:0006622; GO:0006898; GO:0007605; GO:0010008; GO:0010976; GO:0015485; GO:0015917; GO:0016020; GO:0019899; GO:0030666; GO:0030669; GO:0031210; GO:0031902; GO:0038024; GO:0042803; GO:0043202; GO:0043470; GO:0051087; GO:0070062; GO:0099638; GO:1904978; GO:1905671; GO:2000752"
"2020","Pocillopora_acuta_HIv2___RNAseq.g22297.t1",2.5974025974026,0,0,0,0,0,0,0,0,NA,0.288600288600289,0,0.649350649350649,NA,NA,NA,NA,NA,NA,7.6859706800268,3.68233641306884,3.68233641306884,4.41872232712587,5.46172465639773,7.77015937692672,3.68233641306884,6.0528465675844,8.69540440670104,3.68233641306884,5.48141736670379,6.31565654475576,4.64717818865182,83.2445651431727,-0.1376295894637,1.02288410956232,0.00483476763178848,0.0226018354965057,"P51029",1.25e-68,"Protein Wnt-8b","canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; commissural neuron axon guidance [GO:0071679]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; hypothalamus development [GO:0021854]; neuron differentiation [GO:0030182]; otic placode formation [GO:0043049]; sensory epithelium regeneration [GO:0070654]; Wnt signaling pathway [GO:0016055]","GO:0001654; GO:0005109; GO:0005125; GO:0005615; GO:0009880; GO:0016055; GO:0021854; GO:0021879; GO:0030182; GO:0030900; GO:0043049; GO:0045165; GO:0060070; GO:0060898; GO:0070654; GO:0071679"
"2021","Pocillopora_acuta_HIv2___TS.g13643.t1",1.94174757281553,12.5,10.4761904761905,9.33333333333333,3.125,1.6260162601626,1.9047619047619,17.0212765957447,12.7659574468085,5.34351145038168,7.60377950401987,10.6493167272098,4.55824228082992,NA,NA,NA,NA,NA,NA,7.49344156505009,8.25887125628039,7.02247773613795,10.8530180645139,3.68233641306884,6.35805096381544,6.63285646347393,7.32476780740362,3.68233641306884,9.38338636942593,7.06915430522389,5.84107198694587,8.29723662350192,327.793405969973,0.664145865387589,1.215403663512,0.00812407040894556,0.0351185159578567,"A2ASS6",8.24e-23,"Titin (EC 2.7.11.1) (Connectin)","adult heart development [GO:0007512]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of relaxation of cardiac muscle [GO:1901897]; sarcomere organization [GO:0045214]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591]","GO:0001701; GO:0001756; GO:0003007; GO:0004674; GO:0004713; GO:0005200; GO:0005516; GO:0005524; GO:0005634; GO:0005859; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0021591; GO:0030017; GO:0030018; GO:0030506; GO:0031430; GO:0031672; GO:0031674; GO:0035995; GO:0043056; GO:0045214; GO:0046872; GO:0048738; GO:0055002; GO:0055003; GO:0055008; GO:0060419; GO:0106310; GO:1901897"
"2022","Pocillopora_acuta_HIv2___RNAseq.g22344.t1",33.3333333333333,0,0,0,5.26315789473684,7.2463768115942,36,0,23.5294117647059,NA,11.7080310893745,6.15515771526002,18.6491228070175,NA,NA,NA,NA,NA,NA,11.4829822242101,3.68233641306884,10.8107912853795,7.90881337201514,11.4140497328448,3.68233641306884,3.68233641306884,11.8073597808637,12.1087042259767,10.4315542713025,8.7011264131799,11.524777449855,5.87747537650483,1683.07212705083,-0.830328318471971,1.50331938632983,8.28310775801064e-09,2.45505882401365e-07,"Q8VHT8",6.11e-76,"Transcription factor IIIA (TFIIIA)","ribosomal large subunit biogenesis [GO:0042273]","GO:0000995; GO:0003677; GO:0005634; GO:0008097; GO:0042273; GO:0046872"
"2023","Pocillopora_acuta_HIv2___RNAseq.g22345.t2",NA,0,0,0,0,16.6666666666667,0,0,0,NA,2.08333333333333,3.33333333333333,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,6.26832651907503,10.1209783156864,7.52112240205826,9.33649482458345,9.76555035709665,8.0845974933492,3.68233641306884,5.54842281532527,6.76925019663808,5.84774384812403,7.69075654515212,303.75326887591,1.86434304407442,1.71211595176362,0.015931358319787,0.0613991917765517,"O97860",4.2e-95,"Tartrate-resistant acid phosphatase type 5 (TR-AP) (EC 3.1.3.2) (Tartrate-resistant acid ATPase) (TrATPase) (Type 5 acid phosphatase)","bone resorption [GO:0045453]","GO:0003993; GO:0005764; GO:0008198; GO:0008199; GO:0045453"
"2024","Pocillopora_acuta_HIv2___RNAseq.g22361.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,6.5579743664166,6.44283750088468,9.41776294647851,7.26146210646859,10.7132757350892,10.7333054068157,9.18501234043899,3.68233641306884,8.82176997594444,7.64980732046744,6.05079695478599,9.24881768614889,523.476698097692,2.96863193834738,2.25975538564691,0.000466083418632766,0.00307827879776453,"A0A1U8QWA2",0,"Glycine betaine reductase ATRR (Nonribosomal peptide synthetase-like protein ATRR) [Includes: Carboxylic acid reductase (EC 1.2.1.-); Aldehyde reductase (EC 1.1.1.-)]","secondary metabolite biosynthetic process [GO:0044550]; small molecule metabolic process [GO:0044281]","GO:0016491; GO:0031177; GO:0044281; GO:0044550"
"2025","Pocillopora_acuta_HIv2___RNAseq.g22366.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.1096304779767,9.99324889114506,11.9651871533563,11.1103547103063,11.8372366340614,10.2759107127528,4.69145782511396,11.9062576416659,12.1037543147056,7.81630491736815,10.3809343278452,11.9844132443532,8.77745541133725,2478.84737977224,-1.69451721593276,1.48554185652275,0.00763620621521491,0.0333162191687377,"O43602",8.56e-46,"Neuronal migration protein doublecortin (Doublin) (Lissencephalin-X) (Lis-X)","axoneme assembly [GO:0035082]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; retina development in camera-type eye [GO:0060041]","GO:0001764; GO:0005829; GO:0005856; GO:0005874; GO:0005875; GO:0007399; GO:0007417; GO:0008017; GO:0019901; GO:0035082; GO:0035556; GO:0043005; GO:0060041"
"2026","Pocillopora_acuta_HIv2___RNAseq.g22369.t1",0,NA,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.21470030784196,11.8620448232711,8.99710271414824,10.0986629630133,8.19751020292709,11.9437446778378,12.3262946081465,9.30369933745809,9.43471449346097,10.5860459831693,10.1964520111274,9.02954541116727,11.3633586110876,1789.89550639446,1.9838363898172,0.82871817875551,0.00134260945333902,0.00752110888191156,"Q58D55",0,"Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)","carbohydrate metabolic process [GO:0005975]","GO:0004565; GO:0005764; GO:0005773; GO:0005975"
"2027","Pocillopora_acuta_HIv2___RNAseq.g22380.t1",0,0,NA,NA,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.2953985332836,9.99174027462837,7.07161686373946,7.10084180733574,5.59620788443221,6.3891072326092,3.68233641306884,8.26694986749438,3.68233641306884,3.68233641306884,6.57588717027295,6.9825019124037,6.1692724281422,281.573350698295,-0.144329262539002,0.927332707839466,0.774848386092013,0.903077272950799,"Q9Z142",3.35e-83,"Transmembrane protein 33 (Protein DB83)","endoplasmic reticulum tubular network organization [GO:0071786]; innate immune response [GO:0045087]; membrane organization [GO:0061024]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of endoplasmic reticulum tubular network organization [GO:1903371]; response to endoplasmic reticulum stress [GO:0034976]","GO:0005635; GO:0005783; GO:0005789; GO:0034976; GO:0042470; GO:0045087; GO:0061024; GO:0071786; GO:1903371; GO:1903896; GO:1903899"
"2028","Pocillopora_acuta_HIv2___RNAseq.g22389.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.04649220287259,8.53674455497042,9.49639599719956,9.04696134206588,10.851267094397,10.4885398032985,10.3825271848027,9.63823278588926,10.0210316407727,7.53764925099809,9.50458418572667,9.81068394422622,9.19848442722712,853.819519385211,-0.384289490795529,0.654240899459315,0.415359693834901,0.660121152799473,"Q8IZU2",0,"WD repeat-containing protein 17","",""
"2029","Pocillopora_acuta_HIv2___TS.g13789.t1",0,NA,NA,NA,7.54716981132075,0,0,0,0,NA,1.25786163522013,0,2.51572327044025,NA,NA,NA,NA,NA,NA,3.68233641306884,7.83530183461159,8.75019022342549,3.68233641306884,8.84920933576539,3.68233641306884,6.84207077851515,6.11981883186139,9.14704612949172,3.68233641306884,6.22729827859461,7.30972018672257,5.14487637046665,172.287654368725,-0.153178563719394,1.02033607682021,0.000179659752886386,0.00136052286164853,"Q6DJH2",1.35e-94,"L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase (EC 2.7.8.7) (4'-phosphopantetheinyl transferase) (Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase) (AASD-PPT)","fatty acid biosynthetic process [GO:0006633]; protein maturation [GO:0051604]","GO:0000287; GO:0005829; GO:0006633; GO:0008897; GO:0051604"
"2030","Pocillopora_acuta_HIv2___RNAseq.g22488.t1",0,0,0,NA,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.60511707305,11.5757923353694,10.3262552984313,10.4199016488358,10.1449498618767,9.43966730931058,9.2623954486471,10.4410156730441,9.8407627009066,11.7307940600631,10.2786651409535,10.0716201214617,10.4857101604452,1437.65562330468,0.233254395516803,0.68502690964202,0.620388879447544,0.814353603443988,"Q5HZG4",2.39e-38,"Transcription initiation factor TFIID subunit 3 (140 kDa TATA box-binding protein-associated factor) (TBP-associated factor 3) (Transcription initiation factor TFIID 140 kDa subunit) (TAF(II)140) (TAF140) (TAFII-140) (TAFII140)","maintenance of protein location in nucleus [GO:0051457]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]","GO:0000122; GO:0001673; GO:0002039; GO:0005634; GO:0005669; GO:0006357; GO:0006366; GO:0031965; GO:0042789; GO:0043433; GO:0045944; GO:0046872; GO:0046982; GO:0051123; GO:0051457; GO:0060261; GO:0140416"
"2031","Pocillopora_acuta_HIv2___RNAseq.g22492.t1",0,1.44230769230769,0.546448087431694,0,2.63157894736842,1.06837606837607,0,NA,0,NA,0.711088849435484,0.62767094017094,0.794506758700029,NA,NA,NA,NA,NA,NA,9.74683704681859,10.5245287060151,9.8916165142805,8.95715901353381,10.449008465987,9.88736575768285,11.3221424348785,9.57402775762441,7.54029722811113,9.36552326033083,9.72585061852627,9.44035740256433,10.0113438344882,1003.8169446717,0.374914077155749,0.677677999022699,0.435000235832501,0.678453783319497,"Q9Y2U8",2.53e-94,"Inner nuclear membrane protein Man1 (LEM domain-containing protein 3)","negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]","GO:0003677; GO:0005637; GO:0016020; GO:0030512; GO:0030514; GO:0031965; GO:0032926; GO:1990446"
"2032","Pocillopora_acuta_HIv2___RNAseq.g22548.t1",0,0,NA,0,0,0,6.25,0,NA,NA,0.892857142857143,0,2.08333333333333,NA,NA,NA,NA,NA,NA,9.8947317476966,12.6546337694243,10.014973181962,12.7734820497456,10.6432744195211,11.9209151165419,12.5162766524914,11.364548632295,11.5117280928362,12.0227619799219,11.5317325642436,10.6858512148622,12.377613913625,3623.32869299167,1.33034157760401,0.735066709669546,0.0156413287537534,0.0605233223901256,"Q6AWC2",3.71e-114,"Protein WWC2 (BH-3-only member B) (WW domain-containing protein 2)","cell migration [GO:0016477]; hippo signaling [GO:0035329]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355]; regulation of hippo signaling [GO:0035330]","GO:0000122; GO:0005737; GO:0005829; GO:0006355; GO:0008285; GO:0016477; GO:0019900; GO:0035329; GO:0035330; GO:0035331; GO:0035591; GO:0046621; GO:0060090"
"2033","Pocillopora_acuta_HIv2___RNAseq.g6427.t1",3.83480825958702,3.22405361347582,4.48219772275438,3.31457800511509,4.00107411385607,5.97622027534418,3.42786683107275,3.87388898205601,2.89550496205487,3.69778973022943,3.87279824955456,3.85684916760919,3.88874733149993,NA,NA,NA,NA,NA,NA,11.2853002555731,10.068168096673,11.7086001156279,11.8313419153452,10.4194175793854,11.2939180489213,12.471559465486,9.84995163651497,9.66010152373951,12.89987241165,11.1488231048916,10.5846742221682,11.7129719876151,2923.89547938166,0.633762537311807,0.817229324669066,0.197199322156911,0.418900131543187,"O46385",0,"Supervillin (Archvillin) (p205/p250)","actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]","GO:0002102; GO:0005546; GO:0005737; GO:0008154; GO:0015629; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0042995; GO:0051014; GO:0051015; GO:0051016; GO:0060090; GO:0070161"
"2034","Pocillopora_acuta_HIv2___RNAseq.g6431.t1",0,0,0,0,0,0.66079295154185,0,0,0,NA,0.0734214390602056,0.13215859030837,0,NA,NA,NA,NA,NA,NA,9.44061597458744,5.57859373890424,7.19489022163491,3.68233641306884,8.63092136976072,10.7385054198144,7.02415591810061,7.56273982243945,11.1216093238252,3.68233641306884,7.46567046152046,8.79015534244954,6.14118558059139,534.357123254023,-0.483729387387591,1.11528450479885,0.00694763094639364,0.0308347757007173,"P70618",6.62e-155,"Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (CRK1) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha)","angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; bone development [GO:0060348]; cartilage condensation [GO:0001502]; cell morphogenesis [GO:0000902]; cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; cellular response to ionizing radiation [GO:0071479]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to UV-B [GO:0071493]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chondrocyte differentiation [GO:0002062]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; fatty acid oxidation [GO:0019395]; glucose import [GO:0046323]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; p38MAPK cascade [GO:0038066]; placenta development [GO:0001890]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of DNA-templated transcription [GO:0006355]; regulation of ossification [GO:0030278]; regulation of synaptic membrane adhesion [GO:0099179]; regulation of transcription by RNA polymerase II [GO:0006357]; response to dietary excess [GO:0002021]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; response to muscle stretch [GO:0035994]; signal transduction in response to DNA damage [GO:0042770]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; stress-activated MAPK cascade [GO:0051403]; stress-activated protein kinase signaling cascade [GO:0031098]; stress-induced premature senescence [GO:0090400]; striated muscle cell differentiation [GO:0051146]; transcription by RNA polymerase II [GO:0006366]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","GO:0000077; GO:0000165; GO:0000902; GO:0000922; GO:0001502; GO:0001525; GO:0001649; GO:0001890; GO:0002021; GO:0002062; GO:0004672; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006006; GO:0006355; GO:0006357; GO:0006366; GO:0006915; GO:0006974; GO:0007178; GO:0007519; GO:0009749; GO:0010628; GO:0010831; GO:0016301; GO:0019395; GO:0019899; GO:0019903; GO:0030278; GO:0030316; GO:0031098; GO:0031663; GO:0032495; GO:0032496; GO:0032735; GO:0032868; GO:0035331; GO:0035556; GO:0035924; GO:0035994; GO:0038066; GO:0042307; GO:0042770; GO:0045648; GO:0045663; GO:0045944; GO:0046323; GO:0046326; GO:0048010; GO:0048273; GO:0048863; GO:0051146; GO:0051403; GO:0051525; GO:0060045; GO:0060348; GO:0071222; GO:0071223; GO:0071356; GO:0071479; GO:0071493; GO:0071560; GO:0090090; GO:0090336; GO:0090400; GO:0098978; GO:0099179; GO:0106310; GO:1900015; GO:1901741; GO:2000379"
"2035","Pocillopora_acuta_HIv2___RNAseq.g6434.t2",NA,NA,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,11.6995792351943,9.6472827895905,12.1643774779091,11.1441566742614,11.5022178209694,12.2550174913167,12.576227773954,11.7641058940883,12.0133833940085,7.30118552274384,11.2067534074036,11.8287327644339,10.5847740503733,3239.19869425924,-0.494995883235618,0.843280277128066,0.257556856368665,0.499504206290744,"Q6DDW2",0,"Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 (Estrogen-induced gene 121-like protein) (xEIG121L)","negative regulation of nervous system development [GO:0051961]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epidermis development [GO:0045684]","GO:0005886; GO:0030513; GO:0045684; GO:0051961; GO:0070700"
"2036","Pocillopora_acuta_HIv2___RNAseq.23897_t",NA,0,0,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,9.48753444358922,8.99724367835348,10.2060457535445,9.64627435188219,9.57817326417636,8.9735396439084,3.68233641306884,11.8743508983016,11.5378981425312,4.90925637683756,8.88926529661934,10.5368005004286,7.24173009281009,1101.22604156396,-0.54261293205286,1.07317106708784,0.0800462623080426,0.22256615494493,"F8J2D3",9.34e-178,"Phospholipase-B 81 (PLB) (EC 3.1.1.-)","killing of cells of another organism [GO:0031640]; lipid catabolic process [GO:0016042]","GO:0004620; GO:0005576; GO:0016042; GO:0031640; GO:0090729"
"2037","Pocillopora_acuta_HIv2___RNAseq.g6438.t1a",0,0,0,0,0,1.12994350282486,0,0,0,NA,0.125549278091651,0.225988700564972,0,NA,NA,NA,NA,NA,NA,5.52146481986391,3.68233641306884,8.54121067406901,6.89302286053367,5.3992335514363,3.68233641306884,3.68233641306884,7.27429212882864,3.68233641306884,5.79624808010018,5.41548177671071,6.08370751745334,4.74725603596807,64.9188546273738,-0.327100015264207,1.07642939153504,0.0161517405665881,0.0620831186699788,"Q96RW7",6.05e-76,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601]","GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711"
"2038","Pocillopora_acuta_HIv2___TS.g23497.t1a",0,0,14.2857142857143,0,0,0,0,0,NA,0,1.58730158730159,0,2.85714285714286,NA,NA,NA,NA,NA,NA,14.9816933114272,14.5434461118728,15.1926631768891,15.0809214868295,14.7409467687591,14.4891933597805,14.1160162700487,14.4991404560718,14.4176166617096,14.0260634550804,14.6087701058469,14.7664120749714,14.4511281367224,25794.4533181781,-0.246574262110527,0.47486722376053,0.552015221616988,0.767932032877992,"Q02763",6.95e-84,"Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b)","angiogenesis [GO:0001525]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endochondral ossification [GO:0001958]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; response to cAMP [GO:0051591]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to peptide hormone [GO:0043434]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]","GO:0001525; GO:0001666; GO:0001934; GO:0001935; GO:0001938; GO:0001958; GO:0002040; GO:0004672; GO:0004714; GO:0005524; GO:0005576; GO:0005737; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0016323; GO:0016324; GO:0016525; GO:0019838; GO:0032878; GO:0034446; GO:0034451; GO:0035022; GO:0035025; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0043434; GO:0043627; GO:0045121; GO:0045766; GO:0048014; GO:0050728; GO:0051591; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0072012; GO:1902533; GO:2000351; GO:2000352"
"2039","Pocillopora_acuta_HIv2___RNAseq.g6446.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.5486317891533,14.1721829567108,9.90174815300355,13.5651741422702,7.39963524616139,13.2824676821961,14.0482798977125,9.00357696235947,9.49040826578726,13.4959978158837,11.4908102911238,9.26880008329299,13.7128204989547,7264.0806341713,4.27396485334159,0.764677518476373,2.48816784621774e-10,1.22411087509161e-08,"B3EWZ3",0,"Coadhesin","","GO:0016020"
"2040","Pocillopora_acuta_HIv2___RNAseq.g6531.t1",NA,NA,0,NA,NA,33.3333333333333,20,0,0,100,25.5555555555556,11.1111111111111,40,NA,NA,NA,NA,NA,NA,9.07277270383655,9.03876207521893,5.9646645801927,4.86458704699243,8.13467733294935,3.68233641306884,9.30530848192815,6.68016878280013,8.85800706594595,3.68233641306884,6.92836208960019,7.74205809314494,6.11466608605544,244.261072789983,-0.298087572600494,1.00890782117262,0.106496442242729,0.273696613468166,"Q5E9U9",1.05e-146,"GATOR1 complex protein NPRL2 (Nitrogen permease regulator 2-like protein) (NPR2-like protein)","cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]","GO:0005096; GO:0005765; GO:0005774; GO:0010508; GO:0034198; GO:1904262; GO:1990130"
"2041","Pocillopora_acuta_HIv2___RNAseq.g6538.t1",0,NA,NA,NA,0,0,7.14285714285714,0,5.88235294117647,NA,2.17086834733894,1.96078431372549,2.38095238095238,NA,NA,NA,NA,NA,NA,3.68233641306884,9.20427924097985,9.79948914216606,9.30790368143179,8.80958046944986,7.7816664988551,3.68233641306884,8.77605823861739,3.68233641306884,3.68233641306884,6.84083229237754,6.9499601352742,6.73170444948088,307.010396498425,-0.0672617900902179,0.98187150822287,0.722944811065824,0.875577315928563,"E7F654",1.72e-79,"Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.78) (Nucleolar protein 9)","cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; definitive hemopoiesis [GO:0060216]; digestive tract development [GO:0048565]; exocrine pancreas development [GO:0031017]; liver development [GO:0001889]; pancreas morphogenesis [GO:0061113]; rRNA processing [GO:0006364]","GO:0000448; GO:0001889; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0031017; GO:0048565; GO:0051731; GO:0060216; GO:0061113"
"2042","Pocillopora_acuta_HIv2___RNAseq.g6543.t1",0,50,9.375,14.8648648648649,12.6315789473684,5.92105263157895,10.1694915254237,0,0,0,10.2961987969236,14.1571834992888,6.43521409455843,NA,NA,NA,NA,NA,NA,10.1913481260437,7.0676910766358,9.17291965128782,3.68233641306884,9.02778317062813,9.10266065664967,4.60654391542428,9.88658157197762,11.1842251334307,12.5490926657723,8.64711823809189,9.89257153067359,7.40166494551018,1202.15405756106,-0.577154589781551,1.12807186389557,0.0189700359674868,0.0711273044499256,"P46460",0,"Vesicle-fusing ATPase (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein) (NEM-sensitive fusion protein) (Suppressor of K(+) transport growth defect 2) (Protein SKD2) (Vesicular-fusion protein NSF)","Golgi to plasma membrane protein transport [GO:0043001]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; positive regulation of receptor-mediated endocytosis [GO:0048260]; potassium ion transport [GO:0006813]; protein-containing complex disassembly [GO:0032984]; regulation of exocytosis [GO:0017157]; regulation of receptor internalization [GO:0002090]; SNARE complex disassembly [GO:0035494]; vesicle-mediated transport [GO:0016192]","GO:0000149; GO:0001921; GO:0002090; GO:0005524; GO:0005795; GO:0005829; GO:0005886; GO:0006813; GO:0006886; GO:0006891; GO:0016192; GO:0016887; GO:0017075; GO:0017157; GO:0019901; GO:0019905; GO:0030165; GO:0031267; GO:0031748; GO:0032984; GO:0035255; GO:0035494; GO:0043001; GO:0043008; GO:0043198; GO:0043209; GO:0044877; GO:0045732; GO:0046872; GO:0048260; GO:0120283; GO:0140545"
"2043","Pocillopora_acuta_HIv2___RNAseq.g6550.t1",0,NA,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.71611892316596,9.75969966795363,9.31282296358217,9.97833755306733,7.04725325528079,8.09449021168346,3.68233641306884,7.52013679887341,5.22517199274777,11.7611594458599,7.80975272252833,6.96430078673002,8.65520465832663,644.165026877094,0.343725169802928,1.00876276876345,0.20565496593969,0.431038027438296,"Q8BX57",4.69e-171,"PX domain-containing protein kinase-like protein (Modulator of Na,K-ATPase) (MONaKA)","early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of monoatomic ion transport [GO:0043271]; protein targeting to lysosome [GO:0006622]","GO:0003779; GO:0004672; GO:0005524; GO:0005737; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0006622; GO:0006954; GO:0008333; GO:0032780; GO:0032991; GO:0034451; GO:0035091; GO:0043271; GO:0045022; GO:0050804"
"2044","Pocillopora_acuta_HIv2___RNAseq.g6551.t1b",0,0,NA,0,0,NA,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,6.97157030183863,3.68233641306884,6.49588007341306,5.95943109045959,5.96063705750028,5.47509710266606,3.68233641306884,3.68233641306884,4.92742976912218,5.26144406081109,4.59341547743328,26.8497777142162,-0.0885841536772598,0.982218726371514,0.798161804976263,0.914826910543772,"Q9NW07",1.05e-43,"Zinc finger protein 358","embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]","GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0019827; GO:0021915; GO:0035115; GO:0046872"
"2045","Pocillopora_acuta_HIv2___TS.g23643.t1",0,0,0,0,7.14285714285714,0,0,0,0,0,0.714285714285714,0,1.42857142857143,NA,NA,NA,NA,NA,NA,7.15852236535678,10.4896842683859,8.77736480701605,11.1757643283858,7.99690239617268,10.2809704218275,3.68233641306884,9.14834181996278,5.8076943734674,3.68233641306884,7.81999176067126,7.77776515239514,7.86221836894738,625.623341263981,0.0512500690886561,0.975673210892917,0.796622622200618,0.914249975030311,"Q9UHJ3",5.94e-103,"Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1)","cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283]","GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635"
"2046","Pocillopora_acuta_HIv2___RNAseq.g6588.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,9.24368298966931,3.68233641306884,9.00882336383711,3.68233641306884,3.68233641306884,9.99378476620211,10.3512885183707,11.001271255734,6.80105329591574,8.45598321022961,5.14612338160187,536.965559775889,-0.311399502316077,1.06916672365222,9.65627958786051e-05,0.000806399699531261,"Q6ZMT4",2.29e-175,"Lysine-specific demethylase 7A (JmjC domain-containing histone demethylation protein 1D) (Lysine-specific demethylase 7) ([histone H3]-dimethyl-L-lysine9 demethylase 7A) (EC 1.14.11.65)","midbrain development [GO:0030901]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003712; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0008270; GO:0016706; GO:0030901; GO:0032452; GO:0032454; GO:0035064; GO:0035575; GO:0045893; GO:0051864; GO:0071558; GO:0140683"
"2047","Pocillopora_acuta_HIv2___TS.g23649.t1",0,0,0,11.4285714285714,0,0,0,0,0,0,1.14285714285714,2.28571428571429,0,NA,NA,NA,NA,NA,NA,9.810667639544,8.54088102005396,6.51648711029815,10.3981397334274,8.7480145898251,9.50167548246614,6.89653683871883,9.68804051051928,6.65367853148855,11.0127895676863,8.77669110240277,8.28337767633502,9.27000452847053,672.699710186316,0.284064502502447,0.913056929613053,0.377346891494736,0.626465933976577,"B7ZCC9",2.66e-68,"Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; neurogenesis [GO:0022008]","GO:0004930; GO:0005886; GO:0007166; GO:0007189; GO:0022008"
"2048","Pocillopora_acuta_HIv2___RNAseq.g6590.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.64605358581663,8.9451651783571,8.64412982733272,3.68233641306884,6.50510887062065,7.22046409497287,10.0455835692342,6.30287333300819,3.68233641306884,3.68233641306884,6.73563876985489,6.75610040596941,6.71517713374037,249.596663132283,0.0887533699702185,0.952544568332083,0.79054044891285,0.911581851260126,"Q9NYZ3",3.94e-07,"G2 and S phase-expressed protein 1 (GTSE-1) (Protein B99 homolog)","DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; microtubule-based process [GO:0007017]","GO:0005654; GO:0005829; GO:0005881; GO:0006977; GO:0007017; GO:0008017; GO:0015630; GO:0016020"
"2049","Pocillopora_acuta_HIv2___RNAseq.g6622.t1",0,0,0,0,2.4390243902439,0,0,NA,2.56410256410256,NA,0.625390869293308,0.641025641025641,0.609756097560976,NA,NA,NA,NA,NA,NA,8.69611344064921,6.66968775908682,9.91958606205644,8.78512976518017,11.3552563527893,9.73049611281746,8.85330624588099,8.43384636390068,8.5745409179996,3.68233641306884,8.47002994334295,9.39586862747905,7.54419125920686,635.808838313217,-0.746565853787485,1.05414704014397,0.105952818774809,0.272762784472573,"Q5S006",1.41e-12,"Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-)","autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein processing [GO:0010955]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein phosphorylation [GO:0006468]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of gene expression [GO:0010468]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of mitochondrial depolarization [GO:0051900]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; synaptic vesicle recycling [GO:0036465]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","GO:0000139; GO:0000287; GO:0001933; GO:0001934; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0005096; GO:0005524; GO:0005525; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0007029; GO:0007030; GO:0007165; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008021; GO:0008104; GO:0008340; GO:0009267; GO:0010468; GO:0010508; GO:0010738; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0022028; GO:0030159; GO:0030182; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031410; GO:0031647; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034614; GO:0035556; GO:0035564; GO:0035641; GO:0035751; GO:0036465; GO:0036479; GO:0040012; GO:0042802; GO:0042803; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0044325; GO:0044753; GO:0044754; GO:0044877; GO:0045121; GO:0045202; GO:0045746; GO:0046039; GO:0048312; GO:0048812; GO:0051018; GO:0051770; GO:0051900; GO:0051966; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070971; GO:0070973; GO:0071287; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:1900242; GO:1900244; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902902; GO:1903215; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377"
"2050","Pocillopora_acuta_HIv2___RNAseq.g6624.t1",0,NA,0,0,0,0,NA,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.01230688519318,7.33073994748753,8.59775443158888,3.68233641306884,8.05977274574909,3.68233641306884,5.08305273412487,5.86111396217282,6.10133000554887,3.68233641306884,6.00930799510718,7.32645560605057,4.69216038416378,106.717450803412,-0.792975705082086,1.37837853968499,0.000346118484113186,0.00238962183971987,"Q28I85",0,"POC1 centriolar protein homolog A (Pat-interacting protein 2) (Pix2) (xPix2) (WD repeat-containing protein 51A)","","GO:0005737; GO:0005856"
"2051","Pocillopora_acuta_HIv2___RNAseq.g6628.t1",85.7142857142857,NA,46.1538461538462,40,70,39.6825396825397,35,100,32.5581395348837,NA,56.1386013856944,53.0601698043559,59.217032967033,NA,NA,NA,NA,NA,NA,7.67974561220581,4.39481510491619,3.68233641306884,3.68233641306884,6.76451369627749,7.67461468239209,8.01924883694224,8.47147372590907,6.46520689288117,3.68233641306884,6.05166277907306,6.61265526806848,5.49067029007764,107.604430319148,-0.368339489159151,1.02014563187386,0.232812508541643,0.467564582552947,"Q5R4I2",2.6e-07,"E3 ubiquitin-protein ligase RNF8 (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8)","cell division [GO:0051301]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; sperm DNA condensation [GO:0035092]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000781; GO:0003682; GO:0005634; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0030496; GO:0034244; GO:0035092; GO:0035861; GO:0040029; GO:0042393; GO:0042803; GO:0043130; GO:0045190; GO:0045739; GO:0051301; GO:0061630; GO:0070534; GO:0070936; GO:0085020; GO:0140861; GO:1905168"
"2052","Pocillopora_acuta_HIv2___RNAseq.24075_t",0,0,0,4.76190476190476,NA,0,0,0,NA,NA,0.680272108843537,1.19047619047619,0,NA,NA,NA,NA,NA,NA,3.68233641306884,5.6784794012365,4.80540103069894,8.9304384994207,7.28279758058805,7.9542283485874,9.664489285844,7.58127439603332,3.68233641306884,3.68233641306884,6.29441177816154,5.4068291666916,7.18199438963149,180.633913544502,1.18732052781591,1.65852851667109,0.0218020144999079,0.0795319893383779,"O76064",3.82e-09,"E3 ubiquitin-protein ligase RNF8 (hRNF8) (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8)","cell division [GO:0051301]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; signal transduction in response to DNA damage [GO:0042770]; sperm DNA condensation [GO:0035092]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000781; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0030496; GO:0031625; GO:0034244; GO:0035092; GO:0035861; GO:0036297; GO:0040029; GO:0042393; GO:0042770; GO:0042802; GO:0042803; GO:0043130; GO:0045190; GO:0045739; GO:0051301; GO:0051865; GO:0061630; GO:0070534; GO:0070936; GO:0085020; GO:0140861; GO:1905168"
"2053","Pocillopora_acuta_HIv2___RNAseq.g6645.t1",0,NA,0,0,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.9900422944186,11.5282014125052,10.5673653718572,10.6075377399851,10.1778416422755,8.59523604015312,10.2166193531107,9.29533864401342,10.597474551992,3.68233641306884,9.62579934633797,10.3256125009113,8.92598619176459,1274.80137706176,-0.210924972814735,0.88864545989785,0.561080057154722,0.773937787016433,"Q28C33",8.28e-173,"TBC1 domain family member 30","",""
"2054","Pocillopora_acuta_HIv2___RNAseq.g6659.t1",0,0,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.61740237719946,7.12434365571459,5.66344864002848,7.61272588871093,9.01675362337013,6.34225560108856,3.68233641306884,6.58108861241956,6.56263408610192,3.68233641306884,6.28853253107713,6.88826546782391,5.68879959433035,108.086452335157,-0.386220948429022,1.04348012076527,0.0588945035652035,0.176549243433597,"B8VIW9",4.28e-107,"Fibronectin type III domain-containing protein (Neuroglian-like protein)","axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]","GO:0005886; GO:0007411; GO:0030424; GO:0098609"
"2055","Pocillopora_acuta_HIv2___RNAseq.g6695.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.97162831963388,8.24371630971134,9.21145410262565,7.18297737323777,7.64134312075246,8.70481290756462,5.93399417379984,9.87727760944704,3.68233641306884,9.32911896855345,7.97786592983949,8.07680791310557,7.8789239465734,408.243529903674,-0.154919042204795,0.94234103819202,0.572295468296998,0.781914632399983,NA,NA,NA,NA,NA
"2056","Pocillopora_acuta_HIv2___TS.g23788.t2",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.97254505769934,4.82737711805479,5.68586934311609,7.56992190290079,5.68410831247026,8.09909073650838,3.68233641306884,3.68233641306884,3.68233641306884,3.68233641306884,5.2568258123025,4.94143910788467,5.57221251672033,52.0537450489578,0.202920234769127,0.9763510224401,0.48022725055662,0.715345721117503,"P41969",1.24e-20,"ETS domain-containing protein Elk-1","cellular response to gamma radiation [GO:0071480]; cellular response to lipid [GO:0071396]; cellular response to testosterone stimulus [GO:0071394]; gene expression [GO:0010467]; hippocampal neuron apoptotic process [GO:0110088]; liver development [GO:0001889]; lung development [GO:0030324]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to light stimulus [GO:0009416]","GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0003682; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0009416; GO:0010467; GO:0030324; GO:0030374; GO:0030425; GO:0031966; GO:0043025; GO:0043679; GO:0045471; GO:0045893; GO:0045944; GO:0061629; GO:0071394; GO:0071396; GO:0071480; GO:0071774; GO:0110088"
"2057","Pocillopora_acuta_HIv2___RNAseq.g6738.t1",0,NA,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.25281011275677,10.7554040196228,7.82326486527108,9.63597925438866,8.98314918915252,6.69137453308454,9.41770406644581,9.64153408656845,8.15626169331613,7.75155885986295,8.81090406804697,8.77140398941299,8.85040414668095,570.189426857237,0.0522299781409772,0.716246189590486,0.916647066190483,0.969178193941354,"Q6GP04",0,"Protein MON2 homolog","protein transport [GO:0015031]","GO:0015031"
"2058","Pocillopora_acuta_HIv2___RNAseq.g6753.t1",0,NA,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.4354081983143,7.60911950749454,9.85036281449469,11.1266197140467,10.2952340029731,8.87520011878838,5.79202165087362,9.26711416227425,3.68233641306884,3.68233641306884,8.06157529953973,8.70609111822504,7.41705948085442,693.615802338605,-0.711960859886112,1.06147652038516,0.165783741079109,0.372401930574349,"Q8MJC3",4.66e-48,"Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]","erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of neuron apoptotic process [GO:0043525]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]","GO:0004175; GO:0005737; GO:0006508; GO:0030182; GO:0030216; GO:0030218; GO:0031647; GO:0043525; GO:0097153; GO:0097199; GO:0097200; GO:1902004"
"2059","Pocillopora_acuta_HIv2___RNAseq.g5859.t1",0,0,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.32602117141484,3.68233641306884,6.63116616429788,3.68233641306884,8.29735723054694,3.68233641306884,3.68233641306884,7.2278706159692,5.13335110137444,3.68233641306884,5.10274483489475,6.52315325672066,3.68233641306884,52.25457011884,-9.72377704494641,4.00296251684459,1.94506674162182e-05,0.000202398887415957,"P16157",8.66e-29,"Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)","cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165]","GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0010638; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030018; GO:0030507; GO:0030673; GO:0031430; GO:0042383; GO:0043005; GO:0044325; GO:0045199; GO:0045211; GO:0051117; GO:0072659; GO:0170014"
"2060","Pocillopora_acuta_HIv2___RNAseq.g5862.t1",0,NA,0,0,33.3333333333333,0,0,0,0,NA,4.16666666666667,0,8.33333333333333,NA,NA,NA,NA,NA,NA,6.15070113667054,3.68233641306884,7.1034540551447,6.58091230054222,6.71792376881781,5.72947039629047,3.68233641306884,5.84514254962292,5.5336018834485,3.68233641306884,5.47082153297437,6.27016467874089,4.67147838720784,40.3032392184486,-0.825360431508936,1.38835312628594,0.00541376921743011,0.0248586994207495,NA,NA,NA,NA,NA
"2061","Pocillopora_acuta_HIv2___RNAseq.24210_t",0,0,0,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,6.09390500287516,8.56138688278736,5.38589367603326,10.7707323370123,7.37999157022098,6.5620639848483,3.68233641306884,6.92672320941957,7.40013118083982,8.04050244407791,7.08036667011835,6.63732892787776,7.52340441235894,283.139093102888,0.157742306128328,0.939316063793644,0.588238449799872,0.794201525054172,"P07872",0,"Peroxisomal acyl-coenzyme A oxidase 1 (ACO) (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) (Peroxisomal fatty acyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) [Cleaved into: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain]","fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]; spermatogenesis [GO:0007283]; very long-chain fatty acid beta-oxidation [GO:0140493]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0003997; GO:0005504; GO:0005737; GO:0005777; GO:0005778; GO:0005782; GO:0006091; GO:0006629; GO:0006693; GO:0007283; GO:0009062; GO:0016401; GO:0019395; GO:0030165; GO:0033540; GO:0042803; GO:0050660; GO:0050665; GO:0055088; GO:0071949; GO:0140493"
"2062","Pocillopora_acuta_HIv2___RNAseq.g5876.t1",NA,0,0,0,3.10880829015544,0.48780487804878,0,NA,0,0,0.449576646025528,0.121951219512195,0.77720207253886,NA,NA,NA,NA,NA,NA,7.40550595771431,7.70095858672402,6.50448097751675,10.6531651564694,8.21969411849906,7.55890405555477,4.84014736901689,8.0781018333054,8.35184978893498,9.35107167391803,7.86638795176536,7.7119265351941,8.02084936833662,359.956004846843,0.069433099408857,0.83998147764911,0.867898614607039,0.948204967269145,"P07872",0,"Peroxisomal acyl-coenzyme A oxidase 1 (ACO) (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) (Peroxisomal fatty acyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) [Cleaved into: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain]","fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]; spermatogenesis [GO:0007283]; very long-chain fatty acid beta-oxidation [GO:0140493]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0003997; GO:0005504; GO:0005737; GO:0005777; GO:0005778; GO:0005782; GO:0006091; GO:0006629; GO:0006693; GO:0007283; GO:0009062; GO:0016401; GO:0019395; GO:0030165; GO:0033540; GO:0042803; GO:0050660; GO:0050665; GO:0055088; GO:0071949; GO:0140493"
"2063","Pocillopora_acuta_HIv2___RNAseq.g5884.t1",0,0,0,0,0,1.5625,0,0,NA,NA,0.1953125,0.390625,0,NA,NA,NA,NA,NA,NA,6.74355908835771,8.75182214721387,5.35722166815878,3.68233641306884,9.30662784079128,3.68233641306884,3.68233641306884,8.35818531483881,5.8076943734674,3.68233641306884,5.90544560851032,7.1146576571228,4.69623355989785,145.222590221592,-0.561519876727832,1.24484088741549,0.000166306236618703,0.00127071685208151,"F7E235",5.56e-46,"Failed axon connections homolog","","GO:0016020"
"2064","Pocillopora_acuta_HIv2___RNAseq.g5925.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.63539511754732,10.3329089630365,8.91718848910675,3.68233641306884,9.87795742461386,8.51840255502147,8.90018289441995,9.65901449915935,9.60323360652443,3.68233641306884,8.08089563755673,9.13855782739034,7.02323344772312,514.09622132189,-0.326063899268861,1.0161219133326,0.123791583316101,0.30514492034705,"P70085",5.48e-97,"Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (17-alpha-hydroxyprogesterone aldolase) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17)","hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; steroid biosynthetic process [GO:0006694]","GO:0004508; GO:0005506; GO:0006694; GO:0016020; GO:0016829; GO:0020037; GO:0042446; GO:0042448"
"2065","Pocillopora_acuta_HIv2___RNAseq.g5981.t1",0,0,7.04225352112676,11.4583333333333,6.34328358208955,0.763358778625954,0,0,0,NA,2.84524769057507,2.44433842239186,3.34638427580408,NA,NA,NA,NA,NA,NA,7.01680604467962,7.96430909081604,8.73262645402442,3.68233641306884,7.95450868126574,8.2095616944569,3.68233641306884,7.2278706159692,7.60928565147393,4.80766789501754,6.68873089538411,7.70821948948258,5.66924230128563,152.784085071848,-0.482239765481749,1.09720148612734,0.0105153816216921,0.0433935748291455,"A0A2J6RX17",1.84e-07,"Nucleotide-binding leucine-rich repeat (NLR)-like protein (EC 3.5.99.-)","nucleoside metabolic process [GO:0009116]","GO:0009116; GO:0016787; GO:0043531"
"2066","Pocillopora_acuta_HIv2___RNAseq.g5982.t1",4.22535211267606,0,0,0,0.900900900900901,6.66666666666667,4.3956043956044,25,0,NA,4.57650267509422,6.33333333333333,2.38046435229534,NA,NA,NA,NA,NA,NA,11.3834763561948,6.03941460781193,11.1347125998866,10.2959315270834,10.8135465139178,10.0538807398142,9.69707521299146,9.29673546477016,9.75241607237393,9.70931572741662,9.81765048222609,10.4761774014287,9.15912356302352,1201.1360345217,-0.482273618220161,0.823469696317703,0.308185040043763,0.556850520823609,"Q9HB75",4.26e-13,"p53-induced death domain-containing protein 1 (EC 3.4.21.-) (Leucine-rich repeat and death domain-containing protein) [Cleaved into: PIDD-N; PIDD-C; PIDD-CC]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoprocessing [GO:0016540]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; signal transduction [GO:0007165]","GO:0004175; GO:0005123; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0006977; GO:0007165; GO:0008625; GO:0016540; GO:0043065; GO:0043066; GO:0043122; GO:0051092; GO:1905369"
"2067","Pocillopora_acuta_HIv2___RNAseq.g5983.t1",23.8095238095238,14.4827586206897,4.54545454545455,14.0845070422535,31.8181818181818,13.2530120481928,4.65116279069767,31.25,0,0,13.7894600674994,14.6140555422272,12.9648645927716,NA,NA,NA,NA,NA,NA,8.79704173223452,8.49471255582997,9.12758054862443,9.56829066283521,10.4319197687488,8.18381287343643,3.68233641306884,8.54625199406914,9.27238285158771,10.0968946960311,8.62012240964662,9.23503537905292,8.00520944024031,565.539364114296,-0.324176542549069,0.908380574934974,0.390880691751502,0.637683095589186,"Q9HB75",3.15e-12,"p53-induced death domain-containing protein 1 (EC 3.4.21.-) (Leucine-rich repeat and death domain-containing protein) [Cleaved into: PIDD-N; PIDD-C; PIDD-CC]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoprocessing [GO:0016540]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; signal transduction [GO:0007165]","GO:0004175; GO:0005123; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0006977; GO:0007165; GO:0008625; GO:0016540; GO:0043065; GO:0043066; GO:0043122; GO:0051092; GO:1905369"
"2068","Pocillopora_acuta_HIv2___RNAseq.g5984.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.95683089785598,8.42479831485514,9.26826099503974,7.58719755490047,9.46683765125607,7.73507283692995,5.32551295827119,8.47888254572353,7.46780854522067,9.13188014584227,8.0843082445895,8.5277241270192,7.6408923621598,320.89323426398,-0.485194698370847,0.855872128972776,0.267436434380935,0.511193417059053,"A0A2J6RX17",4.2e-06,"Nucleotide-binding leucine-rich repeat (NLR)-like protein (EC 3.5.99.-)","nucleoside metabolic process [GO:0009116]","GO:0009116; GO:0016787; GO:0043531"
"2069","Pocillopora_acuta_HIv2___RNAseq.g6003.t1",100,NA,21.4285714285714,0,58.8235294117647,46.6666666666667,52.1739130434783,NA,100,NA,54.1560972214973,48.8888888888889,58.1065034709536,NA,NA,NA,NA,NA,NA,5.42769788077612,3.68233641306884,5.29770193163976,5.35849991176178,6.01241040467731,3.68233641306884,5.40984312721881,5.03658612426137,3.68233641306884,3.68233641306884,4.72720850326105,5.09134655088468,4.36307045563742,13.2724465626123,-0.171218743592754,0.997156491983512,0.450727079931378,0.692439350411838,"Q6CGG3",2.75e-28,"FK506-binding protein 2 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase)","chaperone-mediated protein folding [GO:0061077]","GO:0003755; GO:0005783; GO:0061077"
"2070","Pocillopora_acuta_HIv2___RNAseq.g6010.t1",100,46.1538461538462,0,68.1818181818182,44.8275862068966,39.2156862745098,30.3030303030303,0,NA,NA,41.0852458900126,38.3878376525435,43.7826541274817,NA,NA,NA,NA,NA,NA,9.3845110870123,6.68494107039366,6.68515093072166,7.3342463704392,7.53005307756441,7.78738559023813,7.17452079654744,7.30255480670073,3.68233641306884,7.40334154893872,7.09690416916251,6.91692126301359,7.27688707531143,169.108798741073,0.125224928678031,0.876918079163407,0.733965656079406,0.882247091293321,"Q6CGG3",1.78e-40,"FK506-binding protein 2 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase)","chaperone-mediated protein folding [GO:0061077]","GO:0003755; GO:0005783; GO:0061077"
"2071","Pocillopora_acuta_HIv2___RNAseq.g6013.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.6305431643296,6.68494107039366,6.16423403991286,3.68233641306884,5.21442834742072,5.20504317817844,3.68233641306884,5.57827407666034,4.25049936715761,3.68233641306884,5.07749724832598,5.56759579909623,4.58739869755572,26.136172759895,-0.48360678301253,1.08580019458474,0.0794379567388417,0.221342825326643,"Q6P5E8",4.68e-74,"Diacylglycerol kinase theta (DAG kinase theta) (EC 2.7.1.107) (EC 2.7.1.93) (Diglyceride kinase theta) (DGK-theta)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493]","GO:0004143; GO:0005524; GO:0005730; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007189; GO:0007205; GO:0008277; GO:0010628; GO:0010629; GO:0010801; GO:0012506; GO:0016363; GO:0016607; GO:0019900; GO:0019933; GO:0030297; GO:0033198; GO:0035556; GO:0043274; GO:0046339; GO:0046834; GO:0046872; GO:0047649; GO:0050731; GO:0051591; GO:0070493; GO:0070528; GO:0090181; GO:0098793; GO:0098794; GO:0098978; GO:0140297; GO:1900242; GO:1903432; GO:2000064; GO:2000182"
"2072","Pocillopora_acuta_HIv2___TS.g30737.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.13391848923153,3.68233641306884,7.34198352049247,3.68233641306884,4.75140430725689,3.68233641306884,5.40984312721881,3.68233641306884,3.68233641306884,8.99448300557185,5.00433145151158,4.91839582862371,5.09026707439944,66.4495848701507,-0.0629165240890804,1.01786170848274,0.0476966781716916,0.150302660068013,NA,NA,NA,NA,NA
"2073","Pocillopora_acuta_HIv2___RNAseq.g6034.t1",8.33333333333333,0,0,0,2.56410256410256,0,0,0,0,NA,1.21082621082621,0,2.72435897435897,NA,NA,NA,NA,NA,NA,8.98491880376123,5.61277682111054,9.27520698974103,7.94938886197888,7.31938199961972,8.74054119719088,10.1406197607821,8.51536505331737,3.68233641306884,3.68233641306884,7.39028723136394,7.55544185190164,7.22513261082625,330.581839289026,-0.0788196613974948,0.871003665606811,0.866621206388202,0.947906664358262,"O55236",0,"mRNA-capping enzyme (HCE) (MCE1) [Includes: mRNA 5'-triphosphate monophosphatase (EC 3.6.1.74) (mRNA 5'-phosphatase); mRNA guanylyltransferase (EC 2.7.7.50) (GTP--RNA guanylyltransferase) (GTase)]","7-methylguanosine mRNA capping [GO:0006370]","GO:0004484; GO:0004651; GO:0004721; GO:0005524; GO:0005525; GO:0005634; GO:0006370; GO:0050355; GO:0140818"
"2074","Pocillopora_acuta_HIv2___RNAseq.24379_t",0,0,NA,0,0,12.5,0,0,0,0,1.38888888888889,2.5,0,NA,NA,NA,NA,NA,NA,9.36144314648242,9.24285011781547,9.16732965307392,9.71635260230834,9.50566414836229,3.68233641306884,10.5174215653963,8.57649000955297,10.4699137031375,3.68233641306884,8.39221377722669,9.41616813212182,7.36825942233156,646.900680113353,-0.167586853598572,0.965232085296932,0.371951502200931,0.621523397393054,"Q19749",2.06e-170,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2)","acetyl-CoA biosynthetic process from pyruvate [GO:0006086]","GO:0004742; GO:0005759; GO:0006086; GO:0045254"
"2075","Pocillopora_acuta_HIv2___RNAseq.g6054.t1",NA,0,0,0,0,NA,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.54919392737284,8.62120790929901,7.79446269476917,10.8297248538736,8.73845249809789,7.39595400278476,3.68233641306884,9.56941294567769,10.2061006721982,3.68233641306884,7.80691823302108,8.77152454762316,6.84231191841901,495.807295994747,-0.192816156020537,0.988996079538261,0.25766463575211,0.499646238305205,"Q16787",5.68e-06,"Laminin subunit alpha-3 (Epiligrin 170 kDa subunit) (E170) (Epiligrin subunit alpha) (Kalinin subunit alpha) (Laminin-5 subunit alpha) (Laminin-6 subunit alpha) (Laminin-7 subunit alpha) (Nicein subunit alpha)","cell-cell adhesion [GO:0098609]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544]; hemidesmosome assembly [GO:0031581]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]","GO:0005102; GO:0005198; GO:0005576; GO:0005604; GO:0005608; GO:0005610; GO:0005783; GO:0005912; GO:0008544; GO:0030056; GO:0030155; GO:0030334; GO:0031581; GO:0035987; GO:0045995; GO:0062023; GO:0070062; GO:0098609"
"2076","Pocillopora_acuta_HIv2___RNAseq.g28958.t1",7.14285714285714,0,0,NA,NA,0,0,NA,0,0,1.02040816326531,0,1.78571428571429,NA,NA,NA,NA,NA,NA,6.75557122368885,6.8289815458267,6.75739185036896,8.32815545810949,5.54035303062331,6.41947826134799,3.68233641306884,8.66357016691129,3.68233641306884,3.68233641306884,6.03405107760831,6.27984453693225,5.78825761828437,102.010691545141,-0.00843563210582329,0.936870699712951,0.927085624443841,0.972821131163357,"P10079",7.19e-80,"Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","","GO:0005509; GO:0005576; GO:0009374; GO:0031410; GO:0032579"
"2077","Pocillopora_acuta_HIv2___RNAseq.g28971.t1a",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.94728948184982,3.68233641306884,9.26043122935279,4.35452149648907,10.6450648196206,13.6416210051915,3.68233641306884,3.68233641306884,7.44497709434963,7.00232507791288,3.81677342975289,10.1878767260729,1603.2281279156,12.4836724115879,2.91505518091902,5.96341388419078e-13,8.21474461151766e-11,"Q91X17",8.41e-23,"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]","antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; ERAD pathway [GO:0036503]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; intracellular calcium ion homeostasis [GO:0006874]; intracellular chloride ion homeostasis [GO:0030644]; intracellular phosphate ion homeostasis [GO:0030643]; intracellular sodium ion homeostasis [GO:0006883]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; monoatomic ion homeostasis [GO:0050801]; multicellular organismal response to stress [GO:0033555]; multicellular organismal-level homeostasis [GO:0048871]; multicellular organismal-level water homeostasis [GO:0050891]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918]","GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005509; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0019864; GO:0030643; GO:0030644; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0036503; GO:0044861; GO:0045177; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0050891; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097709; GO:0097744; GO:0098552; GO:0140367; GO:1990266"
"2078","Pocillopora_acuta_HIv2___RNAseq.g28980.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.79990573373047,5.6460547390973,10.6064304523048,8.97687913254033,10.4939912425057,9.98857350602904,3.68233641306884,10.4142488877972,10.4933192051796,3.68233641306884,8.27840757253221,10.1615791043036,6.39523604076087,762.196422988501,-0.805639995384483,1.35785418274307,0.00529921010495171,0.0244256771695416,"Q9NR20",0,"Dual specificity tyrosine-phosphorylation-regulated kinase 4 (EC 2.7.12.1)","","GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0043231; GO:0046872; GO:0106310"
"2079","Pocillopora_acuta_HIv2___RNAseq.g28981.t1",22.3529411764706,20.979020979021,14.8936170212766,0,54.5454545454545,15.8878504672897,34.2105263157895,0,33.3333333333333,66.6666666666667,26.2869410505302,14.0400409559288,38.5338411451316,NA,NA,NA,NA,NA,NA,7.43542392964019,3.68233641306884,6.93658367102579,8.6359601564125,3.68233641306884,3.68233641306884,7.42540170510466,7.69622648191018,9.4617986842675,3.68233641306884,6.23207402806362,7.0424738359825,5.42167422014474,162.849853198276,-0.182033835457229,0.99922136922147,0.390466894008773,0.63739430999064,"Q8K409",9.75e-156,"DNA polymerase beta (EC 2.7.7.7) (5'-deoxyribose-phosphate lyase) (5'-dRP lyase) (EC 4.2.99.-) (AP lyase) (EC 4.2.99.18)","apoptotic process [GO:0006915]; base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; DNA damage response [GO:0006974]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; homeostasis of number of cells [GO:0048872]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lymph node development [GO:0048535]; neuron apoptotic process [GO:0051402]; pyrimidine dimer repair [GO:0006290]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; salivary gland morphogenesis [GO:0007435]; somatic diversification of immunoglobulins [GO:0016445]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spleen development [GO:0048536]","GO:0000795; GO:0001701; GO:0003677; GO:0003684; GO:0003887; GO:0005634; GO:0005737; GO:0005874; GO:0005876; GO:0006260; GO:0006284; GO:0006287; GO:0006290; GO:0006303; GO:0006915; GO:0006954; GO:0006974; GO:0007435; GO:0008017; GO:0008630; GO:0010332; GO:0016445; GO:0016446; GO:0016829; GO:0019899; GO:0032991; GO:0045471; GO:0046872; GO:0048535; GO:0048536; GO:0048872; GO:0051402; GO:0051575; GO:0055093; GO:0071707; GO:0140078"
"2080","Pocillopora_acuta_HIv2___RNAseq.g28986.t1",0,NA,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.060232093121,5.6784794012365,9.32123686514338,3.68233641306884,10.1571930713709,8.30817848429075,3.68233641306884,9.22518129420966,8.50807837694937,3.68233641306884,7.23055888255281,9.45438434015886,5.00673342494675,400.526022720074,-5.92374732154284,3.7491514477007,9.04753261192689e-07,1.43490692652314e-05,NA,NA,NA,NA,NA
"2081","Pocillopora_acuta_HIv2___RNAseq.g29014.t4",0,0,0,11.1111111111111,4,0,0,0,0,NA,1.67901234567901,2.22222222222222,1,NA,NA,NA,NA,NA,NA,12.7937437607238,13.5687111890828,12.9241655570252,13.6619360561713,11.380659728116,13.7863012457645,14.4285144254565,12.6411554145857,13.293738855185,11.7781319680996,13.025705820021,12.6066926631271,13.4447189769149,9851.55225928265,0.552857086368796,0.726767924337332,0.265976846271242,0.509615724528711,"P29294",2.72e-114,"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]","","GO:0001725; GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0030027; GO:0032154; GO:0046872"
"2082","Pocillopora_acuta_HIv2___RNAseq.g29015.t1",0,0,0,NA,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.0810791565191,10.2558236329284,10.2752164750628,10.8941936133453,11.0753713421679,10.8509656442099,11.8536111926614,10.5908176302988,11.1071711783604,10.433269760241,10.8417519625795,10.8259311564818,10.8575727686772,1911.21292537253,0.0199183922173921,0.577637420031635,0.972944057167582,0.991474251054482,"A0A0G2K2P5",2.34e-12,"Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1)","actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; ameloblast differentiation [GO:0036305]; blastocyst formation [GO:0001825]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to glucose stimulus [GO:0071333]; establishment of endothelial intestinal barrier [GO:0090557]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]","GO:0001825; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005921; GO:0005923; GO:0007605; GO:0008013; GO:0008284; GO:0009410; GO:0014704; GO:0016020; GO:0016301; GO:0016323; GO:0016324; GO:0016327; GO:0019904; GO:0030036; GO:0030054; GO:0030335; GO:0031032; GO:0032496; GO:0032991; GO:0034334; GO:0036305; GO:0043066; GO:0043116; GO:0043296; GO:0044325; GO:0045177; GO:0045216; GO:0045471; GO:0046581; GO:0050839; GO:0051493; GO:0051497; GO:0070160; GO:0071000; GO:0071253; GO:0071333; GO:0071896; GO:0090557; GO:0098609; GO:0150105; GO:1901888; GO:1902396; GO:1903672; GO:1905605; GO:2000049; GO:2000810"
"2083","Pocillopora_acuta_HIv2___TS.g3847.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,6.38096952478058,6.97157030183863,8.53754183487098,7.22884663559278,6.3891072326092,3.68233641306884,3.68233641306884,3.68233641306884,3.68233641306884,5.39197175950364,5.04948523532759,5.73445828367969,69.266419427818,0.173649068136748,0.992849241010968,0.487374242547504,0.720869316311187,"Q91WI7",1.22e-08,"KICSTOR complex protein ITFG2 (Integrin-alpha FG-GAP repeat-containing protein 2)","cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; germinal center B cell differentiation [GO:0002314]; negative regulation of TORC1 signaling [GO:1904262]; regulation of TOR signaling [GO:0032006]","GO:0002314; GO:0005654; GO:0005765; GO:0005794; GO:0005829; GO:0032006; GO:0034198; GO:0042149; GO:0140007; GO:1904262"
"2084","Pocillopora_acuta_HIv2___RNAseq.g29030.t1",NA,18.1818181818182,100,0,51.5151515151515,13.6363636363636,79.0697674418605,0,0,50,34.7114556416882,6.36363636363636,70.146229739253,1,72,72,0.0336709932174732,0.0336709932174732,0.0336709932174732,9.09158918263054,8.09961113792445,5.94660437537211,3.68233641306884,9.0324843971322,8.81782936174425,9.87682043043915,8.71255992242008,9.73544456618406,6.68566082080521,7.96809406077209,8.5037364887478,7.43245163279638,394.707367407646,-0.574377938653157,0.963087688801145,0.15478861087124,0.35577029519174,"Q28CX0",5.21e-46,"Elongator complex protein 6 (Protein TMEM103)","positive regulation of cell migration [GO:0030335]; tRNA wobble uridine modification [GO:0002098]","GO:0002098; GO:0005634; GO:0005737; GO:0030335; GO:0033588"
"2085","Pocillopora_acuta_HIv2___RNAseq.g29031.t1",0,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,4.4307132106762,5.57859373890424,6.25393493464119,5.59933054873005,4.52813742588667,6.06092633439065,6.61664389412953,4.82716794255886,4.37599570701945,3.68233641306884,5.19537801500057,4.88318984415647,5.50756618584466,24.1871031126589,0.408094954592704,0.961411550421862,0.278873911597328,0.524402762404143,"P0CI65",7.55e-23,"Nephrocystin-3","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"2086","Pocillopora_acuta_HIv2___RNAseq.g29032.t1",NA,NA,33.3333333333333,0,33.3333333333333,7.40740740740741,100,NA,0,NA,29.0123456790123,2.46913580246914,55.5555555555556,NA,NA,NA,NA,NA,NA,7.62246689615746,8.25887125628039,8.75268193783633,9.71830564126848,7.81195679750884,7.77015937692672,3.68233641306884,5.47509710266606,7.78511408192754,3.68233641306884,7.05593259167095,7.48946336321925,6.62240182012265,228.763354796898,-0.273468478609721,0.952082276214418,0.296724564086752,0.544233336919957,"Q91WI7",2.45e-30,"KICSTOR complex protein ITFG2 (Integrin-alpha FG-GAP repeat-containing protein 2)","cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; germinal center B cell differentiation [GO:0002314]; negative regulation of TORC1 signaling [GO:1904262]; regulation of TOR signaling [GO:0032006]","GO:0002314; GO:0005654; GO:0005765; GO:0005794; GO:0005829; GO:0032006; GO:0034198; GO:0042149; GO:0140007; GO:1904262"
"2087","Pocillopora_acuta_HIv2___RNAseq.g29045.t1",0,0,0,3.63636363636364,0,2.18579234972678,0,7.69230769230769,0,0,1.35144636783981,2.70289273567962,0,NA,NA,NA,NA,NA,NA,11.202835648163,10.0624306913985,11.0096726837123,11.0534857291541,11.092721731243,8.39299560414697,6.84207077851515,8.96191444442486,7.94170528458551,3.68233641306884,9.02421690084122,10.0417699584257,8.00666384325671,1076.52337667198,-1.0738339214353,1.2112772718958,0.041640221886233,0.135121314804715,"Q9JID6",0,"Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Palmitoyl-CoA ligase) (Phytanate--CoA ligase) (EC 6.2.1.24)","long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0047676; GO:0050197; GO:0070251"
"2088","Pocillopora_acuta_HIv2___RNAseq.g29047.t1",NA,NA,0,3.50877192982456,5.71428571428571,2.85714285714286,3.2258064516129,NA,8.33333333333333,NA,3.93989004769989,4.89974937343358,2.98003072196621,NA,NA,NA,NA,NA,NA,8.84219610301059,9.18063134406443,9.33791875655679,8.93380579129289,8.55667448650459,8.2719852622556,9.96603030901402,7.6791315170708,5.1802014623539,11.376878080178,8.73254531123016,7.91922446509933,9.54586615736099,651.285920095402,0.505164591304938,0.905578089329289,0.254926707866806,0.496030853023238,"Q9JID6",0,"Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Palmitoyl-CoA ligase) (Phytanate--CoA ligase) (EC 6.2.1.24)","long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0047676; GO:0050197; GO:0070251"
"2089","Pocillopora_acuta_HIv2___RNAseq.g29069.t1",0,NA,0,0,0,1.0752688172043,0,0,0,0,0.1194743130227,0.268817204301075,0,NA,NA,NA,NA,NA,NA,9.71231156837949,10.6852779634252,9.89612825443285,10.1574200572985,10.3191471702457,10.6189302997293,3.68233641306884,10.3308326899665,10.6105624314019,7.34586633953267,9.3358813187481,10.1737964228853,8.4979662146109,1021.56433630312,-0.279860980156118,0.931435157614023,0.386250835698653,0.634495410283398,"O60675",3.14e-30,"Transcription factor MafK (Erythroid transcription factor NF-E2 p18 subunit)","negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0043565; GO:0090575"
"2090","Pocillopora_acuta_HIv2___RNAseq.g29070.t1",0,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.70689227093755,8.75893970845155,7.72491691603718,5.63527227912703,7.27216983134098,5.89458481577045,6.68039407196693,7.16145990783134,6.37842387115414,9.65447386203721,7.18675275346544,7.04877255946024,7.32473294747063,190.591220517443,0.0155548278908462,0.831345497255973,0.979416782763755,0.992592793294209,"Q3SZ85",4.68e-37,"Putative peptidyl-tRNA hydrolase PTRHD1 (EC 3.1.1.29) (Peptidyl-tRNA hydrolase domain-containing protein 1)","","GO:0004045"
"2091","Pocillopora_acuta_HIv2___TS.g3927.t1",NA,0,0.719424460431655,0.970873786407767,1.02389078498294,0,0.483091787439614,NA,0.892857142857143,0.571428571428571,0.582695816693461,0.465932732316227,0.699458901070694,NA,NA,NA,NA,NA,NA,7.11283993360409,6.66968775908682,8.54121067406901,10.3115381216252,9.05113740887942,3.68233641306884,3.68233641306884,9.17136999962046,11.0945845130856,3.68233641306884,7.29993776491771,8.99422850585172,5.60564702398371,500.170642831001,-0.380161787263214,1.07698805683501,4.35755266974393e-06,5.59251480170153e-05,"Q9DE14",0,"Serine/threonine-protein kinase atr (Xatr) (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein)","DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; nuclear membrane disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]","GO:0000077; GO:0003677; GO:0004674; GO:0005524; GO:0005635; GO:0006281; GO:0016605; GO:0018105; GO:0035979; GO:0046982; GO:0051081; GO:0090734; GO:0106310"
"2092","Pocillopora_acuta_HIv2___RNAseq.g11896.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.9583736245652,7.7732326587915,10.9945017509261,8.5507670998478,10.7654354527325,10.5299296141824,9.6856581940023,11.3873363229251,11.5017279056179,10.8502346079133,10.2997197231504,11.1214750113534,9.47796443494746,1583.62321090736,-1.22517609779033,0.804531219353337,0.0271280990095989,0.0953074627337476,"Q24JV4",4.04e-11,"UPF0390 protein zgc136864","",""
"2093","Pocillopora_acuta_HIv2___TS.g30330.t1",0,NA,0,0,0,0,3.7037037037037,0,0,NA,0.462962962962963,0,0.925925925925926,NA,NA,NA,NA,NA,NA,8.98994267034317,8.6289994693056,10.3412213032244,8.83280940348506,9.36989503427898,7.64969789161387,8.06706324807728,11.371853434684,9.66369453585729,4.69373610443143,8.76089130953011,9.94732139567757,7.57446122338265,702.806760936339,-1.56254166020492,1.2133925532037,0.0120386420854986,0.0485303565007391,"P42638",1.54e-13,"Tropomyosin-2 (Tropomyosin II) (SmTMII) (TMII)","actin filament organization [GO:0007015]; muscle contraction [GO:0006936]","GO:0005884; GO:0006936; GO:0007015; GO:0051015"
"2094","Pocillopora_acuta_HIv2___RNAseq.g11945.t1",0,NA,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,4.84704733944273,9.19905758140562,7.35523113293712,9.00596229829442,3.68233641306884,10.771952165572,7.90546137986201,8.74568266445487,8.47979355464223,10.0662650265849,8.00587895562647,6.62201822090916,9.38973969034379,491.912962888346,0.687265607407513,1.17633953381919,0.043062805898291,0.138659934219252,NA,NA,NA,NA,NA
"2095","Pocillopora_acuta_HIv2___TS.g30365.t1",1.5625,0,2.38095238095238,0,0,2.40963855421687,0.775193798449612,0,16.6666666666667,NA,2.64388348892061,3.81526104417671,1.1796615448505,NA,NA,NA,NA,NA,NA,5.92950120283598,6.22089677820832,6.22468762788833,7.22786336628594,5.99913827937875,5.59702265161876,3.68233641306884,7.07874584792092,5.1802014623539,6.40118305541264,5.95415766849724,6.08245488407558,5.8258604529189,51.9375364591589,-0.0121031618304763,0.87052701812009,0.974831764739933,0.991913908309692,"A6QLC7",0,"Trafficking protein particle complex subunit 11","vesicle-mediated transport [GO:0016192]","GO:0005794; GO:0016192"
"2096","Pocillopora_acuta_HIv2___RNAseq.g11998.t1",18.232044198895,6,5.71428571428571,0,0,10.7061503416856,7.83582089552239,15.929203539823,0,NA,7.15750052113464,6.52707077630173,7.94553770217578,NA,NA,NA,NA,NA,NA,8.21926968797241,6.54125763453179,8.45199815117828,3.68233641306884,7.59531148880866,7.6114897718209,8.97089640132859,7.82221713810817,3.68233641306884,3.68233641306884,6.62594495129553,7.15422657582727,6.09766332676379,168.420136428668,-0.206667924913832,0.950069269743821,0.563703239152117,0.775628201207784,NA,NA,NA,NA,NA
"2097","Pocillopora_acuta_HIv2___RNAseq.g11999.t1",66.6666666666667,0,0,0,0,0,0,0,NA,NA,8.33333333333333,0,16.6666666666667,NA,NA,NA,NA,NA,NA,3.68233641306884,4.75675715543394,7.74513402854738,4.86458704699243,6.85329648854777,9.21482428293576,4.60654391542428,8.92985739813443,3.68233641306884,8.9327235568929,6.32683966990466,6.17859214827345,6.47508719153586,179.75396889818,0.114561817763975,1.0032015656831,0.263133951334053,0.505709470116362,"Q5ZI89",1.36e-167,"Trafficking protein particle complex subunit 11","vesicle-mediated transport [GO:0016192]","GO:0005794; GO:0016192"
"2098","Pocillopora_acuta_HIv2___RNAseq.g12006.t1",0.602409638554217,0.925925925925926,0,0,2.33463035019455,1.18483412322275,0,0,NA,NA,0.63097500473718,0.527690012287169,0.734259997187192,NA,NA,NA,NA,NA,NA,4.4307132106762,10.7518438472371,6.0681601509144,8.23832351102165,4.93003625965001,10.0336381993137,3.68233641306884,3.68233641306884,6.37842387115414,4.19574235723263,6.23915542333375,5.09793398109272,7.38037686557478,311.703720139308,0.433394671659911,1.11152853197728,0.0505142087252918,0.15655399935775,"Q9DDN6",5.13e-20,"Neuropeptide Y receptor type 2 (NPY2-R) (NPY-Y2 receptor) (Y2 receptor)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cardiac left ventricle morphogenesis [GO:0003214]; outflow tract morphogenesis [GO:0003151]","GO:0001601; GO:0003151; GO:0003214; GO:0005886; GO:0007193; GO:0097730"
"2099","Pocillopora_acuta_HIv2___TS.g30416.t1",0,12.5,0,0,0,0,0,NA,0,NA,1.5625,3.125,0,NA,NA,NA,NA,NA,NA,10.7507272377097,10.8821244265052,11.9342676676306,12.051770092437,12.0736554382762,12.3736673652217,10.5408399250532,10.8017103134127,12.073017599976,9.85467661623101,11.3336456682453,11.526675651401,11.1406156850896,2964.03107475425,-0.226247993758592,0.60650962770729,0.622238907290958,0.815518625865932,"Q00610",0,"Clathrin heavy chain 1 (Clathrin heavy chain on chromosome 17) (CLH-17)","amyloid-beta clearance by transcytosis [GO:0150093]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of protein localization to plasma membrane [GO:1903077]; osteoblast differentiation [GO:0001649]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; transferrin transport [GO:0033572]","GO:0000278; GO:0001649; GO:0003723; GO:0003725; GO:0005198; GO:0005764; GO:0005768; GO:0005819; GO:0005829; GO:0005886; GO:0005925; GO:0006886; GO:0006898; GO:0006914; GO:0016020; GO:0019901; GO:0030118; GO:0030130; GO:0030132; GO:0030136; GO:0030669; GO:0031623; GO:0032051; GO:0032588; GO:0032991; GO:0033572; GO:0036020; GO:0042147; GO:0042470; GO:0045334; GO:0048268; GO:0050750; GO:0051301; GO:0060236; GO:0070062; GO:0071439; GO:0072318; GO:0072583; GO:0072686; GO:0097718; GO:0150093; GO:1900126; GO:1903077; GO:1903561; GO:1990381; GO:1990498"
"2100","Pocillopora_acuta_HIv2___RNAseq.g12035.t1b",7.14285714285714,0,NA,0,0,0,0,0,0,0,0.793650793650794,0,1.78571428571429,NA,NA,NA,NA,NA,NA,12.2906607912795,12.99766029771,11.3265617092313,13.4742194412187,12.064317703809,13.3622054588553,13.167229315005,11.55189911993,11.9504423959059,12.529179888076,12.4714376121021,11.8367763440311,13.106098880173,6376.33135901261,1.01752897598531,0.612128912679903,0.0390062723892387,0.128311740695462,NA,NA,NA,NA,NA
"2101","Pocillopora_acuta_HIv2___RNAseq.g12037.t1",NA,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.30247991645527,9.5315987481135,7.75513657317841,7.22786336628594,8.23065898728289,3.68233641306884,10.8622678230637,7.6176380021177,3.68233641306884,3.68233641306884,7.05746526557039,7.11764997842062,6.99728055272016,360.442188128735,0.0472102500963765,0.94676032982103,0.905701347773804,0.964810500134212,"J9VQH1",3.26e-07,"ATP-dependent permease YOR1 (EC 7.2.2.-) (ABC transporter YOR1)","biological process involved in interaction with host [GO:0051701]","GO:0005524; GO:0005576; GO:0016020; GO:0016887; GO:0051701; GO:0140359; GO:1903561"
"2102","Pocillopora_acuta_HIv2___RNAseq.g12059.t1",0,0,9.52380952380952,0,0,0,0,NA,NA,NA,1.36054421768707,0,2.38095238095238,NA,NA,NA,NA,NA,NA,10.6369035654876,10.7607278575507,11.4425093299659,10.0591457883376,10.8343250912771,9.64829657671162,11.6217283726507,10.7275516534176,12.0214551605411,10.501903930463,10.8254547326403,11.1325489601379,10.5183605051427,2000.41630891975,-0.419665918734462,0.63450397193151,0.369957938083152,0.619767386661422,"Q9UDT6",2.01e-79,"CAP-Gly domain-containing linker protein 2 (Cytoplasmic linker protein 115) (CLIP-115) (Cytoplasmic linker protein 2) (Williams-Beuren syndrome chromosomal region 3 protein) (Williams-Beuren syndrome chromosomal region 4 protein)","cytoplasmic microtubule organization [GO:0031122]","GO:0005634; GO:0005875; GO:0005938; GO:0008017; GO:0031122; GO:0035371; GO:0051010"
"2103","Pocillopora_acuta_HIv2___RNAseq.g12061.t1",0,0,0,0,0,0,0.680272108843537,NA,0,NA,0.0850340136054422,0,0.170068027210884,NA,NA,NA,NA,NA,NA,11.0728213420493,10.3281352485686,10.5849359876299,10.3698463393754,10.6565248383379,11.2563949148521,10.4402736940998,8.92263569484299,10.9997132970783,12.5057313869975,10.7137012743832,10.4473262319877,10.9800763167787,1984.15536540833,0.370778801239228,0.62009935044518,0.438037625793514,0.681163913831888,"Q5R6Y0",0,"HBS1-like protein (EC 3.6.5.-)","nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]","GO:0003746; GO:0003924; GO:0005525; GO:0022626; GO:0032790; GO:0070966; GO:0072344; GO:1990533"
"2104","Pocillopora_acuta_HIv2___RNAseq.g12063.t1",0,0,0,11.1111111111111,0,0,0,NA,NA,NA,1.58730158730159,3.7037037037037,0,NA,NA,NA,NA,NA,NA,6.79100259980268,6.17776049751523,6.45538792833035,6.49062009109581,6.72579711173906,6.52080719718656,7.15240023555519,6.56229197038834,7.97107187406358,4.19574235723263,6.50428818629094,6.9011102968648,6.10746607571708,83.1105924084094,-0.312143141714123,0.832639354041208,0.474941097829604,0.711133337371366,NA,NA,NA,NA,NA
"2105","Pocillopora_acuta_HIv2___TS.g19499.t2",0,0,0,0,0,2.32558139534884,0,0,0,0,0.232558139534884,0.465116279069767,0,NA,NA,NA,NA,NA,NA,7.96707824409319,7.53615091189663,7.23131684908634,3.68233641306884,8.5214140541948,3.68233641306884,3.68233641306884,8.21758883240833,10.5113752647817,3.68233641306884,6.47142698087363,8.48975464891287,4.4530993128344,256.054527035565,-1.14489126044851,2.25476223797158,4.35576297531319e-07,7.73027676993005e-06,"P49013",5.45e-61,"Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III)","","GO:0005509; GO:0005576; GO:0009374"
"2106","Pocillopora_acuta_HIv2___RNAseq.g16430.t1",3.44827586206897,0,0,22.2222222222222,0,4,0,0,0,0,2.96704980842912,5.24444444444444,0.689655172413793,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,3.68233641306884,8.69670157782141,3.68233641306884,7.57885102301497,7.369096855117,8.7188287473744,3.68233641306884,11.3416897685827,6.21168500372547,4.68963487992995,7.73373512752098,366.240535630318,0.249766208741541,1.04497888552781,0.000212592111718779,0.0015736603397648,NA,NA,NA,NA,NA
"2107","Pocillopora_acuta_HIv2___RNAseq.g16431.t1",0,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.07047711082789,7.27190420218942,9.99092062400641,7.90193779854914,8.69363013713572,10.3149136311879,3.68233641306884,10.1981440236588,11.1045304649367,3.68233641306884,8.09111308186297,9.6115404721131,6.57068569161283,654.246721954319,-0.404119209732057,1.05532144185191,0.070029865090407,0.201735106287123,"Q00535",1.82e-176,"Cyclin-dependent kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Cyclin-dependent-like kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit)","axon extension [GO:0048675]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle recycling [GO:1903421]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]","GO:0000226; GO:0000307; GO:0001764; GO:0001963; GO:0002039; GO:0004672; GO:0004674; GO:0004693; GO:0005176; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006886; GO:0007160; GO:0007268; GO:0007409; GO:0007416; GO:0007519; GO:0008045; GO:0008542; GO:0014044; GO:0014069; GO:0016020; GO:0016079; GO:0016241; GO:0016301; GO:0016310; GO:0016533; GO:0018105; GO:0018107; GO:0019233; GO:0021697; GO:0021766; GO:0021819; GO:0021954; GO:0022038; GO:0030027; GO:0030054; GO:0030175; GO:0030182; GO:0030334; GO:0030424; GO:0030425; GO:0030426; GO:0030517; GO:0030549; GO:0031175; GO:0031397; GO:0031594; GO:0031914; GO:0032801; GO:0035249; GO:0035418; GO:0042981; GO:0043005; GO:0043025; GO:0043113; GO:0043125; GO:0043204; GO:0043525; GO:0045786; GO:0045861; GO:0045892; GO:0045956; GO:0046826; GO:0048148; GO:0048156; GO:0048167; GO:0048488; GO:0048489; GO:0048511; GO:0048675; GO:0048709; GO:0048813; GO:0050321; GO:0051301; GO:0051402; GO:0051726; GO:0051879; GO:0051966; GO:0060079; GO:0061001; GO:0070509; GO:0090314; GO:0098793; GO:0106310; GO:1903076; GO:1903421; GO:1904646"
"2108","Pocillopora_acuta_HIv2___RNAseq.g16432.t3",0,NA,NA,0,0,15.3846153846154,0,NA,0,NA,2.56410256410256,5.12820512820513,0,NA,NA,NA,NA,NA,NA,10.9831345921622,8.42479831485514,9.03647946873907,8.05848887682085,10.3682961825431,10.8420928295453,7.34008794471131,10.9156013226186,3.68233641306884,10.7143369849626,9.0365652930027,8.99716959582636,9.07596099017904,986.261818629262,-0.155861813315997,0.933010633619888,0.603389593667053,0.802817319731419,"O43795",0,"Unconventional myosin-Ib (MYH-1c) (Myosin I alpha) (MMI-alpha) (MMIa)","actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; endocytosis [GO:0006897]; post-Golgi vesicle-mediated transport [GO:0006892]","GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005737; GO:0005769; GO:0005884; GO:0005886; GO:0005902; GO:0005903; GO:0006892; GO:0006897; GO:0007015; GO:0010008; GO:0015629; GO:0016459; GO:0030048; GO:0030175; GO:0045177; GO:0045296; GO:0048471; GO:0051015; GO:0051017; GO:0070062; GO:0071944"
"2109","Pocillopora_acuta_HIv2___RNAseq.g16433.t1",1.02657004830918,0.149253731343284,0,0.121065375302663,1.61920714684534,1.0662038184974,2.22222222222222,1.41010575793184,0.26246719160105,0,0.787709529205298,0.601819174935248,0.973599883475348,NA,NA,NA,NA,NA,NA,3.68233641306884,7.24154832662667,6.9801832069997,11.4298393404834,3.68233641306884,6.86537227239914,7.27001054207962,9.33258570019174,3.68233641306884,3.68233641306884,6.38488850410556,5.47195562927959,7.29782137893153,380.323253837966,0.361125810174517,1.08611428602632,0.0145322674889169,0.0570096872686994,"B8UU59",0,"Polycystin-1-related protein (Polycystic kidney disease 1-related protein)","calcium ion transport [GO:0006816]","GO:0005261; GO:0005886; GO:0005929; GO:0006816"
"2110","Pocillopora_acuta_HIv2___TS.g19511.t1",25,31.0344827586207,14.2857142857143,NA,25,14.5454545454545,23.8095238095238,33.3333333333333,NA,NA,23.8583583903781,26.3044235458029,22.0238095238095,NA,NA,NA,NA,NA,NA,10.7814573810675,11.7029159522599,10.9647468044163,12.0702345342384,9.91150737318821,10.9232888049769,10.7249654246801,10.69773831626,9.4535191481937,7.43123314299026,10.4661606882271,10.3617938046251,10.5705275718291,1827.0041560076,0.163806327400536,0.656331960915626,0.735080410789209,0.882706771411799,"Q6ZT12",4.8e-173,"E3 ubiquitin-protein ligase UBR3 (EC 2.3.2.27) (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650)","embryo development ending in birth or egg hatching [GO:0009792]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; olfactory behavior [GO:0042048]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]","GO:0000151; GO:0001701; GO:0001967; GO:0004842; GO:0005737; GO:0006511; GO:0007608; GO:0008270; GO:0009792; GO:0016020; GO:0016567; GO:0042048; GO:0045732; GO:0061630; GO:0071596; GO:1904878"
"2111","Pocillopora_acuta_HIv2___RNAseq.g16446.t1",0,1.61290322580645,0.952380952380952,0,0,0.535714285714286,0,0,0,0,0.310099846390169,0.429723502304147,0.19047619047619,NA,NA,NA,NA,NA,NA,9.52434618730884,7.96430909081604,8.69684289122575,7.50775778510704,9.3271770216302,9.30105970217881,3.68233641306884,9.62383915994034,10.975348908932,5.79624808010018,8.2399265240308,9.62951083380743,6.85034221425418,548.897569762451,-0.859945202540248,1.2531757007488,0.0314888230616274,0.107621535152027,NA,NA,NA,NA,NA
"2112","Pocillopora_acuta_HIv2___RNAseq.g16458.t1",0,0,0,NA,0,0,NA,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.7544201020537,10.3786429865617,9.58010170961061,11.6131120599242,10.476281077297,10.3374304799881,9.89510933656289,10.7460685296556,11.0292532237441,9.5381058365157,10.4348525341914,10.5172249284722,10.3524801399105,1492.2687554284,-0.132126452147628,0.650216498424468,0.769691437690634,0.900786224998571,"Q0VFZ6",1.43e-90,"Cilia- and flagella- associated protein 210 (Coiled-coil domain-containing protein 173)","flagellated sperm motility [GO:0030317]","GO:0005879; GO:0030317; GO:0036126; GO:0160112"
"2113","Pocillopora_acuta_HIv2___RNAseq.g16471.t1",0,0,NA,0,0,1.38888888888889,NA,0,NA,0,0.198412698412698,0.347222222222222,0,NA,NA,NA,NA,NA,NA,6.47868055454933,9.24031059025604,3.68233641306884,3.68233641306884,10.0615817446745,3.68233641306884,11.0921968740108,8.19376023911409,3.68233641306884,3.68233641306884,6.3478212067949,6.41973907289512,6.27590334069467,411.312028123643,0.114849269104042,1.0032753674029,0.532263069703169,0.753052863047526,"Q1MTN8",6.69e-35,"Probable assembly chaperone of rpl4","cytosolic large ribosomal subunit assembly [GO:0180023]","GO:0005634; GO:0005730; GO:0005737; GO:0140597; GO:0180023"
"2114","Pocillopora_acuta_HIv2___RNAseq.g16486.t1",0,NA,NA,0,8.33333333333333,4.16666666666667,0,NA,0,NA,2.08333333333333,1.38888888888889,2.77777777777778,NA,NA,NA,NA,NA,NA,12.6876567471732,9.74902286093635,11.4779229066548,3.68233641306884,12.4404985069704,3.68233641306884,3.68233641306884,12.0243170760854,12.7488846910529,3.68233641306884,8.58576484411484,12.2758559855873,4.89567370264234,2676.39145640268,-13.4145832238622,3.22927861299136,4.89675133548287e-12,4.85113776139892e-10,"B3EWY9",3.19e-114,"Mucin-like protein","cell-matrix adhesion [GO:0007160]","GO:0005509; GO:0005615; GO:0007160; GO:0016020"
"2115","Pocillopora_acuta_HIv2___TS.g19564.t2",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.1660611572198,9.20427924097985,8.9414132214938,9.76629124656936,8.67369836228592,9.48422931252803,11.1333908309606,7.79472045485966,3.68233641306884,9.53491302170352,8.83813332616694,7.8516459217856,9.82462073054827,720.763039468332,0.552309722141263,1.02391166062185,0.163417013505457,0.368516321069993,"Q8VHK9",0,"ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE)","3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]","GO:0000287; GO:0000781; GO:0000976; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0008094; GO:0009615; GO:0010494; GO:0010501; GO:0010628; GO:0016607; GO:0016887; GO:0017148; GO:0030154; GO:0030424; GO:0030425; GO:0031442; GO:0032206; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0044806; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:0090669; GO:1900153; GO:1901534; GO:1903843; GO:1904358; GO:1904582; GO:2000767"
"2116","Pocillopora_acuta_HIv2___RNAseq.24886_t",0,12.9770992366412,13.3802816901408,7.3394495412844,3.52941176470588,8.44793713163065,7.78097982708934,0,0,0,5.34551591914923,5.75289718191125,4.93813465638721,NA,NA,NA,NA,NA,NA,3.68233641306884,5.12032714986833,7.46312695790699,9.5243126552094,3.68233641306884,9.56112642365297,4.51171232812315,9.02733514890453,3.68233641306884,12.2798423594867,6.85347922623586,5.50749426920361,8.19946418326811,705.439505534698,0.338807879327231,1.08180593562201,5.46885304072504e-05,0.000494384314881543,"Q2HJ10",1.12e-120,"Proton-coupled zinc antiporter SLC30A2 (Solute carrier family 30 member 2) (Zinc transporter 2) (ZnT-2)","intracellular zinc ion homeostasis [GO:0006882]; response to zinc ion [GO:0010043]; zinc ion import into lysosome [GO:0140916]; zinc ion import into mitochondrion [GO:0140917]; zinc ion import into zymogen granule [GO:0140915]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]","GO:0005385; GO:0005743; GO:0005765; GO:0005770; GO:0005886; GO:0006829; GO:0006882; GO:0010008; GO:0010043; GO:0030658; GO:0042589; GO:0042802; GO:0046872; GO:0071577; GO:0140826; GO:0140915; GO:0140916; GO:0140917"
"2117","Pocillopora_acuta_HIv2___RNAseq.g16499.t1",18.6046511627907,14.8936170212766,12.1951219512195,0,0,14.5833333333333,21.7391304347826,0,NA,NA,10.2519817379253,7.36923758865248,13.1347258871982,NA,NA,NA,NA,NA,NA,8.18896956663764,6.19950000251922,8.62521464881705,3.68233641306884,3.68233641306884,3.68233641306884,3.68233641306884,6.56229197038834,9.76082750690022,3.68233641306884,5.77484857606067,7.36392802116242,4.18576913095892,159.903063554963,-0.49800227124907,1.18857418322974,0.000868580888359246,0.00520644590519193,"Q4KMD7",3.2e-62,"Speckle targeted PIP5K1A-regulated poly(A) polymerase (Star-PAP) (EC 2.7.7.19) (RNA-binding motif protein 21) (RNA-binding protein 21) (U6 snRNA-specific terminal uridylyltransferase 1) (U6-TUTase) (EC 2.7.7.52)","co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; snRNA processing [GO:0016180]","GO:0003723; GO:0003730; GO:0005524; GO:0005730; GO:0005739; GO:0005847; GO:0008270; GO:0016180; GO:0016607; GO:0050265; GO:0140767; GO:0180010; GO:1990817"
"2118","Pocillopora_acuta_HIv2___RNAseq.g16514.t1",NA,0,0,0,0,0,NA,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.4680060679803,7.874611289381,8.41270432526924,6.94355081454563,8.32789903644394,9.81529055841039,8.38209501305515,3.68233641306884,9.68935267154801,7.42781826027713,6.11298598862389,8.74265053193038,305.657549390828,0.703846839783409,1.19975422993586,0.0327757373530252,0.111325590759116,"Q69Z37",1.91e-15,"Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like)","common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145]","GO:0002244; GO:0005737; GO:0005739; GO:0005769; GO:0017145; GO:0034058; GO:0035726; GO:0042176; GO:0048536"
"2119","Pocillopora_acuta_HIv2___RNAseq.g16522.t1",NA,NA,8.33333333333333,0,0,0,0,0,0,NA,1.19047619047619,0,2.77777777777778,NA,NA,NA,NA,NA,NA,3.68233641306884,6.03941460781193,6.28256793029396,3.68233641306884,7.02203185021144,10.4140421555981,3.68233641306884,6.78080511148754,8.2015332238684,3.68233641306884,5.94697405315467,6.39385490578604,5.50009320052331,189.633389964125,-0.114115995524009,1.02195649364255,0.00680161139976644,0.0302429184318792,"O42602",3.62e-31,"Corticotropin-releasing factor receptor 1 (CRF-R-1) (CRF-R1) (CRFR-1) (Corticotropin-releasing hormone receptor 1) (CRH-R-1) (CRH-R1)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; corticotropin secretion [GO:0051458]; regulation of corticosterone secretion [GO:2000852]","GO:0005886; GO:0007166; GO:0007189; GO:0015056; GO:0051458; GO:0071376; GO:2000852"
"2120","Pocillopora_acuta_HIv2___RNAseq.g16523.t1",0,NA,NA,NA,0,0,NA,0,0,5.88235294117647,0.980392156862745,0,1.96078431372549,NA,NA,NA,NA,NA,NA,7.44280641494388,3.68233641306884,8.36342648242998,3.68233641306884,9.98445945115328,8.30420171157497,11.0842497611572,7.59045235107559,10.2401858909176,3.68233641306884,7.4056791302459,8.72426611810407,6.08709214238774,522.929486330333,-0.391192004767205,1.0934400540655,5.43807229064818e-05,0.000492217006332512,"Q99MU0",1.47e-27,"Protein DBF4 homolog A (ChDBF4)","DNA replication [GO:0006260]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987]","GO:0003676; GO:0006260; GO:0008270; GO:0010571; GO:0031431; GO:0043539; GO:1901987"
"2121","Pocillopora_acuta_HIv2___RNAseq.g16526.t1",0.966183574879227,0,0,0,0,0,0,NA,0,0,0.107353730542136,0,0.193236714975845,NA,NA,NA,NA,NA,NA,3.68233641306884,6.11036395750361,8.94359540495846,10.1915586554545,3.68233641306884,9.91627106320876,7.93153867530596,4.37784214571138,6.59364800818146,11.4591642493068,7.28886549857686,5.4559516769978,9.12177932015593,568.210053125228,4.96493883857928,2.32214892195011,1.3391788952358e-05,0.000147411594678011,"P47179",6.41e-12,"Cell wall protein DAN4 (Delayed anaerobic protein 4)","fungal-type cell wall organization [GO:0031505]","GO:0005199; GO:0005576; GO:0005886; GO:0009277; GO:0031505; GO:0071944; GO:0098552"
"2122","Pocillopora_acuta_HIv2___RNAseq.g16544.t1",0,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.3819792816066,11.6669810386598,10.2339351495901,11.5243841116456,10.3627098686979,11.8306415151848,9.15331824136873,10.4447992728734,11.146212556666,11.5986901114507,10.8343651147744,10.5139272258868,11.1548030036619,2077.0392153111,0.449019328986194,0.653105011309202,0.346855736991481,0.598178297346462,"Q13797",1.28e-109,"Integrin alpha-9 (Integrin alpha-RLC)","cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of vasoconstriction [GO:0045906]; neutrophil chemotaxis [GO:0030593]","GO:0005178; GO:0005886; GO:0007155; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0009925; GO:0030593; GO:0033627; GO:0034679; GO:0045906; GO:0046872; GO:0098609; GO:0098640"
"2123","Pocillopora_acuta_HIv2___RNAseq.g16545.t1",0,NA,17.7777777777778,0,0,0,6.45161290322581,0,0,NA,3.02867383512545,0,6.0573476702509,NA,NA,NA,NA,NA,NA,9.25906492444599,7.7661671588452,10.3437006097635,8.71247567247621,9.61415018064534,8.35121219233997,7.30046701549876,8.09750134092551,9.85340268582999,3.68233641306884,8.29804781938393,9.43356394832207,7.1625316904458,478.921427817363,-0.850603961500736,1.10136560551394,0.096265782023812,0.254178216720047,"P26008",5.12e-104,"Integrin alpha-V (Vitronectin receptor subunit alpha) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain]","angiogenesis [GO:0001525]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]","GO:0001525; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0033627; GO:0034685; GO:0034686; GO:0046872; GO:0098609"
"2124","Pocillopora_acuta_HIv2___TS.g19623.t2",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.46787034384102,3.68233641306884,10.1112479771295,3.68233641306884,7.37006729746139,8.16199739230414,3.68233641306884,6.17109778065781,8.98123917769104,3.68233641306884,6.49928656213603,8.42030451535615,4.5782686089159,269.402234655542,-0.739585640049072,1.42787322151454,1.10070324949175e-06,1.71188944092996e-05,"A6H603",5.93e-111,"NACHT domain- and WD repeat-containing protein 1","negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628]","GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088"
"2125","Pocillopora_acuta_HIv2___RNAseq.g16571.t1",60,28.5714285714286,100,0,NA,57.1428571428571,21.4285714285714,NA,NA,NA,44.5238095238095,28.5714285714286,60.4761904761905,NA,NA,NA,NA,NA,NA,6.38824903660035,6.72972788057412,8.49729563014074,7.40425219505693,3.68233641306884,7.87054151223103,3.68233641306884,6.43348545126895,7.74484218239052,10.4229460892288,6.88560128036291,6.54924174269388,7.22196081803194,243.149505984529,0.10461477423263,0.95465457249812,0.713519236711589,0.870694527950428,NA,NA,NA,NA,NA
"2126","Pocillopora_acuta_HIv2___RNAseq.g29115.t1",0,NA,NA,0,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.147081659564,5.80053168740374,9.32793280505634,3.68233641306884,10.9343709362459,5.65167313584929,3.68233641306884,10.4517102010817,11.3201745547873,3.68233641306884,7.46804842191948,10.436254031347,4.49984281249191,762.405021667792,-8.4290561316454,2.74427055195064,5.16010021231728e-10,2.29648275295252e-08,"P15989",1.08e-10,"Collagen alpha-3(VI) chain","cell adhesion [GO:0007155]","GO:0004867; GO:0005581; GO:0005615; GO:0007155; GO:0062023"
"2127","Pocillopora_acuta_HIv2___RNAseq.g29122.t1",0,0,0,NA,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,10.7010741522299,10.7175766361079,11.3575587848435,9.0250299895197,11.3287610879557,9.09578287388244,3.68233641306884,10.6801920829196,10.0224314383965,3.68233641306884,9.02930798719929,10.818003509269,7.24061246512954,1208.95375356298,-0.691396324012565,1.23595351146436,0.017265761590972,0.0657881916890989,"H2QII6",2.48e-94,"E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2)","mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]","GO:0003723; GO:0003755; GO:0005635; GO:0005642; GO:0005643; GO:0005737; GO:0006457; GO:0006607; GO:0016740; GO:0016925; GO:0031965; GO:0046872; GO:0051028"
"2128","Pocillopora_acuta_HIv2___RNAseq.g29123.t1",0,0,0,NA,0,0.793650793650794,0,0,0,NA,0.0992063492063492,0.198412698412698,0,NA,NA,NA,NA,NA,NA,9.8135029664428,8.23352351804856,7.79446269476917,3.68233641306884,9.28578148331373,9.33260033023362,3.68233641306884,9.5751791564872,3.68233641306884,3.68233641306884,6.87643958015704,8.03025254281635,5.72262661749774,330.269328879342,-0.365080417683721,1.06067286095508,0.156925286701446,0.359254090986025,"A0A0B4K7J2",3.79e-69,"E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358)","germ cell development [GO:0007281]; juvenile hormone mediated signaling pathway [GO:0035626]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore complex assembly [GO:0051292]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of RNA export from nucleus [GO:0046833]; protein import into nucleus [GO:0006606]; regulation of protein localization [GO:0032880]; ventral cord development [GO:0007419]","GO:0005642; GO:0005643; GO:0005737; GO:0006606; GO:0006607; GO:0007281; GO:0007419; GO:0008284; GO:0010628; GO:0019789; GO:0032880; GO:0035626; GO:0046833; GO:0046872; GO:0051028; GO:0051292; GO:1900182"
"2129","Pocillopora_acuta_HIv2___RNAseq.g29133.t2",NA,0,0,NA,NA,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,9.67538135522779,6.77312724931675,9.42324730739192,8.46952865410376,9.30014568009039,3.68233641306884,8.76921698621586,6.3255230136643,9.11590073433909,9.42882038088892,8.09632277743076,8.7680396181427,7.42460593671883,413.361493027157,-0.275445211869837,0.94824224350232,0.352916313047565,0.604101247240622,NA,NA,NA,NA,NA
"2130","Pocillopora_acuta_HIv2___TS.g8859.t1",0,0,0,0,0,0,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.8270605347317,11.3924655678014,11.5512580290541,12.95955374412,11.4880348139968,13.0305008487007,12.3351492866975,10.3967756160985,12.7271621161366,11.0162272035624,11.77241877609,11.3980582220035,12.1467793301764,4182.16340142659,0.49324176654073,0.711870287549875,0.292565725292492,0.53975390951921,"Q96L93",2.53e-127,"Kinesin-like protein KIF16B (Sorting nexin-23)","early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]","GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007018; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0080025"
"2131","Pocillopora_acuta_HIv2___RNAseq.g29141.t1",NA,0,NA,0,0,15.3846153846154,0,NA,NA,0,2.56410256410256,5.12820512820513,0,NA,NA,NA,NA,NA,NA,9.04407912812637,10.8357937970894,8.86287661369108,10.9266460707242,9.24451304423829,9.20846260235005,3.68233641306884,7.94518256625855,3.68233641306884,3.68233641306884,7.71145630616845,7.75579755307663,7.66711505926027,603.45504255163,0.0385721155639781,0.934198877944362,0.849769163776235,0.940807790142563,"A2RU67",4.64e-09,"Protein FAM234B","","GO:0005794; GO:0005815; GO:0016020"
"2132","Pocillopora_acuta_HIv2___RNAseq.g29144.t3",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.7932053425524,12.4474148245473,12.8278452014781,13.142454598712,13.0234880981999,13.2574042227183,13.0789168203129,12.1940762906362,13.0714291297699,13.3769360372627,12.921317056619,12.7820088125273,13.0606253007106,7944.22303649512,0.213670612826471,0.506704321014133,0.625388632949809,0.817424650911444,"Q80X08",1.26e-55,"WASH complex subunit 2","endocytic recycling [GO:0032456]; negative regulation of barbed-end actin filament capping [GO:2000813]; protein localization to endosome [GO:0036010]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0005546; GO:0005547; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0010314; GO:0031901; GO:0032266; GO:0032456; GO:0036010; GO:0042147; GO:0043325; GO:0070273; GO:0071203; GO:0080025; GO:1900024; GO:1901981; GO:1905394; GO:2000813"
"2133","Pocillopora_acuta_HIv2___RNAseq.g29168.t1",0,0,0.900900900900901,1.0989010989011,2.46636771300448,0.126582278481013,0.829875518672199,0,0,NA,0.6025141677733,0.245096675476422,1.0492860331444,NA,NA,NA,NA,NA,NA,7.46472747091322,7.95812695172856,11.1668018045695,9.35386246654289,10.9695054401292,9.47542641826592,8.94558215164935,9.9553959065248,11.1274744398263,9.63074362499101,9.60476466751408,10.1367810123926,9.07274832263555,1035.77646933656,-0.814824440674344,0.660015116722714,0.108158013624012,0.276835517440757,"Q6XUX2",7.32e-90,"Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5)","cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of kinase activity [GO:0033674]","GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0033674; GO:0043066; GO:0044344; GO:0045743; GO:0070161; GO:0070374; GO:0106310"
"2134","Pocillopora_acuta_HIv2___RNAseq.g29169.t1",0,3.17460317460317,0,2.36686390532544,0,2.5462962962963,1.50375939849624,0.917431192660551,0,0,1.05089539673817,1.80103891377709,0.300751879699248,NA,NA,NA,NA,NA,NA,8.69918513939989,9.40808103785765,9.21326362776699,9.4153569016746,8.03807988924657,10.9083268700401,11.0726116062836,7.42065157330268,6.59364800818146,3.68233641306884,8.44515410668224,7.99296564757952,8.89734256578496,675.132472145185,0.287821202966643,0.924759469075252,0.447758025232998,0.689856420640188,"A2CI35",2.88e-22,"Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5)","cellular response to fibroblast growth factor stimulus [GO:0044344]; embryonic organ development [GO:0048568]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]","GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0043066; GO:0044344; GO:0045743; GO:0048568; GO:0070161; GO:0070374; GO:0106310"
"2135","Pocillopora_acuta_HIv2___RNAseq.g29170.t1",0,0,0,0.641025641025641,0,0.277008310249307,1.92307692307692,3.57142857142857,0,NA,0.712504382864494,0.897892504540704,0.480769230769231,NA,NA,NA,NA,NA,NA,8.23630150566297,9.84238241719016,7.41968306595897,9.28436287468612,8.98152926143592,6.88702586188914,3.68233641306884,9.13278270983045,6.24691203794079,12.096062283566,8.18093784312294,8.00344171616582,8.35843397008005,742.860961039848,0.0949793018735724,0.951488650410903,0.703023644127234,0.864965463478761,"Q6XUX1",1.21e-37,"Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5)","cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of kinase activity [GO:0033674]","GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0033674; GO:0043066; GO:0044344; GO:0045743; GO:0070161; GO:0070374; GO:0106310"
"2136","Pocillopora_acuta_HIv2___TS.g8894.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.2022056766112,3.68233641306884,8.49133772109432,10.0483189203131,9.74875011262462,9.81385865764162,3.68233641306884,10.4346875349016,8.68482660432,6.75413069443622,8.15427887480804,9.51236152991035,6.79619621970572,605.848639334105,-0.336331870594232,1.02446951946724,0.102623452134476,0.266537190101107,"Q67E01",9.15e-88,"Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5)","embryonic organ development [GO:0048568]","GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0048568; GO:0070161; GO:0106310"
"2137","Pocillopora_acuta_HIv2___RNAseq.g29181.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,4.21445057288855,7.29178752006676,7.49934036428563,3.68233641306884,8.40771982830346,3.68233641306884,3.68233641306884,8.47888254572353,3.68233641306884,9.76487581933561,6.03864023028789,6.456545944854,5.62073451572178,178.050223413935,-0.0858907144546796,1.02254996053918,0.000768416922379766,0.00469357363399533,NA,NA,NA,NA,NA
"2138","Pocillopora_acuta_HIv2___TS.g8906.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.7709539857881,12.048068669242,11.536886208662,8.99633298823398,12.1845796580938,10.2900334103503,11.7027629544241,11.7262662054081,11.2638943949466,12.8757909735982,11.4395569448747,11.6965160905797,11.1825977991697,3355.9368512108,-0.266905753875133,0.719843278823804,0.5481460962277,0.765435908074671,"Q8CGN4",1.11e-48,"BCL-6 corepressor (BCoR)","blastocyst hatching [GO:0001835]; chromatin remodeling [GO:0006338]; heart development [GO:0007507]; negative regulation of bone mineralization [GO:0030502]; negative regulation of tooth mineralization [GO:0070171]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; roof of mouth development [GO:0060021]; specification of axis polarity [GO:0065001]","GO:0000122; GO:0000977; GO:0001835; GO:0003714; GO:0004842; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0030502; GO:0031072; GO:0042476; GO:0042826; GO:0060021; GO:0065001; GO:0070171; GO:0140261; GO:0140297"
"2139","Pocillopora_acuta_HIv2___RNAseq.g29236.t2",0,NA,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0885970075657,9.40354889628135,10.2366057233796,11.5266144186797,9.45987604407631,9.40855875885978,10.4220451185247,9.08668746717562,3.68233641306884,7.51177934837273,9.08266491959843,8.51082053105321,9.65450930814365,917.616291194816,0.46315730878616,0.916526258160044,0.303502934861119,0.551906770157307,"Q16U49",0,"Mediator of RNA polymerase II transcription subunit 14 (Mediator complex subunit 14)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003712; GO:0006357; GO:0016592"
"2140","Pocillopora_acuta_HIv2___RNAseq.25137_t",0,8.33333333333333,NA,NA,0,0,0,NA,0,NA,1.38888888888889,2.77777777777778,0,NA,NA,NA,NA,NA,NA,3.68233641306884,5.96448686545822,3.68233641306884,9.11675799391177,3.68233641306884,9.3228178130759,7.16350359739089,7.88315412751572,3.68233641306884,11.3371157331036,6.55171817827315,4.52249995595822,8.58093640058808,407.558452060564,0.690988227772388,1.36201691717708,2.23889049000686e-07,4.3317013457614e-06,"C5JHY1",5e-07,"Neutral protease 2 homolog BDBG_02110 (EC 3.4.24.39) (Deuterolysin BDBG_02110)","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0046872"
"2141","Pocillopora_acuta_HIv2___RNAseq.g29254.t1",0,NA,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,9.13332655422424,3.68233641306884,9.67552830032968,10.8269518413181,5.69873558273438,9.60366930790199,3.68233641306884,3.68233641306884,6.33498936518526,7.15543939771872,5.5145393326518,390.139014000169,-0.2183336001354,1.02418949155554,0.478578241069717,0.713845073613735,"Q63486",0,"Ras-related GTP-binding protein A (Rag A) (RagA) (EC 3.6.5.-)","apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; negative regulation of autophagy [GO:0010507]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization [GO:0008104]; protein localization to lysosome [GO:0061462]; protein localization to membrane [GO:0072657]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0006915; GO:0008104; GO:0009267; GO:0010507; GO:0031625; GO:0031669; GO:0032008; GO:0033209; GO:0034198; GO:0035556; GO:0042593; GO:0042803; GO:0043200; GO:0043495; GO:0046982; GO:0051219; GO:0061462; GO:0071230; GO:0072657; GO:1903432; GO:1904263; GO:1990130; GO:1990131; GO:1990877"
"2142","Pocillopora_acuta_HIv2___RNAseq.g29299.t1",6.66666666666667,NA,0,15.3846153846154,14.2857142857143,0,9.52380952380952,0,NA,NA,6.55154369440084,5.12820512820513,7.61904761904762,NA,NA,NA,NA,NA,NA,9.61490257380177,3.68233641306884,3.68233641306884,11.0079164821899,9.45871250106622,3.68233641306884,9.72522844276411,9.36756596037501,3.68233641306884,3.68233641306884,6.75860080255412,7.16117077227614,6.35603083283211,492.660088757215,-0.0432304402171829,1.00156654992888,0.0501331318627609,0.155639755154105,"Q9DCJ9",2.03e-76,"N-acetylneuraminate lyase (NALase) (EC 4.1.3.3) (N-acetylneuraminate pyruvate-lyase) (N-acetylneuraminic acid aldolase) (Sialate lyase) (Sialate-pyruvate lyase) (Sialic acid aldolase) (Sialic acid lyase)","N-acetylneuraminate catabolic process [GO:0019262]","GO:0005737; GO:0008747; GO:0019262; GO:0042802"
"2143","Pocillopora_acuta_HIv2___RNAseq.g29305.t1",0,NA,NA,0,0,0,13.0434782608696,0,0,0,1.6304347826087,0,3.26086956521739,NA,NA,NA,NA,NA,NA,9.2017697847733,9.30249394840278,9.37233470135988,8.656493341284,10.3658160470016,8.11734689253391,9.50690853612286,9.40948504545145,9.00976203881632,9.76487581933561,9.27072861550817,9.47183352348051,9.06962370753583,642.301016633903,-0.235733199587276,0.637466221725497,0.608116020114975,0.805523985969613,NA,NA,NA,NA,NA
"2144","Pocillopora_acuta_HIv2___TS.g9041.t1",0,0,0,0,0,0,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.7415147917266,8.92948273586804,9.74925092460117,7.79464067680062,9.78168821355153,7.41829334707295,9.66254934004683,9.76371296032483,7.98840764607209,10.2929301988867,9.01224708349514,9.20491490725524,8.81957925973503,598.494631939568,-0.221864874681644,0.753025021671101,0.607698364666055,0.805523985969613,NA,NA,NA,NA,NA
"2145","Pocillopora_acuta_HIv2___TS.g9052.t1",2.1671826625387,1.3215859030837,11.25,0,5.36193029490617,1.24826629680999,0,0,4.94505494505495,NA,2.92155778915483,1.50298142898973,4.69477823936122,NA,NA,NA,NA,NA,NA,5.45976149983951,8.79746969413494,6.97157030183863,7.92924455308051,7.58678057169964,8.76098054746593,9.88516233236226,8.19676050826218,5.26843329136292,10.1707384873589,7.90269017874054,6.69666123460058,9.10871912288051,367.026110219639,1.870995728982,1.19937803737027,0.00475202942099364,0.0222510047087251,NA,NA,NA,NA,NA
"2146","Pocillopora_acuta_HIv2___RNAseq.g29327.t1",0,0,0,0,0,0.851063829787234,0.970873786407767,0,2,NA,0.424659735132778,0.570212765957447,0.242718446601942,NA,NA,NA,NA,NA,NA,7.94132135187028,9.03290361665377,7.69923743453429,8.42712219499703,8.15208785145359,10.2389472304673,9.85999045898898,8.6284797783327,8.32937406314622,8.32601225032231,8.66354762307665,8.15010009586742,9.17699515028588,453.000531129078,0.819644880669902,0.630723072390525,0.0997683572545446,0.26099647663768,NA,NA,NA,NA,NA
"2147","Pocillopora_acuta_HIv2___RNAseq.g29331.t1",4.93827160493827,0,0,0,3.50877192982456,0.608519269776876,2.85714285714286,0,0,0,1.19127056616826,0.121703853955375,2.26083727838114,NA,NA,NA,NA,NA,NA,4.95179328310793,4.75675715543394,5.38589367603326,4.62642457401022,4.75140430725689,5.87223972230221,4.27277361158612,5.57827407666034,4.9224776128996,3.68233641306884,4.88003744323593,5.1179685911916,4.64210629528027,12.4738086018029,-0.453081765629391,0.989904177881413,0.229316362355501,0.463277204865719,NA,NA,NA,NA,NA
"2148","Pocillopora_acuta_HIv2___RNAseq.g29369.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.04675156217379,6.17776049751523,4.80540103069894,6.49062009109581,7.27216983134098,9.17839774949258,3.68233641306884,9.39260215105686,4.25049936715761,7.93763424012006,6.42341729337207,6.15348478848564,6.6933497982585,168.847010312782,0.404896169418369,1.04301856701064,0.16300437154112,0.367815168482178,NA,NA,NA,NA,NA
"2149","Pocillopora_acuta_HIv2___RNAseq.g29378.t1",6.74157303370786,10,6.36942675159236,0,20.952380952381,1.92771084337349,9.56937799043062,0,0,0,5.55604695714853,2.3855421686747,8.72655174562236,1,75,75,4.86887613850438e-06,4.86887613850438e-06,4.86887613850438e-06,7.95167965288704,9.06770233724501,4.85281479041193,8.46487807594262,7.38984723548559,9.92534802562995,8.29489711500127,6.5996347665023,3.68233641306884,3.68233641306884,6.99114748252434,6.09526257167114,7.88703239337754,252.262304487637,1.6413533442332,1.29541919251616,0.0196354228566691,0.0731628022992641,NA,NA,NA,NA,NA
"2150","Pocillopora_acuta_HIv2___TS.g9115.t1b",0,0,0,0,0,0.843881856540084,0.709219858156028,0,8,NA,1.06145574607735,1.76877637130802,0.177304964539007,NA,NA,NA,NA,NA,NA,10.1627299305113,8.9881890720638,9.79828441445335,9.19460010756973,9.7918867120139,3.68233641306884,3.68233641306884,10.4321484857469,7.26386591441872,3.68233641306884,7.66787138759842,9.48978309142883,5.84595968376801,537.475336996867,-0.639920869117918,1.23919355984674,2.97034435683999e-05,0.000291670473708986,"Q55E58",4.19e-17,"Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)","cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856]","GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310"
"2151","Pocillopora_acuta_HIv2___TS.g9125.t1",50,66.6666666666667,25,66.6666666666667,NA,NA,NA,33.3333333333333,25.9259259259259,80,49.6560846560847,48.1481481481482,51.6666666666667,NA,NA,NA,NA,NA,NA,8.63004608615769,9.30735463838075,9.69590581005791,10.1859247070722,8.21141522339424,3.68233641306884,3.68233641306884,5.06769837305767,7.25430059498276,11.3625455280371,7.7079863787278,7.77187321753005,7.64409953992555,594.192683409213,-0.0875360218866356,0.950473987362437,0.594767191490952,0.797782046394481,"A0A1L8EYB2",4.68e-155,"Dynein axonemal assembly factor 8 (Dynein axonemal-associated protein 1)","outer dynein arm assembly [GO:0036158]","GO:0036158; GO:0070840; GO:0120293"
"2152","Pocillopora_acuta_HIv2___RNAseq.g29397.t1",0,0,0,0,NA,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0638083648081,10.6076338766908,11.2444766677838,3.68233641306884,8.8825782595145,8.90960331350435,12.9766715800484,10.6334366978586,8.32483645761105,7.69527455782698,9.30206561887154,9.82982728951521,8.77430394822787,1595.80663775653,-0.0482052761845387,0.886951140366624,0.837511125504518,0.935770640474953,"Q9UMN6",2.64e-119,"Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.364) (Myeloid/lymphoid or mixed-lineage leukemia protein 4) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7)","methylation [GO:0032259]; positive regulation of DNA-templated transcription [GO:0045893]","GO:0005634; GO:0005654; GO:0008270; GO:0032259; GO:0035097; GO:0042800; GO:0044665; GO:0045322; GO:0045893; GO:0140945; GO:0140999"
"2153","Pocillopora_acuta_HIv2___RNAseq.g18068.t1",3.7037037037037,0,NA,NA,0,0,0,0,NA,NA,0.617283950617284,0,1.23456790123457,NA,NA,NA,NA,NA,NA,5.92950120283598,3.68233641306884,7.78960555143337,8.44612397784377,7.04725325528079,3.68233641306884,3.68233641306884,8.45654065286637,8.09359153693876,11.5185442460987,6.83281696625043,7.46329843987105,6.2023354926298,414.803634127249,-0.285802131713603,1.04222002006954,0.00121571423452941,0.00690655565130929,"P19493",5.44e-107,"Glutamate receptor 4 (GluR-4) (GluR4) (AMPA-selective glutamate receptor 4) (GluR-D) (Glutamate receptor ionotropic, AMPA 4) (GluA4)","chemical synaptic transmission [GO:0007268]; chemical synaptic transmission, postsynaptic [GO:0099565]; modulation of chemical synaptic transmission [GO:0050804]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of synapse structure or activity [GO:0050803]; response to fungicide [GO:0060992]; synaptic transmission, glutamatergic [GO:0035249]","GO:0004970; GO:0004971; GO:0005886; GO:0007268; GO:0008328; GO:0014069; GO:0030425; GO:0032281; GO:0032983; GO:0034220; GO:0034392; GO:0035249; GO:0042802; GO:0043025; GO:0043195; GO:0043197; GO:0045202; GO:0048787; GO:0050803; GO:0050804; GO:0051968; GO:0060078; GO:0060992; GO:0098839; GO:0098978; GO:0099507; GO:0099565; GO:1904315"
"2154","Pocillopora_acuta_HIv2___TS.g19340.t2",NA,0,0,NA,0,18.1818181818182,0,0,NA,NA,3.03030303030303,6.06060606060606,0,NA,NA,NA,NA,NA,NA,4.72947037839729,5.01287713650611,4.17105584529177,3.68233641306884,4.86250168289467,6.00096166566855,5.93399417379984,8.0715766610533,4.86223652345053,3.68233641306884,5.10093468931997,5.33936821821751,4.86250116042244,36.1481616197367,-0.357225134427827,0.958807175071707,0.328601693569125,0.578699158039927,"Q6TDP4",1.1e-36,"Kelch-like protein 17 (Actinfilin)","actin cytoskeleton organization [GO:0030036]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252]","GO:0005615; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0031208; GO:0032839; GO:0043025; GO:0051015; GO:0060090; GO:0098978; GO:0140252"
"2155","Pocillopora_acuta_HIv2___RNAseq.g18117.t1",0,0,0,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.3867460258848,12.2649540128348,8.61703144250268,12.364495463494,10.3645743782436,12.0533602159917,13.8774788209202,11.9645194631531,3.68233641306884,12.013618593955,10.7589114830049,9.0030415445706,12.5147814214391,4044.64039880152,1.29352891512631,1.55242067651039,0.0252467882986869,0.0898105130231694,"Q54TR1",1.33e-99,"Counting factor associated protein D","G protein-coupled chemorepellent receptor signaling pathway [GO:0140986]; immune response [GO:0006955]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein localization to plasma membrane [GO:0072659]; proteolysis [GO:0006508]; sorocarp morphogenesis [GO:0031288]","GO:0005576; GO:0005615; GO:0006508; GO:0006955; GO:0031288; GO:0031410; GO:0072659; GO:0140986; GO:1903665; GO:2001235"
"2156","Pocillopora_acuta_HIv2___TS.g19369.t1",0,NA,0,NA,NA,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.06563673075528,6.81522472615292,6.51648711029815,6.61544894152208,7.1555024764568,5.80281783295425,6.89653683871883,8.01827956207571,7.75163327373382,4.40467075915833,6.70422382518262,7.30150783066395,6.10693981970128,101.375309482731,-0.755743365086863,0.916962087033832,0.133989491269416,0.3232194799401,"Q921N8",1.26e-06,"G protein pathway suppressor 2 (GPS-2)","B cell differentiation [GO:0030183]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fat cell differentiation [GO:0045598]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; response to mitochondrial depolarisation [GO:0098780]","GO:0000122; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005739; GO:0005829; GO:0006357; GO:0010804; GO:0010875; GO:0017053; GO:0019216; GO:0030183; GO:0030332; GO:0034122; GO:0035360; GO:0045598; GO:0045599; GO:0045944; GO:0046329; GO:0050728; GO:0050859; GO:0098780; GO:1900045"
"2157","Pocillopora_acuta_HIv2___RNAseq.g18127.t1",100,100,NA,100,100,100,100,NA,NA,NA,100,100,100,NA,NA,NA,NA,NA,NA,10.9749280688589,8.7302559334492,11.0138298436159,10.0986629630133,10.3664364807894,10.0785002441612,9.49823239497389,11.2621328421421,10.7547962695506,9.1276464974367,10.1905421537991,10.8744247009914,9.50665960660686,1321.43914464802,-1.10837243426993,0.652250172269453,0.0311570688470262,0.106841119915454,"Q08BJ2",1.46e-68,"KH domain-containing, RNA-binding, signal transduction-associated protein 2","mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]","GO:0000381; GO:0003729; GO:0005634; GO:0006397; GO:0008143"
"2158","Pocillopora_acuta_HIv2___RNAseq.g18134.t1",0,0,0,0,0,0.769230769230769,0,NA,14.7058823529412,NA,1.93438914027149,3.86877828054299,0,NA,NA,NA,NA,NA,NA,11.7607089980364,12.0209649206686,12.5631115341022,12.0184813821083,12.4683623520753,11.5696318349354,11.9831926804014,12.0599046241316,12.1772194946447,11.4800604420029,12.0101638263107,12.205861400598,11.8144662520233,4208.26648408451,-0.300204942215426,0.51639843161142,0.496868784422509,0.727141358277533,"Q9UPN3",0,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha)","Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]","GO:0003723; GO:0003779; GO:0005198; GO:0005509; GO:0005737; GO:0005794; GO:0005856; GO:0005874; GO:0005886; GO:0010632; GO:0015629; GO:0016020; GO:0016055; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0045296; GO:0045773; GO:0051011; GO:0051015; GO:0051893; GO:0150011"
"2159","Pocillopora_acuta_HIv2___RNAseq.g18135.t2",0,5.55555555555556,0,0,5.68181818181818,0,0,0,0,0,1.12373737373737,1.11111111111111,1.13636363636364,NA,NA,NA,NA,NA,NA,13.9667722556264,13.7165466013173,14.8088145049515,13.99547107861,14.4148803938714,13.641194401226,14.2835915911353,14.931254127253,14.3982068154043,13.8983817718657,14.2055113541261,14.5039856194213,13.9070370888309,19691.6561439937,-0.480488706378581,0.493223263659161,0.268237571591664,0.511653374165665,"Q9UPN3",0,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha)","Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060]","GO:0003723; GO:0003779; GO:0005198; GO:0005509; GO:0005737; GO:0005794; GO:0005856; GO:0005874; GO:0005886; GO:0010632; GO:0015629; GO:0016020; GO:0016055; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0045296; GO:0045773; GO:0051011; GO:0051015; GO:0051893; GO:0150011"
"2160","Pocillopora_acuta_HIv2___RNAseq.g18146.t1",0,0,NA,0,NA,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,9.80069986429418,7.05608360716548,8.0143117467574,4.11054575398787,9.64106872144608,9.8497189073358,8.99577356087328,8.21758883240833,10.1837555916916,3.68233641306884,7.95518829990289,9.17148495131952,6.73889164848625,477.512894140359,-0.544526978241704,1.09624268226026,0.0297244427133113,0.102732219690642,"P15535",1.2e-81,"Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1]","acute inflammatory response [GO:0002526]; angiogenesis involved in wound healing [GO:0060055]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; development of secondary sexual characteristics [GO:0045136]; epithelial cell development [GO:0002064]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]; galactose metabolic process [GO:0006012]; glycoprotein biosynthetic process [GO:0009101]; lactose biosynthetic process [GO:0005989]; lipid metabolic process [GO:0006629]; macrophage migration [GO:1905517]; negative regulation of epithelial cell proliferation [GO:0050680]; oligosaccharide biosynthetic process [GO:0009312]; penetration of zona pellucida [GO:0007341]; positive regulation of apoptotic process [GO:0043065]; positive regulation of circulating fibrinogen levels [GO:0061755]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; regulation of acrosome reaction [GO:0060046]; wound healing [GO:0042060]","GO:0000138; GO:0002064; GO:0002526; GO:0003831; GO:0003945; GO:0004461; GO:0005576; GO:0005794; GO:0005886; GO:0005989; GO:0006012; GO:0006486; GO:0006487; GO:0006629; GO:0007155; GO:0007339; GO:0007341; GO:0008092; GO:0008283; GO:0008378; GO:0009101; GO:0009312; GO:0009897; GO:0009986; GO:0016323; GO:0030057; GO:0030145; GO:0030175; GO:0030198; GO:0031526; GO:0032580; GO:0032991; GO:0042060; GO:0043065; GO:0045136; GO:0050673; GO:0050680; GO:0060046; GO:0060054; GO:0060055; GO:0061755; GO:1905517"
"2161","Pocillopora_acuta_HIv2___TS.g19412.t2",0.48780487804878,0,0.819672131147541,0,0,1.16959064327485,0,2.83687943262411,0,NA,0.590438565010588,0.801294015179793,0.32686925229908,NA,NA,NA,NA,NA,NA,9.79783922794957,11.0782303417104,9.70236087644474,3.68233641306884,10.8356698759209,6.97046070240566,9.10269320273321,10.5667133242033,3.68233641306884,11.27246669071,8.66911070682155,8.91698394351747,8.42123747012562,1017.53803600298,-0.12460164766375,0.982405443290891,0.46027226546037,0.701071824728179,"Q6P423",0,"Mediator of RNA polymerase II transcription subunit 23 (Mediator complex subunit 23)","","GO:0005634"
"2162","Pocillopora_acuta_HIv2___RNAseq.25433_t",0,0,0,0,0,0.911161731207289,0,0,0,0,0.0911161731207289,0.182232346241458,0,NA,NA,NA,NA,NA,NA,7.83899717282492,6.34267098328276,8.36342648242998,5.89135073914645,6.79473557793367,3.68233641306884,9.78529625209418,6.18361936369477,7.35614181332736,3.68233641306884,6.59209112108718,7.30738408204214,5.87679816013221,173.434263573899,-0.501970763572083,1.12440660958482,0.022059279626697,0.080389372769097,"Q9I829",3.45e-08,"Shaker-related potassium channel tsha2 (Trout shaker 2)","magnesium ion homeostasis [GO:0010960]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]","GO:0005249; GO:0005251; GO:0008076; GO:0010960; GO:0030424; GO:0033270; GO:0042391; GO:0043204; GO:0044224; GO:0051260; GO:0071805"
"2163","Pocillopora_acuta_HIv2___TS.g19430.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.70225029953105,3.68233641306884,9.06882412885094,7.14835683950801,3.68233641306884,8.92002572290413,3.68233641306884,8.60610586611839,3.68233641306884,3.68233641306884,6.08572449222567,6.74837062412761,5.42307836032373,184.371061763976,-0.13779698114908,1.0213653834747,0.0225577259173102,0.0819168836726023,"P19801",1.01e-120,"Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amiloride-binding protein) (Amiloride-binding protein 1) (Amine oxidase copper domain-containing protein 1) (Histaminase) (Kidney amine oxidase) (KAO) (KDAO)","amine metabolic process [GO:0009308]; putrescine metabolic process [GO:0009445]; response to antibiotic [GO:0046677]","GO:0005507; GO:0005509; GO:0005576; GO:0005615; GO:0005777; GO:0005886; GO:0005923; GO:0008131; GO:0008201; GO:0009308; GO:0009445; GO:0035580; GO:0042803; GO:0046677; GO:0048038; GO:0050232; GO:0052597; GO:0052598; GO:0052599; GO:0052600; GO:0070062"
"2164","Pocillopora_acuta_HIv2___RNAseq.g18187.t1",0,NA,NA,0,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.46296479422179,3.68233641306884,9.62700230902053,4.62642457401022,10.5996140364104,4.83944927859506,4.76881142028858,9.25135185354409,8.68482660432,3.68233641306884,6.82251176965483,9.32515191950336,4.31987161980631,361.132994907348,-7.55690659176975,1.18459732552624,2.93147079365074e-13,4.55922511391013e-11,"Q6DBY9",1.7e-30,"Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST)","carbohydrate metabolic process [GO:0005975]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]","GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0042339; GO:0045130"
"2165","Pocillopora_acuta_HIv2___RNAseq.g18214.t1",3.48258706467662,0,0,0,0,0.112485939257593,0,0.917431192660551,0,0,0.451250419659476,0.205983426383629,0.696517412935323,NA,NA,NA,NA,NA,NA,8.93889786916176,3.68233641306884,9.94702347692423,7.48026504127711,9.34113655667966,3.68233641306884,3.68233641306884,9.89766767076557,7.21538268069822,3.68233641306884,6.75497189477819,9.06802165084589,4.44192213871049,325.638543771285,-9.71153495428555,3.3333380817777,4.6016078885015e-08,1.10196963865377e-06,"A0A1D5NSM8",1.02e-53,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)","cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of complement activation, classical pathway [GO:0045959]","GO:0001945; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0045959; GO:0090136"
"2166","Pocillopora_acuta_HIv2___RNAseq.g18229.t2",0,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.134766419063,11.4977060091417,12.0196904249744,11.8254661897273,11.2795442175162,11.7157785465007,10.9907252791579,10.9435027394055,11.5388764564442,7.77346755820766,11.0719523840139,11.3832760514807,10.7606287165471,2571.42471507339,-0.234965984510912,0.710132861296558,0.606044186407978,0.80427774219699,NA,NA,NA,NA,NA
"2167","Pocillopora_acuta_HIv2___RNAseq.g18231.t1",NA,NA,NA,NA,100,55.1724137931034,66.6666666666667,66.6666666666667,50,100,73.0842911877395,57.27969348659,88.8888888888889,NA,NA,NA,NA,NA,NA,10.3185340072371,10.1515980120199,11.0920967809694,11.7036136460329,11.3344797528307,10.1935178367458,3.68233641306884,10.9647391950506,9.90288306818462,9.82361677004257,9.91674154821824,10.7225465608545,9.110936535582,1531.81475385352,-0.27021360193368,0.897002364825455,0.49893320414269,0.728725625034825,"Q14161",0,"ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2)","brain development [GO:0007420]; regulation of ARF protein signal transduction [GO:0032012]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; synaptic vesicle recycling [GO:0036465]","GO:0005096; GO:0005654; GO:0005925; GO:0007420; GO:0008277; GO:0031267; GO:0032012; GO:0036465; GO:0045202; GO:0046872; GO:0098793"
"2168","Pocillopora_acuta_HIv2___RNAseq.g20693.t1",NA,0,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.2863209378633,12.3621348857154,12.138197091105,11.8918502433129,11.9418789353678,13.0923867455091,13.8184959936967,10.488834167018,12.0800914909941,11.4998399842608,12.0600030474843,11.5870645244696,12.532941570499,5159.18896253828,0.544092248695,0.731077803563519,0.275480474059577,0.519972540362484,"O35375",3.07e-25,"Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2)","angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; heart development [GO:0007507]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; outflow tract septum morphogenesis [GO:0003148]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; trunk neural crest cell migration [GO:0036484]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649]","GO:0001525; GO:0001764; GO:0003148; GO:0005021; GO:0005886; GO:0007411; GO:0007507; GO:0008201; GO:0017154; GO:0021612; GO:0021649; GO:0021675; GO:0021828; GO:0030424; GO:0036484; GO:0036486; GO:0045211; GO:0046872; GO:0048846; GO:0050919; GO:0061549; GO:0061551; GO:0071526; GO:0097374; GO:0097490; GO:0097491; GO:0098978; GO:0099175; GO:1901166; GO:1903375; GO:1904835; GO:1990830"
"2169","Pocillopora_acuta_HIv2___TS.g27350.t1d",31.5789473684211,50,NA,33.3333333333333,36.3636363636364,53.5714285714286,50,50,NA,NA,43.5496208052599,46.7261904761905,39.3141945773525,NA,NA,NA,NA,NA,NA,10.0227485386077,10.3832526994623,10.6795619443339,10.9258013458456,10.3651953462296,10.1740676704813,9.88848562927398,9.65030078139451,10.2097914268884,8.82176997594444,10.1120975358462,10.1855196074908,10.0386754642015,1156.86121388539,-0.0951608577124897,0.554242839024777,0.828307785457231,0.930187841907401,NA,NA,NA,NA,NA
"2170","Pocillopora_acuta_HIv2___RNAseq.g20718.t1",0,0,0,0,1.21212121212121,0,0,0,0,0,0.121212121212121,0,0.242424242424242,NA,NA,NA,NA,NA,NA,3.68233641306884,9.60843127333668,5.90972641462649,10.2385789885322,5.48185943121106,9.42511157114,10.8631125474243,3.68233641306884,5.98677490518935,9.32542746096529,7.4203695418563,4.94860671543292,9.89213236827969,515.313742037359,5.17362409171873,2.25785218757629,8.75612776462898e-06,0.000101807581983596,"Q9SCN0",9.13e-15,"Probable glycosyltransferase STELLO2 (EC 2.4.-.-)","plant-type cell wall cellulose biosynthetic process [GO:0052324]; regulation of plant-type cell wall cellulose biosynthetic process [GO:2001009]","GO:0000139; GO:0005794; GO:0016757; GO:0042802; GO:0052324; GO:2001009"
"2171","Pocillopora_acuta_HIv2___RNAseq.g20738.t1",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,4.95179328310793,4.82737711805479,5.23497525321289,6.54549673248371,5.81325426851759,3.68233641306884,3.68233641306884,5.43126625005349,6.44828135143128,3.68233641306884,5.02994534960682,5.57591408126464,4.483976617949,22.3289346244166,-0.383668726554651,1.07305742622481,0.0104632350490867,0.0432277154384435,NA,NA,NA,NA,NA
"2172","Pocillopora_acuta_HIv2___RNAseq.g20747.t1",0,0,0,0,5.26315789473684,1.9047619047619,0.636942675159236,3.84615384615385,0,0,1.16510163208118,1.15018315018315,1.18002011397922,NA,NA,NA,NA,NA,NA,8.15354005906022,9.27794156335645,8.8419698660937,6.63240153016127,5.99913827937875,8.91742718084503,8.5346223329741,8.12926274614067,9.00976203881632,3.68233641306884,7.71784020098954,8.02673459789793,7.40894580408114,295.345482679338,-0.0613717592735288,0.912113846371737,0.808186003513863,0.919861689866581,"Q66X01",2.56e-21,"NACHT, LRR and PYD domains-containing protein 9C (NALP-zeta)","blastocyst development [GO:0001824]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of inflammatory response [GO:0050727]","GO:0001824; GO:0005524; GO:0005737; GO:0006954; GO:0045087; GO:0050727; GO:0061702"
"2173","Pocillopora_acuta_HIv2___RNAseq.g20756.t1",0,NA,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0862544551206,6.38096952478058,7.09556155255397,8.13666062791065,7.63721909911156,9.08887210895803,3.68233641306884,6.36973004382258,4.9224776128996,9.48945494791873,7.28895363861451,7.22224855270166,7.35565872452737,294.569614470595,0.0102684469354637,0.942771146897222,0.983477350730877,0.994152138938443,"A6QLE5",1.33e-22,"NACHT, LRR and PYD domains-containing protein 3 (EC 3.6.4.-)","detection of biotic stimulus [GO:0009595]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; NLRP3 inflammasome complex assembly [GO:0044546]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type 2 immune response [GO:0002830]; protein homooligomerization [GO:0051260]","GO:0000139; GO:0002674; GO:0002830; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0006954; GO:0009595; GO:0016020; GO:0016887; GO:0031021; GO:0032731; GO:0032753; GO:0035591; GO:0043531; GO:0043565; GO:0044546; GO:0045087; GO:0045630; GO:0045944; GO:0050729; GO:0051260; GO:0070273; GO:0072559; GO:0140297; GO:0140299; GO:1901223; GO:1901981; GO:2000553"
"2174","Pocillopora_acuta_HIv2___RNAseq.g20757.t1",0,6.25,0,NA,0,0.847457627118644,0,NA,0,NA,1.01392251815981,2.36581920903955,0,NA,NA,NA,NA,NA,NA,9.44975813022123,7.92681031311096,9.52581221552609,10.4832842155995,9.43405863799651,9.28099050655367,4.84014736901689,8.44145097007129,4.9224776128996,3.68233641306884,7.79871263840646,8.35471151334294,7.24271376346997,461.402025629345,-0.736354635777305,1.02497810614868,0.0965765647193275,0.25463018711704,"D1BZ82",4.99e-11,"D-inositol 3-phosphate glycosyltransferase (EC 2.4.1.250) (N-acetylglucosamine-inositol-phosphate N-acetylglucosaminyltransferase) (GlcNAc-Ins-P N-acetylglucosaminyltransferase)","mycothiol biosynthetic process [GO:0010125]","GO:0000287; GO:0008375; GO:0010125; GO:0102710"
"2175","Pocillopora_acuta_HIv2___RNAseq.g20761.t1",0,0,0,0,0,1.65289256198347,0,NA,0,NA,0.206611570247934,0.413223140495868,0,NA,NA,NA,NA,NA,NA,6.16911426736902,5.91207600133758,7.12687135132875,5.56232777220043,6.10179861046554,7.4619492718124,3.68233641306884,5.84514254962292,7.57903434039062,6.07894006001887,6.1519590637615,6.56439222383537,5.73952590368762,66.8593165952858,-0.541022141962214,0.968005671037564,0.193059014454129,0.412848958961604,"Q86W24",8.67e-26,"NACHT, LRR and PYD domains-containing protein 14 (Nucleotide-binding oligomerization domain protein 5)","cell differentiation [GO:0030154]; regulation of inflammatory response [GO:0050727]; spermatogenesis [GO:0007283]","GO:0005524; GO:0005737; GO:0007283; GO:0030154; GO:0050727"
"2176","Pocillopora_acuta_HIv2___TS.g27422.t1",0,0,0,0,0.909090909090909,0,0,0,0,0,0.0909090909090909,0,0.181818181818182,NA,NA,NA,NA,NA,NA,5.09121097465794,9.13487596686418,5.72956178137413,8.74351476367351,5.50166800055048,8.50807148292514,3.68233641306884,8.51055382611831,4.9224776128996,3.68233641306884,6.3506607235201,5.95109443912009,6.7502270079201,169.552093986643,0.128115219882932,1.00567312617815,0.306272904944528,0.554851114368444,"Q86W25",5.64e-17,"NACHT, LRR and PYD domains-containing protein 13 (Nucleotide-binding oligomerization domain protein 14)","regulation of inflammatory response [GO:0050727]","GO:0005524; GO:0005737; GO:0050727"
"2177","Pocillopora_acuta_HIv2___TS.g27468.t2",0,0,NA,0,NA,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,12.2796838450536,12.7805208439882,12.2488064278078,13.3539378885853,10.9946037889687,12.7410751963575,13.5100192442796,12.2445079963606,10.5213096002864,13.1309404960114,12.3805405327699,11.6577823316954,13.1032987338444,6293.34531630355,1.15219992589268,0.653103250264519,0.0256098363370844,0.0908962490466186,"Q9QZZ4",0,"Unconventional myosin-XV (Unconventional myosin-15)","actin filament organization [GO:0007015]; endocytosis [GO:0006897]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605]","GO:0000146; GO:0005524; GO:0005737; GO:0005829; GO:0006897; GO:0007015; GO:0007605; GO:0007626; GO:0009416; GO:0015629; GO:0016020; GO:0016459; GO:0032420; GO:0032421; GO:0042472; GO:0051015; GO:0098858"
"2178","Pocillopora_acuta_HIv2___RNAseq.g20810.t1",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.256434885607,12.0075928919568,12.9153039942511,12.1378095763631,12.5034746990853,10.9584504197811,11.0326248601655,12.6537409713799,11.6905198247678,12.7769219182066,12.0932874041564,12.4038948750182,11.7826799332946,4764.4378827596,-0.425294058372361,0.639062762813093,0.368769638566111,0.618206311105729,"P98161",1.1e-102,"Polycystin-1 (PC1) (Autosomal dominant polycystic kidney disease 1 protein)","anatomical structure morphogenesis [GO:0009653]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-independent cell-matrix adhesion [GO:0007161]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell surface receptor signaling pathway [GO:0007166]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cell-matrix adhesion [GO:0007160]; detection of mechanical stimulus [GO:0050982]; digestive tract development [GO:0048565]; embryonic placenta development [GO:0001892]; establishment of epithelial cell polarity [GO:0090162]; genitalia development [GO:0048806]; heart development [GO:0007507]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; liver development [GO:0001889]; lung epithelium development [GO:0060428]; lymph vessel morphogenesis [GO:0036303]; mesonephric duct development [GO:0072177]; mesonephric tubule development [GO:0072164]; metanephric ascending thin limb development [GO:0072218]; metanephric collecting duct development [GO:0072205]; metanephric distal tubule morphogenesis [GO:0072287]; metanephric proximal tubule development [GO:0072237]; mitocytosis [GO:0160040]; neural tube development [GO:0021915]; peptidyl-serine phosphorylation [GO:0018105]; placenta blood vessel development [GO:0060674]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein export from nucleus [GO:0006611]; protein heterotetramerization [GO:0051290]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle [GO:0051726]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic spindle organization [GO:0060236]; regulation of proteasomal protein catabolic process [GO:0061136]; response to fluid shear stress [GO:0034405]; skin development [GO:0043588]; spinal cord development [GO:0021510]; Wnt signaling pathway [GO:0016055]","GO:0000139; GO:0001502; GO:0001701; GO:0001822; GO:0001889; GO:0001892; GO:0002133; GO:0005262; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0006611; GO:0006816; GO:0007156; GO:0007160; GO:0007161; GO:0007166; GO:0007204; GO:0007259; GO:0007507; GO:0009653; GO:0009986; GO:0016020; GO:0016055; GO:0016323; GO:0016328; GO:0018105; GO:0019901; GO:0019904; GO:0021510; GO:0021915; GO:0030155; GO:0030246; GO:0030660; GO:0031514; GO:0034405; GO:0034703; GO:0034704; GO:0036303; GO:0042813; GO:0043588; GO:0044325; GO:0045944; GO:0048565; GO:0048754; GO:0048806; GO:0050982; GO:0051216; GO:0051290; GO:0051726; GO:0060170; GO:0060236; GO:0060428; GO:0060674; GO:0061136; GO:0070062; GO:0070588; GO:0072164; GO:0072177; GO:0072205; GO:0072218; GO:0072237; GO:0072287; GO:0090162; GO:0140416; GO:0140494; GO:0160040; GO:2000045"
"2179","Pocillopora_acuta_HIv2___RNAseq.g20814.t1",48.4536082474227,37.7049180327869,56.5656565656566,65.9574468085106,57.1428571428571,48.2758620689655,53.5433070866142,60.5263157894737,15.9090909090909,66.6666666666667,51.0745729318045,45.6747267217655,56.4744191418434,NA,NA,NA,NA,NA,NA,7.93088772907051,8.42031378710237,10.5387994799435,11.2066942775062,9.74684501760047,10.6883587384854,9.76374179605489,8.43130253662536,6.01048531358257,10.0728835082764,9.28103121842477,8.53166401536448,10.0303984214851,905.133238917064,0.938316654591484,0.83491787439123,0.0819534877236814,0.225785761225777,"Q7Z5N4",0,"Protein sidekick-1","behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]","GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0048148; GO:0060998"
"2180","Pocillopora_acuta_HIv2___TS.g27477.t1",0,0,NA,NA,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.10798813166413,8.68612969094628,8.76754236452289,8.73581748555832,9.2778857139977,8.19244717363121,9.48511949720691,7.91632649873513,7.71039516097916,8.8374127088862,8.57170644261279,8.3560275739798,8.78738531124578,383.62004615546,0.31399625203253,0.634156346513053,0.512307975270584,0.738540375831426,"Q8C2A2",8.26e-21,"tRNA-splicing endonuclease subunit Sen54 (tRNA-intron endonuclease Sen54)","mRNA processing [GO:0006397]; tRNA-type intron splice site recognition and cleavage [GO:0000379]","GO:0000214; GO:0000379; GO:0005730; GO:0006397"
"2181","Pocillopora_acuta_HIv2___RNAseq.g20818.t1",100,NA,100,100,NA,76.9230769230769,66.6666666666667,NA,100,NA,90.5982905982906,92.3076923076923,88.8888888888889,NA,NA,NA,NA,NA,NA,9.08690804625239,9.00024927993811,9.1294984304385,8.91689007272432,8.71524105562279,10.4259675982324,9.19418840935092,9.3715480638659,8.72667943317388,9.76214807201436,9.23293184616136,9.00597500587069,9.45988868645202,618.159002248312,0.315726345495333,0.596164735765088,0.503021575654756,0.73206526217499,"Q3U3R4",0,"Lipase maturation factor 1 (Transmembrane protein 112)","chylomicron remnant clearance [GO:0034382]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein glycosylation [GO:0006486]; protein maturation [GO:0051604]; protein secretion [GO:0009306]; regulation of cholesterol metabolic process [GO:0090181]; regulation of triglyceride metabolic process [GO:0090207]; triglyceride metabolic process [GO:0006641]","GO:0005789; GO:0006486; GO:0006641; GO:0006888; GO:0009306; GO:0034382; GO:0051604; GO:0090181; GO:0090207"
"2182","Pocillopora_acuta_HIv2___RNAseq.g20819.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.5685378434658,11.6801520777672,12.2767511270862,14.0169475559286,12.3485094658974,12.2314295325851,12.228409456928,12.7871261930219,11.5354494512799,13.3180387074957,12.4991351411456,12.3032748161502,12.6949954661409,6571.08172669715,0.233929093638649,0.650387385771477,0.6231785390696,0.816170996172051,"Q27421",6.72e-14,"Protein outspread","","GO:0015629; GO:0051015"
"2183","Pocillopora_acuta_HIv2___RNAseq.g20832.t1",0,0,0,12.1951219512195,17.3913043478261,0,6.66666666666667,NA,0,NA,4.53163662071403,3.04878048780488,6.01449275362319,NA,NA,NA,NA,NA,NA,13.1373273920273,14.1540915443891,12.7249480411237,14.5758802095723,12.6430131622594,13.5286195425223,14.2565241480259,13.0231465407977,12.6756116127376,14.2991599450183,13.5018322138474,12.8408093497891,14.1628550779056,13098.8275693818,1.10572173226149,0.557469969697644,0.0195213104346406,0.0728473256260685,"P24733",0,"Myosin heavy chain, striated muscle","muscle contraction [GO:0006936]; sarcomere organization [GO:0045214]","GO:0000146; GO:0005516; GO:0005524; GO:0006936; GO:0016460; GO:0030016; GO:0032982; GO:0045214; GO:0051015"
"2184","Pocillopora_acuta_HIv2___RNAseq.g20840.t1",100,100,NA,83.3333333333333,60,62.5,66.6666666666667,61.5384615384615,NA,NA,76.2912087912088,76.8429487179487,75.5555555555556,NA,NA,NA,NA,NA,NA,8.67130106083343,8.35601668762938,10.2294731757435,8.94051685607582,9.89783757655176,7.84883394633985,6.06216801367023,9.10434586905403,10.569022724472,11.7915676679265,9.14710835782965,9.69439608133094,8.59982063432836,904.149523669786,-0.690680734230247,0.827621528784011,0.158255298434431,0.361155670015086,"Q5RCE6",2.68e-45,"Ribosomal L1 domain-containing protein 1","regulation of apoptotic process [GO:0042981]; regulation of cellular senescence [GO:2000772]","GO:0005730; GO:0042981; GO:2000772"
"2185","Pocillopora_acuta_HIv2___RNAseq.g20846.t1",NA,0,0,NA,18.75,0,0,NA,0,NA,3.125,0,6.25,NA,NA,NA,NA,NA,NA,11.613144543009,8.18144630735713,8.50026536011128,3.68233641306884,8.1806446225417,3.68233641306884,3.68233641306884,5.4533793909793,10.2604942385456,3.68233641306884,6.69187201148194,8.80158563103738,4.5821583919265,519.710041943882,-8.72908038727743,3.18386563325016,1.43511163203073e-07,2.96535066367035e-06,"Q80ZA4",0,"Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86)","sensory perception of sound [GO:0007605]","GO:0007605; GO:0016020; GO:0032426; GO:0120234"
"2186","Pocillopora_acuta_HIv2___RNAseq.g20848.t1",0,0,NA,0,0,NA,33.3333333333333,0,NA,NA,5.55555555555556,0,11.1111111111111,NA,NA,NA,NA,NA,NA,10.4806997323798,9.62214869763182,8.64144282653843,11.2011197512711,9.18524021089615,9.55110735960129,3.68233641306884,10.2137509606684,8.55143238807744,6.00413425515518,8.71334125952884,9.41451322371204,8.01216929534565,770.32582730031,-0.267001945154075,0.945639346931609,0.384906701831968,0.633510529733452,NA,NA,NA,NA,NA
"2187","Pocillopora_acuta_HIv2___TS.g27514.t1",NA,0,0,0,0,2.5974025974026,0,0,NA,NA,0.371057513914657,0.649350649350649,0,NA,NA,NA,NA,NA,NA,3.68233641306884,6.84260510118125,6.80680485095045,6.85040600762403,4.93003625965001,7.83233483651014,3.68233641306884,7.49101224450391,5.75167028831017,3.68233641306884,5.75518788279365,5.73237201129668,5.77800375429062,66.900272628816,-0.00828609035483247,0.992000888125112,0.945305140386373,0.979503800454796,"Q8TAT6",2.34e-174,"Nuclear protein localization protein 4 homolog (Protein NPL4)","ERAD pathway [GO:0036503]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006511; GO:0007030; GO:0030970; GO:0031625; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0036503; GO:0039536; GO:0042175; GO:0043130; GO:0043161; GO:0044877; GO:0046872; GO:0051117; GO:0070530"
"2188","Pocillopora_acuta_HIv2___TS.g27515.t1",NA,NA,18.1818181818182,0,NA,0,25.9259259259259,NA,0,0,7.35129068462402,0,14.702581369248,NA,NA,NA,NA,NA,NA,3.68233641306884,4.50233927872981,7.95485894137405,3.68233641306884,8.95370811987787,9.90844507883082,3.68233641306884,9.34073373372288,7.59423998853345,3.68233641306884,6.29836707933442,7.50517543931542,5.09155871935343,242.477334585057,-0.200983851441962,1.02742290376408,0.000813348009379348,0.00491611600821684,"Q8TAT6",0,"Nuclear protein localization protein 4 homolog (Protein NPL4)","ERAD pathway [GO:0036503]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006511; GO:0007030; GO:0030970; GO:0031625; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0036503; GO:0039536; GO:0042175; GO:0043130; GO:0043161; GO:0044877; GO:0046872; GO:0051117; GO:0070530"
"2189","Pocillopora_acuta_HIv2___RNAseq.g20860.t1",2.12234706616729,4.58167330677291,4.67836257309941,8.25242718446602,3.25960419091967,3.84615384615385,2.0952380952381,4.06360424028269,3.82022471910112,1.64348925410872,3.83631244763098,4.91281665935532,2.75980823590664,1,-9.36096136567835,-9.36096136567835,0.00246849738623498,0.00246849738623498,0.00246849738623498,11.92667222191,3.68233641306884,10.4043374520596,3.68233641306884,10.1008883965635,3.68233641306884,3.68233641306884,11.9156027894308,11.3281191418614,3.68233641306884,7.40873020671695,11.1351240003651,3.68233641306884,1265.2742161805,-15.5762447772559,3.87381005283364,1.35817286920059e-16,9.35457732386536e-14,"Q01528",3.72e-11,"Hemagglutinin/amebocyte aggregation factor (18K-LAF)","collagen fibril organization [GO:0030199]","GO:0005615; GO:0030199; GO:0031012"
"2190","Pocillopora_acuta_HIv2___RNAseq.g20862.t1",5,0,0,0,0,0,2.08333333333333,0,0,NA,0.787037037037037,0,1.77083333333333,NA,NA,NA,NA,NA,NA,7.32784372520422,3.68233641306884,6.51648711029815,3.68233641306884,6.88869688893527,6.37366676810558,3.68233641306884,6.36973004382258,3.68233641306884,3.68233641306884,5.188810660171,6.15701883626581,4.22060248407619,41.6138324615088,-0.375262291836541,1.0986735158732,0.00720941260996818,0.0317530280117478,"Q9VVU5",7.44e-20,"COP9 signalosome complex subunit 1b (Dch1-2) (Signalosome subunit 1b)","female germ-line stem cell population maintenance [GO:0036099]; germ cell development [GO:0007281]; germarium-derived cystoblast division [GO:0048142]; male germ-line cyst encapsulation [GO:0048140]; protein deneddylation [GO:0000338]; protein stabilization [GO:0050821]","GO:0000338; GO:0005737; GO:0007281; GO:0008180; GO:0036099; GO:0048140; GO:0048142; GO:0050821"
"2191","Pocillopora_acuta_HIv2___RNAseq.g27126.t1",0,NA,0,NA,NA,0,30.7692307692308,0,0,NA,5.12820512820513,0,10.2564102564103,NA,NA,NA,NA,NA,NA,12.4437315437377,12.9159170539464,12.6979135924995,11.7831857841898,12.2844656670444,12.5354548161107,11.3899423979684,11.6471988595082,11.7709908168378,12.1647855510809,12.1633586082924,12.1688600959255,12.1578571206592,4811.4584979593,-0.00207319908151555,0.524472186919047,0.990899438373489,0.99657031670488,"Q9JIH7",6.64e-165,"Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1)","cell volume homeostasis [GO:0006884]; cellular hyperosmotic response [GO:0071474]; cellular response to calcium ion [GO:0071277]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; heart development [GO:0007507]; intracellular chloride ion homeostasis [GO:0030644]; intracellular signal transduction [GO:0035556]; lymphocyte migration into lymph node [GO:0097022]; modulation of chemical synaptic transmission [GO:0050804]; monoatomic cation homeostasis [GO:0055080]; monoatomic ion homeostasis [GO:0050801]; monoatomic ion transport [GO:0006811]; negative regulation of autophagy [GO:0010507]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transport [GO:0010766]; non-membrane-bounded organelle assembly [GO:0140694]; positive regulation of angiogenesis [GO:0045766]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of termination of RNA polymerase II transcription [GO:1904595]; potassium ion homeostasis [GO:0055075]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of monoatomic cation transmembrane transport [GO:1904062]; regulation of mRNA export from nucleus [GO:0010793]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of sodium ion transport [GO:0002028]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]; T cell receptor signaling pathway [GO:0050852]","GO:0000287; GO:0002028; GO:0003084; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006811; GO:0006884; GO:0007165; GO:0007507; GO:0008217; GO:0010507; GO:0010766; GO:0010793; GO:0010820; GO:0016020; GO:0019870; GO:0019901; GO:0019902; GO:0030291; GO:0030295; GO:0030644; GO:0031397; GO:0032991; GO:0033633; GO:0034115; GO:0035556; GO:0035725; GO:0038116; GO:0043232; GO:0045050; GO:0045766; GO:0050801; GO:0050804; GO:0050852; GO:0055075; GO:0055080; GO:0071277; GO:0071474; GO:0072686; GO:0090188; GO:0090263; GO:0097022; GO:0098982; GO:0106310; GO:0140693; GO:0140694; GO:1902305; GO:1903038; GO:1903077; GO:1903288; GO:1903490; GO:1904062; GO:1904595; GO:1990869"
"2192","Pocillopora_acuta_HIv2___RNAseq.g27206.t1",0,8.49056603773585,11.1111111111111,0,2.32558139534884,8.02675585284281,14.8936170212766,0,100,16.0919540229885,16.0939585441304,23.3034643781157,8.88445271014501,NA,NA,NA,NA,NA,NA,11.1990467915509,6.85609801113518,10.2708805838484,9.86831475731293,10.8534815654178,10.8543637860639,6.51519156656932,11.0980466168393,11.3971783509853,5.30690658460733,9.42195086143304,10.9637267817283,7.88017494113773,1311.00459748368,-1.74748947033634,1.84899921014233,0.00169643825662974,0.00923843484333303,"Q86U86",0,"Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D)","chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368]","GO:0000228; GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0006368; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0045582; GO:0045597; GO:0045663; GO:0070316; GO:2000045; GO:2000781; GO:2000819"
"2193","Pocillopora_acuta_HIv2___RNAseq.g27213.t1",14.2857142857143,0,14.2857142857143,0,11.5384615384615,12.0967741935484,6.09756097560976,0,0,NA,6.47824725322758,2.41935483870968,11.551862771375,NA,NA,NA,NA,NA,NA,12.8069615289264,12.6894782799776,11.959541026381,13.3170476936971,12.9096666197785,12.4894285798776,13.4490203302625,12.8345195154622,12.5441533124628,11.8922809415865,12.6892097828412,12.6109684006022,12.7674511650803,6940.96393705128,0.104411405273793,0.567760261893727,0.821211301228671,0.926620983558223,NA,NA,NA,NA,NA
"2194","Pocillopora_acuta_HIv2___RNAseq.g27223.t1",0,0,0,NA,0,0,31.25,NA,0,NA,4.46428571428571,0,7.8125,NA,NA,NA,NA,NA,NA,11.1689257972026,11.0157776054258,11.3673388187463,8.34850106980777,11.5513339927247,10.4103528644367,11.512371199158,11.5999116814888,11.288533101434,11.1865926915512,10.9449638821976,11.3952086783193,10.4947190860759,2230.46917662752,-0.543849683151488,0.684771832734635,0.26198763757895,0.504176315851773,"Q63505",2.03e-92,"General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha)","5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription initiation at RNA polymerase III promoter [GO:0006384]","GO:0000127; GO:0000995; GO:0003677; GO:0005634; GO:0006384; GO:0042791; GO:1990904"
"2195","Pocillopora_acuta_HIv2___RNAseq.g27236.t1d",83.3333333333333,100,100,50,NA,53.8461538461538,66.6666666666667,71.4285714285714,62.5,NA,73.4718406593407,67.5549450549451,83.3333333333333,NA,NA,NA,NA,NA,NA,8.93629753365079,8.91362770448972,8.54983514404054,10.007377890972,9.57602875812779,9.07960589949122,9.19418840935092,6.40197652230091,7.50048072915978,8.55152143395036,8.6710940025534,8.19292373745596,9.14926426765084,465.568375934806,0.642382663015505,0.743030736868971,0.20151492203877,0.424896959994868,"Q7RTR2",4.53e-45,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223"
"2196","Pocillopora_acuta_HIv2___TS.g2144.t1",0,0,0,8.33333333333333,0,0,0,NA,0,NA,1.04166666666667,2.08333333333333,0,NA,NA,NA,NA,NA,NA,8.4263463087757,3.68233641306884,6.9541853393125,3.68233641306884,7.38984723548559,3.68233641306884,3.68233641306884,10.3150712228523,6.46520689288117,3.68233641306884,5.79623390646515,7.91013139986145,3.68233641306884,187.44216437744,-12.0488735512339,3.86777387529675,9.06532138605413e-09,2.6489052227856e-07,NA,NA,NA,NA,NA
"2197","Pocillopora_acuta_HIv2___TS.g2146.t1",1.80614087898856,1.73852573018081,4.69536053661263,1.23915737298637,2.31749710312862,2.37504431052818,3.48139255702281,1.7458777885548,1.9047619047619,0,2.13037581827647,1.80067342140241,2.46007821515052,NA,NA,NA,NA,NA,NA,11.7618101617432,9.16196648053127,9.60236272343259,10.4187012284664,11.2499272802179,8.04288725468262,9.67029351290081,11.3147663364459,11.3047281859879,11.7188886488206,10.4246331813229,11.0467189375655,9.80254742508034,1789.82698127712,-0.715374238278275,0.848930902288464,0.143146016072812,0.337869447858544,"Q9C0G6",0,"Dynein axonemal heavy chain 6 (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)","cilium movement involved in cell motility [GO:0060294]","GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060294; GO:0097729"
"2198","Pocillopora_acuta_HIv2___RNAseq.g27277.t1",NA,37.5,4.16666666666667,0,0,9.67741935483871,0,0,4.44444444444444,NA,6.97356630824373,10.3243727598566,1.38888888888889,NA,NA,NA,NA,NA,NA,8.97228196154268,6.80133194180119,7.3083152768306,7.3342463704392,8.97503127604202,7.85972880706295,3.68233641306884,8.53918284492604,8.73695529848177,3.68233641306884,7.18917466032641,8.50635333156462,5.8719959890882,226.81529627488,-0.68626721654932,1.19994071073526,0.0247349279287241,0.0882718967582199,"Q8HYZ1",2.27e-124,"A-type voltage-gated potassium channel KCND2 (Potassium voltage-gated channel subfamily D member 2) (Voltage-gated potassium channel subunit Kv4.2)","cardiac muscle cell action potential [GO:0086001]; cellular response to hypoxia [GO:0071456]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]","GO:0005249; GO:0005250; GO:0005886; GO:0005901; GO:0008076; GO:0030315; GO:0032809; GO:0042383; GO:0043197; GO:0043204; GO:0044853; GO:0045211; GO:0046872; GO:0051260; GO:0070161; GO:0071456; GO:0071805; GO:0086001; GO:1905030"
"2199","Pocillopora_acuta_HIv2___RNAseq.g27348.t1",NA,100,100,NA,100,100,100,NA,100,NA,100,100,100,NA,NA,NA,NA,NA,NA,12.4816518317287,12.1866920490681,12.1446091561956,3.68233641306884,11.721257239206,11.2147004314969,11.1354898907401,12.1133769282015,10.2413884476995,12.6395398784054,10.9561042265811,11.7404567206063,10.1717517325559,3470.34522900333,-0.177353173206949,0.906309061692851,0.604973067273139,0.803793391691069,NA,NA,NA,NA,NA
"2200","Pocillopora_acuta_HIv2___TS.g25007.t2",91.6666666666667,NA,100,50,66.6666666666667,0,NA,0,NA,NA,51.3888888888889,16.6666666666667,86.1111111111111,NA,NA,NA,NA,NA,NA,6.56356363373408,6.54125763453179,5.49419692800081,11.0818213057489,8.55884984332578,10.6205277604231,9.92777908965568,9.77477907224078,3.68233641306884,10.166619163441,8.24117308441708,6.81474517807406,9.66760099076009,712.83150668421,0.681992688304864,1.15050226283128,0.0423892637823193,0.136948472492175,"Q01149",1.07e-154,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001501; GO:0001568; GO:0002020; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0085029"
"2201","Pocillopora_acuta_HIv2___RNAseq.g26154.t1",0,NA,NA,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.16449048766231,8.74107941055535,7.3083152768306,8.0017642298512,8.51021562574966,9.7156232709556,11.0652897900663,9.90042593084862,7.50048072915978,9.90500119662516,8.98126859483046,8.47678561005019,9.48575157961072,660.786425182662,0.752735886180735,0.68216728047938,0.13750249063921,0.329277487517474,"O94880",5.51e-173,"PHD finger protein 14","germinal center B cell differentiation [GO:0002314]; lung alveolus development [GO:0048286]; mesenchymal cell proliferation [GO:0010463]; mesenchymal cell proliferation involved in lung development [GO:0060916]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000785; GO:0002314; GO:0005634; GO:0005694; GO:0005737; GO:0006357; GO:0008270; GO:0008285; GO:0010463; GO:0042393; GO:0048286; GO:0060916; GO:0072201; GO:0140566; GO:2000584; GO:2000791"
"2202","Pocillopora_acuta_HIv2___RNAseq.g26158.t1",NA,0,NA,0,0,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,9.12622126470242,9.26800230477324,8.39568883872764,8.54196377296752,9.11310611433034,8.8617462232781,10.817646228906,9.26711416227425,7.82428504101232,10.1012177424286,9.13169916934004,8.74528308420939,9.51811525447069,639.647002669024,0.527727201157094,0.66301950340969,0.286268313335049,0.532414155082699,"Q9D4H9",7.81e-63,"PHD finger protein 14","germinal center B cell differentiation [GO:0002314]; lung alveolus development [GO:0048286]; mesenchymal cell proliferation [GO:0010463]; mesenchymal cell proliferation involved in lung development [GO:0060916]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0002314; GO:0005634; GO:0005694; GO:0005737; GO:0006357; GO:0008270; GO:0008285; GO:0010463; GO:0042393; GO:0048286; GO:0060916; GO:0072201; GO:0140566; GO:2000584; GO:2000791"
"2203","Pocillopora_acuta_HIv2___RNAseq.g26161.t1",0,0,0,0,NA,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.90744172849562,3.68233641306884,8.11083112805987,3.68233641306884,9.8310755988393,8.68966045927168,3.68233641306884,9.71857924816042,11.4164693037663,3.68233641306884,6.84034031188686,8.9968794014643,4.68380122230941,508.625014092727,-9.11912442983252,4.16787377721188,4.27221981229204e-07,7.61940658014699e-06,"Q9Y711",2.01e-82,"Alternative oxidase, mitochondrial (EC 1.-.-.-)","alternative respiration [GO:0010230]","GO:0005743; GO:0009916; GO:0010230; GO:0046872; GO:0070469"
"2204","Pocillopora_acuta_HIv2___RNAseq.g26172.t1",NA,0,NA,0,0,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,9.36531352794709,10.7879256440564,8.91273989231603,10.978075914566,9.48638159423404,9.95097177704402,9.9894321741726,9.43507870724526,4.72904561334115,10.6479284163748,9.42828932612974,8.38571186701671,10.4708667852428,972.459807600584,0.933428086310164,1.03352857987226,0.0779653709279112,0.218333228480408,"Q9NRH1",2.77e-10,"Protein YAE1 homolog (Yae1 domain-containing protein 1)","protein maturation by [4Fe-4S] cluster transfer [GO:0106035]","GO:0005634; GO:0005737; GO:0106035"
"2205","Pocillopora_acuta_HIv2___TS.g25053.t3",NA,0,53.125,NA,50,0,80,NA,25,NA,34.6875,8.33333333333333,61.0416666666667,2,59.6153846153846,59.6153846153846,0.0181074057732958,0.00450009011896794,0.0317147214276237,8.92584900242764,8.88138435854897,8.837282424363,8.9066444768695,9.36989503427898,8.38924687130923,3.68233641306884,9.73206185884124,3.68233641306884,10.9966380559268,8.1403674908703,8.10948494659594,8.17125003514467,558.284015053592,-0.0420902748672317,0.945848318666888,0.863003513342873,0.946309918279226,"Q8FS75",1.37e-21,"Large ribosomal subunit protein uL16 (50S ribosomal protein L16)","translation [GO:0006412]","GO:0000049; GO:0003735; GO:0006412; GO:0019843; GO:0022625"
"2206","Pocillopora_acuta_HIv2___RNAseq.g26200.t1",30,NA,NA,0,33.3333333333333,16.6666666666667,NA,100,NA,0,30,38.8888888888889,21.1111111111111,NA,NA,NA,NA,NA,NA,12.6684089027769,15.5716082510032,12.3241793293671,15.7693211503941,13.1127131140995,15.7171498904576,14.87405021387,13.7924468424943,11.9585075365091,15.9859811493692,14.1774366380341,12.7712511450494,15.5836221310188,29175.7743379683,2.49664196608494,0.788011794838062,8.07180945712313e-05,0.000691241278791172,"P02466",3.84e-151,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096"
"2207","Pocillopora_acuta_HIv2___RNAseq.g26209.t1",0,0,0,NA,NA,0,14.7058823529412,NA,0,NA,2.45098039215686,0,4.90196078431372,NA,NA,NA,NA,NA,NA,10.0721186739128,8.14383581458983,9.53017333865691,6.73001114537384,9.21311244248515,10.1532483478955,6.75620037889345,9.46271669966844,4.57231842518309,3.68233641306884,7.83160716797278,8.57008791598128,7.09312641996429,455.515751017263,-1.3551938795421,1.12152662415167,0.0241346087225145,0.08664258638929,"P34147",2.13e-84,"Rho-related protein racA","actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]","GO:0003924; GO:0005525; GO:0005856; GO:0005886; GO:0007015; GO:0007163; GO:0007165; GO:0007264; GO:0008360; GO:0009617; GO:0019901; GO:0030865; GO:0031410; GO:0032956; GO:0042995"
"2208","Pocillopora_acuta_HIv2___RNAseq.g26237.t1",100,NA,NA,100,100,100,100,NA,100,NA,100,100,100,NA,NA,NA,NA,NA,NA,10.0067350129541,8.92948273586804,6.92769983394193,9.0958711139735,8.8825782595145,8.15759426901582,10.4582747825454,7.05895260351335,5.98677490518935,3.68233641306884,7.91862999295848,7.77254812302265,8.06471186289432,432.239410754505,0.00788108473165119,0.88281794069531,0.963993075075095,0.987155360665697,"Q921X9",1.04e-130,"Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein)","protein folding [GO:0006457]","GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0015035"
"2209","Pocillopora_acuta_HIv2___RNAseq.g26269.t1",5.75616732213085,5.11333684765419,5.59776089564174,4.0523945968072,7.98004987531172,14.7058823529412,12.2218639148662,2.11024978466839,5.34967124925284,16.7599720083975,7.96473488476718,6.26630696626476,9.66316280326959,NA,NA,NA,NA,NA,NA,10.5443718335006,9.31219899346198,10.2577941535787,8.700661330839,10.3959077627463,8.33181090131692,9.23914877654576,10.3457494074841,9.99844811330866,9.86995923320575,9.69960505059878,10.3084542541237,9.09075584707388,904.881318656044,-0.980446689957571,0.629910020644276,0.0490640556640942,0.153473724291838,"Q3MHX6",1.84e-14,"Protein OS-9","endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; protein retention in ER lumen [GO:0006621]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005788; GO:0006511; GO:0006621; GO:0030246; GO:0030968; GO:0030970; GO:0034976; GO:0036503"
"2210","Pocillopora_acuta_HIv2___RNAseq.g26274.t1",0,0,NA,NA,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.3857939363956,3.68233641306884,9.68812139331468,7.595757733073,7.37503807012894,11.3751748302083,10.4436660543081,8.26122989030927,3.68233641306884,3.68233641306884,7.61717911469444,7.87850394064347,7.35585428874542,670.122219085364,0.0149873072698828,0.975121358725343,0.915089839705064,0.969019320134147,"Q7ZX22",0,"GATOR2 complex protein WDR24 (EC 2.3.2.27)","autophagy [GO:0006914]; cellular response to nutrient levels [GO:0031669]; positive regulation of TORC1 signaling [GO:1904263]; protein K6-linked ubiquitination [GO:0085020]","GO:0005765; GO:0006914; GO:0031669; GO:0046872; GO:0061630; GO:0061700; GO:0085020; GO:1904263"
"2211","Pocillopora_acuta_HIv2___RNAseq.g26275.t1",0,0,NA,0,1.55038759689922,1.11111111111111,0,0,0,NA,0.332687338501292,0.222222222222222,0.516795865633075,NA,NA,NA,NA,NA,NA,10.4789151142086,10.7321042725205,11.1101684123248,11.2471543562614,10.5573104686258,8.79818649690832,11.5889149601044,8.88597397159546,3.68233641306884,3.68233641306884,9.0763400878687,8.9429408759647,9.20973929977269,1307.06345031341,0.14144421034828,0.795270353774542,0.747932790861822,0.88894758205596,"Q53SF7",2.76e-06,"Cordon-bleu protein-like 1","","GO:0003785; GO:0045296; GO:0070062"
"2212","Pocillopora_acuta_HIv2___RNAseq.g26279.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.65557334666683,8.38392522670103,10.0457550899059,7.28204866049182,7.89366193982619,9.10950577092441,9.63114991763922,8.85216124356356,10.2413884476995,3.68233641306884,8.37775060564873,9.1377080135324,7.61779319776506,497.847743430252,-0.254035913825176,0.920639888132685,0.431397135650839,0.675040065536629,"O73792",7.13e-53,"Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)","angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell-cell adhesion [GO:0071603]; heart development [GO:0007507]; positive regulation of angiogenesis [GO:0045766]; vasculature development [GO:0001944]","GO:0001525; GO:0001568; GO:0001944; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0007507; GO:0043235; GO:0045766; GO:0071603"
"2213","Pocillopora_acuta_HIv2___RNAseq.26080_t",NA,0,71.4285714285714,0,0,0,0,NA,NA,NA,11.9047619047619,0,23.8095238095238,NA,NA,NA,NA,NA,NA,7.81649236998219,5.98993441970487,8.06338218429842,3.68233641306884,8.18346933366442,3.68233641306884,3.68233641306884,9.56941294567769,3.68233641306884,3.68233641306884,5.80343733186718,7.46301864933831,4.14385601439605,148.330462136139,-0.482405783697346,1.17698348392828,0.000239908410494224,0.00174989170417976,"Q8VCK5",3.91e-150,"Kelch-like protein 20 (Kelch-like ECT2-interacting protein)","Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]","GO:0003779; GO:0004842; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390"
"2214","Pocillopora_acuta_HIv2___TS.g25171.t1",0,7.69230769230769,5.88235294117647,0,0,3.05676855895197,1.01010101010101,0,NA,0,1.96017002250413,2.68726906281491,1.3784907902555,NA,NA,NA,NA,NA,NA,9.98426475034793,7.96430909081604,10.7763357972632,11.367128185131,10.4378353197968,7.3029219250034,10.0321249867177,9.06225372000166,10.6617578490858,9.1570241431435,9.6745955767307,10.1844894872991,9.16470166616233,1072.17034475027,-0.57563485901623,0.80780065748666,0.219660629745937,0.450790486470663,"Q99NH2",6.88e-61,"Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (Ephrin-interacting protein) (PHIP)","apical constriction [GO:0003383]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cell-cell adhesion [GO:0098609]; centrosome localization [GO:0051642]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; positive regulation of receptor internalization [GO:0002092]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; regulation of actin filament-based process [GO:0032970]; regulation of cellular localization [GO:0060341]; wound healing, spreading of cells [GO:0044319]","GO:0000226; GO:0002092; GO:0003383; GO:0005546; GO:0005547; GO:0005737; GO:0005819; GO:0005911; GO:0005912; GO:0005923; GO:0005938; GO:0006612; GO:0007155; GO:0007163; GO:0008104; GO:0010801; GO:0012505; GO:0016324; GO:0019903; GO:0022011; GO:0030010; GO:0030054; GO:0031643; GO:0032266; GO:0032970; GO:0032991; GO:0033269; GO:0035091; GO:0042802; GO:0043025; GO:0043219; GO:0043220; GO:0043296; GO:0044295; GO:0044319; GO:0045197; GO:0051301; GO:0051642; GO:0051660; GO:0060341; GO:0070830; GO:0090162; GO:0098609"
"2215","Pocillopora_acuta_HIv2___TS.g787.t1",0,0,0,3.92156862745098,0,2.08333333333333,0,NA,NA,NA,0.857843137254902,2.0016339869281,0,NA,NA,NA,NA,NA,NA,8.13549223134047,10.0710282631604,8.22301936314656,7.05167883442013,7.55213858153997,3.68233641306884,7.55715091401747,7.14279562628233,10.5143627559046,3.68233641306884,7.36123393959496,8.31356171164279,6.40890616754714,356.848410798532,-0.266175033351131,0.990223636145586,0.19791697923061,0.41993122892644,"Q5RFT1",3.09e-63,"Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog)","negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]","GO:0005739; GO:0005765; GO:0008284; GO:0022857; GO:1901029"
"2216","Pocillopora_acuta_HIv2___RNAseq.g8581.t1",NA,NA,NA,7.8125,0,0,0,NA,0,0,1.30208333333333,2.60416666666667,0,NA,NA,NA,NA,NA,NA,6.44918989210843,3.68233641306884,7.74010644098529,3.68233641306884,7.28808184092463,3.68233641306884,3.68233641306884,5.74496152652496,5.83482419616881,3.68233641306884,5.14688459620563,6.61143277934242,3.68233641306884,44.9465383223538,-9.70745563232503,3.73366785593754,9.50878167451884e-06,0.000109259869786876,NA,NA,NA,NA,NA
"2217","Pocillopora_acuta_HIv2___RNAseq.g8587.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.61740237719946,8.89113336269365,6.26832651907503,8.05848887682085,3.68233641306884,9.81385865764162,10.9379829831032,5.92312243117937,3.68233641306884,9.85467661623101,7.37296646500819,5.23470483071831,9.51122809929807,456.761246394455,2.77278605172307,3.82013917741802,0.000123916095816841,0.000996288165589095,"Q19269",2.14e-45,"Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14)","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"2218","Pocillopora_acuta_HIv2___RNAseq.g8588.t1",14.1509433962264,13.0841121495327,11.9047619047619,9.61538461538461,11.4285714285714,1.81818181818182,17.0212765957447,15,17.5757575757576,14.7186147186147,12.6317604202776,11.4186872317713,13.8448336087838,NA,NA,NA,NA,NA,NA,3.68233641306884,10.3412251351717,3.68233641306884,11.0878754177244,3.68233641306884,11.3280478054892,10.2113216336423,3.68233641306884,3.68233641306884,9.50911273392786,7.08892647912997,3.68233641306884,10.4955165451911,783.119333561871,15.4774117501853,3.69354649776281,2.18853875389073e-16,1.43886475164889e-13,"B3EWZ3",3.14e-104,"Coadhesin","","GO:0016020"
"2219","Pocillopora_acuta_HIv2___RNAseq.g8632.t1",0,0,0,0,1.78571428571429,0,0,8.88888888888889,0,0,1.06746031746032,1.77777777777778,0.357142857142857,NA,NA,NA,NA,NA,NA,5.83894995413197,3.68233641306884,8.43967404947304,6.17770847719114,7.75224048005619,3.68233641306884,3.68233641306884,6.31424499730879,3.68233641306884,3.68233641306884,5.29345000235053,6.40548917880777,4.1814108258933,65.2108174309961,-0.587277524426028,1.26526214705336,0.00430104619950396,0.0204908867686513,"Q9JHA8",4.17e-69,"von Willebrand factor A domain-containing protein 7 (Protein G7c)","","GO:0005576"
"2220","Pocillopora_acuta_HIv2___RNAseq.g8666.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.334055555777,10.1311885917524,10.0406701788741,10.3981397334274,6.51427663130281,5.84950698471885,3.68233641306884,9.66767587661766,10.3014262543175,3.68233641306884,7.96016126329254,9.17162089937781,6.74870162720727,619.419182220057,-0.306600162146412,0.995055801610203,0.191376131233577,0.410996935733104,"Q9H9Q2",7.45e-88,"COP9 signalosome complex subunit 7b (SGN7b) (Signalosome subunit 7b) (JAB1-containing signalosome subunit 7b)","COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338]; regulation of protein neddylation [GO:2000434]","GO:0000338; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008180; GO:0010387; GO:2000434"
"2221","Pocillopora_acuta_HIv2___RNAseq.g8671.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.16911426736902,3.68233641306884,6.29666242793451,7.58719755490047,8.5782815116387,7.85972880706295,3.68233641306884,9.98168060800628,3.68233641306884,3.68233641306884,6.12020108291873,6.94161504560347,5.29878712023399,182.094786401444,-0.246822862066582,1.01860595112389,0.332319292234063,0.582908833722227,"Q7KVA1",6.63e-11,"Xylosyltransferase oxt (EC 2.4.2.26) (Imaginal disk type I) (Peptide O-xylosyltransferase)","chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; D-xylose metabolic process [GO:0042732]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan metabolic process [GO:0030201]","GO:0000139; GO:0005789; GO:0015012; GO:0016020; GO:0030158; GO:0030201; GO:0030204; GO:0030206; GO:0042732; GO:0046872; GO:0050650"
"2222","Pocillopora_acuta_HIv2___RNAseq.g8685.t1",0,0,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.08925051517136,3.68233641306884,7.80412787236133,3.68233641306884,8.47378357104876,3.68233641306884,3.68233641306884,8.24393212696616,10.2723081062213,3.68233641306884,6.22950842571131,8.77668043835378,3.68233641306884,253.737824638808,-12.7850677831587,3.66046065003153,4.83004940335735e-11,3.19003810822651e-09,NA,NA,NA,NA,NA
"2223","Pocillopora_acuta_HIv2___RNAseq.g8699.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.4821980503449,7.8947948031256,9.72155449193117,10.9079468920821,8.77632573186842,9.3843085341297,3.68233641306884,10.4378550742282,3.68233641306884,3.68233641306884,7.76519928169166,8.42005395228831,7.11034461109502,603.492748794538,-0.170745311341634,0.953151034997009,0.534135384784407,0.755056118600631,"O60308",0,"Centrosomal protein of 104 kDa (Cep104)","","GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0005929"
"2224","Pocillopora_acuta_HIv2___RNAseq.g8701.t1",0,NA,0,NA,0,8.33333333333333,0,0,0,NA,1.19047619047619,2.77777777777778,0,NA,NA,NA,NA,NA,NA,10.0956019226313,6.62290225491721,9.87571333406333,10.2027609587357,11.099454612726,10.1598553939212,12.9508804029264,8.97244355770215,9.83120947308844,6.48472759049682,9.62955495012086,9.97488458004224,9.28422532019947,1581.74186357219,-0.316595103501306,0.896224433106326,0.336160437424728,0.587012503550799,"P46023",1.72e-14,"G-protein coupled receptor GRL101","","GO:0004930; GO:0005886"
"2225","Pocillopora_acuta_HIv2___RNAseq.g8705.t1",50,NA,NA,NA,30,0,18.1818181818182,0,0,NA,16.3636363636364,0,32.7272727272727,NA,NA,NA,NA,NA,NA,5.25300700550269,3.68233641306884,5.92829418692211,5.73735826925806,7.21780641711855,3.68233641306884,6.36722016743734,7.86816093962977,9.44727814294713,3.68233641306884,5.88661343680222,7.14290933842405,4.63031753518038,114.995887349225,-0.795591423744374,1.37675585264239,0.00091261231584072,0.00543429210269182,"Q9WV70",6.45e-172,"Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)","apoptotic process [GO:0006915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]","GO:0000122; GO:0000786; GO:0002039; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006915; GO:0030690; GO:0030691; GO:0042273; GO:0042393"
"2226","Pocillopora_acuta_HIv2___RNAseq.g17887.t1",NA,0,NA,0,0,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,10.3284783101512,8.95449335454389,10.0679181415957,9.72803135494874,10.3010873113103,10.7776906453779,11.2683190131988,9.11230144045656,9.33682600131803,10.9554499457225,10.0830595518624,9.82932224096636,10.3367968627584,1211.79350708537,0.315891089746892,0.690075276041707,0.514911100020193,0.739989238220648,"Q8TB96",1.57e-139,"T-cell immunomodulatory protein (Protein TIP) (Integrin-alpha FG-GAP repeat-containing protein 1) (Linkin)","","GO:0005886; GO:0070062"
"2227","Pocillopora_acuta_HIv2___TS.g17699.t2",4.54545454545455,0,NA,14.2857142857143,0,5,1.96078431372549,0,0,0,2.86577257165492,3.85714285714286,1.62655971479501,NA,NA,NA,NA,NA,NA,8.16247966683365,7.65577565980928,8.39887563080906,3.68233641306884,8.21418015693213,3.68233641306884,3.68233641306884,6.56229197038834,10.6086999888814,3.68233641306884,6.43316487259292,8.38930548276892,4.47702426241693,262.889461154415,-1.15438104240542,2.27398438952679,7.44550548060604e-07,1.21138122915057e-05,"Q3UVD5",3.11e-27,"Leucine-rich repeat-containing G-protein coupled receptor 6","bone regeneration [GO:1990523]; cell population proliferation [GO:0008283]; positive regulation of cell migration [GO:0030335]; positive regulation of Wnt signaling pathway [GO:0030177]; tissue regeneration [GO:0042246]; Wnt signaling pathway [GO:0016055]","GO:0004930; GO:0005615; GO:0005886; GO:0008283; GO:0016055; GO:0016500; GO:0030177; GO:0030335; GO:0031012; GO:0031982; GO:0042246; GO:1990523"
"2228","Pocillopora_acuta_HIv2___RNAseq.26309_t",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.35172148583958,3.68233641306884,8.30346531674014,3.68233641306884,9.0309190252451,9.71263020603418,8.39656433331989,10.3012241900631,3.68233641306884,3.68233641306884,6.98258702095174,8.13393328619135,5.83124075571212,377.803949000289,-0.322677047253408,1.04413201910069,0.156990125915972,0.359288794501364,NA,NA,NA,NA,NA
"2229","Pocillopora_acuta_HIv2___RNAseq.g17904.t1b",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,4.5939750356694,8.81464828177475,8.68123060976337,6.10548275003066,8.34353368649726,9.69908399890452,3.68233641306884,8.33931014045853,3.68233641306884,3.68233641306884,6.5624273742305,6.72807717709148,6.39677757136952,226.516858983653,-0.0610520435732305,0.983963513312703,0.883001174499693,0.954681491102075,"Q6DFF6",2.02e-22,"Kelch-like protein 20","Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]","GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390"
"2230","Pocillopora_acuta_HIv2___RNAseq.g17932.t1",0,0,0,NA,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.3633047332553,9.78081902102971,11.8877422537461,8.05229567757085,11.8096744774167,10.2839977497027,10.1322342693211,10.1261371965602,12.804448291398,6.77623032629085,10.3016883996292,11.5982613904753,9.00511540878304,2165.47187946705,-1.44609975810341,1.22527230655467,0.0131660723444875,0.0523602063213272,"Q4R4P4",3.49e-103,"Fatty acid 2-hydroxylase (EC 1.14.18.-) (Fatty acid alpha-hydroxylase)","ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fatty acid biosynthetic process [GO:0006633]; galactosylceramide biosynthetic process [GO:0006682]; glucosylceramide biosynthetic process [GO:0006679]; plasma membrane raft organization [GO:0044857]","GO:0005506; GO:0005789; GO:0006633; GO:0006679; GO:0006682; GO:0016020; GO:0020037; GO:0044857; GO:0046513; GO:0061436; GO:0080132"
"2231","Pocillopora_acuta_HIv2___RNAseq.g17942.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.2447423312731,3.68233641306884,6.36503790894442,3.68233641306884,4.86250168289467,5.65167313584929,5.82167741730566,7.72566014842227,7.94170528458551,6.21711944007385,6.01947901754864,7.02792947122399,5.0110285638733,86.6260665472082,-0.661496974611635,1.20918576738629,0.0231753185100167,0.0836138206357898,"P48442",4.42e-125,"Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic membrane potential [GO:0099505]; response to calcium ion [GO:0051592]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; response to metal ion [GO:0010038]; response to organic cyclic compound [GO:0014070]; vasodilation [GO:0042311]","GO:0001503; GO:0002931; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0008284; GO:0009986; GO:0010038; GO:0010628; GO:0014070; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0030424; GO:0032024; GO:0032782; GO:0035729; GO:0042311; GO:0042734; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051592; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:0098978; GO:0099505; GO:1901653; GO:1902476"
"2232","Pocillopora_acuta_HIv2___RNAseq.g17943.t1",0,NA,NA,0,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.2984373315476,3.68233641306884,10.1941877851581,3.68233641306884,10.117938092474,3.68233641306884,3.68233641306884,6.72298244155315,8.69188709951876,3.68233641306884,6.44371148155958,9.20508655005032,3.68233641306884,393.527067993985,-13.6987650046603,3.82930416674791,8.61004841412957e-12,7.78348376637313e-10,NA,NA,NA,NA,NA
"2233","Pocillopora_acuta_HIv2___RNAseq.g17945.t2",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.85812607344819,11.3263850253088,10.7763357972632,5.56232777220043,11.4957109512782,10.3776625976113,3.68233641306884,5.67356605113577,11.4548125866491,8.36973113590363,8.85769944038675,9.85171029195489,7.8636885888186,1248.0805225734,-1.06195371543828,1.41109255810166,0.01172247349522,0.0474011340885834,NA,NA,NA,NA,NA
"2234","Pocillopora_acuta_HIv2___RNAseq.g17955.t1",4.07986111111111,4.11490683229814,1.11731843575419,2.72108843537415,4.32692307692308,8,2.01729106628242,1.89959294436906,3.125,1.60628844839371,3.30082703505059,3.97211764240827,2.6295364276929,NA,NA,NA,NA,NA,NA,11.1341996352901,11.6622478014804,10.6303195750966,11.2150158843026,10.4449021059828,10.0958318130175,9.13384148117489,9.92682061325933,9.6051034969727,12.8761063098557,10.6724388716433,10.3482690853203,10.9966086579662,2151.5415785455,0.320701014191591,0.698714101405974,0.504528931672056,0.733340677314533,"Q8K2V1",0,"Serine/threonine-protein phosphatase 4 regulatory subunit 1","","GO:0005737; GO:0019888"
"2235","Pocillopora_acuta_HIv2___TS.g17771.t1",0,0,NA,NA,0,2.1978021978022,0,0,NA,0,0.313971742543171,0.732600732600733,0,NA,NA,NA,NA,NA,NA,10.4887033031353,9.04750534458592,9.84687113984658,8.21079756841435,9.624563020644,9.91496967806064,3.68233641306884,9.26140233665763,8.25499591993224,3.68233641306884,8.20144811374143,9.49530714404315,6.90758908343972,565.406147799823,-0.614474046490897,1.14117694923386,0.0390286617827093,0.128356199187155,"Q6DIJ4",9.61e-115,"Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10)","autophagy [GO:0006914]; cellular response to interleukin-1 [GO:0071347]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of stress granule assembly [GO:0062030]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; rescue of stalled ribosome [GO:0072344]","GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0006281; GO:0006508; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0030330; GO:0043124; GO:0044325; GO:0062030; GO:0071347; GO:0072344"
"2236","Pocillopora_acuta_HIv2___RNAseq.g17974.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.22354659945218,8.56545323006855,10.1803832661764,10.3673596138748,9.56741869562019,10.212709202241,10.9129116309092,8.63733288117018,6.37842387115414,3.68233641306884,8.67278754037355,8.59742106271462,8.74815401803248,728.689896754895,0.045853040572023,0.826397537415378,0.933492193256794,0.97550979577099,"E7FAM5",1.9e-37,"E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177"
"2237","Pocillopora_acuta_HIv2___RNAseq.26419_t",0,NA,0,0,NA,0,1.85185185185185,0,NA,NA,0.308641975308642,0,0.617283950617284,NA,NA,NA,NA,NA,NA,12.7991169194916,12.7006008355723,12.321456843222,13.3656646277188,12.6558846106552,13.2035359955383,11.8599723493837,11.71220890821,12.7003060426471,12.5628698602774,12.5881616992716,12.4377946648452,12.7385287336981,6486.61851542914,0.206166947793474,0.515609082708925,0.60826514266787,0.805523985969613,"Q4U2R1",2.19e-12,"E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)","DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]","GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630"
"2238","Pocillopora_acuta_HIv2___RNAseq.g18013.t1",11.0891089108911,15,6.0377358490566,3.10679611650485,9.38775510204082,6.7741935483871,9.13705583756345,21.5962441314554,1.5748031496063,3.34346504559271,8.70471576910983,9.61040738919073,7.79902414902893,2,3.87894288150043,3.87894288150043,0.0277626717877877,0.0244950491368555,0.0310302944387199,8.50219715209011,9.56241824191553,10.1877621145204,8.31270509958201,7.60379181609188,5.5687784028515,7.28023528800867,8.23228355748136,6.73914848420464,6.04206022209894,7.8031380378845,8.25303662487768,7.35323945089133,322.839303609797,-0.716575466967824,0.765513457699456,0.154607623154507,0.355523793530491,"B3EWZ3",6.25e-102,"Coadhesin","","GO:0016020"
"2239","Pocillopora_acuta_HIv2___RNAseq.g18014.t1",0,0,NA,NA,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,11.5702107978448,12.1167976904648,10.8438592949459,11.0158766554866,11.0318422201036,11.1258260909552,11.565233747213,10.4604583096882,12.0447144019111,12.7027719723139,11.4477591180927,11.1902170048987,11.7053012312867,3079.39483644596,0.402869233960075,0.513536211888723,0.36225633747733,0.612339225104465,NA,NA,NA,NA,NA
"2240","Pocillopora_acuta_HIv2___RNAseq.g26318.t2",100,100,NA,0,100,100,100,NA,NA,NA,83.3333333333333,66.6666666666667,100,NA,NA,NA,NA,NA,NA,9.87857715777996,9.05330485701912,8.57258423570792,11.2362937897891,8.99283069416338,6.75180294683743,7.91855927919823,6.49442560906471,3.68233641306884,11.0822207769783,8.3662935759607,7.52415082195696,9.20843632996444,715.759265634984,0.277156411270344,0.959956088784265,0.35761666621054,0.608036612209857,"F1LQ48",1.57e-115,"Heterogeneous nuclear ribonucleoprotein L (hnRNP L)","cellular response to amino acid starvation [GO:0034198]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; response to peptide [GO:1901652]","GO:0000381; GO:0000785; GO:0000976; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0007623; GO:0034198; GO:0035770; GO:0043484; GO:0045120; GO:0045202; GO:0045727; GO:0045892; GO:0048025; GO:0048471; GO:0097157; GO:1901652; GO:1990715; GO:1990904"
"2241","Pocillopora_acuta_HIv2___RNAseq.g26348.t2",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.32448441960038,9.82554342269253,9.53162411990669,10.1631662320485,10.81400141928,7.60502134296842,10.0306218066397,11.0713738436583,6.62398624435115,3.68233641306884,8.56721592642145,8.8730940093593,8.2613378434836,794.004564672284,-0.269067269724915,0.936716200592188,0.361414901918535,0.611561347952172,"Q9H6X4",4.51e-11,"Transmembrane protein 134","","GO:0005829; GO:0016020; GO:0048471"
"2242","Pocillopora_acuta_HIv2___RNAseq.g26370.t1",100,100,100,100,100,100,NA,100,NA,NA,100,100,100,NA,NA,NA,NA,NA,NA,11.2386056841752,11.9597899120775,10.721470730952,11.4100426431604,11.557595289116,10.8448287436227,11.6645114442308,11.3192387552757,11.5354494512799,11.8879092756235,11.4139441929514,11.2744719821598,11.553416403743,2796.62584480192,0.215405224541781,0.530639195897858,0.633730654019995,0.823195346182776,NA,NA,NA,NA,NA
"2243","Pocillopora_acuta_HIv2___TS.g22510.t1",0,0,NA,NA,6.66666666666667,0,0,NA,0,NA,1.11111111111111,0,2.22222222222222,NA,NA,NA,NA,NA,NA,6.03460261738071,10.3424092554046,8.8582568221224,8.11305770165279,8.40288284703232,8.1794761914649,11.4580568870868,9.85754169811763,3.68233641306884,8.27326811992073,8.32018885532517,7.36712407954438,9.27325363110596,655.795072330709,0.576321879045235,1.05378389165383,0.101000029018149,0.263266281405187,"Q05B79",0,"ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.12) (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1) (G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein)","3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]","GO:0000287; GO:0000781; GO:0000978; GO:0002151; GO:0003678; GO:0003723; GO:0003724; GO:0003730; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0010494; GO:0010501; GO:0010628; GO:0016607; GO:0016887; GO:0017148; GO:0030154; GO:0030424; GO:0030425; GO:0031442; GO:0034605; GO:0034644; GO:0035925; GO:0043123; GO:0043204; GO:0043488; GO:0044806; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:1900153; GO:1901534; GO:1903843; GO:1904358; GO:1904582; GO:2000767"
"2244","Pocillopora_acuta_HIv2___RNAseq.g26473.t1",0,0,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.0259275992552,11.2343516243492,11.042090542125,8.56821385139866,11.5345951216785,10.4937789454629,8.44708254939947,11.0329322026272,11.7240231805343,9.41151479429387,10.4514510411124,11.271913729244,9.63098835298082,1764.41347259502,-1.2660183136109,0.798313778775597,0.0224613621043689,0.0816468615015135,"O14901",1.58e-62,"Krueppel-like factor 11 (Transforming growth factor-beta-inducible early growth response protein 2) (TGFB-inducible early growth response protein 2) (TIEG-2)","apoptotic process [GO:0006915]; cellular response to peptide [GO:1901653]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006357; GO:0006915; GO:0008285; GO:0016604; GO:0043065; GO:0046872; GO:1901653; GO:1990837; GO:2000045"
"2245","Pocillopora_acuta_HIv2___RNAseq.g26479.t1",33.3333333333333,100,100,NA,NA,100,100,NA,100,NA,88.8888888888889,100,77.7777777777778,NA,NA,NA,NA,NA,NA,9.44793433095869,10.763382426523,11.607011057548,10.4066417571364,10.4658970818047,10.3917635267193,7.99473091893197,9.97994311988779,10.5103780578533,7.76255508842904,9.93302373657922,10.4022327296105,9.46381474354794,1235.75030908346,-0.575431729502344,0.771923976209629,0.23135122550734,0.465920525692407,"Q5R7A7",0,"Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 3)","negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]","GO:0004674; GO:0005524; GO:0005769; GO:0035091; GO:0055037; GO:0106310; GO:2001240"
"2246","Pocillopora_acuta_HIv2___RNAseq.g4177.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.88936696569912,9.68137605324305,9.760429728062,6.02915908265446,9.94346309732349,9.8713515781131,8.01924883694224,9.12021333556051,10.5899421007965,3.68233641306884,8.65868871914633,9.86068304548832,7.45669439280434,675.40358328802,-0.61144738485851,1.05882330945418,0.108286958216565,0.277018493746798,"Q8BW72",1.9e-158,"Lysine-specific demethylase 4A (EC 1.14.11.66) (EC 1.14.11.69) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) ([histone H3]-trimethyl-L-lysine(36) demethylase 4A) ([histone H3]-trimethyl-L-lysine(9) demethylase 4A)","apoptotic chromosome condensation [GO:0030263]; cardiac muscle hypertrophy in response to stress [GO:0014898]; chromatin remodeling [GO:0006338]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of autophagy [GO:0010507]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; regulation of gene expression [GO:0010468]; response to nutrient levels [GO:0031667]","GO:0000785; GO:0001650; GO:0005634; GO:0005654; GO:0005721; GO:0005829; GO:0006338; GO:0008270; GO:0010468; GO:0010507; GO:0010628; GO:0010629; GO:0014898; GO:0030263; GO:0031625; GO:0031667; GO:0032452; GO:0032454; GO:0035064; GO:0045666; GO:0045892; GO:0048712; GO:0051864; GO:0140681; GO:0140684"
"2247","Pocillopora_acuta_HIv2___RNAseq.g4185.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.25300700550269,3.68233641306884,7.84683233870282,3.68233641306884,6.62825944060524,3.68233641306884,7.93153867530596,9.98081212559619,3.68233641306884,3.68233641306884,5.60521316510571,6.67824946469516,4.53217686551626,150.104247154907,-0.579456704783463,1.23780742873183,0.00551627861418385,0.0252428482892095,"Q28DB0",4.99e-149,"Tetratricopeptide repeat protein 39B (TPR repeat protein 39B)","lipid metabolic process [GO:0006629]","GO:0006629"
"2248","Pocillopora_acuta_HIv2___RNAseq.g4192.t1",0,NA,NA,0,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,7.53545846369506,8.40223456164024,9.33459778622641,10.5734235479739,6.51427663130281,8.12187490846922,8.5388626032004,6.23258115521575,10.4251099807366,3.68233641306884,7.93607560515292,8.00840480343533,7.86374640687052,466.105066853951,0.238429675478397,0.923739503865976,0.523933613130944,0.747289124817569,"P13584",2.9e-133,"Cytochrome P450 4B1 (EC 1.14.14.1) (CYPIVB1) (Cytochrome P450-HP)","biphenyl metabolic process [GO:0018879]; fatty acid metabolic process [GO:0006631]","GO:0004497; GO:0005506; GO:0005789; GO:0006631; GO:0018879; GO:0019825; GO:0020037; GO:0070330; GO:1901363"
"2249","Pocillopora_acuta_HIv2___TS.g4809.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.4962751970967,12.0965907522763,10.2656602507442,10.8689265929414,11.4209346490949,10.6575676659639,10.735152206295,9.95451144587373,11.7321719291038,8.13649090394532,10.7364281593335,10.9739106943827,10.4989456242844,2085.15378439413,-0.153827722590925,0.717541846897055,0.725034462628833,0.876641060244514,"Q8TEK3",2.68e-142,"Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4)","DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; gene expression [GO:0010467]; heterochromatin formation [GO:0031507]; methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; telomere organization [GO:0032200]","GO:0000077; GO:0003676; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0010467; GO:0031151; GO:0031507; GO:0032200; GO:0032259; GO:0032991; GO:0042054; GO:0043231; GO:0045944; GO:0046425; GO:0061629; GO:0140938; GO:0140956; GO:2000677"
"2250","Pocillopora_acuta_HIv2___RNAseq.g4201.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,4.95179328310793,8.03648948185279,6.74729698008972,3.68233641306884,6.12628170656021,7.86514535111111,3.68233641306884,6.73139027483494,3.68233641306884,3.68233641306884,5.51877427298321,5.64781973153233,5.38972881443408,66.8253668891851,-0.0529505179918048,1.00272431958783,0.781730102221677,0.907168180241843,NA,NA,NA,NA,NA
"2251","Pocillopora_acuta_HIv2___RNAseq.g4202.t1",0,0,0,NA,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,13.3262018457216,16.1269021358657,12.4108611625726,15.873255604754,13.1291653374723,15.7088207959545,15.5268877684093,13.4228369844692,10.9854311888253,15.7943250924821,14.2304687916527,12.6548993038122,15.8060382794931,32661.3244858288,2.82276683557086,0.766522399915237,9.39163249510804e-06,0.000108153321981881,"Q9U943",1.28e-76,"Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]","Wnt signaling pathway [GO:0016055]","GO:0005319; GO:0005576; GO:0008289; GO:0016055"
"2252","Pocillopora_acuta_HIv2___RNAseq.g4213.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.15070113667054,6.22089677820832,8.20855739098366,3.68233641306884,9.13221106882038,3.68233641306884,3.68233641306884,8.21758883240833,10.9702812206048,3.68233641306884,6.36295820799714,8.53586792989754,4.19004848609674,315.846919435748,-0.903381315356376,1.67702669237293,1.85037709268746e-07,3.6814104908709e-06,"Q8CBH5",2.63e-25,"Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2)","adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]","GO:0002250; GO:0005886; GO:0032393; GO:0042288; GO:0042590"
"2253","Pocillopora_acuta_HIv2___RNAseq.g4222.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.5638642959944,9.67386912869877,8.39568883872764,3.68233641306884,10.3426703452311,11.0496128049575,7.24933793434975,8.41336867966569,11.020874787303,10.5133023951146,9.09049256231113,9.74729338938437,8.43369173523789,988.968000635517,-0.430682324866689,0.912871628027165,0.313060914998345,0.562358802103336,"A2AM05",2.19e-35,"Centlein (Centrosomal protein)","centriole-centriole cohesion [GO:0010457]; protein localization to organelle [GO:0033365]","GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0010457; GO:0019901; GO:0019904; GO:0030674; GO:0033365"
"2254","Pocillopora_acuta_HIv2___RNAseq.g4223.t1",0,0,0,0,0,4.25531914893617,0,NA,0,0,0.472813238770686,1.06382978723404,0,NA,NA,NA,NA,NA,NA,10.3971777422454,5.26408513103678,11.2863177482294,10.8333329972884,9.11458475166504,4.89289037263117,11.5432669348635,11.0325132341439,3.68233641306884,3.68233641306884,8.17288417382413,9.10258597787052,7.24318236977774,1117.74466009842,-0.557375203413853,1.07012755227801,0.127670017118237,0.312403844966702,"P41233",0,"Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; establishment of localization in cell [GO:0051649]; export across plasma membrane [GO:0140115]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to laminar fluid shear stress [GO:0034616]; response to vitamin B3 [GO:0033552]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]","GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005768; GO:0005794; GO:0005886; GO:0006911; GO:0007040; GO:0007189; GO:0008035; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0009986; GO:0010875; GO:0015914; GO:0016197; GO:0016323; GO:0016887; GO:0019905; GO:0023061; GO:0030301; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033552; GO:0033700; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0051649; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071345; GO:0071397; GO:0071466; GO:0071806; GO:0090108; GO:0090554; GO:0090556; GO:0120020; GO:0140115; GO:0140328; GO:0140359"
"2255","Pocillopora_acuta_HIv2___RNAseq.g7119.t3",NA,NA,0,NA,0,0,2.4390243902439,0,0,0,0.348432055749129,0,0.609756097560976,NA,NA,NA,NA,NA,NA,5.9511981009209,6.72972788057412,6.60897372799175,6.97457669156694,5.90231870585895,4.99187376865589,3.68233641306884,6.75631530397046,6.48192780096359,8.28853632360182,6.23677847171733,6.34014672794113,6.13341021549352,78.1142322266098,-0.0855807264092577,0.87624272221143,0.800494779214337,0.915824840917101,"Q80X72",1.27e-11,"Leucine-rich repeat-containing protein 15","negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813]","GO:0001968; GO:0005518; GO:0005615; GO:0005886; GO:0009986; GO:0016324; GO:0030335; GO:0031012; GO:0043236; GO:0046597; GO:0046813; GO:0062023; GO:0140311; GO:1903077"
"2256","Pocillopora_acuta_HIv2___RNAseq.g7120.t1",0,0,0,0,2.06185567010309,0,2.63157894736842,0.775193798449612,0,NA,0.607625379546792,0.155038759689922,1.17335865436788,NA,NA,NA,NA,NA,NA,6.81413639344593,6.03941460781193,6.9801832069997,3.68233641306884,8.95039944272719,7.03963041141765,3.68233641306884,8.97419095340504,3.68233641306884,3.68233641306884,5.95273006680828,7.08024928192934,4.82521085168722,128.687202485184,-0.489237285459726,1.13341239808443,0.0833640910880072,0.228482522349853,"A2ARS0",1.66e-17,"Ankyrin repeat domain-containing protein 63","",""
"2257","Pocillopora_acuta_HIv2___RNAseq.g7125.t1",0,NA,0,NA,0,0,NA,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.99744577812822,10.2770335872061,11.0456479659831,3.68233641306884,8.12295198948429,10.4359819159642,3.68233641306884,10.3967756160985,6.95638151601114,8.89335845675969,8.24902496517729,9.10384057314105,7.39420935721353,727.528501859049,-0.0346869067433802,0.971512822206712,0.838769117262055,0.936114473715985,"Q8CG64",1.28e-09,"Ribitol 5-phosphate transferase FKRP (EC 2.7.8.-) (Fukutin-related protein) (EC 2.4.2.-) (Ribitol-5-phosphate transferase)","adult walking behavior [GO:0007628]; basement membrane organization [GO:0071711]; bone mineralization [GO:0030282]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; central nervous system development [GO:0007417]; connective tissue development [GO:0061448]; connective tissue replacement [GO:0097709]; creatine metabolic process [GO:0006600]; diaphragm development [GO:0060539]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; filtration diaphragm assembly [GO:0036058]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glycolytic process [GO:0006096]; glycoprotein biosynthetic process [GO:0009101]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; localization of cell [GO:0051674]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; muscle cell differentiation [GO:0042692]; muscle contraction [GO:0006936]; muscle structure development [GO:0061061]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; oxygen metabolic process [GO:0072592]; pentitol metabolic process [GO:0019519]; pentose metabolic process [GO:0019321]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; protein glycosylation [GO:0006486]; protein import [GO:0017038]; protein localization [GO:0008104]; protein modification process [GO:0036211]; protein O-linked mannosylation [GO:0035269]; protein processing [GO:0016485]; protein tetramerization [GO:0051262]; reelin-mediated signaling pathway [GO:0038026]; respiratory system process [GO:0003016]; response to activity [GO:0014823]; response to alcohol [GO:0097305]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue development [GO:0007519]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle cell differentiation [GO:0051146]","GO:0000139; GO:0001654; GO:0001701; GO:0001764; GO:0002162; GO:0003007; GO:0003016; GO:0005615; GO:0005654; GO:0005791; GO:0005794; GO:0005829; GO:0006096; GO:0006486; GO:0006600; GO:0006629; GO:0006936; GO:0006954; GO:0007417; GO:0007420; GO:0007507; GO:0007519; GO:0007628; GO:0008104; GO:0009101; GO:0009410; GO:0010001; GO:0010467; GO:0014823; GO:0016485; GO:0016780; GO:0017038; GO:0019321; GO:0019519; GO:0030198; GO:0030282; GO:0035269; GO:0035437; GO:0036058; GO:0036211; GO:0038026; GO:0042383; GO:0042692; GO:0042802; GO:0043010; GO:0043236; GO:0043403; GO:0043491; GO:0046872; GO:0050905; GO:0051146; GO:0051262; GO:0051384; GO:0051674; GO:0060538; GO:0060539; GO:0061061; GO:0061448; GO:0071711; GO:0072592; GO:0097305; GO:0097709; GO:0098528; GO:0098723"
"2258","Pocillopora_acuta_HIv2___RNAseq.g7160.t1",0,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.84456860244933,3.68233641306884,7.85615191270033,3.68233641306884,7.33477781291543,8.79818649690832,7.06029841987015,7.67050686255267,3.68233641306884,3.68233641306884,6.12938357596716,6.87766832073732,5.381098831197,125.615336921993,-0.217251973725862,1.0066629600493,0.336603371583593,0.587431366624649,NA,NA,NA,NA,NA
"2259","Pocillopora_acuta_HIv2___RNAseq.g7178.t1",2.56410256410256,0,NA,0,0,0,0,0,NA,NA,0.366300366300366,0,0.854700854700855,NA,NA,NA,NA,NA,NA,8.8338367793067,11.2356266651066,9.29413767284283,11.0047200732305,8.80592318904832,11.3324405713874,6.58364178294652,9.6137895010874,9.78577137886752,7.56305912788741,9.40529467417112,9.26669170423055,9.54389764411169,1027.50782558941,0.159284203553185,0.85589112559425,0.657427436268082,0.837578652178415,"P86884",5.97e-140,"Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284)","formaldehyde catabolic process [GO:0046294]","GO:0004024; GO:0005829; GO:0008270; GO:0046294; GO:0106321; GO:0106322"
"2260","Pocillopora_acuta_HIv2___RNAseq.g7186.t2",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.7408916857874,11.9262285360051,10.2105806776495,11.1976247017524,9.95258281340783,12.2506401437279,11.0137303216578,10.2048533999906,11.2609329867404,12.6791124575753,11.0437177724294,10.2739683127151,11.8134672321437,2614.94763383048,1.2779325045877,0.634744025649176,0.0129229313121002,0.0516346073199494,"Q8CG80",1.52e-10,"SH2 domain-containing adapter protein F","apoptotic process [GO:0006915]","GO:0006915"
"2261","Pocillopora_acuta_HIv2___RNAseq.g7200.t1",0,11.4942528735632,8.66141732283465,36.3013698630137,1.86046511627907,11.6571428571429,5.81395348837209,0,0,NA,8.4209557245784,11.890553118744,4.08395898187145,NA,NA,NA,NA,NA,NA,10.6536113778283,9.52117743052283,8.64681182264656,9.244253171146,10.3306388012432,8.99341423801164,12.0066987936853,9.98254856774812,3.68233641306884,12.104161019734,9.51656516356348,8.659189396507,10.37394093062,1445.03677755325,0.218528392287088,0.922093059980115,0.550902129508095,0.767210514269699,"P00504",9.02e-167,"Aspartate aminotransferase, cytoplasmic (cAspAT) (EC 2.6.1.1) (EC 2.6.1.3) (Cysteine aminotransferase, cytoplasmic) (Cysteine transaminase, cytoplasmic) (cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A)","2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular response to insulin stimulus [GO:0032869]; fatty acid homeostasis [GO:0055089]; gluconeogenesis [GO:0006094]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; response to glucocorticoid [GO:0051384]","GO:0004069; GO:0004609; GO:0005829; GO:0006094; GO:0006103; GO:0006107; GO:0006114; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0007219; GO:0019550; GO:0019551; GO:0030170; GO:0032869; GO:0047801; GO:0051384; GO:0055089"
"2262","Pocillopora_acuta_HIv2___TS.g22105.t1",0,NA,NA,0,0,0,28.5714285714286,NA,0,NA,4.76190476190476,0,9.52380952380952,NA,NA,NA,NA,NA,NA,9.08221165440498,3.68233641306884,11.2104697465648,3.68233641306884,10.2781897819663,3.68233641306884,3.68233641306884,10.597064662892,8.17655864680531,3.68233641306884,6.77561765579776,9.86889889852668,3.68233641306884,586.4538651294,-14.3735188119337,3.83991242520682,2.0016291444927e-13,3.35763046186465e-11,"F1PZV2",2.55e-32,"Major facilitator superfamily domain-containing protein 12","carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021]","GO:0005764; GO:0005765; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:1903712"
"2263","Pocillopora_acuta_HIv2___RNAseq.g7236.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.50921680081805,10.059553407202,8.78712071333689,9.36886212565265,8.53915224815171,7.96939037271514,3.68233641306884,8.26980134459445,6.30482766574162,6.56351623590136,7.80537773271827,8.08202375452854,7.528731710908,341.495505403178,-0.0829701060023827,0.859344242812103,0.82403019094184,0.928181035883714,"S4X0Q8",4.39e-122,"Adhesion G protein-coupled receptor A3 (G-protein coupled receptor 125)","cell surface receptor signaling pathway [GO:0007166]; convergent extension involved in gastrulation [GO:0060027]; motor neuron migration [GO:0097475]; planar cell polarity pathway involved in axis elongation [GO:0003402]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]","GO:0003402; GO:0004930; GO:0005886; GO:0007166; GO:0009897; GO:0060027; GO:0097475; GO:2000095"
"2264","Pocillopora_acuta_HIv2___RNAseq.g7237.t1",85.7142857142857,0,0,28.5714285714286,NA,33.3333333333333,66.6666666666667,NA,100,NA,44.8979591836735,40.4761904761905,50.7936507936508,NA,NA,NA,NA,NA,NA,8.01724543831422,9.47656623090312,9.28899936606092,9.95533928922177,10.2475322373966,10.7890995720966,6.34755478695309,10.2928517106261,8.36958085695223,8.61946774449079,9.14042372330154,9.24324192187001,9.03760552473307,738.274420104632,0.0339123421380158,0.750644315713383,0.94019715878784,0.977361772653969,"Q8BTQ0",1.54e-49,"Polycomb group RING finger protein 3 (RING finger protein 3A)","random inactivation of X chromosome [GO:0060816]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0005654; GO:0006357; GO:0031519; GO:0035102; GO:0046872; GO:0060816; GO:0140862"
"2265","Pocillopora_acuta_HIv2___RNAseq.g7243.t1",0,0,0,0,0,2.23463687150838,0,0,0,NA,0.248292985723153,0.446927374301676,0,NA,NA,NA,NA,NA,NA,8.26563007823044,3.68233641306884,6.93658367102579,3.68233641306884,5.88788892518078,3.68233641306884,3.68233641306884,9.68697582768588,8.17151122259478,3.68233641306884,5.73602717900619,7.78971794494353,3.68233641306884,147.910878249033,-11.7051697955084,3.74967670765526,1.39383401643449e-08,3.86214850837327e-07,"Q8WU66",1.73e-32,"Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170"
"2266","Pocillopora_acuta_HIv2___TS.g19701.t1b",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.971124639191,11.0407923347598,11.7095615078954,12.1512420056943,11.2699603782819,10.6614526855373,9.15331824136873,10.7014329645607,11.9082910624875,11.8265787012786,11.1393754521055,11.3120741104833,10.9666767937277,2555.55239814709,-0.240366726858178,0.565028077427791,0.595387209586964,0.798116830349013,"Q66JY2",4.12e-41,"INO80 complex subunit D","chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]","GO:0000723; GO:0005634; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507"
"2267","Pocillopora_acuta_HIv2___RNAseq.g13403.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.6440877654689,9.53367400315034,10.2838493505339,3.68233641306884,9.74207123975368,3.68233641306884,3.68233641306884,10.2379399693619,11.5916869662242,3.68233641306884,7.67626549467683,10.4999270582685,4.85260393108514,858.519794854355,-1.20504125633757,2.48474370674887,3.29334228355189e-09,1.11819020632147e-07,"Q86SS6",1.79e-35,"Synaptotagmin-9 (Synaptotagmin IX) (SytIX)","calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; regulation of calcium ion-dependent exocytosis [GO:0017158]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0017156; GO:0017158; GO:0030276; GO:0030669; GO:0030672; GO:0031045; GO:0042802; GO:0070382; GO:0098686; GO:0099502"
"2268","Pocillopora_acuta_HIv2___RNAseq.g13415.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.252523371054,11.2476836755208,12.2939456234393,12.4400928890045,12.6659989344591,12.3440009469814,12.1010145693037,12.5296471499226,12.5382950459082,11.8530915844204,12.2266293790014,12.4560820249566,11.9971767330462,4928.51296166384,-0.346149875909709,0.51131261445422,0.419536524405323,0.664204935310704,"P68252",4.75e-102,"14-3-3 protein gamma (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein gamma, N-terminally processed]","positive regulation of cell-cell adhesion [GO:0022409]; protein localization [GO:0008104]; regulation of neuron differentiation [GO:0045664]; regulation of protein localization [GO:0032880]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]","GO:0005080; GO:0005159; GO:0005737; GO:0007165; GO:0008104; GO:0019904; GO:0022409; GO:0032880; GO:0045664; GO:0048167; GO:0140031; GO:0140311"
"2269","Pocillopora_acuta_HIv2___RNAseq.g13445.t1",0,14.2857142857143,NA,NA,0,0,0,NA,50,NA,10.7142857142857,21.4285714285714,0,NA,NA,NA,NA,NA,NA,8.9020590034213,3.68233641306884,6.94541193766045,3.68233641306884,8.3359398435869,7.63072138130473,3.68233641306884,7.08528261834752,3.68233641306884,3.68233641306884,5.73110968496651,6.990205963217,4.47201340671602,113.460567696748,-0.409787686458331,1.11718847247295,0.00183212351642335,0.00986591010482031,"P97858",6.41e-126,"Solute carrier family 35 member B1 (ATP/ADP exchanger ER) (AXER) (Endoplasmic reticulum ATP/ADP translocase) (UDP-galactose transporter-related protein 1) (UGTrel1)","UDP-galactose transmembrane transport [GO:0072334]","GO:0000139; GO:0005459; GO:0005460; GO:0005471; GO:0005789; GO:0072334"
"2270","Pocillopora_acuta_HIv2___RNAseq.g13476.t1",26.6666666666667,0,12.2448979591837,10.655737704918,5.30973451327434,9.375,8.17610062893082,100,7.72532188841202,0,18.0153459361386,25.551211918666,10.4794799536111,NA,NA,NA,NA,NA,NA,10.48604037741,8.98212090096353,10.9620600241402,10.4890145039914,10.7479245339226,10.9070184686405,9.50906943814264,11.0811301895898,10.5311759856536,9.86995923320575,10.356551365566,10.7616662221432,9.95143650898876,1406.7058331543,-0.610395126809791,0.591615774554903,0.19594274546175,0.417149819010709,"Q9DC11",2.71e-63,"Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein)","","GO:0005886; GO:0062023"
"2271","Pocillopora_acuta_HIv2___TS.g19792.t3c",0,0,2.34375,1.36986301369863,0,2.41254523522316,0.561797752808989,1.10497237569061,0,14.5299145299145,2.23228429073359,0.97747612492248,3.4870924565447,NA,NA,NA,NA,NA,NA,9.5952647091742,9.39672385697905,9.32793280505634,7.14835683950801,9.72765434801823,4.72257309926916,3.68233641306884,8.81753569748032,9.267667622457,3.68233641306884,7.536838180408,9.34721103643722,5.72646532437878,397.742553976533,-1.23762533236552,2.0716959267925,5.26217338829646e-05,0.000478391426073664,"Q55E58",5.83e-18,"Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)","cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856]","GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310"
"2272","Pocillopora_acuta_HIv2___TS.g19792.t3b",0,0,0,0,0,0.728597449908925,0,4.81927710843374,0,NA,0.616430506482518,1.10957491166853,0,NA,NA,NA,NA,NA,NA,9.826193401567,8.21809751775082,4.98269171864354,6.26838653426437,7.92778375594234,8.96349858670414,5.63253479849075,9.44770714891909,5.93804482828044,3.68233641306884,7.08872747036313,7.62448417067048,6.55297077005578,265.044643177104,-0.408601474979374,0.980985797106544,0.189253666254135,0.408257274973872,"P42768",1.8e-59,"Actin nucleation-promoting factor WAS (Wiskott-Aldrich syndrome protein) (WASp)","actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to type II interferon [GO:0071346]; defense response [GO:0006952]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110]","GO:0002625; GO:0003779; GO:0005634; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0006952; GO:0006955; GO:0007596; GO:0008064; GO:0008154; GO:0008544; GO:0010591; GO:0012506; GO:0015629; GO:0016197; GO:0017124; GO:0019901; GO:0030041; GO:0030048; GO:0030695; GO:0031267; GO:0032488; GO:0035861; GO:0042110; GO:0042802; GO:0043274; GO:0045335; GO:0045944; GO:0051492; GO:0051497; GO:0065003; GO:0070062; GO:0071346; GO:1905168; GO:2000146"
"2273","Pocillopora_acuta_HIv2___RNAseq.g24361.t1a",NA,NA,0,14.2857142857143,0,11.1111111111111,12.5,NA,12.5,14.2857142857143,9.24036281179138,12.6322751322751,6.69642857142857,NA,NA,NA,NA,NA,NA,4.21445057288855,5.01287713650611,5.75086179528365,3.68233641306884,5.16318610945075,5.44887968569328,3.68233641306884,3.68233641306884,6.07918960036691,3.68233641306884,4.63987905524646,4.97800489821174,4.30175321228118,12.5622162614302,-0.112211691720813,0.996666221728633,0.629908297361708,0.820810235408986,"Q8TB03",6.2e-07,"Uncharacterized protein CXorf38","",""
"2274","Pocillopora_acuta_HIv2___TS.g14215.t2",NA,NA,0,5.55555555555556,0,0,0,0,NA,NA,0.925925925925926,1.85185185185185,0,NA,NA,NA,NA,NA,NA,7.54234269767134,5.82932356540488,8.62793208013136,3.68233641306884,7.46167087377179,8.75517027377591,3.68233641306884,8.27548738836759,3.68233641306884,3.68233641306884,6.12212725313982,7.11795389060218,5.12630061567746,140.909350798858,-0.302091140894576,1.0471902214317,0.158685537942834,0.361784043446094,"Q13114",3.24e-118,"TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (LMP1-associated protein 1) (LAP1) (RING-type E3 ubiquitin transferase TRAF3)","apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; signal transduction [GO:0007165]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type I interferon-mediated signaling pathway [GO:0060337]","GO:0000151; GO:0001817; GO:0002224; GO:0004842; GO:0005164; GO:0005737; GO:0005739; GO:0005768; GO:0005829; GO:0006915; GO:0007165; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0035666; GO:0042802; GO:0042981; GO:0043122; GO:0050688; GO:0051607; GO:0060337; GO:0061630; GO:0070534; GO:1902554"
"2275","Pocillopora_acuta_HIv2___TS.g14217.t2",1.68776371308017,4.23728813559322,0.636942675159236,0,1.25786163522013,0.863930885529158,0,0.36101083032491,0,0,0.904479787490682,1.09244597028946,0.716513604691906,NA,NA,NA,NA,NA,NA,5.9511981009209,6.85609801113518,4.80540103069894,7.02644217673873,3.68233641306884,6.58890355943315,7.67777391608533,4.74601725290823,3.68233641306884,8.29611005295678,5.93126169270149,4.57345784213315,7.28906554326983,79.3250448038697,3.37123829119163,2.61657753853925,0.000238054012662648,0.00173987531033479,"Q28DL4",2.16e-19,"TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6)","intracellular signaling cassette [GO:0141124]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]","GO:0004842; GO:0005164; GO:0005634; GO:0005811; GO:0005938; GO:0008270; GO:0042981; GO:0043122; GO:0070534; GO:0141124"
"2276","Pocillopora_acuta_HIv2___TS.g14228.t3",0,NA,NA,0,0,0,12.5,0,NA,NA,2.08333333333333,0,4.16666666666667,NA,NA,NA,NA,NA,NA,8.78841539808731,9.54606319595285,3.68233641306884,9.22514637139333,7.26146210646859,8.8938269424416,3.68233641306884,3.68233641306884,3.68233641306884,7.805715019728,6.6249974686347,5.41937734875248,7.83061758851692,249.002350476454,0.466435690210741,1.10496614210251,0.0785512717278854,0.219591340214947,"B2LT62",5.69e-18,"Toll-like receptor 2 (CD antigen CD282)","cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224]","GO:0002224; GO:0004888; GO:0005794; GO:0006954; GO:0030670; GO:0042497; GO:0045087; GO:0045121; GO:0061809; GO:0071726; GO:0071727"
"2277","Pocillopora_acuta_HIv2___TS.g14229.t1",7.51807228915663,7.02822357498617,5.26315789473684,7.63239875389408,8.03858520900322,4.88188976377953,11.2057667103539,7.00636942675159,9.19206579583938,5.69568755085435,7.34622169693557,7.14818946305015,7.54425393082098,NA,NA,NA,NA,NA,NA,5.32602117141484,8.5532195615008,5.06095373478716,7.12479826629565,3.68233641306884,3.68233641306884,3.68233641306884,8.3847272779716,3.68233641306884,8.39815582913653,5.75772214933819,5.22727500206226,6.28816929661413,111.789526593833,0.188848709249663,1.02734982209488,0.107991975301903,0.276459456772873,NA,NA,NA,NA,NA
"2278","Pocillopora_acuta_HIv2___RNAseq.g24413.t1",1.003861003861,1.61145926589078,2.0911528150134,0.911161731207289,0.58644147314098,0.667437928272671,1.14910313901345,0.561009817671809,0.485672656629432,0.146412884333821,0.921371271503464,0.847348279934396,0.995394263072533,NA,NA,NA,NA,NA,NA,8.80561670821774,11.6027220315242,7.40702362398868,11.9090486232778,8.02553521909383,12.2995720960524,11.8930192805903,9.91504821357591,9.17249615278106,11.6607731627936,10.2690855111896,8.66514398353144,11.8730270388477,2120.4187580133,2.95226539858586,0.826662242314725,9.52105964657965e-06,0.000109295719625498,"B2LT62",2.13e-19,"Toll-like receptor 2 (CD antigen CD282)","cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224]","GO:0002224; GO:0004888; GO:0005794; GO:0006954; GO:0030670; GO:0042497; GO:0045087; GO:0045121; GO:0061809; GO:0071726; GO:0071727"
"2279","Pocillopora_acuta_HIv2___TS.g14245.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.99355402052038,8.65594257524443,7.48737098476787,8.07079571851333,3.68233641306884,8.9810247798628,8.5430904176697,5.9967476145607,5.49910115103059,7.40334154893872,7.03133052241774,5.73182203678968,8.3308390080458,185.350483474042,1.5951546146371,1.69993317381674,0.0130451436818691,0.0519793273318334,"Q9DD78",9.1e-18,"Toll-like receptor 2 type-1","inflammatory response [GO:0006954]; innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224]","GO:0002224; GO:0004888; GO:0005886; GO:0006954; GO:0038023; GO:0042497; GO:0045087; GO:0061809"
"2280","Pocillopora_acuta_HIv2___RNAseq.g24427.t2",6.52173913043478,7.9646017699115,8.64197530864197,2.9126213592233,10.1851851851852,6.45161290322581,10.7438016528926,9.33333333333333,6.41891891891892,4.44915254237288,7.36229421041403,6.61621765692257,8.10837076390548,NA,NA,NA,NA,NA,NA,6.5907432092831,7.88178580013571,6.3914623546344,3.68233641306884,3.68233641306884,7.92859676822119,3.68233641306884,6.94844182343232,3.68233641306884,3.68233641306884,5.41527120210509,5.4590640426975,5.37147836151268,66.1343967493415,-0.0419654648336821,1.00729427663858,0.838188110776346,0.936015939156277,"Q704V6",9.22e-20,"Toll-like receptor 6 (CD antigen CD286)","cellular response to diacyl bacterial lipopeptide [GO:0071726]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; toll-like receptor signaling pathway [GO:0002224]","GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0032731; GO:0035355; GO:0035663; GO:0038023; GO:0042802; GO:0045087; GO:0045121; GO:0061809; GO:0071723; GO:0071726; GO:1900227"
"2281","Pocillopora_acuta_HIv2___RNAseq.g14952.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.44280641494388,3.68233641306884,7.60831156614904,3.68233641306884,8.40288284703232,3.68233641306884,3.68233641306884,7.24545671389733,8.07748726595138,3.68233641306884,5.71886268733182,7.75538896159479,3.68233641306884,100.504765074165,-11.3803364332101,3.58990583698165,1.83894912251632e-08,4.91655454862773e-07,"B3EWZ3",5.23e-51,"Coadhesin","","GO:0016020"
"2282","Pocillopora_acuta_HIv2___RNAseq.g14968.t1",0,NA,0,0,NA,0,20.8333333333333,0,NA,NA,3.47222222222222,0,6.94444444444444,NA,NA,NA,NA,NA,NA,9.62462211332919,10.0609927668076,11.0471698948088,10.5340553045551,10.7738780280784,8.79535837652911,9.13664004250746,9.77377656376729,10.7740350309835,13.1029240707817,10.3623452192148,10.3986963261934,10.3259941122362,1938.35959803246,-0.0673418751528704,0.68653681656035,0.875150446733648,0.951384897523899,"Q16739",7.22e-115,"Ceramide glucosyltransferase (EC 2.4.1.80) (GLCT-1) (Glucosylceramide synthase) (GCS) (Glycosylceramide synthase) (UDP-glucose ceramide glucosyltransferase) (UDP-glucose:N-acylsphingosine D-glucosyltransferase)","cell differentiation [GO:0030154]; cornified envelope assembly [GO:1903575]; epidermis development [GO:0008544]; establishment of skin barrier [GO:0061436]; glucosylceramide biosynthetic process [GO:0006679]; glycosphingolipid biosynthetic process [GO:0006688]; intestinal lipid absorption [GO:0098856]; keratinocyte differentiation [GO:0030216]; leptin-mediated signaling pathway [GO:0033210]; neuron development [GO:0048666]; protein lipidation [GO:0006497]; regulation of signal transduction [GO:0009966]","GO:0000139; GO:0006497; GO:0006679; GO:0006688; GO:0008120; GO:0008544; GO:0009966; GO:0016020; GO:0030154; GO:0030216; GO:0033210; GO:0048666; GO:0061436; GO:0098856; GO:0102769; GO:1903575"
"2283","Pocillopora_acuta_HIv2___RNAseq.g14986.t1b",NA,NA,68.75,31.5789473684211,57.1428571428571,18.5185185185185,69.2307692307692,16.6666666666667,NA,NA,43.6479598212054,22.2547108512021,65.0412087912088,1,42.9945054945055,42.9945054945055,0.00633469065875829,0.00633469065875829,0.00633469065875829,7.50758496116064,5.82932356540488,3.68233641306884,6.68205791477539,9.19085794364881,9.31099048337562,3.68233641306884,10.0503456864495,8.97546621812528,10.3191457841604,7.52304453832382,7.88131824449061,7.16477083215703,420.352319681812,-0.0281860086407715,0.951127696682297,0.918571399250568,0.969230866556771,"P70541",4.09e-127,"Translation initiation factor eIF2B subunit gamma (eIF2B GDP-GTP exchange factor subunit gamma)","cytoplasmic translational initiation [GO:0002183]; hippocampus development [GO:0021766]; oligodendrocyte development [GO:0014003]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translation [GO:0006412]; translational initiation [GO:0006413]","GO:0002183; GO:0003743; GO:0005085; GO:0005737; GO:0005829; GO:0005851; GO:0006412; GO:0006413; GO:0009408; GO:0009749; GO:0014003; GO:0021766; GO:0032045; GO:0043434; GO:0050852"
"2284","Pocillopora_acuta_HIv2___RNAseq.g15033.t3",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,13.3384317742977,13.5707331721795,13.6129055165903,13.9266283185487,13.2295039328754,13.6519736689116,13.3394793684088,13.1457825750621,12.9503692369962,13.0638716523635,13.3829679216234,13.2553986071643,13.5105372360824,10875.1504727105,0.205245297740358,0.473461522268927,0.629592945555677,0.820621101605597,"Q96MU7",2.69e-68,"YTH domain-containing protein 1 (Splicing factor YT521) (YT521-B)","dosage compensation by inactivation of X chromosome [GO:0009048]; in utero embryonic development [GO:0001701]; mRNA alternative polyadenylation [GO:0110104]; mRNA export from nucleus [GO:0006406]; mRNA splice site recognition [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; post-transcriptional regulation of gene expression [GO:0010608]; primary follicle stage [GO:0048160]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]","GO:0000381; GO:0000398; GO:0001701; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005886; GO:0006376; GO:0006406; GO:0007283; GO:0009048; GO:0010608; GO:0016607; GO:0048024; GO:0048160; GO:0110104; GO:1990247"
"2285","Pocillopora_acuta_HIv2___RNAseq.g15040.t1",42.4242424242424,100,34.4827586206897,0,20.5882352941176,9.47368421052632,66.6666666666667,NA,0,NA,34.2044484020303,27.3684210526316,41.0404757514291,NA,NA,NA,NA,NA,NA,6.8368956045141,6.38096952478058,6.71656868271498,6.35341254798027,7.09033777769384,6.6664531765618,7.94440170487039,7.04560173813408,7.23497478454503,6.00413425515518,6.82737497969502,6.98487571752041,6.66987424186964,97.4355267211082,-0.278351955776431,0.62903047634446,0.553452186139798,0.768910999935264,NA,NA,NA,NA,NA
"2286","Pocillopora_acuta_HIv2___RNAseq.g6767.t1a",0,0,NA,7.69230769230769,0,3.44827586206897,0,0,NA,NA,1.59151193633952,2.78514588859416,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.34982382480446,5.06095373478716,3.68233641306884,5.31048131328141,5.65167313584929,3.68233641306884,6.59039256814693,3.68233641306884,3.68233641306884,4.83750066422134,4.86530008847064,4.80970123997205,26.9532924624968,-0.0627070222777779,1.00694447487656,0.74619266335016,0.888233946399203,"O35161",1.35e-58,"Cadherin EGF LAG seven-pass G-type receptor 1","anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; neural tube closure [GO:0001843]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060]","GO:0001736; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007266; GO:0007626; GO:0009952; GO:0016020; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0045176; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090179; GO:0090251; GO:0097475; GO:0098609"
"2287","Pocillopora_acuta_HIv2___RNAseq.g14441.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.43542392964019,4.82737711805479,8.13014807555559,4.2857336656916,8.61637518833319,10.1521442250607,5.36842592176402,8.73952990397785,3.68233641306884,10.6420066334547,7.18795010746015,7.32076270211513,7.05513751280516,388.794341792631,-0.226164660429635,1.01346607529656,0.137288493932035,0.328928404212846,"C7MSY6",1.1e-09,"D-inositol 3-phosphate glycosyltransferase (EC 2.4.1.250) (N-acetylglucosamine-inositol-phosphate N-acetylglucosaminyltransferase) (GlcNAc-Ins-P N-acetylglucosaminyltransferase)","mycothiol biosynthetic process [GO:0010125]","GO:0000287; GO:0008375; GO:0010125; GO:0102710"
"2288","Pocillopora_acuta_HIv2___RNAseq.g14459.t1",0,0,0,0,0,0,1.04166666666667,0,0,NA,0.115740740740741,0,0.260416666666667,NA,NA,NA,NA,NA,NA,12.0849136800995,10.89912184261,9.9415775942009,8.48798210411924,11.404415727902,11.298415814845,10.9728362363857,11.2171241370067,11.1678758473225,9.04474975984248,10.6519012744334,11.1631813973063,10.1406211515605,1978.95934218227,-0.76346106322749,0.633905522330479,0.117807579531911,0.294498588031378,"Q8BKX6",0,"Serine/threonine-protein kinase SMG1 (SMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1)","DNA repair [GO:0006281]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of telomere maintenance [GO:0032204]","GO:0000184; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0032204; GO:0033391; GO:0042162; GO:0046854; GO:0046872; GO:0106310"
"2289","Pocillopora_acuta_HIv2___TS.g30518.t2",83.3333333333333,NA,NA,50,NA,50,37.5,0,NA,100,53.4722222222222,33.3333333333333,73.6111111111111,NA,NA,NA,NA,NA,NA,7.48631699375706,5.77108626594745,7.54623947149928,3.68233641306884,6.82432087263943,3.68233641306884,3.68233641306884,8.22935660595687,3.68233641306884,3.68233641306884,5.42690022751443,6.7537140713843,4.10008638364456,71.2715667274008,-0.497065729622153,1.18684374632443,0.00115037248996907,0.00659753675452524,"Q5ZL55",2.23e-26,"Charged multivesicular body protein 6 (Chromatin-modifying protein 6)","late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; protein transport [GO:0015031]; vesicle budding from membrane [GO:0006900]","GO:0000815; GO:0005771; GO:0006900; GO:0015031; GO:0031902; GO:0032511"
"2290","Pocillopora_acuta_HIv2___RNAseq.g14465.t1",NA,0,0,0,0,14.2857142857143,0,NA,NA,NA,2.38095238095238,4.76190476190476,0,NA,NA,NA,NA,NA,NA,9.16449048766231,8.71935049078991,7.40065151733208,9.75682101715786,7.5076208322678,7.26229034322735,8.20698204111156,8.19975452707599,3.68233641306884,8.9082467043071,7.88085443740008,7.1909707554814,8.57073811931876,320.911817191338,0.351816966009411,0.920954765954668,0.36578562537709,0.615415061702248,"Q9HAS0",4.85e-60,"Protein Njmu-R1","intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041]","GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0031410; GO:0099041"
"2291","Pocillopora_acuta_HIv2___RNAseq.g14471.t1",13.1944444444444,9.49367088607595,49.3506493506493,32.7586206896552,27.7397260273973,18.9406099518459,31.6,31.4285714285714,44.0677966101695,5.63380281690141,26.420789220571,27.3378539132636,25.5037245278785,NA,NA,NA,NA,NA,NA,6.37258314463392,6.75880950091271,3.68233641306884,3.68233641306884,8.0811427777168,7.98439388604313,3.68233641306884,8.3635330345621,3.68233641306884,3.68233641306884,5.59721444092129,6.0363863566101,5.15804252523247,92.1463974086918,-0.1240804160472,0.982728823724079,0.842936708876456,0.937478770651933,"Q4R7R1",1.25e-157,"Short-chain dehydrogenase/reductase family 42E member 1 (EC 1.1.1.-)","steroid biosynthetic process [GO:0006694]","GO:0006694; GO:0016020; GO:0016616"
"2292","Pocillopora_acuta_HIv2___RNAseq.g14493.t1",100,NA,NA,0,22.2222222222222,60,53.8461538461538,NA,0,NA,39.3447293447293,20,58.6894586894587,NA,NA,NA,NA,NA,NA,9.84294211329491,3.68233641306884,8.09518833552696,11.1361453551519,7.7407611868036,3.68233641306884,3.68233641306884,8.91537760875694,3.68233641306884,3.68233641306884,6.41420966648785,7.65532113149025,5.17309820148545,401.283295159244,-0.224783977131274,1.04804343046465,0.000480754409139825,0.00316794158259609,"Q9JL56",4.57e-60,"Glycerophosphodiester phosphodiesterase 1 (Glycerophosphoinositol glycerophosphodiesterase GDE1) (EC 3.1.4.44) (Lysophospholipase D GDE1) (EC 3.1.4.-) (Membrane-interacting protein of RGS16)","ethanolamine metabolic process [GO:0006580]; G protein-coupled receptor signaling pathway [GO:0007186]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644]","GO:0004622; GO:0005886; GO:0006580; GO:0006644; GO:0007186; GO:0008081; GO:0008889; GO:0016020; GO:0030659; GO:0046872; GO:0047395; GO:0070291"
"2293","Pocillopora_acuta_HIv2___RNAseq.g14499.t1",37.5,NA,NA,NA,50,0,100,100,100,NA,64.5833333333333,66.6666666666667,62.5,NA,NA,NA,NA,NA,NA,10.0885970075657,9.2016707758339,8.42411896977726,10.9079468920821,8.61009583438926,9.99474624176386,3.68233641306884,9.15297698563148,9.64017831110097,10.5968009814441,9.02994684126575,9.18319342169293,8.87670026083856,804.05845811664,0.0497564914472263,0.889466552741488,0.898923118209444,0.961759300375871,"Q2TBT5",9.56e-114,"Ribonuclease H2 subunit A (RNase H2 subunit A) (EC 3.1.26.4) (Ribonuclease HI large subunit) (RNase HI large subunit) (Ribonuclease HI subunit A)","DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]","GO:0003723; GO:0004523; GO:0005654; GO:0005829; GO:0006298; GO:0006401; GO:0032299; GO:0043137; GO:0046872"
"2294","Pocillopora_acuta_HIv2___RNAseq.g31182.t1",0,NA,NA,0,NA,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,11.8631067159906,10.4060828443015,11.7992952641862,10.3822160641749,11.8627439176644,9.00324966826751,10.2862969684472,10.9699998181204,12.2758670743424,3.68233641306884,10.2531194748564,11.7542025580608,8.75203639165199,2220.17910586946,-0.79726850460043,1.15197455427249,0.0856096143798776,0.23279892129922,"Q29492",0,"Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)","glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; pentose-phosphate shunt [GO:0006098]","GO:0004345; GO:0005829; GO:0006006; GO:0006098; GO:0006739; GO:0016020; GO:0050661; GO:0051156"
"2295","Pocillopora_acuta_HIv2___RNAseq.g31188.t1",0,0,0,NA,0,0,NA,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.8556469288185,3.68233641306884,9.03033317993431,9.6235273196098,7.96111285780312,8.22226515833647,3.68233641306884,8.63512470404645,3.68233641306884,10.813824527413,7.31888439151682,7.43291081673424,7.20485796629939,411.200741691181,-0.0643557244169576,0.983541838790792,0.621476785072188,0.814888969203529,NA,NA,NA,NA,NA
"2296","Pocillopora_acuta_HIv2___RNAseq.g31189.t1",0,0,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.61740237719946,6.74434409930028,5.66344864002848,5.80116198083551,5.13665622490825,7.93890441031561,4.96878174907288,8.44901559327279,7.65349580332634,10.3339149347773,6.93071258130369,6.70400372774706,7.15742143486032,222.991084465011,0.258118861653179,0.88163398992967,0.480942983059692,0.715964029106997,"Q6P1C6",2.52e-150,"Leucine-rich repeats and immunoglobulin-like domains protein 3 (LIG-3)","otolith morphogenesis [GO:0032474]","GO:0005886; GO:0030659; GO:0032474"
"2297","Pocillopora_acuta_HIv2___TS.g14144.t1",100,0,NA,0,0,0,0,NA,NA,NA,16.6666666666667,0,33.3333333333333,NA,NA,NA,NA,NA,NA,11.2312042972904,10.9007302475079,11.4069949407231,11.6416869248782,10.9715457670812,9.98361622478729,11.5236341497661,10.9028215947144,10.0294101199203,7.83725285208544,10.6428897118754,10.9083953439459,10.377384079805,1912.42031115905,-0.333983258107832,0.635287049952117,0.468583105208965,0.707466028137282,"A2AT37",0,"Regulator of nonsense transcripts 2 (Up-frameshift suppressor 2 homolog) (Upf2)","animal organ regeneration [GO:0031100]; liver development [GO:0001889]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to unfolded protein [GO:0006986]","GO:0000184; GO:0001889; GO:0003723; GO:0005737; GO:0005829; GO:0006986; GO:0031100; GO:0035145; GO:0036464; GO:0042162; GO:0048471"
"2298","Pocillopora_acuta_HIv2___TS.g13973.t1",0,NA,100,NA,33.3333333333333,71.4285714285714,16.6666666666667,100,0,NA,45.9183673469388,57.1428571428571,37.5,NA,NA,NA,NA,NA,NA,8.4809303886018,5.26408513103678,5.46801386253237,7.15999107231523,7.4709799250993,6.85441933218098,3.68233641306884,6.025091802042,8.94033410692654,8.33339164675596,6.76795736805598,7.2770700170404,6.25884471907156,153.93226919147,-0.471034153099457,0.98508022710216,0.171857618471315,0.381483823445227,"Q9JKK1",1.28e-80,"Syntaxin-6","endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0000149; GO:0005484; GO:0005654; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0006906; GO:0007032; GO:0008021; GO:0012505; GO:0016020; GO:0016189; GO:0016192; GO:0019905; GO:0030672; GO:0031201; GO:0032456; GO:0032588; GO:0032880; GO:0042147; GO:0045335; GO:0048193; GO:0048278; GO:0048471; GO:0055037; GO:0055038"
"2299","Pocillopora_acuta_HIv2___RNAseq.g5751.t1",0,0,0,NA,0,0,NA,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.29555341930434,9.80507360329363,9.36909216414186,3.68233641306884,10.2926248886437,8.52182983063413,5.23465033534666,9.53432286363424,9.97694999198017,11.878496571936,8.55909300819836,9.29370866554086,7.82447735085585,866.265795606507,-0.249688365790905,0.983594052422369,0.215912038264533,0.445499532305021,"Q9P1Z9",3.1e-114,"Coiled-coil domain-containing protein 180","","GO:0070062"
"2300","Pocillopora_acuta_HIv2___RNAseq.g5755.t1",1.09649122807018,0,0.796812749003984,2.06185567010309,0,0.71301247771836,0.671892497200448,0,0,0,0.534006462209606,0.554973629564291,0.513039294854922,NA,NA,NA,NA,NA,NA,8.2447423312731,8.19201380379921,8.81361363638465,3.68233641306884,8.7874961758332,3.68233641306884,3.68233641306884,6.03904121754544,10.1699278692147,5.70282560183315,6.699666987509,8.41096424605022,4.98836972896778,258.536958638658,-4.78321608666242,4.28707354854162,1.29566916280567e-05,0.000142948579487576,"Q9QX29",2e-47,"Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5)","calcium ion transmembrane transport [GO:0070588]; negative regulation of dendrite morphogenesis [GO:0050774]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane hyperpolarization [GO:1902630]","GO:0003779; GO:0005886; GO:0007204; GO:0008284; GO:0010800; GO:0015279; GO:0030182; GO:0030276; GO:0030425; GO:0030426; GO:0034703; GO:0034704; GO:0042805; GO:0043025; GO:0045666; GO:0045773; GO:0050774; GO:0051117; GO:0051402; GO:0051480; GO:0070588; GO:0070679; GO:0070782; GO:0098793; GO:1902630"
"2301","Pocillopora_acuta_HIv2___RNAseq.g5756.t1",0,NA,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.40533726205741,3.68233641306884,8.851299235118,8.41270432526924,6.89567146066421,3.68233641306884,3.68233641306884,6.0800375531696,3.68233641306884,3.68233641306884,5.80567319016227,6.98293638481561,4.62840999550892,154.397608094926,-0.399314589842828,1.10915967318015,0.00293409695296496,0.0148855764039583,NA,NA,NA,NA,NA
"2302","Pocillopora_acuta_HIv2___RNAseq.g5760.t1",0.210084033613445,0.872410032715376,1.35135135135135,0.707547169811321,0.399002493765586,0.384204909284952,0.695206732528357,1.22358175750834,0.845410628019324,0.426439232409382,0.711523834100744,0.806630899467863,0.616416768733624,NA,NA,NA,NA,NA,NA,8.79417202436679,3.68233641306884,6.32442317864339,3.68233641306884,9.01200070699572,4.32783990674728,10.664226121919,7.54867945930727,3.68233641306884,3.68233641306884,6.14006870502548,7.0723223564764,5.20781505357456,272.828606399679,-0.254526951595562,1.05012177888889,0.00391941379187784,0.0189409960192854,"Q9QX29",4.45e-58,"Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5)","calcium ion transmembrane transport [GO:0070588]; negative regulation of dendrite morphogenesis [GO:0050774]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane hyperpolarization [GO:1902630]","GO:0003779; GO:0005886; GO:0007204; GO:0008284; GO:0010800; GO:0015279; GO:0030182; GO:0030276; GO:0030425; GO:0030426; GO:0034703; GO:0034704; GO:0042805; GO:0043025; GO:0045666; GO:0045773; GO:0050774; GO:0051117; GO:0051402; GO:0051480; GO:0070588; GO:0070679; GO:0070782; GO:0098793; GO:1902630"
"2303","Pocillopora_acuta_HIv2___RNAseq.g5776.t1",0,NA,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.01423630021445,9.55630681922395,8.99289449818981,9.53985800144842,6.52338418771189,3.68233641306884,9.79772249333888,9.81529316588718,3.68233641306884,3.68233641306884,7.12867047052211,7.00562891301443,7.25171202802979,378.00888208754,0.0321758312707221,0.934325853412383,0.885036051872825,0.955539567782169,"Q9MYW0",1.74e-117,"Short transient receptor potential channel 6 (TrpC6)","calcium ion transmembrane transport [GO:0070588]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]","GO:0005261; GO:0005886; GO:0007338; GO:0015279; GO:0034703; GO:0042803; GO:0051480; GO:0070588; GO:0070679"
"2304","Pocillopora_acuta_HIv2___RNAseq.g5778.t1",0,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0590380292361,9.11837381134201,11.4351661074339,10.3089487208653,10.3946917399871,9.53085792045677,7.41617057752188,11.1630304269949,12.3529830451282,3.68233641306884,9.5461596792035,11.080981869756,8.01133748865096,1521.22625540711,-0.763652566083899,1.15552955054007,0.0775096706264934,0.217710529274403,"Q9QX29",1.54e-91,"Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5)","calcium ion transmembrane transport [GO:0070588]; negative regulation of dendrite morphogenesis [GO:0050774]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane hyperpolarization [GO:1902630]","GO:0003779; GO:0005886; GO:0007204; GO:0008284; GO:0010800; GO:0015279; GO:0030182; GO:0030276; GO:0030425; GO:0030426; GO:0034703; GO:0034704; GO:0042805; GO:0043025; GO:0045666; GO:0045773; GO:0050774; GO:0051117; GO:0051402; GO:0051480; GO:0070588; GO:0070679; GO:0070782; GO:0098793; GO:1902630"
"2305","Pocillopora_acuta_HIv2___RNAseq.g5792.t1",0,0,NA,NA,0,20,0,0,NA,NA,3.33333333333333,6.66666666666667,0,NA,NA,NA,NA,NA,NA,4.79011450555827,3.68233641306884,10.3803877251304,7.22786336628594,8.31291471729272,7.06826986579421,4.90654184690663,6.75631530397046,3.68233641306884,8.09365327011805,6.49007334271944,6.78441373300414,6.19573295243473,218.512231469664,-0.425906797011956,1.05757111801814,0.153640509789427,0.354121965035925,"O14656",5.94e-112,"Torsin-1A (Dystonia 1 protein) (Torsin ATPase-1A) (EC 3.6.4.-) (Torsin family 1 member A)","cell adhesion [GO:0007155]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; ERAD pathway [GO:0036503]; intermediate filament cytoskeleton organization [GO:0045104]; neuron projection development [GO:0031175]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; organelle organization [GO:0006996]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein deneddylation [GO:0000338]; protein localization to nucleus [GO:0034504]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of protein localization to cell surface [GO:2000008]; response to oxidative stress [GO:0006979]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle transport [GO:0048489]; wound healing, spreading of cells [GO:0044319]","GO:0000338; GO:0005524; GO:0005635; GO:0005783; GO:0005788; GO:0005789; GO:0005829; GO:0005856; GO:0006979; GO:0006996; GO:0006998; GO:0007155; GO:0008021; GO:0008092; GO:0016020; GO:0016887; GO:0019894; GO:0030141; GO:0030426; GO:0030659; GO:0031175; GO:0031965; GO:0034504; GO:0036503; GO:0042802; GO:0043231; GO:0044319; GO:0045104; GO:0048489; GO:0048499; GO:0051082; GO:0051085; GO:0051584; GO:0051787; GO:0061077; GO:0070062; GO:0071763; GO:0140662; GO:1900244; GO:2000008"
"2306","Pocillopora_acuta_HIv2___RNAseq.g5797.t1",NA,0,0,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.15070113667054,7.87523677967013,3.68233641306884,8.5725426957775,7.81195679750884,7.9643541428103,10.3000870524239,7.30814062619735,5.42703766936634,3.68233641306884,6.87747297265626,6.07603452856238,7.67891141675013,242.772722686329,0.32126716025,1.00580028884436,0.26670439239499,0.510401208203379,"Q9NRR4",0,"Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III) (p241)","defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; rRNA processing [GO:0006364]","GO:0001530; GO:0003723; GO:0004525; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0010586; GO:0010628; GO:0014069; GO:0017151; GO:0031053; GO:0031054; GO:0042803; GO:0045589; GO:0046332; GO:0046872; GO:0050727; GO:0050829; GO:0050830; GO:0070412; GO:0070877; GO:0070878; GO:0098978; GO:2000628"
"2307","Pocillopora_acuta_HIv2___RNAseq.g16366.t1",100,NA,100,100,NA,100,100,NA,100,NA,100,100,100,NA,NA,NA,NA,NA,NA,12.112222928767,11.4907814857026,11.6689505641,12.6244883332194,11.9947989732554,11.3737547771185,11.0061026643489,11.6270827742711,11.7891934963503,10.9590267999277,11.6646402797061,11.8384497473488,11.4908308120634,3410.4185947434,-0.260153426122786,0.55683460906096,0.563918190670753,0.775733746768389,"P53804",1.74e-63,"E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (Protein DCRR1) (RING finger protein 105) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Tetratricopeptide repeat protein 3) (TPR repeat protein 3)","protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0006511; GO:0046872; GO:0070936"
"2308","Pocillopora_acuta_HIv2___TS.g2980.t1",0,0,NA,NA,6.89655172413793,0,0,0,NA,NA,1.14942528735632,0,2.29885057471264,NA,NA,NA,NA,NA,NA,9.86086969936751,7.58520805892439,10.4067106982105,8.02092254567833,10.0021351227915,11.1492550563147,7.67777391608533,8.84262622947576,6.83269238753983,3.68233641306884,8.40605301274567,9.18900682747702,7.62309919801432,658.723223081969,-0.912285253747103,1.12741322836055,0.0601738843600984,0.179676932986058,"O75179",4.34e-96,"Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16)","blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]","GO:0000785; GO:0001673; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246"
"2309","Pocillopora_acuta_HIv2___RNAseq.g16374.t2",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.35158994656897,7.8080468355442,9.52143786112456,9.15476263464744,6.59417161353813,10.2347810881244,3.68233641306884,3.68233641306884,3.68233641306884,3.68233641306884,6.53941356318231,6.16637444947387,6.91245267689074,284.395664013212,0.276582498974403,0.935494442733728,0.45839823966547,0.699322027056362,"Q5F2N2",2.31e-120,"Alpha-(1,3)-fucosyltransferase 11 (EC 2.4.1.-) (Fucosyltransferase XI) (Fuc-TXI) (FucT-XI) (Galactoside 3-L-fucosyltransferase 11) (Fucosyltransferase 11)","fucosylation [GO:0036065]; protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0032580; GO:0036065; GO:0046920"
"2310","Pocillopora_acuta_HIv2___RNAseq.g16384.t1",100,100,NA,100,100,100,100,NA,NA,NA,100,100,100,NA,NA,NA,NA,NA,NA,11.3829993427558,10.642659284446,11.8335057867131,11.0734551976965,10.8450484292051,10.5784077763537,7.24933793434975,10.1740324761798,10.525264256316,7.75155885986295,10.2056269343879,10.952170058234,9.45908381054178,1618.48756955141,-1.05747940889585,0.800355180098828,0.0489012624128435,0.15316324372875,"O46339",2.21e-62,"Homeobox protein homothorax (Homeobox protein dorsotonals)","animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; compound eye development [GO:0048749]; compound eye photoreceptor fate commitment [GO:0001752]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; haltere morphogenesis [GO:0048735]; head morphogenesis [GO:0060323]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing morphogenesis [GO:0007476]; Malpighian tubule development [GO:0072002]; oenocyte differentiation [GO:0001742]; peripheral nervous system development [GO:0007422]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation involved in compound eye morphogenesis [GO:2000497]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; proximal/distal pattern formation [GO:0009954]; regulation of cell fate specification [GO:0042659]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland boundary specification [GO:0007432]; segmentation [GO:0035282]; somatic muscle development [GO:0007525]; specification of animal organ identity [GO:0010092]; specification of segmental identity, antennal segment [GO:0007383]; specification of segmental identity, head [GO:0007380]","GO:0000978; GO:0000981; GO:0000987; GO:0001223; GO:0001228; GO:0001654; GO:0001742; GO:0001752; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006357; GO:0007380; GO:0007383; GO:0007420; GO:0007422; GO:0007432; GO:0007476; GO:0007480; GO:0007525; GO:0008284; GO:0009880; GO:0009887; GO:0009954; GO:0010092; GO:0032993; GO:0034504; GO:0035282; GO:0042659; GO:0045664; GO:0045944; GO:0046982; GO:0048735; GO:0048749; GO:0060323; GO:0072002; GO:0090575; GO:0140297; GO:2000497"
"2311","Pocillopora_acuta_HIv2___RNAseq.g15720.t1",0,0,0,0,0,0,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.69008050215398,7.8080468355442,6.88242140054137,6.35341254798027,7.16703565314199,7.1685916905325,6.51519156656932,6.48445350747802,4.37599570701945,7.01744807002185,6.54626774809829,6.11999735406696,6.97253814212963,86.0116691212927,0.51284717701064,0.874940135088399,0.254726410790944,0.495809824475873,NA,NA,NA,NA,NA
"2312","Pocillopora_acuta_HIv2___RNAseq.g15722.t1",7.93650793650794,10.8695652173913,0,0,1.6304347826087,5.86854460093897,4.00943396226415,0,0,100,13.0314486499711,3.34762196366605,22.7152753362762,NA,NA,NA,NA,NA,NA,9.17555543509735,9.8440555528169,10.0907301281178,10.5015415778244,9.04028584995912,9.97739556517615,7.43457348819984,9.52004417008465,9.53816995678693,9.20201218832341,9.43243639123865,9.47295710800917,9.39191567446814,755.785933726043,-0.0247522008434576,0.640033369636258,0.952841103643573,0.981756213356649,"Q54TD7",2.1e-151,"ATP-dependent RNA helicase ddx24 (EC 3.6.4.13) (DEAD box protein 24)","","GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016887"
"2313","Pocillopora_acuta_HIv2___RNAseq.g15724.t1",0.313807531380753,0.701262272089762,0.641025641025641,0.354609929078014,0.457317073170732,0.744162176032846,0.648021828103683,0,0.412654745529574,0,0.4272861196411,0.442537824546039,0.412034414736162,NA,NA,NA,NA,NA,NA,8.61385859787672,9.07342129246538,3.68233641306884,3.68233641306884,7.22333724403648,9.34811557506063,8.93597345203167,8.52255186961693,8.87050454107045,3.68233641306884,7.16347718113648,7.38251773313388,6.94443662913907,288.070505981545,0.0118784847169735,0.92729937360811,0.949027288425583,0.980200706925709,NA,NA,NA,NA,NA
"2314","Pocillopora_acuta_HIv2___TS.g22381.t1",0,0,1.04477611940298,1.04166666666667,0.56369785794814,0.741656365883807,0.780141843971631,0,0,7.69230769230769,1.18642465461809,0.356664606510095,2.01618470272609,NA,NA,NA,NA,NA,NA,7.64181568123354,5.77108626594745,3.68233641306884,3.68233641306884,7.00281630030243,8.71382842796993,3.68233641306884,4.44278995465828,8.65623322700102,3.68233641306884,5.6957915509388,6.28519831525282,5.10638478662478,108.710282224835,-0.32934590072005,1.04695873735492,0.232172291402689,0.466809401740354,"Q3UQ28",1.8e-91,"Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment]","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"2315","Pocillopora_acuta_HIv2___RNAseq.g15743.t1",0,0,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.05615398516961,5.77108626594745,7.84683233870282,8.12490763773044,8.99122162080411,9.98609699531965,12.1409155989889,7.1175217905995,10.0827150549824,6.9608997877233,8.50783510759682,8.41888895805169,8.59678125714195,796.871525983256,-0.0289603313539153,0.861957761762603,0.866059602336791,0.947699053427095,NA,NA,NA,NA,NA
"2316","Pocillopora_acuta_HIv2___RNAseq.g27358.t1",0,0,NA,5.55555555555556,0,0.50251256281407,3.03030303030303,NA,0,NA,1.29833873552467,1.51451702959241,1.01010101010101,NA,NA,NA,NA,NA,NA,8.2447423312731,3.68233641306884,7.08762485888264,4.7918870276047,6.77213038688595,7.36561316342335,5.69873558273438,6.58108861241956,7.20548442133826,3.68233641306884,6.11119792106996,7.1782141221599,5.04418171998002,84.7355163492139,-0.729206473594768,1.26345641047789,0.00965367961294055,0.0404375389289233,NA,NA,NA,NA,NA
"2317","Pocillopora_acuta_HIv2___RNAseq.g27364.t1",0,0,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,7.95683089785598,8.89759623765196,7.11130286437252,7.00074722714729,7.74459784860138,3.68233641306884,3.68233641306884,5.47509710266606,3.68233641306884,3.68233641306884,5.89155178305706,6.39403302531296,5.38907054080115,110.45554117376,-0.242877816744556,1.0054572765631,0.354048179292325,0.605099003342099,NA,NA,NA,NA,NA
"2318","Pocillopora_acuta_HIv2___RNAseq.g27381.t1",0,NA,0,0,15.3846153846154,0,0,0,0,NA,1.92307692307692,0,3.84615384615385,NA,NA,NA,NA,NA,NA,9.90274168658033,3.68233641306884,6.73712889964964,3.68233641306884,9.81024665157316,6.34225560108856,10.788595599767,9.5331383585555,7.50048072915978,3.68233641306884,7.16615967655805,8.69674726510368,5.63557208801242,455.911303260834,-0.748871140786203,1.39218776064369,6.83574497733483e-05,0.000601046901836906,"F2K079",1.19e-44,"4-hydroxybenzoate brominase (decarboxylating) (EC 1.14.19.55) (Decarboxylating-brominase flavoenzyme Bmp5)","","GO:0004499; GO:0047822; GO:0050660; GO:0050661"
"2319","Pocillopora_acuta_HIv2___RNAseq.g24003.t1a",6.59340659340659,0.666666666666667,NA,0.617283950617284,4.34782608695652,0,0,0.99009900990099,0,5.12820512820513,2.03816527063924,0.454809925436988,4.01735945214206,NA,NA,NA,NA,NA,NA,8.88328018451953,3.68233641306884,8.66544719014244,3.68233641306884,8.00969865137514,9.28704065823237,3.68233641306884,9.21339564675859,9.38985894159072,3.68233641306884,6.81780669248942,8.83233612287728,4.80327726210155,287.327822769965,-0.737870881347925,1.43758648954133,2.87096535810201e-09,9.98212570663162e-08,"Q58CR4",2.25e-53,"Dolichol kinase (EC 2.7.1.108) (Transmembrane protein 15)","dolichyl monophosphate biosynthetic process [GO:0043048]; protein mannosylation [GO:0035268]","GO:0004168; GO:0005789; GO:0035268; GO:0043048"
"2320","Pocillopora_acuta_HIv2___RNAseq.g24013.t1",NA,NA,NA,15.3846153846154,100,42.8571428571429,100,NA,0,100,59.7069597069597,19.4139194139194,100,1,80.7692307692308,80.7692307692308,9.41522564674469e-07,9.41522564674469e-07,9.41522564674469e-07,8.04168655523032,7.04438020601615,4.4496922765333,7.595757733073,5.95850798619116,3.68233641306884,6.93604804798219,5.89248396905691,8.43419122002346,7.70670978863219,6.57417941958075,6.55531240140703,6.59304643775447,119.686051423729,-0.0430649066552741,0.903204130615706,0.870797491127532,0.949587992171491,"A2AX52",3.11e-16,"Collagen alpha-4(VI) chain","cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]","GO:0005518; GO:0005576; GO:0005581; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023"
"2321","Pocillopora_acuta_HIv2___RNAseq.g24034.t1",0,0,NA,NA,0,11.5384615384615,0,0,0,NA,1.64835164835165,2.88461538461538,0,NA,NA,NA,NA,NA,NA,8.84219610301059,10.7010562312499,3.68233641306884,10.1516508984688,9.57710140984208,10.3992280346792,3.68233641306884,8.59251268064315,9.98127532901578,8.34803780681849,8.39577313198657,8.13508438711609,8.65646187685705,689.472685409961,0.0592393686891147,0.957999398259469,0.827931843223983,0.930185348795378,"Q6DBR9",4.01e-24,"KxDL motif-containing protein 1","lysosome localization [GO:0032418]; vesicle-mediated transport [GO:0016192]","GO:0005765; GO:0016192; GO:0032418; GO:0099078"
"2322","Pocillopora_acuta_HIv2___TS.g1161.t2",2.8169014084507,0.952380952380952,1.26582278481013,0.716845878136201,0,2.08333333333333,0.496277915632754,0.694444444444444,0.854700854700855,3.57142857142857,1.34521361433179,1.06034109259916,1.63008613606443,NA,NA,NA,NA,NA,NA,11.7459459303204,11.5616283418255,11.8993043852483,11.9175715343564,10.9234507396248,10.9432124526532,10.0017596205189,11.1974497464878,12.3510349227022,11.7515668826248,11.4292924556362,11.6234371448767,11.2351477663958,2984.6813120525,-0.291988247657906,0.52462644491523,0.509817348792588,0.73717865969569,"P42768",1.37e-34,"Actin nucleation-promoting factor WAS (Wiskott-Aldrich syndrome protein) (WASp)","actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to type II interferon [GO:0071346]; defense response [GO:0006952]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110]","GO:0002625; GO:0003779; GO:0005634; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0006952; GO:0006955; GO:0007596; GO:0008064; GO:0008154; GO:0008544; GO:0010591; GO:0012506; GO:0015629; GO:0016197; GO:0017124; GO:0019901; GO:0030041; GO:0030048; GO:0030695; GO:0031267; GO:0032488; GO:0035861; GO:0042110; GO:0042802; GO:0043274; GO:0045335; GO:0045944; GO:0051492; GO:0051497; GO:0065003; GO:0070062; GO:0071346; GO:1905168; GO:2000146"
"2323","Pocillopora_acuta_HIv2___RNAseq.g24044.t2",2.10526315789474,8.7719298245614,8.23529411764706,3.02013422818792,2.64550264550265,5.72916666666667,3.16027088036117,4.32098765432099,0.854700854700855,3.57142857142857,4.2414678601272,4.53938384568757,3.94355187456684,NA,NA,NA,NA,NA,NA,11.2066145798171,11.2508398955338,10.809596149854,10.8521290922425,10.6524607347095,10.6837817687884,10.9891784866043,11.7962971553309,10.915590572352,10.5952694538431,10.9751757889076,11.0761118384127,10.8742397394024,2051.00399805317,-0.152130488556052,0.498778854625667,0.719859451701268,0.873567170853858,"A2VDZ3",1.85e-73,"Myocyte-specific enhancer factor 2A","apoptotic process [GO:0006915]; cardiac conduction [GO:0061337]; cellular response to calcium ion [GO:0071277]; dendrite morphogenesis [GO:0048813]; DNA-templated transcription [GO:0006351]; ERK5 cascade [GO:0070375]; MAPK cascade [GO:0000165]; mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; ventricular cardiac myofibril assembly [GO:0055005]","GO:0000002; GO:0000122; GO:0000165; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006351; GO:0006357; GO:0006915; GO:0010613; GO:0010628; GO:0019901; GO:0035035; GO:0042826; GO:0045944; GO:0046326; GO:0046332; GO:0046982; GO:0048311; GO:0048813; GO:0055005; GO:0061337; GO:0061629; GO:0070375; GO:0071277; GO:0140297"
"2324","Pocillopora_acuta_HIv2___TS.g1175.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.80115133184057,9.20419319850278,10.0591457883376,5.37766003570327,3.68233641306884,11.0015066355963,8.61060855334333,11.3939379628802,3.68233641306884,7.44952127454106,7.65374723269968,7.24529531638243,687.933076575424,0.0279463103360587,0.985927341364448,0.997535480761,0.999539535415802,"O95163",0,"Elongator complex protein 1 (ELP1) (IkappaB kinase complex-associated protein) (IKK complex-associated protein) (p150)","regulation of translation [GO:0006417]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]; tRNA wobble uridine modification [GO:0002098]","GO:0000049; GO:0002098; GO:0002926; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0033588"
"2325","Pocillopora_acuta_HIv2___RNAseq.g24075.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.43510272459039,4.954754005646,9.20782822277044,3.68233641306884,8.51918132868032,3.68233641306884,3.68233641306884,10.2695736083407,3.68233641306884,9.49931734322374,6.6615102885527,8.22280445949014,5.10021611761525,349.216156479238,-0.33584816457497,1.10241132098896,2.37941168444091e-05,0.000239664419246193,"A4FV72",3.91e-161,"Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Rotamase E)","mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]","GO:0000398; GO:0000413; GO:0003729; GO:0003755; GO:0005634; GO:0005737; GO:0006457; GO:0008143; GO:0016018; GO:0043231; GO:0071007; GO:0071013"
"2326","Pocillopora_acuta_HIv2___RNAseq.g16631.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.22010468013657,8.27386811086179,9.25953116654618,6.50915460878185,8.27899149163462,10.169709559239,7.21775444370806,8.69570839559952,8.99557118539327,7.08949304564378,8.17098866875446,8.48998138386203,7.8519959536469,358.583656186895,-0.356199918434941,0.819542050904398,0.399024665830522,0.645147861231016,"Q5DTI8",2.81e-08,"Extended synaptotagmin-3 (E-Syt3)","endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]","GO:0005509; GO:0005544; GO:0005789; GO:0006869; GO:0008429; GO:0009898; GO:0031210; GO:0035091; GO:0061817; GO:0140268"
"2327","Pocillopora_acuta_HIv2___RNAseq.g16638.t1",4.21052631578947,2.73972602739726,0,0,13.8888888888889,0.4149377593361,0,0,0,NA,2.36156433237908,0.630932757346672,4.52485380116959,NA,NA,NA,NA,NA,NA,5.04675156217379,7.83530183461159,6.25393493464119,3.68233641306884,6.06421730587923,3.68233641306884,3.68233641306884,5.89248396905691,3.68233641306884,3.68233641306884,4.95043716717069,5.38794483696399,4.51292949737739,34.8795437817649,-0.204930351934166,1.04403386927278,0.0243993441287413,0.0873328664880262,NA,NA,NA,NA,NA
"2328","Pocillopora_acuta_HIv2___RNAseq.g16639.t1",0.840336134453782,1.25223613595707,1.21951219512195,0.836820083682008,0.109649122807018,1.22762148337596,1.43884892086331,0,0,0,0.692502407626109,0.663335540603007,0.721669274649212,NA,NA,NA,NA,NA,NA,7.04630611039243,3.68233641306884,5.35722166815878,6.63240153016127,5.02357447611079,3.68233641306884,3.68233641306884,5.12735228357021,7.84981669252407,5.00142931435546,5.30851113144795,6.08085424615126,4.53616801674465,44.5417912661122,-0.815317739410737,1.48535931774456,0.00326068995806378,0.0162573662714355,NA,NA,NA,NA,NA
"2329","Pocillopora_acuta_HIv2___TS.g14799.t1",0,NA,NA,NA,100,20.6896551724138,45.8333333333333,0,12.5,NA,29.8371647509579,11.0632183908046,48.6111111111111,NA,NA,NA,NA,NA,NA,6.66923905548191,6.75880950091271,9.09261493226969,7.94270546705381,7.36007344379064,9.58259847349032,6.86956709787897,8.51536505331737,8.90735931395906,8.75195011199545,8.04502824501499,8.10893035976373,7.98112613026625,307.836356626665,-0.114961801055459,0.697887134417534,0.797815629508924,0.914734397216585,"Q7ZWU7",1.12e-06,"Extended synaptotagmin-2-B (E-Syt2-B)","endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869]","GO:0005509; GO:0005789; GO:0006869; GO:0006897; GO:0008429; GO:0009898; GO:0031210; GO:0035091; GO:0044232; GO:0061817; GO:0140268"
"2330","Pocillopora_acuta_HIv2___RNAseq.27805_t",NA,0,0,NA,32.3232323232323,0,0,0,0,NA,4.61760461760462,0,10.7744107744108,NA,NA,NA,NA,NA,NA,8.7680840551955,8.04817444370993,10.6795619443339,10.7354933915816,9.85426470036135,10.0143233124152,7.25971178892795,9.8404075367595,6.87095227164325,8.72416849554478,9.0795141940473,9.2026541016587,8.95637428643589,736.329919737199,-0.115196268519012,0.707797815293997,0.794646933915042,0.91318245337593,"Q4V8B0",6.04e-66,"Oxidation resistance protein 1 (Protein C7)","adult walking behavior [GO:0007628]; cellular response to hydroperoxide [GO:0071447]; negative regulation of cellular response to oxidative stress [GO:1900408]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; neuron apoptotic process [GO:0051402]; response to oxidative stress [GO:0006979]","GO:0005634; GO:0005730; GO:0005739; GO:0006979; GO:0007628; GO:0016491; GO:0043524; GO:0051402; GO:0071447; GO:1900408; GO:1902083"
"2331","Pocillopora_acuta_HIv2___RNAseq.g11376.t2a",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.92037767491365,10.8886232700364,9.20419319850278,9.96524062863902,10.3114349024393,9.69150297647132,9.57862096280873,10.3362748160354,10.9947306272882,6.48472759049682,9.53757266476316,9.75340224383587,9.32174308569046,975.971196381121,-0.11013217408795,0.81319704215776,0.772695412743812,0.902694972128786,"P56941",0,"NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein)","bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intestinal cholesterol absorption [GO:0030299]; intracellular cholesterol transport [GO:0032367]; intracellular lipid transport [GO:0032365]; lysosomal transport [GO:0007041]; negative regulation of TORC1 signaling [GO:1904262]; protein glycosylation [GO:0006486]","GO:0005319; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005886; GO:0006486; GO:0007041; GO:0008203; GO:0008206; GO:0015485; GO:0030299; GO:0030301; GO:0031902; GO:0032365; GO:0032367; GO:0042632; GO:0048471; GO:1904262"
"2332","Pocillopora_acuta_HIv2___RNAseq.g11376.t2b",14.2857142857143,0,0,0,0,0,0,NA,NA,NA,2.04081632653061,0,3.57142857142857,NA,NA,NA,NA,NA,NA,8.24052811387302,6.84260510118125,6.64213136387843,6.02915908265446,6.80960607508145,8.43359952480108,6.79979156785643,7.48609988346626,7.091790659748,6.04206022209894,7.04173715946393,7.25403121920943,6.82944309971843,129.078117040612,-0.371146051347776,0.701329243089446,0.437213464876124,0.680569904860984,"P21328",2.43e-08,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)","","GO:0003964"
"2333","Pocillopora_acuta_HIv2___RNAseq.g11377.t1",0,0.694444444444444,2.45398773006135,0,0,0.759013282732448,0.2710027100271,2.63157894736842,1.72413793103448,0,0.853416504566825,1.16183492111596,0.54499808801769,NA,NA,NA,NA,NA,NA,5.63634872160117,3.68233641306884,3.68233641306884,9.14026382408328,6.9963526566166,6.67896938259863,3.68233641306884,6.9839132704192,7.78511408192754,3.68233641306884,5.79503075895218,6.21681302872667,5.37324848917769,104.581289561462,-0.214397321081657,1.03247605563543,0.00466249945506439,0.0218955818565102,"Q9DBN1",1.36e-27,"Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2)","establishment of localization in cell [GO:0051649]; retinol transport [GO:0034633]; vitamin A import into cell [GO:0071939]","GO:0005886; GO:0034632; GO:0034633; GO:0038023; GO:0051649; GO:0071939"
"2334","Pocillopora_acuta_HIv2___RNAseq.g11380.t1",0,0,0,0,NA,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.1232862483274,10.9403683618285,10.6906408222384,9.43449375631599,11.0192729278738,9.28704065823237,9.12822800244161,9.35287007747155,3.68233641306884,9.87754023583026,9.35360775036287,8.973681297796,9.73353420292975,1005.0037067195,0.05629118427378,0.880167838922999,0.890828064035744,0.957876642085242,"Q99K70",0,"Ras-related GTP-binding protein C (Rag C) (RagC) (EC 3.6.5.-) (GTPase-interacting protein 2) (TIB929)","cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; negative regulation of autophagy [GO:0010507]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization to lysosome [GO:0061462]; protein localization to membrane [GO:0072657]; response to amino acid [GO:0043200]","GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0009267; GO:0010507; GO:0019003; GO:0032008; GO:0034198; GO:0043200; GO:0043495; GO:0046982; GO:0051020; GO:0060090; GO:0061462; GO:0072657; GO:0140767; GO:1904263; GO:1990131; GO:1990877"
"2335","Pocillopora_acuta_HIv2___RNAseq.g11387.t1",0,0,NA,0,0,2.85714285714286,0,0,NA,0,0.357142857142857,0.714285714285714,0,NA,NA,NA,NA,NA,NA,9.58202262090556,8.0187817757364,8.44584929570958,3.68233641306884,7.55651501959435,3.68233641306884,3.68233641306884,10.2984387599442,3.68233641306884,3.68233641306884,6.23132895372343,7.91303242184451,4.54962548560235,269.602284202778,-0.458098916088287,1.15355632044367,0.000245941394677433,0.00178932649077309,NA,NA,NA,NA,NA
"2336","Pocillopora_acuta_HIv2___RNAseq.g8477.t1a",NA,100,100,NA,100,86.6666666666667,100,NA,100,NA,97.7777777777778,95.5555555555556,100,NA,NA,NA,NA,NA,NA,5.69008050215398,8.35131215849861,7.40702362398868,3.68233641306884,9.7751605052628,7.15975907427809,3.68233641306884,7.56739604255221,3.68233641306884,11.8440930806515,6.88418342265924,6.8243994174053,6.94396742791318,526.04559978348,-0.0877576683322189,1.00832748895125,0.219483249185703,0.450539714036078,"Q6PE54",0,"Probable ATP-dependent RNA helicase DHX40 (EC 3.6.4.13) (DEAH box protein 40)","","GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0016887"
"2337","Pocillopora_acuta_HIv2___TS.g1098.t1",0,NA,NA,0,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.1335323896552,7.38724159684006,9.28556362434665,10.3179913590815,7.82288178250964,8.08524471858609,3.68233641306884,7.83384185377211,3.68233641306884,10.4160223635522,7.86469925144811,7.75163121267049,7.97776729022574,508.201350372812,-0.0356172355028386,0.956711511352468,0.83142210901336,0.931736902945742,"Q9CR92",1.41e-85,"Cilia- and flagella-associated protein 184","cilium assembly [GO:0060271]","GO:0005813; GO:0005930; GO:0036064; GO:0060271"
"2338","Pocillopora_acuta_HIv2___RNAseq.g8496.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.44244904934985,10.371700676942,8.343715901752,7.00074722714729,8.29213377030312,8.94320406797548,3.68233641306884,7.44618040143086,3.68233641306884,8.4121602860133,7.56169642070516,7.44136310718093,7.68202973422938,359.3404651877,0.0214518232299267,0.939778863090701,0.965164311124386,0.98752270488317,"Q8BWQ6",0,"VPS35 endosomal protein-sorting factor-like","endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]","GO:0005768; GO:0006893; GO:0015031; GO:0016020; GO:0032456"
"2339","Pocillopora_acuta_HIv2___TS.g1110.t1",25.8928571428571,0,23.5294117647059,6.66666666666667,17.5824175824176,8.33333333333333,3.90625,0,0,44.4444444444444,13.0355380934425,3,23.071076186885,NA,NA,NA,NA,NA,NA,10.684135919435,9.90783849147242,8.87436168578354,3.68233641306884,8.67570400163745,4.72257309926916,5.52620649542623,6.59039256814693,4.37599570701945,3.68233641306884,6.67218807943279,7.84011797640447,5.5042581824611,348.885701825709,-1.23828927181612,1.71274429155494,0.00912489837944559,0.0385276201241868,"Q5U5A6",5.57e-24,"Notch-regulated ankyrin repeat-containing protein","Notch signaling pathway [GO:0007219]","GO:0004857; GO:0005737; GO:0007219; GO:0019208"
"2340","Pocillopora_acuta_HIv2___RNAseq.g8500.t1",66.6666666666667,87.5,100,100,100,87.5,88.4615384615385,100,100,NA,92.2364672364672,95,88.7820512820513,NA,NA,NA,NA,NA,NA,11.0118038417696,10.7330074102347,10.4518422656734,10.5658522918385,10.195407918667,11.2424573232115,7.24933793434975,9.93222178598616,11.9863856693012,10.3320770399129,10.3700393480945,10.7155322962795,10.0245463999095,1649.95343010061,-0.397233513544612,0.712942061025707,0.396396606856756,0.642550770097065,"Q12830",2.14e-91,"Nucleosome-remodeling factor subunit BPTF (Bromodomain and PHD finger-containing transcription factor) (Fetal Alz-50 clone 1 protein) (Fetal Alzheimer antigen)","anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cellular response to nerve growth factor stimulus [GO:1990090]; chromatin remodeling [GO:0006338]; embryonic placenta development [GO:0001892]; endoderm development [GO:0007492]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000785; GO:0000978; GO:0001892; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0006357; GO:0007420; GO:0007492; GO:0009952; GO:0016589; GO:0030425; GO:0035064; GO:0043565; GO:0044297; GO:0045944; GO:0046872; GO:0048471; GO:0070062; GO:1904949; GO:1990090"
"2341","Pocillopora_acuta_HIv2___RNAseq.g24509.t1",100,NA,0,0,1.88679245283019,72.7272727272727,78.3783783783784,0,15.2173913043478,NA,33.5262293578536,21.9861660079051,45.0662927078021,NA,NA,NA,NA,NA,NA,9.11706711288888,3.68233641306884,7.82800945720994,3.68233641306884,11.0639423969713,3.68233641306884,9.81877863446637,8.71046423487031,6.07918960036691,3.68233641306884,6.73467970890491,8.55973456046147,4.90962485734835,416.301299161005,-0.611914731490031,1.27260553702255,3.59753196244052e-06,4.73904392575043e-05,"Q4R495",7.33e-142,"UNC93-like protein MFSD11 (Major facilitator superfamily domain-containing protein 11)","","GO:0016020"
"2342","Pocillopora_acuta_HIv2___RNAseq.g24534.t1",20,0,0,0,0,0,2.77777777777778,NA,0,NA,2.84722222222222,0,5.69444444444444,NA,NA,NA,NA,NA,NA,3.68233641306884,4.75675715543394,7.6518206655359,8.82557602331017,7.13215111495955,10.687596917982,3.68233641306884,9.69970043120983,3.68233641306884,9.46952542990766,6.92701369775456,6.36966900756859,7.48435838794052,384.113832197477,0.290291391550046,1.04398653331039,0.0790203171735662,0.220604104921533,"Q8BYA0",0,"Tubulin-specific chaperone D (Beta-tubulin cofactor D) (Tubulin-folding cofactor D)","adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]","GO:0000226; GO:0000278; GO:0005096; GO:0005737; GO:0005813; GO:0005912; GO:0005923; GO:0006457; GO:0007021; GO:0007023; GO:0010812; GO:0016328; GO:0031115; GO:0034333; GO:0048487; GO:0048667; GO:0070830"
"2343","Pocillopora_acuta_HIv2___RNAseq.g24543.t1",0,NA,NA,0,0,0,NA,11.1111111111111,NA,0,1.85185185185185,3.7037037037037,0,NA,NA,NA,NA,NA,NA,10.0288605516616,11.9831304803075,10.955591260945,11.8957377936263,10.6262793793499,12.0979031630519,9.91479986072618,10.0935677840436,7.91777144829032,11.8343891322238,10.7348030854226,9.92441408485808,11.5451920859871,2254.991462425,1.07299412511782,0.846832056585456,0.0508738160498425,0.157272630294288,"Q8C5H1",0,"Anoctamin-4 (Transmembrane protein 16D)","calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; establishment of localization in cell [GO:0051649]","GO:0005254; GO:0005886; GO:0017128; GO:0046983; GO:0051649; GO:0061589; GO:0061590; GO:0061591; GO:1902476"
"2344","Pocillopora_acuta_HIv2___RNAseq.g24558.t1",0,0,0,NA,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,10.1049150291741,3.68233641306884,3.68233641306884,8.22244318725274,7.83785566423622,3.68233641306884,8.11346982294029,9.07869273752916,5.16462945902469,6.32513515524326,6.55585571477197,6.09441459571454,233.508554289635,-0.123734417637703,1.0057650622034,0.246931666862334,0.486199241695725,NA,NA,NA,NA,NA
"2345","Pocillopora_acuta_HIv2___TS.g13961.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.62300673298873,9.47872216811105,8.35360495725685,7.89502910942778,9.69344359574772,7.73507283692995,9.27768752474152,8.92263569484299,7.88110490861757,3.68233641306884,8.2542643941733,8.89475917789077,7.61376961045583,422.268471823093,-0.471678544337195,0.915256120897253,0.267235829476971,0.511012564457287,"O15973",6.06e-16,"Rhodopsin, GQ-coupled (GQ-rhodopsin)","cellular response to light stimulus [GO:0071482]; phototransduction [GO:0007602]; visual perception [GO:0007601]","GO:0005886; GO:0007601; GO:0007602; GO:0008020; GO:0071482"
"2346","Pocillopora_acuta_HIv2___RNAseq.g24460.t1",0,0,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.36088805379155,7.73755144868966,6.16423403991286,7.03911674882672,6.64499589542844,9.48948536539531,3.68233641306884,5.74496152652496,8.79383957244156,7.56305912788741,6.82204681919673,6.54178381761987,7.10230982077359,174.66512947855,0.172648083783558,0.912227253538672,0.620687264261451,0.814518289809257,"Q10751",0,"Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II)","angiotensin maturation [GO:0002003]; bradykinin catabolic process [GO:0010815]; cell population proliferation [GO:0008283]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of blood pressure [GO:0008217]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; substance P catabolic process [GO:0010814]","GO:0001822; GO:0002003; GO:0003081; GO:0003084; GO:0004180; GO:0004222; GO:0005737; GO:0005886; GO:0008217; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0010814; GO:0010815; GO:0016020; GO:0031404; GO:0042445; GO:0042447; GO:0048167; GO:0060319; GO:0070573"
"2347","Pocillopora_acuta_HIv2___RNAseq.g24461.t1",69.2307692307692,50,NA,60.8695652173913,25,44.4444444444444,57.1428571428571,66.6666666666667,NA,100,59.1692878377661,55.4951690821256,62.8434065934066,NA,NA,NA,NA,NA,NA,3.68233641306884,7.24154832662667,3.68233641306884,4.93222760608536,7.26682604204426,7.2119491386412,3.68233641306884,5.70976195638337,4.65430837654882,6.75413069443622,5.48177613799724,4.99911384022283,5.96443843577166,50.9742871309974,0.26684850629804,1.02948361999512,0.0881411069499643,0.238190148753655,"Q9GLN7",1.62e-25,"Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form]","angiotensin maturation [GO:0002003]; bradykinin catabolic process [GO:0010815]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; positive regulation of systemic arterial blood pressure [GO:0003084]; regulation of blood pressure [GO:0008217]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; substance P catabolic process [GO:0010814]","GO:0001822; GO:0002003; GO:0003081; GO:0003084; GO:0004180; GO:0004222; GO:0005516; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0008217; GO:0008233; GO:0008237; GO:0008241; GO:0010814; GO:0010815; GO:0031404; GO:0042445; GO:0042447; GO:0046872; GO:0048167; GO:0070573"
"2348","Pocillopora_acuta_HIv2___TS.g13571.t1",0,0,2.92397660818713,0,0.746268656716418,0,0.597609561752988,0,1.36986301369863,0,0.563771784035517,0.273972602739726,0.853570965331308,NA,NA,NA,NA,NA,NA,7.14042550078154,3.68233641306884,9.61747021527548,3.68233641306884,10.0053257361928,3.68233641306884,3.68233641306884,8.1510851760415,9.06244758635359,3.68233641306884,6.23884362799891,8.79535084292898,3.68233641306884,264.733380063895,-13.0135690311161,3.76290348502399,4.81171928922072e-11,3.19003810822651e-09,"Q7RTR2",5.88e-31,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223"
"2349","Pocillopora_acuta_HIv2___TS.g13576.t1",100,0,NA,NA,14.2857142857143,0,0,NA,0,NA,19.047619047619,0,38.0952380952381,NA,NA,NA,NA,NA,NA,3.68233641306884,6.36195368411057,9.21507088400397,6.26838653426437,5.75030036476101,7.69302168712282,6.49753832785703,7.06558112980681,3.68233641306884,5.23798087003036,6.14545063080946,5.87912504094189,6.41177622067703,108.674717476766,0.335442806166819,1.01683436432797,0.120706660350302,0.299776980650202,"A7RR04",1.5e-62,"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1)","mitochondrial translational elongation [GO:0070125]","GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125"
"2350","Pocillopora_acuta_HIv2___RNAseq.g22572.t1",0,0,0,0,NA,0,0,7.14285714285714,NA,NA,1.02040816326531,1.78571428571429,0,NA,NA,NA,NA,NA,NA,5.52146481986391,10.6927245332871,3.68233641306884,8.76636278891704,4.4748864375616,9.00324966826751,10.2672772798658,3.68233641306884,3.68233641306884,11.0601866300936,7.08331613970631,4.20867209932641,9.95796018008621,587.18442038473,9.22779492786164,2.46277583642893,3.33020819608899e-11,2.40959196312831e-09,"P55115",9.29e-54,"Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"2351","Pocillopora_acuta_HIv2___RNAseq.g28892.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.78552843361654,9.60053375310261,10.8796072553489,10.4354168793449,9.9828417779223,10.4094290653816,9.27260817039085,8.82530251522673,8.24542216327784,11.881012637225,9.83177026508373,9.34374042907846,10.319800101089,1175.11664069626,0.54041940792759,0.731979824206864,0.280413283649622,0.52628408407476,"Q3UJD6",0,"Ubiquitin carboxyl-terminal hydrolase 19 (EC 3.4.19.12) (Deubiquitinating enzyme 19) (Ubiquitin thioesterase 19) (Ubiquitin-specific-processing protease 19)","ERAD pathway [GO:0036503]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]","GO:0004843; GO:0005789; GO:0005829; GO:0016579; GO:0031625; GO:0031647; GO:0034976; GO:0036503; GO:0046872; GO:0048642; GO:0050821; GO:0071108; GO:0090068; GO:1900037; GO:1901799; GO:1990380"
"2352","Pocillopora_acuta_HIv2___TS.g11492.t1a",0,0,0,NA,0,0,0,0,3.125,NA,0.390625,0.78125,0,NA,NA,NA,NA,NA,NA,7.22868826190456,3.68233641306884,7.43223115439203,9.34377528002283,7.47561178648212,3.68233641306884,3.68233641306884,6.5996347665023,3.68233641306884,6.42959658710632,5.92388834886855,6.48370047646997,5.36407622126713,118.641928055412,-0.136978392879498,1.02018000759217,0.00389854388941569,0.0188653525649075,"O70340",2.78e-23,"Neuronal pentraxin-2 (NP2) (Neuronal pentraxin II) (NP-II)","associative learning [GO:0008306]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]","GO:0008306; GO:0030246; GO:0043083; GO:0045202; GO:0046872; GO:0098793; GO:0098892; GO:0098978; GO:0099645"
"2353","Pocillopora_acuta_HIv2___RNAseq.g28899.t1",5.55555555555556,0,NA,20,0,0,NA,NA,0,0,3.65079365079365,5,1.85185185185185,NA,NA,NA,NA,NA,NA,3.68233641306884,7.22094502716092,7.522982350118,7.28204866049182,7.45699348383716,3.68233641306884,9.65085453577154,6.18361936369477,3.68233641306884,3.68233641306884,6.00467890733496,5.70565360475752,6.30370420991239,139.344264312218,0.129253368651928,1.00008915349651,0.533648482342631,0.754515312668995,"Q9HAQ2",0,"Kinesin-like protein KIF9","extracellular matrix disassembly [GO:0022617]; microtubule-based movement [GO:0007018]; organelle disassembly [GO:1903008]; regulation of flagellated sperm motility [GO:1901317]; regulation of podosome assembly [GO:0071801]","GO:0002102; GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0022617; GO:0031982; GO:0036126; GO:0042802; GO:0071801; GO:1901317; GO:1903008"
"2354","Pocillopora_acuta_HIv2___RNAseq.g28909.t1",0,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.6001993060933,3.68233641306884,9.35112665652338,3.68233641306884,9.32334629709623,4.42568256259181,9.4960551772978,9.71335987651025,8.01684328996935,3.68233641306884,7.09736224052886,9.2009750852385,4.99374939581923,374.167179606024,-7.01061233025132,3.14503778034771,1.88366908814314e-07,3.73224516313732e-06,"Q3UHX0",2.26e-46,"Nucleolar protein 8","cellular response to leukemia inhibitory factor [GO:1990830]; protein localization to nucleolus [GO:1902570]; rRNA processing [GO:0006364]","GO:0003723; GO:0005730; GO:0006364; GO:1902570; GO:1990830"
"2355","Pocillopora_acuta_HIv2___RNAseq.g28910.t1",0.34965034965035,0,2.31023102310231,2.56410256410256,1.57303370786517,0.432900432900433,6.2200956937799,0.609756097560976,0,0,1.40597698689617,0.721351818912795,2.09060215487955,NA,NA,NA,NA,NA,NA,6.976490469328,11.9929652760034,9.30266102387004,12.1187176360189,8.3359398435869,13.3612503826906,12.1170368359654,10.2459136581504,3.68233641306884,11.3009316186181,9.94342431573006,7.70866828160084,12.1781803498593,2807.76704565131,3.32181454551033,1.97355585885245,0.00034566301849493,0.00238761695296594,"O00339",4.12e-72,"Matrilin-2","axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; response to axon injury [GO:0048678]","GO:0001764; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0048678; GO:0062023; GO:0120216"
"2356","Pocillopora_acuta_HIv2___RNAseq.g28911.t1",NA,NA,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.8129637983014,13.1876710563179,7.87918924357558,12.1946670044325,10.0806129207614,13.2947754716324,13.833442373047,11.718213029633,9.46386116028841,13.3838270827144,11.5849223140704,9.99096803051196,13.1788765976288,5629.05905301619,2.9456646299318,0.757052094396936,3.50046621077876e-06,4.64076473626984e-05,"Q75N90",7.52e-85,"Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide]","anatomical structure morphogenesis [GO:0009653]","GO:0001527; GO:0005201; GO:0005509; GO:0005576; GO:0009653; GO:0031012"
"2357","Pocillopora_acuta_HIv2___RNAseq.g31164.t1a",0,NA,0,0,0,3,NA,0,NA,NA,0.5,1,0,NA,NA,NA,NA,NA,NA,5.9511981009209,4.75675715543394,6.66380671632316,4.11054575398787,5.02357447611079,3.68233641306884,3.68233641306884,3.99577996562374,5.56716625041612,7.23934222464913,5.06728434696033,5.44030510187894,4.69426359204172,28.9047950891105,-0.60087255285791,1.17245784624691,0.0635723868281259,0.187311265651255,NA,NA,NA,NA,NA
"2358","Pocillopora_acuta_HIv2___RNAseq.g31165.t1",0,100,0,66.6666666666667,NA,15.1515151515152,21.4285714285714,NA,100,NA,43.3209647495362,70.4545454545455,7.14285714285714,NA,NA,NA,NA,NA,NA,7.31179009778251,6.4545116118486,7.30148504732473,8.5197169563895,8.06897029611317,8.92261958639937,3.68233641306884,7.24545671389733,7.5245035367715,3.68233641306884,6.87137266726644,7.49044113837785,6.25230419615503,166.294571734729,-0.293522291689762,0.981785579842948,0.207027828509039,0.433032665779658,"Q0VGW4",2.55e-41,"Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (FXNA-like protease)","proteolysis [GO:0006508]","GO:0005789; GO:0006508; GO:0008235; GO:0046872"
"2359","Pocillopora_acuta_HIv2___RNAseq.g25618.t1",7.40740740740741,0,7.8125,0,16.1904761904762,7.39299610894942,5.95238095238095,7.84313725490196,1.68067226890756,0,5.42795701830235,3.38336112655179,7.47255291005291,NA,NA,NA,NA,NA,NA,7.52158968785136,7.50248485470253,8.66808980443327,3.68233641306884,7.30902487906021,7.28680821969973,7.46174035997229,7.9874069688121,5.26843329136292,3.68233641306884,6.63702508920321,7.35090892630397,5.92314125210245,135.994403449728,-0.454746973591807,1.00677607424091,0.159342516029975,0.362721144453504,"Q32P85",3.28e-27,"Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic)","microtubule-based movement [GO:0007018]","GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045505"
"2360","Pocillopora_acuta_HIv2___RNAseq.g25622.t1",11.2426035502959,9.41558441558442,6.06936416184971,2.79850746268657,6.54490106544901,8.08080808080808,6.22083981337481,0,4.32569974554707,0,5.46983082955955,4.92411994092523,6.01554171819388,1,38.8888888888889,38.8888888888889,0.018431845950728,0.018431845950728,0.018431845950728,8.32255120956012,8.83162439855743,6.25393493464119,8.56387194917703,8.30774756796232,8.3741534738921,5.82167741730566,7.57666323111741,6.28579400236677,4.90925637683756,7.32472745614176,7.34933818912956,7.30011672315396,199.378184562436,-0.130587721539155,0.770938158201896,0.755842212609594,0.892988177304097,"Q9Y4B6",0,"DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein)","B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]","GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756"
"2361","Pocillopora_acuta_HIv2___TS.g29560.t1",0,NA,NA,NA,8.33333333333333,5.40540540540541,6.25,0,0,NA,3.33145645645646,1.8018018018018,4.86111111111111,NA,NA,NA,NA,NA,NA,6.5772197832221,8.37468241754283,7.62478293516472,6.43347906989454,6.53243235463258,7.0963417398513,3.68233641306884,9.16220283359575,3.68233641306884,3.68233641306884,6.28481503731103,6.7157948639368,5.85383521068527,134.204703717322,-0.118084941175455,0.951231264511756,0.805019911997641,0.91849869899297,"Q6NXP0",6.02e-09,"EF-hand calcium-binding domain-containing protein 12","","GO:0005509"
"2362","Pocillopora_acuta_HIv2___RNAseq.g5812.t1",0,NA,NA,NA,0,7.14285714285714,0,0,0,0,1.02040816326531,2.38095238095238,0,NA,NA,NA,NA,NA,NA,8.38113716776767,7.20003870083844,10.0679181415957,6.66570112997648,8.68369873791786,7.07768908530409,8.6913826025105,11.1214800224437,10.463744942732,3.68233641306884,8.20351269441553,9.74359580249139,6.66342958633967,602.966167069888,-1.53234888423318,1.58278227262111,0.01454531380368,0.0570299319209614,"Q9QY53",6.36e-127,"Nephrocystin-1","cell projection organization [GO:0030030]; photoreceptor cell outer segment organization [GO:0035845]; protein localization [GO:0008104]; protein localization involved in establishment of planar polarity [GO:0090251]; retina development in camera-type eye [GO:0060041]; spermatid differentiation [GO:0048515]","GO:0005737; GO:0005856; GO:0005911; GO:0005912; GO:0005923; GO:0005929; GO:0008104; GO:0030030; GO:0031514; GO:0032391; GO:0035845; GO:0035869; GO:0048515; GO:0060041; GO:0090251; GO:0097546; GO:0120206"
"2363","Pocillopora_acuta_HIv2___RNAseq.g5827.t1",0,0,0,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.33050193796594,8.90723650973111,6.86389470932694,9.0250299895197,6.07686165919975,3.68233641306884,3.68233641306884,6.7397479573644,10.574758162016,3.68233641306884,6.75650401643304,7.71715288517461,5.79585514769147,296.5956052211,-0.311891512440044,1.04589349042465,0.000874798144518113,0.00524154116085749,NA,NA,NA,NA,NA
"2364","Pocillopora_acuta_HIv2___RNAseq.g26509.t2",4.8780487804878,2.38095238095238,46.1538461538462,2.73972602739726,12.9032258064516,9.70873786407767,0,NA,62.5,NA,17.6580671266516,19.3323540681068,15.9837801851964,NA,NA,NA,NA,NA,NA,7.86115415829834,10.4252083469283,7.49934036428563,9.98808278206217,8.01605425720067,7.23734250716965,7.65444924775928,8.10391005152801,7.11315142623839,3.68233641306884,7.75810295545393,7.71872205151021,7.79748385939765,360.396210252897,0.00997086814280551,0.883681783952355,0.997040653757361,0.999112928914124,NA,NA,NA,NA,NA
"2365","Pocillopora_acuta_HIv2___RNAseq.g26510.t1",0,0,0,17.1428571428571,NA,0,0,NA,NA,NA,2.85714285714286,5.71428571428571,0,NA,NA,NA,NA,NA,NA,9.5786930091216,12.3714444135473,8.1939484205115,12.549973767216,10.3546023605887,11.022078431426,4.69145782511396,11.0020231658651,9.02939732787342,12.7214943254285,10.1515113046692,9.63173285679206,10.6712897525464,2484.61593175398,0.518234115415213,1.05711264408109,0.121842631215226,0.301717482947616,"P12111",1.26e-91,"Collagen alpha-3(VI) chain","cell adhesion [GO:0007155]; muscle organ development [GO:0007517]; neuron apoptotic process [GO:0051402]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; response to glucose [GO:0009749]; response to UV [GO:0009411]","GO:0004867; GO:0005576; GO:0005589; GO:0005615; GO:0005788; GO:0007155; GO:0007517; GO:0009411; GO:0009749; GO:0030020; GO:0031012; GO:0042383; GO:0043491; GO:0051402; GO:0062023; GO:0070062; GO:1903561"
"2366","Pocillopora_acuta_HIv2___RNAseq.g16322.t1",0,NA,NA,0,8.69565217391304,32.0754716981132,0,0,NA,100,20.1101605531466,10.6918238993711,27.1739130434783,NA,NA,NA,NA,NA,NA,7.88297397736584,7.45044931999893,7.77984159395405,6.29014341372585,7.54774870150168,8.12187490846922,3.68233641306884,7.65310005299855,9.27942690028714,3.68233641306884,6.93702316944389,8.02861824522145,5.84542809366634,179.901691118021,-0.486582660416969,1.06542118566763,0.0697318755323253,0.201117018484457,NA,NA,NA,NA,NA
"2367","Pocillopora_acuta_HIv2___RNAseq.g19522.t1",NA,0,NA,NA,0,27.2727272727273,0,NA,41.6666666666667,0,11.489898989899,22.979797979798,0,NA,NA,NA,NA,NA,NA,7.38264830809177,7.50248485470253,7.25273306942338,5.21704338441576,7.29334655580838,3.68233641306884,3.68233641306884,4.1247493465216,6.89589329451837,3.68233641306884,5.67159080526883,6.5898741148727,4.75330749566496,67.0866513340129,-0.81121911420161,1.38124397035133,0.0115392989344809,0.0468964371419871,"P42527",2.44e-11,"Myosin heavy chain kinase A (MHCK-A) (EC 2.7.11.7)","actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; chemotaxis [GO:0006935]; mitotic cytokinesis [GO:0000281]; myosin II filament disassembly [GO:0031037]; protein autophosphorylation [GO:0046777]","GO:0000281; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005826; GO:0005938; GO:0006935; GO:0016208; GO:0016905; GO:0030552; GO:0031037; GO:0042802; GO:0043262; GO:0043531; GO:0045159; GO:0046777; GO:0051015; GO:0051017; GO:0051764"
"2368","Pocillopora_acuta_HIv2___RNAseq.g19523.t2",0,NA,0,0,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.8368956045141,8.20250416305248,8.11083112805987,7.22786336628594,6.40992758448011,6.91889492578439,4.69145782511396,7.45123181602739,6.3603914105578,3.68233641306884,6.58923342369449,7.03385550872785,6.14461133866112,110.951520455169,-0.411915259989381,0.9625603867214,0.217369034088909,0.447675595765624,"Q7RTR2",3.64e-71,"NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","canonical NF-kappaB signal transduction [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:0051898; GO:1900016; GO:1900226; GO:1901223"
"2369","Pocillopora_acuta_HIv2___RNAseq.g6836.t1",0,0,NA,NA,6.52173913043478,0,0,0,NA,NA,1.08695652173913,0,2.17391304347826,NA,NA,NA,NA,NA,NA,5.79120769139532,3.68233641306884,4.80540103069894,3.68233641306884,4.71118491363556,3.68233641306884,3.68233641306884,7.01166301889941,6.95638151601114,3.68233641306884,4.76875202359846,5.85516763412807,3.68233641306884,25.2147696725998,-7.73103171180336,4.08316733363929,0.000605554579239189,0.0038466145955712,"Q8WU66",5.46e-17,"Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170"
"2370","Pocillopora_acuta_HIv2___RNAseq.g6838.t1",0,0,0,0,0,1.56739811912226,2.13903743315508,6.75675675675676,0,NA,1.16257692322601,1.6648309751758,0.53475935828877,NA,NA,NA,NA,NA,NA,6.64356132503947,4.50233927872981,8.21580656604181,3.68233641306884,3.68233641306884,4.21083509301726,5.08305273412487,9.07207698868077,9.80379317860447,3.68233641306884,5.8578474403445,7.48351489428707,4.23217998640192,174.83812090012,-0.608734153204408,1.28271532550095,0.00140094200588142,0.0078087421288119,"Q8WU66",1e-34,"Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170"
"2371","Pocillopora_acuta_HIv2___TS.g13882.t1c",1.87449062754686,2.25794106391121,5.96491228070175,1.59225725881986,8.14783704325913,1.93392425463336,4.80769230769231,2.78980278980279,4.90668272125226,2.08464939987366,3.63601897474932,2.6961216176839,4.57591633181474,NA,NA,NA,NA,NA,NA,3.68233641306884,7.53615091189663,3.68233641306884,8.09509746987116,3.68233641306884,6.97046070240566,7.58210311844481,3.68233641306884,3.68233641306884,10.3612059865892,5.89567002545517,3.68233641306884,8.10900363784149,196.682004132868,12.6423270373682,3.60904487629516,1.72701412732187e-10,9.18365159469982e-09,"Q20191",5.77e-07,"Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13)","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"2372","Pocillopora_acuta_HIv2___RNAseq.g20199.t1",0,0,0,0,0,0,1.75438596491228,4.76190476190476,0,NA,0.724032302979671,0.952380952380952,0.43859649122807,NA,NA,NA,NA,NA,NA,9.26942967149964,3.68233641306884,10.9855336997948,8.23286033009443,9.86922766157433,3.68233641306884,8.82581837105862,9.80060263531949,11.1307225633641,3.68233641306884,7.91612041719119,10.2111032463105,5.62113758807191,729.058672443003,-0.859120565584051,1.50673722587604,3.35894354359491e-07,6.14206819400212e-06,"Q96PM5",2.2e-28,"RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2)","error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630; GO:0070987; GO:0072344"
"2373","Pocillopora_acuta_HIv2___RNAseq.g7250.t1",4,0,0,0,0,0,0,0,NA,0,0.444444444444444,0,0.8,NA,NA,NA,NA,NA,NA,8.28621869280214,3.68233641306884,8.99078577225017,3.68233641306884,7.84805420942548,9.01058243196579,3.68233641306884,9.04073742553968,11.1829740533591,3.68233641306884,6.90886982376177,9.06975403067531,4.74798561684823,426.690885640499,-0.64882199566522,1.32732281162956,2.20241122409305e-09,7.95662186367493e-08,"Q96PM5",1.41e-28,"RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2)","error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630; GO:0070987; GO:0072344"
"2374","Pocillopora_acuta_HIv2___TS.g30234.t1",0,0,0,0,0,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,6.75557122368885,7.35927076110737,6.85453915175415,10.2548150895372,5.7009801482996,6.34225560108856,3.68233641306884,8.23520456120758,8.65983860721754,3.68233641306884,6.75271479700385,7.24122673843354,6.26420285557416,225.356676091785,-0.0872819700535744,0.965054887989021,0.630510182850945,0.821106880075553,NA,NA,NA,NA,NA
"2375","Pocillopora_acuta_HIv2___RNAseq.g385.t1",0,0,0,0,2.96610169491525,1.09090909090909,0,4.81927710843374,0,0,0.887628789425808,1.18203723986857,0.593220338983051,NA,NA,NA,NA,NA,NA,11.0857767707562,4.39481510491619,11.1067667734231,7.11287062487384,10.4307337417582,5.67813700336456,3.68233641306884,12.0543435723214,11.8380980385519,3.68233641306884,8.10662144561031,11.3031437793622,4.91009911185845,1369.13096260708,-7.58762459207394,2.72758174789344,1.6444201713645e-09,6.21015492392068e-08,NA,NA,NA,NA,NA
"2376","Pocillopora_acuta_HIv2___RNAseq.g8746.t1",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.03654092012575,3.68233641306884,7.13459198279071,3.68233641306884,6.69403455193469,3.68233641306884,9.27260817039085,7.92721564972577,3.68233641306884,3.68233641306884,5.6476673340312,6.49494390352915,4.80039076453324,111.381941797227,-0.253005792599157,1.04116456833724,0.00343047893756614,0.0169230720849102,NA,NA,NA,NA,NA
"2377","Pocillopora_acuta_HIv2___TS.g16770.t1",0,0,0,0,8,0,0,5,0,NA,1.44444444444444,1,2,NA,NA,NA,NA,NA,NA,9.334055555777,3.68233641306884,9.55606664229875,7.34446020722041,10.7776144817469,6.5620639848483,3.68233641306884,10.8178469048317,9.54403043985135,3.68233641306884,7.49831474557809,10.0059228049011,4.99070668625505,578.612156492158,-5.91435577033453,4.27036831066269,9.31349366939508e-08,2.01964576363014e-06,NA,NA,NA,NA,NA
"2378","Pocillopora_acuta_HIv2___RNAseq.g24081.t1",0,0,1.42857142857143,6.66666666666667,1.48698884758364,0,1.53846153846154,7.2289156626506,0,0,1.83496041439339,2.77911646586345,0.890804362923322,NA,NA,NA,NA,NA,NA,6.25760738373578,6.92168924401968,7.35523113293712,6.89302286053367,7.79356137219888,4.94358885541907,6.22323459566748,6.78887433798125,3.68233641306884,3.68233641306884,6.05414826086306,6.37552212798437,5.73277439374175,72.8559049486082,-0.336935318449387,0.875178421886871,0.514885262027763,0.739989238220648,"A0A1X7TVA9",3.38e-06,"Death domain-containing ATP nucleosidase (DDAN) (EC 3.5.99.-)","nucleoside metabolic process [GO:0009116]","GO:0009116; GO:0016787"
"2379","Pocillopora_acuta_HIv2___RNAseq.g24082.t1",0,NA,NA,0,1.72413793103448,0,3.07692307692308,6.41025641025641,0,0,1.40141467727675,1.6025641025641,1.20026525198939,NA,NA,NA,NA,NA,NA,7.67349335418918,8.31311141953989,8.57258423570792,6.08052100501175,7.78240969907121,7.44754517716341,3.68233641306884,6.65383698875806,4.57231842518309,3.68233641306884,6.44604931307622,7.05092854058189,5.84117008557055,129.883989336763,-0.718989713015492,1.13679622944761,0.0675817565443215,0.196167474745548,"Q10751",6.37e-43,"Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II)","angiotensin maturation [GO:0002003]; bradykinin catabolic process [GO:0010815]; cell population proliferation [GO:0008283]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of blood pressure [GO:0008217]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; substance P catabolic process [GO:0010814]","GO:0001822; GO:0002003; GO:0003081; GO:0003084; GO:0004180; GO:0004222; GO:0005737; GO:0005886; GO:0008217; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0010814; GO:0010815; GO:0016020; GO:0031404; GO:0042445; GO:0042447; GO:0048167; GO:0060319; GO:0070573"
"2380","Pocillopora_acuta_HIv2___RNAseq.g16360.t1",0,0,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.25300700550269,5.06794590568438,6.56349925127405,5.16572759476787,5.3333020303659,4.94358885541907,4.51171232812315,4.55716825854291,5.22517199274777,5.16462945902469,5.17857526814525,5.38642970768666,4.97072082860383,18.4353462080057,-0.41245236402508,0.742647769650335,0.420183804903214,0.66459334656029,NA,NA,NA,NA,NA
"2381","Pocillopora_acuta_HIv2___RNAseq.g375.t1",1.58227848101266,0,0,0,0.201612903225806,1.07858243451464,0.344827586206897,0.523560209424084,0,0,0.373086161438408,0.320428528787744,0.425743794089072,NA,NA,NA,NA,NA,NA,6.22289842159741,5.12032714986833,6.84512099725677,4.99561439145868,6.54142192988087,8.35121219233997,4.10128477526701,7.38940142422503,5.03316817358995,3.68233641306884,5.82827858685529,6.40640218931001,5.25015498440057,69.3981132913934,-0.947514766626153,1.36808560024127,0.0234004251388393,0.0843418263663522,"F6R2G2",6.19e-16,"NLR family CARD domain-containing protein 4 (Ice protease-activating factor) (Ipaf)","apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of apoptotic process [GO:0042981]","GO:0005524; GO:0005829; GO:0006915; GO:0006954; GO:0016045; GO:0042742; GO:0042981; GO:0045087"
"2382","Pocillopora_acuta_HIv2___RNAseq.g18896.t1",100,NA,66.6666666666667,11.1111111111111,NA,9.09090909090909,28.5714285714286,NA,0,NA,35.9066859066859,6.73400673400673,65.0793650793651,NA,NA,NA,NA,NA,NA,5.76666095136545,4.82737711805479,5.66344864002848,4.7918870276047,5.21442834742072,5.38419442015382,3.68233641306884,4.86526991710116,5.91298961818613,5.60202388220197,5.17106163351861,5.48455949482039,4.85756377221682,18.5202733180795,-0.643395754139242,0.954233995194966,0.191260291298651,0.410870169811925,NA,NA,NA,NA,NA
"2383","Pocillopora_acuta_HIv2___RNAseq.g21020.t1",1.58415841584158,0.658616904500549,0.654205607476635,1.23287671232877,0.554016620498615,0.513698630136986,0.30511060259344,0,0.120772946859903,0,0.562345644023648,0.505193038765241,0.619498249282055,NA,NA,NA,NA,NA,NA,8.31054208298592,3.68233641306884,8.46725630110512,5.11193581531555,9.11310611433034,8.80382613241375,9.46299610747555,8.69146451830397,3.68233641306884,3.68233641306884,6.90081363111367,7.65294108595884,6.14868617626851,265.31221222243,-0.331039310000488,1.00361209623058,0.283917770270129,0.529882145701567,"Q07496",4.55e-59,"Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (cEK8)","axon guidance [GO:0007411]; cell adhesion [GO:0007155]; ephrin receptor signaling pathway [GO:0048013]; fasciculation of sensory neuron axon [GO:0097155]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001108]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; segmentation [GO:0035282]; somitogenesis [GO:0001756]","GO:0001756; GO:0004672; GO:0005004; GO:0005005; GO:0005524; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0018108; GO:0030425; GO:0031901; GO:0035282; GO:0043087; GO:0046777; GO:0048013; GO:0097155; GO:0097161; GO:2001108"
"2384","Pocillopora_acuta_HIv2___RNAseq.g4255.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.56356363373408,7.55269107778438,7.91529616546613,8.50166853559975,7.69390117206977,8.16199739230414,6.03750049456639,6.8285395576186,6.85831417532123,3.68233641306884,6.97958086175333,7.17192294084196,6.7872387826647,145.447625990847,-0.140879685790457,0.840047611404267,0.723351258104321,0.875685160888514,"P35251",1.12e-18,"Replication factor C subunit 1 (Activator 1 140 kDa subunit) (A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (DNA-binding protein PO-GA) (Replication factor C 140 kDa subunit) (RF-C 140 kDa subunit) (RFC140) (Replication factor C large subunit)","DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; telomere maintenance via telomerase [GO:0007004]","GO:0000122; GO:0003677; GO:0003689; GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006261; GO:0006281; GO:0007004; GO:0008047; GO:0016887; GO:0019904; GO:0031391; GO:0043565; GO:0045893; GO:0061860; GO:0070062; GO:0140297"
"2385","Pocillopora_acuta_HIv2___TS.g4906.t1",22.2222222222222,NA,NA,30,50,11.7647058823529,0,NA,0,NA,18.9978213507625,13.921568627451,24.0740740740741,NA,NA,NA,NA,NA,NA,8.99244805004733,6.99657405929672,7.53465822665543,8.62766417813255,8.58470087504098,8.72872998755956,6.08638961748019,7.72149219914936,3.68233641306884,8.20248052335186,7.51574741297828,7.30312715279239,7.72836767316418,237.614912013016,0.0469568257530307,0.888726308431812,0.900567400583459,0.962397827759738,"Q6CGG3",7.54e-39,"FK506-binding protein 2 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase)","chaperone-mediated protein folding [GO:0061077]","GO:0003755; GO:0005783; GO:0061077"
"2386","Pocillopora_acuta_HIv2___RNAseq.g12477.t1",0,0,0,0,0,1.23203285420945,0,0,1.03626943005181,0,0.226830228426126,0.453660456852252,0,NA,NA,NA,NA,NA,NA,4.5939750356694,4.39481510491619,4.6464169258196,7.27137545289193,4.82690108855957,3.68233641306884,6.22323459566748,4.5021858093707,6.49844915574363,7.56305912788741,5.42027487095948,5.01358560303258,5.82696413888637,43.9199696590991,0.273440872712933,0.947420161383707,0.396916039881646,0.643032437370982,"Q62270",5.13e-17,"Tyrosine-protein kinase Srms (EC 2.7.10.2) (PTK70)","cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; innate immune response [GO:0045087]; peptidyl-tyrosine autophosphorylation [GO:0038083]","GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005886; GO:0007169; GO:0030154; GO:0038083; GO:0045087"
"2387","Pocillopora_acuta_HIv2___RNAseq.g10141.t1",0,0,0,0.847457627118644,0,0.520833333333333,0,0,0,NA,0.152032328939109,0.273658192090395,0,NA,NA,NA,NA,NA,NA,8.14454448327006,9.40808103785765,8.92825025166409,10.2642024284676,3.68233641306884,7.97440899118697,3.68233641306884,3.68233641306884,3.68233641306884,3.68233641306884,6.31311692577906,5.62396079482813,7.00227305672998,280.438802198123,0.300851628491416,1.02271597177133,0.347421082153231,0.598771780681107,"P59511",3.39e-165,"A disintegrin and metalloproteinase with thrombospondin motifs 20 (ADAM-TS 20) (ADAM-TS20) (ADAMTS-20) (EC 3.4.24.-)","apoptotic process [GO:0006915]; extracellular matrix organization [GO:0030198]; melanocyte differentiation [GO:0030318]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967]; proteolysis [GO:0006508]; regulation of developmental pigmentation [GO:0048070]; signal transduction [GO:0007165]","GO:0004175; GO:0004222; GO:0005615; GO:0006508; GO:0006915; GO:0007165; GO:0008270; GO:0009967; GO:0030198; GO:0030318; GO:0031012; GO:0043066; GO:0045636; GO:0048070"
"2388","Pocillopora_acuta_HIv2___RNAseq.g10142.t1",NA,0,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.71922149999791,6.43649034287553,3.68233641306884,9.55742127470358,5.97219005110571,3.68233641306884,7.52318888932451,3.68233641306884,3.68233641306884,3.68233641306884,5.46201941233514,4.74768415806203,6.17635466660826,107.101105960192,0.0974975661580876,1.00900968595008,0.50014537410049,0.729801664414609,NA,NA,NA,NA,NA
"2389","Pocillopora_acuta_HIv2___RNAseq.g9148.t1",0,0,0,0,0,1.04166666666667,0,NA,0,NA,0.130208333333333,0.260416666666667,0,NA,NA,NA,NA,NA,NA,7.78785518405689,8.11079559888894,6.85453915175415,9.3886219429448,7.07816103693054,10.5375597056738,11.0468209982491,9.38342879926144,3.68233641306884,3.68233641306884,7.75524552438973,6.95726411701437,8.5532269317651,548.759881849897,1.29008163508482,1.10400936279712,0.0404327826165709,0.131924152439901,NA,NA,NA,NA,NA
"2390","Pocillopora_acuta_HIv2___RNAseq.g17385.t1",0,1.12359550561798,0,0,0,0.599700149925038,0.301204819277108,0.961538461538462,0,0,0.298603893635858,0.536966823416295,0.0602409638554217,NA,NA,NA,NA,NA,NA,6.01423630021445,3.68233641306884,6.58642216671358,10.0668298057314,5.02357447611079,3.68233641306884,3.68233641306884,5.96778646100673,3.68233641306884,7.99465591078525,5.63828507728376,5.45487116342288,5.82169899114463,144.216006204264,-0.0998505520392608,1.01941086286341,0.0203700655026204,0.0753357573451377,"A0A2J6RX17",7.97e-18,"Nucleotide-binding leucine-rich repeat (NLR)-like protein (EC 3.5.99.-)","nucleoside metabolic process [GO:0009116]","GO:0009116; GO:0016787; GO:0043531"
"2391","Pocillopora_acuta_HIv2___RNAseq.g23688.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.5306548131163,5.6784794012365,11.5121206488569,3.68233641306884,9.30144444624961,3.68233641306884,3.68233641306884,7.5950193319465,11.2003912050604,3.68233641306884,7.05474554987416,10.0279260890459,4.08156501070237,747.922168689888,-11.1010569310447,2.90893057457668,7.57715188770528e-11,4.49163626654792e-09,NA,NA,NA,NA,NA
"2392","Pocillopora_acuta_HIv2___RNAseq.g1456.t1b",19.047619047619,32.1428571428571,NA,NA,58.3333333333333,18.3673469387755,62.5,NA,100,NA,48.3985260770975,50.1700680272109,46.6269841269841,NA,NA,NA,NA,NA,NA,5.42769788077612,3.68233641306884,3.68233641306884,7.7721826747894,6.75685543042877,3.68233641306884,6.77088171065989,6.2798424236602,3.68233641306884,3.68233641306884,5.14191421856586,5.16581371220055,5.11801472493116,43.8057449633489,-0.0407531684690257,1.00183937245361,0.737251710052279,0.883702719122835,"P78527",0,"DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1) (DNPK1) (p460)","activation of innate immune response [GO:0002218]; B cell lineage commitment [GO:0002326]; brain development [GO:0007420]; cellular response to insulin stimulus [GO:0032869]; DNA damage response [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via nonhomologous end joining [GO:0006303]; ectopic germ cell programmed cell death [GO:0035234]; heart development [GO:0007507]; immature B cell differentiation [GO:0002327]; immunoglobulin V(D)J recombination [GO:0033152]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maturation of 5.8S rRNA [GO:0000460]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of platelet formation [GO:1905221]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; pro-B cell differentiation [GO:0002328]; protein destabilization [GO:0031648]; protein modification process [GO:0036211]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of epithelial cell proliferation [GO:0050678]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of smooth muscle cell proliferation [GO:0048660]; response to gamma radiation [GO:0010332]; rhythmic process [GO:0048511]; small-subunit processome assembly [GO:0034462]; somitogenesis [GO:0001756]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; T cell receptor V(D)J recombination [GO:0033153]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]","GO:0000460; GO:0000723; GO:0000781; GO:0000785; GO:0001756; GO:0001933; GO:0002218; GO:0002326; GO:0002327; GO:0002328; GO:0002360; GO:0003690; GO:0003723; GO:0004672; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0005958; GO:0006302; GO:0006303; GO:0006468; GO:0006974; GO:0007420; GO:0007507; GO:0008630; GO:0010332; GO:0016020; GO:0016233; GO:0018105; GO:0018107; GO:0019899; GO:0019904; GO:0031571; GO:0031648; GO:0032040; GO:0032869; GO:0032991; GO:0032993; GO:0033077; GO:0033152; GO:0033153; GO:0034462; GO:0034511; GO:0035234; GO:0035979; GO:0036211; GO:0042752; GO:0043065; GO:0043066; GO:0045087; GO:0045621; GO:0045648; GO:0045727; GO:0045944; GO:0048511; GO:0048660; GO:0050678; GO:0061629; GO:0070418; GO:0070419; GO:0097681; GO:0106310; GO:0160049; GO:1902036; GO:1905221; GO:2001034"
"2393","Pocillopora_acuta_HIv2___RNAseq.g1461.t1",6.57370517928287,3.27552986512524,3.21931589537223,7.04225352112676,4.13223140495868,1.230012300123,0.964630225080386,8.10055865921788,6.90737833594976,13.1642512077295,5.46098665939663,5.31114653630853,5.61082678248473,NA,NA,NA,NA,NA,NA,10.7193281781627,11.5757923353694,11.239160163176,7.32395877248941,10.7156642802476,10.93296364491,11.8514845588041,10.021920373159,11.305878050426,10.5246114944297,10.6210761851174,10.8003902090343,10.4417621612005,1943.74249556751,-0.067200872700267,0.756138162687524,0.85594056885217,0.943208347843851,"Q8QGX4",0,"DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1)","double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; ribosome biogenesis [GO:0042254]; telomere maintenance [GO:0000723]","GO:0000723; GO:0000724; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006302; GO:0006303; GO:0008630; GO:0031571; GO:0033152; GO:0035979; GO:0042254; GO:0070419; GO:0106310"
"2394","Pocillopora_acuta_HIv2___TS.g26487.t2",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.50518110741391,11.4179606164221,10.9566714045332,11.5748285384346,10.5895524931289,10.0094539014286,10.6719598780735,8.2726471774265,10.8230477606387,12.9912050803129,10.6812507957813,10.0294199886282,11.3330816029343,2271.16341188827,0.945121175479158,0.763059332009743,0.0734229096405168,0.208314822487335,"O94812",3.97e-167,"BAI1-associated protein 3 (BAP3) (Brain-specific angiogenesis inhibitor I-associated protein 3)","dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of behavior [GO:0050795]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission, GABAergic [GO:0032228]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000149; GO:0001956; GO:0005509; GO:0005543; GO:0005829; GO:0005886; GO:0006887; GO:0007186; GO:0019905; GO:0031902; GO:0032228; GO:0032588; GO:0035774; GO:0042147; GO:0050795; GO:0055038; GO:0098793; GO:0098982; GO:0099503; GO:1905413; GO:1990502"
"2395","Pocillopora_acuta_HIv2___RNAseq.g1520.t1",0,0.943396226415094,NA,0,0,0,0,NA,6.66666666666667,NA,1.08715184186882,1.90251572327044,0,NA,NA,NA,NA,NA,NA,9.92126033057992,9.41710280084655,10.8006009319828,11.1088669396074,10.2468584784016,7.70516284103542,10.587588602048,10.0294994096863,8.10422827110476,3.68233641306884,9.16035050183616,9.82048948435108,8.50021151932124,969.960693615425,-0.421816386630602,0.921369523179848,0.276098639247581,0.520799519832684,"Q5R8W6",6.53e-109,"Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein)","mRNA splice site recognition [GO:0006376]; RNA splicing [GO:0008380]","GO:0003677; GO:0003729; GO:0005634; GO:0005685; GO:0006376; GO:0008380; GO:0016607"
"2396","Pocillopora_acuta_HIv2___RNAseq.g1540.t1",NA,100,100,NA,100,100,100,NA,100,NA,100,100,100,NA,NA,NA,NA,NA,NA,7.29555341930434,3.68233641306884,7.91083219305282,3.68233641306884,7.74842426135321,7.83233483651014,3.68233641306884,5.74496152652496,3.68233641306884,3.68233641306884,5.49437883020897,6.47642156266083,4.5123360977571,77.2252356632481,-0.355244469248254,1.08630965273577,0.00640168981623629,0.0287113306983075,NA,NA,NA,NA,NA
"2397","Pocillopora_acuta_HIv2___RNAseq.g1541.t1",0,0,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,4.79011450555827,7.04438020601615,5.13387918792038,7.02644217673873,5.84362177230977,5.75438588036295,3.68233641306884,5.09793447691117,3.68233641306884,3.68233641306884,5.17377674450239,4.90957727115369,5.4379762178511,31.4968523749022,0.121218071032785,0.964609933461094,0.615222538669278,0.811181659137588,"Q55E58",5.64e-18,"Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1)","cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856]","GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310"
"2398","Pocillopora_acuta_HIv2___RNAseq.g1567.t1",0,0,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.15333993344366,7.91408972240118,7.41336738893051,3.68233641306884,8.23338718506561,8.54222383928769,3.68233641306884,3.68233641306884,10.0210316407727,9.91731266292101,7.22417616120289,7.70069251225626,6.74765981014951,348.435402498641,-0.299729330451102,0.938978721876577,0.514226529174088,0.739561749823408,"B5X186",6.87e-52,"Calumenin-A","","GO:0005509; GO:0005576; GO:0005789; GO:0005794; GO:0033018; GO:0042470"
"2399","Pocillopora_acuta_HIv2___RNAseq.g1619.t1",NA,0,0,NA,60,28.5714285714286,0,NA,0,NA,14.7619047619048,9.52380952380952,20,NA,NA,NA,NA,NA,NA,10.9351338682154,3.68233641306884,11.1881113926371,7.94938886197888,10.6488952270285,12.27974316858,10.6958640377489,11.169141983778,3.68233641306884,3.68233641306884,8.59132877791733,9.52472377694557,7.65793377888909,1489.92940255454,-0.25024745478379,0.985222299505315,0.227219768191441,0.460424030137433,"B6CJY4",1.2e-81,"TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6)","DNA damage response [GO:0006974]; immune system process [GO:0002376]; intracellular signaling cassette [GO:0141124]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]","GO:0002376; GO:0004842; GO:0005164; GO:0005634; GO:0005811; GO:0005938; GO:0006974; GO:0008270; GO:0019899; GO:0042981; GO:0043123; GO:0051092; GO:0070534; GO:0141124"
"2400","Pocillopora_acuta_HIv2___TS.g26647.t2",75,100,50,100,60,90.2439024390244,73.3333333333333,NA,80,100,80.9530261969286,92.5609756097561,71.6666666666667,1,-87.3511904761905,-87.3511904761905,0.000730923566980346,0.000730923566980346,0.000730923566980346,8.35018855407922,6.4545116118486,8.20491904625634,7.96266298558189,6.45833723334534,8.67126450028949,6.86956709787897,7.56273982243945,7.5245035367715,3.68233641306884,7.17410308015596,7.62013763857837,6.72806852173356,172.226346419099,-0.335525537381987,0.922180128047835,0.357668638412649,0.608053500940356,"B6CJY5",4.17e-54,"TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6)","DNA damage response [GO:0006974]; innate immune response [GO:0045087]; intracellular signaling cassette [GO:0141124]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005938; GO:0006974; GO:0008270; GO:0019899; GO:0031663; GO:0033209; GO:0042981; GO:0043122; GO:0043123; GO:0045087; GO:0051092; GO:0061630; GO:0070534; GO:0141124"
"2401","Pocillopora_acuta_HIv2___RNAseq.g1625.t1",0,0,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.169479102916,10.8214295674031,10.5517241815082,10.1859247070722,9.50904034244741,10.8638362171814,12.1262136806555,9.52481946354506,9.81514543399305,11.7328848539909,10.6300497550713,10.1140417048819,11.1460578052606,1862.70233414263,0.678720365244127,0.730535523151179,0.177788304810585,0.391107230536928,"Q9D1D1",3.4e-43,"Tetraspanin-11 (Tspan-11)","","GO:0005886"
"2402","Pocillopora_acuta_HIv2___RNAseq.g1629.t1b",0,0,0,0,0,NA,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0506517870049,11.1442144940706,11.4425093299659,11.9953176728499,9.97797784290129,9.44689043769908,3.68233641306884,11.5327708943752,11.3939379628802,11.9968970451839,10.266350388,10.8795695634255,9.65313121257446,2140.70541068456,-0.0784214364815288,0.878488730365615,0.823142115867032,0.927639649838054,"P48509",1.85e-52,"CD151 antigen (GP27) (Membrane glycoprotein SFA-1) (Platelet-endothelial tetraspan antigen 3) (PETA-3) (Tetraspanin-24) (Tspan-24) (CD antigen CD151)","cell adhesion [GO:0007155]; cell migration [GO:0016477]; positive regulation of cell migration [GO:0030335]; positive regulation of endocytosis [GO:0045807]; T cell proliferation [GO:0042098]; wound healing, spreading of cells [GO:0044319]","GO:0005178; GO:0005604; GO:0005829; GO:0005886; GO:0005925; GO:0007155; GO:0009986; GO:0016020; GO:0016477; GO:0030335; GO:0042098; GO:0044319; GO:0045807"
"2403","Pocillopora_acuta_HIv2___RNAseq.g1639.t1",0,NA,NA,30,NA,0,0,33.3333333333333,16.6666666666667,42.8571428571429,17.5510204081633,20,14.2857142857143,NA,NA,NA,NA,NA,NA,9.06565269531896,3.68233641306884,9.58010170961061,7.45223252512044,9.86484288334115,3.68233641306884,10.9689177842954,9.10274947104266,3.68233641306884,3.68233641306884,7.07638427210046,8.25913663447644,5.89363190972447,481.0914473593,-0.219603937402752,1.01786134555249,0.172013419251455,0.381712503229985,"M0R2J8",0,"Doublecortin domain-containing protein 1 (Doublecortin domain-containing 5 protein)","cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; regulation of mitotic cytokinesis [GO:1902412]","GO:0005737; GO:0005874; GO:0008017; GO:0030246; GO:0030496; GO:0035556; GO:0051301; GO:0072686; GO:0090543; GO:1902412"
"2404","Pocillopora_acuta_HIv2___RNAseq.g1646.t1c",NA,0,0,0,0,0,14.2857142857143,NA,NA,NA,2.38095238095238,0,4.76190476190476,NA,NA,NA,NA,NA,NA,11.3025543993916,10.5937798567736,12.4435871407184,11.4381565548564,12.2529396073342,11.3604331035493,10.0648046717744,11.9167383113857,9.27708270669759,10.1972310919072,11.0847307444388,11.4385804331055,10.7308810557722,2640.2676662569,-0.49935200660486,0.630972071044895,0.296681179864328,0.544233336919957,"Q62448",0,"Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (Novel APOBEC-1 target 1) (Translation repressor NAT1) (p97)","positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]","GO:0003729; GO:0003743; GO:0005737; GO:0006413; GO:0006446; GO:0008135; GO:0014069; GO:0016281; GO:0030424; GO:0045727; GO:0045773; GO:0060999"
"2405","Pocillopora_acuta_HIv2___RNAseq.g1648.t1",0,NA,0,0,0,0,0.549450549450549,NA,0,0,0.0686813186813187,0,0.10989010989011,NA,NA,NA,NA,NA,NA,7.71669636299929,6.39972611558308,7.72999801151893,6.93438880964508,8.68569050529328,7.14192723638692,7.18545318045339,9.88658157197762,8.45509888891413,3.68233641306884,7.38178970958406,8.49481306814065,6.26876635102746,240.260913294207,-1.25625680065082,1.28530533195226,0.0317590839055647,0.108442726536848,"Q3ZCC3",6.91e-119,"TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6)","DNA damage response [GO:0006974]; innate immune response [GO:0045087]; intracellular signaling cassette [GO:0141124]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005938; GO:0006974; GO:0008270; GO:0031663; GO:0033209; GO:0042981; GO:0043122; GO:0043123; GO:0045087; GO:0051092; GO:0061630; GO:0070534; GO:0141124"
"2406","Pocillopora_acuta_HIv2___RNAseq.g1669.t1b",0,NA,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.2140553331679,11.2426193162773,9.83164209005519,9.08076436963003,8.82411742802113,8.15317761141947,11.0068672475463,9.09955135998982,8.8422311864709,12.3331847636542,9.86282107062322,9.36231947954099,10.3633226617055,1377.25190238645,0.525004445326683,0.787913196372118,0.274876318437386,0.519578027950648,"E7F211",2.58e-51,"Tetratricopeptide repeat protein 17 (TPR repeat protein 17)","actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371]","GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0061371"
"2407","Pocillopora_acuta_HIv2___RNAseq.g1680.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.9020590034213,8.99121360085343,6.3914623546344,3.68233641306884,8.41734527221147,3.68233641306884,11.7660013605442,7.77876790621937,5.49910115103059,10.0167786136869,7.51274020887393,7.39774713750343,7.62773328024444,599.896154210263,0.0226996379608203,0.980909622138196,0.900008044175268,0.962066096441584,"Q7T0L6",1.43e-132,"Cyclin-F","cell division [GO:0051301]; negative regulation of centrosome duplication [GO:0010826]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]","GO:0005634; GO:0005814; GO:0010826; GO:0016567; GO:0019005; GO:0031146; GO:0048471; GO:0051301"
"2408","Pocillopora_acuta_HIv2___RNAseq.g1686.t1",NA,0,0,NA,0,0,0,NA,6.25,NA,1.04166666666667,2.08333333333333,0,NA,NA,NA,NA,NA,NA,9.61977053306396,9.38986635288762,9.79466418093227,3.68233641306884,7.90740821600663,6.57554848939467,7.76018667076906,5.40874075538327,10.8789736958906,3.68233641306884,7.46998317204658,8.72191147625535,6.21805486783781,462.608501224375,-0.272570713319134,1.00513227105991,0.16260040387799,0.367522652912422,"P46023",2.8e-128,"G-protein coupled receptor GRL101","","GO:0004930; GO:0005886"
"2409","Pocillopora_acuta_HIv2___TS.g26728.t1",0,19.2307692307692,33.3333333333333,5,33.3333333333333,8,28.5714285714286,NA,NA,NA,18.2098377812664,10.7435897435897,23.8095238095238,NA,NA,NA,NA,NA,NA,7.71669636299929,8.14383581458983,8.34040438161525,10.3179913590815,8.67770685112676,9.16093199677254,6.3073577041051,8.33387141872831,9.07059305352717,9.18173698617498,8.52511259287207,8.42785441359936,8.62237077214479,434.513530168023,0.120887264448428,0.689404996326768,0.796662097037275,0.914249975030311,"Q4V842",3.24e-33,"G patch domain-containing protein 4","","GO:0003676"
"2410","Pocillopora_acuta_HIv2___TS.g26746.t1",0,NA,NA,0,0,15.3846153846154,0,0,NA,NA,2.56410256410256,5.12820512820513,0,NA,NA,NA,NA,NA,NA,7.98231336343907,6.5579743664166,6.03454572419577,7.17153073399211,5.46172465639773,5.91655634503021,6.54983813759369,5.77922341645693,4.4808124149756,6.3122422615894,6.22467614200871,5.94772391509302,6.5016283689244,68.1673269831663,0.535505313988246,0.828761287498965,0.26806017219478,0.511641901639653,"Q8N961",0,"Ankyrin repeat and BTB/POZ domain-containing protein 2","cellular response to toxic substance [GO:0097237]","GO:0046982; GO:0097237"
"2411","Pocillopora_acuta_HIv2___RNAseq.g1726.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.0578429759644,6.85609801113518,9.73042482818803,8.87896121308284,8.92533915550581,11.5588417149261,3.68233641306884,7.90535406062338,3.68233641306884,3.68233641306884,7.49598711986323,8.06025948667009,6.93171475305636,606.828323491101,-0.286973416046946,1.0045238794277,0.370735056281991,0.620278988324202,"A5PMU4",8.73e-79,"Ankyrin repeat and sterile alpha motif domain-containing protein 1B","ephrin receptor signaling pathway [GO:0048013]","GO:0005829; GO:0046875; GO:0048013"
"2412","Pocillopora_acuta_HIv2___RNAseq.g1727.t1",0,0,NA,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.21067749582655,7.42370247120592,6.90070763340096,7.32395877248941,3.68233641306884,6.6664531765618,3.68233641306884,6.53361170979195,10.093410055657,3.68233641306884,6.41995305541401,7.08414866154906,5.75575744927896,186.212034294587,-0.127595270751006,0.987849017691125,0.399839920625708,0.646104861125041,"Q61241",3.3e-82,"Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) (Serine/threonine-protein kinase 22A)","peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]","GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0006468; GO:0007283; GO:0007286; GO:0018105; GO:0031514; GO:0044877; GO:0106310"
"2413","Pocillopora_acuta_HIv2___RNAseq.g1728.t1",0,NA,50,57.1428571428571,60,58.3333333333333,53.3333333333333,NA,53.3333333333333,NA,47.4489795918367,56.2698412698413,40.8333333333333,NA,NA,NA,NA,NA,NA,10.2667233626413,11.5888212494411,8.82549664626014,10.8776894408289,10.9982110731863,12.0140978152667,11.0718810946709,10.5545084233844,10.4176828077159,10.7642569438423,10.7379368857238,10.2125244626376,11.26334930881,1933.70960581424,0.823074026143033,0.601841578171511,0.0909096197738204,0.243638454772751,"Q6XLQ7",7.88e-119,"Calumenin","","GO:0005509; GO:0005576; GO:0005789; GO:0005794; GO:0033018; GO:0042470"
"2414","Pocillopora_acuta_HIv2___RNAseq.g1734.t1",0,NA,NA,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,8.05398145875441,6.78724783184476,7.68668641750811,7.40935653522263,3.68233641306884,3.68233641306884,10.9869655504758,3.68233641306884,3.68233641306884,5.93359198591499,6.50964854873617,5.35753542309381,265.739674943297,-0.06949496888458,1.00862672095371,0.102077988875169,0.265549645879577,"D3YXG0",4.93e-73,"Hemicentin-1 (Fibulin-6) (FIBL-6)","actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]","GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711"
"2415","Pocillopora_acuta_HIv2___RNAseq.g1751.t2",NA,NA,0,0,NA,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,9.10554204314331,6.50720798490726,7.60831156614904,10.6602928241999,7.53892828027555,11.3981733189111,6.79979156785643,9.33122320578472,9.267667622457,9.89756355121408,8.81147019648984,8.57033454356192,9.05260584941775,741.535512962736,0.121522208117503,0.881870120176311,0.685767950042462,0.854768236273754,NA,NA,NA,NA,NA
"2416","Pocillopora_acuta_HIv2___RNAseq.g1753.t1",4.42796133962688,1.7570281124498,1.11843991970175,1.91256830601093,0.534045393858478,0.599907706506691,2.32495991448423,2.67290344136318,2.50044650830505,7.96334678738955,2.58116074296965,1.88857081492713,3.27375067101218,NA,NA,NA,NA,NA,NA,10.6264628100694,10.4072149210408,10.1673787442349,11.4142647033032,9.37976500392886,9.70210528341736,9.45853039827569,9.72585477575089,9.71307871410632,10.7966023051877,10.1391257659315,9.92250800961807,10.3557435222449,1223.02849625253,0.31966627998539,0.561455344335701,0.490121631477718,0.722471538624886,"Q86TZ1",1.17e-117,"Tetratricopeptide repeat protein 6 (TPR repeat protein 6)","",""
"2417","Pocillopora_acuta_HIv2___RNAseq.g1757.t1",2.68456375838926,12.1437422552664,8.60215053763441,6.97424892703863,3.125,7.83625730994152,7.20720720720721,15.359477124183,3.14569536423841,0,6.70783424838989,9.0918841961336,4.32378430064618,NA,NA,NA,NA,NA,NA,9.23176251403244,9.76853701675341,7.96350447387603,11.4033829108036,8.29735723054694,10.7968911931407,10.0411113149488,9.16066928766405,3.68233641306884,10.2212612911686,9.05668136460034,7.66712598383766,10.446236745363,911.6334051936,0.997852727669309,1.30487951397262,0.0407734174565424,0.132825835606178,NA,NA,NA,NA,NA
"2418","Pocillopora_acuta_HIv2___RNAseq.g1763.t1",NA,NA,2.85714285714286,0,0,0,0,NA,0,0,0.408163265306122,0,0.714285714285714,NA,NA,NA,NA,NA,NA,7.09414687449084,10.8706805210469,7.91083219305282,11.1066324026749,5.88788892518078,11.0754672025779,10.0185396303794,9.50199462372655,3.68233641306884,7.88832156922198,8.50368403554209,6.81543980590397,10.1919282651802,844.616833144935,3.18395297700602,1.7839837326284,0.000217454582425262,0.00160390774104997,"Q4LAL6",3.91e-36,"Homeobox protein aristaless-like 4","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0001228; GO:0005634; GO:0006357"
"2419","Pocillopora_acuta_HIv2___RNAseq.g1774.t1",0,0,80,20.9302325581395,13.3333333333333,7.84313725490196,30.3571428571429,0,0,NA,16.9404273337242,5.7546739626083,30.922619047619,NA,NA,NA,NA,NA,NA,7.99738846276564,6.4723009311231,9.28728251883396,8.93716523131706,7.90055154479321,10.1762417979196,10.0063553825055,9.16066928766405,8.98411700666786,6.9219028403352,8.58439750039252,8.66600176414494,8.50279323664009,483.31164242517,-0.128963818598797,0.740811614382329,0.754381375641216,0.89218088448688,"Q8IV04",1.87e-22,"Carabin (TBC1 domain family member 10C)","B cell activation [GO:0042113]; calcineurin-NFAT signaling cascade [GO:0033173]; ERK1 and ERK2 cascade [GO:0070371]; negative regulation of B cell activation [GO:0050869]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0005096; GO:0005829; GO:0005886; GO:0016020; GO:0031527; GO:0033173; GO:0042113; GO:0042147; GO:0050869; GO:0070371; GO:0070373; GO:0070885; GO:0101003"
"2420","Pocillopora_acuta_HIv2___RNAseq.g1775.t1",0,NA,0,0,NA,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,9.86223955743978,10.9597863298555,11.019009503224,11.8691813796174,10.1435026277827,11.746094868453,11.5112939369313,10.3531503142861,9.20245459351382,11.0298964102123,10.7696609521316,10.1160713192493,11.4232505850139,1995.60873695021,1.11051444788303,0.562641862854016,0.0199784720876241,0.0741513992130007,"Q8K561",1.11e-09,"Otoancorin","cell-matrix adhesion [GO:0007160]; multicellular organism growth [GO:0035264]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]","GO:0005576; GO:0007160; GO:0007605; GO:0009986; GO:0016324; GO:0019226; GO:0035264; GO:0098552"
"2421","Pocillopora_acuta_HIv2___RNAseq.g1780.t1",0.4739336492891,0,0,0.454545454545455,2.4390243902439,0.4739336492891,0,0,13.9784946236559,11.1111111111111,2.89310428781346,2.98139474549809,2.80481383012882,NA,NA,NA,NA,NA,NA,7.60285280872257,6.84260510118125,9.54605220525752,8.02725225421589,9.6765294553497,7.71720190845086,5.66606675070968,8.48380065119793,5.63170286483936,7.34586633953267,7.65399303394574,8.18818759707342,7.11979847081807,272.280240908448,-0.664626864536351,0.885295966201351,0.167056757753303,0.374447380155552,"U3JAG9",2.59e-151,"Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1)","cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; negative regulation of intracellular protein transport [GO:0090317]; regulation of centrosome duplication [GO:0010824]; sensory perception of light stimulus [GO:0050953]","GO:0000775; GO:0001669; GO:0005576; GO:0005929; GO:0010824; GO:0030154; GO:0032402; GO:0034451; GO:0035721; GO:0035735; GO:0050953; GO:0060271; GO:0060287; GO:0070121; GO:0090317"
"2422","Pocillopora_acuta_HIv2___RNAseq.g1781.t1",0,0,0,0,0,0,0.833333333333333,0,0,NA,0.0925925925925926,0,0.208333333333333,NA,NA,NA,NA,NA,NA,3.68233641306884,6.15566643149668,5.26676479605173,5.7042294826067,3.68233641306884,3.68233641306884,3.68233641306884,6.4540987163944,3.68233641306884,7.51177934837273,4.95042208402664,4.55357455033053,5.34726961772276,31.6264527311298,0.0869624776945082,1.00860917253511,0.416800543645657,0.661289839032364,"Q5M7F8",8.6e-28,"Ciliary microtubule inner protein 2C","","GO:0005879"
"2423","Pocillopora_acuta_HIv2___TS.g26808.t1b",1.7632241813602,0,0,0,1.11731843575419,0.934142923867352,1.92513368983957,0,2.88065843621399,0,0.862047766703531,0.762960272016269,0.961135261390793,NA,NA,NA,NA,NA,NA,7.7993788153644,9.17797968831809,3.68233641306884,6.86475539414292,7.91763216015926,7.60502134296842,3.68233641306884,3.68233641306884,3.68233641306884,7.72930987565577,6.18234229288842,5.35280404294604,7.01188054283081,141.791048755362,0.385143185762255,1.05700225861104,0.110505579443332,0.281251575060419,"Q90W04",5e-13,"Neuroglobin (Nitrite reductase) (EC 1.7.-.-)","cellular response to hypoxia [GO:0071456]","GO:0005092; GO:0005759; GO:0005829; GO:0019825; GO:0020037; GO:0046872; GO:0071456; GO:0098809"
"2424","Pocillopora_acuta_HIv2___TS.g26808.t1a",0,0,2.36686390532544,0,0,0.740740740740741,0.74487895716946,0,0.253164556962025,0,0.410564816019767,0.198781059540553,0.622348572498981,NA,NA,NA,NA,NA,NA,8.89135824262272,7.92681031311096,8.80163177442047,9.88405858895679,8.80592318904832,3.68233641306884,10.1378300103836,9.15913410823482,9.4410100037472,9.0626023853959,8.57926950289896,9.01981146361471,8.13872754218322,525.687621723794,-0.163661694766108,0.874143899199724,0.647811064362686,0.832069908084707,"Q07157",1.37e-13,"Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1)","actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; ameloblast differentiation [GO:0036305]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493]","GO:0002102; GO:0005516; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005921; GO:0005923; GO:0007043; GO:0008284; GO:0016323; GO:0030036; GO:0030054; GO:0030335; GO:0031032; GO:0032991; GO:0034334; GO:0035633; GO:0036305; GO:0042995; GO:0043066; GO:0043296; GO:0045177; GO:0045216; GO:0045296; GO:0050839; GO:0051493; GO:0051497; GO:0070160; GO:0071896; GO:0090557; GO:0098609; GO:0150105; GO:1901888; GO:1902396; GO:1903672; GO:1905605; GO:2000049; GO:2000810"
"2425","Pocillopora_acuta_HIv2___RNAseq.g1784.t1",0.682205798749289,1.21317157712305,0.822122571001495,0.556117290192113,0.261096605744125,0.601633003867641,0.912964090079124,0.0722021660649819,1.04166666666667,0,0.616317976948849,0.696958140782891,0.535677813114807,NA,NA,NA,NA,NA,NA,6.25760738373578,3.68233641306884,3.68233641306884,7.23886682728914,4.99332554465423,6.85441933218098,3.68233641306884,9.24557709905535,7.39144121826992,3.68233641306884,5.67105830574608,6.31405753175682,5.02805907973533,100.707670736549,-0.123608069556405,1.02291773999694,0.00198812290353047,0.0106083938109282,"Q07157",2.2e-10,"Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1)","actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; ameloblast differentiation [GO:0036305]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493]","GO:0002102; GO:0005516; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005921; GO:0005923; GO:0007043; GO:0008284; GO:0016323; GO:0030036; GO:0030054; GO:0030335; GO:0031032; GO:0032991; GO:0034334; GO:0035633; GO:0036305; GO:0042995; GO:0043066; GO:0043296; GO:0045177; GO:0045216; GO:0045296; GO:0050839; GO:0051493; GO:0051497; GO:0070160; GO:0071896; GO:0090557; GO:0098609; GO:0150105; GO:1901888; GO:1902396; GO:1903672; GO:1905605; GO:2000049; GO:2000810"
"2426","Pocillopora_acuta_HIv2___TS.g26810.t1",53.0655391120507,48.792270531401,35.3571428571429,37.0629370629371,32.0695102685624,37.0174510840825,32.363315696649,22.7272727272727,33.6507936507937,56.25,38.8356232990892,35.8501450112974,41.821101586881,NA,NA,NA,NA,NA,NA,11.2791609499472,12.1250770934499,12.4151891854586,12.6129895504139,10.9543166574009,13.0843063656796,12.9723723241222,11.7376198814498,11.5221542140454,12.9480622707619,12.1651248492729,11.5816881776604,12.7485615208855,5138.63644902218,0.915960428114925,0.611752123359243,0.0631631830126675,0.186488596825067,"Q8K561",1.04e-08,"Otoancorin","cell-matrix adhesion [GO:0007160]; multicellular organism growth [GO:0035264]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]","GO:0005576; GO:0007160; GO:0007605; GO:0009986; GO:0016324; GO:0019226; GO:0035264; GO:0098552"
"2427","Pocillopora_acuta_HIv2___TS.g26815.t1",0,0,0,0,2.76497695852535,0.319488817891374,0.938967136150235,0,0,NA,0.447048101396328,0.0638977635782748,0.925986023668895,NA,NA,NA,NA,NA,NA,7.16748500850389,9.38986635288762,10.5538670842101,10.1180228085228,9.88230256942176,10.0228054211989,3.68233641306884,9.03906894208084,9.08138254696364,11.28296915872,9.02201063055784,9.14482123023605,8.89920003087963,874.439454866878,0.0566607827178065,0.888264806621192,0.876487736720978,0.952449446079971,"U3JAG9",0,"Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1)","cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; negative regulation of intracellular protein transport [GO:0090317]; regulation of centrosome duplication [GO:0010824]; sensory perception of light stimulus [GO:0050953]","GO:0000775; GO:0001669; GO:0005576; GO:0005929; GO:0010824; GO:0030154; GO:0032402; GO:0034451; GO:0035721; GO:0035735; GO:0050953; GO:0060271; GO:0060287; GO:0070121; GO:0090317"
"2428","Pocillopora_acuta_HIv2___RNAseq.g1791.t2",0,0,0,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,13.6689930770191,13.8329447217074,14.3199145735668,13.4394276385866,13.5792737778209,13.9119547941915,13.0619115067908,13.6269238641774,13.6393079835544,14.1399482515654,13.722060018898,13.7668826552277,13.6772373825683,13858.9410335023,-0.0557267000928358,0.527174880221462,0.885051351536419,0.955539567782169,"Q9P281",1.07e-42,"BAH and coiled-coil domain-containing protein 1 (Bromo adjacent homology domain-containing protein 2) (BAH domain-containing protein 2)","","GO:0003682"
"2429","Pocillopora_acuta_HIv2___RNAseq.g1801.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,6.77312724931675,6.44283750088468,9.94536950315196,6.15032817604227,3.68233641306884,3.68233641306884,6.09342916571462,3.68233641306884,3.68233641306884,5.38167736604545,5.21025353375585,5.55310119833505,120.15509755242,-0.00640626293922259,1.01246322705728,0.936398719687549,0.976536811102885,"F6QEU4",1.1e-51,"E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177"
"2430","Pocillopora_acuta_HIv2___TS.g26828.t2",0,0,0,4.34782608695652,0,0,0,12.9032258064516,NA,NA,2.15638148667602,4.31276297335203,0,NA,NA,NA,NA,NA,NA,7.87755006797665,7.82173911168432,5.9646645801927,10.6367398678305,6.13835848329068,3.68233641306884,3.68233641306884,7.94160713666065,3.68233641306884,3.68233641306884,6.11100048999109,6.3209033362379,5.90109764374427,228.540583483828,-0.133745798880647,1.00446520285207,0.513037182307824,0.738717972435119,"E7FAM5",4.44e-47,"E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0061630; GO:0072089; GO:2000177"
"2431","Pocillopora_acuta_HIv2___RNAseq.g1818.t1",46.6666666666667,NA,66.6666666666667,40,64.5833333333333,73.4939759036145,65.7142857142857,27.2727272727273,83.3333333333333,NA,58.4663736113284,56.0250091274188,60.9077380952381,NA,NA,NA,NA,NA,NA,9.09392406096189,8.72299482239946,10.2656602507442,3.68233641306884,10.2141422416954,3.68233641306884,3.68233641306884,9.78576091196377,12.148344885852,3.68233641306884,7.49601728258921,10.3015664702435,4.69046809493496,865.729646052584,-0.942722665312723,1.74714351092182,1.09411161901489e-11,9.47618590265353e-10,"G3MWR8",1.29e-17,"[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3)","actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]","GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0071949; GO:0120501"
"2432","Pocillopora_acuta_HIv2___TS.g26843.t2",5.68720379146919,7.14285714285714,0,6.5015479876161,5.37634408602151,1.69133192389006,10.1083032490975,5.88235294117647,2.39520958083832,50,9.47851507029663,4.72265991527562,14.2343702253176,NA,NA,NA,NA,NA,NA,9.68315353364293,8.22839989032863,7.3083152768306,3.68233641306884,9.48638159423404,3.68233641306884,10.1654876310695,8.04850220834679,3.68233641306884,10.6713754009125,7.46386247745715,7.64173780522464,7.28598714968966,486.495934338675,-0.0657268908112378,0.993454486443197,0.427540718148835,0.672022272039204,"G3V8Y7",2.29e-24,"AP-4 complex accessory subunit Tepsin (ENTH domain-containing protein 2) (Tetra-epsin)","","GO:0005737; GO:0005829; GO:0030662; GO:0031090; GO:0031312; GO:0032588; GO:0044877"
"2433","Pocillopora_acuta_HIv2___RNAseq.g1823.t1",2.22222222222222,0,16.3265306122449,0,2.04081632653061,0.762527233115468,1.97368421052632,0,0,0,2.33257806046395,0.152505446623094,4.51265067430481,NA,NA,NA,NA,NA,NA,11.2327935086068,3.68233641306884,10.0087371708015,10.0941581596419,9.53134849743097,3.68233641306884,3.68233641306884,10.2552806280766,3.68233641306884,3.68233641306884,6.9534000029902,8.94209924359694,4.96470076238345,636.445721887048,-0.315377483044914,1.07076212798362,3.06182308355468e-05,0.000300042066941294,"A7M7B9",1.86e-109,"Endonuclease III-like protein 1 (EC 3.2.2.-) (EC 4.2.99.18) (Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase) (DNA glycosylase/AP lyase)","base-excision repair, AP site formation [GO:0006285]; nucleotide-excision repair [GO:0006289]","GO:0000703; GO:0003677; GO:0003906; GO:0005634; GO:0005739; GO:0006285; GO:0006289; GO:0046872; GO:0051539; GO:0140078"
"2434","Pocillopora_acuta_HIv2___RNAseq.g1828.t1",0,0,0,0,NA,4.25531914893617,0,0,NA,NA,0.60790273556231,1.06382978723404,0,NA,NA,NA,NA,NA,NA,9.42771877417721,9.98265528542106,8.9260446834313,9.25236489737546,10.340145715209,10.5367139080801,4.27277361158612,7.26282800372101,10.4993630394419,9.31801596440613,8.98186238828493,9.29122004319608,8.67250473337377,759.164414432345,-0.310271024311541,0.795738575921064,0.474772505064639,0.711107061846971,NA,NA,NA,NA,NA
"2435","Pocillopora_acuta_HIv2___RNAseq.g1833.t1",0.434027777777778,0.150829562594268,0,1.8,0.175284837861525,0.96064456151224,0.232558139534884,0.401606425702811,1.4336917562724,NA,0.620960340139545,0.949354461216344,0.210467688793547,NA,NA,NA,NA,NA,NA,3.68233641306884,8.17080052642909,5.46801386253237,3.68233641306884,5.26345523824995,3.68233641306884,4.60654391542428,7.50564875204671,7.01438483963671,3.68233641306884,5.27581927865945,5.78676782110692,4.76487073621198,56.9700743348752,-0.359493725964618,1.10973729946012,0.00431652465357478,0.0205443279333023,"Q29RY7",1.26e-21,"Fibroleukin (Fibrinogen-like protein 2)","","GO:0005615; GO:0009986; GO:0016504; GO:0062023"
"2436","Pocillopora_acuta_HIv2___RNAseq.g1863.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.1936168187621,7.94568219541168,11.6004609934389,10.1887444321077,11.4522472419312,9.66232603325918,6.61664389412953,10.4416469626207,11.2920188147424,5.43369409583605,9.58270814822394,11.1959981662991,7.96941813014883,1426.30050883794,-2.67368319645582,1.19901528208143,0.00035648075968595,0.00245063579282204,"Q8TD57",0,"Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b)","cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]","GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729"
"2437","Pocillopora_acuta_HIv2___RNAseq.g1893.t1a",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.94132135187028,8.21809751775082,3.68233641306884,8.5286569909559,6.97019840607377,7.24570716972782,3.68233641306884,9.78077953154168,5.96263381334191,3.68233641306884,6.56944040204687,6.8674539031793,6.27142690091444,195.920686347282,-0.0926945643488549,0.983101027134389,0.582877579039089,0.790283211775532,"Q9Z2L6",2.91e-45,"Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80)","intracellular monoatomic cation homeostasis [GO:0030003]","GO:0003993; GO:0004446; GO:0005615; GO:0005788; GO:0005886; GO:0008707; GO:0016158; GO:0016312; GO:0030003; GO:0030351; GO:0030352; GO:0034417; GO:0046030; GO:0052745; GO:0052826; GO:0052827"
"2438","Pocillopora_acuta_HIv2___TS.g26917.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.25281011275677,6.89581790443942,8.04721098911907,3.68233641306884,8.6473675796025,9.1163185259133,3.68233641306884,7.74221169803492,9.79726582542259,3.68233641306884,7.05460118744951,8.69737324098717,5.41182913391185,287.770077050103,-0.715302256913459,1.33413662662195,2.26985017885407e-05,0.000230393775346984,"Q76KB1",2.36e-11,"Heparan sulfate 2-O-sulfotransferase 1 (cHS2ST) (EC 2.8.2.-)","gene expression [GO:0010467]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin metabolic process [GO:0030202]; ureteric bud formation [GO:0060676]","GO:0000139; GO:0004394; GO:0010467; GO:0015014; GO:0015015; GO:0030202; GO:0042802; GO:0060676"
"2439","Pocillopora_acuta_HIv2___RNAseq.g1898.t2b",NA,NA,6.66666666666667,0,15.3846153846154,100,100,NA,100,NA,53.6752136752137,66.6666666666667,40.6837606837607,NA,NA,NA,NA,NA,NA,9.84432909846235,11.5992593729479,11.0318778666251,11.1244125279783,10.7210104887679,10.9128969521062,11.7861825999674,10.2291908299867,11.405247620349,11.0001143500955,10.9654521707286,10.6463311808382,11.2845731606191,2120.05615473961,0.444164467154309,0.615237417540446,0.354744553539909,0.605798926729342,"Q96JM4",3.59e-81,"Leucine-rich repeat and IQ domain-containing protein 1","regulation of signal transduction [GO:0009966]","GO:0009966"
"2440","Pocillopora_acuta_HIv2___RNAseq.g1909.t1",NA,NA,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.38495933952552,9.06770233724501,5.75086179528365,7.48026504127711,9.3027420432975,3.68233641306884,3.68233641306884,9.31890245677726,3.68233641306884,3.68233641306884,6.40347786656814,7.28796040959055,5.51899532354573,222.475227032672,-0.134406421359863,1.00008498981709,0.56260409238029,0.774525454838707,"C5IAW9",1.42e-15,"Netrin receptor UNC5B-b (Protein unc-5 homolog-b) (Unc-5-like protein B)","","GO:0005042; GO:0005886"
"2441","Pocillopora_acuta_HIv2___TS.g26942.t1",NA,16.6666666666667,27.5,16.6666666666667,18.75,6.79611650485437,56.4516129032258,NA,NA,77.0833333333333,31.4163422963924,13.3764832793959,44.9462365591398,NA,NA,NA,NA,NA,NA,9.826193401567,10.9993573566866,9.74675493360531,3.68233641306884,9.38222197390182,9.99104577152443,3.68233641306884,9.08183374797619,9.19253747569013,3.68233641306884,7.9266953900158,9.44590830654809,6.40748247348351,644.768482616729,-0.336900629777312,1.05217917117377,1.36559618228907e-05,0.000149636236216887,"Q5MCW4",2.56e-73,"Zinc finger protein 569","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"2442","Pocillopora_acuta_HIv2___TS.g26959.t2",0,0,0,14.7058823529412,0,1.65289256198347,4.71698113207547,0,0,0,2.10757560470001,3.27175498298493,0.943396226415094,NA,NA,NA,NA,NA,NA,10.6957062575989,9.14305672267277,9.22944793143695,9.36637299559231,10.1898099526883,7.22046409497287,8.14151872004538,9.04573131574024,9.90288306818462,9.0626023853959,9.19975934443282,9.8127157051298,8.58680298373585,685.102543808353,-0.866691172982281,0.731700952525845,0.0930771303630431,0.248022773318175,NA,NA,NA,NA,NA
"2443","Pocillopora_acuta_HIv2___RNAseq.g1970.t1",5.12820512820513,NA,1.61290322580645,7.69230769230769,8.78048780487805,5.64971751412429,0,1.28205128205128,0,NA,3.76820908092161,3.65601912212082,3.88039903972241,NA,NA,NA,NA,NA,NA,9.20393294375456,11.080360867007,4.80540103069894,9.31566595437349,5.95850798619116,12.0984764129373,12.5721009963068,4.30559910501959,10.2061006721982,9.76214807201436,8.93082940405014,6.89590834757249,10.9657504605278,1578.77647794326,2.32367223889845,3.37454760403753,0.00010556985869587,0.000866607512018763,"B3EWY6",3.2e-87,"Skeletal aspartic acid-rich protein 1","","GO:0005576"
"2444","Pocillopora_acuta_HIv2___RNAseq.g1999.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,10.7312005690166,9.27693827115082,9.13442321085644,7.98722978398025,8.72872998755956,7.22836041943555,9.68164059001861,8.4129752332032,3.68233641306884,7.85461708913587,7.80822405828434,7.9010101199874,467.028899470455,-0.0666786747231397,0.956440114746465,0.749133604631181,0.889440481792665,NA,NA,NA,NA,NA
"2445","Pocillopora_acuta_HIv2___RNAseq.g2004.t1",NA,0,0,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.08935507469727,3.68233641306884,7.99757501876817,9.90478652318717,9.05422290374872,3.68233641306884,7.40687932379528,8.72714495410984,3.68233641306884,10.7072649876924,7.29342380252054,7.51012687287857,7.07672073216251,410.696488889096,-0.0819064866594275,0.995675667746992,0.433338985158559,0.677016102974011,"Q9CS74",4.73e-159,"Protein ecdysoneless homolog","fibroblast proliferation [GO:0048144]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; RNA splicing [GO:0008380]","GO:0005634; GO:0005654; GO:0005829; GO:0006397; GO:0008380; GO:0035035; GO:0045944; GO:0048144; GO:2000045"
"2446","Pocillopora_acuta_HIv2___RNAseq.g2049.t1",100,100,NA,NA,100,100,100,NA,100,NA,100,100,100,NA,NA,NA,NA,NA,NA,3.68233641306884,9.91103459004783,9.13714453657199,3.68233641306884,10.0053257361928,10.4287056781226,10.6853949764276,8.18472166631632,11.4620510398463,3.68233641306884,8.0861387462732,8.49431587839925,7.67796161414714,851.250086625498,0.00543025475842145,0.99045821054292,0.909811716606257,0.966332550227118,"Q9H633",2.78e-28,"Ribonuclease P protein subunit p21 (RNaseP protein p21) (Ribonuclease P/MRP 21 kDa subunit) (Ribonucleoprotein V)","response to xenobiotic stimulus [GO:0009410]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033]","GO:0001682; GO:0004526; GO:0005654; GO:0005655; GO:0008033; GO:0009410; GO:0030681; GO:0033204; GO:0046872"
"2447","Pocillopora_acuta_HIv2___RNAseq.g2053.t1",0,NA,0,0,0,0,NA,NA,16.6666666666667,NA,2.77777777777778,5.55555555555556,0,NA,NA,NA,NA,NA,NA,10.3095251371999,10.0667358836331,9.30266102387004,10.700360248812,9.91320702322601,9.92793098482302,11.5369287730628,10.4090936524543,10.8254552225744,9.26888949378225,10.2260787443438,10.1519884118649,10.3001690768226,1308.26638397136,0.112968430994468,0.632419954688674,0.824219175174406,0.928249330352925,"O75175",2.95e-102,"CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) (Leukocyte receptor cluster member 2)","nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829]","GO:0000289; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0006355; GO:0006417; GO:0030014; GO:0030015; GO:0031047; GO:0120162; GO:2000036"
"2448","Pocillopora_acuta_HIv2___TS.g27082.t3b",0,NA,NA,0,0,0,NA,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,10.2749746039914,5.35078960182194,10.6029851938311,9.00275967315473,9.94761557309954,8.37794169691685,10.6269136962099,11.2314320557529,10.5013720365485,3.68233641306884,8.95991205443957,10.5116758926447,7.40814821623445,987.793304964618,-1.00860516892049,1.35803765339886,0.0195794581530679,0.0730266329876157,"P02597",6.55e-25,"Calmodulin, striated muscle","","GO:0005509; GO:0005737"
"2449","Pocillopora_acuta_HIv2___TS.g27082.t3c",0.934579439252336,0,0,0,0,0.847457627118644,0,0,0,NA,0.198004118485664,0.169491525423729,0.233644859813084,NA,NA,NA,NA,NA,NA,8.50571125650928,3.68233641306884,8.46421758777071,9.16339242140137,6.50510887062065,6.43441652940609,3.68233641306884,7.49590776567488,5.26843329136292,3.68233641306884,6.28841969619524,7.24787575438769,5.3289636380028,151.679688596856,-0.473936432748662,1.1061433519609,0.0039939698809636,0.0192370230963229,"Q6GQV0",7.88e-07,"Tubulin epsilon and delta complex protein 2","positive regulation of smoothened signaling pathway [GO:0045880]","GO:0005737; GO:0005814; GO:0005929; GO:0045880"
"2450","Pocillopora_acuta_HIv2___RNAseq.g2074.t3",0,NA,NA,0,0,0,0,NA,33.3333333333333,NA,5.55555555555556,11.1111111111111,0,NA,NA,NA,NA,NA,NA,9.11936110784449,11.0120621087635,10.8012023613765,9.42973330435663,9.84449939482371,9.68540933104347,11.012969368275,8.96191444442486,6.73914848420464,5.00142931435546,9.16077292194683,9.09322515853484,9.22832068535881,929.357400541093,0.00272808854567057,0.758242489888276,0.978217832293127,0.992220049005353,"Q9Y383",1.86e-80,"Putative RNA-binding protein Luc7-like 2","mRNA splice site recognition [GO:0006376]","GO:0003723; GO:0003729; GO:0005685; GO:0006376; GO:0016607; GO:0019899; GO:0071004"
"2451","Pocillopora_acuta_HIv2___TS.g27112.t2",NA,NA,0,0,20,0,62.5,NA,0,NA,13.75,0,27.5,NA,NA,NA,NA,NA,NA,10.5722578076638,8.79054047643763,10.0788732474779,10.5852415234383,8.55667448650459,9.80685903911164,3.68233641306884,8.69993980176051,9.62919395023602,3.68233641306884,8.40842531587681,9.50738785872856,7.30946277302505,685.974308897141,-0.315606633206514,1.00227071332753,0.123094137541569,0.303811597388695,"A7SDW5",0,"Eukaryotic translation initiation factor 3 subunit L (eIF3l)","formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]","GO:0001732; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290"
"2452","Pocillopora_acuta_HIv2___TS.g27114.t1b",NA,NA,0,0,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,11.8607104805462,11.0180023186861,11.0471698948088,9.83270064455245,10.7748130492114,10.1163584722825,12.4957262451505,11.7463323827002,9.5976093415715,11.8028904474996,11.0292313277009,11.0053270297676,11.0531356256342,2498.56774815607,0.00550527050643435,0.66168123018027,0.991710997521288,0.996770366398326,"P16276",0,"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)","tricarboxylic acid cycle [GO:0006099]","GO:0003994; GO:0005739; GO:0005829; GO:0006099; GO:0046872; GO:0051539"
"2453","Pocillopora_acuta_HIv2___RNAseq.g2098.t1",NA,NA,NA,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,8.51620237562004,6.60695183817265,10.5147991615358,9.0438486539023,8.55012861972864,9.83190024357583,11.3603347042149,8.68933787992155,5.46360254994476,3.68233641306884,8.22594424396853,8.34681411735016,8.1050743705869,660.300829084625,-0.238683527804661,0.881411212623252,0.455006629681999,0.696130303757185,"Q8VHK2",3.84e-86,"Caskin-1 (CASK-interacting protein 1)","regulation of postsynaptic density assembly [GO:0099151]; signal transduction [GO:0007165]","GO:0005737; GO:0007165; GO:0019904; GO:0042802; GO:0098794; GO:0098978; GO:0099151"
"2454","Pocillopora_acuta_HIv2___RNAseq.g2105.t1",0,0,0,NA,0,0,NA,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.15852236535678,3.68233641306884,9.6064986712494,3.68233641306884,6.74915512039247,9.19779700333832,3.68233641306884,9.83079985253019,9.66010152373951,3.68233641306884,6.6932220188882,8.60101550665367,4.78542853112274,318.647140451017,-0.570371540969079,1.26378639316282,6.1084309282072e-09,1.8894149424544e-07,"D2XV59",0,"GTP-binding protein 1","cytoplasmic translation [GO:0002181]; GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414]","GO:0000049; GO:0000177; GO:0002181; GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0046039; GO:0061014; GO:1904678"
"2455","Pocillopora_acuta_HIv2___TS.g27138.t1",0.847457627118644,0,0,0,22.2929936305732,0.4739336492891,19.0839694656489,0,0,NA,4.74426159695887,0.0947867298578199,10.5561051808352,NA,NA,NA,NA,NA,NA,6.53584217462236,5.4315664930872,6.90070763340096,5.73735826925806,3.68233641306884,8.53206295779152,9.75466481053707,7.33026734222755,6.07918960036691,7.64859764944046,6.76325933438009,6.10566863273732,7.42085003602286,175.591876588973,0.313342300534308,0.963633633073753,0.33339879876789,0.583992736642476,"Q09575",3.54e-08,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0005737; GO:0008270; GO:0015074; GO:0019899; GO:0042575"
"2456","Pocillopora_acuta_HIv2___RNAseq.g2134.t1",30.7692307692308,NA,NA,NA,60,83.3333333333333,100,100,100,NA,79.017094017094,94.4444444444444,63.5897435897436,NA,NA,NA,NA,NA,NA,6.30806921954879,6.43649034287553,7.62478293516472,3.68233641306884,8.65552076666099,6.73992398508141,3.68233641306884,7.7380917079869,7.05913344033601,8.71290402167298,6.6639589245465,7.47711961393948,5.85079823515352,144.358099740064,-0.37653309261015,1.0292823681577,0.0894734378643495,0.240522940163445,"O43303",5.29e-15,"Centriolar coiled-coil protein of 110 kDa (Centrosomal protein of 110 kDa) (CP110) (Cep110)","centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; ciliary basal body organization [GO:0032053]; negative regulation of centriole elongation [GO:1903723]; negative regulation of cilium assembly [GO:1902018]; positive regulation of cilium assembly [GO:0045724]; regulation of cytokinesis [GO:0032465]","GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007099; GO:0032053; GO:0032465; GO:0032991; GO:0045724; GO:0051298; GO:1902018; GO:1903723"
"2457","Pocillopora_acuta_HIv2___RNAseq.g2146.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.87515657260048,11.1455717049017,10.3568520822044,10.198570284277,10.3651953462296,11.1815374415111,9.79063490060094,9.81041293133785,8.69891314311557,11.4447799557627,10.1867624362541,9.62130601509758,10.7522188574107,1359.46823152992,0.738311923240109,0.742204590313284,0.145462890825379,0.341443565871192,"P54644",9.89e-06,"RAC family serine/threonine-protein kinase homolog (EC 2.7.11.1)","bleb assembly [GO:0032060]; cellular response to diterpene [GO:1904630]; chemotaxis to cAMP [GO:0043327]; culmination involved in sorocarp development [GO:0031154]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled chemorepellent receptor signaling pathway [GO:0140986]; intracellular signal transduction [GO:0035556]; macropinocytosis [GO:0044351]; maintenance of cell polarity [GO:0030011]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; negative regulation of phagocytosis [GO:0050765]; negative regulation of Ras protein signal transduction [GO:0046580]; phagosome maturation [GO:0090382]; phosphatidylinositol-mediated signaling [GO:0048015]; polyphosphate-mediated signaling [GO:0110094]; positive regulation of macropinocytosis [GO:1905303]; pseudopodium assembly [GO:0031269]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; response to differentiation-inducing factor 1 [GO:1903013]; response to hydrogen peroxide [GO:0042542]","GO:0000281; GO:0004674; GO:0004691; GO:0005524; GO:0005547; GO:0005829; GO:0005886; GO:0005938; GO:0007163; GO:0019887; GO:0030010; GO:0030011; GO:0030295; GO:0030334; GO:0031005; GO:0031036; GO:0031154; GO:0031252; GO:0031267; GO:0031269; GO:0032060; GO:0035556; GO:0042542; GO:0043327; GO:0044351; GO:0046580; GO:0048015; GO:0050765; GO:0050920; GO:0090382; GO:0106310; GO:0110094; GO:0140986; GO:1903013; GO:1904630; GO:1905303"
"2458","Pocillopora_acuta_HIv2___RNAseq.g2174.t1",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.72441441264566,9.39672385697905,10.0917138156792,9.28436287468612,8.58256426650287,9.89662589457563,8.62912130682098,9.52243379378491,10.8751054348922,3.68233641306884,8.96854020696355,9.75924634470097,8.17783406922612,735.19397950187,-0.278146753389719,0.902052985155683,0.472892304262326,0.710014077672907,"Q8K4Q0",0,"Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein)","cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; DNA damage response [GO:0006974]; negative regulation of autophagy [GO:0010507]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of phosphorylation [GO:0042325]; regulation of protein phosphorylation [GO:0001932]; response to xenobiotic stimulus [GO:0009410]; social behavior [GO:0035176]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]","GO:0001558; GO:0001932; GO:0001938; GO:0005737; GO:0005764; GO:0006974; GO:0009267; GO:0009410; GO:0010494; GO:0010506; GO:0010507; GO:0019901; GO:0030307; GO:0030674; GO:0031267; GO:0031669; GO:0031929; GO:0031931; GO:0032008; GO:0035176; GO:0038202; GO:0042325; GO:0045672; GO:0045821; GO:0046676; GO:0046889; GO:0071230; GO:0071333; GO:0071456; GO:0071470; GO:0140767; GO:1901331; GO:1905857"
"2459","Pocillopora_acuta_HIv2___TS.g27196.t3",0,0,0,6.25,0,0,2.04081632653061,NA,0,NA,1.03635204081633,1.5625,0.510204081632653,NA,NA,NA,NA,NA,NA,10.625656536207,11.920690394344,11.7057120887723,10.9608606781467,8.84208470956863,8.28415117937733,7.27001054207962,9.44519029441824,9.16744197358883,12.1740481963177,10.039584659282,9.957217120511,10.1219521980531,1735.45279075612,0.0348212523112494,0.748029081278347,0.947238903219015,0.979700213448218,"Q6NYU2",1.05e-141,"Probable helicase with zinc finger domain (EC 3.6.4.-)","regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]","GO:0003677; GO:0003700; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005829; GO:0016787; GO:0035194; GO:0043186; GO:0046872"
"2460","Pocillopora_acuta_HIv2___RNAseq.g2190.t1",25,NA,NA,0,0,0,1.92307692307692,0,0,NA,3.84615384615385,0,8.97435897435897,NA,NA,NA,NA,NA,NA,4.95179328310793,3.68233641306884,3.68233641306884,6.87896002582645,5.23920445324911,3.68233641306884,7.27001054207962,6.7397479573644,3.68233641306884,3.68233641306884,4.94913983269717,4.85908370397182,5.03919596142252,33.2955708256497,-0.0379037245618438,0.998888734772246,0.745169194510105,0.887568137024691,"O50655",3.45e-08,"Integrase/recombinase xerD homolog","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; symbiont entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]","GO:0003677; GO:0006310; GO:0015074; GO:0044826; GO:0046718; GO:0075713"
"2461","Pocillopora_acuta_HIv2___RNAseq.g2202.t1",0,0,NA,NA,0,0,5.40540540540541,NA,0,NA,0.900900900900901,0,1.8018018018018,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,8.389293996423,3.68233641306884,5.57786625311306,9.31888614220762,3.68233641306884,6.01099506072748,8.47160899932647,3.68233641306884,5.61803325171418,6.42642014453177,4.8096463588966,132.002745555337,-0.210953475775264,1.04693968465514,0.00628048366782226,0.0282593403560867,NA,NA,NA,NA,NA
"2462","Pocillopora_acuta_HIv2___RNAseq.g2228.t1",0,0,0,0,0,5.33333333333333,0,0,NA,NA,0.666666666666667,1.33333333333333,0,NA,NA,NA,NA,NA,NA,10.0979293543734,10.0667358836331,10.3795825117777,7.67865482631837,10.0219616268641,9.94460839326245,3.68233641306884,10.2865403030914,9.65469516297834,3.68233641306884,8.54953808884365,10.088141791817,7.01093438587032,758.211631675731,-0.517692421453906,1.10196322565794,0.0348946549885346,0.11696785394071,NA,NA,NA,NA,NA
"2463","Pocillopora_acuta_HIv2___RNAseq.g2235.t1",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.47868055454933,8.12741068900759,7.13459198279071,3.68233641306884,8.97177126068251,3.68233641306884,3.68233641306884,9.01210706827363,8.25975899506637,3.68233641306884,6.27136662026455,7.97138197227251,4.57135126825659,168.497312524256,-0.650306898134746,1.3380722351164,3.17048493769662e-06,4.25003652815976e-05,NA,NA,NA,NA,NA
"2464","Pocillopora_acuta_HIv2___RNAseq.g2245.t1",0,NA,0,15.7894736842105,4,2.73972602739726,0,0,0,NA,2.81614996395097,4.63229992790195,1,NA,NA,NA,NA,NA,NA,11.9131904557648,11.96748424279,12.1552330041499,12.5054382011278,11.261647035879,11.1060070275224,10.2441175685388,11.3820841865396,11.9906822001325,11.9575068554926,11.6483390777937,11.7405673764932,11.5561107790943,3456.90685838535,-0.147196206949651,0.527621569409003,0.761950242776331,0.896076779536291,"O88974",3.73e-79,"Histone-lysine N-methyltransferase SETDB1 (EC 2.1.1.366) (ERG-associated protein with SET domain) (ESET) (SET domain bifurcated 1)","bone development [GO:0060348]; heterochromatin organization [GO:0070828]; inner cell mass cell proliferation [GO:0001833]; methylation [GO:0032259]; negative regulation of gene expression [GO:0010629]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA methylation-dependent heterochromatin formation [GO:0090309]","GO:0000122; GO:0001833; GO:0003677; GO:0003682; GO:0005634; GO:0005694; GO:0005737; GO:0008270; GO:0010629; GO:0032259; GO:0045869; GO:0046974; GO:0060348; GO:0070828; GO:0090309; GO:0140947; GO:0140948; GO:1990841"
"2465","Pocillopora_acuta_HIv2___TS.g27282.t2",0,NA,NA,0,0,0,0,0,16.6666666666667,14.2857142857143,3.86904761904762,4.16666666666667,3.57142857142857,NA,NA,NA,NA,NA,NA,9.66128498702246,9.21207643129142,10.1849994682421,10.0169294983644,10.9877653205242,7.9542283485874,10.1613726469544,10.5913866616118,7.34717865078807,11.8524506922125,9.79696727055988,9.75452301763773,9.83941152348202,1217.6445189251,-0.0714034781078397,0.797499349171266,0.850366049320427,0.941032894304032,"Q9P1Y6",5.24e-47,"PHD and RING finger domain-containing protein 1","protein ubiquitination [GO:0016567]","GO:0016020; GO:0016567; GO:0046872; GO:0070063"
"2466","Pocillopora_acuta_HIv2___TS.g13106.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.90744172849562,3.68233641306884,5.38589367603326,8.01456480640263,5.63210559944937,3.68233641306884,6.61664389412953,4.90193668648245,6.26649149846874,3.68233641306884,5.37720871286681,5.61877383778589,5.13564358794774,45.5291561547023,-0.180692298112708,1.02023019049249,0.0107138232134362,0.0441117958893088,"A2ALV5",7.69e-36,"Protein shortage in chiasmata 1 ortholog (EC 3.6.-.-) (Protein ZIP2 homolog) (MZip2)","reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130]","GO:0000712; GO:0000794; GO:0003697; GO:0005694; GO:0007130; GO:0007131; GO:0016887"
"2467","Pocillopora_acuta_HIv2___RNAseq.g19568.t1",0,NA,NA,0,0,6.06060606060606,0,NA,0,NA,1.01010101010101,2.02020202020202,0,NA,NA,NA,NA,NA,NA,10.0017717885754,3.68233641306884,7.85149969770019,3.68233641306884,11.1930074630521,11.291914531771,10.5461096710917,10.115889717395,3.68233641306884,9.30307766519526,8.13502797739872,8.56890101595831,7.70115493883913,916.299896945759,-0.0725664071770976,0.980862393901814,0.561614178478162,0.774224072338466,"Q6GQT0",0,"Dual specificity protein phosphatase CDC14A (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog A)","cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605]","GO:0000226; GO:0000922; GO:0004722; GO:0004725; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0007096; GO:0007605; GO:0016604; GO:0017018; GO:0032426; GO:0032467; GO:0051301; GO:0060091; GO:0060271; GO:0072686; GO:1902636"
"2468","Pocillopora_acuta_HIv2___RNAseq.g19602.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,5.77181515294413,8.510721039525,7.64134312075246,9.63254650792257,8.43802838106897,8.30079992882404,3.68233641306884,9.26504026695003,6.86073036371937,5.81572620573166,7.90573452170708,251.623715172221,0.603230763494101,1.14154354856777,0.119996590733945,0.298474752945104,"B0CQN7",5.36e-34,"NADH-cytochrome b5 reductase 1 (EC 1.6.2.2) (Microsomal cytochrome b reductase)","protein histidyl modification to diphthamide [GO:0017183]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]","GO:0002926; GO:0003954; GO:0004128; GO:0005741; GO:0016740; GO:0017183"
"2469","Pocillopora_acuta_HIv2___RNAseq.g19617.t1",0,0,0,NA,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.78205843074092,10.1836640268316,9.200548983538,3.68233641306884,7.79725939496798,9.71861013633086,3.68233641306884,8.43638570133787,9.50650526790926,3.68233641306884,7.3672041180863,8.54455155569881,6.1898566804738,393.332059967859,-0.218548303144105,1.02693936642568,4.14891456416538e-05,0.000389169262361142,"O75970",0,"Multiple PDZ domain protein (Multi-PDZ domain protein 1)","tight junction assembly [GO:0120192]","GO:0005737; GO:0005886; GO:0005923; GO:0014069; GO:0016324; GO:0016327; GO:0030425; GO:0045177; GO:0120192"
"2470","Pocillopora_acuta_HIv2___RNAseq.30019_t",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.28212448841977,12.6460292851985,6.50448097751675,12.4059728884015,7.39963524616139,11.9402312673481,11.402779723049,8.1198078417103,3.68233641306884,12.3281228129609,9.47115209438351,6.79767699337541,12.1446271953916,2423.82724239577,4.61491530452191,1.66843063748757,1.82367182815299e-05,0.000191837013253854,NA,NA,NA,NA,NA
"2471","Pocillopora_acuta_HIv2___RNAseq.g19639.t1",0,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.92564232622162,9.63766760780858,3.68233641306884,3.68233641306884,6.98333603148276,8.85361315525796,3.68233641306884,6.23258115521575,8.47979355464223,3.68233641306884,6.28419794829043,6.66073789612624,5.90765800045461,191.218427317606,-0.101245009641239,0.993357063619222,0.621245908247198,0.814757371771107,"Q6VTH5",1.07e-80,"Radial spoke head 1 homolog (Meichroacidin homolog) (Meichroacidin-like sperm-specific axonemal protein) (Testis-specific gene A2-like protein)","cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; spermatogenesis [GO:0007283]","GO:0001535; GO:0007283; GO:0030154; GO:0036126; GO:0051321; GO:0097729"
"2472","Pocillopora_acuta_HIv2___RNAseq.g19641.t1",5,NA,0,0,0,0,1.92307692307692,0,0,NA,0.865384615384615,0,1.73076923076923,NA,NA,NA,NA,NA,NA,6.92442235164643,3.68233641306884,3.68233641306884,8.5725426957775,6.01241040467731,3.68233641306884,10.3467359852038,6.81280755040102,3.68233641306884,3.68233641306884,5.70806010530503,5.42286262657249,5.99325758403756,185.890968094188,0.0393100170448225,1.0109902939881,0.44337339474175,0.686097441055384,"O95490",5.28e-102,"Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2) (CIRL-2) (Latrophilin homolog 1) (Latrophilin-2) (Lectomedin-1)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0016524; GO:0030246"
"2473","Pocillopora_acuta_HIv2___RNAseq.g19648.t1",100,0,NA,NA,NA,20,100,NA,0,0,36.6666666666667,6.66666666666667,66.6666666666667,NA,NA,NA,NA,NA,NA,8.12180600315947,3.68233641306884,6.33809542335038,3.68233641306884,7.73691422051336,3.68233641306884,3.68233641306884,6.22050512179836,9.12635749845022,3.68233641306884,5.5955360332616,7.50873565345436,3.68233641306884,108.374212776461,-11.2173404770802,3.64754759110875,5.02252488842498e-08,1.19091475387179e-06,"Q6GPB9",0,"Dynein axonemal intermediate chain 4 (WD repeat-containing protein 78)","","GO:0005856; GO:0031514; GO:0120293"
"2474","Pocillopora_acuta_HIv2___TS.g13206.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.2584246478067,11.015035271265,10.7987951378407,10.8609942585279,11.4110460116886,8.71980756887101,10.0895595506413,9.66551540476614,10.7505797598986,3.68233641306884,9.72520940243748,10.5768721924001,8.87354661247481,1347.51054549846,-0.285006514089301,0.918521873520504,0.411511129928194,0.657168362879021,"Q6P0Q8",0,"Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1)","cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515]","GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310"
"2475","Pocillopora_acuta_HIv2___RNAseq.g19671.t1",1.05263157894737,0.578034682080925,7.14285714285714,0,0,1.08695652173913,2.25563909774436,0.826446280991736,2.1978021978022,6.02409638554217,2.1164463887705,0.937847936522798,3.29504484101821,NA,NA,NA,NA,NA,NA,9.7046953808311,8.53674455497042,10.2967025511243,8.96046450079683,9.58991137188566,3.68233641306884,3.68233641306884,7.41549053134096,10.048772673486,3.68233641306884,7.55997908036418,9.4111145017336,5.70884365899475,478.508586338955,-0.755667523402469,1.35178771841278,1.12711054066853e-05,0.000126376177211082,"Q28DV3",0,"Histone deacetylase 3 (HD3) (EC 3.5.1.98) (Protein deacetylase HDAC3) (EC 3.5.1.-) (Protein deacylase HDAC3) (EC 3.5.1.-)","circadian regulation of gene expression [GO:0032922]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752]","GO:0000122; GO:0003682; GO:0003714; GO:0004407; GO:0005634; GO:0005737; GO:0017053; GO:0032922; GO:0033558; GO:0042752; GO:0160008; GO:0160009; GO:0160010"
"2476","Pocillopora_acuta_HIv2___RNAseq.g19690.t1",0,NA,NA,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,6.93499074257248,6.43649034287553,5.49419692800081,3.68233641306884,5.31048131328141,4.05708008052864,3.68233641306884,4.82716794255886,3.68233641306884,3.68233641306884,4.77897530020931,5.24983466789648,4.30811593252214,21.1473618573864,-0.511568867221551,1.15711324413888,0.0802336226140075,0.222871179412847,NA,NA,NA,NA,NA
"2477","Pocillopora_acuta_HIv2___RNAseq.g19741.t1",0,0,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.99993815660658,8.3082641794478,7.6138231242003,3.68233641306884,7.51213554915338,8.86444707352129,3.68233641306884,3.68233641306884,6.88347796904334,3.68233641306884,6.2911431704248,6.93834224241449,5.64394409843512,164.182309936827,-0.265074658450572,1.01189285733049,0.316711658708704,0.565754900773458,"Q9JIP0",8.15e-09,"Transient receptor potential cation channel subfamily V member 5 (TrpV5) (Calcium transporter 2) (CaT2) (Epithelial calcium channel 1) (ECaC1) (Osm-9-like TRP channel 3) (OTRPC3)","calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; protein homotetramerization [GO:0051289]; regulation of urine volume [GO:0035809]","GO:0005262; GO:0005516; GO:0005886; GO:0006816; GO:0016324; GO:0034704; GO:0035809; GO:0046872; GO:0051289; GO:0055074; GO:0060402; GO:0070588; GO:0098703"
"2478","Pocillopora_acuta_HIv2___RNAseq.g19747.t1",0,0,NA,0,0,5.76923076923077,0,NA,NA,NA,0.961538461538462,1.92307692307692,0,NA,NA,NA,NA,NA,NA,5.58022760055378,8.34185668081267,5.85239579733235,3.68233641306884,6.6697303065806,3.68233641306884,7.03630624529082,5.21118775879045,3.68233641306884,3.68233641306884,5.3421050041636,5.3991755752652,5.285034433062,56.0259950999161,-0.0213920470927384,0.998592332788253,0.84625065500499,0.938879303059919,"Q5ZLR1",7.95e-173,"Protein wntless homolog (Integral membrane protein GPR177)","intracellular protein transport [GO:0006886]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055]","GO:0000139; GO:0006886; GO:0012505; GO:0016055; GO:0017147; GO:0030177; GO:0030659; GO:0031090; GO:0061355; GO:0061357"
"2479","Pocillopora_acuta_HIv2___RNAseq.g19752.t1",0,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,10.3876144891268,3.68233641306884,4.99332554465423,7.4619492718124,3.68233641306884,7.33026734222755,3.68233641306884,11.9951561160398,6.0579994829205,6.01517604042925,6.10082292541174,566.990145684457,-0.0102758340597293,1.01289399933899,0.275064242246156,0.519729483977583,"Q922C1",5.91e-28,"Uncharacterized protein C19orf44 homolog","",""
"2480","Pocillopora_acuta_HIv2___RNAseq.g19760.t1",0,0,NA,0,0,0,0,7.14285714285714,NA,NA,1.02040816326531,1.78571428571429,0,NA,NA,NA,NA,NA,NA,9.62300673298873,6.59081673114823,9.67898614056996,11.0348037501259,9.79925876124316,10.1609536317461,8.28987181369227,7.37883065113621,8.40009381532483,3.68233641306884,8.46389584410442,8.97603522025258,7.95175646795627,642.91537174167,-0.211358107576114,0.90783698972992,0.496825123400043,0.727141358277533,NA,NA,NA,NA,NA
"2481","Pocillopora_acuta_HIv2___RNAseq.g19796.t1",NA,0,0,NA,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,5.88506810849203,7.13459198279071,10.5251589530668,7.76362851520386,7.9542283485874,7.98853544336584,3.68233641306884,3.68233641306884,10.3448933957362,6.86431139864494,5.18904594744022,8.53957684984965,351.961773064966,0.999874975551747,1.74940678975905,4.5369805924012e-05,0.00042012091733989,"Q90693",2.45e-152,"Protein patched homolog 1 (PTC) (PTC1)","negative regulation of smoothened signaling pathway [GO:0045879]; smoothened signaling pathway [GO:0007224]","GO:0005119; GO:0005886; GO:0007224; GO:0008158; GO:0045879; GO:0097108"
"2482","Pocillopora_acuta_HIv2___RNAseq.g19798.t1",0,0,5.66037735849057,13.3858267716535,5.61224489795918,5.1980198019802,6,5.19480519480519,0,NA,4.56125266943208,4.75573035368779,4.31815556411244,NA,NA,NA,NA,NA,NA,9.21684416185951,9.92690969295718,9.17848805228091,9.37382752931313,8.83133125715271,9.38618848726225,8.46502172969633,9.95008098811828,7.89955533715642,3.68233641306884,8.59105836488656,9.01525995931357,8.16685677045955,528.91369580518,-0.245095325499572,0.863189980683059,0.537505412390563,0.757894159174996,"Q5R592",3.2e-52,"DNA-directed RNA polymerases I, II, and III subunit RPABC2 (RNA polymerases I, II, and III subunit ABC2) (DNA-directed RNA polymerase II subunit F) (RPB6 homolog)","transcription by RNA polymerase II [GO:0006366]; tRNA transcription by RNA polymerase III [GO:0042797]","GO:0001054; GO:0001055; GO:0001056; GO:0003677; GO:0005634; GO:0005665; GO:0005666; GO:0005736; GO:0006366; GO:0042797"
"2483","Pocillopora_acuta_HIv2___RNAseq.g19799.t1",6.12244897959184,19.047619047619,6.62650602409639,4.92227979274611,5.61797752808989,5.75657894736842,6.50406504065041,0.537634408602151,3.35365853658537,100,15.848876830535,6.72355414658422,24.9741995144857,NA,NA,NA,NA,NA,NA,8.36574609960914,7.11319280397558,8.42411896977726,9.77944594634808,7.91763216015926,8.33181090131692,11.1058214234288,8.90442145322128,8.73011287533301,9.79721256788863,8.8469515201058,8.46840631161999,9.2254967285916,599.982973216266,0.512536981161998,0.703680818316588,0.301986252868231,0.550255626289505,"Q9Y2P8",1.9e-142,"RNA 3'-terminal phosphate cyclase-like protein","endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; ribosomal small subunit biogenesis [GO:0042274]","GO:0000447; GO:0000479; GO:0000480; GO:0004521; GO:0005654; GO:0005730; GO:0032040; GO:0042274"
"2484","Pocillopora_acuta_HIv2___RNAseq.g19800.t1",0.490196078431373,0,0,0,0,0.19723865877712,0.304878048780488,0,0,NA,0.110256976220998,0.0394477317554241,0.198768531802965,NA,NA,NA,NA,NA,NA,5.71611892316596,3.68233641306884,7.44466985220172,8.68874925379205,7.87279230126165,5.08222717563762,3.68233641306884,5.87689277444549,4.65430837654882,3.68233641306884,5.63827678962598,6.31295644552473,4.96359713372724,83.1305005530481,-1.10271379157806,1.85663206636408,0.00389560939501255,0.0188637744524478,"Q96AY4",1.89e-49,"Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"2485","Pocillopora_acuta_HIv2___TS.g13342.t1",0,1.63934426229508,0.492610837438424,0,2.5,0.440528634361233,1.61290322580645,0,0,0,0.668538695990119,0.415974579331263,0.921102812648975,NA,NA,NA,NA,NA,NA,6.61740237719946,3.68233641306884,9.17477817638612,3.68233641306884,7.60379181609188,3.68233641306884,4.76881142028858,8.36886094489307,7.24467051682398,3.68233641306884,5.85076609039584,7.8019007662789,3.89963141451279,123.653371550396,-8.42899719128227,2.41215211332094,5.58246017929987e-08,1.28574369479926e-06,"Q7Z494",1.2e-38,"Nephrocystin-3","atrial septum development [GO:0003283]; cilium assembly [GO:0060271]; convergent extension [GO:0060026]; convergent extension involved in gastrulation [GO:0060027]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; determination of stomach left/right asymmetry [GO:0071909]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; maintenance of animal organ identity [GO:0048496]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; ureter development [GO:0072189]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001947; GO:0003283; GO:0005576; GO:0005829; GO:0005929; GO:0006629; GO:0007163; GO:0007368; GO:0016055; GO:0030198; GO:0030324; GO:0035469; GO:0045494; GO:0048496; GO:0060026; GO:0060027; GO:0060271; GO:0060287; GO:0060993; GO:0071908; GO:0071909; GO:0071910; GO:0072189; GO:0090090; GO:0097543; GO:0097546; GO:1905515; GO:2000095"
"2486","Pocillopora_acuta_HIv2___RNAseq.g19803.t1",0,NA,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.51460448636249,8.38852445472299,6.83563938186455,7.95604127232808,7.14970055854672,7.1685916905325,7.47956854521658,8.66357016691129,3.68233641306884,3.68233641306884,6.85209133826229,6.76917020135078,6.9350124751738,155.208295404502,0.129142172802793,0.740151894627011,0.751684465010204,0.890666347334119,"O88828",1.05e-30,"DNA-directed RNA polymerases I, II, and III subunit RPABC2 (RNA polymerases I, II, and III subunit ABC2) (DNA-directed RNA polymerase II subunit F) (RPB6 homolog)","transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797]","GO:0001650; GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005666; GO:0005736; GO:0006360; GO:0006366; GO:0006383; GO:0042797"
"2487","Pocillopora_acuta_HIv2___RNAseq.g19804.t1",58.5365853658537,74.2857142857143,17.8571428571429,45.3125,58.8235294117647,42.2222222222222,51.8518518518519,80,48.1481481481481,0,47.7037694142698,57.9937169312169,37.4138218973226,NA,NA,NA,NA,NA,NA,7.50758496116064,6.17776049751523,7.45700107032243,7.86705667632816,6.95693746256365,7.55890405555477,9.55162098517574,7.96292728948732,7.54029722811113,9.65741286982199,7.82375030960411,7.48494960232903,8.16255101687918,272.223086356343,0.444018977517381,0.720725388593557,0.364582667462463,0.614895900415949,"Q9Y2P8",8.28e-119,"RNA 3'-terminal phosphate cyclase-like protein","endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; ribosomal small subunit biogenesis [GO:0042274]","GO:0000447; GO:0000479; GO:0000480; GO:0004521; GO:0005654; GO:0005730; GO:0032040; GO:0042274"
"2488","Pocillopora_acuta_HIv2___RNAseq.g19811.t1",20,42.5925925925926,60,45,44.1176470588235,35.2941176470588,73.134328358209,18.75,100,NA,48.7654095174093,48.3273420479303,49.3129938542581,NA,NA,NA,NA,NA,NA,6.11310426585121,4.68019422250907,6.20982478924396,6.64915059978192,5.68410831247026,5.75438588036295,8.14708935828997,6.78080511148754,3.68233641306884,8.04949865353797,6.17504976066037,5.69403577842436,6.65606374289638,82.3567549168917,0.239104503429296,0.911987717420541,0.526623367984272,0.749417590960696,"Q9JJT0",5.44e-57,"RNA 3'-terminal phosphate cyclase-like protein","endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]","GO:0000447; GO:0000479; GO:0000480; GO:0004521; GO:0005730; GO:0006364; GO:0032040; GO:0042274"
"2489","Pocillopora_acuta_HIv2___TS.g13352.t1",0,NA,0,0,0,3.17460317460317,22.5,16.2790697674419,5,NA,5.86920911775563,6.11341823551126,5.625,NA,NA,NA,NA,NA,NA,7.13128978447547,6.85609801113518,7.40702362398868,6.63240153016127,7.11438186546373,7.51815502630389,7.92506365523864,7.77072453374253,7.45952232732554,9.05370371935184,7.48683640771868,7.37658842699919,7.59708438843816,176.894339974269,0.138898454629264,0.613782752951307,0.773259975070813,0.902939781207645,"Q9Y2P8",1.66e-09,"RNA 3'-terminal phosphate cyclase-like protein","endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; ribosomal small subunit biogenesis [GO:0042274]","GO:0000447; GO:0000479; GO:0000480; GO:0004521; GO:0005654; GO:0005730; GO:0032040; GO:0042274"
"2490","Pocillopora_acuta_HIv2___TS.g13354.t1",1.76991150442478,0,2.29885057471264,2.71493212669683,0.779220779220779,0.756143667296786,0.29673590504451,0.892857142857143,0.272479564032698,0,0.978113126428617,0.927282500176692,1.02894375268054,NA,NA,NA,NA,NA,NA,6.56356363373408,7.71570812917624,8.09125087353016,3.68233641306884,5.13665622490825,8.82339275517331,3.68233641306884,7.60410977031447,3.68233641306884,3.68233641306884,5.86640270391119,6.21558338311116,5.51722202471121,111.523911835376,-0.0730543945344565,1.00222952645297,0.735147191094368,0.882713678564581,"Q80XJ3",5.99e-37,"Tetratricopeptide repeat protein 28 (TPR repeat protein 28)","cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0005737; GO:0005813; GO:0007346; GO:0030496; GO:0051301; GO:0072686; GO:0097431; GO:1990023"
"2491","Pocillopora_acuta_HIv2___RNAseq.g19818.t1",14.5833333333333,56.9230769230769,3.69649805447471,16.6666666666667,10.1246105919003,12.0567375886525,9.2741935483871,0.673400673400673,10.7784431137725,0.970873786407767,13.5747834280072,19.4196649931138,7.72990186290064,NA,NA,NA,NA,NA,NA,7.29555341930434,3.68233641306884,6.43017198544678,9.05625926668333,5.81325426851759,6.37366676810558,7.60662732667714,6.99090193750695,3.68233641306884,3.68233641306884,6.06134442114482,6.0424436047689,6.08024523752075,106.75453171734,0.0727468095792094,0.939102924066594,0.797040690173902,0.914548392548243,NA,NA,NA,NA,NA
"2492","Pocillopora_acuta_HIv2___RNAseq.g19819.t1",8.57142857142857,15.4411764705882,11.9205298013245,35.6521739130435,4.16666666666667,11.3507377979569,13.2631578947368,3.84615384615385,9.95475113122172,3.125,11.7291776093121,15.2489986317928,8.20935658683132,NA,NA,NA,NA,NA,NA,6.79100259980268,6.06348383902188,6.83563938186455,6.41389448441836,6.97019840607377,8.08524471858609,6.64888280067412,7.39465756691968,3.68233641306884,9.08897335568575,6.79743135661157,6.3347668735459,7.26009583967724,136.83490378021,0.135996690862292,0.880311388919322,0.728335439823288,0.878545892886669,"Q9JJT0",1.21e-53,"RNA 3'-terminal phosphate cyclase-like protein","endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]","GO:0000447; GO:0000479; GO:0000480; GO:0004521; GO:0005730; GO:0006364; GO:0032040; GO:0042274"
"2493","Pocillopora_acuta_HIv2___RNAseq.g19821.t1",1.17647058823529,0,1.51515151515152,0,0,0.413223140495868,0,0,0,NA,0.344982804875853,0.0826446280991736,0.672905525846702,NA,NA,NA,NA,NA,NA,4.21445057288855,4.26601370117446,5.75086179528365,7.64607003834505,5.71763198038475,5.03801277448085,3.68233641306884,6.66266950447494,3.68233641306884,3.68233641306884,5.03427196062388,5.20559005322015,4.86295386802761,33.0123005002952,-0.116115991684684,0.955350467004223,0.791246690076944,0.911629132170855,"Q7Z494",2.04e-34,"Nephrocystin-3","atrial septum development [GO:0003283]; cilium assembly [GO:0060271]; convergent extension [GO:0060026]; convergent extension involved in gastrulation [GO:0060027]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; determination of stomach left/right asymmetry [GO:0071909]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; maintenance of animal organ identity [GO:0048496]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; ureter development [GO:0072189]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001947; GO:0003283; GO:0005576; GO:0005829; GO:0005929; GO:0006629; GO:0007163; GO:0007368; GO:0016055; GO:0030198; GO:0030324; GO:0035469; GO:0045494; GO:0048496; GO:0060026; GO:0060027; GO:0060271; GO:0060287; GO:0060993; GO:0071908; GO:0071909; GO:0071910; GO:0072189; GO:0090090; GO:0097543; GO:0097546; GO:1905515; GO:2000095"
"2494","Pocillopora_acuta_HIv2___TS.g13364.t1",0,0,0,0,0,0,0,NA,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,7.77039409372247,4.68019422250907,3.68233641306884,7.85997747624031,6.90951792457399,8.41528513965604,3.68233641306884,9.01210706827363,9.55954292947827,7.22345195605642,6.87951436366479,7.38677968582344,6.37224904150614,216.422898284147,-0.170444963653542,1.00107079202543,0.266395832339526,0.510215746684177,"E9QJ05",2.94e-16,"Protein PET117 homolog, mitochondrial","mitochondrial cytochrome c oxidase assembly [GO:0033617]","GO:0005739; GO:0033617"
"2495","Pocillopora_acuta_HIv2___RNAseq.g19824.t1",34.5132743362832,66.6666666666667,38.7755102040816,26.984126984127,30.8370044052863,29.8181818181818,32.0945945945946,28.5714285714286,39.8773006134969,42.2535211267606,37.0391609320907,38.3835409307802,35.6947809334013,NA,NA,NA,NA,NA,NA,9.0416620056765,3.68233641306884,6.77736623688518,8.89977337370387,5.46172465639773,10.034836834142,10.4859593301257,5.98234595970336,6.95638151601114,6.37217112046895,7.36945574461833,6.84389607493478,7.89501541430187,369.281992548475,0.299699076000416,1.01076220618098,0.209956819877134,0.436700523828425,NA,NA,NA,NA,NA
"2496","Pocillopora_acuta_HIv2___RNAseq.g19826.t1",NA,NA,NA,0,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,8.43374494478076,8.18144630735713,8.24798289162422,8.66867414626542,8.11409474785885,8.09449021168346,7.09554146303979,8.25548706414865,3.68233641306884,3.68233641306884,7.2456134602896,7.34672921229626,7.14449770828293,213.93336351019,-0.154485499949614,0.690720004479858,0.806350593858074,0.919002047873547,"P52888",0,"Thimet oligopeptidase (EC 3.4.24.15) (Endopeptidase 24.15) (MP78)","peptide metabolic process [GO:0006518]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]","GO:0000209; GO:0004222; GO:0005758; GO:0005829; GO:0006508; GO:0006518; GO:0046872"
"2497","Pocillopora_acuta_HIv2___RNAseq.g19857.t1",0,0,0,3.7037037037037,0,0,0,0,NA,0,0.411522633744856,0.925925925925926,0,NA,NA,NA,NA,NA,NA,11.9532635777342,11.0451620213554,11.5665497035145,11.5098024588155,11.272941492497,11.2030199859336,11.0907551969501,11.2738780955746,11.4454523162386,10.6757295958382,11.3036554444452,11.5024170371118,11.1048938517786,2568.52675773845,-0.306272914076749,0.508968268596331,0.482455324905037,0.716304025808505,"Q80TC6",0,"Zinc finger SWIM domain-containing protein 5","","GO:0008270; GO:0031462"
"2498","Pocillopora_acuta_HIv2___TS.g13402.t1",0,NA,NA,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.67349335418918,11.6436383490796,8.68645353480887,8.85784395842443,7.61222215514669,7.47620947122109,3.68233641306884,8.39520843214021,7.54812909326947,3.68233641306884,7.52578711744172,7.98310131391088,7.06847292097256,497.651144396046,-0.174392688980879,0.970705813835724,0.36604405786758,0.615593846457876,"Q00277",8.85e-30,"Glutathione peroxidase (GPX) (EC 1.11.1.9)","response to oxidative stress [GO:0006979]","GO:0004602; GO:0006979"
"2499","Pocillopora_acuta_HIv2___RNAseq.g19859.t1",NA,0,0,NA,0,0,NA,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,7.58296597751871,4.39481510491619,3.68233641306884,7.02644217673873,6.43917658127574,7.93890441031561,3.68233641306884,3.68233641306884,3.68233641306884,9.41151479429387,5.75231646973342,5.01383035960019,6.49080257986665,121.501532148406,0.204356308787166,1.0250672907904,0.189580641444685,0.408596989696905,"Q9D531",2.55e-48,"Nucleoredoxin-like protein 2 (Rod-derived cone viability factor 2) (RdCVF2)","photoreceptor cell maintenance [GO:0045494]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601]","GO:0007601; GO:0007608; GO:0045494"
"2500","Pocillopora_acuta_HIv2___RNAseq.g19870.t1",0,0,0,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.1515699447021,4.82737711805479,10.2069538797471,8.03982856487021,10.3812473890888,8.4941803305107,3.68233641306884,9.94830498708524,9.70960681486297,3.68233641306884,7.91237418550596,10.0795366030972,5.74521176791468,593.27662889163,-2.72908395840902,4.20661373568702,1.72867707260058e-05,0.000183445232414489,"Q9Z0U4",7.43e-73,"Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932]","GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430"
"2501","Pocillopora_acuta_HIv2___RNAseq.g28712.t1",8.33333333333333,NA,NA,0,NA,0,0,NA,0,0,1.38888888888889,0,2.77777777777778,NA,NA,NA,NA,NA,NA,6.82556204308159,9.93635154748812,10.473134670939,3.68233641306884,8.7403700024657,6.65382384584395,6.46154219886361,8.64393716395537,9.27473469462144,11.9449359731373,8.26367285534649,8.79154771501262,7.73579799568036,786.846663017914,-0.161940330650116,0.965415529147234,0.43916475457336,0.682139068959308,"Q2VPA6",0,"Helicase POLQ-like (EC 3.6.4.12) (Mus308-like helicase) (POLQ-like helicase)","DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA metabolic process [GO:0006259]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]","GO:0003677; GO:0005524; GO:0005634; GO:0006259; GO:0010792; GO:0016887; GO:0017116; GO:0017117; GO:0045003; GO:0090734; GO:0097681; GO:1905168; GO:1990518"
"2502","Pocillopora_acuta_HIv2___RNAseq.g28726.t1",4.13223140495868,36.7816091954023,0,26.9230769230769,13.6363636363636,25.2840909090909,16.5354330708661,31.1111111111111,19.6969696969697,0,17.4100885947839,27.9593715671302,6.86080562243769,NA,NA,NA,NA,NA,NA,8.82823682316581,8.96067875392427,9.00339208276961,9.31308317152089,7.55651501959435,7.63707489101278,3.68233641306884,6.92672320941957,8.97546621812528,3.68233641306884,7.45658429956702,8.25806667061492,6.65510192851912,291.365278319584,-0.323782317042466,0.978339245807227,0.210664793250246,0.437858251123948,NA,NA,NA,NA,NA
"2503","Pocillopora_acuta_HIv2___RNAseq.g28772.t1",NA,0,0,0,0,1.94174757281553,2.04081632653061,0,0,NA,0.497820487418268,0.388349514563107,0.680272108843537,NA,NA,NA,NA,NA,NA,5.39475910818241,3.68233641306884,5.0980278924796,3.68233641306884,5.3333020303659,5.82637165358479,7.40687932379528,4.93729786847052,3.68233641306884,3.68233641306884,4.87259835291539,4.88914466251345,4.85605204331732,24.1741532058794,-0.0596527067491139,0.9901265958752,0.668138204350941,0.844795445424884,"Q7Z494",2.48e-16,"Nephrocystin-3","atrial septum development [GO:0003283]; cilium assembly [GO:0060271]; convergent extension [GO:0060026]; convergent extension involved in gastrulation [GO:0060027]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; determination of stomach left/right asymmetry [GO:0071909]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; maintenance of animal organ identity [GO:0048496]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; ureter development [GO:0072189]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001947; GO:0003283; GO:0005576; GO:0005829; GO:0005929; GO:0006629; GO:0007163; GO:0007368; GO:0016055; GO:0030198; GO:0030324; GO:0035469; GO:0045494; GO:0048496; GO:0060026; GO:0060027; GO:0060271; GO:0060287; GO:0060993; GO:0071908; GO:0071909; GO:0071910; GO:0072189; GO:0090090; GO:0097543; GO:0097546; GO:1905515; GO:2000095"
"2504","Pocillopora_acuta_HIv2___RNAseq.g28776.t1",5,1.49253731343284,0,NA,0.675675675675676,0.952380952380952,9.375,NA,3.93700787401575,0,2.67907522693815,2.12730871327651,3.01013513513514,NA,NA,NA,NA,NA,NA,7.01680604467962,11.083196681646,8.58102329781235,8.72807884406084,9.25124967744495,11.8579831059028,9.62717647435173,8.47888254572353,3.68233641306884,3.68233641306884,8.19890694977595,7.40205959574586,8.99575430380604,837.280990704429,1.0297104903519,1.09878672756761,0.0707932079461295,0.203407421480496,"Q01149",5.46e-132,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001501; GO:0001568; GO:0002020; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0085029"
"2505","Pocillopora_acuta_HIv2___RNAseq.g28792.t1",0,0,NA,0,1.96078431372549,NA,0,NA,0,NA,0.326797385620915,0,0.65359477124183,NA,NA,NA,NA,NA,NA,8.13549223134047,9.75080782737432,9.78253067427456,10.0057797882067,5.08159533560207,9.6420171781847,8.41514049161076,8.33387141872831,3.68233641306884,9.55080686013332,8.23803782185241,7.00316521460285,9.47291042910196,507.48145315756,0.697919429916461,1.1375728679016,0.0543845697364165,0.165569020557257,"Q17RW2",1.06e-89,"Collagen alpha-1(XXIV) chain","extracellular matrix organization [GO:0030198]","GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0062023"
"2506","Pocillopora_acuta_HIv2___TS.g1340.t1b",NA,0,NA,NA,0,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.7785587435148,12.4316476645011,10.749787346098,13.0078475995347,10.5932675474872,13.3476919534264,12.3317970099342,11.1301213834354,9.62919395023602,13.1630824005723,11.716299559874,10.5761857941543,12.8564133255937,4631.38078039568,1.95257579511089,0.729772980019247,0.000735367509316185,0.00452418360474236,"Q28668",6.52e-72,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","extracellular matrix organization [GO:0030198]","GO:0005581; GO:0005615; GO:0030020; GO:0030198; GO:0046872; GO:0062023"
"2507","Pocillopora_acuta_HIv2___RNAseq.g28794.t1",0,10.7142857142857,0,0,2.27272727272727,0,3.7037037037037,9.52380952380952,0,13.953488372093,4.01680145866192,4.04761904761905,3.9859838697048,NA,NA,NA,NA,NA,NA,10.1025729807753,13.1421652309167,9.2717381762647,13.355036426206,10.3837011555232,13.2531628653758,10.9202354074089,10.4765653666068,5.49910115103059,13.481978166393,10.9886256926501,9.14673576604012,12.8305156192601,4693.2014611543,2.45308438445675,1.51873799203372,0.00139334452191799,0.0077722079309764,"P02466",2e-164,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096"
"2508","Pocillopora_acuta_HIv2___RNAseq.g28798.t1",0,NA,0,0,0,3.77358490566038,NA,NA,0,NA,0.628930817610063,1.25786163522013,0,NA,NA,NA,NA,NA,NA,3.68233641306884,11.0090828059213,3.68233641306884,10.4234969275187,8.29735723054694,10.5939407312674,11.4763898100206,7.6265862610439,3.68233641306884,3.68233641306884,7.41561994185942,5.39419054615947,9.43704933755937,818.906562491054,0.618003360125533,1.27093562633491,0.0129531441643813,0.0516929074665429,"O42350",3.98e-144,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","","GO:0005201; GO:0005576; GO:0005581; GO:0046872"
"2509","Pocillopora_acuta_HIv2___RNAseq.g28801.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,5.25300700550269,8.25383733794239,6.17960196289983,6.74563749188866,9.26329684055916,8.73759746419133,5.73058915105271,8.75587920775937,10.1623292239684,10.0838472631225,7.9165622948887,7.92282284813789,7.91030174163952,403.751288412399,0.024162886678461,0.80185471995436,0.959204054207841,0.984996989007419,NA,NA,NA,NA,NA
"2510","Pocillopora_acuta_HIv2___TS.g1350.t1",68.1818181818182,0,71.4285714285714,6.89655172413793,0,19.2307692307692,57.1428571428571,73.9130434782609,0,NA,32.9770679096016,20.0080728866336,49.1883116883117,NA,NA,NA,NA,NA,NA,11.6305292807941,14.5303888442036,11.0334143846795,13.8704480324451,11.480890676426,14.6265902711724,13.810635975959,13.1276562442135,8.11478681900153,14.0441368878079,12.6269477416703,11.0774554810229,14.1764400023176,11229.3611067898,2.43601809602803,1.08398639924308,0.000596990482274869,0.00380726205274414,"P02466",8.4e-152,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096"
"2511","Pocillopora_acuta_HIv2___RNAseq.g28803.t1b",NA,0,0,0,0,7.89473684210526,0,NA,NA,NA,1.31578947368421,2.63157894736842,0,NA,NA,NA,NA,NA,NA,12.1949889885662,14.2220020389871,10.8733291737699,14.4220477104024,11.6231769633246,14.0693657354891,13.7262248581596,12.2846419586171,11.6517048942819,14.7550720262145,12.9822554347812,11.7255683957119,14.2389424738505,11712.5269697605,2.24046662097318,0.710158675585822,0.000131085859260153,0.00104406710811611,"P02466",4.64e-152,"Collagen alpha-2(I) chain (Alpha-2 type I collagen)","blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to aldehyde [GO:0110096]; cellular response to amino acid stimulus [GO:0071230]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; response to norepinephrine [GO:0071873]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0001501; GO:0001568; GO:0002020; GO:0005576; GO:0005581; GO:0005584; GO:0005615; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0032963; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070208; GO:0071230; GO:0071300; GO:0071873; GO:0085029; GO:0097067; GO:0110096"
"2512","Pocillopora_acuta_HIv2___RNAseq.g28815.t1",0,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,10.238521703893,3.68233641306884,7.3083152768306,3.68233641306884,8.5868343169114,3.68233641306884,3.68233641306884,7.91267833663967,11.3566956835067,3.68233641306884,6.38147273831256,9.08060906355627,3.68233641306884,448.847439035537,-13.5182617835901,3.83568638430077,9.60331015892504e-12,8.52161215574796e-10,"Q5R4J5",7.65e-31,"Synaptotagmin-1 (Synaptotagmin I) (SytI)","calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]","GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0019905; GO:0030154; GO:0030276; GO:0030424; GO:0030672; GO:0031045; GO:0042584; GO:0048488; GO:0048791; GO:0071277; GO:1903235"
"2513","Pocillopora_acuta_HIv2___RNAseq.g28819.t2b",50,0,0,87.5,50,79.1666666666667,NA,0,100,100,51.8518518518519,53.3333333333333,50,NA,NA,NA,NA,NA,NA,12.1958039948835,10.6271973335827,12.5136971843182,12.8162711392706,12.3734133060825,11.6291645176435,12.6357651818304,12.3533457259987,11.7504456235881,12.5154804813656,12.1410584488564,12.2373411669742,12.0447757307386,4844.80064249061,-0.118468624579972,0.586245214527407,0.790827507578268,0.911581851260126,"Q9UIF8",0,"Bromodomain adjacent to zinc finger domain protein 2B (hWALp4)","chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000785; GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0046872"
"2514","Pocillopora_acuta_HIv2___RNAseq.g28832.t1",NA,NA,0,0,0,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.84709907336121,3.68233641306884,10.1617692825809,3.68233641306884,10.2058459025819,9.70512025099798,4.51171232812315,8.98636374320206,3.68233641306884,3.68233641306884,6.81472562331226,8.57668288295898,5.05276836366553,446.642952090615,-0.488175162209763,1.16128678471474,0.00135507050777488,0.00757560561209687,"A1A5K2",2.98e-170,"CLIP-associating protein 1-B (Cytoplasmic linker-associated protein 1-B) (Protein Orbit homolog) (Xorbit) (Xorbit/CLASP)","cell division [GO:0051301]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of supramolecular fiber organization [GO:1902903]","GO:0000776; GO:0005794; GO:0005813; GO:0005819; GO:0005874; GO:0007020; GO:0031023; GO:0031110; GO:0034453; GO:0051301; GO:1902903"
"2515","Pocillopora_acuta_HIv2___RNAseq.g28849.t2",0,0,14.2857142857143,1.5625,0,0.977198697068404,1.32450331125828,NA,0,0,2.01665736600455,0.634924674267101,3.12204351939451,NA,NA,NA,NA,NA,NA,10.0697491819078,10.8450126566742,10.6248939791869,10.9062348859255,11.2623138691022,8.28415117937733,3.68233641306884,10.7719004489847,3.68233641306884,3.68233641306884,8.38112654403652,9.28223877845009,7.48001430962294,1075.03428917634,-0.266201003420178,0.984478571235533,0.468104564399604,0.707177915774562,"Q9Y4A5",0,"Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog)","chromatin organization [GO:0006325]; DNA repair [GO:0006281]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000124; GO:0000786; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006282; GO:0006325; GO:0006355; GO:0006357; GO:0033276; GO:0035267; GO:0042981; GO:0043484; GO:0045893; GO:0051726; GO:1905168; GO:2000779"
"2516","Pocillopora_acuta_HIv2___RNAseq.g28854.t1",2,0,NA,NA,0,0,0,NA,0,NA,0.333333333333333,0,0.666666666666667,NA,NA,NA,NA,NA,NA,9.75865473493039,10.9857821824102,9.28384267770651,11.1103547103063,10.030599681253,8.67742263793333,3.68233641306884,10.1740324761798,10.9695558096741,9.87249066457537,9.45450719880378,10.0433370759488,8.86567732165881,1105.20599410589,-0.179635218358374,0.905365841226102,0.593275002682791,0.79701181865245,"Q5ZKI4",0,"Coiled-coil domain-containing protein 93","Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]","GO:0005769; GO:0006893; GO:0015031"
"2517","Pocillopora_acuta_HIv2___TS.g1420.t1b",NA,NA,0,28.5714285714286,0,0,0,NA,0,NA,4.76190476190476,9.52380952380952,0,NA,NA,NA,NA,NA,NA,8.03195997917701,6.74434409930028,8.3000596879337,5.7042294826067,8.42452232618469,5.77882859435006,3.68233641306884,6.67144653115387,8.29730596819122,6.40118305541264,6.8036216137379,7.9450588985281,5.6621843289477,141.813401693939,-2.40573887012201,1.27392855888229,0.00182433424449178,0.00983891194078614,NA,NA,NA,NA,NA
"2518","Pocillopora_acuta_HIv2___RNAseq.g28873.t1",0,0,NA,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.0495829252399,10.6027012727726,12.3170480991698,11.7333665175362,12.0876437478434,11.5596745954312,12.6103338108727,12.2060147377298,12.2863904993992,12.1303044549498,11.9583060660945,12.1893360018764,11.7272761303125,4187.2944168897,-0.339044246626612,0.553892694134994,0.457183537377172,0.698105270712762,"Q9BUQ8",0,"Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD)","cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; R-loop processing [GO:0062176]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]","GO:0000354; GO:0000375; GO:0000398; GO:0000785; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005682; GO:0005730; GO:0008380; GO:0016887; GO:0046540; GO:0062176; GO:0070062; GO:0071013"
"2519","Pocillopora_acuta_HIv2___TS.g1004.t3",0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.88128218725479,10.5636368951372,11.2837379345342,11.1514012849706,10.5420139576162,11.6441624785897,11.9816378325791,10.005788183643,11.5481374986593,11.4112284825154,11.0013026735499,10.6521919523415,11.3504133947584,2245.04311871858,0.500977394474614,0.60881684891586,0.299804636119533,0.548006351173123,"Q8K135",0,"Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor) (AAVR)","acrosome assembly [GO:0001675]; flagellated sperm motility [GO:0030317]; neuron migration [GO:0001764]; proacrosomal vesicle fusion [GO:0120211]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; response to auditory stimulus [GO:0010996]; spermatogenesis [GO:0007283]","GO:0000139; GO:0001675; GO:0001764; GO:0005794; GO:0005802; GO:0005886; GO:0007283; GO:0010996; GO:0016020; GO:0019065; GO:0030317; GO:0031410; GO:0120211"
"2520","Pocillopora_acuta_HIv2___RNAseq.g14523.t1",0,0,NA,0,0,5,0,0,0,0,0.555555555555556,1,0,NA,NA,NA,NA,NA,NA,7.45745779544039,3.68233641306884,6.52839021051498,6.97457669156694,3.68233641306884,3.68233641306884,7.54027079080636,6.5527975076299,7.75163327373382,5.92487398666357,5.97770094955625,6.39452304007759,5.56087885903491,78.0546211459348,-0.188860047306405,0.952525221679762,0.581676584001756,0.789434218425641,"A6QLU6",1.65e-52,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"2521","Pocillopora_acuta_HIv2___RNAseq.g14533.t1",0,0,0,0,0,1.31578947368421,0,NA,0,NA,0.164473684210526,0.328947368421053,0,NA,NA,NA,NA,NA,NA,4.21445057288855,3.68233641306884,4.85281479041193,5.21704338441576,6.01241040467731,6.60213173979051,3.68233641306884,5.61726033607325,3.68233641306884,6.00413425515518,4.9567254722619,4.87585450342398,5.03759644109983,20.9085223293364,-0.0298214075536245,0.966274299028156,0.871911349277075,0.949769848164727,NA,NA,NA,NA,NA
"2522","Pocillopora_acuta_HIv2___TS.g1039.t1",0,0,0,0,0,0,0,10.7142857142857,0,0,1.07142857142857,2.14285714285714,0,NA,NA,NA,NA,NA,NA,3.68233641306884,8.70098919034049,8.93703891379154,3.68233641306884,9.52135251856767,11.1520190423489,3.68233641306884,3.68233641306884,8.87050454107045,3.68233641306884,6.55935862714632,6.93871375991347,6.18000349437918,425.77966452591,-0.038162368913146,1.00542396444539,0.114506731279912,0.288591280925709,"O75095",2.58e-28,"Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)","","GO:0005509; GO:0005576"
"2523","Pocillopora_acuta_HIv2___RNAseq.g14566.t1",0,0,0,0,0.93984962406015,0.583279325988334,1.23076923076923,4.8780487804878,0,NA,0.847994106811724,1.09226562129523,0.542654713707345,NA,NA,NA,NA,NA,NA,11.0507668041275,8.71569691288499,11.1913267372458,9.6686681122722,11.774347494132,10.2389472304673,11.7785917187777,12.2379816694458,11.9888935337492,7.48543228611298,10.6130652499215,11.6486632477401,9.57746725210303,2273.83053515067,-1.46349927667778,0.911772091088764,0.0132195841185431,0.0525585664350213,"Q6RT24",5.6e-131,"Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10)","attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; establishment of protein localization [GO:0045184]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase chromosome alignment [GO:0051310]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly checkpoint signaling [GO:0007094]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein stability [GO:0031647]; spindle assembly involved in female meiosis I [GO:0007057]","GO:0000278; GO:0000775; GO:0000776; GO:0000940; GO:0003777; GO:0005524; GO:0005737; GO:0005819; GO:0005874; GO:0007018; GO:0007057; GO:0007080; GO:0007088; GO:0007094; GO:0008017; GO:0008608; GO:0019901; GO:0031647; GO:0043515; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051301; GO:0051310; GO:0051315; GO:0051984; GO:0051987; GO:0099607"
"2524","Pocillopora_acuta_HIv2___RNAseq.g14573.t1",0,0,35,NA,50,25,NA,NA,0,NA,18.3333333333333,8.33333333333333,28.3333333333333,NA,NA,NA,NA,NA,NA,9.12622126470242,10.0245706846539,4.98269171864354,9.8700725835762,7.44759246788282,10.9704006862878,3.68233641306884,5.40874075538327,3.68233641306884,4.56256470276067,6.97575276900283,6.12951652393618,7.82198901406948,462.722962177871,0.547674264861978,1.1275062502476,0.0652091175066692,0.190812194136448,NA,NA,NA,NA,NA
"2525","Pocillopora_acuta_HIv2___RNAseq.g3015.t1",0,0,0,0,0,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,12.9401910973228,12.7001391037666,11.9320727916719,13.8268854148967,12.1796462274879,12.2058542903114,11.7937337489066,12.9477198549998,12.1393428573315,14.056293188987,12.6721878575682,12.4277945657628,12.9165811493737,7505.78886989937,0.292031629077518,0.669686222025879,0.537906371849984,0.758090009006934,"A2CG49",0,"Kalirin (EC 2.7.11.1) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain)","adult locomotory behavior [GO:0008344]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; positive regulation of dendritic spine morphogenesis [GO:0061003]; regulation of dendrite development [GO:0050773]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; social behavior [GO:0035176]","GO:0004674; GO:0005085; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0007399; GO:0007409; GO:0007411; GO:0007528; GO:0007595; GO:0007613; GO:0008344; GO:0014069; GO:0019898; GO:0019899; GO:0035176; GO:0035556; GO:0042711; GO:0043025; GO:0046872; GO:0046959; GO:0048471; GO:0050773; GO:0060125; GO:0060137; GO:0061003; GO:0098696; GO:0098793; GO:0098885; GO:0098978; GO:0098989; GO:0099645; GO:0106310; GO:1905274"
"2526","Pocillopora_acuta_HIv2___RNAseq.g3016.t1",0,0,0,NA,16.6666666666667,0,0,0,0,0,1.85185185185185,0,3.33333333333333,NA,NA,NA,NA,NA,NA,11.3290456327728,7.74475914608624,10.6997011441066,7.08871005249906,11.477161695957,10.0443902190306,3.68233641306884,9.3978179774206,9.97694999198017,6.24956979519673,8.76904420681186,10.5761352884474,6.96195312517629,1002.55051305483,-3.08359367358911,1.61426483576986,0.000500162734633725,0.00327198271991958,"P07756",0,"Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I)","'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; carbamoyl phosphate biosynthetic process [GO:0070409]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oleic acid [GO:0071400]; glutamine metabolic process [GO:0006541]; hepatocyte differentiation [GO:0070365]; homocysteine metabolic process [GO:0050667]; liver development [GO:0001889]; midgut development [GO:0007494]; monoatomic anion homeostasis [GO:0055081]; nitric oxide metabolic process [GO:0046209]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to cAMP [GO:0051591]; response to dexamethasone [GO:0071548]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to growth hormone [GO:0060416]; response to lipopolysaccharide [GO:0032496]; response to oleic acid [GO:0034201]; response to starvation [GO:0042594]; response to steroid hormone [GO:0048545]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; triglyceride catabolic process [GO:0019433]; urea cycle [GO:0000050]; vasodilation [GO:0042311]","GO:0000050; GO:0001889; GO:0004087; GO:0004088; GO:0004175; GO:0005509; GO:0005524; GO:0005543; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005886; GO:0006207; GO:0006541; GO:0007494; GO:0009410; GO:0009636; GO:0010043; GO:0014075; GO:0016595; GO:0019433; GO:0030955; GO:0032094; GO:0032496; GO:0032991; GO:0033762; GO:0034201; GO:0036094; GO:0042311; GO:0042594; GO:0042645; GO:0043200; GO:0044344; GO:0044877; GO:0046209; GO:0046872; GO:0048545; GO:0050667; GO:0051384; GO:0051591; GO:0055081; GO:0060416; GO:0070365; GO:0070409; GO:0071242; GO:0071320; GO:0071377; GO:0071400; GO:0071548; GO:0072341"
"2527","Pocillopora_acuta_HIv2___RNAseq.g3030.t1",0,NA,NA,16.6666666666667,NA,0,0,NA,0,0,2.77777777777778,5.55555555555556,0,NA,NA,NA,NA,NA,NA,3.68233641306884,6.34267098328276,7.59722431946636,9.02818355037237,7.01565562740872,8.34348305453574,3.68233641306884,6.8048750249239,5.13335110137444,7.805715019728,6.543583150723,6.04668849724845,7.04047780419754,142.824195624875,0.368910797066202,1.03005586375389,0.189920538999171,0.408976739304076,"Q8R151",0,"NFX1-type zinc finger-containing protein 1","activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048]","GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607"
"2528","Pocillopora_acuta_HIv2___TS.g27574.t1",100,100,NA,100,62.5,100,50,NA,NA,NA,85.4166666666667,100,70.8333333333333,NA,NA,NA,NA,NA,NA,8.90737972402627,9.58860577091688,8.69942855973623,10.9583845017916,8.87910192036563,8.70782435704477,9.48292237233824,10.0602458756955,8.47570709606873,10.8769514882826,9.46365516662664,9.00437263517847,9.92293769807482,831.030059659556,0.575084849921546,0.724848973313184,0.239445628562965,0.476912912632157,"Q9I3S3",1.68e-160,"Guanidinobutyrase (EC 3.5.3.7)","arginine catabolic process [GO:0006527]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]","GO:0006527; GO:0008783; GO:0033389; GO:0046872; GO:0047971"
"2529","Pocillopora_acuta_HIv2___RNAseq.g3051.t1",0,0,0,0,0,0,66.6666666666667,NA,NA,NA,9.52380952380952,0,16.6666666666667,NA,NA,NA,NA,NA,NA,13.014750666589,10.705664243014,12.9102953406508,11.1006566604326,12.909879419759,11.7347085879262,11.6808924230249,12.409760850465,13.0894023238693,10.501903930463,12.0057914446194,12.8668177202666,11.1447651689721,4957.84105687557,-1.42172534154964,0.666141207194398,0.00719342319658989,0.0317115736408035,"P02640",0,"Villin-1","actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]","GO:0001726; GO:0005509; GO:0005546; GO:0005737; GO:0005902; GO:0007173; GO:0008154; GO:0008360; GO:0009617; GO:0010634; GO:0015629; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0032233; GO:0032432; GO:0032433; GO:0035727; GO:0035729; GO:0042803; GO:0043027; GO:0051014; GO:0051015; GO:0051016; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0071364; GO:2000392"
"2530","Pocillopora_acuta_HIv2___RNAseq.g3053.t1",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.61059914302406,11.1250782386746,7.23849148546698,3.68233641306884,9.17535618054152,9.2020727184575,11.6267109967731,7.53447939508006,3.68233641306884,3.68233641306884,7.55597973972243,7.24825252343629,7.86370695600858,711.348214087174,0.167512111120987,0.971406225984325,0.594859742217992,0.797782046394481,"Q9Z0W3",0,"Nuclear pore complex protein Nup160 (160 kDa nucleoporin) (Gene trap locus 1-13 protein) (GTL-13) (Nucleoporin Nup160)","mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]","GO:0005635; GO:0005643; GO:0006406; GO:0006913; GO:0015031; GO:0017056; GO:0031080"
"2531","Pocillopora_acuta_HIv2___RNAseq.g3064.t1",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.1680908270566,10.5096564399031,3.68233641306884,10.4860200180595,11.0466452693727,10.5607633569118,9.83176350643797,4.9224776128996,3.68233641306884,7.55724262698478,7.8864507980738,7.22803445589576,743.069562132778,-0.0435098845284948,0.970648691630059,0.718901144702587,0.872916903708715,"F1RCP1",0,"Beclin-1","autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell division [GO:0051301]; cellular response to nitrogen starvation [GO:0006995]; cellular senescence [GO:0090398]; early endosome to late endosome transport [GO:0045022]; heart development [GO:0007507]; late endosome to vacuole transport [GO:0045324]; mitophagy [GO:0000423]; positive regulation of autophagy [GO:0010508]; regulation of skeletal muscle tissue regeneration [GO:0043416]","GO:0000045; GO:0000407; GO:0000423; GO:0005776; GO:0005789; GO:0005794; GO:0006914; GO:0006995; GO:0007507; GO:0010008; GO:0010508; GO:0030674; GO:0031966; GO:0034271; GO:0034272; GO:0043416; GO:0043548; GO:0045022; GO:0045324; GO:0051301; GO:0090398"
"2532","Pocillopora_acuta_HIv2___RNAseq.g3081.t1",0,0,NA,0,0,1.58730158730159,0,NA,NA,NA,0.264550264550265,0.529100529100529,0,NA,NA,NA,NA,NA,NA,10.7018393663106,11.6936679173134,11.6606893659329,10.5927119528698,10.8044181509158,11.4927853489648,11.8178966270353,11.2774184659902,10.9825577206229,10.8870005939923,11.1910985509948,11.0853846139545,11.2968124880351,2418.36644881713,0.159782322048842,0.567247306659864,0.731826623697238,0.880541581077367,"Q9ULJ8",6.18e-54,"Neurabin-1 (Neurabin-I) (Neural tissue-specific F-actin-binding protein I) (Protein phosphatase 1 regulatory subunit 9A)","actin filament organization [GO:0007015]; calcium-mediated signaling [GO:0019722]; modulation of chemical synaptic transmission [GO:0050804]; neuron projection development [GO:0031175]","GO:0005737; GO:0007015; GO:0014069; GO:0015629; GO:0019722; GO:0030175; GO:0030425; GO:0030864; GO:0031175; GO:0043197; GO:0050804; GO:0051015"
"2533","Pocillopora_acuta_HIv2___RNAseq.g3082.t1",0,NA,0,0,NA,0,0,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,4.90080178660296,4.59616451822093,8.42411896977726,6.74563749188866,5.7009801482996,4.51119975925463,4.10128477526701,7.77475186410084,4.79801079550852,4.69373610443143,5.62466862133518,6.31973271285784,4.92960452981253,66.0171664982006,-1.10779762693692,1.17912432904089,0.0481508860982774,0.151399738391854,"Q6GLN7",4.93e-20,"Transmembrane protein 163","","GO:0008270; GO:0030672; GO:0031901"
"2534","Pocillopora_acuta_HIv2___RNAseq.g3083.t1",NA,NA,2.85714285714286,NA,0,0,0,0,0,NA,0.476190476190476,0,0.952380952380952,NA,NA,NA,NA,NA,NA,8.24894423055902,8.43372565070379,9.33126914756743,11.0863642699884,10.6786750154031,10.1945907492666,8.5346223329741,9.89121114080339,10.9593615676789,8.93756941760066,9.62963335225454,9.82189222040237,9.43737448410671,982.720692493517,-0.244498704929376,0.685789935652647,0.595548444078776,0.798258983889854,"A6QLU1",0,"Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M) (GPDH-M) (EC 1.1.5.3)","glycerol catabolic process [GO:0019563]; glycerol-3-phosphate metabolic process [GO:0006072]","GO:0004368; GO:0005509; GO:0005739; GO:0006072; GO:0019563"
"2535","Pocillopora_acuta_HIv2___RNAseq.g3084.t1",0,NA,NA,0,0,0,NA,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,7.4130444802169,10.2240547583969,6.91875970696607,7.94270546705381,8.16071462997175,9.30105970217881,3.68233641306884,9.40690051112425,3.68233641306884,5.79624808010018,7.25281601621464,7.11635114826956,7.38928088415971,318.664939483294,0.270315878160851,0.987929516861401,0.318242751585396,0.567718692517411,"Q8C996",3.54e-41,"Transmembrane protein 163 (Synaptic vesicle membrane protein of 31 kDa)","myelination [GO:0042552]; zinc export across plasma membrane [GO:0140882]; zinc ion import into synaptic vesicle [GO:0099180]","GO:0005765; GO:0005886; GO:0008270; GO:0030672; GO:0031901; GO:0031902; GO:0042552; GO:0097708; GO:0099180; GO:0140882"
"2536","Pocillopora_acuta_HIv2___RNAseq.g3088.t1",0,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.67974561220581,12.806277896036,6.83563938186455,10.7238771603576,5.78216020895349,11.2072783711131,9.46966884239544,9.17441280994157,10.104026333542,10.5485507782516,9.43316373946612,7.91519686930148,10.9511306096307,1522.71637747625,2.03658746021117,1.69705848350216,0.00143660932232829,0.0079858252260401,"Q6AZT7",0,"Nephrocystin-3","cilium assembly [GO:0060271]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]","GO:0005929; GO:0016055; GO:0060027; GO:0060271; GO:0090090; GO:2000095"
"2537","Pocillopora_acuta_HIv2___RNAseq.g3096.t1",0,0,0,1.23456790123457,0,0.478468899521531,0,NA,0,NA,0.214129600094512,0.428259200189025,0,NA,NA,NA,NA,NA,NA,3.68233641306884,6.15566643149668,7.03904768963524,3.68233641306884,7.96440358360346,7.9794101216033,5.40984312721881,7.80656939979663,6.43114589272003,3.68233641306884,5.98330954852807,6.58470059576484,5.38191850129129,88.9289950337283,-0.25904178346901,1.02722884374896,0.096454891329836,0.254445294217536,NA,NA,NA,NA,NA
"2538","Pocillopora_acuta_HIv2___RNAseq.g3100.t1",0,NA,0,0,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.27149370745176,9.45044034127388,7.85615191270033,8.08906047224294,8.92702347129378,9.69757097951174,9.15055191026263,8.2783219996615,8.07207879611671,7.96642826417093,8.67591218546862,8.48101397744482,8.87081039349242,428.444566449867,0.31404116079147,0.523783267157637,0.485343053992619,0.719133956822883,NA,NA,NA,NA,NA
"2539","Pocillopora_acuta_HIv2___TS.g27624.t4b",0,0,NA,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,8.13290662201816,3.68233641306884,10.6480523160379,8.32063079410679,9.85786923319291,3.68233641306884,8.24972120508824,5.38933004445713,8.91808740451969,7.05636068586273,5.86487097395797,8.2478503977675,378.950304182962,0.314416819500632,1.06382906905133,0.0261965765334011,0.0925066608835727,"Q5UQ13",5.19e-96,"Collagen-like protein 2","","GO:0044423"
"2540","Pocillopora_acuta_HIv2___TS.g27625.t3",25.8426966292135,9.67741935483871,11.9047619047619,9.52380952380952,3.6144578313253,9.52380952380952,19.5402298850575,5.26315789473684,41.6666666666667,23.0769230769231,15.9633932291142,15.1309725927723,16.7958138654562,NA,NA,NA,NA,NA,NA,9.64227287388026,10.1201843168058,6.46782542466738,3.68233641306884,9.70820483932742,3.68233641306884,7.77467435171595,8.93704308206643,3.68233641306884,3.68233641306884,6.73795505407386,7.68753652660207,5.78837358154565,339.565291517415,-0.310652633815796,1.03017939026283,0.213166839939223,0.441727770732242,"Q7Z6J2",7.69e-18,"Protein TAMALIN (General receptor for phosphoinositides 1-associated scaffold protein) (GRP1-associated scaffold protein)","regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; signal transduction [GO:0007165]","GO:0005886; GO:0007165; GO:0014069; GO:0030165; GO:0031267; GO:0042802; GO:0045211; GO:0048471; GO:0098685; GO:0098978; GO:0099152"
"2541","Pocillopora_acuta_HIv2___RNAseq.g3119.t1",0,NA,NA,0,NA,0,0,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,9.45703034318526,10.8205801418535,10.3940080236205,9.39596260251079,11.0878394771665,3.68233641306884,10.3211430105809,9.22371334765989,3.68233641306884,3.68233641306884,8.17472861857839,8.7689855209402,7.58047171621657,840.580272716094,-0.0653856580401267,0.939289886129466,0.736743315968623,0.883529999350813,"Q5RF84",1.44e-103,"Ubiquitin-conjugating enzyme E2 G2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2)","cellular response to interferon-beta [GO:0035458]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]","GO:0004842; GO:0005524; GO:0005783; GO:0005811; GO:0005829; GO:0035458; GO:0036503; GO:0061631; GO:0070936; GO:1904153"
"2542","Pocillopora_acuta_HIv2___RNAseq.g3123.t1",6.06060606060606,3.7037037037037,0,4.59770114942529,6.61157024793388,10,7.40740740740741,50,0,0,8.83809885690764,13.6602809706258,4.01591674318947,NA,NA,NA,NA,NA,NA,13.819615766523,14.0027165976383,13.7557205303973,13.8305004813754,13.1727334534847,13.8421338201422,14.0123717128226,13.6678950536193,14.8955601090525,14.0669674268352,13.9066214951891,13.8623049826154,13.9509380077627,16011.8471935149,0.0741538549540248,0.520547868874128,0.875643387420409,0.951849237610762,"A2ASS6",0,"Titin (EC 2.7.11.1) (Connectin)","adult heart development [GO:0007512]; cardiac muscle tissue development [GO:0048738]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of relaxation of cardiac muscle [GO:1901897]; sarcomere organization [GO:0045214]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; ventricular system development [GO:0021591]","GO:0001701; GO:0001756; GO:0003007; GO:0004674; GO:0004713; GO:0005200; GO:0005516; GO:0005524; GO:0005634; GO:0005859; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0021591; GO:0030017; GO:0030018; GO:0030506; GO:0031430; GO:0031672; GO:0031674; GO:0035995; GO:0043056; GO:0045214; GO:0046872; GO:0048738; GO:0055002; GO:0055003; GO:0055008; GO:0060419; GO:0106310; GO:1901897"
"2543","Pocillopora_acuta_HIv2___RNAseq.g21028.t1a",0,0,0,0,NA,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,12.0210497410786,11.4330441402739,11.7902357367916,11.9734119227953,12.1093020141753,10.8819306717086,10.2046720032397,11.3830704197222,11.411670695369,12.4913948121599,11.5699782157314,11.7430657214273,11.3968907100355,3286.67645973649,-0.244125067953788,0.599585965346827,0.599634963130672,0.800857926605757,"Q86VM9",5.69e-24,"Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1)","RNA destabilization [GO:0050779]","GO:0003723; GO:0016607; GO:0030674; GO:0032991; GO:0046872; GO:0050779; GO:0140262; GO:1990904"
"2544","Pocillopora_acuta_HIv2___RNAseq.g21031.t1b",0,0,0,NA,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,7.56088992856599,7.69923743453429,3.68233641306884,7.90055154479321,9.97864184543936,3.68233641306884,8.71046423487031,3.68233641306884,3.68233641306884,6.02614670535474,6.3349852080671,5.71730820264237,193.798351907002,-0.0368960077508334,1.0090480109073,0.163663216330505,0.368898980988689,"Q58EX7",3.56e-152,"Puratrophin-1 (Pleckstrin homology domain-containing family G member 4) (PH domain-containing family G member 4) (Purkinje cell atrophy-associated protein 1)","axon guidance [GO:0007411]; regulation of small GTPase mediated signal transduction [GO:0051056]","GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0019898; GO:0051056"
"2545","Pocillopora_acuta_HIv2___RNAseq.g21042.t1",0,0,0,NA,NA,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.70774668464791,10.3269393472936,6.48015208458943,10.4671172347619,3.68233641306884,6.49260508637142,3.68233641306884,3.68233641306884,8.3957742487921,3.68233641306884,6.65996803387317,6.38966916883342,6.93026689891292,390.287814664037,0.158606891843191,1.00188804459309,0.25794500203005,0.499988811225226,"F4KGU4",0,"ATP-dependent RNA helicase DEAH12, chloroplastic (EC 3.6.4.13)","","GO:0003676; GO:0003724; GO:0005524; GO:0008270; GO:0009507; GO:0016740; GO:0016887"
"2546","Pocillopora_acuta_HIv2___RNAseq.g21045.t1",NA,0,0,NA,0,2.85714285714286,0,NA,0,NA,0.476190476190476,0.952380952380952,0,NA,NA,NA,NA,NA,NA,5.09121097465794,4.39481510491619,8.77736480701605,7.78719371610229,9.54347243560521,7.98439388604313,9.10840683033364,8.76802052262923,5.8614009438957,10.4821516752615,7.77984308964609,7.60829393676083,7.95139224253135,395.219714824621,-0.105110235867088,0.812655790115292,0.779397528552778,0.905623863511197,"Q98UK4",3.81e-16,"Transcription factor Maf","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357"
"2547","Pocillopora_acuta_HIv2___RNAseq.g21050.t2",1.27388535031847,2.83018867924528,0,0,0.338983050847458,0.912408759124088,0,0,0,2.85714285714286,0.821260869667816,0.748519487673874,0.894002251661757,NA,NA,NA,NA,NA,NA,10.1106635249423,10.572746104799,10.2604209553186,11.2673001353584,9.26861898501721,9.01787806819027,6.7854110415012,10.6651351483302,9.77418457672502,10.5798640745171,9.83022226146993,10.0158046380667,9.64463988487319,1134.17833762189,-0.0713367572796148,0.734670858522823,0.871411891584512,0.949769848164727,"A6QLU6",4.45e-58,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"2548","Pocillopora_acuta_HIv2___RNAseq.g21051.t1",0,0,0,1.32890365448505,0.397614314115308,1.28205128205128,1.41287284144427,0.444444444444444,0,0,0.486588653654035,0.611079876196155,0.362097431111916,NA,NA,NA,NA,NA,NA,8.27801859226,3.68233641306884,3.68233641306884,3.68233641306884,6.24245863124477,3.68233641306884,3.68233641306884,6.58108861241956,8.35630309046855,8.25005742018985,5.61196084119269,6.62804106789234,4.59588061449304,99.1122113804876,-0.376834076691477,1.09699095904309,0.00407168243405949,0.0195366939140857,"Q6QNK2",2.26e-72,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0016607"
"2549","Pocillopora_acuta_HIv2___RNAseq.g21052.t1",NA,0,0,0,0,0,0,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,6.29145478155565,3.68233641306884,7.91529616546613,8.14831825205188,3.68233641306884,7.34242603626167,7.71582316840195,3.99577996562374,3.68233641306884,4.19574235723263,5.66518499658002,5.11344074775664,6.21692924540339,85.5008192126888,0.264230493107019,1.03454848588981,0.105715145254433,0.27254739733143,"Q4R683",5.82e-41,"Cytidine and dCMP deaminase domain-containing protein 1 (EC 3.5.4.5) (Cytidine deaminase)","","GO:0004126; GO:0005634; GO:0005737; GO:0008270"
"2550","Pocillopora_acuta_HIv2___TS.g31406.t3",24.3243243243243,18.9189189189189,20,16.1290322580645,20.3389830508475,22.4489795918367,36.0655737704918,0,75,NA,25.9139791016093,26.499386153764,25.1822202864159,NA,NA,NA,NA,NA,NA,10.3971777422454,11.6007443872851,9.27693827115082,10.5755794849224,9.41018020190878,9.64358959331204,3.68233641306884,10.4734817919133,3.68233641306884,3.68233641306884,8.24247007119444,8.64802288405743,7.83691725833144,932.410373438769,-0.0214277007245187,0.932947414949477,0.95823637323136,0.984472733402787,"Q80YD6",2.1e-72,"Secretion-regulating guanine nucleotide exchange factor (Deafness locus-associated putative guanine nucleotide exchange factor) (DelGEF) (Guanine nucleotide exchange factor-related protein)","negative regulation of protein secretion [GO:0050709]","GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0050709"
"2551","Pocillopora_acuta_HIv2___RNAseq.g21055.t1",1.14942528735632,0.604229607250755,1.28205128205128,0.932400932400932,1.8005540166205,0.519143413367943,0.128700128700129,0.552486187845304,0,0,0.696899085559317,0.521652028172987,0.872146142945646,NA,NA,NA,NA,NA,NA,10.0721186739128,10.9766605721249,8.50322897424329,10.5604198175214,7.89711087890415,11.7541212804872,11.9249216709069,9.58206830802155,5.98677490518935,12.2817477963734,9.95391728776849,8.40826034805423,11.4995742274828,1810.23198076969,2.27687270138878,1.2340051205821,0.00165103513569602,0.00902174998213347,"Q6P1B1",0,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)","bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508]","GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0043069; GO:0070006"
"2552","Pocillopora_acuta_HIv2___RNAseq.g21110.t1",NA,NA,0,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,8.54038827674961,10.5024525723943,3.68233641306884,10.2453662550638,8.46684866936864,10.2410257977503,5.40984312721881,8.52970297551838,11.5693585836427,3.68233641306884,8.08696590838442,8.15772698366963,8.01620483309921,785.209053957985,0.048496777913256,0.982236269026371,0.803408374104527,0.917677827204095,"Q8R5B6",3.81e-47,"SPRY domain-containing SOCS box protein 4 (SSB-4)","intracellular signal transduction [GO:0035556]; positive regulation of protein polyubiquitination [GO:1902916]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0005829; GO:0006511; GO:0016567; GO:0019005; GO:0035556; GO:0042752; GO:0043161; GO:0048511; GO:1902916; GO:1990756"
"2553","Pocillopora_acuta_HIv2___RNAseq.g21114.t1",0,0,NA,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,7.59164829477045,9.87708254069058,8.191910306003,7.94403059481423,3.68233641306884,10.2956479404319,3.68233641306884,3.68233641306884,6.23120017420544,6.68877587346861,5.77362447494227,280.285088466347,-0.0716006929231706,0.98699645303612,0.725059250809259,0.876641060244514,NA,NA,NA,NA,NA
"2554","Pocillopora_acuta_HIv2___RNAseq.g21125.t1",21.0084033613445,3.07692307692308,29.5180722891566,36.4197530864198,18.1818181818182,6.20525059665871,36.6013071895425,NA,0,NA,18.8764409727329,11.4254816900004,26.3274002554655,2,42.6318267419962,42.6318267419962,0.043785081685164,0.043785081685164,0.043785081685164,9.03195276543904,3.68233641306884,3.68233641306884,7.80941950297591,8.4852679818335,8.86983362963277,9.22869534326832,8.19676050826218,9.33005757413356,3.68233641306884,7.19989965447518,7.74527504854742,6.65452426040294,293.417155538705,-0.0413476559192906,0.981852766863292,0.707810280125617,0.866776216459524,NA,NA,NA,NA,NA
"2555","Pocillopora_acuta_HIv2___RNAseq.g9549.t1",0,0,0,NA,0,0,NA,0,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,9.25489806718378,10.814620116801,9.49342109502455,9.56395273519032,9.60996389806225,10.6707342634831,3.68233641306884,10.1055689094759,7.00297301330175,11.5848663953336,9.17833349069251,9.09336499660965,9.26330198477537,1037.4510631288,0.174094332010691,0.927051663410394,0.599843106403628,0.800857926605757,"F1P4W9",0,"Cilia- and flagella-associated protein 65 (Coiled-coil domain-containing protein 108)","flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]","GO:0001669; GO:0002080; GO:0005737; GO:0005886; GO:0007288; GO:0030317; GO:0036126; GO:0097225"
"2556","Pocillopora_acuta_HIv2___TS.g16325.t3",0,0,NA,NA,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,11.1952479577065,11.2502092037155,11.540492608624,7.68668641750811,10.9776494902997,10.6974693401647,10.1010635017712,10.7270338874188,10.8318555474534,8.94721251437447,10.3954920469036,11.0544558983005,9.7365281955068,1649.71693826013,-0.768960313409603,0.800368316925216,0.135057937722866,0.325244041547784,"O43166",0,"Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1)","actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; ephrin receptor signaling pathway [GO:0048013]; regulation of axonogenesis [GO:0050770]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of synaptic plasticity [GO:0048167]","GO:0005096; GO:0005737; GO:0005886; GO:0014069; GO:0015629; GO:0030036; GO:0043087; GO:0043197; GO:0046875; GO:0048013; GO:0048167; GO:0050770; GO:0051056; GO:0061001; GO:0090630"
"2557","Pocillopora_acuta_HIv2___RNAseq.g9585.t2",0,NA,NA,0,0,0,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,9.72015875967158,3.68233641306884,10.8060493408266,6.95026000352262,9.89001758390583,3.68233641306884,7.31370461842393,3.68233641306884,3.68233641306884,6.30918723716948,5.06219477223061,7.55617970210834,373.987046538063,0.158012801728824,1.02743100681075,0.00431805587469832,0.0205448553196173,"P54366",5.77e-29,"Homeobox protein goosecoid","negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0042803; GO:0045892; GO:0046982"
"2558","Pocillopora_acuta_HIv2___RNAseq.g9587.t1",0,0,0,0,2.77777777777778,0,0,0,0,NA,0.308641975308642,0,0.694444444444444,NA,NA,NA,NA,NA,NA,9.08690804625239,10.2695832829601,7.85615191270033,10.4878702659836,7.81924936499603,11.0631853885191,11.7070034615289,9.51645229214345,3.68233641306884,10.9446658605024,9.24334062886551,7.59221960583221,10.8944616518988,1162.93007755643,1.53810408534374,1.65841175390314,0.0164807995996314,0.0631632976706595,"Q91813",9.06e-37,"Homeobox protein OTX2-A (xOTX2-A) (Orthodenticle 2-A) (Orthodenticle-A-like protein A)","positive regulation of DNA-templated transcription [GO:0045893]","GO:0000981; GO:0005634; GO:0043565; GO:0045893"
"2559","Pocillopora_acuta_HIv2___RNAseq.g9592.t1",2.13776722090261,7.61421319796954,5.83941605839416,5.25,NA,5.90909090909091,0,5.55555555555556,12.2448979591837,2.49110320284698,5.22689378932705,7.31475152435994,2.61707162053594,NA,NA,NA,NA,NA,NA,8.11260887285627,3.68233641306884,3.68233641306884,3.68233641306884,7.8046269361412,6.97046070240566,3.68233641306884,5.59791879935115,8.061200365156,3.68233641306884,5.49584977412545,6.65173827731469,4.3399612709362,81.9579401124307,-0.424885959957247,1.12577626816276,0.00569704738342121,0.0259534152295447,"B2RY50",0,"Outer dynein arm-docking complex subunit 2 (Armadillo repeat-containing protein 4)","cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591]","GO:0003341; GO:0003356; GO:0005930; GO:0007368; GO:0007507; GO:0021591; GO:0036158; GO:0097546"
"2560","Pocillopora_acuta_HIv2___TS.g16371.t1",0,NA,NA,0,NA,0,0,NA,0,0,0,0,0,NA,NA,NA,NA,NA,NA,9.06802994240702,9.38297607345041,10.9490933599447,7.66245516740606,9.25124967744495,11.1414876028759,9.57243492293435,10.3685033072803,7.54812909326947,3.68233641306884,8.8626695560082,9.43700107606929,8.28833803594711,829.485684764337,-0.363209107153442,0.93720839277348,0.274857976366131,0.519578027950648,NA,NA,NA,NA,NA
"2561","Pocillopora_acuta_HIv2___TS.g16384.t1",0,0,0,0,4.58015267175572,0,0,0,0,0,0.458015267175573,0,0.916030534351145,NA,NA,NA,NA,NA,NA,10.2521691269701,3.68233641306884,9.86078739941063,3.68233641306884,10.7297163154473,3.68233641306884,3.68233641306884,11.0441985999302,9.28876573707744,3.68233641306884,6.95873192441799,10.2351274357671,3.68233641306884,645.704218748475,-14.5974074873698,3.79876994415303,1.93746953386085e-14,5.0042070246006e-12,NA,NA,NA,NA,NA
"2562","Pocillopora_acuta_HIv2___TS.g16386.t1",0,0,0,0,0,1.0126582278481,0,0,0,0,0.10126582278481,0.20253164556962,0,NA,NA,NA,NA,NA,NA,8.79417202436679,7.670995659781,10.7987951378407,9.39840120632391,10.3420396018687,3.68233641306884,3.68233641306884,9.91777346297248,5.63170286483936,8.58280424228329,7.85013570264139,9.09689661837761,6.60337478690518,560.236769385719,-0.310879395373065,1.026513819504,0.121674149954329,0.301403477468644,"Q24UI6",3.83e-40,"Translation initiation factor IF-2","","GO:0003743; GO:0003924; GO:0005525; GO:0005737"
"2563","Pocillopora_acuta_HIv2___RNAseq.g9631.t1",0,0,1.35746606334842,0.537634408602151,1.04895104895105,0.190114068441065,0,0,0,NA,0.348240621038076,0.145549695408643,0.601604278074866,NA,NA,NA,NA,NA,NA,13.77259215923,9.11283083309763,12.9292639268424,3.68233641306884,13.7763089490112,3.68233641306884,3.68233641306884,13.5872531882006,13.1873298415594,3.68233641306884,9.10949245502166,13.4505496129687,4.7684352970746,5786.08667327334,-14.7559785945729,3.16630469660707,2.32816768458461e-14,5.52042908030029e-12,"Q40375",3.73e-56,"Repetitive proline-rich cell wall protein 2","","GO:0005199; GO:0005576"
"2564","Pocillopora_acuta_HIv2___RNAseq.g19470.t1",NA,0,0,0,12.5,0,0,NA,NA,NA,2.08333333333333,0,4.16666666666667,NA,NA,NA,NA,NA,NA,10.8451827334264,12.9458264208213,11.5813308946421,12.9010168168296,11.1009465507655,12.1895355362863,12.8011381710641,11.6556571808771,9.8983157332313,12.9287358656015,11.8847685903545,11.0162866185885,12.7532505621206,4616.90231220607,1.41753186648247,0.679814040596309,0.00841688834986582,0.036103758331097,"A0A481NSZ4",3.75e-90,"Bactericidal permeability-increasing protein (BPI) (Lipopolysaccharide-binding protein) (LBP)","defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]","GO:0005615; GO:0008289; GO:0042742; GO:0045087"
"2565","Pocillopora_acuta_HIv2___TS.g1247.t1",0,0,0,NA,0,0,NA,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,10.1549270165434,10.5687046672254,10.7615783481506,10.7111864448288,10.4360632003871,11.5675630699138,11.6746510510334,10.6032847580276,10.9208537178864,9.67201872085932,10.7070830994856,10.575341408199,10.8388247907721,1781.53175989994,0.195180724848503,0.59768307350983,0.683832467563088,0.853698671744563,"Q62433",1.73e-44,"Protein NDRG1 (N-myc downstream-regulated gene 1 protein) (Protein Ndr1)","cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; mast cell activation [GO:0045576]; negative regulation of cell population proliferation [GO:0008285]; peripheral nervous system myelin maintenance [GO:0032287]; signal transduction [GO:0007165]","GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005912; GO:0007165; GO:0008017; GO:0008285; GO:0030330; GO:0031267; GO:0032287; GO:0043015; GO:0043209; GO:0045296; GO:0045576; GO:0048471; GO:0055038; GO:0071456"
"2566","Pocillopora_acuta_HIv2___RNAseq.g19502.t1",NA,NA,14.2857142857143,0,0,0,0,NA,0,NA,2.38095238095238,0,4.76190476190476,NA,NA,NA,NA,NA,NA,9.04890124346497,11.374636479285,5.29770193163976,7.96266298558189,5.66700991799266,3.68233641306884,3.68233641306884,3.68233641306884,9.66727861739109,11.3398618943345,7.14050623088964,6.67264562471146,7.60836683706781,675.863195508317,0.267282451470197,0.979650212877526,0.388409049068969,0.636040788057828,"Q9BXT4",1.68e-61,"Tudor domain-containing protein 1 (Cancer/testis antigen 41.1) (CT41.1)","germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; retrotransposon silencing by piRNA-directed DNA methylation [GO:0141196]; siRNA-mediated retrotransposon silencing by heterochromatin formation [GO:0141007]; spermatogenesis [GO:0007283]","GO:0005737; GO:0007281; GO:0007283; GO:0030719; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0046872; GO:0051321; GO:0071546; GO:0141007; GO:0141196; GO:1990904"
"2567","Pocillopora_acuta_HIv2___RNAseq.g30254.t1",NA,NA,0,NA,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,3.68233641306884,3.68233641306884,8.01846561668189,3.68233641306884,8.49892937367819,7.71720190845086,3.68233641306884,8.13865583206398,6.03378121970174,7.78429754414113,6.09206771469931,6.87443369103893,5.3097017383597,125.09559939822,-0.220400054156416,1.01562766863822,0.305696825453395,0.554116480846262,"A6QLU6",4.2e-70,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]","GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189"
"2568","Pocillopora_acuta_HIv2___RNAseq.g12496.t2",0,0,10.8910891089109,1.34228187919463,2.53164556962025,0.789473684210526,0,8,0,NA,2.61716558243737,2.02635111268103,3.35568366963279,NA,NA,NA,NA,NA,NA,6.16911426736902,7.1572797975657,6.0846563529576,7.24978579672844,5.97219005110571,6.61523549873737,7.35949268040431,6.01099506072748,6.51477584410355,5.16462945902469,6.42981548087239,6.15034631525267,6.7092846464921,71.6061771180132,0.437563408313045,0.75315291959865,0.372337007369147,0.622095699963883,"Q9Y4B6",1.71e-125,"DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein)","B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]","GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756"
"2569","Pocillopora_acuta_HIv2___RNAseq.g12498.t1",0,0,NA,0,0,0,0,0,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,7.83899717282492,8.93577621236778,7.64645383920312,7.40425219505693,7.51663604234707,6.75180294683743,6.49753832785703,7.86816093962977,7.8749016404062,5.84054469821112,7.41750640147414,7.74902992688222,7.08598287606606,174.998821825475,-0.507979502826931,0.726315107769817,0.295301843238934,0.542449309195826,"Q9Y4B6",0,"DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein)","B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]","GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756"
"2570","Pocillopora_acuta_HIv2___RNAseq.g24093.t1",1.66666666666667,0,0,0,3.92156862745098,0,0,0,0,NA,0.620915032679739,0,1.39705882352941,NA,NA,NA,NA,NA,NA,6.09390500287516,5.35078960182194,4.6464169258196,5.26613946623341,4.86250168289467,5.38419442015382,6.17913985854655,5.49643519805837,3.68233641306884,5.88338661330132,5.28452451827737,4.95631904454333,5.61272999201141,22.469181785194,0.477983635424399,0.946801457971933,0.270533828495127,0.514394806803407,"Q9Y4B6",5.96e-11,"DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein)","B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]","GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756"
"2571","Pocillopora_acuta_HIv2___RNAseq.g24097.t1",0,0,1.42857142857143,0,0,0,0,0,0,NA,0.158730158730159,0,0.357142857142857,NA,NA,NA,NA,NA,NA,8.51620237562004,3.68233641306884,7.56912417164875,4.62642457401022,6.72579711173906,9.49472232667328,3.68233641306884,6.6888369593493,7.53242220357841,4.40467075915833,6.29228733079151,7.40647656438711,5.1780980971959,153.212837031582,-1.00189526818781,1.8813921969228,0.000227042484663806,0.00167036749652965,"Q5F364",0,"Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)","cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908]","GO:0005524; GO:0006869; GO:0008559; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0070729"
"2572","Pocillopora_acuta_HIv2___RNAseq.g22137.t1",NA,0,20,5.55555555555556,5.55555555555556,2.12765957446809,3.2258064516129,NA,NA,NA,6.07742952286535,2.56107171000788,9.59378733572282,NA,NA,NA,NA,NA,NA,4.90080178660296,6.54125763453179,6.03454572419577,6.41389448441836,6.03856483543094,6.0412356346892,3.68233641306884,4.93729786847052,3.68233641306884,5.23798087003036,5.35102516645076,5.11870932555381,5.58334100734771,29.4876832899408,0.202812634494956,0.943156135996605,0.520634629651265,0.74470522975434,"Q8VHI4",4.86e-07,"Calcium-responsive transcription factor (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein) (Calcium-response factor) (CaRF)","cellular response to calcium ion [GO:0071277]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0001228; GO:0001652; GO:0003677; GO:0005634; GO:0006357; GO:0045944; GO:0071277"
